Citrus Sinensis ID: 044022
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 241 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LSV3 | 433 | Putative wall-associated | no | no | 0.900 | 0.501 | 0.336 | 3e-30 | |
| Q9LMN7 | 733 | Wall-associated receptor | no | no | 0.892 | 0.293 | 0.343 | 3e-29 | |
| Q9LMN6 | 738 | Wall-associated receptor | no | no | 0.892 | 0.291 | 0.339 | 5e-29 | |
| Q9LMN8 | 741 | Wall-associated receptor | no | no | 0.892 | 0.290 | 0.347 | 4e-28 | |
| Q39191 | 735 | Wall-associated receptor | no | no | 0.892 | 0.292 | 0.334 | 8e-28 | |
| Q9LMP1 | 732 | Wall-associated receptor | no | no | 0.858 | 0.282 | 0.336 | 8e-28 | |
| Q9M092 | 786 | Wall-associated receptor | no | no | 0.883 | 0.270 | 0.341 | 1e-27 | |
| Q0WNY5 | 793 | Wall-associated receptor | no | no | 0.896 | 0.272 | 0.341 | 1e-27 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.887 | 0.434 | 0.344 | 4e-27 | |
| O80795 | 372 | Probable inactive recepto | no | no | 0.921 | 0.596 | 0.326 | 4e-27 |
| >sp|Q9LSV3|WAKLS_ARATH Putative wall-associated receptor kinase-like 16 OS=Arabidopsis thaliana GN=WAKL16 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 132 bits (331), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 78/232 (33%), Positives = 131/232 (56%), Gaps = 15/232 (6%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-------RLK 69
IN + +Q++H +++K +GCCL+T +P+LV++ + G+L D + G+ RL+
Sbjct: 150 INEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFITGGSLFDHLHGSMFVSSLTWEHRLE 209
Query: 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
IA ++ ++AYLH G PI+ R+ KT+NIL +E AK DF S P + +TT
Sbjct: 210 IAIEVAGAIAYLHSGASIPIIHRDIKTENILLDENLTAKVADFGASKLKPMDKEQLTT-M 268
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLK 189
V GT GY PEY + +LNEKS+V+SFG L EL++G+ + +T H Y
Sbjct: 269 VQGTLGYLDPEYYTTWLLNEKSDVYSFGVVLMELISGQKALCFERPETSKH---LVSYFV 325
Query: 190 NYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
++ R I ++ + E ++++H +A++ +EC E+RP M++
Sbjct: 326 LATKENRLHEIIDDQVLNE----ENQREIHEAARVAVECTRLKGEERPRMIE 373
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9LMN7|WAK5_ARATH Wall-associated receptor kinase 5 OS=Arabidopsis thaliana GN=WAK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 128 bits (322), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 79/230 (34%), Positives = 127/230 (55%), Gaps = 15/230 (6%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-------RLK 69
IN + +Q++H +++K +GCCL+T +P+LV++ + GTL D + G+ RL+
Sbjct: 450 INEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLTWEHRLR 509
Query: 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
IA ++ +LAYLH PI+ R+ KT NIL +E AK DF S IP + +TT
Sbjct: 510 IAIEVAGTLAYLHSYASIPIIHRDVKTANILLDENLTAKVADFGASRLIPMDQEQLTT-M 568
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLK 189
V GT GY PEY + +LNEKS+V+SFG L ELL+G + + H Y
Sbjct: 569 VQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGEKALCFERPQSSKH---LVSYFV 625
Query: 190 NYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
+ +++ R I ++ + ++++ SA++ +EC E+RP+M
Sbjct: 626 SAMKENRLHEIIDGQVMNEY----NQREIQESARIAVECTRIMGEERPSM 671
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN6|WAK4_ARATH Wall-associated receptor kinase 4 OS=Arabidopsis thaliana GN=WAK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 127 bits (320), Expect = 5e-29, Method: Compositional matrix adjust.
Identities = 78/230 (33%), Positives = 126/230 (54%), Gaps = 15/230 (6%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-------RLK 69
IN + +Q++H +++K +GCCL+T +P+LV++ + GTL D + G+ RL+
Sbjct: 452 INEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLTWEHRLR 511
Query: 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
+A +I +LAYLH PI+ R+ KT NIL +E AK DF S IP + + T
Sbjct: 512 MAVEIAGTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASRLIPMDKEDLAT-M 570
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLK 189
V GT GY PEY + +LNEKS+V+SFG L ELL+G+ + T H Y
Sbjct: 571 VQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFERPQTSKH---IVSYFA 627
Query: 190 NYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
+ ++ R I ++ + ++++ +A++ +EC + E+RP M
Sbjct: 628 SATKENRLHEIIDGQVMNE----NNQREIQKAARIAVECTRLTGEERPGM 673
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN8|WAK3_ARATH Wall-associated receptor kinase 3 OS=Arabidopsis thaliana GN=WAK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 125 bits (313), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 80/230 (34%), Positives = 125/230 (54%), Gaps = 15/230 (6%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRD----CIFGAPLP---RLK 69
I+ + +Q++H +++K +GCCL+T +P+LV++ + GTL D IF + L RL+
Sbjct: 457 IHEVLVLSQINHRNVVKILGCCLETEVPLLVYEFITNGTLFDHLHGSIFDSSLTWEHRLR 516
Query: 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
IA ++ +LAYLH PI+ R+ KT NIL +E AK DF S IP + +TT
Sbjct: 517 IAIEVAGTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASKLIPMDKEQLTT-M 575
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLK 189
V GT GY PEY + +LNEKS+V+SFG L ELL+G+ + H Y
Sbjct: 576 VQGTLGYLDPEYYTTGLLNEKSDVYSFGVVLMELLSGQKALCFERPQASKH---LVSYFV 632
Query: 190 NYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
+ E+ R I ++ + + +++ +A++ EC E+RP M
Sbjct: 633 SATEENRLHEIIDDQVLNE----DNLKEIQEAARIAAECTRLMGEERPRM 678
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q39191|WAK1_ARATH Wall-associated receptor kinase 1 OS=Arabidopsis thaliana GN=WAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 124 bits (310), Expect = 8e-28, Method: Compositional matrix adjust.
Identities = 77/230 (33%), Positives = 123/230 (53%), Gaps = 15/230 (6%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-------RLK 69
IN + +Q++H +++K +GCCL+T +P+LV++ + GTL D + G+ + RLK
Sbjct: 451 INEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFITNGTLFDHLHGSMIDSSLTWEHRLK 510
Query: 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
IA ++ +LAYLH PI+ R+ KT NIL + AK DF S IP + + T
Sbjct: 511 IAIEVAGTLAYLHSSASIPIIHRDIKTANILLDVNLTAKVADFGASRLIPMDKEELET-M 569
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLK 189
V GT GY PEY + +LNEKS+V+SFG L ELL+G+ + + H Y
Sbjct: 570 VQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFKRPQSSKH---LVSYFA 626
Query: 190 NYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
++ R I ++ + + +++ +A++ EC E+RP M
Sbjct: 627 TATKENRLDEIIGGEVMNE----DNLKEIQEAARIAAECTRLMGEERPRM 672
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Required during plant's response to pathogen infection and in plant defense against heavy metal toxicity. Phosphorylates the oxygen-evolving enhancer protein 2 (OEE2) in an GRP-3-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMP1|WAK2_ARATH Wall-associated receptor kinase 2 OS=Arabidopsis thaliana GN=WAK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 124 bits (310), Expect = 8e-28, Method: Compositional matrix adjust.
Identities = 80/238 (33%), Positives = 128/238 (53%), Gaps = 31/238 (13%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-------RLK 69
IN + +Q++H +++K +GCCL+T +P+LV++ + GTL D + G+ RL+
Sbjct: 446 INEVLVLSQINHRNVVKVLGCCLETEVPLLVYEFINSGTLFDHLHGSLYDSSLTWEHRLR 505
Query: 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
IA+++ SLAYLH PI+ R+ KT NIL ++ AK DF S IP + +TT
Sbjct: 506 IATEVAGSLAYLHSSASIPIIHRDIKTANILLDKNLTAKVADFGASRLIPMDKEQLTTI- 564
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLK 189
V GT GY PEY + +LNEKS+V+SFG L ELL+G+ + CF +
Sbjct: 565 VQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKAL-----------CFERPHCP 613
Query: 190 NYL--------EDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
L ++ RF I ++ + + ++++ +A++ EC E+RP M
Sbjct: 614 KNLVSCFASATKNNRFHEIIDGQVMNE----DNQREIQEAARIAAECTRLMGEERPRM 667
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M092|WAKLM_ARATH Wall-associated receptor kinase-like 17 OS=Arabidopsis thaliana GN=WAKL17 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 123 bits (309), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 80/234 (34%), Positives = 127/234 (54%), Gaps = 21/234 (8%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTL-----------RDCIFGAPL 65
IN + +Q++H H++K +GCCL+T +PILV++ + G L I+G
Sbjct: 486 INEVVILSQINHRHVVKLLGCCLETEVPILVYEFIINGNLFKHIHEEEADDYTMIWGM-- 543
Query: 66 PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI 125
RL+IA DI +L+YLH PI R+ K+ NIL +E+ AK DF S S+ +TH
Sbjct: 544 -RLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHW 602
Query: 126 TTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFN 185
TT + GT GY PEY EKS+V+SFG L EL+ G + ++++T +
Sbjct: 603 TT-VISGTVGYVDPEYYRSSQYTEKSDVYSFGVILAELITGDKPVI-MVQNTQEI-IALA 659
Query: 186 EYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
E+ + ++++R + I I D K +Q+ A A L ++C+++ +RP M
Sbjct: 660 EHFRVAMKERRLSDIMDARIRDD----SKPEQVMAVANLAMKCLSSRGRNRPNM 709
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q0WNY5|WAKLN_ARATH Wall-associated receptor kinase-like 18 OS=Arabidopsis thaliana GN=WAKL18 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 123 bits (308), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 79/231 (34%), Positives = 126/231 (54%), Gaps = 15/231 (6%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP--------RL 68
IN + +Q++H H++K +GCCL+T +P+LV++ + G L I RL
Sbjct: 495 INEVVILSQINHRHVVKLLGCCLETEVPMLVYEFIINGNLFKHIHEEESDDYTMLWGMRL 554
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128
+IA DI +L+YLH PI R+ K+ NIL +E+ AK DF S S+ +TH TT
Sbjct: 555 RIAVDIAGALSYLHSSASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTT- 613
Query: 129 RVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYL 188
+ GT GY PEY EKS+V+SFG L EL+ G + ++++T + E+
Sbjct: 614 VISGTVGYVDPEYYQSSQYTEKSDVYSFGVILAELITGDKPVI-MVQNTQEI-VALAEHF 671
Query: 189 KNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
+ +++KR T I I D K +Q+ A A++ ++C+++ + RP M
Sbjct: 672 RVAMKEKRLTDIIDARIRNDC----KPEQVMAVAKVAMKCLSSKGKKRPNM 718
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 121 bits (304), Expect = 4e-27, Method: Compositional matrix adjust.
Identities = 79/229 (34%), Positives = 128/229 (55%), Gaps = 15/229 (6%)
Query: 20 ITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-----RLKIASDI 74
I + + H +++K +G C++ +LV++ + G+L + +F LP R+KIA
Sbjct: 197 INFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 256
Query: 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIP-EGETHITTDRVIGT 133
L++LH +P++ R+FKT NIL + + AK DF L+ P EG+TH++T RV+GT
Sbjct: 257 AKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVST-RVMGT 315
Query: 134 RGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLE 193
GY+APEY+ L KS+V+SFG L E+L GR + D + +H E+ + +L
Sbjct: 316 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM-DKNRPNGEHNLV--EWARPHLL 372
Query: 194 DK-RFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
DK RF + P + I+ Q++ QL +C++ P+ RP M D
Sbjct: 373 DKRRFYRLLDPRLEGHF-SIKGAQKV---TQLAAQCLSRDPKIRPKMSD 417
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O80795|Y1652_ARATH Probable inactive receptor-like protein kinase At1g65250 OS=Arabidopsis thaliana GN=At1g65250 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 121 bits (303), Expect = 4e-27, Method: Compositional matrix adjust.
Identities = 77/236 (32%), Positives = 126/236 (53%), Gaps = 14/236 (5%)
Query: 19 NITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNS 77
+I ++ +S H + +K +GCCL+ P++V+ SV+ + R+KIA DI +
Sbjct: 98 DIAVSSMVSGHKNFMKLVGCCLELDYPVMVYHSVKKHYKLEISEQPWKKRMKIAEDIATA 157
Query: 78 LAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYS 137
LAYLH FPRP V R NIL +E+ VAK DF +SIPEGET + DR +G Y
Sbjct: 158 LAYLHTAFPRPFVYRILSHWNILLDEDGVAKLTDFSHCVSIPEGETFVRVDRDVGLYSYF 217
Query: 138 APEYISICVLNEKSNVFSFGAFL-FELLAGRIHIWDLLKDTHDHG-----CFFNEYLKNY 191
A Y+ ++++K++VF+FG F+ LL G + ++ + + + +N
Sbjct: 218 ADNYVRSGLVSDKTDVFAFGIFMGHRLLLGYEYYFEHYRGEEEESEDGFDSLMKRHARNL 277
Query: 192 L----EDKRFTGIPAPIIVQDIPCIEKEQ--QLHASAQLTLECVNNSPEDRPTMVD 241
L ED+ I +++ + I +++ Q+ A +L+L C S E+ PTMV+
Sbjct: 278 LSTLKEDRPMEEIADSKMIEKMGQISEQERCQMKAFLKLSLRCTGPS-EEVPTMVE 332
|
Arabidopsis thaliana (taxid: 3702) |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 241 | ||||||
| 255582635 | 331 | receptor protein kinase, putative [Ricin | 0.941 | 0.685 | 0.422 | 1e-43 | |
| 224123144 | 344 | predicted protein [Populus trichocarpa] | 0.941 | 0.659 | 0.414 | 2e-43 | |
| 255542656 | 331 | serine-threonine protein kinase, plant-t | 0.954 | 0.694 | 0.421 | 4e-41 | |
| 255542668 | 307 | serine-threonine protein kinase, plant-t | 0.921 | 0.723 | 0.422 | 3e-40 | |
| 255542658 | 356 | serine-threonine protein kinase, plant-t | 0.929 | 0.629 | 0.424 | 8e-39 | |
| 255542662 | 330 | serine-threonine protein kinase, plant-t | 0.929 | 0.678 | 0.406 | 7e-38 | |
| 224065631 | 323 | predicted protein [Populus trichocarpa] | 0.896 | 0.668 | 0.406 | 8e-34 | |
| 359495254 | 331 | PREDICTED: wall-associated receptor kina | 0.912 | 0.664 | 0.407 | 2e-33 | |
| 297740943 | 321 | unnamed protein product [Vitis vinifera] | 0.912 | 0.685 | 0.407 | 3e-33 | |
| 255542676 | 247 | serine-threonine protein kinase, plant-t | 0.622 | 0.607 | 0.519 | 2e-32 |
| >gi|255582635|ref|XP_002532098.1| receptor protein kinase, putative [Ricinus communis] gi|223528232|gb|EEF30288.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 182 bits (461), Expect = 1e-43, Method: Compositional matrix adjust.
Identities = 101/239 (42%), Positives = 141/239 (58%), Gaps = 12/239 (5%)
Query: 13 YGSCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFG------APL 65
Y C N+I +A QMS H + LK +GCCL+T IP+LVF+ +EYGTL ++G PL
Sbjct: 85 YKYCYNDIMFATQMSKHKNFLKLLGCCLETQIPVLVFEPIEYGTLAGRLYGPNKTLYQPL 144
Query: 66 ---PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE 122
RLKIA +I N+++YLH F RPIV RN K NI +E +VAK DF L++SIPEGE
Sbjct: 145 LWRHRLKIAVEIANAVSYLHTAFSRPIVFRNIKPLNIFLDECHVAKLSDFSLAVSIPEGE 204
Query: 123 THITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGC 182
+H+ D + G G APEY NE +V++FG FL LL G+ + D +
Sbjct: 205 SHV-KDMLAGAWGLIAPEYAKTSCFNESQDVYNFGVFLLMLLTGQ-KVVDSYRPQAGEEL 262
Query: 183 FFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
+++K ++ D RF II+ + EK+QQL A L+ C++ + EDRP M+D
Sbjct: 263 GLVDHVKKFIADDRFYETVDSIILGEGSLPEKDQQLQAFTLLSFRCISEADEDRPMMID 321
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123144|ref|XP_002319005.1| predicted protein [Populus trichocarpa] gi|222857381|gb|EEE94928.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 181 bits (460), Expect = 2e-43, Method: Compositional matrix adjust.
Identities = 100/241 (41%), Positives = 144/241 (59%), Gaps = 14/241 (5%)
Query: 11 HTYGSCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----- 64
Y C N+I YA++MS H +K +GCCL+ IPILVF+ V TL D ++G+
Sbjct: 90 EQYEYCFNDIVYASKMSVHKSFMKLLGCCLEARIPILVFEYVGDWTLSDFLWGSEEARCQ 149
Query: 65 ----LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPE 120
+PR KIA D+ N++A+LH F +PIV RN K NIL ++ + AK DF +SISIP+
Sbjct: 150 PLLWIPRSKIAMDMANAVAFLHAAFSKPIVFRNIKPLNILLDDNHEAKLSDFSISISIPK 209
Query: 121 GETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDH 180
GE+H+ D V G G APEY++ NEK +VF+FG FL LL+G++ + D + +
Sbjct: 210 GESHV-RDSVAGATGLIAPEYLTTGNFNEKQDVFNFGVFLLVLLSGQMVV-DFSRPEKE- 266
Query: 181 GCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240
+++K +ED RF + I+ + KEQQL A L+L C++ EDRPTM+
Sbjct: 267 -ILLQDHVKKCIEDDRFNKVIDSTIIAEGTWPGKEQQLQAYTALSLRCISELAEDRPTMI 325
Query: 241 D 241
D
Sbjct: 326 D 326
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542656|ref|XP_002512391.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548352|gb|EEF49843.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 174 bits (440), Expect = 4e-41, Method: Compositional matrix adjust.
Identities = 100/237 (42%), Positives = 138/237 (58%), Gaps = 7/237 (2%)
Query: 9 HRHTYGSCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-- 65
++H +++I A++MS H ++LK +GCCL++ IPI VF+ E GTL D + L
Sbjct: 82 YKHPSEDPVSDIVIASEMSVHRNVLKLLGCCLESEIPIPVFEYAEKGTLEDYVQKTALLW 141
Query: 66 -PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH 124
RLKIA D+ + +AYLH FPRPIV R+ +IL +E+ AK F LSISIPEGETH
Sbjct: 142 KDRLKIAVDVASVIAYLHTAFPRPIVHRDISLASILLDEDCAAKVTGFSLSISIPEGETH 201
Query: 125 ITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFF 184
I D V GT GY APEY + NEK +V+SFG L LL G I H
Sbjct: 202 I-EDEVAGTIGYVAPEYFMKRMFNEKIDVYSFGVVLLVLLTGHGPILRSPTTNESHALVV 260
Query: 185 NEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
+++ ++++RF I P I+++ P EKEQQL + L ++C EDRP + D
Sbjct: 261 --FVEAKIKNERFNEIIDPAILEEGPWPEKEQQLKSFLTLAMQCTRKDEEDRPEITD 315
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542668|ref|XP_002512397.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548358|gb|EEF49849.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 171 bits (432), Expect = 3e-40, Method: Compositional matrix adjust.
Identities = 98/232 (42%), Positives = 141/232 (60%), Gaps = 10/232 (4%)
Query: 17 INNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP------RLK 69
IN+I +A++MS H ++LK +GCCL++ IPILVF+ + G L+D + RL+
Sbjct: 63 INDIVFASEMSVHKNVLKLLGCCLESKIPILVFECAQKGILKDYFYKTDSASLLWQIRLR 122
Query: 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
IA D+ + ++YLH FPRPIV R+ NIL +E+ +AK F LS+SIPEG+THI D
Sbjct: 123 IAVDVASVISYLHSAFPRPIVHRDITLSNILLDEDYIAKVTGFSLSMSIPEGKTHI-EDE 181
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLK 189
V+GT GY AP Y + NEK +V+SFG L LL G+ I L T ++K
Sbjct: 182 VVGTPGYLAPAYFKTLMFNEKIDVYSFGVLLLVLLTGQQPI--LHSPTTTARYSLVNFVK 239
Query: 190 NYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
+ED+RF I P+I+++ P EKE+QL L ++C + + EDRP + D
Sbjct: 240 EKIEDERFDEIIDPVILEEGPWPEKERQLEIFLTLAMQCTHENEEDRPEITD 291
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542658|ref|XP_002512392.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548353|gb|EEF49844.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 166 bits (420), Expect = 8e-39, Method: Compositional matrix adjust.
Identities = 107/252 (42%), Positives = 146/252 (57%), Gaps = 28/252 (11%)
Query: 17 INNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA------PL---P 66
IN+I +A++MS H ++LK +GCCL++ IPILVF+ E G L+D I+ PL
Sbjct: 93 INDIVFASEMSRHKNVLKLLGCCLESEIPILVFEYAEKGKLQDYIYKTDSASFRPLLWKS 152
Query: 67 RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT 126
RLKIA D N +AYLH PRP+V R+ NI +E+ VAK DF +S+SI EGETHI
Sbjct: 153 RLKIAVDAANVIAYLHTACPRPVVHRDITLSNIWLDEDYVAKVTDFTVSMSILEGETHI- 211
Query: 127 TDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHI---WD-LLKDTH---- 178
D V+GT GY+APEY+ + NEK +VFSFG L LL + W+ +LKD
Sbjct: 212 EDFVLGTCGYAAPEYVRSGIFNEKIDVFSFGVLLLVLLTDQKPFQGNWENILKDARFDEI 271
Query: 179 ------DHGCFF-NEYLKNYLEDKR--FTGIPAPIIVQDIPCIEKEQQLHASAQLTLECV 229
+ G + E L+ +L R PIIV++ P EKEQQL A L ++C+
Sbjct: 272 IGSLIVEKGLWSEKEQLETFLTRTRQKLDLTIDPIIVEEGPWPEKEQQLKAFLMLGVQCI 331
Query: 230 NNSPEDRPTMVD 241
+ E+RP + D
Sbjct: 332 DPDEENRPEITD 343
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542662|ref|XP_002512394.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548355|gb|EEF49846.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 163 bits (412), Expect = 7e-38, Method: Compositional matrix adjust.
Identities = 96/236 (40%), Positives = 135/236 (57%), Gaps = 12/236 (5%)
Query: 16 CINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFG------APLP-- 66
IN I YA+ MS H + +K +GCCL+TP PILVF+S + TL D I P+
Sbjct: 82 AINEIVYASAMSVHINSIKLLGCCLETPSPILVFESAKEKTLADRIIDRNDDHFEPVKWK 141
Query: 67 -RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI 125
RLKI +DI N + Y+H FPRPIV RN K NIL +E+ VAK DF L +SIPEG++ +
Sbjct: 142 LRLKIVADIANVVVYIHTAFPRPIVHRNIKASNILLDEDYVAKLSDFSLCVSIPEGKSRV 201
Query: 126 TTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFN 185
D + GT G A E ++ NEKS+V+SFG L +L G+ +D +
Sbjct: 202 -RDIMAGTMGLIASESLATGYFNEKSDVYSFGVVLLVVLTGQ-RSFDFSRTETGEQFLLV 259
Query: 186 EYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
++K ++E F + PIIV + K Q+L L L C+++S E+RPTM++
Sbjct: 260 NHVKKHIETGGFKEMVDPIIVAEEAGNRKGQELEDFRDLALRCIHDSAEERPTMIE 315
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224065631|ref|XP_002301893.1| predicted protein [Populus trichocarpa] gi|222843619|gb|EEE81166.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 149 bits (377), Expect = 8e-34, Method: Compositional matrix adjust.
Identities = 93/229 (40%), Positives = 129/229 (56%), Gaps = 13/229 (5%)
Query: 18 NNITYAAQMS-HNHILKRIGCCLQTPI-PILVFQSVEYGTLRDCIFGAPLP---RLKIAS 72
+I ++QMS HN++LK +GCCL+ P P LV++ E +L I LP RLKIA
Sbjct: 87 RDIVVSSQMSSHNNVLKLLGCCLEIPEGPALVYEYPENRSLDRHIHYGSLPWGTRLKIAK 146
Query: 73 DIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIG 132
+I N++AYLH FPRPI+ R+ K NI N+ AK DF SISIPEGE+ + D ++G
Sbjct: 147 EIANAVAYLHTAFPRPIIHRDIKPANIFLNQNYAAKLSDFSFSISIPEGESKVGDDLLVG 206
Query: 133 TRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYL 192
T G+ P+Y + EK++VFSFG L LL GR T E++K +
Sbjct: 207 TFGFLDPDYTMTNFVTEKTDVFSFGVLLLVLLTGRA--------TRQGEIHLIEHVKLLV 258
Query: 193 EDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
E R P+I + +QQL AS +L L C ++S EDRP M++
Sbjct: 259 EQDRVHEAVDPMIRGNGGEAIDQQQLEASIELALRCTDDSGEDRPLMIE 307
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359495254|ref|XP_002271826.2| PREDICTED: wall-associated receptor kinase-like 8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 148 bits (373), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 95/233 (40%), Positives = 130/233 (55%), Gaps = 13/233 (5%)
Query: 16 CINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-----RLK 69
IN I A+QMS H + LK +GCCL+T IPILV++ G+L D IF P P RL+
Sbjct: 90 AINEIVIASQMSAHKNALKLLGCCLETRIPILVYEFPSGGSLIDRIFSPPNPLSWKSRLR 149
Query: 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
IA DI N +AYLH FPR I+ + K + +++ AK DF LSI++PEGE H+ D
Sbjct: 150 IAYDIANVIAYLHIAFPRSIIHTDIKPSSFFLDQDCAAKLSDFSLSITLPEGEMHV-EDE 208
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG-RIHIWDLLKDTHDHGCFFNEYL 188
+ GT GY APE + V EK++VFSFG L ELL G R H H+ +Y
Sbjct: 209 IRGTFGYLAPETLISGVYTEKNDVFSFGILLLELLIGKRAH-----SIMHEERASIQDYA 263
Query: 189 KNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
++++ GI PII+ I +E Q A L + C ++RPT+V+
Sbjct: 264 QSFVNTYDINGIVDPIILAQPRGIHEELQFQAIFDLAMRCSMKDMDERPTIVN 316
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297740943|emb|CBI31255.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 147 bits (372), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 95/233 (40%), Positives = 130/233 (55%), Gaps = 13/233 (5%)
Query: 16 CINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-----RLK 69
IN I A+QMS H + LK +GCCL+T IPILV++ G+L D IF P P RL+
Sbjct: 82 AINEIVIASQMSAHKNALKLLGCCLETRIPILVYEFPSGGSLIDRIFSPPNPLSWKSRLR 141
Query: 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
IA DI N +AYLH FPR I+ + K + +++ AK DF LSI++PEGE H+ D
Sbjct: 142 IAYDIANVIAYLHIAFPRSIIHTDIKPSSFFLDQDCAAKLSDFSLSITLPEGEMHV-EDE 200
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG-RIHIWDLLKDTHDHGCFFNEYL 188
+ GT GY APE + V EK++VFSFG L ELL G R H H+ +Y
Sbjct: 201 IRGTFGYLAPETLISGVYTEKNDVFSFGILLLELLIGKRAH-----SIMHEERASIQDYA 255
Query: 189 KNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
++++ GI PII+ I +E Q A L + C ++RPT+V+
Sbjct: 256 QSFVNTYDINGIVDPIILAQPRGIHEELQFQAIFDLAMRCSMKDMDERPTIVN 308
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542676|ref|XP_002512401.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548362|gb|EEF49853.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 145 bits (365), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 81/156 (51%), Positives = 105/156 (67%), Gaps = 6/156 (3%)
Query: 17 INNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP----RLKIA 71
IN+I +A++MS H ++LK +GCCL++ IPILVF+ E G L D I+ RLKIA
Sbjct: 85 INDIVFASEMSRHKNVLKLLGCCLESEIPILVFEYAEKGNLHDYIYKTDSASFRRRLKIA 144
Query: 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVI 131
D N +AYLH FPRP+V R+ N+ +E++VAK DF LS+SIPEGETHI D V+
Sbjct: 145 VDAANVIAYLHTAFPRPVVHRHITLSNVWLDEDSVAKVTDFSLSMSIPEGETHI-EDFVM 203
Query: 132 GTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
GT GY+APEY + NEK +VFSFG L LL G+
Sbjct: 204 GTCGYAAPEYARSGIFNEKIDVFSFGVLLLVLLTGQ 239
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 241 | ||||||
| TAIR|locus:2076671 | 355 | AT3G57730 [Arabidopsis thalian | 0.904 | 0.614 | 0.353 | 3.3e-31 | |
| TAIR|locus:2076681 | 359 | AT3G57720 [Arabidopsis thalian | 0.970 | 0.651 | 0.330 | 5.4e-31 | |
| TAIR|locus:2094468 | 433 | AT3G25490 [Arabidopsis thalian | 0.900 | 0.501 | 0.336 | 4.9e-30 | |
| TAIR|locus:2076586 | 351 | AT3G57710 [Arabidopsis thalian | 0.941 | 0.646 | 0.327 | 2.1e-29 | |
| TAIR|locus:2014912 | 732 | WAK2 "wall-associated kinase 2 | 0.883 | 0.290 | 0.344 | 2.1e-28 | |
| TAIR|locus:2014962 | 733 | WAK5 "wall associated kinase 5 | 0.892 | 0.293 | 0.343 | 3.9e-28 | |
| TAIR|locus:2014952 | 738 | WAK4 "wall associated kinase 4 | 0.892 | 0.291 | 0.339 | 1.4e-27 | |
| TAIR|locus:2206235 | 372 | AT1G65250 [Arabidopsis thalian | 0.917 | 0.594 | 0.333 | 2.2e-27 | |
| TAIR|locus:2147805 | 493 | AT5G15080 [Arabidopsis thalian | 0.887 | 0.434 | 0.349 | 3e-27 | |
| TAIR|locus:2057770 | 424 | ARSK1 "root-specific kinase 1" | 0.946 | 0.537 | 0.333 | 3.5e-27 |
| TAIR|locus:2076671 AT3G57730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 343 (125.8 bits), Expect = 3.3e-31, P = 3.3e-31
Identities = 82/232 (35%), Positives = 128/232 (55%)
Query: 19 NITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRD----CIFGAP--LP---RL 68
+I +A+MS HN+ LK +GCCL+ P P+LVF+ E+G L + G LP RL
Sbjct: 112 DIVLSARMSNHNNFLKLLGCCLEFPFPVLVFEFAEHGVLNYRGGITVNGEESLLPLSLRL 171
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128
KI +I N+LAYLH FP+ I+ R+ K ++ + AK D SIS+ EG++ I +
Sbjct: 172 KIGKEIANALAYLHMAFPKIIIYRDVKPLHVFLDNNWTAKLSDLSFSISLEEGKSQIEAE 231
Query: 129 RVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYL 188
V+GT GY P Y + ++ E ++V+SFG FL ++ G I ++ D + G Y+
Sbjct: 232 DVLGTYGYLDPLYFATRIVTEYTDVYSFGVFLMVVITG-ISVYFTGSDGYPVGIL--GYM 288
Query: 189 KNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240
K E+ + I P+I++++ ++ Q+ A L L C EDRP M+
Sbjct: 289 KGLAENGKLNEIVYPMIMKEMTSAQR-LQVEACVLLALRCCEERVEDRPKMI 339
|
|
| TAIR|locus:2076681 AT3G57720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 341 (125.1 bits), Expect = 5.4e-31, P = 5.4e-31
Identities = 83/251 (33%), Positives = 135/251 (53%)
Query: 2 KFYGHEYHRHTYGSCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRD-- 58
+F ++ ++ N I +A+MS HN+ LK IG CL+ +P+LVF+ E+G L
Sbjct: 98 RFSEYKVTQYRVAEVYNEIVLSARMSNHNNFLKLIGFCLEFSLPVLVFEYAEHGVLNHRG 157
Query: 59 --CIFGAP--LP---RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFD 111
+ G LP RLKI +I N++ YLH FP+ ++ R+ K +N+ +E K D
Sbjct: 158 GVIVNGEEVILPLSLRLKIGKEIANAVTYLHMAFPKILIHRHIKPRNVFLDENWTPKLSD 217
Query: 112 FLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIW 171
F +SI++PEG++ I + V GT GY P Y + ++ E ++V+SFG FL +L G+
Sbjct: 218 FSISINLPEGKSRIEVECVQGTIGYLDPVYYTTKMVTEYTDVYSFGVFLMVILTGK---- 273
Query: 172 DLLKDTHDHGCFFN--EYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECV 229
L T G + + Y+K + E+ + G+ P +++DI +K + A L L C
Sbjct: 274 PALASTSSDGDYKHIASYVKGFHENGQLDGVIDPKVMEDITSAQKVH-VEACVVLALRCC 332
Query: 230 NNSPEDRPTMV 240
E+RP M+
Sbjct: 333 ELRDENRPKMI 343
|
|
| TAIR|locus:2094468 AT3G25490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 332 (121.9 bits), Expect = 4.9e-30, P = 4.9e-30
Identities = 78/232 (33%), Positives = 131/232 (56%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-------RLK 69
IN + +Q++H +++K +GCCL+T +P+LV++ + G+L D + G+ RL+
Sbjct: 150 INEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFITGGSLFDHLHGSMFVSSLTWEHRLE 209
Query: 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
IA ++ ++AYLH G PI+ R+ KT+NIL +E AK DF S P + +TT
Sbjct: 210 IAIEVAGAIAYLHSGASIPIIHRDIKTENILLDENLTAKVADFGASKLKPMDKEQLTT-M 268
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLK 189
V GT GY PEY + +LNEKS+V+SFG L EL++G+ + +T H Y
Sbjct: 269 VQGTLGYLDPEYYTTWLLNEKSDVYSFGVVLMELISGQKALCFERPETSKH---LVSYFV 325
Query: 190 NYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
++ R I ++ + E ++++H +A++ +EC E+RP M++
Sbjct: 326 LATKENRLHEIIDDQVLNE----ENQREIHEAARVAVECTRLKGEERPRMIE 373
|
|
| TAIR|locus:2076586 AT3G57710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 326 (119.8 bits), Expect = 2.1e-29, P = 2.1e-29
Identities = 79/241 (32%), Positives = 127/241 (52%)
Query: 10 RHTYGSCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRD----CIFGAP 64
RH N+I +A+MS H++ L+ +GCCL+ P P+LVF+ E+G + + G
Sbjct: 98 RHRVKEVYNDIVLSARMSNHSNFLQLLGCCLEFPFPVLVFEFAEHGAMNQRGGVIVNGEE 157
Query: 65 --LP---RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIP 119
LP RLKI +I N++ YLH FP+ I+ R+ K ++ ++ AK D SIS+P
Sbjct: 158 SLLPWSVRLKIGKEIANAVTYLHTAFPKIIIHRDVKPMHVFLDKNWTAKLSDLSFSISLP 217
Query: 120 EGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHD 179
EG++ I + V+GT GY P Y C + E ++V+SFG L ++ G+ I + D
Sbjct: 218 EGKSRIEAEWVLGTFGYIDPLYHKTCFVTEYTDVYSFGICLLVIITGKPAIMTI-SDGDL 276
Query: 180 HGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
G ++ E+ + + P +++DI ++ Q+ A L L C EDRP M
Sbjct: 277 QGIL--SLVRELCENGKLDEVIDPRLMKDITSGQR-LQVEACVVLALRCCKERDEDRPKM 333
Query: 240 V 240
+
Sbjct: 334 I 334
|
|
| TAIR|locus:2014912 WAK2 "wall-associated kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 312 (114.9 bits), Expect = 2.1e-28, Sum P(2) = 2.1e-28
Identities = 80/232 (34%), Positives = 129/232 (55%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-------RLK 69
IN + +Q++H +++K +GCCL+T +P+LV++ + GTL D + G+ RL+
Sbjct: 446 INEVLVLSQINHRNVVKVLGCCLETEVPLLVYEFINSGTLFDHLHGSLYDSSLTWEHRLR 505
Query: 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
IA+++ SLAYLH PI+ R+ KT NIL ++ AK DF S IP + +TT
Sbjct: 506 IATEVAGSLAYLHSSASIPIIHRDIKTANILLDKNLTAKVADFGASRLIPMDKEQLTTI- 564
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFN--EY 187
V GT GY PEY + +LNEKS+V+SFG L ELL+G+ + + H C N
Sbjct: 565 VQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKAL--CFERPH---CPKNLVSC 619
Query: 188 LKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
+ ++ RF I ++ + + ++++ +A++ EC E+RP M
Sbjct: 620 FASATKNNRFHEIIDGQVMNE----DNQREIQEAARIAAECTRLMGEERPRM 667
|
|
| TAIR|locus:2014962 WAK5 "wall associated kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 323 (118.8 bits), Expect = 3.9e-28, P = 3.9e-28
Identities = 79/230 (34%), Positives = 127/230 (55%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-------RLK 69
IN + +Q++H +++K +GCCL+T +P+LV++ + GTL D + G+ RL+
Sbjct: 450 INEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLTWEHRLR 509
Query: 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
IA ++ +LAYLH PI+ R+ KT NIL +E AK DF S IP + +TT
Sbjct: 510 IAIEVAGTLAYLHSYASIPIIHRDVKTANILLDENLTAKVADFGASRLIPMDQEQLTT-M 568
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLK 189
V GT GY PEY + +LNEKS+V+SFG L ELL+G + + H Y
Sbjct: 569 VQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGEKALCFERPQSSKH---LVSYFV 625
Query: 190 NYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
+ +++ R I ++ + ++++ SA++ +EC E+RP+M
Sbjct: 626 SAMKENRLHEIIDGQVMNEY----NQREIQESARIAVECTRIMGEERPSM 671
|
|
| TAIR|locus:2014952 WAK4 "wall associated kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 318 (117.0 bits), Expect = 1.4e-27, P = 1.4e-27
Identities = 78/230 (33%), Positives = 126/230 (54%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-------RLK 69
IN + +Q++H +++K +GCCL+T +P+LV++ + GTL D + G+ RL+
Sbjct: 452 INEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLTWEHRLR 511
Query: 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
+A +I +LAYLH PI+ R+ KT NIL +E AK DF S IP + + T
Sbjct: 512 MAVEIAGTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASRLIPMDKEDLAT-M 570
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLK 189
V GT GY PEY + +LNEKS+V+SFG L ELL+G+ + T H Y
Sbjct: 571 VQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFERPQTSKH---IVSYFA 627
Query: 190 NYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
+ ++ R I ++ + ++++ +A++ +EC + E+RP M
Sbjct: 628 SATKENRLHEIIDGQVMNE----NNQREIQKAARIAVECTRLTGEERPGM 673
|
|
| TAIR|locus:2206235 AT1G65250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 307 (113.1 bits), Expect = 2.2e-27, P = 2.2e-27
Identities = 79/237 (33%), Positives = 128/237 (54%)
Query: 19 NITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-RLKIASDIVN 76
+I ++ +S H + +K +GCCL+ P++V+ SV+ + I P R+KIA DI
Sbjct: 98 DIAVSSMVSGHKNFMKLVGCCLELDYPVMVYHSVKKHYKLE-ISEQPWKKRMKIAEDIAT 156
Query: 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGY 136
+LAYLH FPRP V R NIL +E+ VAK DF +SIPEGET + DR +G Y
Sbjct: 157 ALAYLHTAFPRPFVYRILSHWNILLDEDGVAKLTDFSHCVSIPEGETFVRVDRDVGLYSY 216
Query: 137 SAPEYISICVLNEKSNVFSFGAFL-FELLAGRIHIWDLLKDTHDHG-----CFFNEYLKN 190
A Y+ ++++K++VF+FG F+ LL G + ++ + + + +N
Sbjct: 217 FADNYVRSGLVSDKTDVFAFGIFMGHRLLLGYEYYFEHYRGEEEESEDGFDSLMKRHARN 276
Query: 191 YL----EDKRFTGIPAPIIVQDIPCIEKEQ--QLHASAQLTLECVNNSPEDRPTMVD 241
L ED+ I +++ + I +++ Q+ A +L+L C S E+ PTMV+
Sbjct: 277 LLSTLKEDRPMEEIADSKMIEKMGQISEQERCQMKAFLKLSLRCTGPS-EEVPTMVE 332
|
|
| TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 309 (113.8 bits), Expect = 3.0e-27, P = 3.0e-27
Identities = 80/229 (34%), Positives = 129/229 (56%)
Query: 20 ITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF--GAPLP---RLKIASDI 74
I + + H +++K +G C++ +LV++ + G+L + +F PLP R+KIA
Sbjct: 197 INFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 256
Query: 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIP-EGETHITTDRVIGT 133
L++LH +P++ R+FKT NIL + + AK DF L+ P EG+TH++T RV+GT
Sbjct: 257 AKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVST-RVMGT 315
Query: 134 RGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLE 193
GY+APEY+ L KS+V+SFG L E+L GR + D + +H E+ + +L
Sbjct: 316 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM-DKNRPNGEHNLV--EWARPHLL 372
Query: 194 DKR-FTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
DKR F + P + I+ Q++ QL +C++ P+ RP M D
Sbjct: 373 DKRRFYRLLDPRLEGHFS-IKGAQKV---TQLAAQCLSRDPKIRPKMSD 417
|
|
| TAIR|locus:2057770 ARSK1 "root-specific kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 305 (112.4 bits), Expect = 3.5e-27, P = 3.5e-27
Identities = 83/249 (33%), Positives = 132/249 (53%)
Query: 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI 60
+ +GH+ HR + I + Q+S+ H++K IG C + +LV++ + G+L + +
Sbjct: 125 LDLHGHQGHREW----LAEILFLGQLSNKHLVKLIGFCCEEEQRVLVYEYMPRGSLENQL 180
Query: 61 FGA-PLP-----RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLL 114
F L R+KIA LA+LH +P++ R+FKT NIL + + AK DF L
Sbjct: 181 FRRNSLAMAWGIRMKIALGAAKGLAFLHEA-EKPVIYRDFKTSNILLDSDYNAKLSDFGL 239
Query: 115 SISIPEGE-THITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDL 173
+ PEGE TH+TT RV+GT+GY+APEYI L ++V+SFG L EL+ G+ + D
Sbjct: 240 AKDGPEGEHTHVTT-RVMGTQGYAAPEYIMTGHLTTMNDVYSFGVVLLELITGKRSM-DN 297
Query: 174 LKDTHDHGCFFNEYLKNYLEDKR-FTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNS 232
+ + E+ + L D+R I P + K + +A L +C++
Sbjct: 298 TRTRREQSLV--EWARPMLRDQRKLERIIDPRLANQ----HKTEAAQVAASLAYKCLSQH 351
Query: 233 PEDRPTMVD 241
P+ RPTM +
Sbjct: 352 PKYRPTMCE 360
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 241 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-20 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-18 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-17 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-17 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-15 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-13 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-13 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-12 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-12 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-11 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-10 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-10 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-08 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-08 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-08 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-08 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-08 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-08 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-07 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-07 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-07 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-07 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-07 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-06 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-06 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-06 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-06 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-06 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-06 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-06 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-05 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-05 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-05 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-05 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-05 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-05 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-05 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-04 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-04 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-04 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-04 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-04 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-04 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-04 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-04 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-04 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-04 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-04 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-04 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-04 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-04 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-04 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.001 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 0.001 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.001 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 0.001 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 0.001 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 0.001 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.001 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 0.002 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 0.002 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 0.002 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.002 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 0.002 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 0.002 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.002 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 0.002 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 0.002 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 0.003 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 0.003 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 0.003 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.004 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 0.004 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 0.004 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 3e-20
Identities = 49/182 (26%), Positives = 81/182 (44%), Gaps = 16/182 (8%)
Query: 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI 60
+K E + I +++H +I+K G LV + E G+L+D +
Sbjct: 23 IKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLL 82
Query: 61 --FGAPLP---RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEEN-VAKWFDFLL 114
L L+I I+ L YLH I+ R+ K +NIL + +N K DF L
Sbjct: 83 KENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGL 139
Query: 115 SISIPEGETHITTDRVIGTRGYSAPEYI-SICVLNEKSNVFSFGAFLFELLAGRIHIWDL 173
S + ++ ++GT Y APE + +EKS+++S G L+EL + DL
Sbjct: 140 SKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----PELKDL 193
Query: 174 LK 175
++
Sbjct: 194 IR 195
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (199), Expect = 4e-18
Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 40/227 (17%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI--FGAPLP---RLKIASDIVNSLA 79
++SH +I++ +G C Q +V + + G L D + G L L++A I +
Sbjct: 57 KLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116
Query: 80 YLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRG---Y 136
YL + V R+ +N L E V K DF LS I E + + G + +
Sbjct: 117 YLES---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG---GGKLPIKW 170
Query: 137 SAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLED- 194
APE + KS+V+SFG L+E+ G + NE + LED
Sbjct: 171 MAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS----------NEEVLELLEDG 220
Query: 195 KRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
R +P P ++ P +L+ +L L+C PEDRPT +
Sbjct: 221 YR---LPRP---ENCP-----DELY---ELMLQCWAYDPEDRPTFSE 253
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 3e-17
Identities = 51/223 (22%), Positives = 87/223 (39%), Gaps = 31/223 (13%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI--FGAPLP---RLKIASDIVNSL 78
++ H +++K +G C + +V + +E G L + L L A I +
Sbjct: 56 RKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115
Query: 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSA 138
YL + + R+ +N L E V K DF LS + + + + + R + A
Sbjct: 116 EYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR-WMA 171
Query: 139 PEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFT 198
PE + KS+V+SFG L+E+ + + NE + YL++
Sbjct: 172 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS---------NEEVLEYLKNGYRL 222
Query: 199 GIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
P P ++ L L+C PEDRPT +
Sbjct: 223 PQP-PNCPPEL------------YDLMLQCWAEDPEDRPTFSE 252
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 5e-17
Identities = 51/224 (22%), Positives = 87/224 (38%), Gaps = 32/224 (14%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF---GAPLP---RLKIASDIVNS 77
++ H +I+K +G C + ++V + + G L D + L L A I
Sbjct: 56 RKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 78 LAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYS 137
+ YL + + R+ +N L E V K DF LS + + + + + R +
Sbjct: 116 MEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR-WM 171
Query: 138 APEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRF 197
APE + KS+V+SFG L+E+ + + N + YL+
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS---------NAEVLEYLKKGYR 222
Query: 198 TGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
P P ++ +L L+C PEDRPT +
Sbjct: 223 LPKP-PNCPPEL------------YKLMLQCWAEDPEDRPTFSE 253
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 5e-15
Identities = 59/236 (25%), Positives = 92/236 (38%), Gaps = 50/236 (21%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRD------CIFGAPLP-------RLKIA 71
++ H ++++ +G C + LV + +E G L D +F +P L A
Sbjct: 52 KLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFA 111
Query: 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVI 131
I + YL + V R+ +N L E+ V K DF LS + + + +
Sbjct: 112 IQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK---- 164
Query: 132 GTRGYS-----APEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFN 185
T G APE + + KS+V+SFG L+E+ G L N
Sbjct: 165 -TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS----------N 213
Query: 186 EYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
E + YL +P P D +L+ +L L C PEDRPT +
Sbjct: 214 EEVLEYLRKGYR--LPKPEYCPD--------ELY---ELMLSCWQLDPEDRPTFSE 256
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 2e-13
Identities = 41/147 (27%), Positives = 67/147 (45%), Gaps = 10/147 (6%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI---FGAPLPRLK-IASDIVNSLAY 80
++ H +I++ LV + E G L D + + I+++L Y
Sbjct: 53 KLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEY 112
Query: 81 LHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPE 140
LH + IV R+ K +NIL +E+ K DF L+ + GE T +GT Y APE
Sbjct: 113 LH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT---FVGTPEYMAPE 166
Query: 141 YISICVLNEKSNVFSFGAFLFELLAGR 167
+ + +++S G L+ELL G+
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-13
Identities = 41/161 (25%), Positives = 65/161 (40%), Gaps = 23/161 (14%)
Query: 18 NNITYAAQMSHNHILKRIGCC--LQTPIPILVFQSVEYGTLRDCIFGAPLPR-------- 67
I + H +I+K G C L+ + + G+LRD L R
Sbjct: 55 REIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDY-----LQRHRDQINLK 109
Query: 68 --LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI 125
L +S I + YL + + R+ +NIL E++ K DF L+ +PE + +
Sbjct: 110 RLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYY 166
Query: 126 T--TDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164
Y APE + + S+V+SFG L+EL
Sbjct: 167 YVKEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 65.1 bits (157), Expect = 3e-12
Identities = 53/230 (23%), Positives = 89/230 (38%), Gaps = 29/230 (12%)
Query: 27 SHNHILKRIGCCLQTPIPILVFQSVEYGTLRD----CIFGAPLP---RLKIASDIVNSLA 79
+I+K LV + V+ G+L D PL L I + I+++L
Sbjct: 56 HPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115
Query: 80 YLHFGFPRPIVLRNFKTQNILFNEE-NVAKWFDFLLSISIPEGETHITTDR----VIGTR 134
YLH + I+ R+ K +NIL + + V K DF L+ +P+ + + +GT
Sbjct: 116 YLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 135 GYSAPEYISICVLNE---KSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNY 191
GY APE + L S+++S G L+ELL G
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP-----------PFEGEKNSSATS 221
Query: 192 LEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
K +P P + + E A++ L + + P++R +
Sbjct: 222 QTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 5e-12
Identities = 53/161 (32%), Positives = 71/161 (44%), Gaps = 20/161 (12%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF-GAPLP---RLKIAS 72
I ++SH +I++ I LV + E G L D + G PL KIA
Sbjct: 46 RREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIAL 105
Query: 73 DIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIG 132
I+ L YLH I+ R+ K +NIL +E V K DF L+ + T V G
Sbjct: 106 QILRGLEYLH---SNGIIHRDLKPENILLDENGVVKIADFGLA-KKLLKSSSSLTTFV-G 160
Query: 133 TRGYSAPEYISICVLNE------KSNVFSFGAFLFELLAGR 167
T Y APE VL K +V+S G L+ELL G+
Sbjct: 161 TPWYMAPE-----VLLGGNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 7e-12
Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 11/164 (6%)
Query: 15 SCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI--FGAPLPRLKIA- 71
S + I + H +I+K IG + ++ + E G+LR I FG P P +A
Sbjct: 45 SIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG-PFPESLVAV 103
Query: 72 --SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
++ LAYLH + ++ R+ K NIL ++ V K DF ++ + +
Sbjct: 104 YVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDAS 158
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDL 173
V+GT + APE I + + S+++S G + ELL G +DL
Sbjct: 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL 202
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-11
Identities = 44/151 (29%), Positives = 72/151 (47%), Gaps = 21/151 (13%)
Query: 26 MSHNHILKRIGCCLQT--PIPILVFQSVEYGTLRDCIFGAPLPRLKI--------ASDIV 75
+ H +I+K GCC + L+ + V G+LRD LP+ K+ A I
Sbjct: 63 LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDY-----LPKHKLNLAQLLLFAQQIC 117
Query: 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRG 135
+AYLH + + R+ +N+L + + + K DF L+ ++PEG + R G
Sbjct: 118 EGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV-REDGDSP 173
Query: 136 --YSAPEYISICVLNEKSNVFSFGAFLFELL 164
+ A E + + S+V+SFG L+ELL
Sbjct: 174 VFWYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 1e-10
Identities = 42/156 (26%), Positives = 70/156 (44%), Gaps = 11/156 (7%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI--FGAPLPRLKIA--- 71
IN I + H +I+K G L+ +V + G+L+D + L +IA
Sbjct: 45 INEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVC 104
Query: 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVI 131
+++ L YLH I+ R+ K NIL + K DF LS + + ++
Sbjct: 105 KELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMV 158
Query: 132 GTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
GT + APE I+ + K++++S G EL G+
Sbjct: 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 2e-10
Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 16/161 (9%)
Query: 25 QMSHNHILKRIGCCLQ-TPIPILVFQSVEY---GTLRDCI--FGAPLPRLKIAS---DIV 75
+ H +I++ G + +F EY G+L + FG LP I I+
Sbjct: 55 SLQHPNIVRYYGSERDEEKNTLNIFL--EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQIL 111
Query: 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRG 135
LAYLH IV R+ K NIL + + V K DF + + + ET T V GT
Sbjct: 112 EGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168
Query: 136 YSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKD 176
+ APE I ++++S G + E+ G+ W L +
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMATGK-PPWSELGN 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-09
Identities = 37/158 (23%), Positives = 70/158 (44%), Gaps = 11/158 (6%)
Query: 16 CINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI---FGAPLPR---LK 69
I+ A++ ++I++ L +V + E G L + G PLP +
Sbjct: 46 AIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWR 105
Query: 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
I+ LA+LH + I+ R+ K+ N+ + + K D ++ + + +
Sbjct: 106 FFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANT 160
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
++GT Y +PE NEKS+V++ G L+E G+
Sbjct: 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-09
Identities = 39/151 (25%), Positives = 75/151 (49%), Gaps = 12/151 (7%)
Query: 25 QMSHNHILKRIGCCLQ-TPIPILVFQSVEYGTLRDCIFG-----APLPRLKIASDIVNSL 78
++SH +++ G C + +PI LVF+ +E+G L D + + L + D+ +
Sbjct: 55 KLSHPKLVQLYGVCTERSPI-CLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGM 113
Query: 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSA 138
AYL ++ R+ +N L E V K DF ++ + + + +T + +S+
Sbjct: 114 AYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK-WSS 169
Query: 139 PEYISICVLNEKSNVFSFGAFLFELLA-GRI 168
PE S + KS+V+SFG ++E+ + G+
Sbjct: 170 PEVFSFSKYSSKSDVWSFGVLMWEVFSEGKT 200
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 7/107 (6%)
Query: 62 GAPLPRLKI-ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPE 120
G P R A+ I+ L +LH R IV R+ K +N+L ++ + D L++ +
Sbjct: 91 GFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG 147
Query: 121 GETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
G+ R GT GY APE + V + + F+ G L+E++AGR
Sbjct: 148 GKK--IKGRA-GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 2e-08
Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 5/98 (5%)
Query: 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
A++IV +L YLH I+ R+ K +NIL + + K DF L+ + + T
Sbjct: 98 YAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-- 152
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
GT Y APE + + + +S G L+E+L G+
Sbjct: 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-08
Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 19/153 (12%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTL--------RDCIFGAPLPRLKIASDIVN 76
+ H ++++ +G LQ +V + + G+L R I A L A D+
Sbjct: 56 TLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQ--LGFALDVCE 113
Query: 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGY 136
+ YL + V R+ +N+L +E+ VAK DF L+ E + ++ +
Sbjct: 114 GMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLA---KEASQGQDSGKL--PVKW 165
Query: 137 SAPEYISICVLNEKSNVFSFGAFLFELLA-GRI 168
+APE + + KS+V+SFG L+E+ + GR+
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-08
Identities = 46/154 (29%), Positives = 65/154 (42%), Gaps = 23/154 (14%)
Query: 27 SHNHILKRIGCCL---QTPIPILVFQSVEYGTLRDCIFGAPLPR---------LKIASDI 74
+I+K G L + I I + + E G+L D I+ R KIA +
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAM-EYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESV 114
Query: 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRV-IGT 133
+ L+YLH R I+ R+ K NIL + K DF +S GE + GT
Sbjct: 115 LKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLAGTFTGT 166
Query: 134 RGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
Y APE I + S+V+S G L E+ R
Sbjct: 167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-08
Identities = 43/191 (22%), Positives = 79/191 (41%), Gaps = 40/191 (20%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI----------FGAPLPR------- 67
Q++H H++K G C Q +L+ + +YG+LR + G+ R
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 68 -----------LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSI 116
+ A I + YL +V R+ +N+L E K DF LS
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 117 SIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL--LAGRIH----- 169
+ E ++++ + + A E + + +S+V+SFG L+E+ L G +
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235
Query: 170 --IWDLLKDTH 178
+++LLK +
Sbjct: 236 ERLFNLLKTGY 246
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-08
Identities = 50/222 (22%), Positives = 84/222 (37%), Gaps = 31/222 (13%)
Query: 20 ITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIAS---DIVN 76
IT +Q ++ K G L+ ++ + + G+ D + P +IA+ +I+
Sbjct: 53 ITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILK 112
Query: 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGY 136
L YLH + R+ K N+L +E+ K DF ++ + +T I + +GT +
Sbjct: 113 GLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFW 167
Query: 137 SAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKR 196
APE I + K++++S G EL G D H F
Sbjct: 168 MAPEVIQQSAYDSKADIWSLGITAIELAKGE----PPNSDMHPMRVLFL----------- 212
Query: 197 FTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238
P + + KE C+N P RPT
Sbjct: 213 IPKNNPPTLTGEFSKPFKE--------FIDACLNKDPSFRPT 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 6e-08
Identities = 52/225 (23%), Positives = 93/225 (41%), Gaps = 36/225 (16%)
Query: 26 MSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI----FGA-PLPRL-KIASDIVNSLA 79
+ H ++++ G L P+ ++V + G+L D + G + L A I N +
Sbjct: 53 LDHENLIRLYGVVLTHPL-MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR 111
Query: 80 YLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD---RVIGTRGY 136
YL + + R+ +NIL ++ K DF L ++P+ E H + +V +
Sbjct: 112 YLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAW 166
Query: 137 SAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKR 196
APE + + S+V+ FG L+E+ W G ++ LK DK
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPW--------AGLSGSQILKKI--DKE 216
Query: 197 FTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
+ P + P Q ++ + L+C ++P DRPT
Sbjct: 217 GERLERP---EACP-----QDIY---NVMLQCWAHNPADRPTFAA 250
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 7e-08
Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 4/102 (3%)
Query: 68 LKIASDIVNSLAYLHFG-FPRPIVL-RNFKTQNILFNEENVAKWFDFLLSISIPEGETHI 125
+I + ++ +L H P VL R+ K NI + N K DF L+ + +
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167
Query: 126 TTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
T +GT Y +PE ++ +EKS+++S G ++EL A
Sbjct: 168 KT--YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 9e-08
Identities = 29/116 (25%), Positives = 55/116 (47%), Gaps = 21/116 (18%)
Query: 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDF-----LLSISIPEGETH 124
A++I+ +L YLH + I+ R+ K +NIL +++ K DF L S PE
Sbjct: 107 YAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163
Query: 125 ITTDRV-------------IGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
T+ +GT Y +PE ++ + S++++ G ++++L G+
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-07
Identities = 53/219 (24%), Positives = 92/219 (42%), Gaps = 55/219 (25%)
Query: 37 CCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKI------ASDIVNSLAYLHFGFPRPIV 90
C L+ PI I V + ++YG+L + + G LK+ A+ + + +AYL + +
Sbjct: 70 CTLEEPIYI-VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYI 125
Query: 91 LRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTR---GYSAPEYISICVL 147
R+ +N+L E N+ K DF L+ I E G + ++APE
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRF 181
Query: 148 NEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIV 206
+ KS+V+SFG L E++ GR+ + G+ ++
Sbjct: 182 SIKSDVWSFGILLTEIVTYGRM---------------------------PYPGMTNAEVL 214
Query: 207 QDI------PCIEK-EQQLHASAQLTLECVNNSPEDRPT 238
Q + PC ++L+ + L+C P+DRPT
Sbjct: 215 QQVDQGYRMPCPPGCPKELY---DIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 41/151 (27%), Positives = 67/151 (44%), Gaps = 19/151 (12%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-LPRLKI---ASDIVNSLA 79
AQ+ H I++ IG C P+ +LV + G L + +P + A + +A
Sbjct: 51 AQLDHPCIVRLIGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMA 109
Query: 80 YL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTR-- 134
YL HF V R+ +N+L + AK DF +S ++ G + R
Sbjct: 110 YLESKHF------VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT--AGRWP 161
Query: 135 -GYSAPEYISICVLNEKSNVFSFGAFLFELL 164
+ APE I+ + KS+V+S+G L+E
Sbjct: 162 LKWYAPECINYGKFSSKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-07
Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 7/155 (4%)
Query: 15 SCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI---FGAPLPRLKIA 71
+ N +SH +I++ L+ ++V + GTL + I + L I
Sbjct: 45 AAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTIL 104
Query: 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNE-ENVAKWFDFLLSISIPEGETHITTDRV 130
V L LH + I+ R+ KTQNIL ++ + V K DF +S + T V
Sbjct: 105 HFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---V 161
Query: 131 IGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165
+GT Y +PE N+KS++++ G L+EL +
Sbjct: 162 VGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-07
Identities = 48/167 (28%), Positives = 69/167 (41%), Gaps = 39/167 (23%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTL--------RDCIFGAPLPR-------- 67
H +I+K G C + PI+VF+ +E+G L D F
Sbjct: 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 68 --LKIASDIVNSLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE 122
L+IA I + + YL HF V R+ T+N L + V K DF +S +
Sbjct: 123 QLLQIAVQIASGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDV---- 172
Query: 123 THITTD--RVIGTR----GYSAPEYISICVLNEKSNVFSFGAFLFEL 163
TTD RV G + PE I +S+V+SFG L+E+
Sbjct: 173 --YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-07
Identities = 50/224 (22%), Positives = 93/224 (41%), Gaps = 43/224 (19%)
Query: 26 MSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFG-----APLPRL-KIASDIVNSLA 79
+ H+ ++K + PI I+ + + G+L D + PLP+L ++ I +A
Sbjct: 58 LQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 116
Query: 80 YLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAP 139
++ R + R+ + NIL + V K DF L+ I + E + + ++AP
Sbjct: 117 FIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAP 172
Query: 140 EYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFT 198
E I+ KS+V+SFG L E++ GRI +
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRI---------------------------PYP 205
Query: 199 GIPAPIIVQDIPCIEKEQQLHASAQ----LTLECVNNSPEDRPT 238
G+ P +++ + + + + + + C N PE+RPT
Sbjct: 206 GMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 2e-07
Identities = 34/106 (32%), Positives = 50/106 (47%), Gaps = 15/106 (14%)
Query: 70 IASDIVNSLAYLH-FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLS--------ISIPE 120
++IV +L YLH G I+ R+ K NIL + K DF LS I++ +
Sbjct: 98 YIAEIVLALEYLHSNG----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153
Query: 121 GETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
E R++GT Y APE I ++ + +S G L+E L G
Sbjct: 154 DEKEDK--RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-07
Identities = 40/151 (26%), Positives = 70/151 (46%), Gaps = 13/151 (8%)
Query: 26 MSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI--FGAPLPRL---KIASDIVNSLAY 80
+ H +I++ +G CL + + V G++ + FG PLP K I++ +AY
Sbjct: 59 LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAY 117
Query: 81 LHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVI----GTRGY 136
LH +V R+ K N++ + K DF + + H T ++ GT +
Sbjct: 118 LH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 137 SAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
APE I+ KS+++S G +FE+ G+
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-07
Identities = 44/165 (26%), Positives = 65/165 (39%), Gaps = 28/165 (16%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGT 133
IV++++Y+H I+ R+ KT NI + + K DF +S + + T V+GT
Sbjct: 110 IVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164
Query: 134 RGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLE 193
Y +PE N KS++++ G L+ELL LK T D N +K
Sbjct: 165 PYYMSPELCQGVKYNFKSDIWALGCVLYELLT--------LKRTFDATNPLNLVVK---- 212
Query: 194 DKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238
IVQ L + PE RPT
Sbjct: 213 -----------IVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPT 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-07
Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 15/149 (10%)
Query: 26 MSHNH-ILKRIGCCLQTPIPIL-VFQSVEYGTLRDCI-----FGAPLPRLKIASDIVNSL 78
++ NH L ++ CC QTP + V + V G L I F R A++I ++L
Sbjct: 51 LARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSAL 109
Query: 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDF-LLSISIPEGETHITTDRVIGTRGYS 137
+LH + I+ R+ K N+L + E K DF + I G TT GT Y
Sbjct: 110 MFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---KTTSTFCGTPDYI 163
Query: 138 APEYISICVLNEKSNVFSFGAFLFELLAG 166
APE + + + ++ G L+E+L G
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-07
Identities = 43/139 (30%), Positives = 63/139 (45%), Gaps = 16/139 (11%)
Query: 37 CCLQTPIPILVFQSVEYGTLRDCIFGA------PLPRLKI-ASDIVNSLAYLHFGFPRPI 89
C QT +F +EY D +F PR + A++IV L +LH R I
Sbjct: 63 SCFQTKDR--LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH---ERGI 117
Query: 90 VLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-ITTDRVIGTRGYSAPEYISICVLN 148
+ R+ K N+L + E K DF + EG +TT GT Y APE +S
Sbjct: 118 IYRDLKLDNVLLDSEGHIKIADFGMC---KEGILGGVTTSTFCGTPDYIAPEILSYQPYG 174
Query: 149 EKSNVFSFGAFLFELLAGR 167
+ ++ G L+E+LAG+
Sbjct: 175 PAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 4e-07
Identities = 28/98 (28%), Positives = 44/98 (44%), Gaps = 6/98 (6%)
Query: 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
+IV +L YLH + I+ R+ K NIL +E+ DF ++ + T
Sbjct: 105 WICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTS 158
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
GT GY APE + + + +S G +E L G+
Sbjct: 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-07
Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 22/163 (13%)
Query: 22 YAAQMSHNHILKRI--------GCCLQTPIPI-LVFQSVEYGTLRDCIF-------GAPL 65
Y M IL ++ QT + LV + G LR I+ G P
Sbjct: 37 YEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPE 96
Query: 66 PR-LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH 124
PR + I++ L +LH R I+ R+ K +N+L + + + D L++ + +G++
Sbjct: 97 PRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS- 152
Query: 125 ITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
T GT G+ APE + + + F+ G L+E++A R
Sbjct: 153 -KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-07
Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 8/150 (5%)
Query: 20 ITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIAS---DIVN 76
IT +Q ++ K G L+ ++ + + G+ D + PL +IA+ +I+
Sbjct: 53 ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILK 112
Query: 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGY 136
L YLH + R+ K N+L +E K DF ++ + +T I + +GT +
Sbjct: 113 GLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFW 167
Query: 137 SAPEYISICVLNEKSNVFSFGAFLFELLAG 166
APE I + K++++S G EL G
Sbjct: 168 MAPEVIKQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-07
Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 39/227 (17%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTL------RDCIFGAPLPRLKIASDIVNSL 78
Q SH++I++ G + +++ + +E G L D F + + + I +
Sbjct: 62 QFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEF-SSYQLVGMLRGIAAGM 120
Query: 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISI---PEGETHITTDRVIGTRG 135
YL V R+ +NIL N K DF LS + PEG T+ T+ I R
Sbjct: 121 KYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG-TYTTSGGKIPIR- 175
Query: 136 YSAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLED 194
++APE I+ S+V+SFG ++E+++ G WD+ +E +K +
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---------HEVMKAINDG 226
Query: 195 KRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
R +PAP+ D P A QL L+C RP VD
Sbjct: 227 FR---LPAPM---DCP--------SAVYQLMLQCWQQDRARRPRFVD 259
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-07
Identities = 25/80 (31%), Positives = 45/80 (56%), Gaps = 3/80 (3%)
Query: 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLN 148
IV R+ K +N+L +++ + D L++ + +G+T T R GT GY APE + +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRA-GTNGYMAPEILKEEPYS 172
Query: 149 EKSNVFSFGAFLFELLAGRI 168
+ F+ G ++E++AGR
Sbjct: 173 YPVDWFAMGCSIYEMVAGRT 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 8e-07
Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRV 130
A++I+ L ++H F +V R+ K NIL +E + D L+ + + H +
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 155
Query: 131 IGTRGYSAPEYISICVLNEKS-NVFSFGAFLFELLAG 166
+GT GY APE + V + S + FS G LF+LL G
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 9e-07
Identities = 33/98 (33%), Positives = 47/98 (47%), Gaps = 5/98 (5%)
Query: 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
I + L YLH + R+ K NIL NEE AK DF +S + +T +
Sbjct: 104 ILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQL--TDTMAKRNT 158
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
VIGT + APE I N K++++S G E+ G+
Sbjct: 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-06
Identities = 38/117 (32%), Positives = 52/117 (44%), Gaps = 14/117 (11%)
Query: 52 EYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFD 111
+ G + I G KIA +V L YL+ I+ R+ K NIL N K D
Sbjct: 96 KGGPIPVEILG------KIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCD 147
Query: 112 FLLSISIPEGE-THITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
F +S GE + D +GT Y +PE I KS+V+S G + EL G+
Sbjct: 148 FGVS-----GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 31/84 (36%), Positives = 45/84 (53%), Gaps = 13/84 (15%)
Query: 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLN 148
IV R+ K +NIL ++ + D L++ IPEGET RV GT GY APE V+N
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPE-----VIN 174
Query: 149 EKSNVFS-----FGAFLFELLAGR 167
+ FS G ++E++ G+
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 68 LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITT 127
+ +A + +AYL + + R+ +NIL E+ V K DF L+ I E + ++++
Sbjct: 107 IDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSS 162
Query: 128 DRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163
D+ I + ++APE S + KS+V+SFG L+E+
Sbjct: 163 DKKIPYK-WTAPEAASHGTFSTKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-06
Identities = 37/150 (24%), Positives = 72/150 (48%), Gaps = 16/150 (10%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI-----FGAPLPRL-KIASDIVNSL 78
++ H ++++ +G L + I V + + G L + + + +L + + D+ +
Sbjct: 55 KLHHKNLVRLLGVILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113
Query: 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSA 138
YL + +V R+ +NIL +E+ VAK DF L+ G D ++A
Sbjct: 114 EYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDNSKLPVKWTA 165
Query: 139 PEYISICVLNEKSNVFSFGAFLFELLA-GR 167
PE + + KS+V+S+G L+E+ + GR
Sbjct: 166 PEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-06
Identities = 38/144 (26%), Positives = 65/144 (45%), Gaps = 8/144 (5%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPR-LKIASDIVNSLAYLHF 83
++ H +I+K IG C L+ + +E L + + R KIA I +L +LH
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHC 798
Query: 84 GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS 143
+V+ N + I+ + ++ L +S+P T + + Y APE
Sbjct: 799 RCSPAVVVGNLSPEKIIIDGKDEPH-----LRLSLPG--LLCTDTKCFISSAYVAPETRE 851
Query: 144 ICVLNEKSNVFSFGAFLFELLAGR 167
+ EKS+++ FG L ELL G+
Sbjct: 852 TKDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-06
Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 14/101 (13%)
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRV 130
A++I L LH IV R+ K +NIL ++ + D L++ +PEG+T RV
Sbjct: 108 AAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV 162
Query: 131 IGTRGYSAPEYISICVLNEK----SNVFSFGAFLFELLAGR 167
GT GY APE V NE+ + ++ G L+E++AG+
Sbjct: 163 -GTVGYMAPE----VVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (113), Expect = 2e-06
Identities = 31/97 (31%), Positives = 46/97 (47%), Gaps = 11/97 (11%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGT 133
+ +L YLH R I+ R+ K QNI + K DF +S + T V+GT
Sbjct: 112 LCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGT 166
Query: 134 RGYSAPEYISICV---LNEKSNVFSFGAFLFELLAGR 167
Y +PE +C N KS+++S G L+EL +
Sbjct: 167 PYYLSPE---LCQNKPYNYKSDIWSLGCVLYELCTLK 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-06
Identities = 28/98 (28%), Positives = 47/98 (47%), Gaps = 9/98 (9%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128
+ +++V + LH R I+ R+ K +N+L ++ K DF LS +
Sbjct: 101 QYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLS------RNGLENK 151
Query: 129 RVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
+ +GT Y APE I ++ S+ +S G +FE L G
Sbjct: 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-06
Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 9/102 (8%)
Query: 68 LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITT 127
LK + D+ ++ YL V R+ +N+L +E+NVAK DF L+ E T
Sbjct: 105 LKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQ 156
Query: 128 DRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA-GRI 168
D ++APE + + KS+V+SFG L+E+ + GR+
Sbjct: 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-06
Identities = 43/179 (24%), Positives = 71/179 (39%), Gaps = 28/179 (15%)
Query: 26 MSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF-------------GAPLPR----- 67
+ H HI++ G C + ++VF+ + +G L + +
Sbjct: 64 LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQ 123
Query: 68 -LKIASDIVNSLAY---LHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET 123
L IAS I + + Y LHF V R+ T+N L + V K DF +S I +
Sbjct: 124 MLAIASQIASGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 177
Query: 124 HITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGC 182
+ R + + PE I +S+++SFG L+E+ W L +T C
Sbjct: 178 YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 8/97 (8%)
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRV 130
A++I+ L ++H F +V R+ K NIL +E + D L+ + + H +
Sbjct: 103 ATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 155
Query: 131 IGTRGYSAPEYISI-CVLNEKSNVFSFGAFLFELLAG 166
+GT GY APE + + ++ FS G LF+LL G
Sbjct: 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 22/160 (13%)
Query: 24 AQMSHNHILKRI--GCCLQTPIPIL--VFQSVEYGTLRDCIFG-APLPRL---KIASDIV 75
A++ H +I+ + G P +L VF+ V TLR+ + LP ++ ++
Sbjct: 33 ARLYHPNIVALLDSGEA---PPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVL 89
Query: 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENV---AKWFDFLLSISIP----EGETHIT-T 127
++LA H + IV R+ K QNI+ ++ V AK DF + +P +T T
Sbjct: 90 DALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRT 146
Query: 128 DRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
V+GT Y APE + + S+++++G E L G+
Sbjct: 147 TEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-06
Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 8/150 (5%)
Query: 20 ITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIAS---DIVN 76
IT +Q +I + G L+ ++ + + G+ D + PL IA+ +I+
Sbjct: 53 ITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILK 112
Query: 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGY 136
L YLH + R+ K N+L +E+ K DF ++ + +T I + +GT +
Sbjct: 113 GLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFW 167
Query: 137 SAPEYISICVLNEKSNVFSFGAFLFELLAG 166
APE I + K++++S G EL G
Sbjct: 168 MAPEVIKQSAYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-06
Identities = 38/152 (25%), Positives = 70/152 (46%), Gaps = 19/152 (12%)
Query: 25 QMSHNHILKRIGCCL-QTPIPILVFQSVEYGTLRDC------IFGAPLPRLKIASDIVNS 77
++SH ++++ G C Q PI I V + + G L + G L + SD+ +
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFI-VTEYMANGCLLNYLRERKGKLGTEW-LLDMCSDVCEA 112
Query: 78 LAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTR--- 134
+ YL + R+ +N L E+NV K DF L+ + + + + GT+
Sbjct: 113 MEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPV 165
Query: 135 GYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
++ PE + KS+V+SFG ++E+ +
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 4e-06
Identities = 57/216 (26%), Positives = 87/216 (40%), Gaps = 37/216 (17%)
Query: 46 LVFQSVEYGTLRDCIFGAP--LPRLKIASDI---VNSLAYLHFGFPRPIVLRNFKTQNIL 100
LVF+ VE TL + + +P LP + S I + ++AY H I+ R+ K +NIL
Sbjct: 77 LVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENIL 132
Query: 101 FNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSN------VF 154
+E V K DF + ++ TD V TR Y APE +L +N V+
Sbjct: 133 VSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPE-----LLVGDTNYGKPVDVW 186
Query: 155 SFGAFLFELLAGRIHIWDLLKDTHDH----------GCFFNEYLKNYLEDKRFTGIPAPI 204
+ G + ELL G L D G + + + + RF G+ P
Sbjct: 187 AIGCIMAELLDGE----PLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPE 242
Query: 205 IVQDIPCIEKEQQLHASAQLTL--ECVNNSPEDRPT 238
Q + +S L C+ P++R T
Sbjct: 243 PSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-06
Identities = 34/102 (33%), Positives = 51/102 (50%), Gaps = 16/102 (15%)
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRV 130
A++I+ L LH V R+ K +NIL ++ + D L++ IPEGE+ RV
Sbjct: 108 AAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV 162
Query: 131 IGTRGYSAPEYISICVLNEKSNVFS-----FGAFLFELLAGR 167
GT GY APE VLN + S G ++E++ G+
Sbjct: 163 -GTVGYMAPE-----VLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 5e-06
Identities = 38/118 (32%), Positives = 52/118 (44%), Gaps = 9/118 (7%)
Query: 56 LRDCIFGAPLPRL-KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLL 114
L++ P L KIA ++ L YLH I+ R+ K NIL N K DF +
Sbjct: 90 LKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGV 147
Query: 115 SISIPEGE-THITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIW 171
S G+ + +GT Y APE I + KS+++S G L EL GR
Sbjct: 148 S-----GQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-06
Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 14/155 (9%)
Query: 18 NNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEY---GTLRDCI--FGAPLPRL--KI 70
I + H I++ GC L+ + +F +EY G+++D + +GA + K
Sbjct: 53 CEIQLLKNLQHERIVQYYGC-LRDDETLSIF--MEYMPGGSVKDQLKAYGALTETVTRKY 109
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR- 129
I+ + YLH IV R+ K NIL + K DF S + + T +
Sbjct: 110 TRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS 166
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164
V GT + +PE IS K++V+S G + E+L
Sbjct: 167 VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-06
Identities = 35/148 (23%), Positives = 62/148 (41%), Gaps = 13/148 (8%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTL-------RDCIFGAPLPRLKIASDIVN 76
A + H H+++ +G CL + L+ Q + G L +D I L I
Sbjct: 64 ASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNI--GSQYLLNWCVQIAK 120
Query: 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGY 136
++YL + +V R+ +N+L K DF L+ + E + +
Sbjct: 121 GMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177
Query: 137 SAPEYISICVLNEKSNVFSFGAFLFELL 164
A E I + KS+V+S+G ++EL+
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 7e-06
Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 7/96 (7%)
Query: 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDF-LLSISIPEGETHITTDRV 130
S+I +L +LH + I+ R+ K +NIL + + K DF L SI EG T
Sbjct: 107 SEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV---THTF 160
Query: 131 IGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
GT Y APE + + + +S GA ++++L G
Sbjct: 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-06
Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 15/148 (10%)
Query: 57 RDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDF-LLS 115
R+ +F R ++IV++L YLH + +V R+ K +N++ +++ K DF L
Sbjct: 88 RERVFSEDRARF-YGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144
Query: 116 ISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLK 175
I +G T T GT Y APE + + + G ++E++ GR+ ++
Sbjct: 145 EGIKDGATMKT---FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--- 198
Query: 176 DTHDHGCFFNEYLKNYLEDKRFTGIPAP 203
DH F L +E+ RF +P
Sbjct: 199 --QDHEKLFELIL---MEEIRFPRTLSP 221
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 7e-06
Identities = 30/97 (30%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRV 130
A++I+ L +LH + I+ R+ K N+L +++ K DF + GE
Sbjct: 102 AAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTF 156
Query: 131 IGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
GT Y APE + NE + +SFG L+E+L G+
Sbjct: 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 8e-06
Identities = 63/241 (26%), Positives = 97/241 (40%), Gaps = 58/241 (24%)
Query: 26 MSHNHILKRIGCCLQTPIP--ILVFQSVEYGTLRDC-------IFGAPLPRLKIASDIVN 76
+ H++I+K G C LV + + YG+LRD + L L AS I
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKL--LLYASQICK 119
Query: 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPE----------GETHIT 126
+ YL + V R+ T+NIL EN K DF L+ +P+ GE+ I
Sbjct: 120 GMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF 176
Query: 127 TDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTH-DHGCF-F 184
+ APE ++ + S+V+SFG L+EL T+ D C
Sbjct: 177 ---------WYAPESLTESKFSVASDVWSFGVVLYELF------------TYSDKSCSPP 215
Query: 185 NEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASA-------QLTLECVNNSPEDRP 237
E+++ DK+ I+ I ++ +L A + EC NN P RP
Sbjct: 216 AEFMRMMGNDKQ----GQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRP 271
Query: 238 T 238
+
Sbjct: 272 S 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 9e-06
Identities = 53/180 (29%), Positives = 79/180 (43%), Gaps = 35/180 (19%)
Query: 64 PLPRL-KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE 122
LP+L +A+ I +AYL R + R+ +NIL E V K DF L+ I E
Sbjct: 101 RLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLI---E 154
Query: 123 THITTDRVIGTR---GYSAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTH 178
T R G + ++APE + KS+V+SFG L E++ GR+
Sbjct: 155 DDEYTARE-GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY-------- 205
Query: 179 DHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238
G E L+ R +P P + P ++L+ L L+C + PE+RPT
Sbjct: 206 -PGMTNREVLEQVERGYR---MPRP---PNCP-----EELY---DLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-05
Identities = 35/102 (34%), Positives = 51/102 (50%), Gaps = 16/102 (15%)
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRV 130
A++I L LH IV R+ K +NIL ++ + D L++ IPEGET RV
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV 162
Query: 131 IGTRGYSAPEYISICVLNEKSNVFS-----FGAFLFELLAGR 167
GT GY APE V+ + FS G ++E++ G+
Sbjct: 163 -GTVGYMAPE-----VVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 34/151 (22%), Positives = 65/151 (43%), Gaps = 19/151 (12%)
Query: 29 NHILKRIGCCLQTPIPILVFQSVEYGTLRD-----------CIFGAPLPRLKI---ASDI 74
+H+++ +G ++V + + G L+ P K A++I
Sbjct: 69 HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-ITTDRVIGT 133
+ +AYL + V R+ +N + E+ K DF ++ I E + + ++
Sbjct: 129 ADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 134 RGYSAPEYISICVLNEKSNVFSFGAFLFELL 164
R + APE + V KS+V+SFG L+E+
Sbjct: 186 R-WMAPESLKDGVFTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-05
Identities = 37/128 (28%), Positives = 61/128 (47%), Gaps = 15/128 (11%)
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRV 130
++IV++L YLH G IV R+ K +N++ +++ K DF L EG T T +
Sbjct: 101 GAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLC---KEGITDAATMKT 154
Query: 131 I-GTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLK 189
GT Y APE + + + G ++E++ GR+ ++ DH F L
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-----QDHEKLFELIL- 208
Query: 190 NYLEDKRF 197
+ED +F
Sbjct: 209 --MEDIKF 214
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-05
Identities = 53/228 (23%), Positives = 95/228 (41%), Gaps = 49/228 (21%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKI------ASDIVNSL 78
Q+ H +++ Q PI I + + +E G+L D + +L I A+ I +
Sbjct: 57 QLQHPRLVRLYAVVTQEPIYI-ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGM 115
Query: 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSA 138
A++ + + R+ + NIL +E K DF L+ I + E + + ++A
Sbjct: 116 AFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTA 171
Query: 139 PEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRF 197
PE I+ KS+V+SFG L E++ GRI +
Sbjct: 172 PEAINYGTFTIKSDVWSFGILLTEIVTYGRI---------------------------PY 204
Query: 198 TGIPAPIIVQDI------PCIEK-EQQLHASAQLTLECVNNSPEDRPT 238
G+ P ++Q++ P + ++L+ +L C PE+RPT
Sbjct: 205 PGMTNPEVIQNLERGYRMPRPDNCPEELY---ELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-05
Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 21/155 (13%)
Query: 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV 146
R + R+ +NIL +E NV K DF L+ I + ++ + APE I V
Sbjct: 192 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV 251
Query: 147 LNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIV 206
+S+V+SFG L+E+ + L + G +E L K T + AP
Sbjct: 252 YTTQSDVWSFGVLLWEIFS--------LGASPYPGVQIDEEFCRRL--KEGTRMRAP--- 298
Query: 207 QDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
E + L+C +N+PEDRPT +
Sbjct: 299 --------EYATPEIYSIMLDCWHNNPEDRPTFSE 325
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDF-LLSISIPEGETHITTDR 129
A++I L +LH + I+ R+ K N++ + E K DF + +I G+T T
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRT 160
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
GT Y APE I+ + + ++FG L+E+LAG+
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-05
Identities = 34/145 (23%), Positives = 72/145 (49%), Gaps = 10/145 (6%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA------PLPRLKIASDIVNSL 78
++ H ++++ +G C + P ++ + + YG L D + + L +A+ I +++
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117
Query: 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSA 138
YL + + R+ +N L E ++ K DF LS + G+T+ ++A
Sbjct: 118 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTA 173
Query: 139 PEYISICVLNEKSNVFSFGAFLFEL 163
PE ++ + KS+V++FG L+E+
Sbjct: 174 PESLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-05
Identities = 40/155 (25%), Positives = 69/155 (44%), Gaps = 19/155 (12%)
Query: 25 QMSHNHILKRIGCCLQT------PIPILVFQSVEYGTLR---------DCIFGAPLPRL- 68
+ H ++++ IG CLQT P P+++ +++G L DC P L
Sbjct: 56 EFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLV 115
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128
K +DI + + YL + + R+ +N + NE DF LS I G+ +
Sbjct: 116 KFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGR 172
Query: 129 RVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163
+ A E ++ V KS+V+SFG ++E+
Sbjct: 173 IAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 2e-05
Identities = 30/94 (31%), Positives = 44/94 (46%), Gaps = 6/94 (6%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGT 133
+V + YLH R I+ R+ K +N+L + K DF + + G+ T GT
Sbjct: 102 VVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGT 155
Query: 134 RGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
Y APE I + + +S G L+ELL GR
Sbjct: 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDF-LLSISIPEGETHITTDR 129
A++I L +LH R I+ R+ K N++ + E K DF + + +G +TT
Sbjct: 107 AAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRT 160
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
GT Y APE I+ + + +++G L+E+LAG+
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRV 130
AS+IV +L YLH + IV R+ K +NIL ++E K DF + + T +
Sbjct: 107 ASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFA-----KKLRDRTWTL 158
Query: 131 IGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
GT Y APE I N+ + ++ G ++E+L G
Sbjct: 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 3e-05
Identities = 46/165 (27%), Positives = 74/165 (44%), Gaps = 30/165 (18%)
Query: 23 AAQMS---HNHILKRIGCCLQTPIPILVFQSVEYGTL-------RDCIFGAPLPRLK--- 69
A MS H +I+K +G CL ++ + +E G L R FG PL LK
Sbjct: 50 AHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELL 109
Query: 70 -IASDIVNSLAYL---HFGFPRPIVLRNFKTQNILFNEEN-----VAKWFDFLLSISIPE 120
I D+ YL HF + R+ +N L +E+ V K DF L+ I +
Sbjct: 110 DICLDVAKGCVYLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK 163
Query: 121 GETH-ITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164
+ + + ++ R + APE + +S+V+SFG ++E+L
Sbjct: 164 SDYYRKEGEGLLPVR-WMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 3e-05
Identities = 33/150 (22%), Positives = 66/150 (44%), Gaps = 2/150 (1%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVN 76
IN I ++ + +I+ + L +V + + G+L D + + +IA+
Sbjct: 64 INEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRE 123
Query: 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGY 136
L L F ++ R+ K+ N+L + K DF I ++ +T ++GT +
Sbjct: 124 CLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYW 181
Query: 137 SAPEYISICVLNEKSNVFSFGAFLFELLAG 166
APE ++ K +++S G E++ G
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-05
Identities = 40/141 (28%), Positives = 66/141 (46%), Gaps = 4/141 (2%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIV---NSLAYL 81
Q SH +I++ IG C Q +V + V+ G PRLK+ I N+ A +
Sbjct: 49 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEGPRLKVKELIQMVENAAAGM 107
Query: 82 HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEY 141
+ + + R+ +N L E+NV K DF +S +G T ++APE
Sbjct: 108 EYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEA 167
Query: 142 ISICVLNEKSNVFSFGAFLFE 162
++ + +S+V+SFG L+E
Sbjct: 168 LNYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 44/175 (25%), Positives = 69/175 (39%), Gaps = 29/175 (16%)
Query: 26 MSHNHILKRIGCCLQTPIPILVFQSVEYGTLRD-----------CIFGAPLPR------- 67
+ H HI+K G C I+VF+ +++G L + G P
Sbjct: 64 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123
Query: 68 --LKIASDIVNSLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE 122
L IAS I + + YL HF V R+ T+N L + K DF +S + +
Sbjct: 124 QMLHIASQIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177
Query: 123 THITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDT 177
+ + + PE I +S+V+SFG L+E+ W L +T
Sbjct: 178 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-05
Identities = 30/98 (30%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDF-LLSISIPEGETHITTDR 129
A++I L +LH + I+ R+ K N++ + E K DF + ++ +G +TT
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKT 160
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
GT Y APE I+ + + ++FG L+E+LAG+
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-05
Identities = 47/169 (27%), Positives = 73/169 (43%), Gaps = 12/169 (7%)
Query: 46 LVFQSVEYGTLR---DCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFN 102
LVF+ VE L + G P P K+ S I + +H+ IV R+ K +N+L +
Sbjct: 77 LVFEYVEKNMLELLEEMPNGVP-PE-KVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS 134
Query: 103 EENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFE 162
+V K DF + ++ EG T+ V TR Y +PE + + +++S G L E
Sbjct: 135 HNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPELLLGAPYGKAVDMWSVGCILGE 193
Query: 163 ------LLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPII 205
L G I L G E +K + + RF G+ P +
Sbjct: 194 LSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAV 242
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-05
Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 15/127 (11%)
Query: 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVI 131
++IV++L YLH R +V R+ K +N++ +++ K DF L EG + T +
Sbjct: 102 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTF 155
Query: 132 -GTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKN 190
GT Y APE + + + G ++E++ GR+ ++ DH F L
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-----QDHERLFELIL-- 208
Query: 191 YLEDKRF 197
+E+ RF
Sbjct: 209 -MEEIRF 214
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 5e-05
Identities = 34/104 (32%), Positives = 50/104 (48%), Gaps = 6/104 (5%)
Query: 65 LPRLKI-ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET 123
LPR A++I+ L +LH + IV R+ K NIL + + K DF + G+
Sbjct: 95 LPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA 151
Query: 124 HITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
T GT Y APE + N + +SFG L+E+L G+
Sbjct: 152 K--TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 5e-05
Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 48/228 (21%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTL------RDCIFGAPLPRLKIASDIVNSL 78
Q H +I++ G ++ +++ + +E G+L D F + + I + +
Sbjct: 61 QFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKF-TVGQLVGMLRGIASGM 119
Query: 79 AYL-HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRG-- 135
YL + V R+ +NIL N V K DF LS + + E TT +G
Sbjct: 120 KYLSEMNY----VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT------KGGK 169
Query: 136 ----YSAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKN 190
++APE I+ S+V+SFG ++E+++ G WD+ D +K
Sbjct: 170 IPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM--SNQD-------VIKA 220
Query: 191 YLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238
+ R +P P+ D P L+ QL L+C +RPT
Sbjct: 221 VEDGYR---LPPPM---DCP-----SALY---QLMLDCWQKDRNERPT 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 6e-05
Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 10/145 (6%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI----FGAPLPRL-KIASDIVNSLA 79
Q H HI+K IG + P+ I V + G LR + + L L + + +LA
Sbjct: 63 QFDHPHIVKLIGVITENPVWI-VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALA 121
Query: 80 YLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAP 139
YL + V R+ +N+L + + K DF LS + E E++ + + AP
Sbjct: 122 YLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL-EDESYYKASKGKLPIKWMAP 177
Query: 140 EYISICVLNEKSNVFSFGAFLFELL 164
E I+ S+V+ FG ++E+L
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 7e-05
Identities = 39/161 (24%), Positives = 71/161 (44%), Gaps = 14/161 (8%)
Query: 20 ITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI--FGA---PLPRLKIASDI 74
I ++ H +I++ +G L + + V G++ + +GA L R I
Sbjct: 57 IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQI 115
Query: 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR----V 130
+ L YLH R I+ R+ K NIL + + K DF +S + T+ +
Sbjct: 116 LKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL 172
Query: 131 IGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIW 171
G+ + APE + K++++S G + E+L G+ H +
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK-HPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 9e-05
Identities = 32/106 (30%), Positives = 46/106 (43%), Gaps = 15/106 (14%)
Query: 69 KIASDIVNSLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI 125
K+ IV +L YL H ++ R+ K NIL + K DF +S + + +
Sbjct: 118 KMTVAIVKALHYLKEKH-----GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK- 171
Query: 126 TTDRVIGTRGYSAPEYISICVLNEK----SNVFSFGAFLFELLAGR 167
R G Y APE I N K ++V+S G L EL G+
Sbjct: 172 --TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 33/140 (23%), Positives = 67/140 (47%), Gaps = 9/140 (6%)
Query: 31 ILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIA---SDIVNSLAYLHFGFPR 87
I K G L+ P ++ + E G++R + P+ I+ +++ +L Y+H
Sbjct: 64 ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIH---KV 120
Query: 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVL 147
++ R+ K NIL K DF ++ + + + +T +GT + APE I+
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEGKY 178
Query: 148 -NEKSNVFSFGAFLFELLAG 166
+ K++++S G ++E+ G
Sbjct: 179 YDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 1e-04
Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 6/102 (5%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128
K++ ++ LAYL I+ R+ K NIL N K DF +S + + +
Sbjct: 107 KVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 160
Query: 129 RVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHI 170
+GTR Y +PE + + +S+++S G L EL GR I
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 45/163 (27%), Positives = 72/163 (44%), Gaps = 17/163 (10%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA----PLPRLKI---ASDIVNS 77
Q S N L + C QT + F +EY D +F LP A++I +
Sbjct: 51 QASSNPFLVGLHSCFQTTSRL--FLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA 108
Query: 78 LAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDF-LLSISIPEGETHITTDRVIGTRGY 136
L +LH R I+ R+ K N+L + + K D+ + + G+ TT GT Y
Sbjct: 109 LNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---TTSTFCGTPNY 162
Query: 137 SAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHD 179
APE + + ++ G +FE++AGR +D++ D D
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGR-SPFDIITDNPD 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 1e-04
Identities = 48/183 (26%), Positives = 78/183 (42%), Gaps = 38/183 (20%)
Query: 28 HNHILKRIGCCLQTPIPILVFQSVEYGTLRD-----------CIFGAPLPRLKIAS--DI 74
H +I+ +G C Q +V + +G LRD P P + + D+
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 75 VNSLAY-----LHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
V S AY + F + + R+ +N+L E++V K DF L+ I + + T
Sbjct: 135 V-SFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT-- 191
Query: 130 VIGTRG-----YSAPEYISICVLNEKSNVFSFGAFLFEL--LAGR----IHIW---DLLK 175
T G + APE + V +S+V+SFG L+E+ L G I + LLK
Sbjct: 192 ---TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 248
Query: 176 DTH 178
+ +
Sbjct: 249 EGY 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 65 LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH 124
L L +A D ++SL I+ R+ K +NIL +EE K DF LS + E
Sbjct: 104 LAELALALDHLHSLG---------IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154
Query: 125 ITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
GT Y APE ++ + ++ +SFG +FE+L G
Sbjct: 155 --AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 41/147 (27%), Positives = 65/147 (44%), Gaps = 11/147 (7%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI------FGAPLPRLKIASDIVNS 77
A M H H+++ +G CL +P LV Q + +G L D + G+ L L I
Sbjct: 64 ASMDHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQL-LLNWCVQIAKG 121
Query: 78 LAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYS 137
+ YL R +V R+ +N+L N K DF L+ + E D +
Sbjct: 122 MMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM 178
Query: 138 APEYISICVLNEKSNVFSFGAFLFELL 164
A E I +S+V+S+G ++EL+
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 28/90 (31%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGT 133
I +L YLH + I+ R+ KTQN+ N+ K D ++ + E + + + +IGT
Sbjct: 111 IAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIA-RVLENQCDMAST-LIGT 165
Query: 134 RGYSAPEYISICVLNEKSNVFSFGAFLFEL 163
Y +PE S N KS+V++ G ++E+
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 35/107 (32%), Positives = 51/107 (47%), Gaps = 12/107 (11%)
Query: 64 PLPRLKI-ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLL---SISIP 119
P PR + A++I ++L YLH IV R+ K +NIL + + DF L I+
Sbjct: 94 PEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS 150
Query: 120 EGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
+ TT GT Y APE I + + + GA L+E+L G
Sbjct: 151 D-----TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 18/152 (11%)
Query: 25 QMSHNHILKRIGCCLQT-PIPILVFQSVEYGTLRDCIF--GAPLPR---LKIASDIVNSL 78
Q H +I+K IG C+Q PI I V + V G+L + L L+++ D +
Sbjct: 48 QYDHPNIVKLIGVCVQKQPIYI-VMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGM 106
Query: 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTR---- 134
YL + + R+ +N L E NV K DF +S EG + +D G +
Sbjct: 107 EYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRE-EEGGIYTVSD---GLKQIPI 159
Query: 135 GYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
++APE ++ +S+V+S+G L+E +
Sbjct: 160 KWTAPEALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 23/154 (14%)
Query: 25 QMSHNHILKRIGCCLQ---TPIPILVFQSVEYGTLRDCIFGAPLPR----------LKIA 71
+ H +I+K G C + I L+ + + G+L++ LPR LK A
Sbjct: 62 NLYHENIVKYKGICTEDGGNGIK-LIMEFLPSGSLKEY-----LPRNKNKINLKQQLKYA 115
Query: 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITT-DRV 130
I + YL R V R+ +N+L E+ K DF L+ +I + + T D +
Sbjct: 116 VQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172
Query: 131 IGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164
+ APE + S+V+SFG L+ELL
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 2e-04
Identities = 43/165 (26%), Positives = 70/165 (42%), Gaps = 30/165 (18%)
Query: 23 AAQM---SHNHILKRIGCCLQT------PIPILVFQSVEYGTLRDCIF-----GAP--LP 66
AA M H +++K IG C + P P+++ +++G L + G P LP
Sbjct: 52 AACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLP 111
Query: 67 R---LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEG-- 121
LK DI + YL R + R+ +N + E+ DF LS I G
Sbjct: 112 LQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY 168
Query: 122 --ETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164
+ I V + A E ++ V KS+V++FG ++E+
Sbjct: 169 YRQGRIAKMPV----KWIAIESLADRVYTSKSDVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 2e-04
Identities = 27/106 (25%), Positives = 52/106 (49%), Gaps = 7/106 (6%)
Query: 62 GAPLPRLK----IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSIS 117
G P P L+ +A++I + +AYL+ + V R+ +N + + K DF ++
Sbjct: 112 GRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD 168
Query: 118 IPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163
I E + + + + + APE + V S+++SFG L+E+
Sbjct: 169 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 3e-04
Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 35/221 (15%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRL-KIASDIVNSL 78
++ H +++ + PI I V + + G+L D + G LP+L +A+ I + +
Sbjct: 57 KLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 115
Query: 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSA 138
AY+ V R+ + NIL E V K DF L+ I + E + ++A
Sbjct: 116 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTA 171
Query: 139 PEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRF 197
PE KS+V+SFG L EL GR+ + N + + +E R
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELTTKGRV----------PYPGMVNREVLDQVE--RG 219
Query: 198 TGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238
+P P E + LH L +C PE+RPT
Sbjct: 220 YRMPCP--------PECPESLH---DLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 3e-04
Identities = 40/145 (27%), Positives = 67/145 (46%), Gaps = 13/145 (8%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTL-------RDCIFGAPLPRLKIASDIVNS 77
Q H +I+K IG C Q +V + V G +D + L +K A D
Sbjct: 48 QYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQL--VKFALDAAAG 105
Query: 78 LAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYS 137
+AYL + + R+ +N L E NV K DF +S +G + + I + ++
Sbjct: 106 MAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK-WT 161
Query: 138 APEYISICVLNEKSNVFSFGAFLFE 162
APE ++ + +S+V+S+G L+E
Sbjct: 162 APEALNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 3e-04
Identities = 42/161 (26%), Positives = 65/161 (40%), Gaps = 21/161 (13%)
Query: 81 LHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPE 140
+ F R + R+ +NIL +E NV K DF L+ I + ++ + APE
Sbjct: 187 MEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246
Query: 141 YISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGI 200
I V +S+V+SFG L+E+ + L + G NE L+D T +
Sbjct: 247 SIFDKVYTTQSDVWSFGVLLWEIFS--------LGASPYPGVQINEEFCQRLKDG--TRM 296
Query: 201 PAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
AP E ++ L C P++RPT
Sbjct: 297 RAP-----------ENATPEIYRIMLACWQGDPKERPTFSA 326
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 3e-04
Identities = 43/153 (28%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 90 VLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTR---GYSAPEYISICV 146
V R+ +NIL N V K DF LS + + + T +G + ++APE I+
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187
Query: 147 LNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLE-DKRFTGIPAPI 204
S+V+S+G ++E+++ G WD+ N+ + N +E D R +P P+
Sbjct: 188 FTSASDVWSYGIVMWEVMSYGERPYWDMS----------NQDVINAIEQDYR---LPPPM 234
Query: 205 IVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237
D P LH QL L+C RP
Sbjct: 235 ---DCPTA-----LH---QLMLDCWQKDRNARP 256
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 3e-04
Identities = 44/152 (28%), Positives = 67/152 (44%), Gaps = 29/152 (19%)
Query: 90 VLRNFKTQNILFNEENVAKWFDFLLSISI---PEGETHITTDRVIGTRGYSAPEYISICV 146
V R+ +NIL N V K DF LS + PE + T I R ++APE I+
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA-AYTTRGGKIPIR-WTAPEAIAYRK 185
Query: 147 LNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPII 205
S+V+S+G ++E+++ G W++ + +K E R +PAP+
Sbjct: 186 FTSASDVWSYGIVMWEVMSYGERPYWEMSN---------QDVIKAIEEGYR---LPAPM- 232
Query: 206 VQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237
D P LH QL L+C +RP
Sbjct: 233 --DCPAA-----LH---QLMLDCWQKDRNERP 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 4e-04
Identities = 41/166 (24%), Positives = 66/166 (39%), Gaps = 26/166 (15%)
Query: 26 MSHNHILKRIGCCLQTPIPILVFQSVEYGTLR--------DCIF---GAPLPRLK----- 69
+ H HI+K G C++ I+VF+ +++G L D + G L
Sbjct: 64 LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123
Query: 70 -IASDIVNSLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI 125
IA I + YL HF V R+ T+N L E + K DF +S + + +
Sbjct: 124 HIAQQIAAGMVYLASQHF------VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR 177
Query: 126 TTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIW 171
+ + PE I +S+V+S G L+E+ W
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 28/93 (30%), Positives = 42/93 (45%), Gaps = 12/93 (12%)
Query: 78 LAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLS------ISIPEGETHITTDRVI 131
L +H + ++ R+ K+ NIL + K DF S +S G T
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT------FC 206
Query: 132 GTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164
GT Y APE ++K+++FS G L+ELL
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELL 239
|
Length = 496 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 4e-04
Identities = 38/158 (24%), Positives = 70/158 (44%), Gaps = 16/158 (10%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEY---GTLRDCI--FGAPLPRLKIA 71
IN I H +I+ L + ++ +EY G+L D I + +IA
Sbjct: 63 INEILIMKDCKHPNIVDYYDSYL---VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA 119
Query: 72 S---DIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128
+++ L YLH + ++ R+ K+ NIL +++ K DF + + + ++ +
Sbjct: 120 YVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS- 175
Query: 129 RVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
V+GT + APE I K +++S G E+ G
Sbjct: 176 -VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 4e-04
Identities = 29/100 (29%), Positives = 50/100 (50%), Gaps = 10/100 (10%)
Query: 68 LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITT 127
L+ ASD+ + YL + + R+ +N+L E +K DF LS GE +
Sbjct: 122 LQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLS----RGE-EVYV 173
Query: 128 DRVIGTRG--YSAPEYISICVLNEKSNVFSFGAFLFELLA 165
+ +G + A E ++ V KS+V+SFG L+E+++
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 4e-04
Identities = 32/99 (32%), Positives = 44/99 (44%), Gaps = 7/99 (7%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128
+IA +V L YL + I+ R+ K N+L N K DF +S + +
Sbjct: 99 RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAK 151
Query: 129 RVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
+GT Y APE IS S+V+S G EL GR
Sbjct: 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 4e-04
Identities = 29/121 (23%), Positives = 55/121 (45%), Gaps = 2/121 (1%)
Query: 46 LVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEEN 105
+V + + G+L D + + +IA+ L L F ++ R+ K+ NIL +
Sbjct: 93 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG 152
Query: 106 VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165
K DF I ++ +T ++GT + APE ++ K +++S G E++
Sbjct: 153 SVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE 210
Query: 166 G 166
G
Sbjct: 211 G 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 4e-04
Identities = 41/152 (26%), Positives = 64/152 (42%), Gaps = 21/152 (13%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGT 133
I+ L Y+H I+ R+ K N+ NE+ K DF L+ + T + T
Sbjct: 129 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG-----YVAT 180
Query: 134 RGYSAPE-YISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYL 192
R Y APE ++ N+ +++S G + ELL GR L T DH + LK L
Sbjct: 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT----LFPGT-DH----IDQLKLIL 231
Query: 193 EDKRFTGIPAPIIVQDIPCIEKEQQLHASAQL 224
R G P +++ I + + Q+
Sbjct: 232 ---RLVGTPGAELLKKISSESARNYIQSLTQM 260
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 4e-04
Identities = 35/102 (34%), Positives = 44/102 (43%), Gaps = 7/102 (6%)
Query: 67 RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT 126
R+ IA +IV +L +LH I+ R+ K +NIL + E DF LS E
Sbjct: 108 RVYIA-EIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA 163
Query: 127 TDRVIGTRGYSAPEYISICVLNEKSNV--FSFGAFLFELLAG 166
GT Y APE I V +S G FELL G
Sbjct: 164 YS-FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 4e-04
Identities = 42/151 (27%), Positives = 67/151 (44%), Gaps = 16/151 (10%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA----PLPRLKI---ASDIVNS 77
Q S++ L + C QT + F +EY D +F LP +++I +
Sbjct: 51 QASNHPFLVGLHSCFQTESRL--FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 108
Query: 78 LAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDF-LLSISIPEGETHITTDRVIGTRGY 136
L YLH R I+ R+ K N+L + E K D+ + + G+T T GT Y
Sbjct: 109 LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNY 162
Query: 137 SAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
APE + + ++ G +FE++AGR
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 5e-04
Identities = 52/230 (22%), Positives = 90/230 (39%), Gaps = 37/230 (16%)
Query: 20 ITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEY---GTLRDCI-----FGAPLPRLKIA 71
I + H +I++ +G T + +F +EY G++ C+ F L R
Sbjct: 59 IETLKDLDHLNIVQYLGF-ETTEEYLSIF--LEYVPGGSIGSCLRTYGRFEEQLVRF-FT 114
Query: 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVI 131
++ LAYLH + I+ R+ K N+L + + + K DF +S + + +
Sbjct: 115 EQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 132 GTRGYSAPEYISI--CVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLK 189
G+ + APE I + K +++S G + E+ AGR W D F
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR-RPW---SDEEAIAAMF----- 222
Query: 190 NYLEDKRFTGIPAPIIVQDI-PCIEKEQQLHASAQLTLECVNNSPEDRPT 238
K AP I D+ + + C +P++RPT
Sbjct: 223 -----KLGNKRSAPPIPPDVSMNLSPV-----ALDFLNACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 6e-04
Identities = 32/104 (30%), Positives = 48/104 (46%), Gaps = 12/104 (11%)
Query: 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
+A I++ +AYLH R IV R+ K N+L N K DF +S +T +
Sbjct: 173 VARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADF--GVSRILAQTMDPCNS 227
Query: 130 VIGTRGYSAPEYISICVLNE------KSNVFSFGAFLFELLAGR 167
+GT Y +PE I+ LN +++S G + E GR
Sbjct: 228 SVGTIAYMSPERINT-DLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 6e-04
Identities = 31/103 (30%), Positives = 48/103 (46%), Gaps = 8/103 (7%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT-T 127
KI+ ++ L YL I+ R+ K NIL N K DF +S G+ +
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMA 155
Query: 128 DRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHI 170
+ +GTR Y +PE + +S+++S G L E+ GR I
Sbjct: 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 6e-04
Identities = 31/145 (21%), Positives = 62/145 (42%), Gaps = 9/145 (6%)
Query: 27 SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI------FGAPLPRLKIASDIVNSLAY 80
+H +I+ +G C +++ + YG L + + F L + + +A+
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 81 LHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPE 140
L + + R+ +N+L + K DF L+ I ++ + APE
Sbjct: 157 LAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213
Query: 141 YISICVLNEKSNVFSFGAFLFELLA 165
I CV +S+V+S+G L+E+ +
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 6e-04
Identities = 51/230 (22%), Positives = 87/230 (37%), Gaps = 33/230 (14%)
Query: 16 CINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIV 75
CI I Q++H +++K ++ +V + + G L I + I V
Sbjct: 49 CIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV 108
Query: 76 --------NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITT 127
++L ++H R ++ R+ K N+ V K D L T
Sbjct: 109 WKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AA 163
Query: 128 DRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEY 187
++GT Y +PE I N KS+++S G L+E+ A + F+ +
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ-------------SPFYGDK 210
Query: 188 LKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237
+ Y K+ P +P ++L QL C+N PE RP
Sbjct: 211 MNLYSLCKKIEQCDYP----PLPSDHYSEELR---QLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 6e-04
Identities = 40/161 (24%), Positives = 65/161 (40%), Gaps = 15/161 (9%)
Query: 15 SCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI-----FGAPLPR-- 67
+N I A ++H +I+ L +V + +G L I +P
Sbjct: 45 DAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQE 104
Query: 68 -LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT 126
+I ++ L LH + I+ R+ K+ NIL ++ K D L IS +
Sbjct: 105 IWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGD--LGISKVLKKNMAK 159
Query: 127 TDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
T IGT Y APE + KS+++S G L+E+
Sbjct: 160 T--QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 6e-04
Identities = 28/100 (28%), Positives = 49/100 (49%), Gaps = 10/100 (10%)
Query: 68 LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITT 127
L A+D+ + YL + + R+ +NIL E VAK DF LS G+ +
Sbjct: 115 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLS----RGQ-EVYV 166
Query: 128 DRVIGTRG--YSAPEYISICVLNEKSNVFSFGAFLFELLA 165
+ +G + A E ++ V S+V+S+G L+E+++
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 6e-04
Identities = 31/154 (20%), Positives = 67/154 (43%), Gaps = 19/154 (12%)
Query: 26 MSHNHILKRIGCCLQTPIPILVFQSVEYGTL-------RDCIFGAPLPRL--KIASDIVN 76
++H ++L+ +G C+++ +LV + G L R + + ++A ++ +
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111
Query: 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGY 136
L +LH + + +N + K D+ L++ + +IT D +
Sbjct: 112 GLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRW 168
Query: 137 SAPEYISICVLN-------EKSNVFSFGAFLFEL 163
APE + I + +KSN++S G ++EL
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 7e-04
Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 9/103 (8%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128
KIA IV +L YLH ++ R+ K N+L N K DF +S + + +
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---VAKT 161
Query: 129 RVIGTRGYSAPEYI----SICVLNEKSNVFSFGAFLFELLAGR 167
G + Y APE I + + KS+V+S G + EL GR
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 7e-04
Identities = 37/148 (25%), Positives = 68/148 (45%), Gaps = 17/148 (11%)
Query: 25 QMSHNHILKRIGCCL-QTPIPILVFQSVEYGT-------LRDCIFG-APLPRLKIASDIV 75
++SH +++ G C Q PI I+ EY + LR+ P L++ D+
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYIVT----EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVC 110
Query: 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRG 135
+AYL + + R+ +N L +++ K DF LS + + E + R
Sbjct: 111 EGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR- 166
Query: 136 YSAPEYISICVLNEKSNVFSFGAFLFEL 163
+S PE + + KS+V++FG ++E+
Sbjct: 167 WSPPEVLLYSKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 7e-04
Identities = 41/177 (23%), Positives = 76/177 (42%), Gaps = 26/177 (14%)
Query: 28 HNHILKRIGCCLQTPIPILVFQSVEYGTLRD------------CIFGAPLPRLKIASDIV 75
H +I+ +G C Q ++ + G LR+ C +P +++ +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 76 NSLAY-----LHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRV 130
S AY + + + + R+ +N+L E+NV K DF L+ I + + T
Sbjct: 143 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 131 IGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL--LAGRIH-------IWDLLKDTH 178
+ APE + + +S+V+SFG L+E+ L G + ++ LLK+ H
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 259
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 7e-04
Identities = 28/97 (28%), Positives = 47/97 (48%), Gaps = 5/97 (5%)
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRV 130
A++IV L +LH + I+ R+ K N++ + + K DF + G+ +T
Sbjct: 102 AAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--F 156
Query: 131 IGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
GT Y APE + + +SFG L+E+L G+
Sbjct: 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 8e-04
Identities = 29/102 (28%), Positives = 48/102 (47%), Gaps = 6/102 (5%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128
K++ ++ L YL I+ R+ K NIL N K DF +S + + +
Sbjct: 107 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 160
Query: 129 RVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHI 170
+GTR Y +PE + + +S+++S G L E+ GR I
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 8e-04
Identities = 46/170 (27%), Positives = 74/170 (43%), Gaps = 33/170 (19%)
Query: 24 AQMSHNHILKRIG-CCLQTPIPILVFQSVEYGTL----RDC-----------------IF 61
A+ H +I+K +G C + P+ L+F+ + YG L R
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPM-CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 62 GAPLP-----RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSI 116
PLP +L IA + +AYL R V R+ T+N L E V K DF LS
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
Query: 117 SIPEGETH-ITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165
+I + + + + I R + PE I +S+V+++G L+E+ +
Sbjct: 179 NIYSADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 8e-04
Identities = 37/142 (26%), Positives = 64/142 (45%), Gaps = 16/142 (11%)
Query: 57 RDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDF-LLS 115
R+ +F R ++IV++L YLH +V R+ K +N++ +++ K DF L
Sbjct: 88 RERVFSEDRARF-YGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143
Query: 116 ISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLK 175
I +G T GT Y APE + + + G ++E++ GR+ ++
Sbjct: 144 EGISDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--- 197
Query: 176 DTHDHGCFFNEYLKNYLEDKRF 197
DH F L +E+ RF
Sbjct: 198 --QDHEKLFELIL---MEEIRF 214
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 8e-04
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 5/95 (5%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128
I +V +L YLH + IV R+ NI+ E++ DF L+ E+ +T+
Sbjct: 117 NIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP-ESKLTS- 172
Query: 129 RVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163
V+GT YS PE + EK++V++FG L+++
Sbjct: 173 -VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 8e-04
Identities = 30/122 (24%), Positives = 53/122 (43%), Gaps = 4/122 (3%)
Query: 46 LVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEEN 105
+V + + G+L D + + +IA+ L L F ++ R+ K+ NIL +
Sbjct: 94 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG 153
Query: 106 VAKWFDFLLSISI-PEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164
K DF I PE ++GT + APE ++ K +++S G E++
Sbjct: 154 SVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210
Query: 165 AG 166
G
Sbjct: 211 EG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 8e-04
Identities = 36/114 (31%), Positives = 52/114 (45%), Gaps = 6/114 (5%)
Query: 53 YGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDF 112
Y R+ F P R A++I ++L YLH IV R+ K +NIL + + DF
Sbjct: 85 YHLQRERCFLEPRARF-YAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDF 140
Query: 113 LLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
L E + TT GT Y APE + + + + GA L+E+L G
Sbjct: 141 GLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 8e-04
Identities = 41/150 (27%), Positives = 66/150 (44%), Gaps = 15/150 (10%)
Query: 26 MSHNH-ILKRIGCCLQTPIPIL-VFQSVEYGTL-----RDCIFGAPLPRLKIASDIVNSL 78
++ H L + CC QT + V + V G L R F P R A+++ +L
Sbjct: 51 LAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLAL 109
Query: 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDF-LLSISIPEGETHITTDRVIGTRGYS 137
+LH ++ R+ K NIL + E K DF + I G +TT GT Y
Sbjct: 110 MFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---VTTTTFCGTPDYI 163
Query: 138 APEYISICVLNEKSNVFSFGAFLFELLAGR 167
APE + + ++ G ++E++AG+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 0.001
Identities = 37/137 (27%), Positives = 56/137 (40%), Gaps = 29/137 (21%)
Query: 78 LAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLS--ISIPEGETHITTDRVIGTRG 135
L YLH ++ R+ K NIL N K DF L+ + E E T+ V+ TR
Sbjct: 116 LKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRW 171
Query: 136 YSAPEYISICVLNEKS-----NVFSFGAFLFELLAGR--------IHIWDLLKDT----- 177
Y APE + L+ +++S G ELL + I +L+ +
Sbjct: 172 YRAPELL----LSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227
Query: 178 -HDHGCFFNEYLKNYLE 193
D +E +NYL+
Sbjct: 228 EEDLKFITSEKARNYLK 244
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 33/104 (31%), Positives = 49/104 (47%), Gaps = 6/104 (5%)
Query: 64 PLPRLKI-ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE 122
P PR + A++I ++L YLH I+ R+ K +NIL + + DF L E
Sbjct: 94 PEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS 150
Query: 123 THITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
TT GT Y APE + + + + GA L+E+L G
Sbjct: 151 K--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.001
Identities = 35/150 (23%), Positives = 65/150 (43%), Gaps = 2/150 (1%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVN 76
IN I + H +I+ + L +V + + G+L D + + +IA+
Sbjct: 64 INEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE 123
Query: 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGY 136
L L F ++ R+ K+ NIL + K DF I ++ +T ++GT +
Sbjct: 124 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYW 181
Query: 137 SAPEYISICVLNEKSNVFSFGAFLFELLAG 166
APE ++ K +++S G E++ G
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 26/85 (30%), Positives = 42/85 (49%)
Query: 81 LHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPE 140
+ F R + R+ +NIL +E NV K DF L+ I + ++ + APE
Sbjct: 192 MEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251
Query: 141 YISICVLNEKSNVFSFGAFLFELLA 165
I V +S+V+SFG L+E+ +
Sbjct: 252 TIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 43/157 (27%), Positives = 69/157 (43%), Gaps = 28/157 (17%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKI--------ASDIVN 76
S++ L + C QT + F +E+ + D +F R K+ +++I
Sbjct: 51 TASNHPFLVGLHSCFQTESRL--FFVIEFVSGGDLMFHMQRQR-KLPEEHARFYSAEISL 107
Query: 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDF-LLSISIPEGETHITTDRVIGTRG 135
+L +LH R I+ R+ K N+L + E K D+ + I G+ TT GT
Sbjct: 108 ALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTFCGTPN 161
Query: 136 YSAPEYISICVLNEKSNVFS-----FGAFLFELLAGR 167
Y APE +L + FS G +FE++AGR
Sbjct: 162 YIAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.001
Identities = 38/160 (23%), Positives = 66/160 (41%), Gaps = 17/160 (10%)
Query: 16 CINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF-----GAPLPRLKI 70
C+ I Q+ H +++K + ++ +V + + G L I +P I
Sbjct: 49 CLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI 108
Query: 71 ASDIV---NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLS--ISIPEGETHI 125
V ++L ++H + I+ R+ K N+ V K D L S H
Sbjct: 109 WKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH- 164
Query: 126 TTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165
++GT Y +PE I N KS+++S G L+E+ A
Sbjct: 165 ---SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.001
Identities = 34/111 (30%), Positives = 52/111 (46%), Gaps = 8/111 (7%)
Query: 57 RDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSI 116
R+ F P R A+++ +++ YLH I+ R+ K +NIL + + DF L
Sbjct: 89 RERCFLEPRARF-YAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLC- 143
Query: 117 SIPEG-ETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
EG E TT GT Y APE + + + + GA L+E+L G
Sbjct: 144 --KEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.001
Identities = 48/176 (27%), Positives = 76/176 (43%), Gaps = 29/176 (16%)
Query: 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEY--GTLRD 58
M + G + + + I + + Q+ H + ++ GC L+ LV +EY G+ D
Sbjct: 54 MSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV---MEYCLGSASD 109
Query: 59 C--IFGAPLPRLKIAS---DIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDF- 112
+ PL ++IA+ + LAYLH ++ R+ K NIL E K DF
Sbjct: 110 LLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFG 166
Query: 113 LLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNE-----KSNVFSFGAFLFEL 163
S S P + +GT + APE I ++E K +V+S G EL
Sbjct: 167 SASKSSP-------ANSFVGTPYWMAPEV--ILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.001
Identities = 36/126 (28%), Positives = 52/126 (41%), Gaps = 12/126 (9%)
Query: 46 LVFQSVEYGTLRDCIFG-APLPRLKI---ASDIVNSLAYLHFGFPRPIVLRNFKTQNILF 101
LV Q E G L I +P + A+++V +L LH IV R+ NIL
Sbjct: 62 LVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILL 118
Query: 102 NEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLF 161
++ + F + + + D Y APE I E + +S GA LF
Sbjct: 119 DDRGHIQLTYFSRWSEVED-----SCDGEAVENMYCAPEVGGISEETEACDWWSLGAILF 173
Query: 162 ELLAGR 167
ELL G+
Sbjct: 174 ELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.002
Identities = 40/177 (22%), Positives = 74/177 (41%), Gaps = 26/177 (14%)
Query: 28 HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVN----------- 76
H +I+ +G C Q ++ + G LR+ + P ++ + DI
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 77 -SLAY-----LHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRV 130
S Y + + + + R+ +N+L E NV K DF L+ + + + T
Sbjct: 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 131 IGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL--LAGRIH-------IWDLLKDTH 178
+ APE + V +S+V+SFG ++E+ L G + ++ LLK+ H
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.002
Identities = 31/128 (24%), Positives = 64/128 (50%), Gaps = 16/128 (12%)
Query: 46 LVFQSVEYGTLRDCIFGAPLPRLKIAS---DIVNSLAYLHFGFPRPIVLRNFKTQNILFN 102
+V + +E G L D + + +IA+ ++ +L+YLH + ++ R+ K+ +IL
Sbjct: 96 VVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLT 152
Query: 103 EENVAKWFDF----LLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGA 158
+ K DF +S +P+ ++ ++GT + APE IS + +++S G
Sbjct: 153 SDGRIKLSDFGFCAQVSKEVPKRKS------LVGTPYWMAPEVISRLPYGTEVDIWSLGI 206
Query: 159 FLFELLAG 166
+ E++ G
Sbjct: 207 MVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.002
Identities = 42/162 (25%), Positives = 68/162 (41%), Gaps = 18/162 (11%)
Query: 60 IFGAPLPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIP 119
I G PL K+ + L L + I+ R+ K N+ NE+ K DF L+
Sbjct: 109 IMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH-- 166
Query: 120 EGETHITTDRVIGTRGYSAPEYI-SICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTH 178
+ +T V TR Y APE I + N+ +++S G + E+L G+ L K
Sbjct: 167 -ADAEMTGYVV--TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT----LFKG-- 217
Query: 179 DHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHA 220
+YL + + TG+P P VQ + + + +
Sbjct: 218 ------KDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKS 253
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.002
Identities = 21/74 (28%), Positives = 35/74 (47%)
Query: 92 RNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKS 151
R+ +NIL + K DF L+ I ++ + APE I CV +S
Sbjct: 238 RDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFES 297
Query: 152 NVFSFGAFLFELLA 165
+V+S+G L+E+ +
Sbjct: 298 DVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.002
Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 12/111 (10%)
Query: 64 PLP---RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPE 120
PLP + I ++ +LAYLH R I+ R+ KT+NI +E A DF + +
Sbjct: 181 PLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237
Query: 121 GETHITTDRV---IGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRI 168
H T + GT ++PE +++ K++++S G LFE+ +
Sbjct: 238 ---HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285
|
Length = 392 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.002
Identities = 26/95 (27%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVI 131
+++V + YLH + I+ R+ K +N+L + + K DF + +P+ T +
Sbjct: 125 AELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLC 176
Query: 132 GTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
GT Y APE I + + ++ G L+E +AG
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.002
Identities = 38/155 (24%), Positives = 67/155 (43%), Gaps = 19/155 (12%)
Query: 28 HNHILKRIGCCLQT-PIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVN---------- 76
H +I+ +G C Q P+ +LV + G LR+ + P + + D
Sbjct: 77 HKNIINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 77 --SLAY-----LHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
S AY + + + + R+ +N+L E+NV K DF L+ + + + T
Sbjct: 136 LVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164
+ APE + V +S+V+SFG L+E+
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.002
Identities = 35/161 (21%), Positives = 73/161 (45%), Gaps = 17/161 (10%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYG-------TLRDCIFGAP---LP 66
+N + + + +H+++ +G Q +++ + + G +LR + P P
Sbjct: 57 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116
Query: 67 RLK----IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE 122
LK +A +I + +AYL+ V R+ +N + E+ K DF ++ I E +
Sbjct: 117 SLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173
Query: 123 THITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163
+ + + + +PE + V S+V+SFG L+E+
Sbjct: 174 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.002
Identities = 30/128 (23%), Positives = 63/128 (49%), Gaps = 16/128 (12%)
Query: 46 LVFQSVEYGTLRDCIFGAPLPRLKIAS---DIVNSLAYLHFGFPRPIVLRNFKTQNILFN 102
+V + +E G L D + + +IA+ ++ +L++LH + ++ R+ K+ +IL
Sbjct: 93 VVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLT 149
Query: 103 EENVAKWFDF----LLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGA 158
+ K DF +S +P ++ ++GT + APE IS + +++S G
Sbjct: 150 SDGRVKLSDFGFCAQVSKEVPRRKS------LVGTPYWMAPEVISRLPYGTEVDIWSLGI 203
Query: 159 FLFELLAG 166
+ E++ G
Sbjct: 204 MVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.002
Identities = 38/129 (29%), Positives = 60/129 (46%), Gaps = 12/129 (9%)
Query: 46 LVFQSVE---YGTLRDCIFGAPLPRLK-IASDIVNSLAYLHFGFPRPIVLRNFKTQNILF 101
LVF+ ++ Y ++D G P +K ++ LA+ H I+ R+ K +N+L
Sbjct: 75 LVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLI 131
Query: 102 NEENVAKWFDFLLSISI-PEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAF 159
N E V K DF L+ S + T V+ TR Y APE + + +++S G
Sbjct: 132 NTEGVLKLADFGLARSFGSPVRPY--THYVV-TRWYRAPELLLGDKGYSTPVDIWSVGCI 188
Query: 160 LFELLAGRI 168
ELL+ R
Sbjct: 189 FAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.003
Identities = 38/155 (24%), Positives = 67/155 (43%), Gaps = 19/155 (12%)
Query: 28 HNHILKRIGCCLQT-PIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVN---------- 76
H +I+ +G C Q P+ ++V + G LR+ + P DI
Sbjct: 77 HKNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 77 --SLAY-----LHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
S AY + + R + R+ +N+L E+NV K DF L+ + + + + T
Sbjct: 136 LVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164
+ APE + V +S+V+SFG ++E+
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIF 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.003
Identities = 30/106 (28%), Positives = 54/106 (50%), Gaps = 6/106 (5%)
Query: 65 LPRL-KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET 123
LP+L ++ I +AY+ + + R+ + N+L +E + K DF L+ I + E
Sbjct: 102 LPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158
Query: 124 HITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA-GRI 168
+ ++APE I+ KS+V+SFG L+E++ G+I
Sbjct: 159 TAREGAKFPIK-WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKI 203
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.003
Identities = 31/97 (31%), Positives = 43/97 (44%), Gaps = 17/97 (17%)
Query: 78 LAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYS 137
L YLH I+ R+ K NIL N + V K DF L+ + + T+RVI T Y
Sbjct: 113 LQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYR 168
Query: 138 APE-------YISICVLNEKSNVFSFGAFLFELLAGR 167
PE Y + +++S G L EL G+
Sbjct: 169 PPELLLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 37.2 bits (86), Expect = 0.004
Identities = 58/226 (25%), Positives = 93/226 (41%), Gaps = 46/226 (20%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTL------RDCIFGAPLPRLKIASDIVNSL 78
Q+SH HI+ G C++ I+V + VE+G L + + P + K+A + ++L
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW-KFKVAKQLASAL 118
Query: 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE-THITTDRVIGTRGYS 137
+YL + +V N T+NIL E + + +S P T ++ + +
Sbjct: 119 SYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIPWI 175
Query: 138 APEYISICVLNEK-----SNVFSFGAFLFEL-LAGRIHIWDLLKDTHDHGCFFNEYLKNY 191
APE CV + K ++ +SFG L+E+ G I LKD K
Sbjct: 176 APE----CVEDSKNLSIAADKWSFGTTLWEICYNGEIP----LKD------------KTL 215
Query: 192 LEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237
E +RF ++ C E A L C+N P RP
Sbjct: 216 AEKERFYEGQCMLVTPS--CKE-------LADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 37.3 bits (87), Expect = 0.004
Identities = 29/88 (32%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 56 LRDCIFGAPLPRLKIAS---DIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDF 112
LRD PLP ++ S ++ +AY+H I+ R+ K N+L + + V K DF
Sbjct: 89 LRDE--ERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADF 143
Query: 113 LLSISIPEGETHITTDRVIGTRGYSAPE 140
L+ E E + + +V TR Y APE
Sbjct: 144 GLARLFSEEEPRLYSHQV-ATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 37.3 bits (87), Expect = 0.004
Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 6/97 (6%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEG--ETHITTDRVI 131
++ L YLH + R+ K NIL E+ K DF +S S+ +G T +
Sbjct: 111 VLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV 167
Query: 132 GTRGYSAPEYIS-ICVLNEKSNVFSFGAFLFELLAGR 167
GT + APE + + + K++++SFG EL G
Sbjct: 168 GTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.004
Identities = 41/156 (26%), Positives = 64/156 (41%), Gaps = 26/156 (16%)
Query: 25 QMSHNHI--LKRIGCCLQTPIPILVFQSVEY---GTLRDCIFGAPLPRLK-IASDIVNSL 78
++ H +I L + + + LVF+ + L +K I ++ L
Sbjct: 54 ELKHPNIVKLLDV-IHTERKL-YLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGL 111
Query: 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLS--ISIPEGETHITTDRVIGTRGY 136
AY H I+ R+ K QNIL N + V K DF L+ IP T V+ T Y
Sbjct: 112 AYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP---LRTYTHEVV-TLWY 164
Query: 137 SAPEYISICVLNEKS-----NVFSFGAFLFELLAGR 167
APE + L K +++S G E++ G+
Sbjct: 165 RAPEIL----LGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 241 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.76 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.74 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.71 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.7 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.64 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.62 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.61 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.6 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.59 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.52 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.51 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.46 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.45 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.44 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.24 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.18 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.18 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.16 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.15 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.06 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.03 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.96 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.94 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.92 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.92 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.85 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.85 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.78 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.75 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.69 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.45 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.39 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.33 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.31 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.25 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.09 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.07 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.04 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.0 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.55 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.53 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.47 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.45 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.4 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.4 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.29 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.14 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.84 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.76 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.42 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.31 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.15 | |
| PLN02236 | 344 | choline kinase | 96.01 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.82 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.47 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 95.46 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 95.29 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.88 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 93.86 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 93.42 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 93.35 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 93.34 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.3 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 93.29 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 92.32 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 92.22 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 92.19 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 91.28 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 91.15 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 91.13 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 91.09 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 90.74 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 89.79 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 89.74 | |
| COG4499 | 434 | Predicted membrane protein [Function unknown] | 87.34 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 86.99 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 85.8 | |
| KOG4720 | 391 | consensus Ethanolamine kinase [Lipid transport and | 85.4 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 85.35 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=301.16 Aligned_cols=217 Identities=22% Similarity=0.263 Sum_probs=176.5
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCc-ceEEEEecCCCCHHHhhcCC----CchHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPI-PILVFQSVEYGTLRDCIFGA----PLPRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~ 76 (241)
|......+....++..+|+++++..+||+||.+||.|...+. ..++||||.+|||.+++... +...-+++.++++
T Consensus 110 K~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~ 189 (364)
T KOG0581|consen 110 KVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLR 189 (364)
T ss_pred EeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHH
Confidence 455555566678889999999999999999999999999995 99999999999999998853 2245689999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSF 156 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~ 156 (241)
||.|||. +++|+||||||+|+|++..|.+||+|||.+..+.+. ...+.+||..|||||.+.+..|+.++|||||
T Consensus 190 GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSL 263 (364)
T KOG0581|consen 190 GLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSL 263 (364)
T ss_pred HHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecc
Confidence 9999994 489999999999999999999999999999877655 3366789999999999999999999999999
Q ss_pred HHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCC
Q 044022 157 GAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDR 236 (241)
Q Consensus 157 G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 236 (241)
|+.++|+++|+.||... ......+.+.+.....+. .+.++.. .+++++++|+..||++||.+|
T Consensus 264 GLsllE~a~GrfP~~~~----~~~~~~~~~Ll~~Iv~~p------pP~lP~~-------~fS~ef~~FV~~CL~Kdp~~R 326 (364)
T KOG0581|consen 264 GLSLLELAIGRFPYPPP----NPPYLDIFELLCAIVDEP------PPRLPEG-------EFSPEFRSFVSCCLRKDPSER 326 (364)
T ss_pred cHHHHHHhhCCCCCCCc----CCCCCCHHHHHHHHhcCC------CCCCCcc-------cCCHHHHHHHHHHhcCCcccC
Confidence 99999999999999652 111223333333332211 1122111 355789999999999999999
Q ss_pred CCCCC
Q 044022 237 PTMVD 241 (241)
Q Consensus 237 pt~~e 241 (241)
||++|
T Consensus 327 ~s~~q 331 (364)
T KOG0581|consen 327 PSAKQ 331 (364)
T ss_pred CCHHH
Confidence 99864
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=309.25 Aligned_cols=203 Identities=26% Similarity=0.358 Sum_probs=169.6
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~ 84 (241)
...++|.+|+++|++|+|+|||+++++|..++.++||||||+.|+|.++|+... .+.+.++.||++|++||.
T Consensus 243 m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe-- 320 (468)
T KOG0197|consen 243 MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE-- 320 (468)
T ss_pred cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH--
Confidence 456889999999999999999999999999889999999999999999998732 156789999999999999
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
++++|||||.++|||++.+..+||+|||+++...... ........-+..|+|||.+..+.++.+|||||||+++||++
T Consensus 321 -s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~f 398 (468)
T KOG0197|consen 321 -SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELF 398 (468)
T ss_pred -hCCccchhhhhhheeeccCceEEEcccccccccCCCc-eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHh
Confidence 9999999999999999999999999999999544432 22333345678899999999999999999999999999999
Q ss_pred h-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 165 A-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 165 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
| |+.|+.. ....+.+... +.+.....++ .++..+.++|..||+.+|++|||++
T Consensus 399 T~G~~py~~---------msn~ev~~~l-e~GyRlp~P~-------------~CP~~vY~lM~~CW~~~P~~RPtF~ 452 (468)
T KOG0197|consen 399 TYGRVPYPG---------MSNEEVLELL-ERGYRLPRPE-------------GCPDEVYELMKSCWHEDPEDRPTFE 452 (468)
T ss_pred ccCCCCCCC---------CCHHHHHHHH-hccCcCCCCC-------------CCCHHHHHHHHHHhhCCcccCCCHH
Confidence 8 8888854 3334444443 3343333332 4557899999999999999999985
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=303.56 Aligned_cols=201 Identities=28% Similarity=0.397 Sum_probs=164.3
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCC-cceEEEEecCCCCHHHhhcCC---Cc---hHHHHHHHHHHHhchhhcCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTP-IPILVFQSVEYGTLRDCIFGA---PL---PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~---~~---~~~~~~~~i~~~l~~lh~~~ 85 (241)
.+.|.+|+.+|.+++|||||+++|+|.+.. .+++||||+++|+|.+++... .. .++.++.+|+.|+.|||
T Consensus 83 ~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH--- 159 (362)
T KOG0192|consen 83 RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH--- 159 (362)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---
Confidence 679999999999999999999999999887 799999999999999999762 11 47899999999999999
Q ss_pred CCC-ceeccCCCCCeeecCCC-CeEEeeccCceecCCCCcceeecccccCCCccCccccc--ccCCCcchhhHHHHHHHH
Q 044022 86 PRP-IVLRNFKTQNILFNEEN-VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS--ICVLNEKSNVFSFGAFLF 161 (241)
Q Consensus 86 ~~~-ivh~dl~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Di~s~G~~~~ 161 (241)
+++ |||||||++|+|++.++ ++||+|||+++...... ...+...||+.|||||++. ...++.++||||||+++|
T Consensus 160 ~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlW 237 (362)
T KOG0192|consen 160 SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLW 237 (362)
T ss_pred cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHH
Confidence 778 99999999999999997 99999999998765432 1123357999999999999 568999999999999999
Q ss_pred HHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 162 ELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 162 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
|++||+.||..... ..........+....++. .+.+.+..++.+||..||+.||++.
T Consensus 238 El~t~~~Pf~~~~~---------~~~~~~v~~~~~Rp~~p~-------------~~~~~l~~l~~~CW~~dp~~RP~f~ 294 (362)
T KOG0192|consen 238 ELLTGEIPFEDLAP---------VQVASAVVVGGLRPPIPK-------------ECPPHLSSLMERCWLVDPSRRPSFL 294 (362)
T ss_pred HHHHCCCCCCCCCH---------HHHHHHHHhcCCCCCCCc-------------cCCHHHHHHHHHhCCCCCCcCCCHH
Confidence 99999999966321 112222222222222222 1336789999999999999999975
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=299.02 Aligned_cols=232 Identities=35% Similarity=0.542 Sum_probs=190.7
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCC-cceEEEEecCCCCHHHhhcCCCc------hHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTP-IPILVFQSVEYGTLRDCIFGAPL------PRLKIASD 73 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~~ 73 (241)
||.+......+ ..+|.+|+.++.+++|||+|+++|||.+.+ +.++|+||+++|||.+.+..... +|++|+.+
T Consensus 104 VK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g 182 (361)
T KOG1187|consen 104 VKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALG 182 (361)
T ss_pred EEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 45444444433 667999999999999999999999999988 59999999999999999977542 58999999
Q ss_pred HHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCC-CCcceeecccccCCCccCcccccccCCCcchh
Q 044022 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPE-GETHITTDRVIGTRGYSAPEYISICVLNEKSN 152 (241)
Q Consensus 74 i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 152 (241)
+|.||+|||+.+...|+|||||++|||+|.+.++||+|||+++..+. ....... ..||.+|+|||+...+..+.++|
T Consensus 183 ~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~--~~gt~gY~~PEy~~~g~lt~KsD 260 (361)
T KOG1187|consen 183 AARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTT--VMGTFGYLAPEYASTGKLTEKSD 260 (361)
T ss_pred HHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeee--cCCCCccCChhhhccCCcCcccc
Confidence 99999999987777899999999999999999999999999966554 2221111 16899999999999999999999
Q ss_pred hHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCcccc-CCCchhHHHHHHHHHHHHHHhccC
Q 044022 153 VFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQ-DIPCIEKEQQLHASAQLTLECVNN 231 (241)
Q Consensus 153 i~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~cl~~ 231 (241)
|||||++++|+++|+.|.+... ........+|.+.....+...++.|+.+.. .++.. .....+..+..+|++.
T Consensus 261 VySFGVvllElitgr~~~d~~~---~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~---~~~~~~~~~a~~C~~~ 334 (361)
T KOG1187|consen 261 VYSFGVVLLELITGRKAVDQSR---PRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDE---KEVKKLAELALRCLRP 334 (361)
T ss_pred cccchHHHHHHHhCCcccCCCC---CcccccHHHHHHHHHHCcchhheeCCCccCCCCChH---HHHHHHHHHHHHHcCc
Confidence 9999999999999998876422 122333788888888888899999999873 33211 4556789999999999
Q ss_pred CCCCCCCCCC
Q 044022 232 SPEDRPTMVD 241 (241)
Q Consensus 232 ~p~~Rpt~~e 241 (241)
+|.+||++.|
T Consensus 335 ~~~~RP~m~~ 344 (361)
T KOG1187|consen 335 DPKERPTMSQ 344 (361)
T ss_pred CCCcCcCHHH
Confidence 9999999854
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=292.90 Aligned_cols=204 Identities=23% Similarity=0.296 Sum_probs=163.1
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
.....+|+++|++|+|||||+++++|...+..|||+||++||.|.+++-++.. ....++.|++.|+.||| ++|
T Consensus 220 ~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH---~~G 296 (475)
T KOG0615|consen 220 TRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLH---SQG 296 (475)
T ss_pred hhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHH---HcC
Confidence 44467999999999999999999999999999999999999999999876643 34568899999999999 999
Q ss_pred ceeccCCCCCeeecCC---CCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCC---CcchhhHHHHHHHHH
Q 044022 89 IVLRNFKTQNILFNEE---NVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVL---NEKSNVFSFGAFLFE 162 (241)
Q Consensus 89 ivh~dl~~~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~Di~s~G~~~~~ 162 (241)
|+||||||+|||+..+ ..+||+|||+++.....+. -.+.+||+.|.|||++.+... ..++||||+||++|-
T Consensus 297 I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sf---m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfv 373 (475)
T KOG0615|consen 297 IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSF---MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFV 373 (475)
T ss_pred cccccCCcceEEeccCCcceEEEecccchhhcccccee---hhhhcCCccccChhheecCCeecccchheeeeccceEEE
Confidence 9999999999999876 6789999999988764432 245689999999999987643 347899999999999
Q ss_pred HHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 163 LLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 163 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+++|.+||.+..- ... +......+.+.-. +.....-++...+||..||..||++|||++|
T Consensus 374 cLsG~pPFS~~~~-----~~s----l~eQI~~G~y~f~----------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~e 433 (475)
T KOG0615|consen 374 CLSGYPPFSEEYT-----DPS----LKEQILKGRYAFG----------PLQWDRISEEALDLINWMLVVDPENRPSADE 433 (475)
T ss_pred EeccCCCcccccC-----Ccc----HHHHHhcCccccc----------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHH
Confidence 9999999965211 111 2222222322211 1223355678899999999999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=279.35 Aligned_cols=208 Identities=23% Similarity=0.337 Sum_probs=170.4
Q ss_pred cccccHHHHHHHHHHHHhcCCCcccceee-eeeeCCc-ceEEEEecCCCCHHHhhcCC--------CchHHHHHHHHHHH
Q 044022 8 YHRHTYGSCINNITYAAQMSHNHILKRIG-CCLQTPI-PILVFQSVEYGTLRDCIFGA--------PLPRLKIASDIVNS 77 (241)
Q Consensus 8 ~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~~-~~lv~e~~~~~sL~~~l~~~--------~~~~~~~~~~i~~~ 77 (241)
.++...+....|+.+|++|+|||||++++ .|.++.. +++|||+|.+|+|.+.++.. +...++++.|++.|
T Consensus 57 md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~A 136 (375)
T KOG0591|consen 57 MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRA 136 (375)
T ss_pred ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHH
Confidence 34556778899999999999999999999 6666555 89999999999999988643 22578999999999
Q ss_pred hchhhcCCCC-CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHH
Q 044022 78 LAYLHFGFPR-PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSF 156 (241)
Q Consensus 78 l~~lh~~~~~-~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~ 156 (241)
|..+|+-..+ .+.||||||.||+++.+|.+|++|||+++.+....+. ..+.+|||.||+||.+...+|+.+|||||+
T Consensus 137 L~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWsl 214 (375)
T KOG0591|consen 137 LYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSL 214 (375)
T ss_pred HHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHH
Confidence 9999942223 3899999999999999999999999999988765443 356789999999999999999999999999
Q ss_pred HHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCC
Q 044022 157 GAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDR 236 (241)
Q Consensus 157 G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 236 (241)
||++|||+.-++||+.. .+.+. ....+++.+.+++ .+.++.++..++..|+..||..|
T Consensus 215 GCllyEMcaL~~PF~g~---------n~~~L-~~KI~qgd~~~~p------------~~~YS~~l~~li~~ci~vd~~~R 272 (375)
T KOG0591|consen 215 GCLLYEMCALQSPFYGD---------NLLSL-CKKIEQGDYPPLP------------DEHYSTDLRELINMCIAVDPEQR 272 (375)
T ss_pred HHHHHHHHhcCCCcccc---------cHHHH-HHHHHcCCCCCCc------------HHHhhhHHHHHHHHHccCCcccC
Confidence 99999999999999652 22222 2233344443333 24778899999999999999999
Q ss_pred CCC
Q 044022 237 PTM 239 (241)
Q Consensus 237 pt~ 239 (241)
|+.
T Consensus 273 P~t 275 (375)
T KOG0591|consen 273 PDT 275 (375)
T ss_pred CCc
Confidence 973
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=312.11 Aligned_cols=215 Identities=24% Similarity=0.378 Sum_probs=180.5
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---------------
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL--------------- 65 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------- 65 (241)
||....+...+...+|.+|++++..|+|||||+++|+|..++.+|||+|||.+|+|..||....+
T Consensus 521 VK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L 600 (774)
T KOG1026|consen 521 VKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPL 600 (774)
T ss_pred HhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCC
Confidence 56676666666889999999999999999999999999999999999999999999999965411
Q ss_pred ---hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccc
Q 044022 66 ---PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYI 142 (241)
Q Consensus 66 ---~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 142 (241)
+.+.++.||+.|+.||- ++.+|||||.++|+|++.+..|||+|||+++-.-........+.-.-+..|||||.+
T Consensus 601 ~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsI 677 (774)
T KOG1026|consen 601 STSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESI 677 (774)
T ss_pred CHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHh
Confidence 46889999999999999 999999999999999999999999999999866544333333333557899999999
Q ss_pred cccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHH
Q 044022 143 SICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHAS 221 (241)
Q Consensus 143 ~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (241)
..++++.+||||||||++||+++ |+.||+...++ + +-.....+.....++ .++..+
T Consensus 678 ly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~---------E-VIe~i~~g~lL~~Pe-------------~CP~~v 734 (774)
T KOG1026|consen 678 LYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ---------E-VIECIRAGQLLSCPE-------------NCPTEV 734 (774)
T ss_pred hcCcccchhhhhhhhhhhhhhhccccCcccccchH---------H-HHHHHHcCCcccCCC-------------CCCHHH
Confidence 99999999999999999999998 99999774433 2 334444555444443 555789
Q ss_pred HHHHHHhccCCCCCCCCCCC
Q 044022 222 AQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 222 ~~l~~~cl~~~p~~Rpt~~e 241 (241)
.+||+.||+.+|++|||+.|
T Consensus 735 Y~LM~~CW~~~P~~RPsF~e 754 (774)
T KOG1026|consen 735 YSLMLECWNENPKRRPSFKE 754 (774)
T ss_pred HHHHHHHhhcCcccCCCHHH
Confidence 99999999999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=292.60 Aligned_cols=203 Identities=20% Similarity=0.269 Sum_probs=169.2
Q ss_pred cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC----CchHHHHHHHHHHHhchhhcCC
Q 044022 10 RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA----PLPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 10 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~~lh~~~ 85 (241)
....+...+||+|.++|+|||||+++++|++.++.|||.|+|+.++|..+++.. +..+..++.||+.||.|||
T Consensus 59 ~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH--- 135 (592)
T KOG0575|consen 59 PKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLH--- 135 (592)
T ss_pred cchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHH---
Confidence 356778899999999999999999999999999999999999999999998854 3357889999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+++|+|||||..|+|++.+.++||+|||+|..+...... ..+.+||+-|.|||++.....+..+||||+||++|.++.
T Consensus 136 ~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~ 213 (592)
T KOG0575|consen 136 SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLV 213 (592)
T ss_pred hcCceecccchhheeecCcCcEEecccceeeeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhh
Confidence 999999999999999999999999999999888755322 234689999999999999999999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|++||.. ....+............ +. ..+....+||+++|+.||.+|||+++
T Consensus 214 G~PPFet---------k~vkety~~Ik~~~Y~~-------P~--------~ls~~A~dLI~~lL~~~P~~Rpsl~~ 265 (592)
T KOG0575|consen 214 GRPPFET---------KTVKETYNKIKLNEYSM-------PS--------HLSAEAKDLIRKLLRPNPSERPSLDE 265 (592)
T ss_pred CCCCccc---------chHHHHHHHHHhcCccc-------cc--------ccCHHHHHHHHHHhcCCcccCCCHHH
Confidence 9999965 22333333332222111 11 12246789999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=280.19 Aligned_cols=224 Identities=20% Similarity=0.253 Sum_probs=178.6
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc------hHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL------PRLKIASDI 74 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~~i 74 (241)
||.++.|-.....+.+.+|++.+..++||||++++.+|.-+..+|+||.||.+||+.+.++.... .+..+++++
T Consensus 56 IK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~ 135 (516)
T KOG0582|consen 56 IKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREV 135 (516)
T ss_pred EEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHH
Confidence 68888777777789999999999999999999999999999999999999999999999976522 466789999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-eee-cccccCCCccCcccccc--cCCCcc
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-ITT-DRVIGTRGYSAPEYISI--CVLNEK 150 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~-~~~~~~~~~~aPE~~~~--~~~~~~ 150 (241)
+.||.||| .+|.+|||+|+.|||++.+|.+||+|||.+..+-..... ... ...+|+++|||||++.. ..|+.|
T Consensus 136 LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfK 212 (516)
T KOG0582|consen 136 LKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFK 212 (516)
T ss_pred HHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccch
Confidence 99999999 999999999999999999999999999998776554322 222 55689999999999643 378999
Q ss_pred hhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhcc
Q 044022 151 SNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVN 230 (241)
Q Consensus 151 ~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 230 (241)
+||||||+...|+.+|..||..... ..-.+..+.+...... -...+.......+.+++.++..||.
T Consensus 213 aDIwSfGITA~ELA~G~aPf~k~pP--------mkvLl~tLqn~pp~~~------t~~~~~d~~k~~~ksf~e~i~~CL~ 278 (516)
T KOG0582|consen 213 ADIWSFGITACELAHGHAPFSKYPP--------MKVLLLTLQNDPPTLL------TSGLDKDEDKKFSKSFREMIALCLV 278 (516)
T ss_pred hhhhhhhHHHHHHhcCCCCcccCCh--------HHHHHHHhcCCCCCcc------cccCChHHhhhhcHHHHHHHHHHhh
Confidence 9999999999999999999966321 1112222222221111 1122223334666789999999999
Q ss_pred CCCCCCCCCCC
Q 044022 231 NSPEDRPTMVD 241 (241)
Q Consensus 231 ~~p~~Rpt~~e 241 (241)
+||++||||++
T Consensus 279 kDP~kRptAsk 289 (516)
T KOG0582|consen 279 KDPSKRPTASK 289 (516)
T ss_pred cCcccCCCHHH
Confidence 99999999863
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=290.64 Aligned_cols=205 Identities=20% Similarity=0.282 Sum_probs=170.8
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC---CchHHHHHHHHHHHhchhhcCCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA---PLPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
...+-.++|+.+|+..+|+|||.+++.|.-.+.+|+||||++||+|.+.+... +.++..++.+++.||+||| .+
T Consensus 312 ~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH---~~ 388 (550)
T KOG0578|consen 312 PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLH---AR 388 (550)
T ss_pred CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHH---hc
Confidence 44566789999999999999999999999999999999999999999999877 5578899999999999999 99
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcC
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
+|+|||||.+|||++.+|.+||+|||+|..+..... ...+.+||++|||||+.....|+++.||||||++++||+.|.
T Consensus 389 gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGE 466 (550)
T KOG0578|consen 389 GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGE 466 (550)
T ss_pred ceeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCC
Confidence 999999999999999999999999999988766543 346789999999999999999999999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+||... . -..-++-...++. ..+.. .+..+..+++|+.+||..|+.+|+||.|
T Consensus 467 PPYlnE-------~--PlrAlyLIa~ng~-P~lk~-----------~~klS~~~kdFL~~cL~~dv~~RasA~e 519 (550)
T KOG0578|consen 467 PPYLNE-------N--PLRALYLIATNGT-PKLKN-----------PEKLSPELKDFLDRCLVVDVEQRASAKE 519 (550)
T ss_pred CCccCC-------C--hHHHHHHHhhcCC-CCcCC-----------ccccCHHHHHHHHHHhhcchhcCCCHHH
Confidence 999541 1 1111111111221 11111 1244578999999999999999999864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=278.52 Aligned_cols=158 Identities=23% Similarity=0.378 Sum_probs=142.0
Q ss_pred ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcC
Q 044022 9 HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 9 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~ 84 (241)
.....+....|+.+|+.++|||||.++++++..+..|+|||||.||+|.++++.... ....++.||+.|+++||
T Consensus 49 ~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~-- 126 (429)
T KOG0595|consen 49 NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLH-- 126 (429)
T ss_pred CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 444566778999999999999999999999999999999999999999999987632 56778999999999999
Q ss_pred CCCCceeccCCCCCeeecCC------CCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEE------NVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGA 158 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~ 158 (241)
+++|+||||||+|||++.. ..+||+|||+++.+..... ..+.+|++.|||||++....|+.|+|+||+|+
T Consensus 127 -~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~ 202 (429)
T KOG0595|consen 127 -ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGT 202 (429)
T ss_pred -HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHH
Confidence 9999999999999999865 5689999999998876543 24568999999999999999999999999999
Q ss_pred HHHHHHhcCccccc
Q 044022 159 FLFELLAGRIHIWD 172 (241)
Q Consensus 159 ~~~~~~~g~~p~~~ 172 (241)
|+|++++|+.||..
T Consensus 203 Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 203 ILYQCLTGKPPFDA 216 (429)
T ss_pred HHHHHHhCCCCccc
Confidence 99999999999965
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=267.45 Aligned_cols=233 Identities=19% Similarity=0.248 Sum_probs=179.3
Q ss_pred ccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHH
Q 044022 3 FYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNS 77 (241)
Q Consensus 3 ~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~ 77 (241)
|...+.+....+-.++|+++|++|+|+|+|.++++|.....+++|+|||+. ++.+-+...+. ...+++.|++.|
T Consensus 35 F~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~a 113 (396)
T KOG0593|consen 35 FVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKA 113 (396)
T ss_pred eccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHH
Confidence 344555556677789999999999999999999999999999999999985 66555655432 356899999999
Q ss_pred hchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHH
Q 044022 78 LAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSF 156 (241)
Q Consensus 78 l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~ 156 (241)
+.|+| +++++||||||+|||++.++.+|++|||+++.+..... ..+-.+.|..|+|||.+.+ ..|+.++||||+
T Consensus 114 i~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAi 188 (396)
T KOG0593|consen 114 IHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAI 188 (396)
T ss_pred hhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc--hhhhhhhhhhccChhhhcccCcCCCcccchhh
Confidence 99999 99999999999999999999999999999998764322 1233578889999999988 689999999999
Q ss_pred HHHHHHHHhcCccccccccc------CCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhH-HHHHHHHHHHHHHhc
Q 044022 157 GAFLFELLAGRIHIWDLLKD------THDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEK-EQQLHASAQLTLECV 229 (241)
Q Consensus 157 G~~~~~~~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~cl 229 (241)
||++.||++|.+-|...... ....+....+...-+..++.+.++.-+......+.... ...+..+.+++..||
T Consensus 189 GCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL 268 (396)
T KOG0593|consen 189 GCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCL 268 (396)
T ss_pred hHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHh
Confidence 99999999999887542111 11223334444555555666666655544333332111 244457899999999
Q ss_pred cCCCCCCCCCCC
Q 044022 230 NNSPEDRPTMVD 241 (241)
Q Consensus 230 ~~~p~~Rpt~~e 241 (241)
..||++|+|.+|
T Consensus 269 ~~dP~~R~sc~q 280 (396)
T KOG0593|consen 269 KMDPDDRLSCEQ 280 (396)
T ss_pred cCCccccccHHH
Confidence 999999999754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=267.85 Aligned_cols=200 Identities=22% Similarity=0.270 Sum_probs=164.3
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
........|..+|.+++||+||++.-.|++...+|+|+||+.||.|...|+.... ...-++.+|+.||.||| +
T Consensus 67 ~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH---~ 143 (357)
T KOG0598|consen 67 KEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLH---S 143 (357)
T ss_pred hhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHH---h
Confidence 3567788999999999999999999999999999999999999999999986533 45668899999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
++|+||||||+|||+|.+|+++|+|||+++..-.... ...+.+||+.|||||++....++..+|.||+|+++|+|++|
T Consensus 144 ~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G 221 (357)
T KOG0598|consen 144 KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTG 221 (357)
T ss_pred CCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhC
Confidence 9999999999999999999999999999985543322 22447899999999999999999999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
.+||.. ....+.......... ... +. --+...+++++..|..||++|.-
T Consensus 222 ~pPF~~---------~~~~~~~~~I~~~k~------~~~-p~-------~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 222 KPPFYA---------EDVKKMYDKILKGKL------PLP-PG-------YLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred CCCCcC---------ccHHHHHHHHhcCcC------CCC-Cc-------cCCHHHHHHHHHHhccCHHHhcC
Confidence 999965 223333333332220 000 00 11256889999999999999963
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=272.40 Aligned_cols=205 Identities=25% Similarity=0.317 Sum_probs=158.4
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCC--cceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHHHHhchhhcCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTP--IPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~~~l~~lh~~~ 85 (241)
.+++.+|+++|.+|+|||||+++|...... .+++.|||+++|||.+++.+.. . ....+..||+.||+|||
T Consensus 58 ~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH--- 134 (313)
T KOG0198|consen 58 SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH--- 134 (313)
T ss_pred HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 667899999999999999999999744433 6899999999999999998764 1 46789999999999999
Q ss_pred CCCceeccCCCCCeeecC-CCCeEEeeccCceecCCCC-cceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNE-ENVAKWFDFLLSISIPEGE-THITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~-~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~ 162 (241)
+++++||||||+|||++. ++.+||+|||.+....... .........||+.|||||++..+ ....++|||||||++.|
T Consensus 135 s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvE 214 (313)
T KOG0198|consen 135 SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVE 214 (313)
T ss_pred hCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEe
Confidence 999999999999999999 7999999999987665311 11122346799999999999953 33459999999999999
Q ss_pred HHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 163 LLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 163 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|+||+.||... ....+......... ..+.++... +....+|+.+|+..||++||||++
T Consensus 215 M~Tg~~PW~~~--------~~~~~~~~~ig~~~-----~~P~ip~~l--------s~~a~~Fl~~C~~~~p~~Rpta~e 272 (313)
T KOG0198|consen 215 MLTGKPPWSEF--------FEEAEALLLIGRED-----SLPEIPDSL--------SDEAKDFLRKCFKRDPEKRPTAEE 272 (313)
T ss_pred ccCCCCcchhh--------cchHHHHHHHhccC-----CCCCCCccc--------CHHHHHHHHHHhhcCcccCcCHHH
Confidence 99999999652 00111111111111 111222222 256889999999999999999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=273.78 Aligned_cols=203 Identities=20% Similarity=0.265 Sum_probs=164.3
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+-..+|-.+|.+| .||.|++++-.|.++..+|+|+||+++|.|.+++++.+. ....++.+|+.||.||| +
T Consensus 116 KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH---~ 192 (604)
T KOG0592|consen 116 KVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLH---S 192 (604)
T ss_pred ccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHH---h
Confidence 445566788999999 899999999999999999999999999999999987643 35678999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc---------ee--ecccccCCCccCcccccccCCCcchhhHH
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH---------IT--TDRVIGTRGYSAPEYISICVLNEKSNVFS 155 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~---------~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 155 (241)
+|||||||||+|||++.+++++|+|||.++.+...... .. ..+.+||..|.+||++.....++.+|+|+
T Consensus 193 ~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWA 272 (604)
T KOG0592|consen 193 NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWA 272 (604)
T ss_pred cCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHH
Confidence 99999999999999999999999999999877543221 11 24588999999999999999999999999
Q ss_pred HHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 156 FGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 156 ~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
|||++|.|+.|.+||..... .-..+.... . +-.+.+.++ +.+.+|+.+.|..||++
T Consensus 273 lGCilyQmlaG~PPFra~Ne---------yliFqkI~~-l------~y~fp~~fp--------~~a~dLv~KLLv~dp~~ 328 (604)
T KOG0592|consen 273 LGCILYQMLAGQPPFRAANE---------YLIFQKIQA-L------DYEFPEGFP--------EDARDLIKKLLVRDPSD 328 (604)
T ss_pred HHHHHHHHhcCCCCCccccH---------HHHHHHHHH-h------cccCCCCCC--------HHHHHHHHHHHccCccc
Confidence 99999999999999965211 111111111 0 111222222 67889999999999999
Q ss_pred CCCCCC
Q 044022 236 RPTMVD 241 (241)
Q Consensus 236 Rpt~~e 241 (241)
|+|+.|
T Consensus 329 Rlt~~q 334 (604)
T KOG0592|consen 329 RLTSQQ 334 (604)
T ss_pred cccHHH
Confidence 999753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=272.27 Aligned_cols=215 Identities=21% Similarity=0.337 Sum_probs=161.3
Q ss_pred cccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCC-cceEEEEecCCCCHHHhhcCCC---------------
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTP-IPILVFQSVEYGTLRDCIFGAP--------------- 64 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~--------------- 64 (241)
|.+...........+.+|+.++.++ +||||++++++|...+ ..++||||+++|+|.+++....
T Consensus 43 K~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~ 122 (338)
T cd05102 43 KMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRG 122 (338)
T ss_pred eccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhh
Confidence 4444333334456789999999999 8999999999887644 5789999999999999886421
Q ss_pred ------------------------------------------------c---hHHHHHHHHHHHhchhhcCCCCCceecc
Q 044022 65 ------------------------------------------------L---PRLKIASDIVNSLAYLHFGFPRPIVLRN 93 (241)
Q Consensus 65 ------------------------------------------------~---~~~~~~~~i~~~l~~lh~~~~~~ivh~d 93 (241)
. ..+.++.|++.||.||| +.+++|||
T Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrD 199 (338)
T cd05102 123 RFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRD 199 (338)
T ss_pred hhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCC
Confidence 0 23568889999999999 89999999
Q ss_pred CCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh-cCccccc
Q 044022 94 FKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWD 172 (241)
Q Consensus 94 l~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~ 172 (241)
|||+|||++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 200 iKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~ 279 (338)
T cd05102 200 LAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 279 (338)
T ss_pred CccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999876543322222233456678999999998889999999999999999997 9999854
Q ss_pred ccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 173 LLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
... .+........+.... ... ..+..+.+++.+||+.||++|||+.|
T Consensus 280 ~~~---------~~~~~~~~~~~~~~~-----~~~--------~~~~~l~~li~~cl~~dp~~RPs~~e 326 (338)
T cd05102 280 VQI---------NEEFCQRLKDGTRMR-----APE--------NATPEIYRIMLACWQGDPKERPTFSA 326 (338)
T ss_pred CCc---------cHHHHHHHhcCCCCC-----CCC--------CCCHHHHHHHHHHccCChhhCcCHHH
Confidence 211 011111111111111 111 22357899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=264.77 Aligned_cols=199 Identities=18% Similarity=0.215 Sum_probs=157.5
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeee----CCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQ----TPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~ 84 (241)
.+.|.+|+.++++++||||+++++++.. ....++||||+++|+|.+++..... ..+.++.+++.|+.|||
T Consensus 62 ~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH-- 139 (283)
T PHA02988 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLY-- 139 (283)
T ss_pred HHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHH--
Confidence 5778899999999999999999999876 3467999999999999999876532 46789999999999999
Q ss_pred CC-CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc--cCCCcchhhHHHHHHHH
Q 044022 85 FP-RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI--CVLNEKSNVFSFGAFLF 161 (241)
Q Consensus 85 ~~-~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~s~G~~~~ 161 (241)
+ .+++||||||+||+++.++.+||+|||++....... ....++..|+|||.+.+ ..++.++||||||+++|
T Consensus 140 -~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~ 213 (283)
T PHA02988 140 -KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLW 213 (283)
T ss_pred -hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHH
Confidence 5 488899999999999999999999999987544322 22357889999999976 67899999999999999
Q ss_pred HHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 162 ELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 162 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|++|+.||.... ..+............ .... ..+..+.+++.+||+.||++|||++|
T Consensus 214 el~~g~~Pf~~~~---------~~~~~~~i~~~~~~~-----~~~~--------~~~~~l~~li~~cl~~dp~~Rps~~e 271 (283)
T PHA02988 214 EIFTGKIPFENLT---------TKEIYDLIINKNNSL-----KLPL--------DCPLEIKCIVEACTSHDSIKRPNIKE 271 (283)
T ss_pred HHHHCCCCCCCCC---------HHHHHHHHHhcCCCC-----CCCC--------cCcHHHHHHHHHHhcCCcccCcCHHH
Confidence 9999999996521 112222221111111 1111 22357899999999999999999864
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=294.18 Aligned_cols=213 Identities=25% Similarity=0.380 Sum_probs=174.2
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----------hHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----------PRLKI 70 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----------~~~~~ 70 (241)
|-.....+.+....|++|..+|..++|||||+++|+|......++++|||++|+|..||++... ..+.+
T Consensus 728 K~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~ 807 (1025)
T KOG1095|consen 728 KSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAF 807 (1025)
T ss_pred EeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHH
Confidence 4444555567788999999999999999999999999999999999999999999999987621 24789
Q ss_pred HHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcc
Q 044022 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEK 150 (241)
Q Consensus 71 ~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 150 (241)
+.+|+.|+.||+ ++++|||||.++|+|++....+||+|||+++-+-............-+..|||||++....++.+
T Consensus 808 a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtsk 884 (1025)
T KOG1095|consen 808 ALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSK 884 (1025)
T ss_pred HHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccc
Confidence 999999999999 99999999999999999999999999999985444333333333356788999999999999999
Q ss_pred hhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhc
Q 044022 151 SNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECV 229 (241)
Q Consensus 151 ~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 229 (241)
+|||||||++||++| |..||... ...+.+......++ ...+. .++..+.++|.+||
T Consensus 885 SDvWsFGVllWEifslG~~PY~~~---------~n~~v~~~~~~ggR---L~~P~-----------~CP~~ly~lM~~CW 941 (1025)
T KOG1095|consen 885 SDVWSFGVLLWEIFSLGATPYPSR---------SNFEVLLDVLEGGR---LDPPS-----------YCPEKLYQLMLQCW 941 (1025)
T ss_pred cchhhhHHHHHHHHhCCCCCCCCc---------chHHHHHHHHhCCc---cCCCC-----------CCChHHHHHHHHHc
Confidence 999999999999999 88898653 23334444444442 12221 34467889999999
Q ss_pred cCCCCCCCCCC
Q 044022 230 NNSPEDRPTMV 240 (241)
Q Consensus 230 ~~~p~~Rpt~~ 240 (241)
+.+|++||++.
T Consensus 942 ~~~pe~RP~F~ 952 (1025)
T KOG1095|consen 942 KHDPEDRPSFR 952 (1025)
T ss_pred cCChhhCccHH
Confidence 99999999974
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=278.29 Aligned_cols=195 Identities=25% Similarity=0.392 Sum_probs=163.4
Q ss_pred HHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCCCceecc
Q 044022 18 NNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPRPIVLRN 93 (241)
Q Consensus 18 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~~ivh~d 93 (241)
.+|+=|++|+||||+.|.|+|.+...+|||||||..|-|...|+.... ....|.++|+.|+.||| .+.|+|||
T Consensus 161 TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRD 237 (904)
T KOG4721|consen 161 TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRD 237 (904)
T ss_pred hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhc
Confidence 478889999999999999999999999999999999999999988643 34679999999999999 99999999
Q ss_pred CCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCcccccc
Q 044022 94 FKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDL 173 (241)
Q Consensus 94 l~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~~ 173 (241)
||.-||||..+..+||+|||.++.....++.. +..||..|||||++...+.+.++|||||||++|||+||..||.+.
T Consensus 238 LKSPNiLIs~~d~VKIsDFGTS~e~~~~STkM---SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV 314 (904)
T KOG4721|consen 238 LKSPNILISYDDVVKISDFGTSKELSDKSTKM---SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV 314 (904)
T ss_pred cCCCceEeeccceEEeccccchHhhhhhhhhh---hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc
Confidence 99999999999999999999998776654433 357999999999999999999999999999999999999999774
Q ss_pred cccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 174 LKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
..... ++++-...+.- +-...++..++-|+++||...|..||++.
T Consensus 315 dssAI------------------IwGVGsNsL~L----pvPstcP~GfklL~Kqcw~sKpRNRPSFr 359 (904)
T KOG4721|consen 315 DSSAI------------------IWGVGSNSLHL----PVPSTCPDGFKLLLKQCWNSKPRNRPSFR 359 (904)
T ss_pred chhee------------------EEeccCCcccc----cCcccCchHHHHHHHHHHhcCCCCCccHH
Confidence 33221 11221111111 11125567899999999999999999985
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=268.67 Aligned_cols=201 Identities=23% Similarity=0.327 Sum_probs=161.9
Q ss_pred cHHHHHHHHHHHHhcC-CCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+...+|+.+++.++ ||||+++++++......++||||+.||.|.+++..... ...+++.|++.|++||| +
T Consensus 62 ~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H---~ 138 (370)
T KOG0583|consen 62 LDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCH---S 138 (370)
T ss_pred cchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHH---h
Confidence 4556668999999998 99999999999999999999999999999999977422 46789999999999999 9
Q ss_pred CCceeccCCCCCeeecCC-CCeEEeeccCceecC-CCCcceeecccccCCCccCcccccccC-CC-cchhhHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEE-NVAKWFDFLLSISIP-EGETHITTDRVIGTRGYSAPEYISICV-LN-EKSNVFSFGAFLFE 162 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~-~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~-~~~Di~s~G~~~~~ 162 (241)
++|+||||||+|+|++.+ +++||+|||++.... ... .....+|++.|+|||++.+.. |+ .++||||+|+++|.
T Consensus 139 ~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ 215 (370)
T KOG0583|consen 139 RGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDG---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYV 215 (370)
T ss_pred CCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCC---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHH
Confidence 999999999999999999 999999999998773 222 235568999999999999876 75 78999999999999
Q ss_pred HHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 163 LLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 163 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|++|+.||.+.. ....... ...+. ..-+.... +..+.+++.+||..||.+|+|+.|
T Consensus 216 ml~G~~PF~d~~---------~~~l~~k-i~~~~---~~~p~~~~----------S~~~~~Li~~mL~~~P~~R~t~~~ 271 (370)
T KOG0583|consen 216 LLCGRLPFDDSN---------VPNLYRK-IRKGE---FKIPSYLL----------SPEARSLIEKMLVPDPSTRITLLE 271 (370)
T ss_pred HHhCCCCCCCcc---------HHHHHHH-HhcCC---ccCCCCcC----------CHHHHHHHHHHcCCCcccCCCHHH
Confidence 999999997611 1111111 11111 11111100 367899999999999999999753
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=274.04 Aligned_cols=211 Identities=22% Similarity=0.261 Sum_probs=171.3
Q ss_pred Cccccccc--ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHH
Q 044022 1 MKFYGHEY--HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDI 74 (241)
Q Consensus 1 iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i 74 (241)
||+..+.. .........+|+-+|+.++|||+++++++|++..++|+|.||+++|.|++++...+. ...+++.||
T Consensus 42 iKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QI 121 (786)
T KOG0588|consen 42 IKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQI 121 (786)
T ss_pred EEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHH
Confidence 45555443 223355578999999999999999999999999999999999999999999865532 578899999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCC-cchhh
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLN-EKSNV 153 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di 153 (241)
+.|+.||| ..+|+|||+||+|+|++..+++||+|||.|.....+... .+.+|++.|.|||++.+.+|+ .++||
T Consensus 122 i~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL---eTSCGSPHYA~PEIV~G~pYdG~~sDV 195 (786)
T KOG0588|consen 122 LDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL---ETSCGSPHYAAPEIVSGRPYDGRPSDV 195 (786)
T ss_pred HHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCccc---cccCCCcccCCchhhcCCCCCCCcccc
Confidence 99999999 999999999999999999999999999999765554432 345899999999999998775 78999
Q ss_pred HHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 154 FSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
||+|+|+|.+++|+.||++ ...+.+......|.+.. +... +.+..+|+++|++.||
T Consensus 196 WSCGVILfALLtG~LPFdD----------dNir~LLlKV~~G~f~M------Ps~I--------s~eaQdLLr~ml~VDp 251 (786)
T KOG0588|consen 196 WSCGVILFALLTGKLPFDD----------DNIRVLLLKVQRGVFEM------PSNI--------SSEAQDLLRRMLDVDP 251 (786)
T ss_pred chhHHHHHHHHhCCCCCCC----------ccHHHHHHHHHcCcccC------CCcC--------CHHHHHHHHHHhccCc
Confidence 9999999999999999975 12233334444454421 1222 2578899999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|.|.+|
T Consensus 252 ~~RiT~~e 259 (786)
T KOG0588|consen 252 STRITTEE 259 (786)
T ss_pred cccccHHH
Confidence 99999764
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=270.51 Aligned_cols=213 Identities=20% Similarity=0.258 Sum_probs=178.2
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVN 76 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~ 76 (241)
||+.+.+.........++|+.+|.+++++||.++|+.+..+..++++||||.||++.+.++.... ...-++++++.
T Consensus 43 iKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~ 122 (467)
T KOG0201|consen 43 IKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLK 122 (467)
T ss_pred EEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHH
Confidence 57788888888899999999999999999999999999999999999999999999999987654 34457889999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSF 156 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~ 156 (241)
|+.||| ..+.+|||||+.|||+..+|.+|++|||++.......... .+.+||++|||||++.+..|+.++|||||
T Consensus 123 ~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSL 197 (467)
T KOG0201|consen 123 GLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSL 197 (467)
T ss_pred Hhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhcc--ccccccccccchhhhccccccchhhhhhh
Confidence 999999 9999999999999999999999999999998877654332 56789999999999998899999999999
Q ss_pred HHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCC
Q 044022 157 GAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDR 236 (241)
Q Consensus 157 G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 236 (241)
|++.+||.+|.+|+.+.-.. ...-.+....|+......+..+++|+..||.+||+.|
T Consensus 198 GITaiEla~GePP~s~~hPm-----------------------rvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~R 254 (467)
T KOG0201|consen 198 GITAIELAKGEPPHSKLHPM-----------------------RVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFR 254 (467)
T ss_pred hHHHHHHhcCCCCCcccCcc-----------------------eEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccC
Confidence 99999999999999662110 0000111112222222455789999999999999999
Q ss_pred CCCCC
Q 044022 237 PTMVD 241 (241)
Q Consensus 237 pt~~e 241 (241)
|||.+
T Consensus 255 psA~~ 259 (467)
T KOG0201|consen 255 PSAKE 259 (467)
T ss_pred cCHHH
Confidence 99864
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=264.38 Aligned_cols=221 Identities=19% Similarity=0.291 Sum_probs=163.0
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----------------
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----------------- 64 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------- 64 (241)
|++..........+|.+|++++.+++||||+++++++...+..++||||+++++|.+++....
T Consensus 52 K~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~ 131 (304)
T cd05096 52 KILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131 (304)
T ss_pred EEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccc
Confidence 444333333456679999999999999999999999999999999999999999999885421
Q ss_pred ------chHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccC
Q 044022 65 ------LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSA 138 (241)
Q Consensus 65 ------~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~a 138 (241)
...++++.+++.||.||| +.+++|+||||+|||++.++.+||+|||.+............+...++..|+|
T Consensus 132 ~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~a 208 (304)
T cd05096 132 LPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMA 208 (304)
T ss_pred cccccHHHHHHHHHHHHHHHHHHH---HCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccC
Confidence 125689999999999999 89999999999999999999999999999876544332222233455778999
Q ss_pred cccccccCCCcchhhHHHHHHHHHHHh--cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHH
Q 044022 139 PEYISICVLNEKSNVFSFGAFLFELLA--GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQ 216 (241)
Q Consensus 139 PE~~~~~~~~~~~Di~s~G~~~~~~~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (241)
||++....++.++||||||+++|+|++ +..||...... ...+............ ......+ .
T Consensus 209 PE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~------~~~~~~~~~~~~~~~~--~~~~~~~--------~ 272 (304)
T cd05096 209 WECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE------QVIENAGEFFRDQGRQ--VYLFRPP--------P 272 (304)
T ss_pred HHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHH------HHHHHHHHHhhhcccc--ccccCCC--------C
Confidence 999988889999999999999999987 55677542111 0111111111110000 0000011 1
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 217 QLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 217 ~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++..+.+++.+||+.||++|||++|
T Consensus 273 ~~~~~~~li~~cl~~~p~~RPs~~~ 297 (304)
T cd05096 273 CPQGLYELMLQCWSRDCRERPSFSD 297 (304)
T ss_pred CCHHHHHHHHHHccCCchhCcCHHH
Confidence 2357899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=245.21 Aligned_cols=209 Identities=22% Similarity=0.363 Sum_probs=164.7
Q ss_pred ccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC----CchHHHHHHHHHHHhchhh
Q 044022 7 EYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA----PLPRLKIASDIVNSLAYLH 82 (241)
Q Consensus 7 ~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~~lh 82 (241)
...+++.+.+.+|++|-+.|+|||||++.+.+...+..++|+|+++|+.|..-+-.. +...-.++.||+.+|.|+|
T Consensus 48 k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH 127 (355)
T KOG0033|consen 48 KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCH 127 (355)
T ss_pred hhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 344468889999999999999999999999999999999999999999996544322 2245578999999999999
Q ss_pred cCCCCCceeccCCCCCeeecC---CCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNE---ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAF 159 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~ 159 (241)
.++|||||+||.|+++-. ..-+|++|||++.....+... ....|||.|+|||++...+++..+|||+.|++
T Consensus 128 ---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~---~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGVi 201 (355)
T KOG0033|consen 128 ---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 201 (355)
T ss_pred ---hcCceeccCChhheeeeeccCCCceeecccceEEEeCCcccc---ccccCCCcccCHHHhhcCCCCCcchhhhhhHH
Confidence 999999999999999953 346899999999988744332 23579999999999999999999999999999
Q ss_pred HHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 160 LFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 160 ~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
+|-++.|.+||++... ..+......+.+ +.+.+.+ +.-+++.++|+++||..||++|.|+
T Consensus 202 LfiLL~G~~PF~~~~~----------~rlye~I~~g~y-d~~~~~w---------~~is~~Ak~LvrrML~~dP~kRIta 261 (355)
T KOG0033|consen 202 LYILLVGYPPFWDEDQ----------HRLYEQIKAGAY-DYPSPEW---------DTVTPEAKSLIRRMLTVNPKKRITA 261 (355)
T ss_pred HHHHHhCCCCCCCccH----------HHHHHHHhcccc-CCCCccc---------CcCCHHHHHHHHHHhccChhhhccH
Confidence 9999999999976111 111111222221 1112222 2334678999999999999999998
Q ss_pred CC
Q 044022 240 VD 241 (241)
Q Consensus 240 ~e 241 (241)
.|
T Consensus 262 ~E 263 (355)
T KOG0033|consen 262 DE 263 (355)
T ss_pred HH
Confidence 64
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=274.18 Aligned_cols=206 Identities=22% Similarity=0.328 Sum_probs=167.7
Q ss_pred cccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHHhchhh
Q 044022 8 YHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNSLAYLH 82 (241)
Q Consensus 8 ~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~l~~lh 82 (241)
..+....+|++|++++++++|||||+++|++..+..+++|||+|.||+|.++|++... .++.++.+++.||+|||
T Consensus 200 ~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh 279 (474)
T KOG0194|consen 200 LTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH 279 (474)
T ss_pred ccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH
Confidence 4556788899999999999999999999999999999999999999999999988752 57889999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~ 162 (241)
+++++||||.++|+|++.++.+||+|||+++....... ......-+..|+|||.+....++.++||||||+++||
T Consensus 280 ---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~--~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~E 354 (474)
T KOG0194|consen 280 ---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVM--KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWE 354 (474)
T ss_pred ---HCCCcchhHhHHHheecCCCeEEeCccccccCCcceee--ccccccCcceecChhhhccCccccccchhheeeeEEe
Confidence 99999999999999999999999999999876542111 1112245788999999999999999999999999999
Q ss_pred HHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 163 LLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 163 ~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
+++ |..||... ...+.......++.....+. ..+..+..++.+||..||++|||+.
T Consensus 355 if~~g~~Py~g~---------~~~~v~~kI~~~~~r~~~~~-------------~~p~~~~~~~~~c~~~~p~~R~tm~ 411 (474)
T KOG0194|consen 355 IFENGAEPYPGM---------KNYEVKAKIVKNGYRMPIPS-------------KTPKELAKVMKQCWKKDPEDRPTMS 411 (474)
T ss_pred eeccCCCCCCCC---------CHHHHHHHHHhcCccCCCCC-------------CCHHHHHHHHHHhccCChhhccCHH
Confidence 998 78888542 22222222223333222222 3336788999999999999999985
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=245.65 Aligned_cols=193 Identities=23% Similarity=0.263 Sum_probs=160.8
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..++..+|.++|+.+.||+++++.+.|.+..+.+|||||.+||.|..++++.. .....++.+|+.|+.||| ++
T Consensus 87 QveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH---~~ 163 (355)
T KOG0616|consen 87 QVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLH---SL 163 (355)
T ss_pred HHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHH---hc
Confidence 45667889999999999999999999999999999999999999999998742 356778999999999999 99
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcC
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
+|++|||||+|||+|++|.+||+|||+++..... + -+.+||+.|+|||.+.+.++..++|.||||+++|||+.|.
T Consensus 164 ~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-T----~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~ 238 (355)
T KOG0616|consen 164 DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-T----WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGY 238 (355)
T ss_pred CeeeccCChHHeeeccCCcEEEEeccceEEecCc-E----EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCC
Confidence 9999999999999999999999999999987654 2 3457999999999999999999999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDR 236 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 236 (241)
+||++.+.. .-..+-+.....+.. -.+.++++|+...|+.|-++|
T Consensus 239 pPF~~~~~~--------~iY~KI~~~~v~fP~----------------~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 239 PPFYDDNPI--------QIYEKILEGKVKFPS----------------YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CCCcCCChH--------HHHHHHHhCcccCCc----------------ccCHHHHHHHHHHHhhhhHhh
Confidence 999773221 111111111111111 223578899999999999888
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=260.53 Aligned_cols=215 Identities=28% Similarity=0.421 Sum_probs=161.9
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC---Cc---hHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA---PL---PRLKIASDI 74 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~---~~~~~~~~i 74 (241)
||.+.........+.|.+|++.+++++||||++++|++...+..++|+||+++|+|.+++... .. .+..++.+|
T Consensus 33 vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i 112 (259)
T PF07714_consen 33 VKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQI 112 (259)
T ss_dssp EEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHH
T ss_pred EEEeccccccccceeeeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 455544444445789999999999999999999999999888899999999999999998765 21 578899999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhH
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
+.||.||| +.+++|++|+++||+++.++.+||+|||++.................+..|+|||.+....++.++|||
T Consensus 113 ~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVy 189 (259)
T PF07714_consen 113 AEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVY 189 (259)
T ss_dssp HHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHH
T ss_pred cccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999 889999999999999999999999999999877433333333344567789999999988899999999
Q ss_pred HHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 155 SFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 155 s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
|||+++||+++ |+.||.+. ...+..... ..+.....+. ..+..+.+++.+||+.||
T Consensus 190 sfG~~l~ei~~~~~~p~~~~---------~~~~~~~~~-~~~~~~~~~~-------------~~~~~~~~li~~C~~~~p 246 (259)
T PF07714_consen 190 SFGMLLYEILTLGKFPFSDY---------DNEEIIEKL-KQGQRLPIPD-------------NCPKDIYSLIQQCWSHDP 246 (259)
T ss_dssp HHHHHHHHHHTTSSGTTTTS---------CHHHHHHHH-HTTEETTSBT-------------TSBHHHHHHHHHHT-SSG
T ss_pred cccccccccccccccccccc---------ccccccccc-cccccceecc-------------chhHHHHHHHHHHcCCCh
Confidence 99999999999 67887542 122222222 2222211111 122578899999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
.+|||+.|
T Consensus 247 ~~RPs~~~ 254 (259)
T PF07714_consen 247 EKRPSFQE 254 (259)
T ss_dssp GGS--HHH
T ss_pred hhCcCHHH
Confidence 99999753
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=270.20 Aligned_cols=222 Identities=21% Similarity=0.348 Sum_probs=181.7
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc------hHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL------PRLKIASDI 74 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~~i 74 (241)
||....+.+.+...+|.+|+++|.+|+|||||.++|+|..++.+|+|+||+++|+|.+|+.++.. +.++++.||
T Consensus 567 VK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqi 646 (807)
T KOG1094|consen 567 VKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQI 646 (807)
T ss_pred EeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHH
Confidence 57888888889999999999999999999999999999999999999999999999999988733 457899999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhH
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
+.|++||. +.++||||+.++|+|++.++++||+|||.++.+-........++.+.+..|+|||.+.-+.++.+||+|
T Consensus 647 asgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvW 723 (807)
T KOG1094|consen 647 ASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVW 723 (807)
T ss_pred HHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhh
Confidence 99999999 999999999999999999999999999999977666555556677889999999999999999999999
Q ss_pred HHHHHHHHHHh--cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCC
Q 044022 155 SFGAFLFELLA--GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNS 232 (241)
Q Consensus 155 s~G~~~~~~~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~ 232 (241)
+||+.+||+++ ...||.++.++. ..+........+. ..... ..+..++..+.++|.+||..|
T Consensus 724 afgvTlwE~~~~C~e~Py~~lt~e~------vven~~~~~~~~~-----~~~~l-----~~P~~cp~~lyelml~Cw~~e 787 (807)
T KOG1094|consen 724 AFGVTLWEVFMLCREQPYSQLTDEQ------VVENAGEFFRDQG-----RQVVL-----SRPPACPQGLYELMLRCWRRE 787 (807)
T ss_pred hhHHHHHHHHHHHhhCchhhhhHHH------HHHhhhhhcCCCC-----cceec-----cCCCcCcHHHHHHHHHHhchh
Confidence 99999999886 678886643331 1111111111110 00000 111245577889999999999
Q ss_pred CCCCCCCCC
Q 044022 233 PEDRPTMVD 241 (241)
Q Consensus 233 p~~Rpt~~e 241 (241)
-++|||+++
T Consensus 788 s~~RPsFe~ 796 (807)
T KOG1094|consen 788 SEQRPSFEQ 796 (807)
T ss_pred hhcCCCHHH
Confidence 999999863
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=262.39 Aligned_cols=164 Identities=24% Similarity=0.303 Sum_probs=139.4
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNS 77 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~ 77 (241)
|+...+.......++.+|++++++++||||+++++++...+..++||||+++++|.+++..... ....++.+++.|
T Consensus 36 k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~ 115 (331)
T cd06649 36 KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG 115 (331)
T ss_pred EEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHH
Confidence 3443333334456799999999999999999999999999999999999999999999865432 356889999999
Q ss_pred hchhhcCCCC-CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHH
Q 044022 78 LAYLHFGFPR-PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSF 156 (241)
Q Consensus 78 l~~lh~~~~~-~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~ 156 (241)
|.||| +. +++|+||||+||+++.++.++|+|||++....... .....++..|+|||++.+..++.++|||||
T Consensus 116 l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 188 (331)
T cd06649 116 LAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSM 188 (331)
T ss_pred HHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHH
Confidence 99999 64 69999999999999999999999999987554322 133468899999999998889999999999
Q ss_pred HHHHHHHHhcCccccc
Q 044022 157 GAFLFELLAGRIHIWD 172 (241)
Q Consensus 157 G~~~~~~~~g~~p~~~ 172 (241)
|+++|+|++|+.||..
T Consensus 189 G~il~el~tg~~p~~~ 204 (331)
T cd06649 189 GLSLVELAIGRYPIPP 204 (331)
T ss_pred HHHHHHHHhCCCCCCC
Confidence 9999999999999954
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=246.66 Aligned_cols=203 Identities=23% Similarity=0.344 Sum_probs=165.0
Q ss_pred HHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 13 YGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 13 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
.+.-.+|+.||+++ -||+|+++.++++.+...++|+|.|+.|.|.|++.+.- ....++++|+..|+.||| .+
T Consensus 66 ~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylH---a~ 142 (411)
T KOG0599|consen 66 REATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLH---AR 142 (411)
T ss_pred HHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHH---Hh
Confidence 34456799999999 79999999999999999999999999999999998752 245689999999999999 99
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc------CCCcchhhHHHHHHHH
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC------VLNEKSNVFSFGAFLF 161 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~Di~s~G~~~~ 161 (241)
.||||||||+|||++++.+++|+|||++..+..+... ...+||++|+|||.+... .|+...|+||+|+|+|
T Consensus 143 ~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImy 219 (411)
T KOG0599|consen 143 NIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMY 219 (411)
T ss_pred hhhhcccChhheeeccccceEEeccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHH
Confidence 9999999999999999999999999999888766543 335899999999999643 5778899999999999
Q ss_pred HHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 162 ELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 162 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.++.|.+||+..- .-.+.....++.+. +.. ++..+.+...++|+.+||+.||++|.|++|
T Consensus 220 TLLaGcpPFwHRk----------QmlMLR~ImeGkyq-F~s---------peWadis~~~KdLIsrlLqVdp~~Ritake 279 (411)
T KOG0599|consen 220 TLLAGCPPFWHRK----------QMLMLRMIMEGKYQ-FRS---------PEWADISATVKDLISRLLQVDPTKRITAKE 279 (411)
T ss_pred HHHcCCCchhHHH----------HHHHHHHHHhcccc-cCC---------cchhhccccHHHHHHHHHeeCchhcccHHH
Confidence 9999999997610 11122222233321 111 222355567899999999999999999864
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=256.41 Aligned_cols=205 Identities=21% Similarity=0.345 Sum_probs=161.6
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--------------------chHHHH
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--------------------LPRLKI 70 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------------~~~~~~ 70 (241)
....+|.+|++++.+++||||+++++++...+..++++||+++++|.+++.... ...+.+
T Consensus 50 ~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 129 (283)
T cd05048 50 KVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129 (283)
T ss_pred HHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHH
Confidence 345678999999999999999999999998889999999999999999986531 134678
Q ss_pred HHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcc
Q 044022 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEK 150 (241)
Q Consensus 71 ~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 150 (241)
+.+++.||.||| +.+++|+||||+||+++.++.++|+|||++................++..|+|||++....++.+
T Consensus 130 ~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 206 (283)
T cd05048 130 AIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE 206 (283)
T ss_pred HHHHHHHHHHHH---hCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchh
Confidence 999999999999 89999999999999999999999999999876543322222233456788999999988889999
Q ss_pred hhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhc
Q 044022 151 SNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECV 229 (241)
Q Consensus 151 ~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 229 (241)
+||||||+++|+|++ |..||..... .+.... ...+..... . ...+..+.+|+.+||
T Consensus 207 sDv~slG~il~el~~~g~~p~~~~~~---------~~~~~~-i~~~~~~~~-----~--------~~~~~~~~~l~~~c~ 263 (283)
T cd05048 207 SDIWSFGVVLWEIFSYGLQPYYGFSN---------QEVIEM-IRSRQLLPC-----P--------EDCPARVYALMIECW 263 (283)
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCH---------HHHHHH-HHcCCcCCC-----c--------ccCCHHHHHHHHHHc
Confidence 999999999999998 9999864211 111111 111111111 1 133468999999999
Q ss_pred cCCCCCCCCCCC
Q 044022 230 NNSPEDRPTMVD 241 (241)
Q Consensus 230 ~~~p~~Rpt~~e 241 (241)
+.||.+|||+.|
T Consensus 264 ~~~p~~Rp~~~~ 275 (283)
T cd05048 264 NEIPARRPRFKD 275 (283)
T ss_pred cCChhhCcCHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=265.03 Aligned_cols=204 Identities=22% Similarity=0.318 Sum_probs=169.7
Q ss_pred cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCc-ceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhh
Q 044022 10 RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPI-PILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLH 82 (241)
Q Consensus 10 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh 82 (241)
....+...+|+.++++++|||||.+.+.|..++. .||||+||+||+|.+.+.... .....|+.|++.|+.|||
T Consensus 44 ~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH 123 (426)
T KOG0589|consen 44 EPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH 123 (426)
T ss_pred chhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence 3455678999999999999999999999999988 999999999999999986553 256789999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~ 162 (241)
+..|+|||||+.|||+++++.++|+|||+++.+..... ...+++||+.|++||.+.+.+|..++|||||||++||
T Consensus 124 ---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yE 198 (426)
T KOG0589|consen 124 ---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYE 198 (426)
T ss_pred ---hhhhhcccchhhhhhccccCceeecchhhhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHH
Confidence 99999999999999999999999999999998876542 2255789999999999999999999999999999999
Q ss_pred HHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 163 LLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 163 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|++-+++|.. .......... .......++ ..++.+++.++..|+..+|..||++.|
T Consensus 199 m~~lk~aF~a---------~~m~~Li~ki-~~~~~~Plp-------------~~ys~el~~lv~~~l~~~P~~RPsa~~ 254 (426)
T KOG0589|consen 199 MCTLKPAFKA---------SNMSELILKI-NRGLYSPLP-------------SMYSSELRSLVKSMLRKNPEHRPSALE 254 (426)
T ss_pred HHhcccccCc---------cchHHHHHHH-hhccCCCCC-------------ccccHHHHHHHHHHhhcCCccCCCHHH
Confidence 9999999954 1112222111 111122211 256678999999999999999999853
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=268.13 Aligned_cols=215 Identities=20% Similarity=0.332 Sum_probs=162.4
Q ss_pred cccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----------------
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---------------- 64 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------- 64 (241)
|.+...........+.+|+++++.+ +|+||++++++|...+..++||||+++|+|.+++....
T Consensus 74 K~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~ 153 (374)
T cd05106 74 KMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISET 153 (374)
T ss_pred EeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccc
Confidence 4443333333456788999999999 89999999999999999999999999999999874321
Q ss_pred ----------------------------------------------------------chHHHHHHHHHHHhchhhcCCC
Q 044022 65 ----------------------------------------------------------LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 65 ----------------------------------------------------------~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
....+++.|++.||.||| +
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~ 230 (374)
T cd05106 154 SSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---S 230 (374)
T ss_pred cccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---H
Confidence 024678999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh-
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA- 165 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~- 165 (241)
++++||||||+|||++.++.++|+|||++................++..|+|||++....++.++||||||+++|+|++
T Consensus 231 ~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~ 310 (374)
T cd05106 231 KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 310 (374)
T ss_pred CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999876544332222223345667999999988889999999999999999997
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|+.||...... .........+..... .. ..+..+.+++.+||+.||++|||++|
T Consensus 311 G~~Pf~~~~~~---------~~~~~~~~~~~~~~~-----~~--------~~~~~l~~li~~cl~~dp~~RPs~~~ 364 (374)
T cd05106 311 GKSPYPGILVN---------SKFYKMVKRGYQMSR-----PD--------FAPPEIYSIMKMCWNLEPTERPTFSQ 364 (374)
T ss_pred CCCCCcccccc---------HHHHHHHHcccCccC-----CC--------CCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 99999652111 111111111110000 01 11257899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=254.43 Aligned_cols=214 Identities=23% Similarity=0.338 Sum_probs=165.1
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----------------
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---------------- 65 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------------- 65 (241)
|.+.........+++.+|+++++.++|+||+++++++...+..++||||+++++|.+++.....
T Consensus 41 K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~ 120 (280)
T cd05049 41 KTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120 (280)
T ss_pred EeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhccccccccccc
Confidence 4443333333567899999999999999999999999999999999999999999999865321
Q ss_pred --hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc
Q 044022 66 --PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS 143 (241)
Q Consensus 66 --~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 143 (241)
....++.+++.|+.+|| +.+++|+||||+||+++.++.++|+|||.+................++..|+|||++.
T Consensus 121 ~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (280)
T cd05049 121 LSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM 197 (280)
T ss_pred HHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhc
Confidence 34678999999999999 8999999999999999999999999999987543332222223334567899999999
Q ss_pred ccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHH
Q 044022 144 ICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASA 222 (241)
Q Consensus 144 ~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (241)
+..++.++||||||+++|+|++ |..||..... .+..... ..+...... . ..+..+.
T Consensus 198 ~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---------~~~~~~~-~~~~~~~~~-----~--------~~~~~~~ 254 (280)
T cd05049 198 YRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---------EEVIECI-TQGRLLQRP-----R--------TCPSEVY 254 (280)
T ss_pred cCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---------HHHHHHH-HcCCcCCCC-----C--------CCCHHHH
Confidence 8999999999999999999998 9999854211 1111111 111111111 1 2235789
Q ss_pred HHHHHhccCCCCCCCCCCC
Q 044022 223 QLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 223 ~l~~~cl~~~p~~Rpt~~e 241 (241)
+++.+||..||++|||++|
T Consensus 255 ~li~~~l~~~p~~Rp~~~e 273 (280)
T cd05049 255 DIMLGCWKRDPQQRINIKD 273 (280)
T ss_pred HHHHHHcCCCcccCCCHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=261.42 Aligned_cols=214 Identities=20% Similarity=0.226 Sum_probs=160.4
Q ss_pred HHHHHHHHHhcC-CCcccceeeeeeeCC-cceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHHhchhhcCCCCC
Q 044022 16 CINNITYAAQMS-HNHILKRIGCCLQTP-IPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 16 ~~~e~~~l~~l~-h~~iv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
-+||++.|++|. ||||+++.+++.+.+ ++++|||||+ .+|+++++.... .+..|+.||++||+|+| ++|
T Consensus 55 nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~G 130 (538)
T KOG0661|consen 55 NLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHG 130 (538)
T ss_pred HHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcC
Confidence 358999999998 999999999999887 9999999997 699999987632 46789999999999999 999
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHHHHHHHHhcC
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
+.|||+||+|||+.....+||+|||+|+...+.... +..+.|..|+|||++.. +.|+.+.||||+|||++|+.+-+
T Consensus 131 fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLr 207 (538)
T KOG0661|consen 131 FFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLR 207 (538)
T ss_pred cccccCChhheEecccceeEecccccccccccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhc
Confidence 999999999999999999999999999987665433 34578999999998864 57899999999999999999999
Q ss_pred cccccccccC----------CCcccchHHH-HHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCC
Q 044022 168 IHIWDLLKDT----------HDHGCFFNEY-LKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDR 236 (241)
Q Consensus 168 ~p~~~~~~~~----------~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 236 (241)
+-|....+.+ ......+.+. ...-.-+-.+.......+..-.+ ..+.+..+++.+|+++||.+|
T Consensus 208 PLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p-----~~s~~~~~li~~ll~WDP~kR 282 (538)
T KOG0661|consen 208 PLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLP-----NASSEAASLIERLLAWDPDKR 282 (538)
T ss_pred ccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCc-----ccCHHHHHHHHHHhcCCCccC
Confidence 8885421110 0000000010 00000011111112111111111 245778999999999999999
Q ss_pred CCCCC
Q 044022 237 PTMVD 241 (241)
Q Consensus 237 pt~~e 241 (241)
|||+|
T Consensus 283 pTA~~ 287 (538)
T KOG0661|consen 283 PTASQ 287 (538)
T ss_pred ccHHH
Confidence 99964
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=265.47 Aligned_cols=198 Identities=21% Similarity=0.273 Sum_probs=167.8
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+...+|++|++.|+|||||.++++|+...++|+|+||+.| +|..++.... .+...++.+++.||.||| +.
T Consensus 44 ~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLh---s~ 119 (808)
T KOG0597|consen 44 ELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLH---SN 119 (808)
T ss_pred HHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hc
Confidence 456688999999999999999999999999999999999985 9999997653 267889999999999999 99
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcC
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
+|.|||+||+|||++..+.+|++|||+++.++.... ..++..||+.|||||...+.+|+..+|+||+|||+||+++|+
T Consensus 120 rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~ 197 (808)
T KOG0597|consen 120 RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQ 197 (808)
T ss_pred CcccccCCcceeeecCCCceeechhhhhhhcccCce--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCC
Confidence 999999999999999999999999999998776433 234567999999999999999999999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
+||+. ..+...++....+..... ...+..+.+++...|.+||.+|.|=
T Consensus 198 PPF~a---------~si~~Lv~~I~~d~v~~p---------------~~~S~~f~nfl~gLL~kdP~~RltW 245 (808)
T KOG0597|consen 198 PPFYA---------RSITQLVKSILKDPVKPP---------------STASSSFVNFLQGLLIKDPAQRLTW 245 (808)
T ss_pred CCchH---------HHHHHHHHHHhcCCCCCc---------------ccccHHHHHHHHHHhhcChhhcccH
Confidence 99965 233444444433332111 1445789999999999999999873
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=266.19 Aligned_cols=215 Identities=19% Similarity=0.325 Sum_probs=162.6
Q ss_pred cccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----------------
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---------------- 64 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------- 64 (241)
|++.........+.+.+|++++..+ +||||++++++|...+..++||||+++|+|.+++....
T Consensus 71 K~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~ 150 (375)
T cd05104 71 KMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAAL 150 (375)
T ss_pred EeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHH
Confidence 4444333334566789999999999 89999999999999999999999999999999885321
Q ss_pred ---------------------------------------------------------------chHHHHHHHHHHHhchh
Q 044022 65 ---------------------------------------------------------------LPRLKIASDIVNSLAYL 81 (241)
Q Consensus 65 ---------------------------------------------------------------~~~~~~~~~i~~~l~~l 81 (241)
.....++.+|+.||.||
T Consensus 151 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l 230 (375)
T cd05104 151 YKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFL 230 (375)
T ss_pred HHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 02356889999999999
Q ss_pred hcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHH
Q 044022 82 HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLF 161 (241)
Q Consensus 82 h~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~ 161 (241)
| +.+++||||||+|||++.++.++|+|||++............+...++..|+|||++.+..++.++||||||+++|
T Consensus 231 H---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ 307 (375)
T cd05104 231 A---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLW 307 (375)
T ss_pred H---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHH
Confidence 9 8999999999999999999999999999987654433222222334566799999999889999999999999999
Q ss_pred HHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 162 ELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 162 ~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
+|++ |..||...... .... .....+..... + . ..+..+.+++.+||+.||++|||+.
T Consensus 308 ellt~g~~p~~~~~~~--------~~~~-~~~~~~~~~~~--~---~--------~~~~~l~~li~~cl~~dP~~RPs~~ 365 (375)
T cd05104 308 EIFSLGSSPYPGMPVD--------SKFY-KMIKEGYRMLS--P---E--------CAPSEMYDIMKSCWDADPLKRPTFK 365 (375)
T ss_pred HHHhcCCCCCCCCCch--------HHHH-HHHHhCccCCC--C---C--------CCCHHHHHHHHHHccCChhHCcCHH
Confidence 9998 88888552111 0111 11111111000 0 0 1124688999999999999999986
Q ss_pred C
Q 044022 241 D 241 (241)
Q Consensus 241 e 241 (241)
|
T Consensus 366 e 366 (375)
T cd05104 366 Q 366 (375)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=268.84 Aligned_cols=205 Identities=22% Similarity=0.324 Sum_probs=170.9
Q ss_pred cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc------hHHHHHHHHHHHhchhhc
Q 044022 10 RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL------PRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 10 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~~i~~~l~~lh~ 83 (241)
....++|+.|+.+|+.++|||+|+++|+|..+..+|||+|||.+|+|.++|+.... ..+.++.||..|+.||.
T Consensus 304 tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE- 382 (1157)
T KOG4278|consen 304 TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE- 382 (1157)
T ss_pred chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH-
Confidence 34678999999999999999999999999999999999999999999999987633 35688999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
.+.++||||.++|+|+..+..+|++|||+++.+..+.... .....-+..|.|||.+....++.++|||+||+++||+
T Consensus 383 --kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEI 459 (1157)
T KOG4278|consen 383 --KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEI 459 (1157)
T ss_pred --HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHH
Confidence 9999999999999999999999999999999887653222 1223456789999999999999999999999999999
Q ss_pred Hh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.| |..||.... ...+..+.+.+...+.+ +.|++.+.+||+.||.++|++||++.|
T Consensus 460 ATYGMsPYPGid----------lSqVY~LLEkgyRM~~P-------------eGCPpkVYeLMraCW~WsPsDRPsFae 515 (1157)
T KOG4278|consen 460 ATYGMSPYPGID----------LSQVYGLLEKGYRMDGP-------------EGCPPKVYELMRACWNWSPSDRPSFAE 515 (1157)
T ss_pred HhcCCCCCCCcc----------HHHHHHHHhccccccCC-------------CCCCHHHHHHHHHHhcCCcccCccHHH
Confidence 98 888885421 22344444444433322 256688999999999999999999864
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=255.28 Aligned_cols=202 Identities=19% Similarity=0.284 Sum_probs=158.2
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~~ 85 (241)
....+.+|++++++++|+||+++++++...+..++|+||+++|+|.+.+.... .....++.|++.||.|||
T Consensus 43 ~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--- 119 (285)
T cd05631 43 GEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ--- 119 (285)
T ss_pred hHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 34567899999999999999999999999999999999999999988764321 146778999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+.+++||||||+||+++.++.++|+|||++........ .....|+..|+|||++.+..++.++||||||+++|+|++
T Consensus 120 ~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~ 196 (285)
T cd05631 120 RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQ 196 (285)
T ss_pred hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHh
Confidence 99999999999999999999999999999876543321 123468999999999998899999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
|+.||....... ..+.......... ..... ..+..+.+|+++||+.||++|||+
T Consensus 197 g~~pf~~~~~~~------~~~~~~~~~~~~~------~~~~~--------~~s~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05631 197 GQSPFRKRKERV------KREEVDRRVKEDQ------EEYSE--------KFSEDAKSICRMLLTKNPKERLGC 250 (285)
T ss_pred CCCCCCCCCcch------hHHHHHHHhhccc------ccCCc--------cCCHHHHHHHHHHhhcCHHHhcCC
Confidence 999996521110 0011111111110 00111 223578899999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=264.28 Aligned_cols=215 Identities=18% Similarity=0.222 Sum_probs=161.3
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchh
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYL 81 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~l 81 (241)
|++...........+.+|+++++.++|+||+++++++...+..++|+||+++++|.+...........++.+|+.||.||
T Consensus 105 K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~L 184 (353)
T PLN00034 105 KVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILSGIAYL 184 (353)
T ss_pred EEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccccCCHHHHHHHHHHHHHHHHHH
Confidence 44433333344567899999999999999999999999999999999999999998765444445678999999999999
Q ss_pred hcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-----cCCCcchhhHHH
Q 044022 82 HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-----CVLNEKSNVFSF 156 (241)
Q Consensus 82 h~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~s~ 156 (241)
| +.+++||||||+|||++.++.+||+|||++........ ......|+..|+|||++.. ...+.++|||||
T Consensus 185 H---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dvwsl 259 (353)
T PLN00034 185 H---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSL 259 (353)
T ss_pred H---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHH
Confidence 9 99999999999999999999999999999876543221 1123468999999998743 234568999999
Q ss_pred HHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCC
Q 044022 157 GAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDR 236 (241)
Q Consensus 157 G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 236 (241)
|+++|+|++|+.||..... ..+........... . ..... ..+..+.+|+.+||+.||++|
T Consensus 260 Gvil~el~~g~~pf~~~~~------~~~~~~~~~~~~~~-~-----~~~~~--------~~~~~l~~li~~~l~~~P~~R 319 (353)
T PLN00034 260 GVSILEFYLGRFPFGVGRQ------GDWASLMCAICMSQ-P-----PEAPA--------TASREFRHFISCCLQREPAKR 319 (353)
T ss_pred HHHHHHHHhCCCCCCCCCC------ccHHHHHHHHhccC-C-----CCCCC--------ccCHHHHHHHHHHccCChhhC
Confidence 9999999999999963111 11111111111000 0 00111 223578999999999999999
Q ss_pred CCCCC
Q 044022 237 PTMVD 241 (241)
Q Consensus 237 pt~~e 241 (241)
||+.|
T Consensus 320 pt~~e 324 (353)
T PLN00034 320 WSAMQ 324 (353)
T ss_pred cCHHH
Confidence 99864
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=272.89 Aligned_cols=203 Identities=21% Similarity=0.230 Sum_probs=160.7
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC-----Cc---hHHHHHHHHHHHhchhhcC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA-----PL---PRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----~~---~~~~~~~~i~~~l~~lh~~ 84 (241)
...+.+|+++++.++|||||++++++...+..++||||+++|+|.+++... .. ....++.|++.||.|||
T Consensus 109 ~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH-- 186 (478)
T PTZ00267 109 AAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH-- 186 (478)
T ss_pred HHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 446778999999999999999999999999999999999999999877432 11 35678899999999999
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
+++|+||||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 187 -~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 265 (478)
T PTZ00267 187 -SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265 (478)
T ss_pred -hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHH
Confidence 8999999999999999999999999999998765432222233456899999999999888999999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|+.||... ...+....... +.....+ . ..+..+.+++.+||..||++|||++|
T Consensus 266 tg~~Pf~~~---------~~~~~~~~~~~-~~~~~~~-----~--------~~s~~~~~li~~~L~~dP~~Rps~~~ 319 (478)
T PTZ00267 266 TLHRPFKGP---------SQREIMQQVLY-GKYDPFP-----C--------PVSSGMKALLDPLLSKNPALRPTTQQ 319 (478)
T ss_pred hCCCCCCCC---------CHHHHHHHHHh-CCCCCCC-----c--------cCCHHHHHHHHHHhccChhhCcCHHH
Confidence 999999541 11122222111 1111111 1 12256889999999999999999753
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=268.78 Aligned_cols=217 Identities=23% Similarity=0.330 Sum_probs=170.1
Q ss_pred Cccccccc-ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHH
Q 044022 1 MKFYGHEY-HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDI 74 (241)
Q Consensus 1 iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i 74 (241)
||+++-+. ..+..+.|.+|+.++++-||.||+-++|+|...+. .||+.+|+|.||+.+++-... +.+.|+.||
T Consensus 419 VK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQi 497 (678)
T KOG0193|consen 419 VKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQI 497 (678)
T ss_pred EEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHH
Confidence 45555332 23467889999999999999999999999988887 999999999999999875432 467899999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc---cCCCcch
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI---CVLNEKS 151 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~ 151 (241)
+.|+.||| .++|+|+|||..|||+..++.|||+|||++................|...|||||++.. .+|++.|
T Consensus 498 aqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qS 574 (678)
T KOG0193|consen 498 AQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQS 574 (678)
T ss_pred HHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCccc
Confidence 99999999 99999999999999999999999999999876655544444455678889999999964 4789999
Q ss_pred hhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccC
Q 044022 152 NVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNN 231 (241)
Q Consensus 152 Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~ 231 (241)
||||||+++|||++|..||..-..+. -++.-++....++.... ...+.+++++|+..||.+
T Consensus 575 DVYaFGiV~YELltg~lPysi~~~dq------------IifmVGrG~l~pd~s~~-------~s~~pk~mk~Ll~~C~~~ 635 (678)
T KOG0193|consen 575 DVYAFGIVWYELLTGELPYSIQNRDQ------------IIFMVGRGYLMPDLSKI-------RSNCPKAMKRLLSDCWKF 635 (678)
T ss_pred chhhhhHHHHHHHhCcCCcCCCChhh------------eEEEecccccCccchhh-------hccCHHHHHHHHHHHHhc
Confidence 99999999999999999996321111 11111111111221111 125557899999999999
Q ss_pred CCCCCCCCC
Q 044022 232 SPEDRPTMV 240 (241)
Q Consensus 232 ~p~~Rpt~~ 240 (241)
++++||++.
T Consensus 636 ~~~eRP~F~ 644 (678)
T KOG0193|consen 636 DREERPLFP 644 (678)
T ss_pred CcccCccHH
Confidence 999999874
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=251.97 Aligned_cols=213 Identities=19% Similarity=0.252 Sum_probs=161.8
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~ 76 (241)
|.............|.+|+.++++++||||+++++++..++..++||||+++|+|.+++.... ...+.++.+++.
T Consensus 39 k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~ 118 (266)
T cd05064 39 HTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLAS 118 (266)
T ss_pred EecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHH
Confidence 344333333345678999999999999999999999999999999999999999999986542 146789999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSF 156 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~ 156 (241)
||+||| +.+++||||||+||+++.++.++++|||.+......... ......++..|+|||.+.+..++.++|||||
T Consensus 119 al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 194 (266)
T cd05064 119 GMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSF 194 (266)
T ss_pred HHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHH
Confidence 999999 999999999999999999999999999987543222111 1112234567999999998899999999999
Q ss_pred HHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 157 GAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 157 G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
|+++|++++ |..||.... ..+..... ..+... + ... ..+..+.+++.+||+.+|++
T Consensus 195 G~~l~ell~~g~~p~~~~~---------~~~~~~~~-~~~~~~--~---~~~--------~~~~~~~~li~~c~~~~p~~ 251 (266)
T cd05064 195 GIVMWEVMSYGERPYWDMS---------GQDVIKAV-EDGFRL--P---APR--------NCPNLLHQLMLDCWQKERGE 251 (266)
T ss_pred HHHHHHHhcCCCCCcCcCC---------HHHHHHHH-HCCCCC--C---CCC--------CCCHHHHHHHHHHcCCCchh
Confidence 999999775 999996521 11112221 111111 1 111 23357889999999999999
Q ss_pred CCCCCC
Q 044022 236 RPTMVD 241 (241)
Q Consensus 236 Rpt~~e 241 (241)
|||++|
T Consensus 252 RP~~~~ 257 (266)
T cd05064 252 RPRFSQ 257 (266)
T ss_pred CCCHHH
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=257.72 Aligned_cols=200 Identities=19% Similarity=0.218 Sum_probs=159.5
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
.....+.+|+.++++++||||+++++++...+..++||||+++|+|.+++..... ....++.|++.||.||| +
T Consensus 35 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~ 111 (312)
T cd05585 35 SEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLH---K 111 (312)
T ss_pred hHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 3456788999999999999999999999999999999999999999998865422 45678899999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
++++||||||+||+++.++.++|+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|
T Consensus 112 ~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg 189 (312)
T cd05585 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189 (312)
T ss_pred CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhC
Confidence 9999999999999999999999999999875332221 12334689999999999988899999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
+.||.... ..+......... ..+.. ..+..+.+++.+||+.||++||++
T Consensus 190 ~~pf~~~~---------~~~~~~~~~~~~-------~~~~~--------~~~~~~~~li~~~L~~dp~~R~~~ 238 (312)
T cd05585 190 LPPFYDEN---------VNEMYRKILQEP-------LRFPD--------GFDRDAKDLLIGLLSRDPTRRLGY 238 (312)
T ss_pred CCCcCCCC---------HHHHHHHHHcCC-------CCCCC--------cCCHHHHHHHHHHcCCCHHHcCCC
Confidence 99996421 112222211110 01111 122568899999999999999875
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=260.56 Aligned_cols=198 Identities=17% Similarity=0.219 Sum_probs=157.4
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
....+.+|++++++++||||+++++++...+..++||||+++++|.+++..... ....++.||+.||.||| +.
T Consensus 38 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH---~~ 114 (323)
T cd05571 38 EVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLH---SC 114 (323)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 456688999999999999999999999999999999999999999998865432 45678899999999999 99
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcC
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
+++||||||+||+++.++.+||+|||++........ ......|++.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 115 ~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 192 (323)
T cd05571 115 DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192 (323)
T ss_pred CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCC
Confidence 999999999999999999999999999865322211 112346899999999999888999999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
.||.... ......... ... ..+.. ..+..+.+++.+||+.||++||+
T Consensus 193 ~Pf~~~~---------~~~~~~~~~-~~~------~~~p~--------~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 193 LPFYNQD---------HEKLFELIL-MEE------IRFPR--------TLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred CCCCCCC---------HHHHHHHHH-cCC------CCCCC--------CCCHHHHHHHHHHccCCHHHcCC
Confidence 9996521 111111111 110 01111 12356889999999999999994
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=252.68 Aligned_cols=204 Identities=18% Similarity=0.301 Sum_probs=158.8
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--------------chHHHHHHHHHHH
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--------------LPRLKIASDIVNS 77 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~i~~~ 77 (241)
...+|.+|+.+++.++||||+++++++......++|+||+++++|.+++.... .....++.+++.|
T Consensus 52 ~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 131 (277)
T cd05062 52 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131 (277)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHH
Confidence 45678899999999999999999999998899999999999999999986421 1356789999999
Q ss_pred hchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHH
Q 044022 78 LAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFG 157 (241)
Q Consensus 78 l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G 157 (241)
|.||| +.+++|+||||+||+++.++.++++|||.+................++..|+|||++.+..++.++||||||
T Consensus 132 l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 208 (277)
T cd05062 132 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 208 (277)
T ss_pred HHHHH---HCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHH
Confidence 99999 899999999999999999999999999998755433222222223456789999999988899999999999
Q ss_pred HHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCC
Q 044022 158 AFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDR 236 (241)
Q Consensus 158 ~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 236 (241)
+++|+|++ |..||.... ..+...... ........ . ..+..+.+++.+||+.||++|
T Consensus 209 ~~l~el~~~~~~p~~~~~---------~~~~~~~~~-~~~~~~~~-----~--------~~~~~~~~li~~~l~~~p~~R 265 (277)
T cd05062 209 VVLWEIATLAEQPYQGMS---------NEQVLRFVM-EGGLLDKP-----D--------NCPDMLFELMRMCWQYNPKMR 265 (277)
T ss_pred HHHHHHHcCCCCCCCCCC---------HHHHHHHHH-cCCcCCCC-----C--------CCCHHHHHHHHHHcCCChhhC
Confidence 99999999 688885421 111111111 11111111 1 122568999999999999999
Q ss_pred CCCCC
Q 044022 237 PTMVD 241 (241)
Q Consensus 237 pt~~e 241 (241)
||+.|
T Consensus 266 ps~~e 270 (277)
T cd05062 266 PSFLE 270 (277)
T ss_pred cCHHH
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=257.97 Aligned_cols=155 Identities=23% Similarity=0.301 Sum_probs=134.9
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
....++.+|++++++++|+||++++++|...+..++||||+++++|.+++..... ....++.+++.|+.||| +
T Consensus 45 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH---~ 121 (333)
T cd06650 45 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR---E 121 (333)
T ss_pred HHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 3456789999999999999999999999999999999999999999999865432 35678899999999999 5
Q ss_pred -CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 87 -RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 87 -~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
.+++|+||||+||+++.++.++|+|||++....... .....++..|+|||++.+..++.++|+||||+++|++++
T Consensus 122 ~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~ 197 (333)
T cd06650 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAI 197 (333)
T ss_pred cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 479999999999999999999999999986543221 123467889999999998889999999999999999999
Q ss_pred cCccccc
Q 044022 166 GRIHIWD 172 (241)
Q Consensus 166 g~~p~~~ 172 (241)
|+.||..
T Consensus 198 g~~p~~~ 204 (333)
T cd06650 198 GRYPIPP 204 (333)
T ss_pred CCCCCCC
Confidence 9999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=253.50 Aligned_cols=204 Identities=23% Similarity=0.348 Sum_probs=161.1
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--------------------chHHHHH
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--------------------LPRLKIA 71 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------------~~~~~~~ 71 (241)
..+.+.+|++++++++|+||+++++++...+..++||||+++++|.+++.... ..++.++
T Consensus 50 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 129 (291)
T cd05094 50 ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129 (291)
T ss_pred HHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHH
Confidence 34678999999999999999999999999999999999999999999986432 1357899
Q ss_pred HHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcch
Q 044022 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKS 151 (241)
Q Consensus 72 ~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 151 (241)
.+|+.|++||| +++++|+||||+||+++.++.++|+|||.+................++..|+|||++.+..++.++
T Consensus 130 ~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 206 (291)
T cd05094 130 SQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 206 (291)
T ss_pred HHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchh
Confidence 99999999999 999999999999999999999999999998755443222222334567789999999988899999
Q ss_pred hhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhcc
Q 044022 152 NVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVN 230 (241)
Q Consensus 152 Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 230 (241)
||||||+++|+|++ |..||..... .+.. .....+...... . ..+..+.+++.+||+
T Consensus 207 Di~slG~il~el~t~g~~p~~~~~~---------~~~~-~~~~~~~~~~~~-----~--------~~~~~~~~li~~~l~ 263 (291)
T cd05094 207 DVWSFGVILWEIFTYGKQPWFQLSN---------TEVI-ECITQGRVLERP-----R--------VCPKEVYDIMLGCWQ 263 (291)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCH---------HHHH-HHHhCCCCCCCC-----c--------cCCHHHHHHHHHHcc
Confidence 99999999999998 9999855211 1111 111222111111 1 123568899999999
Q ss_pred CCCCCCCCCCC
Q 044022 231 NSPEDRPTMVD 241 (241)
Q Consensus 231 ~~p~~Rpt~~e 241 (241)
.||++|||+.+
T Consensus 264 ~~P~~Rpt~~~ 274 (291)
T cd05094 264 REPQQRLNIKE 274 (291)
T ss_pred cChhhCcCHHH
Confidence 99999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=249.04 Aligned_cols=210 Identities=20% Similarity=0.292 Sum_probs=156.4
Q ss_pred cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---------hHHHHHHHHHHHhch
Q 044022 10 RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---------PRLKIASDIVNSLAY 80 (241)
Q Consensus 10 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------~~~~~~~~i~~~l~~ 80 (241)
......|.+|+++++.++|+||+++++++......++||||+++|+|.+++..... ....++.|++.|+.|
T Consensus 36 ~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~ 115 (269)
T cd05042 36 PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115 (269)
T ss_pred hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHH
Confidence 34456789999999999999999999999999999999999999999999865421 346789999999999
Q ss_pred hhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-------cCCCcchhh
Q 044022 81 LHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-------CVLNEKSNV 153 (241)
Q Consensus 81 lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di 153 (241)
|| +++++||||||+||+++.++.++|+|||.+................++..|+|||++.. ..++.++||
T Consensus 116 lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Di 192 (269)
T cd05042 116 LH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNI 192 (269)
T ss_pred HH---hcCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHH
Confidence 99 89999999999999999999999999999865433221112223345677999998743 356789999
Q ss_pred HHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCC
Q 044022 154 FSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNS 232 (241)
Q Consensus 154 ~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~ 232 (241)
||||+++|+|++ |..||..... .+......... ....+.+.+.. ..+..+.+++..|| .|
T Consensus 193 wslG~~l~el~~~~~~p~~~~~~---------~~~~~~~~~~~-~~~~~~~~~~~--------~~~~~~~~~~~~~~-~d 253 (269)
T cd05042 193 WSLGVTMWELFTAADQPYPDLSD---------EQVLKQVVREQ-DIKLPKPQLDL--------KYSDRWYEVMQFCW-LD 253 (269)
T ss_pred HHHHHHHHHHHhCCCCCCCcCCH---------HHHHHHHhhcc-CccCCCCcccc--------cCCHHHHHHHHHHh-cC
Confidence 999999999999 7788854211 11111111111 11222222222 22356778999999 59
Q ss_pred CCCCCCCCC
Q 044022 233 PEDRPTMVD 241 (241)
Q Consensus 233 p~~Rpt~~e 241 (241)
|++|||++|
T Consensus 254 p~~Rpt~~~ 262 (269)
T cd05042 254 PETRPTAEE 262 (269)
T ss_pred cccccCHHH
Confidence 999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=258.91 Aligned_cols=196 Identities=19% Similarity=0.233 Sum_probs=158.0
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+.+.+|++++++++||||+++++++...+..++||||+++++|.+++..... ....++.|++.||.||| +.
T Consensus 61 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~ 137 (329)
T PTZ00263 61 QVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH---SK 137 (329)
T ss_pred hHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 456788999999999999999999999999999999999999999998865432 35567899999999999 99
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcC
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
+++||||||+|||++.++.+||+|||++....... ....|++.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 138 ~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 212 (329)
T PTZ00263 138 DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGY 212 (329)
T ss_pred CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCC
Confidence 99999999999999999999999999987654332 2246889999999999888999999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
.||.... ..+...... .+.. . +... .+..+.+++.+||+.||++||+.
T Consensus 213 ~pf~~~~---------~~~~~~~i~-~~~~-~-----~p~~--------~~~~~~~li~~~L~~dP~~R~~~ 260 (329)
T PTZ00263 213 PPFFDDT---------PFRIYEKIL-AGRL-K-----FPNW--------FDGRARDLVKGLLQTDHTKRLGT 260 (329)
T ss_pred CCCCCCC---------HHHHHHHHh-cCCc-C-----CCCC--------CCHHHHHHHHHHhhcCHHHcCCC
Confidence 9995421 111111111 1110 0 1111 12467899999999999999984
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=252.72 Aligned_cols=204 Identities=23% Similarity=0.335 Sum_probs=160.4
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----------------chHHHHHHHH
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----------------LPRLKIASDI 74 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------------~~~~~~~~~i 74 (241)
..+.+.+|++++++++||||+++++++...+..++|+||+++++|.+++.... ...+.++.++
T Consensus 50 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql 129 (288)
T cd05093 50 ARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129 (288)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHH
Confidence 45678999999999999999999999999999999999999999999986432 1457889999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhH
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
+.||+||| +.+++||||||+||+++.++.++|+|||.+............+...++..|+|||++.+..++.++|+|
T Consensus 130 ~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiw 206 (288)
T cd05093 130 AAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVW 206 (288)
T ss_pred HHHHHHHH---hCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHH
Confidence 99999999 999999999999999999999999999998765433222222233456789999999988899999999
Q ss_pred HHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 155 SFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 155 s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
|||+++|+|++ |..||..... .+.... ...+..... .. ..+..+.+++.+||+.||
T Consensus 207 slG~il~~l~t~g~~p~~~~~~---------~~~~~~-i~~~~~~~~-----~~--------~~~~~l~~li~~~l~~~p 263 (288)
T cd05093 207 SLGVVLWEIFTYGKQPWYQLSN---------NEVIEC-ITQGRVLQR-----PR--------TCPKEVYDLMLGCWQREP 263 (288)
T ss_pred HHHHHHHHHHhCCCCCCCCCCH---------HHHHHH-HHcCCcCCC-----CC--------CCCHHHHHHHHHHccCCh
Confidence 99999999998 8999854211 111111 111211111 11 122568999999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
.+|||+.|
T Consensus 264 ~~Rpt~~~ 271 (288)
T cd05093 264 HMRLNIKE 271 (288)
T ss_pred hhCCCHHH
Confidence 99999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=248.74 Aligned_cols=213 Identities=24% Similarity=0.292 Sum_probs=169.9
Q ss_pred Cccccccc--ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc------hHHHHHH
Q 044022 1 MKFYGHEY--HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL------PRLKIAS 72 (241)
Q Consensus 1 iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~ 72 (241)
||+..+++ .+....+.+.|-+||+.+.||.++.+|+.|+.++..|++||||+||+|...+++.+. .+..++.
T Consensus 107 mKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaA 186 (459)
T KOG0610|consen 107 MKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAA 186 (459)
T ss_pred EEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHH
Confidence 46666555 346677888899999999999999999999999999999999999999999887643 3456899
Q ss_pred HHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCC--------------------------------
Q 044022 73 DIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPE-------------------------------- 120 (241)
Q Consensus 73 ~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~-------------------------------- 120 (241)
+++.||.||| -.|||.|||||+|||+.++|++-|+||.++.....
T Consensus 187 Evl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~ 263 (459)
T KOG0610|consen 187 EVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCL 263 (459)
T ss_pred HHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchh
Confidence 9999999999 89999999999999999999999999988643211
Q ss_pred -C-C--------------------cceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCcccccccccCC
Q 044022 121 -G-E--------------------THITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTH 178 (241)
Q Consensus 121 -~-~--------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~ 178 (241)
. . ......+.+||..|+|||++.+...+.++|.|+||+++|||+.|.-||..
T Consensus 264 ~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG------ 337 (459)
T KOG0610|consen 264 SSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKG------ 337 (459)
T ss_pred ccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCC------
Confidence 0 0 00122356799999999999999999999999999999999999999954
Q ss_pred CcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 179 DHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
....+...+...... ..+. . ...+.++++||++.|.+||++|.-
T Consensus 338 ---~~~~~Tl~NIv~~~l--~Fp~------~-----~~vs~~akDLIr~LLvKdP~kRlg 381 (459)
T KOG0610|consen 338 ---SNNKETLRNIVGQPL--KFPE------E-----PEVSSAAKDLIRKLLVKDPSKRLG 381 (459)
T ss_pred ---CCchhhHHHHhcCCC--cCCC------C-----CcchhHHHHHHHHHhccChhhhhc
Confidence 333444444433221 1111 1 133457899999999999999976
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=247.21 Aligned_cols=206 Identities=22% Similarity=0.298 Sum_probs=158.1
Q ss_pred cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHHHHhchhhcC
Q 044022 10 RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 10 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~~~l~~lh~~ 84 (241)
......+.+|++++++++||||+++++++......++|+||+++++|.+++.... . ....++.+++.||.|||
T Consensus 34 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH-- 111 (252)
T cd05084 34 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE-- 111 (252)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 3446779999999999999999999999999999999999999999999986432 1 45778999999999999
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
+.+++|+||+|+||+++.++.++|+|||.+.................+..|+|||.+.+..++.++|+||||+++|+++
T Consensus 112 -~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~ 190 (252)
T cd05084 112 -SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAF 190 (252)
T ss_pred -hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999987543321111111112345699999998888999999999999999999
Q ss_pred h-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 A-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+ |..||..... ....... ........ .. ..+..+.+++.+||..+|++|||+.|
T Consensus 191 ~~~~~p~~~~~~---------~~~~~~~-~~~~~~~~-----~~--------~~~~~~~~li~~~l~~~p~~Rps~~~ 245 (252)
T cd05084 191 SLGAVPYANLSN---------QQTREAI-EQGVRLPC-----PE--------LCPDAVYRLMERCWEYDPGQRPSFST 245 (252)
T ss_pred hCCCCCccccCH---------HHHHHHH-HcCCCCCC-----cc--------cCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 8 8888854211 1111111 11110010 11 22357889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=255.22 Aligned_cols=195 Identities=23% Similarity=0.253 Sum_probs=157.6
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+.+.+|++++++++||||+++++++...+..++||||+++++|.+++..... ....++.|++.||.||| ++
T Consensus 44 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~ 120 (291)
T cd05612 44 QEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH---SK 120 (291)
T ss_pred HHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 456688999999999999999999999999999999999999999999865432 45678999999999999 99
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcC
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
+++||||||+||+++.++.++|+|||++....... ....|++.|+|||++.+..++.++||||||+++|+|++|+
T Consensus 121 ~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~ 195 (291)
T cd05612 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195 (291)
T ss_pred CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999987654321 2346889999999999888999999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
.||.... ..+......... . .+.. ..+..+.+++.+||+.||.+||+
T Consensus 196 ~pf~~~~---------~~~~~~~i~~~~-~------~~~~--------~~~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 196 PPFFDDN---------PFGIYEKILAGK-L------EFPR--------HLDLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred CCCCCCC---------HHHHHHHHHhCC-c------CCCc--------cCCHHHHHHHHHHcCCCHHHccC
Confidence 9995421 111111111111 0 0111 11256889999999999999996
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=255.55 Aligned_cols=213 Identities=20% Similarity=0.275 Sum_probs=162.0
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~ 76 (241)
|.+.........+++.+|+.+++.++||||++++++|... ..++++||+++|+|.+++..... ..+.++.+++.
T Consensus 42 K~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~ 120 (316)
T cd05108 42 KELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 120 (316)
T ss_pred EeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHH
Confidence 4443333334567899999999999999999999999765 46899999999999999876431 45788999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSF 156 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~ 156 (241)
||+||| +.+++||||||+||+++.++.+||+|||++.................+..|+|||++....++.++|||||
T Consensus 121 ~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 197 (316)
T cd05108 121 GMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 197 (316)
T ss_pred HHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHH
Confidence 999999 89999999999999999999999999999987654433222222334667999999998899999999999
Q ss_pred HHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 157 GAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 157 G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
|+++|++++ |..||.... ..+. ......+... +.+ . .++..+.+++.+||..||++
T Consensus 198 Gv~l~el~t~g~~p~~~~~---------~~~~-~~~~~~~~~~--~~~---~--------~~~~~~~~li~~cl~~~p~~ 254 (316)
T cd05108 198 GVTVWELMTFGSKPYDGIP---------ASEI-SSILEKGERL--PQP---P--------ICTIDVYMIMVKCWMIDADS 254 (316)
T ss_pred HHHHHHHHcCCCCCCCCCC---------HHHH-HHHHhCCCCC--CCC---C--------CCCHHHHHHHHHHccCChhh
Confidence 999999997 999985421 1111 1111111111 111 1 12246889999999999999
Q ss_pred CCCCCC
Q 044022 236 RPTMVD 241 (241)
Q Consensus 236 Rpt~~e 241 (241)
|||+.|
T Consensus 255 Rps~~~ 260 (316)
T cd05108 255 RPKFRE 260 (316)
T ss_pred CcCHHH
Confidence 999853
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=253.09 Aligned_cols=227 Identities=19% Similarity=0.212 Sum_probs=160.5
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-c---hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-L---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|++++++++||||+++++++...+..++||||++++++..+..... . ....++.|++.||.||| +
T Consensus 42 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~ 118 (287)
T cd07848 42 EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH---K 118 (287)
T ss_pred cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 345678899999999999999999999999999999999999877765543321 1 45778999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++|+||||+||+++.++.++|+|||.+......... ......+++.|+|||++.+..++.++|+||||+++|+|++|
T Consensus 119 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g 197 (287)
T cd07848 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG 197 (287)
T ss_pred CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhC
Confidence 99999999999999999999999999998765432211 11234688899999999888899999999999999999999
Q ss_pred CcccccccccCC------CcccchHHHHHHHhhhcccCCCCCCccccCCC--chhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 167 RIHIWDLLKDTH------DHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIP--CIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 167 ~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
++||........ ..+....+................+....... .......+..+.+|+.+||+.||++|||
T Consensus 198 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s 277 (287)
T cd07848 198 QPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL 277 (287)
T ss_pred CCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCC
Confidence 999964211000 00000000111111111100000000000000 0001123467899999999999999999
Q ss_pred CCC
Q 044022 239 MVD 241 (241)
Q Consensus 239 ~~e 241 (241)
++|
T Consensus 278 ~~~ 280 (287)
T cd07848 278 TEQ 280 (287)
T ss_pred HHH
Confidence 864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=255.87 Aligned_cols=165 Identities=21% Similarity=0.255 Sum_probs=135.7
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~ 76 (241)
|.+..+........+.+|++++++++||||+++++++..++..++||||+. ++|.+++..... ....++.|++.
T Consensus 36 K~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~ 114 (288)
T cd07871 36 KEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLR 114 (288)
T ss_pred EEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 444333333445678899999999999999999999999889999999997 599988754321 45678999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFS 155 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s 155 (241)
||+||| +++++||||||+|||++.++.+||+|||.+........ ......+++.|+|||.+.+ ..++.++||||
T Consensus 115 aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws 189 (288)
T cd07871 115 GLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWG 189 (288)
T ss_pred HHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHH
Confidence 999999 99999999999999999999999999999876433221 1123457889999998875 46889999999
Q ss_pred HHHHHHHHHhcCccccc
Q 044022 156 FGAFLFELLAGRIHIWD 172 (241)
Q Consensus 156 ~G~~~~~~~~g~~p~~~ 172 (241)
+|+++|+|++|+.||..
T Consensus 190 lG~~l~~l~~g~~pf~~ 206 (288)
T cd07871 190 VGCILYEMATGRPMFPG 206 (288)
T ss_pred HHHHHHHHHhCCCCCCC
Confidence 99999999999999954
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=259.00 Aligned_cols=199 Identities=18% Similarity=0.225 Sum_probs=157.8
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
.....+.+|+++++.++||||+++++++...+..++||||+++|+|.+++..... ....++.||+.||+||| +
T Consensus 37 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~ 113 (328)
T cd05593 37 DEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLH---S 113 (328)
T ss_pred hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 3456788999999999999999999999999999999999999999988865432 46778999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
++++||||||+|||++.++.+||+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|
T Consensus 114 ~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG 191 (328)
T cd05593 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191 (328)
T ss_pred CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhC
Confidence 9999999999999999999999999999865322211 11234689999999999988899999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
+.||.... ..+......... ..+.. ..+..+.+++.+||..||++||+
T Consensus 192 ~~Pf~~~~---------~~~~~~~~~~~~-------~~~p~--------~~~~~~~~li~~~L~~dP~~R~~ 239 (328)
T cd05593 192 RLPFYNQD---------HEKLFELILMED-------IKFPR--------TLSADAKSLLSGLLIKDPNKRLG 239 (328)
T ss_pred CCCCCCCC---------HHHHHHHhccCC-------ccCCC--------CCCHHHHHHHHHHcCCCHHHcCC
Confidence 99995421 111111111100 01111 12256889999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=257.00 Aligned_cols=214 Identities=18% Similarity=0.215 Sum_probs=158.0
Q ss_pred HHHHHHHHHhcCCCcccceeeeeeeC--CcceEEEEecCCCCHHHhhcCC-----CchHHHHHHHHHHHhchhhcCCCCC
Q 044022 16 CINNITYAAQMSHNHILKRIGCCLQT--PIPILVFQSVEYGTLRDCIFGA-----PLPRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 16 ~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~-----~~~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
..+||.||++|.||||+++.+..... +.+|||+|||++ +|.-++... ..++..++.|++.||.||| .++
T Consensus 163 ~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~g 238 (560)
T KOG0600|consen 163 AIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRG 238 (560)
T ss_pred HHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcC
Confidence 45899999999999999999999876 689999999985 888887664 3367889999999999999 999
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHHHhcC
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
++|||||.+|||+|.+|.+||+|||+++........ ..+..+-|..|+|||.+.+. .|+++.|+||.|||+.||++|+
T Consensus 239 vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gk 317 (560)
T KOG0600|consen 239 VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGK 317 (560)
T ss_pred eeeccccccceEEcCCCCEEeccccceeeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCC
Confidence 999999999999999999999999999866554322 23445678899999999876 7999999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhh--hcccCC---CCCCc-cccCCC--c-hh--HHHHHHHHHHHHHHhccCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLE--DKRFTG---IPAPI-IVQDIP--C-IE--KEQQLHASAQLTLECVNNSPEDR 236 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~---~~~~~-~~~~~~--~-~~--~~~~~~~~~~l~~~cl~~~p~~R 236 (241)
++|.....-. ..+....+.. ....+. ++... +.+..+ . .. ....+....+|+..+|..||++|
T Consensus 318 PI~~G~tEve------Ql~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR 391 (560)
T KOG0600|consen 318 PILQGRTEVE------QLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKR 391 (560)
T ss_pred CCcCCccHHH------HHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccc
Confidence 9986521110 0000000000 011111 01000 000000 0 00 11233667899999999999999
Q ss_pred CCCC
Q 044022 237 PTMV 240 (241)
Q Consensus 237 pt~~ 240 (241)
.||.
T Consensus 392 ~tA~ 395 (560)
T KOG0600|consen 392 GTAS 395 (560)
T ss_pred ccHH
Confidence 9985
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=276.35 Aligned_cols=215 Identities=23% Similarity=0.360 Sum_probs=176.8
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~ 75 (241)
||-+..-+.+.....|+.|+.||-|+.||||+++.|+....+...||+|||++|+|..||+.+.. +...+++.|+
T Consensus 662 IKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIA 741 (996)
T KOG0196|consen 662 IKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIA 741 (996)
T ss_pred EeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHH
Confidence 45555556666788899999999999999999999999999999999999999999999987743 5678999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-eeecccccCCCccCcccccccCCCcchhhH
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-ITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
.|++||. +++.|||||.++|||++.+..+|++|||+++.+.++... .+.....-+..|.|||.+...+++.+||||
T Consensus 742 sGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVW 818 (996)
T KOG0196|consen 742 SGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVW 818 (996)
T ss_pred HHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhcc
Confidence 9999999 999999999999999999999999999999987665411 111112235789999999999999999999
Q ss_pred HHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 155 SFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 155 s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
|||+++||.++ |..||+++.+ .+.++.....-+ ++.+. +++..+.+||..||++|-
T Consensus 819 SyGIVmWEVmSyGERPYWdmSN---------QdVIkaIe~gyR---LPpPm-----------DCP~aL~qLMldCWqkdR 875 (996)
T KOG0196|consen 819 SYGIVMWEVMSYGERPYWDMSN---------QDVIKAIEQGYR---LPPPM-----------DCPAALYQLMLDCWQKDR 875 (996)
T ss_pred ccceEEEEecccCCCcccccch---------HHHHHHHHhccC---CCCCC-----------CCcHHHHHHHHHHHHHHh
Confidence 99999999776 9999987433 344444433222 22222 566889999999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
..||+++|
T Consensus 876 ~~RP~F~q 883 (996)
T KOG0196|consen 876 NRRPKFAQ 883 (996)
T ss_pred hcCCCHHH
Confidence 99999854
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=250.67 Aligned_cols=200 Identities=20% Similarity=0.245 Sum_probs=167.3
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
+..-.+.+||+||..|+||||+.++.+|++.+...+||||..+|.|++++..... ....+++||+.|+.|+| +
T Consensus 95 qDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCH---k 171 (668)
T KOG0611|consen 95 QDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCH---K 171 (668)
T ss_pred HHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHh---h
Confidence 4455678999999999999999999999999999999999999999999976532 46789999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCC-cchhhHHHHHHHHHHHh
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLN-EKSNVFSFGAFLFELLA 165 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~s~G~~~~~~~~ 165 (241)
++++|||||.+|||+|.++++||+|||++........ ..+.+|++-|.+||.+.+.+|. +.+|-||||+++|.++.
T Consensus 172 nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVy 248 (668)
T KOG0611|consen 172 NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVY 248 (668)
T ss_pred ccceecccchhheeecCCCCeeeeccchhhhhccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhh
Confidence 9999999999999999999999999999976655433 2456899999999999998874 88999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|.+||+. ..+...++..........- .+....-||+.||-.||++|.|++|
T Consensus 249 GtMPFDG---------~Dhk~lvrQIs~GaYrEP~----------------~PSdA~gLIRwmLmVNP~RRATieD 299 (668)
T KOG0611|consen 249 GTMPFDG---------RDHKRLVRQISRGAYREPE----------------TPSDASGLIRWMLMVNPERRATIED 299 (668)
T ss_pred cccccCC---------chHHHHHHHhhcccccCCC----------------CCchHHHHHHHHHhcCcccchhHHH
Confidence 9999954 4455555555433322211 1134567999999999999999864
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=262.15 Aligned_cols=214 Identities=18% Similarity=0.334 Sum_probs=162.5
Q ss_pred cccccccccccHHHHHHHHHHHHhcC-CCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----------------
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---------------- 64 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------- 64 (241)
|.+.........+.+.+|+++++++. ||||++++++|...+..++||||+++|+|.+++....
T Consensus 73 K~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~ 152 (400)
T cd05105 73 KMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLD 152 (400)
T ss_pred EecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhcccccccccccc
Confidence 44444333344567999999999995 9999999999999999999999999999998874310
Q ss_pred --------------------------------------------------------------------------------
Q 044022 65 -------------------------------------------------------------------------------- 64 (241)
Q Consensus 65 -------------------------------------------------------------------------------- 64 (241)
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 232 (400)
T cd05105 153 IFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSE 232 (400)
T ss_pred ccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccC
Confidence
Q ss_pred -c---hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcc
Q 044022 65 -L---PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPE 140 (241)
Q Consensus 65 -~---~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE 140 (241)
. ....++.|++.||.||| +.+++|+||||+|||++.++.++|+|||++................++..|+|||
T Consensus 233 ~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 309 (400)
T cd05105 233 GLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE 309 (400)
T ss_pred CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChh
Confidence 0 13568899999999999 8999999999999999999999999999987654433222223345677899999
Q ss_pred cccccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHH
Q 044022 141 YISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLH 219 (241)
Q Consensus 141 ~~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (241)
.+.+..++.++||||||+++|+|++ |..||...... .........+.... ... ..+.
T Consensus 310 ~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~---------~~~~~~~~~~~~~~-----~~~--------~~~~ 367 (400)
T cd05105 310 SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD---------STFYNKIKSGYRMA-----KPD--------HATQ 367 (400)
T ss_pred hhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh---------HHHHHHHhcCCCCC-----CCc--------cCCH
Confidence 9988889999999999999999997 88998542111 11111111111100 011 2335
Q ss_pred HHHHHHHHhccCCCCCCCCCC
Q 044022 220 ASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 220 ~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
.+.+++.+||+.||++|||+.
T Consensus 368 ~l~~li~~cl~~dP~~RPt~~ 388 (400)
T cd05105 368 EVYDIMVKCWNSEPEKRPSFL 388 (400)
T ss_pred HHHHHHHHHCccCHhHCcCHH
Confidence 789999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=258.93 Aligned_cols=206 Identities=18% Similarity=0.183 Sum_probs=161.1
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
....+.+|++++.+++||||+++++++...+..++||||+++++|.+++.... .....++.|++.||.||| +.
T Consensus 44 ~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~ 120 (333)
T cd05600 44 EVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH---EL 120 (333)
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 45678899999999999999999999999999999999999999999986542 246678999999999999 99
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcC
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
+++||||||+||+++.++.+||+|||++..... ......|++.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 121 ~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~ 195 (333)
T cd05600 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGF 195 (333)
T ss_pred CccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCC
Confidence 999999999999999999999999999875543 123456899999999999889999999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.||.... ..+.............. +..... ....+..+.+++.+||..+|.+|||++|
T Consensus 196 ~pf~~~~---------~~~~~~~i~~~~~~~~~--~~~~~~-----~~~~s~~~~~li~~~l~~~~~rr~s~~~ 253 (333)
T cd05600 196 PPFSGST---------PNETWENLKYWKETLQR--PVYDDP-----RFNLSDEAWDLITKLINDPSRRFGSLED 253 (333)
T ss_pred CCCCCCC---------HHHHHHHHHhccccccC--CCCCcc-----ccccCHHHHHHHHHHhhChhhhcCCHHH
Confidence 9995421 11111111111100000 000000 0122357889999999999999999753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=246.59 Aligned_cols=208 Identities=20% Similarity=0.294 Sum_probs=155.3
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC---------chHHHHHHHHHHHhchhh
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---------LPRLKIASDIVNSLAYLH 82 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------~~~~~~~~~i~~~l~~lh 82 (241)
....+.+|+.++++++||||+++++++......++||||+++|+|.+++.... .....++.+++.|+.|||
T Consensus 38 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 117 (269)
T cd05087 38 EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117 (269)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence 44578899999999999999999999998889999999999999999986421 124578899999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-------CCCcchhhHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-------VLNEKSNVFS 155 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~Di~s 155 (241)
+.+++|+||||+||+++.++.++++|||.+................++..|+|||++... .++.++|+||
T Consensus 118 ---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 194 (269)
T cd05087 118 ---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWS 194 (269)
T ss_pred ---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHH
Confidence 899999999999999999999999999998654333222222334567889999988632 3578999999
Q ss_pred HHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 156 FGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 156 ~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
||+++|+|++ |..||...... +... ............+.+... .++.+.+++.+|| .+|+
T Consensus 195 lG~~l~el~~~g~~p~~~~~~~---------~~~~-~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~~c~-~~P~ 255 (269)
T cd05087 195 LGVTIWELFELGSQPYRHLSDE---------QVLT-YTVREQQLKLPKPRLKLP--------LSDRWYEVMQFCW-LQPE 255 (269)
T ss_pred HHHHHHHHHhCCCCCCCCCChH---------HHHH-HHhhcccCCCCCCccCCC--------CChHHHHHHHHHh-cCcc
Confidence 9999999996 99999542111 1111 111111111222221111 2246788999999 6899
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
+|||++|
T Consensus 256 ~Rpt~~~ 262 (269)
T cd05087 256 QRPSAEE 262 (269)
T ss_pred cCCCHHH
Confidence 9999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=263.78 Aligned_cols=208 Identities=23% Similarity=0.331 Sum_probs=169.4
Q ss_pred cccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHHhch
Q 044022 6 HEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNSLAY 80 (241)
Q Consensus 6 ~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~l~~ 80 (241)
.+...+..+.|++|+-+|++++||||++++|+|.... .|+|||+++-|.|..+++.+.. ....++.||+.||+|
T Consensus 428 ~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaY 506 (974)
T KOG4257|consen 428 TDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAY 506 (974)
T ss_pred cCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHH
Confidence 3344456889999999999999999999999997665 7999999999999999987643 346789999999999
Q ss_pred hhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHH
Q 044022 81 LHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFL 160 (241)
Q Consensus 81 lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~ 160 (241)
|| +..+|||||.++|||+.....+|++|||+++.+........ +....+..|||||.+...+++.+||||.||+.+
T Consensus 507 Le---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCm 582 (974)
T KOG4257|consen 507 LE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCM 582 (974)
T ss_pred HH---hhchhhhhhhhhheeecCcceeeecccchhhhccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHH
Confidence 99 99999999999999999999999999999998877654443 345678899999999999999999999999999
Q ss_pred HHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 161 FELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 161 ~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
||++. |..||....+.+- -...+++...+.+ +.+++.+..|+.+||++||.+||++
T Consensus 583 WEIl~lGvkPfqgvkNsDV----------I~~iEnGeRlP~P-------------~nCPp~LYslmskcWayeP~kRPrf 639 (974)
T KOG4257|consen 583 WEILSLGVKPFQGVKNSDV----------IGHIENGERLPCP-------------PNCPPALYSLMSKCWAYEPSKRPRF 639 (974)
T ss_pred HHHHHhcCCccccccccce----------EEEecCCCCCCCC-------------CCCChHHHHHHHHHhccCcccCCcH
Confidence 99987 8899966433220 0111122222211 2455789999999999999999998
Q ss_pred CC
Q 044022 240 VD 241 (241)
Q Consensus 240 ~e 241 (241)
.|
T Consensus 640 te 641 (974)
T KOG4257|consen 640 TE 641 (974)
T ss_pred HH
Confidence 64
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=250.18 Aligned_cols=205 Identities=21% Similarity=0.317 Sum_probs=159.0
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC---------------------chHHH
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---------------------LPRLK 69 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------------~~~~~ 69 (241)
.....+.+|++++++++||||+++++++......|+||||+++++|.+++.... ...+.
T Consensus 49 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 128 (283)
T cd05090 49 QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128 (283)
T ss_pred HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHH
Confidence 445678999999999999999999999999999999999999999999884211 13467
Q ss_pred HHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCc
Q 044022 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNE 149 (241)
Q Consensus 70 ~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 149 (241)
++.+++.||.||| +++++|+||||+||+++.++.++|+|||++................++..|+|||++.+..++.
T Consensus 129 i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 205 (283)
T cd05090 129 IAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSS 205 (283)
T ss_pred HHHHHHHHHHHHH---hcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCc
Confidence 8999999999999 8999999999999999999999999999987654332222223334567799999998888999
Q ss_pred chhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHh
Q 044022 150 KSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLEC 228 (241)
Q Consensus 150 ~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 228 (241)
++|+||||+++|+|++ |..||.... ..+....... ..... ... ..+..+.+++.+|
T Consensus 206 ~~Dv~slG~il~el~~~g~~p~~~~~---------~~~~~~~~~~-~~~~~-----~~~--------~~~~~~~~li~~c 262 (283)
T cd05090 206 DSDIWSFGVVLWEIFSFGLQPYYGFS---------NQEVIEMVRK-RQLLP-----CSE--------DCPPRMYSLMTEC 262 (283)
T ss_pred hhhhHHHHHHHHHHHcCCCCCCCCCC---------HHHHHHHHHc-CCcCC-----CCC--------CCCHHHHHHHHHH
Confidence 9999999999999998 988985411 1111111111 11111 111 1235788999999
Q ss_pred ccCCCCCCCCCCC
Q 044022 229 VNNSPEDRPTMVD 241 (241)
Q Consensus 229 l~~~p~~Rpt~~e 241 (241)
|+.||++||++.+
T Consensus 263 l~~~p~~Rp~~~~ 275 (283)
T cd05090 263 WQEGPSRRPRFKD 275 (283)
T ss_pred cccCcccCcCHHH
Confidence 9999999999853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=250.94 Aligned_cols=214 Identities=16% Similarity=0.225 Sum_probs=162.6
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----------------
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----------------- 64 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------- 64 (241)
|.+.........+.+.+|+.++.+++||||+++++++......++++||+.+++|.+++....
T Consensus 41 K~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~ 120 (283)
T cd05091 41 KTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120 (283)
T ss_pred EEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccc
Confidence 444433333345678899999999999999999999999899999999999999999974210
Q ss_pred ---chHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccc
Q 044022 65 ---LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEY 141 (241)
Q Consensus 65 ---~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 141 (241)
.....++.|++.||.||| +++++||||||.||+++.++.+||+|||++................+++.|+|||+
T Consensus 121 ~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 197 (283)
T cd05091 121 LEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEA 197 (283)
T ss_pred cCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHH
Confidence 124678999999999999 99999999999999999999999999999876543322222233345678999999
Q ss_pred ccccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHH
Q 044022 142 ISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHA 220 (241)
Q Consensus 142 ~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (241)
+.+..++.++||||||+++|+|++ |..||.... ..+.... ......... .. .++..
T Consensus 198 ~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---------~~~~~~~-i~~~~~~~~-----~~--------~~~~~ 254 (283)
T cd05091 198 IMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---------NQDVIEM-IRNRQVLPC-----PD--------DCPAW 254 (283)
T ss_pred HhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC---------HHHHHHH-HHcCCcCCC-----CC--------CCCHH
Confidence 988889999999999999999998 888875411 1111111 112211111 11 23356
Q ss_pred HHHHHHHhccCCCCCCCCCCC
Q 044022 221 SAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 221 ~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+.+++.+||+.+|++|||++|
T Consensus 255 ~~~li~~cl~~~p~~RP~~~~ 275 (283)
T cd05091 255 VYTLMLECWNEFPSRRPRFKD 275 (283)
T ss_pred HHHHHHHHhCCCcccCCCHHH
Confidence 889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=258.61 Aligned_cols=195 Identities=17% Similarity=0.208 Sum_probs=157.3
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|+++++.++||||+++++++...+..++||||+++|+|.+++..... ....++.|++.||.||| +
T Consensus 73 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH---~ 149 (340)
T PTZ00426 73 KQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ---S 149 (340)
T ss_pred hhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 3456788999999999999999999999999999999999999999999866432 45678999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++||||||+|||++.++.++|+|||++....... ....||+.|+|||++.+..++.++|+||||+++|+|++|
T Consensus 150 ~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G 224 (340)
T PTZ00426 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224 (340)
T ss_pred CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcC
Confidence 999999999999999999999999999987654321 234689999999999988899999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
..||..... ........ .+.. ..... .+..+.+++.+||+.||++|+
T Consensus 225 ~~Pf~~~~~---------~~~~~~i~-~~~~------~~p~~--------~~~~~~~li~~~l~~dp~~R~ 271 (340)
T PTZ00426 225 CPPFYANEP---------LLIYQKIL-EGII------YFPKF--------LDNNCKHLMKKLLSHDLTKRY 271 (340)
T ss_pred CCCCCCCCH---------HHHHHHHh-cCCC------CCCCC--------CCHHHHHHHHHHcccCHHHcC
Confidence 999965211 11111111 1110 01111 124678999999999999996
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=256.23 Aligned_cols=198 Identities=17% Similarity=0.227 Sum_probs=156.9
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
....+.+|++++++++||||+++++++...+..|+||||+++|+|..++.... .....++.|++.||.||| ++
T Consensus 38 ~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~ 114 (323)
T cd05595 38 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SR 114 (323)
T ss_pred HHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 45567889999999999999999999999999999999999999998886542 246778999999999999 99
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcC
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
+++||||||+|||++.++.++|+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|+
T Consensus 115 ~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~ 192 (323)
T cd05595 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192 (323)
T ss_pred CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCC
Confidence 999999999999999999999999998865322211 112346899999999999888999999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
.||..... .+......... ..+.. ..++.+.+++.+||..||++||+
T Consensus 193 ~Pf~~~~~---------~~~~~~~~~~~-------~~~p~--------~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05595 193 LPFYNQDH---------ERLFELILMEE-------IRFPR--------TLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred CCCCCCCH---------HHHHHHHhcCC-------CCCCC--------CCCHHHHHHHHHHccCCHHHhCC
Confidence 99954211 11111111111 01111 12256889999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=234.60 Aligned_cols=212 Identities=19% Similarity=0.194 Sum_probs=162.9
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~l~~lh~~~ 85 (241)
-.....++||+.|+.++|+||+.++++|...+...+|+||++ .+|+..++.... ....++.+++.|++|||
T Consensus 43 Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H--- 118 (318)
T KOG0659|consen 43 GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH--- 118 (318)
T ss_pred CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---
Confidence 345678899999999999999999999999999999999997 799999988743 46789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~ 164 (241)
.+.|+||||||.|+|++.+|.+||+|||+++........... .+-|..|+|||.+.+. .|+...||||.|||+.|++
T Consensus 119 ~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELl 196 (318)
T KOG0659|consen 119 SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELL 196 (318)
T ss_pred hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHH
Confidence 999999999999999999999999999999988766544332 2568889999999876 6899999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHH--HHhhhccc---------------CCCCCCccccCCCchhHHHHHHHHHHHHHH
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLK--NYLEDKRF---------------TGIPAPIIVQDIPCIEKEQQLHASAQLTLE 227 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 227 (241)
-|.+-|.... ....... ........ .-.+.+.....+ ..++.+..+|+.+
T Consensus 197 lr~P~fpG~s--------DidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf-----~aas~d~ldLl~~ 263 (318)
T KOG0659|consen 197 LRVPFFPGDS--------DIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLF-----PAASSDALDLLSK 263 (318)
T ss_pred ccCCCCCCCc--------hHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCcccccc-----ccccHHHHHHHHh
Confidence 8876553211 0111000 00111111 111111111111 1344667999999
Q ss_pred hccCCCCCCCCCCC
Q 044022 228 CVNNSPEDRPTMVD 241 (241)
Q Consensus 228 cl~~~p~~Rpt~~e 241 (241)
||.+||.+|+|+.|
T Consensus 264 m~~ynP~~Rita~q 277 (318)
T KOG0659|consen 264 MLTYNPKKRITASQ 277 (318)
T ss_pred hhccCchhcccHHH
Confidence 99999999999864
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=247.98 Aligned_cols=206 Identities=20% Similarity=0.263 Sum_probs=157.9
Q ss_pred ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHHhchhhc
Q 044022 9 HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 9 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~l~~lh~ 83 (241)
.+....++..|+.++++++||||+++++++. ....++++||+++|+|.+++..... ....++.|++.|+.|||
T Consensus 49 ~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH- 126 (279)
T cd05111 49 GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE- 126 (279)
T ss_pred chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH-
Confidence 3344567888899999999999999999885 4457899999999999999865321 46789999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+.+++|+||||+||+++.++.++|+|||.+............+...++..|+|||++.+..++.++||||||+++|++
T Consensus 127 --~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el 204 (279)
T cd05111 127 --EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEM 204 (279)
T ss_pred --HCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHH
Confidence 899999999999999999999999999999765443322222334567789999999888899999999999999999
Q ss_pred Hh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++ |..||.... ..+ .......+... ..+. .+...+.+++.+||..||++|||+.|
T Consensus 205 ~t~g~~p~~~~~---------~~~-~~~~~~~~~~~--~~~~-----------~~~~~~~~li~~c~~~~p~~Rps~~e 260 (279)
T cd05111 205 MSYGAEPYAGMR---------PHE-VPDLLEKGERL--AQPQ-----------ICTIDVYMVMVKCWMIDENVRPTFKE 260 (279)
T ss_pred HcCCCCCCCCCC---------HHH-HHHHHHCCCcC--CCCC-----------CCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 98 999985421 111 11111111111 1111 12246788999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=246.22 Aligned_cols=214 Identities=23% Similarity=0.323 Sum_probs=164.4
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~ 76 (241)
|.............|.+|+.++++++||||+++++++...+..+++|||+++++|.+++.... .....++.+++.
T Consensus 38 k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~ 117 (266)
T cd05033 38 KTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIAS 117 (266)
T ss_pred EEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHH
Confidence 444443444456678999999999999999999999999999999999999999999986532 146788999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSF 156 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~ 156 (241)
|+.||| +.+++|+||+|+||+++.++.++++|||.+................++..|+|||.+.+..++.++|+|||
T Consensus 118 ~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~sl 194 (266)
T cd05033 118 GMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSF 194 (266)
T ss_pred HHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHH
Confidence 999999 89999999999999999999999999999987652222111122334567999999998889999999999
Q ss_pred HHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 157 GAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 157 G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
|+++|++++ |..||..... .+..... ....... . .. ..+..+.+++.+||+.+|++
T Consensus 195 G~~l~~l~~~g~~p~~~~~~---------~~~~~~~-~~~~~~~--~---~~--------~~~~~l~~li~~cl~~~p~~ 251 (266)
T cd05033 195 GIVMWEVMSYGERPYWDMSN---------QDVIKAV-EDGYRLP--P---PM--------DCPSALYQLMLDCWQKDRNE 251 (266)
T ss_pred HHHHHHHHccCCCCCCCCCH---------HHHHHHH-HcCCCCC--C---CC--------CCCHHHHHHHHHHcCCCccc
Confidence 999999998 9999854211 1111111 1111100 0 01 22357889999999999999
Q ss_pred CCCCCC
Q 044022 236 RPTMVD 241 (241)
Q Consensus 236 Rpt~~e 241 (241)
|||++|
T Consensus 252 Rp~~~e 257 (266)
T cd05033 252 RPTFSQ 257 (266)
T ss_pred CcCHHH
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=249.93 Aligned_cols=212 Identities=18% Similarity=0.306 Sum_probs=159.7
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---------------hHHHHHHHHH
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---------------PRLKIASDIV 75 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------------~~~~~~~~i~ 75 (241)
....+|.+|+++++.++|+||+++++++...+..++++||+++++|.+++..... ....++.+++
T Consensus 61 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 140 (296)
T cd05095 61 NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIA 140 (296)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHH
Confidence 3456899999999999999999999999999999999999999999999865421 3678899999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHH
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFS 155 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 155 (241)
.|++||| +.+++|+||||+||+++.++.++|+|||.+............+...++..|+|||......++.++|+||
T Consensus 141 ~al~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwS 217 (296)
T cd05095 141 SGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWA 217 (296)
T ss_pred HHHHHHH---HCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhH
Confidence 9999999 8999999999999999999999999999987654332222222334467899999988888999999999
Q ss_pred HHHHHHHHHh--cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 156 FGAFLFELLA--GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 156 ~G~~~~~~~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
||+++|+|++ |..||....... ..................+.+ . .++..+.+++.+||+.||
T Consensus 218 lG~~l~el~~~~~~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~---~--------~~~~~~~~li~~cl~~~p 281 (296)
T cd05095 218 FGVTLWEILTLCKEQPYSQLSDEQ-----VIENTGEFFRDQGRQVYLPKP---A--------LCPDSLYKLMLSCWRRNA 281 (296)
T ss_pred HHHHHHHHHHhCCCCCccccChHH-----HHHHHHHHHhhccccccCCCC---C--------CCCHHHHHHHHHHcCCCc
Confidence 9999999998 678885422110 000000000000000000000 0 123578899999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|||+.|
T Consensus 282 ~~Rp~~~~ 289 (296)
T cd05095 282 KERPSFQE 289 (296)
T ss_pred ccCCCHHH
Confidence 99999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=248.86 Aligned_cols=218 Identities=21% Similarity=0.253 Sum_probs=164.7
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchh
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYL 81 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~l 81 (241)
|....+......+++.+|++++++++||||+++++++...+..++|+||+++++|..+..........++.+++.|+.||
T Consensus 32 K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~l 111 (279)
T cd06619 32 KVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYL 111 (279)
T ss_pred EEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhhcCCHHHHHHHHHHHHHHHHHH
Confidence 44433333344567899999999999999999999999999999999999999997665433445678999999999999
Q ss_pred hcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHH
Q 044022 82 HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLF 161 (241)
Q Consensus 82 h~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~ 161 (241)
| +.+++|+||||+||+++.++.++|+|||++....... .....++..|+|||++.+..++.++|+||||+++|
T Consensus 112 H---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 184 (279)
T cd06619 112 W---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFM 184 (279)
T ss_pred H---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHH
Confidence 9 9999999999999999999999999999987654322 12346888999999999888999999999999999
Q ss_pred HHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 162 ELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 162 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|++|+.||......... ....... ........ +.... ...++.+.+++.+||+.+|++||+++|
T Consensus 185 ~l~~g~~pf~~~~~~~~~--~~~~~~~-~~~~~~~~-----~~~~~-------~~~~~~~~~li~~~l~~~P~~Rp~~~e 249 (279)
T cd06619 185 ELALGRFPYPQIQKNQGS--LMPLQLL-QCIVDEDP-----PVLPV-------GQFSEKFVHFITQCMRKQPKERPAPEN 249 (279)
T ss_pred HHHhCCCCchhhcccccc--cchHHHH-HHHhccCC-----CCCCC-------CcCCHHHHHHHHHHhhCChhhCCCHHH
Confidence 999999999652211100 0011111 11111110 01100 012356889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=249.31 Aligned_cols=221 Identities=19% Similarity=0.261 Sum_probs=162.4
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----------------c
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----------------L 65 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~ 65 (241)
|.+..+........|.+|++++++++|+|++++++++...+..++||||+++++|.+++.... .
T Consensus 50 K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~ 129 (295)
T cd05097 50 KMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129 (295)
T ss_pred EecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHH
Confidence 444443334455679999999999999999999999999999999999999999999885421 1
Q ss_pred hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc
Q 044022 66 PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC 145 (241)
Q Consensus 66 ~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 145 (241)
..+.++.+++.|+.||| +.+++|+||||+||+++.++.++|+|||.+................++..|+|||++...
T Consensus 130 ~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 206 (295)
T cd05097 130 NLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG 206 (295)
T ss_pred HHHHHHHHHHHHHHHHH---hcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC
Confidence 35678999999999999 999999999999999999999999999998765433222222334456789999999888
Q ss_pred CCCcchhhHHHHHHHHHHHh--cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHH
Q 044022 146 VLNEKSNVFSFGAFLFELLA--GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQ 223 (241)
Q Consensus 146 ~~~~~~Di~s~G~~~~~~~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (241)
.++.++|+||||+++|+|++ |..||...... .................... ... ..+..+.+
T Consensus 207 ~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~---~~~--------~~~~~l~~ 270 (295)
T cd05097 207 KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-----QVIENTGEFFRNQGRQIYLS---QTP--------LCPSPVFK 270 (295)
T ss_pred CcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-----HHHHHHHHhhhhccccccCC---CCC--------CCCHHHHH
Confidence 89999999999999999998 56677542111 00000000000000000000 011 12257999
Q ss_pred HHHHhccCCCCCCCCCCC
Q 044022 224 LTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 224 l~~~cl~~~p~~Rpt~~e 241 (241)
++.+||+.||++|||+++
T Consensus 271 li~~~l~~~p~~RPs~~~ 288 (295)
T cd05097 271 LMMRCWSRDIKDRPTFNK 288 (295)
T ss_pred HHHHHcCCCchhCcCHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=248.88 Aligned_cols=205 Identities=21% Similarity=0.324 Sum_probs=160.3
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--------------chHHHHHHHHHH
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--------------LPRLKIASDIVN 76 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~i~~ 76 (241)
.....+.+|+++++.++|+||+++++++......++|+||+++++|.+++.... ...+.++.+++.
T Consensus 51 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 130 (277)
T cd05032 51 RERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130 (277)
T ss_pred HHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHH
Confidence 345678899999999999999999999999999999999999999999986421 135678999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSF 156 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~ 156 (241)
||.||| +.+++|+||||+||+++.++.++|+|||.+................++..|+|||.+....++.++|||||
T Consensus 131 ~l~~lH---~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 207 (277)
T cd05032 131 GMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSF 207 (277)
T ss_pred HHHHHH---hCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHH
Confidence 999999 99999999999999999999999999999876543322222233346778999999988889999999999
Q ss_pred HHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 157 GAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 157 G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
|+++|++++ |..||.... ..+..+... .+.....+. ..+..+.+++.+||..+|++
T Consensus 208 G~il~el~t~g~~p~~~~~---------~~~~~~~~~-~~~~~~~~~-------------~~~~~~~~li~~~l~~~p~~ 264 (277)
T cd05032 208 GVVLWEMATLAEQPYQGLS---------NEEVLKFVI-DGGHLDLPE-------------NCPDKLLELMRMCWQYNPKM 264 (277)
T ss_pred HHHHHHhhccCCCCCccCC---------HHHHHHHHh-cCCCCCCCC-------------CCCHHHHHHHHHHcCCChhh
Confidence 999999998 888885411 111222221 111111111 11357889999999999999
Q ss_pred CCCCCC
Q 044022 236 RPTMVD 241 (241)
Q Consensus 236 Rpt~~e 241 (241)
|||+.|
T Consensus 265 Rpt~~~ 270 (277)
T cd05032 265 RPTFLE 270 (277)
T ss_pred CCCHHH
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=244.75 Aligned_cols=213 Identities=20% Similarity=0.284 Sum_probs=160.3
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--C---chHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--P---LPRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~---~~~~~~~~~i~~ 76 (241)
|+..........+.|.+|+.++++++|+||+++++++. .+..++|+||+++++|.+++... . ..++.++.+++.
T Consensus 28 k~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~ 106 (257)
T cd05115 28 KVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSM 106 (257)
T ss_pred EEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHH
Confidence 44444434445677999999999999999999999885 45689999999999999998642 2 246789999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCccee-ecccccCCCccCcccccccCCCcchhhHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT-TDRVIGTRGYSAPEYISICVLNEKSNVFS 155 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 155 (241)
|+.||| +++++|+||||+||+++.++.++|+|||.+........... .....++..|+|||.+....++.++||||
T Consensus 107 ~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 183 (257)
T cd05115 107 GMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWS 183 (257)
T ss_pred HHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHH
Confidence 999999 89999999999999999999999999999875433321111 11122356799999998888899999999
Q ss_pred HHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 156 FGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 156 ~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
||+++|++++ |..||..... .+..... ..+.... ... .+++++.+++.+||..||+
T Consensus 184 lG~~l~el~~~g~~p~~~~~~---------~~~~~~~-~~~~~~~-----~~~--------~~~~~l~~li~~c~~~~~~ 240 (257)
T cd05115 184 YGITMWEAFSYGQKPYKKMKG---------PEVMSFI-EQGKRLD-----CPA--------ECPPEMYALMKDCWIYKWE 240 (257)
T ss_pred HHHHHHHHhcCCCCCcCcCCH---------HHHHHHH-HCCCCCC-----CCC--------CCCHHHHHHHHHHcCCChh
Confidence 9999999996 9999965211 1111111 1111111 111 2236788999999999999
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
+||++.+
T Consensus 241 ~Rp~~~~ 247 (257)
T cd05115 241 DRPNFAK 247 (257)
T ss_pred hCcCHHH
Confidence 9999753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=257.44 Aligned_cols=201 Identities=22% Similarity=0.229 Sum_probs=159.7
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
....+.+|++++++++||||+++++++...+..++||||+++|+|.+++..... ....++.|++.||.||| +.
T Consensus 41 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~ 117 (318)
T cd05582 41 DRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SL 117 (318)
T ss_pred hHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 345677899999999999999999999999999999999999999999865432 46788999999999999 99
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcC
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
+++||||||+||+++.++.++|+|||.+......... .....|++.|+|||.+.+..++.++||||||+++|+|++|+
T Consensus 118 ~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 195 (318)
T cd05582 118 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGS 195 (318)
T ss_pred CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc--eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCC
Confidence 9999999999999999999999999998754332111 12346889999999999888899999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.||.... ..+......... .. +.. ..+..+.+++.+||+.||++|||+.+
T Consensus 196 ~p~~~~~---------~~~~~~~i~~~~--~~-----~p~--------~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 196 LPFQGKD---------RKETMTMILKAK--LG-----MPQ--------FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCC---------HHHHHHHHHcCC--CC-----CCC--------CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 9995421 111111111111 00 111 12256889999999999999999753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=252.79 Aligned_cols=200 Identities=20% Similarity=0.213 Sum_probs=156.1
Q ss_pred cHHHHHHHHHHH---HhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYA---AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~ 85 (241)
..+.+.+|++++ +.++||||+++++++...+..|+||||+++++|...+..... ....++.+++.||.|||
T Consensus 42 ~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH--- 118 (324)
T cd05589 42 EVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLH--- 118 (324)
T ss_pred HHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 345677777665 456899999999999999999999999999999988876533 46789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+.+++||||||+||+++.++.+||+|||++........ ......|++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 119 ~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 196 (324)
T cd05589 119 ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLV 196 (324)
T ss_pred hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHh
Confidence 99999999999999999999999999998864322211 1234568999999999998889999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
|+.||.... ..+.......... ..... .+..+.+++.+||..||++||++.
T Consensus 197 G~~pf~~~~---------~~~~~~~i~~~~~-------~~p~~--------~~~~~~~li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 197 GESPFPGDD---------EEEVFDSIVNDEV-------RYPRF--------LSREAISIMRRLLRRNPERRLGSG 247 (324)
T ss_pred CCCCCCCCC---------HHHHHHHHHhCCC-------CCCCC--------CCHHHHHHHHHHhhcCHhHcCCCC
Confidence 999995421 1111222111110 01111 225678999999999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=251.05 Aligned_cols=165 Identities=19% Similarity=0.213 Sum_probs=135.4
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~ 76 (241)
|++...........+.+|+++++.++||||+++++++......++||||+. ++|.+++.... .....++.|++.
T Consensus 36 K~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~ 114 (303)
T cd07869 36 KVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLR 114 (303)
T ss_pred EEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHH
Confidence 444433333345567899999999999999999999999999999999996 68888775432 145678999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFS 155 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s 155 (241)
||.||| +.+++||||||+|||++.++.+||+|||.+........ ......+++.|+|||++.+. .++.++||||
T Consensus 115 al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws 189 (303)
T cd07869 115 GLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWG 189 (303)
T ss_pred HHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHH
Confidence 999999 99999999999999999999999999999875433221 11234678899999998654 5788999999
Q ss_pred HHHHHHHHHhcCccccc
Q 044022 156 FGAFLFELLAGRIHIWD 172 (241)
Q Consensus 156 ~G~~~~~~~~g~~p~~~ 172 (241)
+|+++|+|++|..||..
T Consensus 190 lG~il~~l~~g~~pf~~ 206 (303)
T cd07869 190 VGCIFVEMIQGVAAFPG 206 (303)
T ss_pred HHHHHHHHHhCCCCCCC
Confidence 99999999999999965
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=249.67 Aligned_cols=205 Identities=24% Similarity=0.341 Sum_probs=159.5
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--------------------------
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-------------------------- 64 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------------------------- 64 (241)
...+++.+|++++++++||||+++++.+...+..++++||+.+++|.+++....
T Consensus 45 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 124 (290)
T cd05045 45 SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124 (290)
T ss_pred HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCcccccc
Confidence 345679999999999999999999999999999999999999999999875321
Q ss_pred --chHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccc
Q 044022 65 --LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYI 142 (241)
Q Consensus 65 --~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 142 (241)
...+.++.+++.||.||| +.+++||||||+||+++.++.++|+|||.+................++..|+|||.+
T Consensus 125 ~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~ 201 (290)
T cd05045 125 TMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL 201 (290)
T ss_pred CHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHH
Confidence 134688999999999999 999999999999999999999999999998755433222222233456789999999
Q ss_pred cccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHH
Q 044022 143 SICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHAS 221 (241)
Q Consensus 143 ~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (241)
.+..++.++||||||+++|+|++ |..||.... .+............. ... ..+..+
T Consensus 202 ~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----------~~~~~~~~~~~~~~~-----~~~--------~~~~~~ 258 (290)
T cd05045 202 FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA----------PERLFNLLKTGYRME-----RPE--------NCSEEM 258 (290)
T ss_pred ccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC----------HHHHHHHHhCCCCCC-----CCC--------CCCHHH
Confidence 88889999999999999999998 999985421 111122221111000 011 223578
Q ss_pred HHHHHHhccCCCCCCCCCCC
Q 044022 222 AQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 222 ~~l~~~cl~~~p~~Rpt~~e 241 (241)
.+++.+||+.+|++|||+.|
T Consensus 259 ~~~i~~cl~~~P~~Rp~~~~ 278 (290)
T cd05045 259 YNLMLTCWKQEPDKRPTFAD 278 (290)
T ss_pred HHHHHHHccCCcccCCCHHH
Confidence 89999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=249.91 Aligned_cols=206 Identities=17% Similarity=0.314 Sum_probs=160.5
Q ss_pred ccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhc
Q 044022 11 HTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~ 83 (241)
...+.+.+|+.+++++ +|+||+++++++...+..++++||+.+++|.+++.... .+...++.+++.||.|||
T Consensus 80 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH- 158 (302)
T cd05055 80 SEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA- 158 (302)
T ss_pred HHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 3456789999999999 79999999999999999999999999999999986432 246788999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+.+++|+||||+||+++.++.++++|||.+................++..|+|||.+.+..++.++||||||+++|++
T Consensus 159 --~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el 236 (302)
T cd05055 159 --SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236 (302)
T ss_pred --HCCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHH
Confidence 899999999999999999999999999998765443322222233456789999999988899999999999999999
Q ss_pred Hh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++ |..||..... .+........+.... ... ..++.+.+++.+||+.+|++|||+.|
T Consensus 237 ~t~g~~p~~~~~~---------~~~~~~~~~~~~~~~-----~~~--------~~~~~~~~li~~cl~~~p~~Rpt~~e 293 (302)
T cd05055 237 FSLGSNPYPGMPV---------DSKFYKLIKEGYRMA-----QPE--------HAPAEIYDIMKTCWDADPLKRPTFKQ 293 (302)
T ss_pred HhCCCCCcCCCCc---------hHHHHHHHHcCCcCC-----CCC--------CCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 98 9999854211 111111111111000 001 11257899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=254.13 Aligned_cols=197 Identities=19% Similarity=0.210 Sum_probs=156.3
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
...+.+|++++++++||||+++++++..++..++||||+++++|.+++..... ....++.|++.||.||| +.+
T Consensus 44 ~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ 120 (323)
T cd05584 44 TAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH---QQG 120 (323)
T ss_pred HHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence 45677899999999999999999999999999999999999999999865432 35668889999999999 999
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCc
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRI 168 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~ 168 (241)
++||||||+|||++.++.++|+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|+.
T Consensus 121 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~ 198 (323)
T cd05584 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAP 198 (323)
T ss_pred eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCC
Confidence 99999999999999999999999999865332221 1123468999999999998888999999999999999999999
Q ss_pred ccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 169 HIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 169 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
||.... .......... +.. .+... .+..+.+++.+||+.||++||+
T Consensus 199 pf~~~~---------~~~~~~~~~~-~~~------~~~~~--------~~~~~~~li~~~l~~~p~~R~~ 244 (323)
T cd05584 199 PFTAEN---------RKKTIDKILK-GKL------NLPPY--------LTPEARDLLKKLLKRNPSSRLG 244 (323)
T ss_pred CCCCCC---------HHHHHHHHHc-CCC------CCCCC--------CCHHHHHHHHHHcccCHhHcCC
Confidence 995421 1111111111 110 01111 1256889999999999999994
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=253.21 Aligned_cols=208 Identities=21% Similarity=0.240 Sum_probs=158.4
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
....+.+|+.++.++ +||||+++++++...+..++||||+++|+|..++..... ....++.+++.||.||| +
T Consensus 38 ~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~ 114 (329)
T cd05618 38 DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---E 114 (329)
T ss_pred HHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 345677899998887 899999999999999999999999999999988755422 46778999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
++++||||||+||+++.++.++|+|||++........ ......|++.|+|||++.+..++.++|+||||+++|+|++|
T Consensus 115 ~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 192 (329)
T cd05618 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192 (329)
T ss_pred CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhC
Confidence 9999999999999999999999999999865322111 11234689999999999988999999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
+.||.......... ................ . +.. ..+..+.+++.+||+.||++|||+
T Consensus 193 ~~Pf~~~~~~~~~~-~~~~~~~~~~i~~~~~-~-----~p~--------~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 193 RSPFDIVGSSDNPD-QNTEDYLFQVILEKQI-R-----IPR--------SLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCccCCCcCCcc-cccHHHHHHHHhcCCC-C-----CCC--------CCCHHHHHHHHHHhcCCHHHcCCC
Confidence 99996422111111 1111111111111110 1 111 122567899999999999999996
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=244.08 Aligned_cols=209 Identities=20% Similarity=0.239 Sum_probs=155.1
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc--------hHHHHHHHHHHHhchhh
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL--------PRLKIASDIVNSLAYLH 82 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------~~~~~~~~i~~~l~~lh 82 (241)
...+.|.+|+.+++.++||||+++++.|......++||||+++|+|.+++..... ....++.+++.||.|||
T Consensus 37 ~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH 116 (268)
T cd05086 37 KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH 116 (268)
T ss_pred HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence 3467899999999999999999999999999999999999999999999865311 24578899999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-------cCCCcchhhHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-------CVLNEKSNVFS 155 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~s 155 (241)
+.+++|+||||+|||++.++.++|+|||.+................++..|+|||++.. ..++.++||||
T Consensus 117 ---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 193 (268)
T cd05086 117 ---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWA 193 (268)
T ss_pred ---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHH
Confidence 89999999999999999999999999998754322211112233467888999998753 24577899999
Q ss_pred HHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 156 FGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 156 ~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
||+++|+|++ |..||.... ..+......... .....++.+... ....+.+++.+|| .+|+
T Consensus 194 lG~~l~el~~~~~~p~~~~~---------~~~~~~~~~~~~-~~~~~~~~~~~~--------~~~~~~~l~~~c~-~~P~ 254 (268)
T cd05086 194 LGVTLWELFENAAQPYSHLS---------DREVLNHVIKDQ-QVKLFKPQLELP--------YSERWYEVLQFCW-LSPE 254 (268)
T ss_pred HHHHHHHHHhCCCCCCCCCC---------HHHHHHHHHhhc-ccccCCCccCCC--------CcHHHHHHHHHHh-hCcc
Confidence 9999999997 566774311 111122211111 112222222222 2256788999999 6899
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
+|||++|
T Consensus 255 ~Rp~~~~ 261 (268)
T cd05086 255 KRATAEE 261 (268)
T ss_pred cCCCHHH
Confidence 9999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=252.82 Aligned_cols=208 Identities=19% Similarity=0.220 Sum_probs=159.1
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+.+.+|..++.++ +||||+++++++...+..++||||+++|+|.+++.... ..+..++.|++.||.||| +
T Consensus 38 ~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~ 114 (329)
T cd05588 38 DIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLH---E 114 (329)
T ss_pred HHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 345688899999998 79999999999999999999999999999998875442 246778999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
++++||||||+||+++.++.++|+|||++........ ......|++.|+|||++.+..++.++|+||||+++|++++|
T Consensus 115 ~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g 192 (329)
T cd05588 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192 (329)
T ss_pred CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHC
Confidence 9999999999999999999999999999864322111 11234689999999999988899999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
+.||........ ......+........... . +... .+..+.+++.+||..||.+|||+
T Consensus 193 ~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~-~-----~p~~--------~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 193 RSPFDIVGMSDN-PDQNTEDYLFQVILEKQI-R-----IPRS--------LSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred CCCccccccccc-ccccchHHHHHHHHcCCC-C-----CCCC--------CCHHHHHHHHHHhccCHHHcCCC
Confidence 999964221111 111111222221111111 1 1111 22568899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=251.50 Aligned_cols=200 Identities=21% Similarity=0.268 Sum_probs=156.3
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+.+..|..++..+ +||||+++++++...+..++||||+++|+|.+++..... ....++.|++.||.||| +
T Consensus 38 ~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~ 114 (316)
T cd05592 38 DVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---K 114 (316)
T ss_pred hHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 345566777777754 899999999999999999999999999999998865422 45678999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++||||||+||+++.++.++|+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|
T Consensus 115 ~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G 192 (316)
T cd05592 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIG 192 (316)
T ss_pred CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhC
Confidence 9999999999999999999999999999875433221 12335689999999999988899999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
+.||.... ..+......... +.... ..+..+.+++.+||+.||++||++.
T Consensus 193 ~~Pf~~~~---------~~~~~~~i~~~~-------~~~~~--------~~~~~~~~ll~~~l~~~P~~R~~~~ 242 (316)
T cd05592 193 QSPFHGED---------EDELFDSILNDR-------PHFPR--------WISKEAKDCLSKLFERDPTKRLGVD 242 (316)
T ss_pred CCCCCCCC---------HHHHHHHHHcCC-------CCCCC--------CCCHHHHHHHHHHccCCHHHcCCCh
Confidence 99996421 111111111110 01111 1225678999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=247.01 Aligned_cols=204 Identities=20% Similarity=0.274 Sum_probs=158.0
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--------CchHHHHHHHHHHHhchhhc
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--------PLPRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--------~~~~~~~~~~i~~~l~~lh~ 83 (241)
..+.+..|++++++++|+||+++.+++......++||||+++|+|.+.+... ......++.|++.||.|||
T Consensus 36 ~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH- 114 (280)
T cd05608 36 GYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH- 114 (280)
T ss_pred HHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 3466788999999999999999999999999999999999999998876321 1245678999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+.+++||||||+||+++.++.++|+|||.+......... .....|++.|+|||++.+..++.++|+||||+++|+|
T Consensus 115 --~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el 190 (280)
T cd05608 115 --QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEM 190 (280)
T ss_pred --HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHH
Confidence 999999999999999999999999999998765443221 1234688999999999998999999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
++|+.||....... ...+..... ... ...... ..+..+.+++.+||+.||++||+++
T Consensus 191 ~~g~~pf~~~~~~~-----~~~~~~~~~-----~~~--~~~~~~--------~~~~~~~~li~~~l~~~P~~R~~~~ 247 (280)
T cd05608 191 IAARGPFRARGEKV-----ENKELKQRI-----LND--SVTYPD--------KFSPASKSFCEALLAKDPEKRLGFR 247 (280)
T ss_pred HhCCCCCCCCCcch-----hHHHHHHhh-----ccc--CCCCcc--------cCCHHHHHHHHHHhcCCHHHhcCCC
Confidence 99999996421110 000111110 000 000111 2336788999999999999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=247.31 Aligned_cols=205 Identities=22% Similarity=0.313 Sum_probs=159.9
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-------------------chHHHHH
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-------------------LPRLKIA 71 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------------------~~~~~~~ 71 (241)
...+.+.+|+++++.++|+||+++++++...+..++++||+++++|.+++.... ...+.++
T Consensus 49 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 128 (280)
T cd05092 49 SARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128 (280)
T ss_pred HHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHH
Confidence 345679999999999999999999999999999999999999999999986532 1356788
Q ss_pred HHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcch
Q 044022 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKS 151 (241)
Q Consensus 72 ~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 151 (241)
.+++.|++||| +.+++|+||||+||+++.++.++|+|||.+................+++.|+|||++.+..++.++
T Consensus 129 ~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 205 (280)
T cd05092 129 SQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTES 205 (280)
T ss_pred HHHHHHHHHHH---HCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchh
Confidence 99999999999 999999999999999999999999999998755433222222233456789999999988899999
Q ss_pred hhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhcc
Q 044022 152 NVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVN 230 (241)
Q Consensus 152 Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 230 (241)
||||||+++|+|++ |..||..... .+...... .+.....+ . ..+..+.+++.+||+
T Consensus 206 Di~slG~il~el~~~g~~p~~~~~~---------~~~~~~~~-~~~~~~~~-----~--------~~~~~~~~li~~cl~ 262 (280)
T cd05092 206 DIWSFGVVLWEIFTYGKQPWYQLSN---------TEAIECIT-QGRELERP-----R--------TCPPEVYAIMQGCWQ 262 (280)
T ss_pred hHHHHHHHHHHHHcCCCCCCccCCH---------HHHHHHHH-cCccCCCC-----C--------CCCHHHHHHHHHHcc
Confidence 99999999999998 8999855211 11111111 11110000 1 122568899999999
Q ss_pred CCCCCCCCCCC
Q 044022 231 NSPEDRPTMVD 241 (241)
Q Consensus 231 ~~p~~Rpt~~e 241 (241)
.||.+|||++|
T Consensus 263 ~~P~~Rp~~~~ 273 (280)
T cd05092 263 REPQQRMVIKD 273 (280)
T ss_pred CChhhCCCHHH
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=258.87 Aligned_cols=210 Identities=20% Similarity=0.241 Sum_probs=169.9
Q ss_pred Cccccccc--ccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHH
Q 044022 1 MKFYGHEY--HRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDI 74 (241)
Q Consensus 1 iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i 74 (241)
||+..++. .++..++.+.|.+|+... +||.+++++.+|+...++|.||||+.||++...++.... ....++..+
T Consensus 398 IK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev 477 (694)
T KOG0694|consen 398 IKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEV 477 (694)
T ss_pred EEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHH
Confidence 45555443 557788899999999888 699999999999999999999999999997777765533 456789999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhH
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
+.||.||| +++|++||||.+|||+|.+|.+||+|||+++..-... ...++.+||+.|+|||++.+..|+.++|.|
T Consensus 478 ~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW 552 (694)
T KOG0694|consen 478 VLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWW 552 (694)
T ss_pred HHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCCCC--CccccccCChhhcChhhhccCcccchhhHH
Confidence 99999999 9999999999999999999999999999998654222 234678999999999999999999999999
Q ss_pred HHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 155 SFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 155 s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
||||++|||+.|..||.. +.-.+.......... ..|+ ..+.+..++++++|.+||+
T Consensus 553 ~lGVLlyeML~Gq~PF~g---------ddEee~FdsI~~d~~----~yP~-----------~ls~ea~~il~~ll~k~p~ 608 (694)
T KOG0694|consen 553 GLGVLLYEMLVGESPFPG---------DDEEEVFDSIVNDEV----RYPR-----------FLSKEAIAIMRRLLRKNPE 608 (694)
T ss_pred HHHHHHHHHHcCCCCCCC---------CCHHHHHHHHhcCCC----CCCC-----------cccHHHHHHHHHHhccCcc
Confidence 999999999999999953 122223333322221 1111 2336788999999999999
Q ss_pred CCCCC
Q 044022 235 DRPTM 239 (241)
Q Consensus 235 ~Rpt~ 239 (241)
+|..+
T Consensus 609 kRLG~ 613 (694)
T KOG0694|consen 609 KRLGS 613 (694)
T ss_pred cccCC
Confidence 99876
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=248.31 Aligned_cols=221 Identities=22% Similarity=0.273 Sum_probs=164.4
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------------c---h
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------------L---P 66 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------~---~ 66 (241)
|.+.........+++.+|++++++++||||+++++++...+..++++|++++++|.+++.... . .
T Consensus 52 K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~ 131 (296)
T cd05051 52 KVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131 (296)
T ss_pred EEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHH
Confidence 444433333456789999999999999999999999999999999999999999999986543 1 3
Q ss_pred HHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccC
Q 044022 67 RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV 146 (241)
Q Consensus 67 ~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 146 (241)
.+.++.+++.||+||| +.+++|+||||+||+++.++.++|+|||.+................++..|+|||++.+..
T Consensus 132 ~~~~~~~i~~al~~LH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 208 (296)
T cd05051 132 LLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK 208 (296)
T ss_pred HHHHHHHHHHHHHHHH---HcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC
Confidence 5788999999999999 8999999999999999999999999999987654333222223445677899999998888
Q ss_pred CCcchhhHHHHHHHHHHHh--cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHH
Q 044022 147 LNEKSNVFSFGAFLFELLA--GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQL 224 (241)
Q Consensus 147 ~~~~~Di~s~G~~~~~~~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 224 (241)
++.++||||||+++|++++ |..||.... ..+......... ...........+ ...+..+.++
T Consensus 209 ~~~~~Dv~slG~~l~el~~~~~~~p~~~~~---------~~~~~~~~~~~~---~~~~~~~~~~~~----~~~~~~l~~l 272 (296)
T cd05051 209 FTTKSDVWAFGVTLWEILTLCREQPYEHLT---------DQQVIENAGHFF---RDDGRQIYLPRP----PNCPKDIYEL 272 (296)
T ss_pred CCccchhhhhHHHHHHHHhcCCCCCCCCcC---------hHHHHHHHHhcc---ccccccccCCCc----cCCCHHHHHH
Confidence 9999999999999999998 667774421 111111111100 000000000000 0223578999
Q ss_pred HHHhccCCCCCCCCCCC
Q 044022 225 TLECVNNSPEDRPTMVD 241 (241)
Q Consensus 225 ~~~cl~~~p~~Rpt~~e 241 (241)
+.+||+.||++|||+.|
T Consensus 273 i~~cl~~~p~~Rpt~~e 289 (296)
T cd05051 273 MLECWRRDEEDRPTFRE 289 (296)
T ss_pred HHHHhccChhcCCCHHH
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=244.57 Aligned_cols=204 Identities=20% Similarity=0.276 Sum_probs=157.8
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+..|++++++++||||+++.+++......++||||+++++|.+++.... .....++.|++.||.||| +
T Consensus 37 ~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~ 113 (277)
T cd05607 37 EKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---S 113 (277)
T ss_pred hHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 4456679999999999999999999999999999999999999988875432 135678899999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++||||||+||+++.++.++|+|||.+........ .....++..|+|||++.+..++.++|+||+|+++|+|++|
T Consensus 114 ~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g 190 (277)
T cd05607 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG 190 (277)
T ss_pred CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999876544321 1234678899999999888899999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+.||....... ...+...... ... .. .... ..+..+.+++.+||+.||++|||+.|
T Consensus 191 ~~p~~~~~~~~-----~~~~~~~~~~-~~~----~~-~~~~--------~~~~~~~~li~~~L~~~P~~R~~~~~ 246 (277)
T cd05607 191 RTPFKDHKEKV-----AKEELKRRTL-EDE----VK-FEHQ--------NFTEESKDICRLFLAKKPEDRLGSRE 246 (277)
T ss_pred CCCCCCCcchh-----hHHHHHHHhh-ccc----cc-cccc--------cCCHHHHHHHHHHhccCHhhCCCCcc
Confidence 99986421110 0011111110 000 00 0000 22356899999999999999999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=250.09 Aligned_cols=214 Identities=21% Similarity=0.317 Sum_probs=162.1
Q ss_pred cccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----------------
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---------------- 64 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------- 64 (241)
|............++.+|+++++++ +|+||+++++++...+..+++|||+++++|.+++....
T Consensus 48 k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ 127 (293)
T cd05053 48 KMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE 127 (293)
T ss_pred EEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCcccccccccccccc
Confidence 3333333333456788999999999 89999999999999999999999999999999985321
Q ss_pred ----chHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcc
Q 044022 65 ----LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPE 140 (241)
Q Consensus 65 ----~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE 140 (241)
...+.++.|++.||.||| +.+++|+||||+||+++.++.++++|||.+................++..|+|||
T Consensus 128 ~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 204 (293)
T cd05053 128 TLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPE 204 (293)
T ss_pred ccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHH
Confidence 135678999999999999 9999999999999999999999999999987654432222222233556799999
Q ss_pred cccccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHH
Q 044022 141 YISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLH 219 (241)
Q Consensus 141 ~~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (241)
++.+..++.++||||||+++|++++ |..||.... ..+.... ...+..... .. ..+.
T Consensus 205 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---------~~~~~~~-~~~~~~~~~-----~~--------~~~~ 261 (293)
T cd05053 205 ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---------VEELFKL-LKEGYRMEK-----PQ--------NCTQ 261 (293)
T ss_pred HhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC---------HHHHHHH-HHcCCcCCC-----CC--------CCCH
Confidence 9988889999999999999999997 888885421 1111111 111111111 11 1225
Q ss_pred HHHHHHHHhccCCCCCCCCCCC
Q 044022 220 ASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 220 ~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.+.+++.+||..||++|||+.|
T Consensus 262 ~~~~li~~~l~~~p~~Rps~~e 283 (293)
T cd05053 262 ELYHLMRDCWHEVPSQRPTFKQ 283 (293)
T ss_pred HHHHHHHHHcccCcccCcCHHH
Confidence 7889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=243.04 Aligned_cols=214 Identities=21% Similarity=0.331 Sum_probs=163.7
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIV 75 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~ 75 (241)
|....+......+++.+|++++++++||||+++++.+.. ...++|+||+++++|.+++.... .....++.+++
T Consensus 29 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~ 107 (257)
T cd05040 29 KCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA 107 (257)
T ss_pred eecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHH
Confidence 344333332456789999999999999999999999988 88999999999999999986643 14567889999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-eeecccccCCCccCcccccccCCCcchhhH
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-ITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
.||.||| +.+++|+||+|+||+++.++.++|+|||.+......... .......++..|+|||++.+..++.++|||
T Consensus 108 ~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~ 184 (257)
T cd05040 108 NGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVW 184 (257)
T ss_pred HHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhH
Confidence 9999999 999999999999999999999999999998766442211 111233467789999999888899999999
Q ss_pred HHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 155 SFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 155 s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
|||+++|+|++ |..||..... .+............. ... ..+..+.+++.+||..+|
T Consensus 185 slG~~l~el~t~g~~p~~~~~~---------~~~~~~~~~~~~~~~-----~~~--------~~~~~~~~li~~~l~~~p 242 (257)
T cd05040 185 MFGVTLWEMFTYGEEPWAGLSG---------SQILKKIDKEGERLE-----RPE--------ACPQDIYNVMLQCWAHNP 242 (257)
T ss_pred HHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHhcCCcCC-----CCc--------cCCHHHHHHHHHHCCCCc
Confidence 99999999998 9999854211 111222211111110 011 123578899999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|||+.|
T Consensus 243 ~~Rps~~~ 250 (257)
T cd05040 243 ADRPTFAA 250 (257)
T ss_pred ccCCCHHH
Confidence 99999864
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=253.92 Aligned_cols=205 Identities=24% Similarity=0.356 Sum_probs=157.1
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeee--CCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQ--TPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
..+...+||.+|++|+|||||+++++..+ .+.+|||+|||..|.+...--..+ .+..+++++++.||.|||
T Consensus 151 ~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH--- 227 (576)
T KOG0585|consen 151 PIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLH--- 227 (576)
T ss_pred cHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHH---
Confidence 34688999999999999999999999875 458999999999888765443333 257889999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCC---cceeecccccCCCccCcccccccC----CCcchhhHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE---THITTDRVIGTRGYSAPEYISICV----LNEKSNVFSFGA 158 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Di~s~G~ 158 (241)
.++|+||||||+|+|++.+|++||+|||.+.....+. ........+||+.|+|||.+.++. .+.+.||||+|+
T Consensus 228 ~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGV 307 (576)
T KOG0585|consen 228 YQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGV 307 (576)
T ss_pred hcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhh
Confidence 9999999999999999999999999999997663221 111122368999999999998732 346889999999
Q ss_pred HHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 159 FLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 159 ~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
++|-++.|+.||.+ ....+......... ...+..+ +..+.+++||.++|.+||++|.|
T Consensus 308 TLYCllfG~~PF~~---------~~~~~l~~KIvn~p--------L~fP~~p-----e~~e~~kDli~~lL~KdP~~Ri~ 365 (576)
T KOG0585|consen 308 TLYCLLFGQLPFFD---------DFELELFDKIVNDP--------LEFPENP-----EINEDLKDLIKRLLEKDPEQRIT 365 (576)
T ss_pred hHHHhhhccCCccc---------chHHHHHHHHhcCc--------ccCCCcc-----cccHHHHHHHHHHhhcChhheee
Confidence 99999999999965 11122222211111 1111111 34478899999999999999999
Q ss_pred CCC
Q 044022 239 MVD 241 (241)
Q Consensus 239 ~~e 241 (241)
+.|
T Consensus 366 l~~ 368 (576)
T KOG0585|consen 366 LPD 368 (576)
T ss_pred hhh
Confidence 754
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=251.21 Aligned_cols=200 Identities=19% Similarity=0.250 Sum_probs=157.9
Q ss_pred ccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~ 85 (241)
.....+.+|..++..+ +||||+++++++...+..++||||+++|+|.+++..... ....++.|++.||.|||
T Consensus 37 ~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH--- 113 (320)
T cd05590 37 DDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH--- 113 (320)
T ss_pred cHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 3456677899998877 799999999999999999999999999999988865422 46678999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+++++||||||+|||++.++.++|+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++
T Consensus 114 ~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 191 (320)
T cd05590 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC 191 (320)
T ss_pred HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhh
Confidence 99999999999999999999999999999875432211 1133468999999999998889999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
|+.||.... ..+......... .. ... ..+..+.+++.+||+.||++||++
T Consensus 192 g~~Pf~~~~---------~~~~~~~i~~~~----~~---~~~--------~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 192 GHAPFEAEN---------EDDLFEAILNDE----VV---YPT--------WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCCCC---------HHHHHHHHhcCC----CC---CCC--------CCCHHHHHHHHHHcccCHHHCCCC
Confidence 999996421 111111111111 00 011 122568899999999999999997
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=247.29 Aligned_cols=217 Identities=24% Similarity=0.309 Sum_probs=158.3
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeC--CcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQT--PIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~ 85 (241)
.....|.+|++++++++||||+++++++... ...+++|||+++++|.+++..... .+..++.+++.||.|||
T Consensus 48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH--- 124 (283)
T cd05080 48 QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLH--- 124 (283)
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHH---
Confidence 3466788999999999999999999988754 357899999999999999876533 56789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcce-eecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI-TTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
+.+++|+||||+||+++.++.++|+|||.+.......... ......++..|+|||.+....++.++||||||+++|+|+
T Consensus 125 ~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~ 204 (283)
T cd05080 125 SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204 (283)
T ss_pred HCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHH
Confidence 8999999999999999999999999999987654332111 111223556799999998888999999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhh---hcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLE---DKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|..|+....... .+....... ................+ ...+..+.+++.+||+.+|++|||+++
T Consensus 205 tg~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~ 273 (283)
T cd05080 205 THCDSKQSPPKKF-------EEMIGPKQGQMTVVRLIELLERGMRLPCP----KNCPQEVYILMKNCWETEAKFRPTFRS 273 (283)
T ss_pred hCCCCCCCCcchh-------hhhhcccccccchhhhhhhhhcCCCCCCC----CCCCHHHHHHHHHHhccChhhCCCHHH
Confidence 9999985422110 000000000 00000000000000000 123367899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=252.99 Aligned_cols=215 Identities=21% Similarity=0.350 Sum_probs=161.4
Q ss_pred cccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeC-CcceEEEEecCCCCHHHhhcCCC---------------
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQT-PIPILVFQSVEYGTLRDCIFGAP--------------- 64 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--------------- 64 (241)
|.+.........+.+.+|++++.++ +|+||++++++|... ...++++||+++++|.+++....
T Consensus 43 K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~ 122 (337)
T cd05054 43 KMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKRE 122 (337)
T ss_pred eeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccc
Confidence 4444333334456788999999999 899999999988754 56789999999999999875311
Q ss_pred --------------------------------------------------chHHHHHHHHHHHhchhhcCCCCCceeccC
Q 044022 65 --------------------------------------------------LPRLKIASDIVNSLAYLHFGFPRPIVLRNF 94 (241)
Q Consensus 65 --------------------------------------------------~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl 94 (241)
.....++.+++.||.||| +.+++||||
T Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDi 199 (337)
T cd05054 123 MKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDL 199 (337)
T ss_pred cccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence 024678899999999999 999999999
Q ss_pred CCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh-cCcccccc
Q 044022 95 KTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDL 173 (241)
Q Consensus 95 ~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~ 173 (241)
||+||+++.++.++|+|||++............+...++..|+|||++.+..++.++|||||||++|++++ |..||...
T Consensus 200 kp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~ 279 (337)
T cd05054 200 AARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 279 (337)
T ss_pred CcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999976544332223334456678999999999999999999999999999998 99998541
Q ss_pred cccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 174 LKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.. .+........+..... .. ..+..+.+++.+||+.+|++|||++|
T Consensus 280 ~~---------~~~~~~~~~~~~~~~~-----~~--------~~~~~~~~l~~~cl~~~p~~RPs~~e 325 (337)
T cd05054 280 QI---------DEEFCRRLKEGTRMRA-----PE--------YATPEIYSIMLDCWHNNPEDRPTFSE 325 (337)
T ss_pred Cc---------cHHHHHHHhccCCCCC-----Cc--------cCCHHHHHHHHHHccCChhhCcCHHH
Confidence 11 0111111111111100 01 22357899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=240.76 Aligned_cols=203 Identities=20% Similarity=0.314 Sum_probs=158.7
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
....|.+|+++++.++||||+++++++...+..++||||+++|+|.+++.... .....++.+++.||.||| +
T Consensus 42 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~ 118 (256)
T cd05114 42 SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---R 118 (256)
T ss_pred cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 45678999999999999999999999999999999999999999999886432 146788999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh-
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA- 165 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~- 165 (241)
.+++|+||+|+||+++.++.++++|||.+.......... .....++..|+|||.+.+..++.++|+||||+++|++++
T Consensus 119 ~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~ 197 (256)
T cd05114 119 NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTE 197 (256)
T ss_pred CCccccccCcceEEEcCCCeEEECCCCCccccCCCceec-cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcC
Confidence 999999999999999999999999999887553322211 112234567999999988889999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|+.||.... ..+......... . ...+. ..+..+.+++.+||..+|++|||++|
T Consensus 198 g~~p~~~~~---------~~~~~~~i~~~~-~--~~~~~-----------~~~~~~~~li~~c~~~~p~~Rps~~~ 250 (256)
T cd05114 198 GKMPFEKKS---------NYEVVEMISRGF-R--LYRPK-----------LASMTVYEVMYSCWHEKPEGRPTFAE 250 (256)
T ss_pred CCCCCCCCC---------HHHHHHHHHCCC-C--CCCCC-----------CCCHHHHHHHHHHccCCcccCcCHHH
Confidence 899985421 112222221111 0 01111 12256899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=255.70 Aligned_cols=155 Identities=19% Similarity=0.237 Sum_probs=132.2
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
.+.+.+|++++++|+||||+++++++......++|+|++. ++|..++.... ...+.++.|++.||.||| +++
T Consensus 127 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH---~~~ 202 (391)
T PHA03212 127 RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLH---ENR 202 (391)
T ss_pred hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 3457899999999999999999999999999999999995 78888875432 146788999999999999 899
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCc
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRI 168 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~ 168 (241)
|+||||||+|||++.++.++|+|||++........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.
T Consensus 203 IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~ 281 (391)
T PHA03212 203 IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHD 281 (391)
T ss_pred cccCCCChHhEEEcCCCCEEEEeCCcccccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999999864322111 11123468999999999998889999999999999999999998
Q ss_pred cccc
Q 044022 169 HIWD 172 (241)
Q Consensus 169 p~~~ 172 (241)
||..
T Consensus 282 p~~~ 285 (391)
T PHA03212 282 SLFE 285 (391)
T ss_pred CcCC
Confidence 8754
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=246.46 Aligned_cols=214 Identities=19% Similarity=0.288 Sum_probs=163.5
Q ss_pred cccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----------------
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---------------- 64 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------- 64 (241)
|.+..+......+++.+|+.+++.+ +||||+++++++...+..+++|||+++++|.+++....
T Consensus 53 K~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ 132 (304)
T cd05101 53 KMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDE 132 (304)
T ss_pred eecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcc
Confidence 4444333334567789999999999 89999999999999999999999999999999986431
Q ss_pred ----chHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcc
Q 044022 65 ----LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPE 140 (241)
Q Consensus 65 ----~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE 140 (241)
.....++.|++.||.||| +.+++|+||||+||+++.++.++|+|||.+................++..|+|||
T Consensus 133 ~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE 209 (304)
T cd05101 133 QMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPE 209 (304)
T ss_pred cccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCch
Confidence 024678899999999999 8999999999999999999999999999988665433222222334567899999
Q ss_pred cccccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHH
Q 044022 141 YISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLH 219 (241)
Q Consensus 141 ~~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (241)
++.+..++.++||||||+++|++++ |..||... ...+...... ....... .. ..+.
T Consensus 210 ~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~---------~~~~~~~~~~-~~~~~~~-----~~--------~~~~ 266 (304)
T cd05101 210 ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI---------PVEELFKLLK-EGHRMDK-----PA--------NCTN 266 (304)
T ss_pred hhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC---------CHHHHHHHHH-cCCcCCC-----CC--------CCCH
Confidence 9988889999999999999999998 78887432 1122222221 1111111 01 2236
Q ss_pred HHHHHHHHhccCCCCCCCCCCC
Q 044022 220 ASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 220 ~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.+.+++.+||..+|++|||+.|
T Consensus 267 ~~~~li~~cl~~~p~~Rps~~e 288 (304)
T cd05101 267 ELYMMMRDCWHAIPSHRPTFKQ 288 (304)
T ss_pred HHHHHHHHHcccChhhCCCHHH
Confidence 7889999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=241.07 Aligned_cols=203 Identities=19% Similarity=0.299 Sum_probs=158.2
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~~ 85 (241)
....+.+|++++++++|+||+++++++...+..++++||+++++|.+++.... ...+.++.|++.||+|||
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH--- 121 (263)
T cd05052 45 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 121 (263)
T ss_pred HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 35678999999999999999999999999999999999999999999986532 145778999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+.+++|+||||+||+++.++.++|+|||.+.......... ......+..|+|||.+.+..++.++||||||+++|+|++
T Consensus 122 ~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t 200 (263)
T cd05052 122 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200 (263)
T ss_pred hCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHc
Confidence 8999999999999999999999999999987654432111 111223567999999988889999999999999999998
Q ss_pred -cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 -GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|..||... ...+...... .... ..... ..+..+.+++.+||..||++|||+.|
T Consensus 201 ~g~~p~~~~---------~~~~~~~~~~-~~~~-----~~~~~--------~~~~~~~~li~~cl~~~p~~Rp~~~~ 254 (263)
T cd05052 201 YGMSPYPGI---------DLSQVYELLE-KGYR-----MERPE--------GCPPKVYELMRACWQWNPSDRPSFAE 254 (263)
T ss_pred CCCCCCCCC---------CHHHHHHHHH-CCCC-----CCCCC--------CCCHHHHHHHHHHccCCcccCCCHHH
Confidence 88888541 1111111111 1100 01111 12367899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=257.15 Aligned_cols=206 Identities=16% Similarity=0.218 Sum_probs=159.0
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
....+.+|+.+++.++||||+++++++..++..++||||+++|+|.+++..... ....++.+++.||.||| +.+
T Consensus 86 ~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ 162 (370)
T cd05596 86 DSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIH---SMG 162 (370)
T ss_pred hHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence 345578899999999999999999999999999999999999999999876533 45678889999999999 999
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc----CCCcchhhHHHHHHHHHHH
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC----VLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~Di~s~G~~~~~~~ 164 (241)
++||||||+|||++.++.++|+|||.+......... ......|++.|+|||++.+. .++.++||||||+++|+|+
T Consensus 163 ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyell 241 (370)
T cd05596 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241 (370)
T ss_pred eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHH
Confidence 999999999999999999999999998765433211 12345689999999998653 4788999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC--CCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED--RPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--Rpt~~e 241 (241)
+|+.||.... .................+. . ...+..+.+++.+||..+|.+ |||++|
T Consensus 242 tG~~Pf~~~~---------~~~~~~~i~~~~~~~~~~~-----~------~~~s~~~~~li~~~L~~~p~r~~R~s~~e 300 (370)
T cd05596 242 VGDTPFYADS---------LVGTYSKIMDHKNSLTFPD-----D------IEISKQAKDLICAFLTDREVRLGRNGVDE 300 (370)
T ss_pred hCCCCcCCCC---------HHHHHHHHHcCCCcCCCCC-----c------CCCCHHHHHHHHHHccChhhccCCCCHHH
Confidence 9999996521 1111122111111111111 0 012357889999999999988 998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=250.41 Aligned_cols=200 Identities=19% Similarity=0.225 Sum_probs=157.0
Q ss_pred ccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~ 85 (241)
.....+..|.+++..+ +||||+++++++...+..|+||||+++++|.+.+..... ....++.+++.||.|||
T Consensus 37 ~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--- 113 (321)
T cd05591 37 DDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH--- 113 (321)
T ss_pred hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 3455677899999876 899999999999999999999999999999988865422 45678999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+.+++||||||+||+++.++.++|+|||.+........ ......|++.|+|||++.+..++.++||||||+++|+|++
T Consensus 114 ~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t 191 (321)
T cd05591 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMA 191 (321)
T ss_pred HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhc
Confidence 99999999999999999999999999999875432221 1123468999999999998889999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
|+.||.... ..+......... ... .. ..+..+.+++.+||+.||++||++
T Consensus 192 g~~Pf~~~~---------~~~~~~~i~~~~----~~~---p~--------~~~~~~~~ll~~~L~~dp~~R~~~ 241 (321)
T cd05591 192 GQPPFEADN---------EDDLFESILHDD----VLY---PV--------WLSKEAVSILKAFMTKNPNKRLGC 241 (321)
T ss_pred CCCCCCCCC---------HHHHHHHHHcCC----CCC---CC--------CCCHHHHHHHHHHhccCHHHcCCC
Confidence 999996421 111122211111 000 01 112568899999999999999954
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=253.40 Aligned_cols=157 Identities=22% Similarity=0.262 Sum_probs=130.4
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCC-----cceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhh
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTP-----IPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLH 82 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh 82 (241)
...++.+|++++++++||||+++++++.... ..++||||+. ++|.+++..... ....++.|++.||.|||
T Consensus 42 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH 120 (338)
T cd07859 42 DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120 (338)
T ss_pred hHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHH
Confidence 4557889999999999999999999886432 4799999995 799988865422 46678999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCc-ceeecccccCCCccCcccccc--cCCCcchhhHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET-HITTDRVIGTRGYSAPEYISI--CVLNEKSNVFSFGAF 159 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~s~G~~ 159 (241)
+++++||||||+|||++.++.+||+|||.+........ ........+++.|+|||++.+ ..++.++||||||++
T Consensus 121 ---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvv 197 (338)
T cd07859 121 ---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 197 (338)
T ss_pred ---HCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHH
Confidence 89999999999999999999999999999875432211 111123468899999999875 578899999999999
Q ss_pred HHHHHhcCccccc
Q 044022 160 LFELLAGRIHIWD 172 (241)
Q Consensus 160 ~~~~~~g~~p~~~ 172 (241)
+|+|++|+.||..
T Consensus 198 l~el~tg~~pf~~ 210 (338)
T cd07859 198 FAEVLTGKPLFPG 210 (338)
T ss_pred HHHHHcCCCCCCC
Confidence 9999999999954
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=240.87 Aligned_cols=202 Identities=21% Similarity=0.270 Sum_probs=156.6
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+++.+|+.+++.+.|+||+++++++. .+..++|+||+++++|.+++.... .....++.|++.|+.||| ++
T Consensus 39 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~ 114 (257)
T cd05116 39 LKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE---ET 114 (257)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 4667899999999999999999999885 456799999999999999986542 256789999999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCccee-ecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh-
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT-TDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA- 165 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~- 165 (241)
+++|+||||.||+++.++.++|+|||.+........... .....++..|+|||.+....++.++|+||||+++|+|++
T Consensus 115 ~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~ 194 (257)
T cd05116 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSY 194 (257)
T ss_pred CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhC
Confidence 999999999999999999999999999876544322111 112234578999999988888999999999999999998
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
|..||.... ..+..... ..+.... ... ..+..+.+++.+||+.||++|||++
T Consensus 195 g~~p~~~~~---------~~~~~~~i-~~~~~~~-----~~~--------~~~~~l~~li~~~~~~~p~~Rp~~~ 246 (257)
T cd05116 195 GQKPYKGMK---------GNEVTQMI-ESGERME-----CPQ--------RCPPEMYDLMKLCWTYGVDERPGFA 246 (257)
T ss_pred CCCCCCCCC---------HHHHHHHH-HCCCCCC-----CCC--------CCCHHHHHHHHHHhccCchhCcCHH
Confidence 999985421 11112211 1111111 111 1235788999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=249.19 Aligned_cols=199 Identities=23% Similarity=0.268 Sum_probs=157.7
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
....+.+|+++++.+ +||||+++++++...+..++||||+++++|..++..... ....++.+++.||.||| +
T Consensus 38 ~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~ 114 (318)
T cd05570 38 DVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH---E 114 (318)
T ss_pred HHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 456678899999888 799999999999999999999999999999988865522 46778999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++||||||+||+++.++.++|+|||++........ ......|+..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 115 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G 192 (318)
T cd05570 115 RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAG 192 (318)
T ss_pred CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhC
Confidence 9999999999999999999999999999865322211 11234688999999999988999999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
+.||.... .......... ... .... ..+..+.+++.+||..||++|||+
T Consensus 193 ~~pf~~~~---------~~~~~~~i~~-~~~------~~~~--------~~~~~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 193 QSPFEGDD---------EDELFQSILE-DEV------RYPR--------WLSKEAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred CCCCCCCC---------HHHHHHHHHc-CCC------CCCC--------cCCHHHHHHHHHHccCCHHHcCCC
Confidence 99995421 1111111111 100 0111 122568899999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=243.43 Aligned_cols=206 Identities=19% Similarity=0.290 Sum_probs=157.7
Q ss_pred cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----------chHHHHHHHHHHHh
Q 044022 10 RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----------LPRLKIASDIVNSL 78 (241)
Q Consensus 10 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~~~~~~~~~i~~~l 78 (241)
......|.+|+.++++++|+||+++++++...+..++|+||+++++|.+++.... ...+.++.+|+.|+
T Consensus 50 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l 129 (277)
T cd05036 50 EQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129 (277)
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHH
Confidence 3345679999999999999999999999999889999999999999999985432 13567999999999
Q ss_pred chhhcCCCCCceeccCCCCCeeecCCC---CeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHH
Q 044022 79 AYLHFGFPRPIVLRNFKTQNILFNEEN---VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFS 155 (241)
Q Consensus 79 ~~lh~~~~~~ivh~dl~~~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 155 (241)
.||| +.+++|+||||+||+++.++ .++++|||.+.................+..|+|||++.+..++.++||||
T Consensus 130 ~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws 206 (277)
T cd05036 130 KYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWS 206 (277)
T ss_pred HHHH---HCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHH
Confidence 9999 89999999999999998654 68999999987653322211112223456799999999888999999999
Q ss_pred HHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 156 FGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 156 ~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
||+++|+|++ |..||..... .+........... .... ..+..+.+++.+||+.+|+
T Consensus 207 lG~il~el~~~g~~pf~~~~~---------~~~~~~~~~~~~~------~~~~--------~~~~~~~~~i~~cl~~~p~ 263 (277)
T cd05036 207 FGVLLWEIFSLGYMPYPGRTN---------QEVMEFVTGGGRL------DPPK--------GCPGPVYRIMTDCWQHTPE 263 (277)
T ss_pred HHHHHHHHHcCCCCCCCCCCH---------HHHHHHHHcCCcC------CCCC--------CCCHHHHHHHHHHcCCCcc
Confidence 9999999997 9999854211 1112221111110 0111 1225788999999999999
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
+|||+.|
T Consensus 264 ~Rps~~~ 270 (277)
T cd05036 264 DRPNFAT 270 (277)
T ss_pred cCcCHHH
Confidence 9999864
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=239.74 Aligned_cols=213 Identities=22% Similarity=0.278 Sum_probs=161.9
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~ 76 (241)
|++...........+.+|++++++++||||+++++++...+..++||||+++++|.+++.... .....++.+++.
T Consensus 25 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~ 104 (250)
T cd05085 25 KTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAA 104 (250)
T ss_pred EecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 444433333445678999999999999999999999999999999999999999999886532 246788999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSF 156 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~ 156 (241)
||.|+| +.+++|+||+|+||+++.++.++++|||.+.......... .....++..|+|||++.+..++.++|+|||
T Consensus 105 ~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 180 (250)
T cd05085 105 GMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLKQIPIKWTAPEALNYGRYSSESDVWSY 180 (250)
T ss_pred HHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccccc-CCCCCCcccccCHHHhccCCCCchhHHHHH
Confidence 999999 9999999999999999999999999999986543322111 112234567999999998889999999999
Q ss_pred HHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 157 GAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 157 G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
|+++|++++ |..||..... ....... ..+.... ... ..+..+.+++.+||..+|++
T Consensus 181 G~ll~~~~~~g~~p~~~~~~---------~~~~~~~-~~~~~~~-----~~~--------~~~~~~~~li~~~l~~~p~~ 237 (250)
T cd05085 181 GILLWETFSLGVCPYPGMTN---------QQAREQV-EKGYRMS-----CPQ--------KCPDDVYKVMQRCWDYKPEN 237 (250)
T ss_pred HHHHHHHhcCCCCCCCCCCH---------HHHHHHH-HcCCCCC-----CCC--------CCCHHHHHHHHHHcccCccc
Confidence 999999998 9999854211 1111111 1111100 011 12357899999999999999
Q ss_pred CCCCCC
Q 044022 236 RPTMVD 241 (241)
Q Consensus 236 Rpt~~e 241 (241)
|||+.|
T Consensus 238 Rp~~~~ 243 (250)
T cd05085 238 RPKFSE 243 (250)
T ss_pred CCCHHH
Confidence 999754
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=254.31 Aligned_cols=198 Identities=16% Similarity=0.225 Sum_probs=156.2
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC-
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP- 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~- 86 (241)
....+.+|+++++.++||||+++++++...+..++||||+++|+|..++..... ....++.||+.||.||| +
T Consensus 38 ~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~ 114 (325)
T cd05594 38 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH---SE 114 (325)
T ss_pred HHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hc
Confidence 456678899999999999999999999999999999999999999988865422 45678899999999999 6
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++||||||+|||++.++.++|+|||++......... .....|++.|+|||++.+..++.++||||||+++|+|++|
T Consensus 115 ~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG 192 (325)
T cd05594 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 192 (325)
T ss_pred CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--cccccCCcccCCHHHHccCCCCCccccccccceeeeeccC
Confidence 79999999999999999999999999998753322111 1234689999999999988899999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
..||..... .+......... ..+.. ..+..+.+++.+||+.||++|++
T Consensus 193 ~~Pf~~~~~---------~~~~~~i~~~~-------~~~p~--------~~~~~~~~li~~~L~~dP~~R~~ 240 (325)
T cd05594 193 RLPFYNQDH---------EKLFELILMEE-------IRFPR--------TLSPEAKSLLSGLLKKDPKQRLG 240 (325)
T ss_pred CCCCCCCCH---------HHHHHHHhcCC-------CCCCC--------CCCHHHHHHHHHHhhcCHHHhCC
Confidence 999954211 11111111100 00111 12256889999999999999973
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=248.65 Aligned_cols=200 Identities=19% Similarity=0.225 Sum_probs=156.7
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
....+..|..++... +||||+++++++...+..++||||+++|+|..++..... ....++.|++.||+||| +
T Consensus 38 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH---~ 114 (316)
T cd05620 38 DVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH---S 114 (316)
T ss_pred hHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 345667788888765 899999999999999999999999999999998865422 45678999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
++++||||||+||+++.++.++|+|||.+........ ......|+..|+|||++.+..++.++||||||+++|+|++|
T Consensus 115 ~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g 192 (316)
T cd05620 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIG 192 (316)
T ss_pred CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhC
Confidence 9999999999999999999999999999864322211 12335689999999999988999999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
..||..... .+....... . .+..... .+..+.+++.+||+.||++|||+.
T Consensus 193 ~~Pf~~~~~---------~~~~~~~~~-~------~~~~~~~--------~~~~~~~li~~~l~~dP~~R~~~~ 242 (316)
T cd05620 193 QSPFHGDDE---------DELFESIRV-D------TPHYPRW--------ITKESKDILEKLFERDPTRRLGVV 242 (316)
T ss_pred CCCCCCCCH---------HHHHHHHHh-C------CCCCCCC--------CCHHHHHHHHHHccCCHHHcCCCh
Confidence 999964211 111111111 1 0111111 225688999999999999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=242.75 Aligned_cols=205 Identities=23% Similarity=0.313 Sum_probs=159.0
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----------chHHHHHHHHHHHhc
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----------LPRLKIASDIVNSLA 79 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~~~~~~~~~i~~~l~ 79 (241)
.....+.+|+++++.++||||+++++++...+..++|+||+++++|.+++.... ...+.++.+++.|+.
T Consensus 41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 120 (269)
T cd05044 41 QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120 (269)
T ss_pred hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHH
Confidence 456678999999999999999999999998889999999999999999985421 135678999999999
Q ss_pred hhhcCCCCCceeccCCCCCeeecCCC-----CeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhH
Q 044022 80 YLHFGFPRPIVLRNFKTQNILFNEEN-----VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 80 ~lh~~~~~~ivh~dl~~~nil~~~~~-----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
||| +.+++|+||+|+||+++.++ .++++|||.+................++..|+|||++.+..++.++|||
T Consensus 121 ~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 197 (269)
T cd05044 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVW 197 (269)
T ss_pred HHH---hCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHH
Confidence 999 89999999999999999887 8999999998755433222222233456789999999988899999999
Q ss_pred HHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 155 SFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 155 s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
|||+++|+|++ |..||..... .+..... ..+... ... ...+..+.+++.+||..+|
T Consensus 198 slG~il~ellt~g~~p~~~~~~---------~~~~~~~-~~~~~~-----~~~--------~~~~~~~~~li~~~l~~~p 254 (269)
T cd05044 198 SFGVLMWEILTLGQQPYPALNN---------QEVLQHV-TAGGRL-----QKP--------ENCPDKIYQLMTNCWAQDP 254 (269)
T ss_pred HHHHHHHHHHHcCCCCCcccCH---------HHHHHHH-hcCCcc-----CCc--------ccchHHHHHHHHHHcCCCc
Confidence 99999999998 9999854211 1111111 111000 000 1233678899999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|||+++
T Consensus 255 ~~Rp~~~~ 262 (269)
T cd05044 255 SERPTFDR 262 (269)
T ss_pred ccCCCHHH
Confidence 99999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=240.43 Aligned_cols=214 Identities=23% Similarity=0.311 Sum_probs=167.3
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC---------Cc----hHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA---------PL----PRL 68 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---------~~----~~~ 68 (241)
|++.........+.+.+|+++++.++|+|++++++++......++|+||+++++|.+++... .. ...
T Consensus 29 k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~ 108 (262)
T cd00192 29 KTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLL 108 (262)
T ss_pred EeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHH
Confidence 44444333334778999999999999999999999999989999999999999999998764 11 467
Q ss_pred HHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCC
Q 044022 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLN 148 (241)
Q Consensus 69 ~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 148 (241)
.++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+................++..|+|||.+....++
T Consensus 109 ~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 185 (262)
T cd00192 109 SFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFT 185 (262)
T ss_pred HHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcc
Confidence 89999999999999 999999999999999999999999999999876554322222334567889999999888899
Q ss_pred cchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHH
Q 044022 149 EKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLE 227 (241)
Q Consensus 149 ~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 227 (241)
.++||||+|+++|+|++ |..||.... ..+...... .+.... ... ..+..+.+++.+
T Consensus 186 ~~~Di~slG~il~~l~~~g~~p~~~~~---------~~~~~~~~~-~~~~~~-----~~~--------~~~~~~~~li~~ 242 (262)
T cd00192 186 SKSDVWSFGVLLWEIFTLGATPYPGLS---------NEEVLEYLR-KGYRLP-----KPE--------YCPDELYELMLS 242 (262)
T ss_pred hhhccHHHHHHHHHHHhcCCCCCCCCC---------HHHHHHHHH-cCCCCC-----CCc--------cCChHHHHHHHH
Confidence 99999999999999999 599986531 111111111 111111 111 223678999999
Q ss_pred hccCCCCCCCCCCC
Q 044022 228 CVNNSPEDRPTMVD 241 (241)
Q Consensus 228 cl~~~p~~Rpt~~e 241 (241)
||..||++|||++|
T Consensus 243 ~l~~~p~~Rps~~~ 256 (262)
T cd00192 243 CWQLDPEDRPTFSE 256 (262)
T ss_pred HccCCcccCcCHHH
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=245.53 Aligned_cols=214 Identities=24% Similarity=0.351 Sum_probs=162.3
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----------------
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----------------- 64 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------- 64 (241)
|.+..+........+.+|+.++++++||||+++++++......++++||+++++|.+++....
T Consensus 41 K~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~ 120 (288)
T cd05050 41 KMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120 (288)
T ss_pred EecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccc
Confidence 444333333345679999999999999999999999999899999999999999999986421
Q ss_pred ---------chHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCC
Q 044022 65 ---------LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRG 135 (241)
Q Consensus 65 ---------~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 135 (241)
...+.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.+.................+..
T Consensus 121 ~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 197 (288)
T cd05050 121 GLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR 197 (288)
T ss_pred cccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChh
Confidence 134789999999999999 89999999999999999999999999999875433322111222334567
Q ss_pred ccCcccccccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhH
Q 044022 136 YSAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEK 214 (241)
Q Consensus 136 ~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (241)
|+|||++.+..++.++|+||||+++|+|++ |..||..... .+..... ..+.....+ .
T Consensus 198 y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~---------~~~~~~~-~~~~~~~~~-----~------- 255 (288)
T cd05050 198 WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH---------EEVIYYV-RDGNVLSCP-----D------- 255 (288)
T ss_pred hcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHH-hcCCCCCCC-----C-------
Confidence 999999988889999999999999999997 8888854211 1222221 111111111 1
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 215 EQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 215 ~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
..+..+.+++.+||..+|++|||++|
T Consensus 256 -~~~~~l~~li~~~l~~~p~~Rpt~~e 281 (288)
T cd05050 256 -NCPLELYNLMRLCWSKLPSDRPSFAS 281 (288)
T ss_pred -CCCHHHHHHHHHHcccCcccCCCHHH
Confidence 12357889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=246.83 Aligned_cols=201 Identities=20% Similarity=0.302 Sum_probs=155.3
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--------------------chHHHH
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--------------------LPRLKI 70 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------------~~~~~~ 70 (241)
..+.+.+|++++.++ +||||+++++++...+..++++||+++++|.+++.... .....+
T Consensus 45 ~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 124 (297)
T cd05089 45 DHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124 (297)
T ss_pred HHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHH
Confidence 456789999999999 79999999999999899999999999999999986431 135778
Q ss_pred HHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcc
Q 044022 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEK 150 (241)
Q Consensus 71 ~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 150 (241)
+.+++.||+||| +.+++|+||||+||+++.++.++|+|||++....... .......+..|+|||++.+..++.+
T Consensus 125 ~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~ 198 (297)
T cd05089 125 ASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTK 198 (297)
T ss_pred HHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCch
Confidence 999999999999 8999999999999999999999999999885332111 1111223456999999988889999
Q ss_pred hhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhc
Q 044022 151 SNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECV 229 (241)
Q Consensus 151 ~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 229 (241)
+||||||+++|+|++ |..||.... ..+..... ..+... .... ..+..+.+++.+||
T Consensus 199 ~DvwSlG~il~el~t~g~~pf~~~~---------~~~~~~~~-~~~~~~-----~~~~--------~~~~~~~~li~~~l 255 (297)
T cd05089 199 SDVWSFGVLLWEIVSLGGTPYCGMT---------CAELYEKL-PQGYRM-----EKPR--------NCDDEVYELMRQCW 255 (297)
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCC---------HHHHHHHH-hcCCCC-----CCCC--------CCCHHHHHHHHHHc
Confidence 999999999999997 999995421 11111111 111100 0111 12357889999999
Q ss_pred cCCCCCCCCCCC
Q 044022 230 NNSPEDRPTMVD 241 (241)
Q Consensus 230 ~~~p~~Rpt~~e 241 (241)
+.+|.+|||+++
T Consensus 256 ~~~p~~Rp~~~~ 267 (297)
T cd05089 256 RDRPYERPPFAQ 267 (297)
T ss_pred CCChhhCcCHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=240.67 Aligned_cols=204 Identities=21% Similarity=0.264 Sum_probs=162.2
Q ss_pred cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhc
Q 044022 10 RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 10 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~ 83 (241)
......+.+|++++++++|||++++++++...+..++|+||+++++|.+++.... .....++.+++.||.|||
T Consensus 40 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH- 118 (256)
T cd08529 40 RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH- 118 (256)
T ss_pred HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 3456778999999999999999999999999999999999999999999986541 145678999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+.+++|+||+|+||+++.++.++|+|||.+.......... ....+++.|+|||+..+..++.++|+||||+++|+|
T Consensus 119 --~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 194 (256)
T cd08529 119 --SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA--NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYEC 194 (256)
T ss_pred --HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchh--hccccCccccCHHHhcCCCCCCccchHHHHHHHHHH
Confidence 8999999999999999999999999999987655432211 234578889999999988899999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|+.||.... ..+..... ..+...... . ..+..+.+++.+||+.+|++||++.|
T Consensus 195 ~~g~~p~~~~~---------~~~~~~~~-~~~~~~~~~-----~--------~~~~~~~~~i~~~l~~~p~~Rp~~~~ 249 (256)
T cd08529 195 CTGKHPFDANN---------QGALILKI-IRGVFPPVS-----Q--------MYSQQLAQLIDQCLTKDYRQRPDTFQ 249 (256)
T ss_pred HhCCCCCCCCC---------HHHHHHHH-HcCCCCCCc-----c--------ccCHHHHHHHHHHccCCcccCcCHHH
Confidence 99999995421 11111111 111111111 1 22357899999999999999999753
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=250.21 Aligned_cols=199 Identities=20% Similarity=0.211 Sum_probs=155.1
Q ss_pred HHHHHHHHH-HHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCC
Q 044022 13 YGSCINNIT-YAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 13 ~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..++.+|.. +++.++||||+++++++...+..++||||+++|+|..++..... ....++.||+.||.||| +.
T Consensus 39 ~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~ 115 (323)
T cd05575 39 QKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH---SL 115 (323)
T ss_pred HHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 345556655 46778999999999999999999999999999999998865432 45678999999999999 99
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcC
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
+++||||||+|||++.++.+||+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 116 givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~ 193 (323)
T cd05575 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGL 193 (323)
T ss_pred CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCC
Confidence 999999999999999999999999999865322211 112346899999999999888999999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
.||.... ..+......... . .+.+. .+..+.+++.+||+.||++||++.
T Consensus 194 ~pf~~~~---------~~~~~~~i~~~~-~------~~~~~--------~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 194 PPFYSRD---------TAEMYDNILNKP-L------RLKPN--------ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCC---------HHHHHHHHHcCC-C------CCCCC--------CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 9996521 111112211110 0 11111 125688999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=246.99 Aligned_cols=200 Identities=21% Similarity=0.246 Sum_probs=156.8
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
....+..|..++... +||||+++++++...+..++||||+++|+|.+++.... .....++.|++.||.||| +
T Consensus 38 ~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH---~ 114 (316)
T cd05619 38 DVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH---S 114 (316)
T ss_pred hHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 345567788888764 99999999999999999999999999999999986532 246778999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++||||||+||+++.++.++|+|||++........ ......|+..|+|||++.+..++.++||||||+++|+|++|
T Consensus 115 ~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G 192 (316)
T cd05619 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIG 192 (316)
T ss_pred CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhC
Confidence 9999999999999999999999999999875322211 11234689999999999988899999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
+.||.... ..+......... +.... ..+..+.+++.+||+.||++||++.
T Consensus 193 ~~pf~~~~---------~~~~~~~i~~~~-------~~~~~--------~~~~~~~~li~~~l~~~P~~R~~~~ 242 (316)
T cd05619 193 QSPFHGHD---------EEELFQSIRMDN-------PCYPR--------WLTREAKDILVKLFVREPERRLGVK 242 (316)
T ss_pred CCCCCCCC---------HHHHHHHHHhCC-------CCCCc--------cCCHHHHHHHHHHhccCHhhcCCCh
Confidence 99996421 111122111111 01111 1225678999999999999999985
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=254.68 Aligned_cols=215 Identities=20% Similarity=0.293 Sum_probs=162.5
Q ss_pred cccccccccccHHHHHHHHHHHHhcC-CCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---------------
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL--------------- 65 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------- 65 (241)
|.+.........+.+.+|++++.++. ||||++++++|...+..++|+||+++|+|.+++.....
T Consensus 73 K~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~ 152 (401)
T cd05107 73 KMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGS 152 (401)
T ss_pred EecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccc
Confidence 45544333344567899999999997 99999999999999999999999999999998854210
Q ss_pred --------------------------------------------------------------------------------
Q 044022 66 -------------------------------------------------------------------------------- 65 (241)
Q Consensus 66 -------------------------------------------------------------------------------- 65 (241)
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (401)
T cd05107 153 LISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINE 232 (401)
T ss_pred ccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcC
Confidence
Q ss_pred -------hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccC
Q 044022 66 -------PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSA 138 (241)
Q Consensus 66 -------~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~a 138 (241)
..+.++.+++.||.||| +.+++||||||+|||++.++.++|+|||++................++..|+|
T Consensus 233 ~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~a 309 (401)
T cd05107 233 SPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMA 309 (401)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeC
Confidence 13567889999999999 89999999999999999999999999999876433222222223456788999
Q ss_pred cccccccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHH
Q 044022 139 PEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQ 217 (241)
Q Consensus 139 PE~~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (241)
||.+....++.++||||||+++|||++ |..||..... .+........+.... ... ..
T Consensus 310 PE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~---------~~~~~~~~~~~~~~~-----~p~--------~~ 367 (401)
T cd05107 310 PESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM---------NEQFYNAIKRGYRMA-----KPA--------HA 367 (401)
T ss_pred hHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc---------hHHHHHHHHcCCCCC-----CCC--------CC
Confidence 999988889999999999999999998 8889854211 111111111111110 111 12
Q ss_pred HHHHHHHHHHhccCCCCCCCCCCC
Q 044022 218 LHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 218 ~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+..+.+++.+||..+|.+|||++|
T Consensus 368 ~~~l~~li~~cl~~~P~~RPs~~e 391 (401)
T cd05107 368 SDEIYEIMQKCWEEKFEIRPDFSQ 391 (401)
T ss_pred CHHHHHHHHHHcCCChhHCcCHHH
Confidence 357899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=240.38 Aligned_cols=205 Identities=20% Similarity=0.222 Sum_probs=159.7
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
....+.+|++++++++||||+++++++..++..++|+||+++++|.+.+.... .....++.+++.|+.||| +.
T Consensus 47 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~ 123 (263)
T cd06625 47 EVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH---SN 123 (263)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 34578899999999999999999999999999999999999999999886542 245778999999999999 99
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCccee-ecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT-TDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
+++|+||+|+||+++.++.++|+|||.+........... .....++..|+|||.+.+..++.++||||||+++|++++|
T Consensus 124 ~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 203 (263)
T cd06625 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTE 203 (263)
T ss_pred CeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhC
Confidence 999999999999999999999999999875543211111 0223567889999999988899999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+.||..... .+........... ..+.. ..+..+.+++.+||..+|.+|||+.|
T Consensus 204 ~~p~~~~~~---------~~~~~~~~~~~~~-----~~~~~--------~~~~~~~~li~~~l~~~p~~Rpt~~~ 256 (263)
T cd06625 204 KPPWAEFEA---------MAAIFKIATQPTN-----PQLPS--------HVSPDARNFLRRTFVENAKKRPSAEE 256 (263)
T ss_pred CCCccccch---------HHHHHHHhccCCC-----CCCCc--------cCCHHHHHHHHHHhhcCcccCCCHHH
Confidence 999865211 0111111111100 11111 22356889999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=248.05 Aligned_cols=205 Identities=22% Similarity=0.337 Sum_probs=157.1
Q ss_pred ccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----------------c---hHHH
Q 044022 11 HTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----------------L---PRLK 69 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------------~---~~~~ 69 (241)
.....+.+|+++++++ +||||+++++++...+..++++||+++|+|.+++.... . ....
T Consensus 59 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 138 (314)
T cd05099 59 KDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138 (314)
T ss_pred HHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHH
Confidence 4456788999999999 69999999999998889999999999999999985421 1 2467
Q ss_pred HHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCc
Q 044022 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNE 149 (241)
Q Consensus 70 ~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 149 (241)
++.+++.||.||| +++++|+||||+||+++.++.++|+|||.++...............++..|+|||++.+..++.
T Consensus 139 ~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 215 (314)
T cd05099 139 CAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTH 215 (314)
T ss_pred HHHHHHHHHHHHH---HCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCc
Confidence 8999999999999 9999999999999999999999999999997654322111111223445799999998888999
Q ss_pred chhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHh
Q 044022 150 KSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLEC 228 (241)
Q Consensus 150 ~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 228 (241)
++||||||+++|++++ |..||.... ..+..... ........ .. ..+..+.+++.+|
T Consensus 216 ~~DiwslG~~l~el~~~g~~p~~~~~---------~~~~~~~~-~~~~~~~~-----~~--------~~~~~l~~li~~c 272 (314)
T cd05099 216 QSDVWSFGILMWEIFTLGGSPYPGIP---------VEELFKLL-REGHRMDK-----PS--------NCTHELYMLMREC 272 (314)
T ss_pred cchhhHHHHHHHHHHhCCCCCCCCCC---------HHHHHHHH-HcCCCCCC-----CC--------CCCHHHHHHHHHH
Confidence 9999999999999999 888885421 11111111 11111111 11 1225688999999
Q ss_pred ccCCCCCCCCCCC
Q 044022 229 VNNSPEDRPTMVD 241 (241)
Q Consensus 229 l~~~p~~Rpt~~e 241 (241)
|..+|++|||+.|
T Consensus 273 l~~~p~~Rps~~~ 285 (314)
T cd05099 273 WHAVPTQRPTFKQ 285 (314)
T ss_pred cCCCcccCcCHHH
Confidence 9999999999753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=242.58 Aligned_cols=213 Identities=21% Similarity=0.234 Sum_probs=161.3
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~ 76 (241)
|++..+........+.+|+.+++.+.|+||+++++++... ..++++||+++|+|.+++..... ..+.++.|++.
T Consensus 42 K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~ 120 (279)
T cd05109 42 KVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAK 120 (279)
T ss_pred EEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHH
Confidence 4444444444567788999999999999999999999754 57899999999999999865321 46788999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSF 156 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~ 156 (241)
||.||| +.+++|+||||+||+++.++.++|+|||++................++..|+|||...+..++.++|||||
T Consensus 121 ~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 197 (279)
T cd05109 121 GMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSY 197 (279)
T ss_pred HHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHH
Confidence 999999 99999999999999999999999999999886654322222222234667999999988889999999999
Q ss_pred HHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 157 GAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 157 G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
|+++||+++ |..||..... ............... .. ..+..+.+++.+||..||+.
T Consensus 198 G~~l~el~t~g~~p~~~~~~----------~~~~~~~~~~~~~~~-----~~--------~~~~~~~~li~~~l~~dp~~ 254 (279)
T cd05109 198 GVTVWELMTFGAKPYDGIPA----------REIPDLLEKGERLPQ-----PP--------ICTIDVYMIMVKCWMIDSEC 254 (279)
T ss_pred HHHHHHHHcCCCCCCCCCCH----------HHHHHHHHCCCcCCC-----Cc--------cCCHHHHHHHHHHcCCChhh
Confidence 999999998 8888854111 111111111111110 01 12357889999999999999
Q ss_pred CCCCCC
Q 044022 236 RPTMVD 241 (241)
Q Consensus 236 Rpt~~e 241 (241)
|||+.|
T Consensus 255 Rp~~~~ 260 (279)
T cd05109 255 RPRFRE 260 (279)
T ss_pred CcCHHH
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=238.70 Aligned_cols=203 Identities=19% Similarity=0.331 Sum_probs=158.5
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+.|.+|+.++++++||||+++++++......+++|||+++++|.+++.... . ..+.++.+++.||+||| +
T Consensus 42 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~ 118 (256)
T cd05113 42 SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---S 118 (256)
T ss_pred cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 35679999999999999999999999998888999999999999999986532 1 46789999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh-
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA- 165 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~- 165 (241)
.+++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 119 ~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~ 197 (256)
T cd05113 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSL 197 (256)
T ss_pred CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcC
Confidence 99999999999999999999999999998765433211 1112234567999999988889999999999999999998
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|..||..... .+..... ........+ . ..+..+.+++.+||+.||++|||+.+
T Consensus 198 g~~p~~~~~~---------~~~~~~~-~~~~~~~~~-----~--------~~~~~~~~li~~cl~~~p~~Rp~~~~ 250 (256)
T cd05113 198 GKMPYERFNN---------SETVEKV-SQGLRLYRP-----H--------LASEKVYAIMYSCWHEKAEERPTFQQ 250 (256)
T ss_pred CCCCcCcCCH---------HHHHHHH-hcCCCCCCC-----C--------CCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 9999854211 1111111 111110000 0 12357899999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=248.71 Aligned_cols=207 Identities=21% Similarity=0.232 Sum_probs=159.2
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+.+.+|+.++.++ +||||+++++++...+..++||||+++|+|..++.... ..+..++.|++.||.||| +
T Consensus 38 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH---~ 114 (327)
T cd05617 38 DIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLH---E 114 (327)
T ss_pred HHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 455688999999998 69999999999999999999999999999998875432 246788999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
++++||||||+|||++.++.++|+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|
T Consensus 115 ~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g 192 (327)
T cd05617 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG 192 (327)
T ss_pred CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhC
Confidence 9999999999999999999999999999875322211 11335689999999999988999999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
..||....... .....+........... .+... .+..+.+++.+||..||++|+++.
T Consensus 193 ~~pf~~~~~~~---~~~~~~~~~~~~~~~~~------~~p~~--------~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 193 RSPFDIITDNP---DMNTEDYLFQVILEKPI------RIPRF--------LSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCccCCCc---ccccHHHHHHHHHhCCC------CCCCC--------CCHHHHHHHHHHhccCHHHcCCCC
Confidence 99996422211 11111112221111110 11111 124678999999999999999863
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=241.04 Aligned_cols=203 Identities=17% Similarity=0.210 Sum_probs=160.7
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~ 84 (241)
...+.+.+|+.+++.++|+||+++++.+..++..++++||+++++|.+++.... .....++.+++.|+.+||
T Consensus 40 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH-- 117 (255)
T cd08219 40 SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH-- 117 (255)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh--
Confidence 456778899999999999999999999999999999999999999999875421 145788999999999999
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
+.+++|+||+|+||+++.++.++++|||.+......... .....++..|+|||++.+..++.++|+||||+++|+|+
T Consensus 118 -~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~ 194 (255)
T cd08219 118 -EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY--ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELC 194 (255)
T ss_pred -hCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc--cccccCCccccCHHHHccCCcCchhhhhhhchhheehh
Confidence 999999999999999999999999999998765443221 12345788899999998888999999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|..||.... ......... .+.....+ . ..+..+.+++.+||+.||++|||+.|
T Consensus 195 ~g~~p~~~~~---------~~~~~~~~~-~~~~~~~~-----~--------~~~~~~~~li~~~l~~~P~~Rp~~~~ 248 (255)
T cd08219 195 TLKHPFQANS---------WKNLILKVC-QGSYKPLP-----S--------HYSYELRSLIKQMFKRNPRSRPSATT 248 (255)
T ss_pred hccCCCCCCC---------HHHHHHHHh-cCCCCCCC-----c--------ccCHHHHHHHHHHHhCCcccCCCHHH
Confidence 9999995411 111111111 11111111 1 12356889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=244.80 Aligned_cols=204 Identities=20% Similarity=0.315 Sum_probs=157.9
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--------------chHHHHHHHHHHH
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--------------LPRLKIASDIVNS 77 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~i~~~ 77 (241)
....+.+|+.+++.++||||+++++++......++||||+++|+|.+++.... .....++.+++.|
T Consensus 52 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 131 (288)
T cd05061 52 ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131 (288)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHH
Confidence 34568899999999999999999999998889999999999999999986421 1346789999999
Q ss_pred hchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHH
Q 044022 78 LAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFG 157 (241)
Q Consensus 78 l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G 157 (241)
|.||| +++++||||||+||+++.++.++++|||++................++..|+|||.+.+..++.++|+||||
T Consensus 132 l~~lH---~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG 208 (288)
T cd05061 132 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFG 208 (288)
T ss_pred HHHHH---hCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHH
Confidence 99999 999999999999999999999999999998755433222222233456779999999888899999999999
Q ss_pred HHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCC
Q 044022 158 AFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDR 236 (241)
Q Consensus 158 ~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 236 (241)
+++|+|++ |..||.... ..+...... .+.....+ . ..+..+.+++.+||+.||++|
T Consensus 209 ~~l~el~~~~~~p~~~~~---------~~~~~~~~~-~~~~~~~~-----~--------~~~~~~~~li~~~l~~~p~~R 265 (288)
T cd05061 209 VVLWEITSLAEQPYQGLS---------NEQVLKFVM-DGGYLDQP-----D--------NCPERVTDLMRMCWQFNPKMR 265 (288)
T ss_pred HHHHHHHhCCCCCCCCCC---------HHHHHHHHH-cCCCCCCC-----C--------CCCHHHHHHHHHHcCCChhHC
Confidence 99999998 788885421 111111111 11111111 1 122578999999999999999
Q ss_pred CCCCC
Q 044022 237 PTMVD 241 (241)
Q Consensus 237 pt~~e 241 (241)
||+.|
T Consensus 266 ps~~~ 270 (288)
T cd05061 266 PTFLE 270 (288)
T ss_pred cCHHH
Confidence 99853
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=241.16 Aligned_cols=202 Identities=21% Similarity=0.299 Sum_probs=155.6
Q ss_pred ccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--------------------chHHH
Q 044022 11 HTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--------------------LPRLK 69 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------------~~~~~ 69 (241)
...+.+.+|++++.++ +||||+++++++...+..+++|||+++++|.+++.... .....
T Consensus 37 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 116 (270)
T cd05047 37 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116 (270)
T ss_pred HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHH
Confidence 4456788999999999 89999999999999999999999999999999986421 13578
Q ss_pred HHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCc
Q 044022 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNE 149 (241)
Q Consensus 70 ~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 149 (241)
++.+++.|++||| +.+++|+||||+||+++.++.++++|||++....... .......+..|+|||++....++.
T Consensus 117 ~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~ 190 (270)
T cd05047 117 FAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTT 190 (270)
T ss_pred HHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCCCccccchhh---hccCCCCccccCChHHHccCCCCc
Confidence 8999999999999 8999999999999999999999999999875322111 111122355799999998888999
Q ss_pred chhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHh
Q 044022 150 KSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLEC 228 (241)
Q Consensus 150 ~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 228 (241)
++|+||||+++|+|++ |..||.... ..+...... .......+ . ..+..+.+++.+|
T Consensus 191 ~~Di~slG~il~el~~~g~~pf~~~~---------~~~~~~~~~-~~~~~~~~-----~--------~~~~~~~~li~~~ 247 (270)
T cd05047 191 NSDVWSYGVLLWEIVSLGGTPYCGMT---------CAELYEKLP-QGYRLEKP-----L--------NCDDEVYDLMRQC 247 (270)
T ss_pred hhhHHHHHHHHHHHHcCCCCCccccC---------HHHHHHHHh-CCCCCCCC-----C--------cCCHHHHHHHHHH
Confidence 9999999999999997 999985421 111111111 11000000 0 1225688999999
Q ss_pred ccCCCCCCCCCCC
Q 044022 229 VNNSPEDRPTMVD 241 (241)
Q Consensus 229 l~~~p~~Rpt~~e 241 (241)
|..||.+|||++|
T Consensus 248 l~~~p~~Rps~~~ 260 (270)
T cd05047 248 WREKPYERPSFAQ 260 (270)
T ss_pred cccChhhCCCHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=246.23 Aligned_cols=154 Identities=23% Similarity=0.303 Sum_probs=134.5
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC-
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP- 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~- 86 (241)
...++.+|++++++++||||+++++++..++..++|+||+++++|.+++..... ....++.+++.||.||| +
T Consensus 42 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~ 118 (308)
T cd06615 42 IRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLR---EK 118 (308)
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hh
Confidence 456688999999999999999999999999999999999999999999865422 45688999999999999 5
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++|+||+|+||+++.++.++|+|||.+....... .....++..|+|||.+.+..++.++|+||||+++|++++|
T Consensus 119 ~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 194 (308)
T cd06615 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194 (308)
T ss_pred CCEEECCCChHHEEEecCCcEEEccCCCcccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhC
Confidence 589999999999999999999999999886543321 1234678899999999888889999999999999999999
Q ss_pred Cccccc
Q 044022 167 RIHIWD 172 (241)
Q Consensus 167 ~~p~~~ 172 (241)
+.||..
T Consensus 195 ~~p~~~ 200 (308)
T cd06615 195 RYPIPP 200 (308)
T ss_pred CCCCCC
Confidence 999854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=247.15 Aligned_cols=214 Identities=20% Similarity=0.307 Sum_probs=160.9
Q ss_pred cccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----------------
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---------------- 64 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------- 64 (241)
|.+..+........+.+|+.+++.+ +|+||+++++++...+..++|+||+++++|.+++....
T Consensus 56 K~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~ 135 (307)
T cd05098 56 KMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEE 135 (307)
T ss_pred EeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccc
Confidence 3443332333456788999999999 89999999999999999999999999999999986421
Q ss_pred ----chHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcc
Q 044022 65 ----LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPE 140 (241)
Q Consensus 65 ----~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE 140 (241)
...+.++.+++.||+||| +.+++|+||||+||+++.++.++|+|||.+................++..|+|||
T Consensus 136 ~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE 212 (307)
T cd05098 136 QLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 212 (307)
T ss_pred cCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChH
Confidence 135688999999999999 8999999999999999999999999999987554322111111122446799999
Q ss_pred cccccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHH
Q 044022 141 YISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLH 219 (241)
Q Consensus 141 ~~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (241)
++.+..++.++|+||||+++|+|++ |..||.... ..+..... ........ .. ..+.
T Consensus 213 ~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~---------~~~~~~~~-~~~~~~~~-----~~--------~~~~ 269 (307)
T cd05098 213 ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---------VEELFKLL-KEGHRMDK-----PS--------NCTN 269 (307)
T ss_pred HhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC---------HHHHHHHH-HcCCCCCC-----CC--------cCCH
Confidence 9988889999999999999999998 888884311 11222221 11111111 11 1235
Q ss_pred HHHHHHHHhccCCCCCCCCCCC
Q 044022 220 ASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 220 ~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.+.+++.+||..+|++|||+.|
T Consensus 270 ~~~~li~~~l~~~p~~Rps~~e 291 (307)
T cd05098 270 ELYMMMRDCWHAVPSQRPTFKQ 291 (307)
T ss_pred HHHHHHHHHcccChhhCcCHHH
Confidence 7889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=239.13 Aligned_cols=203 Identities=18% Similarity=0.318 Sum_probs=159.2
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~~ 85 (241)
..+.+.+|+.++++++|+||+++++++...+..++++||+++++|.+++.... ...+.++.+++.||+|||
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH--- 120 (261)
T cd05072 44 SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE--- 120 (261)
T ss_pred hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 45688999999999999999999999999999999999999999999986532 145778999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+.+++|+||+|+||+++.++.++|+|||.+.......... .....++..|+|||++....++.++|+||||+++|+|++
T Consensus 121 ~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t 199 (261)
T cd05072 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199 (261)
T ss_pred HCCeeccccchhhEEecCCCcEEECCCccceecCCCceec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHc
Confidence 8999999999999999999999999999998765432211 122235667999999988889999999999999999998
Q ss_pred -cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 -GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|..||..... .+...... ... ..+. .. ..+..+.+++.+||..+|++|||+++
T Consensus 200 ~g~~p~~~~~~---------~~~~~~~~-~~~----~~~~-~~--------~~~~~~~~li~~~l~~~p~~Rp~~~~ 253 (261)
T cd05072 200 YGKIPYPGMSN---------SDVMSALQ-RGY----RMPR-ME--------NCPDELYDIMKTCWKEKAEERPTFDY 253 (261)
T ss_pred cCCCCCCCCCH---------HHHHHHHH-cCC----CCCC-CC--------CCCHHHHHHHHHHccCCcccCcCHHH
Confidence 9999854211 11111111 111 0111 01 12256889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=254.54 Aligned_cols=205 Identities=16% Similarity=0.165 Sum_probs=158.6
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
....+.+|+.+++.++|+||+++++++...+..++||||+++|+|.+++.... . ....++.|++.||.||| +
T Consensus 44 ~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~ 120 (330)
T cd05601 44 TVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---Q 120 (330)
T ss_pred HHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 45668899999999999999999999999999999999999999999986641 1 35678899999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc------ccCCCcchhhHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS------ICVLNEKSNVFSFGAFL 160 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~Di~s~G~~~ 160 (241)
.+++||||||+||+++.++.++|+|||.+......... ......+++.|+|||++. ...++.++||||||+++
T Consensus 121 ~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il 199 (330)
T cd05601 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIA 199 (330)
T ss_pred CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeeccccee
Confidence 99999999999999999999999999999766543322 223346899999999986 45677899999999999
Q ss_pred HHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 161 FELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 161 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
|+|++|+.||..... .+..............+.. . ..+..+.+++..||. +|++|||++
T Consensus 200 ~el~~g~~Pf~~~~~---------~~~~~~i~~~~~~~~~~~~---~--------~~~~~~~~li~~ll~-~p~~R~t~~ 258 (330)
T cd05601 200 YEMIYGRSPFHEGTS---------AKTYNNIMNFQRFLKFPED---P--------KVSSDFLDLIQSLLC-GQKERLGYE 258 (330)
T ss_pred eeeccCCCCCCCCCH---------HHHHHHHHcCCCccCCCCC---C--------CCCHHHHHHHHHHcc-ChhhCCCHH
Confidence 999999999954211 1111111111111111110 0 122568899999998 999999985
Q ss_pred C
Q 044022 241 D 241 (241)
Q Consensus 241 e 241 (241)
+
T Consensus 259 ~ 259 (330)
T cd05601 259 G 259 (330)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=241.39 Aligned_cols=206 Identities=20% Similarity=0.301 Sum_probs=160.3
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC-----C---chHHHHHHHHHHHhchhh
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA-----P---LPRLKIASDIVNSLAYLH 82 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----~---~~~~~~~~~i~~~l~~lh 82 (241)
.....+.+|+++++.++||||+++++++...+..++++||+++++|.+++... . .....++.+++.||.|||
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH 123 (267)
T cd08228 44 KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123 (267)
T ss_pred HHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh
Confidence 34567889999999999999999999999999999999999999999887421 1 145788999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~ 162 (241)
+.+++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+
T Consensus 124 ---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~e 198 (267)
T cd08228 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198 (267)
T ss_pred ---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHH
Confidence 999999999999999999999999999998765433221 123457888999999988888999999999999999
Q ss_pred HHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 163 LLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 163 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|++|+.||..... ...+...... ........ ....+..+.+++.+||..+|++|||+.|
T Consensus 199 l~~g~~p~~~~~~-------~~~~~~~~~~-~~~~~~~~------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 257 (267)
T cd08228 199 MAALQSPFYGDKM-------NLFSLCQKIE-QCDYPPLP------------TEHYSEKLRELVSMCIYPDPDQRPDIGY 257 (267)
T ss_pred HhcCCCCCccccc-------cHHHHHHHHh-cCCCCCCC------------hhhcCHHHHHHHHHHCCCCcccCcCHHH
Confidence 9999999854211 1111111111 11111100 1133467899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=246.63 Aligned_cols=200 Identities=21% Similarity=0.246 Sum_probs=156.8
Q ss_pred ccHHHHHHHHHHHHhcCC-CcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQMSH-NHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.+..|++++..+.| ++|+++++++...+..++||||+++|+|.+++.... .....++.|++.||.|||
T Consensus 42 ~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--- 118 (324)
T cd05587 42 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH--- 118 (324)
T ss_pred hHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 345678899999999976 468889999998899999999999999999886542 246778999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+++++||||||+|||++.++.++|+|||++........ ......|++.|+|||++.+..++.++||||+|+++|+|++
T Consensus 119 ~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt 196 (324)
T cd05587 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196 (324)
T ss_pred HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHh
Confidence 89999999999999999999999999999865322211 1123468999999999998889999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
|+.||.... ..+......... ..... ..+..+.+++.+||..||++|+++
T Consensus 197 G~~pf~~~~---------~~~~~~~i~~~~-------~~~~~--------~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 197 GQPPFDGED---------EDELFQSIMEHN-------VSYPK--------SLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCCC---------HHHHHHHHHcCC-------CCCCC--------CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 999995421 111222221111 00111 122568899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=239.50 Aligned_cols=213 Identities=23% Similarity=0.296 Sum_probs=160.8
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNS 77 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~ 77 (241)
|.+..+......+.+.+|+++++++.|+|++++++++. ....++|+||+.+++|.+++..... .+..++.+++.|
T Consensus 29 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~ 107 (257)
T cd05060 29 KTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMG 107 (257)
T ss_pred EecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHH
Confidence 34433333335667899999999999999999999875 4567999999999999999976542 467899999999
Q ss_pred hchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCccee-ecccccCCCccCcccccccCCCcchhhHHH
Q 044022 78 LAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT-TDRVIGTRGYSAPEYISICVLNEKSNVFSF 156 (241)
Q Consensus 78 l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~ 156 (241)
++||| ..+++|+||||+||+++.++.++|+|||.+........... .....++..|+|||.+.+..++.++|||||
T Consensus 108 l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 184 (257)
T cd05060 108 MAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSY 184 (257)
T ss_pred HHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHH
Confidence 99999 89999999999999999999999999999876644332211 111223467999999988889999999999
Q ss_pred HHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 157 GAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 157 G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
|+++|++++ |..||..... .+...... ....... .. ..+..+.+++.+||..+|++
T Consensus 185 G~~l~~~~~~g~~p~~~~~~---------~~~~~~~~-~~~~~~~-----~~--------~~~~~l~~li~~cl~~~p~~ 241 (257)
T cd05060 185 GVTLWEAFSYGAKPYGEMKG---------AEVIAMLE-SGERLPR-----PE--------ECPQEIYSIMLSCWKYRPED 241 (257)
T ss_pred HHHHHHHHcCCCCCcccCCH---------HHHHHHHH-cCCcCCC-----CC--------CCCHHHHHHHHHHhcCChhh
Confidence 999999998 9999854211 11111111 1111111 11 22357889999999999999
Q ss_pred CCCCCC
Q 044022 236 RPTMVD 241 (241)
Q Consensus 236 Rpt~~e 241 (241)
|||+.|
T Consensus 242 Rp~~~~ 247 (257)
T cd05060 242 RPTFSE 247 (257)
T ss_pred CcCHHH
Confidence 999853
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=248.63 Aligned_cols=210 Identities=20% Similarity=0.304 Sum_probs=165.8
Q ss_pred ccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHHhch
Q 044022 7 EYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNSLAY 80 (241)
Q Consensus 7 ~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~l~~ 80 (241)
..+.+..+.|.+|+.+|.+| .|.+|+.+++|-..++.+|||||+=+ .+|...|+.... ....++.|++.++.+
T Consensus 397 ~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~ 475 (677)
T KOG0596|consen 397 EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKT 475 (677)
T ss_pred hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHH
Confidence 34446788899999999999 58999999999999999999999875 699999876532 356789999999999
Q ss_pred hhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-----------CCCc
Q 044022 81 LHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-----------VLNE 149 (241)
Q Consensus 81 lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~ 149 (241)
.| ..||||.||||.|+|+- .|.+||+|||++..+..+.+.....+.+||+-||+||.+... ..+.
T Consensus 476 IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r 551 (677)
T KOG0596|consen 476 IH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISR 551 (677)
T ss_pred HH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecC
Confidence 99 99999999999999986 578999999999999988888888889999999999999643 2467
Q ss_pred chhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhc
Q 044022 150 KSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECV 229 (241)
Q Consensus 150 ~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 229 (241)
+|||||+|||+|+|+.|+.||.+.. .-+.+ +..+.++.-.-.++.... ...+.++|+.||
T Consensus 552 ~SDvWSLGCILYqMvYgktPf~~~~----------n~~aK-------l~aI~~P~~~Iefp~~~~---~~~li~~mK~CL 611 (677)
T KOG0596|consen 552 KSDVWSLGCILYQMVYGKTPFGQII----------NQIAK-------LHAITDPNHEIEFPDIPE---NDELIDVMKCCL 611 (677)
T ss_pred ccchhhhhhHHHHHHhcCCchHHHH----------HHHHH-------HHhhcCCCccccccCCCC---chHHHHHHHHHH
Confidence 8999999999999999999996611 11111 112222211101111100 023889999999
Q ss_pred cCCCCCCCCCCC
Q 044022 230 NNSPEDRPTMVD 241 (241)
Q Consensus 230 ~~~p~~Rpt~~e 241 (241)
.+||++|||+.|
T Consensus 612 ~rdPkkR~si~e 623 (677)
T KOG0596|consen 612 ARDPKKRWSIPE 623 (677)
T ss_pred hcCcccCCCcHH
Confidence 999999999864
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=247.84 Aligned_cols=158 Identities=18% Similarity=0.222 Sum_probs=130.5
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~~ 85 (241)
..+.+.+|+++++.++||||++++++|..++..++|+||+++|+|.+++.... .....++.|++.||+|||
T Consensus 42 ~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--- 118 (327)
T cd08227 42 MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH--- 118 (327)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 34567789999999999999999999999999999999999999999985431 246788999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcce-----eecccccCCCccCcccccc--cCCCcchhhHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI-----TTDRVIGTRGYSAPEYISI--CVLNEKSNVFSFGA 158 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~s~G~ 158 (241)
+.+++||||||+||+++.++.++++||+............ ......++..|+|||++.+ ..++.++||||||+
T Consensus 119 ~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~ 198 (327)
T cd08227 119 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 198 (327)
T ss_pred HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHH
Confidence 8999999999999999999999999998654332211100 0112345677999999976 35889999999999
Q ss_pred HHHHHHhcCccccc
Q 044022 159 FLFELLAGRIHIWD 172 (241)
Q Consensus 159 ~~~~~~~g~~p~~~ 172 (241)
++|++++|+.||..
T Consensus 199 il~el~~g~~pf~~ 212 (327)
T cd08227 199 TACELANGHVPFKD 212 (327)
T ss_pred HHHHHHHCCCCCCC
Confidence 99999999999965
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=255.41 Aligned_cols=203 Identities=15% Similarity=0.188 Sum_probs=156.6
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
....+.+|+++++.++||||+++++++...+..++||||+++|+|.+++..... ....++.|++.||.||| +.
T Consensus 44 ~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~ 120 (364)
T cd05599 44 QVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIH---KL 120 (364)
T ss_pred HHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 445678899999999999999999999999999999999999999999865422 46778999999999999 99
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc------------------------------------eeecccc
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH------------------------------------ITTDRVI 131 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~------------------------------------~~~~~~~ 131 (241)
+++||||||+|||++.++.++|+|||++......... ......+
T Consensus 121 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (364)
T cd05599 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTV 200 (364)
T ss_pred CeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccc
Confidence 9999999999999999999999999998654321100 0011246
Q ss_pred cCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCc
Q 044022 132 GTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPC 211 (241)
Q Consensus 132 ~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (241)
||+.|+|||++....++.++|||||||++|+|++|..||.... ..+..............+. ..
T Consensus 201 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~---------~~~~~~~i~~~~~~~~~~~-----~~-- 264 (364)
T cd05599 201 GTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDN---------PQETYRKIINWKETLQFPD-----EV-- 264 (364)
T ss_pred cCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCC---------HHHHHHHHHcCCCccCCCC-----CC--
Confidence 8999999999998889999999999999999999999996521 1111111111111011111 00
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 212 IEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 212 ~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
..++.+.+++.+|+. +|.+|++
T Consensus 265 ----~~s~~~~~li~~ll~-~p~~R~~ 286 (364)
T cd05599 265 ----PLSPEAKDLIKRLCC-EAERRLG 286 (364)
T ss_pred ----CCCHHHHHHHHHHcc-CHhhcCC
Confidence 123567899999996 9999998
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=255.57 Aligned_cols=206 Identities=19% Similarity=0.240 Sum_probs=160.5
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
.....+.+|++++..++|+||+++++++...+..++||||+++++|.+++..... ....++.|++.||.||| +
T Consensus 43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~ 119 (350)
T cd05573 43 NQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVH---K 119 (350)
T ss_pred cHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 4456788999999999999999999999999999999999999999999866522 46678999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCC---------------------------cceeecccccCCCccCc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE---------------------------THITTDRVIGTRGYSAP 139 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~aP 139 (241)
.+++||||||+||+++.++.++|+|||.+....... .........|++.|+||
T Consensus 120 ~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 199 (350)
T cd05573 120 LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAP 199 (350)
T ss_pred CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCH
Confidence 999999999999999999999999999987654332 00112335689999999
Q ss_pred ccccccCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHH
Q 044022 140 EYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLH 219 (241)
Q Consensus 140 E~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (241)
|++.+..++.++|||||||++|+|++|+.||.... ..+..............+.. . ..++
T Consensus 200 E~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~---------~~~~~~~i~~~~~~~~~p~~---~--------~~~~ 259 (350)
T cd05573 200 EVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT---------LQETYNKIINWKESLRFPPD---P--------PVSP 259 (350)
T ss_pred HHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC---------HHHHHHHHhccCCcccCCCC---C--------CCCH
Confidence 99999899999999999999999999999996521 11111111110000011100 0 1236
Q ss_pred HHHHHHHHhccCCCCCCCC-CC
Q 044022 220 ASAQLTLECVNNSPEDRPT-MV 240 (241)
Q Consensus 220 ~~~~l~~~cl~~~p~~Rpt-~~ 240 (241)
.+.+++.+||. ||.+||+ ++
T Consensus 260 ~~~~li~~ll~-dp~~R~~s~~ 280 (350)
T cd05573 260 EAIDLICRLLC-DPEDRLGSFE 280 (350)
T ss_pred HHHHHHHHHcc-ChhhcCCCHH
Confidence 78899999997 9999999 64
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=250.17 Aligned_cols=205 Identities=20% Similarity=0.163 Sum_probs=156.1
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+.+.+|+++++++ +|+||+++++++...+..++||||+++|+|.+++.... .....++.||+.||.||| +
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~ 123 (332)
T cd05614 47 TVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLH---K 123 (332)
T ss_pred HHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 345678899999999 58999999999999999999999999999999886542 245678889999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHHHh
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~~ 165 (241)
++++||||||+|||++.++.++|+|||++.......... .....|+..|+|||++.+. .++.++||||||+++|+|++
T Consensus 124 ~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt 202 (332)
T cd05614 124 LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLT 202 (332)
T ss_pred CCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhc
Confidence 999999999999999999999999999987543322111 1234689999999998765 47889999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
|+.||...... ............ . .+.+.. ..+..+.+++.+||+.||++||++.
T Consensus 203 g~~pf~~~~~~-----~~~~~~~~~~~~-~------~~~~~~--------~~~~~~~~li~~~l~~dp~~R~~~~ 257 (332)
T cd05614 203 GASPFTLEGER-----NTQSEVSRRILK-C------DPPFPS--------FIGPEAQDLLHKLLRKDPKKRLGAG 257 (332)
T ss_pred CCCCCCCCCCC-----CCHHHHHHHHhc-C------CCCCCC--------CCCHHHHHHHHHHcCCCHHHcCCCC
Confidence 99999542111 011111111111 0 111111 1225688999999999999999653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=240.43 Aligned_cols=212 Identities=21% Similarity=0.305 Sum_probs=165.6
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHh
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSL 78 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l 78 (241)
|.+...........+.+|+.+++++.|+||+++++.+...+..++||||+++++|.+++..... ....++.+++.|+
T Consensus 35 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l 114 (277)
T cd06640 35 KIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGL 114 (277)
T ss_pred EEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHH
Confidence 4443333334567889999999999999999999999999999999999999999999876543 4567889999999
Q ss_pred chhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHH
Q 044022 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGA 158 (241)
Q Consensus 79 ~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~ 158 (241)
.||| +.+++|+||+|+||+++.++.++++|||.+......... .....++..|+|||++.+..++.++|+||||+
T Consensus 115 ~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~ 189 (277)
T cd06640 115 DYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGI 189 (277)
T ss_pred HHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc--cccccCcccccCHhHhccCCCccHHHHHHHHH
Confidence 9999 899999999999999999999999999998766443221 12345778899999998888999999999999
Q ss_pred HHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 159 FLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 159 ~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
++|+|++|..||...... ...... ... ..+.+ ....+..+.+++.+||..+|++|||
T Consensus 190 il~el~tg~~p~~~~~~~---------~~~~~~-~~~-----~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~ 246 (277)
T cd06640 190 TAIELAKGEPPNSDMHPM---------RVLFLI-PKN-----NPPTL--------TGEFSKPFKEFIDACLNKDPSFRPT 246 (277)
T ss_pred HHHHHHHCCCCCCCcChH---------hHhhhh-hcC-----CCCCC--------chhhhHHHHHHHHHHcccCcccCcC
Confidence 999999999998642111 001000 000 00111 1234567889999999999999999
Q ss_pred CCC
Q 044022 239 MVD 241 (241)
Q Consensus 239 ~~e 241 (241)
++|
T Consensus 247 ~~~ 249 (277)
T cd06640 247 AKE 249 (277)
T ss_pred HHH
Confidence 864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=242.58 Aligned_cols=212 Identities=23% Similarity=0.306 Sum_probs=164.5
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHh
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSL 78 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l 78 (241)
|.+.........+.+.+|++++++++||||+++++++...+..++|+||+++++|.+++..... ....++.+++.|+
T Consensus 35 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l 114 (277)
T cd06642 35 KIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGL 114 (277)
T ss_pred EEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHH
Confidence 4444333334456789999999999999999999999999999999999999999998876533 4567899999999
Q ss_pred chhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHH
Q 044022 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGA 158 (241)
Q Consensus 79 ~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~ 158 (241)
.||| +.+++|+||+|+||+++.++.++++|||.+........ ......++..|+|||++.+..++.++|+||||+
T Consensus 115 ~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 189 (277)
T cd06642 115 DYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGI 189 (277)
T ss_pred HHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHH
Confidence 9999 89999999999999999999999999999876543221 112235778899999999888899999999999
Q ss_pred HHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 159 FLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 159 ~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
++|++++|+.|+...... ..... .... ..+.+.. ..+..+.+++.+||..+|++|||
T Consensus 190 il~el~tg~~p~~~~~~~---------~~~~~-~~~~-----~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rp~ 246 (277)
T cd06642 190 TAIELAKGEPPNSDLHPM---------RVLFL-IPKN-----SPPTLEG--------QYSKPFKEFVEACLNKDPRFRPT 246 (277)
T ss_pred HHHHHHhCCCCCcccchh---------hHHhh-hhcC-----CCCCCCc--------ccCHHHHHHHHHHccCCcccCcC
Confidence 999999999998542111 00000 0001 0111111 23356889999999999999999
Q ss_pred CCC
Q 044022 239 MVD 241 (241)
Q Consensus 239 ~~e 241 (241)
+.|
T Consensus 247 ~~~ 249 (277)
T cd06642 247 AKE 249 (277)
T ss_pred HHH
Confidence 854
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=240.95 Aligned_cols=204 Identities=22% Similarity=0.347 Sum_probs=156.9
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCc------ceEEEEecCCCCHHHhhcCC-------Cc---hHHHHHHHHH
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPI------PILVFQSVEYGTLRDCIFGA-------PL---PRLKIASDIV 75 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~~~-------~~---~~~~~~~~i~ 75 (241)
....+.+|++.++.++|+||+++++++..... .++++||+++++|..++... .. ....++.+++
T Consensus 44 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~ 123 (273)
T cd05035 44 EIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123 (273)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHH
Confidence 45678999999999999999999998876543 79999999999999887432 11 3567899999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHH
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFS 155 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 155 (241)
.||.||| +.+++|+||||+||+++.++.++|+|||.+.................+..|+|||++.+..++.++||||
T Consensus 124 ~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~S 200 (273)
T cd05035 124 LGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWA 200 (273)
T ss_pred HHHHHHH---hCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHH
Confidence 9999999 8999999999999999999999999999988665433222222233467899999998888999999999
Q ss_pred HHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 156 FGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 156 ~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
||+++|+|++ |..||..... .+...... .+.....+ . ..+..+.+++.+||+.||+
T Consensus 201 lG~il~el~~~g~~p~~~~~~---------~~~~~~~~-~~~~~~~~-----~--------~~~~~~~~li~~~l~~~p~ 257 (273)
T cd05035 201 FGVTMWEIATRGQTPYPGVEN---------HEIYDYLR-HGNRLKQP-----E--------DCLDELYDLMYSCWRADPK 257 (273)
T ss_pred HHHHHHHHHhCCCCCCCCCCH---------HHHHHHHH-cCCCCCCC-----c--------CCCHHHHHHHHHHcCCChh
Confidence 9999999999 8888854211 11222211 11111111 1 2235789999999999999
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
+|||+.|
T Consensus 258 ~Rp~~~e 264 (273)
T cd05035 258 DRPTFTK 264 (273)
T ss_pred hCcCHHH
Confidence 9999854
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=254.96 Aligned_cols=159 Identities=17% Similarity=0.220 Sum_probs=135.1
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
.....+.+|++++++++|+||+++++++...+..++||||+++|+|.+++..... ....++.|++.||.||| +
T Consensus 43 ~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH---~ 119 (381)
T cd05626 43 NQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH---K 119 (381)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 3456788999999999999999999999999999999999999999999865432 35567889999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCc-------------------------------------------
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET------------------------------------------- 123 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~------------------------------------------- 123 (241)
.+|+||||||+|||++.++.++|+|||++........
T Consensus 120 ~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (381)
T cd05626 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQ 199 (381)
T ss_pred CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccc
Confidence 9999999999999999999999999998753210000
Q ss_pred --ceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCccccc
Q 044022 124 --HITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 124 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
........||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 200 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~ 250 (381)
T cd05626 200 HQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLA 250 (381)
T ss_pred ccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcC
Confidence 0001234689999999999988899999999999999999999999965
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=247.79 Aligned_cols=199 Identities=20% Similarity=0.233 Sum_probs=154.1
Q ss_pred HHHHHHHHH-HHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 13 YGSCINNIT-YAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 13 ~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
...+.+|.. +++.++||||+++++++...+..++||||+++++|...+.... .....++.||+.||.||| +.
T Consensus 39 ~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH---~~ 115 (321)
T cd05603 39 QNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLH---SL 115 (321)
T ss_pred HHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 344556654 5788899999999999999999999999999999988876542 245678899999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcC
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
+++||||||+||+++.++.+||+|||++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|.
T Consensus 116 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 193 (321)
T cd05603 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGL 193 (321)
T ss_pred CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCC
Confidence 999999999999999999999999999865322211 123346899999999999888999999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
.||.... .......... .. .. +.. ..+..+.+++.+||+.||.+||++.
T Consensus 194 ~pf~~~~---------~~~~~~~i~~-~~-~~-----~~~--------~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 194 PPFYSRD---------VSQMYDNILH-KP-LQ-----LPG--------GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCC---------HHHHHHHHhc-CC-CC-----CCC--------CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 9996521 1111111111 10 00 111 1225688999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=247.91 Aligned_cols=199 Identities=21% Similarity=0.235 Sum_probs=154.5
Q ss_pred HHHHHHHH-HHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCCC
Q 044022 14 GSCINNIT-YAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 14 ~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
..+..|.. +++.++||||+++++++...+..++||||+++++|.+++..... ....++.||+.||.||| +.+
T Consensus 40 ~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~g 116 (325)
T cd05602 40 KHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH---SLN 116 (325)
T ss_pred HHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence 34445544 56778999999999999999999999999999999998865432 45668899999999999 999
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCc
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRI 168 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~ 168 (241)
++||||||+|||++.++.++|+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 117 iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 194 (325)
T cd05602 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 194 (325)
T ss_pred eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCC
Confidence 99999999999999999999999999865322211 1233468999999999998889999999999999999999999
Q ss_pred ccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 169 HIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 169 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
||.... ..+........ .. ...+. .+..+.+++.+||+.||.+||++.+
T Consensus 195 pf~~~~---------~~~~~~~i~~~-~~------~~~~~--------~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 195 PFYSRN---------TAEMYDNILNK-PL------QLKPN--------ITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred CCCCCC---------HHHHHHHHHhC-Cc------CCCCC--------CCHHHHHHHHHHcccCHHHCCCCCC
Confidence 996421 11111221111 00 01111 2256889999999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=238.00 Aligned_cols=197 Identities=25% Similarity=0.370 Sum_probs=151.7
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
.....|.+|+.++.+++||||+++++++......++|+||+++++|..++.... .....++.||+.|++|||
T Consensus 46 ~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--- 122 (262)
T cd05077 46 DISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE--- 122 (262)
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---
Confidence 344578889999999999999999999999889999999999999998876431 246789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCC-------eEEeeccCceecCCCCcceeecccccCCCccCccccc-ccCCCcchhhHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENV-------AKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS-ICVLNEKSNVFSFG 157 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~-------~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~s~G 157 (241)
+.+++||||||+|||++.++. ++++|||.+...... ....++..|+|||.+. +..++.++||||||
T Consensus 123 ~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 196 (262)
T cd05077 123 DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFG 196 (262)
T ss_pred hCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHH
Confidence 999999999999999987664 899999988654322 2235678899999886 45688999999999
Q ss_pred HHHHHHH-hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCC
Q 044022 158 AFLFELL-AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDR 236 (241)
Q Consensus 158 ~~~~~~~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 236 (241)
+++|+|+ +|..||..... .+.. .... .... .. . .....+.+++.+||+.||.+|
T Consensus 197 ~~l~el~~~~~~p~~~~~~---------~~~~-~~~~-~~~~-~~-----~--------~~~~~~~~li~~cl~~dp~~R 251 (262)
T cd05077 197 TTLWEICYNGEIPLKDKTL---------AEKE-RFYE-GQCM-LV-----T--------PSCKELADLMTHCMNYDPNQR 251 (262)
T ss_pred HHHHHHHhCCCCCCCCcch---------hHHH-HHHh-cCcc-CC-----C--------CChHHHHHHHHHHcCCChhhC
Confidence 9999997 58888754111 1111 1111 1000 00 0 112468899999999999999
Q ss_pred CCCCC
Q 044022 237 PTMVD 241 (241)
Q Consensus 237 pt~~e 241 (241)
||+.|
T Consensus 252 p~~~~ 256 (262)
T cd05077 252 PFFRA 256 (262)
T ss_pred cCHHH
Confidence 99853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=246.46 Aligned_cols=202 Identities=20% Similarity=0.284 Sum_probs=155.6
Q ss_pred ccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--------------------chHHH
Q 044022 11 HTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--------------------LPRLK 69 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------------~~~~~ 69 (241)
....++.+|+.++.++ +|+||+++++++...+..++|+||+++++|.+++.... ...+.
T Consensus 49 ~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 128 (303)
T cd05088 49 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128 (303)
T ss_pred HHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHH
Confidence 3456788999999999 89999999999999999999999999999999986421 13578
Q ss_pred HHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCc
Q 044022 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNE 149 (241)
Q Consensus 70 ~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 149 (241)
++.+++.|++||| +++++||||||+||+++.++.++|+|||++....... .......+..|+|||++.+..++.
T Consensus 129 ~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~ 202 (303)
T cd05088 129 FAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTT 202 (303)
T ss_pred HHHHHHHHHHHHH---hCCccccccchheEEecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcc
Confidence 8999999999999 9999999999999999999999999999885322111 111122356799999998888899
Q ss_pred chhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHh
Q 044022 150 KSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLEC 228 (241)
Q Consensus 150 ~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 228 (241)
++||||||+++|++++ |..||..... .+..... ........ .. ..+..+.+++.+|
T Consensus 203 ~~Di~slG~il~ellt~g~~p~~~~~~---------~~~~~~~-~~~~~~~~-----~~--------~~~~~~~~li~~~ 259 (303)
T cd05088 203 NSDVWSYGVLLWEIVSLGGTPYCGMTC---------AELYEKL-PQGYRLEK-----PL--------NCDDEVYDLMRQC 259 (303)
T ss_pred cccchhhhhHHHHHHhcCCCCcccCCh---------HHHHHHH-hcCCcCCC-----CC--------CCCHHHHHHHHHH
Confidence 9999999999999998 9999854211 1111111 11100000 00 1225688999999
Q ss_pred ccCCCCCCCCCCC
Q 044022 229 VNNSPEDRPTMVD 241 (241)
Q Consensus 229 l~~~p~~Rpt~~e 241 (241)
|+.+|++|||+++
T Consensus 260 l~~~p~~Rp~~~~ 272 (303)
T cd05088 260 WREKPYERPSFAQ 272 (303)
T ss_pred cCCChhhCcCHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=246.75 Aligned_cols=205 Identities=21% Similarity=0.328 Sum_probs=158.6
Q ss_pred ccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--------------------chHHH
Q 044022 11 HTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--------------------LPRLK 69 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------------~~~~~ 69 (241)
...+++.+|+++++++ +||||++++++|...+..++++||+++|+|.+++.... ..++.
T Consensus 59 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 138 (334)
T cd05100 59 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138 (334)
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHH
Confidence 3456889999999999 89999999999999999999999999999999986421 13467
Q ss_pred HHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCc
Q 044022 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNE 149 (241)
Q Consensus 70 ~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 149 (241)
++.|++.||.||| +.+++|+||||+||+++.++.++|+|||.++...............++..|+|||++.+..++.
T Consensus 139 ~~~qi~~al~~LH---~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 215 (334)
T cd05100 139 CAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 215 (334)
T ss_pred HHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCc
Confidence 8999999999999 9999999999999999999999999999987654432222122223456799999999888999
Q ss_pred chhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHh
Q 044022 150 KSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLEC 228 (241)
Q Consensus 150 ~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 228 (241)
++||||||+++|+|++ |..||.... ..+...... .......+ . ..+..+.+++.+|
T Consensus 216 ~~Di~slG~il~el~~~g~~p~~~~~---------~~~~~~~~~-~~~~~~~~-----~--------~~~~~l~~li~~c 272 (334)
T cd05100 216 QSDVWSFGVLLWEIFTLGGSPYPGIP---------VEELFKLLK-EGHRMDKP-----A--------NCTHELYMIMREC 272 (334)
T ss_pred hhhhHHHHHHHHHHHhcCCCCCCCCC---------HHHHHHHHH-cCCCCCCC-----C--------CCCHHHHHHHHHH
Confidence 9999999999999998 888885421 112222211 11111111 1 1225688999999
Q ss_pred ccCCCCCCCCCCC
Q 044022 229 VNNSPEDRPTMVD 241 (241)
Q Consensus 229 l~~~p~~Rpt~~e 241 (241)
|+.+|++|||+.|
T Consensus 273 l~~~p~~Rps~~e 285 (334)
T cd05100 273 WHAVPSQRPTFKQ 285 (334)
T ss_pred cccChhhCcCHHH
Confidence 9999999999854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=236.90 Aligned_cols=205 Identities=24% Similarity=0.358 Sum_probs=158.3
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~~~l~~lh~~~ 85 (241)
.....+.+|++++++++|+||+++++++......++|+||+++++|.+++.... . ..+.++.+++.|+.|||
T Consensus 34 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH--- 110 (251)
T cd05041 34 DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE--- 110 (251)
T ss_pred HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 355679999999999999999999999999999999999999999999985432 1 45778899999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+.+++|+||+|+||+++.++.++|+|||.+.................+..|+|||.+.+..++.++|+||||+++|++++
T Consensus 111 ~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t 190 (251)
T cd05041 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFS 190 (251)
T ss_pred hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHh
Confidence 99999999999999999999999999999875543222111122233566999999988889999999999999999999
Q ss_pred -cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 -GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|..||..... ....... .... ....+ ...+..+.+++.+||..+|.+|||++|
T Consensus 191 ~~~~p~~~~~~---------~~~~~~~-~~~~--~~~~~-----------~~~~~~~~~li~~~l~~~p~~Rp~~~e 244 (251)
T cd05041 191 LGDTPYPGMSN---------QQTRERI-ESGY--RMPAP-----------QLCPEEIYRLMLQCWAYDPENRPSFSE 244 (251)
T ss_pred ccCCCCccCCH---------HHHHHHH-hcCC--CCCCC-----------ccCCHHHHHHHHHHhccChhhCcCHHH
Confidence 8888854211 1111111 1110 00000 122357899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=253.67 Aligned_cols=154 Identities=22% Similarity=0.285 Sum_probs=134.1
Q ss_pred HHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCCCce
Q 044022 15 SCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPRPIV 90 (241)
Q Consensus 15 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~~iv 90 (241)
.+.+|++++++++||||+++++++......|++||++. ++|.+++..... .+..++.|++.||.||| +++|+
T Consensus 132 ~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH---~~giv 207 (392)
T PHA03207 132 TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH---GRGII 207 (392)
T ss_pred cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence 45689999999999999999999999999999999996 688888854322 46789999999999999 89999
Q ss_pred eccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCccc
Q 044022 91 LRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHI 170 (241)
Q Consensus 91 h~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~ 170 (241)
||||||+|||++.++.++|+|||++................||..|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 208 HrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf 287 (392)
T PHA03207 208 HRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287 (392)
T ss_pred ccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999999999987655443322223456899999999999888999999999999999999999999
Q ss_pred cc
Q 044022 171 WD 172 (241)
Q Consensus 171 ~~ 172 (241)
..
T Consensus 288 ~~ 289 (392)
T PHA03207 288 FG 289 (392)
T ss_pred CC
Confidence 65
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=237.18 Aligned_cols=203 Identities=22% Similarity=0.354 Sum_probs=158.4
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC---c---hHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---L---PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~---~~~~~~~~i~~~l~~lh~~~ 85 (241)
..+++.+|++++++++|+||+++++++...+..++++||+++++|.+++.... . ....++.+++.|+.+||
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--- 120 (261)
T cd05068 44 DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE--- 120 (261)
T ss_pred cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 45678999999999999999999999999999999999999999999986543 1 46788999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+.+++|+||||+||+++.++.++|+|||.+........... .....+..|+|||++.+..++.++|+||||+++|++++
T Consensus 121 ~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t 199 (261)
T cd05068 121 AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR-EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199 (261)
T ss_pred hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc-CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHh
Confidence 89999999999999999999999999999887653221111 11123457999999998889999999999999999999
Q ss_pred -cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 -GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|+.||.... ...... .......... .. ..+..+.+++.+||+.+|++|||+++
T Consensus 200 ~g~~p~~~~~---------~~~~~~-~~~~~~~~~~-----~~--------~~~~~~~~li~~~l~~~P~~Rp~~~~ 253 (261)
T cd05068 200 YGRMPYPGMT---------NAEVLQ-QVDQGYRMPC-----PP--------GCPKELYDIMLDCWKEDPDDRPTFET 253 (261)
T ss_pred cCCCCCCCCC---------HHHHHH-HHHcCCCCCC-----CC--------cCCHHHHHHHHHHhhcCcccCCCHHH
Confidence 999985421 111111 1111110000 01 12367899999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=238.97 Aligned_cols=205 Identities=21% Similarity=0.265 Sum_probs=158.6
Q ss_pred ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhc
Q 044022 9 HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 9 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~ 83 (241)
......++.+|+.++++++||||+++++++.. ...++|+||+++|+|.+++.... ...+.++.+++.|++|||
T Consensus 49 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH- 126 (279)
T cd05057 49 SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE- 126 (279)
T ss_pred CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 33445778899999999999999999999987 77899999999999999986642 146788999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+.+++|+||+|+||+++.++.++|+|||.+................++..|+|||.+....++.++|+||||+++|++
T Consensus 127 --~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el 204 (279)
T cd05057 127 --EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWEL 204 (279)
T ss_pred --hCCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHH
Confidence 899999999999999999999999999998766543322221222235679999999888889999999999999999
Q ss_pred Hh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 164 LA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 164 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
++ |+.||... ...+...... .+... ..+ . .++..+.+++.+||..||+.|||+.
T Consensus 205 ~~~g~~p~~~~---------~~~~~~~~~~-~~~~~--~~~---~--------~~~~~~~~~~~~~l~~~p~~Rp~~~ 259 (279)
T cd05057 205 MTFGAKPYEGI---------PAVEIPDLLE-KGERL--PQP---P--------ICTIDVYMVLVKCWMIDAESRPTFK 259 (279)
T ss_pred hcCCCCCCCCC---------CHHHHHHHHh-CCCCC--CCC---C--------CCCHHHHHHHHHHcCCChhhCCCHH
Confidence 98 99998542 1112221111 11111 111 1 1224688999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=237.72 Aligned_cols=205 Identities=24% Similarity=0.347 Sum_probs=159.0
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.+.+|++++++++|+|++++.+++...+..++||||+++++|.+++.... .....++.+++.|+.|||
T Consensus 48 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--- 124 (268)
T cd05063 48 KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS--- 124 (268)
T ss_pred HHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 345678999999999999999999999999999999999999999999986532 146788999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCccee-ecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT-TDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
+.+++|+||||+||+++.++.++++|||.+........... ......+..|+|||++....++.++|+||||+++|+++
T Consensus 125 ~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell 204 (268)
T cd05063 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 204 (268)
T ss_pred HCCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHH
Confidence 89999999999999999999999999999876543322111 11122345699999998888899999999999999999
Q ss_pred h-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 A-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+ |+.||.... ..+...... ... ..+. .. ..+..+.+++.+||..+|++||++.+
T Consensus 205 ~~g~~p~~~~~---------~~~~~~~i~-~~~--~~~~---~~--------~~~~~~~~li~~c~~~~p~~Rp~~~~ 259 (268)
T cd05063 205 SFGERPYWDMS---------NHEVMKAIN-DGF--RLPA---PM--------DCPSAVYQLMLQCWQQDRARRPRFVD 259 (268)
T ss_pred hCCCCCCCcCC---------HHHHHHHHh-cCC--CCCC---CC--------CCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 7 999985421 112222221 111 0010 01 12357889999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=239.50 Aligned_cols=224 Identities=20% Similarity=0.227 Sum_probs=163.3
Q ss_pred ccccccHHHHHHHHHHHHhcCCCcccceeeeeee-----CCcceEEEEecCCCCHHHhhcCCC-c---hHHHHHHHHHHH
Q 044022 7 EYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQ-----TPIPILVFQSVEYGTLRDCIFGAP-L---PRLKIASDIVNS 77 (241)
Q Consensus 7 ~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~-~---~~~~~~~~i~~~ 77 (241)
..+....++-++|+++|+.++|+||+.+.+.+.. -+..|+|+|+|+ .+|.+.++... . ....++.|++.|
T Consensus 59 F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrg 137 (359)
T KOG0660|consen 59 FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRG 137 (359)
T ss_pred hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHh
Confidence 3344567888999999999999999999999875 236899999995 79999998775 2 356678899999
Q ss_pred hchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHH
Q 044022 78 LAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSF 156 (241)
Q Consensus 78 l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~ 156 (241)
|+|+| +.+++||||||.|++++.+..+||+|||+++..........-+..+.|..|+|||.+... .|+...||||.
T Consensus 138 LKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSv 214 (359)
T KOG0660|consen 138 LKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSV 214 (359)
T ss_pred cchhh---cccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhh
Confidence 99999 999999999999999999999999999999987543212222446778899999988654 78999999999
Q ss_pred HHHHHHHHhcCccccccc--------------ccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHH
Q 044022 157 GAFLFELLAGRIHIWDLL--------------KDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASA 222 (241)
Q Consensus 157 G~~~~~~~~g~~p~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (241)
|||+.||++|++-|.... .+.........+.++.+.... ...+...+...++ ..++...
T Consensus 215 GCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~sl--p~~p~~~f~~~fp-----~a~p~Ai 287 (359)
T KOG0660|consen 215 GCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSL--PQIPKQPFSSIFP-----NANPLAI 287 (359)
T ss_pred hHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhC--CCCCCCCHHHHcC-----CCCHHHH
Confidence 999999999998874310 000000001111112221111 1111111111122 3336788
Q ss_pred HHHHHhccCCCCCCCCCCC
Q 044022 223 QLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 223 ~l~~~cl~~~p~~Rpt~~e 241 (241)
+|+.+||..||.+|+|++|
T Consensus 288 dLlekmL~fdP~kRita~e 306 (359)
T KOG0660|consen 288 DLLEKMLVFDPKKRITAEE 306 (359)
T ss_pred HHHHHHhccCccccCCHHH
Confidence 9999999999999999875
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=238.26 Aligned_cols=205 Identities=23% Similarity=0.351 Sum_probs=155.2
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeC------CcceEEEEecCCCCHHHhhcCC-----C-----chHHHHHHHH
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQT------PIPILVFQSVEYGTLRDCIFGA-----P-----LPRLKIASDI 74 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~-----~-----~~~~~~~~~i 74 (241)
...+.+.+|+++++.++|+||+++++++... ...++++||+++|+|.+++... . .....++.++
T Consensus 42 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i 121 (272)
T cd05075 42 SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121 (272)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHH
Confidence 3466788999999999999999999987532 2568999999999999886321 1 1356789999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhH
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
+.||+||| +++++||||||+||+++.++.++|+|||.+................++..|+|||+..+..++.++|||
T Consensus 122 ~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~ 198 (272)
T cd05075 122 ASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVW 198 (272)
T ss_pred HHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHH
Confidence 99999999 899999999999999999999999999998866443322222233456789999999988899999999
Q ss_pred HHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 155 SFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 155 s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
|||+++|++++ |+.||..... .+.... ...+.... ... ..+..+.+++.+||+.||
T Consensus 199 slG~il~el~~~g~~p~~~~~~---------~~~~~~-~~~~~~~~-----~~~--------~~~~~~~~li~~~l~~~p 255 (272)
T cd05075 199 SFGVTMWEIATRGQTPYPGVEN---------SEIYDY-LRQGNRLK-----QPP--------DCLDGLYSLMSSCWLLNP 255 (272)
T ss_pred HHHHHHHHHHcCCCCCCCCCCH---------HHHHHH-HHcCCCCC-----CCC--------CCCHHHHHHHHHHcCCCc
Confidence 99999999999 7888854111 111111 11111100 011 122568899999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|||++|
T Consensus 256 ~~Rps~~~ 263 (272)
T cd05075 256 KDRPSFET 263 (272)
T ss_pred ccCcCHHH
Confidence 99999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=237.65 Aligned_cols=204 Identities=22% Similarity=0.330 Sum_probs=158.8
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+.|.+|+.++++++||||+++++++..++..++||||+++++|.+++..... ..+.++.+++.|+++|| +
T Consensus 48 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~ 124 (267)
T cd05066 48 QRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---D 124 (267)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 456789999999999999999999999999999999999999999999865421 46788999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceee-cccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITT-DRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
.+++|+||||+||+++.++.++++|||.+............ ....++..|+|||++.+..++.++|+||||+++|++++
T Consensus 125 ~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~ 204 (267)
T cd05066 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204 (267)
T ss_pred CCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhc
Confidence 99999999999999999999999999998766543221111 11223457999999998889999999999999999886
Q ss_pred -cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 -GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|..||..... .+...... ... ..+. .. ..+..+.+++.+||+.+|.+|||+.+
T Consensus 205 ~g~~p~~~~~~---------~~~~~~~~-~~~--~~~~---~~--------~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (267)
T cd05066 205 YGERPYWEMSN---------QDVIKAIE-EGY--RLPA---PM--------DCPAALHQLMLDCWQKDRNERPKFEQ 258 (267)
T ss_pred CCCCCcccCCH---------HHHHHHHh-CCC--cCCC---CC--------CCCHHHHHHHHHHcccCchhCCCHHH
Confidence 9999865211 11111111 110 0110 01 12357889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=263.24 Aligned_cols=205 Identities=20% Similarity=0.256 Sum_probs=157.9
Q ss_pred ccccHHHHHHHHHHHHhcC-CCcccceeeeee-eC------CcceEEEEecCCCCHHHhhcCC------CchHHHHHHHH
Q 044022 9 HRHTYGSCINNITYAAQMS-HNHILKRIGCCL-QT------PIPILVFQSVEYGTLRDCIFGA------PLPRLKIASDI 74 (241)
Q Consensus 9 ~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~------~~~~lv~e~~~~~sL~~~l~~~------~~~~~~~~~~i 74 (241)
+++..+...+||++|++|+ |+|||.+++... .. -.+++.||||+||+|-+++... +..+++|+.++
T Consensus 74 de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv 153 (738)
T KOG1989|consen 74 DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDV 153 (738)
T ss_pred CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHH
Confidence 4456777889999999996 999999999432 21 2568999999999999998643 33689999999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCC-cce------eecccccCCCccCccccc---c
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE-THI------TTDRVIGTRGYSAPEYIS---I 144 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~------~~~~~~~~~~~~aPE~~~---~ 144 (241)
++|+++||.+ +-+|+|||||.+|||++.++..||||||.+....... ... ..-...-|+.|+|||.+. +
T Consensus 154 ~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg 232 (738)
T KOG1989|consen 154 CEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSG 232 (738)
T ss_pred HHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcC
Confidence 9999999954 5669999999999999999999999999875332211 100 011234689999999874 5
Q ss_pred cCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHH
Q 044022 145 CVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQL 224 (241)
Q Consensus 145 ~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 224 (241)
..++.|+|||||||++|.++....||..... ...+...+..+....++..+.+|
T Consensus 233 ~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--------------------------laIlng~Y~~P~~p~ys~~l~~L 286 (738)
T KOG1989|consen 233 LPIGEKSDIWALGCLLYKLCYFTTPFEESGK--------------------------LAILNGNYSFPPFPNYSDRLKDL 286 (738)
T ss_pred CCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--------------------------eeEEeccccCCCCccHHHHHHHH
Confidence 5789999999999999999999999965100 11112222222223677899999
Q ss_pred HHHhccCCCCCCCCCC
Q 044022 225 TLECVNNSPEDRPTMV 240 (241)
Q Consensus 225 ~~~cl~~~p~~Rpt~~ 240 (241)
|+.||+.||.+||++-
T Consensus 287 I~~mL~~nP~~RPnI~ 302 (738)
T KOG1989|consen 287 IRTMLQPNPDERPNIY 302 (738)
T ss_pred HHHHhccCcccCCCHH
Confidence 9999999999999873
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=240.52 Aligned_cols=213 Identities=23% Similarity=0.289 Sum_probs=165.9
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHh
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSL 78 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l 78 (241)
|.+..+........+.+|++++++++|+|++++++++..+...++|+||+++++|.+++..... ....++.+++.|+
T Consensus 32 k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l 111 (274)
T cd06609 32 KVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGL 111 (274)
T ss_pred EEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHH
Confidence 4444333334556788999999999999999999999999999999999999999999887532 4678899999999
Q ss_pred chhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHH
Q 044022 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGA 158 (241)
Q Consensus 79 ~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~ 158 (241)
.||| +.+++|+||+|+||+++.++.++++|||.+........ ......++..|+|||++.+..++.++|+||||+
T Consensus 112 ~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~ 186 (274)
T cd06609 112 EYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGI 186 (274)
T ss_pred HHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHH
Confidence 9999 89999999999999999999999999999877654321 112345778899999999888999999999999
Q ss_pred HHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 159 FLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 159 ~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
++|++++|+.||..... ........ .. ..+.+... ..+..+.+++.+||..+|++|||
T Consensus 187 il~~l~tg~~p~~~~~~---------~~~~~~~~-~~-----~~~~~~~~-------~~~~~~~~~l~~~l~~~p~~Rpt 244 (274)
T cd06609 187 TAIELAKGEPPLSDLHP---------MRVLFLIP-KN-----NPPSLEGN-------KFSKPFKDFVSLCLNKDPKERPS 244 (274)
T ss_pred HHHHHHhCCCCcccCch---------HHHHHHhh-hc-----CCCCCccc-------ccCHHHHHHHHHHhhCChhhCcC
Confidence 99999999999954210 01111111 11 01111111 13357889999999999999999
Q ss_pred CCC
Q 044022 239 MVD 241 (241)
Q Consensus 239 ~~e 241 (241)
+++
T Consensus 245 ~~~ 247 (274)
T cd06609 245 AKE 247 (274)
T ss_pred HHH
Confidence 854
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=252.86 Aligned_cols=157 Identities=18% Similarity=0.279 Sum_probs=135.9
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
....+.+|+.+++.++||||+++++++..+...++||||+++|+|.+++..... ....++.+|+.||.||| +++
T Consensus 86 ~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH---~~~ 162 (370)
T cd05621 86 DSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIH---SMG 162 (370)
T ss_pred hHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence 345678999999999999999999999999999999999999999999876533 45678899999999999 999
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc----CCCcchhhHHHHHHHHHHH
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC----VLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~Di~s~G~~~~~~~ 164 (241)
|+||||||+|||++.++.+||+|||++........ .......||+.|+|||++.+. .++.++|+||+|+++|+|+
T Consensus 163 IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell 241 (370)
T cd05621 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241 (370)
T ss_pred eEecCCCHHHEEECCCCCEEEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHH
Confidence 99999999999999999999999999976543221 122345789999999998754 3778999999999999999
Q ss_pred hcCccccc
Q 044022 165 AGRIHIWD 172 (241)
Q Consensus 165 ~g~~p~~~ 172 (241)
+|+.||..
T Consensus 242 ~G~~Pf~~ 249 (370)
T cd05621 242 VGDTPFYA 249 (370)
T ss_pred hCCCCCCC
Confidence 99999964
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=238.79 Aligned_cols=214 Identities=21% Similarity=0.338 Sum_probs=161.6
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~ 76 (241)
|....+........|.+|+.++++++||||+++.+++..++..++|+||+++++|.+++.... .....++.+++.
T Consensus 38 K~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~ 117 (269)
T cd05065 38 KTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAA 117 (269)
T ss_pred EEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHH
Confidence 444443344456789999999999999999999999999999999999999999999986532 146788999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccc---cCCCccCcccccccCCCcchhh
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVI---GTRGYSAPEYISICVLNEKSNV 153 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~---~~~~~~aPE~~~~~~~~~~~Di 153 (241)
|++||| +.+++|+||+|+||+++.++.++++|||.+................ .+..|+|||++.+..++.++||
T Consensus 118 al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv 194 (269)
T cd05065 118 GMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDV 194 (269)
T ss_pred HHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhh
Confidence 999999 8999999999999999999999999999886554322111111111 1346999999998889999999
Q ss_pred HHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCC
Q 044022 154 FSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNS 232 (241)
Q Consensus 154 ~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~ 232 (241)
||||+++||+++ |..||..... .+...... .. ...+. .. ..+..+.+++.+||..+
T Consensus 195 wslG~~l~e~l~~g~~p~~~~~~---------~~~~~~i~-~~--~~~~~---~~--------~~~~~~~~li~~~l~~~ 251 (269)
T cd05065 195 WSYGIVMWEVMSYGERPYWDMSN---------QDVINAIE-QD--YRLPP---PM--------DCPTALHQLMLDCWQKD 251 (269)
T ss_pred hhhHHHHHHHhcCCCCCCCCCCH---------HHHHHHHH-cC--CcCCC---cc--------cCCHHHHHHHHHHcCCC
Confidence 999999999886 9999865211 11111111 11 01111 11 22356889999999999
Q ss_pred CCCCCCCCC
Q 044022 233 PEDRPTMVD 241 (241)
Q Consensus 233 p~~Rpt~~e 241 (241)
|++|||+++
T Consensus 252 p~~Rp~~~~ 260 (269)
T cd05065 252 RNARPKFGQ 260 (269)
T ss_pred hhhCcCHHH
Confidence 999999853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=247.46 Aligned_cols=205 Identities=16% Similarity=0.196 Sum_probs=159.8
Q ss_pred cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCC
Q 044022 10 RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 10 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~ 85 (241)
+........|=.+|....+|+||+++-.|++...+|+||||++||++.++|..... ....++.+++.|+..+|
T Consensus 182 ~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH--- 258 (550)
T KOG0605|consen 182 KNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIH--- 258 (550)
T ss_pred hhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHH---
Confidence 35567788899999999999999999999999999999999999999999876533 45678889999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCC---------------------CCcce-----e-------------
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPE---------------------GETHI-----T------------- 126 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~---------------------~~~~~-----~------------- 126 (241)
+.|++||||||+|+|||..|++||+|||++..... ..... .
T Consensus 259 ~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~ 338 (550)
T KOG0605|consen 259 QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWK 338 (550)
T ss_pred HcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHH
Confidence 99999999999999999999999999999853311 00000 0
Q ss_pred ------ecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCC
Q 044022 127 ------TDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGI 200 (241)
Q Consensus 127 ------~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (241)
..+.+|||-|+|||++.+..|+..+|.||+|||+|||+.|.+||+... ..+.-+....-......
T Consensus 339 ~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~t---------p~~T~rkI~nwr~~l~f 409 (550)
T KOG0605|consen 339 RNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSET---------PQETYRKIVNWRETLKF 409 (550)
T ss_pred hhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCC---------HHHHHHHHHHHhhhccC
Confidence 113679999999999999999999999999999999999999997621 12222222211111122
Q ss_pred CCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 201 PAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
+... ..+....+||.+|+. ||++|..
T Consensus 410 P~~~-----------~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 410 PEEV-----------DLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred CCcC-----------cccHHHHHHHHHHhc-CHHHhcC
Confidence 2111 222567899999999 9999975
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=259.71 Aligned_cols=205 Identities=19% Similarity=0.225 Sum_probs=158.6
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCC--------cceEEEEecCCCCHHHhhcCCC-----c---hHHHHHHHH
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTP--------IPILVFQSVEYGTLRDCIFGAP-----L---PRLKIASDI 74 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~e~~~~~sL~~~l~~~~-----~---~~~~~~~~i 74 (241)
.....+.+|+.++..++|+|++++++.+.... ..++||||+++|+|.+++.... . ....++.|+
T Consensus 73 ~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~ql 152 (496)
T PTZ00283 73 ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV 152 (496)
T ss_pred HHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHH
Confidence 44567889999999999999999988775432 3679999999999999885421 1 356789999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhH
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
+.||.||| +.+++||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||
T Consensus 153 l~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVw 229 (496)
T PTZ00283 153 LLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMF 229 (496)
T ss_pred HHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHH
Confidence 99999999 899999999999999999999999999998765433222222345689999999999988999999999
Q ss_pred HHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 155 SFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 155 s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
|||+++|+|++|+.||... ...+...... .+.... +.. ..++.+.+++.+||+.||+
T Consensus 230 SlGvilyeLltG~~Pf~~~---------~~~~~~~~~~-~~~~~~-----~~~--------~~~~~l~~li~~~L~~dP~ 286 (496)
T PTZ00283 230 SLGVLLYELLTLKRPFDGE---------NMEEVMHKTL-AGRYDP-----LPP--------SISPEMQEIVTALLSSDPK 286 (496)
T ss_pred HHHHHHHHHHHCCCCCCCC---------CHHHHHHHHh-cCCCCC-----CCC--------CCCHHHHHHHHHHcccChh
Confidence 9999999999999999541 1112222211 111111 111 1235788999999999999
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
+|||+.+
T Consensus 287 ~RPs~~e 293 (496)
T PTZ00283 287 RRPSSSK 293 (496)
T ss_pred hCcCHHH
Confidence 9999753
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=227.12 Aligned_cols=200 Identities=19% Similarity=0.273 Sum_probs=166.0
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC------CchHHHHHHHHHHHhchhhcC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA------PLPRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~------~~~~~~~~~~i~~~l~~lh~~ 84 (241)
....++.+|++|...|+||||.+++++|.++...|+++||...|+|...|+.. +.....++.|++.|+.|+|
T Consensus 64 ~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h-- 141 (281)
T KOG0580|consen 64 QVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH-- 141 (281)
T ss_pred cchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc--
Confidence 56788999999999999999999999999999999999999999999999843 2356789999999999999
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
.++++||||||+|+|++..+..|++|||-++..+... ..+.+||.-|++||...+...+..+|+|++|++.||++
T Consensus 142 -~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yefl 216 (281)
T KOG0580|consen 142 -LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNK----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFL 216 (281)
T ss_pred -cCCcccCCCCHHHhccCCCCCeeccCCCceeecCCCC----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHH
Confidence 9999999999999999999999999999987665332 34568999999999999999999999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.|.+||.+.. ..+..+...+-. ...+ . ..+....++|.+|+.++|.+|.+..|
T Consensus 217 vg~ppFes~~---------~~etYkrI~k~~----~~~p---~--------~is~~a~dlI~~ll~~~p~~r~~l~~ 269 (281)
T KOG0580|consen 217 VGLPPFESQS---------HSETYKRIRKVD----LKFP---S--------TISGGAADLISRLLVKNPIERLALTE 269 (281)
T ss_pred hcCCchhhhh---------hHHHHHHHHHcc----ccCC---c--------ccChhHHHHHHHHhccCccccccHHH
Confidence 9999996521 222222222111 1111 1 22256789999999999999988653
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=246.16 Aligned_cols=204 Identities=18% Similarity=0.264 Sum_probs=160.0
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
..+.+.+|+.++++++|+|++++++.+..+...++|+||+++++|.+++..... ....++.+++.||.||| +.+
T Consensus 60 ~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH---~~g 136 (296)
T cd06654 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQ 136 (296)
T ss_pred hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence 456788999999999999999999999999999999999999999999875432 56788999999999999 899
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCc
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRI 168 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~ 168 (241)
++|+||||+||+++.++.++|+|||.+......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.
T Consensus 137 i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~ 214 (296)
T cd06654 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214 (296)
T ss_pred cccCCCCHHHEEEcCCCCEEECccccchhccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999988754332211 122357889999999988888999999999999999999999
Q ss_pred ccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 169 HIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 169 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
||..... ............ ..... . ...+..+.+++.+||..+|++|||++|
T Consensus 215 pf~~~~~---------~~~~~~~~~~~~-~~~~~---~--------~~~~~~l~~li~~~l~~~p~~Rpt~~e 266 (296)
T cd06654 215 PYLNENP---------LRALYLIATNGT-PELQN---P--------EKLSAIFRDFLNRCLDMDVEKRGSAKE 266 (296)
T ss_pred CCCCCCH---------HHhHHHHhcCCC-CCCCC---c--------cccCHHHHHHHHHHCcCCcccCcCHHH
Confidence 9954211 011111111110 00000 0 123356889999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=242.93 Aligned_cols=200 Identities=21% Similarity=0.295 Sum_probs=156.0
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC---Cc---hHHHHHHHHHHHhchhhcCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA---PL---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+|+++++.++||||+++++++..++..++||||+++|+|.+++... .. ....++.|++.|+.||| +
T Consensus 44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~ 120 (285)
T cd05605 44 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---R 120 (285)
T ss_pred HHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 456788999999999999999999999999999999999999999887432 11 35678999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++|+||||+||+++.++.++|+|||.+......... ....|+..|+|||++.+..++.++||||+|+++|++++|
T Consensus 121 ~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g 197 (285)
T cd05605 121 ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI---RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEG 197 (285)
T ss_pred CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc---ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHC
Confidence 99999999999999999999999999998765433221 234688999999999988899999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
..||...... ...+.......... .... ...+..+.+++.+||..||++||+
T Consensus 198 ~~pf~~~~~~------~~~~~~~~~~~~~~------~~~~--------~~~~~~~~~li~~~l~~~P~~R~~ 249 (285)
T cd05605 198 KSPFRQRKEK------VKREEVERRVKEDQ------EEYS--------EKFSEAARSICRQLLTKDPGFRLG 249 (285)
T ss_pred CCCCCCCchh------hHHHHHHHHhhhcc------cccC--------cccCHHHHHHHHHHccCCHHHhcC
Confidence 9999642111 00011111111100 0001 123357889999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=246.49 Aligned_cols=165 Identities=21% Similarity=0.256 Sum_probs=134.8
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~ 76 (241)
|.+...........+.+|++++++++||||+++++++..++..++||||++ ++|.+++.... .....++.|++.
T Consensus 37 K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~ 115 (309)
T cd07872 37 KEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILR 115 (309)
T ss_pred EEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 444333333345568899999999999999999999999999999999997 58888775432 135678899999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFS 155 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s 155 (241)
||.||| +.+++||||||+||+++.++.++|+|||.+......... .....++..|+|||.+.+ ..++.++||||
T Consensus 116 aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Diws 190 (309)
T cd07872 116 GLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWG 190 (309)
T ss_pred HHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHH
Confidence 999999 999999999999999999999999999998754332211 122357889999998865 45789999999
Q ss_pred HHHHHHHHHhcCccccc
Q 044022 156 FGAFLFELLAGRIHIWD 172 (241)
Q Consensus 156 ~G~~~~~~~~g~~p~~~ 172 (241)
||+++|+|++|+.||..
T Consensus 191 lG~il~el~tg~~pf~~ 207 (309)
T cd07872 191 VGCIFFEMASGRPLFPG 207 (309)
T ss_pred HHHHHHHHHhCCCCCCC
Confidence 99999999999999954
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=235.99 Aligned_cols=203 Identities=20% Similarity=0.333 Sum_probs=157.5
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+.|.+|++++++++|+||+++++++...+..++|+||+++++|.+++.... .....++.+++.|++||| +
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~ 118 (256)
T cd05059 42 SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---S 118 (256)
T ss_pred CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 34578899999999999999999999999999999999999999999986532 145789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh-
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA- 165 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~- 165 (241)
.+++|+||||+||+++.++.++|+|||.+........... ....++..|+|||.+.+..++.++|+||||+++|++++
T Consensus 119 ~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~ 197 (256)
T cd05059 119 NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197 (256)
T ss_pred CCcccccccHhhEEECCCCcEEECCcccceeccccccccc-CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhcc
Confidence 9999999999999999999999999999876543221111 11123457999999998889999999999999999998
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|..||..... .+...... ... .... .. ..+..+.+++.+||..+|++|||+.|
T Consensus 198 g~~p~~~~~~---------~~~~~~~~-~~~--~~~~---~~--------~~~~~~~~li~~cl~~~p~~Rpt~~~ 250 (256)
T cd05059 198 GKMPYERFSN---------SEVVESVS-AGY--RLYR---PK--------LAPTEVYTIMYSCWHEKPEDRPAFKK 250 (256)
T ss_pred CCCCCCCCCH---------HHHHHHHH-cCC--cCCC---CC--------CCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 8999854211 11111111 110 0000 01 12357899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=236.32 Aligned_cols=204 Identities=22% Similarity=0.288 Sum_probs=153.5
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeee-eCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCL-QTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~l~~lh~~~ 85 (241)
..+.+.+|+.+++.++||||+++++++. .++..++++||+.+++|.+++..... ..+.++.+++.||.|||
T Consensus 39 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--- 115 (262)
T cd05058 39 EVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA--- 115 (262)
T ss_pred HHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 4567889999999999999999999776 45568999999999999999865321 35678899999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc--eeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH--ITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+.+++|+||||+||+++.++.++|+|||.+......... .......++..|+|||++.+..++.++||||||+++|+|
T Consensus 116 ~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 195 (262)
T cd05058 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 195 (262)
T ss_pred hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHH
Confidence 899999999999999999999999999998754332111 111123456789999999888899999999999999999
Q ss_pred Hhc-CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAG-RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++| .+||... ...+....... +.... ... ..+..+.+++.+||..+|++|||+.|
T Consensus 196 ~~~~~~~~~~~---------~~~~~~~~~~~-~~~~~-----~~~--------~~~~~~~~li~~cl~~~p~~Rp~~~~ 251 (262)
T cd05058 196 MTRGAPPYPDV---------DSFDITVYLLQ-GRRLL-----QPE--------YCPDPLYEVMLSCWHPKPEMRPTFSE 251 (262)
T ss_pred HcCCCCCCCCC---------CHHHHHHHHhc-CCCCC-----CCC--------cCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 995 5555331 11111111111 11000 001 12256889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=236.21 Aligned_cols=202 Identities=23% Similarity=0.346 Sum_probs=159.5
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~~ 85 (241)
....+.+|+++++.++|+||+++++++......++||||+++++|.+++.... .....++.+++.|+.|||
T Consensus 45 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--- 121 (261)
T cd05148 45 KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE--- 121 (261)
T ss_pred hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 45678899999999999999999999999999999999999999999987532 146789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+.+++|+||+|+||+++.++.++|+|||.+.......... ....++..|+|||++....++.++|+||||+++|++++
T Consensus 122 ~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~ 199 (261)
T cd05148 122 EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199 (261)
T ss_pred HCCeeccccCcceEEEcCCceEEEccccchhhcCCccccc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHc
Confidence 8999999999999999999999999999987654332211 12345677999999988889999999999999999998
Q ss_pred -cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 -GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|+.||.... ..+.......... . .. .. ..+..+.+++.+||..||++|||+.+
T Consensus 200 ~g~~p~~~~~---------~~~~~~~~~~~~~-~--~~---~~--------~~~~~~~~~i~~~l~~~p~~Rpt~~~ 253 (261)
T cd05148 200 YGQVPYPGMN---------NHEVYDQITAGYR-M--PC---PA--------KCPQEIYKIMLECWAAEPEDRPSFKA 253 (261)
T ss_pred CCCCCCCcCC---------HHHHHHHHHhCCc-C--CC---CC--------CCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 899985421 1112222211111 0 00 01 22367889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=247.49 Aligned_cols=200 Identities=22% Similarity=0.218 Sum_probs=155.2
Q ss_pred cHHHHHHHHH-HHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNIT-YAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
....+.+|.. +++.++||||+++++++...+..++||||+++|+|..++..... ....++.||+.||.||| +
T Consensus 38 ~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~ 114 (325)
T cd05604 38 EQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH---S 114 (325)
T ss_pred HHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 3445566655 46778999999999999999999999999999999988765422 46678999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++||||||+|||++.++.++|+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|
T Consensus 115 ~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G 192 (325)
T cd05604 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192 (325)
T ss_pred CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcC
Confidence 9999999999999999999999999999864322111 12334689999999999988999999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
..||.... ..+....... ... .+.+. .+..+.+++.+||+.+|.+||++.
T Consensus 193 ~~pf~~~~---------~~~~~~~~~~-~~~------~~~~~--------~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 193 LPPFYCRD---------VAEMYDNILH-KPL------VLRPG--------ASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred CCCCCCCC---------HHHHHHHHHc-CCc------cCCCC--------CCHHHHHHHHHHhccCHHhcCCCC
Confidence 99996521 1111111111 100 01111 224678999999999999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=244.10 Aligned_cols=157 Identities=21% Similarity=0.214 Sum_probs=127.5
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeee--CCcceEEEEecCCCCHHHhhcCCC----------c---hHHHHHHHHHHH
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQ--TPIPILVFQSVEYGTLRDCIFGAP----------L---PRLKIASDIVNS 77 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~----------~---~~~~~~~~i~~~ 77 (241)
...+.+|++++++++||||+++++++.. ....++++||+. ++|.+++.... . ....++.|++.|
T Consensus 42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 120 (317)
T cd07868 42 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120 (317)
T ss_pred cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHH
Confidence 4567899999999999999999999864 446789999996 68888764221 1 246789999999
Q ss_pred hchhhcCCCCCceeccCCCCCeee----cCCCCeEEeeccCceecCCCCc-ceeecccccCCCccCccccccc-CCCcch
Q 044022 78 LAYLHFGFPRPIVLRNFKTQNILF----NEENVAKWFDFLLSISIPEGET-HITTDRVIGTRGYSAPEYISIC-VLNEKS 151 (241)
Q Consensus 78 l~~lh~~~~~~ivh~dl~~~nil~----~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~-~~~~~~ 151 (241)
|.||| +.+++||||||+|||+ +..+.+||+|||++........ ........+|+.|+|||++.+. .++.++
T Consensus 121 l~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 197 (317)
T cd07868 121 IHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI 197 (317)
T ss_pred HHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchh
Confidence 99999 9999999999999999 4567899999999976543221 1122345678999999998764 578999
Q ss_pred hhHHHHHHHHHHHhcCcccccc
Q 044022 152 NVFSFGAFLFELLAGRIHIWDL 173 (241)
Q Consensus 152 Di~s~G~~~~~~~~g~~p~~~~ 173 (241)
||||+||++|+|++|++||...
T Consensus 198 DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 198 DIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred hHHHHHHHHHHHHhCCCCccCC
Confidence 9999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=254.16 Aligned_cols=202 Identities=18% Similarity=0.276 Sum_probs=161.2
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCc--ceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPI--PILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~ 85 (241)
..++|..|+.+|+.|+||||++++.+|..... .-+|+|++..|+|..|+++... ....|++||+.||.|||+.
T Consensus 84 ~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~- 162 (632)
T KOG0584|consen 84 ELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ- 162 (632)
T ss_pred HHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-
Confidence 45889999999999999999999999987654 7799999999999999988754 3467999999999999975
Q ss_pred CCCceeccCCCCCeeecCC-CCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEE-NVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
..+|+|||||.+|||++.+ |.+||||+|+|........ ..++|||.|||||..- ..|+..+||||||..++||+
T Consensus 163 ~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMv 237 (632)
T KOG0584|consen 163 DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMV 237 (632)
T ss_pred CCCccccccccceEEEcCCcCceeecchhHHHHhhcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHH
Confidence 5689999999999999865 8999999999987654432 3468999999999988 78899999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|+..||....+. ..+..-+-...+...+..+.+ +.+++||.+|+.. .+.|||+.|
T Consensus 238 T~eYPYsEC~n~-----AQIYKKV~SGiKP~sl~kV~d----------------Pevr~fIekCl~~-~~~R~sa~e 292 (632)
T KOG0584|consen 238 TSEYPYSECTNP-----AQIYKKVTSGIKPAALSKVKD----------------PEVREFIEKCLAT-KSERLSAKE 292 (632)
T ss_pred hccCChhhhCCH-----HHHHHHHHcCCCHHHhhccCC----------------HHHHHHHHHHhcC-chhccCHHH
Confidence 999999542221 111111111111222222222 5789999999999 999999854
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=254.51 Aligned_cols=159 Identities=18% Similarity=0.212 Sum_probs=134.7
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|++++++++||||+++++++...+..|+||||+++|+|.+++..... ....++.|++.||.||| +
T Consensus 43 ~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH---~ 119 (377)
T cd05629 43 DQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH---K 119 (377)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 3456788999999999999999999999999999999999999999999865432 35568899999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCc------------c------------------------------
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET------------H------------------------------ 124 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~------------~------------------------------ 124 (241)
.+++||||||+|||++.++.++|+|||++........ .
T Consensus 120 ~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (377)
T cd05629 120 LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKK 199 (377)
T ss_pred CCeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhh
Confidence 9999999999999999999999999998853211000 0
Q ss_pred ---eeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCccccc
Q 044022 125 ---ITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 125 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 200 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (377)
T cd05629 200 NRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCS 250 (377)
T ss_pred cccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCC
Confidence 000124689999999999988899999999999999999999999954
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=255.81 Aligned_cols=213 Identities=21% Similarity=0.317 Sum_probs=171.1
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc------hHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL------PRLKIASDI 74 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~~i 74 (241)
||....+.-....++|++|+.+|.+|+|+|++++||+... ....||+|+++.|||.++|.+... ..-.++.||
T Consensus 143 VKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~Qi 221 (1039)
T KOG0199|consen 143 VKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQI 221 (1039)
T ss_pred EEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHH
Confidence 4556555554589999999999999999999999999987 557899999999999999987321 234689999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCC-cceeecccccCCCccCcccccccCCCcchhh
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE-THITTDRVIGTRGYSAPEYISICVLNEKSNV 153 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 153 (241)
+.|+.||. .+++|||||.++|+|+.....+||+|||+.+.+.... .........-+..|+|||.+....++.+||+
T Consensus 222 A~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDv 298 (1039)
T KOG0199|consen 222 AKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDV 298 (1039)
T ss_pred HHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchh
Confidence 99999999 9999999999999999999999999999999876542 2233333445678999999999999999999
Q ss_pred HHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCC
Q 044022 154 FSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNS 232 (241)
Q Consensus 154 ~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~ 232 (241)
|+|||.+|||++ |..||-. ......+.... .+.....+ ..+++++.+++++||..+
T Consensus 299 WmyGVTiWEMFtyGEePW~G---------~~g~qIL~~iD-~~erLpRP-------------k~csedIY~imk~cWah~ 355 (1039)
T KOG0199|consen 299 WMYGVTIWEMFTYGEEPWVG---------CRGIQILKNID-AGERLPRP-------------KYCSEDIYQIMKNCWAHN 355 (1039)
T ss_pred hhhhhhHHhhhccCCCCCCC---------CCHHHHHHhcc-ccccCCCC-------------CCChHHHHHHHHHhccCC
Confidence 999999999998 7888843 22233333333 22222111 256689999999999999
Q ss_pred CCCCCCCC
Q 044022 233 PEDRPTMV 240 (241)
Q Consensus 233 p~~Rpt~~ 240 (241)
|.+|||+.
T Consensus 356 paDRptFs 363 (1039)
T KOG0199|consen 356 PADRPTFS 363 (1039)
T ss_pred ccccccHH
Confidence 99999974
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=240.84 Aligned_cols=223 Identities=22% Similarity=0.245 Sum_probs=162.5
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeC--CcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQT--PIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDI 74 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i 74 (241)
|.+...........+.+|++++++++|||++++.+++... ...++||||+++++|.+++.... ..+..++.++
T Consensus 39 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i 118 (284)
T cd05079 39 KSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQI 118 (284)
T ss_pred EEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHH
Confidence 4444444444567899999999999999999999998765 46789999999999999986532 2467899999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-eeecccccCCCccCcccccccCCCcchhh
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-ITTDRVIGTRGYSAPEYISICVLNEKSNV 153 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 153 (241)
+.||.||| +.+++|+||||+||+++.++.++|+|||.+......... .......++..|+|||++.+..++.++||
T Consensus 119 ~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di 195 (284)
T cd05079 119 CKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDV 195 (284)
T ss_pred HHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccc
Confidence 99999999 999999999999999999999999999998765433221 11123346677999999988889999999
Q ss_pred HHHHHHHHHHHhcCcccccccccC------CCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHH
Q 044022 154 FSFGAFLFELLAGRIHIWDLLKDT------HDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLE 227 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 227 (241)
||||+++|+++++..|........ ............. ...+..... .. ..+..+.+|+.+
T Consensus 196 ~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~--------~~~~~~~~li~~ 261 (284)
T cd05079 196 WSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV-LEEGKRLPR-----PP--------NCPEEVYQLMRK 261 (284)
T ss_pred hhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH-HHcCccCCC-----CC--------CCCHHHHHHHHH
Confidence 999999999999877653321100 0000011111111 111111100 11 233678999999
Q ss_pred hccCCCCCCCCCCC
Q 044022 228 CVNNSPEDRPTMVD 241 (241)
Q Consensus 228 cl~~~p~~Rpt~~e 241 (241)
||+.||++|||++|
T Consensus 262 ~l~~~p~~Rpt~~~ 275 (284)
T cd05079 262 CWEFQPSKRTTFQN 275 (284)
T ss_pred HccCCcccCcCHHH
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=253.86 Aligned_cols=156 Identities=19% Similarity=0.246 Sum_probs=132.9
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..++.+|++++++|+|+|||++++++..++..++|+|++. ++|.+++.... ..++.++.|++.||.||| +.
T Consensus 204 ~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~ 279 (461)
T PHA03211 204 YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GE 279 (461)
T ss_pred ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 3457799999999999999999999999999999999995 78888875432 246789999999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcC
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
+|+||||||+|||++.++.++|+|||++................||..|+|||++.+..++.++|||||||++|||++|.
T Consensus 280 gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~ 359 (461)
T PHA03211 280 GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHT 359 (461)
T ss_pred CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcC
Confidence 99999999999999999999999999987654332221222346899999999999889999999999999999999988
Q ss_pred ccccc
Q 044022 168 IHIWD 172 (241)
Q Consensus 168 ~p~~~ 172 (241)
.|+..
T Consensus 360 ~~lf~ 364 (461)
T PHA03211 360 ASLFS 364 (461)
T ss_pred CCccc
Confidence 76644
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=236.56 Aligned_cols=212 Identities=20% Similarity=0.266 Sum_probs=160.9
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~ 76 (241)
|.+.........+.+.+|++++++++||||+++++++.. +..++|+||+++++|.+++.... ..+..++.+++.
T Consensus 40 k~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~ 118 (270)
T cd05056 40 KTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118 (270)
T ss_pred EecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHH
Confidence 444444434456689999999999999999999998865 45789999999999999986532 146778999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSF 156 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~ 156 (241)
||.||| +.+++|+||||+||+++..+.++++|||.+........... ....++..|+|||.+....++.++|||||
T Consensus 119 ~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 194 (270)
T cd05056 119 ALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMF 194 (270)
T ss_pred HHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccccceec-CCCCccccccChhhhccCCCCchhhhHHH
Confidence 999999 89999999999999999999999999999876654322221 22234567999999988889999999999
Q ss_pred HHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 157 GAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 157 G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
|+++|++++ |..||..... .+..... ..+.... ... ..+..+.+++.+||..+|++
T Consensus 195 G~il~el~~~g~~pf~~~~~---------~~~~~~~-~~~~~~~-----~~~--------~~~~~~~~li~~~l~~~P~~ 251 (270)
T cd05056 195 GVCMWEILMLGVKPFQGVKN---------NDVIGRI-ENGERLP-----MPP--------NCPPTLYSLMTKCWAYDPSK 251 (270)
T ss_pred HHHHHHHHHcCCCCCCCCCH---------HHHHHHH-HcCCcCC-----CCC--------CCCHHHHHHHHHHcCCChhh
Confidence 999999986 9999854211 1111111 1111111 111 22357899999999999999
Q ss_pred CCCCCC
Q 044022 236 RPTMVD 241 (241)
Q Consensus 236 Rpt~~e 241 (241)
|||+.|
T Consensus 252 Rpt~~~ 257 (270)
T cd05056 252 RPRFTE 257 (270)
T ss_pred CcCHHH
Confidence 999853
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=239.44 Aligned_cols=206 Identities=21% Similarity=0.313 Sum_probs=158.6
Q ss_pred cccHHHHHHHHHHHHhcCCCcccceeeeeee-CCcceEEEEecCCCCHHHhhcCCC---------c---hHHHHHHHHHH
Q 044022 10 RHTYGSCINNITYAAQMSHNHILKRIGCCLQ-TPIPILVFQSVEYGTLRDCIFGAP---------L---PRLKIASDIVN 76 (241)
Q Consensus 10 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~---------~---~~~~~~~~i~~ 76 (241)
......+.+|++++++++|+||+++++++.. ....+++++|+++++|.+++.... . ....++.+++.
T Consensus 49 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~ 128 (280)
T cd05043 49 EIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128 (280)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHH
Confidence 3446778999999999999999999998776 467899999999999999985421 1 35788999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSF 156 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~ 156 (241)
||.||| +.+++|+||+|+||+++.++.++|+|||+++...............++..|+|||++.+..++.++|||||
T Consensus 129 ~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 205 (280)
T cd05043 129 GMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSF 205 (280)
T ss_pred HHHHHH---HCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHh
Confidence 999999 99999999999999999999999999999876543332222223345677999999988889999999999
Q ss_pred HHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 157 GAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 157 G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
|+++|++++ |+.||..... .+. ......... ... .. ..+..+.+++.+||..||++
T Consensus 206 G~~l~el~~~g~~p~~~~~~---------~~~-~~~~~~~~~--~~~---~~--------~~~~~~~~li~~~l~~~p~~ 262 (280)
T cd05043 206 GVLLWELMTLGQTPYVEIDP---------FEM-AAYLKDGYR--LAQ---PI--------NCPDELFAVMACCWALDPEE 262 (280)
T ss_pred HHHHHHHhcCCCCCcCcCCH---------HHH-HHHHHcCCC--CCC---CC--------cCCHHHHHHHHHHcCCChhh
Confidence 999999999 9999965211 111 111111110 000 11 12357899999999999999
Q ss_pred CCCCCC
Q 044022 236 RPTMVD 241 (241)
Q Consensus 236 Rpt~~e 241 (241)
|||+.|
T Consensus 263 Rps~~~ 268 (280)
T cd05043 263 RPSFSQ 268 (280)
T ss_pred CCCHHH
Confidence 999854
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=237.93 Aligned_cols=196 Identities=23% Similarity=0.360 Sum_probs=150.8
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+|.+|+.++++++||||+++++++...+..++||||+++|+|..++.... ..++.++.|++.||.||| +
T Consensus 59 ~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~ 135 (274)
T cd05076 59 IALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---D 135 (274)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---c
Confidence 34578899999999999999999999999999999999999999999886532 246789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCC-------CeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEEN-------VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGA 158 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~-------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~ 158 (241)
++++||||||+||+++..+ .++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+
T Consensus 136 ~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~ 209 (274)
T cd05076 136 KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGT 209 (274)
T ss_pred CCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHH
Confidence 9999999999999997643 4799999987543222 12346778999998865 46789999999999
Q ss_pred HHHHHH-hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 159 FLFELL-AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 159 ~~~~~~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
++|+++ +|..||...... +. ....... ...+ .. ....+.+++.+||+.+|++||
T Consensus 210 ~l~el~~~g~~p~~~~~~~---------~~-~~~~~~~--~~~~-----~~--------~~~~~~~li~~cl~~~p~~Rp 264 (274)
T cd05076 210 TLLEICFDGEVPLKERTPS---------EK-ERFYEKK--HRLP-----EP--------SCKELATLISQCLTYEPTQRP 264 (274)
T ss_pred HHHHHHhCCCCCccccChH---------HH-HHHHHhc--cCCC-----CC--------CChHHHHHHHHHcccChhhCc
Confidence 999984 689998542111 00 1111100 0001 11 113588999999999999999
Q ss_pred CCCC
Q 044022 238 TMVD 241 (241)
Q Consensus 238 t~~e 241 (241)
|+.|
T Consensus 265 s~~~ 268 (274)
T cd05076 265 SFRT 268 (274)
T ss_pred CHHH
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=247.03 Aligned_cols=204 Identities=23% Similarity=0.310 Sum_probs=165.9
Q ss_pred cHHHHHHHHHHHHhcC-CCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC-C--chHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA-P--LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~--~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
....+.+|+++|+++. |||||.++++|+.....++|||++.||.|.+.+... . .....++.+++.+++||| +.
T Consensus 78 ~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH---~~ 154 (382)
T KOG0032|consen 78 DREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLH---SL 154 (382)
T ss_pred cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 4578899999999998 999999999999999999999999999999998764 2 246789999999999999 89
Q ss_pred CceeccCCCCCeeecCC----CCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 88 PIVLRNFKTQNILFNEE----NVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+++||||||+|+|+... +.++++|||++....... .....+||+.|+|||++....++..+||||+|+++|.|
T Consensus 155 gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~---~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiL 231 (382)
T KOG0032|consen 155 GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGE---RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYIL 231 (382)
T ss_pred CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCc---eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHH
Confidence 99999999999999644 479999999998877622 23456899999999999999999999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|.+||....... ... ....+.+ .+..+. ....+..+.++++.|+..||.+|+|+.+
T Consensus 232 L~G~~PF~~~~~~~---------~~~-~i~~~~~-~f~~~~---------w~~is~~akd~i~~ll~~dp~~R~ta~~ 289 (382)
T KOG0032|consen 232 LSGVPPFWGETEFE---------IFL-AILRGDF-DFTSEP---------WDDISESAKDFIRKLLEFDPRKRLTAAQ 289 (382)
T ss_pred hhCCCCCcCCChhH---------HHH-HHHcCCC-CCCCCC---------ccccCHHHHHHHHHhcccCcccCCCHHH
Confidence 99999997632221 011 1111211 112221 1244578899999999999999999853
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=250.27 Aligned_cols=158 Identities=16% Similarity=0.219 Sum_probs=135.8
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
....+.+|+.++.+++|+||+++++.+......++||||+++|+|.+++..... ....++.|++.||.||| ++
T Consensus 44 ~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~ 120 (363)
T cd05628 44 QVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH---QL 120 (363)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 345688899999999999999999999999999999999999999999865422 46778999999999999 99
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCc---------------------------------ceeecccccCC
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET---------------------------------HITTDRVIGTR 134 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~---------------------------------~~~~~~~~~~~ 134 (241)
+|+||||||+|||++.++.++|+|||++........ .......+||+
T Consensus 121 givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~ 200 (363)
T cd05628 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTP 200 (363)
T ss_pred CeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCc
Confidence 999999999999999999999999999865432100 00012346899
Q ss_pred CccCcccccccCCCcchhhHHHHHHHHHHHhcCccccc
Q 044022 135 GYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 135 ~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 201 ~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 201 DYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred cccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 99999999988999999999999999999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=241.82 Aligned_cols=216 Identities=19% Similarity=0.216 Sum_probs=153.4
Q ss_pred HHHHHHHHHHHHhc---CCCcccceeeeeee-----CCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHh
Q 044022 13 YGSCINNITYAAQM---SHNHILKRIGCCLQ-----TPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSL 78 (241)
Q Consensus 13 ~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l 78 (241)
...+.+|+.+++.+ +||||+++++++.. ....++|+||+. ++|.+++.... .....++.|++.||
T Consensus 45 ~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL 123 (290)
T cd07862 45 PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123 (290)
T ss_pred hHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHH
Confidence 44567788887776 69999999999862 346899999996 69999886432 14678999999999
Q ss_pred chhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHH
Q 044022 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGA 158 (241)
Q Consensus 79 ~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~ 158 (241)
.||| +.+++||||||+|||++.++.++|+|||.+....... ......+++.|+|||.+.+..++.++||||||+
T Consensus 124 ~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 197 (290)
T cd07862 124 DFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGC 197 (290)
T ss_pred HHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHH
Confidence 9999 9999999999999999999999999999987654331 123346889999999998888999999999999
Q ss_pred HHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCC------CCCccccCCCchh---HHHHHHHHHHHHHHhc
Q 044022 159 FLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGI------PAPIIVQDIPCIE---KEQQLHASAQLTLECV 229 (241)
Q Consensus 159 ~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~---~~~~~~~~~~l~~~cl 229 (241)
++|+|++|++||...... ......... ......... ............. ....++.+.+++.+||
T Consensus 198 il~el~~g~~~f~~~~~~-----~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 271 (290)
T cd07862 198 IFAEMFRRKPLFRGSSDV-----DQLGKILDV-IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCL 271 (290)
T ss_pred HHHHHHcCCCCcCCCCHH-----HHHHHHHHH-hCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHh
Confidence 999999999999652111 011111100 000000000 0000000000000 0123356789999999
Q ss_pred cCCCCCCCCCCC
Q 044022 230 NNSPEDRPTMVD 241 (241)
Q Consensus 230 ~~~p~~Rpt~~e 241 (241)
+.||++|||+.|
T Consensus 272 ~~~P~~R~s~~~ 283 (290)
T cd07862 272 TFNPAKRISAYS 283 (290)
T ss_pred ccCchhcCCHHH
Confidence 999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=244.63 Aligned_cols=199 Identities=20% Similarity=0.241 Sum_probs=156.4
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
....+..|..++..+ +|++|+++++++...+..++||||+++|+|.+++.... .....++.|++.||.||| +
T Consensus 43 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~ 119 (323)
T cd05616 43 DVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH---S 119 (323)
T ss_pred HHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 345577788888887 57899999999999999999999999999999886542 246789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++||||||+|||++.++.++|+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|
T Consensus 120 ~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg 197 (323)
T cd05616 120 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197 (323)
T ss_pred CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhC
Confidence 9999999999999999999999999999875432211 12335689999999999988999999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
+.||.... ..+....... ... .... ..+..+.+++.+||+.||++|+++
T Consensus 198 ~~Pf~~~~---------~~~~~~~i~~-~~~------~~p~--------~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 198 QAPFEGED---------EDELFQSIME-HNV------AYPK--------SMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCCCC---------HHHHHHHHHh-CCC------CCCC--------cCCHHHHHHHHHHcccCHHhcCCC
Confidence 99995421 1111111111 110 0111 122567899999999999999986
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=254.79 Aligned_cols=158 Identities=16% Similarity=0.224 Sum_probs=134.6
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
....+.+|++++++++|+||+++++.+...+..++||||+++|+|.+++..... ....++.||+.||+||| ++
T Consensus 44 ~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH---~~ 120 (376)
T cd05598 44 QAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVH---KM 120 (376)
T ss_pred hHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 456788999999999999999999999999999999999999999999866532 34567889999999999 99
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCC-----------------------------------------ccee
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE-----------------------------------------THIT 126 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-----------------------------------------~~~~ 126 (241)
+|+||||||+|||++.++.++|+|||++....... ....
T Consensus 121 ~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (376)
T cd05598 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCL 200 (376)
T ss_pred CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhccccc
Confidence 99999999999999999999999999874221000 0000
Q ss_pred ecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCccccc
Q 044022 127 TDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 127 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 201 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 246 (376)
T cd05598 201 AHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA 246 (376)
T ss_pred ccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCC
Confidence 1134689999999999988899999999999999999999999965
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=235.25 Aligned_cols=194 Identities=25% Similarity=0.392 Sum_probs=153.2
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHHHHhchhhcCCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
...|.+|+.++++++||||+++++++.. +..++|+||+++++|.+++.... . .++.++.+++.||.||| ++
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~ 120 (259)
T cd05037 45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DK 120 (259)
T ss_pred HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hC
Confidence 6788999999999999999999999988 77899999999999999987543 1 46788999999999999 99
Q ss_pred CceeccCCCCCeeecCCC-------CeEEeeccCceecCCCCcceeecccccCCCccCccccccc--CCCcchhhHHHHH
Q 044022 88 PIVLRNFKTQNILFNEEN-------VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC--VLNEKSNVFSFGA 158 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~-------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~s~G~ 158 (241)
+++|+||||+||+++.++ .++++|||.+...... ....++..|+|||++... .++.++|+||||+
T Consensus 121 ~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~ 194 (259)
T cd05037 121 KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGT 194 (259)
T ss_pred CeecccCccceEEEecCccccCCceeEEeCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHH
Confidence 999999999999999887 7999999998765431 223466789999999876 7889999999999
Q ss_pred HHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 159 FLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 159 ~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
++|++++ |..||...... +..... .... ....+ ....+.+++.+||..+|++||
T Consensus 195 ~~~~l~~~~~~p~~~~~~~---------~~~~~~-~~~~--~~~~~-------------~~~~~~~li~~~l~~~p~~Rp 249 (259)
T cd05037 195 TLLEICSNGEEPLSTLSSS---------EKERFY-QDQH--RLPMP-------------DCAELANLINQCWTYDPTKRP 249 (259)
T ss_pred HHHHHHhCCCCCcccCCch---------hHHHHH-hcCC--CCCCC-------------CchHHHHHHHHHhccChhhCC
Confidence 9999999 57777552110 111111 1110 00000 015788999999999999999
Q ss_pred CCCC
Q 044022 238 TMVD 241 (241)
Q Consensus 238 t~~e 241 (241)
|+.|
T Consensus 250 t~~~ 253 (259)
T cd05037 250 SFRA 253 (259)
T ss_pred CHHH
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=243.27 Aligned_cols=233 Identities=19% Similarity=0.269 Sum_probs=164.6
Q ss_pred Ccccccc-cccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHH
Q 044022 1 MKFYGHE-YHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASD 73 (241)
Q Consensus 1 iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~ 73 (241)
||.+..+ ......+.+.+|++++++++|+||+++++++...+..+++|||+++++|.+++.... .....++.+
T Consensus 30 vK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~ 109 (314)
T cd08216 30 VKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKD 109 (314)
T ss_pred EEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHH
Confidence 3454433 334566789999999999999999999999999999999999999999999986531 135678999
Q ss_pred HHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCc-----ceeecccccCCCccCccccccc--C
Q 044022 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET-----HITTDRVIGTRGYSAPEYISIC--V 146 (241)
Q Consensus 74 i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~--~ 146 (241)
++.||.||| +.+++|+||||+||+++.++.++++||+.+........ ........++..|+|||++... .
T Consensus 110 l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 186 (314)
T cd08216 110 VLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG 186 (314)
T ss_pred HHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCC
Confidence 999999999 99999999999999999999999999998865432211 0111223466789999998753 5
Q ss_pred CCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHH----hhhccc-------C----CCCCCccccCCCc
Q 044022 147 LNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNY----LEDKRF-------T----GIPAPIIVQDIPC 211 (241)
Q Consensus 147 ~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~-------~----~~~~~~~~~~~~~ 211 (241)
++.++|+||||+++|+|++|+.||....... ...+..... ...... . ...........+.
T Consensus 187 ~~~~~Diws~G~il~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (314)
T cd08216 187 YNEKSDIYSVGITACELANGHVPFKDMPATQ-----MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDH 261 (314)
T ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhc
Confidence 7889999999999999999999996522110 000000000 000000 0 0000011111111
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 212 IEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 212 ~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
......+..+.+++.+||..||++|||++|
T Consensus 262 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 291 (314)
T cd08216 262 PYTRTFSEHFHQFVELCLQRDPESRPSASQ 291 (314)
T ss_pred chhhHHHHHHHHHHHHHhhcCCCcCcCHHH
Confidence 112244567889999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=250.26 Aligned_cols=157 Identities=17% Similarity=0.250 Sum_probs=135.2
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
....+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++..... ....++.||+.||.||| +++
T Consensus 86 ~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ 162 (371)
T cd05622 86 DSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH---SMG 162 (371)
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence 345578899999999999999999999999999999999999999999876543 35678899999999999 999
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc----CCCcchhhHHHHHHHHHHH
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC----VLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~Di~s~G~~~~~~~ 164 (241)
++||||||+|||++.++.+||+|||++......... ......||+.|+|||++... .++.++||||||+++|+|+
T Consensus 163 ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell 241 (371)
T cd05622 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241 (371)
T ss_pred EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHH
Confidence 999999999999999999999999998765433211 12345689999999998754 3778999999999999999
Q ss_pred hcCccccc
Q 044022 165 AGRIHIWD 172 (241)
Q Consensus 165 ~g~~p~~~ 172 (241)
+|..||..
T Consensus 242 ~G~~Pf~~ 249 (371)
T cd05622 242 VGDTPFYA 249 (371)
T ss_pred hCCCCCCC
Confidence 99999964
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=240.67 Aligned_cols=204 Identities=23% Similarity=0.321 Sum_probs=156.5
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~l~~lh~~~ 85 (241)
.....+.+|+.++++++||||+++++++... ..++++||+++|+|.+++..... ..+.++.+++.||.|||
T Consensus 51 ~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH--- 126 (303)
T cd05110 51 KANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE--- 126 (303)
T ss_pred HHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---
Confidence 3345788999999999999999999998654 46799999999999999876421 46788999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+++++|+||||+||+++.++.+||+|||.+................++..|+|||++.+..++.++||||||+++|++++
T Consensus 127 ~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t 206 (303)
T cd05110 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206 (303)
T ss_pred hcCeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHh
Confidence 89999999999999999999999999999976544322222223345678999999988889999999999999999997
Q ss_pred -cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 -GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|..||.... ..+ .......+... ..+ . .++..+.+++..||..+|++|||++|
T Consensus 207 ~g~~p~~~~~---------~~~-~~~~~~~~~~~--~~~---~--------~~~~~~~~li~~c~~~~p~~Rp~~~~ 260 (303)
T cd05110 207 FGGKPYDGIP---------TRE-IPDLLEKGERL--PQP---P--------ICTIDVYMVMVKCWMIDADSRPKFKE 260 (303)
T ss_pred CCCCCCCCCC---------HHH-HHHHHHCCCCC--CCC---C--------CCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 888885411 111 11111111111 110 1 12256889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=237.15 Aligned_cols=203 Identities=20% Similarity=0.292 Sum_probs=159.1
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
.+.+.+|+.++++++||||+++++++...+..++++||+++++|.+++..... ....++.+++.|+.||| +.+
T Consensus 50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~ 126 (267)
T cd06628 50 LDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH---NRG 126 (267)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHH---hcC
Confidence 35688999999999999999999999999999999999999999999865422 45688999999999999 899
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcce----eecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI----TTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
++|+||+|+||+++.++.++|+|||.+.......... ......++..|+|||.+.+..++.++|+||||+++|+++
T Consensus 127 ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~ 206 (267)
T cd06628 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEML 206 (267)
T ss_pred cccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHh
Confidence 9999999999999999999999999987664321110 111234778899999998888899999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|+.||..... ......... . ..+.... ..+..+.+++.+||+.||.+|||+.|
T Consensus 207 ~g~~p~~~~~~---------~~~~~~~~~-~-----~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (267)
T cd06628 207 TGKHPFPDCTQ---------LQAIFKIGE-N-----ASPEIPS--------NISSEAIDFLEKTFEIDHNKRPTAAE 260 (267)
T ss_pred hCCCCCCCccH---------HHHHHHHhc-c-----CCCcCCc--------ccCHHHHHHHHHHccCCchhCcCHHH
Confidence 99999965211 011111111 1 1111111 22367889999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=239.68 Aligned_cols=213 Identities=22% Similarity=0.253 Sum_probs=161.5
Q ss_pred cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCC
Q 044022 10 RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 10 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~ 85 (241)
......+.+|+++++.++||||+++++++...+.+++|+||+++++|.+++..... ....++.+++.|+.|||.
T Consensus 44 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-- 121 (284)
T cd06620 44 SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN-- 121 (284)
T ss_pred chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH--
Confidence 34467889999999999999999999999999999999999999999998865432 456889999999999993
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
..+++|+||+|+||+++.++.++|+|||++........ ....++..|+|||++.+..++.++|+||||+++|++++
T Consensus 122 ~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~t 197 (284)
T cd06620 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELAL 197 (284)
T ss_pred hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHh
Confidence 25899999999999999999999999998765432211 23467889999999988889999999999999999999
Q ss_pred cCcccccccccCCC--cccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHD--HGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|..||......... ......+......... .+.+.. ...+..+.+++.+||..||++|||++|
T Consensus 198 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~-------~~~~~~~~~li~~~l~~dp~~Rpt~~e 262 (284)
T cd06620 198 GKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PPRLPS-------SDFPEDLRDFVDACLLKDPTERPTPQQ 262 (284)
T ss_pred CCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CCCCCc-------hhcCHHHHHHHHHHhcCCcccCcCHHH
Confidence 99999753221100 0000111111111110 001000 123357889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=252.74 Aligned_cols=158 Identities=16% Similarity=0.224 Sum_probs=134.3
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
....+.+|++++++++|+||+++++.+...+..++||||+++|+|.+++..... ....++.||+.||.||| +.
T Consensus 44 ~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH---~~ 120 (382)
T cd05625 44 QVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVH---KM 120 (382)
T ss_pred HHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 456788999999999999999999999999999999999999999998865422 35668889999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCC---------------------------------------------
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE--------------------------------------------- 122 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~--------------------------------------------- 122 (241)
+|+||||||+|||++.++.++|+|||++.......
T Consensus 121 ~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (382)
T cd05625 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQH 200 (382)
T ss_pred CeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccc
Confidence 99999999999999999999999999874321000
Q ss_pred cceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCccccc
Q 044022 123 THITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 123 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
.........||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 201 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (382)
T cd05625 201 QRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA 250 (382)
T ss_pred ccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCC
Confidence 00001234689999999999988999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=233.87 Aligned_cols=206 Identities=23% Similarity=0.345 Sum_probs=160.5
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--Cc---hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--PL---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+.+.+|++++++++||||+++++++...+..+++|||+++++|.+++... .. ....++.+++.|+.||| +
T Consensus 43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~ 119 (262)
T cd06613 43 DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---E 119 (262)
T ss_pred hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 5678899999999999999999999999999999999999999999987654 22 46778999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc---CCCcchhhHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC---VLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~s~G~~~~~~ 163 (241)
.+++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+... .++.++|+||||+++|+|
T Consensus 120 ~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~ 197 (262)
T cd06613 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197 (262)
T ss_pred CCceecCCChhhEEECCCCCEEECccccchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHH
Confidence 9999999999999999999999999999875543211 11234577889999998776 788999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|+.||..... .+......... ...... ......+..+.+++.+||..+|..|||+.|
T Consensus 198 ~tg~~p~~~~~~---------~~~~~~~~~~~----~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 256 (262)
T cd06613 198 AELQPPMFDLHP---------MRALFLISKSN----FPPPKL------KDKEKWSPVFHDFIKKCLTKDPKKRPTATK 256 (262)
T ss_pred HhCCCCCCCCCH---------HHHHHHHHhcc----CCCccc------cchhhhhHHHHHHHHHHcCCChhhCCCHHH
Confidence 999999965211 11111111110 011110 011234567899999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=235.10 Aligned_cols=199 Identities=22% Similarity=0.329 Sum_probs=158.3
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~~ 85 (241)
..+++.+|+.+++.++|+||+++++++......++|+||+++++|.+++.... .....++.+++.|+.|||
T Consensus 43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh--- 119 (256)
T cd05039 43 AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE--- 119 (256)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 46789999999999999999999999998889999999999999999986543 146789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+.+++|+||+|+||+++.++.++|+|||.+........ ....+..|+|||++....++.++|+||||+++|++++
T Consensus 120 ~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~ 194 (256)
T cd05039 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194 (256)
T ss_pred hCCccchhcccceEEEeCCCCEEEcccccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999876533221 2234567999999988889999999999999999997
Q ss_pred -cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 -GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|..||.... ..+....... ...... .. ..++.+.+++.+||..+|++|||++|
T Consensus 195 ~g~~p~~~~~---------~~~~~~~~~~-~~~~~~-----~~--------~~~~~~~~li~~~l~~~p~~Rp~~~~ 248 (256)
T cd05039 195 FGRVPYPRIP---------LKDVVPHVEK-GYRMEA-----PE--------GCPPEVYKVMKDCWELDPAKRPTFKQ 248 (256)
T ss_pred cCCCCCCCCC---------HHHHHHHHhc-CCCCCC-----cc--------CCCHHHHHHHHHHhccChhhCcCHHH
Confidence 999985421 1111111111 101000 11 12367889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=247.37 Aligned_cols=155 Identities=19% Similarity=0.233 Sum_probs=130.0
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCC------cceEEEEecCCCCHHHhhcCC--CchHHHHHHHHHHHhchhh
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTP------IPILVFQSVEYGTLRDCIFGA--PLPRLKIASDIVNSLAYLH 82 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~lh 82 (241)
.....+.+|+.+++.++||||+++++++...+ ..++||||+. ++|.+.+... ......++.|++.||.|||
T Consensus 62 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH 140 (359)
T cd07876 62 THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELDHERMSYLLYQMLCGIKHLH 140 (359)
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCC-cCHHHHHhccCCHHHHHHHHHHHHHHHHHHH
Confidence 44667889999999999999999999987543 4699999997 5677665433 2245678999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~ 162 (241)
+.+++||||||+||+++.++.++|+|||++........ .....++..|+|||.+.+..++.++||||||+++|+
T Consensus 141 ---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~e 214 (359)
T cd07876 141 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214 (359)
T ss_pred ---hCCcccCCCCHHHEEECCCCCEEEecCCCccccccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHH
Confidence 99999999999999999999999999999865432211 123467889999999998899999999999999999
Q ss_pred HHhcCccccc
Q 044022 163 LLAGRIHIWD 172 (241)
Q Consensus 163 ~~~g~~p~~~ 172 (241)
|++|+.||..
T Consensus 215 l~tg~~pf~~ 224 (359)
T cd07876 215 LVKGSVIFQG 224 (359)
T ss_pred HHhCCCCCCC
Confidence 9999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=239.02 Aligned_cols=205 Identities=20% Similarity=0.277 Sum_probs=156.8
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC----Cc---hHHHHHHHHHHHhchhhc
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA----PL---PRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----~~---~~~~~~~~i~~~l~~lh~ 83 (241)
.....+.+|++++++++|+||+++++.+...+..++|+||+++++|..++... .. ....++.+++.|+.|||.
T Consensus 41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~ 120 (286)
T cd06622 41 SKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120 (286)
T ss_pred HHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34568899999999999999999999999999999999999999999988663 11 457889999999999993
Q ss_pred CCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccC------CCcchhhHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV------LNEKSNVFSFG 157 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~------~~~~~Di~s~G 157 (241)
+.+++|+||+|+||+++.++.++|+|||.+........ ....++..|+|||.+.+.. ++.++|+||||
T Consensus 121 --~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG 194 (286)
T cd06622 121 --EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLG 194 (286)
T ss_pred --cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHH
Confidence 35899999999999999999999999999875533221 2235778899999986543 47899999999
Q ss_pred HHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 158 AFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 158 ~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
+++|++++|+.||..... ........... ....+.+.. ..+..+.+++.+||..+|++||
T Consensus 195 ~il~~l~~g~~pf~~~~~---------~~~~~~~~~~~---~~~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rp 254 (286)
T cd06622 195 LSILEMALGRYPYPPETY---------ANIFAQLSAIV---DGDPPTLPS--------GYSDDAQDFVAKCLNKIPNRRP 254 (286)
T ss_pred HHHHHHHhCCCCCCCcch---------hhHHHHHHHHh---hcCCCCCCc--------ccCHHHHHHHHHHcccCcccCC
Confidence 999999999999954210 11111111000 000111111 2346788999999999999999
Q ss_pred CCCC
Q 044022 238 TMVD 241 (241)
Q Consensus 238 t~~e 241 (241)
|++|
T Consensus 255 ~~~~ 258 (286)
T cd06622 255 TYAQ 258 (286)
T ss_pred CHHH
Confidence 9853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=234.75 Aligned_cols=197 Identities=23% Similarity=0.378 Sum_probs=152.2
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.+.+|+.++++++|||++++++++...+..++||||+.+|+|.+++.... ...+.++.|++.||+|||
T Consensus 41 ~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH--- 117 (258)
T cd05078 41 NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE--- 117 (258)
T ss_pred HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 345678899999999999999999999999899999999999999999986542 146778999999999999
Q ss_pred CCCceeccCCCCCeeecCCCC--------eEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENV--------AKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSF 156 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~--------~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~ 156 (241)
+.+++||||||+||+++.++. ++++|||.+...... ....++..|+|||++.+. .++.++|||||
T Consensus 118 ~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 191 (258)
T cd05078 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSF 191 (258)
T ss_pred HCCeecCCCccceEEEecccccccCCCceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHH
Confidence 999999999999999987765 589999987654322 223567889999999864 57889999999
Q ss_pred HHHHHHHHhcC-cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 157 GAFLFELLAGR-IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 157 G~~~~~~~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
|+++|++++|. .|+..... ..... ..... ...+. .....+.+++.+||+.||++
T Consensus 192 G~~l~~l~~g~~~~~~~~~~---------~~~~~-~~~~~--~~~~~-------------~~~~~~~~li~~~l~~~p~~ 246 (258)
T cd05078 192 GTTLWEIFSGGDKPLSALDS---------QKKLQ-FYEDR--HQLPA-------------PKWTELANLINQCMDYEPDF 246 (258)
T ss_pred HHHHHHHHcCCCCChhhccH---------HHHHH-HHHcc--ccCCC-------------CCcHHHHHHHHHHhccChhh
Confidence 99999999985 55533111 01111 11110 01111 11246889999999999999
Q ss_pred CCCCCC
Q 044022 236 RPTMVD 241 (241)
Q Consensus 236 Rpt~~e 241 (241)
|||++|
T Consensus 247 Rps~~~ 252 (258)
T cd05078 247 RPSFRA 252 (258)
T ss_pred CCCHHH
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=236.87 Aligned_cols=203 Identities=25% Similarity=0.336 Sum_probs=159.9
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
.+++.+|++++++++|+||+++++++......++++||+.+++|.+++.... .....++.+++.|+.||| +.
T Consensus 42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~ 118 (256)
T cd06612 42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SN 118 (256)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 6789999999999999999999999999999999999999999999986432 146788999999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcC
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
+++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||++.+..++.++||||||+++|+|++|+
T Consensus 119 ~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~ 196 (256)
T cd06612 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196 (256)
T ss_pred CcccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999876544321 112345788899999998888999999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.||...... +...... . .....+. .....+..+.+++.+||+.||++|||+.|
T Consensus 197 ~p~~~~~~~---------~~~~~~~-~-----~~~~~~~------~~~~~~~~~~~~i~~~l~~~P~~Rps~~~ 249 (256)
T cd06612 197 PPYSDIHPM---------RAIFMIP-N-----KPPPTLS------DPEKWSPEFNDFVKKCLVKDPEERPSAIQ 249 (256)
T ss_pred CCCCCcchh---------hhhhhhc-c-----CCCCCCC------chhhcCHHHHHHHHHHHhcChhhCcCHHH
Confidence 998542111 0000000 0 0000000 01123357899999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=240.51 Aligned_cols=201 Identities=20% Similarity=0.285 Sum_probs=157.5
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+|+.++++++|+|++++++.+...+..++||||+++++|.+++.... .....++.|++.||.||| +
T Consensus 44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~ 120 (285)
T cd05630 44 ESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---Q 120 (285)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 4557889999999999999999999999999999999999999998874321 146778999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++|+||||+||+++.++.++|+|||++......... ....|+..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 121 ~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 197 (285)
T cd05630 121 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 197 (285)
T ss_pred CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhC
Confidence 99999999999999999999999999998765433221 223688999999999988899999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
+.||...... ...+.......... ..... ..+..+.+++.+||+.||++|||+
T Consensus 198 ~~Pf~~~~~~------~~~~~~~~~~~~~~------~~~~~--------~~~~~~~~li~~~l~~~p~~R~s~ 250 (285)
T cd05630 198 QSPFQQRKKK------IKREEVERLVKEVQ------EEYSE--------KFSPDARSLCKMLLCKDPKERLGC 250 (285)
T ss_pred CCCCCCCCcc------chHHHHHhhhhhhh------hhcCc--------cCCHHHHHHHHHHhhcCHHHccCC
Confidence 9999652111 01111111111100 00111 123568899999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=240.12 Aligned_cols=204 Identities=23% Similarity=0.323 Sum_probs=159.3
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC-----C---chHHHHHHHHHHHhchhhc
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA-----P---LPRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----~---~~~~~~~~~i~~~l~~lh~ 83 (241)
...++.+|+++++.++|+||+++++++...+..++++||+++++|.+++... . .....++.+++.|+.|||
T Consensus 45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH- 123 (267)
T cd08229 45 ARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH- 123 (267)
T ss_pred HHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 4567889999999999999999999999999999999999999999987531 1 145688999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+.+++|+||+|+||+++.++.++++|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|
T Consensus 124 --~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l 199 (267)
T cd08229 124 --SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred --HCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHH
Confidence 999999999999999999999999999988755433211 1234578889999999888889999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
++|..||...... ..+...... ... .+... ....+..+.+++.+||..||++|||+.
T Consensus 200 ~~g~~p~~~~~~~-------~~~~~~~~~-~~~-----~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rpt~~ 256 (267)
T cd08229 200 AALQSPFYGDKMN-------LYSLCKKIE-QCD-----YPPLP-------SDHYSEELRQLVNMCINPDPEKRPDIT 256 (267)
T ss_pred HhCCCCcccccch-------HHHHhhhhh-cCC-----CCCCC-------cccccHHHHHHHHHhcCCCcccCCCHH
Confidence 9999998542110 111111111 000 00000 113446789999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=229.76 Aligned_cols=209 Identities=19% Similarity=0.280 Sum_probs=158.8
Q ss_pred cccHHHHHHHHHHHHhcCCCcccceeeeeeeCC-----cceEEEEecCCCCHHHhhcCC--------CchHHHHHHHHHH
Q 044022 10 RHTYGSCINNITYAAQMSHNHILKRIGCCLQTP-----IPILVFQSVEYGTLRDCIFGA--------PLPRLKIASDIVN 76 (241)
Q Consensus 10 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~--------~~~~~~~~~~i~~ 76 (241)
.+..+..++|++..++++|||+++++++...+. ..|+++.|...|||.+.+... +.+.+.|+.++++
T Consensus 59 ~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~ 138 (302)
T KOG2345|consen 59 QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICR 138 (302)
T ss_pred hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHH
Confidence 456788899999999999999999999887543 489999999999999987543 2267899999999
Q ss_pred HhchhhcCCCCC--ceeccCCCCCeeecCCCCeEEeeccCceecCCC-------CcceeecccccCCCccCcccccc---
Q 044022 77 SLAYLHFGFPRP--IVLRNFKTQNILFNEENVAKWFDFLLSISIPEG-------ETHITTDRVIGTRGYSAPEYISI--- 144 (241)
Q Consensus 77 ~l~~lh~~~~~~--ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~-------~~~~~~~~~~~~~~~~aPE~~~~--- 144 (241)
||.+|| +.. ..||||||.|||+...+.++++|||.+...... ...+.-.....|..|+|||.+..
T Consensus 139 gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~ 215 (302)
T KOG2345|consen 139 GLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSH 215 (302)
T ss_pred HHHHHh---ccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccC
Confidence 999999 555 999999999999999999999999998654321 01111123457889999999864
Q ss_pred cCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHH
Q 044022 145 CVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQL 224 (241)
Q Consensus 145 ~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 224 (241)
+..+.++|||||||++|.|+.|..||.... ...+... .......+..+...-+++.+.++
T Consensus 216 ~ti~ertDIWSLGCtLYa~mf~~sPfe~~~-----------------~~GgSla---LAv~n~q~s~P~~~~yse~l~~l 275 (302)
T KOG2345|consen 216 CTITERTDIWSLGCTLYAMMFGESPFERIY-----------------QQGGSLA---LAVQNAQISIPNSSRYSEALHQL 275 (302)
T ss_pred cccccccchhhhhHHHHHHHHcCCcchHHh-----------------hcCCeEE---EeeeccccccCCCCCccHHHHHH
Confidence 457899999999999999999999995411 1111110 11111111122222356889999
Q ss_pred HHHhccCCCCCCCCCCC
Q 044022 225 TLECVNNSPEDRPTMVD 241 (241)
Q Consensus 225 ~~~cl~~~p~~Rpt~~e 241 (241)
+..|++.||.+|||+.|
T Consensus 276 ik~mlqvdP~qRP~i~~ 292 (302)
T KOG2345|consen 276 IKSMLQVDPNQRPTIPE 292 (302)
T ss_pred HHHHhcCCcccCCCHHH
Confidence 99999999999999753
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=242.23 Aligned_cols=200 Identities=20% Similarity=0.244 Sum_probs=156.4
Q ss_pred cHHHHHHHHHHHHhcC-CCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
....+..|..+++.+. |++|+++++++...+..++||||+++|+|.+++.... .....++.+++.||.||| +
T Consensus 43 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH---~ 119 (323)
T cd05615 43 DVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH---R 119 (323)
T ss_pred HHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 4556788999998885 5778889999999999999999999999999886542 256788999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
++++||||||+|||++.++.++|+|||++........ ......|++.|+|||++.+..++.++|+||+|+++|+|++|
T Consensus 120 ~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG 197 (323)
T cd05615 120 RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 197 (323)
T ss_pred CCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhC
Confidence 9999999999999999999999999999875432211 11234589999999999988899999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
+.||..... ......... ... .... ..+..+.+++.+||+.+|++|+++.
T Consensus 198 ~~pf~~~~~---------~~~~~~i~~-~~~------~~p~--------~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 198 QPPFDGEDE---------DELFQSIME-HNV------SYPK--------SLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCCCCCCCH---------HHHHHHHHh-CCC------CCCc--------cCCHHHHHHHHHHcccCHhhCCCCC
Confidence 999965211 111111111 100 0011 1225678999999999999999863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=237.00 Aligned_cols=204 Identities=19% Similarity=0.356 Sum_probs=157.7
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----------c---hHHHHHHHHHHHh
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----------L---PRLKIASDIVNSL 78 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------~---~~~~~~~~i~~~l 78 (241)
..+.+.+|++++++++|+||+++++++......++|+||+++++|.+++.... . .+..++.+++.||
T Consensus 51 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l 130 (275)
T cd05046 51 LQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130 (275)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHH
Confidence 45679999999999999999999999998889999999999999999986433 1 4677899999999
Q ss_pred chhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHH
Q 044022 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGA 158 (241)
Q Consensus 79 ~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~ 158 (241)
+||| +.+++|+||||+||+++.++.++++|||++........ .......++..|+|||.+.+..++.++||||||+
T Consensus 131 ~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~ 206 (275)
T cd05046 131 DHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGV 206 (275)
T ss_pred HHhh---hcCcccCcCccceEEEeCCCcEEEcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHH
Confidence 9999 89999999999999999999999999998764432211 1112234566799999998888889999999999
Q ss_pred HHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 159 FLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 159 ~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
++|++++ |..||..... ..... ....+... ... .. ..+..+.+++.+||+.+|++||
T Consensus 207 ~l~~l~~~~~~p~~~~~~---------~~~~~-~~~~~~~~-~~~---~~--------~~~~~l~~~i~~~l~~~p~~Rp 264 (275)
T cd05046 207 LMWEVFTQGELPFYGLSD---------EEVLN-RLQAGKLE-LPV---PE--------GCPSRLYKLMTRCWAVNPKDRP 264 (275)
T ss_pred HHHHHHhCCCCCccccch---------HHHHH-HHHcCCcC-CCC---CC--------CCCHHHHHHHHHHcCCCcccCC
Confidence 9999998 7888854211 11111 11111111 000 11 1225789999999999999999
Q ss_pred CCCC
Q 044022 238 TMVD 241 (241)
Q Consensus 238 t~~e 241 (241)
|+.|
T Consensus 265 ~~~~ 268 (275)
T cd05046 265 SFSE 268 (275)
T ss_pred CHHH
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=237.50 Aligned_cols=205 Identities=21% Similarity=0.327 Sum_probs=160.7
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--------CchHHHHHHHHHHHhchhhc
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--------PLPRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--------~~~~~~~~~~i~~~l~~lh~ 83 (241)
..+++.+|++++++++|+|++++++++...+..++||||+++++|.+++... ......++.+++.|+.|||
T Consensus 45 ~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh- 123 (267)
T cd08224 45 ARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH- 123 (267)
T ss_pred hHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH-
Confidence 4677899999999999999999999999999999999999999999988532 1146788999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+.+++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|++
T Consensus 124 --~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l 199 (267)
T cd08224 124 --SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred --hCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHH
Confidence 999999999999999999999999999998765433211 1223578889999999888899999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|+.||.... ....+...... .+.....+ ....+..+.+++.+||..+|++|||+.+
T Consensus 200 ~~g~~p~~~~~-------~~~~~~~~~~~-~~~~~~~~------------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ 257 (267)
T cd08224 200 AALQSPFYGDK-------MNLYSLCKKIE-KCDYPPLP------------ADHYSEELRDLVSRCINPDPEKRPDISY 257 (267)
T ss_pred HHCCCCcccCC-------ccHHHHHhhhh-cCCCCCCC------------hhhcCHHHHHHHHHHcCCCcccCCCHHH
Confidence 99999985421 11111111111 11111111 1133457889999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=252.66 Aligned_cols=150 Identities=23% Similarity=0.271 Sum_probs=130.2
Q ss_pred cHHHHHHHHHHHHhcC-C-----CcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc------hHHHHHHHHHHHhc
Q 044022 12 TYGSCINNITYAAQMS-H-----NHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL------PRLKIASDIVNSLA 79 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~~i~~~l~ 79 (241)
...+-..|+.+|..|+ | -|+|+++++|...++.|||+|.+. -+|.++++.+.. ....++.||+.||.
T Consensus 225 f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~ 303 (586)
T KOG0667|consen 225 FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALL 303 (586)
T ss_pred HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Confidence 4566778999999996 4 299999999999999999999996 799999987743 35678999999999
Q ss_pred hhhcCCCCCceeccCCCCCeeecCC--CCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHH
Q 044022 80 YLHFGFPRPIVLRNFKTQNILFNEE--NVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFG 157 (241)
Q Consensus 80 ~lh~~~~~~ivh~dl~~~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G 157 (241)
+|| +.+|+|+||||+|||+..- ..+||+|||.+....... -+.+.+.+|+|||++.+.+|+.+.||||||
T Consensus 304 ~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLG 375 (586)
T KOG0667|consen 304 FLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLG 375 (586)
T ss_pred HHH---hCCeeeccCChhheeeccCCcCceeEEecccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehh
Confidence 999 9999999999999999654 478999999987544332 145778999999999999999999999999
Q ss_pred HHHHHHHhcCccc
Q 044022 158 AFLFELLAGRIHI 170 (241)
Q Consensus 158 ~~~~~~~~g~~p~ 170 (241)
||+.||++|.+-|
T Consensus 376 CIlAEL~tG~PLf 388 (586)
T KOG0667|consen 376 CILAELFTGEPLF 388 (586)
T ss_pred hhHHhHhcCcccc
Confidence 9999999997666
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=232.34 Aligned_cols=201 Identities=22% Similarity=0.289 Sum_probs=155.8
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~~ 85 (241)
..+++.+|+.++++++|+|++++++++. ....+++|||+++++|.+++.... .....++.+++.||+|||
T Consensus 44 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--- 119 (260)
T cd05070 44 SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE--- 119 (260)
T ss_pred CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 3567999999999999999999999875 456899999999999999986532 146789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+.+++|+||+|+||+++.++.++|+|||.+........... ....++..|+|||+..+..++.++|+||||+++|++++
T Consensus 120 ~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 198 (260)
T cd05070 120 RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198 (260)
T ss_pred HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc-cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHh
Confidence 89999999999999999999999999999876543321111 11234567999999988889999999999999999999
Q ss_pred -cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 166 -GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 166 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
|..||.... ..+....... ..... ... ..+..+.+++.+||..+|++|||++
T Consensus 199 ~g~~p~~~~~---------~~~~~~~~~~-~~~~~-----~~~--------~~~~~~~~li~~~l~~~p~~Rpt~~ 251 (260)
T cd05070 199 KGRVPYPGMN---------NREVLEQVER-GYRMP-----CPQ--------DCPISLHELMLQCWKKDPEERPTFE 251 (260)
T ss_pred cCCCCCCCCC---------HHHHHHHHHc-CCCCC-----CCC--------cCCHHHHHHHHHHcccCcccCcCHH
Confidence 889985421 1122222111 11000 011 2235789999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=237.95 Aligned_cols=204 Identities=17% Similarity=0.262 Sum_probs=160.6
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
..+.+.+|+.++++++|||++++++++...+..++|+||+++++|..++..... .+..++.+++.|+.||| +.+
T Consensus 59 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH---~~~ 135 (296)
T cd06655 59 KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH---ANQ 135 (296)
T ss_pred hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence 456788999999999999999999999999999999999999999998876532 56788999999999999 999
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCc
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRI 168 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~ 168 (241)
++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|++++|+.
T Consensus 136 i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~ 213 (296)
T cd06655 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213 (296)
T ss_pred cccCCCCHHHEEECCCCCEEEccCccchhccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999988755433211 123457888999999988889999999999999999999999
Q ss_pred ccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 169 HIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 169 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
||..... .+......... ...... .. ..+..+.+++.+||..||++|||+.+
T Consensus 214 pf~~~~~---------~~~~~~~~~~~-~~~~~~---~~--------~~~~~~~~li~~~l~~dp~~Rpt~~~ 265 (296)
T cd06655 214 PYLNENP---------LRALYLIATNG-TPELQN---PE--------KLSPIFRDFLNRCLEMDVEKRGSAKE 265 (296)
T ss_pred CCCCCCH---------HHHHHHHHhcC-CcccCC---cc--------cCCHHHHHHHHHHhhcChhhCCCHHH
Confidence 9954111 11111111111 000000 01 22356889999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=232.85 Aligned_cols=203 Identities=22% Similarity=0.283 Sum_probs=162.1
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~ 84 (241)
...+++.+|++++++++|+||+++++++...+..++++||+++++|.+++.... .....++.+++.|+.|||
T Consensus 41 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh-- 118 (256)
T cd08221 41 KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH-- 118 (256)
T ss_pred hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--
Confidence 456778999999999999999999999999999999999999999999986541 145778999999999999
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
+.+++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+|+
T Consensus 119 -~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~ 195 (256)
T cd08221 119 -KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL 195 (256)
T ss_pred -hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHH
Confidence 89999999999999999999999999999876544332 123346788999999998888899999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|..||... ...+...... .+...... ...+..+.+++.+||..+|.+|||++|
T Consensus 196 ~g~~~~~~~---------~~~~~~~~~~-~~~~~~~~-------------~~~~~~~~~~i~~~l~~~p~~R~s~~~ 249 (256)
T cd08221 196 TLKRTFDAT---------NPLNLVVKIV-QGNYTPVV-------------SVYSSELISLVHSLLQQDPEKRPTADE 249 (256)
T ss_pred HCCCCCCCC---------CHHHHHHHHH-cCCCCCCc-------------cccCHHHHHHHHHHcccCcccCCCHHH
Confidence 999998541 1112222211 11111110 123357889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=236.89 Aligned_cols=202 Identities=19% Similarity=0.278 Sum_probs=157.0
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+|++++++++|+|++++.+.+..++..++++||+++++|.+++.... .....++.|++.||.||| +
T Consensus 44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~ 120 (285)
T cd05632 44 ESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---R 120 (285)
T ss_pred HHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 3457889999999999999999999999999999999999999988875321 146788999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++||||+|+||+++.++.++|+|||.+......... ....++..|+|||++.+..++.++|+||||+++|++++|
T Consensus 121 ~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 197 (285)
T cd05632 121 ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEG 197 (285)
T ss_pred CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhC
Confidence 99999999999999999999999999998765432211 234688999999999888899999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
..||...... ...+.......... ..... ..+..+.+|+..||+.||++|||+.
T Consensus 198 ~~P~~~~~~~------~~~~~~~~~~~~~~------~~~~~--------~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 198 QSPFRGRKEK------VKREEVDRRVLETE------EVYSA--------KFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred CCCCCCCCHH------HHHHHHHHhhhccc------cccCc--------cCCHHHHHHHHHHccCCHhHcCCCc
Confidence 9999642110 00011111000000 00111 1235678999999999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=237.11 Aligned_cols=206 Identities=20% Similarity=0.271 Sum_probs=156.6
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
....+.+|+.++++++||||+++++++...+..++|+||+++++|.+++.... .....++.|++.|+.||| +.
T Consensus 49 ~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~ 125 (267)
T cd06646 49 DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH---SK 125 (267)
T ss_pred hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 34567899999999999999999999999999999999999999999875432 246778999999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc---ccCCCcchhhHHHHHHHHHHH
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS---ICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~s~G~~~~~~~ 164 (241)
+++|+|++|+||+++.++.++|+|||.+........ ......++..|+|||.+. ...++.++|+||||+++|+|+
T Consensus 126 ~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~ 203 (267)
T cd06646 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELA 203 (267)
T ss_pred CccccCCCHHHEEECCCCCEEECcCccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHH
Confidence 999999999999999999999999999876543211 112345788899999884 345778999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|+.||....... . ... ..... ...+.... ....+..+.+++.+||..+|++|||+++
T Consensus 204 ~g~~p~~~~~~~~--------~-~~~-~~~~~---~~~~~~~~------~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 261 (267)
T cd06646 204 ELQPPMFDLHPMR--------A-LFL-MSKSN---FQPPKLKD------KTKWSSTFHNFVKISLTKNPKKRPTAER 261 (267)
T ss_pred hCCCCccccchhh--------h-hee-eecCC---CCCCCCcc------ccccCHHHHHHHHHHhhCChhhCcCHHH
Confidence 9999985421110 0 000 00000 00111100 0122357899999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=236.63 Aligned_cols=216 Identities=22% Similarity=0.255 Sum_probs=165.5
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--C---chHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--P---LPRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~---~~~~~~~~~i~~ 76 (241)
|.+..........++.+|++++++++||||+++++++...+..++++||+++++|.+++... . .....++.+++.
T Consensus 32 k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~ 111 (265)
T cd06605 32 KTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLK 111 (265)
T ss_pred EEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHH
Confidence 44444444455678999999999999999999999999999999999999999999998654 1 145678999999
Q ss_pred HhchhhcCCC-CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHH
Q 044022 77 SLAYLHFGFP-RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFS 155 (241)
Q Consensus 77 ~l~~lh~~~~-~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 155 (241)
|+.||| + .+++|+||+|+||+++.++.++|+|||.+........ ....++..|+|||.+.+..++.++|+||
T Consensus 112 ~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~s 184 (265)
T cd06605 112 GLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWS 184 (265)
T ss_pred HHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHH
Confidence 999999 7 9999999999999999999999999998865533221 1145788899999998889999999999
Q ss_pred HHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 156 FGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 156 ~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
||+++|++++|+.||...... .....+......... .+.... ...+..+.+++.+||..||++
T Consensus 185 lG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~------~~~~~~-------~~~~~~~~~li~~~l~~~p~~ 247 (265)
T cd06605 185 LGLSLIELATGRFPYPPENDP----PDGIFELLQYIVNEP------PPRLPS-------GKFSPDFQDFVNLCLIKDPRE 247 (265)
T ss_pred HHHHHHHHHhCCCCCCccccc----cccHHHHHHHHhcCC------CCCCCh-------hhcCHHHHHHHHHHcCCCchh
Confidence 999999999999999652110 011111111111110 001100 013467899999999999999
Q ss_pred CCCCCC
Q 044022 236 RPTMVD 241 (241)
Q Consensus 236 Rpt~~e 241 (241)
|||+.|
T Consensus 248 Rpt~~~ 253 (265)
T cd06605 248 RPSYKE 253 (265)
T ss_pred CcCHHH
Confidence 999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=238.09 Aligned_cols=211 Identities=22% Similarity=0.219 Sum_probs=152.3
Q ss_pred HHHHHHHhcCCCcccceeeeeeeCC-----cceEEEEecCCCCHHHhhcCC-----Cc---hHHHHHHHHHHHhchhhcC
Q 044022 18 NNITYAAQMSHNHILKRIGCCLQTP-----IPILVFQSVEYGTLRDCIFGA-----PL---PRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 18 ~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~-----~~---~~~~~~~~i~~~l~~lh~~ 84 (241)
+|+++|+.+.|||||++.-+|.... ...+||||++ .+|.++++.. .. ...-+..||.+||+|||
T Consensus 66 rEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh-- 142 (364)
T KOG0658|consen 66 RELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH-- 142 (364)
T ss_pred HHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH--
Confidence 6999999999999999988887432 4569999998 6999988742 22 23457889999999999
Q ss_pred CCCCceeccCCCCCeeecCC-CCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEE-NVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~ 162 (241)
+.+|+||||||+|+|+|.+ |.+||+|||.|+.+...... .+...|..|+|||.+.+. .|+.+.||||.||++.|
T Consensus 143 -~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aE 218 (364)
T KOG0658|consen 143 -SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAE 218 (364)
T ss_pred -hcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHH
Confidence 8999999999999999977 89999999999987665432 345788999999999876 68999999999999999
Q ss_pred HHhcCcccccccccCCCcccchHHHHHHHhh---------hcccCCCCCCccccCCC-chhHHHHHHHHHHHHHHhccCC
Q 044022 163 LLAGRIHIWDLLKDTHDHGCFFNEYLKNYLE---------DKRFTGIPAPIIVQDIP-CIEKEQQLHASAQLTLECVNNS 232 (241)
Q Consensus 163 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~cl~~~ 232 (241)
|+.|++-|.... ......+..+.+-- +....+...+.+....- ........++..+|+.++|.++
T Consensus 219 Ll~g~plFpG~s-----~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~ 293 (364)
T KOG0658|consen 219 LLKGQPLFPGDS-----SVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYS 293 (364)
T ss_pred HhcCCcccCCCC-----HHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccC
Confidence 999999885410 11111111111100 11111111111111100 0011233467889999999999
Q ss_pred CCCCCCCC
Q 044022 233 PEDRPTMV 240 (241)
Q Consensus 233 p~~Rpt~~ 240 (241)
|++|.|+.
T Consensus 294 P~~R~~~~ 301 (364)
T KOG0658|consen 294 PSKRLSAL 301 (364)
T ss_pred hhhcCCHH
Confidence 99999874
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=236.23 Aligned_cols=204 Identities=20% Similarity=0.228 Sum_probs=156.7
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--C---chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--P---LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~---~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+.+.+|+++++.++|||++++++++...+..++|+||+++++|..++... . .....++.+++.||.||| +
T Consensus 45 ~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~ 121 (282)
T cd06643 45 ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---E 121 (282)
T ss_pred HHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 4567889999999999999999999999999999999999999998877532 1 246788999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc-----ccCCCcchhhHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS-----ICVLNEKSNVFSFGAFLF 161 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~s~G~~~~ 161 (241)
.+++|+||+|+||+++.++.++++|||.+........ ......++..|+|||++. ...++.++|+||||+++|
T Consensus 122 ~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~ 199 (282)
T cd06643 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 199 (282)
T ss_pred CCeeecCCCcccEEEccCCCEEEcccccccccccccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHH
Confidence 9999999999999999999999999999865433211 123346788999999984 345778999999999999
Q ss_pred HHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 162 ELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 162 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|++|+.||.... ..+......... ...... .. ..+..+.+++.+||+.||++|||+++
T Consensus 200 el~~g~~p~~~~~---------~~~~~~~~~~~~-~~~~~~---~~--------~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (282)
T cd06643 200 EMAQIEPPHHELN---------PMRVLLKIAKSE-PPTLAQ---PS--------RWSSEFKDFLKKCLEKNVDARWTTTQ 258 (282)
T ss_pred HHccCCCCccccC---------HHHHHHHHhhcC-CCCCCC---cc--------ccCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999985421 111111111111 001000 01 12357889999999999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=232.36 Aligned_cols=201 Identities=21% Similarity=0.276 Sum_probs=155.4
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc------hHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL------PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~~i~~~l~~lh~~~ 85 (241)
..+.+.+|++++++++|+|++++++++. .+..+++|||+++++|.+++..... ....++.+++.||.|||
T Consensus 44 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--- 119 (260)
T cd05069 44 MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE--- 119 (260)
T ss_pred cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 4567899999999999999999999875 4568999999999999999865321 35788999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+.+++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||+..+...+.++|+||||+++|++++
T Consensus 120 ~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t 198 (260)
T cd05069 120 RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198 (260)
T ss_pred hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHh
Confidence 899999999999999999999999999998765432211 1112235667999999988889999999999999999999
Q ss_pred -cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 166 -GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 166 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
|..||..... .+...... ..... .... ..+..+.+++.+||..||++|||++
T Consensus 199 ~g~~p~~~~~~---------~~~~~~~~-~~~~~-----~~~~--------~~~~~~~~li~~~l~~~p~~Rp~~~ 251 (260)
T cd05069 199 KGRVPYPGMVN---------REVLEQVE-RGYRM-----PCPQ--------GCPESLHELMKLCWKKDPDERPTFE 251 (260)
T ss_pred CCCCCCCCCCH---------HHHHHHHH-cCCCC-----CCCc--------ccCHHHHHHHHHHccCCcccCcCHH
Confidence 8999864211 11111111 11100 0111 2236789999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=246.13 Aligned_cols=155 Identities=18% Similarity=0.218 Sum_probs=130.7
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeC------CcceEEEEecCCCCHHHhhcCCC--chHHHHHHHHHHHhchhh
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQT------PIPILVFQSVEYGTLRDCIFGAP--LPRLKIASDIVNSLAYLH 82 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~lh 82 (241)
.....+.+|+.+++.++||||+++++++... ...++||||+. ++|.+.+.... .....++.|++.||.|||
T Consensus 65 ~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH 143 (364)
T cd07875 65 THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143 (364)
T ss_pred hhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHHhcCCHHHHHHHHHHHHHHHHHHh
Confidence 3456788999999999999999999987643 35799999996 57877765432 245678999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~ 162 (241)
+++++||||||+||+++.++.++|+|||++........ .....++..|+|||++.+..++.++||||||+++|+
T Consensus 144 ---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~e 217 (364)
T cd07875 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217 (364)
T ss_pred ---hCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHH
Confidence 99999999999999999999999999999975543221 123467899999999998899999999999999999
Q ss_pred HHhcCccccc
Q 044022 163 LLAGRIHIWD 172 (241)
Q Consensus 163 ~~~g~~p~~~ 172 (241)
|++|+.||..
T Consensus 218 ll~g~~pf~~ 227 (364)
T cd07875 218 MIKGGVLFPG 227 (364)
T ss_pred HHhCCCCCCC
Confidence 9999999954
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=242.55 Aligned_cols=156 Identities=19% Similarity=0.253 Sum_probs=131.1
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
.....+.+|++++++++||||+++++++...+..++|+||+. ++|.+++.... .....++.+++.||.|||
T Consensus 46 ~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH--- 121 (301)
T cd07873 46 GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH--- 121 (301)
T ss_pred CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 345567899999999999999999999999999999999997 69988876432 135678899999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~ 164 (241)
+.+++|+||||+||+++.++.++|+|||.+......... .....+++.|+|||.+.+. .++.++||||||+++|+|+
T Consensus 122 ~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~ 199 (301)
T cd07873 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMS 199 (301)
T ss_pred hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999998754332211 1223567889999988654 5788999999999999999
Q ss_pred hcCccccc
Q 044022 165 AGRIHIWD 172 (241)
Q Consensus 165 ~g~~p~~~ 172 (241)
+|++||..
T Consensus 200 tg~~~f~~ 207 (301)
T cd07873 200 TGRPLFPG 207 (301)
T ss_pred hCCCCCCC
Confidence 99999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=244.81 Aligned_cols=215 Identities=20% Similarity=0.340 Sum_probs=158.0
Q ss_pred cccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeC-CcceEEEEecCCCCHHHhhcCCC---------------
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQT-PIPILVFQSVEYGTLRDCIFGAP--------------- 64 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--------------- 64 (241)
|...........+.+.+|+.++.++ +||||+++++++... ...++++||+++|+|.+++....
T Consensus 43 K~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~ 122 (343)
T cd05103 43 KMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQ 122 (343)
T ss_pred EEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCcccccccccccccc
Confidence 4444333334456788999999999 689999999988754 46789999999999999875321
Q ss_pred --------------------------------------------------------chHHHHHHHHHHHhchhhcCCCCC
Q 044022 65 --------------------------------------------------------LPRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 65 --------------------------------------------------------~~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
.....++.+++.||+||| +++
T Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ 199 (343)
T cd05103 123 GKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRK 199 (343)
T ss_pred ccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 023568899999999999 999
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh-cC
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA-GR 167 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~-g~ 167 (241)
++||||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|++++ |.
T Consensus 200 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~ 279 (343)
T cd05103 200 CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 279 (343)
T ss_pred eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999999876533322222223345677999999988889999999999999999997 88
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.||...... ....... ..+.....+ . ..++.+.+++..||+.||++|||+.|
T Consensus 280 ~p~~~~~~~--------~~~~~~~-~~~~~~~~~-----~--------~~~~~~~~~~~~cl~~~p~~Rps~~e 331 (343)
T cd05103 280 SPYPGVKID--------EEFCRRL-KEGTRMRAP-----D--------YTTPEMYQTMLDCWHGEPSQRPTFSE 331 (343)
T ss_pred CCCCCcccc--------HHHHHHH-hccCCCCCC-----C--------CCCHHHHHHHHHHccCChhhCcCHHH
Confidence 898542110 1111111 111111111 0 11246889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=237.80 Aligned_cols=213 Identities=18% Similarity=0.310 Sum_probs=163.9
Q ss_pred cccccccccccHHHHHHHHHHHHhcC---CCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMS---HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIV 75 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~ 75 (241)
|.+..........++.+|+.++++++ |||++++++++......++|+||+++++|.+++..... ..+.++.+++
T Consensus 32 K~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~ 111 (277)
T cd06917 32 KIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVL 111 (277)
T ss_pred EEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHH
Confidence 55544444455677889999999997 99999999999999999999999999999999876543 4577899999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhH
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVF 154 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~ 154 (241)
.|+.||| +.+++|+||+|+||+++.++.++++|||.+......... .....++..|+|||.+.+. .++.++|+|
T Consensus 112 ~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~ 186 (277)
T cd06917 112 VALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIW 186 (277)
T ss_pred HHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc--cccccCCcceeCHHHhccCCccccchhHH
Confidence 9999999 999999999999999999999999999998766543321 1234678889999988654 568899999
Q ss_pred HHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 155 SFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 155 s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
|||+++|+|++|..||...... ...... .....+.+... ..+..+.+++.+||..||+
T Consensus 187 slG~~l~~ll~g~~p~~~~~~~---------~~~~~~------~~~~~~~~~~~-------~~~~~~~~~i~~~l~~~p~ 244 (277)
T cd06917 187 SLGITIYEMATGNPPYSDVDAF---------RAMMLI------PKSKPPRLEDN-------GYSKLLREFVAACLDEEPK 244 (277)
T ss_pred HHHHHHHHHHhCCCCCCCCChh---------hhhhcc------ccCCCCCCCcc-------cCCHHHHHHHHHHcCCCcc
Confidence 9999999999999999542110 000000 00011111111 1335788999999999999
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
+|||+.|
T Consensus 245 ~R~~~~~ 251 (277)
T cd06917 245 ERLSAEE 251 (277)
T ss_pred cCcCHHH
Confidence 9999753
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=236.48 Aligned_cols=214 Identities=25% Similarity=0.322 Sum_probs=155.2
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeC--CcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQT--PIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~ 84 (241)
..+.+.+|++++++++||||+++++++... ...++|+||+++++|.+++.... .....++.+++.||.|||
T Consensus 48 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH-- 125 (284)
T cd05081 48 HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG-- 125 (284)
T ss_pred HHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH--
Confidence 456789999999999999999999987543 46889999999999999986432 246788999999999999
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCccee-ecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT-TDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+.+++|+||||+||+++.++.++|+|||.+........... .....++..|+|||++.+..++.++|+||||+++|+|
T Consensus 126 -~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 204 (284)
T cd05081 126 -SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204 (284)
T ss_pred -HCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHH
Confidence 89999999999999999999999999999886644322111 1112234569999999888899999999999999999
Q ss_pred HhcCcccccccccCC------CcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTH------DHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
++|..|+........ ..................... .. ...+..+.+++.+||+.+|++||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~--------~~~~~~~~~li~~cl~~~p~~Rp 271 (284)
T cd05081 205 FTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLP-----AP--------PGCPAEIYAIMKECWNNDPSQRP 271 (284)
T ss_pred hhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCC-----CC--------CCCCHHHHHHHHHHccCChhhCC
Confidence 998776543211100 000000011111111110000 00 12235789999999999999999
Q ss_pred CCCC
Q 044022 238 TMVD 241 (241)
Q Consensus 238 t~~e 241 (241)
|+.|
T Consensus 272 t~~e 275 (284)
T cd05081 272 SFSE 275 (284)
T ss_pred CHHH
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=232.60 Aligned_cols=202 Identities=23% Similarity=0.303 Sum_probs=155.8
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+|.+|++++++++|+||+++++.+. ....++||||+++++|.+++.... .....++.+++.||+|||
T Consensus 44 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH--- 119 (262)
T cd05071 44 SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE--- 119 (262)
T ss_pred CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---
Confidence 3567899999999999999999999874 456899999999999999987531 146788999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+.+++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||+..+..++.++|+||||+++|++++
T Consensus 120 ~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt 198 (262)
T cd05071 120 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 198 (262)
T ss_pred HCCccccccCcccEEEcCCCcEEeccCCceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHc
Confidence 899999999999999999999999999998765433211 1122345677999999988889999999999999999999
Q ss_pred -cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 -GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|..||..... .+...... ..... . .. ...+..+.+++.+||+.||++|||+.+
T Consensus 199 ~g~~p~~~~~~---------~~~~~~~~-~~~~~--~---~~--------~~~~~~l~~li~~~l~~~p~~Rp~~~~ 252 (262)
T cd05071 199 KGRVPYPGMVN---------REVLDQVE-RGYRM--P---CP--------PECPESLHDLMCQCWRKEPEERPTFEY 252 (262)
T ss_pred CCCCCCCCCCh---------HHHHHHHh-cCCCC--C---Cc--------cccCHHHHHHHHHHccCCcccCCCHHH
Confidence 8888854211 11111111 11000 0 00 123467899999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=235.17 Aligned_cols=206 Identities=19% Similarity=0.295 Sum_probs=159.2
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
....+.+|++++++++|+||+++++++...+..++++||+++++|.+++..... ....++.+++.|++||| +.
T Consensus 45 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~ 121 (265)
T cd06631 45 EYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH---NN 121 (265)
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 346688999999999999999999999999999999999999999999865322 45678899999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCc----ceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET----HITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+++|+||+|+||+++.++.++|+|||.+........ ........++..|+|||++.+..++.++|+||||+++|++
T Consensus 122 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l 201 (265)
T cd06631 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEM 201 (265)
T ss_pred CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHH
Confidence 999999999999999999999999998865432111 1111234578889999999988889999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|..||...... ............. +.... ..+..+.+++++||+.+|++|||++|
T Consensus 202 ~~g~~p~~~~~~~--------~~~~~~~~~~~~~-----~~~~~--------~~~~~~~~~i~~~l~~~p~~Rp~~~~ 258 (265)
T cd06631 202 ATGKPPLASMDRL--------AAMFYIGAHRGLM-----PRLPD--------SFSAAAIDFVTSCLTRDQHERPSALQ 258 (265)
T ss_pred HhCCCccccCChH--------HHHHHhhhccCCC-----CCCCC--------CCCHHHHHHHHHHhcCCcccCCCHHH
Confidence 9999999542110 0000000000111 11111 23367899999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=245.60 Aligned_cols=155 Identities=19% Similarity=0.213 Sum_probs=130.3
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCC------cceEEEEecCCCCHHHhhcCCC--chHHHHHHHHHHHhchhh
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTP------IPILVFQSVEYGTLRDCIFGAP--LPRLKIASDIVNSLAYLH 82 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~lh 82 (241)
.....+.+|+.+++.++||||+++++++.... ..++||||+. ++|.+.+...- .....++.|++.||.|||
T Consensus 58 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH 136 (355)
T cd07874 58 THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136 (355)
T ss_pred HHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhc-ccHHHHHhhcCCHHHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999886432 4699999997 57777665432 245678999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~ 162 (241)
+.+++||||||+||+++.++.+||+|||++........ .....++..|+|||++.+..++.++||||||+++|+
T Consensus 137 ---~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~e 210 (355)
T cd07874 137 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210 (355)
T ss_pred ---hCCcccCCCChHHEEECCCCCEEEeeCcccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHH
Confidence 99999999999999999999999999999876543221 123468899999999998889999999999999999
Q ss_pred HHhcCccccc
Q 044022 163 LLAGRIHIWD 172 (241)
Q Consensus 163 ~~~g~~p~~~ 172 (241)
|++|+.||..
T Consensus 211 l~~g~~pf~~ 220 (355)
T cd07874 211 MVRHKILFPG 220 (355)
T ss_pred HHhCCCCCCC
Confidence 9999999954
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=244.06 Aligned_cols=202 Identities=20% Similarity=0.283 Sum_probs=165.3
Q ss_pred cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHHhchhhcC
Q 044022 10 RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 10 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~l~~lh~~ 84 (241)
.-...++.+|++.|+.++|||||++|++...+..+|+|+|+=.+|+|++|+-++.. -..+++.||+.|+.|+|
T Consensus 58 ~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH-- 135 (864)
T KOG4717|consen 58 TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH-- 135 (864)
T ss_pred hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh--
Confidence 34567788999999999999999999999999999999999999999999977643 35689999999999999
Q ss_pred CCCCceeccCCCCCeeec-CCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCC-cchhhHHHHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFN-EENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLN-EKSNVFSFGAFLFE 162 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~s~G~~~~~ 162 (241)
+..+|||||||+|+.+. +-|-+|+.|||++..+..+... ++.+|+..|-|||.+.+..|+ +++||||||+|+|.
T Consensus 136 -qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyM 211 (864)
T KOG4717|consen 136 -QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYM 211 (864)
T ss_pred -hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHH
Confidence 99999999999998875 5589999999999877665433 445899999999999998876 78899999999999
Q ss_pred HHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 163 LLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 163 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++.|++||...... +.+.....-. ...+..-+.++++||..||..||++|.|.+|
T Consensus 212 LVCGq~PFqeANDS---------ETLTmImDCK---------------YtvPshvS~eCrdLI~sMLvRdPkkRAslEe 266 (864)
T KOG4717|consen 212 LVCGQPPFQEANDS---------ETLTMIMDCK---------------YTVPSHVSKECRDLIQSMLVRDPKKRASLEE 266 (864)
T ss_pred HHhCCCccccccch---------hhhhhhhccc---------------ccCchhhhHHHHHHHHHHHhcCchhhccHHH
Confidence 99999999763322 1111111111 0111255678999999999999999998764
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=239.90 Aligned_cols=204 Identities=18% Similarity=0.256 Sum_probs=159.9
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
..+.+.+|+.+++.++|+|++++++++..++..++|+||+++++|.+++..... ....++.+++.||.||| +.+
T Consensus 59 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ 135 (297)
T cd06656 59 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH---SNQ 135 (297)
T ss_pred hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence 456788999999999999999999999999999999999999999999866432 56788999999999999 899
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCc
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRI 168 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~ 168 (241)
++|+||+|+||+++.++.++|+|||.+......... .....+++.|+|||.+.+..++.++|+||||+++|++++|..
T Consensus 136 i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~ 213 (297)
T cd06656 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213 (297)
T ss_pred cccCCCCHHHEEECCCCCEEECcCccceEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999998765433211 123457888999999998888999999999999999999999
Q ss_pred ccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 169 HIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 169 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
||....... ........+ .+.... ....+..+.+++.+||..+|++|||++|
T Consensus 214 pf~~~~~~~---------~~~~~~~~~----~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~ 265 (297)
T cd06656 214 PYLNENPLR---------ALYLIATNG----TPELQN--------PERLSAVFRDFLNRCLEMDVDRRGSAKE 265 (297)
T ss_pred CCCCCCcch---------heeeeccCC----CCCCCC--------ccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 995411100 000000000 000000 0123356789999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=232.46 Aligned_cols=199 Identities=21% Similarity=0.301 Sum_probs=155.1
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeee-eCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCL-QTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~ 84 (241)
..+.+.+|+.++++++|+|++++++++. ..+..++++||+++++|.+++.... ...+.++.+++.||.|||
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-- 119 (256)
T cd05082 42 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-- 119 (256)
T ss_pred hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 3567899999999999999999999765 4457899999999999999986542 145788999999999999
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
+.+++|+||||+||+++.++.++++|||.+....... .....+..|+|||++....++.++||||||+++|+|+
T Consensus 120 -~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~ 193 (256)
T cd05082 120 -ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 193 (256)
T ss_pred -hCCEeccccchheEEEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHH
Confidence 8999999999999999999999999999987544322 1223456799999998888999999999999999999
Q ss_pred h-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 A-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+ |+.||... ...+....... .... .... ..+..+.+++.+||+.+|++|||+.+
T Consensus 194 ~~g~~p~~~~---------~~~~~~~~~~~-~~~~-----~~~~--------~~~~~~~~li~~~l~~~p~~Rpt~~~ 248 (256)
T cd05082 194 SFGRVPYPRI---------PLKDVVPRVEK-GYKM-----DAPD--------GCPPVVYDVMKQCWHLDAATRPSFLQ 248 (256)
T ss_pred hCCCCCCCCC---------CHHHHHHHHhc-CCCC-----CCCC--------CCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 7 99998541 11122222111 1110 1111 22357889999999999999999854
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=228.59 Aligned_cols=207 Identities=20% Similarity=0.236 Sum_probs=165.6
Q ss_pred HHHHHHHHHHHHhc-CCCcccceeeeeee----CCcceEEEEecCCCCHHHhhcCCCc------hHHHHHHHHHHHhchh
Q 044022 13 YGSCINNITYAAQM-SHNHILKRIGCCLQ----TPIPILVFQSVEYGTLRDCIFGAPL------PRLKIASDIVNSLAYL 81 (241)
Q Consensus 13 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~~i~~~l~~l 81 (241)
.+...+|+++--.. .|||||.+++++.+ ...+.+|||.|+||.|++.++.... ..-.++++|..|+.||
T Consensus 98 s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~l 177 (400)
T KOG0604|consen 98 SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYL 177 (400)
T ss_pred CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHH
Confidence 34456788766555 79999999999875 3478899999999999999987643 3567999999999999
Q ss_pred hcCCCCCceeccCCCCCeeecC---CCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHH
Q 044022 82 HFGFPRPIVLRNFKTQNILFNE---ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGA 158 (241)
Q Consensus 82 h~~~~~~ivh~dl~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~ 158 (241)
| +.+|.||||||+|+|... +..+||+|||+++....... ..+.+.|++|.|||++-..+++..+|+||+|+
T Consensus 178 H---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~---L~TPc~TPyYvaPevlg~eKydkscdmwSlgV 251 (400)
T KOG0604|consen 178 H---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGD---LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGV 251 (400)
T ss_pred H---hcchhhccCChhheeeecCCCCcceEecccccccccCCCcc---ccCCcccccccCHHHhCchhcCCCCCccchhH
Confidence 9 999999999999999954 46789999999987654322 24457899999999999999999999999999
Q ss_pred HHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 159 FLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 159 ~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
++|-|+.|.+||++.-.. -+.-.++.....+.+ .+|..+...-+++.+++|+.+|..+|++|.|
T Consensus 252 imYIlLCGyPPFYS~hg~------aispgMk~rI~~gqy----------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlT 315 (400)
T KOG0604|consen 252 IMYILLCGYPPFYSNHGL------AISPGMKRRIRTGQY----------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLT 315 (400)
T ss_pred HHHHhhcCCCcccccCCc------cCChhHHhHhhccCc----------cCCChhHhHHHHHHHHHHHHHhcCCchhhee
Confidence 999999999999873222 222234444444433 2444555678889999999999999999999
Q ss_pred CCC
Q 044022 239 MVD 241 (241)
Q Consensus 239 ~~e 241 (241)
++|
T Consensus 316 I~~ 318 (400)
T KOG0604|consen 316 IEE 318 (400)
T ss_pred HHH
Confidence 864
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=248.25 Aligned_cols=159 Identities=16% Similarity=0.214 Sum_probs=136.3
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
.....+.+|+.++.+++|+||+++++++...+..++||||+++|+|.+++..... ....++.|++.||.||| +
T Consensus 43 ~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH---~ 119 (360)
T cd05627 43 EQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH---Q 119 (360)
T ss_pred hhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 3456788899999999999999999999999999999999999999999865432 45678999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc---------------------------------eeecccccC
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH---------------------------------ITTDRVIGT 133 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~---------------------------------~~~~~~~~~ 133 (241)
++++||||||+|||++.++.++|+|||++......... .......||
T Consensus 120 ~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 199 (360)
T cd05627 120 LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGT 199 (360)
T ss_pred CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCC
Confidence 99999999999999999999999999998644221000 001134689
Q ss_pred CCccCcccccccCCCcchhhHHHHHHHHHHHhcCccccc
Q 044022 134 RGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 134 ~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 200 ~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 200 PDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred ccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 999999999988999999999999999999999999965
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=233.20 Aligned_cols=206 Identities=20% Similarity=0.273 Sum_probs=157.2
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
....+.+|+.+++.++||||+++++++...+..++|+||+++++|.+++.... .....++.+++.|+.||| +.
T Consensus 49 ~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~ 125 (267)
T cd06645 49 DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH---SK 125 (267)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 34567889999999999999999999999999999999999999999886543 256788999999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc---ccCCCcchhhHHHHHHHHHHH
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS---ICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~s~G~~~~~~~ 164 (241)
+++|+||||+||+++.++.++|+|||.+....... .......++..|+|||++. ...++.++|+||||+++|+|+
T Consensus 126 ~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~ 203 (267)
T cd06645 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELA 203 (267)
T ss_pred CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHh
Confidence 99999999999999999999999999987654321 1123346888999999874 345788999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|..||...... ........ ... ..+...... ..+..+.+++.+||..+|++|||+++
T Consensus 204 ~~~~p~~~~~~~---------~~~~~~~~-~~~---~~~~~~~~~------~~~~~~~~li~~~l~~~P~~R~~~~~ 261 (267)
T cd06645 204 ELQPPMFDLHPM---------RALFLMTK-SNF---QPPKLKDKM------KWSNSFHHFVKMALTKNPKKRPTAEK 261 (267)
T ss_pred cCCCCcccccch---------hhHHhhhc-cCC---CCCcccccC------CCCHHHHHHHHHHccCCchhCcCHHH
Confidence 999998542110 00001000 100 011110000 12246889999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=235.31 Aligned_cols=204 Identities=20% Similarity=0.256 Sum_probs=155.9
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC-----CchHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA-----PLPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----~~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+++.+|++++++++|+|++++++.+..++..++||||+++++|..++... ...+..++.|++.|+.||| +
T Consensus 52 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~ 128 (292)
T cd06644 52 ELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---S 128 (292)
T ss_pred HHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---c
Confidence 4667889999999999999999999999999999999999999998876432 1246789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc-----ccCCCcchhhHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS-----ICVLNEKSNVFSFGAFLF 161 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~s~G~~~~ 161 (241)
.+++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||++. ...++.++|+||||+++|
T Consensus 129 ~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~ 206 (292)
T cd06644 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 206 (292)
T ss_pred CCeeecCCCcceEEEcCCCCEEEccCccceecccccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHH
Confidence 9999999999999999999999999998765433211 112345788999999985 345678999999999999
Q ss_pred HHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 162 ELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 162 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|++|..||..... .+......... .+.... ....+..+.+++.+||..||++|||++|
T Consensus 207 el~~g~~p~~~~~~---------~~~~~~~~~~~------~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 265 (292)
T cd06644 207 EMAQIEPPHHELNP---------MRVLLKIAKSE------PPTLSQ------PSKWSMEFRDFLKTALDKHPETRPSAAQ 265 (292)
T ss_pred HHhcCCCCCccccH---------HHHHHHHhcCC------CccCCC------CcccCHHHHHHHHHHhcCCcccCcCHHH
Confidence 99999999854211 11111111100 000000 0122356889999999999999999754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=247.16 Aligned_cols=156 Identities=22% Similarity=0.282 Sum_probs=130.9
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCC-----cceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhh
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTP-----IPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLH 82 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh 82 (241)
..+++.+|+++++.++|+||+++++++...+ ..++|+||+. ++|.+.+..... ....++.|++.||.|||
T Consensus 42 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH 120 (372)
T cd07853 42 SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH 120 (372)
T ss_pred HHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999998766 7899999996 688887754422 46678999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLF 161 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~ 161 (241)
+.+++||||||+|||++.++.++|+|||++......... ......++..|+|||.+.+. .++.++||||+||++|
T Consensus 121 ---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ 196 (372)
T cd07853 121 ---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFA 196 (372)
T ss_pred ---hCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHH
Confidence 899999999999999999999999999998765432211 11234578899999998764 4789999999999999
Q ss_pred HHHhcCccccc
Q 044022 162 ELLAGRIHIWD 172 (241)
Q Consensus 162 ~~~~g~~p~~~ 172 (241)
+|++|+.||..
T Consensus 197 el~~g~~pf~~ 207 (372)
T cd07853 197 ELLGRRILFQA 207 (372)
T ss_pred HHHcCCCCCCC
Confidence 99999999954
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=236.66 Aligned_cols=224 Identities=23% Similarity=0.335 Sum_probs=162.9
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeee--CCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQ--TPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDI 74 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i 74 (241)
|.+...........|.+|+++++.++|+||+++++++.. ....++++||+++++|.+++.... .....++.++
T Consensus 39 K~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l 118 (284)
T cd05038 39 KSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI 118 (284)
T ss_pred EEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHH
Confidence 444333322346789999999999999999999999877 557899999999999999987654 1467889999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcce-eecccccCCCccCcccccccCCCcchhh
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI-TTDRVIGTRGYSAPEYISICVLNEKSNV 153 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di 153 (241)
+.||.||| +.+++|+||+|+||+++.++.++|+|||.+.......... ......++..|+|||...+..++.++|+
T Consensus 119 ~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di 195 (284)
T cd05038 119 CKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDV 195 (284)
T ss_pred HHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccch
Confidence 99999999 8999999999999999999999999999988765332211 1112234566999999988889999999
Q ss_pred HHHHHHHHHHHhcCcccccccccCCC-----cccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHh
Q 044022 154 FSFGAFLFELLAGRIHIWDLLKDTHD-----HGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLEC 228 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 228 (241)
||||+++|+|++|..|+......... ................. ....+ ..++..+.+++.+|
T Consensus 196 ~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-----------~~~~~~~~~li~~c 262 (284)
T cd05038 196 WSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE--RLPRP-----------PSCPDEVYDLMKLC 262 (284)
T ss_pred HHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC--cCCCC-----------ccCCHHHHHHHHHH
Confidence 99999999999999998552211100 00000111111111110 00000 12235789999999
Q ss_pred ccCCCCCCCCCCC
Q 044022 229 VNNSPEDRPTMVD 241 (241)
Q Consensus 229 l~~~p~~Rpt~~e 241 (241)
|..+|++|||+.|
T Consensus 263 l~~~p~~Rpt~~e 275 (284)
T cd05038 263 WEAEPQDRPSFAD 275 (284)
T ss_pred hccChhhCCCHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=238.66 Aligned_cols=157 Identities=20% Similarity=0.202 Sum_probs=127.1
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeee--CCcceEEEEecCCCCHHHhhcCCC-------------chHHHHHHHHHHH
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQ--TPIPILVFQSVEYGTLRDCIFGAP-------------LPRLKIASDIVNS 77 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~-------------~~~~~~~~~i~~~ 77 (241)
...+.+|++++++++||||+++++++.. ....++|+||+. ++|.+++.... .....++.|++.|
T Consensus 42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 120 (317)
T cd07867 42 SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120 (317)
T ss_pred cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHH
Confidence 3467899999999999999999999864 457799999996 58877764210 1256789999999
Q ss_pred hchhhcCCCCCceeccCCCCCeee----cCCCCeEEeeccCceecCCCCcc-eeecccccCCCccCccccccc-CCCcch
Q 044022 78 LAYLHFGFPRPIVLRNFKTQNILF----NEENVAKWFDFLLSISIPEGETH-ITTDRVIGTRGYSAPEYISIC-VLNEKS 151 (241)
Q Consensus 78 l~~lh~~~~~~ivh~dl~~~nil~----~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~ 151 (241)
|.||| +.+++||||||+||++ +.++.++|+|||++......... .......++..|+|||++.+. .++.++
T Consensus 121 L~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 197 (317)
T cd07867 121 IHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI 197 (317)
T ss_pred HHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHH
Confidence 99999 8999999999999999 56679999999999765433211 112234678899999998764 578999
Q ss_pred hhHHHHHHHHHHHhcCcccccc
Q 044022 152 NVFSFGAFLFELLAGRIHIWDL 173 (241)
Q Consensus 152 Di~s~G~~~~~~~~g~~p~~~~ 173 (241)
||||||+++|+|++|++||...
T Consensus 198 DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 198 DIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred HHHhHHHHHHHHHhCCCCcccc
Confidence 9999999999999999999653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=233.64 Aligned_cols=219 Identities=21% Similarity=0.290 Sum_probs=165.6
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-------chHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-------LPRLKIASDI 74 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------~~~~~~~~~i 74 (241)
|++..+......+.+.+|+++++.++|+|++++++.+...+..++|+|++++++|.+++.... .....++.++
T Consensus 32 k~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql 111 (267)
T cd06610 32 KRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEV 111 (267)
T ss_pred EEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHH
Confidence 444433333356789999999999999999999999999999999999999999999986531 1456789999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcce--eecccccCCCccCccccccc-CCCcch
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI--TTDRVIGTRGYSAPEYISIC-VLNEKS 151 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~ 151 (241)
+.|+++|| +.+++|+||+|+||+++.++.++|+|||.+.......... ......++..|+|||++... .++.++
T Consensus 112 ~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~ 188 (267)
T cd06610 112 LKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKA 188 (267)
T ss_pred HHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCccc
Confidence 99999999 9999999999999999999999999999987665443221 22334578899999998876 788999
Q ss_pred hhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccC
Q 044022 152 NVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNN 231 (241)
Q Consensus 152 Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~ 231 (241)
|+||||+++|+|++|+.||...... +......... .+....... ....++.+.+++.+||..
T Consensus 189 Dv~slG~i~~~l~~g~~p~~~~~~~---------~~~~~~~~~~------~~~~~~~~~---~~~~~~~~~~li~~~l~~ 250 (267)
T cd06610 189 DIWSFGITAIELATGAAPYSKYPPM---------KVLMLTLQND------PPSLETGAD---YKKYSKSFRKMISLCLQK 250 (267)
T ss_pred chHhHhHHHHHHHhCCCCccccChh---------hhHHHHhcCC------CCCcCCccc---cccccHHHHHHHHHHcCC
Confidence 9999999999999999999652111 0111111110 011111000 013346789999999999
Q ss_pred CCCCCCCCCC
Q 044022 232 SPEDRPTMVD 241 (241)
Q Consensus 232 ~p~~Rpt~~e 241 (241)
||++|||++|
T Consensus 251 ~p~~Rp~~~~ 260 (267)
T cd06610 251 DPSKRPTAEE 260 (267)
T ss_pred ChhhCcCHHH
Confidence 9999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=236.25 Aligned_cols=221 Identities=22% Similarity=0.230 Sum_probs=161.0
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeC--CcceEEEEecCCCCHHHhhcCC-----C---chHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQT--PIPILVFQSVEYGTLRDCIFGA-----P---LPRLKIA 71 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~-----~---~~~~~~~ 71 (241)
|.+..........++.+|++++++++||||+++++++... +..++||||+++++|.+++... . .....++
T Consensus 32 k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~ 111 (287)
T cd06621 32 KTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIA 111 (287)
T ss_pred EEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHH
Confidence 4444333334567799999999999999999999988653 4689999999999998876421 1 1356799
Q ss_pred HHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcch
Q 044022 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKS 151 (241)
Q Consensus 72 ~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 151 (241)
.+++.||+||| +.+++|+||+|+||+++.++.++|+|||++........ ....++..|+|||.+.+..++.++
T Consensus 112 ~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~ 184 (287)
T cd06621 112 ESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITS 184 (287)
T ss_pred HHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccccccccc----ccccCCccccCHHHhcCCCCCchh
Confidence 99999999999 89999999999999999999999999999865433221 123467789999999888899999
Q ss_pred hhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccC
Q 044022 152 NVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNN 231 (241)
Q Consensus 152 Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~ 231 (241)
|+||||+++|+|++|..||....... ....+.. .............. .... ...++.+.+++.+||+.
T Consensus 185 Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~-~~~~------~~~~~~~~~li~~~l~~ 252 (287)
T cd06621 185 DVWSLGLTLLEVAQNRFPFPPEGEPP----LGPIELL-SYIVNMPNPELKDE-PGNG------IKWSEEFKDFIKQCLEK 252 (287)
T ss_pred hHHHHHHHHHHHHhCCCCCCcccCCC----CChHHHH-HHHhcCCchhhccC-CCCC------CchHHHHHHHHHHHcCC
Confidence 99999999999999999996531110 0111111 11111111111110 0000 12346789999999999
Q ss_pred CCCCCCCCCC
Q 044022 232 SPEDRPTMVD 241 (241)
Q Consensus 232 ~p~~Rpt~~e 241 (241)
+|++|||+.|
T Consensus 253 ~p~~Rpt~~e 262 (287)
T cd06621 253 DPTRRPTPWD 262 (287)
T ss_pred CcccCCCHHH
Confidence 9999999854
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=231.22 Aligned_cols=213 Identities=24% Similarity=0.339 Sum_probs=164.4
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC---c---hHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---L---PRLKIASDIV 75 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~---~~~~~~~~i~ 75 (241)
|.............+.+|+.+++.++|+||+++++++...+..+++|||+++++|.+++.... . ....++.+++
T Consensus 34 K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~ 113 (258)
T smart00219 34 KTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIA 113 (258)
T ss_pred EEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHH
Confidence 444433333357789999999999999999999999999899999999999999999986532 2 4678899999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHH
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFS 155 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 155 (241)
.|+++|| +.+++|+||+|+||+++.++.++++|||.+............ ...++..|+|||.+.+..++.++|+||
T Consensus 114 ~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~s 189 (258)
T smart00219 114 RGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWS 189 (258)
T ss_pred HHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHH
Confidence 9999999 999999999999999999999999999998766554222211 223678899999998888999999999
Q ss_pred HHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 156 FGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 156 ~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
+|+++++|++ |..||... ......... ......... . ..+..+.+++.+||..||+
T Consensus 190 lG~i~~~l~~~g~~p~~~~---------~~~~~~~~~-~~~~~~~~~-----~--------~~~~~~~~~i~~~l~~~p~ 246 (258)
T smart00219 190 FGVLLWEIFTLGESPYPGM---------SNEEVLEYL-KKGYRLPKP-----E--------NCPPEIYKLMLQCWAEDPE 246 (258)
T ss_pred HHHHHHHHHhCCCCCCCCC---------CHHHHHHHH-hcCCCCCCC-----C--------cCCHHHHHHHHHHCcCChh
Confidence 9999999998 78887541 111111111 111111111 1 1335788999999999999
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
+|||+.|
T Consensus 247 ~Rpt~~~ 253 (258)
T smart00219 247 DRPTFSE 253 (258)
T ss_pred hCcCHHH
Confidence 9999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=232.72 Aligned_cols=202 Identities=22% Similarity=0.272 Sum_probs=159.9
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|++++++++||||+++++.+..+...++++||+++++|.+++..... ....++.+++.||.||| +
T Consensus 35 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH---~ 111 (262)
T cd05572 35 GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLH---N 111 (262)
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---h
Confidence 4457799999999999999999999999999999999999999999999876432 45678899999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+....++.++|+||||+++|++++|
T Consensus 112 ~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g 188 (262)
T cd05572 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTG 188 (262)
T ss_pred CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhC
Confidence 999999999999999999999999999987665432 11234578889999999888889999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
..||...... ..+..............+ . ..+..+.+++.+||..+|++|||
T Consensus 189 ~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~-----~--------~~~~~~~~~i~~~l~~~p~~R~~ 240 (262)
T cd05572 189 RPPFGEDDED-------PMEIYNDILKGNGKLEFP-----N--------YIDKAAKDLIKQLLRRNPEERLG 240 (262)
T ss_pred CCCcCCCCCC-------HHHHHHHHhccCCCCCCC-----c--------ccCHHHHHHHHHHccCChhhCcC
Confidence 9999653210 111111111101000000 0 11357899999999999999999
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=237.28 Aligned_cols=205 Identities=17% Similarity=0.281 Sum_probs=160.3
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
...+.+.+|+.+++.++|||++++++++..++..++|+||+++++|..++..... ....++.+++.||.||| +.
T Consensus 60 ~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~ 136 (297)
T cd06659 60 QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLH---SQ 136 (297)
T ss_pred chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 3456788999999999999999999999999999999999999999998765432 46788999999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcC
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
+++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||++.+..++.++|+||||+++|+|++|+
T Consensus 137 ~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~ 214 (297)
T cd06659 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214 (297)
T ss_pred CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998865433221 112346788999999998888999999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.||.... ..+.......... ....... ..+..+.+++.+||..+|++|||++|
T Consensus 215 ~p~~~~~---------~~~~~~~~~~~~~----~~~~~~~--------~~~~~l~~~i~~~l~~~P~~Rps~~~ 267 (297)
T cd06659 215 PPYFSDS---------PVQAMKRLRDSPP----PKLKNAH--------KISPVLRDFLERMLTREPQERATAQE 267 (297)
T ss_pred CCCCCCC---------HHHHHHHHhccCC----CCccccC--------CCCHHHHHHHHHHhcCCcccCcCHHH
Confidence 9985411 1111111111100 0000001 12256889999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=233.57 Aligned_cols=204 Identities=23% Similarity=0.311 Sum_probs=155.8
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--C-----chHHHHHHHHHHHhchhhcC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--P-----LPRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~-----~~~~~~~~~i~~~l~~lh~~ 84 (241)
..+.+.+|++++++++|+||+++++++..++..++|+||+++++|.+++... . .....++.+++.|++|||
T Consensus 48 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH-- 125 (268)
T cd06624 48 YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH-- 125 (268)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH--
Confidence 4567899999999999999999999999999999999999999999988653 1 135678899999999999
Q ss_pred CCCCceeccCCCCCeeecC-CCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc--CCCcchhhHHHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNE-ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC--VLNEKSNVFSFGAFLF 161 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~s~G~~~~ 161 (241)
+.+++|+||||+||+++. .+.++|+|||.+........ ......++..|+|||++... .++.++|+||||+++|
T Consensus 126 -~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~ 202 (268)
T cd06624 126 -DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIV 202 (268)
T ss_pred -HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHH
Confidence 899999999999999976 67999999999875533221 11223578899999998654 3788999999999999
Q ss_pred HHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 162 ELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 162 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++++|..||....... ........... .+.+.. ...+.+.+++.+||+.+|++|||+.|
T Consensus 203 ~l~~g~~p~~~~~~~~--------~~~~~~~~~~~-----~~~~~~--------~~~~~~~~li~~~l~~~p~~Rpt~~~ 261 (268)
T cd06624 203 EMATGKPPFIELGEPQ--------AAMFKVGMFKI-----HPEIPE--------SLSAEAKNFILRCFEPDPDKRASAHD 261 (268)
T ss_pred HHHhCCCCCccccChh--------hhHhhhhhhcc-----CCCCCc--------ccCHHHHHHHHHHcCCCchhCCCHHH
Confidence 9999999985421110 00000000000 011111 23356889999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=236.35 Aligned_cols=205 Identities=20% Similarity=0.176 Sum_probs=156.5
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+.+.+|+++++.++||||+++++.+..++..++||||+++++|.+++..... ....++.+++.|+.||| +.
T Consensus 44 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~ 120 (305)
T cd05609 44 QIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH---NY 120 (305)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 355788999999999999999999999999999999999999999999865432 35677889999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCC-------------cceeecccccCCCccCcccccccCCCcchhhH
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE-------------THITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
+++|+||+|+||+++.++.++++|||.++...... .........++..|+|||.+....++.++|+|
T Consensus 121 ~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 200 (305)
T cd05609 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWW 200 (305)
T ss_pred CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHH
Confidence 99999999999999999999999999876321100 00011123567789999999888899999999
Q ss_pred HHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 155 SFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 155 s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
|||+++|++++|..||.... ..+......... ...+.... ..+..+.+++.+||+.||+
T Consensus 201 slG~vl~el~~g~~pf~~~~---------~~~~~~~~~~~~----~~~~~~~~--------~~~~~~~~li~~~l~~~P~ 259 (305)
T cd05609 201 AMGIILYEFLVGCVPFFGDT---------PEELFGQVISDD----IEWPEGDE--------ALPADAQDLISRLLRQNPL 259 (305)
T ss_pred HHHHHHHHHHhCCCCCCCCC---------HHHHHHHHHhcc----cCCCCccc--------cCCHHHHHHHHHHhccChh
Confidence 99999999999999995421 111111111111 01111101 1235688999999999999
Q ss_pred CCCCCC
Q 044022 235 DRPTMV 240 (241)
Q Consensus 235 ~Rpt~~ 240 (241)
+|||+.
T Consensus 260 ~R~~~~ 265 (305)
T cd05609 260 ERLGTG 265 (305)
T ss_pred hccCcc
Confidence 999953
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=229.71 Aligned_cols=154 Identities=22% Similarity=0.299 Sum_probs=133.4
Q ss_pred HHHHHHHHHHHHhcCCCc-ccceeeeeeeCC------cceEEEEecCCCCHHHhhcCCCc--------hHHHHHHHHHHH
Q 044022 13 YGSCINNITYAAQMSHNH-ILKRIGCCLQTP------IPILVFQSVEYGTLRDCIFGAPL--------PRLKIASDIVNS 77 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~--------~~~~~~~~i~~~ 77 (241)
.....+|+.+++.|+|+| ||.+++++.... .+++|+||+. -+|..++..... .+..++.||+.|
T Consensus 54 P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~g 132 (323)
T KOG0594|consen 54 PSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRG 132 (323)
T ss_pred CchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHH
Confidence 344679999999999999 999999998876 7899999996 699999876541 367899999999
Q ss_pred hchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHH
Q 044022 78 LAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSF 156 (241)
Q Consensus 78 l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~ 156 (241)
|+||| +++|+||||||+|||++.+|.+||+|||+++....+... .+..+.|.-|+|||++.+. .|++..||||+
T Consensus 133 l~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~ 207 (323)
T KOG0594|consen 133 LAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSL 207 (323)
T ss_pred HHHHH---hCCeecccCCcceEEECCCCcEeeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhH
Confidence 99999 999999999999999999999999999999866544322 2345678889999999887 78999999999
Q ss_pred HHHHHHHHhcCccccc
Q 044022 157 GAFLFELLAGRIHIWD 172 (241)
Q Consensus 157 G~~~~~~~~g~~p~~~ 172 (241)
|||+.||+++++-|..
T Consensus 208 GcIfaEm~~~~~LFpG 223 (323)
T KOG0594|consen 208 GCIFAEMFTRRPLFPG 223 (323)
T ss_pred HHHHHHHHhCCCCCCC
Confidence 9999999999988854
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=229.46 Aligned_cols=202 Identities=23% Similarity=0.317 Sum_probs=156.1
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~~ 85 (241)
...++.+|+.++++++|+|++++++++. .+..++++||+++++|.+++.... .....++.+++.||+|||
T Consensus 44 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH--- 119 (260)
T cd05067 44 SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE--- 119 (260)
T ss_pred cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---
Confidence 4567999999999999999999999874 456899999999999999886432 145778999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+.+++|+||+|+||+++.++.++++|||.+.......... .....++..|+|||++....++.++||||||+++|++++
T Consensus 120 ~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~ 198 (260)
T cd05067 120 RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 198 (260)
T ss_pred cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHh
Confidence 8999999999999999999999999999987655322111 122345678999999988889999999999999999999
Q ss_pred -cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 -GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|+.||.... ..+..... ......... . ..+..+.+++.+||..+|++|||+++
T Consensus 199 ~g~~p~~~~~---------~~~~~~~~-~~~~~~~~~-----~--------~~~~~~~~li~~~l~~~p~~Rp~~~~ 252 (260)
T cd05067 199 YGRIPYPGMT---------NPEVIQNL-ERGYRMPRP-----D--------NCPEELYELMRLCWKEKPEERPTFEY 252 (260)
T ss_pred CCCCCCCCCC---------hHHHHHHH-HcCCCCCCC-----C--------CCCHHHHHHHHHHccCChhhCCCHHH
Confidence 999995421 11111111 111111111 1 12257899999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=228.93 Aligned_cols=203 Identities=23% Similarity=0.375 Sum_probs=157.8
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
....|.+|++++++++|||++++++++......++|+||+++++|.+++.... . ....++.+++.|+++|| +
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~ 118 (256)
T cd05112 42 SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---S 118 (256)
T ss_pred CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 35679999999999999999999999999899999999999999999986532 1 35778899999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh-
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA- 165 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~- 165 (241)
.+++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||++.+..++.++|+||||+++|++++
T Consensus 119 ~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~ 197 (256)
T cd05112 119 SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSE 197 (256)
T ss_pred CCccccccccceEEEcCCCeEEECCCcceeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcC
Confidence 99999999999999999999999999998765432211 1112234567999999988889999999999999999998
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|..||.... ..+.......... ...+. ..+..+.+++.+||..+|++|||++|
T Consensus 198 g~~p~~~~~---------~~~~~~~~~~~~~---~~~~~-----------~~~~~~~~l~~~~l~~~p~~Rp~~~~ 250 (256)
T cd05112 198 GKTPYENRS---------NSEVVETINAGFR---LYKPR-----------LASQSVYELMQHCWKERPEDRPSFSL 250 (256)
T ss_pred CCCCCCcCC---------HHHHHHHHhCCCC---CCCCC-----------CCCHHHHHHHHHHcccChhhCCCHHH
Confidence 999985411 1112222111110 01111 12257899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=238.15 Aligned_cols=204 Identities=17% Similarity=0.266 Sum_probs=159.4
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
..+.+.+|+.++++++|+|++++++.+...+..++|+||+++++|.+++..... ....++.+|+.|+.||| +.+
T Consensus 62 ~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ 138 (292)
T cd06658 62 RRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLH---NQG 138 (292)
T ss_pred HHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence 456788999999999999999999999999999999999999999998855432 56788999999999999 899
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCc
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRI 168 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~ 168 (241)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|++++|..
T Consensus 139 ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~ 216 (292)
T cd06658 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216 (292)
T ss_pred EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998865433221 1123457889999999988889999999999999999999999
Q ss_pred ccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 169 HIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 169 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
||..... ........ .......... ...+..+.+++.+||..||++|||++|
T Consensus 217 p~~~~~~---------~~~~~~~~-~~~~~~~~~~-----------~~~~~~~~~li~~~l~~~P~~Rpt~~~ 268 (292)
T cd06658 217 PYFNEPP---------LQAMRRIR-DNLPPRVKDS-----------HKVSSVLRGFLDLMLVREPSQRATAQE 268 (292)
T ss_pred CCCCCCH---------HHHHHHHH-hcCCCccccc-----------cccCHHHHHHHHHHccCChhHCcCHHH
Confidence 9854111 11111111 1000000000 022356889999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=232.90 Aligned_cols=203 Identities=22% Similarity=0.325 Sum_probs=160.6
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
...+.+.+|++++++++||||+++++++..++..++|+||+++++|..++..... ....++.+++.|+.+|| +.
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh---~~ 120 (277)
T cd06641 44 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLH---SE 120 (277)
T ss_pred HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHc---cC
Confidence 3456788999999999999999999999999999999999999999999876533 45778999999999999 99
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcC
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
+++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+..++.++|+||||+++|++++|.
T Consensus 121 ~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 198 (277)
T cd06641 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198 (277)
T ss_pred CeecCCCCHHhEEECCCCCEEEeecccceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999876543221 112345778899999998888899999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.||..... ...... ..... .+.+.. ..+..+.+++.+||..+|.+||++.|
T Consensus 199 ~p~~~~~~---------~~~~~~-~~~~~-----~~~~~~--------~~~~~~~~~i~~~l~~~p~~Rp~~~~ 249 (277)
T cd06641 199 PPHSELHP---------MKVLFL-IPKNN-----PPTLEG--------NYSKPLKEFVEACLNKEPSFRPTAKE 249 (277)
T ss_pred CCCCccch---------HHHHHH-HhcCC-----CCCCCc--------ccCHHHHHHHHHHccCChhhCcCHHH
Confidence 99854111 011111 11110 111111 22357889999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=243.61 Aligned_cols=199 Identities=20% Similarity=0.190 Sum_probs=152.4
Q ss_pred HHHHHHHHHHHHhc---CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCC
Q 044022 13 YGSCINNITYAAQM---SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 13 ~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.+|..++..+ +||||+++++++......++||||+++|+|..++..... ....++.||+.||.|||
T Consensus 37 ~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH--- 113 (330)
T cd05586 37 VAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLH--- 113 (330)
T ss_pred HHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 34456677777765 699999999999999999999999999999988865432 45678999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~ 164 (241)
+++++||||||+|||++.++.++|+|||++........ ......|+..|+|||++.+. .++.++||||||+++|+|+
T Consensus 114 ~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell 191 (330)
T cd05586 114 KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMC 191 (330)
T ss_pred HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEec
Confidence 99999999999999999999999999999865322211 11335689999999998754 4789999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
+|..||.... ..+...... .+.. ..+.. ..+..+.+++.+||..||++||++
T Consensus 192 tG~~Pf~~~~---------~~~~~~~i~-~~~~-~~~~~------------~~~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 192 CGWSPFYAED---------TQQMYRNIA-FGKV-RFPKN------------VLSDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred cCCCCCCCCC---------HHHHHHHHH-cCCC-CCCCc------------cCCHHHHHHHHHHcCCCHHHCCCC
Confidence 9999995421 111111111 1110 11110 122567899999999999999965
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=230.71 Aligned_cols=201 Identities=22% Similarity=0.344 Sum_probs=156.2
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~~ 85 (241)
..+.+.+|++++++++|+||+++++.+.. ...++++||+++++|.+++.... ..+..++.+++.||.|||
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH--- 119 (260)
T cd05073 44 SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--- 119 (260)
T ss_pred HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---
Confidence 35678999999999999999999999877 77899999999999999986532 145778999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+.+++|+||+|+||+++.++.++|+|||.+.......... .....++..|+|||++....++.++|+||||+++|++++
T Consensus 120 ~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t 198 (260)
T cd05073 120 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 198 (260)
T ss_pred hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHh
Confidence 8999999999999999999999999999987654332211 122235567999999988888999999999999999998
Q ss_pred -cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 166 -GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 166 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
|..||..... .... ............ . ..+..+.+++.+||+.+|++|||++
T Consensus 199 ~g~~p~~~~~~---------~~~~-~~~~~~~~~~~~-----~--------~~~~~~~~~i~~~l~~~p~~Rp~~~ 251 (260)
T cd05073 199 YGRIPYPGMSN---------PEVI-RALERGYRMPRP-----E--------NCPEELYNIMMRCWKNRPEERPTFE 251 (260)
T ss_pred cCCCCCCCCCH---------HHHH-HHHhCCCCCCCc-----c--------cCCHHHHHHHHHHcccCcccCcCHH
Confidence 9999854211 1111 111111110000 1 2235788999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=229.41 Aligned_cols=203 Identities=24% Similarity=0.336 Sum_probs=158.3
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc------hHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL------PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~~i~~~l~~lh~~~ 85 (241)
...++.+|+.++++++|+||+++++++......++|+||+++++|.+++..... ....++.+++.|+.|||
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh--- 120 (261)
T cd05034 44 SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE--- 120 (261)
T ss_pred CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 456799999999999999999999999988899999999999999999866431 45788999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+.+++|+||+|+||+++.++.++++|||.+.......... ......+..|+|||.+.+..++.++|+||||+++|++++
T Consensus 121 ~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t 199 (261)
T cd05034 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199 (261)
T ss_pred hCCcccCCcchheEEEcCCCCEEECccccceeccchhhhh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHh
Confidence 8999999999999999999999999999987654321111 112234567999999998889999999999999999998
Q ss_pred -cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 -GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|+.||.... .......... +.....+ . ..+..+.+++.+||..+|++|||+++
T Consensus 200 ~g~~p~~~~~---------~~~~~~~~~~-~~~~~~~-----~--------~~~~~~~~~i~~~l~~~p~~Rp~~~~ 253 (261)
T cd05034 200 YGRVPYPGMT---------NREVLEQVER-GYRMPRP-----P--------NCPEELYDLMLQCWDKDPEERPTFEY 253 (261)
T ss_pred CCCCCCCCCC---------HHHHHHHHHc-CCCCCCC-----C--------CCCHHHHHHHHHHcccCcccCCCHHH
Confidence 999984421 1111111111 1000000 1 11357899999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=233.49 Aligned_cols=155 Identities=19% Similarity=0.263 Sum_probs=130.7
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-------chHHHHHHHHHHHhchhhcC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-------LPRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------~~~~~~~~~i~~~l~~lh~~ 84 (241)
....+.+|+.++++++||||+++++++..++..++|+||++ ++|.+++.... .....++.|++.||.|||
T Consensus 42 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH-- 118 (285)
T cd07861 42 VPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH-- 118 (285)
T ss_pred chHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH--
Confidence 34678899999999999999999999999999999999997 68888875421 135678999999999999
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~ 163 (241)
+.+++|+||+|+||+++.++.++|+|||.+........ ......+++.|+|||.+.+. .++.++|+||||+++|++
T Consensus 119 -~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l 195 (285)
T cd07861 119 -SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEM 195 (285)
T ss_pred -hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHH
Confidence 89999999999999999999999999999875543221 11223567889999988654 468899999999999999
Q ss_pred HhcCccccc
Q 044022 164 LAGRIHIWD 172 (241)
Q Consensus 164 ~~g~~p~~~ 172 (241)
++|+.||..
T Consensus 196 ~tg~~~~~~ 204 (285)
T cd07861 196 ATKKPLFHG 204 (285)
T ss_pred HHCCCCCCC
Confidence 999999954
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=229.85 Aligned_cols=203 Identities=20% Similarity=0.258 Sum_probs=158.5
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeee-CCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhc
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQ-TPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~ 83 (241)
...+.+.+|++++++++|+|++++.+.+.. .+..++++||+++++|.+++.... .....++.+++.|+.+||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH- 119 (257)
T cd08223 41 RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH- 119 (257)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 445678899999999999999999998764 446789999999999999886531 146789999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+.+++|+||+|+||+++.++.++|+|||.+........ ......+++.|+|||+..+..++.++|+||||++++++
T Consensus 120 --~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l 195 (257)
T cd08223 120 --EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEM 195 (257)
T ss_pred --hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHH
Confidence 99999999999999999999999999999876543221 11234578889999999988899999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|+.||... .......... .+.... ... ..+..+.+++.+||+.||++|||+.|
T Consensus 196 ~~g~~~~~~~---------~~~~~~~~~~-~~~~~~-----~~~--------~~~~~~~~li~~~l~~~p~~Rp~~~~ 250 (257)
T cd08223 196 ATLKHAFNAK---------DMNSLVYRII-EGKLPP-----MPK--------DYSPELGELIATMLSKRPEKRPSVKS 250 (257)
T ss_pred HcCCCCCCCC---------CHHHHHHHHH-hcCCCC-----Ccc--------ccCHHHHHHHHHHhccCcccCCCHHH
Confidence 9999998531 1111111111 111111 111 23367899999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=256.21 Aligned_cols=216 Identities=24% Similarity=0.340 Sum_probs=171.9
Q ss_pred CcccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC---------------
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--------------- 64 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------- 64 (241)
||...........+.+..|+++|+.+ +|+||+.++|+|...+..++|.||++.|+|..+++...
T Consensus 333 VK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~ 412 (609)
T KOG0200|consen 333 VKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNER 412 (609)
T ss_pred EEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCcccc
Confidence 35555555556788899999999999 79999999999999999999999999999999997655
Q ss_pred --c---hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceee-cccccCCCccC
Q 044022 65 --L---PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITT-DRVIGTRGYSA 138 (241)
Q Consensus 65 --~---~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~-~~~~~~~~~~a 138 (241)
. ..+.++.||+.|++||+ +.++|||||.++|||+..+..+||+|||+++........... +...-+..|||
T Consensus 413 ~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmA 489 (609)
T KOG0200|consen 413 DALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMA 489 (609)
T ss_pred CCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecC
Confidence 2 24688999999999999 999999999999999999999999999999855443332211 11114567999
Q ss_pred cccccccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHH
Q 044022 139 PEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQ 217 (241)
Q Consensus 139 PE~~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (241)
||.+....++.+|||||||+++||+++ |..||.... ...+. ......+...+.+. .+
T Consensus 490 pEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~--------~~~~l-~~~l~~G~r~~~P~-------------~c 547 (609)
T KOG0200|consen 490 PESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP--------PTEEL-LEFLKEGNRMEQPE-------------HC 547 (609)
T ss_pred HHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC--------cHHHH-HHHHhcCCCCCCCC-------------CC
Confidence 999999999999999999999999998 778884411 11222 33455554444333 34
Q ss_pred HHHHHHHHHHhccCCCCCCCCCCC
Q 044022 218 LHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 218 ~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
..++.++|+.||+.+|++||++.|
T Consensus 548 ~~eiY~iM~~CW~~~p~~RP~F~~ 571 (609)
T KOG0200|consen 548 SDEIYDLMKSCWNADPEDRPTFSE 571 (609)
T ss_pred CHHHHHHHHHHhCCCcccCCCHHH
Confidence 477889999999999999999853
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=243.78 Aligned_cols=149 Identities=23% Similarity=0.278 Sum_probs=127.1
Q ss_pred HHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCCCCCc
Q 044022 15 SCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGFPRPI 89 (241)
Q Consensus 15 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~~~~i 89 (241)
....|+.++++++|+||+++++++...+..++|+|++. ++|.+++.... ..+..++.|++.||.||| +++|
T Consensus 103 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i 178 (357)
T PHA03209 103 TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRI 178 (357)
T ss_pred ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence 34679999999999999999999999999999999995 68888875432 146789999999999999 8999
Q ss_pred eeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCcc
Q 044022 90 VLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIH 169 (241)
Q Consensus 90 vh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p 169 (241)
+||||||+|||++..+.++|+|||.+........ .....|+..|+|||++.+..++.++||||||+++|+|+++..|
T Consensus 179 vHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~ 255 (357)
T PHA03209 179 IHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST 255 (357)
T ss_pred ecCCCCHHHEEECCCCCEEEecCccccccccCcc---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence 9999999999999999999999999864332211 1234588999999999988999999999999999999986555
Q ss_pred c
Q 044022 170 I 170 (241)
Q Consensus 170 ~ 170 (241)
+
T Consensus 256 ~ 256 (357)
T PHA03209 256 I 256 (357)
T ss_pred c
Confidence 4
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=228.13 Aligned_cols=211 Identities=18% Similarity=0.193 Sum_probs=155.4
Q ss_pred HHHHHHHHHhcCCCcccceeeeeeeC--CcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHHhchhhcCCCCC
Q 044022 16 CINNITYAAQMSHNHILKRIGCCLQT--PIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 16 ~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
.++||.+|.+++|||||.+..+.... +..|||||||++ +|...+..-.. ....++.|++.|++||| ...
T Consensus 122 sLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~w 197 (419)
T KOG0663|consen 122 SLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNW 197 (419)
T ss_pred hHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hce
Confidence 57999999999999999999988754 368999999985 88888865431 35568889999999999 999
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHHHhcC
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
|+|||||++|+|++..|.+||+|||+++..+...... +..+=|..|+|||.+.+. .|+.+.|+||+|||+.|+++++
T Consensus 198 ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~--T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~k 275 (419)
T KOG0663|consen 198 ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPY--TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQK 275 (419)
T ss_pred eEecccchhheeeccCCcEEecccchhhhhcCCcccC--cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcC
Confidence 9999999999999999999999999999877653222 234557889999999886 5899999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhh---hccc--------------CCCCCCccccCCCchhHHHHHHHHHHHHHHhcc
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLE---DKRF--------------TGIPAPIIVQDIPCIEKEQQLHASAQLTLECVN 230 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 230 (241)
+-|..... ...... ...... +..+ ...+...+...++.. .-++.-.+|++.+|.
T Consensus 276 Plf~G~sE-----~dQl~~-If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~---~lse~g~~Lln~llt 346 (419)
T KOG0663|consen 276 PLFPGKSE-----IDQLDK-IFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGAL---SLSEQGFDLLNKLLT 346 (419)
T ss_pred CCCCCCch-----HHHHHH-HHHHhCCCccccCCCccccchhhccccCCCCchhhhhhcccc---ccchhHHHHHHHHhc
Confidence 88854111 001111 111111 1111 111111122222211 122556799999999
Q ss_pred CCCCCCCCCCC
Q 044022 231 NSPEDRPTMVD 241 (241)
Q Consensus 231 ~~p~~Rpt~~e 241 (241)
+||.+|.||+|
T Consensus 347 ~dP~kR~tA~~ 357 (419)
T KOG0663|consen 347 YDPGKRITAED 357 (419)
T ss_pred cCccccccHHH
Confidence 99999999975
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=228.03 Aligned_cols=198 Identities=22% Similarity=0.330 Sum_probs=154.2
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc------hHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL------PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~~i~~~l~~lh~~~ 85 (241)
..+.+.+|+.++++++|||++++++++... ..++++||+++++|.+++..... ..+.++.+++.|+.|||
T Consensus 42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH--- 117 (254)
T cd05083 42 TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE--- 117 (254)
T ss_pred hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 346789999999999999999999998655 47999999999999999865421 35778999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+.+++||||+|+||+++.++.++|+|||.+....... .....+..|+|||.+.+..++.++|+||||+++|++++
T Consensus 118 ~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~ 192 (254)
T cd05083 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFS 192 (254)
T ss_pred hCCeeccccCcceEEEcCCCcEEECCCccceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHh
Confidence 8999999999999999999999999999987543221 12234567999999988889999999999999999997
Q ss_pred -cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 -GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|+.||.... ..+..... ..+.. .. ... ..+..+.+++.+||+.+|+.|||+++
T Consensus 193 ~g~~p~~~~~---------~~~~~~~~-~~~~~---~~--~~~--------~~~~~~~~li~~~l~~~p~~Rp~~~~ 246 (254)
T cd05083 193 YGRAPYPKMS---------LKEVKECV-EKGYR---ME--PPE--------GCPADVYVLMTSCWETEPKKRPSFHK 246 (254)
T ss_pred CCCCCCccCC---------HHHHHHHH-hCCCC---CC--CCC--------cCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999985421 11111111 11110 00 011 22367889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=261.46 Aligned_cols=204 Identities=18% Similarity=0.234 Sum_probs=156.6
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC----C-----------chHHHHHHHHHH
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA----P-----------LPRLKIASDIVN 76 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----~-----------~~~~~~~~~i~~ 76 (241)
..++|.+|++++++++||||+++++++...+..++||||++|++|.+++... . ...+.++.+++.
T Consensus 45 ~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~ 124 (932)
T PRK13184 45 LKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124 (932)
T ss_pred HHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHH
Confidence 3567999999999999999999999999999999999999999999987531 0 124678999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCC----------------cceeecccccCCCccCcc
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE----------------THITTDRVIGTRGYSAPE 140 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~----------------~~~~~~~~~~~~~~~aPE 140 (241)
||.||| +.+++||||||+||+++.++.++|+|||++....... .........||+.|+|||
T Consensus 125 AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE 201 (932)
T PRK13184 125 TIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPE 201 (932)
T ss_pred HHHHHH---HCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHH
Confidence 999999 8999999999999999999999999999987652110 001112346899999999
Q ss_pred cccccCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHH
Q 044022 141 YISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHA 220 (241)
Q Consensus 141 ~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (241)
++.+..++.++||||||+++|+|++|+.||...... +.... .. . ..+. ...+ ....+..
T Consensus 202 ~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~---------ki~~~---~~-i-~~P~-~~~p------~~~iP~~ 260 (932)
T PRK13184 202 RLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR---------KISYR---DV-I-LSPI-EVAP------YREIPPF 260 (932)
T ss_pred HhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh---------hhhhh---hh-c-cChh-hccc------cccCCHH
Confidence 999889999999999999999999999999541110 00000 00 0 0000 0000 0122356
Q ss_pred HHHHHHHhccCCCCCCCCC
Q 044022 221 SAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 221 ~~~l~~~cl~~~p~~Rpt~ 239 (241)
+.+++.+||+.||++||+.
T Consensus 261 L~~LI~rcL~~DP~kR~ss 279 (932)
T PRK13184 261 LSQIAMKALAVDPAERYSS 279 (932)
T ss_pred HHHHHHHHccCChhhCcCH
Confidence 8899999999999999874
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=247.05 Aligned_cols=211 Identities=18% Similarity=0.221 Sum_probs=168.1
Q ss_pred Cccccccccc-ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHH
Q 044022 1 MKFYGHEYHR-HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~ 75 (241)
||++.+.+.. ...+.+.+|+++|+.|+|||||+++.+...+..+|+||||+.+|.+++++.++.. ....+..|++
T Consensus 86 iK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~v 165 (596)
T KOG0586|consen 86 IKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIV 165 (596)
T ss_pred EEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHH
Confidence 4555554432 3446688999999999999999999999999999999999999999999988754 3556788999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCC-CcchhhH
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVL-NEKSNVF 154 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~ 154 (241)
.|++||| ++.|||||||++|+|++.+.++||+|||++..+..... ..+.+|++.|.|||++.+..+ .+++|+|
T Consensus 166 saveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~W 239 (596)
T KOG0586|consen 166 SAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM---LQTFCGSPPYAAPELFNGKKYDGPEVDIW 239 (596)
T ss_pred HHHHHHh---hcceeccccchhhcccccccceeeeccccceeeccccc---ccccCCCCCccChHhhcCcccCCcceehh
Confidence 9999999 99999999999999999999999999999988765433 245689999999999998765 5899999
Q ss_pred HHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 155 SFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 155 s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
|+|+++|.++.|..||+.. .+.......+...+.-. .-.+.++.+++++++..+|.
T Consensus 240 slgvvly~LV~GsLPFDG~----------------------~lk~Lr~rvl~gk~rIp--~~ms~dce~lLrk~lvl~Ps 295 (596)
T KOG0586|consen 240 SLGVVLYALVEGSLPFDGQ----------------------NLKELRPRVLRGKYRIP--FYMSCDCEDLLRKFLVLNPS 295 (596)
T ss_pred hhhhhheeeeecccccCCc----------------------ccccccchheeeeeccc--ceeechhHHHHHHhhccCcc
Confidence 9999999999999999641 11111111111111100 01224678999999999999
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
+|+++++
T Consensus 296 kr~~~dq 302 (596)
T KOG0586|consen 296 KRGPCDQ 302 (596)
T ss_pred ccCCHHH
Confidence 9999864
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=229.74 Aligned_cols=208 Identities=20% Similarity=0.281 Sum_probs=158.7
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
.+.+.+|+.++++++|+|++++++++...+..++|+||+++++|.+++..... .+..++.+++.||.||| +.+
T Consensus 52 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ 128 (272)
T cd06629 52 VKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH---SKG 128 (272)
T ss_pred HHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCC
Confidence 34678899999999999999999999999999999999999999999876432 45678899999999999 899
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccC--CCcchhhHHHHHHHHHHHhc
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV--LNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~s~G~~~~~~~~g 166 (241)
++|+||+|+||+++.++.++++|||.+................++..|+|||.+.... ++.++|+||||+++|++++|
T Consensus 129 i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g 208 (272)
T cd06629 129 ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAG 208 (272)
T ss_pred eeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhC
Confidence 9999999999999999999999999987654322222222345788899999987654 78899999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
..||..... .+.............. ...... ..+..+.+++.+||..+|++|||++|
T Consensus 209 ~~p~~~~~~---------~~~~~~~~~~~~~~~~-~~~~~~--------~~~~~~~~li~~~l~~~p~~Rps~~~ 265 (272)
T cd06629 209 RRPWSDEEA---------IAAMFKLGNKRSAPPI-PPDVSM--------NLSPVALDFLNACFTINPDNRPTARE 265 (272)
T ss_pred CCCCcCcch---------HHHHHHhhccccCCcC-Cccccc--------cCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 999854110 1111111111111111 111111 22367889999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=236.86 Aligned_cols=202 Identities=22% Similarity=0.264 Sum_probs=157.6
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~~ 85 (241)
..+.+.+|+++++.++|+||+++++.+......++||||+.+++|.+++.... .....++.+++.||.|||
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--- 120 (316)
T cd05574 44 KVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH--- 120 (316)
T ss_pred HHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---
Confidence 55678899999999999999999999999999999999999999999986532 135678899999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc---------------------------eeecccccCCCccC
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH---------------------------ITTDRVIGTRGYSA 138 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~a 138 (241)
+.+++|+||||+||+++.++.++|+|||.+......... .......|+..|+|
T Consensus 121 ~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~a 200 (316)
T cd05574 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIA 200 (316)
T ss_pred HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcC
Confidence 899999999999999999999999999987654322110 01112357888999
Q ss_pred cccccccCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHH
Q 044022 139 PEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQL 218 (241)
Q Consensus 139 PE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (241)
||++.+..++.++||||||+++|++++|+.||..... ........... . ... .. ...+
T Consensus 201 PE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~---------~~~~~~~~~~~-~-~~~-----~~------~~~~ 258 (316)
T cd05574 201 PEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR---------DETFSNILKKE-V-TFP-----GS------PPVS 258 (316)
T ss_pred HHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch---------HHHHHHHhcCC-c-cCC-----Cc------cccC
Confidence 9999988899999999999999999999999954211 11111111100 0 000 00 0134
Q ss_pred HHHHHHHHHhccCCCCCCCC
Q 044022 219 HASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 219 ~~~~~l~~~cl~~~p~~Rpt 238 (241)
..+.+++.+||..||++|||
T Consensus 259 ~~~~~li~~~l~~~p~~R~s 278 (316)
T cd05574 259 SSARDLIRKLLVKDPSKRLG 278 (316)
T ss_pred HHHHHHHHHHccCCHhHCCC
Confidence 67999999999999999999
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=238.36 Aligned_cols=157 Identities=17% Similarity=0.195 Sum_probs=134.0
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+.+.+|+.+++.++|+||+++++++...++.++||||+++|+|.+++.... . ....++.||+.||.||| +
T Consensus 44 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~ 120 (331)
T cd05597 44 ETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---Q 120 (331)
T ss_pred hHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 45568899999999999999999999999999999999999999999986531 1 45678899999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-----cCCCcchhhHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-----CVLNEKSNVFSFGAFLF 161 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~s~G~~~~ 161 (241)
++++||||||+|||++.++.++|+|||.+.......... .....|++.|+|||++.. ..++.++||||||+++|
T Consensus 121 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~ 199 (331)
T cd05597 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMY 199 (331)
T ss_pred CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHH
Confidence 999999999999999999999999999987654332211 122458999999999863 35678999999999999
Q ss_pred HHHhcCccccc
Q 044022 162 ELLAGRIHIWD 172 (241)
Q Consensus 162 ~~~~g~~p~~~ 172 (241)
+|++|+.||..
T Consensus 200 el~~g~~Pf~~ 210 (331)
T cd05597 200 EMLYGETPFYA 210 (331)
T ss_pred HHhhCCCCCCC
Confidence 99999999954
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=232.97 Aligned_cols=204 Identities=23% Similarity=0.296 Sum_probs=157.4
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC---c---hHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---L---PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~---~~~~~~~~i~~~l~~lh~~~ 85 (241)
....+.+|++++++++|||++++++++...+..|+|+||+++++|.+++.... . ....++.+++.|+.|||
T Consensus 36 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH--- 112 (277)
T cd05577 36 GEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH--- 112 (277)
T ss_pred hhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 45567889999999999999999999999999999999999999999886532 1 35678899999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+.+++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||++.+..++.++|+||||+++|+|++
T Consensus 113 ~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~ 189 (277)
T cd05577 113 QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIA 189 (277)
T ss_pred hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhh
Confidence 89999999999999999999999999998875543211 122356788999999988888999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|+.||....... . .+... ..... . ...... ..++.+.+++.+||+.||++||+++|
T Consensus 190 g~~p~~~~~~~~-----~-~~~~~----~~~~~-~-~~~~~~--------~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 190 GRSPFRQRKEKV-----E-KEELK----RRTLE-M-AVEYPD--------KFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CCCCCCCCcccc-----c-HHHHH----hcccc-c-cccCCc--------cCCHHHHHHHHHHccCChhHccCCCc
Confidence 999996522110 0 00000 00000 0 000111 12367889999999999999996643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=229.86 Aligned_cols=202 Identities=25% Similarity=0.306 Sum_probs=158.7
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC---c---hHHHHHHHHHHHhchhhcC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---L---PRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~---~~~~~~~~i~~~l~~lh~~ 84 (241)
.....+.+|++++++++|||++++++.+...+..++|+||+++++|.+++.... . ....++.+++.|+.|||
T Consensus 41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-- 118 (256)
T cd08220 41 DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH-- 118 (256)
T ss_pred HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--
Confidence 346778999999999999999999999998999999999999999999986532 1 45778999999999999
Q ss_pred CCCCceeccCCCCCeeecCC-CCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEE-NVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+++++|+||+|+||+++.+ +.++++|||.+......... ....++..|+|||.+.+..++.++|+||||+++|++
T Consensus 119 -~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l 194 (256)
T cd08220 119 -TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYEL 194 (256)
T ss_pred -hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHH
Confidence 8999999999999999865 46799999998866543211 224578899999999988889999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|+.||.... ......... ........+ ..+..+.+++.+||..+|++|||++|
T Consensus 195 ~~~~~~~~~~~---------~~~~~~~~~-~~~~~~~~~-------------~~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (256)
T cd08220 195 ASLKRAFEAAN---------LPALVLKIM-SGTFAPISD-------------RYSPDLRQLILSMLNLDPSKRPQLSQ 249 (256)
T ss_pred HhCCCCcccCc---------hHHHHHHHH-hcCCCCCCC-------------CcCHHHHHHHHHHccCChhhCCCHHH
Confidence 99999985411 111111111 111111111 12357889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=230.87 Aligned_cols=202 Identities=19% Similarity=0.238 Sum_probs=160.3
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~~ 85 (241)
...++.+|+.++++++||||+++++++...+..++|+||+++++|.+++.... ...+.++.+++.|+.|||
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--- 118 (256)
T cd08218 42 EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH--- 118 (256)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 45678999999999999999999999999999999999999999999886431 246788999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+.+++|+||+|+||+++.++.++++|||.+......... .....++..|+|||++.+..++.++|+||||++++++++
T Consensus 119 ~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~ 196 (256)
T cd08218 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196 (256)
T ss_pred hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHc
Confidence 899999999999999999999999999998765443211 122357888999999988888999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|+.||... ...+...... .+..... .. ..+..+.+++.+||+.+|++||++.|
T Consensus 197 g~~~~~~~---------~~~~~~~~~~-~~~~~~~-----~~--------~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08218 197 LKHAFEAG---------NMKNLVLKII-RGSYPPV-----SS--------HYSYDLRNLVSQLFKRNPRDRPSVNS 249 (256)
T ss_pred CCCCccCC---------CHHHHHHHHh-cCCCCCC-----cc--------cCCHHHHHHHHHHhhCChhhCcCHHH
Confidence 99998541 1111222211 1111111 11 22357899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=251.03 Aligned_cols=205 Identities=23% Similarity=0.339 Sum_probs=163.7
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC-------CchHHHHHHHHHHHhchhhc
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA-------PLPRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-------~~~~~~~~~~i~~~l~~lh~ 83 (241)
+..+-+..||.+-++|+|.|||+++|++.+++++-|.||-.+||||.+++... +.+...+-+||++||.|||
T Consensus 614 r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLH- 692 (1226)
T KOG4279|consen 614 REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLH- 692 (1226)
T ss_pred hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhh-
Confidence 34555778999999999999999999999999999999999999999998653 2246678999999999999
Q ss_pred CCCCCceeccCCCCCeeec-CCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc--CCCcchhhHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFN-EENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC--VLNEKSNVFSFGAFL 160 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~s~G~~~ 160 (241)
+..|||||||-+|+|++ -.|.+||+|||.++.+..-..+. .+..||..|||||++..+ .|+.++|||||||.+
T Consensus 693 --en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T--ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~ 768 (1226)
T KOG4279|consen 693 --ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT--ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTM 768 (1226)
T ss_pred --hcceeeccccCCcEEEeeccceEEecccccchhhccCCccc--cccccchhhhChHhhccCCcCCCchhhhhhcccee
Confidence 99999999999999997 56899999999998776543332 456799999999999765 588999999999999
Q ss_pred HHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 161 FELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 161 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
.||.||++||..+.+.. . ...+-+-+ ..- +..| ++.+...+.+|.+|+..||.+||+|.
T Consensus 769 vEMATGrPPF~Elgspq-------A----AMFkVGmy--KvH----P~iP----eelsaeak~FilrcFepd~~~R~sA~ 827 (1226)
T KOG4279|consen 769 VEMATGRPPFVELGSPQ-------A----AMFKVGMY--KVH----PPIP----EELSAEAKNFILRCFEPDPCDRPSAK 827 (1226)
T ss_pred EeeccCCCCeeecCChh-------H----hhhhhcce--ecC----CCCc----HHHHHHHHHHHHHHcCCCcccCccHH
Confidence 99999999997643321 0 00001100 001 1111 35567789999999999999999986
Q ss_pred C
Q 044022 241 D 241 (241)
Q Consensus 241 e 241 (241)
+
T Consensus 828 ~ 828 (1226)
T KOG4279|consen 828 D 828 (1226)
T ss_pred H
Confidence 4
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=229.35 Aligned_cols=202 Identities=21% Similarity=0.260 Sum_probs=159.7
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+.+.+|+++++.++|+||+++++++...+..++++||+++++|.+++..... ....++.+++.|++||| +.
T Consensus 45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~ 121 (258)
T cd06632 45 AVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH---DR 121 (258)
T ss_pred HHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 456789999999999999999999999999999999999999999999865532 45678899999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccC-CCcchhhHHHHHHHHHHHhc
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV-LNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~s~G~~~~~~~~g 166 (241)
+++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.... ++.++|+||||+++|++++|
T Consensus 122 ~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g 198 (258)
T cd06632 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATG 198 (258)
T ss_pred CcccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhC
Confidence 99999999999999999999999999987654432 113345788899999987766 88999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+.||.... ..+............. +.. ..++.+.+++++||+.+|++|||++|
T Consensus 199 ~~pf~~~~---------~~~~~~~~~~~~~~~~-----~~~--------~~~~~~~~li~~~l~~~p~~Rp~~~~ 251 (258)
T cd06632 199 KPPWSQLE---------GVAAVFKIGRSKELPP-----IPD--------HLSDEAKDFILKCLQRDPSLRPTAAE 251 (258)
T ss_pred CCCcccCc---------HHHHHHHHHhcccCCC-----cCC--------CcCHHHHHHHHHHhhcCcccCcCHHH
Confidence 99996521 1111111111111111 111 12357889999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=241.46 Aligned_cols=152 Identities=20% Similarity=0.291 Sum_probs=129.5
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeC------CcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhh
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQT------PIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLH 82 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh 82 (241)
....+.+|++++++++||||+++++++... ...+++++++ +++|.+++..... ....++.|++.||.|||
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 135 (343)
T cd07878 57 HARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH 135 (343)
T ss_pred HHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 445678999999999999999999988643 3468999988 6899988865433 46778999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFLF 161 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~~ 161 (241)
+.+++||||||+||+++.++.+||+|||++....... ....+++.|+|||++.+ ..++.++||||||+++|
T Consensus 136 ---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 207 (343)
T cd07878 136 ---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 207 (343)
T ss_pred ---HCCeecccCChhhEEECCCCCEEEcCCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHH
Confidence 9999999999999999999999999999987654322 23467889999999876 46889999999999999
Q ss_pred HHHhcCccccc
Q 044022 162 ELLAGRIHIWD 172 (241)
Q Consensus 162 ~~~~g~~p~~~ 172 (241)
+|++|+.||..
T Consensus 208 el~~g~~pf~~ 218 (343)
T cd07878 208 ELLKGKALFPG 218 (343)
T ss_pred HHHHCCCCCCC
Confidence 99999999954
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=233.33 Aligned_cols=203 Identities=23% Similarity=0.298 Sum_probs=153.9
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeeeC------CcceEEEEecCCCCHHHhhcCCC---c---hHHHHHHHHHHHh
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQT------PIPILVFQSVEYGTLRDCIFGAP---L---PRLKIASDIVNSL 78 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~---~---~~~~~~~~i~~~l 78 (241)
....+.+|+.+++++ +|+|++++++++... ...++++||+.+++|.+++.... . ....++.|++.|+
T Consensus 45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l 124 (272)
T cd06637 45 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124 (272)
T ss_pred cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence 456788999999999 799999999998753 35789999999999999887532 1 3567899999999
Q ss_pred chhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc-----ccCCCcchhh
Q 044022 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS-----ICVLNEKSNV 153 (241)
Q Consensus 79 ~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di 153 (241)
+||| +++++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++. ...++.++|+
T Consensus 125 ~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv 199 (272)
T cd06637 125 SHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDL 199 (272)
T ss_pred HHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhH
Confidence 9999 89999999999999999999999999999876533211 123346788999999986 3357889999
Q ss_pred HHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 154 FSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
||||+++|+|++|..||...... ... ... ... ....... ...+..+.+++.+||..||
T Consensus 200 ~slGv~l~el~~g~~p~~~~~~~--------~~~-~~~-~~~-----~~~~~~~-------~~~~~~~~~li~~~l~~~p 257 (272)
T cd06637 200 WSLGITAIEMAEGAPPLCDMHPM--------RAL-FLI-PRN-----PAPRLKS-------KKWSKKFQSFIESCLVKNH 257 (272)
T ss_pred HHHHHHHHHHHhCCCCccccCHH--------HHH-HHH-hcC-----CCCCCCC-------CCcCHHHHHHHHHHcCCCh
Confidence 99999999999999999542110 000 000 000 0000000 0122568899999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
.+|||++|
T Consensus 258 ~~Rpt~~~ 265 (272)
T cd06637 258 SQRPTTEQ 265 (272)
T ss_pred hhCCCHHH
Confidence 99999854
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=232.57 Aligned_cols=156 Identities=20% Similarity=0.240 Sum_probs=133.1
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+.+.+|++++++++|+|++++++++......++|+||+++++|..++.... ..+..++.+++.||.||| +.
T Consensus 43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH---~~ 119 (286)
T cd07847 43 IKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH---KH 119 (286)
T ss_pred ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 44568899999999999999999999999999999999999888887765432 246789999999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHHHHHHHHhc
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~~~~~~g 166 (241)
+++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||++.+ ..++.++|+||||+++|+|++|
T Consensus 120 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g 197 (286)
T cd07847 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197 (286)
T ss_pred CceecCCChhhEEEcCCCcEEECccccceecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhC
Confidence 9999999999999999999999999998766543211 122346788999999876 4578899999999999999999
Q ss_pred Cccccc
Q 044022 167 RIHIWD 172 (241)
Q Consensus 167 ~~p~~~ 172 (241)
.+||..
T Consensus 198 ~~p~~~ 203 (286)
T cd07847 198 QPLWPG 203 (286)
T ss_pred CCCCCC
Confidence 999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=233.53 Aligned_cols=204 Identities=20% Similarity=0.279 Sum_probs=157.1
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+.|.+|++++++++|+|++++++++...+..++||||+++++|.+++.... .....++.+++.|+.||| +
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~ 121 (280)
T cd06611 45 ELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---S 121 (280)
T ss_pred HHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 45678899999999999999999999999999999999999999999986532 256789999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc-----ccCCCcchhhHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS-----ICVLNEKSNVFSFGAFLF 161 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~s~G~~~~ 161 (241)
.+++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+. ...++.++|+||||+++|
T Consensus 122 ~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~ 199 (280)
T cd06611 122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLI 199 (280)
T ss_pred CCcccCCCChhhEEECCCCCEEEccCccchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHH
Confidence 9999999999999999999999999998765433221 112345788899999875 345678999999999999
Q ss_pred HHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 162 ELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 162 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|++|+.||..... .+...... .... +.+.. ....+..+.+++.+||..+|.+|||+++
T Consensus 200 ~l~~g~~p~~~~~~---------~~~~~~~~-~~~~-----~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~ 258 (280)
T cd06611 200 ELAQMEPPHHELNP---------MRVLLKIL-KSEP-----PTLDQ------PSKWSSSFNDFLKSCLVKDPDDRPTAAE 258 (280)
T ss_pred HHHhCCCCcccCCH---------HHHHHHHh-cCCC-----CCcCC------cccCCHHHHHHHHHHhccChhhCcCHHH
Confidence 99999999865211 11111111 1100 00000 0122356889999999999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=236.70 Aligned_cols=158 Identities=18% Similarity=0.198 Sum_probs=129.2
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC---c---hHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---L---PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~---~~~~~~~~i~~~l~~lh~~~ 85 (241)
..+.+.+|+.+++.++||||++++++|..++..++|+||+.+++|.+++.... . ....++.|++.||.|||
T Consensus 42 ~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH--- 118 (328)
T cd08226 42 HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH--- 118 (328)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---
Confidence 45778899999999999999999999999999999999999999999886532 1 34578999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-----eeecccccCCCccCccccccc--CCCcchhhHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-----ITTDRVIGTRGYSAPEYISIC--VLNEKSNVFSFGA 158 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~s~G~ 158 (241)
+.+++||||||+||+++.++.++++||+.+......... .......++..|+|||++.+. .++.++||||||+
T Consensus 119 ~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~ 198 (328)
T cd08226 119 QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGI 198 (328)
T ss_pred hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHH
Confidence 899999999999999999999999999754332211100 001112345679999999763 4789999999999
Q ss_pred HHHHHHhcCccccc
Q 044022 159 FLFELLAGRIHIWD 172 (241)
Q Consensus 159 ~~~~~~~g~~p~~~ 172 (241)
++|++++|+.||..
T Consensus 199 ~l~el~~g~~p~~~ 212 (328)
T cd08226 199 TACELATGRVPFQD 212 (328)
T ss_pred HHHHHHhCCCCCCC
Confidence 99999999999965
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=260.08 Aligned_cols=205 Identities=20% Similarity=0.324 Sum_probs=153.2
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeC--CcceEEEEecCCCCHHHhhcCC-----C---chHHHHHHHHHHHhch
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQT--PIPILVFQSVEYGTLRDCIFGA-----P---LPRLKIASDIVNSLAY 80 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~-----~---~~~~~~~~~i~~~l~~ 80 (241)
.....|.+|+.++++|+|||||+++++|... ..+|+||||+++++|.+++... . ...+.++.||+.||.|
T Consensus 54 ~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaY 133 (1021)
T PTZ00266 54 REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAY 133 (1021)
T ss_pred HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999988653 4689999999999999988642 1 1467899999999999
Q ss_pred hhcCC----CCCceeccCCCCCeeecC-----------------CCCeEEeeccCceecCCCCcceeecccccCCCccCc
Q 044022 81 LHFGF----PRPIVLRNFKTQNILFNE-----------------ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAP 139 (241)
Q Consensus 81 lh~~~----~~~ivh~dl~~~nil~~~-----------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aP 139 (241)
||... ..+|+|+||||+|||++. .+.+||+|||++........ .....+++.|+||
T Consensus 134 LHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAP 210 (1021)
T PTZ00266 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSP 210 (1021)
T ss_pred HHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCH
Confidence 99321 145999999999999964 34589999999876543321 1234689999999
Q ss_pred ccccc--cCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHH
Q 044022 140 EYISI--CVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQ 217 (241)
Q Consensus 140 E~~~~--~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (241)
|++.+ ..++.++|||||||++|+|++|..||.... ........... .. ..+. . ..
T Consensus 211 EvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~--------~~~qli~~lk~-~p--~lpi----~--------~~ 267 (1021)
T PTZ00266 211 ELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN--------NFSQLISELKR-GP--DLPI----K--------GK 267 (1021)
T ss_pred HHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC--------cHHHHHHHHhc-CC--CCCc----C--------CC
Confidence 99864 357899999999999999999999995411 11112221111 10 0000 0 12
Q ss_pred HHHHHHHHHHhccCCCCCCCCCCC
Q 044022 218 LHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 218 ~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+..+.+||..||..+|.+|||+.|
T Consensus 268 S~eL~dLI~~~L~~dPeeRPSa~Q 291 (1021)
T PTZ00266 268 SKELNILIKNLLNLSAKERPSALQ 291 (1021)
T ss_pred CHHHHHHHHHHhcCChhHCcCHHH
Confidence 357889999999999999999853
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=229.08 Aligned_cols=207 Identities=20% Similarity=0.288 Sum_probs=164.1
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
.....+.+|++++.+++|+|++++++++...+..++|+||+++++|.+++.... .....++.+++.|+.||| +
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh---~ 117 (264)
T cd06623 41 EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH---T 117 (264)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh---c
Confidence 456789999999999999999999999999999999999999999999987532 246789999999999999 8
Q ss_pred -CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 87 -RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 87 -~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
.+++|+||+|+||+++.++.++|+|||.+.......... ....++..|+|||.+....++.++|+||||+++|++++
T Consensus 118 ~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~t 195 (264)
T cd06623 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECAL 195 (264)
T ss_pred cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999987665433221 23457788999999988888999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|+.||..... ....+....... ... ...... ..+..+.+++.+||..+|++|||+.|
T Consensus 196 g~~p~~~~~~------~~~~~~~~~~~~-~~~-----~~~~~~-------~~~~~l~~li~~~l~~~p~~R~~~~~ 252 (264)
T cd06623 196 GKFPFLPPGQ------PSFFELMQAICD-GPP-----PSLPAE-------EFSPEFRDFISACLQKDPKKRPSAAE 252 (264)
T ss_pred CCCCCccccc------cCHHHHHHHHhc-CCC-----CCCCcc-------cCCHHHHHHHHHHccCChhhCCCHHH
Confidence 9999966321 011222222211 111 111111 13367899999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=232.64 Aligned_cols=219 Identities=22% Similarity=0.286 Sum_probs=169.0
Q ss_pred ccccHHHHHHHHHHHHhc--CCCcccceeeeeeeCC----cceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhc
Q 044022 9 HRHTYGSCINNITYAAQM--SHNHILKRIGCCLQTP----IPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLA 79 (241)
Q Consensus 9 ~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~ 79 (241)
...+++++.+|.+|++.. +|+||+.+++.=..+. ++|+|++|.+.|||+|+|...+. ..++++..++.||+
T Consensus 243 ~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLa 322 (513)
T KOG2052|consen 243 SSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLA 322 (513)
T ss_pred cccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHH
Confidence 346788999999999885 9999999988754332 68999999999999999998866 46889999999999
Q ss_pred hhh-----cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCC--CcceeecccccCCCccCcccccccCC-----
Q 044022 80 YLH-----FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEG--ETHITTDRVIGTRGYSAPEYISICVL----- 147 (241)
Q Consensus 80 ~lh-----~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~~~aPE~~~~~~~----- 147 (241)
+|| +..+..|.|||||.+|||+.+++.+-|+|+|++..-... ......+..+||..|||||++.....
T Consensus 323 HLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fe 402 (513)
T KOG2052|consen 323 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFE 402 (513)
T ss_pred HHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhh
Confidence 999 344566999999999999999999999999999865543 23344566789999999999975421
Q ss_pred -CcchhhHHHHHHHHHHHhc----------CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHH
Q 044022 148 -NEKSNVFSFGAFLFELLAG----------RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQ 216 (241)
Q Consensus 148 -~~~~Di~s~G~~~~~~~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (241)
-..+||||||+++||+..+ ++||++....++ -.+.++.......+.+.++.++ ....
T Consensus 403 syk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP-----s~eeMrkVVCv~~~RP~ipnrW-------~s~~ 470 (513)
T KOG2052|consen 403 SYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP-----SFEEMRKVVCVQKLRPNIPNRW-------KSDP 470 (513)
T ss_pred hhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC-----CHHHHhcceeecccCCCCCccc-------ccCH
Confidence 1468999999999999864 478887654432 2233333333333333333333 3336
Q ss_pred HHHHHHHHHHHhccCCCCCCCCC
Q 044022 217 QLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 217 ~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
....+..+|+.||..||.-|-||
T Consensus 471 ~l~~m~klMkeCW~~Np~aRltA 493 (513)
T KOG2052|consen 471 ALRVMAKLMKECWYANPAARLTA 493 (513)
T ss_pred HHHHHHHHHHHhhcCCchhhhHH
Confidence 77888999999999999999886
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=248.50 Aligned_cols=215 Identities=16% Similarity=0.194 Sum_probs=147.7
Q ss_pred HHHHHHHHHHhcCCCcccceeeeeeeC--------CcceEEEEecCCCCHHHhhcC----C-Cc---hHHHHHHHHHHHh
Q 044022 15 SCINNITYAAQMSHNHILKRIGCCLQT--------PIPILVFQSVEYGTLRDCIFG----A-PL---PRLKIASDIVNSL 78 (241)
Q Consensus 15 ~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~sL~~~l~~----~-~~---~~~~~~~~i~~~l 78 (241)
...+|+.++++++||||+++++++... ..+++||||++ ++|.+++.. . .. ....++.|++.||
T Consensus 105 ~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL 183 (440)
T PTZ00036 105 YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRAL 183 (440)
T ss_pred hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Confidence 345799999999999999998887532 24679999997 578776642 1 11 3567889999999
Q ss_pred chhhcCCCCCceeccCCCCCeeecCCC-CeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHH
Q 044022 79 AYLHFGFPRPIVLRNFKTQNILFNEEN-VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSF 156 (241)
Q Consensus 79 ~~lh~~~~~~ivh~dl~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~ 156 (241)
.||| +++|+||||||+|||++.++ .+||+|||++......... ....+++.|+|||++.+. .++.++|||||
T Consensus 184 ~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 257 (440)
T PTZ00036 184 AYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSL 257 (440)
T ss_pred HHHH---HCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHH
Confidence 9999 99999999999999998665 7999999999765433221 234678999999998764 68999999999
Q ss_pred HHHHHHHHhcCcccccccccCCCcccchHHHHHHHh---------hhcccCCCCCCccc-cCCCchhHHHHHHHHHHHHH
Q 044022 157 GAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYL---------EDKRFTGIPAPIIV-QDIPCIEKEQQLHASAQLTL 226 (241)
Q Consensus 157 G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~ 226 (241)
||++|+|++|.+||...... ........... ....+....-+... .+.........+..+.+|+.
T Consensus 258 Gvil~elltG~~pf~~~~~~-----~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~ 332 (440)
T PTZ00036 258 GCIIAEMILGYPIFSGQSSV-----DQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFIS 332 (440)
T ss_pred HHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHH
Confidence 99999999999999652111 00111100000 00000000000000 00000000123357889999
Q ss_pred HhccCCCCCCCCCCC
Q 044022 227 ECVNNSPEDRPTMVD 241 (241)
Q Consensus 227 ~cl~~~p~~Rpt~~e 241 (241)
+||.+||.+|||+.|
T Consensus 333 ~~L~~dP~~R~ta~e 347 (440)
T PTZ00036 333 QFLKYEPLKRLNPIE 347 (440)
T ss_pred HHCCCChhHCcCHHH
Confidence 999999999999854
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=230.31 Aligned_cols=204 Identities=17% Similarity=0.274 Sum_probs=159.8
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
..+.+.+|+.++++++|+|++++++++...+..++++||+++++|.+++..... ....++.+++.|+++|| +.+
T Consensus 59 ~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~ 135 (285)
T cd06648 59 RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLH---AQG 135 (285)
T ss_pred HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 456688999999999999999999999999999999999999999999876432 45789999999999999 999
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCc
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRI 168 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~ 168 (241)
++||||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+..++.++|+||||+++|++++|..
T Consensus 136 i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~ 213 (285)
T cd06648 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP 213 (285)
T ss_pred eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998765433221 1123457889999999988888999999999999999999999
Q ss_pred ccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 169 HIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 169 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
||.... ............ .+..... ...+..+.+++.+||+.+|++|||+.|
T Consensus 214 p~~~~~---------~~~~~~~~~~~~------~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~~ 265 (285)
T cd06648 214 PYFNEP---------PLQAMKRIRDNL------PPKLKNL------HKVSPRLRSFLDRMLVRDPAQRATAAE 265 (285)
T ss_pred CCcCCC---------HHHHHHHHHhcC------CCCCccc------ccCCHHHHHHHHHHcccChhhCcCHHH
Confidence 985411 111111111110 0011000 012357899999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=229.19 Aligned_cols=204 Identities=20% Similarity=0.244 Sum_probs=153.8
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeee--CCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQ--TPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
....+.+|++++++++||||+++++++.. ....++++||+++++|.+++.... .....++.+++.||.|||
T Consensus 47 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH--- 123 (266)
T cd06651 47 EVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH--- 123 (266)
T ss_pred HHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 34568889999999999999999998875 356789999999999999886542 245678999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCc-ceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET-HITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
+.+++|+||+|+||+++.++.++|+|||++........ ........++..|+|||++.+..++.++|+||||+++|+++
T Consensus 124 ~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~ 203 (266)
T cd06651 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEML 203 (266)
T ss_pred hCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHH
Confidence 89999999999999999999999999999875533211 11112234788899999998888999999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|+.||..... ........... ..+.+.. ...+.+.+++ +||..+|++|||++|
T Consensus 204 ~g~~pf~~~~~---------~~~~~~~~~~~-----~~~~~~~--------~~~~~~~~li-~~~~~~p~~Rp~~~e 257 (266)
T cd06651 204 TEKPPWAEYEA---------MAAIFKIATQP-----TNPQLPS--------HISEHARDFL-GCIFVEARHRPSAEE 257 (266)
T ss_pred HCCCCccccch---------HHHHHHHhcCC-----CCCCCch--------hcCHHHHHHH-HHhcCChhhCcCHHH
Confidence 99999964211 11111111111 0111111 2235567777 688899999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=234.26 Aligned_cols=204 Identities=19% Similarity=0.278 Sum_probs=159.7
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
..+.+.+|+.++++++|||++++++++...+..++|+||+++++|.+++.+... .+..++.+++.|+.||| +.+
T Consensus 59 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH---~~g 135 (293)
T cd06647 59 KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQ 135 (293)
T ss_pred HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 456788999999999999999999999999999999999999999999876533 45778999999999999 999
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCc
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRI 168 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~ 168 (241)
++|+||+|+||+++.++.++|+|||.+......... .....+++.|+|||.+....++.++|+||||+++|++++|+.
T Consensus 136 i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~ 213 (293)
T cd06647 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213 (293)
T ss_pred EeeccCCHHHEEEcCCCCEEEccCcceecccccccc--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999988655433221 123457888999999988888999999999999999999999
Q ss_pred ccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 169 HIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 169 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
||....... ........+ .+... .....+..+.+++.+||..+|++|||++|
T Consensus 214 pf~~~~~~~---------~~~~~~~~~------~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ 265 (293)
T cd06647 214 PYLNENPLR---------ALYLIATNG------TPELQ------NPEKLSAIFRDFLNRCLEMDVEKRGSAKE 265 (293)
T ss_pred CCCCCChhh---------heeehhcCC------CCCCC------CccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 995421100 000000000 00000 01123356889999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=233.44 Aligned_cols=205 Identities=26% Similarity=0.394 Sum_probs=157.0
Q ss_pred HHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcC-CC---chHHHHHHHHHHHhchhhcCCCCCce
Q 044022 15 SCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFG-AP---LPRLKIASDIVNSLAYLHFGFPRPIV 90 (241)
Q Consensus 15 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~---~~~~~~~~~i~~~l~~lh~~~~~~iv 90 (241)
...+|+.++++++||||+++++++......++|||++.+++|.+++.. .. ..+..++.+++.||.+|| +.+++
T Consensus 44 ~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~ 120 (260)
T PF00069_consen 44 ENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLH---SKGIV 120 (260)
T ss_dssp HHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred hhhhhhhccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccc
Confidence 345699999999999999999999999999999999998899999872 22 256889999999999999 89999
Q ss_pred eccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc-ccCCCcchhhHHHHHHHHHHHhcCcc
Q 044022 91 LRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS-ICVLNEKSNVFSFGAFLFELLAGRIH 169 (241)
Q Consensus 91 h~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~s~G~~~~~~~~g~~p 169 (241)
|+||||+||+++.++.++|+|||.+....... .......++..|+|||+.. +...+.++|+||+|+++|+|++|..|
T Consensus 121 H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p 198 (260)
T PF00069_consen 121 HRDIKPENILLDENGEVKLIDFGSSVKLSENN--ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLP 198 (260)
T ss_dssp ESSBSGGGEEESTTSEEEESSGTTTEESTSTT--SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSS
T ss_pred cccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999999997642211 1223456788999999998 78899999999999999999999999
Q ss_pred cccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 170 IWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|..... ...................... ......+.+++.+||+.||++|||++|
T Consensus 199 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~~l~~~p~~R~~~~~ 253 (260)
T PF00069_consen 199 FEESNS------DDQLEIIEKILKRPLPSSSQQS-----------REKSEELRDLIKKMLSKDPEQRPSAEE 253 (260)
T ss_dssp STTSSH------HHHHHHHHHHHHTHHHHHTTSH-----------TTSHHHHHHHHHHHSSSSGGGSTTHHH
T ss_pred cccccc------hhhhhhhhhccccccccccccc-----------chhHHHHHHHHHHHccCChhHCcCHHH
Confidence 965200 0011111111110000000000 011267999999999999999999753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=231.92 Aligned_cols=195 Identities=21% Similarity=0.237 Sum_probs=157.1
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+.+.+|++++++++||||+++++++..++..++||||+++++|.+++..... ....++.+++.||.||| +.
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH---~~ 120 (290)
T cd05580 44 QVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH---SL 120 (290)
T ss_pred HHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 456788999999999999999999999999999999999999999999865432 45678899999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcC
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
+++|+||+|+||+++.++.++|+|||.+...... .....+++.|+|||.+.+...+.++|+||||+++|+|++|+
T Consensus 121 ~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 195 (290)
T cd05580 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGY 195 (290)
T ss_pred CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999998765443 12345788999999998888889999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
.||.... ..+...... .+.. .+... .+..+.+++.+||..||++|++
T Consensus 196 ~p~~~~~---------~~~~~~~~~-~~~~------~~~~~--------~~~~l~~li~~~l~~~p~~R~~ 242 (290)
T cd05580 196 PPFFDDN---------PIQIYEKIL-EGKV------RFPSF--------FSPDAKDLIRNLLQVDLTKRLG 242 (290)
T ss_pred CCCCCCC---------HHHHHHHHh-cCCc------cCCcc--------CCHHHHHHHHHHccCCHHHccC
Confidence 9985421 111111111 1110 11111 1257889999999999999993
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=247.78 Aligned_cols=153 Identities=18% Similarity=0.251 Sum_probs=130.1
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---------hHHHHHHHHHHHhchhhc
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---------PRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------~~~~~~~~i~~~l~~lh~ 83 (241)
...+.+|++++++++||||+++++++...+..++|++++. ++|..++..... ....++.|++.||.|||
T Consensus 207 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH- 284 (501)
T PHA03210 207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH- 284 (501)
T ss_pred HHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH-
Confidence 4568899999999999999999999999999999999995 677777644321 34578999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+++|+||||||+|||++.++.+||+|||++.......... .....|+..|+|||++.+..++.++|||||||++|+|
T Consensus 285 --~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 361 (501)
T PHA03210 285 --DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361 (501)
T ss_pred --hCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHH
Confidence 8999999999999999999999999999997664432211 1234689999999999988999999999999999999
Q ss_pred HhcCccc
Q 044022 164 LAGRIHI 170 (241)
Q Consensus 164 ~~g~~p~ 170 (241)
++|..++
T Consensus 362 l~~~~~p 368 (501)
T PHA03210 362 LSHDFCP 368 (501)
T ss_pred HHCCCCC
Confidence 9987543
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=227.93 Aligned_cols=203 Identities=19% Similarity=0.206 Sum_probs=154.5
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeC--CcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQT--PIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
.+.+.+|++++++++||||+++++++... ...++++||+++++|.+++.... .....++.+++.||.||| +
T Consensus 48 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH---~ 124 (265)
T cd06652 48 VNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH---S 124 (265)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 45788899999999999999999988763 46789999999999999986542 246788999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcce-eecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI-TTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
.+++|+||+|+||+++.++.++|+|||.+.......... ......++..|+|||++.+..++.++|+||||+++|++++
T Consensus 125 ~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~ 204 (265)
T cd06652 125 NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204 (265)
T ss_pred CCEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhh
Confidence 999999999999999999999999999887543221111 1122357888999999988888999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|+.||.... ............. .+... ...+..+.+++.+||. +|++|||++|
T Consensus 205 g~~p~~~~~---------~~~~~~~~~~~~~-----~~~~~--------~~~~~~~~~~i~~~l~-~p~~Rp~~~~ 257 (265)
T cd06652 205 EKPPWAEFE---------AMAAIFKIATQPT-----NPVLP--------PHVSDHCRDFLKRIFV-EAKLRPSADE 257 (265)
T ss_pred CCCCCCccc---------hHHHHHHHhcCCC-----CCCCc--------hhhCHHHHHHHHHHhc-ChhhCCCHHH
Confidence 999985411 0011111111110 11111 1233568899999994 9999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=234.26 Aligned_cols=154 Identities=19% Similarity=0.240 Sum_probs=129.4
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHHhchhhcCCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
...+.+|++++++++|+||+++++++...+..++||||+. ++|.+++..... ....++.+++.||.||| +.
T Consensus 47 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~ 122 (291)
T cd07844 47 PFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QR 122 (291)
T ss_pred chhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 3457789999999999999999999999999999999997 599988765321 45678899999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHHHHHHHHhc
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~~~~~~g 166 (241)
+++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||++.+ ..++.++||||+|+++|+|++|
T Consensus 123 ~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g 200 (291)
T cd07844 123 RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200 (291)
T ss_pred CeecccCCHHHEEEcCCCCEEECccccccccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998654322111 112245778999999875 4578899999999999999999
Q ss_pred Cccccc
Q 044022 167 RIHIWD 172 (241)
Q Consensus 167 ~~p~~~ 172 (241)
+.||..
T Consensus 201 ~~~~~~ 206 (291)
T cd07844 201 RPLFPG 206 (291)
T ss_pred CCCCCC
Confidence 999954
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=231.83 Aligned_cols=153 Identities=22% Similarity=0.323 Sum_probs=126.7
Q ss_pred HHHHHHHHHHHHhc---CCCcccceeeeeeeC-----CcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHh
Q 044022 13 YGSCINNITYAAQM---SHNHILKRIGCCLQT-----PIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSL 78 (241)
Q Consensus 13 ~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l 78 (241)
..++.+|+++++.+ +||||+++++++... ...++++|++. ++|.+++.... .....++.|++.||
T Consensus 43 ~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al 121 (288)
T cd07863 43 PLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121 (288)
T ss_pred chHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Confidence 34566788877766 699999999988642 35799999997 58988876532 14577899999999
Q ss_pred chhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHH
Q 044022 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGA 158 (241)
Q Consensus 79 ~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~ 158 (241)
.||| +.+++|+||||+||+++.++.++|+|||.+........ .....++..|+|||++.+..++.++||||+|+
T Consensus 122 ~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 195 (288)
T cd07863 122 DFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGC 195 (288)
T ss_pred HHHH---hCCeecCCCCHHHEEECCCCCEEECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHH
Confidence 9999 89999999999999999999999999999876543221 12345788999999998888999999999999
Q ss_pred HHHHHHhcCccccc
Q 044022 159 FLFELLAGRIHIWD 172 (241)
Q Consensus 159 ~~~~~~~g~~p~~~ 172 (241)
++|+|++|++||..
T Consensus 196 ~l~~l~~g~~~f~~ 209 (288)
T cd07863 196 IFAEMFRRKPLFCG 209 (288)
T ss_pred HHHHHHhCCcCcCC
Confidence 99999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=226.88 Aligned_cols=208 Identities=21% Similarity=0.321 Sum_probs=160.6
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|+++++.++|+||+++++.+...+..++|+||+++++|.+++..... ....++.+++.|+.||| +
T Consensus 41 ~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~ 117 (264)
T cd06626 41 KTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH---S 117 (264)
T ss_pred HHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHH---H
Confidence 3567889999999999999999999999999999999999999999999876522 45678999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCccee--ecccccCCCccCcccccccC---CCcchhhHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT--TDRVIGTRGYSAPEYISICV---LNEKSNVFSFGAFLF 161 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~---~~~~~Di~s~G~~~~ 161 (241)
.+++|+||+|+||+++.++.++|+|||.+........... .....++..|+|||++.+.. .+.++||||||+++|
T Consensus 118 ~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~ 197 (264)
T cd06626 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVL 197 (264)
T ss_pred CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHH
Confidence 9999999999999999999999999999876644322111 11235678899999998766 789999999999999
Q ss_pred HHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 162 ELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 162 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++++|+.||...... ....... ..... +.+... ...+..+.+++.+||+.+|.+|||++|
T Consensus 198 ~l~~g~~pf~~~~~~--------~~~~~~~-~~~~~-----~~~~~~------~~~~~~~~~li~~~l~~~p~~R~~~~~ 257 (264)
T cd06626 198 EMATGKRPWSELDNE--------FQIMFHV-GAGHK-----PPIPDS------LQLSPEGKDFLDRCLESDPKKRPTASE 257 (264)
T ss_pred HHHhCCCCccCCcch--------HHHHHHH-hcCCC-----CCCCcc------cccCHHHHHHHHHHccCCcccCCCHHH
Confidence 999999999542110 0001110 11111 111111 012356789999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=232.32 Aligned_cols=198 Identities=23% Similarity=0.374 Sum_probs=153.4
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--C---chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--P---LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~---~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+++.+|+++++.++|||++++.+++...+..++|+||+. |+|.+.+... . .....++.+++.||.||| +
T Consensus 58 ~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~ 133 (307)
T cd06607 58 KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---S 133 (307)
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 44678899999999999999999999999999999999997 6777766432 1 245678999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc---ccCCCcchhhHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS---ICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~s~G~~~~~~ 163 (241)
.+++|+||+|+||+++.++.++|+|||.+...... ....++..|+|||++. ...++.++||||||+++|++
T Consensus 134 ~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el 207 (307)
T cd06607 134 HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207 (307)
T ss_pred CCceecCCCcccEEECCCCCEEEeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHH
Confidence 99999999999999999999999999988654332 2235778899999874 35678899999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|..||..... ........... .+... ....+..+.+++.+||+.||++|||+.+
T Consensus 208 ~tg~~p~~~~~~---------~~~~~~~~~~~------~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 263 (307)
T cd06607 208 AERKPPLFNMNA---------MSALYHIAQND------SPTLS-------SNDWSDYFRNFVDSCLQKIPQDRPSSEE 263 (307)
T ss_pred HcCCCCCCCccH---------HHHHHHHhcCC------CCCCC-------chhhCHHHHHHHHHHhcCChhhCcCHHH
Confidence 999999854211 11111111000 00000 1134467899999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=230.73 Aligned_cols=204 Identities=21% Similarity=0.304 Sum_probs=159.9
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
....+.+|++++++++|+|++++++.+...+..++++||+++++|.+++.... . .+..++.+++.||.||| +
T Consensus 58 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~ 134 (286)
T cd06614 58 NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---S 134 (286)
T ss_pred hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 46678899999999999999999999999999999999999999999987653 2 46778999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++|++++|
T Consensus 135 ~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g 212 (286)
T cd06614 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212 (286)
T ss_pred CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhC
Confidence 9999999999999999999999999998765433221 11233567889999999888889999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+.||..... ........ ......... ....+..+.+++.+||+.+|.+|||++|
T Consensus 213 ~~p~~~~~~---------~~~~~~~~-~~~~~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 266 (286)
T cd06614 213 EPPYLREPP---------LRALFLIT-TKGIPPLKN-----------PEKWSPEFKDFLNKCLVKDPEKRPSAEE 266 (286)
T ss_pred CCCCCCCCH---------HHHHHHHH-hcCCCCCcc-----------hhhCCHHHHHHHHHHhccChhhCcCHHH
Confidence 999854111 01111111 111111110 0113357889999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=237.04 Aligned_cols=156 Identities=18% Similarity=0.201 Sum_probs=133.3
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--Cc---hHHHHHHHHHHHhchhhcCCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--PL---PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~---~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
...+.+|+.++..++|+||+++++++...+..++||||+++|+|.+++... .. ....++.|++.||.||| +.
T Consensus 45 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~ 121 (332)
T cd05623 45 TACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QL 121 (332)
T ss_pred HHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 445788999999999999999999999999999999999999999998653 11 35678899999999999 99
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-----cCCCcchhhHHHHHHHHH
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-----CVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~s~G~~~~~ 162 (241)
+++||||||+|||++.++.++|+|||++......... ......|++.|+|||++.. ..++.++||||||+++|+
T Consensus 122 ~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~e 200 (332)
T cd05623 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYE 200 (332)
T ss_pred CeEecCCCHHHEEECCCCCEEEeecchheecccCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHH
Confidence 9999999999999999999999999998754332221 1233468999999999863 457889999999999999
Q ss_pred HHhcCccccc
Q 044022 163 LLAGRIHIWD 172 (241)
Q Consensus 163 ~~~g~~p~~~ 172 (241)
|++|+.||..
T Consensus 201 ll~g~~Pf~~ 210 (332)
T cd05623 201 MLYGETPFYA 210 (332)
T ss_pred HhcCCCCCCC
Confidence 9999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=230.69 Aligned_cols=202 Identities=24% Similarity=0.337 Sum_probs=164.1
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--Cc---hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--PL---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..++...|+.++++++.|++|++||.+.....+|+|||||-.||+.+.++.. +. .+..++.+-+.||.||| .
T Consensus 71 DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~ 147 (502)
T KOG0574|consen 71 DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---D 147 (502)
T ss_pred hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---H
Confidence 5678899999999999999999999998888999999999999999987644 22 35678889999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
..-+|||||+-|||++.+|..|++|||++..++..- ...+++.||+.|||||++..-.|+.++||||+|+...||..|
T Consensus 148 ~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG 225 (502)
T KOG0574|consen 148 LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEG 225 (502)
T ss_pred HHHHHhhcccccEEEcccchhhhhhccccchhhhhH--HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcC
Confidence 889999999999999999999999999998765532 234678999999999999999999999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
++||.+.- .. ..+..++... ++.+ ..++.-+..+.+++++||.++|++|.||
T Consensus 226 ~PPYsDIH-PM-----------------RAIFMIPT~P-PPTF--~KPE~WS~~F~DFi~~CLiK~PE~R~TA 277 (502)
T KOG0574|consen 226 RPPYSDIH-PM-----------------RAIFMIPTKP-PPTF--KKPEEWSSEFNDFIRSCLIKKPEERKTA 277 (502)
T ss_pred CCCccccc-cc-----------------ceeEeccCCC-CCCC--CChHhhhhHHHHHHHHHhcCCHHHHHHH
Confidence 99996621 10 0011111100 0111 1123455679999999999999999886
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=227.59 Aligned_cols=205 Identities=20% Similarity=0.320 Sum_probs=153.9
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCC------cceEEEEecCCCCHHHhhcCC-----C-----chHHHHHHHH
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTP------IPILVFQSVEYGTLRDCIFGA-----P-----LPRLKIASDI 74 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~-----~-----~~~~~~~~~i 74 (241)
...+++.+|++++++++||||+++++++.... ..+++++|+.+|+|.+++... . .....++.++
T Consensus 43 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i 122 (273)
T cd05074 43 SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122 (273)
T ss_pred HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Confidence 34667889999999999999999999886532 247889999999998876321 1 1357899999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhH
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
+.|++||| +.+++|+||||+||+++.++.++++|||.+................++..|++||.+....++.++|||
T Consensus 123 ~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~ 199 (273)
T cd05074 123 ASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVW 199 (273)
T ss_pred HHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhH
Confidence 99999999 899999999999999999999999999998765433222122223456779999999888889999999
Q ss_pred HHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 155 SFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 155 s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
|||+++|++++ |+.||..... .+...... ...... ... ..+..+.+++.+||+.+|
T Consensus 200 slG~il~el~~~g~~p~~~~~~---------~~~~~~~~-~~~~~~-----~~~--------~~~~~~~~l~~~~l~~~p 256 (273)
T cd05074 200 AFGVTMWEIMTRGQTPYAGVEN---------SEIYNYLI-KGNRLK-----QPP--------DCLEDVYELMCQCWSPEP 256 (273)
T ss_pred HHHHHHHHHhhCCCCCCCCCCH---------HHHHHHHH-cCCcCC-----CCC--------CCCHHHHHHHHHHcCCCh
Confidence 99999999999 8888854211 11111111 111100 011 123578999999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|||+.|
T Consensus 257 ~~Rps~~~ 264 (273)
T cd05074 257 KCRPSFQH 264 (273)
T ss_pred hhCcCHHH
Confidence 99999853
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=246.42 Aligned_cols=198 Identities=23% Similarity=0.382 Sum_probs=158.8
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--Cc---hHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--PL---PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~---~~~~~~~~i~~~l~~lh~~~ 85 (241)
...++++.||+.|++++|||++.+.|+|..+...|+|||||- ||-.|.+.-+ +. .+..|..+.+.||+|||
T Consensus 68 EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH--- 143 (948)
T KOG0577|consen 68 EKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH--- 143 (948)
T ss_pred HHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---
Confidence 457778999999999999999999999999999999999996 6888876433 33 35677889999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc---cCCCcchhhHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI---CVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~s~G~~~~~ 162 (241)
+.+.+|||||+-|||++..|.||++|||.+..... .++.+|||+|||||++.- +.|+-++||||+|+...|
T Consensus 144 S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIE 217 (948)
T KOG0577|consen 144 SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 217 (948)
T ss_pred HhhHHhhhccccceEecCCCeeeeccccchhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhh
Confidence 99999999999999999999999999998865433 256789999999999864 579999999999999999
Q ss_pred HHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 163 LLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 163 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
+..+++|+..++- ...+.....+. .|. ....+-+..+++|+..||.+=|.+|||.+
T Consensus 218 LAERkPPlFnMNA---------MSALYHIAQNe------sPt-------Lqs~eWS~~F~~Fvd~CLqKipqeRptse 273 (948)
T KOG0577|consen 218 LAERKPPLFNMNA---------MSALYHIAQNE------SPT-------LQSNEWSDYFRNFVDSCLQKIPQERPTSE 273 (948)
T ss_pred hhhcCCCccCchH---------HHHHHHHHhcC------CCC-------CCCchhHHHHHHHHHHHHhhCcccCCcHH
Confidence 9999999866311 01111111111 111 11124456799999999999999999975
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=236.06 Aligned_cols=154 Identities=18% Similarity=0.243 Sum_probs=129.5
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
...+.+|++++++++|+||+++++++...+..++|+||+. ++|.+++.... .....++.||+.||.||| ++
T Consensus 43 ~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~ 118 (284)
T cd07839 43 PSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SH 118 (284)
T ss_pred ccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 4567889999999999999999999999999999999997 58888765421 146789999999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHHHhc
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~~g 166 (241)
+++|+||+|+||+++.++.++|+|||.+.......... ....++..|+|||.+.+. .++.++||||||+++|+|++|
T Consensus 119 ~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg 196 (284)
T cd07839 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196 (284)
T ss_pred CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc--CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhc
Confidence 99999999999999999999999999987554322111 223567889999988764 468999999999999999999
Q ss_pred Cccccc
Q 044022 167 RIHIWD 172 (241)
Q Consensus 167 ~~p~~~ 172 (241)
..|+..
T Consensus 197 ~~p~~~ 202 (284)
T cd07839 197 GRPLFP 202 (284)
T ss_pred CCCCcC
Confidence 988754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=228.53 Aligned_cols=202 Identities=19% Similarity=0.225 Sum_probs=160.8
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC-Cc---hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA-PL---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|++++++++||||+++++++..+...++|+||+.+++|..++... .. ....++.+++.||.||| +
T Consensus 42 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh---~ 118 (258)
T cd05578 42 GSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH---S 118 (258)
T ss_pred hHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHH---h
Confidence 35678999999999999999999999999999999999999999999998665 22 46788999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+....++.++|+||||+++|++++|
T Consensus 119 ~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g 195 (258)
T cd05578 119 KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRG 195 (258)
T ss_pred CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhC
Confidence 9999999999999999999999999999876544321 1234577889999999888889999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
..||...... ........ ... ....... ..+..+.+++.+||..||.+||++
T Consensus 196 ~~p~~~~~~~------~~~~~~~~-~~~------~~~~~~~--------~~~~~~~~~i~~~l~~~p~~R~~~ 247 (258)
T cd05578 196 KRPYRGHSRT------IRDQIRAK-QET------ADVLYPA--------TWSTEAIDAINKLLERDPQKRLGD 247 (258)
T ss_pred CCCCCCCCcc------HHHHHHHH-hcc------ccccCcc--------cCcHHHHHHHHHHccCChhHcCCc
Confidence 9999653211 01111111 110 0011111 122678899999999999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=229.51 Aligned_cols=165 Identities=18% Similarity=0.209 Sum_probs=133.5
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~ 76 (241)
|.+..+........+.+|+++++.++|+||+++++++..++..++|+||+. ++|.+++.... .....++.+++.
T Consensus 36 K~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~ 114 (291)
T cd07870 36 KVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLR 114 (291)
T ss_pred EEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHH
Confidence 444433333444567899999999999999999999999889999999996 68877664321 245678899999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFS 155 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s 155 (241)
||.||| +.+++|+||||+||+++.++.++|+|||.+......... .....++..|+|||.+.+. .++.++|+||
T Consensus 115 ~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 189 (291)
T cd07870 115 GLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWG 189 (291)
T ss_pred HHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHH
Confidence 999999 899999999999999999999999999988754332211 1223467889999998753 5788999999
Q ss_pred HHHHHHHHHhcCccccc
Q 044022 156 FGAFLFELLAGRIHIWD 172 (241)
Q Consensus 156 ~G~~~~~~~~g~~p~~~ 172 (241)
||+++|++++|..||..
T Consensus 190 lG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 190 AGCIFIEMLQGQPAFPG 206 (291)
T ss_pred HHHHHHHHHhCCCCCCC
Confidence 99999999999999964
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=227.33 Aligned_cols=208 Identities=20% Similarity=0.286 Sum_probs=159.6
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+.+.+|++++++++|+||+++++++...+..++|+||+++++|.+++.... .....++.+++.||.||| +.
T Consensus 46 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH---~~ 122 (268)
T cd06630 46 VVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH---EN 122 (268)
T ss_pred HHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 45778999999999999999999999999999999999999999999986542 245778999999999999 99
Q ss_pred CceeccCCCCCeeecCCC-CeEEeeccCceecCCCCcc--eeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 88 PIVLRNFKTQNILFNEEN-VAKWFDFLLSISIPEGETH--ITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~-~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
+++|+||+|+||+++.++ .++|+|||.+......... .......++..|+|||.+.+..++.++|+||+|+++++++
T Consensus 123 ~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 202 (268)
T cd06630 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMA 202 (268)
T ss_pred CeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHH
Confidence 999999999999998776 5899999998765443111 1112345788899999998888899999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|..||...... ............. ..+... ...+..+.+++.+||..+|++|||+.|
T Consensus 203 ~g~~p~~~~~~~------~~~~~~~~~~~~~-----~~~~~~--------~~~~~~~~~~i~~~l~~~p~~R~~~~~ 260 (268)
T cd06630 203 TAKPPWNAEKHS------NHLALIFKIASAT-----TAPSIP--------EHLSPGLRDVTLRCLELQPEDRPPSRE 260 (268)
T ss_pred hCCCCCCCCCCc------chHHHHHHHhccC-----CCCCCc--------hhhCHHHHHHHHHHcCCCcccCcCHHH
Confidence 999998542111 0011111100000 001111 133467889999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=228.26 Aligned_cols=204 Identities=23% Similarity=0.256 Sum_probs=159.9
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
.....+.+|++++++++|+||+++++.+...+..++++||+++++|.+++.... ..+..++.|++.||+||| +
T Consensus 35 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH---~ 111 (265)
T cd05579 35 NQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLH---S 111 (265)
T ss_pred hHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 456678899999999999999999999999999999999999999999986532 246789999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCc------ceeecccccCCCccCcccccccCCCcchhhHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET------HITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFL 160 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~ 160 (241)
.+++|+||+|+||+++.++.++|+|||++........ ........++..|+|||.......+.++|+||||+++
T Consensus 112 ~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~ 191 (265)
T cd05579 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCIL 191 (265)
T ss_pred cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHH
Confidence 9999999999999999999999999998765433211 0122334577889999999888889999999999999
Q ss_pred HHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 161 FELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 161 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
|++++|..||.... ..+....... +... .+ ... ..+..+.+++.+||+.+|++|||+
T Consensus 192 ~~l~~g~~p~~~~~---------~~~~~~~~~~-~~~~-~~-----~~~------~~~~~~~~~i~~~l~~~p~~Rpt~ 248 (265)
T cd05579 192 YEFLVGIPPFHGET---------PEEIFQNILN-GKIE-WP-----EDV------EVSDEAIDLISKLLVPDPEKRLGA 248 (265)
T ss_pred HHHHhCCCCCCCCC---------HHHHHHHHhc-CCcC-CC-----ccc------cCCHHHHHHHHHHhcCCHhhcCCC
Confidence 99999999995421 1111111111 1110 00 000 013678899999999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=228.73 Aligned_cols=204 Identities=24% Similarity=0.307 Sum_probs=154.7
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeeeCC------cceEEEEecCCCCHHHhhcCCC--------chHHHHHHHHHH
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQTP------IPILVFQSVEYGTLRDCIFGAP--------LPRLKIASDIVN 76 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~--------~~~~~~~~~i~~ 76 (241)
..+++.+|+.+++++ .|+||+++++++.... ..++|+||+++++|.+++.... .....++.|++.
T Consensus 45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~ 124 (275)
T cd06608 45 EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLR 124 (275)
T ss_pred hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHH
Confidence 356789999999999 7999999999997654 4899999999999998875421 135678999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-----cCCCcch
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-----CVLNEKS 151 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~ 151 (241)
||.||| +.+++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||++.. ..++.++
T Consensus 125 al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 199 (275)
T cd06608 125 GLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARS 199 (275)
T ss_pred HHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCccceecccchhh--hcCccccccccCHhHhcccccccCCccccc
Confidence 999999 999999999999999999999999999998765432211 123457888999998753 2467889
Q ss_pred hhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccC
Q 044022 152 NVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNN 231 (241)
Q Consensus 152 Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~ 231 (241)
||||||+++|++++|+.||..... ........ ... .+.+. .....+..+.+++.+||..
T Consensus 200 Dv~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~-~~~-----~~~~~------~~~~~~~~~~~li~~~l~~ 258 (275)
T cd06608 200 DVWSLGITAIELADGKPPLCDMHP---------MRALFKIP-RNP-----PPTLK------SPENWSKKFNDFISECLIK 258 (275)
T ss_pred cHHHhHHHHHHHHhCCCCccccch---------HHHHHHhh-ccC-----CCCCC------chhhcCHHHHHHHHHHhhc
Confidence 999999999999999999964211 01111111 110 01110 0113446789999999999
Q ss_pred CCCCCCCCCC
Q 044022 232 SPEDRPTMVD 241 (241)
Q Consensus 232 ~p~~Rpt~~e 241 (241)
||++|||++|
T Consensus 259 dp~~Rpt~~~ 268 (275)
T cd06608 259 NYEQRPFMEE 268 (275)
T ss_pred ChhhCcCHHH
Confidence 9999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=230.74 Aligned_cols=158 Identities=22% Similarity=0.273 Sum_probs=134.3
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|++++++++|+||+++++++...+..++|+||++++.+..+..... .....++.+++.|+.||| +
T Consensus 42 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~ 118 (288)
T cd07833 42 DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH---S 118 (288)
T ss_pred cchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 456788999999999999999999999999999999999999776666554432 246778999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHHHh
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~~ 165 (241)
.+++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||++.+. .++.++|+||||+++|++++
T Consensus 119 ~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~ 197 (288)
T cd07833 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197 (288)
T ss_pred CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHh
Confidence 99999999999999999999999999998765544321 11234577889999999887 78899999999999999999
Q ss_pred cCccccc
Q 044022 166 GRIHIWD 172 (241)
Q Consensus 166 g~~p~~~ 172 (241)
|+.||..
T Consensus 198 g~~~~~~ 204 (288)
T cd07833 198 GEPLFPG 204 (288)
T ss_pred CCCCCCC
Confidence 9999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=233.04 Aligned_cols=203 Identities=22% Similarity=0.282 Sum_probs=153.1
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeee------CCcceEEEEecCCCCHHHhhcCCC---c---hHHHHHHHHHHHh
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQ------TPIPILVFQSVEYGTLRDCIFGAP---L---PRLKIASDIVNSL 78 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~---~---~~~~~~~~i~~~l 78 (241)
...++.+|+.+++++ +|+|++++++++.. ....+++|||+.+|+|.+++.... . ....++.|++.|+
T Consensus 55 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al 134 (282)
T cd06636 55 EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGL 134 (282)
T ss_pred HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHH
Confidence 346788899999999 79999999999863 346799999999999999886432 1 3567888999999
Q ss_pred chhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc-----ccCCCcchhh
Q 044022 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS-----ICVLNEKSNV 153 (241)
Q Consensus 79 ~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di 153 (241)
.||| +.+++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+. ...++.++|+
T Consensus 135 ~~LH---~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dv 209 (282)
T cd06636 135 AHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDI 209 (282)
T ss_pred HHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccch
Confidence 9999 89999999999999999999999999999865432211 112346788999999886 3457789999
Q ss_pred HHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 154 FSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
||||+++|+|++|..||...... +...... .. ...... ....+..+.+++.+||+.||
T Consensus 210 wslG~~l~el~~g~~p~~~~~~~---------~~~~~~~-~~-----~~~~~~-------~~~~~~~~~~li~~cl~~~p 267 (282)
T cd06636 210 WSLGITAIEMAEGAPPLCDMHPM---------RALFLIP-RN-----PPPKLK-------SKKWSKKFIDFIEGCLVKNY 267 (282)
T ss_pred hHHHHHHHHHHhCCCCccccCHH---------hhhhhHh-hC-----CCCCCc-------ccccCHHHHHHHHHHhCCCh
Confidence 99999999999999999652111 0000000 00 000000 01233678999999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
.+|||+.|
T Consensus 268 ~~Rp~~~e 275 (282)
T cd06636 268 LSRPSTEQ 275 (282)
T ss_pred hhCcCHHH
Confidence 99999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=226.68 Aligned_cols=203 Identities=20% Similarity=0.335 Sum_probs=156.9
Q ss_pred cHHHHHHHHHHHHh-cCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC-----C---chHHHHHHHHHHHhchhh
Q 044022 12 TYGSCINNITYAAQ-MSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA-----P---LPRLKIASDIVNSLAYLH 82 (241)
Q Consensus 12 ~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----~---~~~~~~~~~i~~~l~~lh 82 (241)
...++.+|+.++.+ ++||||+++++++...+..++++||+++++|.+++... . ...+.++.+++.|+.|||
T Consensus 51 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh 130 (269)
T cd08528 51 SIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH 130 (269)
T ss_pred HHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc
Confidence 44567789988875 69999999999999999999999999999999887321 1 146788999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~ 162 (241)
. ..+++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||||+++|+
T Consensus 131 ~--~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~ 205 (269)
T cd08528 131 K--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQ 205 (269)
T ss_pred c--CCceeecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHH
Confidence 3 3689999999999999999999999999987654432 1233467888999999998889999999999999999
Q ss_pred HHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 163 LLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 163 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+++|+.||.... ........ .......... ...+..+.+++.+||+.||++|||+.|
T Consensus 206 l~~g~~p~~~~~---------~~~~~~~~-~~~~~~~~~~------------~~~~~~l~~li~~cl~~~p~~Rp~~~e 262 (269)
T cd08528 206 MCTLQPPFYSTN---------MLSLATKI-VEAVYEPLPE------------GMYSEDVTDVITSCLTPDAEARPDIIQ 262 (269)
T ss_pred HHhCCCcccccC---------HHHHHHHH-hhccCCcCCc------------ccCCHHHHHHHHHHCCCCCccCCCHHH
Confidence 999999985421 11111111 1111111110 012357889999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=229.24 Aligned_cols=155 Identities=22% Similarity=0.313 Sum_probs=130.3
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~~ 85 (241)
....+.+|++++++++||||+++++++...+..++|+||+. ++|..++.... .....++.+++.|++|||
T Consensus 42 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh--- 117 (284)
T cd07860 42 VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH--- 117 (284)
T ss_pred cchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 34678899999999999999999999999999999999996 68988875432 146788999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccC-CCcchhhHHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV-LNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~s~G~~~~~~~ 164 (241)
+.+++|+||+|+||+++.++.++++|||.+......... .....++..|+|||.+.+.. ++.++|+||||+++|+++
T Consensus 118 ~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~ 195 (284)
T cd07860 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195 (284)
T ss_pred HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHH
Confidence 899999999999999999999999999998654332211 12234677899999887644 578899999999999999
Q ss_pred hcCccccc
Q 044022 165 AGRIHIWD 172 (241)
Q Consensus 165 ~g~~p~~~ 172 (241)
+|+.||..
T Consensus 196 tg~~p~~~ 203 (284)
T cd07860 196 TRRALFPG 203 (284)
T ss_pred HCCCCCCC
Confidence 99999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=229.84 Aligned_cols=156 Identities=21% Similarity=0.269 Sum_probs=132.8
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
....+.+|+.++++++||||+++++++..+...++|+||+ +++|.+++.... ..+..++.+++.||.||| +
T Consensus 42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~ 117 (286)
T cd07832 42 IPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---A 117 (286)
T ss_pred hhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 4567899999999999999999999999999999999999 999999885432 246789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHHHh
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~~ 165 (241)
.+++|+||+|+||+++.++.++++|||.+........ .......++..|+|||.+.+. .++.++||||+|+++|++++
T Consensus 118 ~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~t 196 (286)
T cd07832 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLN 196 (286)
T ss_pred CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHc
Confidence 9999999999999999999999999999876544321 111234678899999988654 46889999999999999999
Q ss_pred cCccccc
Q 044022 166 GRIHIWD 172 (241)
Q Consensus 166 g~~p~~~ 172 (241)
|.+||..
T Consensus 197 g~~~~~~ 203 (286)
T cd07832 197 GSPLFPG 203 (286)
T ss_pred CCcCcCC
Confidence 9877743
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=235.71 Aligned_cols=157 Identities=17% Similarity=0.195 Sum_probs=134.7
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--Cc---hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--PL---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
....+.+|+.++..++|+||+++++++...+..++||||+++|+|.+++... .. ....++.|++.||.||| +
T Consensus 44 ~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~ 120 (331)
T cd05624 44 ETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---Q 120 (331)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 3455788999999999999999999999999999999999999999998653 11 35678899999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-----cCCCcchhhHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-----CVLNEKSNVFSFGAFLF 161 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~s~G~~~~ 161 (241)
++++||||||+|||++.++.++|+|||++.......... .....|++.|+|||++.+ ..++.++|+||||+++|
T Consensus 121 ~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ 199 (331)
T cd05624 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ-SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMY 199 (331)
T ss_pred CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee-eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhh
Confidence 999999999999999999999999999987654432221 133468999999999875 45788999999999999
Q ss_pred HHHhcCccccc
Q 044022 162 ELLAGRIHIWD 172 (241)
Q Consensus 162 ~~~~g~~p~~~ 172 (241)
+|++|+.||..
T Consensus 200 ell~g~~Pf~~ 210 (331)
T cd05624 200 EMLYGETPFYA 210 (331)
T ss_pred hhhhCCCCccC
Confidence 99999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=228.90 Aligned_cols=203 Identities=22% Similarity=0.266 Sum_probs=152.1
Q ss_pred HHHHHHHHHHHHhc-CCCcccceeeeee-----eCCcceEEEEecCCCCHHHhhcCC-----Cc---hHHHHHHHHHHHh
Q 044022 13 YGSCINNITYAAQM-SHNHILKRIGCCL-----QTPIPILVFQSVEYGTLRDCIFGA-----PL---PRLKIASDIVNSL 78 (241)
Q Consensus 13 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~sL~~~l~~~-----~~---~~~~~~~~i~~~l 78 (241)
...+.+|+.+++.+ +||||+++++++. .++..++||||+++++|.+++... .. ....++.+++.|+
T Consensus 58 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l 137 (286)
T cd06638 58 DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137 (286)
T ss_pred HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHH
Confidence 46688899999999 7999999999885 345689999999999999876421 11 3567899999999
Q ss_pred chhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-----cCCCcchhh
Q 044022 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-----CVLNEKSNV 153 (241)
Q Consensus 79 ~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di 153 (241)
.||| +.+++|+||||+||+++.++.++++|||.+........ ......++..|+|||++.. ..++.++|+
T Consensus 138 ~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv 212 (286)
T cd06638 138 QHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDV 212 (286)
T ss_pred HHHH---hCCccccCCCHHhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhh
Confidence 9999 89999999999999999999999999999876543221 1123468889999998753 347889999
Q ss_pred HHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 154 FSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
||+|+++|++++|+.||...... +....... ........+ . ..+..+.+++.+||+.||
T Consensus 213 ~slGvi~~el~~g~~p~~~~~~~---------~~~~~~~~-~~~~~~~~~---~--------~~~~~~~~li~~~l~~~p 271 (286)
T cd06638 213 WSLGITAIELGDGDPPLADLHPM---------RALFKIPR-NPPPTLHQP---E--------LWSNEFNDFIRKCLTKDY 271 (286)
T ss_pred hhHHHHHHHHhcCCCCCCCCchh---------HHHhhccc-cCCCcccCC---C--------CcCHHHHHHHHHHccCCc
Confidence 99999999999999998652110 00111000 000000000 0 122568899999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|||+.|
T Consensus 272 ~~Rps~~e 279 (286)
T cd06638 272 EKRPTVSD 279 (286)
T ss_pred ccCCCHHH
Confidence 99999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=231.66 Aligned_cols=156 Identities=21% Similarity=0.276 Sum_probs=132.4
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+.+.+|+++++.++||||+++++++...+..++|+||+++++|..+..... .....++.+++.|++||| +.
T Consensus 43 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~ 119 (286)
T cd07846 43 VKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH---SH 119 (286)
T ss_pred hhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 45678899999999999999999999999999999999999888888765432 256788999999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHHHhc
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~~g 166 (241)
+++|+||+|+||+++.++.++|+|||++......... .....++..|+|||++.+. .++.++||||||+++|++++|
T Consensus 120 ~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g 197 (286)
T cd07846 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197 (286)
T ss_pred CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcC
Confidence 9999999999999999999999999998765443221 1224577889999998753 467899999999999999999
Q ss_pred Cccccc
Q 044022 167 RIHIWD 172 (241)
Q Consensus 167 ~~p~~~ 172 (241)
++||..
T Consensus 198 ~~~~~~ 203 (286)
T cd07846 198 EPLFPG 203 (286)
T ss_pred CCCCCC
Confidence 998853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=261.24 Aligned_cols=212 Identities=23% Similarity=0.343 Sum_probs=160.8
Q ss_pred HHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-hHHHHHHHHHHHhchhhcCCCCCceeccCC
Q 044022 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-PRLKIASDIVNSLAYLHFGFPRPIVLRNFK 95 (241)
Q Consensus 17 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~ 95 (241)
..|++++++++|||||+++++|...+..++||||+++|+|.++++.... .+.+++.+++.|++|||..++.+++|||||
T Consensus 731 ~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk 810 (968)
T PLN00113 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLS 810 (968)
T ss_pred HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCC
Confidence 3568999999999999999999999999999999999999999976443 578899999999999997667799999999
Q ss_pred CCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCcccccccc
Q 044022 96 TQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLK 175 (241)
Q Consensus 96 ~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~ 175 (241)
|+||+++.++.+++. |+........ ....++..|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 811 p~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~ 883 (968)
T PLN00113 811 PEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG 883 (968)
T ss_pred HHhEEECCCCceEEE-eccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC
Confidence 999999998888775 4443322111 223578899999999988999999999999999999999999854211
Q ss_pred cCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 176 DTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
......++.+............++.+....+. ...+...+.+++.+||+.||++|||++|
T Consensus 884 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~Cl~~~P~~RPt~~e 943 (968)
T PLN00113 884 ----VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV--NQNEIVEVMNLALHCTATDPTARPCAND 943 (968)
T ss_pred ----CCCcHHHHHHHhcCccchhheeCccccCCCCc--cHHHHHHHHHHHHhhCcCCchhCcCHHH
Confidence 12223344433332232333334443322221 1244567889999999999999999864
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=222.19 Aligned_cols=203 Identities=25% Similarity=0.374 Sum_probs=160.9
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--Cc---hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--PL---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
....+.+|++++++++|+|++++.+.+......++++||+++++|.+++... .. ....++.+++.|+.+|| .
T Consensus 40 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~ 116 (253)
T cd05122 40 KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---S 116 (253)
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---c
Confidence 5677899999999999999999999999999999999999999999998665 22 45678999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+...+.++|+||||+++|++++|
T Consensus 117 ~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g 193 (253)
T cd05122 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEG 193 (253)
T ss_pred CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999876654321 2334678899999999888889999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+.||..... .+...... .......... . ..+..+.+++.+||..||++|||++|
T Consensus 194 ~~p~~~~~~---------~~~~~~~~-~~~~~~~~~~-----~------~~~~~~~~~i~~~l~~~p~~R~t~~~ 247 (253)
T cd05122 194 KPPYSELPP---------MKALFKIA-TNGPPGLRNP-----E------KWSDEFKDFLKKCLQKNPEKRPTAEQ 247 (253)
T ss_pred CCCCCCCch---------HHHHHHHH-hcCCCCcCcc-----c------ccCHHHHHHHHHHccCChhhCCCHHH
Confidence 999854210 11111111 1111111110 0 11357899999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=224.73 Aligned_cols=202 Identities=22% Similarity=0.266 Sum_probs=158.3
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~~ 85 (241)
..+.+.+|++++++++|+|++++++.+......++|+||+++++|.+++.... .....++.+++.|+.|||
T Consensus 42 ~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--- 118 (257)
T cd08225 42 EKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH--- 118 (257)
T ss_pred hhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 45678899999999999999999999999999999999999999999886532 146788999999999999
Q ss_pred CCCceeccCCCCCeeecCCC-CeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEEN-VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
+.+++|+||+|+||+++.++ .++++|||.+.......... ....++..|+|||+..+..++.++|+||||+++|+++
T Consensus 119 ~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~ 196 (257)
T cd08225 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA--YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELC 196 (257)
T ss_pred HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc--cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 89999999999999999885 46999999887654332211 2235788899999998888999999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|..||.... ..+....... ..... ... ..+..+.+++.+||..+|++|||++|
T Consensus 197 ~g~~p~~~~~---------~~~~~~~~~~-~~~~~-----~~~--------~~~~~~~~~i~~~l~~~p~~Rpt~~~ 250 (257)
T cd08225 197 TLKHPFEGNN---------LHQLVLKICQ-GYFAP-----ISP--------NFSRDLRSLISQLFKVSPRDRPSITS 250 (257)
T ss_pred hCCCCCCCcc---------HHHHHHHHhc-ccCCC-----CCC--------CCCHHHHHHHHHHhccChhhCcCHHH
Confidence 9999985411 1111221111 11111 111 12257889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=241.00 Aligned_cols=205 Identities=19% Similarity=0.268 Sum_probs=162.8
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.|+-||+||..+.||+||++++.|..++.+||..|||.||.+...+-... .++..++.+++.||.|||
T Consensus 71 EELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH--- 147 (1187)
T KOG0579|consen 71 EELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH--- 147 (1187)
T ss_pred hHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---
Confidence 356678899999999999999999999999999999999999999988765432 367788999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-----cCCCcchhhHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-----CVLNEKSNVFSFGAFL 160 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~s~G~~~ 160 (241)
+..|+|||||+.|||+..+|.++++|||++... ..+.....+.+||++|||||++.+ .+|+.++||||||+.+
T Consensus 148 s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn--~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITL 225 (1187)
T KOG0579|consen 148 SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN--KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITL 225 (1187)
T ss_pred hcchhhhhccccceEEEecCcEeeecccccccc--hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHH
Confidence 999999999999999999999999999998653 334445577899999999998854 4789999999999999
Q ss_pred HHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 161 FELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 161 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
.||..+.+|-.... ....+....+.. .+.+... ..-+..+.+++..||.+||..||++.
T Consensus 226 IEMAqiEPPHheln---------pMRVllKiaKSe------PPTLlqP------S~Ws~~F~DfLk~cL~Knp~~Rp~aa 284 (1187)
T KOG0579|consen 226 IEMAQIEPPHHELN---------PMRVLLKIAKSE------PPTLLQP------SHWSRSFSDFLKRCLVKNPRNRPPAA 284 (1187)
T ss_pred HHHhccCCCccccc---------hHHHHHHHhhcC------CCcccCc------chhhhHHHHHHHHHHhcCCccCCCHH
Confidence 99999999854311 111111111111 1111111 13335789999999999999999985
Q ss_pred C
Q 044022 241 D 241 (241)
Q Consensus 241 e 241 (241)
+
T Consensus 285 q 285 (1187)
T KOG0579|consen 285 Q 285 (1187)
T ss_pred H
Confidence 3
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=227.50 Aligned_cols=204 Identities=16% Similarity=0.252 Sum_probs=158.9
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
....+.+|+.++++++|+|++++++.+...+..++||||+++++|.+++..... ....++.+++.|++||| +.+
T Consensus 60 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~g 136 (292)
T cd06657 60 RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLH---AQG 136 (292)
T ss_pred HHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence 456788999999999999999999999999999999999999999998755432 45778999999999999 899
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCc
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRI 168 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~ 168 (241)
++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||+|+++|++++|..
T Consensus 137 ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~ 214 (292)
T cd06657 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 214 (292)
T ss_pred eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998876543321 1123457888999999988888999999999999999999999
Q ss_pred ccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 169 HIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 169 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
||.... ..+......... ..... .. . ..+..+.+++.+||..||.+|||+.|
T Consensus 215 p~~~~~---------~~~~~~~~~~~~-~~~~~--~~-~--------~~~~~l~~li~~~l~~~P~~R~~~~~ 266 (292)
T cd06657 215 PYFNEP---------PLKAMKMIRDNL-PPKLK--NL-H--------KVSPSLKGFLDRLLVRDPAQRATAAE 266 (292)
T ss_pred CCCCCC---------HHHHHHHHHhhC-CcccC--Cc-c--------cCCHHHHHHHHHHHhCCcccCcCHHH
Confidence 985411 111111111100 00000 00 0 12256789999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=227.49 Aligned_cols=154 Identities=20% Similarity=0.228 Sum_probs=130.4
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeC--CcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQT--PIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.+|+.++++++||||+++++++... +..++|+||+. ++|.+++.... .....++.+++.||.|||
T Consensus 48 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--- 123 (293)
T cd07843 48 PITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH--- 123 (293)
T ss_pred hhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 44678899999999999999999999877 78999999997 59988876432 146789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~ 164 (241)
+.+++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+. .++.++|+||||+++|+|+
T Consensus 124 ~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~ 201 (293)
T cd07843 124 DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELL 201 (293)
T ss_pred HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHH
Confidence 89999999999999999999999999999876654321 11233567889999998754 4688999999999999999
Q ss_pred hcCccccc
Q 044022 165 AGRIHIWD 172 (241)
Q Consensus 165 ~g~~p~~~ 172 (241)
+|..||..
T Consensus 202 ~g~~~f~~ 209 (293)
T cd07843 202 TKKPLFPG 209 (293)
T ss_pred hCCCCCCC
Confidence 99999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=228.66 Aligned_cols=198 Identities=22% Similarity=0.350 Sum_probs=153.2
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--C---chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--P---LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~---~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...++.+|++++++++|+|++++++++......++|+||+. |+|.+.+... . ..+..++.+++.|+.||| +
T Consensus 68 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~ 143 (317)
T cd06635 68 KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---S 143 (317)
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 34578899999999999999999999999999999999997 5787776432 1 246678999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc---ccCCCcchhhHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS---ICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~s~G~~~~~~ 163 (241)
.+++|+||+|+||+++.++.++|+|||.+...... ....++..|+|||++. ...++.++|+||||+++|+|
T Consensus 144 ~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el 217 (317)
T cd06635 144 HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217 (317)
T ss_pred CCcccCCCCcccEEECCCCCEEEecCCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHH
Confidence 99999999999999999999999999987654322 2335788899999974 35678899999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|+.||.... .............. ... ....+..+.+++.+||+.+|.+|||+.|
T Consensus 218 ~~g~~p~~~~~---------~~~~~~~~~~~~~~-~~~------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 273 (317)
T cd06635 218 AERKPPLFNMN---------AMSALYHIAQNESP-TLQ------------SNEWSDYFRNFVDSCLQKIPQDRPTSEE 273 (317)
T ss_pred HhCCCCCCCcc---------HHHHHHHHHhccCC-CCC------------CccccHHHHHHHHHHccCCcccCcCHHH
Confidence 99999985521 11111111111110 000 0123356899999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=224.27 Aligned_cols=206 Identities=18% Similarity=0.255 Sum_probs=159.5
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeee--CCcceEEEEecCCCCHHHhhcCC-----C---chHHHHHHHHHHHhch
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQ--TPIPILVFQSVEYGTLRDCIFGA-----P---LPRLKIASDIVNSLAY 80 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~-----~---~~~~~~~~~i~~~l~~ 80 (241)
...+++.+|++++++++|+||+++++++.. ....++++||+++++|.+++... . ...+.++.+++.||.+
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~ 120 (265)
T cd08217 41 KEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120 (265)
T ss_pred HHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999998764 34678999999999999988542 1 1467889999999999
Q ss_pred hhcCC--CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHH
Q 044022 81 LHFGF--PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGA 158 (241)
Q Consensus 81 lh~~~--~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~ 158 (241)
||..+ +.+++|+||+|+||+++.++.++++|||.+.......... ....++..|+|||.+....++.++|+||||+
T Consensus 121 lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~--~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~ 198 (265)
T cd08217 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA--KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGC 198 (265)
T ss_pred HhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcccc--cccccCCCccChhhhcCCCCCchhHHHHHHH
Confidence 99543 6789999999999999999999999999988765433211 2346788999999998888899999999999
Q ss_pred HHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 159 FLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 159 ~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
++|+|++|+.||.... ..+.... ...+... .+.. ..+..+.+++.+||+.+|++|||
T Consensus 199 il~~l~~g~~p~~~~~---------~~~~~~~-~~~~~~~-----~~~~--------~~~~~~~~l~~~~l~~~p~~Rp~ 255 (265)
T cd08217 199 LIYELCALSPPFTARN---------QLQLASK-IKEGKFR-----RIPY--------RYSSELNEVIKSMLNVDPDKRPS 255 (265)
T ss_pred HHHHHHHCCCcccCcC---------HHHHHHH-HhcCCCC-----CCcc--------ccCHHHHHHHHHHccCCcccCCC
Confidence 9999999999985411 1111111 1111111 1111 23357889999999999999999
Q ss_pred CCC
Q 044022 239 MVD 241 (241)
Q Consensus 239 ~~e 241 (241)
++|
T Consensus 256 ~~~ 258 (265)
T cd08217 256 TEE 258 (265)
T ss_pred HHH
Confidence 864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=228.61 Aligned_cols=216 Identities=20% Similarity=0.222 Sum_probs=155.8
Q ss_pred cccccccccccHHHHHHHHHHHHhcC-CCcccceeeeeeeCCcceEEEEecCCCCHHHhhc-----C-CC---chHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF-----G-AP---LPRLKIA 71 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~-----~-~~---~~~~~~~ 71 (241)
|.+...........+.+|+.++.++. |+||+++++++..++..++++||+. +++.++.. . .. .....++
T Consensus 35 K~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~ 113 (288)
T cd06616 35 KRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIA 113 (288)
T ss_pred EEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHH
Confidence 44433333345667889999999996 9999999999999889999999986 56655432 1 11 1457889
Q ss_pred HHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc---CCC
Q 044022 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC---VLN 148 (241)
Q Consensus 72 ~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~ 148 (241)
.+++.||+|||. ..+++||||||+||+++.++.++|+|||++......... ....++..|+|||++... .++
T Consensus 114 ~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~ 188 (288)
T cd06616 114 VATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSARDGYD 188 (288)
T ss_pred HHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc---ccccCccCccCHHHhccccccCCc
Confidence 999999999993 358999999999999999999999999998654432211 223578889999998766 688
Q ss_pred cchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHh
Q 044022 149 EKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLEC 228 (241)
Q Consensus 149 ~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 228 (241)
.++||||||+++|++++|+.||.... ...+....... + ..+.+..... ...+..+.+|+.+|
T Consensus 189 ~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~-~-----~~~~~~~~~~----~~~~~~l~~li~~~ 250 (288)
T cd06616 189 VRSDVWSLGITLYEVATGKFPYPKWN--------SVFDQLTQVVK-G-----DPPILSNSEE----REFSPSFVNFINLC 250 (288)
T ss_pred chhhhhHHHHHHHHHHhCCCCchhcc--------hHHHHHhhhcC-C-----CCCcCCCcCC----CccCHHHHHHHHHH
Confidence 99999999999999999999985411 00111111100 0 0111111110 12346789999999
Q ss_pred ccCCCCCCCCCCC
Q 044022 229 VNNSPEDRPTMVD 241 (241)
Q Consensus 229 l~~~p~~Rpt~~e 241 (241)
|+.||++|||++|
T Consensus 251 l~~~p~~Rpt~~~ 263 (288)
T cd06616 251 LIKDESKRPKYKE 263 (288)
T ss_pred ccCChhhCcCHHH
Confidence 9999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=228.00 Aligned_cols=155 Identities=21% Similarity=0.295 Sum_probs=131.5
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC---c---hHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---L---PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~---~~~~~~~~i~~~l~~lh~~~ 85 (241)
....+.+|+++++.++|||++++++++...+..++++||+. ++|.+++.... . ....++.+++.||.|||
T Consensus 41 ~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH--- 116 (283)
T cd07835 41 VPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--- 116 (283)
T ss_pred chhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 44678899999999999999999999999999999999995 79999886543 1 46789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~ 164 (241)
+.+++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||++.+. .++.++|+||||+++|+++
T Consensus 117 ~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~ 194 (283)
T cd07835 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMV 194 (283)
T ss_pred HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHH
Confidence 899999999999999999999999999998754332211 1223457889999988654 4688999999999999999
Q ss_pred hcCccccc
Q 044022 165 AGRIHIWD 172 (241)
Q Consensus 165 ~g~~p~~~ 172 (241)
+|+.||..
T Consensus 195 ~g~~pf~~ 202 (283)
T cd07835 195 NRRPLFPG 202 (283)
T ss_pred hCCCCCCC
Confidence 99999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=223.03 Aligned_cols=197 Identities=20% Similarity=0.171 Sum_probs=151.1
Q ss_pred HHHHHHHHH-HhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCCCc
Q 044022 15 SCINNITYA-AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPRPI 89 (241)
Q Consensus 15 ~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~~i 89 (241)
.+..|..++ .+++|+|++++++++...+..++|+||+++++|.+++.... .....++.|++.||.||| +.++
T Consensus 42 ~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~i 118 (260)
T cd05611 42 NVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH---QRGI 118 (260)
T ss_pred HHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence 344554444 44589999999999999999999999999999999986542 246788999999999999 8999
Q ss_pred eeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCcc
Q 044022 90 VLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIH 169 (241)
Q Consensus 90 vh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p 169 (241)
+|+||+|+||+++.++.++|+|||.+...... ....++..|+|||.+.+..++.++|+||||+++|++++|..|
T Consensus 119 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p 192 (260)
T cd05611 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192 (260)
T ss_pred ecCCCCHHHeEECCCCcEEEeecccceecccc------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCC
Confidence 99999999999999999999999988654331 233577889999999887889999999999999999999999
Q ss_pred cccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 170 IWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
|..... ....... ...... ....... ..+..+.+++.+||+.||++|||+.
T Consensus 193 ~~~~~~---------~~~~~~~-~~~~~~--~~~~~~~--------~~~~~~~~~i~~~l~~~p~~R~~~~ 243 (260)
T cd05611 193 FHAETP---------DAVFDNI-LSRRIN--WPEEVKE--------FCSPEAVDLINRLLCMDPAKRLGAN 243 (260)
T ss_pred CCCCCH---------HHHHHHH-HhcccC--CCCcccc--------cCCHHHHHHHHHHccCCHHHccCCC
Confidence 954211 1111111 111100 0001111 2336789999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=226.75 Aligned_cols=219 Identities=21% Similarity=0.205 Sum_probs=151.4
Q ss_pred HHHHHHHHHHHhcC-CCcccceeeeeeeC--CcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCC
Q 044022 14 GSCINNITYAAQMS-HNHILKRIGCCLQT--PIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 14 ~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
....+|+.++.++. |+|++++++++... +..++|+||+. ++|.+.+.... .....++.+++.||.|||
T Consensus 42 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH--- 117 (282)
T cd07831 42 VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH--- 117 (282)
T ss_pred hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 34567999999995 99999999999987 88999999997 58888775421 146788999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~~~~~ 164 (241)
+.+++|+||+|+||+++. +.++|+|||.+......... ....++..|+|||++.. ..++.++|+||||+++|+|+
T Consensus 118 ~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~ 193 (282)
T cd07831 118 RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL 193 (282)
T ss_pred HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHH
Confidence 899999999999999999 99999999998765433221 22356788999997654 45688999999999999999
Q ss_pred hcCcccccccccCC------CcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTH------DHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 165 ~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
+|..||........ ..+....++........ ......+..............+..+.+++.+||+.+|++|||
T Consensus 194 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~ 272 (282)
T cd07831 194 SLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR-HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT 272 (282)
T ss_pred cCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc-cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccC
Confidence 99999954211000 00000000000000000 000000000000000001134578999999999999999999
Q ss_pred CCC
Q 044022 239 MVD 241 (241)
Q Consensus 239 ~~e 241 (241)
++|
T Consensus 273 ~~~ 275 (282)
T cd07831 273 AKQ 275 (282)
T ss_pred HHH
Confidence 864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=231.42 Aligned_cols=158 Identities=22% Similarity=0.216 Sum_probs=129.8
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeC--CcceEEEEecCCCCHHHhhcCC------C---chHHHHHHHHHHHhch
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQT--PIPILVFQSVEYGTLRDCIFGA------P---LPRLKIASDIVNSLAY 80 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~------~---~~~~~~~~~i~~~l~~ 80 (241)
..+.+.+|+.++++++||||+++++++... ...++|+||++ ++|.+.+... . .....++.|++.||.|
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 123 (316)
T cd07842 45 ISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY 123 (316)
T ss_pred ccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHH
Confidence 356778899999999999999999999987 78999999997 5777665322 1 1356789999999999
Q ss_pred hhcCCCCCceeccCCCCCeeecC----CCCeEEeeccCceecCCCCc-ceeecccccCCCccCccccccc-CCCcchhhH
Q 044022 81 LHFGFPRPIVLRNFKTQNILFNE----ENVAKWFDFLLSISIPEGET-HITTDRVIGTRGYSAPEYISIC-VLNEKSNVF 154 (241)
Q Consensus 81 lh~~~~~~ivh~dl~~~nil~~~----~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~ 154 (241)
|| +.+++|+||||+||+++. ++.+||+|||++........ ........++..|+|||++.+. .++.++|+|
T Consensus 124 lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~ 200 (316)
T cd07842 124 LH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIW 200 (316)
T ss_pred HH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHH
Confidence 99 999999999999999999 99999999999876543322 1122234567889999988764 578999999
Q ss_pred HHHHHHHHHHhcCcccccc
Q 044022 155 SFGAFLFELLAGRIHIWDL 173 (241)
Q Consensus 155 s~G~~~~~~~~g~~p~~~~ 173 (241)
|||+++|+|++|++||...
T Consensus 201 slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 201 AIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred HHHHHHHHHHhcCCCCcCC
Confidence 9999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=231.28 Aligned_cols=204 Identities=23% Similarity=0.292 Sum_probs=165.7
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc------hHHHHHHHHHHHhchhhcC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL------PRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~~i~~~l~~lh~~ 84 (241)
.++.-.++|-++|.+++.+.||.+--.|...+.+|+|+..|.||+|.-.|..... ....++.+|+.||.+||
T Consensus 227 ~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH-- 304 (591)
T KOG0986|consen 227 KGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH-- 304 (591)
T ss_pred hhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH--
Confidence 4566678999999999999999999999999999999999999999888866532 35678999999999999
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
..+||.||+||+|||+|..|+++|+|+|++..++.+..... .+||.+|||||++....|+...|.||+||++|+|+
T Consensus 305 -~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~---rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi 380 (591)
T KOG0986|consen 305 -RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRG---RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMI 380 (591)
T ss_pred -hcceeeccCChhheeeccCCCeEeeccceEEecCCCCcccc---ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHH
Confidence 99999999999999999999999999999999887765443 38999999999999999999999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
.|+.||...- ...+.... +.+...+. -...+..+++.+++.+..|.+||++|....
T Consensus 381 ~G~sPFr~~K---------------eKvk~eEv----drr~~~~~-~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 381 AGHSPFRQRK---------------EKVKREEV----DRRTLEDP-EEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cccCchhhhh---------------hhhhHHHH----HHHHhcch-hhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 9999996511 11110000 00000000 011135668899999999999999997653
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=262.51 Aligned_cols=204 Identities=20% Similarity=0.319 Sum_probs=162.9
Q ss_pred cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCC
Q 044022 10 RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 10 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~ 85 (241)
+...+...+|..++..++|||+|+++|+=......+|.||||++|+|.+.+..... ....+-.|++.|++|||
T Consensus 1275 ~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH--- 1351 (1509)
T KOG4645|consen 1275 HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLH--- 1351 (1509)
T ss_pred cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHH---
Confidence 56677888999999999999999999999999999999999999999999876532 23456789999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc--eeecccccCCCccCccccccc---CCCcchhhHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH--ITTDRVIGTRGYSAPEYISIC---VLNEKSNVFSFGAFL 160 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~s~G~~~ 160 (241)
+.|||||||||.||+++.+|.+|++|||.++.+...... .......||+.|||||++.+. ....+.||||+||++
T Consensus 1352 ~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVV 1431 (1509)
T KOG4645|consen 1352 EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVV 1431 (1509)
T ss_pred hcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceE
Confidence 999999999999999999999999999999887665311 122356799999999999865 355789999999999
Q ss_pred HHHHhcCcccccccccCCCcccchHHHHHHH-hhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 161 FELLAGRIHIWDLLKDTHDHGCFFNEYLKNY-LEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 161 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
.||+||+.||....++ |.-.+ ...+....++. ..+.+-++++..||+.||++|=|+
T Consensus 1432 lEM~tGkrPW~~~dne----------~aIMy~V~~gh~Pq~P~-------------~ls~~g~dFle~Cl~~dP~~Rw~~ 1488 (1509)
T KOG4645|consen 1432 LEMATGKRPWAELDNE----------WAIMYHVAAGHKPQIPE-------------RLSSEGRDFLEHCLEQDPKMRWTA 1488 (1509)
T ss_pred EEeecCCCchhhccch----------hHHHhHHhccCCCCCch-------------hhhHhHHHHHHHHHhcCchhhhHH
Confidence 9999999999653221 11111 12222222222 133567899999999999999766
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=224.10 Aligned_cols=201 Identities=20% Similarity=0.273 Sum_probs=160.2
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC-----Cc---hHHHHHHHHHHHhchhh
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA-----PL---PRLKIASDIVNSLAYLH 82 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----~~---~~~~~~~~i~~~l~~lh 82 (241)
....++.+|++++++++|+||+++.+++......++|+||+++++|.+++... .. ....++.+++.|+.|||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh 120 (256)
T cd08530 41 KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120 (256)
T ss_pred HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Confidence 34567889999999999999999999999999999999999999999987551 11 35688999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~ 162 (241)
+.+++|+||+|.||+++.++.++++|||.+........ ....++..|+|||.+.+..++.++|+||||+++|+
T Consensus 121 ---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~----~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~ 193 (256)
T cd08530 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA----KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYE 193 (256)
T ss_pred ---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCCc----ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHH
Confidence 99999999999999999999999999999876654421 22457888999999988888999999999999999
Q ss_pred HHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 163 LLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 163 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+++|+.||.... ..+... ........... ...+.++.+++.+||..+|++|||+.|
T Consensus 194 l~~g~~p~~~~~---------~~~~~~-~~~~~~~~~~~-------------~~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08530 194 MATFAPPFEARS---------MQDLRY-KVQRGKYPPIP-------------PIYSQDLQNFIRSMLQVKPKLRPNCDK 249 (256)
T ss_pred HHhCCCCCCCCC---------HHHHHH-HHhcCCCCCCc-------------hhhCHHHHHHHHHHcCCCcccCCCHHH
Confidence 999999985411 111111 11111111111 133467899999999999999999754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=221.55 Aligned_cols=207 Identities=23% Similarity=0.255 Sum_probs=163.1
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeC--CcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQT--PIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~ 84 (241)
...+.+.+|+.++++++|+||+++++.+... ...++++||+++++|.+++..... .+..++.+++.|+.|||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh-- 118 (260)
T cd06606 41 EELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH-- 118 (260)
T ss_pred HHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 3467889999999999999999999999988 789999999999999999866522 46788999999999999
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
+.+++|+||+|+||+++.++.++|+|||.+................++..|+|||.......+.++|+||||+++++++
T Consensus 119 -~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~ 197 (260)
T cd06606 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMA 197 (260)
T ss_pred -HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHH
Confidence 8999999999999999999999999999988765543211123346788999999998888999999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|..||.... ................ .+.. ..+..+.+++.+||+.||++|||+.|
T Consensus 198 ~g~~p~~~~~--------~~~~~~~~~~~~~~~~-----~~~~--------~~~~~l~~~i~~~l~~~p~~Rp~~~~ 253 (260)
T cd06606 198 TGKPPWSELG--------NPMAALYKIGSSGEPP-----EIPE--------HLSEEAKDFLRKCLRRDPKKRPTADE 253 (260)
T ss_pred hCCCCCCCCC--------chHHHHHhccccCCCc-----CCCc--------ccCHHHHHHHHHhCcCChhhCCCHHH
Confidence 9999986522 1111111111101111 1111 12367899999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=229.85 Aligned_cols=218 Identities=19% Similarity=0.177 Sum_probs=155.8
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHHHHhchhhcCCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
...+.+|++++++++|+||+++++++...+..++||||+ +++|.+++.... . ....++.|++.||.||| +.
T Consensus 46 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~ 121 (298)
T cd07841 46 NFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SN 121 (298)
T ss_pred hHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 455778999999999999999999999989999999999 899999987654 2 35788999999999999 99
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHHHHHHHHhc
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~~~~~~g 166 (241)
+++|+||+|+||+++.++.++|+|||.+.......... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|
T Consensus 122 ~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g 199 (298)
T cd07841 122 WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLR 199 (298)
T ss_pred CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcC
Confidence 99999999999999999999999999987654432111 22345778999998854 4578899999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhh--h---cccCCCCCC---ccccCCCc-hhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLE--D---KRFTGIPAP---IIVQDIPC-IEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~--~---~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
.+||...... ............ . ......... ......+. ......+..+.+++.+||..||++||
T Consensus 200 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 274 (298)
T cd07841 200 VPFLPGDSDI-----DQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRI 274 (298)
T ss_pred CccccCCccH-----HHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCc
Confidence 7777431110 001111000000 0 000000000 00000000 00012346788999999999999999
Q ss_pred CCCC
Q 044022 238 TMVD 241 (241)
Q Consensus 238 t~~e 241 (241)
|+.|
T Consensus 275 s~~e 278 (298)
T cd07841 275 TARQ 278 (298)
T ss_pred CHHH
Confidence 9864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=231.95 Aligned_cols=154 Identities=19% Similarity=0.228 Sum_probs=130.3
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeC------CcceEEEEecCCCCHHHhhcCC--CchHHHHHHHHHHHhchhhc
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQT------PIPILVFQSVEYGTLRDCIFGA--PLPRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~lh~ 83 (241)
....+.+|+.++++++|+||+++++++... ...++|+||+. ++|.+.+... ......++.|++.||.|||
T Consensus 58 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH- 135 (353)
T cd07850 58 HAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLLYQMLCGIKHLH- 135 (353)
T ss_pred HHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhcCCHHHHHHHHHHHHHHHHHHH-
Confidence 456778999999999999999999988643 25699999996 6888877643 2245678999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+.+++|+||||+||+++.++.++|+|||.+........ .....++..|+|||.+.+..++.++||||||+++|+|
T Consensus 136 --~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 210 (353)
T cd07850 136 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 210 (353)
T ss_pred --hCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHH
Confidence 89999999999999999999999999999976543321 1223578889999999988999999999999999999
Q ss_pred HhcCccccc
Q 044022 164 LAGRIHIWD 172 (241)
Q Consensus 164 ~~g~~p~~~ 172 (241)
++|+.||..
T Consensus 211 ~~g~~pf~~ 219 (353)
T cd07850 211 IRGTVLFPG 219 (353)
T ss_pred HHCCCCCCC
Confidence 999999954
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=226.39 Aligned_cols=212 Identities=22% Similarity=0.280 Sum_probs=154.2
Q ss_pred cccccccccccHHHHHHHHHH-HHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC-----C---chHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITY-AAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA-----P---LPRLKIAS 72 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----~---~~~~~~~~ 72 (241)
|............++..|+.+ ++.+.||||+++++++...+..++++||++ ++|.+++... . .....++.
T Consensus 32 K~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~ 110 (283)
T cd06617 32 KRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAV 110 (283)
T ss_pred EEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHH
Confidence 444333333345566677765 556689999999999999999999999996 7888776432 1 14568999
Q ss_pred HHHHHhchhhcCCCC-CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc----cCC
Q 044022 73 DIVNSLAYLHFGFPR-PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI----CVL 147 (241)
Q Consensus 73 ~i~~~l~~lh~~~~~-~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~ 147 (241)
|++.|+.||| ++ +++|+||||+||+++.++.++|+|||.+........ .....++..|+|||.+.+ ..+
T Consensus 111 qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~ 184 (283)
T cd06617 111 SIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA---KTIDAGCKPYMAPERINPELNQKGY 184 (283)
T ss_pred HHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccccccccccc---cccccCCccccChhhcCCccccccc
Confidence 9999999999 76 999999999999999999999999999875533211 122457888999998865 346
Q ss_pred CcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHH
Q 044022 148 NEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLE 227 (241)
Q Consensus 148 ~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 227 (241)
+.++|+||||+++|+|++|+.||..... .. +....... ......+. ...+..+.+++.+
T Consensus 185 ~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~-~~~~~~~~-~~~~~~~~------------~~~~~~l~~li~~ 243 (283)
T cd06617 185 DVKSDVWSLGITMIELATGRFPYDSWKT-------PF-QQLKQVVE-EPSPQLPA------------EKFSPEFQDFVNK 243 (283)
T ss_pred CccccchhhHHHHHHHHhCCCCCCcccc-------CH-HHHHHHHh-cCCCCCCc------------cccCHHHHHHHHH
Confidence 7899999999999999999999854211 11 11111111 11111110 1233678999999
Q ss_pred hccCCCCCCCCCCC
Q 044022 228 CVNNSPEDRPTMVD 241 (241)
Q Consensus 228 cl~~~p~~Rpt~~e 241 (241)
||..+|++|||++|
T Consensus 244 ~l~~~p~~Rp~~~~ 257 (283)
T cd06617 244 CLKKNYKERPNYPE 257 (283)
T ss_pred HccCChhhCcCHHH
Confidence 99999999999853
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=225.98 Aligned_cols=203 Identities=21% Similarity=0.259 Sum_probs=152.5
Q ss_pred HHHHHHHHHHHHhc-CCCcccceeeeeeeC-----CcceEEEEecCCCCHHHhhcCC-----C---chHHHHHHHHHHHh
Q 044022 13 YGSCINNITYAAQM-SHNHILKRIGCCLQT-----PIPILVFQSVEYGTLRDCIFGA-----P---LPRLKIASDIVNSL 78 (241)
Q Consensus 13 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~-----~---~~~~~~~~~i~~~l 78 (241)
...+.+|+.+++++ +|||++++++++... +..++|+||+++++|.++++.. . .....++.+++.||
T Consensus 62 ~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al 141 (291)
T cd06639 62 DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141 (291)
T ss_pred HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH
Confidence 45677899999999 899999999998754 3589999999999999887531 1 14567899999999
Q ss_pred chhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-----CCCcchhh
Q 044022 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-----VLNEKSNV 153 (241)
Q Consensus 79 ~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Di 153 (241)
.||| +.+++|+||||+||+++.++.++|+|||.+......... .....++..|+|||++... .++.++|+
T Consensus 142 ~~lH---~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di 216 (291)
T cd06639 142 QHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDV 216 (291)
T ss_pred HHHH---hCCeeccCCCHHHEEEcCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccch
Confidence 9999 899999999999999999999999999998765432211 1234578889999988643 36789999
Q ss_pred HHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 154 FSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
||||+++|+|++|+.||...... +...... .........+ +.....+.+++.+||+.+|
T Consensus 217 ~slGvi~~el~~g~~p~~~~~~~---------~~~~~~~-~~~~~~~~~~-----------~~~~~~l~~li~~~l~~~p 275 (291)
T cd06639 217 WSLGITAIELGDGDPPLFDMHPV---------KTLFKIP-RNPPPTLLHP-----------EKWCRSFNHFISQCLIKDF 275 (291)
T ss_pred HHHHHHHHHHhhCCCCCCCCcHH---------HHHHHHh-cCCCCCCCcc-----------cccCHHHHHHHHHHhhcCh
Confidence 99999999999999998652110 1111111 1111111000 1223568999999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|||+.|
T Consensus 276 ~~Rps~~~ 283 (291)
T cd06639 276 EARPSVTH 283 (291)
T ss_pred hhCcCHHH
Confidence 99999754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=241.19 Aligned_cols=151 Identities=17% Similarity=0.208 Sum_probs=123.1
Q ss_pred HHHHHHHHHHHHhcCCC------cccceeeeeeeC-CcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchh
Q 044022 13 YGSCINNITYAAQMSHN------HILKRIGCCLQT-PIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYL 81 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~l 81 (241)
...+..|+++++.++|. +++++++++... +++|+|++++ +++|.+++.... .....++.||+.||.||
T Consensus 169 ~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yL 247 (467)
T PTZ00284 169 TRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYF 247 (467)
T ss_pred HHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Confidence 34566788888887654 578888888754 5789999998 688988876542 24678899999999999
Q ss_pred hcCCC-CCceeccCCCCCeeecCCC----------------CeEEeeccCceecCCCCcceeecccccCCCccCcccccc
Q 044022 82 HFGFP-RPIVLRNFKTQNILFNEEN----------------VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI 144 (241)
Q Consensus 82 h~~~~-~~ivh~dl~~~nil~~~~~----------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 144 (241)
| . .+|+||||||+|||++.++ .+||+|||.+...... .....||+.|+|||++.+
T Consensus 248 H---~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~ 319 (467)
T PTZ00284 248 H---TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLG 319 (467)
T ss_pred H---hcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhc
Confidence 9 6 5999999999999998765 4999999987532221 134578999999999999
Q ss_pred cCCCcchhhHHHHHHHHHHHhcCccccc
Q 044022 145 CVLNEKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 145 ~~~~~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
..++.++|||||||++|||++|+.||..
T Consensus 320 ~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 320 LGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999954
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=219.20 Aligned_cols=203 Identities=24% Similarity=0.369 Sum_probs=160.7
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|++++++++|+|++++++++...+..++++||+++++|.+++..... ....++.+++.|+.+|| +
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~ 117 (254)
T cd06627 41 EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLH---E 117 (254)
T ss_pred HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHh---h
Confidence 3456789999999999999999999999999999999999999999998865422 45678999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||...+...+.++|+||+|+++|++++|
T Consensus 118 ~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g 195 (254)
T cd06627 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195 (254)
T ss_pred CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999998766543321 1234578889999999877888999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
..||..... ........ .... +.... ..+..+.+++.+||..+|++|||+.|
T Consensus 196 ~~p~~~~~~---------~~~~~~~~-~~~~-----~~~~~--------~~~~~~~~~i~~~l~~~p~~R~~~~~ 247 (254)
T cd06627 196 NPPYYDLNP---------MAALFRIV-QDDH-----PPLPE--------GISPELKDFLMQCFQKDPNLRPTAKQ 247 (254)
T ss_pred CCCCCCccH---------HHHHHHHh-ccCC-----CCCCC--------CCCHHHHHHHHHHHhCChhhCcCHHH
Confidence 999864210 11111111 1111 11111 12257889999999999999999854
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=225.81 Aligned_cols=218 Identities=19% Similarity=0.181 Sum_probs=158.1
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--C---chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--P---LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~---~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
....+.+|++++++++|+||+++++++..+...++|+||++ ++|.+++... . ..+..++.+++.||.||| +
T Consensus 41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~ 116 (283)
T cd05118 41 IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---S 116 (283)
T ss_pred hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---H
Confidence 45678899999999999999999999999999999999997 5888877653 2 246789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHHHh
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~~ 165 (241)
.+++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+. .++.++|+||||+++|++++
T Consensus 117 ~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~t 194 (283)
T cd05118 117 HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLS 194 (283)
T ss_pred CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999876654331 11223567789999998776 78899999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhc---ccCCCCC------CccccC-CC--chhHHHHHHHHHHHHHHhccCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDK---RFTGIPA------PIIVQD-IP--CIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~------~~~~~~-~~--~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
|+.||....... ........ .... ....... ...... .. .......+..+.+++.+||..||
T Consensus 195 g~~~~~~~~~~~-----~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P 268 (283)
T cd05118 195 RRPLFPGKSEID-----QLFKIFRT-LGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDP 268 (283)
T ss_pred CCCCCCCCCHHH-----HHHHHHHH-cCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCc
Confidence 999985421100 00000000 0000 0000000 000000 00 00112345788999999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
.+||++.|
T Consensus 269 ~~Rp~~~~ 276 (283)
T cd05118 269 HKRITAEQ 276 (283)
T ss_pred ccCcCHHH
Confidence 99999854
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=221.54 Aligned_cols=204 Identities=20% Similarity=0.215 Sum_probs=155.7
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeC--CcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQT--PIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~ 84 (241)
.....+.+|++++++++|+||+++++++... +.+++++||+++++|.+++..... ....++.+++.|+.|||
T Consensus 46 ~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH-- 123 (264)
T cd06653 46 KEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH-- 123 (264)
T ss_pred HHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 3456788999999999999999999998754 467899999999999998865422 45678999999999999
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCc-ceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET-HITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+.+++|+||+|+||+++.++.++|+|||.+........ ........++..|+|||.+.+..++.++|+||||+++|++
T Consensus 124 -~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 202 (264)
T cd06653 124 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEM 202 (264)
T ss_pred -hCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHH
Confidence 89999999999999999999999999999876533111 0111224578889999999888889999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
++|+.||..... .+.......... .+.+.. ..++.+.+++.+||. +|..|||+.
T Consensus 203 ~~g~~p~~~~~~---------~~~~~~~~~~~~-----~~~~p~--------~~~~~~~~~i~~~l~-~~~~r~~~~ 256 (264)
T cd06653 203 LTEKPPWAEYEA---------MAAIFKIATQPT-----KPMLPD--------GVSDACRDFLKQIFV-EEKRRPTAE 256 (264)
T ss_pred HhCCCCCCccCH---------HHHHHHHHcCCC-----CCCCCc--------ccCHHHHHHHHHHhc-CcccCccHH
Confidence 999999964211 111111111110 011111 233678999999999 579999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=226.58 Aligned_cols=198 Identities=22% Similarity=0.363 Sum_probs=152.6
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--C---chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--P---LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~---~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...++.+|+++++.++|+|++++.+++......++|+||+. |+|.+.+... . ..+..++.+++.|+.||| +
T Consensus 58 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~ 133 (308)
T cd06634 58 KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---S 133 (308)
T ss_pred HHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 34578899999999999999999999999999999999996 6887766432 1 246778899999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc---ccCCCcchhhHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS---ICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~s~G~~~~~~ 163 (241)
.+++|+||+|+||+++.++.++++|||.+...... ....++..|+|||++. ...++.++||||||+++|++
T Consensus 134 ~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el 207 (308)
T cd06634 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207 (308)
T ss_pred CCcccCCCCHHhEEECCCCcEEECCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHH
Confidence 99999999999999999999999999988654332 2235788899999975 34578899999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|..||..... .+......... . +.. .....+..+.+++.+||..+|.+|||+++
T Consensus 208 ~~g~~p~~~~~~---------~~~~~~~~~~~-~-----~~~-------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ 263 (308)
T cd06634 208 AERKPPLFNMNA---------MSALYHIAQNE-S-----PAL-------QSGHWSEYFRNFVDSCLQKIPQDRPTSEV 263 (308)
T ss_pred HcCCCCCccccH---------HHHHHHHhhcC-C-----CCc-------CcccccHHHHHHHHHHhhCCcccCCCHHH
Confidence 999999854210 11111111111 0 000 01133467889999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=219.39 Aligned_cols=189 Identities=21% Similarity=0.179 Sum_probs=148.0
Q ss_pred HHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCCCcee
Q 044022 16 CINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPRPIVL 91 (241)
Q Consensus 16 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~~ivh 91 (241)
+.+|...+....||||+++++++...+..++||||+++|+|.+++..... ....++.+++.||.||| +.+++|
T Consensus 32 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H 108 (237)
T cd05576 32 YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALH---REGIVC 108 (237)
T ss_pred hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---hCCeec
Confidence 44566666677899999999999999999999999999999998865422 45788999999999999 899999
Q ss_pred ccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCcccc
Q 044022 92 RNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIW 171 (241)
Q Consensus 92 ~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~ 171 (241)
+||||+||+++.++.++++|||.+....... ....++..|+|||......++.++|+||+|+++|++++|..|+.
T Consensus 109 ~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 109 RDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred cCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 9999999999999999999999876543321 12245667999999988888999999999999999999998874
Q ss_pred cccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 172 DLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
...... ... ... .+.. ..+..+.+++.+||+.||++|||+.
T Consensus 184 ~~~~~~---------------~~~--~~~---~~~~--------~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 184 CHPSGI---------------NTH--TTL---NIPE--------WVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred cCchhc---------------ccc--ccc---CCcc--------cCCHHHHHHHHHHccCCHHHhcCCC
Confidence 311000 000 000 0111 1235688999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=226.25 Aligned_cols=156 Identities=20% Similarity=0.284 Sum_probs=131.3
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-------chHHHHHHHHHHHhchhhc
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-------LPRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------~~~~~~~~~i~~~l~~lh~ 83 (241)
.....+.+|++++++++|+||+++++++...+..++|+||++ ++|.+++.... .....++.+++.||.|||
T Consensus 40 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH- 117 (284)
T cd07836 40 GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH- 117 (284)
T ss_pred cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH-
Confidence 345678899999999999999999999999999999999997 58888775432 146789999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~ 162 (241)
+.+++|+||+|+||+++.++.++++|||.+........ ......++..|++||.+.+. .++.++|+||||+++|+
T Consensus 118 --~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~ 193 (284)
T cd07836 118 --ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAE 193 (284)
T ss_pred --HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHH
Confidence 89999999999999999999999999999875433221 11223567889999988654 56889999999999999
Q ss_pred HHhcCccccc
Q 044022 163 LLAGRIHIWD 172 (241)
Q Consensus 163 ~~~g~~p~~~ 172 (241)
+++|+.||..
T Consensus 194 l~~g~~~~~~ 203 (284)
T cd07836 194 MITGRPLFPG 203 (284)
T ss_pred HHhCCCCCCC
Confidence 9999999865
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=219.84 Aligned_cols=203 Identities=23% Similarity=0.303 Sum_probs=161.5
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--------chHHHHHHHHHHHhchhh
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--------LPRLKIASDIVNSLAYLH 82 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------~~~~~~~~~i~~~l~~lh 82 (241)
...+.+.+|++++++++|+|++++.+.+......++|+|++++++|.+++.... .....++.+++.|+.+||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 120 (258)
T cd08215 41 KEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120 (258)
T ss_pred HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH
Confidence 456678899999999999999999999999999999999999999999886531 146789999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~ 162 (241)
+.+++|+||+|+||+++.++.++|+|||.+........ ......+++.|+|||......++.++|+||+|+++++
T Consensus 121 ---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~ 195 (258)
T cd08215 121 ---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYE 195 (258)
T ss_pred ---hCCEecccCChHHeEEcCCCcEEECCccceeecccCcc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHH
Confidence 89999999999999999999999999999876544431 2233467888999999988889999999999999999
Q ss_pred HHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 163 LLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 163 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|++|+.||.... ..+...... ...... +.. ..+..+.+++.+||..+|++|||+.|
T Consensus 196 l~~g~~p~~~~~---------~~~~~~~~~-~~~~~~-----~~~--------~~~~~~~~~i~~~l~~~p~~Rp~~~~ 251 (258)
T cd08215 196 LCTLKHPFEGEN---------LLELALKIL-KGQYPP-----IPS--------QYSSELRNLVSSLLQKDPEERPSIAQ 251 (258)
T ss_pred HHcCCCCCCCCc---------HHHHHHHHh-cCCCCC-----CCC--------CCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999999985421 111111111 111111 111 12257889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=229.80 Aligned_cols=167 Identities=22% Similarity=0.236 Sum_probs=133.1
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCC-----cceEEEEecCCCCHHHhhcCCCc---hHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTP-----IPILVFQSVEYGTLRDCIFGAPL---PRLKIASD 73 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~ 73 (241)
|.+..........++.+|+.++++++|+||+++++++.... ..++++||+. ++|.+.+..... ....++.|
T Consensus 36 K~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~l~~~~~~~i~~q 114 (336)
T cd07849 36 KKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQHLSNDHIQYFLYQ 114 (336)
T ss_pred EEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhcCCCCHHHHHHHHHH
Confidence 44433233345667889999999999999999999876443 5799999996 688888766433 45678999
Q ss_pred HHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcce-eecccccCCCccCcccccc-cCCCcch
Q 044022 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI-TTDRVIGTRGYSAPEYISI-CVLNEKS 151 (241)
Q Consensus 74 i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~ 151 (241)
++.||.+|| +.+++|+||||+||+++.++.++|+|||++.......... ......++..|+|||++.+ ..++.++
T Consensus 115 l~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 191 (336)
T cd07849 115 ILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAI 191 (336)
T ss_pred HHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHH
Confidence 999999999 9999999999999999999999999999987654322111 1122457888999998754 4678999
Q ss_pred hhHHHHHHHHHHHhcCccccc
Q 044022 152 NVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 152 Di~s~G~~~~~~~~g~~p~~~ 172 (241)
||||+|+++|+|++|+.||..
T Consensus 192 DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 192 DIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred HHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999954
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=235.27 Aligned_cols=193 Identities=22% Similarity=0.286 Sum_probs=154.2
Q ss_pred HHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCCCCCcee
Q 044022 16 CINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGFPRPIVL 91 (241)
Q Consensus 16 ~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~~~~ivh 91 (241)
-.+|+.++... .||||+++.+.+....+.|+|||.+.++-+.+.+...+. .+..|+.+|+.|+.||| .+|+||
T Consensus 362 ~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH---~~gvvh 438 (612)
T KOG0603|consen 362 NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLH---EQGVVH 438 (612)
T ss_pred cccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHH---hcCeee
Confidence 44667666555 799999999999999999999999999888887765533 34569999999999999 999999
Q ss_pred ccCCCCCeee-cCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCccc
Q 044022 92 RNFKTQNILF-NEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHI 170 (241)
Q Consensus 92 ~dl~~~nil~-~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~ 170 (241)
|||||.|||+ +..++++|+|||.+...... .....-|..|.|||++....+++++|+||||+++|+|++|+.||
T Consensus 439 RDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~ 513 (612)
T KOG0603|consen 439 RDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLF 513 (612)
T ss_pred cCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCcc
Confidence 9999999999 68999999999999776554 12335577899999999889999999999999999999999999
Q ss_pred ccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 171 WDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
....+. .+ .......+.+. +.-+...++|+.+||+.||.+|||+.+
T Consensus 514 ~~~P~~--------~e-i~~~i~~~~~s----------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~ 559 (612)
T KOG0603|consen 514 AAHPAG--------IE-IHTRIQMPKFS----------------ECVSDEAKDLLQQLLQVDPALRLGADE 559 (612)
T ss_pred ccCCch--------HH-HHHhhcCCccc----------------cccCHHHHHHHHHhccCChhhCcChhh
Confidence 652221 11 11111111111 234467899999999999999999864
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=220.75 Aligned_cols=184 Identities=18% Similarity=0.210 Sum_probs=145.3
Q ss_pred CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeec
Q 044022 27 SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFN 102 (241)
Q Consensus 27 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~ 102 (241)
+|+|++++++++...+..++||||+++++|.+++..... ....++.|++.|+.||| +.+++|+||+|+||+++
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~ 143 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYD 143 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEe
Confidence 799999999999999999999999999999999876522 46789999999999999 89999999999999999
Q ss_pred CCC-CeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcc
Q 044022 103 EEN-VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHG 181 (241)
Q Consensus 103 ~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~ 181 (241)
.++ .++|+|||.+....... ...++..|+|||++.+..++.++|+||||+++|+|++|+.||.......
T Consensus 144 ~~~~~~~l~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---- 213 (267)
T PHA03390 144 RAKDRIYLCDYGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE---- 213 (267)
T ss_pred CCCCeEEEecCccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch----
Confidence 998 99999999987654332 2357889999999998889999999999999999999999996422111
Q ss_pred cchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 182 CFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
.....+.... .. .. .... ..++.+.+++.+||+.+|.+||+.
T Consensus 214 ~~~~~~~~~~--~~---~~---~~~~--------~~~~~~~~li~~~l~~~p~~R~~~ 255 (267)
T PHA03390 214 LDLESLLKRQ--QK---KL---PFIK--------NVSKNANDFVQSMLKYNINYRLTN 255 (267)
T ss_pred hhHHHHHHhh--cc---cC---Cccc--------ccCHHHHHHHHHHhccChhhCCch
Confidence 0011111110 00 00 0000 233678999999999999999964
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=230.88 Aligned_cols=158 Identities=18% Similarity=0.244 Sum_probs=130.5
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeee----CCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhh
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQ----TPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLH 82 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh 82 (241)
.....+.+|+.++++++||||+++++++.. ....++|+||+. ++|.+++..... ....++.+++.||.|||
T Consensus 46 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 124 (334)
T cd07855 46 TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124 (334)
T ss_pred cchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456678899999999999999999998863 346799999996 689998865432 46788999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc--eeecccccCCCccCcccccc-cCCCcchhhHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH--ITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAF 159 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~ 159 (241)
+.+++|+||||+||+++.++.++|+|||.+......... .......++..|+|||.+.+ ..++.++|+||||++
T Consensus 125 ---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~ 201 (334)
T cd07855 125 ---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCI 201 (334)
T ss_pred ---HCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHH
Confidence 899999999999999999999999999998765432211 11123467888999999865 457899999999999
Q ss_pred HHHHHhcCccccc
Q 044022 160 LFELLAGRIHIWD 172 (241)
Q Consensus 160 ~~~~~~g~~p~~~ 172 (241)
+|+|++|+.||..
T Consensus 202 l~el~~g~~pf~~ 214 (334)
T cd07855 202 FAEMLGRRQLFPG 214 (334)
T ss_pred HHHHHcCCCccCC
Confidence 9999999999954
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=223.47 Aligned_cols=196 Identities=18% Similarity=0.206 Sum_probs=148.1
Q ss_pred HHHHHHHHHHh---cCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCC
Q 044022 15 SCINNITYAAQ---MSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 15 ~~~~e~~~l~~---l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
.+.+|..+++. .+|||++.+++++...+..++||||+++++|.+++..... ....++.|++.||.||| +.
T Consensus 40 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH---~~ 116 (279)
T cd05633 40 LALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH---NR 116 (279)
T ss_pred HHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 34555544443 4799999999999998999999999999999998865422 46778999999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHHHHHHHHhc
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~~~~~~g 166 (241)
+++|+||||+||+++.++.++++|||.+........ ....++..|+|||.+.. ..++.++|+||||+++|++++|
T Consensus 117 ~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 192 (279)
T cd05633 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192 (279)
T ss_pred CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhC
Confidence 999999999999999999999999999865433221 22358899999998863 5678999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
..||....... .......... ....+.. ..+..+.+++.+||..||++||+
T Consensus 193 ~~pf~~~~~~~-------~~~~~~~~~~------~~~~~~~--------~~~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 193 HSPFRQHKTKD-------KHEIDRMTLT------VNVELPD--------SFSPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred CCCcCCCCCcC-------HHHHHHHhhc------CCcCCcc--------ccCHHHHHHHHHHhcCCHHHhcC
Confidence 99996521110 0111111000 0011111 23367889999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=223.73 Aligned_cols=156 Identities=21% Similarity=0.271 Sum_probs=131.4
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeC--CcceEEEEecCCCCHHHhhcCC--Cc---hHHHHHHHHHHHhchhhcC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQT--PIPILVFQSVEYGTLRDCIFGA--PL---PRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~--~~---~~~~~~~~i~~~l~~lh~~ 84 (241)
....+.+|++++++++|+|++++++++... +..++|+||++ ++|.+++... .. ....++.+++.|+++||
T Consensus 41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH-- 117 (287)
T cd07840 41 FPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH-- 117 (287)
T ss_pred chHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 345688999999999999999999999887 78999999997 5898887654 11 46789999999999999
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~~~~ 163 (241)
+.+++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+.+ ..++.++||||||+++|+|
T Consensus 118 -~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el 195 (287)
T cd07840 118 -SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAEL 195 (287)
T ss_pred -HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHH
Confidence 89999999999999999999999999999876654321 11122356778999998765 3578999999999999999
Q ss_pred HhcCccccc
Q 044022 164 LAGRIHIWD 172 (241)
Q Consensus 164 ~~g~~p~~~ 172 (241)
++|+.||..
T Consensus 196 ~t~~~p~~~ 204 (287)
T cd07840 196 FLGKPIFQG 204 (287)
T ss_pred HhCCCCCCC
Confidence 999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=224.44 Aligned_cols=198 Identities=22% Similarity=0.351 Sum_probs=152.3
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--C---chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--P---LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~---~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+.+.+|+++++.++|||++++++++......++|+||+. ++|.+++... . ..+..++.+++.|+.||| +
T Consensus 64 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~ 139 (313)
T cd06633 64 KWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---S 139 (313)
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 34578899999999999999999999999999999999996 6787776432 1 246778999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc---ccCCCcchhhHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS---ICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~s~G~~~~~~ 163 (241)
.+++|+||+|+||+++.++.++|+|||.+...... +...++..|+|||++. ...++.++|+||||+++|+|
T Consensus 140 ~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el 213 (313)
T cd06633 140 HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213 (313)
T ss_pred CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHH
Confidence 99999999999999999999999999987543221 2346788899999984 35678899999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|..||..... ........... ... .... ..+..+.+++.+||+.+|.+|||+.|
T Consensus 214 ~~g~~p~~~~~~---------~~~~~~~~~~~-~~~----~~~~--------~~~~~l~~li~~~l~~~P~~Rp~~~~ 269 (313)
T cd06633 214 AERKPPLFNMNA---------MSALYHIAQND-SPT----LQSN--------EWTDSFRGFVDYCLQKIPQERPASAE 269 (313)
T ss_pred HhCCCCCCCCCh---------HHHHHHHHhcC-CCC----CCcc--------ccCHHHHHHHHHHccCChhhCcCHHH
Confidence 999999865211 11111111110 000 0001 12246889999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=225.50 Aligned_cols=228 Identities=22% Similarity=0.264 Sum_probs=167.4
Q ss_pred CcccccccccccHHHHHHHHHHHHhc--CCCcccceeeeeeeCC----cceEEEEecCCCCHHHhhcCCCc---hHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQM--SHNHILKRIGCCLQTP----IPILVFQSVEYGTLRDCIFGAPL---PRLKIA 71 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~ 71 (241)
||+|.- +..++|++|-+|.... +|+||+++++.-.... .+++|++|.+.|||.++|+.+.. ...+++
T Consensus 238 VKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~ntisw~~~cria 313 (534)
T KOG3653|consen 238 VKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANTISWNSLCRIA 313 (534)
T ss_pred EEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhccccHHHHHHHH
Confidence 455543 5677899988888765 8999999999876554 78999999999999999999866 356899
Q ss_pred HHHHHHhchhhc------CCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc
Q 044022 72 SDIVNSLAYLHF------GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC 145 (241)
Q Consensus 72 ~~i~~~l~~lh~------~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 145 (241)
..+++||+|||+ ..+.+|+|||||.+|||+..++++-|+|||++..+.........-..+||..|||||++.+.
T Consensus 314 ~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEga 393 (534)
T KOG3653|consen 314 ESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGA 393 (534)
T ss_pred HHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhh
Confidence 999999999995 33457999999999999999999999999999887765444334457899999999999765
Q ss_pred C-CC-----cchhhHHHHHHHHHHHhcCcccc-------cccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCch
Q 044022 146 V-LN-----EKSNVFSFGAFLFELLAGRIHIW-------DLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCI 212 (241)
Q Consensus 146 ~-~~-----~~~Di~s~G~~~~~~~~g~~p~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (241)
. +. .+.||||+|.++|||+++-.-++ .+.-+.+.++..-.+.++...-.....+.....+...
T Consensus 394 inl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h---- 469 (534)
T KOG3653|consen 394 INLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH---- 469 (534)
T ss_pred cccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC----
Confidence 2 22 36899999999999999643221 1111111122222333444433333323332232222
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 213 EKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 213 ~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
.....+.+.+..||+.||+.|.|+
T Consensus 470 ---~~~~~l~et~EeCWDhDaeARLTA 493 (534)
T KOG3653|consen 470 ---AGMAVLCETIEECWDHDAEARLTA 493 (534)
T ss_pred ---ccHHHHHHHHHHHcCCchhhhhhh
Confidence 334678999999999999999997
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=224.98 Aligned_cols=213 Identities=20% Similarity=0.272 Sum_probs=153.7
Q ss_pred cccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--C---chHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--P---LPRLKIASDIV 75 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~---~~~~~~~~~i~ 75 (241)
|.+..........++.+|+.++.+. .|+||+++++++......+++|||+. ++|.+++... . ..+..++.+++
T Consensus 46 K~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~ 124 (296)
T cd06618 46 KQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIV 124 (296)
T ss_pred EEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHH
Confidence 4443333333456677788777777 49999999999999999999999985 5777766442 1 13568999999
Q ss_pred HHhchhhcCCC-CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccC----CCcc
Q 044022 76 NSLAYLHFGFP-RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV----LNEK 150 (241)
Q Consensus 76 ~~l~~lh~~~~-~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~ 150 (241)
.|+.||| + .+++|+||+|+||+++.++.++|+|||.+......... ....++..|+|||.+.+.. ++.+
T Consensus 125 ~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~ 198 (296)
T cd06618 125 KALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIR 198 (296)
T ss_pred HHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccc
Confidence 9999999 6 58999999999999999999999999998755432221 2234677899999987553 7889
Q ss_pred hhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhcc
Q 044022 151 SNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVN 230 (241)
Q Consensus 151 ~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 230 (241)
+|+||||+++|+|++|+.||...... .+......... ....... . ..+..+.+++.+||.
T Consensus 199 ~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~~-~~~~~~~---~--------~~~~~l~~li~~~l~ 258 (296)
T cd06618 199 ADVWSLGISLVELATGQFPYKNCKTE--------FEVLTKILQEE-PPSLPPN---E--------GFSPDFCSFVDLCLT 258 (296)
T ss_pred hhHHHHHHHHHHHHhCCCCCCcchhH--------HHHHHHHhcCC-CCCCCCC---C--------CCCHHHHHHHHHHcc
Confidence 99999999999999999998541100 11111111111 0001100 0 123578999999999
Q ss_pred CCCCCCCCCCC
Q 044022 231 NSPEDRPTMVD 241 (241)
Q Consensus 231 ~~p~~Rpt~~e 241 (241)
.||++|||+++
T Consensus 259 ~~p~~Rp~~~~ 269 (296)
T cd06618 259 KDHRKRPKYRE 269 (296)
T ss_pred CChhhCCCHHH
Confidence 99999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=236.09 Aligned_cols=166 Identities=23% Similarity=0.333 Sum_probs=145.0
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCC------cceEEEEecCCCCHHHhhcCCCc-------hH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTP------IPILVFQSVEYGTLRDCIFGAPL-------PR 67 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~-------~~ 67 (241)
||.++.+++....+...+|+++|++|+|+|||++.++=.... ...+|||||.+|||...++..+. ..
T Consensus 43 vK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~ 122 (732)
T KOG4250|consen 43 VKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEF 122 (732)
T ss_pred HHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHH
Confidence 688888888888899999999999999999999998865433 56899999999999999987532 46
Q ss_pred HHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCC----CCeEEeeccCceecCCCCcceeecccccCCCccCccccc
Q 044022 68 LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEE----NVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS 143 (241)
Q Consensus 68 ~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 143 (241)
+.++.+++.|+.||| +++|+||||||.||++... ...||+|||.|+.+...+. ..+.+||..|++||...
T Consensus 123 l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~---~~S~vGT~~YLhPel~E 196 (732)
T KOG4250|consen 123 LDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSL---FTSLVGTEEYLHPELYE 196 (732)
T ss_pred HHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCe---eeeecCchhhcChHHHh
Confidence 788999999999999 9999999999999998532 3569999999999887763 34578999999999998
Q ss_pred -ccCCCcchhhHHHHHHHHHHHhcCccccc
Q 044022 144 -ICVLNEKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 144 -~~~~~~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
...++..+|.|||||++|+.+||..||-.
T Consensus 197 ~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 197 RQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred hccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 48889999999999999999999999954
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=222.14 Aligned_cols=205 Identities=20% Similarity=0.187 Sum_probs=156.0
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+++.+|++++.++ +||||+++++++......++||||+.+++|.+++..... ....++.|++.||.||| +
T Consensus 47 ~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~ 123 (288)
T cd05583 47 TAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLH---Q 123 (288)
T ss_pred HHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHH---H
Confidence 456788999999999 599999999999999999999999999999998765421 45678889999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccC--CCcchhhHHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV--LNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~s~G~~~~~~~ 164 (241)
.+++|+||+|.||+++.++.++++|||++.......... .....++..|+|||.+.+.. .+.++|+||||+++|+|+
T Consensus 124 ~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~ 202 (288)
T cd05583 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL 202 (288)
T ss_pred CCeeccCCCHHHeEECCCCCEEEEECccccccccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHH
Confidence 999999999999999999999999999887544332111 12235788999999987654 678999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
+|..||...... ....+......... ..... ..+..+.+++.+||+.||++|||+.
T Consensus 203 tg~~p~~~~~~~-----~~~~~~~~~~~~~~-------~~~~~--------~~~~~l~~li~~~l~~~p~~R~t~~ 258 (288)
T cd05583 203 TGASPFTVDGEQ-----NSQSEISRRILKSK-------PPFPK--------TMSAEARDFIQKLLEKDPKKRLGAN 258 (288)
T ss_pred hCCCCcccCccc-----chHHHHHHHHHccC-------CCCCc--------ccCHHHHHHHHHHhcCCHhhccCcc
Confidence 999998531110 01111111111110 00111 1225688999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=223.04 Aligned_cols=164 Identities=20% Similarity=0.237 Sum_probs=134.0
Q ss_pred cccccccccccHHHHHHHHHHHHhcC-CCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDI 74 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i 74 (241)
|.+.............+|+..+++++ |+|++++++++...+..++||||+ +++|.+.+.... .....++.++
T Consensus 30 k~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l 108 (283)
T cd07830 30 KKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQI 108 (283)
T ss_pred EEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHH
Confidence 44433333333445567999999998 999999999999999999999999 789998876542 1467889999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhh
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNV 153 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di 153 (241)
+.+|.||| +.+++|+||+|+||+++.++.++|+|||.+......... ....++..|+|||.+.. ..++.++|+
T Consensus 109 ~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di 182 (283)
T cd07830 109 LQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY---TDYVSTRWYRAPEILLRSTSYSSPVDI 182 (283)
T ss_pred HHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc---CCCCCcccccCceeeecCcCcCCccch
Confidence 99999999 899999999999999999999999999998765443221 22357788999998754 457899999
Q ss_pred HHHHHHHHHHHhcCccccc
Q 044022 154 FSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~ 172 (241)
||||++++++++|+.||..
T Consensus 183 ~s~G~~l~el~~g~~~~~~ 201 (283)
T cd07830 183 WALGCIMAELYTLRPLFPG 201 (283)
T ss_pred hhHHHHHHHHHhCCCccCC
Confidence 9999999999999999854
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=221.77 Aligned_cols=204 Identities=19% Similarity=0.178 Sum_probs=154.3
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+++.+|++++.++ .|+||+++++++..++..++|+||+++++|.+++..... ....++.+++.||.||| +
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH---~ 123 (290)
T cd05613 47 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH---K 123 (290)
T ss_pred HHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 346788899999999 589999999999988899999999999999998865432 34567779999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc--CCCcchhhHHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC--VLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~s~G~~~~~~~ 164 (241)
.+++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||.+.+. .++.++|+||||+++|+++
T Consensus 124 ~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll 202 (290)
T cd05613 124 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELL 202 (290)
T ss_pred CCeeccCCCHHHeEECCCCCEEEeeCccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHh
Confidence 99999999999999999999999999998765432211 11234578899999998753 4678999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
+|..||..... .....+......... +.... ..+..+.+++.+||+.||++||+.
T Consensus 203 ~g~~p~~~~~~-----~~~~~~~~~~~~~~~-------~~~~~--------~~~~~~~~ll~~~l~~~p~~R~~~ 257 (290)
T cd05613 203 TGASPFTVDGE-----KNSQAEISRRILKSE-------PPYPQ--------EMSALAKDIIQRLLMKDPKKRLGC 257 (290)
T ss_pred cCCCCCCcCCc-----cccHHHHHHHhhccC-------CCCCc--------cCCHHHHHHHHHHhcCCHHHhcCC
Confidence 99999853111 111111111111111 00111 123578899999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=222.91 Aligned_cols=155 Identities=21% Similarity=0.270 Sum_probs=127.9
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc------hHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL------PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~~i~~~l~~lh~~~ 85 (241)
..+.+.+|++++++++|+||+++++++......++|+||++ ++|.+.+..... ....++.+|+.||.|||
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--- 119 (294)
T PLN00009 44 VPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH--- 119 (294)
T ss_pred chHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---
Confidence 34678899999999999999999999999999999999996 688777644321 34578899999999999
Q ss_pred CCCceeccCCCCCeeecC-CCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNE-ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~ 163 (241)
+++++|+||+|+||+++. ++.+||+|||.+........ ......++..|+|||++.+. .++.++|+||||+++|++
T Consensus 120 ~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l 197 (294)
T PLN00009 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEM 197 (294)
T ss_pred hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 899999999999999985 45789999999875433211 11223567889999988654 578899999999999999
Q ss_pred HhcCccccc
Q 044022 164 LAGRIHIWD 172 (241)
Q Consensus 164 ~~g~~p~~~ 172 (241)
++|..||..
T Consensus 198 ~tg~~pf~~ 206 (294)
T PLN00009 198 VNQKPLFPG 206 (294)
T ss_pred HhCCCCCCC
Confidence 999999954
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=224.34 Aligned_cols=157 Identities=19% Similarity=0.241 Sum_probs=127.4
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCC--------cceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHh
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTP--------IPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSL 78 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l 78 (241)
....+.+|++++++++||||+++++++...+ ..++|+||+. ++|.+.+.... .....++.|++.||
T Consensus 54 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al 132 (310)
T cd07865 54 FPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGL 132 (310)
T ss_pred chhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHH
Confidence 3446678999999999999999999987654 3499999996 58888775432 14678999999999
Q ss_pred chhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc--eeecccccCCCccCccccccc-CCCcchhhHH
Q 044022 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH--ITTDRVIGTRGYSAPEYISIC-VLNEKSNVFS 155 (241)
Q Consensus 79 ~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s 155 (241)
.||| +.+++|+||+|+||+++.++.++|+|||.+......... .......++..|+|||.+.+. .++.++|+||
T Consensus 133 ~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 209 (310)
T cd07865 133 YYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWG 209 (310)
T ss_pred HHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHH
Confidence 9999 899999999999999999999999999998765432211 111223567889999988654 4688999999
Q ss_pred HHHHHHHHHhcCccccc
Q 044022 156 FGAFLFELLAGRIHIWD 172 (241)
Q Consensus 156 ~G~~~~~~~~g~~p~~~ 172 (241)
||+++|+|++|..||..
T Consensus 210 lG~~l~el~t~~~~~~~ 226 (310)
T cd07865 210 AGCIMAEMWTRSPIMQG 226 (310)
T ss_pred HHHHHHHHHhCCCCCCC
Confidence 99999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=225.65 Aligned_cols=157 Identities=25% Similarity=0.342 Sum_probs=130.1
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeeeC--CcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQT--PIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~ 85 (241)
....+.+|+.+++++ +||||+++++++... ...++|+||+. ++|..++..... .+..++.+++.||.|||
T Consensus 49 ~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--- 124 (337)
T cd07852 49 DAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKALKYIH--- 124 (337)
T ss_pred hhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 345677899999999 999999999998653 36799999997 699998876432 45678999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc---eeecccccCCCccCcccccc-cCCCcchhhHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH---ITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFLF 161 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~~ 161 (241)
+.+++|+||+|+||+++.++.++|+|||.+......... .......++..|+|||++.+ ..++.++|+||||+++|
T Consensus 125 ~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~ 204 (337)
T cd07852 125 SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILG 204 (337)
T ss_pred HCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHH
Confidence 899999999999999999999999999998765443221 11223457888999998765 45788999999999999
Q ss_pred HHHhcCccccc
Q 044022 162 ELLAGRIHIWD 172 (241)
Q Consensus 162 ~~~~g~~p~~~ 172 (241)
+|++|+.||..
T Consensus 205 el~tg~~pf~~ 215 (337)
T cd07852 205 EMLLGKPLFPG 215 (337)
T ss_pred HHHhCCCCCCC
Confidence 99999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=224.15 Aligned_cols=154 Identities=22% Similarity=0.261 Sum_probs=127.5
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeC--CcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQT--PIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.+|+.++++++|+||+++++++... +..++|+||+. ++|.+++.... .....++.|++.||.|||
T Consensus 50 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH--- 125 (309)
T cd07845 50 PISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH--- 125 (309)
T ss_pred cchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---
Confidence 34567899999999999999999998765 46799999996 58888776431 246789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~~~~~ 164 (241)
+.+++|+||+|+||+++.++.++|+|||.+.......... ....++..|+|||.+.+ ..++.++|+||+|+++|+|+
T Consensus 126 ~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~ 203 (309)
T cd07845 126 ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELL 203 (309)
T ss_pred hCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCCC--CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHH
Confidence 8999999999999999999999999999987665432111 12235677999999865 45789999999999999999
Q ss_pred hcCccccc
Q 044022 165 AGRIHIWD 172 (241)
Q Consensus 165 ~g~~p~~~ 172 (241)
+|.+||..
T Consensus 204 ~g~~~f~~ 211 (309)
T cd07845 204 AHKPLLPG 211 (309)
T ss_pred hCCCCCCC
Confidence 99999954
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=215.93 Aligned_cols=226 Identities=19% Similarity=0.163 Sum_probs=162.4
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeee-CCcceEEEEecCCCCHHHhhcCCCc---------hHHHHHHHHHHHhchh
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQ-TPIPILVFQSVEYGTLRDCIFGAPL---------PRLKIASDIVNSLAYL 81 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~---------~~~~~~~~i~~~l~~l 81 (241)
...+..+|+-+++.|+|||++.+..+|.. +...++++||.++ +|.+.++-+.. ....++.||+.|+.||
T Consensus 70 iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YL 148 (438)
T KOG0666|consen 70 ISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYL 148 (438)
T ss_pred cCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHH
Confidence 45678899999999999999999999987 7789999999985 89888754321 2457899999999999
Q ss_pred hcCCCCCceeccCCCCCeeecCC----CCeEEeeccCceecCCCCcc-eeecccccCCCccCccccccc-CCCcchhhHH
Q 044022 82 HFGFPRPIVLRNFKTQNILFNEE----NVAKWFDFLLSISIPEGETH-ITTDRVIGTRGYSAPEYISIC-VLNEKSNVFS 155 (241)
Q Consensus 82 h~~~~~~ivh~dl~~~nil~~~~----~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s 155 (241)
| ++=++||||||.|||+..+ |.+||+|+|+++...+.... ...+.++-|..|+|||.+.+. .|+++.|+||
T Consensus 149 H---~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWA 225 (438)
T KOG0666|consen 149 H---SNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWA 225 (438)
T ss_pred h---hhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHH
Confidence 9 8889999999999999877 89999999999877654322 234556678889999999986 5889999999
Q ss_pred HHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhh---hcccCCCCCCccccCC-------C----------chhH-
Q 044022 156 FGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLE---DKRFTGIPAPIIVQDI-------P----------CIEK- 214 (241)
Q Consensus 156 ~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~-------~----------~~~~- 214 (241)
+|||+.|+++-.+.|............+..+.+....+ ...-...++-.--+.. + .+..
T Consensus 226 iGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~ 305 (438)
T KOG0666|consen 226 IGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHK 305 (438)
T ss_pred HHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHH
Confidence 99999999999888755333222233333333333222 1111111110000000 0 0000
Q ss_pred -HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 215 -EQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 215 -~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
..-++...+|+..+|.+||.+|.|+++
T Consensus 306 ~k~k~~~a~~LL~klL~yDP~kRIta~q 333 (438)
T KOG0666|consen 306 HKVKDPSALDLLQKLLTYDPIKRITAEQ 333 (438)
T ss_pred hcCCCchHHHHHHHHhccCchhhccHHH
Confidence 001134678999999999999999864
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=215.62 Aligned_cols=200 Identities=21% Similarity=0.248 Sum_probs=159.2
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+.+.+|++++++++|+||+++++.+..++..++||||+++++|.+++.... .....++.+++.|+.||| +.
T Consensus 36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh---~~ 112 (250)
T cd05123 36 EVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLH---SL 112 (250)
T ss_pred HHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 45678999999999999999999999999999999999999999999986652 246778999999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcC
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
+++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||...+...+.++|+||||+++|++++|.
T Consensus 113 ~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~ 190 (250)
T cd05123 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190 (250)
T ss_pred CceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCC
Confidence 999999999999999999999999999876544321 113345788899999998888899999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
.||..... .+....... . . ..+... .+..+.+++.+||..||++|||+.
T Consensus 191 ~p~~~~~~---------~~~~~~~~~-~---~---~~~~~~--------~~~~l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 191 PPFYAEDR---------KEIYEKILK-D---P---LRFPEF--------LSPEARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred CCCCCCCH---------HHHHHHHhc-C---C---CCCCCC--------CCHHHHHHHHHHhcCCHhhCCCcc
Confidence 99954211 111111111 1 0 011111 125688999999999999999983
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=225.09 Aligned_cols=153 Identities=22% Similarity=0.247 Sum_probs=129.2
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeee-CCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQ-TPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|++++++++||||+++.++|.. ....++++||+ +++|..++..... ....++.+++.||.||| +
T Consensus 51 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH---~ 126 (328)
T cd07856 51 VLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH---S 126 (328)
T ss_pred chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 345678899999999999999999999875 45788999998 5799988876543 34568899999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHHHHHHHHh
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~~~~~~ 165 (241)
.+++|+||+|+||+++.++.++|+|||.+....... ....++..|+|||.+.+ ..++.++|+||||+++|++++
T Consensus 127 ~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t 201 (328)
T cd07856 127 AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLE 201 (328)
T ss_pred CCcccCCCCHHHEeECCCCCEEeCccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999987543221 22356778999998865 468899999999999999999
Q ss_pred cCccccc
Q 044022 166 GRIHIWD 172 (241)
Q Consensus 166 g~~p~~~ 172 (241)
|+.||..
T Consensus 202 g~~~f~~ 208 (328)
T cd07856 202 GKPLFPG 208 (328)
T ss_pred CCCCCCC
Confidence 9999854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=220.66 Aligned_cols=201 Identities=18% Similarity=0.215 Sum_probs=159.3
Q ss_pred cHHHHHHHHHHHHhcC-CCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
....+.+|++++++++ |+||+++++++...+..++|||++++++|.+++..... ....++.+++.||.+|| +
T Consensus 44 ~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh---~ 120 (280)
T cd05581 44 KVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH---S 120 (280)
T ss_pred HHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 4567889999999998 99999999999999999999999999999999876522 56788999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc------------------eeecccccCCCccCcccccccCCC
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH------------------ITTDRVIGTRGYSAPEYISICVLN 148 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~------------------~~~~~~~~~~~~~aPE~~~~~~~~ 148 (241)
.+++|+||+|+||+++.++.++++|||.+......... .......++..|+|||......++
T Consensus 121 ~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~ 200 (280)
T cd05581 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAG 200 (280)
T ss_pred CCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCC
Confidence 99999999999999999999999999998765433210 112234567889999999888889
Q ss_pred cchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHh
Q 044022 149 EKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLEC 228 (241)
Q Consensus 149 ~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 228 (241)
.++|+||||++++++++|+.||..... ........ ... ..... ..++.+.+++.+|
T Consensus 201 ~~~Di~slG~~l~~l~~g~~p~~~~~~---------~~~~~~~~-~~~------~~~~~--------~~~~~~~~li~~~ 256 (280)
T cd05581 201 KSSDLWALGCIIYQMLTGKPPFRGSNE---------YLTFQKIL-KLE------YSFPP--------NFPPDAKDLIEKL 256 (280)
T ss_pred hhhhHHHHHHHHHHHHhCCCCCCCccH---------HHHHHHHH-hcC------CCCCC--------ccCHHHHHHHHHH
Confidence 999999999999999999999965210 01111111 000 00111 1135688999999
Q ss_pred ccCCCCCCCCC
Q 044022 229 VNNSPEDRPTM 239 (241)
Q Consensus 229 l~~~p~~Rpt~ 239 (241)
|+.+|++|||+
T Consensus 257 l~~~p~~R~~~ 267 (280)
T cd05581 257 LVLDPQDRLGV 267 (280)
T ss_pred hcCCHhhCCCc
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=225.67 Aligned_cols=158 Identities=22% Similarity=0.251 Sum_probs=134.3
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCC-----cceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchh
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTP-----IPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYL 81 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~l 81 (241)
...+.+.+|+.++++++|+||+++.+++.... ..++++||+. ++|.+++..... ....++.+++.||++|
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~L 119 (330)
T cd07834 41 IDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYL 119 (330)
T ss_pred hhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 45677899999999999999999999998765 7899999997 589888866422 4577999999999999
Q ss_pred hcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-eeecccccCCCccCccccccc-CCCcchhhHHHHHH
Q 044022 82 HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-ITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAF 159 (241)
Q Consensus 82 h~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~ 159 (241)
| +.+++|+||||.||+++.++.++|+|||.+......... .......++..|+|||.+.+. .++.++|+||||++
T Consensus 120 H---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~i 196 (330)
T cd07834 120 H---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCI 196 (330)
T ss_pred H---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHH
Confidence 9 899999999999999999999999999999876554210 111234578889999999887 78899999999999
Q ss_pred HHHHHhcCccccc
Q 044022 160 LFELLAGRIHIWD 172 (241)
Q Consensus 160 ~~~~~~g~~p~~~ 172 (241)
+|+|++|+.||..
T Consensus 197 l~~l~~g~~pf~~ 209 (330)
T cd07834 197 FAELLTRKPLFPG 209 (330)
T ss_pred HHHHHcCCCCcCC
Confidence 9999999999965
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=221.70 Aligned_cols=155 Identities=17% Similarity=0.176 Sum_probs=126.7
Q ss_pred cHHHHHHHHHHHHhcC-CCcccceeeeeeeCCc-----ceEEEEecCCCCHHHhhcCC---------CchHHHHHHHHHH
Q 044022 12 TYGSCINNITYAAQMS-HNHILKRIGCCLQTPI-----PILVFQSVEYGTLRDCIFGA---------PLPRLKIASDIVN 76 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~-----~~lv~e~~~~~sL~~~l~~~---------~~~~~~~~~~i~~ 76 (241)
....+.+|+.++++++ |+||+++++++...+. .++|+||+++ +|.+++... ......++.+|+.
T Consensus 43 ~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~ 121 (295)
T cd07837 43 IPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121 (295)
T ss_pred CchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHH
Confidence 3467889999999995 6999999999987655 7999999984 888876432 1146788999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecC-CCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNE-ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVF 154 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~ 154 (241)
||.||| +.+++|+||+|+||+++. ++.++|+|||.+......... .....+++.|+|||.+.+ ..++.++|+|
T Consensus 122 ~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~ 196 (295)
T cd07837 122 GVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIW 196 (295)
T ss_pred HHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHH
Confidence 999999 899999999999999998 889999999998755332111 112245778999998865 3578999999
Q ss_pred HHHHHHHHHHhcCccccc
Q 044022 155 SFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 155 s~G~~~~~~~~g~~p~~~ 172 (241)
|||+++|+|++|..||..
T Consensus 197 slG~~l~~l~~g~~~~~~ 214 (295)
T cd07837 197 SVGCIFAEMSRKQPLFPG 214 (295)
T ss_pred HHHHHHHHHHcCCCCCCC
Confidence 999999999999999854
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=215.69 Aligned_cols=209 Identities=20% Similarity=0.262 Sum_probs=164.2
Q ss_pred Cccccccc--ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHH
Q 044022 1 MKFYGHEY--HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDI 74 (241)
Q Consensus 1 iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i 74 (241)
||+..++. .++....-+.|-++|+..+||.+..+.-.|+..+.+|.||||..||.|.-.+..... ....+-..|
T Consensus 198 iKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEI 277 (516)
T KOG0690|consen 198 IKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEI 277 (516)
T ss_pred hhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHH
Confidence 45555554 334566677899999999999999999999999999999999999999887766422 344577899
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhH
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
+.||.||| +++||.||+|.+|+|+|++|++||+|||+++.--... ....+.+||+.|+|||++....|+.++|.|
T Consensus 278 vsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWW 352 (516)
T KOG0690|consen 278 VSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWW 352 (516)
T ss_pred HHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccccc--ceeccccCChhhcCchhhccccccceeehh
Confidence 99999999 9999999999999999999999999999997643332 233567899999999999999999999999
Q ss_pred HHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 155 SFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 155 s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
.+|+++|||+.|+.||+...++. . +-.-...+..+.. .-+++.+.|+...|.+||+
T Consensus 353 G~GVVMYEMmCGRLPFyn~dh~k-----L---FeLIl~ed~kFPr----------------~ls~eAktLLsGLL~kdP~ 408 (516)
T KOG0690|consen 353 GVGVVMYEMMCGRLPFYNKDHEK-----L---FELILMEDLKFPR----------------TLSPEAKTLLSGLLKKDPK 408 (516)
T ss_pred hhhHHHHHHHhccCcccccchhH-----H---HHHHHhhhccCCc----------------cCCHHHHHHHHHHhhcChH
Confidence 99999999999999997632221 0 0011111221111 1124577899999999999
Q ss_pred CCCC
Q 044022 235 DRPT 238 (241)
Q Consensus 235 ~Rpt 238 (241)
+|..
T Consensus 409 kRLG 412 (516)
T KOG0690|consen 409 KRLG 412 (516)
T ss_pred hhcC
Confidence 9964
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=226.31 Aligned_cols=156 Identities=19% Similarity=0.253 Sum_probs=129.9
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeC-----CcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchh
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQT-----PIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYL 81 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~l 81 (241)
.....+.+|+.+++.++|+||+++++++... ...++|+||+. ++|.+++..... ....++.+++.||.||
T Consensus 46 ~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 124 (337)
T cd07858 46 IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124 (337)
T ss_pred chhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456778899999999999999999988644 34799999996 789888865422 4678899999999999
Q ss_pred hcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHHHH
Q 044022 82 HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFL 160 (241)
Q Consensus 82 h~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~ 160 (241)
| +.+++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.. ..++.++|+||||+++
T Consensus 125 H---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 199 (337)
T cd07858 125 H---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIF 199 (337)
T ss_pred H---hCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHH
Confidence 9 89999999999999999999999999999876543321 1123457888999998865 4688999999999999
Q ss_pred HHHHhcCccccc
Q 044022 161 FELLAGRIHIWD 172 (241)
Q Consensus 161 ~~~~~g~~p~~~ 172 (241)
|+|++|+.||..
T Consensus 200 ~~l~~g~~pf~~ 211 (337)
T cd07858 200 AELLGRKPLFPG 211 (337)
T ss_pred HHHHcCCCCCCC
Confidence 999999999954
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=219.31 Aligned_cols=156 Identities=24% Similarity=0.319 Sum_probs=132.9
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--Cc---hHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--PL---PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~---~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.+.+|+.++++++|+|++++++++...+..++|+||++ ++|.+++... .. ....++.+++.||.+||
T Consensus 40 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH--- 115 (282)
T cd07829 40 GIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH--- 115 (282)
T ss_pred cccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---
Confidence 345678899999999999999999999999999999999997 6999998665 22 46788999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~ 164 (241)
+.+++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+... .++.++|+||||+++|+++
T Consensus 116 ~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~ 193 (282)
T cd07829 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMI 193 (282)
T ss_pred HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHH
Confidence 89999999999999999999999999999876543321 11223456779999998766 7889999999999999999
Q ss_pred hcCccccc
Q 044022 165 AGRIHIWD 172 (241)
Q Consensus 165 ~g~~p~~~ 172 (241)
+|..||..
T Consensus 194 ~~~~~~~~ 201 (282)
T cd07829 194 TGKPLFPG 201 (282)
T ss_pred hCCCCCCC
Confidence 99999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=213.13 Aligned_cols=213 Identities=20% Similarity=0.280 Sum_probs=159.6
Q ss_pred CcccccccccccHHHHHHHHHHHHhcC-CCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--Cc--hH-HHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--PL--PR-LKIASDI 74 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~--~~-~~~~~~i 74 (241)
||.+....+++..++++..+.++..-. .|.||+.+|+|......++-||.|. ..++.+++.- +. .+ -++...+
T Consensus 122 VK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~ 200 (391)
T KOG0983|consen 122 VKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-TCAEKLLKRIKGPIPERILGKMTVAI 200 (391)
T ss_pred EEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHH
Confidence 466666677778888888888887654 6999999999999998999999884 4444444332 11 22 2566678
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc---cCCCcch
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI---CVLNEKS 151 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~ 151 (241)
+.||.||.+ +++|+|||+||+|||+|..|++|++|||++..+.....+ +...|.+.|||||.+.- ..|+.++
T Consensus 201 v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh---trsAGC~~YMaPERidp~~~~kYDiRa 275 (391)
T KOG0983|consen 201 VKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH---TRSAGCAAYMAPERIDPPDKPKYDIRA 275 (391)
T ss_pred HHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc---ccccCCccccCccccCCCCCCccchhh
Confidence 999999997 889999999999999999999999999999877665433 33468999999999864 3688999
Q ss_pred hhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccC
Q 044022 152 NVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNN 231 (241)
Q Consensus 152 Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~ 231 (241)
||||||+.++|++||+.||..-. ..+.-..+-+. +. + +.+.+. ...++++.+++..||.+
T Consensus 276 DVWSlGITlveLaTg~yPy~~c~-------tdFe~ltkvln-~e-----P-P~L~~~------~gFSp~F~~fv~~CL~k 335 (391)
T KOG0983|consen 276 DVWSLGITLVELATGQYPYKGCK-------TDFEVLTKVLN-EE-----P-PLLPGH------MGFSPDFQSFVKDCLTK 335 (391)
T ss_pred hhhhhccchhhhhcccCCCCCCC-------ccHHHHHHHHh-cC-----C-CCCCcc------cCcCHHHHHHHHHHhhc
Confidence 99999999999999999995411 11111111111 11 1 222221 13557899999999999
Q ss_pred CCCCCCCC
Q 044022 232 SPEDRPTM 239 (241)
Q Consensus 232 ~p~~Rpt~ 239 (241)
|+.+||.-
T Consensus 336 d~r~RP~Y 343 (391)
T KOG0983|consen 336 DHRKRPKY 343 (391)
T ss_pred CcccCcch
Confidence 99999963
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=221.21 Aligned_cols=156 Identities=21% Similarity=0.210 Sum_probs=128.0
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCC----------cceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHH
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTP----------IPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVN 76 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----------~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~ 76 (241)
....+.+|++++++++|||++++++++.... ..++|+||+++ ++.+.+.... .....++.+++.
T Consensus 49 ~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~ 127 (302)
T cd07864 49 FPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLE 127 (302)
T ss_pred chHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHH
Confidence 3456788999999999999999999987654 78999999975 7777765432 246789999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFS 155 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s 155 (241)
||+||| +.+++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+.+. .++.++||||
T Consensus 128 aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s 203 (302)
T cd07864 128 GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWS 203 (302)
T ss_pred HHHHHH---hCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHH
Confidence 999999 89999999999999999999999999999876543321 111223457789999988643 5688999999
Q ss_pred HHHHHHHHHhcCccccc
Q 044022 156 FGAFLFELLAGRIHIWD 172 (241)
Q Consensus 156 ~G~~~~~~~~g~~p~~~ 172 (241)
||+++|++++|++||..
T Consensus 204 lG~~~~el~~g~~~~~~ 220 (302)
T cd07864 204 CGCILGELFTKKPIFQA 220 (302)
T ss_pred HHHHHHHHHhCCCCCCC
Confidence 99999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=216.89 Aligned_cols=201 Identities=18% Similarity=0.215 Sum_probs=155.6
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC-----C---chHHHHHHHHHHHhchhhc
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA-----P---LPRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----~---~~~~~~~~~i~~~l~~lh~ 83 (241)
...++.+|+.++++++||||+++++++......++|+||+++++|.+++... . .....++.+++.|+.|||
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH- 123 (260)
T cd08222 45 ETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH- 123 (260)
T ss_pred hHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH-
Confidence 4456778999999999999999999999988999999999999999887531 1 145788999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+.+++|+||+|+||+++. +.++++|||.+......... .....++..|+|||...+..++.++|+||||+++|++
T Consensus 124 --~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l 198 (260)
T cd08222 124 --QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198 (260)
T ss_pred --HcCccccCCChhheEeec-CCEeecccCceeecCCCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHH
Confidence 999999999999999975 56999999988765432221 1234577889999999888888999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|..||... ...+...... .+. .+... ...+..+.+++.+||..||++||++.|
T Consensus 199 ~~~~~~~~~~---------~~~~~~~~~~-~~~-----~~~~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~ 253 (260)
T cd08222 199 CCLAHAFEGQ---------NFLSVVLRIV-EGP-----TPSLP--------ETYSRQLNSIMQSMLNKDPSLRPSAAE 253 (260)
T ss_pred HhCCCCCCCc---------cHHHHHHHHH-cCC-----CCCCc--------chhcHHHHHHHHHHhcCChhhCcCHHH
Confidence 9999998531 1111111111 111 11111 134467899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=217.10 Aligned_cols=217 Identities=19% Similarity=0.219 Sum_probs=153.8
Q ss_pred HHHHHHHHHHHHhc---CCCcccceeeeeeeCCc-----ceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHh
Q 044022 13 YGSCINNITYAAQM---SHNHILKRIGCCLQTPI-----PILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSL 78 (241)
Q Consensus 13 ~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~-----~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l 78 (241)
...+.+|+.+++++ +|+|++++++++...+. .++++||+. ++|.+++.... ..+..++.+++.||
T Consensus 42 ~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al 120 (287)
T cd07838 42 PLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120 (287)
T ss_pred hhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHH
Confidence 44567788887776 59999999999987776 899999997 58988875432 14678999999999
Q ss_pred chhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHH
Q 044022 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGA 158 (241)
Q Consensus 79 ~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~ 158 (241)
.||| +.+++|+||+|+||+++.++.++|+|||.+......... ....++..|+|||++.+..++.++|+||||+
T Consensus 121 ~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~ 194 (287)
T cd07838 121 DFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGC 194 (287)
T ss_pred HHHH---HCCeeeccCChhhEEEccCCCEEEeccCcceeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHH
Confidence 9999 899999999999999999999999999998765433211 1234678899999999888999999999999
Q ss_pred HHHHHHhcCcccccccccCCCcccchHHHHHHHhhhc--ccCCCC---CCccccCCC---chhHHHHHHHHHHHHHHhcc
Q 044022 159 FLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDK--RFTGIP---APIIVQDIP---CIEKEQQLHASAQLTLECVN 230 (241)
Q Consensus 159 ~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~---~~~~~~~~~---~~~~~~~~~~~~~l~~~cl~ 230 (241)
++|+|++|.+||...... .............. ...... ......... ..........+.+++.+||+
T Consensus 195 ~l~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 269 (287)
T cd07838 195 IFAELFRRRPLFRGTSEA-----DQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLT 269 (287)
T ss_pred HHHHHHhCCCcccCCChH-----HHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhc
Confidence 999999999998642111 11111111100000 000000 000000000 00011334677899999999
Q ss_pred CCCCCCCCCCC
Q 044022 231 NSPEDRPTMVD 241 (241)
Q Consensus 231 ~~p~~Rpt~~e 241 (241)
.||++|||++|
T Consensus 270 ~dp~~Rp~~~~ 280 (287)
T cd07838 270 FNPHKRISAFE 280 (287)
T ss_pred cCCccCCCHHH
Confidence 99999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=216.48 Aligned_cols=194 Identities=19% Similarity=0.208 Sum_probs=147.5
Q ss_pred HHHHHHH---HHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCCC
Q 044022 16 CINNITY---AAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 16 ~~~e~~~---l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
+..|..+ ++...||||+++.+++...+..++|+||+.+++|..++..... .+..++.|++.|+.||| +.+
T Consensus 41 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ 117 (278)
T cd05606 41 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH---NRF 117 (278)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence 4444443 4445799999999999999999999999999999998865432 46789999999999999 899
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHHHhcC
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
++|+||+|+||+++.++.++|+|||.+........ ....|+..|+|||++.+. .++.++||||+|+++|+|++|+
T Consensus 118 i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~ 193 (278)
T cd05606 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 193 (278)
T ss_pred EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCC
Confidence 99999999999999999999999999865433221 234688999999998754 6889999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
.||....... . ......... ....+.. ..+..+.+++.+||..+|++||
T Consensus 194 ~p~~~~~~~~------~-~~~~~~~~~------~~~~~~~--------~~s~~~~~li~~~l~~~p~~R~ 242 (278)
T cd05606 194 SPFRQHKTKD------K-HEIDRMTLT------MAVELPD--------SFSPELRSLLEGLLQRDVNRRL 242 (278)
T ss_pred CCCCCCCccc------h-HHHHHHhhc------cCCCCCC--------cCCHHHHHHHHHHhhcCHHhcc
Confidence 9996521110 0 000010000 0111111 1235788999999999999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=218.27 Aligned_cols=204 Identities=14% Similarity=0.146 Sum_probs=143.3
Q ss_pred HHHHHHHhcCCCcccceeeeeeeCC----cceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCCCc
Q 044022 18 NNITYAAQMSHNHILKRIGCCLQTP----IPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPRPI 89 (241)
Q Consensus 18 ~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~~i 89 (241)
.+...+..+.|+|++++++++.... ..+++++++. .++.+.+.... .....++.|++.|+.||| +.++
T Consensus 72 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i 147 (294)
T PHA02882 72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIH---EHGI 147 (294)
T ss_pred HHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 3444556678999999998766543 3367777764 46666654321 235678999999999999 8999
Q ss_pred eeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-----eeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 90 VLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-----ITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 90 vh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
+||||||+|||++.++.++|+|||+++........ .......||+.|+|||+..+..++.++||||||+++|+|+
T Consensus 148 iHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~ 227 (294)
T PHA02882 148 SHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWA 227 (294)
T ss_pred ecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999999999999998765322111 1112346899999999999889999999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|+.||...............+....... +.. ... ..+..+.+++..||..+|++||++++
T Consensus 228 ~g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~-------~~~--------~~~~~~~~~~~~~~~~~~~~rp~~~~ 288 (294)
T PHA02882 228 GIKLPWKGFGHNGNLIHAAKCDFIKRLHE-GKI-------KIK--------NANKFIYDFIECVTKLSYEEKPDYDA 288 (294)
T ss_pred hCCCCCCccccchHHHHHhHHHHHHHhhh-hhh-------ccC--------CCCHHHHHHHHHHHhCCCCCCCCHHH
Confidence 99999965321110000000111111111 000 001 12256889999999999999999753
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=222.46 Aligned_cols=154 Identities=19% Similarity=0.235 Sum_probs=129.4
Q ss_pred HHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCCCce
Q 044022 15 SCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPRPIV 90 (241)
Q Consensus 15 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~~iv 90 (241)
.+.+|++++++++|+||+++++++...+..++||||+. ++|.+++.... .....++.|++.||.||| +.+++
T Consensus 66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~ 141 (335)
T PTZ00024 66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLH---KWYFM 141 (335)
T ss_pred hHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 57899999999999999999999999999999999997 69998886542 246789999999999999 99999
Q ss_pred eccCCCCCeeecCCCCeEEeeccCceecCCCCc------------ceeecccccCCCccCccccccc-CCCcchhhHHHH
Q 044022 91 LRNFKTQNILFNEENVAKWFDFLLSISIPEGET------------HITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFG 157 (241)
Q Consensus 91 h~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G 157 (241)
|+||+|+||+++.++.++++|||.+........ ........++..|+|||.+.+. .++.++|+||||
T Consensus 142 H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 221 (335)
T PTZ00024 142 HRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG 221 (335)
T ss_pred cccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHH
Confidence 999999999999999999999999876541110 0111223457789999998764 468899999999
Q ss_pred HHHHHHHhcCccccc
Q 044022 158 AFLFELLAGRIHIWD 172 (241)
Q Consensus 158 ~~~~~~~~g~~p~~~ 172 (241)
+++|+|++|..||..
T Consensus 222 ~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 222 CIFAELLTGKPLFPG 236 (335)
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999954
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=221.34 Aligned_cols=156 Identities=17% Similarity=0.259 Sum_probs=125.6
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCC--------cceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhc
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTP--------IPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLA 79 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~ 79 (241)
...+.+|++++++++|+||+++++++.... ..++|+||+. ++|...+.... .....++.+++.||.
T Consensus 51 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~ 129 (311)
T cd07866 51 PITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGIN 129 (311)
T ss_pred chhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHH
Confidence 346789999999999999999999876433 4699999996 57777665432 146778999999999
Q ss_pred hhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc---------eeecccccCCCccCccccccc-CCCc
Q 044022 80 YLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH---------ITTDRVIGTRGYSAPEYISIC-VLNE 149 (241)
Q Consensus 80 ~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~---------~~~~~~~~~~~~~aPE~~~~~-~~~~ 149 (241)
||| +.+++|+||||+||+++.++.++|+|||++......... .......+++.|+|||.+.+. .++.
T Consensus 130 ~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 206 (311)
T cd07866 130 YLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTT 206 (311)
T ss_pred HHH---hCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCc
Confidence 999 899999999999999999999999999998754432111 111223467789999988654 5789
Q ss_pred chhhHHHHHHHHHHHhcCccccc
Q 044022 150 KSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 150 ~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
++||||||+++|+|++|++||..
T Consensus 207 ~~Dv~slG~il~el~~g~~~~~~ 229 (311)
T cd07866 207 AVDIWGIGCVFAEMFTRRPILQG 229 (311)
T ss_pred hhHhHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999854
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=222.98 Aligned_cols=152 Identities=21% Similarity=0.272 Sum_probs=126.1
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCC------cceEEEEecCCCCHHHhhcCC-C-chHHHHHHHHHHHhchhhc
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTP------IPILVFQSVEYGTLRDCIFGA-P-LPRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~-~-~~~~~~~~~i~~~l~~lh~ 83 (241)
....+.+|+.++++++|+||+++++++.... .+++|+||+. .+|....... . .....++.+++.|++|||
T Consensus 57 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH- 134 (342)
T cd07879 57 FAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH- 134 (342)
T ss_pred chhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 3456889999999999999999999987543 4589999996 5787765432 2 245678899999999999
Q ss_pred CCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~~~ 162 (241)
+.+++||||+|+||+++.++.++|+|||.+....... ....++..|+|||.+.+ ..++.++|+||||+++|+
T Consensus 135 --~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~e 207 (342)
T cd07879 135 --SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAE 207 (342)
T ss_pred --HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHH
Confidence 8999999999999999999999999999987543321 22356778999999876 457889999999999999
Q ss_pred HHhcCccccc
Q 044022 163 LLAGRIHIWD 172 (241)
Q Consensus 163 ~~~g~~p~~~ 172 (241)
+++|+.||..
T Consensus 208 l~~g~~pf~~ 217 (342)
T cd07879 208 MLTGKTLFKG 217 (342)
T ss_pred HHhCCCCCCC
Confidence 9999999964
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=225.62 Aligned_cols=152 Identities=22% Similarity=0.306 Sum_probs=129.2
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCc------ceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhh
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPI------PILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLH 82 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh 82 (241)
....+.+|+.++++++|+|++++.+++...+. .++|+||+ +++|.+++..... ....++.+++.||.|||
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH 135 (343)
T cd07851 57 HAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH 135 (343)
T ss_pred HHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45667889999999999999999998875544 89999999 5799998876443 46788999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFLF 161 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~~ 161 (241)
+.+++|+||+|+||+++.++.++|+|||.+....... ....++..|+|||.+.+ ..++.++||||||+++|
T Consensus 136 ---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~ 207 (343)
T cd07851 136 ---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 207 (343)
T ss_pred ---HCCeecCCCCHHHeEECCCCCEEEccccccccccccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHH
Confidence 8999999999999999999999999999987654321 22356788999998865 36788999999999999
Q ss_pred HHHhcCccccc
Q 044022 162 ELLAGRIHIWD 172 (241)
Q Consensus 162 ~~~~g~~p~~~ 172 (241)
++++|+.||..
T Consensus 208 elltg~~pf~~ 218 (343)
T cd07851 208 ELLTGKTLFPG 218 (343)
T ss_pred HHHhCCCCCCC
Confidence 99999999954
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=223.16 Aligned_cols=152 Identities=22% Similarity=0.301 Sum_probs=127.3
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeC------CcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhh
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQT------PIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLH 82 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh 82 (241)
..+.+.+|++++++++|+||+++++++... ...+++++++ +++|.+.+..... .+..++.|++.|+.|||
T Consensus 59 ~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 137 (345)
T cd07877 59 HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 137 (345)
T ss_pred HHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 356788999999999999999999988643 3467888887 7899888765433 46778999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFLF 161 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~~ 161 (241)
+.+++|+||||+||+++.++.++|+|||++....... ....++..|+|||.+.+ ..++.++|+||||+++|
T Consensus 138 ---~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~ 209 (345)
T cd07877 138 ---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 209 (345)
T ss_pred ---HCCeeecCCChHHEEEcCCCCEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHH
Confidence 8999999999999999999999999999987543321 22356888999998865 46788999999999999
Q ss_pred HHHhcCccccc
Q 044022 162 ELLAGRIHIWD 172 (241)
Q Consensus 162 ~~~~g~~p~~~ 172 (241)
++++|+.||..
T Consensus 210 el~~g~~pf~~ 220 (345)
T cd07877 210 ELLTGRTLFPG 220 (345)
T ss_pred HHHhCCCCCCC
Confidence 99999999854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=210.91 Aligned_cols=226 Identities=19% Similarity=0.265 Sum_probs=166.9
Q ss_pred CcccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~ 75 (241)
||+..+- .-+...+..+|++++.+. .|+||+.++++|+++..+|+|||-|.||+|...+++.. .....+.++|+
T Consensus 108 VKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia 186 (463)
T KOG0607|consen 108 VKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIA 186 (463)
T ss_pred hhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHH
Confidence 4555443 446788899999999999 69999999999999999999999999999999887642 24677899999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCC---CeEEeeccCceecC--CC---CcceeecccccCCCccCccccc----
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEEN---VAKWFDFLLSISIP--EG---ETHITTDRVIGTRGYSAPEYIS---- 143 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~---~~~l~df~~~~~~~--~~---~~~~~~~~~~~~~~~~aPE~~~---- 143 (241)
.||.||| .+||.|||+||+|||...-+ -+||+||.+...+. .+ .......+.+|+..|||||+..
T Consensus 187 ~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~ 263 (463)
T KOG0607|consen 187 SALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVD 263 (463)
T ss_pred HHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhcc
Confidence 9999999 99999999999999996554 46999997754322 11 1112234578999999999873
Q ss_pred -ccCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcc--cchHHH---HHHHhhhcccCCCCCCccccCCCchhHHHH
Q 044022 144 -ICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHG--CFFNEY---LKNYLEDKRFTGIPAPIIVQDIPCIEKEQQ 217 (241)
Q Consensus 144 -~~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~--~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (241)
...|+.++|.||||+|+|-|++|.+||...-.+..... +.=... +..-..++. -++++..+ ...
T Consensus 264 qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk-YeFPdkdW---------ahI 333 (463)
T KOG0607|consen 264 QATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK-YEFPDKDW---------AHI 333 (463)
T ss_pred ccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccC-CcCChhhh---------HHh
Confidence 23688999999999999999999999966433321111 111111 111112222 23444333 344
Q ss_pred HHHHHHHHHHhccCCCCCCCCCC
Q 044022 218 LHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 218 ~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
+....+++...|..|+..|.++.
T Consensus 334 S~eakdlisnLlvrda~~rlsa~ 356 (463)
T KOG0607|consen 334 SSEAKDLISNLLVRDAKQRLSAA 356 (463)
T ss_pred hHHHHHHHHHHHhccHHhhhhhh
Confidence 56778999999999999998874
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=223.77 Aligned_cols=158 Identities=18% Similarity=0.274 Sum_probs=126.9
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeC--------------CcceEEEEecCCCCHHHhhcCCCc---hHHHHHHH
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQT--------------PIPILVFQSVEYGTLRDCIFGAPL---PRLKIASD 73 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------------~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~ 73 (241)
...+.+.+|++++++++||||+++++++... ...++|+||+. ++|.+++..... ....++.|
T Consensus 44 ~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~q 122 (342)
T cd07854 44 QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQ 122 (342)
T ss_pred chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHH
Confidence 3466788999999999999999999876643 35789999997 699888865432 56788999
Q ss_pred HHHHhchhhcCCCCCceeccCCCCCeeecC-CCCeEEeeccCceecCCCCcce-eecccccCCCccCcccccc-cCCCcc
Q 044022 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNE-ENVAKWFDFLLSISIPEGETHI-TTDRVIGTRGYSAPEYISI-CVLNEK 150 (241)
Q Consensus 74 i~~~l~~lh~~~~~~ivh~dl~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~ 150 (241)
|+.||.||| +.+++|+||||+||+++. ++.++++|||.+.......... ......++..|+|||.+.. ..++.+
T Consensus 123 i~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 199 (342)
T cd07854 123 LLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKA 199 (342)
T ss_pred HHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCch
Confidence 999999999 899999999999999975 4578999999987653321111 1122356788999998754 457889
Q ss_pred hhhHHHHHHHHHHHhcCccccc
Q 044022 151 SNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 151 ~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
+||||||+++|+|++|+.||..
T Consensus 200 ~DiwSlGvil~el~~g~~pf~~ 221 (342)
T cd07854 200 IDMWAAGCIFAEMLTGKPLFAG 221 (342)
T ss_pred hhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=219.71 Aligned_cols=152 Identities=20% Similarity=0.252 Sum_probs=128.6
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCC------cceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhh
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTP------IPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLH 82 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh 82 (241)
....+.+|++++++++||||+++++++.... .+++|+||+ +++|.+++..... ....++.|++.|+.|||
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH 135 (343)
T cd07880 57 FAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH 135 (343)
T ss_pred HHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3556889999999999999999999987554 358999999 6899988765433 46778999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFLF 161 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~~ 161 (241)
+.+++|+||+|+||+++.++.++++|||.+....... ....++..|+|||.+.+ ..++.++|+||||+++|
T Consensus 136 ---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~ 207 (343)
T cd07880 136 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMA 207 (343)
T ss_pred ---hCCeecCCCCHHHEEEcCCCCEEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHH
Confidence 8999999999999999999999999999987543321 22356788999999875 35788999999999999
Q ss_pred HHHhcCccccc
Q 044022 162 ELLAGRIHIWD 172 (241)
Q Consensus 162 ~~~~g~~p~~~ 172 (241)
++++|..||..
T Consensus 208 ~l~~g~~pf~~ 218 (343)
T cd07880 208 EMLTGKPLFKG 218 (343)
T ss_pred HHHhCCCCCCC
Confidence 99999999964
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=218.87 Aligned_cols=157 Identities=21% Similarity=0.231 Sum_probs=127.7
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeeeC----CcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhh
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQT----PIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLH 82 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh 82 (241)
..+.+.+|+.+++++ .||||+++++.+... ...+++++++. ++|.+++..... ....++.|++.||.|||
T Consensus 44 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH 122 (332)
T cd07857 44 LAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH 122 (332)
T ss_pred hHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 356788999999999 599999999875432 35688889885 689988865422 45778999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcce--eecccccCCCccCcccccc-cCCCcchhhHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI--TTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAF 159 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~ 159 (241)
+.+++|+||||+||+++.++.++|+|||.+.......... ......++..|+|||++.+ ..++.++|+||+|++
T Consensus 123 ---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~ 199 (332)
T cd07857 123 ---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCI 199 (332)
T ss_pred ---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHH
Confidence 9999999999999999999999999999987654322111 1123467889999998765 467899999999999
Q ss_pred HHHHHhcCccccc
Q 044022 160 LFELLAGRIHIWD 172 (241)
Q Consensus 160 ~~~~~~g~~p~~~ 172 (241)
+|++++|++||..
T Consensus 200 l~~l~~g~~pf~~ 212 (332)
T cd07857 200 LAELLGRKPVFKG 212 (332)
T ss_pred HHHHHhCCcCCCC
Confidence 9999999999854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-33 Score=235.91 Aligned_cols=214 Identities=21% Similarity=0.272 Sum_probs=174.4
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~ 75 (241)
||++..........+++.|+-+|.+|+|||+++++++|..+. +-||++|++.|+|.++++.+.. ..+.|..||+
T Consensus 730 iKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIA 808 (1177)
T KOG1025|consen 730 IKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIA 808 (1177)
T ss_pred EEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHH
Confidence 577777777778899999999999999999999999998776 7899999999999999977633 3578999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHH
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFS 155 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 155 (241)
+|+.||| ++++|||||-++|+|+..-..+||.|||+++.+.............-++.|+|-|.+....++.+|||||
T Consensus 809 kgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWs 885 (1177)
T KOG1025|consen 809 KGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWS 885 (1177)
T ss_pred HHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhh
Confidence 9999999 9999999999999999999999999999998877654443334444567899999999999999999999
Q ss_pred HHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 156 FGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 156 ~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
|||.+||++| |..|+.... .+-..++.+.+... ..+ ..++-++..++.+||..|+.
T Consensus 886 fGVtiWElmTFGa~Py~gi~----------~~eI~dlle~geRL--sqP-----------piCtiDVy~~mvkCwmid~~ 942 (1177)
T KOG1025|consen 886 FGVTIWELMTFGAKPYDGIP----------AEEIPDLLEKGERL--SQP-----------PICTIDVYMVMVKCWMIDAD 942 (1177)
T ss_pred hhhhHHHHHhcCCCccCCCC----------HHHhhHHHhccccC--CCC-----------CCccHHHHHHHHHHhccCcc
Confidence 9999999998 888875421 11223333333221 111 14556889999999999999
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
.||++++
T Consensus 943 ~rp~fke 949 (1177)
T KOG1025|consen 943 SRPTFKE 949 (1177)
T ss_pred cCccHHH
Confidence 9999863
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=217.19 Aligned_cols=151 Identities=21% Similarity=0.233 Sum_probs=128.5
Q ss_pred HHHHHHHHHHHHhcC-C-C----cccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc------hHHHHHHHHHHHhch
Q 044022 13 YGSCINNITYAAQMS-H-N----HILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL------PRLKIASDIVNSLAY 80 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~-h-~----~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~~i~~~l~~ 80 (241)
.+..+-|+++|+++. + | .+|.+.+||.-.++.|+|+|.+ |.|+.+++.++.. .+..++.|++.++++
T Consensus 129 reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~f 207 (415)
T KOG0671|consen 129 REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAF 207 (415)
T ss_pred hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHH
Confidence 445667999999993 2 3 4678899999999999999999 6799999988632 467889999999999
Q ss_pred hhcCCCCCceeccCCCCCeeecC--------------------CCCeEEeeccCceecCCCCcceeecccccCCCccCcc
Q 044022 81 LHFGFPRPIVLRNFKTQNILFNE--------------------ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPE 140 (241)
Q Consensus 81 lh~~~~~~ivh~dl~~~nil~~~--------------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE 140 (241)
|| +.+++|.||||+|||+.. +..++++|||.+....... +..+.|.-|+|||
T Consensus 208 Lh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPE 279 (415)
T KOG0671|consen 208 LH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPE 279 (415)
T ss_pred HH---hcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCch
Confidence 99 999999999999999832 3358999999997655443 4457789999999
Q ss_pred cccccCCCcchhhHHHHHHHHHHHhcCccccc
Q 044022 141 YISICVLNEKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 141 ~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
++.+.+|+.++||||+|||++|+++|..-|+.
T Consensus 280 ViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 280 VILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred heeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 99999999999999999999999999988754
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=207.92 Aligned_cols=203 Identities=24% Similarity=0.282 Sum_probs=160.3
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
.+.+.+|++.+++++|+|++++++++......++++|++.+++|..++.... .....++.+++.++.+|| +.+
T Consensus 31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~ 107 (244)
T smart00220 31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLH---SNG 107 (244)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HcC
Confidence 6889999999999999999999999999899999999999889999986643 246788999999999999 899
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCc
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRI 168 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~ 168 (241)
++|+||+|.||+++.++.++++|||.+....... ......++..|++||......++.++|+||||++++++++|..
T Consensus 108 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~ 184 (244)
T smart00220 108 IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKP 184 (244)
T ss_pred eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999988765432 1123457788999999988888999999999999999999999
Q ss_pred ccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 169 HIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 169 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
||.... .... ............... . ...+..+.+++.+||..+|++|||+.|
T Consensus 185 p~~~~~--------~~~~-~~~~~~~~~~~~~~~----~-------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 237 (244)
T smart00220 185 PFPGDD--------QLLE-LFKKIGKPKPPFPPP----E-------WKISPEAKDLIRKLLVKDPEKRLTAEE 237 (244)
T ss_pred CCCCCC--------cHHH-HHHHHhccCCCCccc----c-------ccCCHHHHHHHHHHccCCchhccCHHH
Confidence 985421 0111 111111111100000 0 002357889999999999999999853
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=225.87 Aligned_cols=204 Identities=20% Similarity=0.273 Sum_probs=162.1
Q ss_pred ccHHHHHHHHHHHHhc-CCCcccceeeeeee-----CCcceEEEEecCCCCHHHhhcCCCch------HHHHHHHHHHHh
Q 044022 11 HTYGSCINNITYAAQM-SHNHILKRIGCCLQ-----TPIPILVFQSVEYGTLRDCIFGAPLP------RLKIASDIVNSL 78 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~------~~~~~~~i~~~l 78 (241)
+..++...|.++++.+ .|||++.++|++.. ++++|+|||||.+||..+++++.... +..++..++.|+
T Consensus 57 d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl 136 (953)
T KOG0587|consen 57 DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGL 136 (953)
T ss_pred cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHH
Confidence 3556677899999998 68999999999874 45899999999999999999876432 456788999999
Q ss_pred chhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-----CCCcchhh
Q 044022 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-----VLNEKSNV 153 (241)
Q Consensus 79 ~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Di 153 (241)
.+|| ...++|||+|-.|||++.++.+|+.|||++..+.... ...++.+||++|||||++... .|+..+|+
T Consensus 137 ~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~ 211 (953)
T KOG0587|consen 137 AHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDL 211 (953)
T ss_pred HHHh---hcceeeecccCceEEEeccCcEEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccch
Confidence 9999 9999999999999999999999999999998765432 234567899999999999643 57789999
Q ss_pred HHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 154 FSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
||||++..||..|.+|+.++-. ++.+. .+.+.+.+.+.. .+.-++.+.++|..||.+|.
T Consensus 212 WsLGITaIEladG~PPl~DmHP------------mraLF---~IpRNPPPkLkr------p~kWs~~FndFIs~cL~Kd~ 270 (953)
T KOG0587|consen 212 WSLGITAIEMAEGAPPLCDMHP------------MRALF---LIPRNPPPKLKR------PKKWSKKFNDFISTCLVKDY 270 (953)
T ss_pred hhccceeehhcCCCCCccCcch------------hhhhc---cCCCCCCccccc------hhhHHHHHHHHHHHHHhhcc
Confidence 9999999999999999977311 11111 111222222221 23455789999999999999
Q ss_pred CCCCCCC
Q 044022 234 EDRPTMV 240 (241)
Q Consensus 234 ~~Rpt~~ 240 (241)
..||+..
T Consensus 271 e~RP~~~ 277 (953)
T KOG0587|consen 271 EQRPSTE 277 (953)
T ss_pred ccCcchh
Confidence 9999875
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=232.78 Aligned_cols=205 Identities=19% Similarity=0.202 Sum_probs=161.2
Q ss_pred ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-c---hHHHHHHHHHHHhchhhcC
Q 044022 9 HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-L---PRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 9 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~---~~~~~~~~i~~~l~~lh~~ 84 (241)
.+....-|..|=.+|.--..+.||.++-.|++++++|+||||++||+|.+++.+.. . ....++..|+.||.-+|
T Consensus 115 Kr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH-- 192 (1317)
T KOG0612|consen 115 KRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLH-- 192 (1317)
T ss_pred hchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHH--
Confidence 34455667788888888889999999999999999999999999999999998876 2 24567889999999999
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-----cCCCcchhhHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-----CVLNEKSNVFSFGAF 159 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~s~G~~ 159 (241)
+.|+|||||||+|||+|..|++||+|||.|-.+...+.. .++..+|||-|.+||++.. +.|++.+|.||+||+
T Consensus 193 -~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~ 270 (1317)
T KOG0612|consen 193 -SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVF 270 (1317)
T ss_pred -hccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHH
Confidence 999999999999999999999999999999888755443 3466789999999999953 568899999999999
Q ss_pred HHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 160 LFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 160 ~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
+|||+.|..||+. ....+..........-..+++. ..-++..++||.+.+. +|+.|..
T Consensus 271 ~YEMlyG~TPFYa---------dslveTY~KIm~hk~~l~FP~~-----------~~VSeeakdLI~~ll~-~~e~RLg 328 (1317)
T KOG0612|consen 271 MYEMLYGETPFYA---------DSLVETYGKIMNHKESLSFPDE-----------TDVSEEAKDLIEALLC-DREVRLG 328 (1317)
T ss_pred HHHHHcCCCcchH---------HHHHHHHHHHhchhhhcCCCcc-----------cccCHHHHHHHHHHhc-Chhhhcc
Confidence 9999999999976 2233333333333322233311 1234667788877553 5666654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=207.90 Aligned_cols=214 Identities=20% Similarity=0.239 Sum_probs=152.6
Q ss_pred cccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--------CchHH-HHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--------PLPRL-KIA 71 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--------~~~~~-~~~ 71 (241)
|............+++.|.++..+= +-||||+++|.+..++..|+-||+|. .||.-+-+.- +..++ ++.
T Consensus 95 KrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~It 173 (361)
T KOG1006|consen 95 KRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHIT 173 (361)
T ss_pred EEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhhee
Confidence 3333333334567788888877765 56999999999999999999999996 6775543211 11122 344
Q ss_pred HHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc--CCCc
Q 044022 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC--VLNE 149 (241)
Q Consensus 72 ~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~ 149 (241)
...+.||.||.. ...|+|||+||+|||++..|.+|++|||.+..+..+-.. +.-.|..+|+|||.+... .++.
T Consensus 174 vatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAk---T~daGCrpYmAPERi~p~~~gyDi 248 (361)
T KOG1006|consen 174 VATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAK---TVDAGCRPYMAPERIDPSDKGYDI 248 (361)
T ss_pred eeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHh---hhccCCccccChhccCCccCCcch
Confidence 456789999987 778999999999999999999999999999766543221 223688899999998643 5899
Q ss_pred chhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhh--hcccCCCCCCccccCCCchhHHHHHHHHHHHHHH
Q 044022 150 KSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLE--DKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLE 227 (241)
Q Consensus 150 ~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 227 (241)
+||+||||+.+||+.||..|+.. |......+.. .+.. +.+..+.. .-..+..+..++..
T Consensus 249 RSDvWSLGITL~EvAtG~fPyr~-----------w~svfeql~~Vv~gdp-----p~l~~~~~---~~~~s~~~~~fint 309 (361)
T KOG1006|consen 249 RSDVWSLGITLYEVATGNFPYRK-----------WDSVFEQLCQVVIGDP-----PILLFDKE---CVHYSFSMVRFINT 309 (361)
T ss_pred hhhhhhhcceEeeeecCCCCcch-----------HHHHHHHHHHHHcCCC-----CeecCccc---ccccCHHHHHHHHH
Confidence 99999999999999999999854 2222222111 1111 11111110 11355789999999
Q ss_pred hccCCCCCCCCCC
Q 044022 228 CVNNSPEDRPTMV 240 (241)
Q Consensus 228 cl~~~p~~Rpt~~ 240 (241)
|+.+|-++||...
T Consensus 310 Cl~Kd~~~Rpky~ 322 (361)
T KOG1006|consen 310 CLIKDRSDRPKYD 322 (361)
T ss_pred HhhcccccCcchh
Confidence 9999999999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=233.10 Aligned_cols=173 Identities=27% Similarity=0.371 Sum_probs=123.3
Q ss_pred ceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceec
Q 044022 44 PILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISI 118 (241)
Q Consensus 44 ~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~ 118 (241)
+||-||||+..+|.+++..+-. ..++++++|+.||+|+| ++|++||||||.||+++.++.+||+|||++.-.
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~ 747 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDL 747 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhh
Confidence 4788999988777887766533 35788999999999999 999999999999999999999999999998751
Q ss_pred C----------------CCCcceeecccccCCCccCcccccccC---CCcchhhHHHHHHHHHHHhcCcccccccccCCC
Q 044022 119 P----------------EGETHITTDRVIGTRGYSAPEYISICV---LNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHD 179 (241)
Q Consensus 119 ~----------------~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~ 179 (241)
. .+......+..+||.-|+|||++.+.. |+.|+||||+|+|++||+.- |..
T Consensus 748 ~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~T------- 817 (1351)
T KOG1035|consen 748 KENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGT------- 817 (1351)
T ss_pred hhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc---CCc-------
Confidence 1 011112335678999999999997654 99999999999999999864 422
Q ss_pred cccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 180 HGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.+.....+.++. .+.+. .+ .++. . .....-.++|+.|++.||++||||.|
T Consensus 818 -sMERa~iL~~LR-~g~iP---~~---~~f~---~-~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 818 -SMERASILTNLR-KGSIP---EP---ADFF---D-PEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred -hHHHHHHHHhcc-cCCCC---CC---cccc---c-ccchHHHHHHHHHhcCCCccCCCHHH
Confidence 011111111211 11111 11 0000 0 11133468999999999999999964
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=227.62 Aligned_cols=102 Identities=22% Similarity=0.184 Sum_probs=92.7
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
....+.+|+.+++.++|+||+++++++...+..|+||||+.+++|.+++.... .....++.+|+.||.||| ..
T Consensus 47 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH---~~ 123 (669)
T cd05610 47 MVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH---RH 123 (669)
T ss_pred HHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 34678899999999999999999999999999999999999999999986532 246789999999999999 88
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCce
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSI 116 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~ 116 (241)
+|+||||||+|||++.++.++|+|||+++
T Consensus 124 gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 124 GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=226.19 Aligned_cols=202 Identities=23% Similarity=0.303 Sum_probs=155.5
Q ss_pred HHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--Cc------hHHHHHHHHHHHhchhhc
Q 044022 13 YGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--PL------PRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 13 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~------~~~~~~~~i~~~l~~lh~ 83 (241)
.+-..+||+.|+.- +|||||++++.=.++.+.|+..|.|. .||.+++... .. ....++.|++.||++||
T Consensus 546 ~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH- 623 (903)
T KOG1027|consen 546 FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH- 623 (903)
T ss_pred HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH-
Confidence 34567899999987 79999999999888899999999997 6999999874 11 23678899999999999
Q ss_pred CCCCCceeccCCCCCeeecC---C--CCeEEeeccCceecCCCCcc-eeecccccCCCccCcccccccCCCcchhhHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNE---E--NVAKWFDFLLSISIPEGETH-ITTDRVIGTRGYSAPEYISICVLNEKSNVFSFG 157 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~---~--~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G 157 (241)
+.+||||||||.||||+. + ..++|+|||+++.+..+... .......||-+|.|||.+....-+.++||+|+|
T Consensus 624 --sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslG 701 (903)
T KOG1027|consen 624 --SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLG 701 (903)
T ss_pred --hcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcC
Confidence 899999999999999976 2 47899999999988765333 234566799999999999988888899999999
Q ss_pred HHHHHHHhc-CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCC
Q 044022 158 AFLFELLAG-RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDR 236 (241)
Q Consensus 158 ~~~~~~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 236 (241)
|++|+.++| ..||.+.... ..+......- ...+.+. .++ ...+||.+|++.+|..|
T Consensus 702 CvfyYvltgG~HpFGd~~~R-----------~~NIl~~~~~----L~~L~~~------~d~--eA~dLI~~ml~~dP~~R 758 (903)
T KOG1027|consen 702 CVFYYVLTGGSHPFGDSLER-----------QANILTGNYT----LVHLEPL------PDC--EAKDLISRMLNPDPQLR 758 (903)
T ss_pred ceEEEEecCCccCCCchHHh-----------hhhhhcCccc----eeeeccC------chH--HHHHHHHHhcCCCcccC
Confidence 999998886 8999762111 0011100000 0000000 011 67899999999999999
Q ss_pred CCCCC
Q 044022 237 PTMVD 241 (241)
Q Consensus 237 pt~~e 241 (241)
|||.+
T Consensus 759 Psa~~ 763 (903)
T KOG1027|consen 759 PSATD 763 (903)
T ss_pred CCHHH
Confidence 99863
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=204.73 Aligned_cols=204 Identities=19% Similarity=0.307 Sum_probs=164.0
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeC-CcceEEEEecCCCCHHHhhc-----CC-C------chHHHHHHHHHHHh
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQT-PIPILVFQSVEYGTLRDCIF-----GA-P------LPRLKIASDIVNSL 78 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~-----~~-~------~~~~~~~~~i~~~l 78 (241)
....++.|.-.+.-+.|||+.++.+++.+. ..+++++.++.-|+|..|+. +. . .+...++.|++.|+
T Consensus 330 Qv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am 409 (563)
T KOG1024|consen 330 QVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAM 409 (563)
T ss_pred HHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHH
Confidence 345677888888888999999999988764 47788999998899999987 21 1 14567899999999
Q ss_pred chhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHH
Q 044022 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGA 158 (241)
Q Consensus 79 ~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~ 158 (241)
+||| +++++|.||.++|+++++..++||+|=.+++-+-....+...+....+..||+||.+....|+.++|+||||+
T Consensus 410 ~hlh---~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGV 486 (563)
T KOG1024|consen 410 EHLH---NHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGV 486 (563)
T ss_pred HHHH---hcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHH
Confidence 9999 9999999999999999999999999988887655554555555666789999999999999999999999999
Q ss_pred HHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 159 FLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 159 ~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
++||++| |+.|+.+... ..+....+.+.....+- .++.++..+|.-||+..|++||
T Consensus 487 llWELmtlg~~PyaeIDP----------fEm~~ylkdGyRlaQP~-------------NCPDeLf~vMacCWallpeeRP 543 (563)
T KOG1024|consen 487 LLWELMTLGKLPYAEIDP----------FEMEHYLKDGYRLAQPF-------------NCPDELFTVMACCWALLPEERP 543 (563)
T ss_pred HHHHHHhcCCCCccccCH----------HHHHHHHhccceecCCC-------------CCcHHHHHHHHHHHhcCcccCC
Confidence 9999998 8889855322 22444445554332221 3446788999999999999999
Q ss_pred CCCC
Q 044022 238 TMVD 241 (241)
Q Consensus 238 t~~e 241 (241)
+++|
T Consensus 544 sf~Q 547 (563)
T KOG1024|consen 544 SFSQ 547 (563)
T ss_pred CHHH
Confidence 9864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=212.33 Aligned_cols=156 Identities=18% Similarity=0.274 Sum_probs=141.4
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+....|-++|...+.|.||++|..|.+++..||+||-|-||.|+..+.+... ....++..+++|+.||| .
T Consensus 462 kQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH---~ 538 (732)
T KOG0614|consen 462 KQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLH---R 538 (732)
T ss_pred hHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHH---h
Confidence 3456678899999999999999999999999999999999999999999976532 45667889999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
++|+.|||||+|++++.+|-+||.|||+++.+..+... .+.+||+.|.|||.+.....+.++|.||||+++||+++|
T Consensus 539 k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G 615 (732)
T KOG0614|consen 539 KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTG 615 (732)
T ss_pred cCceeccCChhheeeccCCceEEeehhhHHHhccCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcC
Confidence 99999999999999999999999999999988776543 446899999999999999999999999999999999999
Q ss_pred Cccccc
Q 044022 167 RIHIWD 172 (241)
Q Consensus 167 ~~p~~~ 172 (241)
.+||..
T Consensus 616 ~pPFs~ 621 (732)
T KOG0614|consen 616 SPPFSG 621 (732)
T ss_pred CCCCCC
Confidence 999965
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-30 Score=203.29 Aligned_cols=210 Identities=20% Similarity=0.245 Sum_probs=162.0
Q ss_pred Cccccccccc--ccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC----CchHHHHHHH
Q 044022 1 MKFYGHEYHR--HTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA----PLPRLKIASD 73 (241)
Q Consensus 1 iK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~ 73 (241)
||++.++.-- +..+--+.|-++|..- +-|.+++++.+|+.-+.+|.||||+.||+|--.++.- ++....++.+
T Consensus 379 iKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaE 458 (683)
T KOG0696|consen 379 IKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAE 458 (683)
T ss_pred hhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHH
Confidence 3455444321 2233344577777765 5689999999999999999999999999997766543 3467889999
Q ss_pred HHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhh
Q 044022 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNV 153 (241)
Q Consensus 74 i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 153 (241)
|+.||-+|| +++|+.||||.+|+|++.+|++||+|||.++.--... .+..+.+||+-|+|||.+...+|+.++|.
T Consensus 459 iaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDW 533 (683)
T KOG0696|consen 459 IAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDW 533 (683)
T ss_pred HHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccccCC--cceeeecCCCcccccceEEecccccchhH
Confidence 999999999 9999999999999999999999999999997543322 23355789999999999999999999999
Q ss_pred HHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 154 FSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
||+|+++|||+.|++||.. +.-.+......+.... +| ...+.+..+++...|.+.|
T Consensus 534 Wa~GVLLyEmlaGQpPFdG---------eDE~elF~aI~ehnvs-----------yP----KslSkEAv~ickg~ltK~P 589 (683)
T KOG0696|consen 534 WAFGVLLYEMLAGQPPFDG---------EDEDELFQAIMEHNVS-----------YP----KSLSKEAVAICKGLLTKHP 589 (683)
T ss_pred HHHHHHHHHHHcCCCCCCC---------CCHHHHHHHHHHccCc-----------Cc----ccccHHHHHHHHHHhhcCC
Confidence 9999999999999999954 2333444444332211 11 1233567789999999999
Q ss_pred CCCCCC
Q 044022 234 EDRPTM 239 (241)
Q Consensus 234 ~~Rpt~ 239 (241)
.+|..+
T Consensus 590 ~kRLGc 595 (683)
T KOG0696|consen 590 GKRLGC 595 (683)
T ss_pred ccccCC
Confidence 999754
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=201.97 Aligned_cols=224 Identities=19% Similarity=0.229 Sum_probs=161.6
Q ss_pred ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCC------cceEEEEecCCCCHHHhhcCCCc--hHHHHHHHHHHHhch
Q 044022 9 HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTP------IPILVFQSVEYGTLRDCIFGAPL--PRLKIASDIVNSLAY 80 (241)
Q Consensus 9 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~l~~ 80 (241)
+....++..+|..++..+.|+||++++.+|.-.. ..|+|||+|. .+|.+.+..... +...+..|++.|+++
T Consensus 55 n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~~elDH~tis~i~yq~~~~ik~ 133 (369)
T KOG0665|consen 55 NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVILMELDHETISYILYQMLCGIKH 133 (369)
T ss_pred cCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHHHhcchHHHHHHHHHHHHHHHH
Confidence 3456788899999999999999999999998543 5799999996 799998764322 456788999999999
Q ss_pred hhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHH
Q 044022 81 LHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFL 160 (241)
Q Consensus 81 lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~ 160 (241)
|| +.+|+||||||+||++..+..+||.|||+++.-... ...+-.+.+..|+|||++.+..+...+||||+||++
T Consensus 134 lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~ 207 (369)
T KOG0665|consen 134 LH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 207 (369)
T ss_pred HH---hcceeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHH
Confidence 99 999999999999999999999999999999764433 122345678899999999999999999999999999
Q ss_pred HHHHhcCcccccccc---------cCCCcccchHH----HHHHHhh-hccc------CCCCCCccccCCCchhHHHHHHH
Q 044022 161 FELLAGRIHIWDLLK---------DTHDHGCFFNE----YLKNYLE-DKRF------TGIPAPIIVQDIPCIEKEQQLHA 220 (241)
Q Consensus 161 ~~~~~g~~p~~~~~~---------~~~~~~~~~~~----~~~~~~~-~~~~------~~~~~~~~~~~~~~~~~~~~~~~ 220 (241)
.||++|..-|....+ .-......+.. .++.+.. ...+ .-++|..+....... ......
T Consensus 208 gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~--~~~~~~ 285 (369)
T KOG0665|consen 208 GELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGS--KLDCSL 285 (369)
T ss_pred HHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCC--ccchHH
Confidence 999999987743110 00001111111 1111111 1111 112222222222111 123356
Q ss_pred HHHHHHHhccCCCCCCCCCCC
Q 044022 221 SAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 221 ~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.++++.+||..||++|.+++|
T Consensus 286 ardll~~MLvi~pe~Risv~d 306 (369)
T KOG0665|consen 286 ARDLLSKMLVIDPEKRISVDD 306 (369)
T ss_pred HHHHHHHhhccChhhcccHHH
Confidence 789999999999999999764
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-31 Score=216.84 Aligned_cols=212 Identities=18% Similarity=0.181 Sum_probs=161.9
Q ss_pred Cccccccc-ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHH
Q 044022 1 MKFYGHEY-HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDI 74 (241)
Q Consensus 1 iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i 74 (241)
||+..+.- ....+.++.+|+.||+++.||.||.+.--|+..+..++|||-+.|.-|+-.+..... ....++.||
T Consensus 594 vKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQI 673 (888)
T KOG4236|consen 594 VKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQI 673 (888)
T ss_pred eeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHH
Confidence 45554332 335668899999999999999999999999999999999999976555555544321 123568899
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCC---CCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcch
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEE---NVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKS 151 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 151 (241)
+.||+||| .++|+|+||||+|+|+... ..+||+|||+++.++..+.. .+++||+.|+|||++....|...-
T Consensus 674 L~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR---rsVVGTPAYLaPEVLrnkGyNrSL 747 (888)
T KOG4236|consen 674 LVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR---RSVVGTPAYLAPEVLRNKGYNRSL 747 (888)
T ss_pred HHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh---hhhcCCccccCHHHHhhccccccc
Confidence 99999999 9999999999999999654 57999999999988765532 457899999999999999999999
Q ss_pred hhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccC
Q 044022 152 NVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNN 231 (241)
Q Consensus 152 Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~ 231 (241)
|+||.|+|+|.-++|..||... +.+.+...+ .. -..+...+ .+.+....+||...|+.
T Consensus 748 DMWSVGVIiYVsLSGTFPFNEd--------EdIndQIQN----Aa-FMyPp~PW---------~eis~~AidlIn~LLqV 805 (888)
T KOG4236|consen 748 DMWSVGVIIYVSLSGTFPFNED--------EDINDQIQN----AA-FMYPPNPW---------SEISPEAIDLINNLLQV 805 (888)
T ss_pred cceeeeEEEEEEecccccCCCc--------cchhHHhhc----cc-cccCCCch---------hhcCHHHHHHHHHHHHH
Confidence 9999999999999999999652 112221111 11 11122222 23445678899999988
Q ss_pred CCCCCCCCC
Q 044022 232 SPEDRPTMV 240 (241)
Q Consensus 232 ~p~~Rpt~~ 240 (241)
+=.+|-|.+
T Consensus 806 km~kRysvd 814 (888)
T KOG4236|consen 806 KMRKRYSVD 814 (888)
T ss_pred HHHHhcchH
Confidence 888887754
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=193.48 Aligned_cols=153 Identities=19% Similarity=0.281 Sum_probs=126.6
Q ss_pred HHHHHHHHHhcCCCcccceeeeeeeC--------CcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhh
Q 044022 16 CINNITYAAQMSHNHILKRIGCCLQT--------PIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLH 82 (241)
Q Consensus 16 ~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh 82 (241)
.++|+++|+.|+|+|++.+++.|... ..+++||.+|++ +|...+.... ..+.+++.++..||.|+|
T Consensus 63 alreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH 141 (376)
T KOG0669|consen 63 ALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH 141 (376)
T ss_pred HHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH
Confidence 57999999999999999999888632 257999999984 7777775542 246788999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCC--cceeecccccCCCccCccccccc-CCCcchhhHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE--THITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAF 159 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~ 159 (241)
...|+|||+|+.|+|++.++.++|+|||+++.++... .....+..+-|..|++||.+.+. .++++.|||+-|||
T Consensus 142 ---r~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCi 218 (376)
T KOG0669|consen 142 ---RNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCI 218 (376)
T ss_pred ---HhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHH
Confidence 8999999999999999999999999999997654432 22223344558889999999875 58899999999999
Q ss_pred HHHHHhcCccccc
Q 044022 160 LFELLAGRIHIWD 172 (241)
Q Consensus 160 ~~~~~~g~~p~~~ 172 (241)
+.+|++|.+.+..
T Consensus 219 maeMwtrspimqg 231 (376)
T KOG0669|consen 219 MAEMWTRSPIMQG 231 (376)
T ss_pred HHHHHccCccccC
Confidence 9999999987754
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=228.68 Aligned_cols=190 Identities=17% Similarity=0.186 Sum_probs=131.5
Q ss_pred HHhcCC-Ccccceeeeee-------eCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCCCCCc
Q 044022 23 AAQMSH-NHILKRIGCCL-------QTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGFPRPI 89 (241)
Q Consensus 23 l~~l~h-~~iv~~~~~~~-------~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~~~~i 89 (241)
.+.++| +||+.++++|. ....++.++|++ +++|.+++.... ..++.++.||+.||.||| +++|
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gI 101 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGI 101 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 345677 78999999883 334677888988 579999996532 256789999999999999 9999
Q ss_pred eeccCCCCCeeecCCC-------------------CeEEeeccCceecCCCCc--------------ceeecccccCCCc
Q 044022 90 VLRNFKTQNILFNEEN-------------------VAKWFDFLLSISIPEGET--------------HITTDRVIGTRGY 136 (241)
Q Consensus 90 vh~dl~~~nil~~~~~-------------------~~~l~df~~~~~~~~~~~--------------~~~~~~~~~~~~~ 136 (241)
+||||||+|||++..+ .+|++|||.++....... ........+|+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 9999999999996544 455556665543211000 0001123578889
Q ss_pred cCcccccccCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHH
Q 044022 137 SAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQ 216 (241)
Q Consensus 137 ~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (241)
+|||++.+..++.++|||||||++|||++|..|+.... ........ .. ..+... .
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----------~~~~~~~~-~~----~~~~~~---------~ 236 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----------RTMSSLRH-RV----LPPQIL---------L 236 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----------HHHHHHHH-hh----cChhhh---------h
Confidence 99999998899999999999999999999988864310 01111110 00 000000 1
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 217 QLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 217 ~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
......+++..||..+|.+|||+.|
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~e 261 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSE 261 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHH
Confidence 1234568899999999999999864
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=199.74 Aligned_cols=163 Identities=24% Similarity=0.257 Sum_probs=136.4
Q ss_pred ccccHHHHHHHHHHHHhcCCCcccceeeeee-eCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhc
Q 044022 9 HRHTYGSCINNITYAAQMSHNHILKRIGCCL-QTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 9 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~ 83 (241)
.....+...+|.+|-+.|.||.||++|++|. +.+.+|-|+|||+|.+|.-+++.+.. ....|+.||+.||.||..
T Consensus 507 KeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNE 586 (775)
T KOG1151|consen 507 KENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNE 586 (775)
T ss_pred hhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhc
Confidence 3455677889999999999999999999997 45678999999999999989987643 467899999999999984
Q ss_pred CCCCCceeccCCCCCeeec---CCCCeEEeeccCceecCCCCcc-----eeecccccCCCccCccccccc----CCCcch
Q 044022 84 GFPRPIVLRNFKTQNILFN---EENVAKWFDFLLSISIPEGETH-----ITTDRVIGTRGYSAPEYISIC----VLNEKS 151 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~---~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~----~~~~~~ 151 (241)
++-+|+|.||||.|||+. ..|.+||+|||+++.+...+.. -..+...||..|++||.+..+ ..+.++
T Consensus 587 -ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKV 665 (775)
T KOG1151|consen 587 -IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKV 665 (775)
T ss_pred -cCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccce
Confidence 367899999999999995 4578999999999887654322 122345689999999988654 467899
Q ss_pred hhHHHHHHHHHHHhcCccccc
Q 044022 152 NVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 152 Di~s~G~~~~~~~~g~~p~~~ 172 (241)
||||+|+|+|..+.|+.||..
T Consensus 666 DVWSvGVIFyQClYGrKPFGh 686 (775)
T KOG1151|consen 666 DVWSVGVIFYQCLYGRKPFGH 686 (775)
T ss_pred eeEeeehhhhhhhccCCCCCC
Confidence 999999999999999999965
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-29 Score=183.94 Aligned_cols=165 Identities=20% Similarity=0.209 Sum_probs=132.9
Q ss_pred cccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhc----CC-C---chHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF----GA-P---LPRLKIAS 72 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~----~~-~---~~~~~~~~ 72 (241)
|......+.+...+.++|+.+..+- ..|.+|+++|....++..|+-||.|. .||.-+-+ .. . ...-+++.
T Consensus 77 Kri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~ 155 (282)
T KOG0984|consen 77 KRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAV 155 (282)
T ss_pred eeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHH
Confidence 3333344455667788888887776 67999999999999999999999996 68866532 22 1 12447899
Q ss_pred HHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc----cCCC
Q 044022 73 DIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI----CVLN 148 (241)
Q Consensus 73 ~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~ 148 (241)
.+..||.|||+ +..++|||+||+|||++.+|++|++|||.+..+.++-.. +.-.|...|+|||.+.. ..|+
T Consensus 156 Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~ 230 (282)
T KOG0984|consen 156 SVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK---TMDAGCKPYMAPERINPELNQKGYS 230 (282)
T ss_pred HHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH---HHhcCCCccCChhhcCcccCcccce
Confidence 99999999997 778999999999999999999999999999877654322 22357889999998854 3788
Q ss_pred cchhhHHHHHHHHHHHhcCccccc
Q 044022 149 EKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 149 ~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
.+|||||||+.+.||.+++.||..
T Consensus 231 vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 231 VKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred eehhhhhhhhhhhhhhhccccccc
Confidence 999999999999999999999854
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=174.23 Aligned_cols=154 Identities=19% Similarity=0.232 Sum_probs=130.1
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~l~~lh~~~ 85 (241)
-.-.+.++|+.+++.|+|.|||+++++.-.++.+.+|+|||. -.|..+...... ....++.|++.|+.|+|
T Consensus 43 gvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fch--- 118 (292)
T KOG0662|consen 43 GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH--- 118 (292)
T ss_pred CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---
Confidence 345678999999999999999999999988999999999996 588777654321 35678999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccC-CCcchhhHHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV-LNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~s~G~~~~~~~ 164 (241)
++.+.|||+||+|++++.+|..|++|||+++..+.+..+-.. .+-|..|++|.++.+.. |+...|+||-|||+.|+.
T Consensus 119 shnvlhrdlkpqnllin~ngelkladfglarafgipvrcysa--evvtlwyrppdvlfgakly~tsidmwsagcifaela 196 (292)
T KOG0662|consen 119 SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA--EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196 (292)
T ss_pred hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec--eeeeeeccCcceeeeeehhccchHhhhcchHHHHHh
Confidence 999999999999999999999999999999887766544332 34577899999998864 788999999999999999
Q ss_pred h-cCccc
Q 044022 165 A-GRIHI 170 (241)
Q Consensus 165 ~-g~~p~ 170 (241)
. |++-|
T Consensus 197 nagrplf 203 (292)
T KOG0662|consen 197 NAGRPLF 203 (292)
T ss_pred hcCCCCC
Confidence 7 44444
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=203.95 Aligned_cols=159 Identities=18% Similarity=0.277 Sum_probs=135.2
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
+.......|-.||..-.++.||+++-.|.+.+.+|+||+|++||++-.+|-..+. ....++.++..|+.+.| +
T Consensus 671 nQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVH---k 747 (1034)
T KOG0608|consen 671 NQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVH---K 747 (1034)
T ss_pred hhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHH---h
Confidence 4455667788888888999999999999999999999999999999998765433 34567889999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecC---------CC-------------------------------Cccee
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIP---------EG-------------------------------ETHIT 126 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~---------~~-------------------------------~~~~~ 126 (241)
.|++||||||+|||||.+|++||+|||+|.-+. .+ ...+.
T Consensus 748 mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ 827 (1034)
T KOG0608|consen 748 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRIL 827 (1034)
T ss_pred ccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhh
Confidence 999999999999999999999999999985432 00 00111
Q ss_pred ecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCccccc
Q 044022 127 TDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 127 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
....+||+-|+|||++....++..+|.||.|+|+|||+.|++||..
T Consensus 828 ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~ 873 (1034)
T KOG0608|consen 828 AHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLA 873 (1034)
T ss_pred hhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccC
Confidence 2346799999999999999999999999999999999999999965
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=185.24 Aligned_cols=218 Identities=21% Similarity=0.252 Sum_probs=162.0
Q ss_pred Cccccccccc--ccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC---C-chHHHHHHH
Q 044022 1 MKFYGHEYHR--HTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA---P-LPRLKIASD 73 (241)
Q Consensus 1 iK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~-~~~~~~~~~ 73 (241)
||+..++... +..+..+.|-.+..+- +||.+|-++.+|+.+..++.|.||.+||+|--.++.. + .....+..+
T Consensus 280 mkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~e 359 (593)
T KOG0695|consen 280 MKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE 359 (593)
T ss_pred hhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHH
Confidence 3444444422 3455566777777776 7899999999999999999999999999986544432 1 135567889
Q ss_pred HHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhh
Q 044022 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNV 153 (241)
Q Consensus 74 i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 153 (241)
|..||.||| ++||+.||||..|+|++..|.+|++|+|.++.--.+.. ..++.+||+-|.|||.+.+..|...+|.
T Consensus 360 i~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd--~tstfcgtpnyiapeilrgeeygfsvdw 434 (593)
T KOG0695|consen 360 ICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDW 434 (593)
T ss_pred HHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCCCc--ccccccCCCcccchhhhcccccCceehH
Confidence 999999999 99999999999999999999999999999976543322 2356789999999999999999999999
Q ss_pred HHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 154 FSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
|++|++++||+.|+.||+.... .+....-.+++....-+.++ .++. ..+.....+++..|.+||
T Consensus 435 walgvlmfemmagrspfdivgm--~n~d~ntedylfqvilekqi-ripr-------------slsvkas~vlkgflnkdp 498 (593)
T KOG0695|consen 435 WALGVLMFEMMAGRSPFDIVGM--DNPDMNTEDYLFQVILEKQI-RIPR-------------SLSVKASHVLKGFLNKDP 498 (593)
T ss_pred HHHHHHHHHHHcCCCCcceecC--CCcccchhHHHHHHHhhhcc-cccc-------------eeehhhHHHHHHhhcCCc
Confidence 9999999999999999976332 22222333333333322221 1111 111234568888899999
Q ss_pred CCCCCC
Q 044022 234 EDRPTM 239 (241)
Q Consensus 234 ~~Rpt~ 239 (241)
++|...
T Consensus 499 ~erlgc 504 (593)
T KOG0695|consen 499 KERLGC 504 (593)
T ss_pred HHhcCC
Confidence 998653
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=208.61 Aligned_cols=128 Identities=23% Similarity=0.283 Sum_probs=99.5
Q ss_pred eCCcceEEEEecCCCCHHHhhcCCCc------------------------hHHHHHHHHHHHhchhhcCCCCCceeccCC
Q 044022 40 QTPIPILVFQSVEYGTLRDCIFGAPL------------------------PRLKIASDIVNSLAYLHFGFPRPIVLRNFK 95 (241)
Q Consensus 40 ~~~~~~lv~e~~~~~sL~~~l~~~~~------------------------~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~ 95 (241)
.....++|+||+.+++|.+++..... ....++.|++.||.||| +++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 45678999999999999998865321 12368899999999999 8999999999
Q ss_pred CCCeeecC-CCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccC----------------------CCcchh
Q 044022 96 TQNILFNE-ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV----------------------LNEKSN 152 (241)
Q Consensus 96 ~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----------------------~~~~~D 152 (241)
|+|||++. ++.+||+|||++.......... .....+++.|+|||.+.... +..++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 5799999999997654332221 13456789999999664321 234569
Q ss_pred hHHHHHHHHHHHhcCcccc
Q 044022 153 VFSFGAFLFELLAGRIHIW 171 (241)
Q Consensus 153 i~s~G~~~~~~~~g~~p~~ 171 (241)
||||||++|+|+++..|+.
T Consensus 362 VwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cHHHHHHHHHHHhCcCCCc
Confidence 9999999999999776643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-27 Score=177.83 Aligned_cols=170 Identities=29% Similarity=0.450 Sum_probs=146.6
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--Cc---hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--PL---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+.+.+|++.++.++|++++++++++......++++|++.+++|.+++... .. .+..++.+++.++.+|| +
T Consensus 34 ~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~ 110 (215)
T cd00180 34 LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---S 110 (215)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 3578999999999999999999999999988999999999989999998754 22 46788999999999999 8
Q ss_pred CCceeccCCCCCeeecC-CCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNE-ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~ 164 (241)
.+++|+||+|.||+++. .+.++|+||+.+........ ......+...|++||..... ..+.++|+|++|++++++
T Consensus 111 ~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l- 187 (215)
T cd00180 111 NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL- 187 (215)
T ss_pred CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-
Confidence 89999999999999999 89999999999876654321 11223567789999999876 778999999999999998
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
..+.+++..|++.+|++|||+++
T Consensus 188 ------------------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~ 210 (215)
T cd00180 188 ------------------------------------------------------PELKDLIRKMLQKDPEKRPSAKE 210 (215)
T ss_pred ------------------------------------------------------HHHHHHHHHHhhCCcccCcCHHH
Confidence 25778999999999999999753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=176.25 Aligned_cols=155 Identities=15% Similarity=0.258 Sum_probs=128.8
Q ss_pred cHHHHHHHHHHHHhcC-CCcccceeeeeee--CCcceEEEEecCCCCHHHhhcCCCc-hHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMS-HNHILKRIGCCLQ--TPIPILVFQSVEYGTLRDCIFGAPL-PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+...+|+.||+.|+ ||||++++++..+ +..+.+|+||..+.+....-..... .+..++.+++.||.|+| ++
T Consensus 75 kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCH---S~ 151 (338)
T KOG0668|consen 75 KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCH---SM 151 (338)
T ss_pred HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHH---hc
Confidence 3566889999999997 9999999999875 4578899999998887776554433 46678999999999999 99
Q ss_pred CceeccCCCCCeeecCC-CCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHHHh
Q 044022 88 PIVLRNFKTQNILFNEE-NVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~~ 165 (241)
||.|||+||.|++++.. ..++++|+|++-..-.+... +-.+.+..|-.||.+... .++.+-|+|||||++..|+.
T Consensus 152 GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miF 228 (338)
T KOG0668|consen 152 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 228 (338)
T ss_pred CcccccCCcceeeechhhceeeeeecchHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHh
Confidence 99999999999999976 46899999999765444332 234567788899998765 57889999999999999999
Q ss_pred cCccccc
Q 044022 166 GRIHIWD 172 (241)
Q Consensus 166 g~~p~~~ 172 (241)
.+-||..
T Consensus 229 rkepFFh 235 (338)
T KOG0668|consen 229 RKEPFFH 235 (338)
T ss_pred ccCcccC
Confidence 9999965
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-28 Score=198.28 Aligned_cols=151 Identities=23% Similarity=0.269 Sum_probs=127.2
Q ss_pred HHHHHHHHHHHhcCC------CcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-------hHHHHHHHHHHHhch
Q 044022 14 GSCINNITYAAQMSH------NHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-------PRLKIASDIVNSLAY 80 (241)
Q Consensus 14 ~~~~~e~~~l~~l~h------~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------~~~~~~~~i~~~l~~ 80 (241)
+.=++|+++|++|.. -|+++++..|...+++|||||-+. .+|...|++.+. ....++.|+..||..
T Consensus 473 KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALkl 551 (752)
T KOG0670|consen 473 KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKL 551 (752)
T ss_pred hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHH
Confidence 344689999999942 389999999999999999999985 899999987643 245789999999999
Q ss_pred hhcCCCCCceeccCCCCCeeecCC-CCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHH
Q 044022 81 LHFGFPRPIVLRNFKTQNILFNEE-NVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAF 159 (241)
Q Consensus 81 lh~~~~~~ivh~dl~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~ 159 (241)
|. ..+++|+||||.|||++.. ..+||||||.+........ +-..-+.+|.|||.+.+.+|+...|+||.||.
T Consensus 552 LK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgct 624 (752)
T KOG0670|consen 552 LK---KCGVLHADIKPDNILVNESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCT 624 (752)
T ss_pred HH---hcCeeecccCccceEeccCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeecee
Confidence 99 9999999999999999876 5679999999865443221 12234568999999999999999999999999
Q ss_pred HHHHHhcCccccc
Q 044022 160 LFELLAGRIHIWD 172 (241)
Q Consensus 160 ~~~~~~g~~p~~~ 172 (241)
+||+.||+..|..
T Consensus 625 LYElYtGkIlFpG 637 (752)
T KOG0670|consen 625 LYELYTGKILFPG 637 (752)
T ss_pred eEEeeccceecCC
Confidence 9999999988854
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=189.58 Aligned_cols=92 Identities=18% Similarity=0.277 Sum_probs=76.5
Q ss_pred ccccccHHHHHHHHHHHHhcC-----C---CcccceeeeeeeC----CcceEEEEecCCCCHHHhhcCCC-----c-hHH
Q 044022 7 EYHRHTYGSCINNITYAAQMS-----H---NHILKRIGCCLQT----PIPILVFQSVEYGTLRDCIFGAP-----L-PRL 68 (241)
Q Consensus 7 ~~~~~~~~~~~~e~~~l~~l~-----h---~~iv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~-----~-~~~ 68 (241)
++.++..+..+.||++|++++ | .+||++++.|... .+.|||+|++ |.+|..++.... . ...
T Consensus 112 KSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK 190 (590)
T KOG1290|consen 112 KSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVK 190 (590)
T ss_pred ehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHH
Confidence 345566777889999999993 3 3799999999854 4899999999 789998886542 1 356
Q ss_pred HHHHHHHHHhchhhcCCCCCceeccCCCCCeee
Q 044022 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILF 101 (241)
Q Consensus 69 ~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~ 101 (241)
.|+.|++.||.|||. +.+|+|.||||+|||+
T Consensus 191 ~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 191 EICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred HHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 799999999999998 7799999999999998
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=173.48 Aligned_cols=154 Identities=19% Similarity=0.170 Sum_probs=110.5
Q ss_pred CCHHHhhcCCC--c---hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeec
Q 044022 54 GTLRDCIFGAP--L---PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128 (241)
Q Consensus 54 ~sL~~~l~~~~--~---~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 128 (241)
|||.+++.... . .+..++.|++.||.||| +.+ ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc------
Confidence 68888886421 2 57889999999999999 665 999999999999999 99887654322
Q ss_pred ccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccC
Q 044022 129 RVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQD 208 (241)
Q Consensus 129 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (241)
..|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ............. .......
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~--------~~~~~~~~~~~~~-~~~~~~~---- 129 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE--------LSAILEILLNGMP-ADDPRDR---- 129 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch--------hcHHHHHHHHHhc-cCCcccc----
Confidence 2578999999999999999999999999999999999999854211 1111111111110 0000000
Q ss_pred CCchhHHHHHH--HHHHHHHHhccCCCCCCCCCCC
Q 044022 209 IPCIEKEQQLH--ASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 209 ~~~~~~~~~~~--~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+. ...... .+.+++.+||..||.+|||+.|
T Consensus 130 -~~--~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ 161 (176)
T smart00750 130 -SN--LESVSAARSFADFMRVCASRLPQRREAANH 161 (176)
T ss_pred -cc--HHHHHhhhhHHHHHHHHHhcccccccCHHH
Confidence 00 112222 6899999999999999999853
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=199.01 Aligned_cols=205 Identities=21% Similarity=0.286 Sum_probs=159.3
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
...-.++|+-+++..+|+|||.++|.+......|+.||||-+|+|.+.-+... .+...+.++.+.|+.||| +.
T Consensus 55 d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylh---s~ 131 (829)
T KOG0576|consen 55 DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLH---SQ 131 (829)
T ss_pred cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhh---cC
Confidence 45566789999999999999999999999999999999999999998766543 366778889999999999 99
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc---ccCCCcchhhHHHHHHHHHHH
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS---ICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~s~G~~~~~~~ 164 (241)
+-+|||||-.||+++..+-+|++|||.+...+. +........||++|+|||+.. .+.|...+|||++|+..-|+-
T Consensus 132 gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~ 209 (829)
T KOG0576|consen 132 GKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELG 209 (829)
T ss_pred CcccccccccceeecccCceeecccCchhhhhh--hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhh
Confidence 999999999999999999999999999876543 233345678999999999874 356889999999999999998
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
..++|..+. +.-....+....-+. +.-..+-- .-.+.+.+|++.||.++|++|||++
T Consensus 210 eLqpplfdl----------hpmr~l~LmTkS~~q----pp~lkDk~-----kws~~fh~fvK~altknpKkRptae 266 (829)
T KOG0576|consen 210 ELQPPLFDL----------HPMRALFLMTKSGFQ----PPTLKDKT-----KWSEFFHNFVKGALTKNPKKRPTAE 266 (829)
T ss_pred hcCCccccc----------chHHHHHHhhccCCC----CCcccCCc-----cchHHHHHHHHHHhcCCCccCCChh
Confidence 888886541 111111111111111 11111111 2235789999999999999999986
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=194.80 Aligned_cols=150 Identities=23% Similarity=0.300 Sum_probs=131.5
Q ss_pred HHHHHHHHHhcC---CCcccceeeeeeeCCcceEEEEec-CCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCC
Q 044022 16 CINNITYAAQMS---HNHILKRIGCCLQTPIPILVFQSV-EYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 16 ~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~-~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
.--||+||..|+ |+||++++++|++.+.+|++||-. ++.+|++++.-.+. ....+.+|++.|+++|| +.
T Consensus 613 Vp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh---~~ 689 (772)
T KOG1152|consen 613 VPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLH---DQ 689 (772)
T ss_pred cchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccc---cc
Confidence 345999999997 999999999999999999999986 56799999976643 45678999999999999 99
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCC-CcchhhHHHHHHHHHHHhc
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVL-NEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~s~G~~~~~~~~g 166 (241)
+|||||||-+|+.++.+|-+||+|||.+....++.. ...+||..|.|||++.+.+| +...|||++|+++|.++..
T Consensus 690 ~ivhrdikdenvivd~~g~~klidfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyk 765 (772)
T KOG1152|consen 690 GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYK 765 (772)
T ss_pred CceecccccccEEEecCCeEEEeeccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEec
Confidence 999999999999999999999999999876655543 44679999999999998876 4678999999999999999
Q ss_pred Cccccc
Q 044022 167 RIHIWD 172 (241)
Q Consensus 167 ~~p~~~ 172 (241)
.-||+.
T Consensus 766 enpyyn 771 (772)
T KOG1152|consen 766 ENPYYN 771 (772)
T ss_pred cCCCcC
Confidence 999864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=194.13 Aligned_cols=208 Identities=16% Similarity=0.198 Sum_probs=137.7
Q ss_pred HHHHHHHHHhcCCCcc-----cceeeeeee--------CCcceEEEEecCCCCHHHhhcCCC------------------
Q 044022 16 CINNITYAAQMSHNHI-----LKRIGCCLQ--------TPIPILVFQSVEYGTLRDCIFGAP------------------ 64 (241)
Q Consensus 16 ~~~e~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~------------------ 64 (241)
+..|+.++.+++|.++ ++++++|.. .+..++|+||+++++|.+++....
T Consensus 219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~ 298 (507)
T PLN03224 219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP 298 (507)
T ss_pred hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence 4457777888877654 677777753 346799999999999999886421
Q ss_pred ----------chHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCC
Q 044022 65 ----------LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTR 134 (241)
Q Consensus 65 ----------~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 134 (241)
.....++.+++.+|.||| +.+++||||||+||+++.++.++|+|||++......... ......+++
T Consensus 299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp 374 (507)
T PLN03224 299 DNMPQDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDP 374 (507)
T ss_pred hhcccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCc
Confidence 013467889999999999 899999999999999999999999999998654332211 111223478
Q ss_pred CccCcccccccCC----------------------CcchhhHHHHHHHHHHHhcCc-ccccccccCCCc---ccchHHHH
Q 044022 135 GYSAPEYISICVL----------------------NEKSNVFSFGAFLFELLAGRI-HIWDLLKDTHDH---GCFFNEYL 188 (241)
Q Consensus 135 ~~~aPE~~~~~~~----------------------~~~~Di~s~G~~~~~~~~g~~-p~~~~~~~~~~~---~~~~~~~~ 188 (241)
.|+|||.+..... ..+.|+||+||++++|++|.. |+.......... ......+.
T Consensus 375 ~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r 454 (507)
T PLN03224 375 RYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR 454 (507)
T ss_pred ceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH
Confidence 8999998753221 124699999999999999875 664321110000 00000000
Q ss_pred HHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC---CCCCCCCC
Q 044022 189 KNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP---EDRPTMVD 241 (241)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p---~~Rpt~~e 241 (241)
...... .+++. ....+....+++.++|..+| .+|+|++|
T Consensus 455 --~~~~~~----------~~~~~--~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~e 496 (507)
T PLN03224 455 --MYKGQK----------YDFSL--LDRNKEAGWDLACKLITKRDQANRGRLSVGQ 496 (507)
T ss_pred --hhcccC----------CCccc--ccccChHHHHHHHHHhccCCCCcccCCCHHH
Confidence 000010 01110 11233678899999999876 68999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=172.19 Aligned_cols=157 Identities=28% Similarity=0.327 Sum_probs=134.4
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+.+.+|++.++.++|+|++++++++......++++|++.+++|.+++.... . ....++.+++.++.+|| +
T Consensus 40 ~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~ 116 (225)
T smart00221 40 QREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---S 116 (225)
T ss_pred HHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 56788899999999999999999999998889999999999889999986543 2 36778999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccc-cccCCCcchhhHHHHHHHHHHHh
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYI-SICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
.+++|+|++|.|++++..+.++|+|||.+......... ......++..|++||.. ....++.++|+|+||++++++++
T Consensus 117 ~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~ 195 (225)
T smart00221 117 LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLW 195 (225)
T ss_pred CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHH
Confidence 89999999999999999999999999998766543200 11233567789999998 66677889999999999999999
Q ss_pred cCccccc
Q 044022 166 GRIHIWD 172 (241)
Q Consensus 166 g~~p~~~ 172 (241)
|+.||..
T Consensus 196 g~~pf~~ 202 (225)
T smart00221 196 GPEPFSG 202 (225)
T ss_pred CCCCccc
Confidence 9999944
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-27 Score=182.39 Aligned_cols=156 Identities=20% Similarity=0.271 Sum_probs=125.9
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCC-----cceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhh
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTP-----IPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLH 82 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh 82 (241)
..+++.+|+++|..++|.|++..+++..-.. ..|+++|++. .+|...+-+.. .....++.||++||+|||
T Consensus 95 s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLH 173 (449)
T KOG0664|consen 95 SCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLH 173 (449)
T ss_pred HHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHh
Confidence 4677899999999999999999988875433 4578889885 57777765432 134456789999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLF 161 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~ 161 (241)
+.+|.||||||.|+|++.+..+||+|||+++.......... +..+-|-+|+|||.+.+. .|+.+.||||.|||+.
T Consensus 174 ---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFa 249 (449)
T KOG0664|consen 174 ---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFA 249 (449)
T ss_pred ---hcchhhccCCCccEEeccCceEEecccccccccchhhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHH
Confidence 99999999999999999999999999999986654432221 223457789999999876 6899999999999999
Q ss_pred HHHhcCccccc
Q 044022 162 ELLAGRIHIWD 172 (241)
Q Consensus 162 ~~~~g~~p~~~ 172 (241)
|++.++.-|..
T Consensus 250 ELLgRrILFQA 260 (449)
T KOG0664|consen 250 ELLQRKILFQA 260 (449)
T ss_pred HHHhhhhhhhc
Confidence 99998877754
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-26 Score=173.96 Aligned_cols=153 Identities=22% Similarity=0.382 Sum_probs=123.2
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceee-eeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIG-CCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~-~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+|.+|...--.| .|.||+.-|+ .|+..+.+..++||++.|+|..-+...+. ...+++.|+++|+.|+| +
T Consensus 63 t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMH---s 139 (378)
T KOG1345|consen 63 TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMH---S 139 (378)
T ss_pred hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhh---c
Confidence 467899998876666 5889997665 66677888999999999999998877654 45679999999999999 9
Q ss_pred CCceeccCCCCCeeecCC--CCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-----CCCcchhhHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEE--NVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-----VLNEKSNVFSFGAF 159 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Di~s~G~~ 159 (241)
+.+||||||.+|||+... -.+|++|||.....+.... ....+-.|.+||.+... ...+.+|+|.||++
T Consensus 140 knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi 214 (378)
T KOG1345|consen 140 KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGII 214 (378)
T ss_pred cchhhcccccceEEEecCCccEEEeeecccccccCceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeee
Confidence 999999999999999543 4899999999876543321 12234457899877543 34678999999999
Q ss_pred HHHHHhcCccccc
Q 044022 160 LFELLAGRIHIWD 172 (241)
Q Consensus 160 ~~~~~~g~~p~~~ 172 (241)
+|..++|.+||+.
T Consensus 215 ~f~cltG~~PWQk 227 (378)
T KOG1345|consen 215 FFYCLTGKFPWQK 227 (378)
T ss_pred eeeeecCCCcchh
Confidence 9999999999975
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=179.02 Aligned_cols=160 Identities=23% Similarity=0.336 Sum_probs=132.3
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-hHHHHHHHHHHHhchhhcCCCCCc
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-PRLKIASDIVNSLAYLHFGFPRPI 89 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~~l~~lh~~~~~~i 89 (241)
...+..+|++.|..+ -+.||+++.+++-.+++.++|+||+++....++...... ....++..++.||+++| ..||
T Consensus 77 ~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h---~~GI 153 (418)
T KOG1167|consen 77 SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLH---KNGI 153 (418)
T ss_pred CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhh---ccCc
Confidence 456688999999999 578999999999999999999999999999999887765 45678999999999999 9999
Q ss_pred eeccCCCCCeeecCC-CCeEEeeccCceecC-----------------C-------------------------CCccee
Q 044022 90 VLRNFKTQNILFNEE-NVAKWFDFLLSISIP-----------------E-------------------------GETHIT 126 (241)
Q Consensus 90 vh~dl~~~nil~~~~-~~~~l~df~~~~~~~-----------------~-------------------------~~~~~~ 126 (241)
|||||||.|+|.+.. +.-.|.|||++.... . ......
T Consensus 154 vHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~ 233 (418)
T KOG1167|consen 154 VHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSE 233 (418)
T ss_pred cccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccce
Confidence 999999999999865 566899999986110 0 000001
Q ss_pred ecccccCCCccCccccccc-CCCcchhhHHHHHHHHHHHhcCccccccc
Q 044022 127 TDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELLAGRIHIWDLL 174 (241)
Q Consensus 127 ~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~~g~~p~~~~~ 174 (241)
.-...||++|+|||++..+ ..++++||||.|+|++.+++++.||....
T Consensus 234 ~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 234 RANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred ecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCc
Confidence 1135699999999999876 56789999999999999999999997643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=170.34 Aligned_cols=204 Identities=19% Similarity=0.232 Sum_probs=151.1
Q ss_pred ccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc------hHHHHHHHHHHHhch
Q 044022 7 EYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL------PRLKIASDIVNSLAY 80 (241)
Q Consensus 7 ~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~~i~~~l~~ 80 (241)
+......+.|..|.-.|+-+.||||.+++|.|.+..++.++.+||+.|||++.+..... +..+++.+++.|++|
T Consensus 225 ~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaf 304 (448)
T KOG0195|consen 225 EVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAF 304 (448)
T ss_pred hcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHH
Confidence 33445667788899999999999999999999999999999999999999999988743 788999999999999
Q ss_pred hhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCC---cchhhHHHH
Q 044022 81 LHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLN---EKSNVFSFG 157 (241)
Q Consensus 81 lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~---~~~Di~s~G 157 (241)
||+. +.-|.---|+...+++|.+.+.+|+--..-.++.. ....-.+.|++||.+...+-+ .++|+|||+
T Consensus 305 lhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe-------~gr~y~pawmspealqrkped~n~raadmwsfa 376 (448)
T KOG0195|consen 305 LHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE-------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFA 376 (448)
T ss_pred Hhhc-chhhhhhhcccceEEecchhhhheecccceeeeec-------cccccCcccCCHHHHhcCchhcchhhhhHHHHH
Confidence 9964 23344457889999999998887753222111111 112456789999999876543 578999999
Q ss_pred HHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 158 AFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 158 ~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
+++||+.|+..||.+...-+ .+... .. ++ ....+++ +.+..+..++.-|+..||.+||
T Consensus 377 illwel~trevpfadlspme-cgmki-------al-eg-----lrv~ipp--------gis~hm~klm~icmnedpgkrp 434 (448)
T KOG0195|consen 377 ILLWELNTREVPFADLSPME-CGMKI-------AL-EG-----LRVHIPP--------GISRHMNKLMNICMNEDPGKRP 434 (448)
T ss_pred HHHHHhhccccccccCCchh-hhhhh-------hh-cc-----ccccCCC--------CccHHHHHHHHHHhcCCCCcCC
Confidence 99999999999997743221 11111 00 11 1111122 2335688999999999999999
Q ss_pred CCC
Q 044022 238 TMV 240 (241)
Q Consensus 238 t~~ 240 (241)
.++
T Consensus 435 kfd 437 (448)
T KOG0195|consen 435 KFD 437 (448)
T ss_pred Ccc
Confidence 886
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=175.54 Aligned_cols=202 Identities=23% Similarity=0.315 Sum_probs=146.3
Q ss_pred HHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHHhchhhcCCCCCc-eeccCCC
Q 044022 23 AAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNSLAYLHFGFPRPI-VLRNFKT 96 (241)
Q Consensus 23 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~l~~lh~~~~~~i-vh~dl~~ 96 (241)
|+++.|.|+.+++|.+.+++..+.|.+||..|+|.+.+..... -...++++|+.|+.||| ...| +|+.++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence 4578999999999999999999999999999999999987543 35678999999999999 4444 9999999
Q ss_pred CCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc---C----CCcchhhHHHHHHHHHHHhcCcc
Q 044022 97 QNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC---V----LNEKSNVFSFGAFLFELLAGRIH 169 (241)
Q Consensus 97 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~----~~~~~Di~s~G~~~~~~~~g~~p 169 (241)
.|++++..+.+|++|||+....................-|.|||.+... . .+.+.|+||||++++|+++++.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998665421111111111233458999999763 1 46779999999999999999999
Q ss_pred cccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 170 IWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
|......... .+......+.+ .+...+...... +..+.+..++++||..+|.+||+++
T Consensus 158 ~~~~~~~~~~-----~eii~~~~~~~------~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~ 215 (484)
T KOG1023|consen 158 FDLRNLVEDP-----DEIILRVKKGG------SNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIE 215 (484)
T ss_pred cccccccCCh-----HHHHHHHHhcC------CCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHH
Confidence 9764333211 22222211101 111112211111 2334688999999999999999985
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.5e-25 Score=189.81 Aligned_cols=207 Identities=15% Similarity=0.202 Sum_probs=153.6
Q ss_pred HHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC-Cc---hHHHHHHHHHHHhchhhcCCCCCcee
Q 044022 16 CINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA-PL---PRLKIASDIVNSLAYLHFGFPRPIVL 91 (241)
Q Consensus 16 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~---~~~~~~~~i~~~l~~lh~~~~~~ivh 91 (241)
+..|+.+-..|+|+|++..+..+.+.....-+||||++ +|..++... .. .+-.++.|++.|+.|+| ..|+.|
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h---~~Giah 443 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLH---SMGLAH 443 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHH---hcCcee
Confidence 55677788889999999888877766555555999998 999998775 22 45678999999999999 999999
Q ss_pred ccCCCCCeeecCCCCeEEeeccCceecCCCCcc--eeecccccCCCccCcccccccCCCc-chhhHHHHHHHHHHHhcCc
Q 044022 92 RNFKTQNILFNEENVAKWFDFLLSISIPEGETH--ITTDRVIGTRGYSAPEYISICVLNE-KSNVFSFGAFLFELLAGRI 168 (241)
Q Consensus 92 ~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~-~~Di~s~G~~~~~~~~g~~ 168 (241)
||+|++|+++..++.+||+|||.+.....+... ......+|+.+|+|||++....|++ ..||||.|+++..|++|+.
T Consensus 444 rdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~ 523 (601)
T KOG0590|consen 444 RDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRF 523 (601)
T ss_pred ccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCC
Confidence 999999999999999999999998776655433 3334567999999999999998886 5799999999999999999
Q ss_pred ccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 169 HIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 169 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
||.......... ..... ....-....+..-...-+...+.++.+||+.||.+|.|+++
T Consensus 524 ~Wk~a~~~~~~~----------~~~~~-----~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~ 581 (601)
T KOG0590|consen 524 PWKVAKKSDNSF----------KTNNY-----SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQ 581 (601)
T ss_pred ccccccccccch----------hhhcc-----ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHH
Confidence 996632221100 00000 00000000000111133356788999999999999999863
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.5e-21 Score=154.84 Aligned_cols=188 Identities=17% Similarity=0.276 Sum_probs=132.9
Q ss_pred CCCcccceeeeeeeC---------------------------CcceEEEEecCCCCHHHhhcCCC---chHHHHHHHHHH
Q 044022 27 SHNHILKRIGCCLQT---------------------------PIPILVFQSVEYGTLRDCIFGAP---LPRLKIASDIVN 76 (241)
Q Consensus 27 ~h~~iv~~~~~~~~~---------------------------~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~ 76 (241)
+|||||++.+.|.++ ..+|+||.-+. -||..++-... ....-++.|+++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCCCchHHHHHHHHHHHH
Confidence 699999999988752 36789999886 59999886543 245668899999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeec--CC--CCeEEeeccCceecCCCCccee----ecccccCCCccCcccccccC--
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFN--EE--NVAKWFDFLLSISIPEGETHIT----TDRVIGTRGYSAPEYISICV-- 146 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~--~~--~~~~l~df~~~~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~-- 146 (241)
|+.||| ++++.|||+|.+|||+. .+ ....|+|||++-.......... .-..-|+...+|||+....+
T Consensus 353 av~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 353 AVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 999999 99999999999999983 33 4567899999865443211111 01123667789999886532
Q ss_pred ----CCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHH
Q 044022 147 ----LNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASA 222 (241)
Q Consensus 147 ----~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (241)
.-.++|.|+.|-+.||+++..-||+..- +...+... + .+.++ +.+.. ..+..++
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-------em~L~~r~-Y-qe~qL-----Palp~--------~vpp~~r 487 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-------EMLLDTRT-Y-QESQL-----PALPS--------RVPPVAR 487 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccc-------hheechhh-h-hhhhC-----CCCcc--------cCChHHH
Confidence 1258999999999999999999998721 11111111 1 11111 22222 2336788
Q ss_pred HHHHHhccCCCCCCCCCC
Q 044022 223 QLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 223 ~l~~~cl~~~p~~Rpt~~ 240 (241)
+++...|+.||++|+++.
T Consensus 488 qlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 488 QLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred HHHHHHhcCCccccCCcc
Confidence 999999999999999863
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.9e-20 Score=148.37 Aligned_cols=215 Identities=27% Similarity=0.349 Sum_probs=158.2
Q ss_pred cHHHHHHHHHHHHhcCCC-cccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----c---hHHHHHHHHHHHhchhhc
Q 044022 12 TYGSCINNITYAAQMSHN-HILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----L---PRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~---~~~~~~~~i~~~l~~lh~ 83 (241)
....+.+|++++..+.|+ +++++.+.+......+++++++.++++.+++.... . ....++.+++.++.++|
T Consensus 40 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H- 118 (384)
T COG0515 40 EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH- 118 (384)
T ss_pred HHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH-
Confidence 477899999999999988 79999999977777899999999999997776542 1 45778999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCC-CeEEeeccCceecCCCCcce----eecccccCCCccCcccccc---cCCCcchhhHH
Q 044022 84 GFPRPIVLRNFKTQNILFNEEN-VAKWFDFLLSISIPEGETHI----TTDRVIGTRGYSAPEYISI---CVLNEKSNVFS 155 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~s 155 (241)
..+++|||+||+||+++..+ .++++|||.+.......... ......++..|+|||.+.+ .......|+||
T Consensus 119 --~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s 196 (384)
T COG0515 119 --SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWS 196 (384)
T ss_pred --hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHH
Confidence 89999999999999999998 79999999987554433221 2345678999999999987 57889999999
Q ss_pred HHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 156 FGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 156 ~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
+|++++++++|..||...... ................ ........... ......+.+++..++..+|..
T Consensus 197 ~g~~~~~~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~--~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 265 (384)
T COG0515 197 LGITLYELLTGLPPFEGEKNS-----SATSQTLKIILELPTP--SLASPLSPSNP----ELISKAASDLLKKLLAKDPKN 265 (384)
T ss_pred HHHHHHHHHhCCCCCCCCCcc-----ccHHHHHHHHHhcCCc--ccccccCcccc----chhhHHHHHHHHHHHhcCchh
Confidence 999999999999996442111 0011111111111110 00000000000 123356789999999999999
Q ss_pred CCCCC
Q 044022 236 RPTMV 240 (241)
Q Consensus 236 Rpt~~ 240 (241)
|.+..
T Consensus 266 r~~~~ 270 (384)
T COG0515 266 RLSSS 270 (384)
T ss_pred cCCHH
Confidence 98753
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.9e-22 Score=174.73 Aligned_cols=212 Identities=22% Similarity=0.212 Sum_probs=145.3
Q ss_pred CcccccccccccHHHHHH---HHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCIN---NITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASD 73 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~ 73 (241)
||+|-+.-..-..+.|.+ |++ ....++||.+++.-+-...+-.|||-+|.. -+|+|++...+. .+.-++.|
T Consensus 51 vKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvk-hnLyDRlSTRPFL~~iEKkWiaFQ 128 (1431)
T KOG1240|consen 51 VKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVK-HNLYDRLSTRPFLVLIEKKWIAFQ 128 (1431)
T ss_pred EEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHh-hhhhhhhccchHHHHHHHHHHHHH
Confidence 567765444434444444 454 444599999999988888888899999997 599999987765 23346889
Q ss_pred HHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceec--CCC----CcceeecccccCCCccCccccccc--
Q 044022 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISI--PEG----ETHITTDRVIGTRGYSAPEYISIC-- 145 (241)
Q Consensus 74 i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~--~~~----~~~~~~~~~~~~~~~~aPE~~~~~-- 145 (241)
++.|+.-+| ..+|+|||||.+|||+..=+.+.|+||...++. +.+ -...-.++ ..-.+|.|||.+...
T Consensus 129 LL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTS-rRRtCYiAPERFv~~~~ 204 (1431)
T KOG1240|consen 129 LLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTS-RRRTCYIAPERFVSALG 204 (1431)
T ss_pred HHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecC-CceeeecChHhhhcccc
Confidence 999999999 999999999999999999999999999765432 111 11111111 223469999988652
Q ss_pred --------C-CCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHH
Q 044022 146 --------V-LNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKE 215 (241)
Q Consensus 146 --------~-~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (241)
. .+++=||+|+||++.|+++ |++||.-.+ +..+...+ ...+...+..
T Consensus 205 ~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-------------L~aYr~~~--~~~~e~~Le~-------- 261 (1431)
T KOG1240|consen 205 KTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-------------LLAYRSGN--ADDPEQLLEK-------- 261 (1431)
T ss_pred ccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-------------HHhHhccC--ccCHHHHHHh--------
Confidence 1 4677899999999999998 678874311 11110000 0000000000
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 216 QQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 216 ~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
-+...++.++..|++.||++|.+|+|
T Consensus 262 Ied~~~Rnlil~Mi~rdPs~RlSAed 287 (1431)
T KOG1240|consen 262 IEDVSLRNLILSMIQRDPSKRLSAED 287 (1431)
T ss_pred CcCccHHHHHHHHHccCchhccCHHH
Confidence 11146789999999999999999874
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=6e-20 Score=150.55 Aligned_cols=122 Identities=16% Similarity=0.053 Sum_probs=96.3
Q ss_pred HHHHHHHHHHHHhcCCCcccc-eeeeeeeCCcceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhhcCCCCCcee
Q 044022 13 YGSCINNITYAAQMSHNHILK-RIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVL 91 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~~~ivh 91 (241)
...|.+|+++|++++|+|+++ ++++ +..++||||++|++|... .. .....++.+++.+|.||| +.+|+|
T Consensus 65 ~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~LVmE~~~G~~L~~~-~~--~~~~~~~~~i~~aL~~lH---~~gIiH 134 (365)
T PRK09188 65 RHLAAREIRALKTVRGIGVVPQLLAT----GKDGLVRGWTEGVPLHLA-RP--HGDPAWFRSAHRALRDLH---RAGITH 134 (365)
T ss_pred HHHHHHHHHHHHhccCCCCCcEEEEc----CCcEEEEEccCCCCHHHh-Cc--cchHHHHHHHHHHHHHHH---HCCCee
Confidence 556899999999999999985 4432 457999999999999743 21 123578889999999999 999999
Q ss_pred ccC-CCCCeeecCCCCeEEeeccCceecCCCCccee------ecccccCCCccCcccccc
Q 044022 92 RNF-KTQNILFNEENVAKWFDFLLSISIPEGETHIT------TDRVIGTRGYSAPEYISI 144 (241)
Q Consensus 92 ~dl-~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~------~~~~~~~~~~~aPE~~~~ 144 (241)
||| ||+|||++.++.++|+|||+++.......... .....+++.|+|||++..
T Consensus 135 rDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 135 NDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999 99999999999999999999987654331111 124457788999999853
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.4e-20 Score=151.75 Aligned_cols=166 Identities=27% Similarity=0.369 Sum_probs=123.4
Q ss_pred cceEEEEecCCCCHHHhhcCCCc-------hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCc
Q 044022 43 IPILVFQSVEYGTLRDCIFGAPL-------PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLS 115 (241)
Q Consensus 43 ~~~lv~e~~~~~sL~~~l~~~~~-------~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~ 115 (241)
++++.|++|+..+|.+++..... ..+.++.|++.|+.| ++.+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 57899999999999999974422 356788899999987 67899999999999999999999999998
Q ss_pred eecCCCC----cceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHH
Q 044022 116 ISIPEGE----THITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKN 190 (241)
Q Consensus 116 ~~~~~~~----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 190 (241)
....... .....+..+||..||+||.+.+..|+.++||||||+|++|++. -.-++.. ...
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---------------~~t 468 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---------------IAT 468 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---------------HHh
Confidence 8776554 2333456689999999999999999999999999999999997 2222211 001
Q ss_pred HhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 191 YLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
. .....+..++....++| .-..|+.+++...|.+||++.
T Consensus 469 ~--~d~r~g~ip~~~~~d~p---------~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 469 L--TDIRDGIIPPEFLQDYP---------EEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred h--hhhhcCCCChHHhhcCc---------HHHHHHHHhcCCCcccCchHH
Confidence 0 00011112222222222 334799999999999999763
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=130.59 Aligned_cols=148 Identities=12% Similarity=0.071 Sum_probs=110.7
Q ss_pred HHHHHHHHHHhcC-CCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhhcCCCCCceecc
Q 044022 15 SCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVLRN 93 (241)
Q Consensus 15 ~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~~~ivh~d 93 (241)
.|.+|+++|++|. |+++++++++ +..+++|||+.|.+|.+.... ....++.+++.++.++| ..|++|||
T Consensus 47 l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~---~~~~~~~qi~~~L~~lH---~~GIvHrD 116 (218)
T PRK12274 47 LARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR---GDLAYFRAARRLLQQLH---RCGVAHND 116 (218)
T ss_pred HHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh---hhHHHHHHHHHHHHHHH---HCcCccCC
Confidence 5789999999995 4789999886 346899999999999765432 23467889999999999 99999999
Q ss_pred C-CCCCeeecCCCCeEEeeccCceecCCCCcc----ee-------ecccccCCCccCccccccc-CCC-cchhhHHHHHH
Q 044022 94 F-KTQNILFNEENVAKWFDFLLSISIPEGETH----IT-------TDRVIGTRGYSAPEYISIC-VLN-EKSNVFSFGAF 159 (241)
Q Consensus 94 l-~~~nil~~~~~~~~l~df~~~~~~~~~~~~----~~-------~~~~~~~~~~~aPE~~~~~-~~~-~~~Di~s~G~~ 159 (241)
| ||.|||++.++.++|+|||++......... .. ......++.+++|+..... ..+ ...+.++-|.-
T Consensus 117 L~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~ 196 (218)
T PRK12274 117 LAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKP 196 (218)
T ss_pred CCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcch
Confidence 9 799999999999999999999854433210 00 0012245556666544322 233 45567799999
Q ss_pred HHHHHhcCccccc
Q 044022 160 LFELLAGRIHIWD 172 (241)
Q Consensus 160 ~~~~~~g~~p~~~ 172 (241)
+|.++||..+.+.
T Consensus 197 ~~~~~~~~~~~~~ 209 (218)
T PRK12274 197 VYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHhccCCccc
Confidence 9999999988755
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.5e-19 Score=150.58 Aligned_cols=186 Identities=22% Similarity=0.244 Sum_probs=147.5
Q ss_pred HHHHHHHHHHhcC-CCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCCCc
Q 044022 15 SCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPRPI 89 (241)
Q Consensus 15 ~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~~i 89 (241)
....|-.++...+ ||.+|++...++.+...+++.++..+|.|...+..... ....+...++.+++++| +.++
T Consensus 42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh---~l~i 118 (612)
T KOG0603|consen 42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLH---KLGI 118 (612)
T ss_pred ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcc---hhHH
Confidence 4556777888886 99999999999999999999999999999988877644 23456778899999999 9999
Q ss_pred eeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCcc
Q 044022 90 VLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIH 169 (241)
Q Consensus 90 vh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p 169 (241)
+++|+|++||+++.+|.+++.|||.++....... .+|+..|||||... .....+|.||||++.++|++|..|
T Consensus 119 iyrd~k~enilld~~Ghi~~tdfglske~v~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~p 190 (612)
T KOG0603|consen 119 AYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLP 190 (612)
T ss_pred HHhcccccceeecccCccccCCchhhhHhHhhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCC
Confidence 9999999999999999999999999876544321 27899999999998 567899999999999999999999
Q ss_pred cccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 170 IWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
|.. +.+..+.+... .-+ ...+....+++.+++..+|..|.-.
T Consensus 191 f~~-------------~~~~~Il~~~~----~~p-----------~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 191 FGG-------------DTMKRILKAEL----EMP-----------RELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred Cch-------------HHHHHHhhhcc----CCc-----------hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 954 22333322111 000 1334556788888888888887543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.2e-19 Score=134.80 Aligned_cols=128 Identities=13% Similarity=0.090 Sum_probs=98.7
Q ss_pred HHHHHHHHHhcCCCcccceeeeeeeC--------CcceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhhcCCCC
Q 044022 16 CINNITYAAQMSHNHILKRIGCCLQT--------PIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 16 ~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
+.+|++.+.++.|++|.....++... +..+++|||++|.+|.++.... .....+++.++..+| ..
T Consensus 82 ~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~----~~~~~~i~~~l~~lH---~~ 154 (232)
T PRK10359 82 YENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPEIS----EDVKAKIKASIESLH---QH 154 (232)
T ss_pred HHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhhcc----HHHHHHHHHHHHHHH---Hc
Confidence 67999999999999999998886532 3578999999999998874321 234668999999999 99
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+++|||++|.|++++.++ ++++|||........... ..+.....+..++|+||||+.+..+..
T Consensus 155 gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 155 GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CCccCCCChHHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 999999999999999988 999999987644221110 012333445678999999998765543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=136.38 Aligned_cols=154 Identities=19% Similarity=0.179 Sum_probs=126.6
Q ss_pred HHHHHHHHHHhcCC----Ccccceeeee-eeCCcceEEEEecCCCCHHHhhcCCCc------hHHHHHHHHHHHhchhhc
Q 044022 15 SCINNITYAAQMSH----NHILKRIGCC-LQTPIPILVFQSVEYGTLRDCIFGAPL------PRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 15 ~~~~e~~~l~~l~h----~~iv~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~~i~~~l~~lh~ 83 (241)
.+..|+.++..+.. +++..+++.. ......++||+.+ |.+|.++....+. +.+.++.|++.+|.++|
T Consensus 62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH- 139 (322)
T KOG1164|consen 62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH- 139 (322)
T ss_pred cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH-
Confidence 67889999999973 5888888888 4677889999988 7999998754431 57889999999999999
Q ss_pred CCCCCceeccCCCCCeeecCC-----CCeEEeeccCce--ecCCCCc----cee--ecccccCCCccCcccccccCCCcc
Q 044022 84 GFPRPIVLRNFKTQNILFNEE-----NVAKWFDFLLSI--SIPEGET----HIT--TDRVIGTRGYSAPEYISICVLNEK 150 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~-----~~~~l~df~~~~--~~~~~~~----~~~--~~~~~~~~~~~aPE~~~~~~~~~~ 150 (241)
+.|++||||||.|+++... ..+.+.|||+++ ....... ... .....||..|.++....+...+.+
T Consensus 140 --~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~ 217 (322)
T KOG1164|consen 140 --SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR 217 (322)
T ss_pred --hcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc
Confidence 9999999999999999865 468999999998 3222211 111 123459999999999999999999
Q ss_pred hhhHHHHHHHHHHHhcCccccc
Q 044022 151 SNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 151 ~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
.|+||++.++.++..|..||..
T Consensus 218 DDles~~Y~l~el~~g~LPW~~ 239 (322)
T KOG1164|consen 218 DDLESLFYMLLELLKGSLPWEA 239 (322)
T ss_pred hhhhhHHHHHHHHhcCCCCCcc
Confidence 9999999999999999999955
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.1e-18 Score=127.66 Aligned_cols=163 Identities=17% Similarity=0.147 Sum_probs=131.2
Q ss_pred ccccccHHHHHHHHHHHHhcCC-CcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHHhch
Q 044022 7 EYHRHTYGSCINNITYAAQMSH-NHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNSLAY 80 (241)
Q Consensus 7 ~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~l~~ 80 (241)
|++.....++..|.++...|++ ..|.++..+..+.....+||+++ |.||+++.+-... +.+-++-|++.-+.|
T Consensus 48 Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEy 126 (341)
T KOG1163|consen 48 ESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEY 126 (341)
T ss_pred ecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHH
Confidence 4455567788999999999987 67778888888888899999999 7899998754322 567788999999999
Q ss_pred hhcCCCCCceeccCCCCCeeecC---CCCeEEeeccCceecCCCCcc-----eeecccccCCCccCcccccccCCCcchh
Q 044022 81 LHFGFPRPIVLRNFKTQNILFNE---ENVAKWFDFLLSISIPEGETH-----ITTDRVIGTRGYSAPEYISICVLNEKSN 152 (241)
Q Consensus 81 lh~~~~~~ivh~dl~~~nil~~~---~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~D 152 (241)
+| .++++||||||+|+|+.- ...+.++|||+++...+..+. .......||..|.+--...+...+...|
T Consensus 127 vH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDD 203 (341)
T KOG1163|consen 127 VH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDD 203 (341)
T ss_pred HH---hhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhh
Confidence 99 999999999999999964 456889999999876543221 2223456888888877777667788899
Q ss_pred hHHHHHHHHHHHhcCcccccc
Q 044022 153 VFSFGAFLFELLAGRIHIWDL 173 (241)
Q Consensus 153 i~s~G~~~~~~~~g~~p~~~~ 173 (241)
+=|+|.++.++-.|..||+.+
T Consensus 204 meSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 204 MESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred hhhhcceeeeeecCCCccccc
Confidence 999999999999999999763
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-17 Score=131.18 Aligned_cols=156 Identities=19% Similarity=0.250 Sum_probs=102.7
Q ss_pred ceEEEEecCCCCHHHhhcC-----CCc------hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeec
Q 044022 44 PILVFQSVEYGTLRDCIFG-----APL------PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDF 112 (241)
Q Consensus 44 ~~lv~e~~~~~sL~~~l~~-----~~~------~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df 112 (241)
.+++|+-+. ++|.+++.. ... .++.+-.|++..+++|| ..|+||+||+|+|++++.+|.+.|+||
T Consensus 114 ~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgdi~~~nfll~~~G~v~Lg~F 189 (288)
T PF14531_consen 114 RFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGDIKPENFLLDQDGGVFLGDF 189 (288)
T ss_dssp EEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEE-TTS-EEE--G
T ss_pred hhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecccceeeEEEcCCCCEEEcCh
Confidence 367777774 789887542 111 24556689999999999 999999999999999999999999999
Q ss_pred cCceecCCCCcceeecccccCCCccCccccccc--------CCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccch
Q 044022 113 LLSISIPEGETHITTDRVIGTRGYSAPEYISIC--------VLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFF 184 (241)
Q Consensus 113 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--------~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~ 184 (241)
+........... ...+..|.+||..... .++.+.|.|++|+++|.+++|..||...........
T Consensus 190 ~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--- 261 (288)
T PF14531_consen 190 SSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--- 261 (288)
T ss_dssp GGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---
T ss_pred HHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc---
Confidence 877654432211 2334678899977542 467889999999999999999999976432211100
Q ss_pred HHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCC
Q 044022 185 NEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDR 236 (241)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 236 (241)
.+..+. ..++.++.||..+|+.||.+|
T Consensus 262 -----------~f~~C~--------------~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 -----------DFSRCR--------------DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -----------GGTTSS-----------------HHHHHHHHHHT-SSGGGS
T ss_pred -----------cchhcC--------------CcCHHHHHHHHHHccCCcccC
Confidence 111111 344789999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.3e-17 Score=123.49 Aligned_cols=101 Identities=17% Similarity=0.102 Sum_probs=81.4
Q ss_pred cHHHHHHHHHHHHhc-----CCCcccceeeeeeeCC---c-ceEEEEe--cCCCCHHHhhcCCCc-hHHHHHHHHHHHh-
Q 044022 12 TYGSCINNITYAAQM-----SHNHILKRIGCCLQTP---I-PILVFQS--VEYGTLRDCIFGAPL-PRLKIASDIVNSL- 78 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~-~~lv~e~--~~~~sL~~~l~~~~~-~~~~~~~~i~~~l- 78 (241)
..+.+.+|+++++++ .||||++++|++.++. . +.+|+|| +.++||.++++.... ....++.+++.++
T Consensus 39 ~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~ 118 (210)
T PRK10345 39 GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLK 118 (210)
T ss_pred hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcccccHhHHHHHHHHHHHH
Confidence 456789999999999 5799999999998763 3 3478999 557999999976432 2245677888777
Q ss_pred chhhcCCCCCceeccCCCCCeeecCC----CCeEEeeccCc
Q 044022 79 AYLHFGFPRPIVLRNFKTQNILFNEE----NVAKWFDFLLS 115 (241)
Q Consensus 79 ~~lh~~~~~~ivh~dl~~~nil~~~~----~~~~l~df~~~ 115 (241)
.||| +.+|+||||||+|||++.. ..++|+||+.+
T Consensus 119 ~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 119 RYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 8999 9999999999999999743 47999995433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=7e-16 Score=121.13 Aligned_cols=158 Identities=16% Similarity=0.172 Sum_probs=132.3
Q ss_pred ccHHHHHHHHHHHHhcC-CCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHHhchhhcC
Q 044022 11 HTYGSCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~l~~lh~~ 84 (241)
....++..|.+..+.|. -+.|..++-+-..+.+..||+|++ |.||+|+..-... +...++.|++.-+.++|
T Consensus 65 S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH-- 141 (449)
T KOG1165|consen 65 SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH-- 141 (449)
T ss_pred CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH--
Confidence 45677888999999995 489998888877788899999999 7899998754322 46778999999999999
Q ss_pred CCCCceeccCCCCCeeecCC-----CCeEEeeccCceecCCCCcc-----eeecccccCCCccCcccccccCCCcchhhH
Q 044022 85 FPRPIVLRNFKTQNILFNEE-----NVAKWFDFLLSISIPEGETH-----ITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~-----~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
++.+|.|||||+|+||..- ..+.++|||+++....+.+. ....+..||..||+--.-.+...+.+.|+=
T Consensus 142 -~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLE 220 (449)
T KOG1165|consen 142 -EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLE 220 (449)
T ss_pred -hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHH
Confidence 9999999999999999743 46889999999876654332 223456699999999988888899999999
Q ss_pred HHHHHHHHHHhcCccccc
Q 044022 155 SFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 155 s~G~~~~~~~~g~~p~~~ 172 (241)
|+|=++.+++.|..||..
T Consensus 221 aLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 221 ALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred HhhhhhhhhccCCCcccc
Confidence 999999999999999976
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=4e-16 Score=117.83 Aligned_cols=96 Identities=13% Similarity=0.121 Sum_probs=73.9
Q ss_pred HHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHh-hcCCCc---hHHHHHHHHHHHhchh-hcCCCCCcee
Q 044022 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDC-IFGAPL---PRLKIASDIVNSLAYL-HFGFPRPIVL 91 (241)
Q Consensus 17 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~-l~~~~~---~~~~~~~~i~~~l~~l-h~~~~~~ivh 91 (241)
.+|++++.++.++++.....+. ....++||||++++++... +..... ....++.+++.+|.++ | +.+++|
T Consensus 67 ~~E~~~l~~l~~~~v~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiH 141 (190)
T cd05147 67 EKEMRNLKRLVTAGIPCPEPIL--LKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQ---DCRLVH 141 (190)
T ss_pred HHHHHHHHHHHHCCCCCCcEEE--ecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHH---hCCccc
Confidence 4599999999888774433322 2234899999988777554 333222 4678899999999998 8 889999
Q ss_pred ccCCCCCeeecCCCCeEEeeccCceec
Q 044022 92 RNFKTQNILFNEENVAKWFDFLLSISI 118 (241)
Q Consensus 92 ~dl~~~nil~~~~~~~~l~df~~~~~~ 118 (241)
|||||+||+++ ++.++|+|||++...
T Consensus 142 rDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 142 ADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCCCHHHEEEE-CCcEEEEEccccccC
Confidence 99999999998 578999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.2e-16 Score=137.94 Aligned_cols=141 Identities=24% Similarity=0.283 Sum_probs=103.7
Q ss_pred HHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCC-------------cceeecccccCCCccCc
Q 044022 73 DIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE-------------THITTDRVIGTRGYSAP 139 (241)
Q Consensus 73 ~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-------------~~~~~~~~~~~~~~~aP 139 (241)
+++.++.||| .-+|||||+||+|.++..-|.+|++|||+++...... .......++||+.|.||
T Consensus 151 dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaP 227 (1205)
T KOG0606|consen 151 DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAP 227 (1205)
T ss_pred hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccCh
Confidence 3478999999 9999999999999999999999999999986543211 11122346899999999
Q ss_pred ccccccCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHH
Q 044022 140 EYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLH 219 (241)
Q Consensus 140 E~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (241)
|++....|...+|.|++|+|+|+++.|..||+....+ +...........+.-.+. ....
T Consensus 228 eVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe---------elfg~visd~i~wpE~de------------a~p~ 286 (1205)
T KOG0606|consen 228 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---------ELFGQVISDDIEWPEEDE------------ALPP 286 (1205)
T ss_pred hhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH---------HHHhhhhhhhccccccCc------------CCCH
Confidence 9999999999999999999999999999999653221 222222221111111111 1124
Q ss_pred HHHHHHHHhccCCCCCCC
Q 044022 220 ASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 220 ~~~~l~~~cl~~~p~~Rp 237 (241)
+..+++.+.|+.+|..|-
T Consensus 287 Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 287 EAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred HHHHHHHHHHHhChHhhc
Confidence 678899999999998874
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.5e-15 Score=113.69 Aligned_cols=99 Identities=12% Similarity=0.149 Sum_probs=77.7
Q ss_pred HHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHh-hcCCCc---hHHHHHHHHHHHhchhhcCCC-CCce
Q 044022 16 CINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDC-IFGAPL---PRLKIASDIVNSLAYLHFGFP-RPIV 90 (241)
Q Consensus 16 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~-l~~~~~---~~~~~~~~i~~~l~~lh~~~~-~~iv 90 (241)
+.+|.+.+.++.|+++.....+... ..++||||++++++... +..... ....++.+++.++.++| . .+++
T Consensus 66 ~~~E~~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH---~~~giv 140 (190)
T cd05145 66 AEKEFRNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLY---QEAGLV 140 (190)
T ss_pred HHHHHHHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHH---HhCCEe
Confidence 4679999999999987544443332 24899999988755332 433322 56789999999999999 7 9999
Q ss_pred eccCCCCCeeecCCCCeEEeeccCceecCC
Q 044022 91 LRNFKTQNILFNEENVAKWFDFLLSISIPE 120 (241)
Q Consensus 91 h~dl~~~nil~~~~~~~~l~df~~~~~~~~ 120 (241)
||||||+||+++ ++.++|+|||++.....
T Consensus 141 HrDlkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 141 HGDLSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred cCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence 999999999999 88999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.9e-16 Score=121.94 Aligned_cols=149 Identities=18% Similarity=0.240 Sum_probs=112.4
Q ss_pred HHHHHhcCCCcccceeeeeeeCC-----cceEEEEecCCCCHHHhhcCCCc--------hHHHHHHHHHHHhchhhcCCC
Q 044022 20 ITYAAQMSHNHILKRIGCCLQTP-----IPILVFQSVEYGTLRDCIFGAPL--------PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 20 ~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~--------~~~~~~~~i~~~l~~lh~~~~ 86 (241)
+..|-++-|.|||+++.||.+.+ ...+++||++.|++.++|++... ...+|+.||+.||.|||++ +
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 45566778999999999998644 46789999999999999976521 2357999999999999976 7
Q ss_pred CCceeccCCCCCeeecCCCCeEEeec--cCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDF--LLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df--~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
..++|++++.+.|++..++-+|++.- ......-............+.++|.+||+-....-+.++|||+||....+|.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 78999999999999999998887642 1111111111111112234567899999887777788999999999999999
Q ss_pred hcCcc
Q 044022 165 AGRIH 169 (241)
Q Consensus 165 ~g~~p 169 (241)
.+..-
T Consensus 277 ilEiq 281 (458)
T KOG1266|consen 277 ILEIQ 281 (458)
T ss_pred Hheec
Confidence 88653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.6e-16 Score=138.40 Aligned_cols=205 Identities=18% Similarity=0.190 Sum_probs=155.5
Q ss_pred HHHHHHHHHhcC-CCcccceeeeeeeCCcceEEEEecCCCCHHHhh-cCCC-----chHHHHHHHHHHHhchhhcCCCCC
Q 044022 16 CINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI-FGAP-----LPRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 16 ~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l-~~~~-----~~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
...|..+.+.+. |+|++++++...+....++++++..++++...+ .... ...-.+..|+..++.|+|. ..+
T Consensus 67 i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~ 144 (601)
T KOG0590|consen 67 IDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENG 144 (601)
T ss_pred cCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccc
Confidence 334777778886 999999999999999999999999999999988 4332 2467789999999999996 678
Q ss_pred ceeccCCCCCeeecCCC-CeEEeeccCceecCC-CCcceeeccccc-CCCccCccccccc-CCCcchhhHHHHHHHHHHH
Q 044022 89 IVLRNFKTQNILFNEEN-VAKWFDFLLSISIPE-GETHITTDRVIG-TRGYSAPEYISIC-VLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~-~~~l~df~~~~~~~~-~~~~~~~~~~~~-~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~ 164 (241)
+.|+|++|+|.+++..+ ..+++|||++..... ...........| ++.|.|||...+. ...+..|+||.|+++..++
T Consensus 145 ~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~ 224 (601)
T KOG0590|consen 145 VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAML 224 (601)
T ss_pred cccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccc
Confidence 99999999999999999 999999999987766 444444555677 9999999999874 5568899999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|..|+....... ..+..............+ ........+++..++..+|+.|.+.++
T Consensus 225 ~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~k~l~~~~~~r~s~~~ 282 (601)
T KOG0590|consen 225 TGELPWDFPSRKD-----------------GRYSSWKSNKGRFTQLPW--NSISDQAHDLLHKILKENPSNRLSIEE 282 (601)
T ss_pred cCCCCcccccccc-----------------ccceeecccccccccCcc--ccCChhhhhcccccccCCchhcccccc
Confidence 9999986532221 111111111100000000 112245678899999999999998764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.9e-15 Score=113.93 Aligned_cols=100 Identities=16% Similarity=0.179 Sum_probs=88.9
Q ss_pred HHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhhcCCCCCceecc
Q 044022 14 GSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVLRN 93 (241)
Q Consensus 14 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~~~ivh~d 93 (241)
.++.+|++++..++|+++.....++......+++|||++|++|.+.+.........++.+++.++.++| +.+++|+|
T Consensus 44 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~D 120 (211)
T PRK14879 44 ERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGMEELELSREIGRLVGKLH---SAGIIHGD 120 (211)
T ss_pred HHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhccHHHHHHHHHHHHHHHHHH---hCCcccCC
Confidence 467889999999999998877777777778899999999999999987654467788999999999999 99999999
Q ss_pred CCCCCeeecCCCCeEEeeccCcee
Q 044022 94 FKTQNILFNEENVAKWFDFLLSIS 117 (241)
Q Consensus 94 l~~~nil~~~~~~~~l~df~~~~~ 117 (241)
++|.||+++ ++.++++|||.+..
T Consensus 121 l~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 121 LTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcccEEEE-CCCEEEEECCcccC
Confidence 999999999 78899999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.1e-15 Score=112.37 Aligned_cols=97 Identities=18% Similarity=0.175 Sum_probs=83.4
Q ss_pred HHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhhcCCCCCceecc
Q 044022 14 GSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVLRN 93 (241)
Q Consensus 14 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~~~ivh~d 93 (241)
.++.+|++++..++|+++.....++......++||||++|++|.+++..... .++.+++.+|.+|| +.+++|+|
T Consensus 42 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~---~~~~~i~~~l~~lH---~~gi~H~D 115 (199)
T TIGR03724 42 ERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND---ELLREIGRLVGKLH---KAGIVHGD 115 (199)
T ss_pred HHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH---HHHHHHHHHHHHHH---HCCeecCC
Confidence 5677899999999988766555555566778999999999999998765432 78899999999999 99999999
Q ss_pred CCCCCeeecCCCCeEEeeccCcee
Q 044022 94 FKTQNILFNEENVAKWFDFLLSIS 117 (241)
Q Consensus 94 l~~~nil~~~~~~~~l~df~~~~~ 117 (241)
++|.||+++ ++.++++|||.+..
T Consensus 116 l~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 116 LTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCcceEEEE-CCcEEEEECCCCcC
Confidence 999999999 88999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.58 E-value=9e-15 Score=127.31 Aligned_cols=97 Identities=13% Similarity=0.133 Sum_probs=87.0
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhhcCCCCCceec
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVLR 92 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~~~ivh~ 92 (241)
..++.+|++++++++|++++....++......++||||+++++|.+++. ....++.+++.++.+|| +.+++||
T Consensus 380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~----~~~~~~~~i~~~L~~lH---~~giiHr 452 (535)
T PRK09605 380 TERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE----GNPELVRKVGEIVAKLH---KAGIVHG 452 (535)
T ss_pred HHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH----HHHHHHHHHHHHHHHHH---hCCCccC
Confidence 3568899999999999999988777777777899999999999999886 35678999999999999 9999999
Q ss_pred cCCCCCeeecCCCCeEEeeccCcee
Q 044022 93 NFKTQNILFNEENVAKWFDFLLSIS 117 (241)
Q Consensus 93 dl~~~nil~~~~~~~~l~df~~~~~ 117 (241)
|+||+||++ .++.++|+|||+++.
T Consensus 453 Dlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 453 DLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCChHHEEE-ECCcEEEEeCccccc
Confidence 999999999 678899999999865
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.8e-14 Score=111.56 Aligned_cols=102 Identities=16% Similarity=0.145 Sum_probs=81.9
Q ss_pred cHHHHHHHHHHHHhcCCCcc--cceeeeeeeCC----cceEEEEecCC-CCHHHhhcCCCchHHHHHHHHHHHhchhhcC
Q 044022 12 TYGSCINNITYAAQMSHNHI--LKRIGCCLQTP----IPILVFQSVEY-GTLRDCIFGAPLPRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~----~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~ 84 (241)
...++.+|++++.+|+|+++ +..+++..... ..++|+|+++| .+|.+++...... ...+.+++.++.+||
T Consensus 83 ~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~-~~~~~~i~~~l~~lH-- 159 (239)
T PRK01723 83 ERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEAPLS-EEQWQAIGQLIARFH-- 159 (239)
T ss_pred hhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcCCCC-HHHHHHHHHHHHHHH--
Confidence 34668899999999998775 56666654332 23599999997 6999888665332 334678999999999
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCcee
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSIS 117 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~ 117 (241)
+.||+|+||||.|||++.++.++|+|||.+..
T Consensus 160 -~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 160 -DAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred -HCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 99999999999999999999999999998754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.8e-14 Score=119.22 Aligned_cols=146 Identities=16% Similarity=0.129 Sum_probs=111.2
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCch-HHHHHHHHHHHhchhhcCCCCCcee
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-RLKIASDIVNSLAYLHFGFPRPIVL 91 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-~~~~~~~i~~~l~~lh~~~~~~ivh 91 (241)
.+...+.++-|+.+|||||+++++.+..++..|+|+|-+ ..|..+++....- .---+.||+.||.|||. +.+++|
T Consensus 53 ~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~~~~v~~Gl~qIl~AL~FL~~--d~~lvH 128 (690)
T KOG1243|consen 53 TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELGKEEVCLGLFQILAALSFLND--DCNLVH 128 (690)
T ss_pred hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhHHHHHHHHHHHHHHHHHHHhc--cCCeee
Confidence 566778899999999999999999999999999999998 4788777765432 22347899999999986 778999
Q ss_pred ccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 92 RNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 92 ~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
+++.-..++++..|..||++|.++........ .......--.|..|+.+.... -..|.|-||+++++++.|
T Consensus 129 gNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 129 GNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 99999999999999999999988755433221 011111122344555433221 235999999999999999
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.1e-14 Score=126.85 Aligned_cols=150 Identities=17% Similarity=0.151 Sum_probs=118.2
Q ss_pred HHHHHHHHHhcC---CCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCCC
Q 044022 16 CINNITYAAQMS---HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 16 ~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
|+--.+++.+|+ -+.|.++.....-.+-.++|+||.+.|||.++++.... -.+.++.+++.-+..|| ..+
T Consensus 738 fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH---~~~ 814 (974)
T KOG1166|consen 738 FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLH---AMG 814 (974)
T ss_pred eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHH---hcc
Confidence 333445566665 23555666666667777999999999999999986543 35778899999999999 999
Q ss_pred ceeccCCCCCeeecC-------CCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHH
Q 044022 89 IVLRNFKTQNILFNE-------ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLF 161 (241)
Q Consensus 89 ivh~dl~~~nil~~~-------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~ 161 (241)
|||+||||+|+|+.. ...++|+|||.+.-+.--.....-....+|-.+-++|...+++|+...|.|.|+-+++
T Consensus 815 IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h 894 (974)
T KOG1166|consen 815 IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVH 894 (974)
T ss_pred eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHH
Confidence 999999999999943 3468999999997554322222334457788899999999999999999999999999
Q ss_pred HHHhcCc
Q 044022 162 ELLAGRI 168 (241)
Q Consensus 162 ~~~~g~~ 168 (241)
.|+.|+.
T Consensus 895 ~mLFG~y 901 (974)
T KOG1166|consen 895 VMLFGKY 901 (974)
T ss_pred HHHHHHH
Confidence 9999874
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.4e-13 Score=98.42 Aligned_cols=101 Identities=15% Similarity=0.115 Sum_probs=85.0
Q ss_pred HHHHHHHHHHHHhcCC--CcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhhcCCCCCce
Q 044022 13 YGSCINNITYAAQMSH--NHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIV 90 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~~~iv 90 (241)
...+.+|+.+++.++| .++++++++....+..++++||++++++..+ .......++.+++.+++.+|.....+++
T Consensus 35 ~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~---~~~~~~~~~~~~~~~l~~lh~~~~~~i~ 111 (155)
T cd05120 35 GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV---SEEEKEDIAEQLAELLAKLHQLPLLVLC 111 (155)
T ss_pred hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC---CHHHHHHHHHHHHHHHHHHhCCCceEEE
Confidence 4678999999999976 5888999988887889999999998877655 2234567788999999999943335799
Q ss_pred eccCCCCCeeecCCCCeEEeeccCce
Q 044022 91 LRNFKTQNILFNEENVAKWFDFLLSI 116 (241)
Q Consensus 91 h~dl~~~nil~~~~~~~~l~df~~~~ 116 (241)
|+|++|.|++++..+.+++.||+.+.
T Consensus 112 H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 112 HGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred ecCCCcceEEEECCcEEEEEeccccc
Confidence 99999999999998999999999775
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.2e-13 Score=105.42 Aligned_cols=96 Identities=15% Similarity=0.161 Sum_probs=74.7
Q ss_pred HHHHHHHHHHhcCCCc--ccceeeeeeeCCcceEEEEecCCCCHHHhhc-CCCc---hHHHHHHHHHHHhchhhcCCCCC
Q 044022 15 SCINNITYAAQMSHNH--ILKRIGCCLQTPIPILVFQSVEYGTLRDCIF-GAPL---PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 15 ~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~-~~~~---~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
.+.+|++++.++.+.. +.+++++ ...++||||+.+++|..... .... ....++.+++.++.+|| ..+
T Consensus 96 ~~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~g 168 (237)
T smart00090 96 WAEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLY---KEG 168 (237)
T ss_pred HHHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHH---hcC
Confidence 4678999999997532 3344432 23589999999888876542 2222 24678999999999999 899
Q ss_pred -ceeccCCCCCeeecCCCCeEEeeccCceec
Q 044022 89 -IVLRNFKTQNILFNEENVAKWFDFLLSISI 118 (241)
Q Consensus 89 -ivh~dl~~~nil~~~~~~~~l~df~~~~~~ 118 (241)
++|+||||+||+++ ++.++++|||.+...
T Consensus 169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 169 ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 99999999999999 889999999988643
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.7e-13 Score=101.94 Aligned_cols=97 Identities=11% Similarity=0.100 Sum_probs=78.7
Q ss_pred HHHHHHHHHHhcCCCc--ccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhhcCCCCCceec
Q 044022 15 SCINNITYAAQMSHNH--ILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVLR 92 (241)
Q Consensus 15 ~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~~~ivh~ 92 (241)
.+.+|+.++.++.|++ +.+.++ ....++||||+++++|...... .....++.+++.++.++| ..+++|+
T Consensus 79 ~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--~~~~~~~~~i~~~l~~lh---~~gi~H~ 149 (198)
T cd05144 79 AAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--EDPEEVLDEILEEIVKAY---KHGIIHG 149 (198)
T ss_pred HHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--ccHHHHHHHHHHHHHHHH---HCCCCcC
Confidence 4678999999997774 444443 2345899999999999876542 345678889999999999 8999999
Q ss_pred cCCCCCeeecCCCCeEEeeccCceecCC
Q 044022 93 NFKTQNILFNEENVAKWFDFLLSISIPE 120 (241)
Q Consensus 93 dl~~~nil~~~~~~~~l~df~~~~~~~~ 120 (241)
||+|.||+++.++.++|+|||.+.....
T Consensus 150 Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 150 DLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCcccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.8e-11 Score=92.27 Aligned_cols=91 Identities=15% Similarity=0.166 Sum_probs=68.0
Q ss_pred HHHHHHHhcCCCc--ccceeeeeeeCCcceEEEEecCCC-----CHHHhhcCCCchHHHHHHHHHHHhchhhcCCC-CCc
Q 044022 18 NNITYAAQMSHNH--ILKRIGCCLQTPIPILVFQSVEYG-----TLRDCIFGAPLPRLKIASDIVNSLAYLHFGFP-RPI 89 (241)
Q Consensus 18 ~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~-----sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~-~~i 89 (241)
.|.+.+.++.+.. +.+.++. ...++||||++++ +|.+.... .....++.+++.++.++| . .++
T Consensus 66 ~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~--~~~~~~~~~~~~~l~~lh---~~~~i 136 (187)
T cd05119 66 KEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL--EDPEELYDQILELMRKLY---REAGL 136 (187)
T ss_pred HHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc--ccHHHHHHHHHHHHHHHh---hccCc
Confidence 4666666664432 3344433 2468999999984 34333221 456788999999999999 7 999
Q ss_pred eeccCCCCCeeecCCCCeEEeeccCceec
Q 044022 90 VLRNFKTQNILFNEENVAKWFDFLLSISI 118 (241)
Q Consensus 90 vh~dl~~~nil~~~~~~~~l~df~~~~~~ 118 (241)
+|+||+|+||+++ ++.++++|||.+...
T Consensus 137 vH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 137 VHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 9999999999999 899999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.18 E-value=8.5e-11 Score=87.08 Aligned_cols=93 Identities=15% Similarity=0.067 Sum_probs=70.9
Q ss_pred HHHHHHHHHHHhcCCCccc-ceeeeeeeCCcceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhhcCCCCC----
Q 044022 14 GSCINNITYAAQMSHNHIL-KRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRP---- 88 (241)
Q Consensus 14 ~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~~~---- 88 (241)
..+.+|+.+++.+.+.+++ +++.+. ....++||||++|.++.+. .......+.+++.+++.|| ..+
T Consensus 37 ~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~----~~~~~~~~~~l~~~l~~LH---~~~~~~~ 107 (170)
T cd05151 37 INRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTE----DFSDPENLEKIAKLLKKLH---SSPLPDL 107 (170)
T ss_pred cCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccccc----cccCHHHHHHHHHHHHHHh---CCCCCCc
Confidence 3567899999999665554 445443 3345899999999887653 1222346678999999999 666
Q ss_pred -ceeccCCCCCeeecCCCCeEEeeccCce
Q 044022 89 -IVLRNFKTQNILFNEENVAKWFDFLLSI 116 (241)
Q Consensus 89 -ivh~dl~~~nil~~~~~~~~l~df~~~~ 116 (241)
++|+|++|.||+++ ++.++++||+.+.
T Consensus 108 ~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 108 VPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred eeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 59999999999999 6789999998774
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.7e-10 Score=84.46 Aligned_cols=99 Identities=18% Similarity=0.185 Sum_probs=79.8
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhhcCCCCCcee
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVL 91 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~~~ivh 91 (241)
...+-.+|++++.+++--.+..-.-+..+.+...|+|||.+|..|.+.+... ...++..+=.-+.-|| ..+|+|
T Consensus 42 rr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~---~~~~~r~vG~~vg~lH---~~givH 115 (204)
T COG3642 42 RRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA---RPDLLREVGRLVGKLH---KAGIVH 115 (204)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc---chHHHHHHHHHHHHHH---hcCeec
Confidence 3456778999999987655544444455677788999999999999988876 3566777777888899 999999
Q ss_pred ccCCCCCeeecCCCCeEEeeccCcee
Q 044022 92 RNFKTQNILFNEENVAKWFDFLLSIS 117 (241)
Q Consensus 92 ~dl~~~nil~~~~~~~~l~df~~~~~ 117 (241)
+||+++|+.+...+ +.++|||++..
T Consensus 116 GDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 116 GDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999998766 89999999863
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.16 E-value=6.4e-11 Score=100.06 Aligned_cols=149 Identities=20% Similarity=0.249 Sum_probs=117.5
Q ss_pred HHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHH----HhchhhcCCC
Q 044022 17 INNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVN----SLAYLHFGFP 86 (241)
Q Consensus 17 ~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~----~l~~lh~~~~ 86 (241)
++|+..-+.+ .|+|.|+.+..+...+..++-+|++. .+|..+...... .......+... |+..+| .
T Consensus 165 ~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s 240 (524)
T KOG0601|consen 165 LREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---S 240 (524)
T ss_pred cchhhcccccCccccccccCcccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---C
Confidence 4566666666 58999999999999999999999995 788877655422 34556666667 999999 9
Q ss_pred CCceeccCCCCCeeecCC-CCeEEeeccCceecCCCCccee---ecccccCCCccCcccccccCCCcchhhHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEE-NVAKWFDFLLSISIPEGETHIT---TDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~ 162 (241)
..++|-|++|.||++..+ ...+++|||....+........ .-+..+...|++||+.. ..++..+|++++|.++.+
T Consensus 241 ~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~ 319 (524)
T KOG0601|consen 241 NNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILE 319 (524)
T ss_pred CcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHh
Confidence 999999999999999999 8899999999887765432211 11225677899999988 456889999999999999
Q ss_pred HHhcCccc
Q 044022 163 LLAGRIHI 170 (241)
Q Consensus 163 ~~~g~~p~ 170 (241)
...+..+.
T Consensus 320 ~~l~~~~~ 327 (524)
T KOG0601|consen 320 AILGSHLP 327 (524)
T ss_pred hHhhcccc
Confidence 99886553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.6e-11 Score=109.49 Aligned_cols=189 Identities=20% Similarity=0.187 Sum_probs=133.1
Q ss_pred CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeec
Q 044022 27 SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFN 102 (241)
Q Consensus 27 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~ 102 (241)
++|-++...-.+......+++++|+.+++|...+++.+. .....+..+..++.+|| ...++|+|++|.|++..
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~ 938 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIA 938 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccc---cchhhcccccccchhhc
Confidence 345555444445556678999999999999998877642 33456677888999999 77799999999999999
Q ss_pred CCCCeEEeeccCceecC------CC-------------------Ccc----eeecccccCCCccCcccccccCCCcchhh
Q 044022 103 EENVAKWFDFLLSISIP------EG-------------------ETH----ITTDRVIGTRGYSAPEYISICVLNEKSNV 153 (241)
Q Consensus 103 ~~~~~~l~df~~~~~~~------~~-------------------~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 153 (241)
.++..++++|+...... .. ... .......+++.|.+||...+......+|.
T Consensus 939 ~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~ 1018 (1205)
T KOG0606|consen 939 YDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADW 1018 (1205)
T ss_pred ccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchh
Confidence 99999999997322111 00 000 11234568899999999999999999999
Q ss_pred HHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCch-hHHHHHHHHHHHHHHhccCC
Q 044022 154 FSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCI-EKEQQLHASAQLTLECVNNS 232 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~~ 232 (241)
|++|+++++.++|.+||.+..... ...+. ...+.+.. .....+....+++...+..+
T Consensus 1019 ~~~g~~l~e~l~g~pp~na~tpq~---------~f~ni-------------~~~~~~~p~g~~~~s~~aq~~~~~ll~~~ 1076 (1205)
T KOG0606|consen 1019 WSSGVCLFEVLTGIPPFNAETPQQ---------IFENI-------------LNRDIPWPEGPEEGSYEAQDLINRLLTEE 1076 (1205)
T ss_pred hhhhhhhhhhhcCCCCCCCcchhh---------hhhcc-------------ccCCCCCCCCccccChhhhhhhhhhhccC
Confidence 999999999999999997633221 01111 11111110 01133356788999999999
Q ss_pred CCCCCCCC
Q 044022 233 PEDRPTMV 240 (241)
Q Consensus 233 p~~Rpt~~ 240 (241)
|.+|..+.
T Consensus 1077 ~~qr~~a~ 1084 (1205)
T KOG0606|consen 1077 PTQRLGAK 1084 (1205)
T ss_pred chhccCcc
Confidence 99998763
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.06 E-value=6.9e-10 Score=94.19 Aligned_cols=103 Identities=14% Similarity=0.100 Sum_probs=74.6
Q ss_pred HHHHHHHHHHhcC----CCcccceeeeee-eCCcceEEEEecCCCCHHHhhcCC--CchHHHHHHHHHH-HhchhhcCCC
Q 044022 15 SCINNITYAAQMS----HNHILKRIGCCL-QTPIPILVFQSVEYGTLRDCIFGA--PLPRLKIASDIVN-SLAYLHFGFP 86 (241)
Q Consensus 15 ~~~~e~~~l~~l~----h~~iv~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~-~l~~lh~~~~ 86 (241)
+|.+|++.+.+++ |.+-+.+-..+. .....++||||++|++|.+..... ......++..++. .+..+| .
T Consensus 199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~---~ 275 (437)
T TIGR01982 199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVL---R 275 (437)
T ss_pred CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHH---h
Confidence 4777888777773 333333323222 234569999999999998876432 2244556666665 467788 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCC
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPE 120 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~ 120 (241)
.|++|+|++|.||+++.++.++++|||.+...+.
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999999977653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.8e-09 Score=81.36 Aligned_cols=96 Identities=10% Similarity=0.085 Sum_probs=70.3
Q ss_pred HHHHHHHHHhcCC--CcccceeeeeeeCCcceEEEEecCCCCHHH-hhcCCC---chHHHHHHHHHHHhchh-hcCCCCC
Q 044022 16 CINNITYAAQMSH--NHILKRIGCCLQTPIPILVFQSVEYGTLRD-CIFGAP---LPRLKIASDIVNSLAYL-HFGFPRP 88 (241)
Q Consensus 16 ~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~---~~~~~~~~~i~~~l~~l-h~~~~~~ 88 (241)
..+|++.|+++.. -++...+++ ...++||||+.++.+.. .++... .....+..+++.++..+ | ..+
T Consensus 73 a~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H---~~g 145 (197)
T cd05146 73 AEKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYK---ECN 145 (197)
T ss_pred HHHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHH---hCC
Confidence 3489999999954 355566654 45689999997543321 222211 13456678999999988 8 889
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecC
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIP 119 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~ 119 (241)
++|+||++.||++. ++.+.++|||.+....
T Consensus 146 lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 146 LVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred eecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999999999997 4679999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.7e-09 Score=77.45 Aligned_cols=103 Identities=19% Similarity=0.151 Sum_probs=80.0
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCC-CCHHHhhcCCC-----ch-HHHHHHHHHHHhchhhcC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEY-GTLRDCIFGAP-----LP-RLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~-----~~-~~~~~~~i~~~l~~lh~~ 84 (241)
...+-.+|+++|.+++--.|.--.-++.+....+++|||++| .++.+++.... .. ...++..|-..+.-||
T Consensus 53 tr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH-- 130 (229)
T KOG3087|consen 53 TRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH-- 130 (229)
T ss_pred HHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh--
Confidence 566788999999998765555444455566677899999975 48888876541 12 3578888889999999
Q ss_pred CCCCceeccCCCCCeeecCCC---CeEEeeccCcee
Q 044022 85 FPRPIVLRNFKTQNILFNEEN---VAKWFDFLLSIS 117 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~---~~~l~df~~~~~ 117 (241)
..+++|+||+++||++..++ .+.++|||++..
T Consensus 131 -~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 131 -DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred -hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99999999999999997665 347899998854
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=7.3e-09 Score=77.67 Aligned_cols=100 Identities=14% Similarity=0.127 Sum_probs=67.1
Q ss_pred cHHHHHHHHHHHHhcCCC--cccceeeeeeeCCcceEEEEecC--CCCHHHhhcCC--CchHHHHHHHHHHHhch-hhcC
Q 044022 12 TYGSCINNITYAAQMSHN--HILKRIGCCLQTPIPILVFQSVE--YGTLRDCIFGA--PLPRLKIASDIVNSLAY-LHFG 84 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~--~~sL~~~l~~~--~~~~~~~~~~i~~~l~~-lh~~ 84 (241)
......+|.+.|.++..- ++.+.+++ . ..++||||+. |..+..+.... ......++.+++..+.. +|
T Consensus 51 ~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--~--~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~-- 124 (188)
T PF01163_consen 51 IREWAKKEFRNLKRLYEAGVPVPKPYDY--N--RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLH-- 124 (188)
T ss_dssp HHHHHHHHHHHHHHCCCTT-SS--EEEE--E--TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHH--
T ss_pred HHHHHHHHHHHHHHHHHCCccCCcEEEE--e--CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHH--
Confidence 345577899999999765 45566544 2 3589999998 65554433332 23455677777774444 68
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecC
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIP 119 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~ 119 (241)
..|++|+|+++.||+++.+ .+.++|||.+....
T Consensus 125 -~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 125 -KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp -CTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred -hcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 8999999999999999987 89999999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=7e-09 Score=82.25 Aligned_cols=99 Identities=9% Similarity=0.080 Sum_probs=75.8
Q ss_pred HHHHHHHHHHhcCCCcc--cceeeeeee-----CCcceEEEEecCCC-CHHHhhcCC---Cc---hHHHHHHHHHHHhch
Q 044022 15 SCINNITYAAQMSHNHI--LKRIGCCLQ-----TPIPILVFQSVEYG-TLRDCIFGA---PL---PRLKIASDIVNSLAY 80 (241)
Q Consensus 15 ~~~~e~~~l~~l~h~~i--v~~~~~~~~-----~~~~~lv~e~~~~~-sL~~~l~~~---~~---~~~~~~~~i~~~l~~ 80 (241)
.+.+|.+.+.+|...+| ++.+++... ....++|+|++++. +|.+++... .. .+..++.+++..++-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 47899999999854333 344555543 22468999999865 899887532 11 345788999999999
Q ss_pred hhcCCCCCceeccCCCCCeeecC-------CCCeEEeeccCce
Q 044022 81 LHFGFPRPIVLRNFKTQNILFNE-------ENVAKWFDFLLSI 116 (241)
Q Consensus 81 lh~~~~~~ivh~dl~~~nil~~~-------~~~~~l~df~~~~ 116 (241)
|| ..|++|+|+++.|||++. +..+.++||+.+.
T Consensus 154 LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 154 MH---AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HH---HCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99 999999999999999975 4678999998774
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=4.7e-10 Score=96.49 Aligned_cols=148 Identities=19% Similarity=0.224 Sum_probs=97.3
Q ss_pred HHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcce-------eecccccCCCccCccccc
Q 044022 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI-------TTDRVIGTRGYSAPEYIS 143 (241)
Q Consensus 71 ~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~ 143 (241)
+.+.+.|+.|+|. +.++||++|.|++|.++..+.+||+.|+++.......... .........-|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3455689999997 7789999999999999999999999999887554421110 001112335589999999
Q ss_pred ccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHH
Q 044022 144 ICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASA 222 (241)
Q Consensus 144 ~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (241)
+...++++|++|+|+++|.+.. |+..+.. ... ............-+ ...... .-+.+++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a-~~~-----~~~~~~~~~~~~~~------~~~~s~--------~~p~el~ 242 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAA-NGG-----LLSYSFSRNLLNAG------AFGYSN--------NLPSELR 242 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhc-cCC-----cchhhhhhcccccc------cccccc--------cCcHHHH
Confidence 9888999999999999999995 4443322 111 01111111111000 000011 2225678
Q ss_pred HHHHHhccCCCCCCCCCC
Q 044022 223 QLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 223 ~l~~~cl~~~p~~Rpt~~ 240 (241)
+=+.+++..++..||++.
T Consensus 243 ~~l~k~l~~~~~~rp~~~ 260 (700)
T KOG2137|consen 243 ESLKKLLNGDSAVRPTLD 260 (700)
T ss_pred HHHHHHhcCCcccCcchh
Confidence 888999999999999653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.85 E-value=3e-09 Score=90.12 Aligned_cols=144 Identities=20% Similarity=0.188 Sum_probs=109.1
Q ss_pred HHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcC----CCchHHHHHHHHHHHhchhhcCCCCCceec
Q 044022 18 NNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFG----APLPRLKIASDIVNSLAYLHFGFPRPIVLR 92 (241)
Q Consensus 18 ~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~lh~~~~~~ivh~ 92 (241)
.|+-+...+ -|.+.+..+..|.+-.+.++--|||+++++...... .+...+++..+++.++.++| ++.++|.
T Consensus 314 ~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~ 390 (524)
T KOG0601|consen 314 GEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHL 390 (524)
T ss_pred hhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc---chhhhcc
Confidence 455555555 688899888888888888899999999988776522 13467888999999999999 9999999
Q ss_pred cCCCCCeeecCC-CCeEEeeccCceecCCCCcceeecccccCCCc-cCcccccccCCCcchhhHHHHHHHHHHHhcCc
Q 044022 93 NFKTQNILFNEE-NVAKWFDFLLSISIPEGETHITTDRVIGTRGY-SAPEYISICVLNEKSNVFSFGAFLFELLAGRI 168 (241)
Q Consensus 93 dl~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~-~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~ 168 (241)
|++|+||++..+ +..+++||+....+........ ..+..| .++.......+..+.|++|||.-+.+.+++.+
T Consensus 391 d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~~~----~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 391 DVKPSNILISNDGFFSKLGDFGCWTRLAFSSGVFH----HIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred cccccceeeccchhhhhccccccccccceeccccc----ccccccccchhhccccccccccccccccccccccccCcc
Confidence 999999999886 7888999998764332221111 122233 35555566678889999999999999988864
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.3e-08 Score=76.60 Aligned_cols=103 Identities=14% Similarity=0.124 Sum_probs=81.4
Q ss_pred cHHHHHHHHHHHHhcCCC--cccceeeeeeeCC----cceEEEEecCC-CCHHHhhcC----CCchHHHHHHHHHHHhch
Q 044022 12 TYGSCINNITYAAQMSHN--HILKRIGCCLQTP----IPILVFQSVEY-GTLRDCIFG----APLPRLKIASDIVNSLAY 80 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~----~~~lv~e~~~~-~sL~~~l~~----~~~~~~~~~~~i~~~l~~ 80 (241)
......+|.+.+..|... ...+.+++..... ..++|+|++++ .+|.+++.. .......++.+++..++-
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence 455678899988888543 3445666665532 34899999986 479998876 233567889999999999
Q ss_pred hhcCCCCCceeccCCCCCeeecCCC---CeEEeeccCcee
Q 044022 81 LHFGFPRPIVLRNFKTQNILFNEEN---VAKWFDFLLSIS 117 (241)
Q Consensus 81 lh~~~~~~ivh~dl~~~nil~~~~~---~~~l~df~~~~~ 117 (241)
|| ..|++|+|+++.|||++.++ .+.++||+.+..
T Consensus 134 lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99 99999999999999999887 889999987754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=8.7e-08 Score=78.77 Aligned_cols=161 Identities=16% Similarity=0.174 Sum_probs=103.0
Q ss_pred HHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc--
Q 044022 67 RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-- 144 (241)
Q Consensus 67 ~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-- 144 (241)
.++.++.++.+.+-|| ..|.+-+|++++|+|+++++.+.+.|-..-..-.++... -..+|...|++||.-.-
T Consensus 119 llrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~~---~cpVg~~eftPPElQ~~~s 192 (637)
T COG4248 119 LLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLH---LCPVGVSEFTPPELQTLPS 192 (637)
T ss_pred HHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceeeccCCceE---ecccCccccCCHHHhcccc
Confidence 5788999999999999 999999999999999999999999875433222222211 23478899999996642
Q ss_pred ---cCCCcchhhHHHHHHHHHHHhc-CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccc----cCCCchhHHH
Q 044022 145 ---CVLNEKSNVFSFGAFLFELLAG-RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIV----QDIPCIEKEQ 216 (241)
Q Consensus 145 ---~~~~~~~Di~s~G~~~~~~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 216 (241)
-.-+..+|.+.+|+++++++.| +.||....-.....+..-.+. ..+.+...++.... +.... -+.
T Consensus 193 f~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I-----a~g~f~ya~~~~~g~~p~P~~~P--~~~ 265 (637)
T COG4248 193 FVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI-----AHGRFAYASDQRRGLKPPPRSIP--LSM 265 (637)
T ss_pred ccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh-----hcceeeechhccCCCCCCCCCCC--hhh
Confidence 2346789999999999998886 899865432222222221111 11111111111100 01111 123
Q ss_pred HHHHHHHHHHHhccCC--CCCCCCCC
Q 044022 217 QLHASAQLTLECVNNS--PEDRPTMV 240 (241)
Q Consensus 217 ~~~~~~~l~~~cl~~~--p~~Rpt~~ 240 (241)
-.+++..+..+|+... +.-|||++
T Consensus 266 Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 266 LPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred cCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 3467788899998653 67899874
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.75 E-value=4.2e-08 Score=75.70 Aligned_cols=105 Identities=21% Similarity=0.325 Sum_probs=75.0
Q ss_pred cHHHHHHHHHHHHhcCCC--cccceeeeeeeC---CcceEEEEecCCCCHHHhhcC---CCchHHHHHHHHHHHhchhhc
Q 044022 12 TYGSCINNITYAAQMSHN--HILKRIGCCLQT---PIPILVFQSVEYGTLRDCIFG---APLPRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~i~~~l~~lh~ 83 (241)
....+.+|+++++.+++. ++.+++.+.... +..++||||++|.++.+.+.. .......++.+++.+++.||.
T Consensus 38 ~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~ 117 (223)
T cd05154 38 SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLRPELSPEERRALARALADTLAALHS 117 (223)
T ss_pred ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhC
Confidence 456788999999999763 456677776653 367899999999888776531 111334555666666666662
Q ss_pred C-----------------------------------------------------CCCCceeccCCCCCeeecC--CCCeE
Q 044022 84 G-----------------------------------------------------FPRPIVLRNFKTQNILFNE--ENVAK 108 (241)
Q Consensus 84 ~-----------------------------------------------------~~~~ivh~dl~~~nil~~~--~~~~~ 108 (241)
. ....++|+|+.+.||+++. ++.+.
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~ 197 (223)
T cd05154 118 VDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVA 197 (223)
T ss_pred CChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEE
Confidence 1 1345799999999999998 56688
Q ss_pred EeeccCce
Q 044022 109 WFDFLLSI 116 (241)
Q Consensus 109 l~df~~~~ 116 (241)
|+||+.+.
T Consensus 198 iID~e~~~ 205 (223)
T cd05154 198 VLDWELAT 205 (223)
T ss_pred EEeccccc
Confidence 99998774
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.69 E-value=6.7e-08 Score=83.52 Aligned_cols=103 Identities=13% Similarity=0.091 Sum_probs=67.2
Q ss_pred HHHHHHHHHHhcC----CCcccceeeeeee-CCcceEEEEecCCCCHHHh--hcCCCchHHHHHHHHHHH-hchhhcCCC
Q 044022 15 SCINNITYAAQMS----HNHILKRIGCCLQ-TPIPILVFQSVEYGTLRDC--IFGAPLPRLKIASDIVNS-LAYLHFGFP 86 (241)
Q Consensus 15 ~~~~e~~~l~~l~----h~~iv~~~~~~~~-~~~~~lv~e~~~~~sL~~~--l~~~~~~~~~~~~~i~~~-l~~lh~~~~ 86 (241)
+|.+|+..+.+++ +.+.+.+-.++.+ ....++||||+.|+++.+. +.........++...+.. +.-+. .
T Consensus 202 D~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif---~ 278 (537)
T PRK04750 202 DLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF---R 278 (537)
T ss_pred CHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH---h
Confidence 3566766666663 4444444343332 3456899999999999874 333332222333322222 22234 6
Q ss_pred CCceeccCCCCCeeecCCC----CeEEeeccCceecCC
Q 044022 87 RPIVLRNFKTQNILFNEEN----VAKWFDFLLSISIPE 120 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~----~~~l~df~~~~~~~~ 120 (241)
.|++|+|++|.||+++.++ .+++.|||.....+.
T Consensus 279 ~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 279 DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 7999999999999999888 999999999987654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.6e-06 Score=65.84 Aligned_cols=102 Identities=11% Similarity=0.100 Sum_probs=77.5
Q ss_pred cHHHHHHHHHHHHhcCCCc--ccceeeeeeeC-----CcceEEEEecC-CCCHHHhhcCCCc------hHHHHHHHHHHH
Q 044022 12 TYGSCINNITYAAQMSHNH--ILKRIGCCLQT-----PIPILVFQSVE-YGTLRDCIFGAPL------PRLKIASDIVNS 77 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~-----~~~~lv~e~~~-~~sL~~~l~~~~~------~~~~~~~~i~~~ 77 (241)
....|.+|+..+++|...+ +.+.. ++... -..++|+|-+. ..+|.+++..... .+..++.+++..
T Consensus 62 g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ 140 (216)
T PRK09902 62 GRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALA 140 (216)
T ss_pred CchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHH
Confidence 6778999999999995433 33333 33211 14579999775 3589988865322 356889999999
Q ss_pred hchhhcCCCCCceeccCCCCCeeecCCCC--eEEeeccCcee
Q 044022 78 LAYLHFGFPRPIVLRNFKTQNILFNEENV--AKWFDFLLSIS 117 (241)
Q Consensus 78 l~~lh~~~~~~ivh~dl~~~nil~~~~~~--~~l~df~~~~~ 117 (241)
++-|| ..++.|+|+.+.||+++..+. +.++||..++.
T Consensus 141 ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 141 FKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 99999 999999999999999986677 89999977653
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.5e-06 Score=73.19 Aligned_cols=128 Identities=16% Similarity=0.223 Sum_probs=96.6
Q ss_pred HHHHHHHhcCCCcccceeeeeee----CCcceEEEEecCC-CCHHHhhcCCC-------------------chHHHHHHH
Q 044022 18 NNITYAAQMSHNHILKRIGCCLQ----TPIPILVFQSVEY-GTLRDCIFGAP-------------------LPRLKIASD 73 (241)
Q Consensus 18 ~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~-~sL~~~l~~~~-------------------~~~~~~~~~ 73 (241)
.-++.++++.|+|+|++.++|.. ...+++|++|+++ ++|.+.-.... ...+.++.|
T Consensus 322 ~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~Q 401 (655)
T KOG3741|consen 322 SLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQ 401 (655)
T ss_pred HHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHH
Confidence 45888999999999999998873 3367999999863 68877643321 124678999
Q ss_pred HHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhh
Q 044022 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNV 153 (241)
Q Consensus 74 i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 153 (241)
+..||.++| +.|+.-+-|.+.+|+++.+.+++|+..|..-...... .+| + ....+-|.
T Consensus 402 LtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~--------------~~~--l---e~~Qq~D~ 459 (655)
T KOG3741|consen 402 LTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP--------------TEP--L---ESQQQNDL 459 (655)
T ss_pred HHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecCCC--------------Ccc--h---hHHhhhhH
Confidence 999999999 8999999999999999999888887766554332221 011 1 11245688
Q ss_pred HHHHHHHHHHHhcC
Q 044022 154 FSFGAFLFELLAGR 167 (241)
Q Consensus 154 ~s~G~~~~~~~~g~ 167 (241)
-.||.+++.+.+|.
T Consensus 460 ~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 460 RDLGLLLLALATGT 473 (655)
T ss_pred HHHHHHHHHHhhcc
Confidence 89999999999985
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=2.3e-06 Score=66.77 Aligned_cols=99 Identities=16% Similarity=0.114 Sum_probs=69.7
Q ss_pred cHHHHHHHHHHHHhcCCC--cccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhhcCCCCCc
Q 044022 12 TYGSCINNITYAAQMSHN--HILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPI 89 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~~~i 89 (241)
......+|.++|++|... .+.+.+++ +..++|||+.+|-.|...-- .....-.++..|+..+...- ..|+
T Consensus 152 sRl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-~~en~~~il~~il~~~~~~~---~~Gi 223 (304)
T COG0478 152 SRLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL-DVENPDEILDKILEEVRKAY---RRGI 223 (304)
T ss_pred HHHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC-cccCHHHHHHHHHHHHHHHH---HcCc
Confidence 345578899999999654 66666654 35689999999866665431 11122234444444444444 5789
Q ss_pred eeccCCCCCeeecCCCCeEEeeccCceec
Q 044022 90 VLRNFKTQNILFNEENVAKWFDFLLSISI 118 (241)
Q Consensus 90 vh~dl~~~nil~~~~~~~~l~df~~~~~~ 118 (241)
||+|+++-||+++.+|.+.++||-.+.+.
T Consensus 224 VHGDlSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 224 VHGDLSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred cccCCchheEEEecCCCEEEEeCcccccC
Confidence 99999999999999999999999766543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.31 E-value=3.2e-06 Score=63.65 Aligned_cols=98 Identities=20% Similarity=0.176 Sum_probs=78.6
Q ss_pred HHHHHHHHhcCC-CcccceeeeeeeCCcceEEEEecCCCCH-------HHhhcCCCchHHHHHHHHHHHhchhhcCCCCC
Q 044022 17 INNITYAAQMSH-NHILKRIGCCLQTPIPILVFQSVEYGTL-------RDCIFGAPLPRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 17 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~sL-------~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
.+|.-+++.|++ +++++++|+| + ..+|.|+...+++ .++....-..+.+++.+++..+.+|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C---G-~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC---G-RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC---C-CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888999976 6999999999 2 2568899976654 34444444478999999999999999655567
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceec
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISI 118 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~ 118 (241)
+.-+|++++|+.++.++.+|++|.+.....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 889999999999999999999999776543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.25 E-value=4e-06 Score=63.96 Aligned_cols=66 Identities=18% Similarity=0.140 Sum_probs=51.6
Q ss_pred cceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCce
Q 044022 43 IPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSI 116 (241)
Q Consensus 43 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~ 116 (241)
..+++|||++|..|.+...-.. .++..+.+++.-+| +.|++|+|..|.|++++.++ ++++||+..+
T Consensus 117 ~~~ll~EYIeG~~l~d~~~i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIEDIDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred EEEEEEEEecCeecccchhcCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 4568999999988876543211 24456778899999 99999999999999998554 8999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.3e-05 Score=60.71 Aligned_cols=46 Identities=7% Similarity=-0.154 Sum_probs=34.7
Q ss_pred HHHHHHHHHHHhcC-CCcccceeeeeeeCCcceEEEEecCCCCHHHh
Q 044022 14 GSCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDC 59 (241)
Q Consensus 14 ~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~ 59 (241)
.+..+|+++++.+. +--+.+++++....+..++|||+++|.+|...
T Consensus 36 ~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 36 YELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 45678999999984 33455677777666678999999998887654
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.07 E-value=4.5e-05 Score=57.77 Aligned_cols=96 Identities=22% Similarity=0.273 Sum_probs=71.5
Q ss_pred cHHHHHHHHHHHHhcC------CCcccceeeeeeeCCcceEEEEecC------CCCHHHhhcCCCchHHHHHHHHHHHhc
Q 044022 12 TYGSCINNITYAAQMS------HNHILKRIGCCLQTPIPILVFQSVE------YGTLRDCIFGAPLPRLKIASDIVNSLA 79 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~lv~e~~~------~~sL~~~l~~~~~~~~~~~~~i~~~l~ 79 (241)
..++..+|+....++. +.+|.+++|+..++.-.-+|+|... ..||.++++...... .+...+-.-..
T Consensus 54 ~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~~~L~~f~~ 132 (199)
T PF10707_consen 54 RYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-ELRQALDEFKR 132 (199)
T ss_pred hhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HHHHHHHHHHH
Confidence 4677788888888877 7799999999998887888999753 247888887665543 34444444455
Q ss_pred hhhcCCCCCceeccCCCCCeeecCCC----CeEEee
Q 044022 80 YLHFGFPRPIVLRNFKTQNILFNEEN----VAKWFD 111 (241)
Q Consensus 80 ~lh~~~~~~ivh~dl~~~nil~~~~~----~~~l~d 111 (241)
+|- +..|+.+|++|.||++.... .+.|+|
T Consensus 133 ~l~---~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 133 YLL---DHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHH---HcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 666 78899999999999996442 467777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.04 E-value=2e-06 Score=74.25 Aligned_cols=144 Identities=17% Similarity=0.095 Sum_probs=105.3
Q ss_pred HHHHHHHHHhcCCCc-ccceeeeeeeCCcceEEEEecCCC-CHHHhhcCCC-----chHHHHHHHHHHHhchhhcCCCCC
Q 044022 16 CINNITYAAQMSHNH-ILKRIGCCLQTPIPILVFQSVEYG-TLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 16 ~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
..-++++|.+++||| .+..++.+..+...+++++++.++ +-..-....+ .+.....+.-..+++++| +..
T Consensus 280 ~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~---~~~ 356 (829)
T KOG0576|consen 280 RRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELH---SSY 356 (829)
T ss_pred hHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccc---ccc
Confidence 345889999999999 777788888888899999999766 2222222111 123445666778899999 555
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCc
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRI 168 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~ 168 (241)
-+|+| ||+... +..+.++|+....+.... ......+++.|+|||+.....+....|.|+.|.-..++.-|-+
T Consensus 357 ~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~p 428 (829)
T KOG0576|consen 357 KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLP 428 (829)
T ss_pred ccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCC
Confidence 67888 666554 677899998876665543 2344578999999999999999999999999976666766766
Q ss_pred cc
Q 044022 169 HI 170 (241)
Q Consensus 169 p~ 170 (241)
|-
T Consensus 429 Pr 430 (829)
T KOG0576|consen 429 PR 430 (829)
T ss_pred CC
Confidence 54
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.00 E-value=5e-05 Score=59.01 Aligned_cols=103 Identities=10% Similarity=0.032 Sum_probs=62.0
Q ss_pred HHHHHHHHHHHHhcCCCc--ccceeeeeeeCCcceEEEEecCCCC-HHHhhcCCCc------------------------
Q 044022 13 YGSCINNITYAAQMSHNH--ILKRIGCCLQTPIPILVFQSVEYGT-LRDCIFGAPL------------------------ 65 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~s-L~~~l~~~~~------------------------ 65 (241)
.....+|.++++.+..-. +.+.+++....+...+|||+++|.+ +...+.....
T Consensus 36 ~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~ 115 (226)
T TIGR02172 36 KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTS 115 (226)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 445688999999986433 4567777777777889999998753 2222211100
Q ss_pred ---h-HHHHHHH----------HHHH-hchhhc-CCCCCceeccCCCCCeeecCCCCeEEeeccCce
Q 044022 66 ---P-RLKIASD----------IVNS-LAYLHF-GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSI 116 (241)
Q Consensus 66 ---~-~~~~~~~----------i~~~-l~~lh~-~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~ 116 (241)
. ...+..+ +... ..+|.. .....++|+|+.|.|++++.++ +.++||+.+.
T Consensus 116 ~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 116 TFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 0 0001000 0011 111110 1133468999999999999888 9999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00033 Score=60.65 Aligned_cols=103 Identities=14% Similarity=0.102 Sum_probs=69.1
Q ss_pred HHHHHHHHHHhcC----CCcccceeeeee-eCCcceEEEEecCCCCHHHh--hcCCCchHHHHHHHHHHHh-chhhcCCC
Q 044022 15 SCINNITYAAQMS----HNHILKRIGCCL-QTPIPILVFQSVEYGTLRDC--IFGAPLPRLKIASDIVNSL-AYLHFGFP 86 (241)
Q Consensus 15 ~~~~e~~~l~~l~----h~~iv~~~~~~~-~~~~~~lv~e~~~~~sL~~~--l~~~~~~~~~~~~~i~~~l-~~lh~~~~ 86 (241)
.+.+|+..+.+++ +..-+.+=.+++ -.+.-.++|||+.|..+.+. ++..+..+..++..++.+. ..+- .
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~---~ 283 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL---R 283 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH---h
Confidence 4667888777773 222223323332 34556899999999999887 4444444334444333321 2222 5
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCC
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPE 120 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~ 120 (241)
.|+.|+|..|-||+++.++.+.+.|||.......
T Consensus 284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 7899999999999999999999999999877653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00094 Score=52.15 Aligned_cols=31 Identities=16% Similarity=0.184 Sum_probs=25.8
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCce
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSI 116 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~ 116 (241)
...++|+|+.+.|++++......|+||+.+.
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 4458999999999999877666799998763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00057 Score=63.37 Aligned_cols=148 Identities=15% Similarity=0.154 Sum_probs=97.6
Q ss_pred HHHHHHHHHhcCCCcccceeeeeeeCCc----ceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCC
Q 044022 16 CINNITYAAQMSHNHILKRIGCCLQTPI----PILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 16 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
-..|...+..+.|+|++.++.|-.+... ..+..+++...++...++.-.. ....+..++..|++++| +.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h---~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH---SL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH---Hh
Confidence 3457778888899999999988776542 2344567777777776655432 33456778999999999 55
Q ss_pred CceeccCCCC---CeeecCCCCeEEe--eccCceecCCCCcceeecccccCCCccCcccccccCCCc--chhhHHHHHHH
Q 044022 88 PIVLRNFKTQ---NILFNEENVAKWF--DFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNE--KSNVFSFGAFL 160 (241)
Q Consensus 88 ~ivh~dl~~~---nil~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~--~~Di~s~G~~~ 160 (241)
...|.-+... +-..+..+...++ ||+.+.......... ....+..+.++|......... ..|+|.+|.+.
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 5555555554 3444555666666 787776655432211 123445567788776554443 47999999999
Q ss_pred HHHHhcCcc
Q 044022 161 FELLAGRIH 169 (241)
Q Consensus 161 ~~~~~g~~p 169 (241)
..+..|..+
T Consensus 383 ~~~~~~~~i 391 (1351)
T KOG1035|consen 383 LQLSQGEDI 391 (1351)
T ss_pred hhhhhcCcc
Confidence 988887643
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00025 Score=60.47 Aligned_cols=163 Identities=18% Similarity=0.213 Sum_probs=89.9
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCC-cceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhhcCCCCCcee
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTP-IPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVL 91 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~~~ivh 91 (241)
.-+.+...++++.+.|+|+..+++...... ...+|+|++ +.||++.+.........+. .+++.|
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~~s~~--------------~~~~~~ 90 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKDESLL--------------AHGVLH 90 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccchhhhc--------------ccccce
Confidence 345667788899999999999988775432 468999999 4899998875442111111 112222
Q ss_pred ccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCcccc
Q 044022 92 RNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIW 171 (241)
Q Consensus 92 ~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~ 171 (241)
.|+ .+++|- .. +. | | ....+++||||+|.++.++.-|..-+.
T Consensus 91 -----~~~-------~~~td~-~~---t~---------------~--~-----~~~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 91 -----LNI-------IYITDH-FL---TK---------------Y--P-----SPIGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred -----ehh-------hhcccc-cc---cc---------------C--C-----CCCCcchhhhhHHHHHHHHHHhhHHHH
Confidence 111 222330 00 00 0 0 111259999999999999998876553
Q ss_pred cccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 172 DLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
.. ...+......+....... ...-...+...-.+.+.+..+...|+-..|..||...
T Consensus 133 ~~---------~~s~~l~~i~k~~~~d~~---~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~ 189 (725)
T KOG1093|consen 133 EL---------TESEYLEILLKYYTDDQE---LLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPM 189 (725)
T ss_pred HH---------HHHHHHHHHHHhccCchh---HHHHHHHHHHHHhhhHhHHHHhccCCccccccccchh
Confidence 31 111222222211110000 0000000011124456778999999999999999653
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00049 Score=59.56 Aligned_cols=102 Identities=14% Similarity=0.070 Sum_probs=68.9
Q ss_pred HHHHHHHHHHHhc----CCCc------ccceeeeeeeCCcceEEEEecCCCCHHHh--hcCCCchHHHHHHHHHHHhch-
Q 044022 14 GSCINNITYAAQM----SHNH------ILKRIGCCLQTPIPILVFQSVEYGTLRDC--IFGAPLPRLKIASDIVNSLAY- 80 (241)
Q Consensus 14 ~~~~~e~~~l~~l----~h~~------iv~~~~~~~~~~~~~lv~e~~~~~sL~~~--l~~~~~~~~~~~~~i~~~l~~- 80 (241)
-.|.+|++...++ +|-+ |.+++..+ .....++||||.|..+.+. +.+.......++..+.++...
T Consensus 239 LDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q 316 (538)
T KOG1235|consen 239 LDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ 316 (538)
T ss_pred cchHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH
Confidence 3467777666665 4544 33333333 3346899999999877664 555555555666665555443
Q ss_pred hhcCCCCCceeccCCCCCeeecC----CCCeEEeeccCceecCC
Q 044022 81 LHFGFPRPIVLRNFKTQNILFNE----ENVAKWFDFLLSISIPE 120 (241)
Q Consensus 81 lh~~~~~~ivh~dl~~~nil~~~----~~~~~l~df~~~~~~~~ 120 (241)
+- ..|++|+|=.|-||++.. +..+.+-|||+....+.
T Consensus 317 If---~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 317 IF---KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HH---hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 22 567999999999999984 67889999999876543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00092 Score=51.96 Aligned_cols=96 Identities=15% Similarity=0.144 Sum_probs=61.3
Q ss_pred HHHHHHHHHhcC--CCcccceeeeeeeCCcceEEEEecCCC-----CHHHhhcCCCchHHHHHHHHHHHhchhhcCCCCC
Q 044022 16 CINNITYAAQMS--HNHILKRIGCCLQTPIPILVFQSVEYG-----TLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 16 ~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~-----sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
..+|+..|.++. +-.+.+-+++. ...+||||+... .|.+.-.... ....+..+++..+.-|-. ..+
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~-e~~~~~~~~v~~~~~l~~--~a~ 187 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELE-EAEGLYEDVVEYMRRLYK--EAG 187 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccCCcCch-hHHHHHHHHHHHHHHHHH--hcC
Confidence 345676676663 22333333332 457999998432 2222211111 244566677777777651 489
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecC
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIP 119 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~ 119 (241)
+||+||+.-|||+. ++.+.|+|++.+....
T Consensus 188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99999999999999 8899999999886543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0016 Score=60.27 Aligned_cols=44 Identities=9% Similarity=0.132 Sum_probs=33.5
Q ss_pred HHHHHHHHHHHHhcC-CCcc--cceeeeeeeC---CcceEEEEecCCCCH
Q 044022 13 YGSCINNITYAAQMS-HNHI--LKRIGCCLQT---PIPILVFQSVEYGTL 56 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~~~~lv~e~~~~~sL 56 (241)
...+.+|+++++.+. |.++ .+++.+|... +..++||||++|..+
T Consensus 82 ~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 82 AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence 456889999999995 6665 6777777654 467899999987653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0014 Score=50.70 Aligned_cols=105 Identities=16% Similarity=0.233 Sum_probs=57.0
Q ss_pred cHHHHHHHHHHHHhcCCC--cccceeeeeee---CCcceEEEEecCCCCHHH----------------hhc---CC----
Q 044022 12 TYGSCINNITYAAQMSHN--HILKRIGCCLQ---TPIPILVFQSVEYGTLRD----------------CIF---GA---- 63 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~---~~~~~lv~e~~~~~sL~~----------------~l~---~~---- 63 (241)
....+.+|..+++.|... .+.+++..... ....+++|++++|.++.. .+. ..
T Consensus 33 ~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~ 112 (239)
T PF01636_consen 33 AAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPF 112 (239)
T ss_dssp HHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTC
T ss_pred CHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccccccccccchhhhhhcccccccc
Confidence 456778899999988533 24566654432 335689999999887777 110 00
Q ss_pred -Cc---h--HH-------HH------------HHHHHH-Hhchhh----cCCCCCceeccCCCCCeeec-CCCCeEEeec
Q 044022 64 -PL---P--RL-------KI------------ASDIVN-SLAYLH----FGFPRPIVLRNFKTQNILFN-EENVAKWFDF 112 (241)
Q Consensus 64 -~~---~--~~-------~~------------~~~i~~-~l~~lh----~~~~~~ivh~dl~~~nil~~-~~~~~~l~df 112 (241)
.. . .. .. ...+.. .+..++ ......++|+|+.+.||+++ .++.+.|+||
T Consensus 113 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~ 192 (239)
T PF01636_consen 113 SPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDF 192 (239)
T ss_dssp CCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--G
T ss_pred cccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEec
Confidence 00 0 00 00 011111 222222 11256799999999999999 5566679999
Q ss_pred cCce
Q 044022 113 LLSI 116 (241)
Q Consensus 113 ~~~~ 116 (241)
+.+.
T Consensus 193 e~a~ 196 (239)
T PF01636_consen 193 EDAG 196 (239)
T ss_dssp TT-E
T ss_pred ccce
Confidence 8664
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0056 Score=48.45 Aligned_cols=29 Identities=10% Similarity=0.154 Sum_probs=25.2
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCce
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSI 116 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~ 116 (241)
..++|+|+.|.||+++.++ +.++||+.+.
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 3589999999999999877 7899998774
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0059 Score=49.35 Aligned_cols=31 Identities=23% Similarity=0.568 Sum_probs=27.1
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCce
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSI 116 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~ 116 (241)
..+++|+|+.|.|++++.++.+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 4579999999999999988777899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.00053 Score=65.51 Aligned_cols=147 Identities=11% Similarity=-0.100 Sum_probs=101.1
Q ss_pred HHHhcCCCcccceeeeee--eCCcceEEEEecCCCCHHHhhcCCCc--------hHHHHHHHHHHHhchhhcC--CCCCc
Q 044022 22 YAAQMSHNHILKRIGCCL--QTPIPILVFQSVEYGTLRDCIFGAPL--------PRLKIASDIVNSLAYLHFG--FPRPI 89 (241)
Q Consensus 22 ~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~--------~~~~~~~~i~~~l~~lh~~--~~~~i 89 (241)
-++...|++++....=.. ....-+.+++++.+|.+.+.+-+... .......+...+..-+|+. .+.-.
T Consensus 1282 e~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~ 1361 (2724)
T KOG1826|consen 1282 ELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTN 1361 (2724)
T ss_pred hhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccc
Confidence 344457887776654333 23356788999999999998755421 1222222324444444422 23346
Q ss_pred eeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCcc
Q 044022 90 VLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIH 169 (241)
Q Consensus 90 vh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p 169 (241)
+|+++++.|.++..+-.++++++|+.+...... ...+..++++.|++|+......++.++|+|..|+..|....|..+
T Consensus 1362 v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~ 1439 (2724)
T KOG1826|consen 1362 VSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAY 1439 (2724)
T ss_pred hhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHH
Confidence 899999999999999999999999987322221 122445678888899988888888889999999999998887766
Q ss_pred c
Q 044022 170 I 170 (241)
Q Consensus 170 ~ 170 (241)
|
T Consensus 1440 f 1440 (2724)
T KOG1826|consen 1440 F 1440 (2724)
T ss_pred H
Confidence 5
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.03 Score=45.63 Aligned_cols=32 Identities=16% Similarity=0.354 Sum_probs=28.2
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCcee
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSIS 117 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~ 117 (241)
...++|+|+.+.|++++...-+-|.||+.+..
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 44689999999999999998899999998854
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.012 Score=48.49 Aligned_cols=71 Identities=23% Similarity=0.169 Sum_probs=51.1
Q ss_pred cceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCcee
Q 044022 43 IPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSIS 117 (241)
Q Consensus 43 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~ 117 (241)
..|++|++. |+++...-.....+.+.++.+.+.-+.-+.. +-..-||++.-.||+++ +|++.|+||-+++.
T Consensus 300 y~yl~~kdh-gt~is~ik~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 300 YLYLHFKDH-GTPISIIKADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred EEEEEEecC-CceeeeeecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeec
Confidence 456677765 5666544333344667777776666665553 45678999999999999 99999999999873
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.041 Score=45.62 Aligned_cols=31 Identities=13% Similarity=0.219 Sum_probs=26.3
Q ss_pred CCCceeccCCCCCeeecC-CCCeEEeeccCce
Q 044022 86 PRPIVLRNFKTQNILFNE-ENVAKWFDFLLSI 116 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~-~~~~~l~df~~~~ 116 (241)
...++|+|+++.||+++. ++.+.++||..+.
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 446899999999999986 4679999998774
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.012 Score=47.85 Aligned_cols=96 Identities=14% Similarity=0.167 Sum_probs=64.0
Q ss_pred HHHHHHHHHHHhc-CCCccc-ceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-hHHHHHHHHHHHhchhhcCCCCCce
Q 044022 14 GSCINNITYAAQM-SHNHIL-KRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-PRLKIASDIVNSLAYLHFGFPRPIV 90 (241)
Q Consensus 14 ~~~~~e~~~l~~l-~h~~iv-~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~~l~~lh~~~~~~iv 90 (241)
-+..+|+..|+.| .|..=| +.++ .+..|+|||++.|-.|.+.-+-..+ +...- +..-+--|. .+|++
T Consensus 155 laa~kEfafmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~---lm~~Iv~la---~~GlI 224 (465)
T KOG2268|consen 155 LAATKEFAFMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRHVEDPPTLYDD---LMGLIVRLA---NHGLI 224 (465)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeeecCChHHHHHH---HHHHHHHHH---HcCce
Confidence 3456788888888 343322 3333 3456899999988888765533222 22222 222222344 89999
Q ss_pred eccCCCCCeeecCCCCeEEeeccCceecC
Q 044022 91 LRNFKTQNILFNEENVAKWFDFLLSISIP 119 (241)
Q Consensus 91 h~dl~~~nil~~~~~~~~l~df~~~~~~~ 119 (241)
|+|.+-=||++..++.++++||-...+.+
T Consensus 225 HgDFNEFNimv~dd~~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 225 HGDFNEFNIMVKDDDKIVVIDFPQMVSTS 253 (465)
T ss_pred ecccchheeEEecCCCEEEeechHhhccC
Confidence 99999999999999999999997665443
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.053 Score=44.72 Aligned_cols=30 Identities=20% Similarity=0.316 Sum_probs=25.4
Q ss_pred CceeccCCCCCeeecC-CCCeEEeeccCcee
Q 044022 88 PIVLRNFKTQNILFNE-ENVAKWFDFLLSIS 117 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~-~~~~~l~df~~~~~ 117 (241)
-+.|.|+.+.||+++. ++.++++||+.+..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 3689999999999975 57899999988753
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.091 Score=39.92 Aligned_cols=86 Identities=23% Similarity=0.223 Sum_probs=62.4
Q ss_pred HHHHHHHHHHHHhcC---CCcc--cceeeeeeeC------------------CcceEEEEecCCCCHHHhhcCCCchHHH
Q 044022 13 YGSCINNITYAAQMS---HNHI--LKRIGCCLQT------------------PIPILVFQSVEYGTLRDCIFGAPLPRLK 69 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~---h~~i--v~~~~~~~~~------------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 69 (241)
..-|..|.+...+|+ +.++ |+++||..-. ..+.||.||.+... ....+
T Consensus 98 ~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~ 168 (207)
T PF13095_consen 98 ADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR 168 (207)
T ss_pred cChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh
Confidence 346888988888884 3466 8999998522 13457777765433 12334
Q ss_pred HHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCc
Q 044022 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLS 115 (241)
Q Consensus 70 ~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~ 115 (241)
-+.+|.+-+..+| ..||+-+|+++.|.. .-+|+|||.+
T Consensus 169 ~~~~~~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 169 DIPQMLRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 5667888889999 999999999999987 3488999754
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.11 Score=38.67 Aligned_cols=96 Identities=6% Similarity=-0.045 Sum_probs=62.2
Q ss_pred cHHHHHHHHHHHHhcCCCcccc-eeeeeeeCCcceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhhcCCCCCce
Q 044022 12 TYGSCINNITYAAQMSHNHILK-RIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIV 90 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~~~iv 90 (241)
-...+..|+++|..+.-.++.+ ++.+- . -.+.|||..|.+|...-...... -+..+++..--|- ..||-
T Consensus 58 ~r~~l~kEakiLeil~g~~~~p~vy~yg--~--~~i~me~i~G~~L~~~~~~~~rk---~l~~vlE~a~~LD---~~GI~ 127 (201)
T COG2112 58 PRRNLEKEAKILEILAGEGVTPEVYFYG--E--DFIRMEYIDGRPLGKLEIGGDRK---HLLRVLEKAYKLD---RLGIE 127 (201)
T ss_pred chhhHHHHHHHHHHhhhcCCCceEEEec--h--hhhhhhhhcCcchhhhhhcccHH---HHHHHHHHHHHHH---Hhccc
Confidence 3567889999999998766654 44442 2 23459999988888765543222 2223333333344 67788
Q ss_pred eccCC-CCCeeecCCCCeEEeeccCcee
Q 044022 91 LRNFK-TQNILFNEENVAKWFDFLLSIS 117 (241)
Q Consensus 91 h~dl~-~~nil~~~~~~~~l~df~~~~~ 117 (241)
|+.|+ |...++..++.+.|+||..+..
T Consensus 128 H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 128 HGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhcCCceeEEecCCcEEEEEccchhh
Confidence 88886 4555555566899999988763
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.88 E-value=0.053 Score=41.85 Aligned_cols=74 Identities=16% Similarity=0.165 Sum_probs=48.9
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhH
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
+.+|.-.|++ ..+.+|+|..|+||+-|+.|-+||.|-+....- +.-|.--|+ ...++++++-
T Consensus 151 i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~--------------~V~~vN~~Y---~~lT~~aE~~ 212 (308)
T PF07387_consen 151 IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN--------------QVNMVNIEY---ESLTQEAEVK 212 (308)
T ss_pred HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhhh--------------eeeEEeeec---cccChHHHHH
Confidence 3566777854 677999999999999999999999996544210 000111111 2345677777
Q ss_pred HHHHHHHHHHhc
Q 044022 155 SFGAFLFELLAG 166 (241)
Q Consensus 155 s~G~~~~~~~~g 166 (241)
+|-.-+++++..
T Consensus 213 ~fv~s~l~~v~~ 224 (308)
T PF07387_consen 213 VFVKSCLKLVEK 224 (308)
T ss_pred HHHHHHHHHHHH
Confidence 776666676664
|
The function of this family is unknown. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.86 E-value=0.049 Score=44.54 Aligned_cols=32 Identities=22% Similarity=0.605 Sum_probs=27.2
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCcee
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSIS 117 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~ 117 (241)
..+++|+|+.+.||+++.+....|+||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 56899999999999999766668999988743
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=93.42 E-value=0.16 Score=40.95 Aligned_cols=44 Identities=11% Similarity=0.032 Sum_probs=28.2
Q ss_pred ccHHHHHHHHHHHHhcC--C-CcccceeeeeeeCCcceEEEEecCCC
Q 044022 11 HTYGSCINNITYAAQMS--H-NHILKRIGCCLQTPIPILVFQSVEYG 54 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~--h-~~iv~~~~~~~~~~~~~lv~e~~~~~ 54 (241)
....-|..|..-|+.|. . -.+.+++++....+..++|+||++.+
T Consensus 51 ~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 51 SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 34566889999999993 3 35668888887777789999998765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.35 E-value=0.079 Score=41.18 Aligned_cols=31 Identities=26% Similarity=0.474 Sum_probs=26.6
Q ss_pred CCCceeccCCCCCeeecC-CCCeEEeeccCce
Q 044022 86 PRPIVLRNFKTQNILFNE-ENVAKWFDFLLSI 116 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~-~~~~~l~df~~~~ 116 (241)
...++|+|+.+.||+++. ++.+.++||..+.
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 346899999999999998 5789999998763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.34 E-value=0.078 Score=42.98 Aligned_cols=31 Identities=19% Similarity=0.256 Sum_probs=27.0
Q ss_pred CCCceeccCCCCCeeecCC----CCeEEeeccCce
Q 044022 86 PRPIVLRNFKTQNILFNEE----NVAKWFDFLLSI 116 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~----~~~~l~df~~~~ 116 (241)
...++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 5568999999999999985 889999998773
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.30 E-value=0.47 Score=39.99 Aligned_cols=29 Identities=17% Similarity=0.052 Sum_probs=23.7
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCce
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSI 116 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~ 116 (241)
....|.|+-+.||+.+. +.+.++||..+.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 45689999999998754 568999998774
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=93.29 E-value=0.072 Score=43.37 Aligned_cols=31 Identities=26% Similarity=0.573 Sum_probs=27.5
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCce
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSI 116 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~ 116 (241)
..+++|+|+.+.|++++.++.+.|+||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 5789999999999999988877899998774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=92.32 E-value=0.094 Score=40.14 Aligned_cols=30 Identities=23% Similarity=0.308 Sum_probs=21.0
Q ss_pred CCceeccCCCCCeee-cCCCCeEEeeccCce
Q 044022 87 RPIVLRNFKTQNILF-NEENVAKWFDFLLSI 116 (241)
Q Consensus 87 ~~ivh~dl~~~nil~-~~~~~~~l~df~~~~ 116 (241)
..+.|+|+.+.||++ +.++.++++||..+.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 357899999999999 888999999998774
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.22 E-value=0.14 Score=38.50 Aligned_cols=30 Identities=7% Similarity=0.118 Sum_probs=25.4
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCcee
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSIS 117 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~ 117 (241)
...+|+|+.|.|++++.++ ++++||+.+..
T Consensus 77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 3468999999999998777 88999998753
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=92.19 E-value=0.25 Score=39.44 Aligned_cols=46 Identities=9% Similarity=0.058 Sum_probs=34.7
Q ss_pred HHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCce
Q 044022 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSI 116 (241)
Q Consensus 70 ~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~ 116 (241)
.+..+-.++.-.+.. ..-++|+|+.|.|++.+..+.+.|+||..+.
T Consensus 137 ~~~~l~~~l~~~~~~-~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 137 KLKELRRALEEVPKD-DLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHhhhcCCC-ceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence 344455555555521 1358999999999999999999999998774
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=91.28 E-value=0.19 Score=40.84 Aligned_cols=30 Identities=23% Similarity=0.336 Sum_probs=25.7
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCce
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSI 116 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~ 116 (241)
..+++|+|+.+.|++++. +.+.++||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 467899999999999987 678899998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=91.15 E-value=1.7 Score=33.97 Aligned_cols=55 Identities=15% Similarity=0.138 Sum_probs=39.4
Q ss_pred ccccccccccHHHHHHHHHHHHhcCC---CcccceeeeeeeCCcceEEEEecCCCCHH
Q 044022 3 FYGHEYHRHTYGSCINNITYAAQMSH---NHILKRIGCCLQTPIPILVFQSVEYGTLR 57 (241)
Q Consensus 3 ~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~~~~~lv~e~~~~~sL~ 57 (241)
+|.+...+....-|..|+.-|..|.- -++.+++.+-...++.++|+||++.+.+.
T Consensus 42 ~FvK~n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 42 FFVKCNQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred eEEEecchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 34444444555678889998888843 34567777777788999999999876654
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.13 E-value=0.53 Score=38.19 Aligned_cols=69 Identities=12% Similarity=0.103 Sum_probs=47.9
Q ss_pred HHHHHHHHHHHHhcCC---Ccccceeeeeee---CCcceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhh
Q 044022 13 YGSCINNITYAAQMSH---NHILKRIGCCLQ---TPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLH 82 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h---~~iv~~~~~~~~---~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh 82 (241)
...|.+|...|+.|.- -.+.++++++.. .+..++|||+++++++.+. ...+.....+...++.+++-||
T Consensus 51 ~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~~~-~~~~~~~~~l~~~l~~~La~LH 125 (297)
T PRK10593 51 PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSVEAP-ARTPERWEQLKDQIVEGLLAWH 125 (297)
T ss_pred chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEecCCC-CCCHHHHHHHHHHHHHHHHHHh
Confidence 3578899999999943 356788887754 3568999999998887652 1111123445566677777777
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.09 E-value=0.48 Score=39.04 Aligned_cols=28 Identities=21% Similarity=0.453 Sum_probs=25.4
Q ss_pred ceeccCCCCCeeecCCCC-eEEeeccCce
Q 044022 89 IVLRNFKTQNILFNEENV-AKWFDFLLSI 116 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~-~~l~df~~~~ 116 (241)
++|+|+.|.||+++.+.. +.++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999999884 8999998774
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=90.74 E-value=0.25 Score=37.43 Aligned_cols=31 Identities=23% Similarity=0.283 Sum_probs=25.2
Q ss_pred CCCceeccCCCCCeeecCCC-----CeEEeeccCce
Q 044022 86 PRPIVLRNFKTQNILFNEEN-----VAKWFDFLLSI 116 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~-----~~~l~df~~~~ 116 (241)
...++|||+.+.|+++..++ .+.++||..+.
T Consensus 119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred ceEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 45689999999999997553 57899997764
|
subfamily of choline kinases |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=89.79 E-value=0.2 Score=40.88 Aligned_cols=31 Identities=13% Similarity=0.247 Sum_probs=27.7
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCce
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSI 116 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~ 116 (241)
..+++|+|+.+.|++++.++.+.++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 4579999999999999999999999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=89.74 E-value=0.27 Score=39.49 Aligned_cols=30 Identities=17% Similarity=0.275 Sum_probs=24.5
Q ss_pred CCceeccCCCCCeeecCCCC-eEEeeccCce
Q 044022 87 RPIVLRNFKTQNILFNEENV-AKWFDFLLSI 116 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~-~~l~df~~~~ 116 (241)
..++|+|+.+.|++++.++. .-|+||+.+.
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 45899999999999997554 5699998763
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG4499 Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Probab=87.34 E-value=7.9 Score=32.30 Aligned_cols=123 Identities=15% Similarity=0.143 Sum_probs=72.4
Q ss_pred HHHHHHhcCCCcccceeeeeeeCCcceEEEEecCC-CCHHHhhcCCCchHHHHHHHHHHHhchhhcCCCCCceeccCCCC
Q 044022 19 NITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEY-GTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQ 97 (241)
Q Consensus 19 e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~ 97 (241)
++.++.+ ..|+++.-+.. .++.+.|-++-... .++...-.......++++.+.+..|.-+- +.-.|-=+.|+
T Consensus 41 ~~~lld~-~~~f~~~eit~--~~Ds~vIsy~i~~~~~~F~~~k~~~k~~Klr~a~~~I~~l~e~~----~tr~~~~laPe 113 (434)
T COG4499 41 LAELLDK-SPPFIVAEITE--DNDSFVISYPIPEAAKSFASAKRKEKTRKLRLALQNIATLSELN----NTRYTFFLAPE 113 (434)
T ss_pred HHHHhcc-CCCccceeecc--cCceeEEEecCccccchHHHHHHHHHHHHHHHHHHHHHHHHHhh----ccceeEEecch
Confidence 4555555 34455444322 34444455444322 23333222223345676777777766543 44567778899
Q ss_pred CeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhH-HHHHHHHHHHhcCcccccc
Q 044022 98 NILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVF-SFGAFLFELLAGRIHIWDL 173 (241)
Q Consensus 98 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~-s~G~~~~~~~~g~~p~~~~ 173 (241)
||+++.++.+.+..+|+-..+++ .=+.|| +.| .+-+++..++.|+.+|...
T Consensus 114 Nilf~~~l~p~~vH~Glk~~lpP--------------ye~tee-----------~f~~~ykA~~~~~fn~k~~Fe~l 165 (434)
T COG4499 114 NILFDGGLTPFFVHRGLKNSLPP--------------YEMTEE-----------RFLKEYKALAIYAFNGKFSFESL 165 (434)
T ss_pred heEEcCCCceEEEecchhccCCC--------------CCCCHH-----------HHHHHHHHHHHHHHcCCccHHHH
Confidence 99999999999999987644321 113333 344 5667777888899888653
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=86.99 E-value=0.6 Score=44.56 Aligned_cols=32 Identities=19% Similarity=0.346 Sum_probs=26.5
Q ss_pred CCCceeccCCCCCeeecCCC--Ce-EEeeccCcee
Q 044022 86 PRPIVLRNFKTQNILFNEEN--VA-KWFDFLLSIS 117 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~--~~-~l~df~~~~~ 117 (241)
..+++|+|+.+.||+++.++ .+ -|+|||-+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 56799999999999999875 44 4999998754
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=85.80 E-value=1.4 Score=37.44 Aligned_cols=31 Identities=19% Similarity=0.263 Sum_probs=26.2
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCcee
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSIS 117 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~ 117 (241)
...++|||+.+.||++..+ .++++||.++..
T Consensus 222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~~ 252 (401)
T PRK09550 222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAFY 252 (401)
T ss_pred CCceeeccCCcccEEeeCC-CcEEEecccccc
Confidence 5569999999999999776 589999987753
|
|
| >KOG4720 consensus Ethanolamine kinase [Lipid transport and metabolism] | Back alignment and domain information |
|---|
Probab=85.40 E-value=3.3 Score=33.60 Aligned_cols=38 Identities=18% Similarity=0.146 Sum_probs=28.9
Q ss_pred HHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHH
Q 044022 17 INNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRD 58 (241)
Q Consensus 17 ~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~ 58 (241)
.+|+...+.| .|..-.++++.|.++ +|+||++|.+|..
T Consensus 126 e~Ev~afk~L~a~G~ap~Ly~tF~NG----Lvyefi~g~tL~p 164 (391)
T KOG4720|consen 126 ENEVIAFKLLAAYGFAPKLYGTFNNG----LVYEFIQGKTLEP 164 (391)
T ss_pred HHHHHHHHHHHHcCcChhhhheecCc----eEEeeecCcccCh
Confidence 3577777777 577788899988544 7999999888743
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=85.35 E-value=1.7 Score=35.85 Aligned_cols=37 Identities=16% Similarity=0.127 Sum_probs=22.9
Q ss_pred HHHHHHHHHhchh-hcCCCCCceeccCCCCCeeecCCC
Q 044022 69 KIASDIVNSLAYL-HFGFPRPIVLRNFKTQNILFNEEN 105 (241)
Q Consensus 69 ~~~~~i~~~l~~l-h~~~~~~ivh~dl~~~nil~~~~~ 105 (241)
.+..|++.-.-.. ...+-...+|-||||.|||+....
T Consensus 283 fifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~ 320 (444)
T PHA03111 283 FIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD 320 (444)
T ss_pred HHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence 3455665443222 222234589999999999996554
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 241 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-19 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-19 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-18 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-10 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-06 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-06 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-06 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-05 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-05 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-05 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-05 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-05 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-05 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-05 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-05 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-05 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-05 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-05 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-05 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-05 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-05 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-05 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-05 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-05 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-05 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-05 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-05 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-05 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-05 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-05 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-05 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-05 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-05 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-05 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-05 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-05 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-05 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-05 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-05 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-05 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-05 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-05 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-05 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-05 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-05 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-05 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-05 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-05 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-05 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-05 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-05 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-05 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-05 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-05 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-05 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-05 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-05 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-04 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-04 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-04 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-04 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-04 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-04 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-04 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-04 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-04 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-04 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-04 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-04 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-04 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-04 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-04 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-04 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-04 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-04 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-04 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-04 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-04 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-04 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-04 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-04 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-04 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-04 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-04 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-04 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-04 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-04 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-04 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-04 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-04 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-04 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-04 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-04 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-04 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-04 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-04 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-04 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-04 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-04 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-04 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-04 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-04 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-04 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-04 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-04 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-04 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 241 | |||
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 4e-47 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 3e-44 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 8e-40 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 7e-34 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-25 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-21 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-20 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-20 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-20 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-19 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-19 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-19 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-19 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 4e-19 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 7e-19 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 9e-19 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-17 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 5e-17 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 4e-15 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-14 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-13 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 5e-13 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-12 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 8e-12 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 9e-12 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-11 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-11 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-11 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-11 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 3e-11 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 7e-11 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 9e-11 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 1e-10 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 1e-10 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-10 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-10 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 4e-10 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 4e-10 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 4e-10 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 4e-10 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 6e-10 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 6e-10 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 7e-10 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 8e-10 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-09 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-09 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-09 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-09 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-09 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-09 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 4e-09 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 4e-09 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 4e-09 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 5e-09 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 6e-09 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 9e-09 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 9e-09 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-08 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-08 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-08 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-08 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-08 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 3e-08 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 3e-08 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 3e-08 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-08 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 4e-08 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-08 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 4e-08 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 5e-08 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 5e-08 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 5e-08 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 6e-08 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 7e-08 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 8e-08 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 9e-08 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-07 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-07 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-07 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-07 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-07 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-07 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 3e-07 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-07 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 4e-07 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 4e-07 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 5e-07 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 5e-07 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 6e-07 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 8e-07 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 8e-07 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 8e-07 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 9e-07 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 9e-07 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-06 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-06 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-06 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-06 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-06 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-06 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-06 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-06 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-06 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-06 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 3e-06 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 3e-06 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-06 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 3e-06 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 5e-06 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 5e-06 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 7e-06 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 7e-06 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 7e-06 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 8e-06 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 9e-06 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-05 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-05 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-05 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-05 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-05 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-05 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 3e-05 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 3e-05 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-05 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-05 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-05 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-05 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-05 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 3e-05 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 4e-05 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 4e-05 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 4e-05 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 4e-05 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 4e-05 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 4e-05 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 4e-05 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 5e-05 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 5e-05 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 5e-05 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 6e-05 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 6e-05 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 8e-05 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 8e-05 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-04 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-04 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-04 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-04 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 1e-04 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-04 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-04 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-04 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-04 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-04 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-04 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-04 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-04 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-04 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-04 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-04 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-04 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 3e-04 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 3e-04 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 3e-04 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 4e-04 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 4e-04 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 4e-04 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 7e-04 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 7e-04 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 8e-04 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 9e-04 |
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-47
Identities = 72/228 (31%), Positives = 104/228 (45%), Gaps = 24/228 (10%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP--------RLKIASDIVN 76
H H++ IG C + IL+++ +E G L+ ++G+ LP RL+I
Sbjct: 91 FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEG-ETHITTDRVIGTRG 135
L YLH I+ R+ K+ NIL +E V K DF +S E +TH++T V GT G
Sbjct: 151 GLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGTLG 206
Query: 136 YSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFN--EYLKNYLE 193
Y PEY L EKS+V+SFG LFE+L R I N E+
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-----VQSLPREMVNLAEWAVESHN 261
Query: 194 DKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
+ + I P + I + L ++C+ S EDRP+M D
Sbjct: 262 NGQLEQIVDPNLADKIR----PESLRKFGDTAVKCLALSSEDRPSMGD 305
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-44
Identities = 66/222 (29%), Positives = 111/222 (50%), Gaps = 14/222 (6%)
Query: 28 HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA-----PLP---RLKIASDIVNSLA 79
H ++L+ G C+ +LV+ + G++ C+ PL R +IA LA
Sbjct: 86 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLA 145
Query: 80 YLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAP 139
YLH I+ R+ K NIL +EE A DF L+ + +TH+TT V GT G+ AP
Sbjct: 146 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAP 204
Query: 140 EYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTG 199
EY+S +EK++VF +G L EL+ G+ DL + +D +++K L++K+
Sbjct: 205 EYLSTGKSSEKTDVFGYGVMLLELITGQRAF-DLARLANDDDVMLLDWVKGLLKEKKLEA 263
Query: 200 IPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
+ + + ++++ Q+ L C +SP +RP M +
Sbjct: 264 LVDVDLQGNYK----DEEVEQLIQVALLCTQSSPMERPKMSE 301
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-40
Identities = 53/232 (22%), Positives = 98/232 (42%), Gaps = 26/232 (11%)
Query: 20 ITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFG----APLP---RLKIAS 72
I A+ H ++++ +G LV+ + G+L D + PL R KIA
Sbjct: 81 IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQ 140
Query: 73 DIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE-THITTDRVI 131
N + +LH + R+ K+ NIL +E AK DF L+ + + T +T+ R++
Sbjct: 141 GAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS-RIV 196
Query: 132 GTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNY 191
GT Y APE + + KS+++SFG L E++ G + D H + +
Sbjct: 197 GTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAV-----DEHREPQLLLDIKEEI 250
Query: 192 LEDKRFTGIPAPIIVQDIPCIEK--EQQLHASAQLTLECVNNSPEDRPTMVD 241
++++ + D + + A + +C++ RP +
Sbjct: 251 EDEEK----TIEDYI-D-KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-34
Identities = 49/244 (20%), Positives = 91/244 (37%), Gaps = 38/244 (15%)
Query: 24 AQMSHNHILKRIGCCLQTPIP----ILVFQSVEYGTLRDCIFGAPLP---RLKIASDIVN 76
M H +IL+ IG + L+ E G+L D + + IA +
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMAR 132
Query: 77 SLAYLH------FGFPRP-IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
LAYLH +P I R+ K++N+L A DF L++ G++ T
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHG 192
Query: 130 VIGTRGYSAPEYISICVLNE-----KSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFF 184
+GTR Y APE + + + + ++++ G L+EL +
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT----------AADGPV 242
Query: 185 NEYLKNYLE----DKRFTGIPAPIIVQ----DIP-CIEKEQQLHASAQLTLECVNNSPED 235
+EY+ + E + ++ + + +K + + EC ++ E
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 236 RPTM 239
R +
Sbjct: 303 RLSA 306
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 45/253 (17%), Positives = 81/253 (32%), Gaps = 45/253 (17%)
Query: 24 AQMSHNHILKRIGCCLQTPIPI-----LVFQSVEYGTLRDCIFGAPLP---RLKIASDIV 75
M H++I + I + LV + G+L + ++A +
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVT 121
Query: 76 NSLAYLHFGFPR------PIVLRNFKTQNILFNEENVAKWFDFLLSI------SIPEGET 123
LAYLH PR I R+ ++N+L + DF LS+ + GE
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 124 HITTDRVIGTRGYSAPEYISICV-------LNEKSNVFSFGAFLFELLAGRIHIWDLLKD 176
+GT Y APE + V ++ ++++ G +E+
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR--------CT 233
Query: 177 THDHGCFFNEYLKNYLE----DKRFTGIPAPIIVQ----DIP--CIEKEQQLHASAQLTL 226
G EY + F + + + P E + + +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 227 ECVNNSPEDRPTM 239
+C + E R T
Sbjct: 294 DCWDQDAEARLTA 306
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-21
Identities = 45/240 (18%), Positives = 88/240 (36%), Gaps = 32/240 (13%)
Query: 25 QMSHNHILKRIGCCLQTPIPI----LVFQSVEYGTLRDCIFGAPLP---RLKIASDIVNS 77
M H +IL I ++ L+ E G+L D + L LK+A V+
Sbjct: 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSG 146
Query: 78 LAYLHFGFPR-----PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR--V 130
L +LH I R+ K++NIL + D L++ +
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 131 IGTRGYSAPEYISICVL------NEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFF 184
+GT+ Y PE + + ++++SFG L+E+ + ++ +
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG----GIVEEYQLPY 262
Query: 185 NEYLKNYLEDKRFTGIPAPIIVQ----DIP-CIEKEQQLHASAQLTLECVNNSPEDRPTM 239
++ + D + + + ++ P ++ L +L EC ++P R T
Sbjct: 263 HDLVP---SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-20
Identities = 45/240 (18%), Positives = 84/240 (35%), Gaps = 32/240 (13%)
Query: 25 QMSHNHILKRIGCCLQTPIPI----LVFQSVEYGTLRDCIFGAPLP---RLKIASDIVNS 77
+ H +IL I + LV E+G+L D + + +K+A +
Sbjct: 92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASG 151
Query: 78 LAYLHFGFPR-----PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR--V 130
LA+LH I R+ K++NIL + D L++ I
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 211
Query: 131 IGTRGYSAPEYISICVL------NEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFF 184
+GT+ Y APE + + +++++++ G +E+ H +
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR-------CSIGGIHEDYQ 264
Query: 185 NEYLKNYLEDKRFTGIPAPIIVQ----DIP-CIEKEQQLHASAQLTLECVNNSPEDRPTM 239
Y D + + Q +IP + + L A++ EC + R T
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-20
Identities = 44/156 (28%), Positives = 69/156 (44%), Gaps = 15/156 (9%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP---RLKIASDIVNSLAY 80
A + H +I+ G CL+ P LV + G L + G +P + A I + Y
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNY 120
Query: 81 LHFGFPRPIVLRNFKTQNILFNEE--------NVAKWFDFLLSISIPEGETHITTDRVIG 132
LH PI+ R+ K+ NIL ++ + K DF L+ T G
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAG 176
Query: 133 TRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRI 168
+ APE I + ++ S+V+S+G L+ELL G +
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV 212
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-20
Identities = 54/234 (23%), Positives = 89/234 (38%), Gaps = 41/234 (17%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF--GAPLP---RLKIASDIVNSLA 79
+ H ++LK IG + + + ++ GTLR I + P R+ A DI + +A
Sbjct: 63 CLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMA 122
Query: 80 YLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR---------- 129
YLH I+ R+ + N L E DF L+ + + +T R
Sbjct: 123 YLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 130 --VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEY 187
V+G + APE I+ +EK +VFSFG L E++ D+ ++
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN-ADP------DYLPRTMDF 232
Query: 188 LKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
N + P + +T+ C + PE RP+ V
Sbjct: 233 GLNVRGFLD------RYCPPNCP--------PSFFPITVRCCDLDPEKRPSFVK 272
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-19
Identities = 46/152 (30%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI----FGAPLP---RLKIASDIVN 76
++ H +I+ +G Q P +V + + G+L + L RL +A D+
Sbjct: 89 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAK 148
Query: 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGY 136
+ YLH PIV RN K+ N+L +++ K DF LS + T +++ GT +
Sbjct: 149 GMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEW 205
Query: 137 SAPEYISICVLNEKSNVFSFGAFLFELLAGRI 168
APE + NEKS+V+SFG L+EL +
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-19
Identities = 46/220 (20%), Positives = 86/220 (39%), Gaps = 30/220 (13%)
Query: 28 HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI--FGAPLP---RLKIASDIVNSLAYLH 82
H +IL +G + I V Q E +L + + IA + YLH
Sbjct: 79 HVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYI 142
+ I+ R+ K+ NI +E+N K DF L+ +++ G+ + APE I
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 143 SICVLN---EKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTG 199
+ N +S+V++FG L+EL+ G++ ++ ++ + L
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI----NNRDQIIEMVGRGSLSP----- 245
Query: 200 IPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
+ + P +L EC+ ++RP+
Sbjct: 246 -DLSKVRSNCP--------KRMKRLMAECLKKKRDERPSF 276
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-19
Identities = 28/156 (17%), Positives = 61/156 (39%), Gaps = 19/156 (12%)
Query: 24 AQMSHNHILKRIGCCLQTPIPIL--VFQSVEYGTLRDCI---FGAPLP---RLKIASDIV 75
SH ++L +G C P P + + YG+L + + + +K A D+
Sbjct: 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMA 121
Query: 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRG 135
+A+LH I +++++ +E+ A+ + S + +
Sbjct: 122 RGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPA 173
Query: 136 YSAPEYI---SICVLNEKSNVFSFGAFLFELLAGRI 168
+ APE + ++++SF L+EL+ +
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV 209
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 7e-19
Identities = 46/247 (18%), Positives = 91/247 (36%), Gaps = 44/247 (17%)
Query: 24 AQMSHNHILKRIGCCLQTPIPI----LVFQSVEYGTLRDCIFGAPLP---RLKIASDIVN 76
+ H +IL I + + L+ E G+L D + L L+I I +
Sbjct: 57 VMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIAS 116
Query: 77 SLAYLH-----FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR-- 129
LA+LH I R+ K++NIL + D L++ + +
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 130 VIGTRGYSAPE------YISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCF 183
+GT+ Y APE + ++ ++++FG L+E+ + +
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV---------- 226
Query: 184 FNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKE-----------QQLHASAQLTLECVNNS 232
+Y + + P+ ++ + C++++ L + A+L EC +
Sbjct: 227 -EDYKPPFYDVVPND--PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQN 283
Query: 233 PEDRPTM 239
P R T
Sbjct: 284 PSARLTA 290
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 9e-19
Identities = 49/224 (21%), Positives = 86/224 (38%), Gaps = 36/224 (16%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA-------PLPRLKIASDIVN 76
++++H +I+K G CL LV + E G+L + + GA +
Sbjct: 56 SRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113
Query: 77 SLAYLHFGFPRPIVLRNFKTQNILFNEEN-VAKWFDFLLSISIPEGETHITTDRVIGTRG 135
+AYLH P+ ++ R+ K N+L V K DF + + G+
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAA 168
Query: 136 YSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDK 195
+ APE +EK +VFS+G L+E++ R +D + +
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP-FDEIGGPA------FRIMWAVHNGT 221
Query: 196 RFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
R P +++++P L C + P RP+M
Sbjct: 222 R------PPLIKNLP--------KPIESLMTRCWSKDPSQRPSM 251
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 4e-17
Identities = 35/162 (21%), Positives = 64/162 (39%), Gaps = 21/162 (12%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-----RLKIASDIVNSL 78
Q H +++ +G C+ P ++ + TL + A + +IA +IV +
Sbjct: 84 RQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGM 143
Query: 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLS---ISIPEGETHITTDRVIGTRG 135
YLH + I+ ++ K++N+ ++ V DF L + G G
Sbjct: 144 GYLH---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 136 YSAPEYISICVL---------NEKSNVFSFGAFLFELLAGRI 168
+ APE I ++ S+VF+ G +EL A
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW 241
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-17
Identities = 49/228 (21%), Positives = 82/228 (35%), Gaps = 40/228 (17%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-----RLKIASDIVNSL 78
+ ++H +I+K G P +V + V G L + P +L++ DI +
Sbjct: 78 SNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 79 AYLHFGFPRPIVLRNFKTQNILFNEEN-----VAKWFDFLLSISIPEGETHITTDRVIGT 133
Y+ PIV R+ ++ NI + AK DF LS ++ + ++G
Sbjct: 136 EYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----QQSVHSVSGLLGN 189
Query: 134 RGYSAPEYISICVL--NEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNY 191
+ APE I EK++ +SF L+ +L G +D
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP-FDEYSYGK-----IKFINMIR 243
Query: 192 LEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
E R P I +D P + C + P+ RP
Sbjct: 244 EEGLR------PTIPEDCP--------PRLRNVIELCWSGDPKKRPHF 277
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-15
Identities = 45/150 (30%), Positives = 74/150 (49%), Gaps = 10/150 (6%)
Query: 23 AAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF-GAPLPR---LKIASDIVNSL 78
++Q+SH +I+ I + LV + +E TL + I PL + + I++ +
Sbjct: 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGI 124
Query: 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT-TDRVIGTRGYS 137
+ H IV R+ K QNIL + K FDF I+ ET +T T+ V+GT Y
Sbjct: 125 KHAH---DMRIVHRDIKPQNILIDSNKTLKIFDF--GIAKALSETSLTQTNHVLGTVQYF 179
Query: 138 APEYISICVLNEKSNVFSFGAFLFELLAGR 167
+PE +E ++++S G L+E+L G
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-14
Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 12/154 (7%)
Query: 23 AAQMSHNHILK--RIGC--CLQTPIPILVFQSVEYGTLRDCIF-GAPLPR---LKIASDI 74
AA ++H I+ G P+P +V + V+ TLRD + P+ +++ +D
Sbjct: 66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT-TDRVIGT 133
+L + H I+ R+ K NI+ + N K DF ++ +I + +T T VIGT
Sbjct: 126 CQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 134 RGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
Y +PE ++ +S+V+S G L+E+L G
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-13
Identities = 32/161 (19%), Positives = 59/161 (36%), Gaps = 32/161 (19%)
Query: 23 AAQMSHNHILKRIGCCLQTPIPI-----------LVFQSVEYGTLRDCIF-GAPLP---R 67
A ++ H+ +PI + + + L + PL
Sbjct: 88 AGRLQEPHV-----------VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRA 136
Query: 68 LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT- 126
+ I I ++L H R+ K +NIL + ++ A DF I+ + +T
Sbjct: 137 VAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDF--GIASATTDEKLTQ 191
Query: 127 TDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
+GT Y APE S ++++++ L+E L G
Sbjct: 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 66.6 bits (162), Expect = 5e-13
Identities = 24/148 (16%), Positives = 56/148 (37%), Gaps = 27/148 (18%)
Query: 31 ILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLH-FGFPRPI 89
+ R+ LQT +L+ S + +L RL++ ++ LA LH +G +
Sbjct: 183 LYPRMQSNLQTFGEVLLSHSSTHKSL------VHHARLQLTLQVIRLLASLHHYG----L 232
Query: 90 VLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVL-- 147
V + +I+ ++ F + +G + ++ RG++ PE + +L
Sbjct: 233 VHTYLRPVDIVLDQRGGVFLTGF--EHLVRDGASAVSP----IGRGFAPPETTAERMLPF 286
Query: 148 --------NEKSNVFSFGAFLFELLAGR 167
+ ++ G ++ +
Sbjct: 287 GQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 1e-12
Identities = 31/153 (20%), Positives = 60/153 (39%), Gaps = 20/153 (13%)
Query: 23 AAQMSHNHILK-----RIGCCLQTPIPILVFQSVEYGTLRDCIFGA-PLPR-LKIASDIV 75
A++ H I++ P+ +V + V +L+ P+ + +I+
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEIL 192
Query: 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT-TDRVIGTR 134
+L+YLH +V + K +NI+ EE + K D + I + GT
Sbjct: 193 PALSYLH---SIGLVYNDLKPENIMLTEEQL-KLIDLGAV-------SRINSFGYLYGTP 241
Query: 135 GYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
G+ APE + +++++ G L L
Sbjct: 242 GFQAPEIVR-TGPTVATDIYTVGRTLAALTLDL 273
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 8e-12
Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 43/225 (19%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF-----GAPLPR---LKIASDIVN 76
++ H +++ + PI I V + + G+L D F G L + +A+ I +
Sbjct: 318 KLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIAS 374
Query: 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGY 136
+AY+ V R+ + NIL E V K DF L+ I + E + +
Sbjct: 375 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-W 430
Query: 137 SAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDK 195
+APE KS+V+SFG L EL GR+ ++ N + + +E
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----------NREVLDQVER- 479
Query: 196 RFTG--IPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238
G +P P + P + LH L +C PE+RPT
Sbjct: 480 ---GYRMPCP---PECP-----ESLH---DLMCQCWRKEPEERPT 510
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 9e-12
Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 43/225 (19%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF-----GAPLPR---LKIASDIVN 76
++ H +++ + PI I V + + G+L D F G L + +A+ I +
Sbjct: 235 KLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIAS 291
Query: 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGY 136
+AY+ V R+ + NIL E V K DF L+ I + E + +
Sbjct: 292 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-W 347
Query: 137 SAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDK 195
+APE KS+V+SFG L EL GR+ ++ N + + +E
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----------NREVLDQVER- 396
Query: 196 RFTG--IPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238
G +P P + P + LH L +C PE+RPT
Sbjct: 397 ---GYRMPCP---PECP-----ESLH---DLMCQCWRKEPEERPT 427
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 2e-11
Identities = 22/148 (14%), Positives = 52/148 (35%), Gaps = 26/148 (17%)
Query: 31 ILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIV 90
+ R+ LQT +L+ S + +L RL++ ++ LA LH +V
Sbjct: 178 LYPRMQSNLQTFGEVLLSHSSTHKSLVH------HARLQLTLQVIRLLASLHH---YGLV 228
Query: 91 LRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVL--- 147
+ +I+ ++ F + +G +++ +RG+ PE +
Sbjct: 229 HTYLRPVDIVLDQRGGVFLTGF--EHLVRDGARVVSS----VSRGFEPPELEARRATISY 282
Query: 148 --------NEKSNVFSFGAFLFELLAGR 167
+ ++ G ++ +
Sbjct: 283 HRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-11
Identities = 39/174 (22%), Positives = 64/174 (36%), Gaps = 25/174 (14%)
Query: 16 CINNITYAAQMSHNHILKRIGCCLQTPIP----ILVFQSVEYGTLRDCI-----FGAPLP 66
+H +IL+ + CL+ L+ + GTL + I G L
Sbjct: 73 AQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT 132
Query: 67 R---LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDF----LLSISIP 119
L + I L +H + R+ K NIL +E D I +
Sbjct: 133 EDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE 189
Query: 120 EGETHITTDRVIGTRG---YSAPEYISI---CVLNEKSNVFSFGAFLFELLAGR 167
+T R Y APE S+ CV++E+++V+S G L+ ++ G
Sbjct: 190 GSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-11
Identities = 45/227 (19%), Positives = 92/227 (40%), Gaps = 44/227 (19%)
Query: 25 QMSHNHILKRIGCCLQTPIPI-LVFQSVEYGTLRDCIF-----GAPLPR---LKIASDIV 75
++ H ++++ +G C + P P ++ + + YG L D + + L +A+ I
Sbjct: 272 EIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQIS 328
Query: 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRG 135
+++ YL + + RN +N L E ++ K DF LS + +
Sbjct: 329 SAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 384
Query: 136 YSAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLED 194
++APE ++ + KS+V++FG L+E+ G + + LE
Sbjct: 385 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----------LSQVYELLEK 434
Query: 195 KRFTG--IPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
+ P + P ++++ +L C +P DRP+
Sbjct: 435 ----DYRMERP---EGCP-----EKVY---ELMRACWQWNPSDRPSF 466
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-11
Identities = 55/230 (23%), Positives = 90/230 (39%), Gaps = 33/230 (14%)
Query: 24 AQMSHNHILKRIGCCLQTPI-PI-LVFQSVEYGTLRDCIFGA----PLPRL-KIASDIVN 76
+ H +I+K G C + I L+ + + G+L++ + L + K A I
Sbjct: 78 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK 137
Query: 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET--HITTDRVIGTR 134
+ YL R V R+ +N+L E+ K DF L+ +I + + DR
Sbjct: 138 GMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF 194
Query: 135 GYSAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFF----NEYLK 189
Y APE + S+V+SFG L ELL + G L
Sbjct: 195 WY-APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253
Query: 190 NYLED-KRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238
N L++ KR +P P + P +++ QL +C P +R +
Sbjct: 254 NTLKEGKR---LPCP---PNCP-----DEVY---QLMRKCWEFQPSNRTS 289
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-11
Identities = 60/231 (25%), Positives = 89/231 (38%), Gaps = 37/231 (16%)
Query: 24 AQMSHNHILKRIGCCLQT-PIPI-LVFQSVEYGTLRDCIFG--APLPRL-KIASDIVNSL 78
+ H HI+K GCC + LV + V G+LRD + L +L A I +
Sbjct: 88 RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGM 147
Query: 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYS- 137
AYLH + + R+ +N+L + + + K DF L+ ++PEG + G S
Sbjct: 148 AYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV----REDGDSP 200
Query: 138 ----APEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGC----FFNEYL 188
APE + S+V+SFG L+ELL K G L
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260
Query: 189 KNYLED-KRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238
LE +R +P P P +++ L C RPT
Sbjct: 261 TELLERGER---LPRP---DKCP-----AEVY---HLMKNCWETEASFRPT 297
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 7e-11
Identities = 39/191 (20%), Positives = 69/191 (36%), Gaps = 26/191 (13%)
Query: 9 HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI---FGAPL 65
+ I S + + ++ + Q L+D +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 66 PR----LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEG 121
L I I ++ +LH + ++ R+ K NI F ++V K DF L ++ +
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 122 ETHITTD----------RVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG----- 166
E T +GT+ Y +PE I + K ++FS G LFELL
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277
Query: 167 -RIHIWDLLKD 176
R+ I +++
Sbjct: 278 ERVRIITDVRN 288
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 9e-11
Identities = 32/124 (25%), Positives = 52/124 (41%), Gaps = 15/124 (12%)
Query: 52 EY---GTLRDCI---FGAPLPR---LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFN 102
E+ GTL I G L + L++ I + Y+H + ++ R+ K NI
Sbjct: 100 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLV 156
Query: 103 EENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFE 162
+ K DF L S+ + GT Y +PE IS ++ ++++ G L E
Sbjct: 157 DTKQVKIGDFGLVTSLKNDGKRTRS---KGTLRYMSPEQISSQDYGKEVDLYALGLILAE 213
Query: 163 LLAG 166
LL
Sbjct: 214 LLHV 217
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-10
Identities = 26/102 (25%), Positives = 48/102 (47%), Gaps = 4/102 (3%)
Query: 68 LKIASDIVNSLAYLH--FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI 125
L++ + + +L H ++ R+ K N+ + + K DF L+ + +
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173
Query: 126 TTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
T +GT Y +PE ++ NEKS+++S G L+EL A
Sbjct: 174 KT--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-10
Identities = 38/181 (20%), Positives = 63/181 (34%), Gaps = 34/181 (18%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEEN-----VAKWFDFLLSISIPEGET 123
+ + LA+LH IV R+ K NIL + N A DF L + G
Sbjct: 122 TLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178
Query: 124 HIT-TDRVIGTRGYSAPEYISICV---LNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHD 179
+ V GT G+ APE +S ++FS G + +++ H + +
Sbjct: 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG---KSLQ 235
Query: 180 HGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQ-LTLECVNNSPEDRPT 238
N L + C+ E+ A+ L + + P+ RP+
Sbjct: 236 RQ--ANILLGAC----------------SLDCLHPEKHEDVIARELIEKMIAMDPQKRPS 277
Query: 239 M 239
Sbjct: 278 A 278
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-10
Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 49/228 (21%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF-----GAPLPR---LKIASDIVN 76
+ H+ ++K + PI I + + + G+L D F G+ P + ++ I
Sbjct: 239 TLQHDKLVKLHAVVTKEPIYI-ITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQIAE 295
Query: 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRG- 135
+A++ R + R+ + NIL + V K DF L+ I + E G +
Sbjct: 296 GMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFP 348
Query: 136 --YSAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYL 192
++APE I+ KS+V+SFG L E++ GRI + N + L
Sbjct: 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS----------NPEVIRAL 398
Query: 193 EDKRFTG--IPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238
E G +P P ++ P ++L+ + + C N PE+RPT
Sbjct: 399 ER----GYRMPRP---ENCP-----EELY---NIMMRCWKNRPEERPT 431
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-10
Identities = 32/152 (21%), Positives = 61/152 (40%), Gaps = 21/152 (13%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA----PLPRL-KIASDIVNSL 78
A + + H+ + +G CL + + + + Q + +G L D + L I +
Sbjct: 72 ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 79 AYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTR- 134
YL V R+ +N+L K DF L+ + E + G +
Sbjct: 131 NYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---GGKV 181
Query: 135 --GYSAPEYISICVLNEKSNVFSFGAFLFELL 164
+ A E I + +S+V+S+G ++EL+
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELM 213
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-10
Identities = 59/233 (25%), Positives = 90/233 (38%), Gaps = 39/233 (16%)
Query: 24 AQMSHNHILKRIGCCLQTPI-PI-LVFQSVEYGTLRDCIFGA----PLPRL-KIASDIVN 76
+ + I+K G + LV + + G LRD + RL +S I
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 138
Query: 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGY 136
+ YL R V R+ +NIL E K DF L+ +P + + G
Sbjct: 139 GMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV----REPGQ 191
Query: 137 S-----APEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFF----NE 186
S APE +S + + +S+V+SFG L+EL + GC
Sbjct: 192 SPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251
Query: 187 YLKNYLED-KRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238
L LE+ +R +PAP P ++H +L C SP+DRP+
Sbjct: 252 RLLELLEEGQR---LPAP---PACP-----AEVH---ELMKLCWAPSPQDRPS 290
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-10
Identities = 35/153 (22%), Positives = 58/153 (37%), Gaps = 15/153 (9%)
Query: 25 QMSHNHILKRIGCCLQTPIP----ILVFQSVEYGTLRDCI--FGAPLPRL--KIASDIVN 76
+ H +I++ T +LV + + GTL+ + F ++ I+
Sbjct: 81 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK 140
Query: 77 SLAYLHFGFPRPIVLRNFKTQNILFNEEN-VAKWFDFLLSISIPEGETHITTDRVIGTRG 135
L +LH P PI+ R+ K NI K D L+ VIGT
Sbjct: 141 GLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPE 195
Query: 136 YSAPEYISICVLNEKSNVFSFGAFLFELLAGRI 168
+ APE +E +V++FG + E+
Sbjct: 196 FMAPEMYEEKY-DESVDVYAFGMCMLEMATSEY 227
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-10
Identities = 55/239 (23%), Positives = 93/239 (38%), Gaps = 50/239 (20%)
Query: 24 AQMSHNHILKRIGCCLQTPI-PI-LVFQSVEYGTLRDCIFGAPLPR----------LKIA 71
+ H++I+K G C + L+ + + YG+LRD + L + L+
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD--Y---LQKHKERIDHIKLLQYT 120
Query: 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVI 131
S I + YL + + R+ T+NIL EN K DF L+ +P+ +
Sbjct: 121 SQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV---- 173
Query: 132 GTRGYS-----APEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGC--- 182
G S APE ++ + S+V+SFG L+EL + G
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 233
Query: 183 --FFNEYLKNYLED-KRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238
+L L++ R +P P P +++ + EC NN+ RP+
Sbjct: 234 GQMIVFHLIELLKNNGR---LPRP---DGCP-----DEIY---MIMTECWNNNVNQRPS 278
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 57.7 bits (139), Expect = 4e-10
Identities = 27/163 (16%), Positives = 51/163 (31%), Gaps = 23/163 (14%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI------FGAPLP---RLKIASDIV 75
+ +K L +LV + YGTL + I +P + A ++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWF-----------DFLLSISIPEGETH 124
+ +H I+ + K N + + + D SI +
Sbjct: 183 YMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 125 ITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
T G+ E +S N + + F A ++ +L G
Sbjct: 240 TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-10
Identities = 55/239 (23%), Positives = 94/239 (39%), Gaps = 50/239 (20%)
Query: 24 AQMSHNHILKRIGCCLQTPI-PI-LVFQSVEYGTLRDCIFGAPLPR----------LKIA 71
+ H++I+K G C + L+ + + YG+LRD + L + L+
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD--Y---LQKHKERIDHIKLLQYT 151
Query: 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVI 131
S I + YL + + R+ T+NIL EN K DF L+ +P+ + +
Sbjct: 152 SQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKV---- 204
Query: 132 GTRGYS-----APEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGC--- 182
G S APE ++ + S+V+SFG L+EL + G
Sbjct: 205 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 264
Query: 183 --FFNEYLKNYLED-KRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238
+L L++ R +P P P +++ + EC NN+ RP+
Sbjct: 265 GQMIVFHLIELLKNNGR---LPRP---DGCP-----DEIY---MIMTECWNNNVNQRPS 309
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 6e-10
Identities = 53/227 (23%), Positives = 86/227 (37%), Gaps = 46/227 (20%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF------GAPLPRL-KIASDIVN 76
Q H HI+K IG + P+ I + + G LR F L L A +
Sbjct: 446 RQFDHPHIVKLIGVITENPVWI-IMELCTLGELRS--FLQVRKFSLDLASLILYAYQLST 502
Query: 77 SLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGT 133
+LAYL F V R+ +N+L + + K DF LS + + + + +
Sbjct: 503 ALAYLESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 134 RGYSAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYL 192
+ APE I+ S+V+ FG ++E+L G + N + +
Sbjct: 557 KWM-APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK----------NNDVIGRI 605
Query: 193 ED-KRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238
E+ +R +P P + P L+ L +C P RP
Sbjct: 606 ENGER---LPMP---PNCP-----PTLY---SLMTKCWAYDPSRRPR 638
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-10
Identities = 36/150 (24%), Positives = 60/150 (40%), Gaps = 11/150 (7%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI---FGAPLPR---LKIASDIVNS 77
A M H +I++ + +V E G L I G L I +
Sbjct: 78 ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA 137
Query: 78 LAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYS 137
L ++H R I+ R+ K+QNI ++ + DF ++ + IGT Y
Sbjct: 138 LKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYL 192
Query: 138 APEYISICVLNEKSNVFSFGAFLFELLAGR 167
+PE N KS++++ G L+EL +
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLK 222
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-10
Identities = 37/188 (19%), Positives = 57/188 (30%), Gaps = 44/188 (23%)
Query: 23 AAQMSHNHILKRIGC-------CLQTPIPILVFQSVEY--GTLRDCI--FGAPLP---RL 68
H ++ LQT E +L+ +GA LP
Sbjct: 111 EKVGQHPCCVRLEQAWEEGGILYLQT----------ELCGPSLQQHCEAWGASLPEAQVW 160
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128
D + +LA+LH + +V + K NI K DF L + +
Sbjct: 161 GYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV-- 215
Query: 129 RVIGTRGYSAPEYISICVLNE----KSNVFSFGAFLFELLAGRIH-----IWDLLKDTHD 179
G Y APE +L ++VFS G + E+ W L+ +
Sbjct: 216 -QEGDPRYMAPE-----LLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL 269
Query: 180 HGCFFNEY 187
F
Sbjct: 270 PPEFTAGL 277
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-09
Identities = 48/247 (19%), Positives = 85/247 (34%), Gaps = 57/247 (23%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSV---------EY---GTLRDCIF---GAPLPR- 67
A++ H I++ L+ + S + L+D +
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 68 ---LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH 124
L I I ++ +LH + ++ R+ K NI F ++V K DF L ++ + E
Sbjct: 118 SVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 125 ITTDRV----------IGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLL 174
T +GT+ Y +PE I + K ++FS G LFELL
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP-------- 226
Query: 175 KDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234
F + + P+ Q PC + + ++ SP
Sbjct: 227 --------FSTQMERVRTLTDVRNLKFPPLFTQKYPCE---------YVMVQDMLSPSPM 269
Query: 235 DRPTMVD 241
+RP ++
Sbjct: 270 ERPEAIN 276
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 1e-09
Identities = 11/103 (10%), Positives = 28/103 (27%), Gaps = 10/103 (9%)
Query: 67 RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT 126
+ + ++ A L + +V +F N+ + D +
Sbjct: 196 LHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----R 247
Query: 127 TDRVIGTRGYSAPEYI--SICVLNEKSNVFSFGAFLFELLAGR 167
Y+ E++ S N + G ++ +
Sbjct: 248 GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-09
Identities = 39/151 (25%), Positives = 69/151 (45%), Gaps = 21/151 (13%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF-----GAPLPR---LKIASDIVN 76
Q+ H +++ Q PI I + + +E G+L D F G L L +A+ I
Sbjct: 64 QLQHQRLVRLYAVVTQEPIYI-ITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAE 120
Query: 77 SLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGT 133
+A++ ++ + R+ + NIL ++ K DF L+ I + E
Sbjct: 121 GMAFIEERNY------IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 174
Query: 134 RGYSAPEYISICVLNEKSNVFSFGAFLFELL 164
+ ++APE I+ KS+V+SFG L E++
Sbjct: 175 K-WTAPEAINYGTFTIKSDVWSFGILLTEIV 204
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-09
Identities = 14/147 (9%), Positives = 41/147 (27%), Gaps = 34/147 (23%)
Query: 23 AAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPR--LKIASDIVNSLAY 80
+++ + + + ++V + + G+L++ +P P ++ + +
Sbjct: 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADA 144
Query: 81 LHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPE 140
H + L + + + +
Sbjct: 145 AH---RAGVALSIDHPSRVRVSIDGDVV----------------------LAYPATMPDA 179
Query: 141 YISICVLNEKSNVFSFGAFLFELLAGR 167
N + ++ GA L+ LL R
Sbjct: 180 -------NPQDDIRGIGASLYALLVNR 199
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-09
Identities = 47/227 (20%), Positives = 92/227 (40%), Gaps = 44/227 (19%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA----PLPRL-KIASDIVNSL 78
Q+ + +I++ IG C + + V + G L + G P+ + ++ + +
Sbjct: 65 HQLDNPYIVRLIGVCQAEALML-VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123
Query: 79 AYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTR- 134
YL +F V R+ +N+L + AK DF LS ++ +++ T +
Sbjct: 124 KYLEEKNF------VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKW 175
Query: 135 --GYSAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNY 191
+ APE I+ + +S+V+S+G ++E L+ G+ + E +
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---------PEVMAFI 226
Query: 192 LEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238
+ KR + P + P +L+ L +C EDRP
Sbjct: 227 EQGKR---MECP---PECP-----PELY---ALMSDCWIYKWEDRPD 259
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-09
Identities = 34/151 (22%), Positives = 64/151 (42%), Gaps = 19/151 (12%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA---PLPRL-KIASDIVNSLA 79
Q+ + +I++ IG C + V + E G L + + ++ + +
Sbjct: 73 QQLDNPYIVRMIGICEAESWML-VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 131
Query: 80 YL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTR-- 134
YL +F V R+ +N+L ++ AK DF LS ++ E + +
Sbjct: 132 YLEESNF------VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT--HGKWP 183
Query: 135 -GYSAPEYISICVLNEKSNVFSFGAFLFELL 164
+ APE I+ + KS+V+SFG ++E
Sbjct: 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAF 214
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-09
Identities = 32/152 (21%), Positives = 61/152 (40%), Gaps = 21/152 (13%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA----PLPRL-KIASDIVNSL 78
A + + H+ + +G CL + + + + Q + +G L D + L I +
Sbjct: 72 ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 79 AYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTR- 134
YL V R+ +N+L K DF L+ + E + G +
Sbjct: 131 NYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---GGKV 181
Query: 135 --GYSAPEYISICVLNEKSNVFSFGAFLFELL 164
+ A E I + +S+V+S+G ++EL+
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELM 213
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-09
Identities = 26/113 (23%), Positives = 46/113 (40%), Gaps = 14/113 (12%)
Query: 68 LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDF----LLSISIPEGET 123
LKI ++ ++H P PI+ R+ K +N+L + + K DF +S +
Sbjct: 139 LKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197
Query: 124 HITTDRV------IGTRGYSAPEYISI---CVLNEKSNVFSFGAFLFELLAGR 167
V T Y PE I + + EK ++++ G L+ L +
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-09
Identities = 54/227 (23%), Positives = 92/227 (40%), Gaps = 40/227 (17%)
Query: 25 QMSHNHILKRIG-CCLQTPIPILVFQSVEYGTLRDCIF----GAPLP---RLKIASDIVN 76
Q SH +I++ IG C + PI I V + V+ G F GA L L++ D
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYI-VMELVQGGDFLT--FLRTEGARLRVKTLLQMVGDAAA 224
Query: 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE-THITTDRVIGTRG 135
+ YL + + R+ +N L E+NV K DF +S +G R + +
Sbjct: 225 GMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK- 280
Query: 136 YSAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLED 194
++APE ++ + +S+V+SFG L+E + G +L + + +
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---------QQTREFVEKG 331
Query: 195 KRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
R +P P + P + +L +C P RP+
Sbjct: 332 GR---LPCP---ELCP-----DAVF---RLMEQCWAYEPGQRPSFST 364
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 5e-09
Identities = 31/152 (20%), Positives = 62/152 (40%), Gaps = 20/152 (13%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA----PLPRL-KIASDIVNSL 78
+ H ++++ G L P+ + V + G+L D + L L + A + +
Sbjct: 76 HSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 79 AYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTR- 134
YL F + R+ +N+L ++ K DF L ++P+ + H +
Sbjct: 135 GYLESKRF------IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKV 186
Query: 135 --GYSAPEYISICVLNEKSNVFSFGAFLFELL 164
+ APE + + S+ + FG L+E+
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-09
Identities = 51/224 (22%), Positives = 87/224 (38%), Gaps = 42/224 (18%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGT----LRDCIFGAPLPRL-KIASDIVNSLA 79
Q H HI+K IG + P+ I + + G L+ + L L A + +LA
Sbjct: 72 QFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 80 YL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGY 136
YL F V R+ +N+L + + K DF LS + + + + + + +
Sbjct: 131 YLESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-W 183
Query: 137 SAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLED- 194
APE I+ S+V+ FG ++E+L G + N + +E+
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK----------NNDVIGRIENG 233
Query: 195 KRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238
+R +P P + P L+ L +C P RP
Sbjct: 234 ER---LPMP---PNCP-----PTLY---SLMTKCWAYDPSRRPR 263
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 54.3 bits (130), Expect = 9e-09
Identities = 28/103 (27%), Positives = 45/103 (43%), Gaps = 9/103 (8%)
Query: 68 LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILF---NEENVAKWFDFLLSISIPEGETH 124
+ SDI ++L YLH I+ R+ K +NI+ + + K D + + +GE
Sbjct: 124 RTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC 180
Query: 125 ITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
+GT Y APE + + +SFG FE + G
Sbjct: 181 TE---FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 9e-09
Identities = 35/152 (23%), Positives = 69/152 (45%), Gaps = 20/152 (13%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA----PLPRL-KIASDIVNSL 78
Q+ + +I++ IG C + + V + G L + G P+ + ++ + +
Sbjct: 391 HQLDNPYIVRLIGVCQAEALML-VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 449
Query: 79 AYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTR- 134
YL +F V RN +N+L + AK DF LS ++ +++ T +
Sbjct: 450 KYLEEKNF------VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKW 501
Query: 135 --GYSAPEYISICVLNEKSNVFSFGAFLFELL 164
+ APE I+ + +S+V+S+G ++E L
Sbjct: 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-08
Identities = 37/161 (22%), Positives = 67/161 (41%), Gaps = 13/161 (8%)
Query: 15 SCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI-----FGAPLPR-- 67
CI I Q++H +++K ++ +V + + G L I +P
Sbjct: 78 DCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 137
Query: 68 -LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT 126
K + ++L ++H R ++ R+ K N+ V K D L T
Sbjct: 138 VWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 194
Query: 127 TDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
+ ++GT Y +PE I N KS+++S G L+E+ A +
Sbjct: 195 S--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-08
Identities = 31/152 (20%), Positives = 60/152 (39%), Gaps = 21/152 (13%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA----PLPRL-KIASDIVNSL 78
+ H HI++ +G C + + + V Q + G+L D + L I +
Sbjct: 70 GSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 79 AYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTR- 134
YL V RN +N+L + + DF ++ +P + + +
Sbjct: 129 YYLEEHGM------VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS---EAKT 179
Query: 135 --GYSAPEYISICVLNEKSNVFSFGAFLFELL 164
+ A E I +S+V+S+G ++EL+
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELM 211
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-08
Identities = 43/189 (22%), Positives = 75/189 (39%), Gaps = 40/189 (21%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSV----------EY---GTLRDCIF--GAPLPR- 67
A ++H ++++ L+ + +V EY GTL D I R
Sbjct: 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 68 --LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI 125
++ I+ +L+Y+H + I+ R+ K NI +E K DF L+ ++ +
Sbjct: 117 EYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 126 TTDR------------VIGTRGYSAPEYIS-ICVLNEKSNVFSFGAFLFELLAG------ 166
D IGT Y A E + NEK +++S G FE++
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME 233
Query: 167 RIHIWDLLK 175
R++I L+
Sbjct: 234 RVNILKKLR 242
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-08
Identities = 37/151 (24%), Positives = 69/151 (45%), Gaps = 21/151 (13%)
Query: 25 QMSHNHILKRIGCCLQTPIPI-LVFQSVEYGTLRDCIF----GAPLPR---LKIASDIVN 76
++SH +++ G CL+ PI LV + +E+G L D + L + D+
Sbjct: 59 KLSHPKLVQLYGVCLEQA-PICLVTEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCE 115
Query: 77 SLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGT 133
+AYL + R+ +N L E V K DF ++ + + + +T
Sbjct: 116 GMAYLEEACV------IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 169
Query: 134 RGYSAPEYISICVLNEKSNVFSFGAFLFELL 164
+ +++PE S + KS+V+SFG ++E+
Sbjct: 170 K-WASPEVFSFSRYSSKSDVWSFGVLMWEVF 199
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-08
Identities = 31/150 (20%), Positives = 66/150 (44%), Gaps = 19/150 (12%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF----GAPLPR---LKIASDIVNS 77
++SH ++K G C + +V + + G L + + G L L++ D+
Sbjct: 59 KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLN--YLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 78 LAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTR 134
+A+L F + R+ +N L + + K DF ++ + + + + +
Sbjct: 117 MAFLESHQF------IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK 170
Query: 135 GYSAPEYISICVLNEKSNVFSFGAFLFELL 164
+SAPE + KS+V++FG ++E+
Sbjct: 171 -WSAPEVFHYFKYSSKSDVWAFGILMWEVF 199
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-08
Identities = 52/233 (22%), Positives = 88/233 (37%), Gaps = 55/233 (23%)
Query: 25 QMSHNHILKRIGCCLQTPIPIL-VFQSVEYGTLRDCIF---GAPLPRLK----IASDIVN 76
SH ++L +G CL++ L V +++G LR+ F P +K +
Sbjct: 82 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAK 139
Query: 77 SLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGT 133
+ YL F V R+ +N + +E+ K DF L+ + + E V
Sbjct: 140 GMKYLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----YYSVHNK 189
Query: 134 RGYS------APEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNE 186
G A E + KS+V+SFG L+EL+ G D+
Sbjct: 190 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----------TF 239
Query: 187 YLKNYLED-KRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238
+ YL +R + P + P L+ ++ L+C + E RP+
Sbjct: 240 DITVYLLQGRR---LLQP---EYCP-----DPLY---EVMLKCWHPKAEMRPS 278
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-08
Identities = 28/123 (22%), Positives = 47/123 (38%), Gaps = 25/123 (20%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENV-------------AKWFDFLLS 115
+ I + +A+LH I+ R+ K QNIL + + DF L
Sbjct: 119 SLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 116 ISIPEGETHITTDR--VIGTRGYSAPEYIS-------ICVLNEKSNVFSFGAFLFELLAG 166
+ G++ T+ GT G+ APE + L ++FS G + +L+
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
Query: 167 RIH 169
H
Sbjct: 236 GKH 238
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-08
Identities = 34/106 (32%), Positives = 49/106 (46%), Gaps = 18/106 (16%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILF---NEENVAKWFDFLLSISIPEGETHI 125
I +++ + YLH IV R+ K +N+L ++ + K DF LS +
Sbjct: 140 VIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK 196
Query: 126 TTDRVIGTRGYSAPEYISICVL----NEKSNVFSFGAFLFELLAGR 167
+GT Y APE VL +EK +V+S G LF LLAG
Sbjct: 197 E---RLGTAYYIAPE-----VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-08
Identities = 34/152 (22%), Positives = 71/152 (46%), Gaps = 22/152 (14%)
Query: 25 QMSHNHILKRIGCCLQTPIPI-LVFQSVEYGTLRDCIF-----GAPLPR---LKIASDIV 75
++ H ++++ +G C + P P ++ + + YG L D + + L +A+ I
Sbjct: 65 EIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQIS 121
Query: 76 NSLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIG 132
+++ YL +F + R+ +N L E ++ K DF LS +
Sbjct: 122 SAMEYLEKKNF------IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 133 TRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164
+ ++APE ++ + KS+V++FG L+E+
Sbjct: 176 IK-WTAPESLAYNKFSIKSDVWAFGVLLWEIA 206
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 4e-08
Identities = 35/148 (23%), Positives = 62/148 (41%), Gaps = 16/148 (10%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA----PLPRL-KIASDIVNSLA 79
+ H HI+K IG + P I + + YG L + + L + I ++A
Sbjct: 69 NLDHPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 80 YL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGY 136
YL + V R+ +NIL K DF LS I + + + + + + +
Sbjct: 128 YLESINC------VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK-W 180
Query: 137 SAPEYISICVLNEKSNVFSFGAFLFELL 164
+PE I+ S+V+ F ++E+L
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEIL 208
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-08
Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 18/106 (16%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILF---NEENVAKWFDFLLSISIPEGETHI 125
+I +++ + Y+H IV R+ K +N+L +++ + DF LS +
Sbjct: 130 RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK 186
Query: 126 TTDRVIGTRGYSAPEYISICVL----NEKSNVFSFGAFLFELLAGR 167
IGT Y APE VL +EK +V+S G L+ LL+G
Sbjct: 187 D---KIGTAYYIAPE-----VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 4e-08
Identities = 26/99 (26%), Positives = 42/99 (42%), Gaps = 7/99 (7%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128
++ ++L Y H R ++ R+ K +N+L + K DF S+ P T
Sbjct: 118 TFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TM- 172
Query: 129 RVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
GT Y PE I +EK +++ G +E L G
Sbjct: 173 --CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-08
Identities = 47/229 (20%), Positives = 94/229 (41%), Gaps = 53/229 (23%)
Query: 25 QMSHNHILKRIGCCLQTPIPI-LVFQSVEYGTLRDCIF-----GAPLPR---LKIASDIV 75
Q+ H+++++ +G ++ + +V + + G+L D + + L LK + D+
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVC 299
Query: 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTR- 134
++ YL V R+ +N+L +E+NVAK DF L+ + +
Sbjct: 300 EAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--------TGKL 348
Query: 135 --GYSAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNY 191
++APE + + KS+V+SFG L+E+ + GR+ + + +
Sbjct: 349 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----------LKDVVPR 398
Query: 192 LEDKRFTG--IPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238
+E G + AP P ++ + C + RPT
Sbjct: 399 VEK----GYKMDAP---DGCP-----PAVY---DVMKNCWHLDAATRPT 432
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 5e-08
Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 16/102 (15%)
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRV 130
A++I L LH IV R+ K +NIL ++ + D L++ +PEG+T RV
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV 346
Query: 131 IGTRGYSAPEYISICVLNEKS---NV--FSFGAFLFELLAGR 167
GT GY APE V+ + + ++ G L+E++AG+
Sbjct: 347 -GTVGYMAPE-----VVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 5e-08
Identities = 50/230 (21%), Positives = 81/230 (35%), Gaps = 49/230 (21%)
Query: 25 QMSHNHILKRIGCCLQT-PIPILVFQSVEYGTL----RDCIFGAPLPRL-KIASDIVNSL 78
++H ++L IG L +P ++ + +G L R + L + +
Sbjct: 78 GLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGM 137
Query: 79 AYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIG--- 132
YL F V R+ +N + +E K DF L+ I + E +
Sbjct: 138 EYLAEQKF------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191
Query: 133 ---TRGYSAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYL 188
T A E + KS+V+SFG L+ELL G + L
Sbjct: 192 VKWT----ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID----------PFDL 237
Query: 189 KNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238
++L R +P P + P L+ Q+ +C P RPT
Sbjct: 238 THFLAQGRR--LPQP---EYCP-----DSLY---QVMQQCWEADPAVRPT 274
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 6e-08
Identities = 33/151 (21%), Positives = 67/151 (44%), Gaps = 21/151 (13%)
Query: 25 QMSHNHILKRIGCCLQTPIPI-LVFQSVEYGTLRDCIF----GAPLPR---LKIASDIVN 76
+SH +++ G C + PI ++ + + G L + + L++ D+
Sbjct: 75 NLSHEKLVQLYGVCTKQR-PIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCE 131
Query: 77 SLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGT 133
++ YL F + R+ +N L N++ V K DF LS + + E +
Sbjct: 132 AMEYLESKQF------LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 185
Query: 134 RGYSAPEYISICVLNEKSNVFSFGAFLFELL 164
R +S PE + + KS++++FG ++E+
Sbjct: 186 R-WSPPEVLMYSKFSSKSDIWAFGVLMWEIY 215
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 7e-08
Identities = 49/233 (21%), Positives = 88/233 (37%), Gaps = 55/233 (23%)
Query: 25 QMSHNHILKRIGCCLQTPIPIL-VFQSVEYGTLRDCIF---GAPLPRLK----IASDIVN 76
SH ++L +G CL++ L V +++G LR+ F P +K +
Sbjct: 146 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAK 203
Query: 77 SLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIG- 132
+ +L F V R+ +N + +E+ K DF L+ + + E ++
Sbjct: 204 GMKFLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 133 -----TRGYSAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNE 186
A E + KS+V+SFG L+EL+ G D+
Sbjct: 258 LPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----------TF 303
Query: 187 YLKNYLED-KRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238
+ YL +R + P + P L+ ++ L+C + E RP+
Sbjct: 304 DITVYLLQGRR---LLQP---EYCP-----DPLY---EVMLKCWHPKAEMRPS 342
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 8e-08
Identities = 28/99 (28%), Positives = 47/99 (47%), Gaps = 6/99 (6%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128
K++ ++ L YL I+ R+ K NIL N K DF +S ++ +
Sbjct: 135 KVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDF--GVSGQLIDSMANS- 189
Query: 129 RVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
+GTR Y +PE + + +S+++S G L E+ GR
Sbjct: 190 -FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 9e-08
Identities = 26/99 (26%), Positives = 45/99 (45%), Gaps = 7/99 (7%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128
+++ N+L+Y H + ++ R+ K +N+L K DF S+ P
Sbjct: 113 TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDL- 167
Query: 129 RVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
GT Y PE I + +EK +++S G +E L G+
Sbjct: 168 --CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-07
Identities = 24/101 (23%), Positives = 43/101 (42%), Gaps = 8/101 (7%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128
I ++NS +Y+H + I R+ K NIL ++ K DF S + + + +
Sbjct: 155 CIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GS- 210
Query: 129 RVIGTRGYSAPEYIS--ICVLNEKSNVFSFGAFLFELLAGR 167
GT + PE+ S K +++S G L+ +
Sbjct: 211 --RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 33/106 (31%), Positives = 48/106 (45%), Gaps = 18/106 (16%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILF---NEENVAKWFDFLLSISIPEGETHI 125
+I + + + Y+H IV R+ K +NIL ++ K DF LS +
Sbjct: 125 RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181
Query: 126 TTDRVIGTRGYSAPEYISICVL----NEKSNVFSFGAFLFELLAGR 167
IGT Y APE VL +EK +V+S G L+ LL+G
Sbjct: 182 D---RIGTAYYIAPE-----VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 2e-07
Identities = 33/103 (32%), Positives = 47/103 (45%), Gaps = 18/103 (17%)
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRV 130
A++I+ L ++H R +V R+ K NIL +E + D L+ + + H V
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASV 351
Query: 131 IGTRGYSAPEYISICVLNEKSNV------FSFGAFLFELLAGR 167
GT GY APE VL + FS G LF+LL G
Sbjct: 352 -GTHGYMAPE-----VLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 34/101 (33%), Positives = 45/101 (44%), Gaps = 18/101 (17%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILF---NEENVAKWFDFLLSISIPEGETHITTDRV 130
I++ + YLH IV R+ K +NIL N K DF LS +
Sbjct: 155 ILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD---R 208
Query: 131 IGTRGYSAPEYISICVL----NEKSNVFSFGAFLFELLAGR 167
+GT Y APE VL NEK +V+S G ++ LL G
Sbjct: 209 LGTAYYIAPE-----VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-07
Identities = 25/110 (22%), Positives = 46/110 (41%), Gaps = 15/110 (13%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128
+++ ++ +H IV + K N L + + K DF ++ + T + D
Sbjct: 131 SYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKD 186
Query: 129 RVIGTRGYSAPEYI-----------SICVLNEKSNVFSFGAFLFELLAGR 167
+GT Y PE I S ++ KS+V+S G L+ + G+
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-07
Identities = 23/110 (20%), Positives = 44/110 (40%), Gaps = 15/110 (13%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128
+++ ++ +H IV + K N L + + K DF ++ + T + D
Sbjct: 159 SYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKD 214
Query: 129 RVIGTRGYSAPEYIS-----------ICVLNEKSNVFSFGAFLFELLAGR 167
+G Y PE I ++ KS+V+S G L+ + G+
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-07
Identities = 33/118 (27%), Positives = 50/118 (42%), Gaps = 19/118 (16%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE--THIT 126
KIA IV +L +LH ++ R+ K N+L N K DF +S G +
Sbjct: 113 KIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGIS-----GYLVDDVA 165
Query: 127 TDRVIGTRGYSAPEYISICVL----NEKSNVFSFGAFLFELLAGR------IHIWDLL 174
D G + Y APE I+ + + KS+++S G + EL R + L
Sbjct: 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL 223
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-07
Identities = 25/110 (22%), Positives = 46/110 (41%), Gaps = 15/110 (13%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128
+++ ++ +H IV + K N L + + K DF ++ + T + D
Sbjct: 112 SYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKD 167
Query: 129 RVIGTRGYSAPEYI-----------SICVLNEKSNVFSFGAFLFELLAGR 167
+GT Y PE I S ++ KS+V+S G L+ + G+
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-07
Identities = 28/105 (26%), Positives = 45/105 (42%), Gaps = 19/105 (18%)
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRV 130
++V +L YL + I+ R+ K NIL +E DF ++ +P T +
Sbjct: 121 ICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT---M 174
Query: 131 IGTRGYSAPEYISICVLNEKSNV--------FSFGAFLFELLAGR 167
GT+ Y APE + + + +S G +ELL GR
Sbjct: 175 AGTKPYMAPE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-07
Identities = 33/159 (20%), Positives = 68/159 (42%), Gaps = 27/159 (16%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRD-----------CIFGAPLPR---LKI 70
+ + +H+++ +G Q +++ + + G L+ AP +++
Sbjct: 84 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRV 130
A +I + +AYL+ V R+ +N + E+ K DF ++ I E + +
Sbjct: 144 AGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-----R 195
Query: 131 IGTRGY-----SAPEYISICVLNEKSNVFSFGAFLFELL 164
G +G +PE + V S+V+SFG L+E+
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 5e-07
Identities = 30/102 (29%), Positives = 53/102 (51%), Gaps = 15/102 (14%)
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRV 130
+ IV+ L +LH R I+ R+ K +N+L +++ + D L++ + G+T T
Sbjct: 295 TAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGY 349
Query: 131 IGTRGYSAPEYISICVLNEKS---NV--FSFGAFLFELLAGR 167
GT G+ APE +L + +V F+ G L+E++A R
Sbjct: 350 AGTPGFMAPE-----LLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 5e-07
Identities = 33/106 (31%), Positives = 46/106 (43%), Gaps = 11/106 (10%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILF--NEENVAKWFDFLLSISIP---EGET 123
I I ++L YLH + I R+ K +N LF N+ K DF LS GE
Sbjct: 172 NIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228
Query: 124 HITTDRVIGTRGYSAPEYISICVL--NEKSNVFSFGAFLFELLAGR 167
+ T + GT + APE ++ K + +S G L LL G
Sbjct: 229 YGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 6e-07
Identities = 31/104 (29%), Positives = 46/104 (44%), Gaps = 12/104 (11%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128
KI ++ + LH IV R+ K +NIL +++ K DF S + GE
Sbjct: 128 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-- 182
Query: 129 RVIGTRGYSAPEYISICVLNEKSN------VFSFGAFLFELLAG 166
V GT Y APE I + + ++S G ++ LLAG
Sbjct: 183 -VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 8e-07
Identities = 32/106 (30%), Positives = 45/106 (42%), Gaps = 14/106 (13%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE--THIT 126
K+ IV +L YL ++ R+ K NIL +E K DF +S G
Sbjct: 128 KMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGIS-----GRLVDDKA 180
Query: 127 TDRVIGTRGYSAPEYISICVLNE-----KSNVFSFGAFLFELLAGR 167
DR G Y APE I + +++V+S G L EL G+
Sbjct: 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 8e-07
Identities = 52/232 (22%), Positives = 91/232 (39%), Gaps = 53/232 (22%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF----GAPLPR---LKIASDIVN 76
Q H +I++ G ++ ++V + +E G+L F A + + I +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIAS 158
Query: 77 SLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGT 133
+ YL + V R+ +NIL N V K DF L + + + T
Sbjct: 159 GMKYLSDMGY------VHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-----EAAYTT 207
Query: 134 RG------YSAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNE 186
RG +++PE I+ S+V+S+G L+E+++ G W++ +
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------QD 258
Query: 187 YLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238
+K E R +P P D P L+ QL L+C +RP
Sbjct: 259 VIKAVDEGYR---LPPP---MDCP-----AALY---QLMLDCWQKDRNNRPK 296
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 9e-07
Identities = 25/112 (22%), Positives = 44/112 (39%), Gaps = 18/112 (16%)
Query: 68 LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILF----NEENVAKWFDFLLSISIPEGET 123
L + D+V + +L IV RN K NI+ + ++V K DF + + + E
Sbjct: 115 LIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
Query: 124 HITTDRVIGTRGYSAPEYISICVL--------NEKSNVFSFGAFLFELLAGR 167
++ + GT Y P+ VL +++S G + G
Sbjct: 172 FVS---LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 9e-07
Identities = 34/113 (30%), Positives = 51/113 (45%), Gaps = 12/113 (10%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILF---NEENVAKWFDFLLSISIPEGETHITTDRV 130
I+ ++AYLH IV R+ K +N+L+ + K DF LS + T V
Sbjct: 157 ILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT---V 210
Query: 131 IGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCF 183
GT GY APE + C + +++S G + LL G +D + D F
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD---ERGDQFMF 260
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 35/161 (21%), Positives = 60/161 (37%), Gaps = 33/161 (20%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRD--------CIFGAPLPR---LKIASD 73
+ +H +I++ IG LQ+ ++ + + G L+ + L L +A D
Sbjct: 130 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189
Query: 74 IVNSLAYL---HFGFPRPIVLRNFKTQNILFN---EENVAKWFDFLLSISIPEGETHITT 127
I YL HF + R+ +N L VAK DF ++ I +
Sbjct: 190 IACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY--- 240
Query: 128 DRVIGTRGYS-----APEYISICVLNEKSNVFSFGAFLFEL 163
G PE + K++ +SFG L+E+
Sbjct: 241 --RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-06
Identities = 36/154 (23%), Positives = 64/154 (41%), Gaps = 18/154 (11%)
Query: 25 QMSHNHILKRIGCCLQTPIPI-LVFQSVEYGTLRDCIF--GAPLPRL--KIASD----IV 75
+ H HI++ + + + +VF+ ++ L I +AS I+
Sbjct: 82 MLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 76 NSLAYLHFGFPRPIVLRNFKTQNILF-NEENVA--KWFDFLLSISIPEGETHITTDRVIG 132
+L Y H I+ R+ K +L ++EN A K F ++I + E +G
Sbjct: 141 EALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVG 195
Query: 133 TRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
T + APE + + +V+ G LF LL+G
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-06
Identities = 25/112 (22%), Positives = 44/112 (39%), Gaps = 18/112 (16%)
Query: 68 LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILF----NEENVAKWFDFLLSISIPEGET 123
L + D+V + +L IV RN K NI+ + ++V K DF + + + E
Sbjct: 115 LIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
Query: 124 HITTDRVIGTRGYSAPEYISICVL--------NEKSNVFSFGAFLFELLAGR 167
++ + GT Y P+ VL +++S G + G
Sbjct: 172 FVS---LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-06
Identities = 37/160 (23%), Positives = 73/160 (45%), Gaps = 41/160 (25%)
Query: 25 QMSHNHILKRIGCCLQTPIPI-LVFQSVEYGTLRDCIF-----GAPLPR---LKIASDIV 75
Q+ H+++++ +G ++ + +V + + G+L D + + L LK + D+
Sbjct: 70 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVC 127
Query: 76 NSLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIG 132
++ YL +F V R+ +N+L +E+NVAK DF L+ +
Sbjct: 128 EAMEYLEGNNF------VHRDLAARNVLVSEDNVAKVSDFGLT-------------KEAS 168
Query: 133 TRGY--------SAPEYISICVLNEKSNVFSFGAFLFELL 164
+ +APE + + KS+V+SFG L+E+
Sbjct: 169 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 208
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-06
Identities = 29/104 (27%), Positives = 47/104 (45%), Gaps = 12/104 (11%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128
I ++ ++++LH IV R+ K +NIL ++ + DF S + GE
Sbjct: 204 SIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE-- 258
Query: 129 RVIGTRGYSAPEYISICVLNEKSN------VFSFGAFLFELLAG 166
+ GT GY APE + + +++ G LF LLAG
Sbjct: 259 -LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-06
Identities = 35/161 (21%), Positives = 60/161 (37%), Gaps = 33/161 (20%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRD--------CIFGAPLPR---LKIASD 73
+ +H +I++ IG LQ+ ++ + + G L+ + L L +A D
Sbjct: 89 KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 74 IVNSLAYL---HFGFPRPIVLRNFKTQNIL---FNEENVAKWFDFLLSISIPEGETHITT 127
I YL HF + R+ +N L VAK DF ++ I +
Sbjct: 149 IACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY--- 199
Query: 128 DRVIGTRGYS-----APEYISICVLNEKSNVFSFGAFLFEL 163
G PE + K++ +SFG L+E+
Sbjct: 200 --RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-06
Identities = 34/164 (20%), Positives = 66/164 (40%), Gaps = 35/164 (21%)
Query: 25 QMSHNHILKRIGCCLQ------TPIPILVFQSVEYGTLRD-------CIFGAPLPR---L 68
+ H H+ K +G L+ PIP+++ +++G L LP +
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 69 KIASDIVNSLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI 125
+ DI + YL +F + R+ +N + E+ DF LS I G+ +
Sbjct: 141 RFMVDIACGMEYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY- 193
Query: 126 TTDRVIGTRG-----YSAPEYISICVLNEKSNVFSFGAFLFELL 164
G + A E ++ + S+V++FG ++E++
Sbjct: 194 ----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-06
Identities = 32/100 (32%), Positives = 46/100 (46%), Gaps = 18/100 (18%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILF---NEENVAKWFDFLLSISIPEGETHITTDRV 130
+ + + Y+H IV R+ K +NIL ++ K DF LS +
Sbjct: 130 VFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---R 183
Query: 131 IGTRGYSAPEYISICVL----NEKSNVFSFGAFLFELLAG 166
IGT Y APE VL +EK +V+S G L+ LL+G
Sbjct: 184 IGTAYYIAPE-----VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 2e-06
Identities = 25/100 (25%), Positives = 46/100 (46%), Gaps = 18/100 (18%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILF---NEENVAKWFDFLLSISIPEGETHITTDRV 130
+++++AY H + R+ K +N LF + ++ K DF L+ G+ T
Sbjct: 115 VLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT---K 168
Query: 131 IGTRGYSAPEYISICVL----NEKSNVFSFGAFLFELLAG 166
+GT Y +P+ VL + + +S G ++ LL G
Sbjct: 169 VGTPYYVSPQ-----VLEGLYGPECDEWSAGVMMYVLLCG 203
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-06
Identities = 35/158 (22%), Positives = 63/158 (39%), Gaps = 31/158 (19%)
Query: 24 AQMSHNHILKRIGCCLQTPIPIL-VFQSVEYGTLRDCIF----GAPLPR---LKIASDIV 75
Q H +I++ G + + V + +E G+L F + + +
Sbjct: 105 GQFDHPNIIRLEGVVTRGR-LAMIVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVG 161
Query: 76 NSLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIG 132
+ YL + V R+ +N+L + V K DF LS + + D
Sbjct: 162 AGMRYLSDLGY------VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----DAAYT 210
Query: 133 TRG------YSAPEYISICVLNEKSNVFSFGAFLFELL 164
T G ++APE I+ + S+V+SFG ++E+L
Sbjct: 211 TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-06
Identities = 36/163 (22%), Positives = 68/163 (41%), Gaps = 34/163 (20%)
Query: 25 QMSHNHILKRIGCCLQT-----PIPILVFQSVEYGTL-------RDCIFGAPLPR---LK 69
SH ++++ +G C++ P P+++ ++YG L R +P LK
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 70 IASDIVNSLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT 126
DI + YL +F + R+ +N + ++ DF LS I G+ +
Sbjct: 152 FMVDIALGMEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY-- 203
Query: 127 TDRVIGTRG-----YSAPEYISICVLNEKSNVFSFGAFLFELL 164
G + A E ++ V KS+V++FG ++E+
Sbjct: 204 ---RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-06
Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 9/96 (9%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILF--NEENVA-KWFDFLLSISIPEGETHITTDRV 130
I+ S+AY H IV RN K +N+L + A K DF L+I + + E
Sbjct: 137 ILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---F 190
Query: 131 IGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
GT GY +PE + ++ ++++ G L+ LL G
Sbjct: 191 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 3e-06
Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 9/96 (9%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILF--NEENVA-KWFDFLLSISIPEGETHITTDRV 130
I+ S+AY H IV RN K +N+L + A K DF L+I + + E
Sbjct: 114 ILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---F 167
Query: 131 IGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
GT GY +PE + ++ ++++ G L+ LL G
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-06
Identities = 40/164 (24%), Positives = 67/164 (40%), Gaps = 30/164 (18%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRD----------------CIFGAPLPR 67
+ H HI++ G C + ++VF+ + +G L + PL
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 68 ---LKIASDIVNSLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEG 121
L +AS + + YL HF V R+ T+N L + V K DF +S I
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211
Query: 122 E-THITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164
+ + ++ R + PE I +S+V+SFG L+E+
Sbjct: 212 DYYRVGGRTMLPIR-WMPPESILYRKFTTESDVWSFGVVLWEIF 254
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 5e-06
Identities = 31/130 (23%), Positives = 58/130 (44%), Gaps = 13/130 (10%)
Query: 46 LVFQSVEYGTLRDCIFGAPLP----RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILF 101
+VF+ V G + + PL R D++ + YLH+ + I+ R+ K N+L
Sbjct: 115 MVFELVNQGPVMEVPTLKPLSEDQAR-FYFQDLIKGIEYLHY---QKIIHRDIKPSNLLV 170
Query: 102 NEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLN---EKSNVFSFGA 158
E+ K DF +S + ++ +GT + APE +S + +V++ G
Sbjct: 171 GEDGHIKIADFGVSNEFKGSDALLSN--TVGTPAFMAPESLSETRKIFSGKALDVWAMGV 228
Query: 159 FLFELLAGRI 168
L+ + G+
Sbjct: 229 TLYCFVFGQC 238
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 5e-06
Identities = 38/158 (24%), Positives = 65/158 (41%), Gaps = 28/158 (17%)
Query: 25 QMSHNHILKRIGCCLQTPIPI-LVFQSVEYGTLRDCIFGAPLPR--------LKIASDIV 75
+ H +I+K + + +V ++ E G L + I A ++ ++
Sbjct: 76 SLDHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134
Query: 76 NSLAYLHFGFPRPIVLRNFKTQNILF---NEENVAKWFDFLLSISIPEGETHITTDRVIG 132
N+LAY H + +V ++ K +NILF + + K DF L+ E G
Sbjct: 135 NALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAG 188
Query: 133 TRGYSAPEYISICVLN----EKSNVFSFGAFLFELLAG 166
T Y APE V K +++S G ++ LL G
Sbjct: 189 TALYMAPE-----VFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-06
Identities = 38/155 (24%), Positives = 68/155 (43%), Gaps = 25/155 (16%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTL----RDCIFGAPLPRL-KIASDIVNSL 78
Q SH++I++ G + +++ + +E G L R+ + +L + I +
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 160
Query: 79 AYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRG 135
YL ++ V R+ +NIL N V K DF LS + + + T G
Sbjct: 161 KYLANMNY------VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EATYTTSG 209
Query: 136 ------YSAPEYISICVLNEKSNVFSFGAFLFELL 164
++APE IS S+V+SFG ++E++
Sbjct: 210 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVM 244
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-06
Identities = 31/164 (18%), Positives = 58/164 (35%), Gaps = 43/164 (26%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI--FGAPLPR---LKIASDIVNSLA 79
++SH H++ G C+ ILV + V++G+L + + L++A + ++
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127
Query: 80 YL---HFGFPRPIVLRNFKTQNIL--------FNEENVAKWFDFLLSISIPEGETHITTD 128
+L + N +NIL K D +S
Sbjct: 128 FLEENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS------------- 168
Query: 129 RVIGTRGY-------SAPEYISIC-VLNEKSNVFSFGAFLFELL 164
+ + PE I LN ++ +SFG L+E+
Sbjct: 169 ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 7e-06
Identities = 35/165 (21%), Positives = 61/165 (36%), Gaps = 39/165 (23%)
Query: 27 SHNHILKRIGCCLQTPIPILVFQSVEYGTLRD-----------------CIFGAPLPR-- 67
H +I+ +G C Q ++ + G LR+ L
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 68 -LKIASDIVNSLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET 123
+ A + + YL + R+ +N+L E+NV K DF L+ I +
Sbjct: 193 LVSCAYQVARGMEYLASKKC------IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 246
Query: 124 HITTDRVIGTRG-----YSAPEYISICVLNEKSNVFSFGAFLFEL 163
+ T G + APE + + +S+V+SFG L+E+
Sbjct: 247 Y-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 8e-06
Identities = 33/174 (18%), Positives = 59/174 (33%), Gaps = 56/174 (32%)
Query: 27 SHNHILKRIGCCLQTPIPILV-FQSVEYGTLRD-----------CIFGAPLPR------- 67
H +++ +G C + P++V + ++G L
Sbjct: 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 68 --LKIASDIVNSLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE 122
+ + + + +L + R+ +NIL +E+NV K DF L+
Sbjct: 149 HLICYSFQVAKGMEFLASRKC------IHRDLAARNILLSEKNVVKICDFGLA------- 195
Query: 123 THITTDRVIGTRGY-------------SAPEYISICVLNEKSNVFSFGAFLFEL 163
R I APE I V +S+V+SFG L+E+
Sbjct: 196 ------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 9e-06
Identities = 25/96 (26%), Positives = 44/96 (45%), Gaps = 8/96 (8%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILF--NEENVA-KWFDFLLSISIPEGETHITTDRV 130
I+ ++ + H +V RN K +N+L + A K DF L+I + +
Sbjct: 119 ILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--F 173
Query: 131 IGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
GT GY +PE + + ++++ G L+ LL G
Sbjct: 174 AGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-05
Identities = 35/105 (33%), Positives = 46/105 (43%), Gaps = 13/105 (12%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE--THIT 126
KI V +L +L I+ R+ K NIL + K DF IS G+ I
Sbjct: 129 KITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDF--GIS---GQLVDSIA 181
Query: 127 TDRVIGTRGYSAPEYISICVLNE----KSNVFSFGAFLFELLAGR 167
R G R Y APE I + +S+V+S G L+EL GR
Sbjct: 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-05
Identities = 27/106 (25%), Positives = 50/106 (47%), Gaps = 18/106 (16%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILF---NEENVAKWFDFLLSISIPEGETHI 125
I +V++++++H +V R+ K +N+LF N+ K DF + P +
Sbjct: 110 YIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166
Query: 126 TTDRVIGTRGYSAPEYISICVL-----NEKSNVFSFGAFLFELLAG 166
T T Y+APE +L +E +++S G L+ +L+G
Sbjct: 167 KT--PCFTLHYAAPE-----LLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-05
Identities = 25/107 (23%), Positives = 43/107 (40%), Gaps = 19/107 (17%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILF--NEENVA--KWFDFLLSISIPEGETH 124
+ I ++ YLH + +V R+ K NIL+ N + DF + +
Sbjct: 120 AVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 125 ITTDRVIGTRGYSAPEYISICVLNEKS-----NVFSFGAFLFELLAG 166
+ T T + APE VL + +++S G L+ +L G
Sbjct: 177 LMT--PCYTANFVAPE-----VLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 2e-05
Identities = 28/101 (27%), Positives = 48/101 (47%), Gaps = 10/101 (9%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILF---NEENVAKWFDFLLSISIPEGETHI 125
+ +++++ YLH IV R+ K +N+L+ E + DF LS G +
Sbjct: 110 LVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--M 164
Query: 126 TTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
+T GT GY APE ++ ++ + +S G + LL G
Sbjct: 165 ST--ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-05
Identities = 34/153 (22%), Positives = 69/153 (45%), Gaps = 8/153 (5%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIAS---D 73
IN I + + +I+ + L +V + + G+L D + + +IA+ +
Sbjct: 65 INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE 124
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGT 133
+ +L +LH ++ R+ K+ NIL + K DF I ++ +T ++GT
Sbjct: 125 CLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179
Query: 134 RGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
+ APE ++ K +++S G E++ G
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-05
Identities = 28/97 (28%), Positives = 46/97 (47%), Gaps = 10/97 (10%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVA----KWFDFLLSISIPEGETHITTDR 129
I+N + YLH I + K +NI+ + NV K DF L+ I G
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--- 176
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
+ GT + APE ++ L +++++S G + LL+G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 3e-05
Identities = 20/95 (21%), Positives = 40/95 (42%), Gaps = 8/95 (8%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILF--NEENVAKWFDFLLSISIPEGETHITTDRVI 131
L ++H IV + K +NI+ + + K DF L+ + E
Sbjct: 158 ACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TT 211
Query: 132 GTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
T ++APE + + +++++ G + LL+G
Sbjct: 212 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-05
Identities = 33/173 (19%), Positives = 57/173 (32%), Gaps = 55/173 (31%)
Query: 27 SHNHILKRIGCCLQTPIPILVFQSVEYGTLRD-----------------CIFGAPLPR-- 67
H +I+ +G C Q ++ + G LR+ + +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 68 -LKIASDIVNSLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET 123
+ + + YL + R+ +N+L E NV K DF L+
Sbjct: 159 LVSCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLA-------- 204
Query: 124 HITTDRVIGTRGYS-------------APEYISICVLNEKSNVFSFGAFLFEL 163
R I Y APE + V +S+V+SFG ++E+
Sbjct: 205 -----RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 3e-05
Identities = 22/95 (23%), Positives = 41/95 (43%), Gaps = 8/95 (8%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILF--NEENVAKWFDFLLSISIPEGETHITTDRVI 131
+ L ++H V + K +NI+F N K DF L+ + ++
Sbjct: 264 VCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TT 317
Query: 132 GTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
GT ++APE + ++++S G + LL+G
Sbjct: 318 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 3e-05
Identities = 29/95 (30%), Positives = 45/95 (47%), Gaps = 7/95 (7%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISI-PEGETHITTDRVIG 132
IV YLH ++ R+ K N+ NE+ K DF L+ + +GE G
Sbjct: 124 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL---CG 177
Query: 133 TRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
T Y APE +S + + +V+S G ++ LL G+
Sbjct: 178 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-05
Identities = 33/153 (21%), Positives = 69/153 (45%), Gaps = 8/153 (5%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIAS---D 73
N + H ++++ L ++ + ++ G L D + L +IA+
Sbjct: 90 FNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEA 149
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGT 133
++ +LAYLH + ++ R+ K+ +IL + K DF I + + ++GT
Sbjct: 150 VLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGT 204
Query: 134 RGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
+ APE IS + + +++S G + E++ G
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-05
Identities = 29/95 (30%), Positives = 45/95 (47%), Gaps = 7/95 (7%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISI-PEGETHITTDRVIG 132
IV YLH ++ R+ K N+ NE+ K DF L+ + +GE G
Sbjct: 150 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL---CG 203
Query: 133 TRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
T Y APE +S + + +V+S G ++ LL G+
Sbjct: 204 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 3e-05
Identities = 28/95 (29%), Positives = 41/95 (43%), Gaps = 7/95 (7%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISI-PEGETHITTDRVIG 132
I+ + YLH I+ R+ N+L K DF L+ + E H T G
Sbjct: 121 IITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL---CG 174
Query: 133 TRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
T Y +PE + +S+V+S G + LL GR
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-05
Identities = 38/153 (24%), Positives = 68/153 (44%), Gaps = 8/153 (5%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIAS---D 73
IT +Q ++ K G L+ ++ + + G+ D + PL +IA+ +
Sbjct: 68 QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILRE 127
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGT 133
I+ L YLH + R+ K N+L +E K DF ++ + + + T +GT
Sbjct: 128 ILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 182
Query: 134 RGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
+ APE I + K++++S G EL G
Sbjct: 183 PFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 4e-05
Identities = 27/106 (25%), Positives = 46/106 (43%), Gaps = 20/106 (18%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILF---NEENVAKWFDFLLSISIPEGETHI 125
+I DI ++ +LH I R+ K +N+L+ ++ V K DF + + +
Sbjct: 132 EIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--L 186
Query: 126 TTDRVIGTRGYSAPEYISICVLNEKS-----NVFSFGAFLFELLAG 166
T T Y APE VL + +++S G ++ LL G
Sbjct: 187 QT--PCYTPYYVAPE-----VLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 4e-05
Identities = 26/106 (24%), Positives = 42/106 (39%), Gaps = 19/106 (17%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILF---NEENVAKWFDFLLSISIPEGETHI 125
+I I ++ YLH I R+ K +N+L+ + K DF + +
Sbjct: 165 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 221
Query: 126 TTDRVIGTRGYSAPEYISICVLNEKS-----NVFSFGAFLFELLAG 166
T T Y APE VL + +++S G ++ LL G
Sbjct: 222 T---PCYTPYYVAPE-----VLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 4e-05
Identities = 39/163 (23%), Positives = 67/163 (41%), Gaps = 33/163 (20%)
Query: 26 MSHNHILKRIG--------CCLQTPIPI-LVFQSVEYGTL-----RDCIFGAPLPRLKI- 70
++ N +L+ QT + V + G L R+ +F R +
Sbjct: 196 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF--SEDRARFY 253
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLS-ISIPEGETHITTDR 129
++IV++L YLH + +V R+ K +N++ +++ K DF L I +G T
Sbjct: 254 GAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKT 308
Query: 130 VIGTRGYSAPEYISICVLNEKSNVF-----SFGAFLFELLAGR 167
GT Y APE VL + G ++E++ GR
Sbjct: 309 FCGTPEYLAPE-----VLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 4e-05
Identities = 42/169 (24%), Positives = 66/169 (39%), Gaps = 39/169 (23%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRD-----------CIFGAPLPR----- 67
+ H HI+K G C I+VF+ +++G L + G P
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 68 ----LKIASDIVNSLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPE 120
L IAS I + + YL HF V R+ T+N L + K DF +S +
Sbjct: 132 LSQMLHIASQIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYS 185
Query: 121 GETHITTDRVIGTRG-----YSAPEYISICVLNEKSNVFSFGAFLFELL 164
+ + +G + PE I +S+V+SFG L+E+
Sbjct: 186 TDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 229
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 4e-05
Identities = 36/172 (20%), Positives = 61/172 (35%), Gaps = 51/172 (29%)
Query: 27 SHNHILKRIGCCLQTPIPILVFQSVEYGTLRD----------CIFGAPLPR--------- 67
+H +I+ +G C +++ + YG L + C +P
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 68 ---LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH 124
L + + +A+L + + R+ +NIL + K DF L+
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLA--------- 192
Query: 125 ITTDRVIGTRGY-------------SAPEYISICVLNEKSNVFSFGAFLFEL 163
R I APE I CV +S+V+S+G FL+EL
Sbjct: 193 ----RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 4e-05
Identities = 33/173 (19%), Positives = 57/173 (32%), Gaps = 55/173 (31%)
Query: 27 SHNHILKRIGCCLQTPIPILVFQSVEYGTLRD-----------------CIFGAPLPR-- 67
H +I+ +G C Q ++ + G LR+ + +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 68 -LKIASDIVNSLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET 123
+ + + YL + R+ +N+L E NV K DF L+
Sbjct: 205 LVSCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLA-------- 250
Query: 124 HITTDRVIGTRGYS-------------APEYISICVLNEKSNVFSFGAFLFEL 163
R I Y APE + V +S+V+SFG ++E+
Sbjct: 251 -----RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-05
Identities = 26/95 (27%), Positives = 42/95 (44%), Gaps = 7/95 (7%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGT 133
IV+++ Y H + IV R+ K +N+L + + K DF S G G
Sbjct: 123 IVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF---CGA 176
Query: 134 RGYSAPEYIS-ICVLNEKSNVFSFGAFLFELLAGR 167
Y+APE + +V+S G L+ L++G
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 5e-05
Identities = 34/163 (20%), Positives = 64/163 (39%), Gaps = 37/163 (22%)
Query: 27 SHNHILKRIGCCLQTPIPILVFQSVEYGTLRD---------------CIFGAPLPR---L 68
H +I+ +G C +++ + YG L + I + L
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 69 KIASDIVNSLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI 125
+S + +A+L + + R+ +N+L +VAK DF L+ I +
Sbjct: 168 HFSSQVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY- 220
Query: 126 TTDRVIGTRG-----YSAPEYISICVLNEKSNVFSFGAFLFEL 163
++ + APE I CV +S+V+S+G L+E+
Sbjct: 221 ----IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 5e-05
Identities = 26/97 (26%), Positives = 49/97 (50%), Gaps = 10/97 (10%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVA----KWFDFLLSISIPEGETHITTDR 129
I++ + YLH + I + K +NI+ ++N+ K DF L+ I +G
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--- 177
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
+ GT + APE ++ L +++++S G + LL+G
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 5e-05
Identities = 26/95 (27%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGT 133
++ + +LH I+ R+ K NI+ + K DF L+ + G + + T V+ T
Sbjct: 173 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV-T 226
Query: 134 RGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRI 168
R Y APE I E +++S G + E++ +I
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 6e-05
Identities = 30/164 (18%), Positives = 61/164 (37%), Gaps = 16/164 (9%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI---FGAPLPRLKIAS- 72
+ + +H +I+ + +V + YG+ +D I F + L IA
Sbjct: 74 QGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI 133
Query: 73 --DIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET-----HI 125
++ +L Y+H V R+ K +IL + + ++S+ H
Sbjct: 134 LQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190
Query: 126 TTDRVIGTRGYSAPEYISICVL--NEKSNVFSFGAFLFELLAGR 167
+ + +PE + + + KS+++S G EL G
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 6e-05
Identities = 29/102 (28%), Positives = 53/102 (51%), Gaps = 13/102 (12%)
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRV 130
++IV++L YLH + I+ R+ K +NIL NE+ + DF + + +
Sbjct: 136 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
Query: 131 IGTRGYSAPEYISICVLNEK-----SNVFSFGAFLFELLAGR 167
+GT Y +PE +L EK S++++ G +++L+AG
Sbjct: 193 VGTAQYVSPE-----LLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 8e-05
Identities = 25/96 (26%), Positives = 40/96 (41%), Gaps = 9/96 (9%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILF---NEENVAKWFDFLLSISIPEGETHITTDRV 130
I+ + YLH IV + K QNIL K DF +S I +
Sbjct: 140 ILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---I 193
Query: 131 IGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
+GT Y APE ++ + +++++ G + LL
Sbjct: 194 MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 8e-05
Identities = 26/97 (26%), Positives = 49/97 (50%), Gaps = 10/97 (10%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVA----KWFDFLLSISIPEGETHITTDR 129
I++ + YLH + I + K +NI+ ++N+ K DF L+ I +G
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--- 177
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
+ GT + APE ++ L +++++S G + LL+G
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 1e-04
Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 9/97 (9%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEE-NVAKWFDFLLSISIPEGETHITTDRVIG 132
+V ++ + H R +V R+ K +NIL + AK DF + + D G
Sbjct: 148 VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT-DFD---G 200
Query: 133 TRGYSAPEYIS-ICVLNEKSNVFSFGAFLFELLAGRI 168
TR YS PE+IS + V+S G L++++ G I
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI 237
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 38/143 (26%), Positives = 59/143 (41%), Gaps = 24/143 (16%)
Query: 37 CCLQTPIPI-LVFQSVEYGTL-----RDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIV 90
C QT + V + V G L + F P A +I L +L + I+
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQ---SKGII 464
Query: 91 LRNFKTQNILFNEENVAKWFDFLLS-ISIPEGETHITTDRVIGTRGYSAPEYISICVLNE 149
R+ K N++ + E K DF + +I +G T T GT Y APE ++
Sbjct: 465 YRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPE-----IIAY 516
Query: 150 KSNVF-----SFGAFLFELLAGR 167
+ +FG L+E+LAG+
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 1e-04
Identities = 27/97 (27%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 68 LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI-T 126
+ + + + +L R + R+ +NIL +E+NV K DF L+ I + ++
Sbjct: 196 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252
Query: 127 TDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163
D + + + APE I V +S+V+SFG L+E+
Sbjct: 253 GDARLPLK-WMAPETIFDRVYTIQSDVWSFGVLLWEI 288
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 1e-04
Identities = 24/97 (24%), Positives = 44/97 (45%), Gaps = 10/97 (10%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILF----NEENVAKWFDFLLSISIPEGETHITTDR 129
I++ + YLH + I + K +NI+ K DF ++ I G
Sbjct: 117 ILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--- 170
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
+ GT + APE ++ L +++++S G + LL+G
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 1e-04
Identities = 28/99 (28%), Positives = 44/99 (44%), Gaps = 12/99 (12%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILF---NEENVAKWFDFLLSISIPEGETHITTDRV 130
++ ++ YLH I+ R+ K +N+L E+ + K DF S + E T +
Sbjct: 123 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---L 176
Query: 131 IGTRGYSAPEYISICVL---NEKSNVFSFGAFLFELLAG 166
GT Y APE + N + +S G LF L+G
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 1e-04
Identities = 26/94 (27%), Positives = 45/94 (47%), Gaps = 6/94 (6%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGT 133
++ + +LH I+ R+ K NI+ + K DF L+ + G + + T V+ T
Sbjct: 136 MLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV-T 189
Query: 134 RGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
R Y APE I E +++S G + E++ G
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 1e-04
Identities = 40/177 (22%), Positives = 63/177 (35%), Gaps = 47/177 (26%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRD------------------------- 58
A+ + +I+K +G C L+F+ + YG L +
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 59 CIFGAPLPR---LKIASDIVNSLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDF 112
PL L IA + +AYL F V R+ T+N L E V K DF
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADF 218
Query: 113 LLSISIPEGETHITTDRVIGTRGY-----SAPEYISICVLNEKSNVFSFGAFLFELL 164
LS +I + + PE I +S+V+++G L+E+
Sbjct: 219 GLSRNIYSADYY-----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 1e-04
Identities = 28/104 (26%), Positives = 44/104 (42%), Gaps = 12/104 (11%)
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILF---NEENVAKWFDFLLSISIPEGETHI 125
++ ++ YLH I+ R+ K +N+L E+ + K DF S + E
Sbjct: 243 LYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 299
Query: 126 TTDRVIGTRGYSAPEYISICVL---NEKSNVFSFGAFLFELLAG 166
T + GT Y APE + N + +S G LF L+G
Sbjct: 300 T---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 22/95 (23%), Positives = 41/95 (43%), Gaps = 8/95 (8%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILF--NEENVAKWFDFLLSISIPEGETHITTDRVI 131
I + ++H I+ + K +NIL + K DF L+ E
Sbjct: 196 ICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NF 249
Query: 132 GTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
GT + APE ++ ++ ++++S G + LL+G
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 2e-04
Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 10/155 (6%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI--FGAPLPRLKIAS-- 72
I I+ Q H++K G + +V + G++ D I L +IA+
Sbjct: 72 IKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATIL 131
Query: 73 -DIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVI 131
+ L YLHF + R+ K NIL N E AK DF ++ + + T VI
Sbjct: 132 QSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VI 186
Query: 132 GTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166
GT + APE I N ++++S G E+ G
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 40/144 (27%), Positives = 61/144 (42%), Gaps = 26/144 (18%)
Query: 37 CCLQTPIPI-LVFQSVEYGTL-----RDCIFGAPLPRLKI-ASDIVNSLAYLHFGFPRPI 89
C QT + V + V G L R P + +++I +L YLH R I
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKL--PEEHARFYSAEISLALNYLH---ERGI 174
Query: 90 VLRNFKTQNILFNEENVAKWFDFLLS-ISIPEGETHITTDRVIGTRGYSAPEYISICVLN 148
+ R+ K N+L + E K D+ + + G+T T GT Y APE +L
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPE-----ILR 226
Query: 149 EKSNVF-----SFGAFLFELLAGR 167
+ F + G +FE++AGR
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 28/165 (16%), Positives = 64/165 (38%), Gaps = 31/165 (18%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRD-----------------CIFGAPLP 66
A++ H +++ +G + ++F +G L + + L
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 67 R---LKIASDIVNSLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPE 120
+ + + I + YL H V ++ T+N+L ++ K D L +
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
Query: 121 GET-HITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164
+ + + ++ R + APE I + S+++S+G L+E+
Sbjct: 181 ADYYKLLGNSLLPIR-WMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 38/183 (20%), Positives = 59/183 (32%), Gaps = 63/183 (34%)
Query: 25 QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRD-------------------------C 59
Q++H H++K G C Q +L+ + +YG+LR
Sbjct: 82 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 60 IFGAPLPR---LKIASDIVNSLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFL 113
L + A I + YL V R+ +NIL E K DF
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKISDFG 195
Query: 114 LSISIPEGETHITTDRVIGTRGY-------------SAPEYISICVLNEKSNVFSFGAFL 160
LS R + A E + + +S+V+SFG L
Sbjct: 196 LS-------------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 161 FEL 163
+E+
Sbjct: 243 WEI 245
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 14/80 (17%), Positives = 28/80 (35%), Gaps = 13/80 (16%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILF--NEENVAKWFDFLLSISIPEGETHITTDRVI 131
+ +L +LH I + + +NI++ + K +F + + G+ +
Sbjct: 111 VCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LF 164
Query: 132 GTRGYSAPEYISICVLNEKS 151
Y APE V
Sbjct: 165 TAPEYYAPE-----VHQHDV 179
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 40/144 (27%), Positives = 61/144 (42%), Gaps = 26/144 (18%)
Query: 37 CCLQTPIPI-LVFQSVEYGTL-----RDCIFGAPLPRLKI-ASDIVNSLAYLHFGFPRPI 89
C QT + V + V G L R P + +++I +L YLH R I
Sbjct: 77 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKL--PEEHARFYSAEISLALNYLH---ERGI 131
Query: 90 VLRNFKTQNILFNEENVAKWFDFLLS-ISIPEGETHITTDRVIGTRGYSAPEYISICVLN 148
+ R+ K N+L + E K D+ + + G+T T GT Y APE +L
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPE-----ILR 183
Query: 149 EKSNVF-----SFGAFLFELLAGR 167
+ F + G +FE++AGR
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGR 207
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 2e-04
Identities = 18/119 (15%), Positives = 35/119 (29%), Gaps = 27/119 (22%)
Query: 68 LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE----- 122
+ + L Y+H +V + K NI + ++
Sbjct: 118 KDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174
Query: 123 -------THITTDRV-IGTRGYSAPEYISICVLNE------KSNVFSFGAFLFELLAGR 167
T I++ +V G + A E VL E K+++F+ +
Sbjct: 175 IGDLGHVTRISSPQVEEGDSRFLANE-----VLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 2e-04
Identities = 24/98 (24%), Positives = 44/98 (44%), Gaps = 11/98 (11%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEE--NVAKWFDFLLSISIPEGETHITTDRVI 131
++ ++ + H ++ R+ K +NIL + + K DF + + D
Sbjct: 158 VLEAVRHCH---NCGVLHRDIKDENILIDLNRGEL-KLIDFGSGALLKDTVYT-DFD--- 209
Query: 132 GTRGYSAPEYIS-ICVLNEKSNVFSFGAFLFELLAGRI 168
GTR YS PE+I + V+S G L++++ G I
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 247
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 3e-04
Identities = 29/103 (28%), Positives = 48/103 (46%), Gaps = 17/103 (16%)
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLS-ISIPEGETHITTDR 129
A++I L +L + I+ R+ K N++ + E K DF + +I +G T T
Sbjct: 127 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKT 180
Query: 130 VIGTRGYSAPEYISICVLNEKSNVF-----SFGAFLFELLAGR 167
GT Y APE ++ + +FG L+E+LAG+
Sbjct: 181 FCGTPDYIAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 3e-04
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 7/95 (7%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGT 133
I++++ Y H +V R+ K +N+L + AK DF LS + +GE T+ G+
Sbjct: 120 ILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGS 173
Query: 134 RGYSAPEYIS-ICVLNEKSNVFSFGAFLFELLAGR 167
Y+APE IS + +++S G L+ LL G
Sbjct: 174 PNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 3e-04
Identities = 26/100 (26%), Positives = 43/100 (43%), Gaps = 17/100 (17%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGT 133
+V+++ YL + I+ R+ K +NI+ E+ K DF + + G+ T GT
Sbjct: 139 LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF---CGT 192
Query: 134 RGYSAPEYISICVLNEKS------NVFSFGAFLFELLAGR 167
Y APE VL ++S G L+ L+
Sbjct: 193 IEYCAPE-----VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 4e-04
Identities = 38/159 (23%), Positives = 60/159 (37%), Gaps = 32/159 (20%)
Query: 28 HNHILKRIGCCLQTPIPILVFQSVEYGTLRD-----------------CIFGAPLPR--- 67
H +I+ +G C L + +G L D + L
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 68 LKIASDIVNSLAYL---HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH 124
L A+D+ + YL F + R+ +NIL E VAK DF LS +
Sbjct: 145 LHFAADVARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSRG--QEVYV 196
Query: 125 ITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163
T + R + A E ++ V S+V+S+G L+E+
Sbjct: 197 KKTMGRLPVR-WMAIESLNYSVYTTNSDVWSYGVLLWEI 234
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 4e-04
Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 7/95 (7%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGT 133
I+ ++ Y H IV R+ K +N+L ++ K DF LS + +G T+ G+
Sbjct: 117 IICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGS 170
Query: 134 RGYSAPEYIS-ICVLNEKSNVFSFGAFLFELLAGR 167
Y+APE I+ + +V+S G L+ +L GR
Sbjct: 171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 39.1 bits (92), Expect = 7e-04
Identities = 42/144 (29%), Positives = 62/144 (43%), Gaps = 26/144 (18%)
Query: 37 CCLQTPIPI-LVFQSVEYGTL-----RDCIFGAPLPRLKI-ASDIVNSLAYLHFGFPRPI 89
CC QTP + V + V G L + F R + A++I+++L +LH + I
Sbjct: 91 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF--DEARARFYAAEIISALMFLH---DKGI 145
Query: 90 VLRNFKTQNILFNEENVAKWFDFLLS-ISIPEGETHITTDRVIGTRGYSAPEYISICVLN 148
+ R+ K N+L + E K DF + I G T T GT Y APE +L
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAPE-----ILQ 197
Query: 149 EKSNVF-----SFGAFLFELLAGR 167
E + G L+E+L G
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 39.1 bits (92), Expect = 7e-04
Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 17/103 (16%)
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLS-ISIPEGETHITTDR 129
++IV++L YLH R +V R+ K +N++ +++ K DF L I +G T
Sbjct: 111 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKT 164
Query: 130 VIGTRGYSAPEYISICVLNEKSNVF-----SFGAFLFELLAGR 167
GT Y APE VL + G ++E++ GR
Sbjct: 165 FCGTPEYLAPE-----VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 38.7 bits (91), Expect = 8e-04
Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 17/103 (16%)
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLS-ISIPEGETHITTDR 129
A++I+ L +LH + IV R+ K NIL +++ K DF + ++ T+
Sbjct: 124 AAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNT 177
Query: 130 VIGTRGYSAPEYISICVLNEKSNVF-----SFGAFLFELLAGR 167
GT Y APE +L + SFG L+E+L G+
Sbjct: 178 FCGTPDYIAPE-----ILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 39.0 bits (91), Expect = 9e-04
Identities = 29/100 (29%), Positives = 49/100 (49%), Gaps = 17/100 (17%)
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGT 133
I++ + Y H +V R+ K +N+L + AK DF LS + +GE T+ G+
Sbjct: 125 ILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGS 178
Query: 134 RGYSAPEYISICVLNEK------SNVFSFGAFLFELLAGR 167
Y+APE V++ + +++S G L+ LL G
Sbjct: 179 PNYAAPE-----VISGRLYAGPEVDIWSSGVILYALLCGT 213
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 241 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.54 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.34 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.02 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.81 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.58 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.34 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.12 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.87 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.64 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.61 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.01 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.9 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.72 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.47 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.43 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.37 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.21 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.04 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.89 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 93.67 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 91.79 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.54 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.67 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 89.25 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 89.09 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 87.92 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 87.74 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 86.8 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 86.62 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 82.6 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=343.32 Aligned_cols=215 Identities=17% Similarity=0.247 Sum_probs=172.3
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----------------
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---------------- 64 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------- 64 (241)
||.+.........++|.+|+.++++|+|||||+++|+|..++..++|||||++|+|.+++....
T Consensus 61 vK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~ 140 (308)
T 4gt4_A 61 IKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 140 (308)
T ss_dssp EEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEEC
T ss_pred EEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCcccccccccccccccc
Confidence 4666555555667889999999999999999999999999999999999999999999985421
Q ss_pred ----chHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcc
Q 044022 65 ----LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPE 140 (241)
Q Consensus 65 ----~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE 140 (241)
..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++...........+...||+.|+|||
T Consensus 141 ~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE 217 (308)
T 4gt4_A 141 ALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPE 217 (308)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHH
Confidence 136789999999999999 8999999999999999999999999999998654433333334567899999999
Q ss_pred cccccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHH
Q 044022 141 YISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLH 219 (241)
Q Consensus 141 ~~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (241)
++.+..++.++|||||||++|||+| |..||.... ..+..... ..+...+.+ . .++.
T Consensus 218 ~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~---------~~~~~~~i-~~~~~~~~p-----~--------~~~~ 274 (308)
T 4gt4_A 218 AIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---------NQDVVEMI-RNRQVLPCP-----D--------DCPA 274 (308)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC---------HHHHHHHH-HTTCCCCCC-----T--------TCCH
T ss_pred HHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC---------HHHHHHHH-HcCCCCCCc-----c--------cchH
Confidence 9999999999999999999999998 899996521 12222222 222222211 1 2336
Q ss_pred HHHHHHHHhccCCCCCCCCCCC
Q 044022 220 ASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 220 ~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.+.+|+.+||+.||++|||+.|
T Consensus 275 ~~~~li~~C~~~dP~~RPs~~e 296 (308)
T 4gt4_A 275 WVYALMIECWNEFPSRRPRFKD 296 (308)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHH
Confidence 7889999999999999999854
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=342.68 Aligned_cols=214 Identities=22% Similarity=0.327 Sum_probs=172.0
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----------------
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---------------- 64 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------- 64 (241)
||.+... .....++|.+|+++|++|+|||||+++|+|.+++..++|||||++|+|.+++....
T Consensus 48 vK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~ 126 (299)
T 4asz_A 48 VKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELT 126 (299)
T ss_dssp EEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCC
T ss_pred EEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCC
Confidence 3555432 33456789999999999999999999999999999999999999999999996431
Q ss_pred -chHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc
Q 044022 65 -LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS 143 (241)
Q Consensus 65 -~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 143 (241)
..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++...............||+.|+|||++.
T Consensus 127 ~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~ 203 (299)
T 4asz_A 127 QSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM 203 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHc
Confidence 146889999999999999 8999999999999999999999999999998665444333334456899999999999
Q ss_pred ccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHH
Q 044022 144 ICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASA 222 (241)
Q Consensus 144 ~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (241)
+..++.++|||||||++|||+| |+.||.... ..+..... ..+.....+ . .+++.+.
T Consensus 204 ~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~---------~~~~~~~i-~~~~~~~~p-----~--------~~~~~~~ 260 (299)
T 4asz_A 204 YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---------NNEVIECI-TQGRVLQRP-----R--------TCPQEVY 260 (299)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---------HHHHHHHH-HHTCCCCCC-----T--------TCCHHHH
T ss_pred CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------HHHHHHHH-HcCCCCCCC-----c--------cchHHHH
Confidence 9999999999999999999998 899996521 12222222 222222211 1 2236789
Q ss_pred HHHHHhccCCCCCCCCCCC
Q 044022 223 QLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 223 ~l~~~cl~~~p~~Rpt~~e 241 (241)
+|+.+||+.||++|||++|
T Consensus 261 ~li~~cl~~dP~~RPs~~~ 279 (299)
T 4asz_A 261 ELMLGCWQREPHMRKNIKG 279 (299)
T ss_dssp HHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHcCCChhHCcCHHH
Confidence 9999999999999999853
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=335.16 Aligned_cols=210 Identities=21% Similarity=0.296 Sum_probs=159.2
Q ss_pred cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHHHHhchhhcC
Q 044022 10 RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 10 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~~~l~~lh~~ 84 (241)
....++|.+|++++++++|||||+++|++.+ +.+++|||||++|+|.+++.... . .++.++.||+.||.|||
T Consensus 73 ~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH-- 149 (307)
T 3omv_A 73 PEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH-- 149 (307)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH--
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 3456789999999999999999999998864 56899999999999999996542 2 57889999999999999
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc---cCCCcchhhHHHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI---CVLNEKSNVFSFGAFLF 161 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~s~G~~~~ 161 (241)
+++|+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|
T Consensus 150 -~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~ 228 (307)
T 3omv_A 150 -AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLY 228 (307)
T ss_dssp -HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHH
T ss_pred -HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHH
Confidence 89999999999999999999999999999986554333333345689999999999964 35889999999999999
Q ss_pred HHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 162 ELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 162 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
||+||+.||..... ..........+...+.. +.... .+++.+.+|+.+||+.||++|||+.|
T Consensus 229 Elltg~~Pf~~~~~---------~~~~~~~~~~~~~~p~~-~~~~~--------~~~~~l~~li~~cl~~dP~~RPs~~e 290 (307)
T 3omv_A 229 ELMTGELPYSHINN---------RDQIIFMVGRGYASPDL-SKLYK--------NCPKAMKRLVADCVKKVKEERPLFPQ 290 (307)
T ss_dssp HHHHSSCTTTTCCC---------HHHHHHHHHTTCCCCCS-TTSCT--------TSCHHHHHHHHHHTCSSSTTSCCHHH
T ss_pred HHHHCCCCCCCCCh---------HHHHHHHHhcCCCCCCc-ccccc--------cchHHHHHHHHHHcCCCHhHCcCHHH
Confidence 99999999964211 11222222222111100 11112 23367899999999999999999853
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=340.50 Aligned_cols=214 Identities=21% Similarity=0.291 Sum_probs=163.1
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----------------
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---------------- 64 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------- 64 (241)
||.+.. ......++|.+|+++|++|+|||||+++|+|.+.+..++|||||++|+|.++++...
T Consensus 76 vK~l~~-~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~ 154 (329)
T 4aoj_A 76 VKALKE-ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154 (329)
T ss_dssp EEEESC-CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCS
T ss_pred EEEECc-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCC
Confidence 455543 233456789999999999999999999999999999999999999999999986531
Q ss_pred ---chHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccc
Q 044022 65 ---LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEY 141 (241)
Q Consensus 65 ---~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 141 (241)
..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++...............||+.|+|||+
T Consensus 155 l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~ 231 (329)
T 4aoj_A 155 LGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPES 231 (329)
T ss_dssp CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhh
Confidence 146789999999999999 89999999999999999999999999999986654433333345679999999999
Q ss_pred ccccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHH
Q 044022 142 ISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHA 220 (241)
Q Consensus 142 ~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (241)
+.+..++.++|||||||++|||+| |+.||.... ..+...... .+.....+ . .+++.
T Consensus 232 ~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~---------~~~~~~~i~-~g~~~~~p-----~--------~~~~~ 288 (329)
T 4aoj_A 232 ILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS---------NTEAIDCIT-QGRELERP-----R--------ACPPE 288 (329)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC---------HHHHHHHHH-HTCCCCCC-----T--------TCCHH
T ss_pred hcCCCCCccccccchHHHHHHHHcCCCCCCCCCC---------HHHHHHHHH-cCCCCCCc-----c--------cccHH
Confidence 999999999999999999999999 899996522 122222222 22211111 1 22367
Q ss_pred HHHHHHHhccCCCCCCCCCCC
Q 044022 221 SAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 221 ~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+.+|+.+||+.||++|||++|
T Consensus 289 ~~~li~~cl~~dP~~RPs~~e 309 (329)
T 4aoj_A 289 VYAIMRGCWQREPQQRHSIKD 309 (329)
T ss_dssp HHHHHHHHCCSSTTTSCCHHH
T ss_pred HHHHHHHHcCcChhHCcCHHH
Confidence 899999999999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=331.35 Aligned_cols=214 Identities=16% Similarity=0.207 Sum_probs=173.3
Q ss_pred Cccccccc--ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHH
Q 044022 1 MKFYGHEY--HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDI 74 (241)
Q Consensus 1 iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i 74 (241)
||++.+.. .....+.+.+|+++|++|+|||||++++++.+++.+|+|||||+||+|.+++.... .....++.||
T Consensus 62 iK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi 141 (311)
T 4aw0_A 62 IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141 (311)
T ss_dssp EEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHH
T ss_pred EEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHH
Confidence 35554322 33456789999999999999999999999999999999999999999999986542 2467899999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhH
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
+.||.||| +++|+||||||+|||++.++.+||+|||+++............+.+||+.|+|||++.+..++.++|||
T Consensus 142 ~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiW 218 (311)
T 4aw0_A 142 VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLW 218 (311)
T ss_dssp HHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHH
T ss_pred HHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHH
Confidence 99999999 999999999999999999999999999999987654443444567899999999999999999999999
Q ss_pred HHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 155 SFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 155 s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
|+||++|+|++|+.||... ...+......... + .. ... .++++.+|+.+||+.||+
T Consensus 219 SlGvilyeml~G~~PF~~~---------~~~~~~~~i~~~~-~-~~-----p~~--------~s~~~~dli~~lL~~dp~ 274 (311)
T 4aw0_A 219 ALGCIIYQLVAGLPPFRAG---------NEGLIFAKIIKLE-Y-DF-----PEK--------FFPKARDLVEKLLVLDAT 274 (311)
T ss_dssp HHHHHHHHHHHSSCSSCCS---------SHHHHHHHHHHTC-C-CC-----CTT--------CCHHHHHHHHHHSCSSGG
T ss_pred HHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHcCC-C-CC-----Ccc--------cCHHHHHHHHHHccCCHh
Confidence 9999999999999999541 1222222222211 1 11 111 225688999999999999
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
+|||++|
T Consensus 275 ~R~t~~e 281 (311)
T 4aw0_A 275 KRLGCEE 281 (311)
T ss_dssp GSTTSGG
T ss_pred HCcChHH
Confidence 9999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=332.57 Aligned_cols=214 Identities=16% Similarity=0.246 Sum_probs=171.2
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNS 77 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~ 77 (241)
||++... .....+.+.+|+++|++++|||||+++++|..++.+|+|||||+||+|.+++..... ....++.||+.|
T Consensus 104 iK~i~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~a 182 (346)
T 4fih_A 104 VKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQA 182 (346)
T ss_dssp EEEEEGG-GCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHH
T ss_pred EEEEecC-chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHH
Confidence 4555433 234567789999999999999999999999999999999999999999999876543 467899999999
Q ss_pred hchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHH
Q 044022 78 LAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFG 157 (241)
Q Consensus 78 l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G 157 (241)
|.||| +++|+||||||+|||++.++.+||+|||+++........ ....+||+.|+|||++.+..++.++||||||
T Consensus 183 L~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlG 257 (346)
T 4fih_A 183 LSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLG 257 (346)
T ss_dssp HHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHH
T ss_pred HHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHH
Confidence 99999 999999999999999999999999999999876543322 2456899999999999999999999999999
Q ss_pred HHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 158 AFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 158 ~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
|++|||++|+.||... ...+......... ...... . ...++++.+|+.+||+.||++||
T Consensus 258 vilyeml~G~~PF~~~---------~~~~~~~~i~~~~-~~~~~~---~--------~~~s~~~~dli~~~L~~dP~~R~ 316 (346)
T 4fih_A 258 IMVIEMVDGEPPYFNE---------PPLKAMKMIRDNL-PPRLKN---L--------HKVSPSLKGFLDRLLVRDPAQRA 316 (346)
T ss_dssp HHHHHHHHSSCTTTTS---------CHHHHHHHHHHSS-CCCCSC---G--------GGSCHHHHHHHHHHSCSSTTTSC
T ss_pred HHHHHHHHCCCCCCCc---------CHHHHHHHHHcCC-CCCCCc---c--------ccCCHHHHHHHHHHcCCChhHCc
Confidence 9999999999999541 1122222222111 111110 0 12336789999999999999999
Q ss_pred CCCC
Q 044022 238 TMVD 241 (241)
Q Consensus 238 t~~e 241 (241)
|++|
T Consensus 317 ta~e 320 (346)
T 4fih_A 317 TAAE 320 (346)
T ss_dssp CHHH
T ss_pred CHHH
Confidence 9864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=334.43 Aligned_cols=213 Identities=20% Similarity=0.225 Sum_probs=169.8
Q ss_pred Cccccccc-ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHH
Q 044022 1 MKFYGHEY-HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASD 73 (241)
Q Consensus 1 iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~ 73 (241)
||++.... .....++|.+|+++|++|+|||||++++++.+++.+|+|||||+||+|.+++.... .....++.|
T Consensus 54 iK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~q 133 (350)
T 4b9d_A 54 IKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ 133 (350)
T ss_dssp EEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHH
T ss_pred EEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHH
Confidence 45554332 33456789999999999999999999999999999999999999999999985431 146789999
Q ss_pred HHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhh
Q 044022 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNV 153 (241)
Q Consensus 74 i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 153 (241)
|+.||.||| +++|+||||||+|||++.++.+||+|||+++....... .....+||+.|+|||++.+..++.++||
T Consensus 134 i~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~l~~~~y~~~~Di 208 (350)
T 4b9d_A 134 ICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--LARACIGTPYYLSPEICENKPYNNKSDI 208 (350)
T ss_dssp HHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH--HHHHHHSCCTTCCHHHHTTCCCCHHHHH
T ss_pred HHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc--cccccCCCccccCHHHHCCCCCCcHHHH
Confidence 999999999 99999999999999999999999999999976543211 1234579999999999999999999999
Q ss_pred HHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 154 FSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
|||||++|+|++|+.||... ...+....... +.+... .. ..+.++.+|+.+||+.||
T Consensus 209 wSlGvilyemltG~~PF~~~---------~~~~~~~~i~~-~~~~~~-----~~--------~~s~~~~~li~~~L~~dP 265 (350)
T 4b9d_A 209 WALGCVLYELCTLKHAFEAG---------SMKNLVLKIIS-GSFPPV-----SL--------HYSYDLRSLVSQLFKRNP 265 (350)
T ss_dssp HHHHHHHHHHHHSSCSCCCS---------SHHHHHHHHHH-TCCCCC-----CT--------TSCHHHHHHHHHHTCSSG
T ss_pred HHHHHHHHHHHHCCCCCCCc---------CHHHHHHHHHc-CCCCCC-----Cc--------cCCHHHHHHHHHHccCCh
Confidence 99999999999999999541 22222332222 211111 11 123578999999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|||++|
T Consensus 266 ~~R~s~~e 273 (350)
T 4b9d_A 266 RDRPSVNS 273 (350)
T ss_dssp GGSCCHHH
T ss_pred hHCcCHHH
Confidence 99999854
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=323.99 Aligned_cols=202 Identities=17% Similarity=0.255 Sum_probs=158.1
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeee----CCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhh
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQ----TPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLH 82 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh 82 (241)
...++|.+|++++++|+|||||+++++|.. ++.+++|||||++|+|.+++..... ....++.||+.||.|||
T Consensus 67 ~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH 146 (290)
T 3fpq_A 67 SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 146 (290)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456779999999999999999999999875 3468999999999999999965422 46789999999999999
Q ss_pred cCCCCC--ceeccCCCCCeeecC-CCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHH
Q 044022 83 FGFPRP--IVLRNFKTQNILFNE-ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAF 159 (241)
Q Consensus 83 ~~~~~~--ivh~dl~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~ 159 (241)
+++ |+||||||+|||++. ++.+||+|||+|+...... ....+||+.|+|||++.+ .++.++|||||||+
T Consensus 147 ---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvi 218 (290)
T 3fpq_A 147 ---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMC 218 (290)
T ss_dssp ---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHH
T ss_pred ---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCc----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHH
Confidence 777 999999999999984 7899999999997543322 234689999999998874 69999999999999
Q ss_pred HHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 160 LFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 160 ~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
+|+|++|+.||..... ......... .+ ......... .++.+.+|+.+||+.||++|||+
T Consensus 219 lyelltg~~Pf~~~~~--------~~~~~~~i~-~~----~~~~~~~~~--------~~~~~~~li~~~L~~dP~~R~s~ 277 (290)
T 3fpq_A 219 MLEMATSEYPYSECQN--------AAQIYRRVT-SG----VKPASFDKV--------AIPEVKEIIEGCIRQNKDERYSI 277 (290)
T ss_dssp HHHHHHSSCTTTTCSS--------HHHHHHHHT-TT----CCCGGGGGC--------CCHHHHHHHHHHSCSSGGGSCCH
T ss_pred HHHHHHCCCCCCCCCc--------HHHHHHHHH-cC----CCCCCCCcc--------CCHHHHHHHHHHccCChhHCcCH
Confidence 9999999999954211 111111111 11 111111111 22568899999999999999998
Q ss_pred CC
Q 044022 240 VD 241 (241)
Q Consensus 240 ~e 241 (241)
+|
T Consensus 278 ~e 279 (290)
T 3fpq_A 278 KD 279 (290)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=334.04 Aligned_cols=214 Identities=16% Similarity=0.246 Sum_probs=171.2
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNS 77 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~ 77 (241)
||++... .....+.+.+|+++|++|+|||||+++++|..++.+|+|||||+||+|.+++..... ....++.||+.|
T Consensus 181 iK~i~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~a 259 (423)
T 4fie_A 181 VKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQA 259 (423)
T ss_dssp EEEEEST-TCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHH
T ss_pred EEEEecc-chhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHH
Confidence 4555433 234567799999999999999999999999999999999999999999999876543 567899999999
Q ss_pred hchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHH
Q 044022 78 LAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFG 157 (241)
Q Consensus 78 l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G 157 (241)
|.||| +++|+||||||+|||++.++.+||+|||+++....... .....+||+.|+|||++.+..|+.++||||||
T Consensus 260 L~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlG 334 (423)
T 4fie_A 260 LSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLG 334 (423)
T ss_dssp HHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHH
T ss_pred HHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHH
Confidence 99999 99999999999999999999999999999987654322 22456899999999999999999999999999
Q ss_pred HHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 158 AFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 158 ~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
|++|||++|+.||... ...+......... ...... .. ..++.+.+|+.+||..||++||
T Consensus 335 vilyeml~G~~PF~~~---------~~~~~~~~i~~~~-~~~~~~---~~--------~~s~~~~dli~~~L~~dP~~R~ 393 (423)
T 4fie_A 335 IMVIEMVDGEPPYFNE---------PPLKAMKMIRDNL-PPRLKN---LH--------KVSPSLKGFLDRLLVRDPAQRA 393 (423)
T ss_dssp HHHHHHHHSSCTTTTS---------CHHHHHHHHHHSC-CCCCSC---TT--------SSCHHHHHHHHHHSCSSTTTSC
T ss_pred HHHHHHHHCCCCCCCc---------CHHHHHHHHHcCC-CCCCcc---cc--------cCCHHHHHHHHHHcCCChhHCc
Confidence 9999999999999541 1222222222211 111110 11 1235789999999999999999
Q ss_pred CCCC
Q 044022 238 TMVD 241 (241)
Q Consensus 238 t~~e 241 (241)
|++|
T Consensus 394 ta~e 397 (423)
T 4fie_A 394 TAAE 397 (423)
T ss_dssp CHHH
T ss_pred CHHH
Confidence 9864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=336.52 Aligned_cols=215 Identities=20% Similarity=0.318 Sum_probs=170.8
Q ss_pred cccccccccccHHHHHHHHHHHHhcCC-CcccceeeeeeeC-CcceEEEEecCCCCHHHhhcCCC---------------
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSH-NHILKRIGCCLQT-PIPILVFQSVEYGTLRDCIFGAP--------------- 64 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--------------- 64 (241)
|.+.........++|.+|+++|.+++| ||||+++|+|... +.+++|||||++|+|.++++...
T Consensus 100 K~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~ 179 (353)
T 4ase_A 100 KMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 179 (353)
T ss_dssp EEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CT
T ss_pred EEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhcc
Confidence 455444444456789999999999966 8999999999765 56899999999999999996421
Q ss_pred -----chHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCc
Q 044022 65 -----LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAP 139 (241)
Q Consensus 65 -----~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aP 139 (241)
..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++...........+...||+.|+||
T Consensus 180 ~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAP 256 (353)
T 4ase_A 180 DFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 256 (353)
T ss_dssp TCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred ccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCH
Confidence 136789999999999999 899999999999999999999999999999877655544455567799999999
Q ss_pred ccccccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHH
Q 044022 140 EYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQL 218 (241)
Q Consensus 140 E~~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (241)
|++.+..++.++|||||||++|||+| |+.||..... .+........+.....++ .++
T Consensus 257 E~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~---------~~~~~~~i~~g~~~~~p~-------------~~~ 314 (353)
T 4ase_A 257 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---------DEEFCRRLKEGTRMRAPD-------------YTT 314 (353)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC---------SHHHHHHHHHTCCCCCCT-------------TCC
T ss_pred HHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHHcCCCCCCCc-------------cCC
Confidence 99999999999999999999999998 8999965211 112222222332222221 123
Q ss_pred HHHHHHHHHhccCCCCCCCCCCC
Q 044022 219 HASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 219 ~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+.+.+++.+||+.||++|||++|
T Consensus 315 ~~~~~li~~c~~~dP~~RPt~~e 337 (353)
T 4ase_A 315 PEMYQTMLDCWHGEPSQRPTFSE 337 (353)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHHcCcChhHCcCHHH
Confidence 57889999999999999999853
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=325.28 Aligned_cols=201 Identities=20% Similarity=0.255 Sum_probs=158.1
Q ss_pred HHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCCCceec
Q 044022 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPRPIVLR 92 (241)
Q Consensus 17 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~~ivh~ 92 (241)
.+|++++++|+|||||++++++.+++.+|+|||||+||+|.++++... .....++.||+.||.||| +++|+||
T Consensus 98 ~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHR 174 (336)
T 4g3f_A 98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHG 174 (336)
T ss_dssp THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECS
T ss_pred HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceec
Confidence 479999999999999999999999999999999999999999996542 256789999999999999 9999999
Q ss_pred cCCCCCeeecCCC-CeEEeeccCceecCCCCc---ceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCc
Q 044022 93 NFKTQNILFNEEN-VAKWFDFLLSISIPEGET---HITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRI 168 (241)
Q Consensus 93 dl~~~nil~~~~~-~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~ 168 (241)
||||+|||++.++ .+||+|||+++....... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 175 DlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~ 254 (336)
T 4g3f_A 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254 (336)
T ss_dssp CCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcC
Confidence 9999999999987 699999999987654321 122344679999999999999999999999999999999999999
Q ss_pred ccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 169 HIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 169 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
||...... ..... ...... +...+.+. .++.+.+++.+||+.||++|||++|
T Consensus 255 Pf~~~~~~-----~~~~~----i~~~~~----~~~~~~~~--------~s~~~~~li~~~L~~dP~~R~sa~e 306 (336)
T 4g3f_A 255 PWTQYFRG-----PLCLK----IASEPP----PIREIPPS--------CAPLTAQAIQEGLRKEPVHRASAME 306 (336)
T ss_dssp SSTTTCCS-----CCHHH----HHHSCC----GGGGSCTT--------SCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCHH-----HHHHH----HHcCCC----CchhcCcc--------CCHHHHHHHHHHccCCHhHCcCHHH
Confidence 99652211 11111 111110 00111122 2367889999999999999999853
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=312.78 Aligned_cols=210 Identities=23% Similarity=0.305 Sum_probs=157.0
Q ss_pred Cccccccc--ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHH
Q 044022 1 MKFYGHEY--HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDI 74 (241)
Q Consensus 1 iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i 74 (241)
||++.+.. ......++.+|++++++++|||||++++++..++..|+||||+ +|+|.+++..... ....++.||
T Consensus 43 iK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi 121 (275)
T 3hyh_A 43 LKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQI 121 (275)
T ss_dssp EEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHH
T ss_pred EEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHH
Confidence 45555332 2245678999999999999999999999999999999999999 6899998865422 567899999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCC-Ccchhh
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVL-NEKSNV 153 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di 153 (241)
+.||.||| +++|+||||||+|||++.++.+||+|||+++....... ..+..||+.|+|||++.+..+ +.++||
T Consensus 122 ~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~---~~~~~GT~~Y~APE~~~~~~y~~~~~Di 195 (275)
T 3hyh_A 122 ISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVISGKLYAGPEVDV 195 (275)
T ss_dssp HHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHH
T ss_pred HHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc---cCCeeECcccCChhhhcCCCCCCChhhh
Confidence 99999999 99999999999999999999999999999976544322 234579999999999998776 579999
Q ss_pred HHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 154 FSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
||+||++|+|++|+.||... ...+....... +.. . +... .++.+.+|+.+||+.||
T Consensus 196 wSlGvily~lltg~~PF~~~---------~~~~~~~~i~~-~~~-~-----~p~~--------~s~~~~~li~~~L~~dP 251 (275)
T 3hyh_A 196 WSCGVILYVMLCRRLPFDDE---------SIPVLFKNISN-GVY-T-----LPKF--------LSPGAAGLIKRMLIVNP 251 (275)
T ss_dssp HHHHHHHHHHHHSSCSSCCS---------SHHHHHHHHHH-TCC-C-----CCTT--------SCHHHHHHHHHHSCSSG
T ss_pred HHHHHHHHHHHHCCCCCCCC---------CHHHHHHHHHc-CCC-C-----CCCC--------CCHHHHHHHHHHccCCh
Confidence 99999999999999999541 12222222222 111 1 1111 22578899999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|||++|
T Consensus 252 ~~R~s~~e 259 (275)
T 3hyh_A 252 LNRISIHE 259 (275)
T ss_dssp GGSCCHHH
T ss_pred hHCcCHHH
Confidence 99999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=322.20 Aligned_cols=200 Identities=22% Similarity=0.225 Sum_probs=156.8
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
...++.+|+++|++++|||||++++++..++.+|+|||||+||+|.+++..... ....++.||+.||.||| ++
T Consensus 69 ~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH---~~ 145 (304)
T 3ubd_A 69 DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SL 145 (304)
T ss_dssp ECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 445788999999999999999999999999999999999999999999865422 46789999999999999 99
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcC
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
+|+||||||+|||++.++.+||+|||+++....... ...+.+||+.|+|||++.+..++.++||||+||++|+|++|+
T Consensus 146 ~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~ 223 (304)
T 3ubd_A 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223 (304)
T ss_dssp TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCC
Confidence 999999999999999999999999999986543322 223467999999999999999999999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
.||... ...+......... . .. ... .++++.+|+.+||+.||++|||+.
T Consensus 224 ~PF~~~---------~~~~~~~~i~~~~-~-~~-----p~~--------~s~~~~~li~~~L~~dP~~R~ta~ 272 (304)
T 3ubd_A 224 LPFQGK---------DRKETMTMILKAK-L-GM-----PQF--------LSPEAQSLLRMLFKRNPANRLGAG 272 (304)
T ss_dssp CSSCCS---------SHHHHHHHHHHCC-C-CC-----CTT--------SCHHHHHHHHHHTCSSGGGSTTCS
T ss_pred CCCCCc---------CHHHHHHHHHcCC-C-CC-----CCc--------CCHHHHHHHHHHcccCHHHCCCCC
Confidence 999541 1222233222211 1 11 111 225788999999999999999973
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=315.01 Aligned_cols=218 Identities=20% Similarity=0.204 Sum_probs=154.6
Q ss_pred HHHHHHHHhcCCCcccceeeeeeeCC----cceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcC-----
Q 044022 17 INNITYAAQMSHNHILKRIGCCLQTP----IPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFG----- 84 (241)
Q Consensus 17 ~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~----- 84 (241)
..|+..+.+++|||||+++++|...+ .+++|||||++|+|.++++.... .+++++.+++.||+|||+.
T Consensus 45 e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~ 124 (303)
T 3hmm_A 45 EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124 (303)
T ss_dssp HHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTT
T ss_pred HHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhcc
Confidence 34566667889999999999998654 57999999999999999987654 5788999999999999931
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc--eeecccccCCCccCccccccc------CCCcchhhHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH--ITTDRVIGTRGYSAPEYISIC------VLNEKSNVFSF 156 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~------~~~~~~Di~s~ 156 (241)
...+|+||||||+|||++.++++||+|||+++........ .......||+.|+|||++.+. .++.++|||||
T Consensus 125 ~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~ 204 (303)
T 3hmm_A 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204 (303)
T ss_dssp CBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred CCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhH
Confidence 1238999999999999999999999999999866443322 122345799999999998754 36789999999
Q ss_pred HHHHHHHHhcCcccccccccCC-----CcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccC
Q 044022 157 GAFLFELLAGRIHIWDLLKDTH-----DHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNN 231 (241)
Q Consensus 157 G~~~~~~~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~ 231 (241)
||++|||+||.+||........ .......+........... .+.++.. .........+.+|+.+||+.
T Consensus 205 Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----rp~~p~~---~~~~~~~~~l~~li~~cl~~ 277 (303)
T 3hmm_A 205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL----RPNIPNR---WQSCEALRVMAKIMRECWYA 277 (303)
T ss_dssp HHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC----CCCCCGG---GGSSHHHHHHHHHHHTTCCS
T ss_pred HHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccC----CCCCCcc---ccchHHHHHHHHHHHHHccc
Confidence 9999999999888754221110 0011111122222111111 1111111 11124557789999999999
Q ss_pred CCCCCCCCCC
Q 044022 232 SPEDRPTMVD 241 (241)
Q Consensus 232 ~p~~Rpt~~e 241 (241)
||++|||+.|
T Consensus 278 dP~~RPt~~e 287 (303)
T 3hmm_A 278 NGAARLTALR 287 (303)
T ss_dssp SGGGSCCHHH
T ss_pred CHhHCcCHHH
Confidence 9999999853
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=313.58 Aligned_cols=213 Identities=22% Similarity=0.318 Sum_probs=155.6
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCC------------cceEEEEecCCCCHHHhhcCCCc---
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTP------------IPILVFQSVEYGTLRDCIFGAPL--- 65 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------------~~~lv~e~~~~~sL~~~l~~~~~--- 65 (241)
||...........+++.+|+++|++|+|||||+++++|...+ ..|+|||||++|+|.+++.....
T Consensus 35 iK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~ 114 (299)
T 4g31_A 35 IKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE 114 (299)
T ss_dssp EEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGG
T ss_pred EEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCCh
Confidence 455544344445678999999999999999999999997644 36899999999999999976532
Q ss_pred ----hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc----------eeecccc
Q 044022 66 ----PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH----------ITTDRVI 131 (241)
Q Consensus 66 ----~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~----------~~~~~~~ 131 (241)
....++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++........ ......+
T Consensus 115 ~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (299)
T 4g31_A 115 RERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQV 191 (299)
T ss_dssp SCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------
T ss_pred hHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcc
Confidence 25679999999999999 899999999999999999999999999999866443211 1123457
Q ss_pred cCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCc
Q 044022 132 GTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPC 211 (241)
Q Consensus 132 ~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (241)
||+.|+|||++.+..++.++|||||||++|||++ ||.... ......... .... .+
T Consensus 192 GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--------~~~~~~~~~-~~~~------------~p- 246 (299)
T 4g31_A 192 GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--------ERVRTLTDV-RNLK------------FP- 246 (299)
T ss_dssp CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--------HHHHHHHHH-HTTC------------CC-
T ss_pred cCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--------HHHHHHHHH-hcCC------------CC-
Confidence 9999999999999999999999999999999996 764310 000111111 1110 11
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 212 IEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 212 ~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
......++...+|+.+||+.||++|||++|
T Consensus 247 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 276 (299)
T 4g31_A 247 PLFTQKYPCEYVMVQDMLSPSPMERPEAIN 276 (299)
T ss_dssp HHHHHHCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCcccCHHHHHHHHHHcCCChhHCcCHHH
Confidence 111233456788999999999999999853
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=303.88 Aligned_cols=168 Identities=19% Similarity=0.254 Sum_probs=137.5
Q ss_pred Ccccccccc-cccHHHHHHHHHHHHhcCCCcccceeeeeeeC------CcceEEEEecCCCCHHHhhcCCCc----hHHH
Q 044022 1 MKFYGHEYH-RHTYGSCINNITYAAQMSHNHILKRIGCCLQT------PIPILVFQSVEYGTLRDCIFGAPL----PRLK 69 (241)
Q Consensus 1 iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~----~~~~ 69 (241)
||++..... ....+++.+|+++|++|+|||||++++++... +..|+|||||. |+|.+++..... ....
T Consensus 84 iK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~ 162 (398)
T 4b99_A 84 IKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRY 162 (398)
T ss_dssp EEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHH
T ss_pred EEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHH
Confidence 455543332 23456789999999999999999999987643 57899999996 689999876532 4678
Q ss_pred HHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCC--cceeecccccCCCccCccccccc-C
Q 044022 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE--THITTDRVIGTRGYSAPEYISIC-V 146 (241)
Q Consensus 70 ~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~-~ 146 (241)
++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++...... ........+||+.|+|||++.+. .
T Consensus 163 ~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~ 239 (398)
T 4b99_A 163 FLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHE 239 (398)
T ss_dssp HHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSC
T ss_pred HHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCC
Confidence 9999999999999 9999999999999999999999999999998654321 11223456899999999998875 5
Q ss_pred CCcchhhHHHHHHHHHHHhcCccccc
Q 044022 147 LNEKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 147 ~~~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
++.++||||+||++|+|++|++||..
T Consensus 240 ~~~~~DiWSlG~il~ell~G~~pF~g 265 (398)
T 4b99_A 240 YTQAIDLWSVGCIFGEMLARRQLFPG 265 (398)
T ss_dssp CCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred CCChhheehhHHHHHHHHHCCCCCCC
Confidence 68999999999999999999999954
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=301.18 Aligned_cols=158 Identities=18% Similarity=0.291 Sum_probs=135.3
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-hHHHHHHHHHHHhchhhcCCCCCc
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-PRLKIASDIVNSLAYLHFGFPRPI 89 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~~l~~lh~~~~~~i 89 (241)
...++.+|+++|+.+ .|||||+++++|...++.|+||||+++|+|.++++..+. ....++.|++.||.||| +++|
T Consensus 62 ~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH---~~gI 138 (361)
T 4f9c_A 62 HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIH---QFGI 138 (361)
T ss_dssp CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence 456788999999998 699999999999999999999999999999999976544 46789999999999999 9999
Q ss_pred eeccCCCCCeeecCC-CCeEEeeccCceecCCCCcc--------------------------eeecccccCCCccCcccc
Q 044022 90 VLRNFKTQNILFNEE-NVAKWFDFLLSISIPEGETH--------------------------ITTDRVIGTRGYSAPEYI 142 (241)
Q Consensus 90 vh~dl~~~nil~~~~-~~~~l~df~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~aPE~~ 142 (241)
+||||||+|||++.+ +.+||+|||+++........ ......+||+.|+|||++
T Consensus 139 iHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l 218 (361)
T 4f9c_A 139 VHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVL 218 (361)
T ss_dssp ECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHH
T ss_pred EeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHH
Confidence 999999999999877 79999999999765432110 112345799999999999
Q ss_pred ccc-CCCcchhhHHHHHHHHHHHhcCccccc
Q 044022 143 SIC-VLNEKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 143 ~~~-~~~~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
.+. .++.++||||+||++|+|++|+.||..
T Consensus 219 ~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 219 TKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred cCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 876 488999999999999999999999965
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=310.80 Aligned_cols=204 Identities=16% Similarity=0.206 Sum_probs=164.2
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+.+.+|+++|++|+|||||+++++|...+.+++|||||+||+|.+++.... . ....++.||+.||.||| +
T Consensus 197 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~ 273 (573)
T 3uto_A 197 DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 273 (573)
T ss_dssp HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---H
T ss_pred hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 45678899999999999999999999999999999999999999999986432 2 46789999999999999 9
Q ss_pred CCceeccCCCCCeeecCC--CCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEE--NVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
++|+||||||+|||++.+ +.+||+|||+++........ ...+||+.|+|||++.+..++.++||||+||++|+|+
T Consensus 274 ~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~---~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml 350 (573)
T 3uto_A 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 350 (573)
T ss_dssp TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce---eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999999999854 89999999999887654322 3357999999999999999999999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|..||... ...+......... . . ....... ..++.+.+|+.+||..||++|||++|
T Consensus 351 ~G~~Pf~~~---------~~~~~~~~i~~~~-~-~-~~~~~~~--------~~s~~~~dli~~~L~~dp~~R~t~~e 407 (573)
T 3uto_A 351 SGLSPFGGE---------NDDETLRNVKSCD-W-N-MDDSAFS--------GISEDGKDFIRKLLLADPNTRMTIHQ 407 (573)
T ss_dssp HSCCSSCCS---------SHHHHHHHHHTTC-C-C-CCSGGGT--------TSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred HCCCCCCCc---------CHHHHHHHHHhCC-C-C-CCccccc--------CCCHHHHHHHHHHccCChhHCcCHHH
Confidence 999999642 1222222222111 1 0 1111111 22357889999999999999999753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=305.99 Aligned_cols=199 Identities=19% Similarity=0.208 Sum_probs=156.9
Q ss_pred HHHHHHH---HHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCC
Q 044022 13 YGSCINN---ITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 13 ~~~~~~e---~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.+| +.+++.++|||||+++++|.+.+.+|+|||||+||+|.+++..... ....++.||+.||.|||
T Consensus 233 ~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH--- 309 (689)
T 3v5w_A 233 ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH--- 309 (689)
T ss_dssp HHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred HHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 3344444 5666778999999999999999999999999999999999865432 46789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~~~~~ 164 (241)
+++|+||||||+|||++.+|.+||+|||+|........ .+.+||+.|+|||++.. ..++.++|+||+||++|+|+
T Consensus 310 ~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmL 385 (689)
T 3v5w_A 310 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385 (689)
T ss_dssp TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHH
T ss_pred HCCccccCCchHHeEEeCCCCEEecccceeeecCCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999987655432 34589999999999964 57899999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
+|++||...... ...+......... . .. ... .++.+.+|+.+||..||++|++.
T Consensus 386 tG~~PF~~~~~~------~~~~i~~~i~~~~-~-~~-----p~~--------~S~~a~dLI~~lL~~dP~~Rl~~ 439 (689)
T 3v5w_A 386 RGHSPFRQHKTK------DKHEIDRMTLTMA-V-EL-----PDS--------FSPELRSLLEGLLQRDVNRRLGC 439 (689)
T ss_dssp HSSCTTCGGGCC------CHHHHHHHHHHCC-C-CC-----CTT--------SCHHHHHHHHHHTCSCGGGCTTC
T ss_pred hCCCCCCCCChH------HHHHHHHhhcCCC-C-CC-----Ccc--------CCHHHHHHHHHHccCCHhHCCCC
Confidence 999999652111 1111111111111 0 11 111 22578899999999999999984
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=282.38 Aligned_cols=232 Identities=28% Similarity=0.444 Sum_probs=178.3
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----c---hHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----L---PRLKIAS 72 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~---~~~~~~~ 72 (241)
||++..........++.+|++++++++||||+++++++...+..++||||+++|+|.+++.... . .+..++.
T Consensus 59 vK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ 138 (326)
T 3uim_A 59 VKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138 (326)
T ss_dssp EEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHH
T ss_pred EEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHH
Confidence 3555544444455579999999999999999999999999999999999999999999987642 1 4678999
Q ss_pred HHHHHhchhhcCCCC---CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCc
Q 044022 73 DIVNSLAYLHFGFPR---PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNE 149 (241)
Q Consensus 73 ~i~~~l~~lh~~~~~---~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 149 (241)
+++.||.||| +. +++||||||+|||++.++.++|+|||.+.......... .....||+.|+|||++.+..++.
T Consensus 139 ~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ 214 (326)
T 3uim_A 139 GSARGLAYLH---DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSE 214 (326)
T ss_dssp HHHHHHHHHH---HSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECH
T ss_pred HHHHHHHHHH---hCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccc-cccccCCcCccCHHHhccCCCCc
Confidence 9999999999 66 99999999999999999999999999998765433322 23456899999999998888999
Q ss_pred chhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhc
Q 044022 150 KSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECV 229 (241)
Q Consensus 150 ~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 229 (241)
++||||||+++|+|++|..||..... .........++..............+.......+ ...+..+.+++.+||
T Consensus 215 ~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl 289 (326)
T 3uim_A 215 KTDVFGYGVMLLELITGQRAFDLARL-ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYK----DEEVEQLIQVALLCT 289 (326)
T ss_dssp HHHHHHHHHHHHHHHHCCCSBCHHHH-TTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCC----HHHHHHHHHHHHHHT
T ss_pred cccchhHHHHHHHHHhCCCccccccc-ccccchhHHHHHHHHhhchhhhhhcChhhccccC----HHHHHHHHHHHHHHh
Confidence 99999999999999999999964211 1112233444444444444444443433333322 466788999999999
Q ss_pred cCCCCCCCCCCC
Q 044022 230 NNSPEDRPTMVD 241 (241)
Q Consensus 230 ~~~p~~Rpt~~e 241 (241)
+.||++|||++|
T Consensus 290 ~~dP~~Rps~~e 301 (326)
T 3uim_A 290 QSSPMERPKMSE 301 (326)
T ss_dssp CSCGGGSCCHHH
T ss_pred CcCCccCCCHHH
Confidence 999999999853
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=279.07 Aligned_cols=221 Identities=31% Similarity=0.466 Sum_probs=173.7
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--------chHHHHHHHHHHHhchhh
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--------LPRLKIASDIVNSLAYLH 82 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------~~~~~~~~~i~~~l~~lh 82 (241)
...+.+.+|++++++++||||+++++++...+..++||||+++|+|.+++.... ..++.++.+++.||.|||
T Consensus 77 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH 156 (321)
T 2qkw_B 77 QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156 (321)
T ss_dssp SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc
Confidence 456789999999999999999999999999999999999999999999986542 146789999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~ 162 (241)
+.+++||||||+||+++.++.+||+|||.+................|++.|+|||++.+..++.++||||||+++|+
T Consensus 157 ---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 233 (321)
T 2qkw_B 157 ---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233 (321)
T ss_dssp ---HTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHH
T ss_pred ---CCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHH
Confidence 89999999999999999999999999999986543322222234468899999999988899999999999999999
Q ss_pred HHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 163 LLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 163 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|++|+.||...... ......++..............++...... ....+..+.+++.+||+.||++|||++|
T Consensus 234 ll~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~e 305 (321)
T 2qkw_B 234 VLCARSAIVQSLPR---EMVNLAEWAVESHNNGQLEQIVDPNLADKI----RPESLRKFGDTAVKCLALSSEDRPSMGD 305 (321)
T ss_dssp HHHCCTTCSCSSSS---SCCCHHHHTHHHHTTTCCCSSSSSSCTTCS----CHHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHhCCCcccccCcH---HHHHHHHHhhhccccccHHHhcChhhcccc----CHHHHHHHHHHHHHHcCCCcccCcCHHH
Confidence 99999999653222 112222222222333333333333322222 2366788999999999999999999853
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=287.99 Aligned_cols=215 Identities=20% Similarity=0.303 Sum_probs=168.8
Q ss_pred CcccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC---------------
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--------------- 64 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------- 64 (241)
||++.........+.+.+|+++++++ +||||++++++|...+..++||||+++|+|.+++....
T Consensus 118 vK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~ 197 (370)
T 2psq_A 118 VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197 (370)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CC
T ss_pred EEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCcccccccccccccc
Confidence 35555444445567899999999999 89999999999999999999999999999999986532
Q ss_pred -----chHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCc
Q 044022 65 -----LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAP 139 (241)
Q Consensus 65 -----~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aP 139 (241)
...+.++.||+.||.||| +++++||||||+|||++.++.+||+|||++................+++.|+||
T Consensus 198 ~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP 274 (370)
T 2psq_A 198 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 274 (370)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCH
T ss_pred ccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECH
Confidence 135678999999999999 899999999999999999999999999999876544332222334567889999
Q ss_pred ccccccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHH
Q 044022 140 EYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQL 218 (241)
Q Consensus 140 E~~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (241)
|++.+..++.++||||||+++|+|++ |..||..... .+.... ...+..... .. ..+
T Consensus 275 E~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~---------~~~~~~-~~~~~~~~~-----~~--------~~~ 331 (370)
T 2psq_A 275 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---------EELFKL-LKEGHRMDK-----PA--------NCT 331 (370)
T ss_dssp HHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---------GGHHHH-HHTTCCCCC-----CT--------TSC
T ss_pred hHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH---------HHHHHH-HhcCCCCCC-----CC--------CCC
Confidence 99998899999999999999999999 9999965211 111111 112211111 11 123
Q ss_pred HHHHHHHHHhccCCCCCCCCCCC
Q 044022 219 HASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 219 ~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
..+.+++.+||+.||++|||+.|
T Consensus 332 ~~l~~li~~~l~~dP~~Rpt~~e 354 (370)
T 2psq_A 332 NELYMMMRDCWHAVPSQRPTFKQ 354 (370)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHH
Confidence 57899999999999999999853
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=274.57 Aligned_cols=205 Identities=17% Similarity=0.251 Sum_probs=165.3
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
...+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++..... ....++.+++.||.||| +.
T Consensus 59 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~ 135 (297)
T 3fxz_A 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SN 135 (297)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 3467789999999999999999999999999999999999999999999876533 46789999999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcC
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
+++||||||+|||++.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 136 ~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 213 (297)
T 3fxz_A 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213 (297)
T ss_dssp TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999998876543322 23457899999999999999999999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.||.... ..+.......... ..... .. ..+..+.+++.+||+.||++|||++|
T Consensus 214 ~pf~~~~---------~~~~~~~~~~~~~-~~~~~---~~--------~~~~~~~~li~~~l~~dp~~Rps~~e 266 (297)
T 3fxz_A 214 PPYLNEN---------PLRALYLIATNGT-PELQN---PE--------KLSAIFRDFLNRCLEMDVEKRGSAKE 266 (297)
T ss_dssp CTTTTSC---------HHHHHHHHHHHCS-CCCSC---GG--------GSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCCC---------HHHHHHHHHhCCC-CCCCC---cc--------ccCHHHHHHHHHHccCChhHCcCHHH
Confidence 9995421 1111111111111 11111 11 22357889999999999999999753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=278.61 Aligned_cols=211 Identities=19% Similarity=0.270 Sum_probs=166.1
Q ss_pred Cccccccc-ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHH
Q 044022 1 MKFYGHEY-HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~ 75 (241)
||++.... .....+++.+|++++++++||||+++++++...+..++||||+++++|.+++.... .....++.|++
T Consensus 45 iK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~ 124 (328)
T 3fe3_A 45 IKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV 124 (328)
T ss_dssp EEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHH
T ss_pred EEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHH
Confidence 35544332 23456778899999999999999999999999999999999999999999985432 24678999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCC-cchhhH
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLN-EKSNVF 154 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~ 154 (241)
.||.||| +.+++||||||+||+++.++.+||+|||++........ .....||+.|+|||++.+..+. .++|||
T Consensus 125 ~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 198 (328)
T 3fe3_A 125 SAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVW 198 (328)
T ss_dssp HHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHH
T ss_pred HHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhh
Confidence 9999999 89999999999999999999999999999976544322 2345789999999999887765 789999
Q ss_pred HHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 155 SFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 155 s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
|+|+++|+|++|+.||... ...+....... +.. . +.. ..+..+.+++.+||..||+
T Consensus 199 slG~il~ell~g~~pf~~~---------~~~~~~~~i~~-~~~-~-----~p~--------~~s~~~~~li~~~L~~dP~ 254 (328)
T 3fe3_A 199 SLGVILYTLVSGSLPFDGQ---------NLKELRERVLR-GKY-R-----IPF--------YMSTDCENLLKRFLVLNPI 254 (328)
T ss_dssp HHHHHHHHHHHSSCSSCCS---------SHHHHHHHHHH-CCC-C-----CCT--------TSCHHHHHHHHHHCCSSTT
T ss_pred hhHHHHHHHHhCCCCCCCC---------CHHHHHHHHHh-CCC-C-----CCC--------CCCHHHHHHHHHHCCCChh
Confidence 9999999999999999542 12222222221 111 0 111 1225688999999999999
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
+|||++|
T Consensus 255 ~R~t~~e 261 (328)
T 3fe3_A 255 KRGTLEQ 261 (328)
T ss_dssp TSCCHHH
T ss_pred HCcCHHH
Confidence 9999853
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=289.91 Aligned_cols=215 Identities=22% Similarity=0.307 Sum_probs=166.1
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~ 75 (241)
||.+.........++|.+|++++++++||||+++++++...+..++||||+++|+|.+++.... ...+.++.|++
T Consensus 144 vK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~ 223 (377)
T 3cbl_A 144 VKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAA 223 (377)
T ss_dssp EEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHH
T ss_pred EEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence 3555444333455678999999999999999999999999999999999999999999986532 24678999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHH
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFS 155 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 155 (241)
.||.||| +.+++||||||+|||++.++.+||+|||++................++..|+|||.+.+..++.++||||
T Consensus 224 ~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 300 (377)
T 3cbl_A 224 AGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWS 300 (377)
T ss_dssp HHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHH
T ss_pred HHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHH
Confidence 9999999 8999999999999999999999999999998654432211112223567799999999888999999999
Q ss_pred HHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 156 FGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 156 ~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
||+++|||++ |..||..... .+ .......+.....+ . ..+..+.+++.+||+.||+
T Consensus 301 lG~il~el~t~g~~p~~~~~~---------~~-~~~~~~~~~~~~~~-----~--------~~~~~l~~li~~cl~~dP~ 357 (377)
T 3cbl_A 301 FGILLWETFSLGASPYPNLSN---------QQ-TREFVEKGGRLPCP-----E--------LCPDAVFRLMEQCWAYEPG 357 (377)
T ss_dssp HHHHHHHHHTTSCCSSTTSCH---------HH-HHHHHHTTCCCCCC-----T--------TCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHhCCCCCCCCCCH---------HH-HHHHHHcCCCCCCC-----C--------CCCHHHHHHHHHHcCCCch
Confidence 9999999998 9999865211 11 11222222111111 1 1225788999999999999
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
+|||++|
T Consensus 358 ~Rps~~~ 364 (377)
T 3cbl_A 358 QRPSFST 364 (377)
T ss_dssp GSCCHHH
T ss_pred hCcCHHH
Confidence 9999853
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=277.71 Aligned_cols=218 Identities=22% Similarity=0.234 Sum_probs=163.2
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCC----cceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTP----IPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.+|+.++++++||||+++++++.... .+++||||+++|+|.+++..... .+..++.|++.||.|||
T Consensus 62 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH--- 138 (322)
T 3soc_A 62 SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLH--- 138 (322)
T ss_dssp HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---
Confidence 445667999999999999999999998755 36999999999999999976543 46789999999999999
Q ss_pred CC----------CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-----cCCCcc
Q 044022 86 PR----------PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-----CVLNEK 150 (241)
Q Consensus 86 ~~----------~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~ 150 (241)
+. +++||||||+|||++.++.+||+|||.+................||+.|+|||++.+ ..++.+
T Consensus 139 ~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 218 (322)
T 3soc_A 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLR 218 (322)
T ss_dssp CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHH
T ss_pred hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCcc
Confidence 88 999999999999999999999999999987665443333344578999999999986 355678
Q ss_pred hhhHHHHHHHHHHHhcCcccccccccCCCcc-------cchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHH
Q 044022 151 SNVFSFGAFLFELLAGRIHIWDLLKDTHDHG-------CFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQ 223 (241)
Q Consensus 151 ~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (241)
+||||||+++|+|++|+.||........... ....+..... .... ..+.+... ......+..+.+
T Consensus 219 ~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~---~~~~~~~~~l~~ 290 (322)
T 3soc_A 219 IDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVV-VHKK----KRPVLRDY---WQKHAGMAMLCE 290 (322)
T ss_dssp HHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHH-TTSC----CCCCCCGG---GGSSHHHHHHHH
T ss_pred chhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhh-hccc----CCCCcccc---ccccchHHHHHH
Confidence 9999999999999999999965322211100 0111111111 1111 11111111 111245577999
Q ss_pred HHHHhccCCCCCCCCCCC
Q 044022 224 LTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 224 l~~~cl~~~p~~Rpt~~e 241 (241)
++.+||+.||++|||++|
T Consensus 291 li~~cl~~dP~~Rps~~e 308 (322)
T 3soc_A 291 TIEECWDHDAEARLSAGC 308 (322)
T ss_dssp HHHHHTCSSGGGSCCHHH
T ss_pred HHHHHccCChhhCcCHHH
Confidence 999999999999999853
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=275.09 Aligned_cols=214 Identities=25% Similarity=0.318 Sum_probs=159.1
Q ss_pred Cccccccc-ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-------hHHHHHH
Q 044022 1 MKFYGHEY-HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-------PRLKIAS 72 (241)
Q Consensus 1 iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------~~~~~~~ 72 (241)
||++.... .....+++.+|++++++++||||+++++++...+..++||||+++|+|.+++..... .++.++.
T Consensus 65 vK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~ 144 (309)
T 3p86_A 65 VKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAY 144 (309)
T ss_dssp EEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHH
T ss_pred EEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHH
Confidence 35544322 234457799999999999999999999999999999999999999999999976532 3678999
Q ss_pred HHHHHhchhhcCCCCC--ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcc
Q 044022 73 DIVNSLAYLHFGFPRP--IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEK 150 (241)
Q Consensus 73 ~i~~~l~~lh~~~~~~--ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 150 (241)
|++.||+||| +.+ ++||||||+||+++.++.+||+|||++........ ......||+.|+|||++.+..++.+
T Consensus 145 qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~ 219 (309)
T 3p86_A 145 DVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEK 219 (309)
T ss_dssp HHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCCCCTT
T ss_pred HHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc--ccccCCCCccccChhhhcCCCCCch
Confidence 9999999999 888 99999999999999999999999999875433221 1234568999999999999999999
Q ss_pred hhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhcc
Q 044022 151 SNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVN 230 (241)
Q Consensus 151 ~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 230 (241)
+||||||+++|+|++|+.||.... ..+............ .+... .+..+.+++.+||+
T Consensus 220 ~DiwslG~il~elltg~~Pf~~~~---------~~~~~~~~~~~~~~~-----~~~~~--------~~~~l~~li~~~l~ 277 (309)
T 3p86_A 220 SDVYSFGVILWELATLQQPWGNLN---------PAQVVAAVGFKCKRL-----EIPRN--------LNPQVAAIIEGCWT 277 (309)
T ss_dssp HHHHHHHHHHHHHHHCCCTTTTSC---------HHHHHHHHHHSCCCC-----CCCTT--------SCHHHHHHHHHHTC
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCC---------HHHHHHHHHhcCCCC-----CCCcc--------CCHHHHHHHHHHcc
Confidence 999999999999999999996521 111111111111111 11111 22578899999999
Q ss_pred CCCCCCCCCCC
Q 044022 231 NSPEDRPTMVD 241 (241)
Q Consensus 231 ~~p~~Rpt~~e 241 (241)
.||++|||++|
T Consensus 278 ~dP~~Rps~~~ 288 (309)
T 3p86_A 278 NEPWKRPSFAT 288 (309)
T ss_dssp SSGGGSCCHHH
T ss_pred CChhhCcCHHH
Confidence 99999999753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=278.02 Aligned_cols=217 Identities=22% Similarity=0.251 Sum_probs=164.3
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVN 76 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~ 76 (241)
||++.........+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++..... ....++.|++.
T Consensus 37 vK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~ 116 (323)
T 3tki_A 37 VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 116 (323)
T ss_dssp EEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHH
T ss_pred EEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHH
Confidence 35554333334457789999999999999999999999999999999999999999999976532 56789999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCC-CcchhhHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVL-NEKSNVFS 155 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~s 155 (241)
||.||| +.+++||||||+|||++.++.+||+|||++................||+.|+|||++.+..+ +.++||||
T Consensus 117 aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 193 (323)
T 3tki_A 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193 (323)
T ss_dssp HHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHH
T ss_pred HHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHH
Confidence 999999 89999999999999999999999999999976543332222344578999999999987765 67899999
Q ss_pred HHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 156 FGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 156 ~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
||+++|+|++|..||....... .. .......... .. .. ...+..+.+|+.+||+.||++
T Consensus 194 lG~il~~ll~g~~pf~~~~~~~-------~~-~~~~~~~~~~---~~-~~---------~~~~~~~~~li~~~L~~dP~~ 252 (323)
T 3tki_A 194 CGIVLTAMLAGELPWDQPSDSC-------QE-YSDWKEKKTY---LN-PW---------KKIDSAPLALLHKILVENPSA 252 (323)
T ss_dssp HHHHHHHHHHSSCSCSSSCTTS-------HH-HHHHHTTCTT---ST-TG---------GGSCHHHHHHHHHHSCSSTTT
T ss_pred HHHHHHHHHhCCCCCCCCchHH-------HH-HHHHhccccc---CC-cc---------ccCCHHHHHHHHHHccCChhh
Confidence 9999999999999996522111 11 1111111100 00 00 122356789999999999999
Q ss_pred CCCCCC
Q 044022 236 RPTMVD 241 (241)
Q Consensus 236 Rpt~~e 241 (241)
|||++|
T Consensus 253 R~t~~e 258 (323)
T 3tki_A 253 RITIPD 258 (323)
T ss_dssp SCCHHH
T ss_pred CcCHHH
Confidence 999853
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=276.41 Aligned_cols=215 Identities=23% Similarity=0.345 Sum_probs=169.3
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----------------
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---------------- 64 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------- 64 (241)
||++.........+.+.+|++++++++||||+++++++...+..++||||+++++|.+++....
T Consensus 58 vK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ 137 (314)
T 2ivs_A 58 VKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137 (314)
T ss_dssp EEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC---------
T ss_pred EEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCccccccccccc
Confidence 3555544444556789999999999999999999999999999999999999999999986431
Q ss_pred ---------c---hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeeccccc
Q 044022 65 ---------L---PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIG 132 (241)
Q Consensus 65 ---------~---~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 132 (241)
. ....++.+++.||.||| +.+++|+||||+||+++.++.++|+|||.+................+
T Consensus 138 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 214 (314)
T 2ivs_A 138 SLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRI 214 (314)
T ss_dssp -------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCS
T ss_pred ccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCC
Confidence 1 36789999999999999 89999999999999999999999999999987655443333344457
Q ss_pred CCCccCcccccccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCc
Q 044022 133 TRGYSAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPC 211 (241)
Q Consensus 133 ~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (241)
++.|+|||.+.+..++.++||||||+++|+|++ |..||...... + ............ ...
T Consensus 215 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---------~-~~~~~~~~~~~~-----~~~---- 275 (314)
T 2ivs_A 215 PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE---------R-LFNLLKTGHRME-----RPD---- 275 (314)
T ss_dssp CGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---------G-HHHHHHTTCCCC-----CCT----
T ss_pred cccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---------H-HHHHhhcCCcCC-----CCc----
Confidence 788999999998889999999999999999999 99999652211 1 111111121111 111
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 212 IEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 212 ~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
..++.+.+++.+||+.||++|||++|
T Consensus 276 ----~~~~~~~~li~~~l~~dp~~Rps~~~ 301 (314)
T 2ivs_A 276 ----NCSEEMYRLMLQCWKQEPDKRPVFAD 301 (314)
T ss_dssp ----TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ----cCCHHHHHHHHHHccCChhhCcCHHH
Confidence 12257899999999999999999753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=275.97 Aligned_cols=215 Identities=22% Similarity=0.326 Sum_probs=166.1
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~ 75 (241)
||++.........+.|.+|+.++++++||||+++++++...+..++||||+++++|.+++.... . ....++.+++
T Consensus 82 vK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~ 161 (325)
T 3kul_A 82 IKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVG 161 (325)
T ss_dssp EEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHH
T ss_pred EEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHH
Confidence 3555544444566789999999999999999999999999999999999999999999996542 1 4678999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-eeecccccCCCccCcccccccCCCcchhhH
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-ITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
.||.||| +.+++||||||+|||++.++.++|+|||++......... .......+|+.|+|||++.+..++.++|||
T Consensus 162 ~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 238 (325)
T 3kul_A 162 AGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVW 238 (325)
T ss_dssp HHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHH
T ss_pred HHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHH
Confidence 9999999 899999999999999999999999999999876543221 122223456789999999988999999999
Q ss_pred HHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 155 SFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 155 s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
|||+++|+|++ |..||.... ..+......... ... ... ..+..+.+++.+||+.||
T Consensus 239 slG~il~ell~~g~~p~~~~~---------~~~~~~~~~~~~-~~~-----~~~--------~~~~~l~~li~~~l~~dp 295 (325)
T 3kul_A 239 SFGVVMWEVLAYGERPYWNMT---------NRDVISSVEEGY-RLP-----APM--------GCPHALHQLMLDCWHKDR 295 (325)
T ss_dssp HHHHHHHHHHTTSCCTTTTSC---------HHHHHHHHHTTC-CCC-----CCT--------TCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHHHHHcCCCCCcccCC---------HHHHHHHHHcCC-CCC-----CCC--------CcCHHHHHHHHHHccCCh
Confidence 99999999999 999995521 112222221111 111 111 223578999999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|||+.|
T Consensus 296 ~~Rps~~e 303 (325)
T 3kul_A 296 AQRPRFSQ 303 (325)
T ss_dssp GGSCCHHH
T ss_pred hhCcCHHH
Confidence 99999753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=272.78 Aligned_cols=208 Identities=27% Similarity=0.384 Sum_probs=163.2
Q ss_pred cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcC
Q 044022 10 RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 10 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~ 84 (241)
....+.|.+|++++++++||||+++++++...+..++||||+++++|.+++.... ..+..++.|++.||.|||
T Consensus 48 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH-- 125 (310)
T 3s95_A 48 EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH-- 125 (310)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH--
T ss_pred HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 3456789999999999999999999999999999999999999999999987532 146789999999999999
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCccee------------ecccccCCCccCcccccccCCCcchh
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT------------TDRVIGTRGYSAPEYISICVLNEKSN 152 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~------------~~~~~~~~~~~aPE~~~~~~~~~~~D 152 (241)
+.+++||||||+||+++.++.+||+|||.+........... .....||+.|+|||++.+..++.++|
T Consensus 126 -~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 204 (310)
T 3s95_A 126 -SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVD 204 (310)
T ss_dssp -HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHH
T ss_pred -hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHH
Confidence 89999999999999999999999999999987644322110 11456899999999999999999999
Q ss_pred hHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCC
Q 044022 153 VFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNS 232 (241)
Q Consensus 153 i~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~ 232 (241)
|||||+++|+|++|..|+..................... .... .+..+.+++.+||+.|
T Consensus 205 i~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~--------~~~~l~~li~~~l~~d 263 (310)
T 3s95_A 205 VFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY-------------CPPN--------CPPSFFPITVRCCDLD 263 (310)
T ss_dssp HHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT-------------CCTT--------CCTTHHHHHHHHTCSS
T ss_pred HHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc-------------CCCC--------CCHHHHHHHHHHccCC
Confidence 999999999999999998653322221221211111111 0011 1145889999999999
Q ss_pred CCCCCCCCC
Q 044022 233 PEDRPTMVD 241 (241)
Q Consensus 233 p~~Rpt~~e 241 (241)
|++|||++|
T Consensus 264 P~~Rps~~~ 272 (310)
T 3s95_A 264 PEKRPSFVK 272 (310)
T ss_dssp GGGSCCHHH
T ss_pred hhhCcCHHH
Confidence 999999753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=276.49 Aligned_cols=204 Identities=20% Similarity=0.261 Sum_probs=163.5
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+.+.+|+.++++++||||+++++++...+..++||||+++|+|.+++..... ....++.||+.||.||| +.
T Consensus 58 ~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~ 134 (361)
T 2yab_A 58 CREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TK 134 (361)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHH---HT
T ss_pred HHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 357899999999999999999999999999999999999999999999976532 46789999999999999 89
Q ss_pred CceeccCCCCCeeecCCC----CeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 88 PIVLRNFKTQNILFNEEN----VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+++||||||+||+++.++ .+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|
T Consensus 135 givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~l 211 (361)
T 2yab_A 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211 (361)
T ss_dssp TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHH
Confidence 999999999999998877 799999999987654322 1335689999999999988999999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|..||... ...+....... ... . ..+.. ....+..+.+|+.+||..||++|||++|
T Consensus 212 l~g~~Pf~~~---------~~~~~~~~i~~-~~~-~-~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~t~~e 269 (361)
T 2yab_A 212 LSGASPFLGD---------TKQETLANITA-VSY-D-FDEEF--------FSQTSELAKDFIRKLLVKETRKRLTIQE 269 (361)
T ss_dssp HHSCCSSCCS---------SHHHHHHHHHT-TCC-C-CCHHH--------HTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HhCCCCCCCC---------CHHHHHHHHHh-cCC-C-CCchh--------ccCCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 9999999552 11122222211 110 0 00000 1122367889999999999999999853
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=279.66 Aligned_cols=215 Identities=20% Similarity=0.318 Sum_probs=169.9
Q ss_pred CcccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC---------------
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--------------- 64 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------- 64 (241)
||++..........++.+|+++++++ +||||+++++++...+..++||||+++|+|.+++....
T Consensus 106 vK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~ 185 (382)
T 3tt0_A 106 VKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185 (382)
T ss_dssp EEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCC
T ss_pred EEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccc
Confidence 35555544445567899999999999 99999999999999999999999999999999986432
Q ss_pred --c---hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCc
Q 044022 65 --L---PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAP 139 (241)
Q Consensus 65 --~---~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aP 139 (241)
. .++.++.+++.||.||| +.+++||||||+|||++.++.+||+|||++................+++.|+||
T Consensus 186 ~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP 262 (382)
T 3tt0_A 186 EQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 262 (382)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCH
T ss_pred cccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCH
Confidence 1 46789999999999999 899999999999999999999999999999866544332333444577889999
Q ss_pred ccccccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHH
Q 044022 140 EYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQL 218 (241)
Q Consensus 140 E~~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (241)
|++.+..++.++||||||+++|+|++ |..||... ...+..... ..+..... ... .+
T Consensus 263 E~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~---------~~~~~~~~~-~~~~~~~~-----~~~--------~~ 319 (382)
T 3tt0_A 263 EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV---------PVEELFKLL-KEGHRMDK-----PSN--------CT 319 (382)
T ss_dssp HHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---------CHHHHHHHH-HTTCCCCC-----CSS--------CC
T ss_pred HHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---------CHHHHHHHH-HcCCCCCC-----Ccc--------CC
Confidence 99999899999999999999999999 99998542 112222222 22211111 111 22
Q ss_pred HHHHHHHHHhccCCCCCCCCCCC
Q 044022 219 HASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 219 ~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
..+.+++.+||+.||++|||++|
T Consensus 320 ~~l~~li~~~l~~dP~~Rps~~e 342 (382)
T 3tt0_A 320 NELYMMMRDCWHAVPSQRPTFKQ 342 (382)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHH
Confidence 57899999999999999999853
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=281.06 Aligned_cols=216 Identities=20% Similarity=0.329 Sum_probs=167.3
Q ss_pred CcccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCC-cceEEEEecCCCCHHHhhcCCC--------------
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTP-IPILVFQSVEYGTLRDCIFGAP-------------- 64 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~-------------- 64 (241)
||++.........+.+.+|+++++++ +||||+++++++...+ ..++||||+++|+|.+++....
T Consensus 57 vK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 136 (359)
T 3vhe_A 57 VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFR 136 (359)
T ss_dssp EEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------
T ss_pred EEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhh
Confidence 35555444444567899999999999 7899999999998755 4899999999999999986532
Q ss_pred -----------------------------------------------------c---hHHHHHHHHHHHhchhhcCCCCC
Q 044022 65 -----------------------------------------------------L---PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 65 -----------------------------------------------------~---~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
. ....++.+++.||.||| +.+
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ 213 (359)
T 3vhe_A 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRK 213 (359)
T ss_dssp -----------------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred cccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCC
Confidence 1 25678999999999999 899
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh-cC
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA-GR 167 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~-g~ 167 (241)
++||||||+|||++.++.++|+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 214 ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 293 (359)
T 3vhe_A 214 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 293 (359)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCC
Confidence 99999999999999999999999999987655444344445668889999999998899999999999999999998 99
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.||..... .+........+.....+ .. .++.+.+++.+||+.||++|||++|
T Consensus 294 ~p~~~~~~---------~~~~~~~~~~~~~~~~~-----~~--------~~~~l~~li~~~l~~dP~~Rps~~e 345 (359)
T 3vhe_A 294 SPYPGVKI---------DEEFCRRLKEGTRMRAP-----DY--------TTPEMYQTMLDCWHGEPSQRPTFSE 345 (359)
T ss_dssp CSSTTCCC---------SHHHHHHHHHTCCCCCC-----TT--------CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCccch---------hHHHHHHHHcCCCCCCC-----CC--------CCHHHHHHHHHHccCChhhCCCHHH
Confidence 99954211 11112222222111111 11 2257889999999999999999853
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=279.39 Aligned_cols=216 Identities=19% Similarity=0.273 Sum_probs=167.0
Q ss_pred CcccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC---------------
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--------------- 64 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------- 64 (241)
||++.........+.+.+|+.+++++ +||||+++++++...+..++||||+++|+|.+++....
T Consensus 80 vK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~ 159 (344)
T 1rjb_A 80 VKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159 (344)
T ss_dssp EEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC------------
T ss_pred EEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcc
Confidence 35555444445667899999999999 99999999999999999999999999999999986542
Q ss_pred ------------chHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeeccccc
Q 044022 65 ------------LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIG 132 (241)
Q Consensus 65 ------------~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 132 (241)
...+.++.+++.||.||| +.+++||||||+||+++.++.++|+|||.+................+
T Consensus 160 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~ 236 (344)
T 1rjb_A 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARL 236 (344)
T ss_dssp ---------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEE
T ss_pred cccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccC
Confidence 135679999999999999 89999999999999999999999999999976654443333445567
Q ss_pred CCCccCcccccccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCc
Q 044022 133 TRGYSAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPC 211 (241)
Q Consensus 133 ~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (241)
|+.|+|||.+.+..++.++||||||+++|+|++ |..||...... .........+.... ....
T Consensus 237 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---------~~~~~~~~~~~~~~-----~~~~--- 299 (344)
T 1rjb_A 237 PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD---------ANFYKLIQNGFKMD-----QPFY--- 299 (344)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---------HHHHHHHHTTCCCC-----CCTT---
T ss_pred ccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH---------HHHHHHHhcCCCCC-----CCCC---
Confidence 888999999998899999999999999999998 99999652211 11111111111111 1111
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 212 IEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 212 ~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.++.+.+++.+||+.||++|||++|
T Consensus 300 -----~~~~l~~li~~~l~~dp~~Rps~~~ 324 (344)
T 1rjb_A 300 -----ATEEIYIIMQSCWAFDSRKRPSFPN 324 (344)
T ss_dssp -----CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -----CCHHHHHHHHHHcCCCchhCcCHHH
Confidence 2257899999999999999999753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=279.09 Aligned_cols=215 Identities=23% Similarity=0.337 Sum_probs=167.4
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----------------
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---------------- 64 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------- 64 (241)
||++..+......+.+.+|++++++++||||+++++++...+..++||||+++++|.+++....
T Consensus 82 vK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ 161 (343)
T 1luf_A 82 VKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161 (343)
T ss_dssp EEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC---------------
T ss_pred EEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccc
Confidence 3555554444556789999999999999999999999999999999999999999999986521
Q ss_pred ---------c---hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeeccccc
Q 044022 65 ---------L---PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIG 132 (241)
Q Consensus 65 ---------~---~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 132 (241)
. .++.++.+++.||.||| +++++||||||+||+++.++.+||+|||.+................+
T Consensus 162 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 238 (343)
T 1luf_A 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAI 238 (343)
T ss_dssp -------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCB
T ss_pred cccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcc
Confidence 1 35779999999999999 89999999999999999999999999999876543322222234467
Q ss_pred CCCccCcccccccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCc
Q 044022 133 TRGYSAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPC 211 (241)
Q Consensus 133 ~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (241)
++.|+|||.+.+..++.++||||||+++|+|++ |..||.... ..+..... ..+..... ...
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~---------~~~~~~~~-~~~~~~~~-----~~~--- 300 (343)
T 1luf_A 239 PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA---------HEEVIYYV-RDGNILAC-----PEN--- 300 (343)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---------HHHHHHHH-HTTCCCCC-----CTT---
T ss_pred cceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC---------hHHHHHHH-hCCCcCCC-----CCC---
Confidence 889999999998899999999999999999999 999996521 11222222 12211111 111
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 212 IEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 212 ~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.+..+.+++.+||+.||++|||+.|
T Consensus 301 -----~~~~l~~li~~~l~~~p~~Rps~~~ 325 (343)
T 1luf_A 301 -----CPLELYNLMRLCWSKLPADRPSFCS 325 (343)
T ss_dssp -----CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -----CCHHHHHHHHHHcccCcccCCCHHH
Confidence 2257899999999999999999753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=270.90 Aligned_cols=214 Identities=17% Similarity=0.268 Sum_probs=168.5
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNS 77 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~ 77 (241)
||++.... ....+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++..... ....++.+++.|
T Consensus 75 vK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~ 153 (321)
T 2c30_A 75 VKMMDLRK-QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQA 153 (321)
T ss_dssp EEEEETTT-CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred EEEEeccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 35554322 34567799999999999999999999999999999999999999999999876543 467899999999
Q ss_pred hchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHH
Q 044022 78 LAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFG 157 (241)
Q Consensus 78 l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G 157 (241)
|.||| +.+++||||||+||+++.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||
T Consensus 154 L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG 228 (321)
T 2c30_A 154 LAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLG 228 (321)
T ss_dssp HHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHH
T ss_pred HHHHH---HCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHH
Confidence 99999 899999999999999999999999999998876543221 2345789999999999988999999999999
Q ss_pred HHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 158 AFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 158 ~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
+++|+|++|+.||.... ..+....... ........ .. ..+..+.+++.+||+.||++||
T Consensus 229 ~il~el~~g~~pf~~~~---------~~~~~~~~~~-~~~~~~~~---~~--------~~~~~l~~li~~~l~~dp~~Rp 287 (321)
T 2c30_A 229 IMVIEMVDGEPPYFSDS---------PVQAMKRLRD-SPPPKLKN---SH--------KVSPVLRDFLERMLVRDPQERA 287 (321)
T ss_dssp HHHHHHHHSSCTTTTSC---------HHHHHHHHHH-SSCCCCTT---GG--------GSCHHHHHHHHHHSCSSTTTSC
T ss_pred HHHHHHHhCCCCCCCCC---------HHHHHHHHhc-CCCCCcCc---cc--------cCCHHHHHHHHHHccCChhhCc
Confidence 99999999999996421 1111222111 11111100 01 2235788999999999999999
Q ss_pred CCCC
Q 044022 238 TMVD 241 (241)
Q Consensus 238 t~~e 241 (241)
|++|
T Consensus 288 s~~e 291 (321)
T 2c30_A 288 TAQE 291 (321)
T ss_dssp CHHH
T ss_pred CHHH
Confidence 9853
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=282.65 Aligned_cols=206 Identities=19% Similarity=0.270 Sum_probs=163.4
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|++++++++||||+++++++...+..++||||+++|+|.+.+..... ....++.||+.||.||| +
T Consensus 52 ~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH---~ 128 (444)
T 3soa_A 52 RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH---Q 128 (444)
T ss_dssp HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 3456789999999999999999999999999999999999999999998865432 46789999999999999 8
Q ss_pred CCceeccCCCCCeeec---CCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFN---EENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
.+|+||||||+|||++ .++.+||+|||++......... .....||+.|+|||++.+..++.++||||+|+++|+|
T Consensus 129 ~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel 206 (444)
T 3soa_A 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYIL 206 (444)
T ss_dssp TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHH
Confidence 9999999999999998 4678999999999766543321 1335789999999999988999999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|..||... ...+....... +.. ..+.+.+ . ..++.+.+|+.+||+.||++|||+.|
T Consensus 207 l~G~~Pf~~~---------~~~~~~~~i~~-~~~-~~~~~~~-~--------~~s~~~~~li~~~L~~dP~~Rpta~e 264 (444)
T 3soa_A 207 LVGYPPFWDE---------DQHRLYQQIKA-GAY-DFPSPEW-D--------TVTPEAKDLINKMLTINPSKRITAAE 264 (444)
T ss_dssp HHSSCSCCCS---------SHHHHHHHHHH-TCC-CCCTTTT-T--------TSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HhCCCCCCCc---------cHHHHHHHHHh-CCC-CCCcccc-c--------cCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 9999999552 11222222221 111 1111111 1 12357889999999999999999853
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=281.79 Aligned_cols=215 Identities=20% Similarity=0.267 Sum_probs=165.8
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--------c---hHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--------L---PRLK 69 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------~---~~~~ 69 (241)
||++..........++.+|+.++++++||||+++++++...+..++||||+++|+|.+++.... . ..+.
T Consensus 106 vK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~ 185 (367)
T 3l9p_A 106 VKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185 (367)
T ss_dssp EEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHH
T ss_pred EEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHH
Confidence 3555544445566789999999999999999999999999999999999999999999986431 1 4678
Q ss_pred HHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCC---CeEEeeccCceecCCCCcceeecccccCCCccCcccccccC
Q 044022 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEEN---VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV 146 (241)
Q Consensus 70 ~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 146 (241)
++.+++.||.||| +++|+||||||+|||++.++ .+||+|||++................+|+.|+|||++.+..
T Consensus 186 i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 262 (367)
T 3l9p_A 186 VARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI 262 (367)
T ss_dssp HHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCC
Confidence 9999999999999 89999999999999999554 59999999987542222112223346788999999999889
Q ss_pred CCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHH
Q 044022 147 LNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLT 225 (241)
Q Consensus 147 ~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 225 (241)
++.++||||||+++|+|++ |..||... ...+.......... ... .. ..+..+.+++
T Consensus 263 ~~~~~DvwslG~il~ellt~g~~pf~~~---------~~~~~~~~i~~~~~-~~~-----~~--------~~~~~l~~li 319 (367)
T 3l9p_A 263 FTSKTDTWSFGVLLWEIFSLGYMPYPSK---------SNQEVLEFVTSGGR-MDP-----PK--------NCPGPVYRIM 319 (367)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTC---------CHHHHHHHHHTTCC-CCC-----CT--------TCCHHHHHHH
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCC---------CHHHHHHHHHcCCC-CCC-----Cc--------cCCHHHHHHH
Confidence 9999999999999999998 99999542 11222222222211 111 11 1225688999
Q ss_pred HHhccCCCCCCCCCCC
Q 044022 226 LECVNNSPEDRPTMVD 241 (241)
Q Consensus 226 ~~cl~~~p~~Rpt~~e 241 (241)
.+||+.||++|||++|
T Consensus 320 ~~~l~~dP~~Rps~~e 335 (367)
T 3l9p_A 320 TQCWQHQPEDRPNFAI 335 (367)
T ss_dssp HHHTCSSGGGSCCHHH
T ss_pred HHHcCCCHhHCcCHHH
Confidence 9999999999999753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=276.41 Aligned_cols=209 Identities=21% Similarity=0.243 Sum_probs=160.6
Q ss_pred ccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.+.+|..++.++ +||||+++++++...+..++||||+++|+|..++.... .....++.+|+.||.|||
T Consensus 94 ~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH--- 170 (396)
T 4dc2_A 94 EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH--- 170 (396)
T ss_dssp --CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---
T ss_pred HHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 3456688999999987 89999999999999999999999999999999886532 246788999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+++|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|+||||+++|+|++
T Consensus 171 ~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~ 248 (396)
T 4dc2_A 171 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 248 (396)
T ss_dssp HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred HCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHh
Confidence 89999999999999999999999999999975332221 2244679999999999999999999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
|+.||............ ..+........... .. ... .+..+.+|+.+||+.||++||++
T Consensus 249 G~~Pf~~~~~~~~~~~~-~~~~~~~~i~~~~~-~~-----p~~--------~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 249 GRSPFDIVGSSDNPDQN-TEDYLFQVILEKQI-RI-----PRS--------LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp SSCSSTTTTC------C-CHHHHHHHHHHCCC-CC-----CTT--------SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCCCCcccccccccchh-hHHHHHHHHhcccc-CC-----CCc--------CCHHHHHHHHHHhcCCHhHcCCC
Confidence 99999642221111111 11112121111111 11 111 22578899999999999999997
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=269.51 Aligned_cols=230 Identities=16% Similarity=0.192 Sum_probs=171.4
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCC--cceEEEEecCCCCHHHhhcCCC-------chHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTP--IPILVFQSVEYGTLRDCIFGAP-------LPRLKIA 71 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~-------~~~~~~~ 71 (241)
||++.........+.+.+|++++++++||||+++++++.... ..++||||+++++|.+++.... .....++
T Consensus 39 vK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~ 118 (319)
T 4euu_A 39 IKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118 (319)
T ss_dssp EEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHH
T ss_pred EEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHH
Confidence 466665555566788899999999999999999999998655 7799999999999999987642 1467899
Q ss_pred HHHHHHhchhhcCCCCCceeccCCCCCeee----cCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc----
Q 044022 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILF----NEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS---- 143 (241)
Q Consensus 72 ~~i~~~l~~lh~~~~~~ivh~dl~~~nil~----~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---- 143 (241)
.|++.||.||| +.+++||||||+||++ +..+.+||+|||.+......... ....|++.|+|||++.
T Consensus 119 ~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~ 192 (319)
T 4euu_A 119 RDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVL 192 (319)
T ss_dssp HHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHTS
T ss_pred HHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCce---eecccCCCccCHHHhhhccc
Confidence 99999999999 8999999999999999 77888999999999876554322 2346899999999986
Q ss_pred ----ccCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccC------CCCCCc--cccCCC-
Q 044022 144 ----ICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFT------GIPAPI--IVQDIP- 210 (241)
Q Consensus 144 ----~~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~--~~~~~~- 210 (241)
+..++.++||||||+++|+|++|+.||...... ....+.+.......... ...... +....+
T Consensus 193 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 267 (319)
T 4euu_A 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP-----RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPV 267 (319)
T ss_dssp CCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG-----GGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCT
T ss_pred cccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc-----chhHHHHHHHhcCCCcccchhhhcccCCccccCccCCc
Confidence 467889999999999999999999999642211 11222222222211100 000000 000111
Q ss_pred -chhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 211 -CIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 211 -~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.......+..+.+++.+||+.||++|||++|
T Consensus 268 ~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~e 299 (319)
T 4euu_A 268 SCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299 (319)
T ss_dssp TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred ccccchhHHHHhHHHHHHhccCChhhhccHHH
Confidence 1122466778999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=275.97 Aligned_cols=205 Identities=22% Similarity=0.345 Sum_probs=162.4
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|++++++++||||+++++++...+..++||||+++|+|.+++..... ....++.||+.||.||| +
T Consensus 70 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~ 146 (362)
T 2bdw_A 70 RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH---S 146 (362)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 3457789999999999999999999999999999999999999999998866532 46789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCC---CeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEEN---VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
.+++||||||+|||++.++ .+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|
T Consensus 147 ~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l 223 (362)
T 2bdw_A 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYIL 223 (362)
T ss_dssp TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHH
Confidence 9999999999999998654 599999999976654322 1235789999999999988999999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|..||.... ..+...... .+.. ..+.+.+ ...+..+.+|+.+||+.||++|||++|
T Consensus 224 l~g~~Pf~~~~---------~~~~~~~i~-~~~~-~~~~~~~---------~~~~~~~~~li~~~L~~dP~~R~t~~e 281 (362)
T 2bdw_A 224 LVGYPPFWDED---------QHRLYAQIK-AGAY-DYPSPEW---------DTVTPEAKSLIDSMLTVNPKKRITADQ 281 (362)
T ss_dssp HHSSCSSCCSS---------HHHHHHHHH-HTCC-CCCTTGG---------GGSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHCCCCCCCCC---------HHHHHHHHH-hCCC-CCCcccc---------cCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 99999996521 112222211 1111 1111111 122357889999999999999999753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=277.92 Aligned_cols=214 Identities=22% Similarity=0.324 Sum_probs=156.2
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~ 76 (241)
|.+.........++|.+|++++++++||||+++++++...+..++||||+++|+|.+++..... .++.++.+++.
T Consensus 79 K~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~ 158 (373)
T 2qol_A 79 KTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158 (373)
T ss_dssp EECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHH
T ss_pred EEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHH
Confidence 4444433444567899999999999999999999999999999999999999999999976432 46789999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-eeecccccCCCccCcccccccCCCcchhhHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-ITTDRVIGTRGYSAPEYISICVLNEKSNVFS 155 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 155 (241)
||.||| +.+++||||||+|||++.++.+||+|||++......... .......++..|+|||++.+..++.++||||
T Consensus 159 aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~S 235 (373)
T 2qol_A 159 GMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWS 235 (373)
T ss_dssp HHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHH
Confidence 999999 899999999999999999999999999999765443211 1111223567899999999889999999999
Q ss_pred HHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 156 FGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 156 ~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
||+++|++++ |+.||.... ..+.......... .... . ..+..+.+++.+||+.||+
T Consensus 236 lG~il~ellt~g~~P~~~~~---------~~~~~~~i~~~~~-~~~~-----~--------~~~~~l~~li~~cl~~dp~ 292 (373)
T 2qol_A 236 YGIVLWEVMSYGERPYWEMS---------NQDVIKAVDEGYR-LPPP-----M--------DCPAALYQLMLDCWQKDRN 292 (373)
T ss_dssp HHHHHHHHHTTC-CTTTTCC---------HHHHHHHHHTTEE-CCCC-----T--------TCBHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHhCCCCCCCCCC---------HHHHHHHHHcCCC-CCCC-----c--------cccHHHHHHHHHHhCcChh
Confidence 9999999998 999996521 1222222221111 1100 1 1225789999999999999
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
+|||++|
T Consensus 293 ~RPs~~~ 299 (373)
T 2qol_A 293 NRPKFEQ 299 (373)
T ss_dssp GSCCHHH
T ss_pred hCcCHHH
Confidence 9999753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=271.38 Aligned_cols=199 Identities=17% Similarity=0.238 Sum_probs=160.5
Q ss_pred cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCC
Q 044022 10 RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 10 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
......+.+|++++++++||||+++++++...+..++||||+++|+|.+++.... .....++.+|+.||.|||
T Consensus 46 ~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--- 122 (337)
T 1o6l_A 46 KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH--- 122 (337)
T ss_dssp TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred hhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 3456788999999999999999999999999999999999999999999886532 246778999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+++|+||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++|+||||+++|+|++
T Consensus 123 ~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 200 (337)
T 1o6l_A 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200 (337)
T ss_dssp HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHH
T ss_pred HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhc
Confidence 89999999999999999999999999999875432221 1234578999999999998899999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
|..||.... ..+......... . .+... .+..+.+++.+||+.||++||
T Consensus 201 g~~Pf~~~~---------~~~~~~~i~~~~-~------~~p~~--------~s~~~~~li~~lL~~dP~~R~ 248 (337)
T 1o6l_A 201 GRLPFYNQD---------HERLFELILMEE-I------RFPRT--------LSPEAKSLLAGLLKKDPKQRL 248 (337)
T ss_dssp SSCSSCCSS---------HHHHHHHHHHCC-C------CCCTT--------SCHHHHHHHHHHTCSSTTTST
T ss_pred CCCCCCCCC---------HHHHHHHHHcCC-C------CCCCC--------CCHHHHHHHHHHhhcCHHHhc
Confidence 999996521 112222221111 0 11111 225788999999999999999
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=271.45 Aligned_cols=204 Identities=20% Similarity=0.263 Sum_probs=163.0
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++..... ....++.+++.||.||| +.
T Consensus 57 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~ 133 (326)
T 2y0a_A 57 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SL 133 (326)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHH---HT
T ss_pred hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHH---HC
Confidence 467899999999999999999999999999999999999999999999876432 56789999999999999 89
Q ss_pred CceeccCCCCCeeecCCC----CeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 88 PIVLRNFKTQNILFNEEN----VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+++||||||+||+++.++ .+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|
T Consensus 134 ~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l 210 (326)
T 2y0a_A 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 210 (326)
T ss_dssp TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999998887 899999999987654322 1334689999999999988999999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|..||.... ..+......... . . ...... ...+..+.+++.+||+.||++|||++|
T Consensus 211 l~g~~pf~~~~---------~~~~~~~~~~~~-~-~-~~~~~~--------~~~~~~~~~li~~~L~~dP~~Rpt~~e 268 (326)
T 2y0a_A 211 LSGASPFLGDT---------KQETLANVSAVN-Y-E-FEDEYF--------SNTSALAKDFIRRLLVKDPKKRMTIQD 268 (326)
T ss_dssp HHSCCSSCCSS---------HHHHHHHHHHTC-C-C-CCHHHH--------TTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHCcCCCCCCC---------HHHHHHHHHhcC-C-C-cCcccc--------ccCCHHHHHHHHHHccCChhhCCCHHH
Confidence 99999995421 112222211111 0 0 000000 122357889999999999999999753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=274.43 Aligned_cols=213 Identities=19% Similarity=0.235 Sum_probs=160.3
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~ 76 (241)
|.+.........++|.+|++++++++||||+++++++..+. .++|++++.+|+|.+++.... ...+.++.+++.
T Consensus 50 K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~ 128 (327)
T 3poz_A 50 KELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128 (327)
T ss_dssp EEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHH
T ss_pred eecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 33433344456788999999999999999999999998765 788999999999999986532 146789999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSF 156 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~ 156 (241)
||.||| +.+++||||||+|||++.++.+||+|||++................+|..|+|||++.+..++.++|||||
T Consensus 129 ~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 205 (327)
T 3poz_A 129 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 205 (327)
T ss_dssp HHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhh
Confidence 999999 89999999999999999999999999999987655443333334456788999999999999999999999
Q ss_pred HHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 157 GAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 157 G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
|+++|+|++ |+.||...... +..... ..+..... .. ..+..+.+++.+||+.||++
T Consensus 206 G~il~ellt~g~~p~~~~~~~---------~~~~~~-~~~~~~~~-----~~--------~~~~~~~~li~~~l~~~p~~ 262 (327)
T 3poz_A 206 GVTVWELMTFGSKPYDGIPAS---------EISSIL-EKGERLPQ-----PP--------ICTIDVYMIMVKCWMIDADS 262 (327)
T ss_dssp HHHHHHHHTTSCCTTTTCCGG---------GHHHHH-HTTCCCCC-----CT--------TBCHHHHHHHHHHTCSCGGG
T ss_pred HHHHHHHHhcCCCCccCCCHH---------HHHHHH-HcCCCCCC-----Cc--------cCCHHHHHHHHHHcCCChhh
Confidence 999999999 99999652211 111111 11111111 11 12257889999999999999
Q ss_pred CCCCCC
Q 044022 236 RPTMVD 241 (241)
Q Consensus 236 Rpt~~e 241 (241)
|||+.|
T Consensus 263 Rps~~e 268 (327)
T 3poz_A 263 RPKFRE 268 (327)
T ss_dssp SCCHHH
T ss_pred CCCHHH
Confidence 999753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=272.78 Aligned_cols=216 Identities=20% Similarity=0.323 Sum_probs=169.2
Q ss_pred CcccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC---------------
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--------------- 64 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------- 64 (241)
||++.........+.+.+|+++++++ +||||+++++++...+..++||||+++|+|.+++....
T Consensus 58 vK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 137 (313)
T 1t46_A 58 VKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137 (313)
T ss_dssp EEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC------------
T ss_pred HHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhccccccccccccccccc
Confidence 35554444444567899999999999 99999999999999999999999999999999986432
Q ss_pred ----c---hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCcc
Q 044022 65 ----L---PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYS 137 (241)
Q Consensus 65 ----~---~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (241)
. ..+.++.+++.||.||| +.+++|+||||+||+++.++.++|+|||.+................+++.|+
T Consensus 138 ~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 214 (313)
T 1t46_A 138 DELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWM 214 (313)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGC
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceee
Confidence 1 46789999999999999 8999999999999999999999999999998766554433334455778899
Q ss_pred CcccccccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHH
Q 044022 138 APEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQ 216 (241)
Q Consensus 138 aPE~~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (241)
|||.+.+..++.++||||||+++|+|++ |..||...... .............. ... .
T Consensus 215 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---------~~~~~~~~~~~~~~-----~~~--------~ 272 (313)
T 1t46_A 215 APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD---------SKFYKMIKEGFRML-----SPE--------H 272 (313)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---------HHHHHHHHHTCCCC-----CCT--------T
T ss_pred ChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch---------hHHHHHhccCCCCC-----Ccc--------c
Confidence 9999998899999999999999999999 99998652211 11111111111110 011 1
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 217 QLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 217 ~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.+..+.+++.+||+.||++|||++|
T Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~e 297 (313)
T 1t46_A 273 APAEMYDIMKTCWDADPLKRPTFKQ 297 (313)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHH
Confidence 2257899999999999999999853
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=272.98 Aligned_cols=204 Identities=15% Similarity=0.206 Sum_probs=163.2
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
....+.+|++++++++||||+++++++...+..++||||+++++|.+++.... . ....++.|++.||.||| +
T Consensus 44 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~ 120 (321)
T 1tki_A 44 DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---S 120 (321)
T ss_dssp HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 35568899999999999999999999999999999999999999999997642 1 46789999999999999 8
Q ss_pred CCceeccCCCCCeeecC--CCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNE--ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
.+++||||||+|||++. ++.+||+|||.+......... ....+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 121 ~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 197 (321)
T 1tki_A 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197 (321)
T ss_dssp TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH
T ss_pred CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc---ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999987 789999999999876544322 2346899999999999888899999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|..||.... ..+......... .. ..... ....+..+.+++.+||..||++|||++|
T Consensus 198 ~g~~pf~~~~---------~~~~~~~i~~~~-~~--~~~~~--------~~~~s~~~~~li~~~L~~dp~~Rpt~~e 254 (321)
T 1tki_A 198 SGINPFLAET---------NQQIIENIMNAE-YT--FDEEA--------FKEISIEAMDFVDRLLVKERKSRMTASE 254 (321)
T ss_dssp HSSCTTCCSS---------HHHHHHHHHHTC-CC--CCHHH--------HTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred hCCCCCcCCC---------HHHHHHHHHcCC-CC--CChhh--------hccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999996521 112222222111 10 00000 0122367899999999999999999853
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=269.86 Aligned_cols=209 Identities=21% Similarity=0.235 Sum_probs=161.2
Q ss_pred ccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.+.+|+.+++++ +||||+++++++...+..++||||+++|+|.+++.... .....++.+|+.||.|||
T Consensus 51 ~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH--- 127 (345)
T 3a8x_A 51 EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH--- 127 (345)
T ss_dssp HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---
T ss_pred HHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 3456688999999998 89999999999999999999999999999999886532 246788999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+++|+||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++|+||||+++|+|++
T Consensus 128 ~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 205 (345)
T 3a8x_A 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 205 (345)
T ss_dssp HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred HCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHh
Confidence 89999999999999999999999999999975432221 1234578999999999998899999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
|+.||.............. ............ . +... .+..+.+++.+||+.||++|||+
T Consensus 206 g~~pf~~~~~~~~~~~~~~-~~~~~~i~~~~~-~-----~p~~--------~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 206 GRSPFDIVGSSDNPDQNTE-DYLFQVILEKQI-R-----IPRS--------LSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp SSCTTTTTTC-------CH-HHHHHHHHHCCC-C-----CCTT--------SCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCcCCcccccccccccH-HHHHHHHHcCCC-C-----CCCC--------CCHHHHHHHHHHhcCCHhHCCCC
Confidence 9999965222111111111 111111111111 1 1111 22578899999999999999997
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=273.72 Aligned_cols=215 Identities=18% Similarity=0.263 Sum_probs=167.1
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--------------Cch
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--------------PLP 66 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--------------~~~ 66 (241)
||.+..........++.+|++++++++||||+++++++...+..++||||+++++|.+++... ...
T Consensus 60 iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ 139 (322)
T 1p4o_A 60 IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139 (322)
T ss_dssp EEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHH
T ss_pred EEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHH
Confidence 355544444445667999999999999999999999999999999999999999999998642 124
Q ss_pred HHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccC
Q 044022 67 RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV 146 (241)
Q Consensus 67 ~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 146 (241)
.+.++.+++.||.||| +++++||||||+||+++.++.++|+|||.+................+++.|+|||.+.+..
T Consensus 140 ~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 216 (322)
T 1p4o_A 140 MIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV 216 (322)
T ss_dssp HHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCC
Confidence 6788999999999999 8999999999999999999999999999987654333222233445678899999999888
Q ss_pred CCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHH
Q 044022 147 LNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLT 225 (241)
Q Consensus 147 ~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 225 (241)
++.++||||||+++|+|++ |..||.... ..+..... ..+..... .. ..+..+.+++
T Consensus 217 ~~~~~Di~slG~il~el~~~g~~p~~~~~---------~~~~~~~~-~~~~~~~~-----~~--------~~~~~l~~li 273 (322)
T 1p4o_A 217 FTTYSDVWSFGVVLWEIATLAEQPYQGLS---------NEQVLRFV-MEGGLLDK-----PD--------NCPDMLFELM 273 (322)
T ss_dssp CCHHHHHHHHHHHHHHHHHTSCCTTTTSC---------HHHHHHHH-HTTCCCCC-----CT--------TCCHHHHHHH
T ss_pred CCchhhHHHHHHHHHHHHhcCCCccccCC---------HHHHHHHH-HcCCcCCC-----CC--------CCCHHHHHHH
Confidence 9999999999999999999 889985421 11222221 11211111 11 1225788999
Q ss_pred HHhccCCCCCCCCCCC
Q 044022 226 LECVNNSPEDRPTMVD 241 (241)
Q Consensus 226 ~~cl~~~p~~Rpt~~e 241 (241)
.+||+.||++|||+.|
T Consensus 274 ~~~l~~dp~~Rps~~e 289 (322)
T 1p4o_A 274 RMCWQYNPKMRPSFLE 289 (322)
T ss_dssp HHHTCSSGGGSCCHHH
T ss_pred HHHcCCCcccCcCHHH
Confidence 9999999999999853
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=277.30 Aligned_cols=215 Identities=20% Similarity=0.320 Sum_probs=166.8
Q ss_pred cccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC-----------------
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA----------------- 63 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------- 63 (241)
|.+.........+.+.+|+++++++ +||||+++++++...+..++||||+++|+|.+++...
T Consensus 82 K~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~ 161 (333)
T 2i1m_A 82 KMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161 (333)
T ss_dssp EEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCC
T ss_pred HhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhccccccccccccccccc
Confidence 4444333334567799999999999 8999999999999999999999999999999998642
Q ss_pred -CchHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccc
Q 044022 64 -PLPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYI 142 (241)
Q Consensus 64 -~~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 142 (241)
....+.++.+++.||.||| +.+++||||||+||+++.++.++|+|||++................+++.|+|||.+
T Consensus 162 ~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 238 (333)
T 2i1m_A 162 STRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI 238 (333)
T ss_dssp CHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHh
Confidence 1146789999999999999 899999999999999999999999999999765444333333445577889999999
Q ss_pred cccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHH
Q 044022 143 SICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHAS 221 (241)
Q Consensus 143 ~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (241)
.+..++.++||||||+++|+|++ |..||...... ............... ... .+..+
T Consensus 239 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---------~~~~~~~~~~~~~~~-----~~~--------~~~~l 296 (333)
T 2i1m_A 239 FDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN---------SKFYKLVKDGYQMAQ-----PAF--------APKNI 296 (333)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS---------HHHHHHHHHTCCCCC-----CTT--------CCHHH
T ss_pred ccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh---------HHHHHHHhcCCCCCC-----CCC--------CCHHH
Confidence 98899999999999999999998 99998652111 111122222211111 111 12578
Q ss_pred HHHHHHhccCCCCCCCCCCC
Q 044022 222 AQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 222 ~~l~~~cl~~~p~~Rpt~~e 241 (241)
.+++.+||+.||++|||++|
T Consensus 297 ~~li~~~l~~~p~~Rps~~~ 316 (333)
T 2i1m_A 297 YSIMQACWALEPTHRPTFQQ 316 (333)
T ss_dssp HHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHhccChhhCcCHHH
Confidence 89999999999999999853
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=266.05 Aligned_cols=196 Identities=20% Similarity=0.288 Sum_probs=160.3
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++..... ....++.+++.||.||| +
T Consensus 48 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~ 124 (318)
T 1fot_A 48 KQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---S 124 (318)
T ss_dssp TCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---T
T ss_pred hHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 3567788999999999999999999999999999999999999999999865422 46778999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
++++||||||+|||++.++.+||+|||++....... ....||+.|+|||++.+..++.++|+||||+++|+|++|
T Consensus 125 ~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 199 (318)
T 1fot_A 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199 (318)
T ss_dssp TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHS
T ss_pred CCccccCCChheEEEcCCCCEEEeecCcceecCCcc-----ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhC
Confidence 999999999999999999999999999998754322 335789999999999988999999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
..||.... ..+......... . . .... .+..+.+++.+||..||++||+
T Consensus 200 ~~pf~~~~---------~~~~~~~i~~~~-~-~-----~p~~--------~~~~~~~li~~lL~~dp~~R~~ 247 (318)
T 1fot_A 200 YTPFYDSN---------TMKTYEKILNAE-L-R-----FPPF--------FNEDVKDLLSRLITRDLSQRLG 247 (318)
T ss_dssp SCTTCCSS---------HHHHHHHHHHCC-C-C-----CCTT--------SCHHHHHHHHHHTCSCTTTCTT
T ss_pred CCCCCCCC---------HHHHHHHHHhCC-C-C-----CCCC--------CCHHHHHHHHHHhccCHHHcCC
Confidence 99996521 112222221111 0 1 1111 2257889999999999999993
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=272.76 Aligned_cols=213 Identities=20% Similarity=0.270 Sum_probs=163.0
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~ 76 (241)
|.+...........+.+|+.++++++||||+++++++. .+..++|+||+.+|+|.+++.... .....++.+++.
T Consensus 48 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~ 126 (325)
T 3kex_A 48 KVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 126 (325)
T ss_dssp EEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHH
T ss_pred EeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHH
Confidence 34434444455677889999999999999999999986 456889999999999999986642 257889999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSF 156 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~ 156 (241)
||.||| +.+++||||||+|||++.++.+||+|||++................++..|+|||++.+..++.++|||||
T Consensus 127 ~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 203 (325)
T 3kex_A 127 GMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSY 203 (325)
T ss_dssp HHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHh
Confidence 999999 89999999999999999999999999999987655443333344567889999999998899999999999
Q ss_pred HHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 157 GAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 157 G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
|+++|++++ |..||..... .+..... ........+. . .+..+.+++.+||+.||++
T Consensus 204 G~~l~el~~~g~~p~~~~~~---------~~~~~~~-~~~~~~~~~~-----~--------~~~~~~~li~~~l~~dp~~ 260 (325)
T 3kex_A 204 GVTVWELMTFGAEPYAGLRL---------AEVPDLL-EKGERLAQPQ-----I--------CTIDVYMVMVKCWMIDENI 260 (325)
T ss_dssp HHHHHHHHTTSCCTTTTSCT---------THHHHHH-HTTCBCCCCT-----T--------BCTTTTHHHHHHTCSCTTT
T ss_pred HHHHHHHHhCCCCCccccCH---------HHHHHHH-HcCCCCCCCC-----c--------CcHHHHHHHHHHcCCChhh
Confidence 999999999 9999965211 1111111 1111111111 1 1135778999999999999
Q ss_pred CCCCCC
Q 044022 236 RPTMVD 241 (241)
Q Consensus 236 Rpt~~e 241 (241)
|||+.|
T Consensus 261 Rps~~e 266 (325)
T 3kex_A 261 RPTFKE 266 (325)
T ss_dssp SCCHHH
T ss_pred CcCHHH
Confidence 999753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=282.61 Aligned_cols=199 Identities=23% Similarity=0.315 Sum_probs=158.3
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCC-cceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTP-IPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~ 84 (241)
..+.|.+|++++++++||||+++++++...+ ..++||||+++|+|.+++.... ...+.++.|++.||.|||
T Consensus 229 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH-- 306 (450)
T 1k9a_A 229 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-- 306 (450)
T ss_dssp TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH--
T ss_pred HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 4678999999999999999999999987765 7899999999999999986532 146789999999999999
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
+++++||||||+|||++.++.+||+|||++....... ....++..|+|||++.+..++.++||||||+++|+|+
T Consensus 307 -~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~ 380 (450)
T 1k9a_A 307 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 380 (450)
T ss_dssp -HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHH
T ss_pred -hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence 8999999999999999999999999999998544321 2235678899999999999999999999999999999
Q ss_pred h-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 A-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+ |..||...... +..... ..+..... .. .++..+.++|.+||+.||++|||+.|
T Consensus 381 t~g~~P~~~~~~~---------~~~~~i-~~~~~~~~-----p~--------~~~~~l~~li~~cl~~dp~~Rpt~~~ 435 (450)
T 1k9a_A 381 SFGRVPYPRIPLK---------DVVPRV-EKGYKMDA-----PD--------GCPPAVYDVMKNCWHLDAATRPTFLQ 435 (450)
T ss_dssp TTTCCSSTTSCTT---------THHHHH-HTTCCCCC-----CT--------TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hCCCCCCCCCCHH---------HHHHHH-HcCCCCCC-----CC--------cCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 8 99999653211 111111 11211111 11 22367899999999999999999753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=272.20 Aligned_cols=213 Identities=23% Similarity=0.313 Sum_probs=164.1
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCC--------------------------------------
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTP-------------------------------------- 42 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-------------------------------------- 42 (241)
||++.........+.+.+|++++++++||||++++++|...+
T Consensus 36 vK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 115 (332)
T 3qd2_B 36 IKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRM 115 (332)
T ss_dssp EEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC----------------------------
T ss_pred EEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeec
Confidence 455554444456778999999999999999999999986543
Q ss_pred -------------------cceEEEEecCCCCHHHhhcCCCc-------hHHHHHHHHHHHhchhhcCCCCCceeccCCC
Q 044022 43 -------------------IPILVFQSVEYGTLRDCIFGAPL-------PRLKIASDIVNSLAYLHFGFPRPIVLRNFKT 96 (241)
Q Consensus 43 -------------------~~~lv~e~~~~~sL~~~l~~~~~-------~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~ 96 (241)
..++||||+++++|.+++..... ....++.|++.||.||| +.+++||||||
T Consensus 116 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp 192 (332)
T 3qd2_B 116 DPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKP 192 (332)
T ss_dssp ----------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCG
T ss_pred cccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHH---hCCeeecCCCc
Confidence 27999999999999999976532 25789999999999999 89999999999
Q ss_pred CCeeecCCCCeEEeeccCceecCCCCcc----------eeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 97 QNILFNEENVAKWFDFLLSISIPEGETH----------ITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 97 ~nil~~~~~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
+||+++.++.+||+|||.+......... .......||+.|+|||.+.+..++.++||||||+++|+|++|
T Consensus 193 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 272 (332)
T 3qd2_B 193 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272 (332)
T ss_dssp GGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSC
T ss_pred ccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHc
Confidence 9999999999999999999876543211 112334689999999999988999999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
..|+... ....... ... .. .......++.+.+++.+||+.||++|||++|
T Consensus 273 ~~~~~~~-----------~~~~~~~-~~~-----~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 322 (332)
T 3qd2_B 273 FSTQMER-----------VRIITDV-RNL-----KF--------PLLFTQKYPQEHMMVQDMLSPSPTERPEATD 322 (332)
T ss_dssp CCCHHHH-----------HHHHHHH-HTT-----CC--------CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHH
T ss_pred CCChhHH-----------HHHHHHh-hcc-----CC--------CcccccCChhHHHHHHHHccCCCCcCCCHHH
Confidence 8776331 0111111 011 00 0112244467789999999999999999853
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=270.42 Aligned_cols=203 Identities=19% Similarity=0.235 Sum_probs=162.4
Q ss_pred cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCC
Q 044022 10 RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 10 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~ 85 (241)
....+.+.+|++++++++|||||+++++|...+..++||||+.+|+|.+++..... ....++.+++.||.|||
T Consensus 56 ~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH--- 132 (384)
T 4fr4_A 56 RNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ--- 132 (384)
T ss_dssp TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 34567889999999999999999999999999999999999999999999876532 46788999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc---cCCCcchhhHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI---CVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~s~G~~~~~ 162 (241)
+.+|+||||||+|||++.++.++|+|||++........ .....||+.|+|||++.. ..++.++||||||+++|+
T Consensus 133 ~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~e 209 (384)
T 4fr4_A 133 NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYE 209 (384)
T ss_dssp HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHH
T ss_pred HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHH
Confidence 89999999999999999999999999999987654322 234579999999999974 358899999999999999
Q ss_pred HHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 163 LLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 163 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
|++|+.||...... ...+......... ... .. ..+..+.+|+.+||+.||++||++
T Consensus 210 lltG~~Pf~~~~~~------~~~~~~~~~~~~~--~~~-----p~--------~~s~~~~~li~~lL~~dP~~R~s~ 265 (384)
T 4fr4_A 210 LLRGRRPYHIRSST------SSKEIVHTFETTV--VTY-----PS--------AWSQEMVSLLKKLLEPNPDQRFSQ 265 (384)
T ss_dssp HHHSSCSSCCCTTS------CHHHHHHHHHHCC--CCC-----CT--------TSCHHHHHHHHHHSCSSGGGSCCS
T ss_pred HHhCCCCCCCCCCc------cHHHHHHHHhhcc--cCC-----CC--------cCCHHHHHHHHHHhcCCHhHhccc
Confidence 99999999642111 1122222211111 011 11 122578999999999999999983
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=265.41 Aligned_cols=202 Identities=20% Similarity=0.293 Sum_probs=158.2
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeee--CCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQ--TPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
.+.+.+|++++++++||||+++++++.. .+..++||||+++++|.+++..... ....++.|++.||.||| +.
T Consensus 80 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~ 156 (298)
T 2zv2_A 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLH---YQ 156 (298)
T ss_dssp -CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 4678999999999999999999999986 5678999999999999987765433 46789999999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccC---CCcchhhHHHHHHHHHHH
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV---LNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~Di~s~G~~~~~~~ 164 (241)
+++||||||+||+++.++.+||+|||++......... .....||+.|+|||.+.+.. .+.++||||||+++|+|+
T Consensus 157 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~ 234 (298)
T 2zv2_A 157 KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234 (298)
T ss_dssp TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred CeeccCCCHHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence 9999999999999999999999999999876543322 23457899999999997654 367899999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|+.||... .......... .... ..+. ... .++.+.+++.+||+.||++|||++|
T Consensus 235 ~g~~pf~~~---------~~~~~~~~~~-~~~~-~~~~---~~~--------~~~~l~~li~~~l~~dp~~R~s~~e 289 (298)
T 2zv2_A 235 FGQCPFMDE---------RIMCLHSKIK-SQAL-EFPD---QPD--------IAEDLKDLITRMLDKNPESRIVVPE 289 (298)
T ss_dssp HSSCSSCCS---------SHHHHHHHHH-HCCC-CCCS---SSC--------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred HCCCCCCCc---------cHHHHHHHHh-cccC-CCCC---ccc--------cCHHHHHHHHHHhhcChhhCCCHHH
Confidence 999999541 1111111111 1111 1111 111 2257899999999999999999753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=278.31 Aligned_cols=169 Identities=18% Similarity=0.208 Sum_probs=140.0
Q ss_pred Ccccccccc-cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC---C---chHHHHHHH
Q 044022 1 MKFYGHEYH-RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA---P---LPRLKIASD 73 (241)
Q Consensus 1 iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~---~~~~~~~~~ 73 (241)
||++..+.. ....+.+.+|++++++++|||||++++++...+..++||||+++|+|.+++... . .....++.|
T Consensus 57 vK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~q 136 (389)
T 3gni_B 57 VRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQG 136 (389)
T ss_dssp EEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHH
T ss_pred EEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHH
Confidence 355543332 234567888999999999999999999999999999999999999999998653 1 146789999
Q ss_pred HHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCc-----ceeecccccCCCccCcccccc--cC
Q 044022 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET-----HITTDRVIGTRGYSAPEYISI--CV 146 (241)
Q Consensus 74 i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~--~~ 146 (241)
|+.||.||| +.+|+||||||+|||++.++.+||+|||.+........ ........|++.|+|||++.+ ..
T Consensus 137 i~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 213 (389)
T 3gni_B 137 VLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQG 213 (389)
T ss_dssp HHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSC
T ss_pred HHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCC
Confidence 999999999 89999999999999999999999999998765432211 111123468889999999987 57
Q ss_pred CCcchhhHHHHHHHHHHHhcCccccc
Q 044022 147 LNEKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 147 ~~~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
++.++||||||+++|+|++|+.||..
T Consensus 214 ~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 214 YDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 89999999999999999999999965
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=269.10 Aligned_cols=215 Identities=19% Similarity=0.305 Sum_probs=169.4
Q ss_pred CcccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC---------------
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--------------- 64 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------- 64 (241)
||++..+......+++.+|+++++++ +||||+++++++...+..++||||+++++|.+++....
T Consensus 72 vK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 151 (334)
T 2pvf_A 72 VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151 (334)
T ss_dssp EEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC-------
T ss_pred EeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhcccccccccccccccc
Confidence 35555444445567899999999999 99999999999999999999999999999999987542
Q ss_pred --c---hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCc
Q 044022 65 --L---PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAP 139 (241)
Q Consensus 65 --~---~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aP 139 (241)
. .++.++.+++.||.||| +.+++|+||||+||+++.++.+||+|||.+................+++.|+||
T Consensus 152 ~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 228 (334)
T 2pvf_A 152 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 228 (334)
T ss_dssp -CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCH
T ss_pred ccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeCh
Confidence 1 35788999999999999 899999999999999999999999999999876654433333344567889999
Q ss_pred ccccccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHH
Q 044022 140 EYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQL 218 (241)
Q Consensus 140 E~~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (241)
|++.+..++.++||||||+++|+|++ |..||... ...+..... ..+..... .. ..+
T Consensus 229 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~---------~~~~~~~~~-~~~~~~~~-----~~--------~~~ 285 (334)
T 2pvf_A 229 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI---------PVEELFKLL-KEGHRMDK-----PA--------NCT 285 (334)
T ss_dssp HHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC---------CHHHHHHHH-HHTCCCCC-----CT--------TCC
T ss_pred HHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC---------CHHHHHHHH-hcCCCCCC-----Cc--------cCC
Confidence 99988889999999999999999999 99998542 112222222 11211111 11 122
Q ss_pred HHHHHHHHHhccCCCCCCCCCCC
Q 044022 219 HASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 219 ~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
..+.+++.+||+.||++|||++|
T Consensus 286 ~~l~~li~~~l~~dp~~Rps~~e 308 (334)
T 2pvf_A 286 NELYMMMRDCWHAVPSQRPTFKQ 308 (334)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHH
Confidence 57889999999999999999753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=260.94 Aligned_cols=217 Identities=22% Similarity=0.250 Sum_probs=166.7
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVN 76 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~ 76 (241)
||++.........+.+.+|+.++++++||||+++++++...+..++|+||+++++|.+++..... ....++.+++.
T Consensus 37 vK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ 116 (276)
T 2yex_A 37 VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 116 (276)
T ss_dssp EEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHH
T ss_pred EEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHH
Confidence 35554433344567899999999999999999999999999999999999999999999876532 46789999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCC-CcchhhHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVL-NEKSNVFS 155 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~s 155 (241)
||.||| +.+++|+||+|+||+++.++.++|+|||.+................+++.|+|||.+.+..+ +.++||||
T Consensus 117 ~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 193 (276)
T 2yex_A 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193 (276)
T ss_dssp HHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHH
T ss_pred HHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHH
Confidence 999999 89999999999999999999999999999876543322222234568899999999987665 67899999
Q ss_pred HHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 156 FGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 156 ~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
||+++|+|++|..||....... .. .......... .. . .. ..+..+.+++.+||+.||++
T Consensus 194 lG~il~~l~~g~~p~~~~~~~~-------~~-~~~~~~~~~~---~~-~-~~--------~~~~~~~~li~~~l~~~p~~ 252 (276)
T 2yex_A 194 CGIVLTAMLAGELPWDQPSDSC-------QE-YSDWKEKKTY---LN-P-WK--------KIDSAPLALLHKILVENPSA 252 (276)
T ss_dssp HHHHHHHHHHSSCCCSCSCTTS-------HH-HHHHHTTCTT---ST-T-GG--------GSCHHHHHHHHHHSCSSTTT
T ss_pred HHHHHHHHHhCCCCCCCCchHH-------HH-HHHhhhcccc---cC-c-hh--------hcCHHHHHHHHHHCCCCchh
Confidence 9999999999999996522111 01 1111111100 00 0 01 22357889999999999999
Q ss_pred CCCCCC
Q 044022 236 RPTMVD 241 (241)
Q Consensus 236 Rpt~~e 241 (241)
|||++|
T Consensus 253 Rps~~~ 258 (276)
T 2yex_A 253 RITIPD 258 (276)
T ss_dssp SCCHHH
T ss_pred CCCHHH
Confidence 999753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=271.80 Aligned_cols=200 Identities=19% Similarity=0.243 Sum_probs=158.3
Q ss_pred ccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
.....+.+|.++++.+ +||||+++++++...+..++||||+++|+|.+++.... .....++.+|+.||.|||
T Consensus 65 ~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--- 141 (353)
T 3txo_A 65 DDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH--- 141 (353)
T ss_dssp TTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---
T ss_pred hHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 4566788999999998 79999999999999999999999999999999986532 246789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+++|+||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++
T Consensus 142 ~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 219 (353)
T 3txo_A 142 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC 219 (353)
T ss_dssp HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHH
T ss_pred HCCCcccCCCHHHEEECCCCCEEEccccceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHh
Confidence 89999999999999999999999999999875332221 2234579999999999998899999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
|+.||... ...+.......... . .... .+..+.+++.+||+.||++||++
T Consensus 220 G~~Pf~~~---------~~~~~~~~i~~~~~----~---~p~~--------~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 220 GHAPFEAE---------NEDDLFEAILNDEV----V---YPTW--------LHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp SSCSSCCS---------SHHHHHHHHHHCCC----C---CCTT--------SCHHHHHHHHHHTCSSGGGSTTS
T ss_pred CCCCCCCC---------CHHHHHHHHHcCCC----C---CCCC--------CCHHHHHHHHHHhhhCHHHccCC
Confidence 99999652 11222222222111 0 0111 22568899999999999999997
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=271.13 Aligned_cols=225 Identities=24% Similarity=0.310 Sum_probs=169.0
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeC--CcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQT--PIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~ 75 (241)
||++..+......+.+.+|++++++++||||+++++++... ...++||||+++++|.+++..... ....++.+++
T Consensus 65 vK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~ 144 (318)
T 3lxp_A 65 VKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQIC 144 (318)
T ss_dssp EEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHH
T ss_pred EEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHH
Confidence 45665554445577899999999999999999999999874 578999999999999999977643 5678999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-eeecccccCCCccCcccccccCCCcchhhH
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-ITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
.||.||| +.+++|+||||+||+++.++.++|+|||.+......... .......++..|+|||++.+..++.++|||
T Consensus 145 ~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 221 (318)
T 3lxp_A 145 EGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVW 221 (318)
T ss_dssp HHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHH
T ss_pred HHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHH
Confidence 9999999 899999999999999999999999999999876554322 122334577889999999988899999999
Q ss_pred HHHHHHHHHHhcCcccccccccC-----CCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhc
Q 044022 155 SFGAFLFELLAGRIHIWDLLKDT-----HDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECV 229 (241)
Q Consensus 155 s~G~~~~~~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 229 (241)
|||+++|+|++|..||....... ...................... ... ..+..+.+++.+||
T Consensus 222 slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~--------~~~~~l~~li~~~l 288 (318)
T 3lxp_A 222 SFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLP-----RPD--------KCPAEVYHLMKNCW 288 (318)
T ss_dssp HHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCC-----CCT--------TCCHHHHHHHHHHT
T ss_pred HHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCC-----CCc--------cccHHHHHHHHHHc
Confidence 99999999999999986521110 0000000001111111111111 111 22367899999999
Q ss_pred cCCCCCCCCCCC
Q 044022 230 NNSPEDRPTMVD 241 (241)
Q Consensus 230 ~~~p~~Rpt~~e 241 (241)
+.||++|||++|
T Consensus 289 ~~dP~~Rps~~e 300 (318)
T 3lxp_A 289 ETEASFRPTFEN 300 (318)
T ss_dssp CSSGGGSCCHHH
T ss_pred CCCcccCcCHHH
Confidence 999999999853
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=266.97 Aligned_cols=212 Identities=20% Similarity=0.268 Sum_probs=152.7
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~~ 76 (241)
|...........+.+.+|+.++++++||||+++++++. .+..++||||+++++|.+++.... . ....++.+++.
T Consensus 49 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~ 127 (281)
T 1mp8_A 49 KTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 127 (281)
T ss_dssp EECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHH
T ss_pred EeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 33333333345677999999999999999999999984 567899999999999999986432 1 46788999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSF 156 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~ 156 (241)
||.||| +.+++||||||+||+++.++.++|+|||.+......... ......+++.|+|||.+.+..++.++|||||
T Consensus 128 ~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 203 (281)
T 1mp8_A 128 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMF 203 (281)
T ss_dssp HHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred HHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHH
Confidence 999999 899999999999999999999999999998765443221 1123346778999999998899999999999
Q ss_pred HHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 157 GAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 157 G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
|+++|+|++ |..||...... +...... ...... .... .+..+.+++.+||+.||++
T Consensus 204 G~~l~ell~~g~~pf~~~~~~---------~~~~~i~-~~~~~~-----~~~~--------~~~~l~~li~~~l~~~p~~ 260 (281)
T 1mp8_A 204 GVCMWEILMHGVKPFQGVKNN---------DVIGRIE-NGERLP-----MPPN--------CPPTLYSLMTKCWAYDPSR 260 (281)
T ss_dssp HHHHHHHHTTSCCTTTTCCGG---------GHHHHHH-TTCCCC-----CCTT--------CCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHhcCCCCCCcCCHH---------HHHHHHH-cCCCCC-----CCCC--------CCHHHHHHHHHHccCChhh
Confidence 999999996 99999652211 1111111 111111 1111 2267889999999999999
Q ss_pred CCCCCC
Q 044022 236 RPTMVD 241 (241)
Q Consensus 236 Rpt~~e 241 (241)
|||+.|
T Consensus 261 Rps~~~ 266 (281)
T 1mp8_A 261 RPRFTE 266 (281)
T ss_dssp SCCHHH
T ss_pred CcCHHH
Confidence 999753
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=264.22 Aligned_cols=217 Identities=23% Similarity=0.343 Sum_probs=166.5
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC----C---chHHHHHHHHHHHhchhhc
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA----P---LPRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----~---~~~~~~~~~i~~~l~~lh~ 83 (241)
...+.+.+|++++++++||||+++++++...+..++||||+++++|.+++... . ..+..++.+++.||.|||
T Consensus 72 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH- 150 (307)
T 2nru_A 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH- 150 (307)
T ss_dssp THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred HHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh-
Confidence 34677999999999999999999999999999999999999999999998632 1 146789999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+.+++|+||||+||+++.++.++|+|||.+................|++.|+|||.+.+ .++.++||||||+++|+|
T Consensus 151 --~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l 227 (307)
T 2nru_A 151 --ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEI 227 (307)
T ss_dssp --HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHH
T ss_pred --cCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHH
Confidence 89999999999999999999999999999987655433333344578999999998874 578999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhh-cccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLED-KRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|..||....... ............ .......+..+.. .....+..+.+++.+||+.||++|||++|
T Consensus 228 ~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 296 (307)
T 2nru_A 228 ITGLPAVDEHREPQ-----LLLDIKEEIEDEEKTIEDYIDKKMND-----ADSTSVEAMYSVASQCLHEKKNKRPDIKK 296 (307)
T ss_dssp HHCCCSBCTTBSSS-----BTTHHHHHHHTTSCCHHHHSCSSCSC-----CCHHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHCCCCcccCcchH-----HHHHHHHHhhhhhhhhhhhccccccc-----cchHHHHHHHHHHHHHcCCCcccCcCHHH
Confidence 99999996532211 111111111111 1111111111111 11356678999999999999999999753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=272.12 Aligned_cols=197 Identities=23% Similarity=0.317 Sum_probs=158.2
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
....+.+|+++++.++||||+++++++...+..++||||+ +|+|.+++.... .....++.|++.||.||| +.
T Consensus 52 ~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~ 127 (336)
T 3h4j_B 52 MHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH---RH 127 (336)
T ss_dssp CSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HH
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 4567899999999999999999999999999999999999 689988875432 256789999999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCC-CcchhhHHHHHHHHHHHhc
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVL-NEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~s~G~~~~~~~~g 166 (241)
+++||||||+|||++.++.+||+|||++......... ....||+.|+|||++.+..+ ++++||||||+++|+|++|
T Consensus 128 givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 204 (336)
T 3h4j_B 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVG 204 (336)
T ss_dssp TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTT---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHS
T ss_pred CeEecCCchhhEEEcCCCCEEEEEeccceeccCCccc---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhC
Confidence 9999999999999999999999999999765543321 33468999999999987765 6899999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCC--CccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPA--PIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+.||........ ...+.. ..... ..+..+.+++.+||+.||.+|||++|
T Consensus 205 ~~Pf~~~~~~~~------------------~~~i~~~~~~~p~--------~~s~~~~~li~~~L~~dP~~Rpt~~e 255 (336)
T 3h4j_B 205 RLPFDDEFIPNL------------------FKKVNSCVYVMPD--------FLSPGAQSLIRRMIVADPMQRITIQE 255 (336)
T ss_dssp SCSSBCSSSTTC------------------BCCCCSSCCCCCT--------TSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred CCCCCCccHHHH------------------HHHHHcCCCCCcc--------cCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 999965211110 000000 01111 12357889999999999999999853
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=269.85 Aligned_cols=204 Identities=18% Similarity=0.263 Sum_probs=160.8
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--------CchHHHHHHHHHHHhchhhc
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--------PLPRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--------~~~~~~~~~~i~~~l~~lh~ 83 (241)
..+.+.+|++++++++||||+++++++...+..++||||+++++|.+.+... ......++.||+.||.|||
T Consensus 69 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH- 147 (351)
T 3c0i_A 69 STEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH- 147 (351)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 4678999999999999999999999999999999999999999998877432 1246789999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCCC---eEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNEENV---AKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFL 160 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~ 160 (241)
+++++||||||+|||++.++. +||+|||++......... .....||+.|+|||++.+..++.++||||||+++
T Consensus 148 --~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 223 (351)
T 3c0i_A 148 --DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223 (351)
T ss_dssp --HTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred --HCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHH
Confidence 899999999999999987654 999999999876553321 2345789999999999988899999999999999
Q ss_pred HHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 161 FELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 161 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
|+|++|..||.... .+....... +... ..+.. ....+..+.+++.+||+.||++|||+.
T Consensus 224 ~~ll~g~~pf~~~~----------~~~~~~i~~-~~~~--~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~ 282 (351)
T 3c0i_A 224 FILLSGCLPFYGTK----------ERLFEGIIK-GKYK--MNPRQ--------WSHISESAKDLVRRMLMLDPAERITVY 282 (351)
T ss_dssp HHHHHSSCSSCSSH----------HHHHHHHHH-TCCC--CCHHH--------HTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHCCCCCCCcH----------HHHHHHHHc-CCCC--CCccc--------cccCCHHHHHHHHHHCCCChhHCcCHH
Confidence 99999999996511 111111111 1110 00000 012236789999999999999999975
Q ss_pred C
Q 044022 241 D 241 (241)
Q Consensus 241 e 241 (241)
|
T Consensus 283 e 283 (351)
T 3c0i_A 283 E 283 (351)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=268.35 Aligned_cols=201 Identities=21% Similarity=0.261 Sum_probs=162.0
Q ss_pred ccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
.....+.+|..++.++ +||||+++++++...+..++||||+++|+|.+++.... .....++.|++.||.|||
T Consensus 59 ~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--- 135 (345)
T 1xjd_A 59 DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH--- 135 (345)
T ss_dssp TCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---
T ss_pred hhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 4566788999999987 99999999999999999999999999999999986532 246788999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+++++||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++|+||||+++|+|++
T Consensus 136 ~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 213 (345)
T 1xjd_A 136 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 213 (345)
T ss_dssp HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhc
Confidence 89999999999999999999999999999975432221 1234578999999999999899999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
|..||.... ..+......... ...... .+..+.+++.+||..||++|||+.
T Consensus 214 g~~Pf~~~~---------~~~~~~~i~~~~-------~~~p~~--------~s~~~~~li~~lL~~dp~~R~~~~ 264 (345)
T 1xjd_A 214 GQSPFHGQD---------EEELFHSIRMDN-------PFYPRW--------LEKEAKDLLVKLFVREPEKRLGVR 264 (345)
T ss_dssp SSCSSCCSS---------HHHHHHHHHHCC-------CCCCTT--------SCHHHHHHHHHHSCSSGGGSBTTB
T ss_pred CCCCCCCCC---------HHHHHHHHHhCC-------CCCCcc--------cCHHHHHHHHHHhcCCHhHcCCCh
Confidence 999996421 112222221111 011111 225788999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=269.07 Aligned_cols=213 Identities=18% Similarity=0.314 Sum_probs=152.9
Q ss_pred ccccccc-ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcc------eEEEEecCCCCHHHhhcCC---------C-
Q 044022 2 KFYGHEY-HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIP------ILVFQSVEYGTLRDCIFGA---------P- 64 (241)
Q Consensus 2 K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~------~lv~e~~~~~sL~~~l~~~---------~- 64 (241)
|++..+. .....+++.+|++++++++||||+++++++...... ++|+||+++|+|.+++... .
T Consensus 57 K~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~ 136 (323)
T 3qup_A 57 KMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136 (323)
T ss_dssp EEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCH
T ss_pred EEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCH
Confidence 4444332 334567899999999999999999999999876654 9999999999999988432 1
Q ss_pred chHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc
Q 044022 65 LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI 144 (241)
Q Consensus 65 ~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 144 (241)
..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||.+................+++.|+|||.+.+
T Consensus 137 ~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 213 (323)
T 3qup_A 137 QTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD 213 (323)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcC
Confidence 246789999999999999 89999999999999999999999999999976654433222233456778999999998
Q ss_pred cCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHH
Q 044022 145 CVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQ 223 (241)
Q Consensus 145 ~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (241)
..++.++||||||+++|+|++ |..||...... +.......... .. ... ..+..+.+
T Consensus 214 ~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---------~~~~~~~~~~~-~~-----~~~--------~~~~~l~~ 270 (323)
T 3qup_A 214 NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---------EIYNYLIGGNR-LK-----QPP--------ECMEEVYD 270 (323)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---------GHHHHHHTTCC-CC-----CCT--------TCCHHHHH
T ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccccChH---------HHHHHHhcCCC-CC-----CCC--------ccCHHHHH
Confidence 899999999999999999999 89999652211 11111111111 11 111 12257899
Q ss_pred HHHHhccCCCCCCCCCC
Q 044022 224 LTLECVNNSPEDRPTMV 240 (241)
Q Consensus 224 l~~~cl~~~p~~Rpt~~ 240 (241)
++.+||+.||++|||+.
T Consensus 271 li~~~l~~dp~~Rps~~ 287 (323)
T 3qup_A 271 LMYQCWSADPKQRPSFT 287 (323)
T ss_dssp HHHHTTCSSGGGSCCHH
T ss_pred HHHHHccCChhhCcCHH
Confidence 99999999999999964
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=261.55 Aligned_cols=203 Identities=23% Similarity=0.359 Sum_probs=161.3
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+++.+|++++++++||||+++++++...+..++||||+++++|.+++..... ....++.+++.||.||| +
T Consensus 48 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~ 124 (269)
T 4hcu_A 48 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---E 124 (269)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---h
Confidence 457799999999999999999999999999999999999999999999965421 46789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh-
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA- 165 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~- 165 (241)
.+++|+||||+||+++.++.++|+|||.+........ .......+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 125 ~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~ 203 (269)
T 4hcu_A 125 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE 203 (269)
T ss_dssp TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCeecCCcchheEEEcCCCCEEecccccccccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcC
Confidence 9999999999999999999999999999876543221 11123346678999999998899999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|..||.... ..+.......... ... .. ..+..+.+++.+||+.||++|||+.|
T Consensus 204 g~~p~~~~~---------~~~~~~~~~~~~~---~~~---~~--------~~~~~~~~li~~~l~~~p~~Rps~~~ 256 (269)
T 4hcu_A 204 GKIPYENRS---------NSEVVEDISTGFR---LYK---PR--------LASTHVYQIMNHCWRERPEDRPAFSR 256 (269)
T ss_dssp SCCTTTTCC---------HHHHHHHHHTTCC---CCC---CT--------TSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCCC---------HHHHHHHHhcCcc---CCC---CC--------cCCHHHHHHHHHHccCCcccCcCHHH
Confidence 999995421 1222222221111 011 11 12257889999999999999999753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=259.97 Aligned_cols=203 Identities=19% Similarity=0.288 Sum_probs=161.7
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+++.+|++++++++||||+++++++...+..++||||+++++|.+++.... ..+..++.+++.||.||| +
T Consensus 46 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~ 122 (268)
T 3sxs_A 46 SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---S 122 (268)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 45779999999999999999999999999999999999999999999986532 256789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh-
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA- 165 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~- 165 (241)
.+++|+||||+||+++.++.++|+|||.+.......... .....+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 123 ~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~ 201 (268)
T 3sxs_A 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSL 201 (268)
T ss_dssp TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTT
T ss_pred CCeecCCcCcceEEECCCCCEEEccCccceecchhhhhc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcC
Confidence 999999999999999999999999999998765543222 223345677999999998889999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|..||.... ..+...... .+.. ...+ . ..+..+.+++.+||+.||++|||++|
T Consensus 202 g~~p~~~~~---------~~~~~~~~~-~~~~--~~~~---~--------~~~~~l~~li~~~l~~~p~~Rps~~~ 254 (268)
T 3sxs_A 202 GKMPYDLYT---------NSEVVLKVS-QGHR--LYRP---H--------LASDTIYQIMYSCWHELPEKRPTFQQ 254 (268)
T ss_dssp TCCTTTTSC---------HHHHHHHHH-TTCC--CCCC---T--------TSCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred CCCCccccC---------hHHHHHHHH-cCCC--CCCC---C--------cChHHHHHHHHHHcCCChhhCcCHHH
Confidence 999985421 111111111 1111 1111 1 11256889999999999999999853
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=266.27 Aligned_cols=213 Identities=20% Similarity=0.241 Sum_probs=146.5
Q ss_pred ccHHHHHHHHHHHHhcC-CCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~ 85 (241)
.....+.+|+.+++.+. ||||+++++++...+..++||||+++|+|.+++..... ....++.+++.||.|||
T Consensus 47 ~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH--- 123 (325)
T 3kn6_A 47 RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH--- 123 (325)
T ss_dssp GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 34567889999999997 99999999999999999999999999999999876532 56789999999999999
Q ss_pred CCCceeccCCCCCeeecCCC---CeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEEN---VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~ 162 (241)
+.+++||||||+|||++.++ .+||+|||++......... .....+|+.|+|||++.+..++.++||||||+++|+
T Consensus 124 ~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ 201 (325)
T 3kn6_A 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYT 201 (325)
T ss_dssp HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHH
T ss_pred HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHH
Confidence 89999999999999998765 8999999999865443221 233467999999999998899999999999999999
Q ss_pred HHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 163 LLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 163 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|++|..||....... ......+...... .+... .+.......++.+.+|+.+||+.||++|||++|
T Consensus 202 ll~g~~pf~~~~~~~--~~~~~~~~~~~i~-~~~~~----------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 267 (325)
T 3kn6_A 202 MLSGQVPFQSHDRSL--TCTSAVEIMKKIK-KGDFS----------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSG 267 (325)
T ss_dssp HHHSSCTTC---------CCCHHHHHHHHT-TTCCC----------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTT
T ss_pred HHhCCCCCCCCcccc--ccccHHHHHHHHH-cCCCC----------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHH
Confidence 999999996532211 0111112222211 11110 011111223467899999999999999999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=268.91 Aligned_cols=196 Identities=15% Similarity=0.154 Sum_probs=161.4
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|++++++++||||+++++++...+..++||||+++|+|.+++.... .....++.+|+.||.||| +
T Consensus 83 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~ 159 (350)
T 1rdq_E 83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---S 159 (350)
T ss_dssp TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 456788999999999999999999999999999999999999999999986532 256789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
++|+||||||+|||++.++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|+|++|
T Consensus 160 ~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 234 (350)
T 1rdq_E 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234 (350)
T ss_dssp TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CCcccccCccceEEECCCCCEEEcccccceeccCCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhC
Confidence 999999999999999999999999999998764432 334689999999999988999999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
..||.... ..+....... +.. . +... .+..+.+++.+||+.||++||+
T Consensus 235 ~~Pf~~~~---------~~~~~~~i~~-~~~-~-----~p~~--------~~~~~~~li~~lL~~dp~~R~~ 282 (350)
T 1rdq_E 235 YPPFFADQ---------PIQIYEKIVS-GKV-R-----FPSH--------FSSDLKDLLRNLLQVDLTKRFG 282 (350)
T ss_dssp SCSSCCSS---------HHHHHHHHHH-CCC-C-----CCTT--------CCHHHHHHHHHHSCSCTTTCTT
T ss_pred CCCCCCCC---------HHHHHHHHHc-CCC-C-----CCCC--------CCHHHHHHHHHHhhcCHHhccC
Confidence 99996521 1122222221 111 1 1111 2257889999999999999998
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=273.18 Aligned_cols=204 Identities=18% Similarity=0.203 Sum_probs=161.9
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
....+.+|++++++++||||+++++++...+..++||||+++|+|.+++.... . ....++.|++.||.||| +
T Consensus 91 ~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~ 167 (387)
T 1kob_A 91 DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---E 167 (387)
T ss_dssp HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---H
T ss_pred hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 34578899999999999999999999999999999999999999999987542 2 46789999999999999 8
Q ss_pred CCceeccCCCCCeeecC--CCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNE--ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
.+++||||||+|||++. .+.+||+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 168 ~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 244 (387)
T 1kob_A 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 244 (387)
T ss_dssp TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred CCeeecccchHHeEEecCCCCceEEEecccceecCCCcce---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHH
Confidence 99999999999999974 478999999999876544322 2346899999999999888999999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|..||.... ..+......... . .. ...... ..+..+.+++.+||+.||++|||++|
T Consensus 245 tg~~Pf~~~~---------~~~~~~~i~~~~-~-~~-~~~~~~--------~~s~~~~~li~~~L~~dP~~Rpt~~e 301 (387)
T 1kob_A 245 SGLSPFAGED---------DLETLQNVKRCD-W-EF-DEDAFS--------SVSPEAKDFIKNLLQKEPRKRLTVHD 301 (387)
T ss_dssp HSCCSSCCSS---------HHHHHHHHHHCC-C-CC-CSSTTT--------TSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred hCCCCCCCCC---------HHHHHHHHHhCC-C-CC-Cccccc--------cCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999996521 112222221111 1 11 111111 12357889999999999999999853
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=271.56 Aligned_cols=208 Identities=20% Similarity=0.211 Sum_probs=158.0
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC---------------------------
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--------------------------- 63 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--------------------------- 63 (241)
...+.+.+|++++++++||||+++++++...+..++||||+++|+|.+++...
T Consensus 70 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (345)
T 3hko_A 70 KDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149 (345)
T ss_dssp CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccc
Confidence 45678999999999999999999999999999999999999999999998520
Q ss_pred -----------------CchHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCC--CeEEeeccCceecCCCC--
Q 044022 64 -----------------PLPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEEN--VAKWFDFLLSISIPEGE-- 122 (241)
Q Consensus 64 -----------------~~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~--~~~l~df~~~~~~~~~~-- 122 (241)
......++.+++.||.||| +.+++||||||+||+++.++ .+||+|||.+.......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~ 226 (345)
T 3hko_A 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG 226 (345)
T ss_dssp HHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC
T ss_pred cccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCcc
Confidence 0124568999999999999 89999999999999998776 89999999998653321
Q ss_pred cceeecccccCCCccCcccccc--cCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCC
Q 044022 123 THITTDRVIGTRGYSAPEYISI--CVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGI 200 (241)
Q Consensus 123 ~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (241)
.........|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.... ..+........... .
T Consensus 227 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---------~~~~~~~~~~~~~~--~ 295 (345)
T 3hko_A 227 EYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVN---------DADTISQVLNKKLC--F 295 (345)
T ss_dssp --------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---------HHHHHHHHHHCCCC--T
T ss_pred ccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---------hHHHHHHHHhcccc--c
Confidence 1112234568999999999875 578899999999999999999999995421 12222222221111 1
Q ss_pred CCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 201 PAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
..+. . ...++.+.+++.+||+.||.+|||+.|
T Consensus 296 ~~~~-~--------~~~~~~~~~li~~~l~~~p~~Rps~~~ 327 (345)
T 3hko_A 296 ENPN-Y--------NVLSPLARDLLSNLLNRNVDERFDAMR 327 (345)
T ss_dssp TSGG-G--------GGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred CCcc-c--------ccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 1111 0 122367899999999999999999753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=290.51 Aligned_cols=214 Identities=21% Similarity=0.294 Sum_probs=163.6
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~ 75 (241)
||++.........++|.+|++++++++|||||++++++.. +..++||||+++|+|.+++..... ....++.+++
T Consensus 368 vK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~ 446 (613)
T 2ozo_A 368 IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 446 (613)
T ss_dssp EEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHH
T ss_pred EEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHH
Confidence 4566555455567889999999999999999999999976 568999999999999999865421 4678999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCc-ceeecccccCCCccCcccccccCCCcchhhH
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET-HITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
.||.||| +++|+||||||+|||++.++.+||+|||+++....... ........+++.|+|||++.+..++.++|||
T Consensus 447 ~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvw 523 (613)
T 2ozo_A 447 MGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 523 (613)
T ss_dssp HHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHH
Confidence 9999999 89999999999999999999999999999976543221 1111223456789999999988999999999
Q ss_pred HHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 155 SFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 155 s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
|||+++|||++ |+.||..... .+..... ..+.....+ . .++..+.++|.+||+.||
T Consensus 524 SlGv~l~ellt~G~~Pf~~~~~---------~~~~~~i-~~~~~~~~p-----~--------~~~~~l~~li~~cl~~dP 580 (613)
T 2ozo_A 524 SYGVTMWEALSYGQKPYKKMKG---------PEVMAFI-EQGKRMECP-----P--------ECPPELYALMSDCWIYKW 580 (613)
T ss_dssp HHHHHHHHHHTTSCCTTTTCCS---------HHHHHHH-HTTCCCCCC-----T--------TCCHHHHHHHHHTTCSST
T ss_pred HHHHHHHHHHHCCCCCCCCCCH---------HHHHHHH-HcCCCCCCC-----C--------cCCHHHHHHHHHHcCCCh
Confidence 99999999998 9999965221 1222222 222111111 1 223678999999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|||++|
T Consensus 581 ~~RPs~~~ 588 (613)
T 2ozo_A 581 EDRPDFLT 588 (613)
T ss_dssp TTSCCHHH
T ss_pred hHCcCHHH
Confidence 99999753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=284.52 Aligned_cols=203 Identities=20% Similarity=0.318 Sum_probs=161.9
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC---c---hHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---L---PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~---~~~~~~~~i~~~l~~lh~~~ 85 (241)
..+.|.+|++++++++||||++++++|...+..++||||+++|+|.+++.... . ..+.++.|++.||.|||
T Consensus 259 ~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH--- 335 (495)
T 1opk_A 259 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 335 (495)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---
T ss_pred chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 56789999999999999999999999999999999999999999999986432 1 46788999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+++++||||||+|||++.++.+||+|||++........ .......++..|+|||++....++.++||||||+++|+|++
T Consensus 336 ~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t 414 (495)
T 1opk_A 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414 (495)
T ss_dssp HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred hCCcccCCCChhhEEECCCCcEEEeecccceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHh
Confidence 89999999999999999999999999999986644321 12223345678999999998899999999999999999999
Q ss_pred -cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 -GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|..||...... +..... ..+.... ... ..+..+.+|+.+||+.||++|||++|
T Consensus 415 ~g~~p~~~~~~~---------~~~~~~-~~~~~~~-----~~~--------~~~~~l~~li~~cl~~dP~~RPs~~e 468 (495)
T 1opk_A 415 YGMSPYPGIDLS---------QVYELL-EKDYRME-----RPE--------GCPEKVYELMRACWQWNPSDRPSFAE 468 (495)
T ss_dssp TSCCSSTTCCGG---------GHHHHH-HTTCCCC-----CCT--------TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCCCCHH---------HHHHHH-HcCCCCC-----CCC--------CCCHHHHHHHHHHcCcChhHCcCHHH
Confidence 99998652211 111111 1111111 111 22367899999999999999999853
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=269.01 Aligned_cols=166 Identities=20% Similarity=0.259 Sum_probs=139.1
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC-------Cc---hHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA-------PL---PRLKI 70 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-------~~---~~~~~ 70 (241)
||.+.........+.+.+|++++++++||||+++++++..++..++||||++ ++|.+++... .. ....+
T Consensus 35 iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~ 113 (317)
T 2pmi_A 35 LKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYF 113 (317)
T ss_dssp EEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHH
T ss_pred EEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHH
Confidence 3555444444556788999999999999999999999999999999999998 6999887532 11 35678
Q ss_pred HHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCc
Q 044022 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNE 149 (241)
Q Consensus 71 ~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~ 149 (241)
+.|++.||.||| +.+++||||||+||+++.++.+||+|||.+......... .....+|+.|+|||++.+. .++.
T Consensus 114 ~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~ 188 (317)
T 2pmi_A 114 QWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT--FSSEVVTLWYRAPDVLMGSRTYST 188 (317)
T ss_dssp HHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC--CCCCCSCCTTCCHHHHTTCCCCCT
T ss_pred HHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCccc--CCCCcccccccCchHhhCCCCCCc
Confidence 899999999999 899999999999999999999999999999876433211 1234689999999999764 6899
Q ss_pred chhhHHHHHHHHHHHhcCccccc
Q 044022 150 KSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 150 ~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
++||||||+++|+|++|+.||..
T Consensus 189 ~~DiwslG~il~el~~g~~pf~~ 211 (317)
T 2pmi_A 189 SIDIWSCGCILAEMITGKPLFPG 211 (317)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCC
T ss_pred HHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999964
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=264.56 Aligned_cols=206 Identities=22% Similarity=0.292 Sum_probs=156.7
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+++.+|+.++++++||||+++++++...+..++||||+++++|.+++.... .....++.+++.||.||| +
T Consensus 53 ~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~ 129 (294)
T 4eqm_A 53 ETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH---D 129 (294)
T ss_dssp HHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 445789999999999999999999999999999999999999999999986542 256789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++||||||+||+++.++.++|+|||.+......... ......||+.|+|||.+.+..++.++||||||+++|+|++|
T Consensus 130 ~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g 208 (294)
T 4eqm_A 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVG 208 (294)
T ss_dssp TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred CCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999998765433211 12335689999999999998999999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
+.||.... ..+......... ... ........ .+..+.+++.+||+.||++||+.
T Consensus 209 ~~pf~~~~---------~~~~~~~~~~~~-~~~-~~~~~~~~--------~~~~l~~li~~~l~~dp~~R~~~ 262 (294)
T 4eqm_A 209 EPPFNGET---------AVSIAIKHIQDS-VPN-VTTDVRKD--------IPQSLSNVILRATEKDKANRYKT 262 (294)
T ss_dssp SCSSCSSC---------HHHHHHHHHSSC-CCC-HHHHSCTT--------SCHHHHHHHHHHSCSSGGGSCSS
T ss_pred CCCCCCCC---------hHHHHHHHhhcc-CCC-cchhcccC--------CCHHHHHHHHHHhcCCHhHcccc
Confidence 99995521 111111111111 000 00011111 22678899999999999999953
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=266.61 Aligned_cols=225 Identities=23% Similarity=0.247 Sum_probs=166.0
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeC--CcceEEEEecCCCCHHHhhcCCC-----chHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQT--PIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASD 73 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~ 73 (241)
||++..+......+.+.+|++++++++||||+++++++... ...++||||+++++|.+++.... ..+..++.+
T Consensus 55 vK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 134 (302)
T 4e5w_A 55 VKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 134 (302)
T ss_dssp EEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHH
T ss_pred EEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHH
Confidence 46665555556678899999999999999999999999876 56899999999999999984321 146789999
Q ss_pred HHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-eeecccccCCCccCcccccccCCCcchh
Q 044022 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-ITTDRVIGTRGYSAPEYISICVLNEKSN 152 (241)
Q Consensus 74 i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~D 152 (241)
++.||.||| +.+++|+||||+||+++.++.++|+|||.+......... .......+|..|+|||.+.+..++.++|
T Consensus 135 i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 211 (302)
T 4e5w_A 135 ICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASD 211 (302)
T ss_dssp HHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHH
T ss_pred HHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchh
Confidence 999999999 899999999999999999999999999999876554322 2223455778899999999888999999
Q ss_pred hHHHHHHHHHHHhcCccccccccc-----CCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHH
Q 044022 153 VFSFGAFLFELLAGRIHIWDLLKD-----THDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLE 227 (241)
Q Consensus 153 i~s~G~~~~~~~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 227 (241)
|||||+++|+|++|..|+...... ....................... ... ..++.+.+++.+
T Consensus 212 i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~--------~~~~~l~~li~~ 278 (302)
T 4e5w_A 212 VWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLP-----CPP--------NCPDEVYQLMRK 278 (302)
T ss_dssp HHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCC-----CCT--------TCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCC-----CCC--------CCCHHHHHHHHH
Confidence 999999999999999987442110 00011111111111111111111 111 122678999999
Q ss_pred hccCCCCCCCCCCC
Q 044022 228 CVNNSPEDRPTMVD 241 (241)
Q Consensus 228 cl~~~p~~Rpt~~e 241 (241)
||+.||++|||++|
T Consensus 279 ~l~~dp~~Rps~~~ 292 (302)
T 4e5w_A 279 CWEFQPSNRTSFQN 292 (302)
T ss_dssp TTCSSGGGSCCHHH
T ss_pred HcCCCCCCCCCHHH
Confidence 99999999999853
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=268.71 Aligned_cols=216 Identities=21% Similarity=0.352 Sum_probs=168.0
Q ss_pred CcccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCC-cceEEEEecCCCCHHHhhcCCC--------------
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTP-IPILVFQSVEYGTLRDCIFGAP-------------- 64 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~-------------- 64 (241)
||++.........+.+.+|+++++++ +||||+++++++...+ ..++||||+++++|.+++....
T Consensus 62 vK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 141 (316)
T 2xir_A 62 VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141 (316)
T ss_dssp EEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------C
T ss_pred EEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhh
Confidence 35555444444567899999999999 7899999999988755 5899999999999999987642
Q ss_pred ---c---hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccC
Q 044022 65 ---L---PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSA 138 (241)
Q Consensus 65 ---~---~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~a 138 (241)
. ....++.+++.||.||| +.+++||||||+||+++.++.++|+|||.+................+++.|+|
T Consensus 142 ~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~a 218 (316)
T 2xir_A 142 KDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 218 (316)
T ss_dssp TTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCC
T ss_pred ccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecC
Confidence 1 35778999999999999 89999999999999999999999999999987655444344445567889999
Q ss_pred cccccccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHH
Q 044022 139 PEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQ 217 (241)
Q Consensus 139 PE~~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (241)
||.+.+..++.++||||||+++|+|++ |..||...... ...... ...+.....+ .. .
T Consensus 219 PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------~~~~~~-~~~~~~~~~~-----~~--------~ 276 (316)
T 2xir_A 219 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------EEFCRR-LKEGTRMRAP-----DY--------T 276 (316)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--------HHHHHH-HHHTCCCCCC-----TT--------C
T ss_pred chhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh--------HHHHHH-hccCccCCCC-----CC--------C
Confidence 999998899999999999999999998 99999542111 111111 1122111111 11 1
Q ss_pred HHHHHHHHHHhccCCCCCCCCCCC
Q 044022 218 LHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 218 ~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+..+.+++.+||+.||++|||++|
T Consensus 277 ~~~l~~li~~~l~~dp~~Rps~~e 300 (316)
T 2xir_A 277 TPEMYQTMLDCWHGEPSQRPTFSE 300 (316)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHH
Confidence 257889999999999999999853
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=264.13 Aligned_cols=155 Identities=20% Similarity=0.250 Sum_probs=133.7
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
....+.+|++++++++||||+++++++..++..++||||++ ++|.+.+..... ....++.|++.||.||| +
T Consensus 62 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~ 137 (311)
T 3niz_A 62 IPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---Q 137 (311)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred hhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 45678899999999999999999999999999999999997 588887765421 46788999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHHHHHHHHh
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~~~~~~ 165 (241)
.+++||||||+|||++.++.+||+|||.+......... .....+|+.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 138 ~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 215 (311)
T 3niz_A 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215 (311)
T ss_dssp TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH
T ss_pred CCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHh
Confidence 99999999999999999999999999999876533221 133468999999999876 468999999999999999999
Q ss_pred cCccccc
Q 044022 166 GRIHIWD 172 (241)
Q Consensus 166 g~~p~~~ 172 (241)
|+.||..
T Consensus 216 g~~pf~~ 222 (311)
T 3niz_A 216 GKPLFPG 222 (311)
T ss_dssp SSCSCCC
T ss_pred CCCCCCC
Confidence 9999965
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=278.00 Aligned_cols=207 Identities=15% Similarity=0.207 Sum_probs=163.5
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
.....+.+|+.+++.++||||++++++|...+..++||||+++|+|.+++..... ....++.+|+.||.||| ++
T Consensus 111 ~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH---~~ 187 (410)
T 3v8s_A 111 SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH---SM 187 (410)
T ss_dssp CCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 3455688999999999999999999999999999999999999999999876543 46778999999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccC----CCcchhhHHHHHHHHHH
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV----LNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Di~s~G~~~~~~ 163 (241)
+|+||||||+|||++.++.+||+|||++........ .......||+.|+|||++.+.. ++.++||||||+++|+|
T Consensus 188 givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyel 266 (410)
T 3v8s_A 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 266 (410)
T ss_dssp TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHH
T ss_pred CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHH
Confidence 999999999999999999999999999987654432 2224567999999999998655 78899999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC--CCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED--RPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--Rpt~~e 241 (241)
++|+.||... ...+..............+.. . ..+..+.+|+.+||..+|.+ |||++|
T Consensus 267 l~G~~Pf~~~---------~~~~~~~~i~~~~~~~~~p~~---~--------~~s~~~~~li~~lL~~~~~rlgR~~~~e 326 (410)
T 3v8s_A 267 LVGDTPFYAD---------SLVGTYSKIMNHKNSLTFPDD---N--------DISKEAKNLICAFLTDREVRLGRNGVEE 326 (410)
T ss_dssp HHSSCTTCCS---------SHHHHHHHHHTHHHHCCCCTT---C--------CCCHHHHHHHHHHSSCGGGCTTSSCHHH
T ss_pred HhCCCCCCCC---------ChhhHHHHHHhccccccCCCc---c--------cccHHHHHHHHHHccChhhhCCCCCHHH
Confidence 9999999642 112222222221111111111 0 11257889999999999988 998753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=266.93 Aligned_cols=215 Identities=23% Similarity=0.313 Sum_probs=156.9
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeee--CCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHHhchhhc
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQ--TPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~l~~lh~ 83 (241)
...+.+.+|++++++++||||+++++++.. ....++||||+++++|.+++..... ....++.+++.||.|||
T Consensus 53 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH- 131 (295)
T 3ugc_A 53 EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG- 131 (295)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH-
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh-
Confidence 345779999999999999999999999864 3568999999999999999865421 46789999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-eeecccccCCCccCcccccccCCCcchhhHHHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-ITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~ 162 (241)
+.+++||||||+||+++.++.+||+|||.+......... .......++..|+|||.+.+..++.++||||||+++|+
T Consensus 132 --~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 209 (295)
T 3ugc_A 132 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 209 (295)
T ss_dssp --HTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred --cCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHH
Confidence 899999999999999999999999999999765443221 11223346677999999998999999999999999999
Q ss_pred HHhcCccccccccc------CCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCC
Q 044022 163 LLAGRIHIWDLLKD------THDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDR 236 (241)
Q Consensus 163 ~~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 236 (241)
|++|..|+...... ........................ .. ..+..+.+++.+||+.||++|
T Consensus 210 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~--------~~~~~l~~li~~~l~~dp~~R 276 (295)
T 3ugc_A 210 LFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR-----PD--------GCPDEIYMIMTECWNNNVNQR 276 (295)
T ss_dssp HHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCC-----CT--------TCCHHHHHHHHHHSCSSGGGS
T ss_pred HHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCC-----Cc--------CcCHHHHHHHHHHcCCChhhC
Confidence 99999988542111 000000001111111111111111 11 223678999999999999999
Q ss_pred CCCCC
Q 044022 237 PTMVD 241 (241)
Q Consensus 237 pt~~e 241 (241)
||++|
T Consensus 277 ps~~e 281 (295)
T 3ugc_A 277 PSFRD 281 (295)
T ss_dssp CCHHH
T ss_pred CCHHH
Confidence 99853
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=276.26 Aligned_cols=201 Identities=25% Similarity=0.308 Sum_probs=162.6
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
.....+.+|+++++.++||||+++++++...+..++||||+++|+|.+++..... ....++.||+.||.||| +
T Consensus 58 ~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~ 134 (476)
T 2y94_A 58 DVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH---R 134 (476)
T ss_dssp TTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHH---T
T ss_pred HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 3456789999999999999999999999999999999999999999999976532 46789999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCC-CcchhhHHHHHHHHHHHh
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVL-NEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~s~G~~~~~~~~ 165 (241)
.+++||||||+|||++.++.+||+|||++........ .....||+.|+|||++.+..+ +.++||||||+++|+|++
T Consensus 135 ~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ellt 211 (476)
T 2y94_A 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLC 211 (476)
T ss_dssp TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH
T ss_pred CCCCcccccHHHEEEecCCCeEEEeccchhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhh
Confidence 9999999999999999999999999999987654332 133478999999999987765 689999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|..||.... ......... .+.. .. ... .+..+.+++.+||..||++|||++|
T Consensus 212 G~~Pf~~~~---------~~~~~~~i~-~~~~-~~-----p~~--------~s~~~~~Li~~~L~~dP~~Rpt~~e 263 (476)
T 2y94_A 212 GTLPFDDDH---------VPTLFKKIC-DGIF-YT-----PQY--------LNPSVISLLKHMLQVDPMKRATIKD 263 (476)
T ss_dssp SSCSSCCSS---------SHHHHHHHH-TTCC-CC-----CTT--------CCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCCCCCCC---------HHHHHHHHh-cCCc-CC-----Ccc--------CCHHHHHHHHHHcCCCchhCcCHHH
Confidence 999996521 112222221 1111 00 111 1256889999999999999999853
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=268.56 Aligned_cols=211 Identities=18% Similarity=0.232 Sum_probs=157.0
Q ss_pred cccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHh
Q 044022 4 YGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSL 78 (241)
Q Consensus 4 ~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l 78 (241)
+.........+.+.+|+.++++++||||+++++++.... .++|++++.+|+|.+++.... ...+.++.|++.||
T Consensus 52 ~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL 130 (327)
T 3lzb_A 52 LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130 (327)
T ss_dssp ECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHH
T ss_pred eccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 333334456788999999999999999999999998765 789999999999999986532 14678999999999
Q ss_pred chhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHH
Q 044022 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGA 158 (241)
Q Consensus 79 ~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~ 158 (241)
.||| +.+++||||||+|||++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+
T Consensus 131 ~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 207 (327)
T 3lzb_A 131 NYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 207 (327)
T ss_dssp HHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHH
Confidence 9999 8999999999999999999999999999998765443333333345677899999999999999999999999
Q ss_pred HHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 159 FLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 159 ~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
++|+|++ |..||...... +..... ........ .. ..+..+.+++.+||+.||.+||
T Consensus 208 il~ell~~g~~p~~~~~~~---------~~~~~~-~~~~~~~~-----~~--------~~~~~l~~li~~~l~~dp~~Rp 264 (327)
T 3lzb_A 208 TVWELMTFGSKPYDGIPAS---------EISSIL-EKGERLPQ-----PP--------ICTIDVYMIMRKCWMIDADSRP 264 (327)
T ss_dssp HHHHHHTTSCCTTTTCCGG---------GHHHHH-HTTCCCCC-----CT--------TBCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHCCCCCCCCCCHH---------HHHHHH-HcCCCCCC-----Cc--------cCCHHHHHHHHHHcCCChhHCc
Confidence 9999999 99999652211 111111 11111111 11 1225688999999999999999
Q ss_pred CCCC
Q 044022 238 TMVD 241 (241)
Q Consensus 238 t~~e 241 (241)
|++|
T Consensus 265 s~~e 268 (327)
T 3lzb_A 265 KFRE 268 (327)
T ss_dssp CHHH
T ss_pred CHHH
Confidence 9753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=273.77 Aligned_cols=204 Identities=20% Similarity=0.232 Sum_probs=161.7
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+.+.+|++++++++||||+++++++...+..++||||+++++|.+++.... .....++.|++.||.||| +
T Consensus 129 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~ 205 (373)
T 2x4f_A 129 DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH---Q 205 (373)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 46779999999999999999999999999999999999999999998875432 246788999999999999 8
Q ss_pred CCceeccCCCCCeee--cCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILF--NEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 87 ~~ivh~dl~~~nil~--~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
.+++||||||+|||+ +.++.+||+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 206 ~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 282 (373)
T 2x4f_A 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282 (373)
T ss_dssp TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC---CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHH
T ss_pred CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc---ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHH
Confidence 999999999999999 56788999999999876543321 2346899999999999888999999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|..||.... ..+......... . .... .... ..++.+.+|+.+||+.||++|||++|
T Consensus 283 tg~~pf~~~~---------~~~~~~~i~~~~-~-~~~~-~~~~--------~~~~~~~~li~~~L~~dp~~Rps~~e 339 (373)
T 2x4f_A 283 SGLSPFLGDN---------DAETLNNILACR-W-DLED-EEFQ--------DISEEAKEFISKLLIKEKSWRISASE 339 (373)
T ss_dssp HSSCTTCCSS---------HHHHHHHHHHTC-C-CSCS-GGGT--------TSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred hCCCCCCCCC---------HHHHHHHHHhcc-C-CCCh-hhhc--------cCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 9999995421 112222222111 0 1111 1111 12367899999999999999999853
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=264.61 Aligned_cols=199 Identities=19% Similarity=0.201 Sum_probs=151.7
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
....+.+|++++++++||||+++++++...+..++||||+++++|.+++.... .....++.+++.||.||| +.
T Consensus 64 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~ 140 (327)
T 3a62_A 64 DTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH---QK 140 (327)
T ss_dssp -------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred HHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 45668899999999999999999999999999999999999999999986532 246778999999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcC
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
+++||||||+|||++.++.+||+|||++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|+
T Consensus 141 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 218 (327)
T 3a62_A 141 GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218 (327)
T ss_dssp TCCCCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CEEcccCCHHHeEECCCCcEEEEeCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCC
Confidence 999999999999999999999999999875433221 123456899999999999888999999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
.||.... ..+......... . . +... .+..+.+++.+||+.||++||++
T Consensus 219 ~pf~~~~---------~~~~~~~i~~~~-~-~-----~p~~--------~~~~~~~li~~~L~~dp~~R~~~ 266 (327)
T 3a62_A 219 PPFTGEN---------RKKTIDKILKCK-L-N-----LPPY--------LTQEARDLLKKLLKRNAASRLGA 266 (327)
T ss_dssp CSCCCSS---------HHHHHHHHHHTC-C-C-----CCTT--------SCHHHHHHHHHHSCSCGGGSTTS
T ss_pred CCCCCCC---------HHHHHHHHHhCC-C-C-----CCCC--------CCHHHHHHHHHHHhcCHhhccCC
Confidence 9996521 112222222111 0 1 1111 12578899999999999999965
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=264.72 Aligned_cols=204 Identities=19% Similarity=0.264 Sum_probs=163.4
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++..... ....++.+++.||.||| +.
T Consensus 58 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~ 134 (321)
T 2a2a_A 58 SREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TK 134 (321)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHH---HT
T ss_pred hHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 467799999999999999999999999999999999999999999999976532 46789999999999999 89
Q ss_pred CceeccCCCCCeeecCCC----CeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 88 PIVLRNFKTQNILFNEEN----VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+++|+||||+||+++.++ .++|+|||.+........ .....|++.|+|||.+.+..++.++||||||+++|+|
T Consensus 135 ~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 211 (321)
T 2a2a_A 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211 (321)
T ss_dssp TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred CeecCCCChHHEEEecCCCCcCCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHH
Confidence 999999999999999888 799999999987654322 1234689999999999988999999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|..||.... ..+......... . ...+.... ..+..+.+++.+||+.||++|||++|
T Consensus 212 ~~g~~pf~~~~---------~~~~~~~i~~~~-~--~~~~~~~~--------~~~~~~~~li~~~l~~dp~~Rps~~e 269 (321)
T 2a2a_A 212 LSGASPFLGDT---------KQETLANITSVS-Y--DFDEEFFS--------HTSELAKDFIRKLLVKETRKRLTIQE 269 (321)
T ss_dssp HHSCCSSCCSS---------HHHHHHHHHTTC-C--CCCHHHHT--------TCCHHHHHHHHTTSCSSTTTSCCHHH
T ss_pred HHCCCCCCCCC---------HHHHHHHHHhcc-c--ccChhhhc--------ccCHHHHHHHHHHcCCChhhCcCHHH
Confidence 99999995421 112222211111 0 00111111 22357899999999999999999753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=262.85 Aligned_cols=213 Identities=22% Similarity=0.304 Sum_probs=170.4
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNS 77 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~ 77 (241)
||++.........+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++..... ....++.+++.|
T Consensus 52 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~ 131 (303)
T 3a7i_A 52 IKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKG 131 (303)
T ss_dssp EEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHH
T ss_pred EEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHH
Confidence 46665555455678899999999999999999999999999999999999999999999976543 467899999999
Q ss_pred hchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHH
Q 044022 78 LAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFG 157 (241)
Q Consensus 78 l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G 157 (241)
|.||| +.+++|+||+|+||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.++||||||
T Consensus 132 l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 206 (303)
T 3a7i_A 132 LDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 206 (303)
T ss_dssp HHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHH
T ss_pred HHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHH
Confidence 99999 89999999999999999999999999999977654322 12345688999999999988999999999999
Q ss_pred HHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 158 AFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 158 ~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
+++|+|++|..||.... ..+..... ..... +.+.... +..+.+++.+||+.||++||
T Consensus 207 ~il~~l~~g~~p~~~~~---------~~~~~~~~-~~~~~-----~~~~~~~--------~~~l~~li~~~l~~dp~~Rp 263 (303)
T 3a7i_A 207 ITAIELARGEPPHSELH---------PMKVLFLI-PKNNP-----PTLEGNY--------SKPLKEFVEACLNKEPSFRP 263 (303)
T ss_dssp HHHHHHHHSSCTTTTSC---------HHHHHHHH-HHSCC-----CCCCSSC--------CHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHHHccCCCCCCCcC---------HHHHHHHh-hcCCC-----CCCcccc--------CHHHHHHHHHHcCCChhhCc
Confidence 99999999999995421 11111111 11111 1111222 25688999999999999999
Q ss_pred CCCC
Q 044022 238 TMVD 241 (241)
Q Consensus 238 t~~e 241 (241)
|++|
T Consensus 264 s~~~ 267 (303)
T 3a7i_A 264 TAKE 267 (303)
T ss_dssp CHHH
T ss_pred CHHH
Confidence 9853
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=274.83 Aligned_cols=214 Identities=20% Similarity=0.259 Sum_probs=154.4
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeee-CCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQ-TPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIV 75 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~ 75 (241)
|.+.........++|.+|+.++++++||||+++++++.. .+..++||||+++|+|.+++..... ....++.|++
T Consensus 123 K~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~ 202 (373)
T 3c1x_A 123 KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 202 (373)
T ss_dssp EECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHH
T ss_pred EEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHH
Confidence 444443444557789999999999999999999998754 5578999999999999999976432 4678899999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc--eeecccccCCCccCcccccccCCCcchhh
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH--ITTDRVIGTRGYSAPEYISICVLNEKSNV 153 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 153 (241)
.||.||| +.+++||||||+|||++.++.+||+|||++......... .......+++.|+|||++.+..++.++||
T Consensus 203 ~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 279 (373)
T 3c1x_A 203 KGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDV 279 (373)
T ss_dssp HHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHH
T ss_pred HHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHH
Confidence 9999999 899999999999999999999999999999765432211 11123356778999999998899999999
Q ss_pred HHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCC
Q 044022 154 FSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNS 232 (241)
Q Consensus 154 ~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~ 232 (241)
||||+++|+|++ |.+||....... . .... ..+.... ... ..+..+.+++.+||+.|
T Consensus 280 wSlG~il~ellt~~~~p~~~~~~~~------~---~~~~-~~~~~~~-----~p~--------~~~~~l~~li~~cl~~d 336 (373)
T 3c1x_A 280 WSFGVLLWELMTRGAPPYPDVNTFD------I---TVYL-LQGRRLL-----QPE--------YCPDPLYEVMLKCWHPK 336 (373)
T ss_dssp HHHHHHHHHHHTTSCCSCTTSCSSC------H---HHHH-HTTCCCC-----CCT--------TCCHHHHHHHHHHTCSS
T ss_pred HHHHHHHHHHHhCcCCCCCCCCHHH------H---HHHH-HcCCCCC-----CCC--------CCCHHHHHHHHHHcCCC
Confidence 999999999999 677775422111 1 1111 1111111 111 12257889999999999
Q ss_pred CCCCCCCCC
Q 044022 233 PEDRPTMVD 241 (241)
Q Consensus 233 p~~Rpt~~e 241 (241)
|++|||++|
T Consensus 337 p~~RPs~~e 345 (373)
T 3c1x_A 337 AEMRPSFSE 345 (373)
T ss_dssp GGGSCCHHH
T ss_pred hhhCcCHHH
Confidence 999999753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=266.59 Aligned_cols=213 Identities=23% Similarity=0.300 Sum_probs=159.7
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~ 76 (241)
|.+...........+.+|++++++++||||+++++++...+..++||||+++++|.+++.... ..++.++.+++.
T Consensus 79 K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~ 158 (333)
T 1mqb_A 79 KTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 158 (333)
T ss_dssp EEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHH
T ss_pred EEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHH
Confidence 455444444456679999999999999999999999999999999999999999999986532 146789999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-eeecccccCCCccCcccccccCCCcchhhHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-ITTDRVIGTRGYSAPEYISICVLNEKSNVFS 155 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 155 (241)
||.||| +.+++||||||+||+++.++.+||+|||.+......... .......++..|+|||.+.+..++.++||||
T Consensus 159 aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 235 (333)
T 1mqb_A 159 GMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWS 235 (333)
T ss_dssp HHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHH
T ss_pred HHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHH
Confidence 999999 899999999999999999999999999998765433211 1112234577899999999889999999999
Q ss_pred HHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 156 FGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 156 ~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
||+++|++++ |..||.... ..+....... +..... .. ..+..+.+++.+||+.||+
T Consensus 236 lG~il~ellt~g~~pf~~~~---------~~~~~~~~~~-~~~~~~-----~~--------~~~~~l~~li~~~l~~~p~ 292 (333)
T 1mqb_A 236 FGIVMWEVMTYGERPYWELS---------NHEVMKAIND-GFRLPT-----PM--------DCPSAIYQLMMQCWQQERA 292 (333)
T ss_dssp HHHHHHHHHTTSCCTTTTCC---------HHHHHHHHHT-TCCCCC-----CT--------TCBHHHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHcCCCCCcccCC---------HHHHHHHHHC-CCcCCC-----cc--------cCCHHHHHHHHHHcCCChh
Confidence 9999999998 999995421 1122222211 111110 11 1225789999999999999
Q ss_pred CCCCCC
Q 044022 235 DRPTMV 240 (241)
Q Consensus 235 ~Rpt~~ 240 (241)
+|||+.
T Consensus 293 ~Rps~~ 298 (333)
T 1mqb_A 293 RRPKFA 298 (333)
T ss_dssp TSCCHH
T ss_pred hCcCHH
Confidence 999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=259.72 Aligned_cols=202 Identities=25% Similarity=0.371 Sum_probs=153.1
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
...+.+.+|++++++++||||+++++++...+..++||||+++++|.+++..... ....++.+++.||.||| +.
T Consensus 48 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH---~~ 124 (271)
T 3dtc_A 48 QTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLH---DE 124 (271)
T ss_dssp -CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHH---HS
T ss_pred HHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 4467899999999999999999999999999999999999999999999876543 46789999999999999 77
Q ss_pred C---ceeccCCCCCeeecC--------CCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHH
Q 044022 88 P---IVLRNFKTQNILFNE--------ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSF 156 (241)
Q Consensus 88 ~---ivh~dl~~~nil~~~--------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~ 156 (241)
+ ++||||||+||+++. ++.++|+|||.+........ ....+++.|+|||.+.+..++.++|||||
T Consensus 125 ~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 200 (271)
T 3dtc_A 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSY 200 (271)
T ss_dssp SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHH
T ss_pred CCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHH
Confidence 7 899999999999986 67899999999976544322 23468899999999998889999999999
Q ss_pred HHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCC
Q 044022 157 GAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDR 236 (241)
Q Consensus 157 G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 236 (241)
|+++|+|++|+.||.... ............... .... ..++.+.+++.+||+.||++|
T Consensus 201 G~~l~~l~~g~~p~~~~~---------~~~~~~~~~~~~~~~-----~~~~--------~~~~~~~~li~~~l~~~p~~R 258 (271)
T 3dtc_A 201 GVLLWELLTGEVPFRGID---------GLAVAYGVAMNKLAL-----PIPS--------TCPEPFAKLMEDCWNPDPHSR 258 (271)
T ss_dssp HHHHHHHHHCCCTTTTSC---------HHHHHHHHHTSCCCC-----CCCT--------TCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHhCCCCCCCCC---------HHHHHHhhhcCCCCC-----CCCc--------ccCHHHHHHHHHHhcCCcccC
Confidence 999999999999996521 111111111111111 1111 122578999999999999999
Q ss_pred CCCCC
Q 044022 237 PTMVD 241 (241)
Q Consensus 237 pt~~e 241 (241)
||++|
T Consensus 259 ps~~e 263 (271)
T 3dtc_A 259 PSFTN 263 (271)
T ss_dssp CCHHH
T ss_pred cCHHH
Confidence 99853
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=263.28 Aligned_cols=214 Identities=20% Similarity=0.278 Sum_probs=166.3
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~ 75 (241)
||++.........+++.+|++++++++||||+++++++ ..+..++||||+++++|.+++.... .....++.+++
T Consensus 42 vK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~ 120 (287)
T 1u59_A 42 IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120 (287)
T ss_dssp EEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHH
T ss_pred EEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHH
Confidence 35555444445677899999999999999999999999 5667899999999999999986432 14678999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-eeecccccCCCccCcccccccCCCcchhhH
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-ITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
.||.||| +.+++|+||||+||+++.++.++|+|||.+......... .......+++.|+|||.+.+..++.++|||
T Consensus 121 ~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 197 (287)
T 1u59_A 121 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 197 (287)
T ss_dssp HHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHH
T ss_pred HHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHH
Confidence 9999999 899999999999999999999999999999876543322 112233467889999999888899999999
Q ss_pred HHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 155 SFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 155 s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
|||+++|+|++ |+.||..... .+...... .+.... .... .+..+.+++.+||+.||
T Consensus 198 slG~il~ellt~g~~p~~~~~~---------~~~~~~i~-~~~~~~-----~~~~--------~~~~l~~li~~~l~~~p 254 (287)
T 1u59_A 198 SYGVTMWEALSYGQKPYKKMKG---------PEVMAFIE-QGKRME-----CPPE--------CPPELYALMSDCWIYKW 254 (287)
T ss_dssp HHHHHHHHHHTTSCCTTTTCCT---------HHHHHHHH-TTCCCC-----CCTT--------CCHHHHHHHHHTTCSSG
T ss_pred HHHHHHHHHHcCCCCCcccCCH---------HHHHHHHh-cCCcCC-----CCCC--------cCHHHHHHHHHHcCCCh
Confidence 99999999998 9999965211 12222221 111111 1112 22678999999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|||+.|
T Consensus 255 ~~Rps~~~ 262 (287)
T 1u59_A 255 EDRPDFLT 262 (287)
T ss_dssp GGSCCHHH
T ss_pred hhCcCHHH
Confidence 99999753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=259.73 Aligned_cols=205 Identities=22% Similarity=0.338 Sum_probs=161.3
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|++++++++||||+++++++...+..++||||+++++|.+.+.... .....++.+++.||.||| +
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~ 123 (284)
T 3kk8_A 47 RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH---S 123 (284)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 445778899999999999999999999999999999999999999988875432 246789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCC---eEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEENV---AKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
.+++||||||+||+++.++. ++|+|||.+......... ....+++.|+|||.+.+..++.++||||||+++|+|
T Consensus 124 ~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 200 (284)
T 3kk8_A 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYIL 200 (284)
T ss_dssp TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHH
Confidence 99999999999999976655 999999999776543321 234689999999999998999999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|..||.... ..+...... .+.. ..+.+.. . ..++.+.+++.+||+.||++|||++|
T Consensus 201 ~~g~~pf~~~~---------~~~~~~~~~-~~~~-~~~~~~~-~--------~~~~~~~~li~~~l~~dp~~Rps~~~ 258 (284)
T 3kk8_A 201 LVGYPPFWDED---------QHRLYAQIK-AGAY-DYPSPEW-D--------TVTPEAKSLIDSMLTVNPKKRITADQ 258 (284)
T ss_dssp HHSSCSSCCSS---------HHHHHHHHH-HTCC-CCCTTTT-T--------TSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHCCCCCCCCc---------hhHHHHHHH-hccc-cCCchhh-c--------ccCHHHHHHHHHHcccChhhCCCHHH
Confidence 99999995521 111122211 1111 1111110 1 12257889999999999999999853
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=270.57 Aligned_cols=206 Identities=20% Similarity=0.234 Sum_probs=151.4
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+.+.+|+.++++++||||+++++++...+..++||||+++|+|.+++.... .....++.|++.||.||| ++
T Consensus 59 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH---~~ 135 (361)
T 3uc3_A 59 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH---SM 135 (361)
T ss_dssp SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 34678899999999999999999999999999999999999999999885432 256789999999999999 89
Q ss_pred CceeccCCCCCeeecCCCC--eEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcc-hhhHHHHHHHHHHH
Q 044022 88 PIVLRNFKTQNILFNEENV--AKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEK-SNVFSFGAFLFELL 164 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~s~G~~~~~~~ 164 (241)
+++||||||+||+++.++. +||+|||++........ .....||+.|+|||++.+..++.+ +||||||+++|+|+
T Consensus 136 ~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 212 (361)
T 3uc3_A 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVML 212 (361)
T ss_dssp TCCSCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHH
T ss_pred CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHH
Confidence 9999999999999987765 99999999874332221 233468999999999988777655 89999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|+.||...... ............... ..+.. . ..+..+.+|+.+||+.||++|||++|
T Consensus 213 ~g~~Pf~~~~~~-----~~~~~~~~~~~~~~~--~~~~~---~--------~~s~~~~~li~~~L~~dP~~Rps~~e 271 (361)
T 3uc3_A 213 VGAYPFEDPEEP-----RDYRKTIQRILSVKY--SIPDD---I--------RISPECCHLISRIFVADPATRISIPE 271 (361)
T ss_dssp HSSCSCC----C-----CCHHHHHHHHHTTCC--CCCTT---S--------CCCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred hCCCCCCCCccH-----HHHHHHHHHHhcCCC--CCCCc---C--------CCCHHHHHHHHHHccCChhHCcCHHH
Confidence 999999652211 112222222211110 11110 0 11257889999999999999999853
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=259.25 Aligned_cols=166 Identities=17% Similarity=0.200 Sum_probs=136.0
Q ss_pred Cccccccc-ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcC-CC----chHHHHHHHH
Q 044022 1 MKFYGHEY-HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFG-AP----LPRLKIASDI 74 (241)
Q Consensus 1 iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~----~~~~~~~~~i 74 (241)
||++.... .......+.+|++++++++||||+++++++..++..++||||+.+ +|.+.+.. .. .....++.|+
T Consensus 32 vK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql 110 (292)
T 3o0g_A 32 LKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQL 110 (292)
T ss_dssp EEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHH
T ss_pred EEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHH
Confidence 35554333 223457789999999999999999999999999999999999975 66555433 21 2467899999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccC-CCcchhh
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV-LNEKSNV 153 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di 153 (241)
+.||.||| +.+++||||||+||+++.++.+||+|||.+......... .....+|+.|+|||++.+.. ++.++||
T Consensus 111 ~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di 185 (292)
T 3o0g_A 111 LKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDM 185 (292)
T ss_dssp HHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHH
T ss_pred HHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc--ccCCccccCCcChHHHcCCCCcCchHHH
Confidence 99999999 899999999999999999999999999999876533221 13346789999999998765 7999999
Q ss_pred HHHHHHHHHHHhcCccccc
Q 044022 154 FSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~ 172 (241)
||||+++|+|++|..||..
T Consensus 186 wslG~il~~l~~~~~p~~~ 204 (292)
T 3o0g_A 186 WSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp HHHHHHHHHHTTTSCCSCC
T ss_pred HHHHHHHHHHHHcCCCCcC
Confidence 9999999999999888644
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=260.74 Aligned_cols=218 Identities=23% Similarity=0.330 Sum_probs=160.4
Q ss_pred cHHHHHHHHHHHHh--cCCCcccceeeeeeeC----CcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhh
Q 044022 12 TYGSCINNITYAAQ--MSHNHILKRIGCCLQT----PIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLH 82 (241)
Q Consensus 12 ~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh 82 (241)
....+.+|.+++.. ++||||+++++++... ...++||||+++|+|.++++.... ....++.+++.||.|||
T Consensus 43 ~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH 122 (301)
T 3q4u_A 43 DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLH 122 (301)
T ss_dssp GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHH
T ss_pred cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHH
Confidence 45667778887777 7999999999987653 458999999999999999976644 46789999999999999
Q ss_pred cCC-----CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcce--eecccccCCCccCccccccc------CCCc
Q 044022 83 FGF-----PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI--TTDRVIGTRGYSAPEYISIC------VLNE 149 (241)
Q Consensus 83 ~~~-----~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~------~~~~ 149 (241)
... +.+++||||||+|||++.++.+||+|||++.......... ......||+.|+|||++.+. .++.
T Consensus 123 ~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 202 (301)
T 3q4u_A 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYK 202 (301)
T ss_dssp SCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHH
T ss_pred HhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCc
Confidence 322 5689999999999999999999999999997654433221 12334789999999999876 4557
Q ss_pred chhhHHHHHHHHHHHhc----------CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHH
Q 044022 150 KSNVFSFGAFLFELLAG----------RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLH 219 (241)
Q Consensus 150 ~~Di~s~G~~~~~~~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (241)
++||||||+++|+|++| ..||....... ...................+. .......+.
T Consensus 203 ~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~ 270 (301)
T 3q4u_A 203 RVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND----PSFEDMRKVVCVDQQRPNIPN--------RWFSDPTLT 270 (301)
T ss_dssp HHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS----CCHHHHHHHHTTSCCCCCCCG--------GGGGSHHHH
T ss_pred hhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC----cchhhhhHHHhccCCCCCCCh--------hhccCccHH
Confidence 99999999999999999 77775432211 111222222111111111111 111235667
Q ss_pred HHHHHHHHhccCCCCCCCCCCC
Q 044022 220 ASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 220 ~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.+.+++.+||+.||++|||++|
T Consensus 271 ~l~~li~~cl~~dP~~Rps~~~ 292 (301)
T 3q4u_A 271 SLAKLMKECWYQNPSARLTALR 292 (301)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhcChhhCCCHHH
Confidence 8999999999999999999853
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=265.14 Aligned_cols=200 Identities=20% Similarity=0.235 Sum_probs=161.6
Q ss_pred ccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.+.+|.+++..+ +||||+++++++...+..++||||+++|+|.+++.... .....++.+|+.||.|||
T Consensus 62 ~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--- 138 (353)
T 2i0e_A 62 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ--- 138 (353)
T ss_dssp TCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---
T ss_pred hHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 4567788999999988 89999999999999999999999999999999986532 256789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+.+|+||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++|+||||+++|+|++
T Consensus 139 ~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 216 (353)
T 2i0e_A 139 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 216 (353)
T ss_dssp HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHH
T ss_pred HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHc
Confidence 89999999999999999999999999999975432221 1234578999999999998899999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
|+.||... ...+......... . . .... .+..+.+++.+||..||++||++
T Consensus 217 G~~Pf~~~---------~~~~~~~~i~~~~-~-~-----~p~~--------~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 217 GQAPFEGE---------DEDELFQSIMEHN-V-A-----YPKS--------MSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp SSCSSCCS---------SHHHHHHHHHHCC-C-C-----CCTT--------SCHHHHHHHHHHTCSCTTSCTTC
T ss_pred CCCCCCCC---------CHHHHHHHHHhCC-C-C-----CCCC--------CCHHHHHHHHHHhhcCHHHcCCC
Confidence 99999642 1122222222211 1 1 1111 22578899999999999999976
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=279.33 Aligned_cols=202 Identities=21% Similarity=0.324 Sum_probs=159.9
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~ 84 (241)
...+.|.+|++++++++||||+++++++. .+..++||||+++|+|.+++.... ...+.++.|++.||.|||
T Consensus 225 ~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH-- 301 (454)
T 1qcf_A 225 MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-- 301 (454)
T ss_dssp BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH--
T ss_pred ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 35788999999999999999999999986 567899999999999999997531 146789999999999999
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
+++++||||||+|||++.++.+||+|||++........ .......++..|+|||++....++.++||||||+++|+|+
T Consensus 302 -~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~ 379 (454)
T 1qcf_A 302 -QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379 (454)
T ss_dssp -HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred -hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHH
Confidence 89999999999999999999999999999976543211 1112234577899999999889999999999999999999
Q ss_pred h-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 165 A-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 165 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
+ |+.||.... ..+...... .+.....+ . ..++.+.+++.+||+.||++|||++
T Consensus 380 t~g~~P~~~~~---------~~~~~~~i~-~~~~~~~~-----~--------~~~~~l~~li~~cl~~dp~~RPt~~ 433 (454)
T 1qcf_A 380 TYGRIPYPGMS---------NPEVIRALE-RGYRMPRP-----E--------NCPEELYNIMMRCWKNRPEERPTFE 433 (454)
T ss_dssp TTSCCSSTTCC---------HHHHHHHHH-HTCCCCCC-----T--------TSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hCCCCCCCCCC---------HHHHHHHHH-cCCCCCCC-----C--------CCCHHHHHHHHHHccCChhHCcCHH
Confidence 9 999995421 122222222 12111111 1 2236789999999999999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=258.44 Aligned_cols=213 Identities=21% Similarity=0.289 Sum_probs=159.6
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC-----C---chHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA-----P---LPRLKIAS 72 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----~---~~~~~~~~ 72 (241)
||.+..+......+.+.+|++++++++||||+++++++...+..++||||+++++|.+++... . .....++.
T Consensus 52 iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ 131 (285)
T 3is5_A 52 IKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131 (285)
T ss_dssp EEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHH
T ss_pred EEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHH
Confidence 355555555556788999999999999999999999999999999999999999999987432 1 14678999
Q ss_pred HHHHHhchhhcCCCCCceeccCCCCCeee---cCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCc
Q 044022 73 DIVNSLAYLHFGFPRPIVLRNFKTQNILF---NEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNE 149 (241)
Q Consensus 73 ~i~~~l~~lh~~~~~~ivh~dl~~~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 149 (241)
+++.||.||| +.+++||||||+||++ +.++.++|+|||.+........ .....+++.|+|||.+. ..++.
T Consensus 132 qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~ 204 (285)
T 3is5_A 132 QMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTF 204 (285)
T ss_dssp HHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCH
T ss_pred HHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc---CcCcccccCcCChHHhc-cCCCc
Confidence 9999999999 8999999999999999 4567899999999976543322 23346899999999886 56789
Q ss_pred chhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhc
Q 044022 150 KSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECV 229 (241)
Q Consensus 150 ~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 229 (241)
++||||||+++|+|++|+.||.... ..+............. ..... .++.+.+++.+||
T Consensus 205 ~~Di~slG~il~~ll~g~~pf~~~~---------~~~~~~~~~~~~~~~~----~~~~~--------~~~~~~~li~~~L 263 (285)
T 3is5_A 205 KCDIWSAGVVMYFLLTGCLPFTGTS---------LEEVQQKATYKEPNYA----VECRP--------LTPQAVDLLKQML 263 (285)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSS---------HHHHHHHHHHCCCCCC----C--CC--------CCHHHHHHHHHHT
T ss_pred ccCeehHHHHHHHHHhCCCCCCCCC---------HHHHHhhhccCCcccc----cccCc--------CCHHHHHHHHHHc
Confidence 9999999999999999999995421 1111111111110000 00001 1256889999999
Q ss_pred cCCCCCCCCCCC
Q 044022 230 NNSPEDRPTMVD 241 (241)
Q Consensus 230 ~~~p~~Rpt~~e 241 (241)
+.||++|||++|
T Consensus 264 ~~dP~~Rps~~e 275 (285)
T 3is5_A 264 TKDPERRPSAAQ 275 (285)
T ss_dssp CSCTTTSCCHHH
T ss_pred cCChhhCcCHHH
Confidence 999999999854
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=258.86 Aligned_cols=198 Identities=22% Similarity=0.333 Sum_probs=153.6
Q ss_pred HHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHHhchhhcCCCCC
Q 044022 14 GSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 14 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
+.+.+|++++++++||||+++++++.... ++||||+++++|.+++..... ....++.+++.||.||| +.+
T Consensus 68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~ 142 (287)
T 4f0f_A 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQN 142 (287)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSS
T ss_pred HHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCC
Confidence 78999999999999999999999986554 799999999999988854421 46789999999999999 888
Q ss_pred --ceeccCCCCCeeecCCCC-----eEEeeccCceecCCCCcceeecccccCCCccCccccc--ccCCCcchhhHHHHHH
Q 044022 89 --IVLRNFKTQNILFNEENV-----AKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS--ICVLNEKSNVFSFGAF 159 (241)
Q Consensus 89 --ivh~dl~~~nil~~~~~~-----~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Di~s~G~~ 159 (241)
++|+||||+||+++.++. ++|+|||.+...... .....+++.|+|||++. ...++.++||||||++
T Consensus 143 ~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~ 217 (287)
T 4f0f_A 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMI 217 (287)
T ss_dssp SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHH
T ss_pred CCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHH
Confidence 999999999999988776 999999998754332 23356899999999984 4567889999999999
Q ss_pred HHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 160 LFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 160 ~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
+|+|++|+.||...... .............. +..... .++.+.+++.+||+.||++|||+
T Consensus 218 l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~-----~~~~~~--------~~~~l~~li~~~l~~dp~~Rps~ 277 (287)
T 4f0f_A 218 LYTILTGEGPFDEYSYG-------KIKFINMIREEGLR-----PTIPED--------CPPRLRNVIELCWSGDPKKRPHF 277 (287)
T ss_dssp HHHHHHSSCTTTTCCCC-------HHHHHHHHHHSCCC-----CCCCTT--------SCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHcCCCCCcccccc-------HHHHHHHHhccCCC-----CCCCcc--------cCHHHHHHHHHHhcCChhhCcCH
Confidence 99999999999652111 11111111111111 111122 22578999999999999999998
Q ss_pred CC
Q 044022 240 VD 241 (241)
Q Consensus 240 ~e 241 (241)
+|
T Consensus 278 ~~ 279 (287)
T 4f0f_A 278 SY 279 (287)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=261.08 Aligned_cols=209 Identities=21% Similarity=0.333 Sum_probs=151.5
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.|.+|++++++++||||+++++++ ..+..++||||+++++|.+++..... ....++.+++.||.|||
T Consensus 62 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH--- 137 (289)
T 3og7_A 62 QQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH--- 137 (289)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---
T ss_pred HHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 4567799999999999999999999965 55668999999999999999865422 46789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc---ccCCCcchhhHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS---ICVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~s~G~~~~~ 162 (241)
+.+++||||||+||+++.++.++|+|||.+................|++.|+|||.+. +..++.++||||||+++|+
T Consensus 138 ~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~e 217 (289)
T 3og7_A 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYE 217 (289)
T ss_dssp HTTCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHH
T ss_pred hCCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHH
Confidence 8999999999999999999999999999987654332222223456899999999986 5677889999999999999
Q ss_pred HHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 163 LLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 163 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|++|+.||..... .+........+...... ..... ..+..+.+++.+||+.||++|||++|
T Consensus 218 l~~g~~p~~~~~~---------~~~~~~~~~~~~~~~~~-~~~~~--------~~~~~l~~li~~~l~~~p~~Rps~~e 278 (289)
T 3og7_A 218 LMTGQLPYSNINN---------RDQIIEMVGRGSLSPDL-SKVRS--------NCPKRMKRLMAECLKKKRDERPSFPR 278 (289)
T ss_dssp HHHSSCTTSSCCC---------HHHHHHHHHHTSCCCCT-TSSCT--------TSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHCCCCccccch---------HHHHHHHhcccccCcch-hhccc--------cCCHHHHHHHHHHccCChhhCCCHHH
Confidence 9999999965211 11122222222211111 11111 22367899999999999999999753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=262.99 Aligned_cols=212 Identities=20% Similarity=0.274 Sum_probs=160.5
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~~ 76 (241)
|.+.........+++.+|+.++++++||||+++++++.. +..++||||+++++|.+++.... . ....++.+++.
T Consensus 46 K~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~ 124 (281)
T 3cc6_A 46 KTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICK 124 (281)
T ss_dssp EECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHH
T ss_pred EecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHH
Confidence 455444444567789999999999999999999999865 45789999999999999986432 1 46788999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSF 156 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~ 156 (241)
||.||| +.+++|+||||+||+++.++.++|+|||.+......... ......+++.|+|||.+.+..++.++|||||
T Consensus 125 ~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 200 (281)
T 3cc6_A 125 AMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMF 200 (281)
T ss_dssp HHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHH
Confidence 999999 899999999999999999999999999998765443221 1123456778999999998899999999999
Q ss_pred HHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 157 GAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 157 G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
|+++|+|++ |+.||...... +....... ......+ . ..++.+.+++.+||+.||++
T Consensus 201 G~il~~llt~g~~p~~~~~~~---------~~~~~~~~-~~~~~~~-----~--------~~~~~l~~li~~~l~~~p~~ 257 (281)
T 3cc6_A 201 AVCMWEILSFGKQPFFWLENK---------DVIGVLEK-GDRLPKP-----D--------LCPPVLYTLMTRCWDYDPSD 257 (281)
T ss_dssp HHHHHHHHTTTCCTTTTSCGG---------GHHHHHHH-TCCCCCC-----T--------TCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHhCCCCCcccCChH---------HHHHHHhc-CCCCCCC-----C--------CCCHHHHHHHHHHccCCchh
Confidence 999999998 99999642211 11111111 1111111 1 12257889999999999999
Q ss_pred CCCCCC
Q 044022 236 RPTMVD 241 (241)
Q Consensus 236 Rpt~~e 241 (241)
|||++|
T Consensus 258 Rps~~e 263 (281)
T 3cc6_A 258 RPRFTE 263 (281)
T ss_dssp SCCHHH
T ss_pred CcCHHH
Confidence 999753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=259.34 Aligned_cols=156 Identities=22% Similarity=0.293 Sum_probs=131.6
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.+.+|++++++++||||+++++++...+..++||||+. ++|.+++.... .....++.|++.||.|||
T Consensus 42 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--- 117 (288)
T 1ob3_A 42 GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117 (288)
T ss_dssp CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---
Confidence 345778899999999999999999999999999999999997 59998886532 146789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~ 164 (241)
+.+++||||||+||+++.++.+||+|||.+......... .....+|+.|+|||++.+. .++.++||||||+++|+|+
T Consensus 118 ~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~ 195 (288)
T 1ob3_A 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195 (288)
T ss_dssp HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHH
T ss_pred HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHH
Confidence 899999999999999999999999999998765432211 1234679999999998764 5899999999999999999
Q ss_pred hcCccccc
Q 044022 165 AGRIHIWD 172 (241)
Q Consensus 165 ~g~~p~~~ 172 (241)
+|+.||..
T Consensus 196 ~g~~pf~~ 203 (288)
T 1ob3_A 196 NGTPLFPG 203 (288)
T ss_dssp HSSCSCCC
T ss_pred hCCCCCCC
Confidence 99999965
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=260.62 Aligned_cols=202 Identities=23% Similarity=0.361 Sum_probs=151.7
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-------hHHHHHHHHHHHhchhhcC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-------PRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------~~~~~~~~i~~~l~~lh~~ 84 (241)
..+.|.+|++++++++||||+++++++. +..++||||+++++|.+++..... ..+.++.+++.||.|||+.
T Consensus 44 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 121 (307)
T 2eva_A 44 ERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121 (307)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhC
Confidence 4577999999999999999999999986 458999999999999999976531 4578899999999999932
Q ss_pred CCCCceeccCCCCCeeecCCCC-eEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEENV-AKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~-~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
..++++||||||+||+++.++. +||+|||.+....... ....|++.|+|||++.+..++.++||||||+++|+|
T Consensus 122 ~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 196 (307)
T 2eva_A 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEV 196 (307)
T ss_dssp SSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHH
T ss_pred CCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHH
Confidence 2289999999999999998886 7999999987544321 233589999999999988999999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|+.||...... .......... +.. +...... +..+.+++.+||+.||++|||++|
T Consensus 197 ~~g~~p~~~~~~~-------~~~~~~~~~~-~~~-----~~~~~~~--------~~~l~~li~~~l~~dp~~Rps~~e 253 (307)
T 2eva_A 197 ITRRKPFDEIGGP-------AFRIMWAVHN-GTR-----PPLIKNL--------PKPIESLMTRCWSKDPSQRPSMEE 253 (307)
T ss_dssp HHTCCTTTTTCSS-------HHHHHHHHHT-TCC-----CCCBTTC--------CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHCCCCchhhCcc-------HHHHHHHHhc-CCC-----CCccccc--------CHHHHHHHHHHhcCChhhCcCHHH
Confidence 9999999642111 1111111111 111 1111222 256889999999999999999753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=273.61 Aligned_cols=207 Identities=17% Similarity=0.173 Sum_probs=162.0
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--Cc---hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--PL---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
....+.+|+.++..++||||++++++|...+..++||||+++|+|.+++... .. ....++.+++.||.||| +
T Consensus 117 ~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~ 193 (437)
T 4aw2_A 117 ETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---Q 193 (437)
T ss_dssp TTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 3445889999999999999999999999999999999999999999999763 22 46778999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc-----ccCCCcchhhHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS-----ICVLNEKSNVFSFGAFLF 161 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~s~G~~~~ 161 (241)
.+|+||||||+|||++.++.+||+|||++......... ......||+.|+|||++. ...++.++||||||+++|
T Consensus 194 ~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ 272 (437)
T 4aw2_A 194 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMY 272 (437)
T ss_dssp TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHH
T ss_pred CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHH
Confidence 99999999999999999999999999999776544332 223457999999999997 456899999999999999
Q ss_pred HHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC--CCCC
Q 044022 162 ELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED--RPTM 239 (241)
Q Consensus 162 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--Rpt~ 239 (241)
+|++|+.||... ...+..............+. .... .++.+.+|+.+||..+|++ ||++
T Consensus 273 elltG~~Pf~~~---------~~~~~~~~i~~~~~~~~~p~--~~~~--------~s~~~~dLi~~lL~~~~~r~~r~~~ 333 (437)
T 4aw2_A 273 EMLYGETPFYAE---------SLVETYGKIMNHKERFQFPT--QVTD--------VSENAKDLIRRLICSREHRLGQNGI 333 (437)
T ss_dssp HHHHSSCTTCCS---------SHHHHHHHHHTHHHHCCCCS--SCCC--------SCHHHHHHHHTTSSCGGGCTTTTTT
T ss_pred HHHhCCCCCCCC---------ChhHHHHhhhhccccccCCc--cccc--------CCHHHHHHHHHHhcccccccCCCCH
Confidence 999999999652 11222222221111111111 1111 2257889999999998888 9987
Q ss_pred CC
Q 044022 240 VD 241 (241)
Q Consensus 240 ~e 241 (241)
+|
T Consensus 334 ~e 335 (437)
T 4aw2_A 334 ED 335 (437)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=262.65 Aligned_cols=214 Identities=21% Similarity=0.279 Sum_probs=159.9
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeee-eCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCL-QTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIV 75 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~ 75 (241)
|.+.........+++.+|+.++++++||||+++++++. .++..++||||+++++|.+++..... ....++.+++
T Consensus 59 k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~ 138 (298)
T 3f66_A 59 KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 138 (298)
T ss_dssp EEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHH
T ss_pred EecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHH
Confidence 44444334445678999999999999999999999865 45678999999999999999965421 4678899999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCc--ceeecccccCCCccCcccccccCCCcchhh
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET--HITTDRVIGTRGYSAPEYISICVLNEKSNV 153 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 153 (241)
.||.||| +.+++||||||+||+++.++.++|+|||.+........ ........+|+.|+|||.+.+..++.++||
T Consensus 139 ~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 215 (298)
T 3f66_A 139 KGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDV 215 (298)
T ss_dssp HHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHH
T ss_pred HHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHH
Confidence 9999999 89999999999999999999999999999976543321 112233456788999999998899999999
Q ss_pred HHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCC
Q 044022 154 FSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNS 232 (241)
Q Consensus 154 ~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~ 232 (241)
||||+++|++++ |.+||...... +...... ..... ..... .+..+.+++.+||+.|
T Consensus 216 ~slG~il~~l~~~~~~~~~~~~~~---------~~~~~~~-~~~~~-----~~~~~--------~~~~l~~li~~~l~~~ 272 (298)
T 3f66_A 216 WSFGVLLWELMTRGAPPYPDVNTF---------DITVYLL-QGRRL-----LQPEY--------CPDPLYEVMLKCWHPK 272 (298)
T ss_dssp HHHHHHHHHHHTTSCCSSTTSCTT---------THHHHHH-TTCCC-----CCCTT--------CCHHHHHHHHHHTCSS
T ss_pred HHHHHHHHHHHhCCCCCCccCCHH---------HHHHHHh-cCCCC-----CCCcc--------CCHHHHHHHHHHcCCC
Confidence 999999999999 55565432111 1111111 11110 01111 1256889999999999
Q ss_pred CCCCCCCCC
Q 044022 233 PEDRPTMVD 241 (241)
Q Consensus 233 p~~Rpt~~e 241 (241)
|++|||++|
T Consensus 273 p~~Rps~~e 281 (298)
T 3f66_A 273 AEMRPSFSE 281 (298)
T ss_dssp GGGSCCHHH
T ss_pred hhhCcCHHH
Confidence 999999753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=259.36 Aligned_cols=208 Identities=19% Similarity=0.273 Sum_probs=161.1
Q ss_pred ccccccc-ccccHHHHHHHHHHHHhcCCCcccceeeeeeeC--CcceEEEEecCCCCHHHhhcCCCc------hHHHHHH
Q 044022 2 KFYGHEY-HRHTYGSCINNITYAAQMSHNHILKRIGCCLQT--PIPILVFQSVEYGTLRDCIFGAPL------PRLKIAS 72 (241)
Q Consensus 2 K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~ 72 (241)
|++.... .....+.|.+|+.++++++||||+++++++... +..++||||+++|+|.+++..... .+..++.
T Consensus 39 K~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ 118 (271)
T 3kmu_A 39 KVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118 (271)
T ss_dssp EEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHH
T ss_pred EEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHH
Confidence 4554332 234567799999999999999999999999876 788999999999999999976531 4678999
Q ss_pred HHHHHhchhhcCCCCC--ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCc-
Q 044022 73 DIVNSLAYLHFGFPRP--IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNE- 149 (241)
Q Consensus 73 ~i~~~l~~lh~~~~~~--ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~- 149 (241)
+++.||.||| +.+ ++|+||||+||+++.++.++++|||++..... ....+|+.|+|||.+.+...+.
T Consensus 119 qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~ 188 (271)
T 3kmu_A 119 DMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTN 188 (271)
T ss_dssp HHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSC
T ss_pred HHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeecc-------cCccCCccccChhhhccCCCCCC
Confidence 9999999999 888 99999999999999999999999888754322 2246789999999998765444
Q ss_pred --chhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHH
Q 044022 150 --KSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLE 227 (241)
Q Consensus 150 --~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 227 (241)
++||||||+++|+|++|+.||.... ..+............ ..... .+..+.+++.+
T Consensus 189 ~~~~Di~slG~il~el~~g~~p~~~~~---------~~~~~~~~~~~~~~~-----~~~~~--------~~~~~~~li~~ 246 (271)
T 3kmu_A 189 RRSADMWSFAVLLWELVTREVPFADLS---------NMEIGMKVALEGLRP-----TIPPG--------ISPHVSKLMKI 246 (271)
T ss_dssp HHHHHHHHHHHHHHHHHHCSCTTTTSC---------HHHHHHHHHHSCCCC-----CCCTT--------CCHHHHHHHHH
T ss_pred CchhhHHHHHHHHHHHHhCCCCccccC---------hHHHHHHHHhcCCCC-----CCCCC--------CCHHHHHHHHH
Confidence 7999999999999999999996421 112222222222111 11112 22578999999
Q ss_pred hccCCCCCCCCCCC
Q 044022 228 CVNNSPEDRPTMVD 241 (241)
Q Consensus 228 cl~~~p~~Rpt~~e 241 (241)
||+.||++|||++|
T Consensus 247 ~l~~~p~~Rps~~~ 260 (271)
T 3kmu_A 247 CMNEDPAKRPKFDM 260 (271)
T ss_dssp HTCSSGGGSCCHHH
T ss_pred HcCCChhhCcCHHH
Confidence 99999999999853
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=267.44 Aligned_cols=204 Identities=24% Similarity=0.297 Sum_probs=147.6
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
.+.+.+|++++++++||||+++++++...+..++||||+++++|.+++..... ....++.|++.||.||| +.+
T Consensus 92 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ 168 (349)
T 2w4o_A 92 KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH---ENG 168 (349)
T ss_dssp -------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence 45688999999999999999999999999999999999999999999876532 46789999999999999 899
Q ss_pred ceeccCCCCCeeecC---CCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 89 IVLRNFKTQNILFNE---ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 89 ivh~dl~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
++||||||+||+++. ++.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++
T Consensus 169 ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 245 (349)
T 2w4o_A 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLC 245 (349)
T ss_dssp CCCCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred eEecCCCcccEEEecCCCCCCEEEccCccccccCcccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHh
Confidence 999999999999975 88999999999876543221 133468999999999998899999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|..||...... ........... .. ... .... ..+..+.+|+.+||+.||++|||++|
T Consensus 246 g~~pf~~~~~~--------~~~~~~i~~~~-~~-~~~-~~~~--------~~~~~~~~li~~~L~~dP~~Rpt~~e 302 (349)
T 2w4o_A 246 GFEPFYDERGD--------QFMFRRILNCE-YY-FIS-PWWD--------EVSLNAKDLVRKLIVLDPKKRLTTFQ 302 (349)
T ss_dssp SSCTTCCTTCH--------HHHHHHHHTTC-CC-CCT-TTTT--------TSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred CCCCCCCCccc--------HHHHHHHHhCC-Cc-cCC-chhh--------hCCHHHHHHHHHHccCChhhCcCHHH
Confidence 99999652111 11111111111 10 011 1111 22357889999999999999999753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=261.77 Aligned_cols=213 Identities=22% Similarity=0.296 Sum_probs=162.2
Q ss_pred cccccccc-cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHH
Q 044022 2 KFYGHEYH-RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~ 76 (241)
|++..... ....+++.+|++++++++||||+++++++ ..+..++||||+++++|.+++..... ....++.+++.
T Consensus 50 K~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~ 128 (291)
T 1xbb_A 50 KILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 128 (291)
T ss_dssp EEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHH
T ss_pred EeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHH
Confidence 44443322 23367899999999999999999999999 66778999999999999999875432 46789999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcce-eecccccCCCccCcccccccCCCcchhhHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI-TTDRVIGTRGYSAPEYISICVLNEKSNVFS 155 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 155 (241)
||.||| +.+++|+||||+||+++.++.++|+|||.+.......... ......+++.|+|||.+.+..++.++||||
T Consensus 129 ~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 205 (291)
T 1xbb_A 129 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWS 205 (291)
T ss_dssp HHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHH
T ss_pred HHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHH
Confidence 999999 8999999999999999999999999999998765443221 122234568899999998888899999999
Q ss_pred HHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 156 FGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 156 ~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
||+++|+|++ |..||..... .+.... ...+.... ... ..+..+.+++.+||+.||+
T Consensus 206 lG~il~~l~~~g~~p~~~~~~---------~~~~~~-~~~~~~~~-----~~~--------~~~~~l~~li~~~l~~dp~ 262 (291)
T 1xbb_A 206 FGVLMWEAFSYGQKPYRGMKG---------SEVTAM-LEKGERMG-----CPA--------GCPREMYDLMNLCWTYDVE 262 (291)
T ss_dssp HHHHHHHHHTTTCCSSTTCCH---------HHHHHH-HHTTCCCC-----CCT--------TCCHHHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHhcCCCCCCCCCH---------HHHHHH-HHcCCCCC-----CCC--------CCCHHHHHHHHHHcCCChh
Confidence 9999999999 9999965211 111111 11121111 111 1226789999999999999
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
+|||+.|
T Consensus 263 ~Rps~~~ 269 (291)
T 1xbb_A 263 NRPGFAA 269 (291)
T ss_dssp TSCCHHH
T ss_pred hCcCHHH
Confidence 9999753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=266.12 Aligned_cols=194 Identities=22% Similarity=0.271 Sum_probs=159.1
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCC-CHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYG-TLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+.+.+|++++++++||||+++++++...+..++||||+.+| +|.+++..... .+..++.+++.||.||| +
T Consensus 72 ~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~ 148 (335)
T 3dls_A 72 KLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR---L 148 (335)
T ss_dssp TTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 4456788999999999999999999999999999999998766 99999876532 46789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCC-CcchhhHHHHHHHHHHHh
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVL-NEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~s~G~~~~~~~~ 165 (241)
.+++||||||+|||++.++.+||+|||.+......... ....||+.|+|||++.+..+ +.++||||||+++|+|++
T Consensus 149 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 225 (335)
T 3dls_A 149 KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225 (335)
T ss_dssp TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEeccCHHHEEEcCCCcEEEeecccceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHh
Confidence 99999999999999999999999999999876554322 23468999999999988776 789999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|..||....... .. .... .. ..+..+.+++.+||+.||++|||++|
T Consensus 226 g~~pf~~~~~~~----------------~~---~~~~---~~--------~~~~~l~~li~~~L~~dP~~Rps~~e 271 (335)
T 3dls_A 226 EENPFCELEETV----------------EA---AIHP---PY--------LVSKELMSLVSGLLQPVPERRTTLEK 271 (335)
T ss_dssp SSCSCSSGGGGT----------------TT---CCCC---SS--------CCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCchhhHHHHH----------------hh---ccCC---Cc--------ccCHHHHHHHHHHccCChhhCcCHHH
Confidence 999996521110 00 0000 00 11257899999999999999999853
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=266.33 Aligned_cols=205 Identities=18% Similarity=0.295 Sum_probs=152.6
Q ss_pred ccHHHHHHHHHHHHhcCC--CcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcC
Q 044022 11 HTYGSCINNITYAAQMSH--NHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~ 84 (241)
...+.+.+|+.++++++| +||+++++++...+..++|||+ .+++|.+++..... .+..++.+++.||.|||
T Consensus 49 ~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH-- 125 (343)
T 3dbq_A 49 QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH-- 125 (343)
T ss_dssp HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHH--
T ss_pred HHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 455788999999999976 9999999999999999999995 57899999865432 56789999999999999
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-----------cCCCcchhh
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-----------CVLNEKSNV 153 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~Di 153 (241)
+.+++||||||+|||++ ++.+||+|||++................||+.|+|||++.+ ..++.++||
T Consensus 126 -~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di 203 (343)
T 3dbq_A 126 -QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 203 (343)
T ss_dssp -HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHH
T ss_pred -hCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhH
Confidence 89999999999999997 67899999999987654433333345579999999999865 568889999
Q ss_pred HHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 154 FSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
||||+++|+|++|+.||..... .. ............. ...... +..+.+++.+||+.||
T Consensus 204 wslG~il~ell~g~~pf~~~~~-------~~-~~~~~~~~~~~~~-----~~~~~~--------~~~l~~li~~~L~~dp 262 (343)
T 3dbq_A 204 WSLGCILYYMTYGKTPFQQIIN-------QI-SKLHAIIDPNHEI-----EFPDIP--------EKDLQDVLKCCLKRDP 262 (343)
T ss_dssp HHHHHHHHHHHHSSCTTTTCCS-------HH-HHHHHHHCTTSCC-----CCCCCS--------CHHHHHHHHHHTCSST
T ss_pred HHHHHHHHHHHhCCCcchhhhh-------HH-HHHHHHhcCCccc-----CCcccC--------CHHHHHHHHHHcCCCh
Confidence 9999999999999999964211 11 1111111111111 111111 1468899999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|||++|
T Consensus 263 ~~Rpt~~e 270 (343)
T 3dbq_A 263 KQRISIPE 270 (343)
T ss_dssp TTSCCHHH
T ss_pred hHCCCHHH
Confidence 99999853
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=277.97 Aligned_cols=201 Identities=23% Similarity=0.293 Sum_probs=154.9
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC-----C-chHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA-----P-LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----~-~~~~~~~~~i~~~l~~lh~~~ 85 (241)
..+.|.+|++++++++||||+++++++.. +..++||||+++|+|.+++... . ...+.++.|++.||.|||
T Consensus 222 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH--- 297 (452)
T 1fmk_A 222 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--- 297 (452)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---
T ss_pred CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 46789999999999999999999999876 6789999999999999999742 1 246789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+++++||||||+|||++.++.+||+|||++........ .......++..|+|||.+....++.++||||||+++|+|++
T Consensus 298 ~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t 376 (452)
T 1fmk_A 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376 (452)
T ss_dssp HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHh
Confidence 89999999999999999999999999999976543221 11122346778999999998899999999999999999999
Q ss_pred -cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 166 -GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 166 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
|+.||.... ..+...... .+..... .. ..++.+.+++.+||+.||++|||++
T Consensus 377 ~g~~P~~~~~---------~~~~~~~i~-~~~~~~~-----~~--------~~~~~l~~li~~cl~~dP~~Rpt~~ 429 (452)
T 1fmk_A 377 KGRVPYPGMV---------NREVLDQVE-RGYRMPC-----PP--------ECPESLHDLMCQCWRKEPEERPTFE 429 (452)
T ss_dssp TTCCSSTTCC---------HHHHHHHHH-TTCCCCC-----CT--------TSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCCCCC---------HHHHHHHHH-cCCCCCC-----CC--------CCCHHHHHHHHHHccCChhhCcCHH
Confidence 999995421 122222221 2211111 11 2236788999999999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=269.71 Aligned_cols=217 Identities=22% Similarity=0.288 Sum_probs=157.7
Q ss_pred Ccccccccc--cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcc----eEEEEecCCCCHHHhhcCCC----chHHHH
Q 044022 1 MKFYGHEYH--RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIP----ILVFQSVEYGTLRDCIFGAP----LPRLKI 70 (241)
Q Consensus 1 iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~----~lv~e~~~~~sL~~~l~~~~----~~~~~~ 70 (241)
||++..+.. ......+.+|++++++++||||+++++++...... ++||||+++++|.+++.... .....+
T Consensus 42 vK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~ 121 (311)
T 3ork_A 42 VKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121 (311)
T ss_dssp EEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHH
T ss_pred EEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHH
Confidence 355544332 23456789999999999999999999999876544 99999999999999986432 246789
Q ss_pred HHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-eeecccccCCCccCcccccccCCCc
Q 044022 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-ITTDRVIGTRGYSAPEYISICVLNE 149 (241)
Q Consensus 71 ~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~ 149 (241)
+.|++.||.||| +.+++||||||+||+++.++.+||+|||.+......... .......|++.|+|||++.+..++.
T Consensus 122 ~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 198 (311)
T 3ork_A 122 IADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDA 198 (311)
T ss_dssp HHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCH
T ss_pred HHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCc
Confidence 999999999999 899999999999999999999999999999765443211 1223356899999999999889999
Q ss_pred chhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhc
Q 044022 150 KSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECV 229 (241)
Q Consensus 150 ~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 229 (241)
++||||||+++|+|++|+.||.... ..+.......... ........ ..+..+.+++.+||
T Consensus 199 ~~Di~slG~~l~~ll~g~~pf~~~~---------~~~~~~~~~~~~~---~~~~~~~~--------~~~~~l~~li~~~l 258 (311)
T 3ork_A 199 RSDVYSLGCVLYEVLTGEPPFTGDS---------PVSVAYQHVREDP---IPPSARHE--------GLSADLDAVVLKAL 258 (311)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSS---------HHHHHHHHHHCCC---CCHHHHST--------TCCHHHHHHHHHHT
T ss_pred hHhHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHHhcCCC---CCcccccC--------CCCHHHHHHHHHHH
Confidence 9999999999999999999995421 1111122111111 01000011 12367889999999
Q ss_pred cCCCCCCCCCC
Q 044022 230 NNSPEDRPTMV 240 (241)
Q Consensus 230 ~~~p~~Rpt~~ 240 (241)
+.||++||++.
T Consensus 259 ~~dP~~R~~~~ 269 (311)
T 3ork_A 259 AKNPENRYQTA 269 (311)
T ss_dssp CSSGGGSCSSH
T ss_pred hcCHhhChhhH
Confidence 99999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=259.25 Aligned_cols=203 Identities=18% Similarity=0.305 Sum_probs=160.7
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--C---chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--P---LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~---~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+++.+|++++++++||||+++++++...+..++||||+++++|.+++... . .....++.+++.||.||| +
T Consensus 62 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~ 138 (283)
T 3gen_A 62 SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---S 138 (283)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 4577999999999999999999999999999999999999999999998662 1 256789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh-
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA- 165 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~- 165 (241)
.+++|+||||+||+++.++.++|+|||.+......... ......+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 139 ~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~ 217 (283)
T 3gen_A 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL 217 (283)
T ss_dssp TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTT
T ss_pred CCccCCCCccceEEEcCCCCEEEccccccccccccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999998765432111 1122345678999999998899999999999999999998
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|+.||.... ..+....... .... .. .. ..++.+.+++.+||+.||++|||++|
T Consensus 218 g~~p~~~~~---------~~~~~~~~~~-~~~~--~~---~~--------~~~~~l~~li~~~l~~~p~~Rps~~~ 270 (283)
T 3gen_A 218 GKMPYERFT---------NSETAEHIAQ-GLRL--YR---PH--------LASEKVYTIMYSCWHEKADERPTFKI 270 (283)
T ss_dssp TCCTTTTSC---------HHHHHHHHHT-TCCC--CC---CT--------TCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred CCCCccccC---------hhHHHHHHhc-ccCC--CC---CC--------cCCHHHHHHHHHHccCChhHCcCHHH
Confidence 999996521 1112222111 1100 01 11 11257889999999999999999753
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=266.04 Aligned_cols=215 Identities=20% Similarity=0.256 Sum_probs=164.2
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--------c---hHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--------L---PRLK 69 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------~---~~~~ 69 (241)
||.+..........++.+|+.++++++||||+++++++...+..++||||+++++|.+++.... . ..+.
T Consensus 65 vK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ 144 (327)
T 2yfx_A 65 VKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144 (327)
T ss_dssp EEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHH
T ss_pred EEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHH
Confidence 3555444444566789999999999999999999999999999999999999999999986542 1 3678
Q ss_pred HHHHHHHHhchhhcCCCCCceeccCCCCCeeecC---CCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccC
Q 044022 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNE---ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV 146 (241)
Q Consensus 70 ~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 146 (241)
++.+++.||.||| +.+++||||||+||+++. ...++|+|||.+................+++.|+|||.+.+..
T Consensus 145 i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 221 (327)
T 2yfx_A 145 VARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI 221 (327)
T ss_dssp HHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCC
Confidence 9999999999999 899999999999999984 4569999999987543332222223456788999999998889
Q ss_pred CCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHH
Q 044022 147 LNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLT 225 (241)
Q Consensus 147 ~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 225 (241)
++.++||||||+++|+|++ |..||.... ..+......... ... ... ..+..+.+++
T Consensus 222 ~~~~~Di~slG~il~ellt~g~~p~~~~~---------~~~~~~~~~~~~-~~~-----~~~--------~~~~~l~~li 278 (327)
T 2yfx_A 222 FTSKTDTWSFGVLLWEIFSLGYMPYPSKS---------NQEVLEFVTSGG-RMD-----PPK--------NCPGPVYRIM 278 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCC---------HHHHHHHHHTTC-CCC-----CCT--------TCCHHHHHHH
T ss_pred CCchhhHHHHHHHHHHHHcCCCCCCCCcC---------HHHHHHHHhcCC-CCC-----CCC--------CCCHHHHHHH
Confidence 9999999999999999998 999985421 112222221111 111 111 1225788999
Q ss_pred HHhccCCCCCCCCCCC
Q 044022 226 LECVNNSPEDRPTMVD 241 (241)
Q Consensus 226 ~~cl~~~p~~Rpt~~e 241 (241)
.+||+.||++|||++|
T Consensus 279 ~~~l~~dp~~Rps~~~ 294 (327)
T 2yfx_A 279 TQCWQHQPEDRPNFAI 294 (327)
T ss_dssp HHHTCSSGGGSCCHHH
T ss_pred HHHhcCChhhCcCHHH
Confidence 9999999999999753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=257.96 Aligned_cols=203 Identities=20% Similarity=0.276 Sum_probs=160.7
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|++++++++||||+++++++...+..++||||+++++|.+++.... .....++.+++.||.||| +
T Consensus 48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~ 124 (277)
T 3f3z_A 48 EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH---K 124 (277)
T ss_dssp SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 456789999999999999999999999999999999999999999999875432 256789999999999999 8
Q ss_pred CCceeccCCCCCeee---cCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILF---NEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 87 ~~ivh~dl~~~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
.+++|+||||+||++ +.++.++|+|||.+......... ....+++.|+|||.+.+ .++.++||||||+++|+|
T Consensus 125 ~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l 200 (277)
T 3f3z_A 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVL 200 (277)
T ss_dssp TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB---CCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHH
T ss_pred CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch---hccCCCCCccChHHhcc-cCCchhhehhHHHHHHHH
Confidence 999999999999999 78899999999999876543322 33468999999999875 489999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
++|+.||.... ..+....... +.. ..+. ......++.+.+++.+||+.||++|||+.
T Consensus 201 ~~g~~p~~~~~---------~~~~~~~~~~-~~~-~~~~---------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ 257 (277)
T 3f3z_A 201 LCGYPPFSAPT---------DSEVMLKIRE-GTF-TFPE---------KDWLNVSPQAESLIRRLLTKSPKQRITSL 257 (277)
T ss_dssp HHSSCSSCCSS---------HHHHHHHHHH-CCC-CCCH---------HHHTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHCCCCCCCCC---------HHHHHHHHHh-CCC-CCCc---------hhhhcCCHHHHHHHHHHccCChhhCcCHH
Confidence 99999995521 1111222111 111 0000 00012236789999999999999999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=261.13 Aligned_cols=215 Identities=19% Similarity=0.212 Sum_probs=162.0
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcc-eEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIP-ILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIV 75 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~ 75 (241)
|.+.........+.+.+|++++++++||||+++++++...+.. ++|+||+.+++|.+++..... ....++.+++
T Consensus 55 K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~ 134 (298)
T 3pls_A 55 KSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVA 134 (298)
T ss_dssp EEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHH
T ss_pred eeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHH
Confidence 4444433444567899999999999999999999999866654 999999999999999976321 4678999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCc--ceeecccccCCCccCcccccccCCCcchhh
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET--HITTDRVIGTRGYSAPEYISICVLNEKSNV 153 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 153 (241)
.||.||| +.+++||||||+||+++.++.++|+|||.+........ ........+++.|+|||.+.+..++.++||
T Consensus 135 ~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 211 (298)
T 3pls_A 135 RGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDV 211 (298)
T ss_dssp HHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHH
T ss_pred HHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhch
Confidence 9999999 89999999999999999999999999999975543221 112233457788999999999899999999
Q ss_pred HHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 154 FSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
||||+++|+|++|..|+...... .+.... ......... .. ..+..+.+++.+||+.||
T Consensus 212 ~slG~il~~l~~g~~~~~~~~~~--------~~~~~~-~~~~~~~~~-----~~--------~~~~~l~~li~~~l~~~p 269 (298)
T 3pls_A 212 WSFGVLLWELLTRGAPPYRHIDP--------FDLTHF-LAQGRRLPQ-----PE--------YCPDSLYQVMQQCWEADP 269 (298)
T ss_dssp HHHHHHHHHHHHTSCCTTTTSCG--------GGHHHH-HHTTCCCCC-----CT--------TCCHHHHHHHHHHTCSSG
T ss_pred hhHHHHHHHHhhCCCCCCccCCH--------HHHHHH-hhcCCCCCC-----Cc--------cchHHHHHHHHHHccCCh
Confidence 99999999999966554331111 111111 111111111 11 122578899999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|||++|
T Consensus 270 ~~Rps~~~ 277 (298)
T 3pls_A 270 AVRPTFRV 277 (298)
T ss_dssp GGSCCHHH
T ss_pred hhCcCHHH
Confidence 99999753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=268.55 Aligned_cols=215 Identities=18% Similarity=0.292 Sum_probs=157.9
Q ss_pred Cccccccc-ccccHHHHHHHHHHHHhcC--CCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHH
Q 044022 1 MKFYGHEY-HRHTYGSCINNITYAAQMS--HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASD 73 (241)
Q Consensus 1 iK~~~~~~-~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~ 73 (241)
||++..+. .....+.+.+|++++++++ ||||+++++++...+..++||| +.+++|.+++..... .+..++.|
T Consensus 85 iK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~q 163 (390)
T 2zmd_A 85 IKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKN 163 (390)
T ss_dssp EEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHH
T ss_pred EEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHH
Confidence 35544322 3345678999999999996 5999999999999999999999 557899999865432 46789999
Q ss_pred HHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc---------
Q 044022 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI--------- 144 (241)
Q Consensus 74 i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------- 144 (241)
|+.||.||| +.+|+||||||+|||++ ++.+||+|||++................||+.|+|||++.+
T Consensus 164 i~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 239 (390)
T 2zmd_A 164 MLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGK 239 (390)
T ss_dssp HHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC--------
T ss_pred HHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccc
Confidence 999999999 99999999999999995 58999999999986654433222345579999999999865
Q ss_pred --cCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHH
Q 044022 145 --CVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASA 222 (241)
Q Consensus 145 --~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (241)
..++.++||||||+++|+|++|+.||..... ................. ... .+..+.
T Consensus 240 ~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------~~~~~~~~~~~~~~~~~-----~~~--------~~~~~~ 298 (390)
T 2zmd_A 240 SKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--------QISKLHAIIDPNHEIEF-----PDI--------PEKDLQ 298 (390)
T ss_dssp ----CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------HHHHHHHHHCTTSCCCC-----CCC--------SCHHHH
T ss_pred cccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--------HHHHHHHHhCccccCCC-----Ccc--------chHHHH
Confidence 3688899999999999999999999964211 11111111111111111 111 125688
Q ss_pred HHHHHhccCCCCCCCCCCC
Q 044022 223 QLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 223 ~l~~~cl~~~p~~Rpt~~e 241 (241)
+|+.+||+.||++|||++|
T Consensus 299 ~li~~~L~~dP~~Rps~~e 317 (390)
T 2zmd_A 299 DVLKCCLKRDPKQRISIPE 317 (390)
T ss_dssp HHHHHHTCSSTTTSCCHHH
T ss_pred HHHHHHcccChhhCCCHHH
Confidence 9999999999999999753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=274.26 Aligned_cols=165 Identities=18% Similarity=0.214 Sum_probs=132.0
Q ss_pred Cccccccc-ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCC------cceEEEEecCCCCHHHhhcCCCc--hHHHHH
Q 044022 1 MKFYGHEY-HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTP------IPILVFQSVEYGTLRDCIFGAPL--PRLKIA 71 (241)
Q Consensus 1 iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~ 71 (241)
||++.... .....+++.+|+.+++.++||||+++++++...+ ..++||||+.+ +|.+.+..... ....++
T Consensus 92 iK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~~l~~~~~~~~~ 170 (464)
T 3ttj_A 92 IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLL 170 (464)
T ss_dssp EEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTSCCCHHHHHHHH
T ss_pred EEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhhcCCHHHHHHHH
Confidence 35444332 2345677899999999999999999999997554 46999999975 57666654322 467799
Q ss_pred HHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcch
Q 044022 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKS 151 (241)
Q Consensus 72 ~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 151 (241)
.|++.||.||| +.+|+||||||+|||++.++.+||+|||++........ .....||+.|+|||++.+..++.++
T Consensus 171 ~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~ 244 (464)
T 3ttj_A 171 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENV 244 (464)
T ss_dssp HHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CCC---C----CCCTTCCHHHHTTCCCCTTH
T ss_pred HHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcc---cCCCcccccccCHHHHcCCCCCHHH
Confidence 99999999999 89999999999999999999999999999976544321 2335789999999999999999999
Q ss_pred hhHHHHHHHHHHHhcCccccc
Q 044022 152 NVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 152 Di~s~G~~~~~~~~g~~p~~~ 172 (241)
|||||||++|+|++|+.||..
T Consensus 245 DiwSlG~il~ell~g~~pF~g 265 (464)
T 3ttj_A 245 DIWSVGCIMGEMVRHKILFPG 265 (464)
T ss_dssp HHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999954
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=274.48 Aligned_cols=205 Identities=21% Similarity=0.292 Sum_probs=163.9
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----c---hHHHHHHHHHHHhchhh
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----L---PRLKIASDIVNSLAYLH 82 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~---~~~~~~~~i~~~l~~lh 82 (241)
.....+.+|++++++++||||+++++++......|+||||++||+|.+++.... . ....++.||+.||.|||
T Consensus 227 ~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH 306 (543)
T 3c4z_A 227 KGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306 (543)
T ss_dssp TCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999999999999999999999999886532 1 45678999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~ 162 (241)
+++|+||||||+|||++.++.+||+|||++......... .....||+.|+|||++.+..++.++|+||||+++|+
T Consensus 307 ---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilye 381 (543)
T 3c4z_A 307 ---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYE 381 (543)
T ss_dssp ---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred ---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHH
Confidence 899999999999999999999999999999876544321 133479999999999999899999999999999999
Q ss_pred HHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 163 LLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 163 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
|++|+.||...... ....+......... . . ... ..+..+.+++.+||+.||++||++.
T Consensus 382 lltG~~PF~~~~~~-----~~~~~~~~~i~~~~-~-~-----~p~--------~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 382 MIAARGPFRARGEK-----VENKELKQRVLEQA-V-T-----YPD--------KFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp HHHSSCSSCCTTCC-----CCHHHHHHHHHHCC-C-C-----CCT--------TSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred HHhCCCCCCCCccc-----hhHHHHHHHHhhcc-c-C-----CCc--------ccCHHHHHHHHHhccCCHhHCCCCc
Confidence 99999999652111 11122222221111 0 1 111 1225788999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=267.80 Aligned_cols=198 Identities=22% Similarity=0.346 Sum_probs=156.6
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--C---chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--P---LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~---~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+++.+|++++++++||||+++++++...+..++||||+. |+|.+++... . ..+..++.+++.||.||| +
T Consensus 97 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~ 172 (348)
T 1u5q_A 97 KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---S 172 (348)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 45678999999999999999999999999999999999997 6888877422 2 246789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc---ccCCCcchhhHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS---ICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~s~G~~~~~~ 163 (241)
.+++||||||+|||++.++.+||+|||++...... ....||+.|+|||++. ...++.++||||||+++|+|
T Consensus 173 ~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~el 246 (348)
T 1u5q_A 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246 (348)
T ss_dssp TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHH
T ss_pred CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999999999999999999998765432 2346899999999985 45788999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|+.||.... ..+.......... ... ... ..++.+.+++.+||+.||++|||++|
T Consensus 247 l~g~~p~~~~~---------~~~~~~~~~~~~~-~~~----~~~--------~~~~~l~~li~~~l~~dP~~Rps~~~ 302 (348)
T 1u5q_A 247 AERKPPLFNMN---------AMSALYHIAQNES-PAL----QSG--------HWSEYFRNFVDSCLQKIPQDRPTSEV 302 (348)
T ss_dssp HHSSCTTTTSC---------HHHHHHHHHHSCC-CCC----CCT--------TSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HhCCCCCCCCC---------hHHHHHHHHhcCC-CCC----CCC--------CCCHHHHHHHHHHcccChhhCcCHHH
Confidence 99999995421 1111222211111 010 011 12256889999999999999999853
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=277.32 Aligned_cols=198 Identities=17% Similarity=0.226 Sum_probs=150.0
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
.....+.+|++++++++||||+++++++...+..++||||+++|+|.+++.... .....++.|++.||.||| +
T Consensus 190 ~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~ 266 (446)
T 4ejn_A 190 DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH---S 266 (446)
T ss_dssp -----------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh---h
Confidence 445678899999999999999999999999999999999999999999886532 246778999999999999 7
Q ss_pred -CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 87 -RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 87 -~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
.+|+||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++
T Consensus 267 ~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 344 (446)
T 4ejn_A 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 344 (446)
T ss_dssp HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH
T ss_pred cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhh
Confidence 8999999999999999999999999999875433221 2234578999999999999999999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
|+.||.... ..+......... . . .... .+..+.+|+.+||+.||++||
T Consensus 345 g~~Pf~~~~---------~~~~~~~i~~~~-~-~-----~p~~--------~~~~~~~li~~~L~~dP~~R~ 392 (446)
T 4ejn_A 345 GRLPFYNQD---------HEKLFELILMEE-I-R-----FPRT--------LGPEAKSLLSGLLKKDPKQRL 392 (446)
T ss_dssp SSCSSCCSS---------HHHHHHHHHHCC-C-C-----CCTT--------SCHHHHHHHHHHTCSSTTTST
T ss_pred CCCCCCCCC---------HHHHHHHHHhCC-C-C-----CCcc--------CCHHHHHHHHHHcccCHHHhC
Confidence 999996521 112222221111 0 0 1111 125788999999999999999
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=271.79 Aligned_cols=165 Identities=22% Similarity=0.295 Sum_probs=140.3
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVN 76 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~ 76 (241)
||++..+......+.+.+|++++++++||||+++++++...+..++||||+++++|.+++.... .....++.+++.
T Consensus 63 ~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~ 142 (360)
T 3eqc_A 63 RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 142 (360)
T ss_dssp EEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred EEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHH
Confidence 3555544444556789999999999999999999999999999999999999999999986532 146789999999
Q ss_pred HhchhhcCCCC-CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHH
Q 044022 77 SLAYLHFGFPR-PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFS 155 (241)
Q Consensus 77 ~l~~lh~~~~~-~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 155 (241)
||.||| +. +++|+||||+||+++.++.++|+|||.+....... .....|++.|+|||++.+..++.++||||
T Consensus 143 ~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 215 (360)
T 3eqc_A 143 GLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWS 215 (360)
T ss_dssp HHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--------CCCCTTCCHHHHTTCCCSHHHHHHH
T ss_pred HHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc----ccCCCCCCCeECHHHHcCCCCCchhhHHH
Confidence 999999 75 89999999999999999999999999986442211 13346899999999999989999999999
Q ss_pred HHHHHHHHHhcCccccc
Q 044022 156 FGAFLFELLAGRIHIWD 172 (241)
Q Consensus 156 ~G~~~~~~~~g~~p~~~ 172 (241)
||+++|+|++|+.||..
T Consensus 216 lG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 216 MGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp HHHHHHHHHHTSCCSSC
T ss_pred HHHHHHHHHhCCCCCCC
Confidence 99999999999999964
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=264.43 Aligned_cols=211 Identities=20% Similarity=0.276 Sum_probs=160.0
Q ss_pred cccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----------------
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---------------- 64 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------- 64 (241)
|.+.........+++.+|+++++++ +||||+++++++...+..++||||+++++|.+++....
T Consensus 58 K~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ 137 (327)
T 1fvr_A 58 KRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137 (327)
T ss_dssp EEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSC
T ss_pred eeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccc
Confidence 4443333445667899999999999 99999999999999999999999999999999987543
Q ss_pred -c---hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcc
Q 044022 65 -L---PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPE 140 (241)
Q Consensus 65 -~---~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE 140 (241)
. ....++.+++.||.||| +.+++||||||+||+++.++.++|+|||++....... ......+++.|+|||
T Consensus 138 ~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE 211 (327)
T 1fvr_A 138 TLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIE 211 (327)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHH
T ss_pred cCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeEEEcccCcCccccccc---cccCCCCCccccChh
Confidence 1 46789999999999999 8999999999999999999999999999986432211 112234678899999
Q ss_pred cccccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHH
Q 044022 141 YISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLH 219 (241)
Q Consensus 141 ~~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (241)
.+.+..++.++||||||+++|+|++ |..||.... ..+...... .+.... ... ..+.
T Consensus 212 ~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~---------~~~~~~~~~-~~~~~~-----~~~--------~~~~ 268 (327)
T 1fvr_A 212 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---------CAELYEKLP-QGYRLE-----KPL--------NCDD 268 (327)
T ss_dssp HHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---------HHHHHHHGG-GTCCCC-----CCT--------TBCH
T ss_pred hhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc---------HHHHHHHhh-cCCCCC-----CCC--------CCCH
Confidence 9988889999999999999999998 999995521 112222211 111111 111 1225
Q ss_pred HHHHHHHHhccCCCCCCCCCCC
Q 044022 220 ASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 220 ~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.+.+++.+||+.||++|||++|
T Consensus 269 ~l~~li~~~l~~dp~~Rps~~e 290 (327)
T 1fvr_A 269 EVYDLMRQCWREKPYERPSFAQ 290 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHccCChhhCcCHHH
Confidence 7899999999999999999753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=286.77 Aligned_cols=214 Identities=22% Similarity=0.297 Sum_probs=161.8
Q ss_pred Ccccccccc-cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHH
Q 044022 1 MKFYGHEYH-RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~ 75 (241)
||++..+.. ....+++.+|++++++++|||||++++++. .+..++||||+++|+|.+++..... .+..++.+|+
T Consensus 401 vK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~ 479 (635)
T 4fl3_A 401 VKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 479 (635)
T ss_dssp EEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHH
T ss_pred EEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHH
Confidence 355544332 234678999999999999999999999996 4568899999999999999865432 4678999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-eeecccccCCCccCcccccccCCCcchhhH
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-ITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
.||.||| +++|+||||||+|||++.++.+||+|||++......... .......+|+.|+|||++.+..++.++|||
T Consensus 480 ~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvw 556 (635)
T 4fl3_A 480 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 556 (635)
T ss_dssp HHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHH
Confidence 9999999 899999999999999999999999999999766443211 122233467889999999988999999999
Q ss_pred HHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 155 SFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 155 s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
|||+++|+|++ |+.||.... ..+.... ...+.....+ . ..+..+.+++.+||+.||
T Consensus 557 SlGv~l~ellt~G~~Pf~~~~---------~~~~~~~-i~~~~~~~~p-----~--------~~~~~l~~li~~cl~~dP 613 (635)
T 4fl3_A 557 SFGVLMWEAFSYGQKPYRGMK---------GSEVTAM-LEKGERMGCP-----A--------GCPREMYDLMNLCWTYDV 613 (635)
T ss_dssp HHHHHHHHHHTTTCCSSTTCC---------HHHHHHH-HHTTCCCCCC-----T--------TCCHHHHHHHHHHTCSST
T ss_pred HHHHHHHHHHhCCCCCCCCCC---------HHHHHHH-HHcCCCCCCC-----C--------CCCHHHHHHHHHHcCCCH
Confidence 99999999998 999995521 1122222 2222211111 1 223678999999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|||+++
T Consensus 614 ~~RPs~~~ 621 (635)
T 4fl3_A 614 ENRPGFAA 621 (635)
T ss_dssp TTSCCHHH
T ss_pred hHCcCHHH
Confidence 99999753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=261.02 Aligned_cols=198 Identities=23% Similarity=0.352 Sum_probs=155.3
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.+.+|++++++++||||+++++++...+..++||||+++++|.+++..... .+..++.|++.||.|||
T Consensus 54 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH--- 130 (289)
T 4fvq_A 54 NYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE--- 130 (289)
T ss_dssp GGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---
T ss_pred HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---
Confidence 4567899999999999999999999999999999999999999999999876432 46789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCC--------eEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENV--------AKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSF 156 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~--------~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~ 156 (241)
+++++||||||+|||++.++. ++|+|||.+...... ....+++.|+|||.+.+ ..++.++|||||
T Consensus 131 ~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 204 (289)
T 4fvq_A 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSF 204 (289)
T ss_dssp HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHH
T ss_pred hCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHH
Confidence 899999999999999998887 999999998644322 23357889999999987 678999999999
Q ss_pred HHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCC
Q 044022 157 GAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDR 236 (241)
Q Consensus 157 G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 236 (241)
|+++|+|++|..|+..... ............. .+ ... +..+.+++.+||+.||++|
T Consensus 205 G~il~el~~g~~~~~~~~~--------~~~~~~~~~~~~~---~~-----~~~--------~~~l~~li~~~l~~dp~~R 260 (289)
T 4fvq_A 205 GTTLWEICSGGDKPLSALD--------SQRKLQFYEDRHQ---LP-----APK--------AAELANLINNCMDYEPDHR 260 (289)
T ss_dssp HHHHHHHHTTTCCTTTTSC--------HHHHHHHHHTTCC---CC-----CCS--------SCTTHHHHHHHSCSSGGGS
T ss_pred HHHHHHHHcCCCCCccccc--------hHHHHHHhhccCC---CC-----CCC--------CHHHHHHHHHHcCCChhHC
Confidence 9999999996554433111 1111111111111 11 111 1357899999999999999
Q ss_pred CCCCC
Q 044022 237 PTMVD 241 (241)
Q Consensus 237 pt~~e 241 (241)
||++|
T Consensus 261 ps~~~ 265 (289)
T 4fvq_A 261 PSFRA 265 (289)
T ss_dssp CCHHH
T ss_pred cCHHH
Confidence 99753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=261.93 Aligned_cols=205 Identities=21% Similarity=0.331 Sum_probs=151.8
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCC-----cceEEEEecCCCCHHHhhcCC-------C---chHHHHHHHHH
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTP-----IPILVFQSVEYGTLRDCIFGA-------P---LPRLKIASDIV 75 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~-------~---~~~~~~~~~i~ 75 (241)
...+.+.+|++++++++||||+++++++.... ..++|+||+++++|.+++... . ...+.++.+++
T Consensus 78 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~ 157 (313)
T 3brb_A 78 REIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157 (313)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHH
Confidence 34577999999999999999999999998654 359999999999999998321 1 14678999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHH
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFS 155 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 155 (241)
.||.||| +.+++||||||+||+++.++.+||+|||.+................+++.|+|||.+.+..++.++||||
T Consensus 158 ~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 234 (313)
T 3brb_A 158 LGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWA 234 (313)
T ss_dssp HHHHHHH---TTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHH
T ss_pred HHHHHHH---hCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHH
Confidence 9999999 9999999999999999999999999999987664433222223345678899999999889999999999
Q ss_pred HHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 156 FGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 156 ~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
||+++|+|++ |..||...... +...... .+... ..... .+..+.+++.+||+.||+
T Consensus 235 lG~il~el~~~g~~p~~~~~~~---------~~~~~~~-~~~~~-----~~~~~--------~~~~l~~li~~~l~~dp~ 291 (313)
T 3brb_A 235 FGVTMWEIATRGMTPYPGVQNH---------EMYDYLL-HGHRL-----KQPED--------CLDELYEIMYSCWRTDPL 291 (313)
T ss_dssp HHHHHHHHHTTSCCSSTTCCGG---------GHHHHHH-TTCCC-----CCBTT--------CCHHHHHHHHHTTCSSGG
T ss_pred HHHHHHHHHhcCCCCCccCCHH---------HHHHHHH-cCCCC-----CCCcc--------ccHHHHHHHHHHcCCChh
Confidence 9999999999 88898552211 1111111 11111 11111 225789999999999999
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
+|||++|
T Consensus 292 ~Rps~~~ 298 (313)
T 3brb_A 292 DRPTFSV 298 (313)
T ss_dssp GSCCHHH
T ss_pred hCcCHHH
Confidence 9999753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=269.63 Aligned_cols=207 Identities=17% Similarity=0.267 Sum_probs=152.9
Q ss_pred HHHHHHHHHHHHh-cCCCcccceeeeeee----CCcceEEEEecCCCCHHHhhcCCC---c---hHHHHHHHHHHHhchh
Q 044022 13 YGSCINNITYAAQ-MSHNHILKRIGCCLQ----TPIPILVFQSVEYGTLRDCIFGAP---L---PRLKIASDIVNSLAYL 81 (241)
Q Consensus 13 ~~~~~~e~~~l~~-l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~---~---~~~~~~~~i~~~l~~l 81 (241)
...+.+|+.++.+ .+||||+++++++.. .+..++||||+++|+|.+++.... . ....++.+|+.||.||
T Consensus 98 ~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~L 177 (400)
T 1nxk_A 98 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177 (400)
T ss_dssp SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3567789998755 489999999999875 557899999999999999997642 1 4678999999999999
Q ss_pred hcCCCCCceeccCCCCCeeecC---CCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHH
Q 044022 82 HFGFPRPIVLRNFKTQNILFNE---ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGA 158 (241)
Q Consensus 82 h~~~~~~ivh~dl~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~ 158 (241)
| +.+|+||||||+|||++. ++.+||+|||++........ .....||+.|+|||++.+..++.++||||||+
T Consensus 178 H---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 251 (400)
T 1nxk_A 178 H---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 251 (400)
T ss_dssp H---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHH
T ss_pred H---HCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHH
Confidence 9 899999999999999998 78999999999986543321 23456899999999999889999999999999
Q ss_pred HHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 159 FLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 159 ~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
++|+|++|..||........... ... ....+.+ ..+.+.+ ...+..+.+|+.+||+.||++|||
T Consensus 252 il~ell~g~~pf~~~~~~~~~~~--~~~----~i~~~~~-~~~~~~~---------~~~s~~~~~li~~~L~~dP~~Rpt 315 (400)
T 1nxk_A 252 IMYILLCGYPPFYSNHGLAISPG--MKT----RIRMGQY-EFPNPEW---------SEVSEEVKMLIRNLLKTEPTQRMT 315 (400)
T ss_dssp HHHHHHHSSCSCCCCTTCSSCCS--HHH----HHHHTCC-CCCTTTT---------TTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred HHHHHHhCCCCCCCCccccccHH--HHH----HHHcCcc-cCCCccc---------ccCCHHHHHHHHHHCCCChhHCcC
Confidence 99999999999965322211110 111 1111111 1111110 122357899999999999999999
Q ss_pred CCC
Q 044022 239 MVD 241 (241)
Q Consensus 239 ~~e 241 (241)
++|
T Consensus 316 ~~e 318 (400)
T 1nxk_A 316 ITE 318 (400)
T ss_dssp HHH
T ss_pred HHH
Confidence 753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=267.43 Aligned_cols=201 Identities=20% Similarity=0.233 Sum_probs=152.2
Q ss_pred ccHHHHHHHHHH-HHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITY-AAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
.....+.+|..+ ++.++||||+++++++...+..|+||||+++|+|.+++.... .....++.+|+.||.|||
T Consensus 80 ~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--- 156 (373)
T 2r5t_A 80 KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH--- 156 (373)
T ss_dssp -----------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 345567777776 467899999999999999999999999999999999886532 245678999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+++|+||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++|+||||+++|+|++
T Consensus 157 ~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 234 (373)
T 2r5t_A 157 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 234 (373)
T ss_dssp HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred HCCceecCCCHHHEEECCCCCEEEeeCccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHc
Confidence 89999999999999999999999999999875332211 1234578999999999999899999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
|..||.... ..+......... . .+.... +..+.+++.+||+.||++||++.
T Consensus 235 G~~Pf~~~~---------~~~~~~~i~~~~-~------~~~~~~--------~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 235 GLPPFYSRN---------TAEMYDNILNKP-L------QLKPNI--------TNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp SSCTTCCSB---------HHHHHHHHHHSC-C------CCCSSS--------CHHHHHHHHHHTCSSGGGSTTTT
T ss_pred CCCCCCCCC---------HHHHHHHHHhcc-c------CCCCCC--------CHHHHHHHHHHcccCHHhCCCCC
Confidence 999996521 122222222111 1 111112 25688999999999999999984
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=278.43 Aligned_cols=204 Identities=24% Similarity=0.289 Sum_probs=162.5
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|++++++++||||+++++++...+..++|+||+.+++|.+++..... ....++.|++.||.||| +
T Consensus 68 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~ 144 (484)
T 3nyv_A 68 TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH---K 144 (484)
T ss_dssp SCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHH---H
T ss_pred hHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 4577899999999999999999999999999999999999999999998865432 46789999999999999 8
Q ss_pred CCceeccCCCCCeee---cCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILF---NEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 87 ~~ivh~dl~~~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
++++||||||+|||+ +.++.+||+|||++......... ....||+.|+|||++.+ .++.++||||+|+++|+|
T Consensus 145 ~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l 220 (484)
T 3nyv_A 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYIL 220 (484)
T ss_dssp TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSH---HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHH
T ss_pred CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccccc---ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHH
Confidence 999999999999999 56789999999998766544321 33468999999999875 689999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|..||... ...+........... ...+.+ ...++.+.+|+.+||+.||++|||++|
T Consensus 221 l~g~~pf~~~---------~~~~~~~~i~~~~~~--~~~~~~---------~~~s~~~~~li~~~L~~dp~~R~s~~e 278 (484)
T 3nyv_A 221 LSGCPPFNGA---------NEYDILKKVEKGKYT--FELPQW---------KKVSESAKDLIRKMLTYVPSMRISARD 278 (484)
T ss_dssp HHSSCSSCCS---------SHHHHHHHHHHCCCC--CCSGGG---------GGSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHCCCCCCCC---------CHHHHHHHHHcCCCC--CCCccc---------ccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 9999999652 112222222221111 111111 123367899999999999999999853
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=257.17 Aligned_cols=200 Identities=20% Similarity=0.330 Sum_probs=158.4
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
.....+.+|+.++++++||||+++++++...+..++||||+++++|.+++.... .....++.+++.||.||| +
T Consensus 51 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH---~ 127 (279)
T 3fdn_A 51 GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---S 127 (279)
T ss_dssp TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---T
T ss_pred hHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 346678999999999999999999999999999999999999999999886532 246789999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++|+||||+||+++.++.++|+|||.+........ ....+++.|+|||.+.+..++.++||||||+++|+|++|
T Consensus 128 ~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 203 (279)
T 3fdn_A 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203 (279)
T ss_dssp TTCEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred CCEecccCChHhEEEcCCCCEEEEeccccccCCcccc----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHC
Confidence 9999999999999999999999999998855433221 334689999999999988899999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
..||... ...+......... . . ... ..+..+.+++.+||+.||++|||++|
T Consensus 204 ~~p~~~~---------~~~~~~~~~~~~~-~-~-----~~~--------~~~~~~~~li~~~l~~~p~~Rps~~e 254 (279)
T 3fdn_A 204 KPPFEAN---------TYQETYKRISRVE-F-T-----FPD--------FVTEGARDLISRLLKHNPSQRPMLRE 254 (279)
T ss_dssp SCTTCCS---------SHHHHHHHHHHTC-C-C-----CCT--------TSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CCCCCCC---------cHHHHHHHHHhCC-C-C-----CCC--------cCCHHHHHHHHHHhccChhhCCCHHH
Confidence 9999541 1112222211111 0 0 111 12256889999999999999999853
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=270.50 Aligned_cols=230 Identities=17% Similarity=0.211 Sum_probs=170.7
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCC--cceEEEEecCCCCHHHhhcCCC----c---hHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTP--IPILVFQSVEYGTLRDCIFGAP----L---PRLKIA 71 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~----~---~~~~~~ 71 (241)
||++.........+.+.+|++++++++||||+++++++...+ ..++||||+++|+|.+++.... . ....++
T Consensus 39 iK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~ 118 (396)
T 4eut_A 39 IKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118 (396)
T ss_dssp EEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHH
T ss_pred EEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHH
Confidence 466665555566788899999999999999999999998655 6799999999999999997642 1 467899
Q ss_pred HHHHHHhchhhcCCCCCceeccCCCCCeee----cCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc---
Q 044022 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILF----NEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI--- 144 (241)
Q Consensus 72 ~~i~~~l~~lh~~~~~~ivh~dl~~~nil~----~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--- 144 (241)
.+++.||.||| +.+++||||||+|||+ +.++.+||+|||.+......... ....|++.|+|||++..
T Consensus 119 ~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~ 192 (396)
T 4eut_A 119 RDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVL 192 (396)
T ss_dssp HHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGS---SCSSSCCTTCCHHHHHHHCC
T ss_pred HHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCcc---ccccCCccccCHHHhhcccc
Confidence 99999999999 8999999999999999 77788999999999876543321 23468999999999865
Q ss_pred -----cCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCC------CCC--ccccCCC-
Q 044022 145 -----CVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGI------PAP--IIVQDIP- 210 (241)
Q Consensus 145 -----~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~--~~~~~~~- 210 (241)
..++.++||||||+++|+|++|+.||....... ...+.+............ ... .+....+
T Consensus 193 ~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~-----~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 267 (396)
T 4eut_A 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR-----RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPV 267 (396)
T ss_dssp --CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT-----TCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCT
T ss_pred ccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc-----chHHHHHHHhcCCCcccchhheeccCCCcccCccCCc
Confidence 467789999999999999999999996522211 112222222221110000 000 0001111
Q ss_pred -chhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 211 -CIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 211 -~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
..........+.+++.+||+.||++|||++|
T Consensus 268 ~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e 299 (396)
T 4eut_A 268 SCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299 (396)
T ss_dssp TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred ccccchHHHhhchHHHHHhhccChhhhccHHH
Confidence 1112466778999999999999999999853
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=257.72 Aligned_cols=201 Identities=19% Similarity=0.253 Sum_probs=141.0
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+.+.+|++++++++||||+++++++...+..++|+||+++++|.+++.... .....++.+++.||.||| +
T Consensus 54 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~ 130 (278)
T 3cok_A 54 MVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---S 130 (278)
T ss_dssp CHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 45789999999999999999999999999999999999999999999987642 146789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++|+||||+||+++.++.++|+|||.+......... .....+++.|+|||.+.+..++.++||||||+++|+|++|
T Consensus 131 ~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 208 (278)
T 3cok_A 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIG 208 (278)
T ss_dssp TTEECSSCCGGGEEECTTCCEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHS
T ss_pred CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999999866433221 1234688999999999988899999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+.||....... .... ..... ..... ..+..+.+++.+||+.||++|||++|
T Consensus 209 ~~p~~~~~~~~---------~~~~----~~~~~---~~~~~--------~~~~~~~~li~~~l~~dp~~Rps~~~ 259 (278)
T 3cok_A 209 RPPFDTDTVKN---------TLNK----VVLAD---YEMPS--------FLSIEAKDLIHQLLRRNPADRLSLSS 259 (278)
T ss_dssp SCSSCCCSCC------------------CCSSC---CCCCT--------TSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCChhHHH---------HHHH----Hhhcc---cCCcc--------ccCHHHHHHHHHHcccCHhhCCCHHH
Confidence 99996521110 0000 00000 01111 12257889999999999999999753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=276.94 Aligned_cols=204 Identities=23% Similarity=0.283 Sum_probs=159.4
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
.....+.+|++++++++||||+++++++...+..++|+||+++++|.+.+.... .....++.+++.||.||| +
T Consensus 63 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~ 139 (486)
T 3mwu_A 63 KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---K 139 (486)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 456789999999999999999999999999999999999999999998875432 256789999999999999 8
Q ss_pred CCceeccCCCCCeeec---CCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFN---EENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
.+|+||||||+|||++ .++.+||+|||++........ .....||+.|+|||++.+ .++.++||||+|+++|+|
T Consensus 140 ~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l 215 (486)
T 3mwu_A 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYIL 215 (486)
T ss_dssp TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHH
T ss_pred CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHH
Confidence 9999999999999995 456799999999876544322 233578999999999875 589999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|..||... ...+............ ..+.+ ...+..+.+++.+||+.||++|||+.|
T Consensus 216 l~g~~pf~~~---------~~~~~~~~i~~~~~~~--~~~~~---------~~~s~~~~~li~~~L~~dp~~R~t~~~ 273 (486)
T 3mwu_A 216 LSGTPPFYGK---------NEYDILKRVETGKYAF--DLPQW---------RTISDDAKDLIRKMLTFHPSLRITATQ 273 (486)
T ss_dssp HHSSCSSCCS---------SHHHHHHHHHHTCCCS--CSGGG---------GGSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HhCCCCCCCC---------CHHHHHHHHHhCCCCC--CCccc---------CCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9999999652 1122222222211110 11111 122357889999999999999999853
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=261.51 Aligned_cols=225 Identities=18% Similarity=0.203 Sum_probs=157.0
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+.+.+|++++++++||||+++++++...+..++||||+++++|.+++..... ....++.+++.||.||| +.
T Consensus 45 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH---~~ 121 (311)
T 4agu_A 45 IKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KH 121 (311)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred HHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 456788999999999999999999999999999999999999999988765422 46789999999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHHHHHHHHhc
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~~~~~~g 166 (241)
+++|+||||+||+++.++.++|+|||.+.......... ....+++.|+|||.+.+ ..++.++||||||+++|+|++|
T Consensus 122 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 199 (311)
T 4agu_A 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199 (311)
T ss_dssp TEECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHS
T ss_pred CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccccc--CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhC
Confidence 99999999999999999999999999998765432221 23468899999999976 5679999999999999999999
Q ss_pred CcccccccccCCC------cccchHHHHHHHhhhcccCCCCCCccccCCCc-hhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHD------HGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPC-IEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 167 ~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
..||......... .+.....................+......+. ......+..+.+++.+||+.||++|||+
T Consensus 200 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 279 (311)
T 4agu_A 200 VPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTC 279 (311)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCH
T ss_pred CCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCH
Confidence 9999652111000 00000000001111111111111100000000 0001233568899999999999999998
Q ss_pred CC
Q 044022 240 VD 241 (241)
Q Consensus 240 ~e 241 (241)
+|
T Consensus 280 ~e 281 (311)
T 4agu_A 280 EQ 281 (311)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=255.88 Aligned_cols=203 Identities=22% Similarity=0.321 Sum_probs=160.5
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+.+.+|++++++++||||+++++++...+..++||||+++++|.+++.... .....++.+++.||.||| +
T Consensus 46 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~ 122 (267)
T 3t9t_A 46 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---E 122 (267)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---h
Confidence 45789999999999999999999999999999999999999999999986542 146789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh-
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA- 165 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~- 165 (241)
.+++|+||||+||+++.++.++|+|||.+........ .......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 123 ~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~ 201 (267)
T 3t9t_A 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE 201 (267)
T ss_dssp TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCcccCCCchheEEECCCCCEEEcccccccccccccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhcc
Confidence 9999999999999999999999999999876543211 11122346778999999998889999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|..||.... ..+....... +.... ... ..+..+.+++.+||+.||++|||+.|
T Consensus 202 g~~p~~~~~---------~~~~~~~i~~-~~~~~-----~~~--------~~~~~l~~li~~~l~~~p~~Rps~~~ 254 (267)
T 3t9t_A 202 GKIPYENRS---------NSEVVEDIST-GFRLY-----KPR--------LASTHVYQIMNHCWRERPEDRPAFSR 254 (267)
T ss_dssp SCCTTTTCC---------HHHHHHHHHT-TCCCC-----CCT--------TSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCCC---------HHHHHHHHhc-CCcCC-----CCc--------cCcHHHHHHHHHHccCChhhCcCHHH
Confidence 899985421 1222222211 11100 011 12257889999999999999999753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=258.69 Aligned_cols=215 Identities=21% Similarity=0.336 Sum_probs=156.5
Q ss_pred cHHHHHHHHHHHHhc--CCCcccceeeeeeeC----CcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhh
Q 044022 12 TYGSCINNITYAAQM--SHNHILKRIGCCLQT----PIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLH 82 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh 82 (241)
....+.+|.+++..+ +||||+++++++... ...++||||+++|+|.+++..... ....++.+++.||.|||
T Consensus 72 ~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH 151 (337)
T 3mdy_A 72 EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLH 151 (337)
T ss_dssp GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHH
T ss_pred ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHH
Confidence 345566677777665 999999999999887 678999999999999999976543 46789999999999999
Q ss_pred cCCCC--------CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcce--eecccccCCCccCcccccccCCCcc--
Q 044022 83 FGFPR--------PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI--TTDRVIGTRGYSAPEYISICVLNEK-- 150 (241)
Q Consensus 83 ~~~~~--------~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~-- 150 (241)
+. +++||||||+|||++.++.+||+|||.+.......... ......||+.|+|||++.+......
T Consensus 152 ---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 228 (337)
T 3mdy_A 152 ---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQ 228 (337)
T ss_dssp ---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTH
T ss_pred ---HhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCcccc
Confidence 77 99999999999999999999999999997664432211 1224578999999999987766654
Q ss_pred ----hhhHHHHHHHHHHHhc----------CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHH
Q 044022 151 ----SNVFSFGAFLFELLAG----------RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQ 216 (241)
Q Consensus 151 ----~Di~s~G~~~~~~~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (241)
+||||||+++|+|++| ..||....... ..... ................. .....
T Consensus 229 ~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~~-------~~~~~ 296 (337)
T 3mdy_A 229 SYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD----PSYED-MREIVCIKKLRPSFPNR-------WSSDE 296 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS----CCHHH-HHHHHTTSCCCCCCCGG-------GGGSH
T ss_pred CccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC----Cchhh-hHHHHhhhccCcccccc-------chhhH
Confidence 9999999999999999 55554321111 11111 11111111111111111 11236
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 217 QLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 217 ~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++..+.+++.+||+.||++|||++|
T Consensus 297 ~~~~l~~li~~~l~~dP~~Rps~~e 321 (337)
T 3mdy_A 297 CLRQMGKLMTECWAHNPASRLTALR 321 (337)
T ss_dssp HHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHHHhhhhChhhCCCHHH
Confidence 6788999999999999999999853
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=267.75 Aligned_cols=158 Identities=25% Similarity=0.306 Sum_probs=132.4
Q ss_pred ccHHHHHHHHHHHHhcC-CCcccceeeeeeeCC--cceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcC
Q 044022 11 HTYGSCINNITYAAQMS-HNHILKRIGCCLQTP--IPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~ 84 (241)
....++.+|+.+++++. ||||+++++++...+ ..|+||||+. ++|.+++..... ....++.|++.||.|||
T Consensus 50 ~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-- 126 (388)
T 3oz6_A 50 TDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLH-- 126 (388)
T ss_dssp HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHH--
T ss_pred HHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 45677889999999997 999999999997544 6899999997 699998876533 46678999999999999
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCc-------------------ceeecccccCCCccCcccccc-
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET-------------------HITTDRVIGTRGYSAPEYISI- 144 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-------------------~~~~~~~~~~~~~~aPE~~~~- 144 (241)
+.+|+||||||+|||++.++.+||+|||+++....... ........||+.|+|||++.+
T Consensus 127 -~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 205 (388)
T 3oz6_A 127 -SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS 205 (388)
T ss_dssp -HTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC
T ss_pred -hCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC
Confidence 89999999999999999999999999999986533110 111233578999999999986
Q ss_pred cCCCcchhhHHHHHHHHHHHhcCccccc
Q 044022 145 CVLNEKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 145 ~~~~~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
..++.++|||||||++|+|++|++||..
T Consensus 206 ~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 206 TKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 5789999999999999999999999954
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=276.13 Aligned_cols=204 Identities=23% Similarity=0.312 Sum_probs=160.2
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
.....+.+|+.++++++||||+++++++...+..++||||+++|+|.+.+.... .....++.+++.||.||| +
T Consensus 78 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~ 154 (494)
T 3lij_A 78 SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH---K 154 (494)
T ss_dssp CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 446778999999999999999999999999999999999999999998875432 256789999999999999 8
Q ss_pred CCceeccCCCCCeeecCC---CCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEE---NVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
.+++||||||+|||++.. +.+||+|||++........ .....||+.|+|||++. ..++.++||||+|+++|+|
T Consensus 155 ~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~l 230 (494)
T 3lij_A 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFIL 230 (494)
T ss_dssp TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHH
T ss_pred CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHH
Confidence 999999999999999764 5599999999987654322 23357899999999886 5689999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|..||... ...+......... . ....+.+ . ..++.+.+++.+||+.||++|||++|
T Consensus 231 l~g~~pf~~~---------~~~~~~~~i~~~~-~-~~~~~~~-~--------~~s~~~~~li~~~L~~dp~~R~s~~e 288 (494)
T 3lij_A 231 LAGYPPFGGQ---------TDQEILRKVEKGK-Y-TFDSPEW-K--------NVSEGAKDLIKQMLQFDSQRRISAQQ 288 (494)
T ss_dssp HHSSCSSCCS---------SHHHHHHHHHHTC-C-CCCSGGG-T--------TSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HhCCCCCCCC---------CHHHHHHHHHhCC-C-CCCchhc-c--------cCCHHHHHHHHHHCCCChhhCccHHH
Confidence 9999999652 1122222222211 1 1111111 1 12357889999999999999999853
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=255.01 Aligned_cols=202 Identities=21% Similarity=0.277 Sum_probs=162.5
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++.... .....++.+++.||.||| +
T Consensus 57 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~ 133 (294)
T 2rku_A 57 HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---R 133 (294)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 346678899999999999999999999999999999999999999999876432 256789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++|+||||+||+++.++.++|+|||.+......... .....+++.|+|||.+.+..++.++||||||+++|+|++|
T Consensus 134 ~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 211 (294)
T 2rku_A 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 211 (294)
T ss_dssp TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHS
T ss_pred CCccccCCChHhEEEcCCCCEEEEeccCceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999999876533221 2334688999999999988899999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+.||.... ..+......... . . .... .+..+.+++.+||+.||++|||++|
T Consensus 212 ~~p~~~~~---------~~~~~~~~~~~~-~-~-----~~~~--------~~~~~~~li~~~l~~~p~~Rps~~~ 262 (294)
T 2rku_A 212 KPPFETSC---------LKETYLRIKKNE-Y-S-----IPKH--------INPVAASLIQKMLQTDPTARPTINE 262 (294)
T ss_dssp SCTTCCSS---------HHHHHHHHHTTC-C-C-----CCTT--------SCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred CCCCCCCC---------HHHHHHHHhhcc-C-C-----Cccc--------cCHHHHHHHHHHcccChhhCcCHHH
Confidence 99995421 111111111111 0 0 1111 1256889999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=256.10 Aligned_cols=202 Identities=17% Similarity=0.249 Sum_probs=156.8
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeee----CCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhh
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQ----TPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLH 82 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh 82 (241)
...+.+.+|+.++++++||||+++++++.. ....++||||+++++|.+++.... .....++.+++.||.|||
T Consensus 67 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH 146 (290)
T 1t4h_A 67 SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 146 (290)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHH
Confidence 456778999999999999999999999875 346899999999999999987532 246789999999999999
Q ss_pred cCCCCC--ceeccCCCCCeeec-CCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHH
Q 044022 83 FGFPRP--IVLRNFKTQNILFN-EENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAF 159 (241)
Q Consensus 83 ~~~~~~--ivh~dl~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~ 159 (241)
+.+ ++|+||||+||+++ .++.++|+|||.+........ ....+++.|+|||.+. ..++.++||||||++
T Consensus 147 ---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~ 218 (290)
T 1t4h_A 147 ---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMC 218 (290)
T ss_dssp ---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSB----EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHH
T ss_pred ---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccccc----ccccCCcCcCCHHHHh-ccCCCcchHHHHHHH
Confidence 888 99999999999997 789999999999865443322 2346899999999887 458999999999999
Q ss_pred HHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 160 LFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 160 ~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
+|+|++|+.||..... ......... .+ ......... .++.+.+++.+||+.||++|||+
T Consensus 219 l~~l~~g~~pf~~~~~--------~~~~~~~~~-~~----~~~~~~~~~--------~~~~l~~li~~~l~~dp~~Rps~ 277 (290)
T 1t4h_A 219 MLEMATSEYPYSECQN--------AAQIYRRVT-SG----VKPASFDKV--------AIPEVKEIIEGCIRQNKDERYSI 277 (290)
T ss_dssp HHHHHHSSCTTTTCSS--------HHHHHHHHT-TT----CCCGGGGGC--------CCHHHHHHHHHHSCSSGGGSCCH
T ss_pred HHHHHhCCCCCCCcCc--------HHHHHHHHh-cc----CCccccCCC--------CCHHHHHHHHHHccCChhhCCCH
Confidence 9999999999954211 111111111 11 111111111 12568999999999999999998
Q ss_pred CC
Q 044022 240 VD 241 (241)
Q Consensus 240 ~e 241 (241)
+|
T Consensus 278 ~e 279 (290)
T 1t4h_A 278 KD 279 (290)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=263.20 Aligned_cols=226 Identities=20% Similarity=0.292 Sum_probs=159.5
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|++++++++||||+++++++...+..++||||+++++|.+++.... .....++.+++.||.||| +
T Consensus 66 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~ 142 (331)
T 4aaa_A 66 MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---S 142 (331)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 345668899999999999999999999999999999999999999988765432 246789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHHHh
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~~ 165 (241)
.+++|+||||+||+++.++.++|+|||.+......... .....+++.|+|||.+.+. .++.++||||||+++|+|++
T Consensus 143 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 220 (331)
T 4aaa_A 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM 220 (331)
T ss_dssp TTCCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH
T ss_pred CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999765433221 1234688999999999865 68899999999999999999
Q ss_pred cCcccccccccCCC------cccchHHHHHHHhhhcccCCCCCCccccCCCch-hHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHD------HGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCI-EKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 166 g~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
|+.||......... .+.....................+......+.. .....++.+.+|+.+||+.||++|||
T Consensus 221 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 300 (331)
T 4aaa_A 221 GEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF 300 (331)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCC
Confidence 99999652111000 000000001111111112222222221111100 00123467899999999999999999
Q ss_pred CCC
Q 044022 239 MVD 241 (241)
Q Consensus 239 ~~e 241 (241)
++|
T Consensus 301 ~~e 303 (331)
T 4aaa_A 301 CAE 303 (331)
T ss_dssp GGG
T ss_pred HHH
Confidence 875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=260.29 Aligned_cols=202 Identities=21% Similarity=0.277 Sum_probs=162.6
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|+.++++++||||+++++++...+..++||||+.+++|.+++.... .....++.+++.||.||| +
T Consensus 83 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~ 159 (335)
T 2owb_A 83 HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---R 159 (335)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 346678899999999999999999999999999999999999999999876432 257789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++|+||||+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++||||||+++|+|++|
T Consensus 160 ~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 237 (335)
T 2owb_A 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 237 (335)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHS
T ss_pred CCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHC
Confidence 99999999999999999999999999999876533221 2334689999999999988899999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+.||.... ..+......... . . +... .+..+.+++.+||+.||++|||++|
T Consensus 238 ~~pf~~~~---------~~~~~~~~~~~~-~-~-----~~~~--------~~~~~~~li~~~l~~dp~~Rps~~e 288 (335)
T 2owb_A 238 KPPFETSC---------LKETYLRIKKNE-Y-S-----IPKH--------INPVAASLIQKMLQTDPTARPTINE 288 (335)
T ss_dssp SCTTCCSS---------HHHHHHHHHHTC-C-C-----CCTT--------SCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred cCCCCCCC---------HHHHHHHHhcCC-C-C-----CCcc--------CCHHHHHHHHHHccCChhHCcCHHH
Confidence 99995421 111111111111 1 1 1111 1256889999999999999999865
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=256.54 Aligned_cols=210 Identities=14% Similarity=0.077 Sum_probs=161.1
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~~~l~~lh~~~ 85 (241)
..+.+.+|+++++++ +|+|++++++++......++||||+ +++|.+++.... . .+..++.|++.||.|||
T Consensus 48 ~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH--- 123 (298)
T 1csn_A 48 DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH--- 123 (298)
T ss_dssp TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---
Confidence 345688999999999 8999999999999999999999999 899999987432 1 57889999999999999
Q ss_pred CCCceeccCCCCCeeecCCCC-----eEEeeccCceecCCCCcc-----eeecccccCCCccCcccccccCCCcchhhHH
Q 044022 86 PRPIVLRNFKTQNILFNEENV-----AKWFDFLLSISIPEGETH-----ITTDRVIGTRGYSAPEYISICVLNEKSNVFS 155 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~-----~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 155 (241)
+.+++||||||+||+++.++. ++|+|||.+......... .......||+.|+|||++.+..++.++||||
T Consensus 124 ~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 203 (298)
T 1csn_A 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEA 203 (298)
T ss_dssp TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHH
T ss_pred hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHH
Confidence 999999999999999987766 999999999876543221 1123456899999999999889999999999
Q ss_pred HHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 156 FGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 156 ~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
||+++|+|++|+.||....... ..+............ ..+.... ..++.+.+++.+||+.||++
T Consensus 204 lG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~--~~~~~~~--------~~~~~l~~li~~~l~~dp~~ 267 (298)
T 1csn_A 204 LGHVFMYFLRGSLPWQGLKAAT------NKQKYERIGEKKQST--PLRELCA--------GFPEEFYKYMHYARNLAFDA 267 (298)
T ss_dssp HHHHHHHHHHSSCTTSSCCSCC------HHHHHHHHHHHHHHS--CHHHHTT--------TSCHHHHHHHHHHHHCCTTC
T ss_pred HHHHHHHHHcCCCCcchhhccc------cHHHHHHHHhhccCc--cHHHHHh--------hCcHHHHHHHHHHhcCCccc
Confidence 9999999999999996522111 111111111111000 0001111 12367899999999999999
Q ss_pred CCCCCC
Q 044022 236 RPTMVD 241 (241)
Q Consensus 236 Rpt~~e 241 (241)
|||+++
T Consensus 268 RP~~~~ 273 (298)
T 1csn_A 268 TPDYDY 273 (298)
T ss_dssp CCCHHH
T ss_pred CCCHHH
Confidence 999753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=255.20 Aligned_cols=199 Identities=19% Similarity=0.231 Sum_probs=161.4
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+.+.+|++++++++||||+++++++...+..++||||+++++|.+++.... .....++.+++.||.||| +.
T Consensus 57 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~ 133 (284)
T 2vgo_A 57 VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH---ER 133 (284)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TT
T ss_pred HHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 45778999999999999999999999999999999999999999999886532 246789999999999999 99
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcC
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
+++|+||||+||+++.++.++|+|||.+........ ....+++.|+|||.+.+..++.++||||||+++|+|++|.
T Consensus 134 ~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 209 (284)
T 2vgo_A 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209 (284)
T ss_dssp TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred CceecCCCHHHEEEcCCCCEEEecccccccCccccc----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCC
Confidence 999999999999999999999999999876544321 3346889999999999888999999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.||.... ..+....... ... ..... .+..+.+++.+||+.||++|||++|
T Consensus 210 ~pf~~~~---------~~~~~~~~~~-~~~------~~~~~--------~~~~~~~li~~~l~~~p~~Rps~~~ 259 (284)
T 2vgo_A 210 PPFDSPS---------HTETHRRIVN-VDL------KFPPF--------LSDGSKDLISKLLRYHPPQRLPLKG 259 (284)
T ss_dssp CTTCCSS---------HHHHHHHHHT-TCC------CCCTT--------SCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCC---------HhHHHHHHhc-ccc------CCCCc--------CCHHHHHHHHHHhhcCHhhCCCHHH
Confidence 9995421 1111111111 110 11111 2256889999999999999999753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=263.03 Aligned_cols=222 Identities=21% Similarity=0.288 Sum_probs=150.7
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcC--------C----CchHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFG--------A----PLPRL 68 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~--------~----~~~~~ 68 (241)
||.+..+......+++.+|++++++++||||+++++++...+..++||||+++++|.+++.. . .....
T Consensus 45 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ 124 (303)
T 2vwi_A 45 IKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA 124 (303)
T ss_dssp EECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHH
T ss_pred EEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHH
Confidence 35555444445567889999999999999999999999999999999999999999998863 1 12467
Q ss_pred HHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc---eeecccccCCCccCcccccc-
Q 044022 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH---ITTDRVIGTRGYSAPEYISI- 144 (241)
Q Consensus 69 ~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~- 144 (241)
.++.+++.||.||| +.+++|+||||+||+++.++.++|+|||.+......... .......+++.|+|||.+.+
T Consensus 125 ~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 201 (303)
T 2vwi_A 125 TILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV 201 (303)
T ss_dssp HHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHH
T ss_pred HHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccc
Confidence 89999999999999 899999999999999999999999999998655432111 11223468899999999876
Q ss_pred cCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhccc--CCCCCCccccCCCchhHHHHHHHHH
Q 044022 145 CVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRF--TGIPAPIIVQDIPCIEKEQQLHASA 222 (241)
Q Consensus 145 ~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (241)
..++.++||||||+++|+|++|+.||...... ............. ........... .+..+.
T Consensus 202 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~ 265 (303)
T 2vwi_A 202 RGYDFKADIWSFGITAIELATGAAPYHKYPPM--------KVLMLTLQNDPPSLETGVQDKEMLKK--------YGKSFR 265 (303)
T ss_dssp HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG--------GHHHHHHTSSCCCTTC-----CCCCC--------CCHHHH
T ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccCchh--------hHHHHHhccCCCccccccccchhhhh--------hhHHHH
Confidence 46889999999999999999999999652211 1111111111000 00111111112 225788
Q ss_pred HHHHHhccCCCCCCCCCCC
Q 044022 223 QLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 223 ~l~~~cl~~~p~~Rpt~~e 241 (241)
+++.+||+.||++|||++|
T Consensus 266 ~li~~~l~~dp~~Rps~~~ 284 (303)
T 2vwi_A 266 KMISLCLQKDPEKRPTAAE 284 (303)
T ss_dssp HHHHHHCCSSGGGSCCHHH
T ss_pred HHHHHHccCChhhCcCHHH
Confidence 9999999999999999753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=259.96 Aligned_cols=227 Identities=19% Similarity=0.282 Sum_probs=160.3
Q ss_pred CcccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~ 75 (241)
||++... .......+.+|++++.++ +||||+++++++...+..++||||+++++|.+++.... .....++.|++
T Consensus 43 vK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~ 121 (316)
T 2ac3_A 43 VKIIEKQ-PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVA 121 (316)
T ss_dssp EEEEECC-SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHH
T ss_pred EEEEeeC-cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHH
Confidence 3555433 234577899999999995 79999999999999999999999999999999986532 24678999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCC---eEEeeccCceecCCCCc-----ceeecccccCCCccCcccccc---
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENV---AKWFDFLLSISIPEGET-----HITTDRVIGTRGYSAPEYISI--- 144 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~---~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~--- 144 (241)
.||.||| +.+++||||||+||+++.++. +||+|||++........ ........|++.|+|||++..
T Consensus 122 ~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 198 (316)
T 2ac3_A 122 SALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE 198 (316)
T ss_dssp HHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSH
T ss_pred HHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccc
Confidence 9999999 899999999999999988776 99999999875432211 111123458999999999875
Q ss_pred --cCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcc--cch---HHHHHHHhhhcccCCCCCCccccCCCchhHHHH
Q 044022 145 --CVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHG--CFF---NEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQ 217 (241)
Q Consensus 145 --~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (241)
..++.++||||||+++|+|++|+.||........... ... ..........+.. ..+. ......
T Consensus 199 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~---------~~~~~~ 268 (316)
T 2ac3_A 199 EASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY-EFPD---------KDWAHI 268 (316)
T ss_dssp HHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCC-CCCH---------HHHTTS
T ss_pred cccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCc-ccCc---------hhcccC
Confidence 4578999999999999999999999965322110000 000 0111111111111 1110 000122
Q ss_pred HHHHHHHHHHhccCCCCCCCCCCC
Q 044022 218 LHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 218 ~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+..+.+|+.+||+.||++|||++|
T Consensus 269 ~~~~~~li~~~L~~dP~~Rps~~e 292 (316)
T 2ac3_A 269 SCAAKDLISKLLVRDAKQRLSAAQ 292 (316)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CHHHHHHHHHHhhCChhhCCCHHH
Confidence 367899999999999999999853
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=262.42 Aligned_cols=207 Identities=17% Similarity=0.178 Sum_probs=160.4
Q ss_pred HHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--Cc---hHHHHHHHHHHHhchhhcCCC
Q 044022 13 YGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--PL---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 13 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
.+.+.+|+++++++ +||||+++++++...+..++||||+ +++|.+++... .. .+..++.+++.||.||| +
T Consensus 48 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~ 123 (330)
T 2izr_A 48 APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---S 123 (330)
T ss_dssp SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 45688999999999 9999999999999999999999999 89999998743 22 56789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCC-----eEEeeccCceecCCCCcce-----eecccccCCCccCcccccccCCCcchhhHHH
Q 044022 87 RPIVLRNFKTQNILFNEENV-----AKWFDFLLSISIPEGETHI-----TTDRVIGTRGYSAPEYISICVLNEKSNVFSF 156 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~-----~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~ 156 (241)
.+++||||||+|||++.++. ++|+|||++.......... ......||+.|+|||++.+..++.++|||||
T Consensus 124 ~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 203 (330)
T 2izr_A 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEAL 203 (330)
T ss_dssp TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHH
Confidence 99999999999999998887 9999999998754432211 1234578999999999999999999999999
Q ss_pred HHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCC
Q 044022 157 GAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDR 236 (241)
Q Consensus 157 G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 236 (241)
|+++|+|++|..||...... ...+............ +...... .. +.+.+++..||+.||.+|
T Consensus 204 G~il~ell~g~~Pf~~~~~~------~~~~~~~~i~~~~~~~--~~~~~~~--------~~-p~~~~li~~~l~~~p~~R 266 (330)
T 2izr_A 204 GHMFMYFLRGSLPWQGLKAD------TLKERYQKIGDTKRAT--PIEVLCE--------NF-PEMATYLRYVRRLDFFEK 266 (330)
T ss_dssp HHHHHHHHHSSCTTTTCCCS------SHHHHHHHHHHHHHHS--CHHHHTT--------TC-HHHHHHHHHHHHCCTTCC
T ss_pred HHHHHHHhcCCCCccccccc------cHHHHHHHHHhhhccC--CHHHHhc--------cC-hHHHHHHHHHHhCCCCCC
Confidence 99999999999999653211 1111111111111000 0000000 12 278999999999999999
Q ss_pred CCCC
Q 044022 237 PTMV 240 (241)
Q Consensus 237 pt~~ 240 (241)
||++
T Consensus 267 P~~~ 270 (330)
T 2izr_A 267 PDYD 270 (330)
T ss_dssp CCHH
T ss_pred CCHH
Confidence 9975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=258.58 Aligned_cols=203 Identities=22% Similarity=0.287 Sum_probs=158.8
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++.... .....++.+++.||.||| +.
T Consensus 49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~ 125 (304)
T 2jam_A 49 RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH---EN 125 (304)
T ss_dssp ---HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 34678899999999999999999999999999999999999999999875432 246789999999999999 89
Q ss_pred CceeccCCCCCeee---cCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 88 PIVLRNFKTQNILF---NEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 88 ~ivh~dl~~~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
+++|+||||+||++ +.++.++|+|||.+........ ....+++.|+|||.+.+..++.++||||||+++|+|+
T Consensus 126 ~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 201 (304)
T 2jam_A 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201 (304)
T ss_dssp TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTT----HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHH
T ss_pred CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcc----ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999 7889999999999865433221 2345899999999999889999999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|..||.... ..+...... .+.. ... ..... ..+..+.+++.+||+.||++|||++|
T Consensus 202 ~g~~pf~~~~---------~~~~~~~i~-~~~~-~~~-~~~~~--------~~~~~~~~li~~~l~~dp~~Rps~~~ 258 (304)
T 2jam_A 202 CGYPPFYEET---------ESKLFEKIK-EGYY-EFE-SPFWD--------DISESAKDFICHLLEKDPNERYTCEK 258 (304)
T ss_dssp HSSCTTTTSC---------HHHHHHHHH-HCCC-CCC-TTTTT--------TSCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred HCCCCCCCCC---------HHHHHHHHH-cCCC-CCC-ccccc--------cCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999996521 111122211 1111 111 11111 12257899999999999999999753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=278.35 Aligned_cols=203 Identities=20% Similarity=0.272 Sum_probs=162.6
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC---c---hHHHHHHHHHHHhchhhcC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---L---PRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~---~~~~~~~~i~~~l~~lh~~ 84 (241)
.....+.+|++++++++||||+++++++...+..++||||++||+|.+++.... . ....++.+|+.||.|||
T Consensus 226 ~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH-- 303 (576)
T 2acx_A 226 KGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH-- 303 (576)
T ss_dssp TCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH--
T ss_pred HHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 456778999999999999999999999999999999999999999999886542 1 46788999999999999
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
+++|+||||||+|||++.++.+||+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 304 -~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~---~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLl 379 (576)
T 2acx_A 304 -RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379 (576)
T ss_dssp -HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCE---ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHH
T ss_pred -HCCEeccCCchheEEEeCCCCeEEEecccceecccCccc---cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHH
Confidence 899999999999999999999999999999876544321 2347999999999999888999999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
+|..||...... ....+.. ........ .... ..+..+.+|+.+||+.||++||++
T Consensus 380 tG~~PF~~~~~~-----~~~~~i~-~~i~~~~~------~~p~--------~~s~~~~dLI~~lL~~dP~~R~g~ 434 (576)
T 2acx_A 380 AGQSPFQQRKKK-----IKREEVE-RLVKEVPE------EYSE--------RFSPQARSLCSQLLCKDPAERLGC 434 (576)
T ss_dssp HSSCSSSCSSSC-----CCHHHHH-HHHHHCCC------CCCT--------TSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred hCCCCCcccccc-----hhHHHHH-HHhhcccc------cCCc--------cCCHHHHHHHHHhccCCHHHcCCC
Confidence 999999652211 0111111 11111110 1111 122578999999999999999953
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=257.45 Aligned_cols=203 Identities=20% Similarity=0.310 Sum_probs=161.7
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC---c---hHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---L---PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~---~~~~~~~~i~~~l~~lh~~~ 85 (241)
..+.+.+|++++++++||||+++++++...+..++||||+++++|.+++.... . ....++.+++.||.|||
T Consensus 52 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--- 128 (288)
T 3kfa_A 52 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 128 (288)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---
Confidence 46789999999999999999999999999999999999999999999986532 1 46788999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+.+++|+||||+||+++.++.++|+|||.+........ .......+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 129 ~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~ 207 (288)
T 3kfa_A 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207 (288)
T ss_dssp HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHh
Confidence 89999999999999999999999999999976654332 22233456788999999998899999999999999999999
Q ss_pred -cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 -GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|..||...... .......... .. .... ..++.+.+++.+||+.||++|||++|
T Consensus 208 ~g~~p~~~~~~~---------~~~~~~~~~~-~~-----~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~ 261 (288)
T 3kfa_A 208 YGMSPYPGIDLS---------QVYELLEKDY-RM-----ERPE--------GCPEKVYELMRACWQWNPSDRPSFAE 261 (288)
T ss_dssp TSCCSSTTCCGG---------GHHHHHHTTC-CC-----CCCT--------TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCCCCHH---------HHHHHHhccC-CC-----CCCC--------CCCHHHHHHHHHHhCCChhhCcCHHH
Confidence 99998552111 1111111111 10 1111 12257899999999999999999853
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=258.85 Aligned_cols=197 Identities=16% Similarity=0.117 Sum_probs=150.7
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
....+.+|+..+.++ +||||++++++|...+..++||||+ +++|.+++.... ..+..++.+++.||.|||
T Consensus 99 ~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--- 174 (311)
T 3p1a_A 99 DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH--- 174 (311)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred HHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 344566677666666 9999999999999999999999999 579988875432 146789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+.+++||||||+|||++.++.+||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++
T Consensus 175 ~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~ 250 (311)
T 3p1a_A 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVAC 250 (311)
T ss_dssp HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHH
T ss_pred HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHh
Confidence 89999999999999999999999999999876644322 233468999999999875 78999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|..|+.... ..... ..+ ...+.... ..++.+.+++.+||+.||++|||++|
T Consensus 251 g~~~~~~~~------------~~~~~-~~~----~~~~~~~~--------~~~~~l~~li~~~L~~dP~~Rpt~~e 301 (311)
T 3p1a_A 251 NMELPHGGE------------GWQQL-RQG----YLPPEFTA--------GLSSELRSVLVMMLEPDPKLRATAEA 301 (311)
T ss_dssp TCCCCSSHH------------HHHHH-TTT----CCCHHHHT--------TSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCCCcc------------HHHHH-hcc----CCCccccc--------CCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 976654310 00111 111 11111111 22367899999999999999999853
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=263.35 Aligned_cols=153 Identities=20% Similarity=0.251 Sum_probs=133.6
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCC------cceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchh
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTP------IPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYL 81 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~l 81 (241)
...+++.+|++++++++||||+++++++...+ ..++||||+ +++|.+++..... ....++.|++.||.||
T Consensus 66 ~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~L 144 (367)
T 1cm8_A 66 LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 144 (367)
T ss_dssp HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999998653 469999999 7899999876433 4677899999999999
Q ss_pred hcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHHHH
Q 044022 82 HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFL 160 (241)
Q Consensus 82 h~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~ 160 (241)
| +.+++||||||+||+++.++.+||+|||++....... ....+|+.|+|||++.+ ..++.++||||+||++
T Consensus 145 H---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 216 (367)
T 1cm8_A 145 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM 216 (367)
T ss_dssp H---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHH
T ss_pred H---HCCccccCcCHHHEEEcCCCCEEEEeeeccccccccc-----CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHH
Confidence 9 8999999999999999999999999999998754322 33468999999999887 6789999999999999
Q ss_pred HHHHhcCccccc
Q 044022 161 FELLAGRIHIWD 172 (241)
Q Consensus 161 ~~~~~g~~p~~~ 172 (241)
|+|++|+.||..
T Consensus 217 ~ell~g~~pf~~ 228 (367)
T 1cm8_A 217 AEMITGKTLFKG 228 (367)
T ss_dssp HHHHHSSCSSCC
T ss_pred HHHHhCCCCCCC
Confidence 999999999964
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=276.05 Aligned_cols=204 Identities=24% Similarity=0.264 Sum_probs=161.1
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|+.++++++||||+++++++...+..++||||+++|+|.+++.... ..+..++.+++.||.||| +
T Consensus 88 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~ 164 (504)
T 3q5i_A 88 KFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH---K 164 (504)
T ss_dssp CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 346779999999999999999999999999999999999999999999875432 256789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCC---CeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEEN---VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
.+++||||||+|||++.++ .+||+|||++........ .....||+.|+|||++. ..++.++||||+|+++|+|
T Consensus 165 ~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l 240 (504)
T 3q5i_A 165 HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYIL 240 (504)
T ss_dssp TTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHH
T ss_pred CCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHH
Confidence 9999999999999998776 699999999987654432 13346899999999987 5689999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|..||... ...+......... .. .. .......+..+.+|+.+||+.||++|||++|
T Consensus 241 l~g~~pf~~~---------~~~~~~~~i~~~~-~~--~~--------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e 298 (504)
T 3q5i_A 241 LCGYPPFGGQ---------NDQDIIKKVEKGK-YY--FD--------FNDWKNISDEAKELIKLMLTYDYNKRCTAEE 298 (504)
T ss_dssp HHSSCSSCCS---------SHHHHHHHHHHCC-CC--CC--------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HhCCCCCCCC---------CHHHHHHHHHcCC-CC--CC--------ccccCCCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 9999999652 1122222222111 10 00 0000122367899999999999999999853
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=255.63 Aligned_cols=204 Identities=19% Similarity=0.271 Sum_probs=159.2
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++.... .....++.+++.||.||| +.
T Consensus 51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~ 127 (283)
T 3bhy_A 51 SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH---SK 127 (283)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred HHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 46789999999999999999999999999999999999999999999986432 257789999999999999 89
Q ss_pred CceeccCCCCCeeecCCC----CeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 88 PIVLRNFKTQNILFNEEN----VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+++|+||||+||+++.++ .++|+|||.+......... ....+++.|+|||.+.+..++.++||||||+++|+|
T Consensus 128 ~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 204 (283)
T 3bhy_A 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 204 (283)
T ss_dssp TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred CccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCcc---cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHH
Confidence 999999999999998877 8999999999876543221 234688999999999988899999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|..||.... ..+....... ... ........ ..+..+.+++.+||+.||++|||++|
T Consensus 205 ~~g~~p~~~~~---------~~~~~~~~~~-~~~--~~~~~~~~--------~~~~~~~~li~~~l~~dp~~Rps~~~ 262 (283)
T 3bhy_A 205 LSGASPFLGET---------KQETLTNISA-VNY--DFDEEYFS--------NTSELAKDFIRRLLVKDPKRRMTIAQ 262 (283)
T ss_dssp HHSSCTTCCSS---------HHHHHHHHHT-TCC--CCCHHHHT--------TCCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred HHCCCCCCCcc---------hHHHHHHhHh-ccc--CCcchhcc--------cCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 99999995421 1111111111 100 00101111 22357889999999999999999753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=266.15 Aligned_cols=215 Identities=23% Similarity=0.256 Sum_probs=161.9
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeee--eCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhc
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCL--QTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~ 83 (241)
...+.+.+|++++++++||||+++++++. ..+..++||||+++++|.+++.... ..+..++.+++.||.|||
T Consensus 66 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH- 144 (327)
T 3lxl_A 66 DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG- 144 (327)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH-
T ss_pred HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH-
Confidence 34567899999999999999999999987 4456899999999999999986521 256789999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-eeecccccCCCccCcccccccCCCcchhhHHHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-ITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~ 162 (241)
+.+++|+||||+||+++.++.++|+|||.+......... .......++..|+|||.+.+..++.++||||||+++|+
T Consensus 145 --~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 222 (327)
T 3lxl_A 145 --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYE 222 (327)
T ss_dssp --HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred --hCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHH
Confidence 899999999999999999999999999999876544322 22233457788999999998889999999999999999
Q ss_pred HHhcCcccccccccC-----CCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 163 LLAGRIHIWDLLKDT-----HDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 163 ~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
|++|..||....... .................+..... .. ..++.+.+++.+||+.||++||
T Consensus 223 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~--------~~~~~l~~li~~~l~~dP~~Rp 289 (327)
T 3lxl_A 223 LFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPA-----PP--------ACPAEVHELMKLCWAPSPQDRP 289 (327)
T ss_dssp HHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCC-----CT--------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCC-----CC--------cccHHHHHHHHHHcCCChhhCc
Confidence 999999986522110 00000000111111111111111 11 2236789999999999999999
Q ss_pred CCCC
Q 044022 238 TMVD 241 (241)
Q Consensus 238 t~~e 241 (241)
|++|
T Consensus 290 s~~e 293 (327)
T 3lxl_A 290 SFSA 293 (327)
T ss_dssp CHHH
T ss_pred CHHH
Confidence 9853
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=268.15 Aligned_cols=157 Identities=20% Similarity=0.196 Sum_probs=125.6
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeee--CCcceEEEEecCCCCHHHhhcCC-------------CchHHHHHHHHHHH
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQ--TPIPILVFQSVEYGTLRDCIFGA-------------PLPRLKIASDIVNS 77 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~-------------~~~~~~~~~~i~~~ 77 (241)
...+.+|++++++++||||+++++++.. ....++||||+. ++|.+++... ...+..++.||+.|
T Consensus 62 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 140 (405)
T 3rgf_A 62 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140 (405)
T ss_dssp CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHH
Confidence 4578899999999999999999999964 568899999996 6888877521 11467899999999
Q ss_pred hchhhcCCCCCceeccCCCCCeee----cCCCCeEEeeccCceecCCCCc-ceeecccccCCCccCccccccc-CCCcch
Q 044022 78 LAYLHFGFPRPIVLRNFKTQNILF----NEENVAKWFDFLLSISIPEGET-HITTDRVIGTRGYSAPEYISIC-VLNEKS 151 (241)
Q Consensus 78 l~~lh~~~~~~ivh~dl~~~nil~----~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~-~~~~~~ 151 (241)
|.||| +.+|+||||||+|||+ +.++.+||+|||++........ ........||+.|+|||++.+. .++.++
T Consensus 141 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 217 (405)
T 3rgf_A 141 IHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI 217 (405)
T ss_dssp HHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHH
T ss_pred HHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchh
Confidence 99999 8999999999999999 6778999999999976543211 1222345789999999999874 589999
Q ss_pred hhHHHHHHHHHHHhcCcccccc
Q 044022 152 NVFSFGAFLFELLAGRIHIWDL 173 (241)
Q Consensus 152 Di~s~G~~~~~~~~g~~p~~~~ 173 (241)
|||||||++|+|++|+.||...
T Consensus 218 DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 218 DIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp HHHHHHHHHHHHHHSSCTTCCC
T ss_pred hhHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=269.29 Aligned_cols=202 Identities=16% Similarity=0.182 Sum_probs=157.5
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--Cc---hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--PL---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
....+.+|..++.+++||||+++++++...+..|+||||+++|+|.+++... .. ....++.+|+.||.||| +
T Consensus 104 ~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~ 180 (412)
T 2vd5_A 104 EVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---R 180 (412)
T ss_dssp GGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 4556889999999999999999999999999999999999999999998652 12 45678999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc-------ccCCCcchhhHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS-------ICVLNEKSNVFSFGAF 159 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-------~~~~~~~~Di~s~G~~ 159 (241)
.+|+||||||+|||++.++.+||+|||++......... ......||+.|+|||++. ...++.++|+||||++
T Consensus 181 ~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvi 259 (412)
T 2vd5_A 181 LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVF 259 (412)
T ss_dssp TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHH
T ss_pred CCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHH
Confidence 99999999999999999999999999999876544322 223457999999999997 3568899999999999
Q ss_pred HHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 160 LFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 160 ~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
+|+|++|+.||.... ..+.............. +.... ..+..+.+|+.+||. +|.+|+
T Consensus 260 lyelltG~~Pf~~~~---------~~~~~~~i~~~~~~~~~--p~~~~--------~~s~~~~dli~~lL~-~p~~Rl 317 (412)
T 2vd5_A 260 AYEMFYGQTPFYADS---------TAETYGKIVHYKEHLSL--PLVDE--------GVPEEARDFIQRLLC-PPETRL 317 (412)
T ss_dssp HHHHHHSSCTTCCSS---------HHHHHHHHHTHHHHCCC--C------------CCCHHHHHHHHTTSS-CGGGCT
T ss_pred HHHHHhCCCCCCCCC---------HHHHHHHHHhcccCcCC--Ccccc--------CCCHHHHHHHHHHcC-ChhhcC
Confidence 999999999996521 11222222211110111 11111 122578999999999 999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=267.33 Aligned_cols=167 Identities=19% Similarity=0.218 Sum_probs=133.1
Q ss_pred Ccccccccc-cccHHHHHHHHHHHHhcCCCcccceeeeeeeC-----CcceEEEEecCCCCHHHhhcCCCc----hHHHH
Q 044022 1 MKFYGHEYH-RHTYGSCINNITYAAQMSHNHILKRIGCCLQT-----PIPILVFQSVEYGTLRDCIFGAPL----PRLKI 70 (241)
Q Consensus 1 iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~ 70 (241)
||.+..... ....+++.+|++++++++||||+++++++... +..|+||||+. ++|.+++..... ....+
T Consensus 56 iK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i 134 (432)
T 3n9x_A 56 IKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTI 134 (432)
T ss_dssp EEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHH
T ss_pred EEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHH
Confidence 354443322 23467899999999999999999999999866 56899999996 699999876532 46789
Q ss_pred HHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc--------------------eeeccc
Q 044022 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH--------------------ITTDRV 130 (241)
Q Consensus 71 ~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~--------------------~~~~~~ 130 (241)
+.||+.||.||| +.+++||||||+|||++.++.+||+|||+++........ ......
T Consensus 135 ~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (432)
T 3n9x_A 135 LYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSH 211 (432)
T ss_dssp HHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------C
T ss_pred HHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCC
Confidence 999999999999 899999999999999999999999999999876443211 112456
Q ss_pred ccCCCccCcccc-cccCCCcchhhHHHHHHHHHHHhcCcccc
Q 044022 131 IGTRGYSAPEYI-SICVLNEKSNVFSFGAFLFELLAGRIHIW 171 (241)
Q Consensus 131 ~~~~~~~aPE~~-~~~~~~~~~Di~s~G~~~~~~~~g~~p~~ 171 (241)
+||+.|+|||++ ....++.++|||||||++|+|++|..||.
T Consensus 212 ~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 212 VVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp CCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred CCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 789999999986 45568999999999999999998665553
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=259.54 Aligned_cols=214 Identities=19% Similarity=0.220 Sum_probs=162.2
Q ss_pred ccccccc-ccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHH
Q 044022 2 KFYGHEY-HRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASD 73 (241)
Q Consensus 2 K~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~ 73 (241)
|++.... .......+.+|+.+++++ .||||+++++++...+..++||||+++|+|.+++.... ..+..++.+
T Consensus 60 K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~q 139 (327)
T 3lm5_A 60 KFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ 139 (327)
T ss_dssp EEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHH
T ss_pred EEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHH
Confidence 4444322 234567899999999999 56999999999999999999999999999999986531 146789999
Q ss_pred HHHHhchhhcCCCCCceeccCCCCCeeecC---CCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcc
Q 044022 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNE---ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEK 150 (241)
Q Consensus 74 i~~~l~~lh~~~~~~ivh~dl~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 150 (241)
++.||.||| +.+++||||||+||+++. ++.++|+|||.+........ .....|++.|+|||++.+..++.+
T Consensus 140 l~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~ 213 (327)
T 3lm5_A 140 ILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTA 213 (327)
T ss_dssp HHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTH
T ss_pred HHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCch
Confidence 999999999 899999999999999988 78999999999987654322 123468999999999998899999
Q ss_pred hhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhcc
Q 044022 151 SNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVN 230 (241)
Q Consensus 151 ~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 230 (241)
+||||||+++|+|++|+.||.... ..+......... . .... .... ..+..+.+++.+||+
T Consensus 214 ~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~~i~~~~-~-~~~~-~~~~--------~~~~~~~~li~~~L~ 273 (327)
T 3lm5_A 214 TDMWNIGIIAYMLLTHTSPFVGED---------NQETYLNISQVN-V-DYSE-ETFS--------SVSQLATDFIQSLLV 273 (327)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSS---------HHHHHHHHHHTC-C-CCCT-TTTT--------TSCHHHHHHHHHHSC
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCC---------chHHHHHHHhcc-c-ccCc-hhhc--------ccCHHHHHHHHHHcC
Confidence 999999999999999999995421 111111111111 0 0111 1111 123578899999999
Q ss_pred CCCCCCCCCCC
Q 044022 231 NSPEDRPTMVD 241 (241)
Q Consensus 231 ~~p~~Rpt~~e 241 (241)
.||++|||++|
T Consensus 274 ~dP~~Rpt~~~ 284 (327)
T 3lm5_A 274 KNPEKRPTAEI 284 (327)
T ss_dssp SSGGGSCCHHH
T ss_pred CChhhCcCHHH
Confidence 99999999853
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=257.77 Aligned_cols=204 Identities=16% Similarity=0.152 Sum_probs=150.6
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+.+.+|+.++++++||||+++++++...+..++|+||+++++|.+++.... .....++.+++.||.||| +.
T Consensus 77 ~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~ 153 (309)
T 2h34_A 77 FRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH---AA 153 (309)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred HHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 35778999999999999999999999999999999999999999999986532 256789999999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcC
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
+++|+||||+||+++.++.++|+|||.+......... ......+++.|+|||.+.+..++.++||||||+++|+|++|+
T Consensus 154 ~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 232 (309)
T 2h34_A 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232 (309)
T ss_dssp TCCCSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSS
T ss_pred cCCcCCCChHHEEEcCCCCEEEecCccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCC
Confidence 9999999999999999999999999998765443211 123346889999999999888999999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC-CCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP-TMV 240 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-t~~ 240 (241)
.||.... . ............ ......... +..+.+++.+||+.||++|| |++
T Consensus 233 ~pf~~~~---------~-~~~~~~~~~~~~---~~~~~~~~~--------~~~l~~li~~~l~~dP~~Rp~s~~ 285 (309)
T 2h34_A 233 PPYQGDQ---------L-SVMGAHINQAIP---RPSTVRPGI--------PVAFDAVIARGMAKNPEDRYVTCG 285 (309)
T ss_dssp CSSCSCH---------H-HHHHHHHHSCCC---CGGGTSTTC--------CTHHHHHHHHHTCSSGGGSCSSHH
T ss_pred CCCCCch---------H-HHHHHHhccCCC---CccccCCCC--------CHHHHHHHHHhccCCHHHHHHhHH
Confidence 9995411 1 111111111100 011111222 24688999999999999999 553
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=260.39 Aligned_cols=220 Identities=18% Similarity=0.229 Sum_probs=154.3
Q ss_pred HHHHHHHHHHH--HhcCCCcccceeeeeee-----CCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhh
Q 044022 13 YGSCINNITYA--AQMSHNHILKRIGCCLQ-----TPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLH 82 (241)
Q Consensus 13 ~~~~~~e~~~l--~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh 82 (241)
...+..|.+++ ..++||||+++++.+.. ...+++||||+++|+|.+++..... ....++.+++.||.|||
T Consensus 49 ~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH 128 (336)
T 3g2f_A 49 RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLH 128 (336)
T ss_dssp HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHH
Confidence 44555555554 45899999999986543 2357899999999999999976543 46789999999999999
Q ss_pred cCCCC---------CceeccCCCCCeeecCCCCeEEeeccCceecCCCCc------ceeecccccCCCccCcccccc---
Q 044022 83 FGFPR---------PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET------HITTDRVIGTRGYSAPEYISI--- 144 (241)
Q Consensus 83 ~~~~~---------~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~--- 144 (241)
+. +++||||||+|||++.++.+||+|||++........ ........||+.|+|||++.+
T Consensus 129 ---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 205 (336)
T 3g2f_A 129 ---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVN 205 (336)
T ss_dssp ---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCC
T ss_pred ---hhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcc
Confidence 77 999999999999999999999999999987653221 111224568999999999986
Q ss_pred ----cCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccc--------hHHHHHHHhhhcccCCCCCCccccCCCch
Q 044022 145 ----CVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCF--------FNEYLKNYLEDKRFTGIPAPIIVQDIPCI 212 (241)
Q Consensus 145 ----~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (241)
..++.++||||||+++|+|++|..||............. ..+............ +.+....+.
T Consensus 206 ~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~- 280 (336)
T 3g2f_A 206 LRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQR----PKFPEAWKE- 280 (336)
T ss_dssp GGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCC----CCCCTTCCC-
T ss_pred cccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccC----CCCCccccc-
Confidence 456678999999999999999988875532221111110 011111111111111 111111111
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 213 EKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 213 ~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
....+..+.+++.+||+.||++|||++|
T Consensus 281 -~~~~~~~l~~li~~cl~~dP~~Rps~~e 308 (336)
T 3g2f_A 281 -NSLAVRSLKETIEDCWDQDAEARLTAQX 308 (336)
T ss_dssp -CSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred -ccchHHHHHHHHHHHhcCChhhCcchHH
Confidence 1245678999999999999999999853
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=264.84 Aligned_cols=165 Identities=19% Similarity=0.243 Sum_probs=129.9
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~ 76 (241)
|++...........+.+|++++++++||||+++++++...+..++||||+. ++|.+++.... .....++.+++.
T Consensus 33 K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~ 111 (324)
T 3mtl_A 33 KEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLR 111 (324)
T ss_dssp EEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHH
T ss_pred EEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 444433333333456689999999999999999999999999999999997 69988876532 146778999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFS 155 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s 155 (241)
||.||| +.+++||||||+||+++.++.+||+|||.+......... .....+|+.|+|||++.+ ..++.++||||
T Consensus 112 aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 186 (324)
T 3mtl_A 112 GLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWG 186 (324)
T ss_dssp HHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHH
T ss_pred HHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc--cccccCcccccChhhhcCCCCCCcHHHHHH
Confidence 999999 899999999999999999999999999998755433221 123467899999999876 56899999999
Q ss_pred HHHHHHHHHhcCccccc
Q 044022 156 FGAFLFELLAGRIHIWD 172 (241)
Q Consensus 156 ~G~~~~~~~~g~~p~~~ 172 (241)
||+++|+|++|+.||..
T Consensus 187 lG~il~~l~~g~~pf~~ 203 (324)
T 3mtl_A 187 VGCIFYEMATGRPLFPG 203 (324)
T ss_dssp HHHHHHHHHHSSCSCCC
T ss_pred HHHHHHHHHhCCCCCCC
Confidence 99999999999999965
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=262.77 Aligned_cols=212 Identities=18% Similarity=0.203 Sum_probs=158.1
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeee----CCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQ----TPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~ 84 (241)
...+.+|+..++.++||||+++++++.. ....++||||+ +++|.+++.... ..+..++.|++.||.|||
T Consensus 92 ~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH-- 168 (345)
T 2v62_A 92 KKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIH-- 168 (345)
T ss_dssp CHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHH--
T ss_pred hhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 3457788999999999999999999987 67899999999 899999987642 257889999999999999
Q ss_pred CCCCceeccCCCCCeeecCCC--CeEEeeccCceecCCCCcc-----eeecccccCCCccCcccccccCCCcchhhHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEEN--VAKWFDFLLSISIPEGETH-----ITTDRVIGTRGYSAPEYISICVLNEKSNVFSFG 157 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~--~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G 157 (241)
+.+++||||||+|||++.++ .+||+|||++......... .......|+..|+|||++.+..++.++||||||
T Consensus 169 -~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 247 (345)
T 2v62_A 169 -ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILG 247 (345)
T ss_dssp -HTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHH
T ss_pred -hCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHH
Confidence 89999999999999999887 9999999999765432111 111345689999999999988899999999999
Q ss_pred HHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 158 AFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 158 ~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
+++|+|++|+.||....... ........... ...+. .+....+ ....+..+.+++.+||+.||++||
T Consensus 248 ~il~ell~g~~pf~~~~~~~----~~~~~~~~~~~-----~~~~~-~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rp 314 (345)
T 2v62_A 248 YCMLRWLCGKLPWEQNLKDP----VAVQTAKTNLL-----DELPQ-SVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKP 314 (345)
T ss_dssp HHHHHHHHSSCTTGGGTTCH----HHHHHHHHHHH-----HTTTH-HHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCC
T ss_pred HHHHHHHhCCCCcccccccc----HHHHHHHHhhc-----ccccH-HHHhhcc---ccccHHHHHHHHHHHhhcCcccCC
Confidence 99999999999995421110 00000001100 00000 0000000 001225789999999999999999
Q ss_pred CCCC
Q 044022 238 TMVD 241 (241)
Q Consensus 238 t~~e 241 (241)
|++|
T Consensus 315 s~~~ 318 (345)
T 2v62_A 315 NYQA 318 (345)
T ss_dssp CHHH
T ss_pred CHHH
Confidence 9753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=255.64 Aligned_cols=205 Identities=22% Similarity=0.303 Sum_probs=157.0
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-------chHHHHHHHHHHHhchhhc
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-------LPRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------~~~~~~~~~i~~~l~~lh~ 83 (241)
...+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++.... .....++.+++.||.|||
T Consensus 61 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH- 139 (295)
T 2clq_A 61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH- 139 (295)
T ss_dssp ---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH-
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH-
Confidence 456779999999999999999999999999999999999999999999986541 135668899999999999
Q ss_pred CCCCCceeccCCCCCeeecC-CCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccC--CCcchhhHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNE-ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV--LNEKSNVFSFGAFL 160 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~s~G~~~ 160 (241)
+.+++|+||||+||+++. ++.++|+|||.+......... .....+++.|+|||.+.+.. ++.++||||||+++
T Consensus 140 --~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il 215 (295)
T 2clq_A 140 --DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTI 215 (295)
T ss_dssp --HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHH
T ss_pred --hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHH
Confidence 899999999999999987 899999999999866543211 13346889999999997653 78999999999999
Q ss_pred HHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 161 FELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 161 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
|+|++|+.||...... ....... ..... .+.+... .+..+.+++.+||+.||++|||++
T Consensus 216 ~~l~~g~~pf~~~~~~-------~~~~~~~-~~~~~-----~~~~~~~--------~~~~~~~li~~~l~~dp~~Rps~~ 274 (295)
T 2clq_A 216 IEMATGKPPFYELGEP-------QAAMFKV-GMFKV-----HPEIPES--------MSAEAKAFILKCFEPDPDKRACAN 274 (295)
T ss_dssp HHHHHTSCTTGGGSSH-------HHHHHHH-HHHCC-----CCCCCTT--------SCHHHHHHHHHTTCSSTTTSCCHH
T ss_pred HHHHHCCCCccCCCch-------hHHHHhh-ccccc-----ccccccc--------CCHHHHHHHHHHccCChhhCCCHH
Confidence 9999999999652111 0111111 01111 1111111 225788999999999999999975
Q ss_pred C
Q 044022 241 D 241 (241)
Q Consensus 241 e 241 (241)
|
T Consensus 275 ~ 275 (295)
T 2clq_A 275 D 275 (295)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=263.32 Aligned_cols=166 Identities=20% Similarity=0.227 Sum_probs=129.2
Q ss_pred Ccccccccc-cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHH
Q 044022 1 MKFYGHEYH-RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~ 75 (241)
||++..+.. ....+.+.+|++++++++||||+++++++...+..++||||++ ++|.+++..... ....++.|++
T Consensus 64 iK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~ 142 (329)
T 3gbz_A 64 IKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLI 142 (329)
T ss_dssp EEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHH
T ss_pred EEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHH
Confidence 355543332 2345678899999999999999999999999999999999997 699999876532 4678999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeec-----CCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCc
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFN-----EENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNE 149 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~-----~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~ 149 (241)
.||.||| +.+++||||||+|||++ ..+.+||+|||.+......... .....+|+.|+|||++.+. .++.
T Consensus 143 ~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~ 217 (329)
T 3gbz_A 143 NGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYST 217 (329)
T ss_dssp HHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCT
T ss_pred HHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccc--cCCCcCCccccCHHHhcCCCCCCc
Confidence 9999999 89999999999999994 4556999999999765433221 1234679999999999875 4799
Q ss_pred chhhHHHHHHHHHHHhcCccccc
Q 044022 150 KSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 150 ~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
++||||||+++|+|++|..||..
T Consensus 218 ~~DiwslG~il~ell~g~~pf~~ 240 (329)
T 3gbz_A 218 SVDIWSIACIWAEMLMKTPLFPG 240 (329)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHHHHHHHHHHHHHHCCCCcCC
Confidence 99999999999999999999954
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=279.87 Aligned_cols=201 Identities=23% Similarity=0.304 Sum_probs=158.8
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC-----C-chHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA-----P-LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----~-~~~~~~~~~i~~~l~~lh~~~ 85 (241)
..+.|.+|+++|++++||||+++++++.. +..++||||+++|+|.+++... . ...+.++.+|+.||.|||
T Consensus 305 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--- 380 (535)
T 2h8h_A 305 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--- 380 (535)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---
T ss_pred CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 45789999999999999999999999876 6789999999999999999742 1 256789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+++++||||||+|||++.++.+||+|||++........ .......++..|+|||++....++.++||||||+++|+|++
T Consensus 381 ~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t 459 (535)
T 2h8h_A 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459 (535)
T ss_dssp HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 89999999999999999999999999999976543211 11122346778999999998899999999999999999999
Q ss_pred -cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 166 -GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 166 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
|+.||.... ..+..... ..+..... .. .++..+.+||.+||+.||++|||++
T Consensus 460 ~g~~P~~~~~---------~~~~~~~i-~~~~~~~~-----~~--------~~~~~l~~li~~cl~~dP~~RPt~~ 512 (535)
T 2h8h_A 460 KGRVPYPGMV---------NREVLDQV-ERGYRMPC-----PP--------ECPESLHDLMCQCWRKEPEERPTFE 512 (535)
T ss_dssp TTCCSSTTCC---------HHHHHHHH-HTTCCCCC-----CT--------TCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCCCCC---------HHHHHHHH-HcCCCCCC-----CC--------CCCHHHHHHHHHHcCCChhHCcCHH
Confidence 999995421 12222222 12211111 11 2235788999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=257.50 Aligned_cols=206 Identities=23% Similarity=0.332 Sum_probs=152.5
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcC-----CC---chHHHHHHHHHHHhchhh
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFG-----AP---LPRLKIASDIVNSLAYLH 82 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-----~~---~~~~~~~~~i~~~l~~lh 82 (241)
....++.+|+.++++++||||+++++++...+..++||||+++++|.+++.. .. .....++.+++.||.|||
T Consensus 74 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 153 (310)
T 2wqm_A 74 KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153 (310)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh
Confidence 4567789999999999999999999999999999999999999999998853 11 246789999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~ 162 (241)
+.+++|+||||+||+++.++.++|+|||.+......... .....+++.|+|||.+.+..++.++||||||+++|+
T Consensus 154 ---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~ 228 (310)
T 2wqm_A 154 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 228 (310)
T ss_dssp ---HTTCCCCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred ---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHH
Confidence 899999999999999999999999999998765433211 123468899999999998899999999999999999
Q ss_pred HHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 163 LLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 163 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|++|..||.... .......... ......... .. ..+..+.+++.+||+.||++|||++|
T Consensus 229 l~~g~~p~~~~~-------~~~~~~~~~~-~~~~~~~~~----~~--------~~~~~l~~li~~~l~~dp~~Rps~~~ 287 (310)
T 2wqm_A 229 MAALQSPFYGDK-------MNLYSLCKKI-EQCDYPPLP----SD--------HYSEELRQLVNMCINPDPEKRPDVTY 287 (310)
T ss_dssp HHHSSCTTC----------CCHHHHHHHH-HTTCSCCCC----TT--------TSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHhCCCCCcccc-------hhHHHHHHHh-hcccCCCCc----cc--------ccCHHHHHHHHHHcCCChhhCCCHHH
Confidence 999999995421 1111111111 111111111 01 12257899999999999999999753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=257.25 Aligned_cols=205 Identities=20% Similarity=0.342 Sum_probs=159.0
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.+.+|++++++++||||+++++++.... .++|+||+++++|.+++.... .....++.+++.||.|||
T Consensus 63 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH--- 138 (291)
T 1u46_A 63 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE--- 138 (291)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---
T ss_pred HHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---
Confidence 45678999999999999999999999997665 889999999999999986531 246789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-eeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-ITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
+.+++|+||||+||+++.++.++|+|||.+......... .......++..|+|||.+.+..++.++||||||+++|+|+
T Consensus 139 ~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 218 (291)
T 1u46_A 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218 (291)
T ss_dssp HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred hCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHH
Confidence 899999999999999999999999999999876544322 1222345677899999998888899999999999999999
Q ss_pred h-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 A-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+ |..||.... ..+............. ... ..+..+.+++.+||+.||++|||+.|
T Consensus 219 ~~g~~p~~~~~---------~~~~~~~~~~~~~~~~-----~~~--------~~~~~l~~li~~~l~~~p~~Rps~~~ 274 (291)
T 1u46_A 219 TYGQEPWIGLN---------GSQILHKIDKEGERLP-----RPE--------DCPQDIYNVMVQCWAHKPEDRPTFVA 274 (291)
T ss_dssp TTSCCTTTTCC---------HHHHHHHHHTSCCCCC-----CCT--------TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hCCCCCcccCC---------HHHHHHHHHccCCCCC-----CCc--------CcCHHHHHHHHHHccCCcccCcCHHH
Confidence 9 999995421 1222222222111111 111 12367899999999999999999753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=275.07 Aligned_cols=235 Identities=20% Similarity=0.212 Sum_probs=165.0
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeee------CCcceEEEEecCCCCHHHhhcCCC-------chH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQ------TPIPILVFQSVEYGTLRDCIFGAP-------LPR 67 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~-------~~~ 67 (241)
||++..+......+++.+|++++++++||||+++++++.. .+..++||||+++|+|.+++.... ...
T Consensus 44 VKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i 123 (676)
T 3qa8_A 44 IKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123 (676)
T ss_dssp ECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHH
T ss_pred EEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHH
Confidence 4666555555567789999999999999999999998765 667899999999999999987632 257
Q ss_pred HHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCC---eEEeeccCceecCCCCcceeecccccCCCccCcccccc
Q 044022 68 LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENV---AKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI 144 (241)
Q Consensus 68 ~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 144 (241)
..++.+++.||.||| +.+++||||||+||+++.++. ++|+|||.+......... ....|++.|+|||.+.+
T Consensus 124 ~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~ 197 (676)
T 3qa8_A 124 RTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC---TEFVGTLQYLAPELLEQ 197 (676)
T ss_dssp HHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCC---CCCCSCCTTCSSCSSCC
T ss_pred HHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccccccccccccccc---ccccCCcccCChHHhcc
Confidence 889999999999999 899999999999999997664 899999999876544322 33578999999999999
Q ss_pred cCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHH
Q 044022 145 CVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQL 224 (241)
Q Consensus 145 ~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 224 (241)
..++.++||||||+++|++++|..||............................+...-......+.......+..+.++
T Consensus 198 ~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dL 277 (676)
T 3qa8_A 198 KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERW 277 (676)
T ss_dssp SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHH
Confidence 99999999999999999999999999542110000000000000000000000000000000000111112355789999
Q ss_pred HHHhccCCCCCCCCCCC
Q 044022 225 TLECVNNSPEDRPTMVD 241 (241)
Q Consensus 225 ~~~cl~~~p~~Rpt~~e 241 (241)
+..||..||++|||++|
T Consensus 278 I~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 278 LQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp HHHHSCSSCC---CCTT
T ss_pred HHHHccCCHhhCcCHHH
Confidence 99999999999999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=251.50 Aligned_cols=201 Identities=23% Similarity=0.319 Sum_probs=159.0
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~~ 85 (241)
..+.+.+|++++++++||||+++++++. .+..++||||+++++|.+++.... .....++.+++.||.|||
T Consensus 51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--- 126 (279)
T 1qpc_A 51 SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--- 126 (279)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---
T ss_pred cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 4678999999999999999999999986 456899999999999999997531 246789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+.+++|+||||+||+++.++.++|+|||.+........ .......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 127 ~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 205 (279)
T 1qpc_A 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205 (279)
T ss_dssp HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHh
Confidence 89999999999999999999999999999987654322 11223346778999999988889999999999999999999
Q ss_pred -cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 166 -GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 166 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
|..||.... ..+....... +... .... ..+..+.+++.+||+.||++|||++
T Consensus 206 ~g~~p~~~~~---------~~~~~~~~~~-~~~~-----~~~~--------~~~~~l~~li~~~l~~~p~~Rps~~ 258 (279)
T 1qpc_A 206 HGRIPYPGMT---------NPEVIQNLER-GYRM-----VRPD--------NCPEELYQLMRLCWKERPEDRPTFD 258 (279)
T ss_dssp TTCCSSTTCC---------HHHHHHHHHT-TCCC-----CCCT--------TCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCcccC---------HHHHHHHHhc-ccCC-----CCcc--------cccHHHHHHHHHHhccChhhCCCHH
Confidence 899985421 1122222211 1110 1111 1225789999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=256.08 Aligned_cols=204 Identities=23% Similarity=0.271 Sum_probs=161.7
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcC--CCc---hHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFG--APL---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~--~~~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++.. ... ....++.+++.||.||| +
T Consensus 67 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~ 143 (314)
T 3com_A 67 DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---F 143 (314)
T ss_dssp CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 457789999999999999999999999999999999999999999999852 222 46789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
.+++|+||+|+||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.++||||||+++|+|++|
T Consensus 144 ~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 221 (314)
T 3com_A 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221 (314)
T ss_dssp TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHS
T ss_pred CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999976544322 12334688999999999988899999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
..||..... ........ ......... .. ..+..+.+++.+||+.||++|||++|
T Consensus 222 ~~p~~~~~~---------~~~~~~~~-~~~~~~~~~---~~--------~~~~~l~~li~~~l~~dp~~Rpt~~~ 275 (314)
T 3com_A 222 KPPYADIHP---------MRAIFMIP-TNPPPTFRK---PE--------LWSDNFTDFVKQCLVKSPEQRATATQ 275 (314)
T ss_dssp SCTTTTSCH---------HHHHHHHH-HSCCCCCSS---GG--------GSCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred CCCCCCCCh---------HHHHHHHh-cCCCcccCC---cc--------cCCHHHHHHHHHHccCChhhCcCHHH
Confidence 999964211 11111111 111111110 11 12357889999999999999999753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=252.56 Aligned_cols=201 Identities=25% Similarity=0.337 Sum_probs=153.3
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|++++++++||||+++++++...+..++||||+++++|.+++.... .....++.+++.||.||| +
T Consensus 53 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~ 129 (276)
T 2h6d_A 53 DVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH---R 129 (276)
T ss_dssp TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred hHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 456788999999999999999999999999999999999999999999986432 256789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCC-CcchhhHHHHHHHHHHHh
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVL-NEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~s~G~~~~~~~~ 165 (241)
.+++|+||+|+||+++.++.++|+|||.+........ .....+++.|+|||.+.+..+ +.++||||||+++|+|++
T Consensus 130 ~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 206 (276)
T 2h6d_A 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLC 206 (276)
T ss_dssp HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred CCCccCCCChhhEEECCCCCEEEeecccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHh
Confidence 9999999999999999999999999999876544322 123467899999999987765 589999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|..||... ...+...... .... .. .. ..+..+.+++.+||+.||++|||++|
T Consensus 207 g~~p~~~~---------~~~~~~~~~~-~~~~-~~-----~~--------~~~~~l~~li~~~l~~~p~~Rps~~~ 258 (276)
T 2h6d_A 207 GTLPFDDE---------HVPTLFKKIR-GGVF-YI-----PE--------YLNRSVATLLMHMLQVDPLKRATIKD 258 (276)
T ss_dssp SSCSSCCS---------SHHHHHHHHH-HCCC-CC-----CT--------TSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCC---------cHHHHHHHhh-cCcc-cC-----ch--------hcCHHHHHHHHHHccCChhhCCCHHH
Confidence 99999541 1112222211 1111 01 11 11256889999999999999999853
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=259.78 Aligned_cols=152 Identities=24% Similarity=0.301 Sum_probs=134.5
Q ss_pred cHHHHHHHHHHHHhcC-----CCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC---c---hHHHHHHHHHHHhch
Q 044022 12 TYGSCINNITYAAQMS-----HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---L---PRLKIASDIVNSLAY 80 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~---~~~~~~~~i~~~l~~ 80 (241)
..+.+.+|+.+++.++ ||||+++++++...+..++||||+ +++|.+++.... . ....++.||+.||.|
T Consensus 74 ~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 152 (360)
T 3llt_A 74 YTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152 (360)
T ss_dssp HHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred hhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Confidence 4566788999999996 999999999999999999999999 899999986543 1 467889999999999
Q ss_pred hhcCCCCCceeccCCCCCeeecC-------------------------CCCeEEeeccCceecCCCCcceeecccccCCC
Q 044022 81 LHFGFPRPIVLRNFKTQNILFNE-------------------------ENVAKWFDFLLSISIPEGETHITTDRVIGTRG 135 (241)
Q Consensus 81 lh~~~~~~ivh~dl~~~nil~~~-------------------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 135 (241)
|| +.+++||||||+|||++. ++.+||+|||++....... ....||+.
T Consensus 153 LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~ 224 (360)
T 3llt_A 153 LR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQ 224 (360)
T ss_dssp HH---HTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGG
T ss_pred HH---HCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCccc
Confidence 99 899999999999999975 7899999999998654432 33568999
Q ss_pred ccCcccccccCCCcchhhHHHHHHHHHHHhcCccccc
Q 044022 136 YSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 136 ~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 225 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 225 YRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp GCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999999999999999965
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=257.72 Aligned_cols=203 Identities=19% Similarity=0.285 Sum_probs=157.0
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeee--CCcceEEEEecCCCCHHHhhcCC--------CchHHHHHHHHHHHhch
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQ--TPIPILVFQSVEYGTLRDCIFGA--------PLPRLKIASDIVNSLAY 80 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~--------~~~~~~~~~~i~~~l~~ 80 (241)
...+.+.+|++++++++||||+++++++.. .+..++||||+++++|.+++... ......++.+++.||.|
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~ 126 (279)
T 2w5a_A 47 AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126 (279)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHH
Confidence 446678999999999999999999998854 56789999999999999998642 12467899999999999
Q ss_pred hhcCCCCC-----ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHH
Q 044022 81 LHFGFPRP-----IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFS 155 (241)
Q Consensus 81 lh~~~~~~-----ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 155 (241)
|| +.+ ++|+||||+||+++.++.++|+|||.+......... .....+++.|+|||.+.+..++.++||||
T Consensus 127 lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 201 (279)
T 2w5a_A 127 CH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWS 201 (279)
T ss_dssp HH---HHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHH
T ss_pred Hh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccccc--ccccCCCccccChHHhccCCCCchhhHHH
Confidence 99 777 999999999999999999999999998765433211 12346889999999999888999999999
Q ss_pred HHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 156 FGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 156 ~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
||+++|+|++|..||.... ..+.... ...+..... ... .+..+.+++.+||+.||++
T Consensus 202 lG~il~~l~~g~~p~~~~~---------~~~~~~~-i~~~~~~~~-----~~~--------~~~~l~~li~~~l~~~p~~ 258 (279)
T 2w5a_A 202 LGCLLYELCALMPPFTAFS---------QKELAGK-IREGKFRRI-----PYR--------YSDELNEIITRMLNLKDYH 258 (279)
T ss_dssp HHHHHHHHHHSSCSSCCSS---------HHHHHHH-HHHTCCCCC-----CTT--------SCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHHHCCCCCcccC---------HHHHHHH-HhhcccccC-----Ccc--------cCHHHHHHHHHHcCCCccc
Confidence 9999999999999996521 1111111 122222111 111 2257899999999999999
Q ss_pred CCCCCC
Q 044022 236 RPTMVD 241 (241)
Q Consensus 236 Rpt~~e 241 (241)
|||++|
T Consensus 259 Rps~~~ 264 (279)
T 2w5a_A 259 RPSVEE 264 (279)
T ss_dssp SCCHHH
T ss_pred CCCHHH
Confidence 999853
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=266.70 Aligned_cols=203 Identities=20% Similarity=0.242 Sum_probs=148.9
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
...+.+|++++++++||||+++++++. .+..++||||+++|+|.+++..... ....++.|++.||.||| +++
T Consensus 184 ~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ 259 (419)
T 3i6u_A 184 ALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENG 259 (419)
T ss_dssp -CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence 346889999999999999999999985 4557999999999999998876532 46789999999999999 899
Q ss_pred ceeccCCCCCeeecCCC---CeEEeeccCceecCCCCcceeecccccCCCccCcccccc---cCCCcchhhHHHHHHHHH
Q 044022 89 IVLRNFKTQNILFNEEN---VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI---CVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~s~G~~~~~ 162 (241)
++||||||+|||++..+ .+||+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|+
T Consensus 260 ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~ 336 (419)
T 3i6u_A 260 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFI 336 (419)
T ss_dssp CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHH
T ss_pred ccccCCChHhEEEecCCCcceEEEeecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHH
Confidence 99999999999997544 599999999976544321 133568999999999864 567889999999999999
Q ss_pred HHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 163 LLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 163 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|++|..||...... ....+ ....+.... .+.. ....+..+.+++.+||+.||++|||++|
T Consensus 337 lltg~~pf~~~~~~-----~~~~~----~i~~~~~~~--~~~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~e 396 (419)
T 3i6u_A 337 CLSGYPPFSEHRTQ-----VSLKD----QITSGKYNF--IPEV--------WAEVSEKALDLVKKLLVVDPKARFTTEE 396 (419)
T ss_dssp HHHSSCSSCCCSSS-----CCHHH----HHHTTCCCC--CHHH--------HTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHCCCCCCCCcch-----HHHHH----HHhcCCCCC--Cchh--------hcccCHHHHHHHHHHccCChhHCcCHHH
Confidence 99999999652111 11111 111111100 0000 0122367899999999999999999853
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=258.33 Aligned_cols=214 Identities=21% Similarity=0.193 Sum_probs=159.3
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
.+.+.+|++++++++||||+++++++...+..++||||++ ++|.+++.... .....++.+++.||.||| +.
T Consensus 56 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~ 131 (346)
T 1ua2_A 56 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 131 (346)
T ss_dssp CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS-EEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HT
T ss_pred hHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCC-CCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 4578899999999999999999999999999999999997 48988886542 257889999999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHHHhc
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~~g 166 (241)
+++||||||+||+++.++.+||+|||++......... .....+|+.|+|||++.+. .++.++||||||+++|+|++|
T Consensus 132 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 209 (346)
T 1ua2_A 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209 (346)
T ss_dssp TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHS
T ss_pred CEECCCCCHHHEEEcCCCCEEEEecccceeccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHC
Confidence 9999999999999999999999999999765433221 2335689999999998754 578999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhh-cc--cCCCC------CCccccCCCch----hHHHHHHHHHHHHHHhccCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLED-KR--FTGIP------APIIVQDIPCI----EKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~------~~~~~~~~~~~----~~~~~~~~~~~l~~~cl~~~p 233 (241)
.+||.... ..+........ +. ....+ +.......+.. .....+..+.+|+.+||+.||
T Consensus 210 ~~~~~~~~---------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 280 (346)
T 1ua2_A 210 VPFLPGDS---------DLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNP 280 (346)
T ss_dssp SCSSCCSS---------HHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSST
T ss_pred CCCCCCCC---------HHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccCh
Confidence 99985421 11111111111 00 00000 00000000000 001233678999999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|||++|
T Consensus 281 ~~Rpt~~e 288 (346)
T 1ua2_A 281 CARITATQ 288 (346)
T ss_dssp TTSCCHHH
T ss_pred hhCCCHHH
Confidence 99999854
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=266.26 Aligned_cols=217 Identities=9% Similarity=0.046 Sum_probs=144.9
Q ss_pred Cccccccc--ccccHHHHHHHHHHHHhc--CCCccccee-------eeeeeC-----------------CcceEEEEecC
Q 044022 1 MKFYGHEY--HRHTYGSCINNITYAAQM--SHNHILKRI-------GCCLQT-----------------PIPILVFQSVE 52 (241)
Q Consensus 1 iK~~~~~~--~~~~~~~~~~e~~~l~~l--~h~~iv~~~-------~~~~~~-----------------~~~~lv~e~~~ 52 (241)
||++.... .....+.+.+|+++++.| +||||++++ +++... ...++||||++
T Consensus 92 vK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~ 171 (371)
T 3q60_A 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS 171 (371)
T ss_dssp EEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS
T ss_pred EEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC
Confidence 35554433 223456677886555555 699988755 444332 23799999998
Q ss_pred CCCHHHhhcCC----Cc-hH------HHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCC
Q 044022 53 YGTLRDCIFGA----PL-PR------LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEG 121 (241)
Q Consensus 53 ~~sL~~~l~~~----~~-~~------~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~ 121 (241)
|+|.+++... .. .+ +.++.|++.||+||| +++|+||||||+|||++.++.+||+|||++......
T Consensus 172 -~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~ 247 (371)
T 3q60_A 172 -VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR 247 (371)
T ss_dssp -EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE
T ss_pred -CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC
Confidence 8999998753 22 34 567799999999999 899999999999999999999999999999865432
Q ss_pred CcceeecccccCCCccCcccccc--cCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCC
Q 044022 122 ETHITTDRVIGTRGYSAPEYISI--CVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTG 199 (241)
Q Consensus 122 ~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (241)
. ....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.......... ........
T Consensus 248 ~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~-----------~~~~~~~~ 311 (371)
T 3q60_A 248 G-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS-----------WKRPSLRV 311 (371)
T ss_dssp E-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTC-----------CCBCCTTS
T ss_pred c-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccc-----------hhhhhhhh
Confidence 1 13456799999999987 678999999999999999999999997632211000 00000000
Q ss_pred CCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 200 IPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
....... .+ .....++.+.+|+.+||+.||++|||++|
T Consensus 312 ~~~~~~~--~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 349 (371)
T 3q60_A 312 PGTDSLA--FG--SCTPLPDFVKTLIGRFLNFDRRRRLLPLE 349 (371)
T ss_dssp CCCCSCC--CT--TSSCCCHHHHHHHHHHTCSSTTTCCCHHH
T ss_pred ccccccc--hh--hccCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 0000000 00 00122367899999999999999999853
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=268.75 Aligned_cols=152 Identities=21% Similarity=0.289 Sum_probs=124.8
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeC-----CcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchh
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQT-----PIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYL 81 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~l 81 (241)
...+++.+|+++|++++||||+++++++... ...|+||||+. ++|.+++..... ....++.||+.||.||
T Consensus 94 ~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 172 (458)
T 3rp9_A 94 IDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYV 172 (458)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3467799999999999999999999999543 46899999985 799998876532 4678999999999999
Q ss_pred hcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-------------------------eeecccccCCCc
Q 044022 82 HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-------------------------ITTDRVIGTRGY 136 (241)
Q Consensus 82 h~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-------------------------~~~~~~~~~~~~ 136 (241)
| +.+|+||||||+|||++.++.+||+|||+++........ ......+||+.|
T Consensus 173 H---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 249 (458)
T 3rp9_A 173 H---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWY 249 (458)
T ss_dssp H---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTT
T ss_pred H---hCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccc
Confidence 9 899999999999999999999999999999865422110 112345689999
Q ss_pred cCcccc-cccCCCcchhhHHHHHHHHHHHhc
Q 044022 137 SAPEYI-SICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 137 ~aPE~~-~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
+|||++ ....++.++|||||||++|||++|
T Consensus 250 ~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 250 RAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 999986 456789999999999999999994
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=258.84 Aligned_cols=204 Identities=18% Similarity=0.238 Sum_probs=157.0
Q ss_pred HHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCCCc
Q 044022 15 SCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPRPI 89 (241)
Q Consensus 15 ~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~~i 89 (241)
.+.+|++++.++ +||||+++++++...+..++||||+++|+|.+++..... ....++.+|+.||.||| +.++
T Consensus 61 ~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH---~~gi 137 (342)
T 2qr7_A 61 DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH---AQGV 137 (342)
T ss_dssp CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCc
Confidence 346789999888 799999999999999999999999999999999866532 46789999999999999 8999
Q ss_pred eeccCCCCCeeecCC----CCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 90 VLRNFKTQNILFNEE----NVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 90 vh~dl~~~nil~~~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+||||||+|||+... +.+||+|||++......... .....+|+.|+|||++.+..++.++||||||+++|+|++
T Consensus 138 vHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 215 (342)
T 2qr7_A 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLT 215 (342)
T ss_dssp ECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhc
Confidence 999999999998543 35999999999865443221 133568999999999988888999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
|..||..... ....+..... ..+.+. ... .... ..+..+.+|+.+||..||++|||++
T Consensus 216 g~~Pf~~~~~------~~~~~~~~~i-~~~~~~-~~~-~~~~--------~~s~~~~~li~~~L~~dP~~R~t~~ 273 (342)
T 2qr7_A 216 GYTPFANGPD------DTPEEILARI-GSGKFS-LSG-GYWN--------SVSDTAKDLVSKMLHVDPHQRLTAA 273 (342)
T ss_dssp SSCSSCSSTT------SCHHHHHHHH-HHCCCC-CCS-TTTT--------TSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCCCCCCc------CCHHHHHHHH-ccCCcc-cCc-cccc--------cCCHHHHHHHHHHCCCChhHCcCHH
Confidence 9999964211 1122222222 222111 010 0001 1235788999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=261.90 Aligned_cols=155 Identities=18% Similarity=0.215 Sum_probs=125.8
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCC------cceEEEEecCCCCHHHhhcCCCc--hHHHHHHHHHHHhchhh
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTP------IPILVFQSVEYGTLRDCIFGAPL--PRLKIASDIVNSLAYLH 82 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~l~~lh 82 (241)
...+.+.+|+.++++++||||+++++++...+ ..++||||+. ++|.+.+..... ....++.|++.||.|||
T Consensus 66 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH 144 (371)
T 2xrw_A 66 THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144 (371)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHHSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHhhccCHHHHHHHHHHHHHHHHHHH
Confidence 44567889999999999999999999997654 6799999997 588888764422 46789999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~ 162 (241)
+.+++||||||+|||++.++.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+
T Consensus 145 ---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 218 (371)
T 2xrw_A 145 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218 (371)
T ss_dssp ---HTTCCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred ---HCCeecccCCHHHEEEcCCCCEEEEEeecccccccccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHH
Confidence 89999999999999999999999999999976543221 123468999999999999899999999999999999
Q ss_pred HHhcCccccc
Q 044022 163 LLAGRIHIWD 172 (241)
Q Consensus 163 ~~~g~~p~~~ 172 (241)
|++|+.||..
T Consensus 219 l~~g~~pf~~ 228 (371)
T 2xrw_A 219 MIKGGVLFPG 228 (371)
T ss_dssp HHHSSCSSCC
T ss_pred HHhCCCCCCC
Confidence 9999999965
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=264.54 Aligned_cols=208 Identities=14% Similarity=0.144 Sum_probs=152.9
Q ss_pred HHHHHHHHHhcCCCcccceeeeeeeC----CcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCCC
Q 044022 16 CINNITYAAQMSHNHILKRIGCCLQT----PIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 16 ~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
+.+|+..+..++||||+++++++... ...++||||+ +++|.+++.... ..++.++.|++.||.||| +
T Consensus 95 ~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~ 170 (364)
T 3op5_A 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---E 170 (364)
T ss_dssp HHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 44566667777899999999999865 4589999999 899999986542 157889999999999999 8
Q ss_pred CCceeccCCCCCeeec--CCCCeEEeeccCceecCCCCcce-----eecccccCCCccCcccccccCCCcchhhHHHHHH
Q 044022 87 RPIVLRNFKTQNILFN--EENVAKWFDFLLSISIPEGETHI-----TTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAF 159 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~--~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~ 159 (241)
.+++||||||+|||++ .++.+||+|||++.......... ......||+.|+|||++.+..++.++||||||++
T Consensus 171 ~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~ 250 (364)
T 3op5_A 171 HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYC 250 (364)
T ss_dssp TTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred CCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHH
Confidence 9999999999999999 88999999999997654322111 1123458999999999999899999999999999
Q ss_pred HHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 160 LFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 160 ~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
+|+|++|+.||...... ............. ......++.+.. ...+..+.+++..||+.||++|||+
T Consensus 251 l~el~~g~~Pf~~~~~~-----~~~~~~~~~~~~~-~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~~p~~RP~~ 317 (364)
T 3op5_A 251 MIQWLTGHLPWEDNLKD-----PKYVRDSKIRYRE-NIASLMDKCFPA-------ANAPGEIAKYMETVKLLDYTEKPLY 317 (364)
T ss_dssp HHHHHHSCCTTGGGTTC-----HHHHHHHHHHHHH-CHHHHHHHHSCT-------TCCCHHHHHHHHHHHTCCTTCCCCH
T ss_pred HHHHHhCCCCccccccC-----HHHHHHHHHHhhh-hHHHHHHHhccc-------ccCHHHHHHHHHHHhcCCCCCCCCH
Confidence 99999999999652111 1111111111000 000000000000 0123678999999999999999997
Q ss_pred C
Q 044022 240 V 240 (241)
Q Consensus 240 ~ 240 (241)
+
T Consensus 318 ~ 318 (364)
T 3op5_A 318 E 318 (364)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=269.74 Aligned_cols=193 Identities=11% Similarity=0.131 Sum_probs=147.5
Q ss_pred ccHHHHHHHH---HHHHhcCCCccccee-------eeeeeCC-----------------cceEEEEecCCCCHHHhhcCC
Q 044022 11 HTYGSCINNI---TYAAQMSHNHILKRI-------GCCLQTP-----------------IPILVFQSVEYGTLRDCIFGA 63 (241)
Q Consensus 11 ~~~~~~~~e~---~~l~~l~h~~iv~~~-------~~~~~~~-----------------~~~lv~e~~~~~sL~~~l~~~ 63 (241)
...+.+.+|+ +++++++|||||+++ +++...+ ..++||||+ +|+|.+++...
T Consensus 115 ~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~ 193 (377)
T 3byv_A 115 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL 193 (377)
T ss_dssp THHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc
Confidence 4567899999 555556899999998 5554443 378999999 58999998642
Q ss_pred ----C-------chHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeeccccc
Q 044022 64 ----P-------LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIG 132 (241)
Q Consensus 64 ----~-------~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 132 (241)
. ..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..... ......|
T Consensus 194 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g 265 (377)
T 3byv_A 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS 265 (377)
T ss_dssp HHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC
T ss_pred cccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC
Confidence 1 235678999999999999 89999999999999999999999999999986433 1234467
Q ss_pred CCCccCccccccc-----------CCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCC
Q 044022 133 TRGYSAPEYISIC-----------VLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIP 201 (241)
Q Consensus 133 ~~~~~aPE~~~~~-----------~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (241)
+.|+|||++.+. .++.++||||||+++|+|++|+.||......... ......
T Consensus 266 -~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~--------------~~~~~~-- 328 (377)
T 3byv_A 266 -RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGS--------------EWIFRS-- 328 (377)
T ss_dssp -TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCS--------------GGGGSS--
T ss_pred -cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccch--------------hhhhhh--
Confidence 899999999887 8999999999999999999999999652211100 000000
Q ss_pred CCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 202 APIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
... .++.+.+++.+||+.||++|||+.|
T Consensus 329 ----~~~--------~~~~~~~li~~~L~~dp~~Rpt~~e 356 (377)
T 3byv_A 329 ----CKN--------IPQPVRALLEGFLRYPKEDRLLPLQ 356 (377)
T ss_dssp ----CCC--------CCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred ----ccC--------CCHHHHHHHHHHcCCCchhCCCHHH
Confidence 011 1257889999999999999999853
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=276.19 Aligned_cols=200 Identities=20% Similarity=0.231 Sum_probs=162.9
Q ss_pred ccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.+.+|.+++..+ +||||+++++++...+.+++||||+++|+|.+++.... .....++.||+.||.|||
T Consensus 383 ~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--- 459 (674)
T 3pfq_A 383 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ--- 459 (674)
T ss_dssp TTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---
T ss_pred HHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 4567788999999988 79999999999999999999999999999999986532 256789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+.+|+||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++
T Consensus 460 ~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyellt 537 (674)
T 3pfq_A 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 537 (674)
T ss_dssp HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHH
T ss_pred hCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHc
Confidence 89999999999999999999999999999986433222 2244679999999999999999999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
|+.||... ...+.......... . ... ..+..+.+|+.+||+.||++||++
T Consensus 538 G~~Pf~~~---------~~~~~~~~i~~~~~--~-----~p~--------~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 538 GQAPFEGE---------DEDELFQSIMEHNV--A-----YPK--------SMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp SSCSSCCS---------SHHHHHHHHHSSCC--C-----CCT--------TSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred CCCCCCCC---------CHHHHHHHHHhCCC--C-----CCc--------cCCHHHHHHHHHHccCCHHHCCCC
Confidence 99999652 11222222222110 1 111 122578999999999999999997
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=256.97 Aligned_cols=219 Identities=21% Similarity=0.286 Sum_probs=162.2
Q ss_pred ccHHHHHHHHHHHHh--cCCCcccceeeeeeeCC----cceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchh
Q 044022 11 HTYGSCINNITYAAQ--MSHNHILKRIGCCLQTP----IPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYL 81 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~l 81 (241)
.....+.+|++++.. ++||||+++++++.... ..++||||+++|+|.+++..... ..+.++.+++.||.||
T Consensus 76 ~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~l 155 (342)
T 1b6c_B 76 REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 155 (342)
T ss_dssp GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHH
Confidence 345678899999988 79999999999998775 78999999999999999976543 4678999999999999
Q ss_pred hcCC-----CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcce--eecccccCCCccCccccccc------CCC
Q 044022 82 HFGF-----PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI--TTDRVIGTRGYSAPEYISIC------VLN 148 (241)
Q Consensus 82 h~~~-----~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~------~~~ 148 (241)
|... +.+++||||||+||+++.++.+||+|||.+.......... ......|++.|+|||.+.+. .++
T Consensus 156 H~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 235 (342)
T 1b6c_B 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 235 (342)
T ss_dssp HCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHH
T ss_pred HHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccC
Confidence 9321 4689999999999999999999999999997665433221 22345689999999998765 233
Q ss_pred cchhhHHHHHHHHHHHhc----------CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHH
Q 044022 149 EKSNVFSFGAFLFELLAG----------RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQL 218 (241)
Q Consensus 149 ~~~Di~s~G~~~~~~~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (241)
.++||||||+++|+|++| ..||....... ........... ..... +.+... .......
T Consensus 236 ~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~----~~~~~~~~~~~-~~~~~----~~~~~~---~~~~~~~ 303 (342)
T 1b6c_B 236 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD----PSVEEMRKVVC-EQKLR----PNIPNR---WQSCEAL 303 (342)
T ss_dssp HHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS----CCHHHHHHHHT-TSCCC----CCCCGG---GGTSHHH
T ss_pred CcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc----ccHHHHHHHHH-HHHhC----CCCccc---ccchhHH
Confidence 689999999999999999 67775422111 11122222221 11111 111111 1112566
Q ss_pred HHHHHHHHHhccCCCCCCCCCCC
Q 044022 219 HASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 219 ~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
..+.+++.+||+.||++|||++|
T Consensus 304 ~~l~~li~~cl~~dp~~Rps~~~ 326 (342)
T 1b6c_B 304 RVMAKIMRECWYANGAARLTALR 326 (342)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHH
T ss_pred HHHHHHHHHHhccChhhCCCHHH
Confidence 78999999999999999999853
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=252.96 Aligned_cols=199 Identities=22% Similarity=0.288 Sum_probs=151.0
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeC-CcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhchhhcC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQT-PIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLAYLHFG 84 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~~lh~~ 84 (241)
..+.+.+|++++++++||||+++++++... +..++||||+++++|.+++.... .....++.+++.||.|||
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH-- 134 (278)
T 1byg_A 57 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-- 134 (278)
T ss_dssp --HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH--
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH--
Confidence 467799999999999999999999987654 47899999999999999986532 246789999999999999
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHH
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~ 164 (241)
+.+++|+||||+||+++.++.++|+|||.+....... ....+++.|+|||.+.+..++.++||||||+++|+|+
T Consensus 135 -~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 208 (278)
T 1byg_A 135 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 208 (278)
T ss_dssp -HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred -hCCccccCCCcceEEEeCCCcEEEeeccccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHH
Confidence 8999999999999999999999999999987544322 2235678899999999888999999999999999999
Q ss_pred h-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 165 A-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 165 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+ |..||..... .+...... .+.. ..... ..++.+.+++.+||+.||++|||+.|
T Consensus 209 t~g~~p~~~~~~---------~~~~~~~~-~~~~-----~~~~~--------~~~~~l~~li~~~l~~~p~~Rps~~~ 263 (278)
T 1byg_A 209 SFGRVPYPRIPL---------KDVVPRVE-KGYK-----MDAPD--------GCPPAVYEVMKNCWHLDAAMRPSFLQ 263 (278)
T ss_dssp TTSCCSCTTSCG---------GGHHHHHT-TTCC-----CCCCT--------TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hCCCCCCCCCCH---------HHHHHHHh-cCCC-----CCCcc--------cCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 8 9999965211 11111111 1110 11111 12367899999999999999999753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=254.52 Aligned_cols=196 Identities=15% Similarity=0.170 Sum_probs=155.4
Q ss_pred ccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--------CchHHHHHHHHHHHhchh
Q 044022 11 HTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--------PLPRLKIASDIVNSLAYL 81 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--------~~~~~~~~~~i~~~l~~l 81 (241)
....++.+|+..+.++ +||||+++++++...+..++||||+++++|.+++... ......++.|++.||.||
T Consensus 52 ~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~l 131 (289)
T 1x8b_A 52 VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131 (289)
T ss_dssp HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH
Confidence 4567788999999999 9999999999999999999999999999999998652 124678999999999999
Q ss_pred hcCCCCCceeccCCCCCeeecCC-------------------CCeEEeeccCceecCCCCcceeecccccCCCccCcccc
Q 044022 82 HFGFPRPIVLRNFKTQNILFNEE-------------------NVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYI 142 (241)
Q Consensus 82 h~~~~~~ivh~dl~~~nil~~~~-------------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 142 (241)
| +.+++||||||+||+++.+ ..++|+|||.+....... ...+++.|+|||.+
T Consensus 132 H---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~ 202 (289)
T 1x8b_A 132 H---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVL 202 (289)
T ss_dssp H---HTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHH
T ss_pred H---hCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHh
Confidence 9 8999999999999999844 479999999998765432 23588999999999
Q ss_pred ccc-CCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHH
Q 044022 143 SIC-VLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHAS 221 (241)
Q Consensus 143 ~~~-~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (241)
.+. .++.++||||||+++|+|++|.+|+.... .... ...+... .+.... +..+
T Consensus 203 ~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------------~~~~-~~~~~~~-----~~~~~~--------~~~~ 256 (289)
T 1x8b_A 203 QENYTHLPKADIFALALTVVCAAGAEPLPRNGD------------QWHE-IRQGRLP-----RIPQVL--------SQEF 256 (289)
T ss_dssp TTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------------HHHH-HHTTCCC-----CCSSCC--------CHHH
T ss_pred cCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------------HHHH-HHcCCCC-----CCCccc--------CHHH
Confidence 866 56689999999999999999988764310 0111 1111111 111222 2578
Q ss_pred HHHHHHhccCCCCCCCCCCC
Q 044022 222 AQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 222 ~~l~~~cl~~~p~~Rpt~~e 241 (241)
.+++.+||+.||++|||+.|
T Consensus 257 ~~li~~~l~~dp~~Rps~~~ 276 (289)
T 1x8b_A 257 TELLKVMIHPDPERRPSAMA 276 (289)
T ss_dssp HHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHhCCCcccCCCHHH
Confidence 99999999999999999853
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=255.03 Aligned_cols=213 Identities=21% Similarity=0.254 Sum_probs=157.2
Q ss_pred HHHHHHHHHHHHhcC---CCcccceeeeeeeCC-----cceEEEEecCCCCHHHhhcCCCc------hHHHHHHHHHHHh
Q 044022 13 YGSCINNITYAAQMS---HNHILKRIGCCLQTP-----IPILVFQSVEYGTLRDCIFGAPL------PRLKIASDIVNSL 78 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~~i~~~l 78 (241)
...+.+|+.++++++ ||||+++++++.... ..++|+||+. ++|.+++..... .+..++.|++.||
T Consensus 55 ~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al 133 (308)
T 3g33_A 55 PISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 133 (308)
T ss_dssp CHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHH
Confidence 456778888888774 999999999998765 5799999997 699999876532 4678999999999
Q ss_pred chhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHH
Q 044022 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGA 158 (241)
Q Consensus 79 ~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~ 158 (241)
.||| +.+++||||||+||+++.++.+||+|||.+........ .....+|+.|+|||++.+..++.++||||||+
T Consensus 134 ~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 207 (308)
T 3g33_A 134 DFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGC 207 (308)
T ss_dssp HHHH---HTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHH
T ss_pred HHHH---HCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHH
Confidence 9999 89999999999999999999999999999976543322 23457899999999999899999999999999
Q ss_pred HHHHHHhcCcccccccccCCCcccchHHHHHHHhhh---cccCCCCC------CccccCCCch---hHHHHHHHHHHHHH
Q 044022 159 FLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLED---KRFTGIPA------PIIVQDIPCI---EKEQQLHASAQLTL 226 (241)
Q Consensus 159 ~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~------~~~~~~~~~~---~~~~~~~~~~~l~~ 226 (241)
++|+|++|+.||.... ..+........ ......+. .......+.. .....++.+.+|+.
T Consensus 208 il~~l~~g~~pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 278 (308)
T 3g33_A 208 IFAEMFRRKPLFCGNS---------EADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLL 278 (308)
T ss_dssp HHHHTTTSSCSCCCSS---------HHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCC---------HHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHH
Confidence 9999999999995521 11111111110 00000000 0000000000 00123367889999
Q ss_pred HhccCCCCCCCCCCC
Q 044022 227 ECVNNSPEDRPTMVD 241 (241)
Q Consensus 227 ~cl~~~p~~Rpt~~e 241 (241)
+||+.||++|||+.|
T Consensus 279 ~~L~~dP~~R~t~~e 293 (308)
T 3g33_A 279 EMLTFNPHKRISAFR 293 (308)
T ss_dssp HHTCSSTTTSCCHHH
T ss_pred HHhcCCCccCCCHHH
Confidence 999999999999853
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=258.87 Aligned_cols=215 Identities=23% Similarity=0.317 Sum_probs=160.3
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCC--cceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHHHHhchhhc
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTP--IPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~~~l~~lh~ 83 (241)
...+.+.+|++++++++||||+++++++...+ ..++||||+++++|.+++.... . ..+.++.+++.||.|||
T Consensus 84 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH- 162 (326)
T 2w1i_A 84 EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG- 162 (326)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH-
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH-
Confidence 45678999999999999999999999987644 7899999999999999986542 1 46789999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCccee-ecccccCCCccCcccccccCCCcchhhHHHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT-TDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~ 162 (241)
+.+++|+||||+||+++.++.++|+|||.+........... .....++..|+|||.+.+..++.++||||||+++|+
T Consensus 163 --~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 240 (326)
T 2w1i_A 163 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 240 (326)
T ss_dssp --HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred --hCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHH
Confidence 89999999999999999999999999999987655432211 223346777999999998889999999999999999
Q ss_pred HHhcCcccccccccC------CCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCC
Q 044022 163 LLAGRIHIWDLLKDT------HDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDR 236 (241)
Q Consensus 163 ~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 236 (241)
|++|..|+....... ....................... .. ..+..+.+++.+||+.||++|
T Consensus 241 l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~--------~~~~~l~~li~~cl~~dP~~R 307 (326)
T 2w1i_A 241 LFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR-----PD--------GCPDEIYMIMTECWNNNVNQR 307 (326)
T ss_dssp HHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCC-----CT--------TCCHHHHHHHHHHSCSSGGGS
T ss_pred HHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCC-----CC--------cccHHHHHHHHHHcCCChhhC
Confidence 999999986421100 00000001111111111111111 11 223678999999999999999
Q ss_pred CCCCC
Q 044022 237 PTMVD 241 (241)
Q Consensus 237 pt~~e 241 (241)
||+.|
T Consensus 308 ps~~e 312 (326)
T 2w1i_A 308 PSFRD 312 (326)
T ss_dssp CCHHH
T ss_pred cCHHH
Confidence 99753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=255.86 Aligned_cols=156 Identities=16% Similarity=0.247 Sum_probs=135.8
Q ss_pred ccHHHHHHHHHHHHhcC-CCcccceeeeeee--CCcceEEEEecCCCCHHHhhcCCCc-hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMS-HNHILKRIGCCLQ--TPIPILVFQSVEYGTLRDCIFGAPL-PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|++++++++ ||||+++++++.. ....++||||+.+++|.+++..... ....++.+++.||.||| +
T Consensus 72 ~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~ 148 (330)
T 3nsz_A 72 VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---S 148 (330)
T ss_dssp CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHH---h
Confidence 34678999999999997 9999999999987 5678999999999999999876544 56789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCC-CeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEEN-VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~~~~~ 164 (241)
.+++||||||+|||++.++ .++|+|||.+........ .....++..|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 149 ~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 225 (330)
T 3nsz_A 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 225 (330)
T ss_dssp TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHH
Confidence 9999999999999999777 899999999986654332 133468889999999877 56899999999999999999
Q ss_pred hcCccccc
Q 044022 165 AGRIHIWD 172 (241)
Q Consensus 165 ~g~~p~~~ 172 (241)
+|+.||..
T Consensus 226 ~g~~p~~~ 233 (330)
T 3nsz_A 226 FRKEPFFH 233 (330)
T ss_dssp HTCSSSSC
T ss_pred hCCCCccc
Confidence 99999954
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=262.51 Aligned_cols=203 Identities=24% Similarity=0.383 Sum_probs=159.4
Q ss_pred HHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCC
Q 044022 13 YGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 13 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
.+.+.+|+.+++++ +||||+++++++...+..++||||+++++|.+++.... .....++.+++.||.||| +.
T Consensus 143 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH---~~ 219 (365)
T 2y7j_A 143 REATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH---AN 219 (365)
T ss_dssp HHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred HHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 56688999999999 89999999999999999999999999999999986432 246789999999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc------cCCCcchhhHHHHHHHH
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI------CVLNEKSNVFSFGAFLF 161 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Di~s~G~~~~ 161 (241)
+++|+||||+||+++.++.++|+|||++......... ....||+.|+|||++.+ ..++.++||||||+++|
T Consensus 220 gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ 296 (365)
T 2y7j_A 220 NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296 (365)
T ss_dssp TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHH
T ss_pred CeecCCCCHHHEEECCCCCEEEEecCcccccCCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHH
Confidence 9999999999999999999999999998876543321 33578999999999863 35788999999999999
Q ss_pred HHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 162 ELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 162 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|++|..||.... ......... .+... ...+ .....+..+.+++.+||+.||++|||++|
T Consensus 297 ell~g~~pf~~~~---------~~~~~~~i~-~~~~~-~~~~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~e 356 (365)
T 2y7j_A 297 TLLAGSPPFWHRR---------QILMLRMIM-EGQYQ-FSSP---------EWDDRSSTVKDLISRLLQVDPEARLTAEQ 356 (365)
T ss_dssp HHHHSSCSSCCSS---------HHHHHHHHH-HTCCC-CCHH---------HHSSSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHCCCCCCCCC---------HHHHHHHHH-hCCCC-CCCc---------ccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999999996521 111111111 11110 0000 00122356889999999999999999853
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=252.19 Aligned_cols=194 Identities=23% Similarity=0.342 Sum_probs=155.6
Q ss_pred HHHHHHHHHHHhcCCCcccceeeeeee----------------CCcceEEEEecCCCCHHHhhcCC---Cc---hHHHHH
Q 044022 14 GSCINNITYAAQMSHNHILKRIGCCLQ----------------TPIPILVFQSVEYGTLRDCIFGA---PL---PRLKIA 71 (241)
Q Consensus 14 ~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~~~~sL~~~l~~~---~~---~~~~~~ 71 (241)
+.+.+|++++++++||||+++++++.. ....++||||+++++|.+++... .. ....++
T Consensus 49 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~ 128 (284)
T 2a19_B 49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128 (284)
T ss_dssp GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHH
Confidence 567899999999999999999998864 34579999999999999998543 11 467899
Q ss_pred HHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcch
Q 044022 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKS 151 (241)
Q Consensus 72 ~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 151 (241)
.+++.||.||| +.+++|+||||+||+++.++.++|+|||.+......... ....+++.|+|||.+.+..++.++
T Consensus 129 ~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~ 202 (284)
T 2a19_B 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEV 202 (284)
T ss_dssp HHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHH
T ss_pred HHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEEECcchhheeccccccc---cccCCcccccChhhhccCCCcchh
Confidence 99999999999 899999999999999999999999999999876554321 234689999999999988899999
Q ss_pred hhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccC
Q 044022 152 NVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNN 231 (241)
Q Consensus 152 Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~ 231 (241)
||||||+++|+|++|..|+... ....... ..... ... .+..+.+++.+||+.
T Consensus 203 Di~slG~il~~l~~~~~~~~~~-----------~~~~~~~-~~~~~--------~~~--------~~~~~~~li~~~l~~ 254 (284)
T 2a19_B 203 DLYALGLILAELLHVCDTAFET-----------SKFFTDL-RDGII--------SDI--------FDKKEKTLLQKLLSK 254 (284)
T ss_dssp HHHHHHHHHHHHHSCCSSHHHH-----------HHHHHHH-HTTCC--------CTT--------SCHHHHHHHHHHTCS
T ss_pred hhHHHHHHHHHHHhcCCcchhH-----------HHHHHHh-hcccc--------ccc--------CCHHHHHHHHHHccC
Confidence 9999999999999999887431 0111111 11111 111 125688999999999
Q ss_pred CCCCCCCCCC
Q 044022 232 SPEDRPTMVD 241 (241)
Q Consensus 232 ~p~~Rpt~~e 241 (241)
||++|||+.|
T Consensus 255 dp~~Rps~~e 264 (284)
T 2a19_B 255 KPEDRPNTSE 264 (284)
T ss_dssp SGGGSCCHHH
T ss_pred ChhhCcCHHH
Confidence 9999999753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=278.27 Aligned_cols=205 Identities=20% Similarity=0.278 Sum_probs=157.6
Q ss_pred ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHHHHhchhhc
Q 044022 9 HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 9 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~~~l~~lh~ 83 (241)
.....+.|.+|+.++++++||||+++++++. .+..++||||+++|+|.+++.... . ..+.++.+++.||.|||
T Consensus 431 ~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH- 508 (656)
T 2j0j_A 431 SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE- 508 (656)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH-
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 3344578999999999999999999999985 456899999999999999986442 1 46788999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+.+++||||||+|||++.++.+||+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|
T Consensus 509 --~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el 585 (656)
T 2j0j_A 509 --SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 585 (656)
T ss_dssp --HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred --hCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHH
Confidence 899999999999999999999999999999766443221 12234567889999999988999999999999999999
Q ss_pred Hh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++ |..||.... ..+....... +.... .... .+..+.+++.+||+.||++|||+.|
T Consensus 586 lt~g~~Pf~~~~---------~~~~~~~i~~-~~~~~-----~~~~--------~~~~l~~li~~~l~~dP~~RPs~~e 641 (656)
T 2j0j_A 586 LMHGVKPFQGVK---------NNDVIGRIEN-GERLP-----MPPN--------CPPTLYSLMTKCWAYDPSRRPRFTE 641 (656)
T ss_dssp HTTSCCTTTTCC---------HHHHHHHHHH-TCCCC-----CCTT--------CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHcCCCCCCCCC---------HHHHHHHHHc-CCCCC-----CCcc--------ccHHHHHHHHHHcCCChhHCcCHHH
Confidence 97 999996421 1122222211 11111 1111 2257889999999999999999753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=256.56 Aligned_cols=198 Identities=15% Similarity=0.118 Sum_probs=159.3
Q ss_pred ccHHHHHHHHHHHHhcC---CCcccceeeeeeeCCcceEEEEecCCCCHHHhhcC------CCc---hHHHHHHHHHHHh
Q 044022 11 HTYGSCINNITYAAQMS---HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFG------APL---PRLKIASDIVNSL 78 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~------~~~---~~~~~~~~i~~~l 78 (241)
....++.+|+++++.++ |+||+++++++...+..++||||+++|+|.+++.. ... .+..++.|++.||
T Consensus 106 ~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L 185 (365)
T 3e7e_A 106 ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185 (365)
T ss_dssp CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHH
T ss_pred CChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHH
Confidence 35667889999999997 89999999999999999999999999999999863 111 4788999999999
Q ss_pred chhhcCCCCCceeccCCCCCeeecC-----------CCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCC
Q 044022 79 AYLHFGFPRPIVLRNFKTQNILFNE-----------ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVL 147 (241)
Q Consensus 79 ~~lh~~~~~~ivh~dl~~~nil~~~-----------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 147 (241)
.||| +++|+||||||+|||++. ++.+||+|||++................||+.|+|||++.+..+
T Consensus 186 ~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 262 (365)
T 3e7e_A 186 EQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW 262 (365)
T ss_dssp HHHH---TTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB
T ss_pred HHHh---hCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC
Confidence 9999 899999999999999998 89999999999976543333333455679999999999999999
Q ss_pred CcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHH
Q 044022 148 NEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLE 227 (241)
Q Consensus 148 ~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 227 (241)
+.++||||||+++|+|++|+.||....... ...... ....+ ..+.+.+++..
T Consensus 263 ~~~~DiwslG~il~elltg~~pf~~~~~~~-----------------~~~~~~-----~~~~~------~~~~~~~~~~~ 314 (365)
T 3e7e_A 263 NYQIDYFGVAATVYCMLFGTYMKVKNEGGE-----------------CKPEGL-----FRRLP------HLDMWNEFFHV 314 (365)
T ss_dssp STHHHHHHHHHHHHHHHHSSCCCEEEETTE-----------------EEECSC-----CTTCS------SHHHHHHHHHH
T ss_pred CccccHHHHHHHHHHHHhCCCccccCCCCc-----------------eeechh-----ccccC------cHHHHHHHHHH
Confidence 999999999999999999999985421110 000000 00011 12467789999
Q ss_pred hccCCCCCCCCC
Q 044022 228 CVNNSPEDRPTM 239 (241)
Q Consensus 228 cl~~~p~~Rpt~ 239 (241)
|++.+|.+|++.
T Consensus 315 ~l~~~p~~r~~~ 326 (365)
T 3e7e_A 315 MLNIPDCHHLPS 326 (365)
T ss_dssp HHCCCCTTCCCC
T ss_pred HcCCCCCCcchH
Confidence 999999999764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=260.06 Aligned_cols=168 Identities=21% Similarity=0.229 Sum_probs=138.3
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeC-----CcceEEEEecCCCCHHHhhcCCCc---hHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQT-----PIPILVFQSVEYGTLRDCIFGAPL---PRLKIAS 72 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~ 72 (241)
||.+.........+.+.+|++++++++||||+++++++... ...++|+||+. ++|.+++..... .+..++.
T Consensus 57 iK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~i~~ 135 (364)
T 3qyz_A 57 IKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLY 135 (364)
T ss_dssp EEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHHCCCCHHHHHHHHH
T ss_pred EEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHhCCCCHHHHHHHHH
Confidence 35554433444567899999999999999999999999754 36899999997 699998876543 4678999
Q ss_pred HHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcce-eecccccCCCccCccccccc-CCCcc
Q 044022 73 DIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI-TTDRVIGTRGYSAPEYISIC-VLNEK 150 (241)
Q Consensus 73 ~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~ 150 (241)
|++.||.||| +.+++||||||+||+++.++.++|+|||.+.......... ......||+.|+|||++.+. .++.+
T Consensus 136 qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 212 (364)
T 3qyz_A 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 212 (364)
T ss_dssp HHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTH
T ss_pred HHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcc
Confidence 9999999999 8999999999999999999999999999998665332111 12334789999999987654 58999
Q ss_pred hhhHHHHHHHHHHHhcCccccc
Q 044022 151 SNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 151 ~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
+||||||+++|+|++|+.||..
T Consensus 213 ~DiwslG~il~ell~g~~pf~~ 234 (364)
T 3qyz_A 213 IDIWSVGCILAEMLSNRPIFPG 234 (364)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCC
T ss_pred hhHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999965
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=257.66 Aligned_cols=211 Identities=18% Similarity=0.222 Sum_probs=159.9
Q ss_pred HHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHh------hcCC--C-c---hHHHHHHHHHHHhchh
Q 044022 14 GSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDC------IFGA--P-L---PRLKIASDIVNSLAYL 81 (241)
Q Consensus 14 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~------l~~~--~-~---~~~~~~~~i~~~l~~l 81 (241)
+.+.+|++++++++||||+++++++...+..++||||+++++|.++ +... . . .+..++.+++.||.||
T Consensus 88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l 167 (348)
T 2pml_X 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI 167 (348)
T ss_dssp HHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence 8899999999999999999999999999999999999999999998 6542 1 1 4678999999999999
Q ss_pred hcCCC-CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCc-chhhHHHHH
Q 044022 82 HFGFP-RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNE-KSNVFSFGA 158 (241)
Q Consensus 82 h~~~~-~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~-~~Di~s~G~ 158 (241)
| + .+++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.+. .++. ++||||||+
T Consensus 168 H---~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~ 240 (348)
T 2pml_X 168 H---NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGI 240 (348)
T ss_dssp H---HTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHH
T ss_pred h---ccCCEeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHH
Confidence 9 7 99999999999999999999999999999865443 22345689999999999877 5665 999999999
Q ss_pred HHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCc--c----ccCCCchhHHHHHHHHHHHHHHhccCC
Q 044022 159 FLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPI--I----VQDIPCIEKEQQLHASAQLTLECVNNS 232 (241)
Q Consensus 159 ~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~----~~~~~~~~~~~~~~~~~~l~~~cl~~~ 232 (241)
++|+|++|..||...... .+....... +.. ..+... . ............+..+.+++.+||+.|
T Consensus 241 il~~l~~g~~pf~~~~~~--------~~~~~~i~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 310 (348)
T 2pml_X 241 CLYVMFYNVVPFSLKISL--------VELFNNIRT-KNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKN 310 (348)
T ss_dssp HHHHHHHSSCSSCCSSCS--------HHHHHHHTS-CCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSS
T ss_pred HHHHHHhCCCCCCCCCcH--------HHHHHHHhc-cCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCC
Confidence 999999999999652110 111222111 111 111000 0 000000000123367899999999999
Q ss_pred CCCCCCCCC
Q 044022 233 PEDRPTMVD 241 (241)
Q Consensus 233 p~~Rpt~~e 241 (241)
|++|||++|
T Consensus 311 P~~Rps~~e 319 (348)
T 2pml_X 311 PAERITSED 319 (348)
T ss_dssp GGGSCCHHH
T ss_pred hhhCCCHHH
Confidence 999999853
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=261.29 Aligned_cols=204 Identities=19% Similarity=0.181 Sum_probs=156.8
Q ss_pred ccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.+.+|+++++++ .||||+++++++...+..++||||+++++|.+++.... .....++.|++.||.|||
T Consensus 100 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--- 176 (355)
T 1vzo_A 100 KTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH--- 176 (355)
T ss_dssp SSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred hHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 3456778899999999 69999999999999999999999999999999986432 246778999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc--cCCCcchhhHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI--CVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~s~G~~~~~~ 163 (241)
+.+++||||||+|||++.++.+||+|||++.......... .....||+.|+|||++.+ ..++.++||||||+++|+|
T Consensus 177 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~el 255 (355)
T 1vzo_A 177 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 255 (355)
T ss_dssp HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHH
T ss_pred HCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHH
Confidence 8999999999999999999999999999997654332211 233568999999999985 3478899999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
++|+.||...... .............. +.... ..+..+.+|+.+||..||++||+
T Consensus 256 l~g~~pf~~~~~~-----~~~~~~~~~~~~~~-------~~~~~--------~~~~~~~~li~~~L~~dP~~R~~ 310 (355)
T 1vzo_A 256 LTGASPFTVDGEK-----NSQAEISRRILKSE-------PPYPQ--------EMSALAKDLIQRLLMKDPKKRLG 310 (355)
T ss_dssp HHSSCTTSCTTSC-----CCHHHHHHHHHHCC-------CCCCT--------TSCHHHHHHHHHHTCSSGGGSTT
T ss_pred HHCCCCCccCCcc-----chHHHHHHHHhccC-------CCCCc--------ccCHHHHHHHHHHhhhCHHHhcC
Confidence 9999999642111 11122222221111 01111 12256889999999999999993
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=261.83 Aligned_cols=163 Identities=21% Similarity=0.290 Sum_probs=124.0
Q ss_pred Cccccccc-ccccHHHHHHHHHHHHhcCCCcccceeeeeeeC------CcceEEEEecCCCCHHHhhcCCCc---hHHHH
Q 044022 1 MKFYGHEY-HRHTYGSCINNITYAAQMSHNHILKRIGCCLQT------PIPILVFQSVEYGTLRDCIFGAPL---PRLKI 70 (241)
Q Consensus 1 iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~ 70 (241)
||.+.... ......++.+|++++++++||||+++++++... ...++|+|++ +++|.+++..... ....+
T Consensus 59 iK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i 137 (367)
T 2fst_X 59 VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL 137 (367)
T ss_dssp EEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-----CCCCHHHHHHH
T ss_pred EEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHH
Confidence 35444332 223467788999999999999999999998754 5679999999 6899998876533 46789
Q ss_pred HHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCc
Q 044022 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNE 149 (241)
Q Consensus 71 ~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~ 149 (241)
+.||+.||.||| +.+++||||||+|||++.++.+||+|||++...... .....+|+.|+|||++.+ ..++.
T Consensus 138 ~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~ 209 (367)
T 2fst_X 138 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQ 209 (367)
T ss_dssp HHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCT
T ss_pred HHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCc
Confidence 999999999999 899999999999999999999999999999765432 133468999999999887 57899
Q ss_pred chhhHHHHHHHHHHHhcCccccc
Q 044022 150 KSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 150 ~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
++|||||||++|+|++|+.||..
T Consensus 210 ~~DiwslG~il~ell~g~~pf~~ 232 (367)
T 2fst_X 210 TVDIWSVGCIMAELLTGRTLFPG 232 (367)
T ss_dssp THHHHHHHHHHHHHHHSSCSCCC
T ss_pred hhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999954
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=257.79 Aligned_cols=168 Identities=20% Similarity=0.182 Sum_probs=136.1
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeC-----CcceEEEEecCCCCHHHhhcCCCc---hHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQT-----PIPILVFQSVEYGTLRDCIFGAPL---PRLKIAS 72 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~ 72 (241)
||.+..........++.+|++++++++||||+++++++... ...++|+||+. ++|.+++..... ....++.
T Consensus 41 iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~ 119 (353)
T 2b9h_A 41 IKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIY 119 (353)
T ss_dssp EEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHCCCCHHHHHHHHH
T ss_pred EEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhhcCCCHHHHHHHHH
Confidence 35554333334566788999999999999999999988754 57899999997 699998876433 4678999
Q ss_pred HHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcce--------eecccccCCCccCcccccc
Q 044022 73 DIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI--------TTDRVIGTRGYSAPEYISI 144 (241)
Q Consensus 73 ~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~ 144 (241)
+++.||.||| +.+++||||||+||+++.++.++|+|||.+.......... ......||+.|+|||++..
T Consensus 120 qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 196 (353)
T 2b9h_A 120 QTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196 (353)
T ss_dssp HHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHS
T ss_pred HHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeecc
Confidence 9999999999 8999999999999999999999999999998765322111 1123467899999998764
Q ss_pred -cCCCcchhhHHHHHHHHHHHhcCccccc
Q 044022 145 -CVLNEKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 145 -~~~~~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
..++.++||||||+++|+|++|+.||..
T Consensus 197 ~~~~~~~~Di~slG~il~~l~~g~~pf~~ 225 (353)
T 2b9h_A 197 SAKYSRAMDVWSCGCILAELFLRRPIFPG 225 (353)
T ss_dssp CCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 6788999999999999999999999965
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=253.87 Aligned_cols=158 Identities=18% Similarity=0.228 Sum_probs=131.9
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeee--------CCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHH
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQ--------TPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNS 77 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~ 77 (241)
.....+.+|++++++++||||+++++++.. .+..++||||+. ++|.+.+.... ..+..++.|++.|
T Consensus 58 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~ 136 (351)
T 3mi9_A 58 GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136 (351)
T ss_dssp SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHH
Confidence 345678899999999999999999999987 346899999997 57777765432 1467899999999
Q ss_pred hchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCc--ceeecccccCCCccCcccccc-cCCCcchhhH
Q 044022 78 LAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET--HITTDRVIGTRGYSAPEYISI-CVLNEKSNVF 154 (241)
Q Consensus 78 l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~ 154 (241)
|.||| +.+++||||||+|||++.++.+||+|||.+........ ........+|+.|+|||++.+ ..++.++|||
T Consensus 137 l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 213 (351)
T 3mi9_A 137 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLW 213 (351)
T ss_dssp HHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHH
T ss_pred HHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHH
Confidence 99999 89999999999999999999999999999986643211 112234568999999999876 4579999999
Q ss_pred HHHHHHHHHHhcCccccc
Q 044022 155 SFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 155 s~G~~~~~~~~g~~p~~~ 172 (241)
|||+++|+|++|..||..
T Consensus 214 slG~il~ell~g~~pf~~ 231 (351)
T 3mi9_A 214 GAGCIMAEMWTRSPIMQG 231 (351)
T ss_dssp HHHHHHHHHHHSSCSCCC
T ss_pred HHHHHHHHHHhCCCCCCC
Confidence 999999999999999965
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=249.29 Aligned_cols=209 Identities=16% Similarity=0.205 Sum_probs=157.1
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeee-eeCCcceEEEEecCCCCHHHhhcCC--Cc---hHHHHHHHHHHHhchhhcCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCC-LQTPIPILVFQSVEYGTLRDCIFGA--PL---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~--~~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
.+++.+|++++++++|++++..+..+ ...+..++||||+ +++|.+++... .. ....++.+++.||.||| +
T Consensus 48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~ 123 (296)
T 4hgt_A 48 HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---S 123 (296)
T ss_dssp CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 34688999999999998877766655 5667789999999 89999998632 22 56789999999999999 8
Q ss_pred CCceeccCCCCCeee---cCCCCeEEeeccCceecCCCCcc-----eeecccccCCCccCcccccccCCCcchhhHHHHH
Q 044022 87 RPIVLRNFKTQNILF---NEENVAKWFDFLLSISIPEGETH-----ITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGA 158 (241)
Q Consensus 87 ~~ivh~dl~~~nil~---~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~ 158 (241)
.+++||||||+||++ +.++.+||+|||.+......... .......+++.|+|||.+.+..++.++||||||+
T Consensus 124 ~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 203 (296)
T 4hgt_A 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGY 203 (296)
T ss_dssp TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHH
T ss_pred CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHH
Confidence 999999999999999 78899999999999876543221 1223457899999999999989999999999999
Q ss_pred HHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 159 FLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 159 ~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
++|+|++|+.||........ ............. . +.+.... ..+..+.+++.+||+.||++|||
T Consensus 204 il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~-~-----~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rpt 267 (296)
T 4hgt_A 204 VLMYFNLGSLPWQGLKAATK--RQKYERISEKKMS-T-----PIEVLCK--------GYPSEFATYLNFCRSLRFDDKPD 267 (296)
T ss_dssp HHHHHHHSSCTTSSCCCSSS--SSHHHHHHHHHHH-S-----CHHHHTT--------TSCHHHHHHHHHHHTSCTTCCCC
T ss_pred HHHHHhcCCCCCcccchhhh--hhhhhhhhccccc-c-----hhhhhhc--------cCCHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999965322211 1111111111100 0 0000001 11257899999999999999999
Q ss_pred CCC
Q 044022 239 MVD 241 (241)
Q Consensus 239 ~~e 241 (241)
++|
T Consensus 268 ~~~ 270 (296)
T 4hgt_A 268 YSY 270 (296)
T ss_dssp HHH
T ss_pred HHH
Confidence 753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=250.46 Aligned_cols=203 Identities=14% Similarity=0.197 Sum_probs=155.1
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeee--eCCcceEEEEecCCCCHHHhhcCC---Cc---hHHHHHHHHHHHhchhh
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCL--QTPIPILVFQSVEYGTLRDCIFGA---PL---PRLKIASDIVNSLAYLH 82 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~---~~---~~~~~~~~i~~~l~~lh 82 (241)
.....+.+|++++++++||||+++++++. ..+..++||||+.++ |.+++... .. ....++.+++.||.|||
T Consensus 48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH 126 (305)
T 2wtk_C 48 NGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH 126 (305)
T ss_dssp THHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH
Confidence 34677999999999999999999999984 455789999999865 76665432 11 46789999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccC--CCcchhhHHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV--LNEKSNVFSFGAFL 160 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~s~G~~~ 160 (241)
+.+++|+||||+||+++.++.++|+|||.+................+++.|+|||++.+.. .+.++||||||+++
T Consensus 127 ---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il 203 (305)
T 2wtk_C 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203 (305)
T ss_dssp ---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHH
T ss_pred ---HCCeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHH
Confidence 8999999999999999999999999999998765433333334556899999999987643 37799999999999
Q ss_pred HHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 161 FELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 161 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
|+|++|..||... ...+...... .... .+... .+..+.+++.+||+.||++|||++
T Consensus 204 ~~l~~g~~p~~~~---------~~~~~~~~i~-~~~~------~~~~~--------~~~~l~~li~~~l~~dp~~Rps~~ 259 (305)
T 2wtk_C 204 YNITTGLYPFEGD---------NIYKLFENIG-KGSY------AIPGD--------CGPPLSDLLKGMLEYEPAKRFSIR 259 (305)
T ss_dssp HHHHHSSCSCCCS---------SHHHHHHHHH-HCCC------CCCSS--------SCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHhCCCCCCCc---------hHHHHHHHHh-cCCC------CCCCc--------cCHHHHHHHHHHccCChhhCCCHH
Confidence 9999999999641 1122222221 1111 11111 225788999999999999999975
Q ss_pred C
Q 044022 241 D 241 (241)
Q Consensus 241 e 241 (241)
|
T Consensus 260 ~ 260 (305)
T 2wtk_C 260 Q 260 (305)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=259.59 Aligned_cols=211 Identities=14% Similarity=0.177 Sum_probs=157.1
Q ss_pred HHHHHHHHHHHhcCCCcccc---------------eeeeeee-CCcceEEEEecCCCCHHHhhcCC---C---chHHHHH
Q 044022 14 GSCINNITYAAQMSHNHILK---------------RIGCCLQ-TPIPILVFQSVEYGTLRDCIFGA---P---LPRLKIA 71 (241)
Q Consensus 14 ~~~~~e~~~l~~l~h~~iv~---------------~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~---~---~~~~~~~ 71 (241)
+.+.+|++++++++||||++ +++++.. .+..++||||+ +++|.+++... . ..+..++
T Consensus 87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~ 165 (352)
T 2jii_A 87 GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVA 165 (352)
T ss_dssp STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHH
T ss_pred chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHH
Confidence 56889999999999999998 5666665 67889999999 89999998754 1 1468899
Q ss_pred HHHHHHhchhhcCCCCCceeccCCCCCeeecCCC--CeEEeeccCceecCCCCcc-----eeecccccCCCccCcccccc
Q 044022 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEEN--VAKWFDFLLSISIPEGETH-----ITTDRVIGTRGYSAPEYISI 144 (241)
Q Consensus 72 ~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~--~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~ 144 (241)
.|++.||.||| +.+++||||||+||+++.++ .++|+|||++......... .......|++.|+|||++.+
T Consensus 166 ~qi~~~L~~LH---~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 242 (352)
T 2jii_A 166 CRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG 242 (352)
T ss_dssp HHHHHHHHHHH---HTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHH---hCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc
Confidence 99999999999 89999999999999999998 9999999999765432211 11123468999999999998
Q ss_pred cCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHH
Q 044022 145 CVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQL 224 (241)
Q Consensus 145 ~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 224 (241)
..++.++||||||+++|+|++|+.||....... ............. ........... ...+..+.++
T Consensus 243 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~~~~-------~~~~~~l~~l 309 (352)
T 2jii_A 243 CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT----EDIMKQKQKFVDK--PGPFVGPCGHW-------IRPSETLQKY 309 (352)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH----HHHHHHHHHHHHS--CCCEECTTSCE-------ECCCHHHHHH
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH----HHHHHHHHhccCC--hhhhhhhcccc-------CCCcHHHHHH
Confidence 899999999999999999999999996532110 0111111111111 11111100000 0112678999
Q ss_pred HHHhccCCCCCCCCCCC
Q 044022 225 TLECVNNSPEDRPTMVD 241 (241)
Q Consensus 225 ~~~cl~~~p~~Rpt~~e 241 (241)
+.+||+.||++|||++|
T Consensus 310 i~~~l~~dp~~Rps~~~ 326 (352)
T 2jii_A 310 LKVVMALTYEEKPPYAM 326 (352)
T ss_dssp HHHHHTCCTTCCCCHHH
T ss_pred HHHHHhCChhhCCCHHH
Confidence 99999999999999753
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=248.41 Aligned_cols=209 Identities=16% Similarity=0.193 Sum_probs=156.7
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeee-eeCCcceEEEEecCCCCHHHhhcCC--Cc---hHHHHHHHHHHHhchhhcCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCC-LQTPIPILVFQSVEYGTLRDCIFGA--PL---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~--~~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
.+++.+|+.++++++|++++..+..+ ...+..++||||+ +++|.+++... .. ....++.|++.||.||| +
T Consensus 48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~ 123 (296)
T 3uzp_A 48 HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---S 123 (296)
T ss_dssp CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 45689999999999998877666655 5566789999999 89999998632 22 46789999999999999 8
Q ss_pred CCceeccCCCCCeee---cCCCCeEEeeccCceecCCCCcce-----eecccccCCCccCcccccccCCCcchhhHHHHH
Q 044022 87 RPIVLRNFKTQNILF---NEENVAKWFDFLLSISIPEGETHI-----TTDRVIGTRGYSAPEYISICVLNEKSNVFSFGA 158 (241)
Q Consensus 87 ~~ivh~dl~~~nil~---~~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~ 158 (241)
++++||||||+||++ +.++.+||+|||.+.......... ......|++.|+|||.+.+..++.++||||||+
T Consensus 124 ~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 203 (296)
T 3uzp_A 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGY 203 (296)
T ss_dssp TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHH
Confidence 999999999999999 488999999999998765433211 123456899999999999989999999999999
Q ss_pred HHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 159 FLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 159 ~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
++|+|++|+.||....... ................ .+.... ..++.+.+++.+||+.||++|||
T Consensus 204 il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~------~~~~~~--------~~~~~l~~li~~~l~~dp~~Rps 267 (296)
T 3uzp_A 204 VLMYFNLGSLPWQGLKAAT--KRQKYERISEKKMSTP------IEVLCK--------GYPSEFATYLNFCRSLRFDDKPD 267 (296)
T ss_dssp HHHHHHHSSCTTSSCCCSS--SSSHHHHHHHHHHHSC------HHHHTT--------TSCHHHHHHHHHHHTSCTTCCCC
T ss_pred HHHHHHhCCCCCCCcCchh--hhhhhhhhcccccCCc------hHHHHh--------hCCHHHHHHHHHHHhcCcCcCCC
Confidence 9999999999996532211 1111111111111000 000111 12257899999999999999999
Q ss_pred CCC
Q 044022 239 MVD 241 (241)
Q Consensus 239 ~~e 241 (241)
++|
T Consensus 268 ~~~ 270 (296)
T 3uzp_A 268 YSY 270 (296)
T ss_dssp HHH
T ss_pred HHH
Confidence 753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=250.05 Aligned_cols=204 Identities=23% Similarity=0.330 Sum_probs=160.3
Q ss_pred cHHHHHHHHHHHHhcC-CCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 12 TYGSCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..+.+.+|++++++++ ||||+++++++...+..++||||+++++|.+++.... .....++.+++.||.||| +
T Consensus 66 ~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~ 142 (298)
T 1phk_A 66 LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---K 142 (298)
T ss_dssp HHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 3567889999999995 9999999999999999999999999999999986532 256789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc------ccCCCcchhhHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS------ICVLNEKSNVFSFGAFL 160 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~Di~s~G~~~ 160 (241)
.+++|+||+|+||+++.++.++|+|||.+......... ....+++.|+|||++. ...++.++||||||+++
T Consensus 143 ~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l 219 (298)
T 1phk_A 143 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219 (298)
T ss_dssp TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHH
T ss_pred CCcccCCCCcceEEEcCCCcEEEecccchhhcCCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHH
Confidence 99999999999999999999999999999876543321 2346889999999885 34678899999999999
Q ss_pred HHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 161 FELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 161 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
|+|++|..||.... ..+......... .. ...+.. ...+..+.+++.+||+.||++|||++
T Consensus 220 ~~l~~g~~p~~~~~---------~~~~~~~~~~~~-~~-~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~ 279 (298)
T 1phk_A 220 YTLLAGSPPFWHRK---------QMLMLRMIMSGN-YQ-FGSPEW---------DDYSDTVKDLVSRFLVVQPQKRYTAE 279 (298)
T ss_dssp HHHHHSSCSSCCSS---------HHHHHHHHHHTC-CC-CCTTTG---------GGSCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HHHHHCCCCCcCcc---------HHHHHHHHhcCC-cc-cCcccc---------cccCHHHHHHHHHHccCCcccCCCHH
Confidence 99999999995421 111222221111 11 111110 12336789999999999999999975
Q ss_pred C
Q 044022 241 D 241 (241)
Q Consensus 241 e 241 (241)
|
T Consensus 280 ~ 280 (298)
T 1phk_A 280 E 280 (298)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=254.29 Aligned_cols=205 Identities=19% Similarity=0.220 Sum_probs=155.7
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--C---chHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--P---LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~---~~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+++.+|++++++++||||+++++++...+..++||||+++++|.+++... . .....++.+++.||.|||
T Consensus 58 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--- 134 (302)
T 2j7t_A 58 EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH--- 134 (302)
T ss_dssp CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---
Confidence 45778999999999999999999999999999999999999999999987542 1 246789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc-----ccCCCcchhhHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS-----ICVLNEKSNVFSFGAFL 160 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~s~G~~~ 160 (241)
+.+++|+||||+||+++.++.++|+|||.+....... .......+++.|+|||.+. ...++.++||||||+++
T Consensus 135 ~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il 212 (302)
T 2j7t_A 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 212 (302)
T ss_dssp HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHH
T ss_pred cCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHH
Confidence 8999999999999999999999999999864321110 0112346889999999983 56788999999999999
Q ss_pred HHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 161 FELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 161 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
|+|++|..||.... ..+......... ..... ... ..+..+.+++.+||+.||++|||++
T Consensus 213 ~~l~~g~~p~~~~~---------~~~~~~~~~~~~-~~~~~---~~~--------~~~~~l~~li~~~l~~dp~~Rps~~ 271 (302)
T 2j7t_A 213 IEMAQIEPPHHELN---------PMRVLLKIAKSD-PPTLL---TPS--------KWSVEFRDFLKIALDKNPETRPSAA 271 (302)
T ss_dssp HHHHHSSCTTTTSC---------HHHHHHHHHHSC-CCCCS---SGG--------GSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred HHHhcCCCCCccCC---------HHHHHHHHhccC-CcccC---Ccc--------ccCHHHHHHHHHHcccChhhCCCHH
Confidence 99999999996521 111111111111 10000 011 2235788999999999999999975
Q ss_pred C
Q 044022 241 D 241 (241)
Q Consensus 241 e 241 (241)
|
T Consensus 272 ~ 272 (302)
T 2j7t_A 272 Q 272 (302)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=260.67 Aligned_cols=203 Identities=19% Similarity=0.254 Sum_probs=149.8
Q ss_pred HHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCCCC
Q 044022 14 GSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 14 ~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+.+|+++++++ +|||||++++++......++||||+. |+|.+++.... .....++.||+.||.||| +.
T Consensus 62 ~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~ 137 (432)
T 3p23_A 62 SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SL 137 (432)
T ss_dssp EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HT
T ss_pred HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HC
Confidence 3467899999999 89999999999999999999999996 69999986553 256789999999999999 89
Q ss_pred CceeccCCCCCeeecC-----CCCeEEeeccCceecCCCCc-ceeecccccCCCccCccccc---ccCCCcchhhHHHHH
Q 044022 88 PIVLRNFKTQNILFNE-----ENVAKWFDFLLSISIPEGET-HITTDRVIGTRGYSAPEYIS---ICVLNEKSNVFSFGA 158 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~-----~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~s~G~ 158 (241)
+|+||||||+|||++. ...++|+|||++........ ........||+.|+|||++. ...++.++|||||||
T Consensus 138 ~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~ 217 (432)
T 3p23_A 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGC 217 (432)
T ss_dssp TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHH
T ss_pred cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHH
Confidence 9999999999999953 33678999999986654321 11223457899999999997 356778999999999
Q ss_pred HHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 159 FLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 159 ~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
++|+|++ |..||..... ............. .... ....+..+.+|+.+||+.||++||
T Consensus 218 il~ellt~g~~pf~~~~~----------~~~~~~~~~~~~~-----~~~~------~~~~~~~~~~li~~~L~~dP~~Rp 276 (432)
T 3p23_A 218 VFYYVISEGSHPFGKSLQ----------RQANILLGACSLD-----CLHP------EKHEDVIARELIEKMIAMDPQKRP 276 (432)
T ss_dssp HHHHHHTTSCBTTBSTTT----------HHHHHHTTCCCCT-----TSCT------TCHHHHHHHHHHHHHSCSSGGGSC
T ss_pred HHHHHHcCCCCCcchhhH----------HHHHHHhccCCcc-----ccCc------cccccHHHHHHHHHHHhCCHhhCC
Confidence 9999999 9999854111 1111111111110 0000 013445688999999999999999
Q ss_pred CCCC
Q 044022 238 TMVD 241 (241)
Q Consensus 238 t~~e 241 (241)
|++|
T Consensus 277 s~~e 280 (432)
T 3p23_A 277 SAKH 280 (432)
T ss_dssp CHHH
T ss_pred CHHH
Confidence 9753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=255.56 Aligned_cols=163 Identities=20% Similarity=0.266 Sum_probs=133.6
Q ss_pred Ccccccccc-cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcc------eEEEEecCCCCHHHhhcCCCc--hHHHHH
Q 044022 1 MKFYGHEYH-RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIP------ILVFQSVEYGTLRDCIFGAPL--PRLKIA 71 (241)
Q Consensus 1 iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~------~lv~e~~~~~sL~~~l~~~~~--~~~~~~ 71 (241)
||++..... .....++.+|+.+++.++||||+++++++...+.. ++||||+. ++|.+.+...-. .+..++
T Consensus 72 iK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~ 150 (371)
T 4exu_A 72 IKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGMEFSEEKIQYLV 150 (371)
T ss_dssp EEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTSCCCHHHHHHHH
T ss_pred EEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhcCCCHHHHHHHH
Confidence 355543322 23467788999999999999999999999876654 99999997 799888865422 567899
Q ss_pred HHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcc
Q 044022 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEK 150 (241)
Q Consensus 72 ~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~ 150 (241)
.+++.||.||| +.+++||||||+||+++.++.++|+|||.+....... ....+|+.|+|||++.+ ..++.+
T Consensus 151 ~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~ 222 (371)
T 4exu_A 151 YQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQT 222 (371)
T ss_dssp HHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTT
T ss_pred HHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccccccCc-----CCcccCccccCHHHhcCCCCCCcH
Confidence 99999999999 8999999999999999999999999999997554321 33568999999999987 678999
Q ss_pred hhhHHHHHHHHHHHhcCccccc
Q 044022 151 SNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 151 ~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
+||||||+++|+|++|+.||..
T Consensus 223 ~DiwslG~il~el~~g~~pf~~ 244 (371)
T 4exu_A 223 VDIWSVGCIMAEMLTGKTLFKG 244 (371)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCC
T ss_pred HhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999964
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=254.31 Aligned_cols=203 Identities=21% Similarity=0.262 Sum_probs=151.5
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeee------CCcceEEEEecCCCCHHHhhcCCC---c---hHHHHHHHHHHHh
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQ------TPIPILVFQSVEYGTLRDCIFGAP---L---PRLKIASDIVNSL 78 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~---~---~~~~~~~~i~~~l 78 (241)
....+.+|+.+++++ +||||+++++++.. .+..++||||+++++|.+++.... . ....++.+++.||
T Consensus 63 ~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l 142 (326)
T 2x7f_A 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142 (326)
T ss_dssp TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHH
Confidence 467889999999999 89999999999987 457899999999999999986531 1 3678899999999
Q ss_pred chhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc-----ccCCCcchhh
Q 044022 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS-----ICVLNEKSNV 153 (241)
Q Consensus 79 ~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di 153 (241)
.||| +.+++|+||||+||+++.++.++|+|||.+........ ......+++.|+|||.+. ...++.++||
T Consensus 143 ~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di 217 (326)
T 2x7f_A 143 SHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDL 217 (326)
T ss_dssp HHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHH
T ss_pred HHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchH
Confidence 9999 89999999999999999999999999999876543211 123346899999999987 4568899999
Q ss_pred HHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 154 FSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
||||+++|+|++|..||.... ............ ..... ... .+..+.+++.+||..||
T Consensus 218 ~slG~il~~l~~g~~p~~~~~---------~~~~~~~~~~~~-~~~~~----~~~--------~~~~l~~li~~~l~~dp 275 (326)
T 2x7f_A 218 WSLGITAIEMAEGAPPLCDMH---------PMRALFLIPRNP-APRLK----SKK--------WSKKFQSFIESCLVKNH 275 (326)
T ss_dssp HHHHHHHHHHHHSSCTTTTSC---------HHHHHHHHHHSC-CCCCS----CSC--------SCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHHHHhCCCCCCCCc---------HHHHHHHhhcCc-cccCC----ccc--------cCHHHHHHHHHHhccCh
Confidence 999999999999999995421 111111111111 11110 111 22578999999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|||++|
T Consensus 276 ~~Rps~~~ 283 (326)
T 2x7f_A 276 SQRPATEQ 283 (326)
T ss_dssp GGSCCHHH
T ss_pred hhCCCHHH
Confidence 99999753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=255.13 Aligned_cols=203 Identities=20% Similarity=0.244 Sum_probs=154.4
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
...+.+|++++++++||||+++++++..+. .++||||+++++|.+++..... ....++.+++.||.||| +.+
T Consensus 59 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ 134 (322)
T 2ycf_A 59 ALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENG 134 (322)
T ss_dssp --CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred hhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence 456889999999999999999999986654 8999999999999998876532 46778999999999999 899
Q ss_pred ceeccCCCCCeeecCCCC---eEEeeccCceecCCCCcceeecccccCCCccCccccc---ccCCCcchhhHHHHHHHHH
Q 044022 89 IVLRNFKTQNILFNEENV---AKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS---ICVLNEKSNVFSFGAFLFE 162 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~s~G~~~~~ 162 (241)
++||||||+||+++.++. +||+|||.+........ .....|++.|+|||++. ...++.++||||||+++|+
T Consensus 135 ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~ 211 (322)
T 2ycf_A 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFI 211 (322)
T ss_dssp EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHH
T ss_pred eeccCCCHHHEEEecCCCCCeEEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHH
Confidence 999999999999987664 99999999987654321 12346899999999974 4568899999999999999
Q ss_pred HHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 163 LLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 163 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|++|..||...... ....... ..+.... .+... ...+..+.+++.+||+.||++|||++|
T Consensus 212 l~~g~~pf~~~~~~-----~~~~~~~----~~~~~~~--~~~~~--------~~~~~~~~~li~~~l~~dP~~Rps~~~ 271 (322)
T 2ycf_A 212 CLSGYPPFSEHRTQ-----VSLKDQI----TSGKYNF--IPEVW--------AEVSEKALDLVKKLLVVDPKARFTTEE 271 (322)
T ss_dssp HHHSSCSSCSTTCS-----SCHHHHH----HHTCCCC--CHHHH--------TTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHhCCCCCcccchH-----HHHHHHH----HhCcccc--Cchhh--------hhcCHHHHHHHHHHcccCHhhCCCHHH
Confidence 99999999652211 1111111 1111100 00000 122367899999999999999999753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=250.53 Aligned_cols=214 Identities=22% Similarity=0.290 Sum_probs=162.1
Q ss_pred Cccccccc-ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHH
Q 044022 1 MKFYGHEY-HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~ 75 (241)
||++.... .....+.+.+|++++++++||||+++++++...+..++|+||+++++|.+++.... .....++.+++
T Consensus 52 lK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~ 131 (287)
T 2wei_A 52 VKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF 131 (287)
T ss_dssp EEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHH
T ss_pred EEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHH
Confidence 35554333 23457789999999999999999999999999999999999999999988875431 25678999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCC---CCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchh
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEE---NVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSN 152 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 152 (241)
.||.||| +.+++|+||||+||+++.+ +.++|+|||.+......... ....+++.|+|||.+.+ .++.++|
T Consensus 132 ~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~D 204 (287)
T 2wei_A 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCD 204 (287)
T ss_dssp HHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC---SCHHHHHTTCCHHHHTT-CCCTHHH
T ss_pred HHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc---ccccCcccccChHHhcC-CCCCchh
Confidence 9999999 8999999999999999754 47999999998765443221 22357889999998875 4889999
Q ss_pred hHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCC
Q 044022 153 VFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNS 232 (241)
Q Consensus 153 i~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~ 232 (241)
|||||+++|+|++|..||.... ..+....... +... ...+. .. ..+..+.+++.+||+.|
T Consensus 205 i~slG~~l~~l~~g~~p~~~~~---------~~~~~~~~~~-~~~~-~~~~~-~~--------~~~~~~~~li~~~l~~d 264 (287)
T 2wei_A 205 VWSAGVILYILLSGTPPFYGKN---------EYDILKRVET-GKYA-FDLPQ-WR--------TISDDAKDLIRKMLTFH 264 (287)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSS---------HHHHHHHHHH-CCCC-CCSGG-GT--------TSCHHHHHHHHHHTCSS
T ss_pred hHhHHHHHHHHHhCCCCCCCCC---------HHHHHHHHHc-CCCC-CCchh-hh--------hcCHHHHHHHHHHcccC
Confidence 9999999999999999996521 1122222211 1110 00000 01 22357889999999999
Q ss_pred CCCCCCCCC
Q 044022 233 PEDRPTMVD 241 (241)
Q Consensus 233 p~~Rpt~~e 241 (241)
|++|||++|
T Consensus 265 p~~Rps~~e 273 (287)
T 2wei_A 265 PSLRITATQ 273 (287)
T ss_dssp GGGSCCHHH
T ss_pred hhhCcCHHH
Confidence 999999853
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=258.43 Aligned_cols=153 Identities=19% Similarity=0.219 Sum_probs=123.8
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeC-----CcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhh
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQT-----PIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLH 82 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh 82 (241)
.+.+.+|++++++++||||+++++++... ...++||||+. |+|.+.+.... .....++.+++.||.|||
T Consensus 73 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH 151 (362)
T 3pg1_A 73 CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH 151 (362)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 37899999999999999999999998643 35799999997 68888876542 146789999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFLF 161 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~~ 161 (241)
+.+++|+||||+||+++.++.++|+|||.+........ .....+++.|+|||++.+ ..++.++||||||+++|
T Consensus 152 ---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 225 (362)
T 3pg1_A 152 ---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMA 225 (362)
T ss_dssp ---HTTCCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHH
T ss_pred ---HCcCEecCCChHHEEEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHH
Confidence 89999999999999999999999999999975443322 133468889999999876 67899999999999999
Q ss_pred HHHhcCccccc
Q 044022 162 ELLAGRIHIWD 172 (241)
Q Consensus 162 ~~~~g~~p~~~ 172 (241)
+|++|+.||..
T Consensus 226 ~l~~g~~pf~~ 236 (362)
T 3pg1_A 226 EMFNRKALFRG 236 (362)
T ss_dssp HHHHSSCSCCC
T ss_pred HHHhCCCCCCC
Confidence 99999999965
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=262.59 Aligned_cols=207 Identities=20% Similarity=0.347 Sum_probs=152.8
Q ss_pred cHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----------hHHHHHHHHHHHhc
Q 044022 12 TYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----------PRLKIASDIVNSLA 79 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~i~~~l~ 79 (241)
..+.+.+|+++++++ +||||+++++++...+..++||||+. |+|.+++..... ..+.++.||+.||.
T Consensus 51 ~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 129 (434)
T 2rio_A 51 FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129 (434)
T ss_dssp GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHH
Confidence 345678999999987 89999999999999999999999996 699999976532 23579999999999
Q ss_pred hhhcCCCCCceeccCCCCCeeecCC-------------CCeEEeeccCceecCCCCcce--eecccccCCCccCcccccc
Q 044022 80 YLHFGFPRPIVLRNFKTQNILFNEE-------------NVAKWFDFLLSISIPEGETHI--TTDRVIGTRGYSAPEYISI 144 (241)
Q Consensus 80 ~lh~~~~~~ivh~dl~~~nil~~~~-------------~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~ 144 (241)
||| +.+|+||||||+|||++.+ +.+||+|||++.......... ......||+.|+|||++.+
T Consensus 130 ~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 206 (434)
T 2rio_A 130 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206 (434)
T ss_dssp HHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred HHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence 999 8999999999999999754 489999999998765432211 1234578999999999975
Q ss_pred -------cCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHH
Q 044022 145 -------CVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQ 216 (241)
Q Consensus 145 -------~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (241)
..++.++||||||+++|+|++ |..||..... .+ ....... . ... .. .......
T Consensus 207 ~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---------~~--~~i~~~~-~-~~~--~~----~~~~~~~ 267 (434)
T 2rio_A 207 SNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS---------RE--SNIIRGI-F-SLD--EM----KCLHDRS 267 (434)
T ss_dssp CCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT---------HH--HHHHHTC-C-CCC--CC----TTCCCHH
T ss_pred ccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh---------hH--HHHhcCC-C-Ccc--cc----ccccccc
Confidence 568899999999999999999 9999954211 00 1111111 0 000 00 0111134
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 217 QLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 217 ~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.+..+.+++.+||+.||++|||+.|
T Consensus 268 ~~~~~~~li~~~L~~dP~~Rps~~e 292 (434)
T 2rio_A 268 LIAEATDLISQMIDHDPLKRPTAMK 292 (434)
T ss_dssp HHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred chHHHHHHHHHHhhCChhhCCCHHH
Confidence 5678999999999999999999853
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=248.77 Aligned_cols=213 Identities=21% Similarity=0.257 Sum_probs=146.1
Q ss_pred CcccccccccccHHH-HHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcC----C-Cc---hHHHHH
Q 044022 1 MKFYGHEYHRHTYGS-CINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFG----A-PL---PRLKIA 71 (241)
Q Consensus 1 iK~~~~~~~~~~~~~-~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~----~-~~---~~~~~~ 71 (241)
||++..........+ +.++...++.++||||+++++++..++..++||||++ |+|.+++.. . .. ....++
T Consensus 37 vK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~ 115 (290)
T 3fme_A 37 VKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIA 115 (290)
T ss_dssp EEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHH
T ss_pred EEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHH
Confidence 355544333333333 4445555788899999999999999999999999997 588777643 1 11 467899
Q ss_pred HHHHHHhchhhcCCCC-CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccc----cccC
Q 044022 72 SDIVNSLAYLHFGFPR-PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYI----SICV 146 (241)
Q Consensus 72 ~~i~~~l~~lh~~~~~-~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~ 146 (241)
.|++.||.||| +. +++||||||+||+++.++.++|+|||.+........ .....+++.|+|||.+ ....
T Consensus 116 ~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~ 189 (290)
T 3fme_A 116 VSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKG 189 (290)
T ss_dssp HHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--
T ss_pred HHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccccccc---ccccCCCccccChhhcChhhcCcC
Confidence 99999999999 77 999999999999999999999999999876544322 1234689999999996 4567
Q ss_pred CCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHH
Q 044022 147 LNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTL 226 (241)
Q Consensus 147 ~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 226 (241)
++.++||||||+++|+|++|+.||.... ... ........... ..... . ..+..+.+++.
T Consensus 190 ~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~-~~~~~~~~~~~-~~~~~----~--------~~~~~~~~li~ 248 (290)
T 3fme_A 190 YSVKSDIWSLGITMIELAILRFPYDSWG-------TPF-QQLKQVVEEPS-PQLPA----D--------KFSAEFVDFTS 248 (290)
T ss_dssp CCHHHHHHHHHHHHHHHHHTSCSSCCCS-------CHH-HHHHHHHHSCC-CCCCT----T--------TSCHHHHHHHH
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCccccC-------chH-HHHHHHhccCC-CCccc----c--------cCCHHHHHHHH
Confidence 8899999999999999999999995411 111 11111111111 11110 1 12257899999
Q ss_pred HhccCCCCCCCCCCC
Q 044022 227 ECVNNSPEDRPTMVD 241 (241)
Q Consensus 227 ~cl~~~p~~Rpt~~e 241 (241)
+||+.||++|||++|
T Consensus 249 ~~l~~~p~~Rpt~~e 263 (290)
T 3fme_A 249 QCLKKNSKERPTYPE 263 (290)
T ss_dssp HHTCSSGGGSCCHHH
T ss_pred HHhhcChhhCcCHHH
Confidence 999999999999853
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=254.23 Aligned_cols=205 Identities=19% Similarity=0.239 Sum_probs=154.3
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.+.+|+.++++++||||+++++++...+..++|+||+++++|.+++.... .....++.+++.||.|||
T Consensus 71 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH--- 147 (319)
T 2y4i_B 71 DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH--- 147 (319)
T ss_dssp CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---
T ss_pred HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 345668899999999999999999999999999999999999999999997653 257889999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCC---cceeecccccCCCccCcccccc---------cCCCcchhh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE---THITTDRVIGTRGYSAPEYISI---------CVLNEKSNV 153 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~~aPE~~~~---------~~~~~~~Di 153 (241)
+.+++|+||||+||+++ ++.++|+|||++....... .........|++.|+|||.+.. ..++.++||
T Consensus 148 ~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di 226 (319)
T 2y4i_B 148 AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDV 226 (319)
T ss_dssp HTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHH
T ss_pred hCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhH
Confidence 89999999999999998 6899999999876543211 1111223458889999999874 347889999
Q ss_pred HHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 154 FSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
||||+++|+|++|..||.... ......... .+....... ...+ ..+.+++.+||+.||
T Consensus 227 ~slG~il~el~~g~~p~~~~~---------~~~~~~~~~-~~~~~~~~~----~~~~--------~~l~~li~~~l~~~p 284 (319)
T 2y4i_B 227 FALGTIWYELHAREWPFKTQP---------AEAIIWQMG-TGMKPNLSQ----IGMG--------KEISDILLFCWAFEQ 284 (319)
T ss_dssp HHHHHHHHHHHHSSCSSSSCC---------HHHHHHHHH-TTCCCCCCC----SSCC--------TTHHHHHHHHHCSST
T ss_pred HHHHHHHHHHHhCCCCCCCCC---------HHHHHHHhc-cCCCCCCCc----CCCC--------HHHHHHHHHHhcCCh
Confidence 999999999999999996421 111222211 111111111 1111 458899999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|||++|
T Consensus 285 ~~Rpt~~~ 292 (319)
T 2y4i_B 285 EERPTFTK 292 (319)
T ss_dssp TTSCCHHH
T ss_pred hhCcCHHH
Confidence 99999753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=262.54 Aligned_cols=152 Identities=22% Similarity=0.215 Sum_probs=132.5
Q ss_pred cHHHHHHHHHHHHhc------CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC---c---hHHHHHHHHHHHhc
Q 044022 12 TYGSCINNITYAAQM------SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---L---PRLKIASDIVNSLA 79 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~---~~~~~~~~i~~~l~ 79 (241)
...++.+|+++++.+ .|+||+++++++...+..++||||+. ++|.+++.... . .+..++.||+.||.
T Consensus 136 ~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~ 214 (429)
T 3kvw_A 136 FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214 (429)
T ss_dssp HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Confidence 356778899999888 56799999999999999999999996 69999886542 1 46789999999999
Q ss_pred hhhcCCCCCceeccCCCCCeeecCCCC--eEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHH
Q 044022 80 YLHFGFPRPIVLRNFKTQNILFNEENV--AKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFG 157 (241)
Q Consensus 80 ~lh~~~~~~ivh~dl~~~nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G 157 (241)
||| +.+|+||||||+|||++.++. +||+|||++....... ....+|+.|+|||++.+..++.++||||||
T Consensus 215 ~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 286 (429)
T 3kvw_A 215 ALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLG 286 (429)
T ss_dssp HHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHH
T ss_pred HHH---HCCeecCCCCHHHeEEccCCCcceEEeecccceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHH
Confidence 999 899999999999999999887 9999999997654332 334689999999999999999999999999
Q ss_pred HHHHHHHhcCccccc
Q 044022 158 AFLFELLAGRIHIWD 172 (241)
Q Consensus 158 ~~~~~~~~g~~p~~~ 172 (241)
|++|+|++|..||..
T Consensus 287 ~il~elltG~~pf~~ 301 (429)
T 3kvw_A 287 CILAELLTGYPLLPG 301 (429)
T ss_dssp HHHHHHHHSSCSSCC
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999954
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=250.09 Aligned_cols=214 Identities=18% Similarity=0.295 Sum_probs=154.9
Q ss_pred cccccc-cccccHHHHHHHHHHHHhcC--CCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHH
Q 044022 2 KFYGHE-YHRHTYGSCINNITYAAQMS--HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDI 74 (241)
Q Consensus 2 K~~~~~-~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i 74 (241)
|++..+ ......+.+.+|++++++++ |+||+++++++...+..++||| +.+++|.+++..... .+..++.++
T Consensus 58 K~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi 136 (313)
T 3cek_A 58 KYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNM 136 (313)
T ss_dssp EEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHH
T ss_pred EEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHH
Confidence 444432 23345678999999999997 5999999999999999999999 557899999865432 567899999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc----------
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI---------- 144 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---------- 144 (241)
+.||.||| +.+++|+||||+||+++. +.+||+|||.+................|++.|+|||.+.+
T Consensus 137 ~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 212 (313)
T 3cek_A 137 LEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 212 (313)
T ss_dssp HHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC--------
T ss_pred HHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccc
Confidence 99999999 899999999999999964 8999999999976654333222234568999999999875
Q ss_pred -cCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHH
Q 044022 145 -CVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQ 223 (241)
Q Consensus 145 -~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (241)
..++.++||||||+++|+|++|..||...... ............... ..... +..+.+
T Consensus 213 ~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~-----~~~~~--------~~~l~~ 271 (313)
T 3cek_A 213 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--------ISKLHAIIDPNHEIE-----FPDIP--------EKDLQD 271 (313)
T ss_dssp --CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--------HHHHHHHHCTTSCCC-----CCCCS--------CHHHHH
T ss_pred cccCCchHHHHHHHHHHHHHHhCCCchhhHHHH--------HHHHHHHHhcccccC-----Ccccc--------hHHHHH
Confidence 46788999999999999999999999642111 111111111111111 11111 256889
Q ss_pred HHHHhccCCCCCCCCCCC
Q 044022 224 LTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 224 l~~~cl~~~p~~Rpt~~e 241 (241)
++.+||+.||++|||++|
T Consensus 272 li~~~l~~dp~~Rps~~e 289 (313)
T 3cek_A 272 VLKCCLKRDPKQRISIPE 289 (313)
T ss_dssp HHHHHTCSSTTTSCCHHH
T ss_pred HHHHHccCCcccCcCHHH
Confidence 999999999999999853
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=247.30 Aligned_cols=205 Identities=21% Similarity=0.310 Sum_probs=148.7
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeee-------------CCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHH
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQ-------------TPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASD 73 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------------~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~ 73 (241)
..+.+.+|++++++++||||+++++++.. .+..++||||+++++|.+++..... ....++.+
T Consensus 45 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~q 124 (303)
T 1zy4_A 45 KLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124 (303)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHH
Confidence 45778999999999999999999998865 3467999999999999999975432 45688999
Q ss_pred HHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCc------------ceeecccccCCCccCccc
Q 044022 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET------------HITTDRVIGTRGYSAPEY 141 (241)
Q Consensus 74 i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~------------~~~~~~~~~~~~~~aPE~ 141 (241)
++.||.||| +.+++|+||||+||+++.++.++|+|||.+........ ........+++.|+|||.
T Consensus 125 i~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 201 (303)
T 1zy4_A 125 ILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEV 201 (303)
T ss_dssp HHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHH
T ss_pred HHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCccc
Confidence 999999999 89999999999999999999999999999876542210 111233468899999999
Q ss_pred cccc-CCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHH
Q 044022 142 ISIC-VLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHA 220 (241)
Q Consensus 142 ~~~~-~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (241)
+.+. .++.++||||||+++|+|++ ||.... ...+...... ... ....+.... ..+..
T Consensus 202 ~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--------~~~~~~~~~~-~~~--~~~~~~~~~--------~~~~~ 259 (303)
T 1zy4_A 202 LDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--------ERVNILKKLR-SVS--IEFPPDFDD--------NKMKV 259 (303)
T ss_dssp HTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--------HHHHHHHHHH-STT--CCCCTTCCT--------TTSHH
T ss_pred ccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--------hHHHHHHhcc-ccc--cccCccccc--------cchHH
Confidence 9764 68899999999999999998 443210 0111111111 110 011111111 22356
Q ss_pred HHHHHHHhccCCCCCCCCCCC
Q 044022 221 SAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 221 ~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+.+++.+||+.||++|||++|
T Consensus 260 ~~~li~~~l~~dp~~Rps~~~ 280 (303)
T 1zy4_A 260 EKKIIRLLIDHDPNKRPGART 280 (303)
T ss_dssp HHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHhcCcccCcCHHH
Confidence 889999999999999999753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=250.34 Aligned_cols=163 Identities=20% Similarity=0.259 Sum_probs=132.9
Q ss_pred Ccccccccc-cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCc------ceEEEEecCCCCHHHhhcCCC--chHHHHH
Q 044022 1 MKFYGHEYH-RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPI------PILVFQSVEYGTLRDCIFGAP--LPRLKIA 71 (241)
Q Consensus 1 iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~~~~--~~~~~~~ 71 (241)
||.+..... ....+++.+|+.++++++||||+++++++...+. .++||||+. ++|.+++...- .....++
T Consensus 54 iK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~ 132 (353)
T 3coi_A 54 IKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGLKFSEEKIQYLV 132 (353)
T ss_dssp EEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTSCCCHHHHHHHH
T ss_pred EEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcCCCCHHHHHHHH
Confidence 355443322 2345678999999999999999999999987653 499999997 69988876542 2567899
Q ss_pred HHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcc
Q 044022 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEK 150 (241)
Q Consensus 72 ~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~ 150 (241)
.+++.||.||| +.+++||||||+||+++.++.++|+|||.+....... ....+++.|+|||++.+ ..++.+
T Consensus 133 ~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~ 204 (353)
T 3coi_A 133 YQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQT 204 (353)
T ss_dssp HHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTT
T ss_pred HHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccCCCCCc-----cccccCcCcCCHHHHhCcCCCCch
Confidence 99999999999 8999999999999999999999999999987543321 23467899999999877 678899
Q ss_pred hhhHHHHHHHHHHHhcCccccc
Q 044022 151 SNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 151 ~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
+||||||+++|+|++|..||..
T Consensus 205 ~Di~slG~il~el~~g~~pf~~ 226 (353)
T 3coi_A 205 VDIWSVGCIMAEMLTGKTLFKG 226 (353)
T ss_dssp HHHHHHHHHHHHHHHSSCSSBS
T ss_pred hhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999965
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=254.05 Aligned_cols=207 Identities=20% Similarity=0.218 Sum_probs=155.1
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeee----CCcceEEEEecCCCCHHHhhcC-----CC---chHHHHHHHHHHHh
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQ----TPIPILVFQSVEYGTLRDCIFG-----AP---LPRLKIASDIVNSL 78 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~-----~~---~~~~~~~~~i~~~l 78 (241)
...+.+.+|++++++++||||+++++++.. ....++|+||+++++|.+++.. .. ..+..++.|++.||
T Consensus 68 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L 147 (317)
T 2buj_A 68 QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147 (317)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 456778999999999999999999999973 3478999999999999998864 11 14678999999999
Q ss_pred chhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-------eeecccccCCCccCcccccccC---CC
Q 044022 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-------ITTDRVIGTRGYSAPEYISICV---LN 148 (241)
Q Consensus 79 ~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~---~~ 148 (241)
.||| +.+++|+||||+||+++.++.++|+|||.+......... .......|++.|+|||.+.+.. ++
T Consensus 148 ~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 224 (317)
T 2buj_A 148 EAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVID 224 (317)
T ss_dssp HHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEEC
T ss_pred HHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCC
Confidence 9999 899999999999999999999999999988754321110 0011234688999999987543 68
Q ss_pred cchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHh
Q 044022 149 EKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLEC 228 (241)
Q Consensus 149 ~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 228 (241)
.++||||||+++|+|++|+.||....... .... .... .. ...+. .. ..+..+.+++.+|
T Consensus 225 ~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~---~~~~-~~--~~~~~---~~--------~~~~~l~~li~~~ 283 (317)
T 2buj_A 225 ERTDVWSLGCVLYAMMFGEGPYDMVFQKG----DSVA---LAVQ-NQ--LSIPQ---SP--------RHSSALWQLLNSM 283 (317)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTHHHHHTT----SCHH---HHHH-CC----CCC---CT--------TSCHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHHhCCCChhhhhccc----chhh---HHhh-cc--CCCCc---cc--------cCCHHHHHHHHHH
Confidence 89999999999999999999995421110 0000 1111 10 00111 01 1225789999999
Q ss_pred ccCCCCCCCCCCC
Q 044022 229 VNNSPEDRPTMVD 241 (241)
Q Consensus 229 l~~~p~~Rpt~~e 241 (241)
|+.||++|||++|
T Consensus 284 l~~dp~~Rps~~~ 296 (317)
T 2buj_A 284 MTVDPHQRPHIPL 296 (317)
T ss_dssp TCSSGGGSCCHHH
T ss_pred hhcChhhCCCHHH
Confidence 9999999999753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=261.27 Aligned_cols=152 Identities=20% Similarity=0.244 Sum_probs=128.8
Q ss_pred cHHHHHHHHHHHHhcC--------CCcccceeeeee----eCCcceEEEEecCCCCHHHhhcCCC---c---hHHHHHHH
Q 044022 12 TYGSCINNITYAAQMS--------HNHILKRIGCCL----QTPIPILVFQSVEYGTLRDCIFGAP---L---PRLKIASD 73 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~--------h~~iv~~~~~~~----~~~~~~lv~e~~~~~sL~~~l~~~~---~---~~~~~~~~ 73 (241)
..+.+.+|++++++++ |+||+++++++. .....++||||+. ++|.+.+.... . ....++.|
T Consensus 76 ~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~q 154 (397)
T 1wak_A 76 YTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQ 154 (397)
T ss_dssp HHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHH
Confidence 4567889999999995 788999999998 4557899999995 66666553321 1 46789999
Q ss_pred HHHHhchhhcCCCC-CceeccCCCCCeeecCCC-----------------------------------------------
Q 044022 74 IVNSLAYLHFGFPR-PIVLRNFKTQNILFNEEN----------------------------------------------- 105 (241)
Q Consensus 74 i~~~l~~lh~~~~~-~ivh~dl~~~nil~~~~~----------------------------------------------- 105 (241)
|+.||.||| ++ +|+||||||+|||++.++
T Consensus 155 i~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (397)
T 1wak_A 155 VLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAE 231 (397)
T ss_dssp HHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGG
T ss_pred HHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccccccccccccc
Confidence 999999999 77 999999999999998775
Q ss_pred --CeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCccccc
Q 044022 106 --VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 106 --~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
.++|+|||.+....... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 232 ~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 295 (397)
T 1wak_A 232 KLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEP 295 (397)
T ss_dssp GCCEEECCGGGCEETTBCS-----CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccceEeccccccccccccC-----ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCC
Confidence 79999999998664332 334689999999999998999999999999999999999999965
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=248.50 Aligned_cols=158 Identities=18% Similarity=0.270 Sum_probs=130.0
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeee--------------eCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHH
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCL--------------QTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASD 73 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--------------~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~ 73 (241)
...+++.+|++++++++||||+++++++. ..+..++||||+. |+|.+++..... ....++.+
T Consensus 50 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~q 128 (320)
T 2i6l_A 50 QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQ 128 (320)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHH
Confidence 45677899999999999999999999874 3457899999997 699999976543 46788999
Q ss_pred HHHHhchhhcCCCCCceeccCCCCCeeec-CCCCeEEeeccCceecCCCCc-ceeecccccCCCccCcccccc-cCCCcc
Q 044022 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFN-EENVAKWFDFLLSISIPEGET-HITTDRVIGTRGYSAPEYISI-CVLNEK 150 (241)
Q Consensus 74 i~~~l~~lh~~~~~~ivh~dl~~~nil~~-~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~-~~~~~~ 150 (241)
++.||.||| +.+++|+||||+||+++ .++.+||+|||.+........ ........++..|+|||.+.+ ..++.+
T Consensus 129 i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 205 (320)
T 2i6l_A 129 LLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKA 205 (320)
T ss_dssp HHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHH
T ss_pred HHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCch
Confidence 999999999 89999999999999997 567999999999876543211 111233457888999998865 678899
Q ss_pred hhhHHHHHHHHHHHhcCccccc
Q 044022 151 SNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 151 ~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
+||||||+++|+|++|+.||..
T Consensus 206 ~Di~slG~il~el~~g~~pf~~ 227 (320)
T 2i6l_A 206 IDMWAAGCIFAEMLTGKTLFAG 227 (320)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCC
T ss_pred hhhHhHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999965
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=253.73 Aligned_cols=216 Identities=19% Similarity=0.217 Sum_probs=140.3
Q ss_pred CcccccccccccHHHHHHHHH-HHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcC------CCc---hHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNIT-YAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFG------APL---PRLKI 70 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~------~~~---~~~~~ 70 (241)
||.+..........++.+|+. +++.++||||+++++++...+..++||||+. ++|.+++.. ... ....+
T Consensus 52 iK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i 130 (327)
T 3aln_A 52 VKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKI 130 (327)
T ss_dssp EEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHH
T ss_pred EEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHH
Confidence 355544433344556667766 6777899999999999999999999999997 588877652 222 46789
Q ss_pred HHHHHHHhchhhcCCCC-CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccc----ccc
Q 044022 71 ASDIVNSLAYLHFGFPR-PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYI----SIC 145 (241)
Q Consensus 71 ~~~i~~~l~~lh~~~~~-~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~ 145 (241)
+.+++.||.||| +. +++||||||+||+++.++.+||+|||.+........ .....|++.|+|||++ .+.
T Consensus 131 ~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ 204 (327)
T 3aln_A 131 TLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQ 204 (327)
T ss_dssp HHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--------------------------------
T ss_pred HHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc---cccCCCCccccCceeeccccCcC
Confidence 999999999999 77 999999999999999999999999999876543321 1233688999999998 455
Q ss_pred CCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHH
Q 044022 146 VLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLT 225 (241)
Q Consensus 146 ~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 225 (241)
.++.++||||||+++|+|++|..||....... + ... ..... ..+.+..... ...+..+.+++
T Consensus 205 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~---~~~--~~~~~-~~~~~~~~~~----~~~~~~l~~li 266 (327)
T 3aln_A 205 GYDVRSDVWSLGITLYELATGRFPYPKWNSVF--------D---QLT--QVVKG-DPPQLSNSEE----REFSPSFINFV 266 (327)
T ss_dssp -CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------C--CCCCS-CCCCCCCCSS----CCCCHHHHHHH
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--------H---HHH--HHhcC-CCCCCCCccc----ccCCHHHHHHH
Confidence 68899999999999999999999996421110 0 000 00000 0011110000 01235789999
Q ss_pred HHhccCCCCCCCCCCC
Q 044022 226 LECVNNSPEDRPTMVD 241 (241)
Q Consensus 226 ~~cl~~~p~~Rpt~~e 241 (241)
.+||+.||++|||++|
T Consensus 267 ~~~l~~dp~~Rps~~e 282 (327)
T 3aln_A 267 NLCLTKDESKRPKYKE 282 (327)
T ss_dssp HHHTCSSGGGSCCHHH
T ss_pred HHHhhCChhhCcCHHH
Confidence 9999999999999753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=247.65 Aligned_cols=153 Identities=22% Similarity=0.314 Sum_probs=130.7
Q ss_pred HHHHHHHHHHHHhc---CCCcccceeeeee-----eCCcceEEEEecCCCCHHHhhcCCC---c---hHHHHHHHHHHHh
Q 044022 13 YGSCINNITYAAQM---SHNHILKRIGCCL-----QTPIPILVFQSVEYGTLRDCIFGAP---L---PRLKIASDIVNSL 78 (241)
Q Consensus 13 ~~~~~~e~~~l~~l---~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~sL~~~l~~~~---~---~~~~~~~~i~~~l 78 (241)
...+.+|+.+++.+ +||||+++++++. .....++|+||+. |+|.+++.... . ....++.+++.||
T Consensus 55 ~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l 133 (326)
T 1blx_A 55 PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133 (326)
T ss_dssp BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHH
T ss_pred CchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHH
Confidence 44677888888777 8999999999987 4557899999997 69999886532 1 4678999999999
Q ss_pred chhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHH
Q 044022 79 AYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGA 158 (241)
Q Consensus 79 ~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~ 158 (241)
.||| +.+++|+||||+||+++.++.++|+|||.+....... ......++..|+|||++.+..++.++||||||+
T Consensus 134 ~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 207 (326)
T 1blx_A 134 DFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGC 207 (326)
T ss_dssp HHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHH
T ss_pred HHHH---HCCceeccCCHHHeEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHH
Confidence 9999 8999999999999999999999999999987554322 123346889999999999889999999999999
Q ss_pred HHHHHHhcCccccc
Q 044022 159 FLFELLAGRIHIWD 172 (241)
Q Consensus 159 ~~~~~~~g~~p~~~ 172 (241)
++|+|++|+.||..
T Consensus 208 il~~l~~g~~pf~~ 221 (326)
T 1blx_A 208 IFAEMFRRKPLFRG 221 (326)
T ss_dssp HHHHHHHSSCSCCC
T ss_pred HHHHHHcCCCCCCC
Confidence 99999999999965
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=248.96 Aligned_cols=152 Identities=22% Similarity=0.232 Sum_probs=132.6
Q ss_pred cHHHHHHHHHHHHhcCCCc------ccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhc
Q 044022 12 TYGSCINNITYAAQMSHNH------ILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLA 79 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~ 79 (241)
..+.+.+|+++++.++|++ ++++++++...+..++||||+ +++|.+++.... .....++.|++.||.
T Consensus 54 ~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~ 132 (339)
T 1z57_A 54 YCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVN 132 (339)
T ss_dssp HHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 3567889999999997654 999999999999999999999 789999986543 146789999999999
Q ss_pred hhhcCCCCCceeccCCCCCeeecC-------------------CCCeEEeeccCceecCCCCcceeecccccCCCccCcc
Q 044022 80 YLHFGFPRPIVLRNFKTQNILFNE-------------------ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPE 140 (241)
Q Consensus 80 ~lh~~~~~~ivh~dl~~~nil~~~-------------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE 140 (241)
||| +++++||||||+||+++. ++.++|+|||.+....... ....||+.|+|||
T Consensus 133 ~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE 204 (339)
T 1z57_A 133 FLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPE 204 (339)
T ss_dssp HHH---HTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHH
T ss_pred HHH---HCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChH
Confidence 999 899999999999999987 6689999999997654332 3346899999999
Q ss_pred cccccCCCcchhhHHHHHHHHHHHhcCccccc
Q 044022 141 YISICVLNEKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 141 ~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
++.+..++.++||||||+++|+|++|..||..
T Consensus 205 ~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 205 VILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp HHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred HhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 99988999999999999999999999999954
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=256.48 Aligned_cols=213 Identities=20% Similarity=0.202 Sum_probs=148.7
Q ss_pred HHHHHHHHhcCCCcccceeeeeeeCCc------ceEEEEecCCCCHHHhhc-----CCCc---hHHHHHHHHHHHhchhh
Q 044022 17 INNITYAAQMSHNHILKRIGCCLQTPI------PILVFQSVEYGTLRDCIF-----GAPL---PRLKIASDIVNSLAYLH 82 (241)
Q Consensus 17 ~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~-----~~~~---~~~~~~~~i~~~l~~lh 82 (241)
.+|+++++.++||||+++++++...+. .++||||+++ ++...+. .... ....++.|++.||.|||
T Consensus 80 ~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH 158 (394)
T 4e7w_A 80 NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH 158 (394)
T ss_dssp CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 379999999999999999999975443 7899999985 4443322 1111 46778999999999999
Q ss_pred cCCCCCceeccCCCCCeeec-CCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHH
Q 044022 83 FGFPRPIVLRNFKTQNILFN-EENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFL 160 (241)
Q Consensus 83 ~~~~~~ivh~dl~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~ 160 (241)
+.+++||||||+|||++ .++.+||+|||++......... ....+|+.|+|||++.+. .++.++||||||+++
T Consensus 159 ---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il 232 (394)
T 4e7w_A 159 ---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVM 232 (394)
T ss_dssp ---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred ---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHH
Confidence 89999999999999999 7899999999999876443221 234689999999998765 589999999999999
Q ss_pred HHHHhcCcccccccccCCCcccchHHHHHHH---------hhhcccCCCCCCccccC-CCchhHHHHHHHHHHHHHHhcc
Q 044022 161 FELLAGRIHIWDLLKDTHDHGCFFNEYLKNY---------LEDKRFTGIPAPIIVQD-IPCIEKEQQLHASAQLTLECVN 230 (241)
Q Consensus 161 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~cl~ 230 (241)
|+|++|+.||...... ....+..... .....+....-+..... .........++.+.+|+.+||+
T Consensus 233 ~ell~g~~pf~~~~~~-----~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (394)
T 4e7w_A 233 AELMQGQPLFPGESGI-----DQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLE 307 (394)
T ss_dssp HHHHHSSCSSCCSSHH-----HHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhC
Confidence 9999999999652110 0111111100 00001111110110000 0000001133678999999999
Q ss_pred CCCCCCCCCCC
Q 044022 231 NSPEDRPTMVD 241 (241)
Q Consensus 231 ~~p~~Rpt~~e 241 (241)
.||++|||+.|
T Consensus 308 ~dP~~R~t~~e 318 (394)
T 4e7w_A 308 YTPSARLTAIE 318 (394)
T ss_dssp SSGGGSCCHHH
T ss_pred CChhhCCCHHH
Confidence 99999999753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=252.94 Aligned_cols=210 Identities=18% Similarity=0.201 Sum_probs=150.7
Q ss_pred HHHHHHHHHhcCCCcccceeeeeeeC--------------------------------------CcceEEEEecCCCCHH
Q 044022 16 CINNITYAAQMSHNHILKRIGCCLQT--------------------------------------PIPILVFQSVEYGTLR 57 (241)
Q Consensus 16 ~~~e~~~l~~l~h~~iv~~~~~~~~~--------------------------------------~~~~lv~e~~~~~sL~ 57 (241)
..+|+++++.++||||+++++++... ...++||||++ ++|.
T Consensus 47 ~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~ 125 (383)
T 3eb0_A 47 KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLH 125 (383)
T ss_dssp CCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHH
T ss_pred HHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHH
Confidence 34799999999999999999998543 34789999997 5877
Q ss_pred HhhcC----C-Cc---hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeec-CCCCeEEeeccCceecCCCCcceeec
Q 044022 58 DCIFG----A-PL---PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFN-EENVAKWFDFLLSISIPEGETHITTD 128 (241)
Q Consensus 58 ~~l~~----~-~~---~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~ 128 (241)
+.+.. . .. ....++.|++.||.||| +.+++||||||+||+++ .++.+||+|||.+......... .
T Consensus 126 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~ 199 (383)
T 3eb0_A 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---V 199 (383)
T ss_dssp HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---C
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---c
Confidence 76642 2 11 46778999999999999 99999999999999998 6889999999999876443321 2
Q ss_pred ccccCCCccCccccccc-CCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHh---------hhcccC
Q 044022 129 RVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYL---------EDKRFT 198 (241)
Q Consensus 129 ~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~ 198 (241)
...+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||...... ........... ....+.
T Consensus 200 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~g~p~~~~~~~~~~~~~ 274 (383)
T 3eb0_A 200 AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSI-----DQLVRIIQIMGTPTKEQMIRMNPHYT 274 (383)
T ss_dssp CCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHHHCCCCHHHHHHHCTTC-
T ss_pred CcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCCHHHHHHhCcccc
Confidence 34678999999998865 4899999999999999999999999652111 01111111000 000111
Q ss_pred CC-----CCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 199 GI-----PAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 199 ~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.. ....+....+ ...+..+.+|+.+||+.||++|||+.|
T Consensus 275 ~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~t~~e 318 (383)
T 3eb0_A 275 EVRFPTLKAKDWRKILP----EGTPSLAIDLLEQILRYEPDLRINPYE 318 (383)
T ss_dssp -CCCCCCCCCCHHHHSC----TTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred cccCCccCcccHHhhCC----CCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 11 1111111011 123367899999999999999999853
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=253.69 Aligned_cols=201 Identities=21% Similarity=0.302 Sum_probs=137.7
Q ss_pred ccHHHHHHHHHHHHhcC-CCcccceeeeeee--------CCcceEEEEecCCCCHHHhhcC----CCc---hHHHHHHHH
Q 044022 11 HTYGSCINNITYAAQMS-HNHILKRIGCCLQ--------TPIPILVFQSVEYGTLRDCIFG----APL---PRLKIASDI 74 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~----~~~---~~~~~~~~i 74 (241)
...+.+.+|+.+++++. ||||+++++++.. ...+++|+||+. |+|.+++.. ... .+..++.++
T Consensus 67 ~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi 145 (337)
T 3ll6_A 67 EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQT 145 (337)
T ss_dssp HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHH
Confidence 34667899999999996 9999999999953 335799999996 799888753 112 467899999
Q ss_pred HHHhchhhcCCCCC--ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcce----------eecccccCCCccCcccc
Q 044022 75 VNSLAYLHFGFPRP--IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI----------TTDRVIGTRGYSAPEYI 142 (241)
Q Consensus 75 ~~~l~~lh~~~~~~--ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~----------~~~~~~~~~~~~aPE~~ 142 (241)
+.||.||| +.+ ++|+||||+|||++.++.+||+|||.+.......... ......+++.|+|||++
T Consensus 146 ~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 222 (337)
T 3ll6_A 146 CRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII 222 (337)
T ss_dssp HHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC------------------------------
T ss_pred HHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhh
Confidence 99999999 888 9999999999999999999999999997654432111 11134588999999998
Q ss_pred ---cccCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHH
Q 044022 143 ---SICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLH 219 (241)
Q Consensus 143 ---~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (241)
.+..++.++||||||+++|+|++|+.||....... ... .... ... .. ..+.
T Consensus 223 ~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------------~~~-~~~~-~~~---~~--------~~~~ 276 (337)
T 3ll6_A 223 DLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-------------IVN-GKYS-IPP---HD--------TQYT 276 (337)
T ss_dssp -CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------------------------CC-CCT---TC--------CSSG
T ss_pred hccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-------------hhc-Cccc-CCc---cc--------ccch
Confidence 55678899999999999999999999995421110 000 0000 000 01 1113
Q ss_pred HHHHHHHHhccCCCCCCCCCCC
Q 044022 220 ASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 220 ~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.+.+++.+||+.||++|||++|
T Consensus 277 ~~~~li~~~l~~~p~~Rps~~e 298 (337)
T 3ll6_A 277 VFHSLIRAMLQVNPEERLSIAE 298 (337)
T ss_dssp GGHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHccCChhhCcCHHH
Confidence 4789999999999999999753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=244.85 Aligned_cols=152 Identities=18% Similarity=0.196 Sum_probs=130.7
Q ss_pred cHHHHHHHHHHHHhcCCCc------ccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC---c---hHHHHHHHHHHHhc
Q 044022 12 TYGSCINNITYAAQMSHNH------ILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---L---PRLKIASDIVNSLA 79 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~---~~~~~~~~i~~~l~ 79 (241)
..+.+.+|++++++++|++ ++.+.+++...+..++||||+ +++|.+++.... . ....++.||+.||.
T Consensus 59 ~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~ 137 (355)
T 2eu9_A 59 YREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Confidence 4567889999999997765 889999999999999999999 567777664332 1 46789999999999
Q ss_pred hhhcCCCCCceeccCCCCCeee-------------------cCCCCeEEeeccCceecCCCCcceeecccccCCCccCcc
Q 044022 80 YLHFGFPRPIVLRNFKTQNILF-------------------NEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPE 140 (241)
Q Consensus 80 ~lh~~~~~~ivh~dl~~~nil~-------------------~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE 140 (241)
||| +.+++||||||+|||+ +.++.+||+|||.+....... ....||+.|+|||
T Consensus 138 ~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE 209 (355)
T 2eu9_A 138 FLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPE 209 (355)
T ss_dssp HHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHH
T ss_pred HHH---HCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCe
Confidence 999 9999999999999999 678899999999997654332 3346899999999
Q ss_pred cccccCCCcchhhHHHHHHHHHHHhcCccccc
Q 044022 141 YISICVLNEKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 141 ~~~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
++.+..++.++||||||+++|+|++|..||..
T Consensus 210 ~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 210 VILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp HHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 99988999999999999999999999999965
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=248.63 Aligned_cols=192 Identities=19% Similarity=0.273 Sum_probs=154.6
Q ss_pred HHHHHHHHHHHHhcC--CCcccceeeeeeeCCcceEEEEecCC-CCHHHhhcCCC----chHHHHHHHHHHHhchhhcCC
Q 044022 13 YGSCINNITYAAQMS--HNHILKRIGCCLQTPIPILVFQSVEY-GTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.+|+.++++++ |+||+++++++...+..++|+|++.+ ++|.+++.... .....++.|++.||.|||
T Consensus 90 ~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH--- 166 (320)
T 3a99_A 90 GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 166 (320)
T ss_dssp CCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---
T ss_pred hhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 356778999999996 59999999999999999999999975 89999886432 246789999999999999
Q ss_pred CCCceeccCCCCCeeec-CCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCC-CcchhhHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFN-EENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVL-NEKSNVFSFGAFLFEL 163 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~s~G~~~~~~ 163 (241)
+.+++||||||+||+++ .++.+||+|||.+........ ....|++.|+|||++.+..+ +.++||||||+++|+|
T Consensus 167 ~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el 242 (320)
T 3a99_A 167 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 242 (320)
T ss_dssp HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHH
T ss_pred HCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccccc----cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHH
Confidence 89999999999999999 778999999999987654322 23468999999999987665 6789999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|+.||.... ...... . ...... +..+.+++.+||+.||++|||++|
T Consensus 243 ~~g~~pf~~~~---------------~~~~~~-~------~~~~~~--------~~~~~~li~~~l~~dp~~Rps~~~ 290 (320)
T 3a99_A 243 VCGDIPFEHDE---------------EIIRGQ-V------FFRQRV--------SSECQHLIRWCLALRPSDRPTFEE 290 (320)
T ss_dssp HHSSCSCCSHH---------------HHHHCC-C------CCSSCC--------CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHCCCCCCChh---------------hhhccc-c------cccccC--------CHHHHHHHHHHccCChhhCcCHHH
Confidence 99999995411 011110 0 011111 257889999999999999999853
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=248.23 Aligned_cols=199 Identities=20% Similarity=0.272 Sum_probs=129.7
Q ss_pred HHHHHhcCCCcccceeeeeee----CCcceEEEEecCCCCHHHhhcCCC---c---hHHHHHHHHHHHhchhhcCCCCCc
Q 044022 20 ITYAAQMSHNHILKRIGCCLQ----TPIPILVFQSVEYGTLRDCIFGAP---L---PRLKIASDIVNSLAYLHFGFPRPI 89 (241)
Q Consensus 20 ~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~---~---~~~~~~~~i~~~l~~lh~~~~~~i 89 (241)
...++.++||||+++++++.. ....++||||+++|+|.+++.... . ....++.+++.||.||| +.++
T Consensus 73 ~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~i 149 (336)
T 3fhr_A 73 DHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNI 149 (336)
T ss_dssp HHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred HHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 344566799999999999976 445899999999999999997652 2 46789999999999999 8999
Q ss_pred eeccCCCCCeeecC---CCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 90 VLRNFKTQNILFNE---ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 90 vh~dl~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
+||||||+||+++. ++.++|+|||.+........ ....+++.|+|||++.+..++.++||||||+++|+|++|
T Consensus 150 vH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 225 (336)
T 3fhr_A 150 AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225 (336)
T ss_dssp ECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHS
T ss_pred ecCCCCHHHEEEEecCCCceEEEeccccceecccccc----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHC
Confidence 99999999999976 45699999999976543322 234678999999999888899999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
..||.......... . ......... ...+.+.. ...+..+.+++.+||+.||++|||++|
T Consensus 226 ~~pf~~~~~~~~~~-----~-~~~~~~~~~-~~~~~~~~---------~~~~~~~~~li~~~L~~dP~~Rpt~~e 284 (336)
T 3fhr_A 226 FPPFYSNTGQAISP-----G-MKRRIRLGQ-YGFPNPEW---------SEVSEDAKQLIRLLLKTDPTERLTITQ 284 (336)
T ss_dssp SCCC----------------------------CCCTTTS---------TTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCccchhhhh-----h-HHHhhhccc-cccCchhh---------ccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 99996532211000 0 000000000 00011000 122367899999999999999999853
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=249.67 Aligned_cols=212 Identities=23% Similarity=0.206 Sum_probs=149.2
Q ss_pred HHHHHHHHHhcCCCcccceeeeeeeCC------cceEEEEecCCCCHHHhhcC-----CCc---hHHHHHHHHHHHhchh
Q 044022 16 CINNITYAAQMSHNHILKRIGCCLQTP------IPILVFQSVEYGTLRDCIFG-----APL---PRLKIASDIVNSLAYL 81 (241)
Q Consensus 16 ~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~-----~~~---~~~~~~~~i~~~l~~l 81 (241)
+.+|++++++++||||++++++|...+ ..++||||++ ++|.+.+.. ... ....++.||+.||.||
T Consensus 94 ~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 172 (420)
T 1j1b_A 94 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172 (420)
T ss_dssp CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 347999999999999999999986422 3679999997 466665432 111 4678899999999999
Q ss_pred hcCCCCCceeccCCCCCeeecCC-CCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHH
Q 044022 82 HFGFPRPIVLRNFKTQNILFNEE-NVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAF 159 (241)
Q Consensus 82 h~~~~~~ivh~dl~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~ 159 (241)
| +.+|+||||||+|||++.+ +.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||+
T Consensus 173 H---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~i 246 (420)
T 1j1b_A 173 H---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCV 246 (420)
T ss_dssp H---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred H---HCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHH
Confidence 9 9999999999999999965 5689999999987644322 1235689999999999765 78999999999999
Q ss_pred HHHHHhcCcccccccccCCCcccchHHHHHHHh---------hhcccCCCCCCccccCCCchh---HHHHHHHHHHHHHH
Q 044022 160 LFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYL---------EDKRFTGIPAPIIVQDIPCIE---KEQQLHASAQLTLE 227 (241)
Q Consensus 160 ~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~ 227 (241)
+|+|++|+.||..... .....+..+... ....+.....+.+... .+. ....+..+.+|+.+
T Consensus 247 l~ell~G~~pf~~~~~-----~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~--~~~~~~~~~~~~~~~~Li~~ 319 (420)
T 1j1b_A 247 LAELLLGQPIFPGDSG-----VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH--PWTKVFRPRTPPEAIALCSR 319 (420)
T ss_dssp HHHHHHSSCSSCCSSH-----HHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCC--CHHHHSCTTSCHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCC--CHHHhcCCCCCHHHHHHHHH
Confidence 9999999999965211 011111111100 0111111111111000 000 01123678999999
Q ss_pred hccCCCCCCCCCCC
Q 044022 228 CVNNSPEDRPTMVD 241 (241)
Q Consensus 228 cl~~~p~~Rpt~~e 241 (241)
||..||++|||+.|
T Consensus 320 ~L~~dP~~R~t~~e 333 (420)
T 1j1b_A 320 LLEYTPTARLTPLE 333 (420)
T ss_dssp HSCSSGGGSCCHHH
T ss_pred hccCChhHCCCHHH
Confidence 99999999999753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=251.91 Aligned_cols=152 Identities=22% Similarity=0.266 Sum_probs=128.9
Q ss_pred cHHHHHHHHHHHHhcC-----------CCcccceeeeeeeCC----cceEEEEecCCCCHHHhhcCCC---c---hHHHH
Q 044022 12 TYGSCINNITYAAQMS-----------HNHILKRIGCCLQTP----IPILVFQSVEYGTLRDCIFGAP---L---PRLKI 70 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~---~---~~~~~ 70 (241)
..+.+.+|++++++++ |+||+++++++...+ ..++|||++ +++|.+++.... . ....+
T Consensus 58 ~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i 136 (373)
T 1q8y_A 58 YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQI 136 (373)
T ss_dssp HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHH
T ss_pred chhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHH
Confidence 3567889999999986 889999999998654 789999999 799999986531 1 46789
Q ss_pred HHHHHHHhchhhcCCCC-CceeccCCCCCeeec------CCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc
Q 044022 71 ASDIVNSLAYLHFGFPR-PIVLRNFKTQNILFN------EENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS 143 (241)
Q Consensus 71 ~~~i~~~l~~lh~~~~~-~ivh~dl~~~nil~~------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 143 (241)
+.||+.||.||| ++ +++||||||+|||++ ..+.+||+|||++....... ....+|+.|+|||++.
T Consensus 137 ~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~ 208 (373)
T 1q8y_A 137 SKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLL 208 (373)
T ss_dssp HHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHH
T ss_pred HHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHh
Confidence 999999999999 77 999999999999995 34479999999997664432 2346899999999999
Q ss_pred ccCCCcchhhHHHHHHHHHHHhcCccccc
Q 044022 144 ICVLNEKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 144 ~~~~~~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
+..++.++||||||+++|+|++|..||..
T Consensus 209 ~~~~~~~~Di~slG~il~el~~g~~pf~~ 237 (373)
T 1q8y_A 209 GAPWGCGADIWSTACLIFELITGDFLFEP 237 (373)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 98999999999999999999999999965
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=245.36 Aligned_cols=156 Identities=21% Similarity=0.233 Sum_probs=126.4
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCc-------ceEEEEecCCCCHHHhhc----CCCc----hHHHHHHHHHH
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPI-------PILVFQSVEYGTLRDCIF----GAPL----PRLKIASDIVN 76 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-------~~lv~e~~~~~sL~~~l~----~~~~----~~~~~~~~i~~ 76 (241)
...++.++++.+..++||||+++++++...+. .++||||+.+ +|...+. .... ....++.+++.
T Consensus 62 ~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~ 140 (360)
T 3e3p_A 62 FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140 (360)
T ss_dssp CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHH
Confidence 34567788999999999999999999976443 7899999985 5544332 2211 45678999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecC-CCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNE-ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVF 154 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~ 154 (241)
||.|||.. +.+++||||||+|||++. ++.+||+|||++......... ....||+.|+|||++.+. .++.++|||
T Consensus 141 al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~ 216 (360)
T 3e3p_A 141 SIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIW 216 (360)
T ss_dssp HHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHH
Confidence 99999932 678999999999999997 899999999999866543321 234689999999998765 489999999
Q ss_pred HHHHHHHHHHhcCccccc
Q 044022 155 SFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 155 s~G~~~~~~~~g~~p~~~ 172 (241)
|||+++|+|++|+.||..
T Consensus 217 slG~il~ell~g~~pf~~ 234 (360)
T 3e3p_A 217 SVGCIFAEMMLGEPIFRG 234 (360)
T ss_dssp HHHHHHHHHHHSSCSSCC
T ss_pred HHHHHHHHHHhCCCCcCC
Confidence 999999999999999965
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=254.86 Aligned_cols=208 Identities=17% Similarity=0.185 Sum_probs=156.0
Q ss_pred HHHHHHHHHHHHhcCC-CcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--Cc---hHHHHHHHHHHHhchhhcCCC
Q 044022 13 YGSCINNITYAAQMSH-NHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--PL---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
..++.+|+++++.|+| +++..+..++...+..++||||+ +++|.+++... .. .++.++.||+.||.||| +
T Consensus 46 ~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~ 121 (483)
T 3sv0_A 46 HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---S 121 (483)
T ss_dssp SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 4468899999999987 55556666667788889999999 89999998632 22 57889999999999999 8
Q ss_pred CCceeccCCCCCeee---cCCCCeEEeeccCceecCCCCcc-----eeecccccCCCccCcccccccCCCcchhhHHHHH
Q 044022 87 RPIVLRNFKTQNILF---NEENVAKWFDFLLSISIPEGETH-----ITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGA 158 (241)
Q Consensus 87 ~~ivh~dl~~~nil~---~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~ 158 (241)
++|+||||||+|||+ +.++.+||+|||++......... .......||..|+|||++.+..++.++||||||+
T Consensus 122 ~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGv 201 (483)
T 3sv0_A 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGY 201 (483)
T ss_dssp TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHH
Confidence 999999999999999 68899999999999876543321 1122457899999999999999999999999999
Q ss_pred HHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 159 FLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 159 ~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
++|+|++|+.||....... ..+......... .... ...+.. ..+..+.+++..||+.||++||+
T Consensus 202 il~elltG~~Pf~~~~~~~------~~~~~~~i~~~~-~~~~-~~~l~~--------~~p~~l~~li~~cl~~dP~~RPs 265 (483)
T 3sv0_A 202 VLMYFLRGSLPWQGLKAGT------KKQKYEKISEKK-VATS-IEALCR--------GYPTEFASYFHYCRSLRFDDKPD 265 (483)
T ss_dssp HHHHHHHSSCTTSSCCCSS------HHHHHHHHHHHH-HHSC-HHHHHT--------TSCHHHHHHHHHHHTCCTTCCCC
T ss_pred HHHHHHhCCCCCccccchh------HHHHHHHHhhcc-cccc-HHHHhc--------CCcHHHHHHHHHHhcCChhhCcC
Confidence 9999999999996532211 111111111100 0000 000011 12357899999999999999999
Q ss_pred CC
Q 044022 239 MV 240 (241)
Q Consensus 239 ~~ 240 (241)
++
T Consensus 266 ~~ 267 (483)
T 3sv0_A 266 YS 267 (483)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=246.53 Aligned_cols=154 Identities=20% Similarity=0.218 Sum_probs=130.7
Q ss_pred cHHHHHHHHHHHHhcC-CC-----cccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHHHHHhc
Q 044022 12 TYGSCINNITYAAQMS-HN-----HILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDIVNSLA 79 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~l~ 79 (241)
...++.+|+++++.++ |+ +|+++++++...+..++||||+. ++|.+++.... .....++.|++.||.
T Consensus 93 ~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~ 171 (382)
T 2vx3_A 93 FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171 (382)
T ss_dssp HHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHH
Confidence 3566788999999885 55 48999999999999999999996 69999886542 146789999999999
Q ss_pred hhhcCCCCCceeccCCCCCeeec--CCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHH
Q 044022 80 YLHFGFPRPIVLRNFKTQNILFN--EENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFG 157 (241)
Q Consensus 80 ~lh~~~~~~ivh~dl~~~nil~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G 157 (241)
|||.. +.+|+||||||+|||++ .++.+||+|||++....... ....+|+.|+|||++.+..++.++||||||
T Consensus 172 ~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 245 (382)
T 2vx3_A 172 FLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLG 245 (382)
T ss_dssp HHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHH
T ss_pred HhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHH
Confidence 99931 36899999999999994 47889999999998764432 335689999999999998999999999999
Q ss_pred HHHHHHHhcCccccc
Q 044022 158 AFLFELLAGRIHIWD 172 (241)
Q Consensus 158 ~~~~~~~~g~~p~~~ 172 (241)
+++|+|++|+.||..
T Consensus 246 ~il~elltg~~pf~~ 260 (382)
T 2vx3_A 246 CILVEMHTGEPLFSG 260 (382)
T ss_dssp HHHHHHHHSSCSSCC
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999965
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=244.18 Aligned_cols=214 Identities=20% Similarity=0.237 Sum_probs=146.7
Q ss_pred CcccccccccccHHH-HHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcC--CC---chHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGS-CINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFG--AP---LPRLKIASDI 74 (241)
Q Consensus 1 iK~~~~~~~~~~~~~-~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~--~~---~~~~~~~~~i 74 (241)
||++..........+ +.++..+++.++||||+++++++...+..++||||+ ++.+..+... .. .....++.++
T Consensus 55 vK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i 133 (318)
T 2dyl_A 55 VKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAI 133 (318)
T ss_dssp EEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHH
T ss_pred EEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHH
Confidence 355544333223333 444556788889999999999999999999999999 5666665542 11 2467899999
Q ss_pred HHHhchhhcCCCC-CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc-----ccCCC
Q 044022 75 VNSLAYLHFGFPR-PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS-----ICVLN 148 (241)
Q Consensus 75 ~~~l~~lh~~~~~-~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~ 148 (241)
+.||.||| +. +++|+||||+||+++.++.++|+|||.+........ .....+++.|+|||.+. ...++
T Consensus 134 ~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~ 207 (318)
T 2dyl_A 134 VKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYD 207 (318)
T ss_dssp HHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC--------CC
T ss_pred HHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc---ccccCCCccccChhhcccccccccCCc
Confidence 99999999 75 999999999999999999999999999876543321 12346889999999984 45678
Q ss_pred cchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHh
Q 044022 149 EKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLEC 228 (241)
Q Consensus 149 ~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 228 (241)
.++||||||+++|+|++|+.||..... ..+......... ....+. .. ..+..+.+++.+|
T Consensus 208 ~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~~-~~~~~~---~~--------~~~~~l~~li~~~ 267 (318)
T 2dyl_A 208 IRADVWSLGISLVELATGQFPYKNCKT--------DFEVLTKVLQEE-PPLLPG---HM--------GFSGDFQSFVKDC 267 (318)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTTTCCS--------HHHHHHHHHHSC-CCCCCS---SS--------CCCHHHHHHHHHH
T ss_pred cccchhhHHHHHHHHHhCCCCCCCCCc--------cHHHHHHHhccC-CCCCCc---cC--------CCCHHHHHHHHHH
Confidence 899999999999999999999954111 111222221111 111111 01 1125788999999
Q ss_pred ccCCCCCCCCCCC
Q 044022 229 VNNSPEDRPTMVD 241 (241)
Q Consensus 229 l~~~p~~Rpt~~e 241 (241)
|+.||.+|||++|
T Consensus 268 l~~dp~~Rps~~~ 280 (318)
T 2dyl_A 268 LTKDHRKRPKYNK 280 (318)
T ss_dssp TCSCTTTSCCHHH
T ss_pred ccCChhHCcCHHH
Confidence 9999999999753
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=267.58 Aligned_cols=199 Identities=20% Similarity=0.245 Sum_probs=155.5
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCc-----ceEEEEecCCCCHHHhhcCCCc--hHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPI-----PILVFQSVEYGTLRDCIFGAPL--PRLKIASD 73 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~ 73 (241)
||++...........+.+|++++++++||||+++++++...+. .|+||||+++++|.+++...-. .++.++.+
T Consensus 111 iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~q 190 (681)
T 2pzi_A 111 LKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLE 190 (681)
T ss_dssp EEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----CCCCHHHHHHHHHH
T ss_pred EEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHH
Confidence 3555443334456678999999999999999999999987665 6999999999999988765322 57789999
Q ss_pred HHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhh
Q 044022 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNV 153 (241)
Q Consensus 74 i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 153 (241)
|+.||.||| +++|+||||||+|||++.+ .+||+|||++...... ....||+.|+|||++.+.. +.++||
T Consensus 191 i~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi 259 (681)
T 2pzi_A 191 ILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDI 259 (681)
T ss_dssp HHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHH
T ss_pred HHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCCC-CCceeh
Confidence 999999999 8999999999999999985 8999999999876543 3346899999999987654 889999
Q ss_pred HHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 154 FSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
||||+++|+|++|..||...... .... . ......+..+.+++.+||+.||
T Consensus 260 ~slG~~l~~l~~g~~~~~~~~~~----------------------~~~~-----~---~~~~~~~~~l~~li~~~l~~dP 309 (681)
T 2pzi_A 260 YTVGRTLAALTLDLPTRNGRYVD----------------------GLPE-----D---DPVLKTYDSYGRLLRRAIDPDP 309 (681)
T ss_dssp HHHHHHHHHHHSCCCEETTEECS----------------------SCCT-----T---CHHHHHCHHHHHHHHHHTCSSG
T ss_pred hhhHHHHHHHHhCCCCCcccccc----------------------cccc-----c---ccccccCHHHHHHHhhhccCCh
Confidence 99999999999999888541110 0000 0 0111234678899999999999
Q ss_pred CCCCCCC
Q 044022 234 EDRPTMV 240 (241)
Q Consensus 234 ~~Rpt~~ 240 (241)
++|||..
T Consensus 310 ~~R~~~~ 316 (681)
T 2pzi_A 310 RQRFTTA 316 (681)
T ss_dssp GGSCSSH
T ss_pred hhCCCHH
Confidence 9999863
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=244.09 Aligned_cols=192 Identities=22% Similarity=0.331 Sum_probs=150.0
Q ss_pred HHHHHHHHHHHHhc----CCCcccceeeeeeeCCcceEEEEe-cCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhc
Q 044022 13 YGSCINNITYAAQM----SHNHILKRIGCCLQTPIPILVFQS-VEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 13 ~~~~~~e~~~l~~l----~h~~iv~~~~~~~~~~~~~lv~e~-~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~ 83 (241)
...+.+|+.++.++ +||||+++++++...+..++|+|+ +.+++|.+++.... .....++.+++.||.|||
T Consensus 78 ~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH- 156 (312)
T 2iwi_A 78 SVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH- 156 (312)
T ss_dssp -CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH-
T ss_pred hHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 44567899999999 899999999999999999999999 78899999986532 256789999999999999
Q ss_pred CCCCCceeccCCCCCeeec-CCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCC-cchhhHHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFN-EENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLN-EKSNVFSFGAFLF 161 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~s~G~~~~ 161 (241)
+.+++|+||||+||+++ .++.++|+|||.+........ ....++..|+|||++.+..+. .++||||||+++|
T Consensus 157 --~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~ 230 (312)
T 2iwi_A 157 --SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLY 230 (312)
T ss_dssp --HHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHH
T ss_pred --HCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHH
Confidence 89999999999999999 889999999999987654322 334688999999998876664 5899999999999
Q ss_pred HHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 162 ELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 162 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|++|+.||.... .... ... . +.. ..+..+.+++.+||+.||++|||++|
T Consensus 231 ~l~~g~~pf~~~~---------------~~~~-~~~-~-----~~~--------~~~~~~~~li~~~l~~~p~~Rps~~e 280 (312)
T 2iwi_A 231 DMVCGDIPFERDQ---------------EILE-AEL-H-----FPA--------HVSPDCCALIRRCLAPKPSSRPSLEE 280 (312)
T ss_dssp HHHHSSCSCCSHH---------------HHHH-TCC-C-----CCT--------TSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHCCCCCCChH---------------HHhh-hcc-C-----Ccc--------cCCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999995411 0000 100 0 111 12256889999999999999999853
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=232.04 Aligned_cols=189 Identities=10% Similarity=0.079 Sum_probs=143.1
Q ss_pred Ccccccccc--cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc--hHHHHHHHHHH
Q 044022 1 MKFYGHEYH--RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL--PRLKIASDIVN 76 (241)
Q Consensus 1 iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~ 76 (241)
||++..... ....+.+.+|++++.+++||||+++++++...+..|+||||+++++|.+++..... ....++.|++.
T Consensus 61 vK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~ 140 (286)
T 3uqc_A 61 LTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAA 140 (286)
T ss_dssp EEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHH
T ss_pred EEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcCCChHHHHHHHHHHHH
Confidence 456654433 23457899999999999999999999999999999999999999999999976543 46789999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSF 156 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~ 156 (241)
||.||| +++++||||||+|||++.++.++|++++ |++ .++.++|||||
T Consensus 141 aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~----------------------~~~-------~~~~~~Di~sl 188 (286)
T 3uqc_A 141 AADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMP-------DANPQDDIRGI 188 (286)
T ss_dssp HHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC----------------------CCT-------TCCHHHHHHHH
T ss_pred HHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc----------------------ccC-------CCCchhHHHHH
Confidence 999999 8999999999999999999999988543 222 26789999999
Q ss_pred HHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCC--CccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 157 GAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPA--PIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 157 G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
|+++|+|++|+.||........... .......... ..... ..+..+.+++.+||+.||+
T Consensus 189 G~il~elltg~~Pf~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~--------~~~~~l~~li~~~l~~dP~ 249 (286)
T 3uqc_A 189 GASLYALLVNRWPLPEAGVRSGLAP-----------AERDTAGQPIEPADIDR--------DIPFQISAVAARSVQGDGG 249 (286)
T ss_dssp HHHHHHHHHSEECSCCCSBCCCSEE-----------CCBCTTSCBCCHHHHCT--------TSCHHHHHHHHHHHCTTSS
T ss_pred HHHHHHHHHCCCCCCcCCcchhhHH-----------HHHHhccCCCChhhccc--------CCCHHHHHHHHHHcccCCc
Confidence 9999999999999965322110000 0000000000 00111 2236789999999999999
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
+| |++|
T Consensus 250 ~R-s~~e 255 (286)
T 3uqc_A 250 IR-SAST 255 (286)
T ss_dssp CC-CHHH
T ss_pred cC-CHHH
Confidence 99 8753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=230.19 Aligned_cols=186 Identities=17% Similarity=0.237 Sum_probs=139.2
Q ss_pred HHHHHHHHHHH-HhcCCCcccceeeeeee----CCcceEEEEecCCCCHHHhhcCCC---c---hHHHHHHHHHHHhchh
Q 044022 13 YGSCINNITYA-AQMSHNHILKRIGCCLQ----TPIPILVFQSVEYGTLRDCIFGAP---L---PRLKIASDIVNSLAYL 81 (241)
Q Consensus 13 ~~~~~~e~~~l-~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~---~---~~~~~~~~i~~~l~~l 81 (241)
...+.+|+.++ +.++||||+++++++.. .+..++||||+++++|.+++.... . ....++.+++.||.||
T Consensus 54 ~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l 133 (299)
T 3m2w_A 54 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133 (299)
T ss_dssp SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 45678899998 55599999999999987 667899999999999999986542 2 4678999999999999
Q ss_pred hcCCCCCceeccCCCCCeeecC---CCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHH
Q 044022 82 HFGFPRPIVLRNFKTQNILFNE---ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGA 158 (241)
Q Consensus 82 h~~~~~~ivh~dl~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~ 158 (241)
| +.+++||||||+||+++. ++.++|+|||++..... ..++.++||||||+
T Consensus 134 H---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~------------------------~~~~~~~DiwslG~ 186 (299)
T 3m2w_A 134 H---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG------------------------EKYDKSCDMWSLGV 186 (299)
T ss_dssp H---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT------------------------CGGGGHHHHHHHHH
T ss_pred H---hCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc------------------------ccCCchhhHHHHHH
Confidence 9 899999999999999998 78999999998864321 34678999999999
Q ss_pred HHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 159 FLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 159 ~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
++|+|++|..||........ ........... ....+.......+..+.+++.+||+.||++|||
T Consensus 187 il~el~tg~~pf~~~~~~~~--------------~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps 250 (299)
T 3m2w_A 187 IMYILLCGYPPFYSNHGLAI--------------SPGMKTRIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT 250 (299)
T ss_dssp HHHHHHHSSCSCCC---------------------CCSCCSSCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHCCCCCCCCcchhh--------------hHHHHHHHhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCC
Confidence 99999999999965211100 00000000000 001111111233467999999999999999999
Q ss_pred CCC
Q 044022 239 MVD 241 (241)
Q Consensus 239 ~~e 241 (241)
++|
T Consensus 251 ~~e 253 (299)
T 3m2w_A 251 ITE 253 (299)
T ss_dssp HHH
T ss_pred HHH
Confidence 853
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=237.08 Aligned_cols=192 Identities=13% Similarity=0.138 Sum_probs=139.5
Q ss_pred ccHHHHHHHHHHHHhcCC-Ccccceeee---------------------eee-----CCcceEEEEecCCCCHHHhhc--
Q 044022 11 HTYGSCINNITYAAQMSH-NHILKRIGC---------------------CLQ-----TPIPILVFQSVEYGTLRDCIF-- 61 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h-~~iv~~~~~---------------------~~~-----~~~~~lv~e~~~~~sL~~~l~-- 61 (241)
...+.+.+|+.+++.++| +|...+..+ +.. ....+++|+.+ +++|.+++.
T Consensus 120 ~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l 198 (413)
T 3dzo_A 120 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL 198 (413)
T ss_dssp -CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHh
Confidence 457789999999999987 332211111 111 12456777766 589999884
Q ss_pred ----CCCc-----hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeeccccc
Q 044022 62 ----GAPL-----PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIG 132 (241)
Q Consensus 62 ----~~~~-----~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 132 (241)
.... .++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||++...... .....|
T Consensus 199 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g 270 (413)
T 3dzo_A 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG 270 (413)
T ss_dssp HHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC
T ss_pred hcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC
Confidence 1111 45678899999999999 899999999999999999999999999998764432 234467
Q ss_pred CCCccCcccc----------cccCCCcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCC
Q 044022 133 TRGYSAPEYI----------SICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPA 202 (241)
Q Consensus 133 ~~~~~aPE~~----------~~~~~~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (241)
+.|+|||++ ....++.++||||||+++|+|++|+.||......... ...+...
T Consensus 271 -~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~--------------~~~~~~~-- 333 (413)
T 3dzo_A 271 -RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS--------------EWIFRSC-- 333 (413)
T ss_dssp -TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS--------------GGGGSSC--
T ss_pred -CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhH--------------HHHHhhc--
Confidence 899999999 5556788999999999999999999999653211100 0000000
Q ss_pred CccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCC
Q 044022 203 PIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMV 240 (241)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~ 240 (241)
... ++.+.+|+.+||+.||++|||+.
T Consensus 334 ----~~~--------~~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 334 ----KNI--------PQPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp ----CCC--------CHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ----ccC--------CHHHHHHHHHHccCChhhCcCHH
Confidence 011 25789999999999999999964
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=8.6e-34 Score=231.93 Aligned_cols=195 Identities=12% Similarity=0.049 Sum_probs=142.1
Q ss_pred ccHHHHHHHHHHHHhcC--------------------------CCcccceeeeeee-------------CCcceEEEEec
Q 044022 11 HTYGSCINNITYAAQMS--------------------------HNHILKRIGCCLQ-------------TPIPILVFQSV 51 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~--------------------------h~~iv~~~~~~~~-------------~~~~~lv~e~~ 51 (241)
...+.+.+|+.+++.++ ||||+++++++.. .+..++||||+
T Consensus 65 ~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~ 144 (336)
T 2vuw_A 65 KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFE 144 (336)
T ss_dssp BCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEE
T ss_pred hhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEec
Confidence 44588999999999996 4555555555543 67899999999
Q ss_pred CCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCC--------------------CeE
Q 044022 52 EYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEEN--------------------VAK 108 (241)
Q Consensus 52 ~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~--------------------~~~ 108 (241)
++|++.+.+..... ....++.||+.||.|||. +.+|+||||||+|||++.++ .+|
T Consensus 145 ~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vk 222 (336)
T 2vuw_A 145 FGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVS 222 (336)
T ss_dssp CCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEE
T ss_pred CCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEE
Confidence 99976666644322 567899999999999993 37899999999999999887 899
Q ss_pred EeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHH-HHHHHhcCcccccccccCCCcccchHH-
Q 044022 109 WFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAF-LFELLAGRIHIWDLLKDTHDHGCFFNE- 186 (241)
Q Consensus 109 l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~-~~~~~~g~~p~~~~~~~~~~~~~~~~~- 186 (241)
|+|||+++..... ...||+.|+|||++.+.. +.++||||++.+ .+++++|..||... .+..
T Consensus 223 L~DFG~a~~~~~~-------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~ 285 (336)
T 2vuw_A 223 IIDYTLSRLERDG-------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHY 285 (336)
T ss_dssp ECCCTTCBEEETT-------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHH
T ss_pred EeeccccEecCCC-------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhH
Confidence 9999999865432 236899999999998766 899999998766 77888999998431 0101
Q ss_pred HHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCC
Q 044022 187 YLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNS 232 (241)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~ 232 (241)
............. ..........++.+.+|+.+||+.|
T Consensus 286 ~~~~~~~~~~~~~--------~~~~~~~~~~s~~~~dli~~~L~~d 323 (336)
T 2vuw_A 286 LTDKMLKQMTFKT--------KCNTPAMKQIKRKIQEFHRTMLNFS 323 (336)
T ss_dssp HHHHHHHTCCCSS--------CCCSHHHHHHHHHHHHHHHHGGGSS
T ss_pred HHHhhhhhhccCc--------ccchhhhhhcCHHHHHHHHHHhccC
Confidence 1111111111111 1111223467788999999999987
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-33 Score=242.26 Aligned_cols=154 Identities=15% Similarity=0.082 Sum_probs=117.6
Q ss_pred ccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-chHHHHHHHHHHHhchhhcCCCCC
Q 044022 11 HTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-LPRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
...++|.+|+++|+++ .|+||+++++++++++..||||||++|++|.+++.... .....++.||+.||.|+| ++|
T Consensus 283 ~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH---~~G 359 (569)
T 4azs_A 283 RNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALE---KQG 359 (569)
T ss_dssp HHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHH---HTT
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHH---HCC
Confidence 3456799999999999 79999999999999999999999999999999997764 456679999999999999 999
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCc
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRI 168 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~ 168 (241)
||||||||+|||++.++.+||+|||+++....... .....+||+.|+|||++.+ ....++|+||+|++.+++.++..
T Consensus 360 IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 360 FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp CEESCCCGGGEEECTTSCEEECCCTTEESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 99999999999999999999999999986654332 2244679999999999975 45678999999999888776655
Q ss_pred cc
Q 044022 169 HI 170 (241)
Q Consensus 169 p~ 170 (241)
++
T Consensus 437 ~~ 438 (569)
T 4azs_A 437 NW 438 (569)
T ss_dssp HH
T ss_pred hh
Confidence 44
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-26 Score=198.35 Aligned_cols=149 Identities=15% Similarity=0.085 Sum_probs=127.3
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhhcCCCCCceec
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVLR 92 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~~~ivh~ 92 (241)
.+++.+|++++++++||||+++..++...+..++||||+++++|.+++.. ...++.|++.||.||| +++|+||
T Consensus 383 ~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~----~~~i~~qi~~aL~~LH---~~gIiHr 455 (540)
T 3en9_A 383 KSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED----NLDIAYKIGEIVGKLH---KNDVIHN 455 (540)
T ss_dssp HHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT----CTHHHHHHHHHHHHHH---HTTEECT
T ss_pred HHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH----HHHHHHHHHHHHHHHH---HCcCccC
Confidence 45689999999999999999777777788888999999999999999987 6789999999999999 8999999
Q ss_pred cCCCCCeeecCCCCeEEeeccCceecCCCCcce-----eecccccCCCccCcccccc--cCCCcchhhHHHHHHHHHHHh
Q 044022 93 NFKTQNILFNEENVAKWFDFLLSISIPEGETHI-----TTDRVIGTRGYSAPEYISI--CVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 93 dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~s~G~~~~~~~~ 165 (241)
||||+|||++. .+||+|||+++......... ......||+.|+|||++.. ..|+..+|+||..+-..+-+.
T Consensus 456 DiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~ 533 (540)
T 3en9_A 456 DLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVE 533 (540)
T ss_dssp TCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHH
T ss_pred CCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHH
Confidence 99999999998 99999999998775532211 1134578999999999986 567788899999988888877
Q ss_pred cCccc
Q 044022 166 GRIHI 170 (241)
Q Consensus 166 g~~p~ 170 (241)
++.+|
T Consensus 534 ~r~rY 538 (540)
T 3en9_A 534 RRARY 538 (540)
T ss_dssp TCSCC
T ss_pred hcccc
Confidence 76655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=4.3e-20 Score=147.13 Aligned_cols=105 Identities=15% Similarity=0.090 Sum_probs=88.1
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhhcCCCCCceec
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVLR 92 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~~~ivh~ 92 (241)
..++.+|++++++++ | +++.+++.. +..++||||+++++|.+ +.. .....++.+++.||.||| +.+++||
T Consensus 148 ~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--~~~~~i~~qi~~~l~~lH---~~giiHr 217 (282)
T 1zar_A 148 IRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--ENPDEVLDMILEEVAKFY---HRGIVHG 217 (282)
T ss_dssp HHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--SCHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred HHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--hhHHHHHHHHHHHHHHHH---HCCCEeC
Confidence 567899999999999 5 777776544 56799999999999999 532 335579999999999999 9999999
Q ss_pred cCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc
Q 044022 93 NFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS 143 (241)
Q Consensus 93 dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 143 (241)
||||+|||++ ++.++|+|||+++.. ..+.|||++.
T Consensus 218 Dlkp~NILl~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~ 252 (282)
T 1zar_A 218 DLSQYNVLVS-EEGIWIIDFPQSVEV---------------GEEGWREILE 252 (282)
T ss_dssp CCSTTSEEEE-TTEEEECCCTTCEET---------------TSTTHHHHHH
T ss_pred CCCHHHEEEE-CCcEEEEECCCCeEC---------------CCCCHHHHHH
Confidence 9999999999 999999999998642 3357888774
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.2e-14 Score=114.22 Aligned_cols=97 Identities=12% Similarity=0.097 Sum_probs=76.7
Q ss_pred HHHHHHHHHHHhcCCCcc--cceeeeeeeCCcceEEEEecCC-C----CHHHhhcCC-CchHHHHHHHHHHHhchhhcCC
Q 044022 14 GSCINNITYAAQMSHNHI--LKRIGCCLQTPIPILVFQSVEY-G----TLRDCIFGA-PLPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 14 ~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~-~~~~~~~~~~i~~~l~~lh~~~ 85 (241)
..+.+|++++.++.|+++ +..+++ +..++||||+.+ | +|.+..... ......++.+++.|+.+||.
T Consensus 115 ~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~-- 188 (258)
T 1zth_A 115 IWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQ-- 188 (258)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHH--
T ss_pred HHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHH--
Confidence 368899999999988765 333332 357999999942 3 777765432 23567899999999999994
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceec
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISI 118 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~ 118 (241)
+.+++||||||.|||++. .++|+|||++...
T Consensus 189 ~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 189 EAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 468999999999999998 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.34 E-value=4e-13 Score=110.45 Aligned_cols=71 Identities=18% Similarity=0.230 Sum_probs=59.3
Q ss_pred ceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCC----------CeEEeecc
Q 044022 44 PILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEEN----------VAKWFDFL 113 (241)
Q Consensus 44 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~----------~~~l~df~ 113 (241)
.++||||+.|++|..+... .....++.|++.++.+|| ..++|||||||.|||++.++ .+.|+||+
T Consensus 186 ~~LVME~i~G~~L~~l~~~--~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~ 260 (397)
T 4gyi_A 186 HTIVMSLVDALPMRQVSSV--PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFP 260 (397)
T ss_dssp TEEEEECCSCEEGGGCCCC--SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCT
T ss_pred ceEEEEecCCccHhhhccc--HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeC
Confidence 4799999999888775443 234567899999999999 89999999999999998776 38999999
Q ss_pred CceecC
Q 044022 114 LSISIP 119 (241)
Q Consensus 114 ~~~~~~ 119 (241)
.+....
T Consensus 261 Q~V~~~ 266 (397)
T 4gyi_A 261 QMVSMD 266 (397)
T ss_dssp TCEETT
T ss_pred CcccCC
Confidence 887643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.07 E-value=3e-10 Score=89.02 Aligned_cols=103 Identities=10% Similarity=-0.044 Sum_probs=81.5
Q ss_pred HHHHHHHHHHHHhcC-CCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhhcC-------
Q 044022 13 YGSCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFG------- 84 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~------- 84 (241)
...+.+|+.+++.+. +..+.++++++...+..++|||+++|.+|.+.+.. ......++.+++.+++.||..
T Consensus 53 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~-~~~~~~~~~~l~~~l~~LH~~~~~~~~~ 131 (263)
T 3tm0_A 53 TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED-EQSPEKIIELYAECIRLFHSIDISDCPY 131 (263)
T ss_dssp TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT-TTCHHHHHHHHHHHHHHHHHSCCTTCSC
T ss_pred HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccCC-cccHHHHHHHHHHHHHHHhCCCcccCCC
Confidence 346889999999994 56778899999888889999999999999886432 223457788888899999941
Q ss_pred -------------------------------------------------CCCCceeccCCCCCeeecCCCCeEEeeccCc
Q 044022 85 -------------------------------------------------FPRPIVLRNFKTQNILFNEENVAKWFDFLLS 115 (241)
Q Consensus 85 -------------------------------------------------~~~~ivh~dl~~~nil~~~~~~~~l~df~~~ 115 (241)
....++|+|+++.||+++....+.|+||+.+
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 132 TNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp BCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred cchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 0144899999999999987666679999876
Q ss_pred e
Q 044022 116 I 116 (241)
Q Consensus 116 ~ 116 (241)
.
T Consensus 212 ~ 212 (263)
T 3tm0_A 212 G 212 (263)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.02 E-value=4.1e-10 Score=87.86 Aligned_cols=99 Identities=10% Similarity=-0.014 Sum_probs=74.4
Q ss_pred HHHHHHHHHHHhcCCCc--ccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhhcCC------
Q 044022 14 GSCINNITYAAQMSHNH--ILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGF------ 85 (241)
Q Consensus 14 ~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~------ 85 (241)
..+.+|+.+++.+.+.+ +.+++++...++..++||||++|.+|. ... .....++.+++..++.||...
T Consensus 58 ~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~--~~~~~~~~~l~~~l~~lh~~~~~~~~~ 133 (264)
T 1nd4_A 58 NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH--LAPAEKVSIMADAMRRLHTLDPATCPF 133 (264)
T ss_dssp SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC--CCHHHHHHHHHHHHHHHTTSCGGGCCC
T ss_pred hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc--CCHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 56789999999995544 456888887777889999999998884 221 223456777777788887321
Q ss_pred -------------------------------------------------CCCceeccCCCCCeeecCCCCeEEeeccCce
Q 044022 86 -------------------------------------------------PRPIVLRNFKTQNILFNEENVAKWFDFLLSI 116 (241)
Q Consensus 86 -------------------------------------------------~~~ivh~dl~~~nil~~~~~~~~l~df~~~~ 116 (241)
...++|+|++|.||+++.++.+.|+||+.+.
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 134 DHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp BCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877667799998774
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.81 E-value=7.8e-09 Score=84.69 Aligned_cols=105 Identities=16% Similarity=0.174 Sum_probs=78.1
Q ss_pred HHHHHHHHHHHHhcCC--CcccceeeeeeeC---CcceEEEEecCCCCHHHh-hcCCC-chHHHHHHHHHHHhchhhcCC
Q 044022 13 YGSCINNITYAAQMSH--NHILKRIGCCLQT---PIPILVFQSVEYGTLRDC-IFGAP-LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~---~~~~lv~e~~~~~sL~~~-l~~~~-~~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.+|+.+++.|.. ..+++++.++... +..++|||+++|.++.+. +.... ..+..++.+++..|+.||...
T Consensus 80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~ 159 (359)
T 3dxp_A 80 AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVD 159 (359)
T ss_dssp --CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSC
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCC
Confidence 4578889999999964 4577888888766 458999999998887542 22211 245667888888888888410
Q ss_pred -------------------------------------------------------CCCceeccCCCCCeeecCCCC--eE
Q 044022 86 -------------------------------------------------------PRPIVLRNFKTQNILFNEENV--AK 108 (241)
Q Consensus 86 -------------------------------------------------------~~~ivh~dl~~~nil~~~~~~--~~ 108 (241)
...++|+|+++.||+++.++. +.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~ 239 (359)
T 3dxp_A 160 YQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLA 239 (359)
T ss_dssp TTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEE
T ss_pred chhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEE
Confidence 246899999999999987753 68
Q ss_pred EeeccCcee
Q 044022 109 WFDFLLSIS 117 (241)
Q Consensus 109 l~df~~~~~ 117 (241)
|+||+.+..
T Consensus 240 viDwe~a~~ 248 (359)
T 3dxp_A 240 VLDWELSTL 248 (359)
T ss_dssp ECCCTTCEE
T ss_pred EECcccccc
Confidence 999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.58 E-value=1.9e-08 Score=80.55 Aligned_cols=157 Identities=15% Similarity=0.213 Sum_probs=91.0
Q ss_pred cHHHHHHHHHHHHhcC-CCc--ccceeeeeeeCC---cceEEEEecCCCCHHHhhc-CCC-chHHHHHHHHHHHhchhhc
Q 044022 12 TYGSCINNITYAAQMS-HNH--ILKRIGCCLQTP---IPILVFQSVEYGTLRDCIF-GAP-LPRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~-h~~--iv~~~~~~~~~~---~~~lv~e~~~~~sL~~~l~-~~~-~~~~~~~~~i~~~l~~lh~ 83 (241)
....+.+|+++++.+. +.. +.+++......+ ..++||++++|.+|.+... ... ..+..++.+++..++.||.
T Consensus 53 ~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~ 132 (304)
T 3sg8_A 53 GSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHS 132 (304)
T ss_dssp HHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCccccccCCHHHHHHHHHHHHHHHHHHHc
Confidence 3567889999999984 333 234444433322 4589999999988865322 111 1233445555555555542
Q ss_pred -------------------------------------------------------CCCCCceeccCCCCCeeecC--CCC
Q 044022 84 -------------------------------------------------------GFPRPIVLRNFKTQNILFNE--ENV 106 (241)
Q Consensus 84 -------------------------------------------------------~~~~~ivh~dl~~~nil~~~--~~~ 106 (241)
.....++|+|+++.||+++. ...
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~ 212 (304)
T 3sg8_A 133 INISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTI 212 (304)
T ss_dssp SCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEE
T ss_pred CCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCE
Confidence 11235799999999999998 456
Q ss_pred eEEeeccCceecCCCCcceeecccccCCCccCcccccc---c-----------CCCcchhhHHHHHHHHHHHhcCcccc
Q 044022 107 AKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI---C-----------VLNEKSNVFSFGAFLFELLAGRIHIW 171 (241)
Q Consensus 107 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~-----------~~~~~~Di~s~G~~~~~~~~g~~p~~ 171 (241)
+.++||+.+............ .....-..|+.... . ......+.|+++.++|.+.+|..+|.
T Consensus 213 ~~~iD~~~~~~~~~~~Dl~~~---~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 213 CGIIDFGDAAISDPDNDFISL---MEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp EEECCCTTCEEECTTHHHHTT---CCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred EEEEeCCCCccCChHHHHHHH---HhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 789999987654321100000 00000011211110 0 01122688999999999999998874
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=2.2e-06 Score=67.13 Aligned_cols=104 Identities=12% Similarity=0.033 Sum_probs=71.5
Q ss_pred HHHHHHHHHHHHhcCC-CcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhhc--------
Q 044022 13 YGSCINNITYAAQMSH-NHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHF-------- 83 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~-------- 83 (241)
...+.+|..+|+.|.. --+.++++++...+..++|||+++|.++.+...........+..++...++-||.
T Consensus 63 ~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~ 142 (272)
T 4gkh_A 63 ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPF 142 (272)
T ss_dssp HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCGGGCCB
T ss_pred HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCCHHHHHHHHHHHHHHHHHhcCCCcccCCc
Confidence 4567889999998843 2356788888888899999999998887765433322222333333333333331
Q ss_pred -----------------------------------------------CCCCCceeccCCCCCeeecCCCCeEEeeccCce
Q 044022 84 -----------------------------------------------GFPRPIVLRNFKTQNILFNEENVAKWFDFLLSI 116 (241)
Q Consensus 84 -----------------------------------------------~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~ 116 (241)
.....++|+|+.+.||+++..+.+-|+||+.+.
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 143 NSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp BCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred CcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 001237899999999999987777899998774
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.87 E-value=4.7e-05 Score=60.80 Aligned_cols=47 Identities=11% Similarity=0.044 Sum_probs=34.4
Q ss_pred cHHHHHHHHHHHHhcCCC---cccceeeeee-eCCcceEEEEecCCCCHHH
Q 044022 12 TYGSCINNITYAAQMSHN---HILKRIGCCL-QTPIPILVFQSVEYGTLRD 58 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~~~~sL~~ 58 (241)
....+.+|+++|+.|.+. .+.+.+.+.. ..+..++||++++|.++..
T Consensus 52 ~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~ 102 (306)
T 3tdw_A 52 GADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGE 102 (306)
T ss_dssp HHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHH
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECch
Confidence 356788999999999653 2445566553 3456789999999988866
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=9.9e-05 Score=60.04 Aligned_cols=45 Identities=9% Similarity=-0.079 Sum_probs=32.8
Q ss_pred HHHHHHHHHHHhcCC---CcccceeeeeeeC---CcceEEEEecCCCCHHH
Q 044022 14 GSCINNITYAAQMSH---NHILKRIGCCLQT---PIPILVFQSVEYGTLRD 58 (241)
Q Consensus 14 ~~~~~e~~~l~~l~h---~~iv~~~~~~~~~---~~~~lv~e~~~~~sL~~ 58 (241)
..+.+|+.+++.|.. -.+.+++.++... +..++|||+++|.++.+
T Consensus 72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChhh
Confidence 467889999998842 3466778777654 35689999999877653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0052 Score=49.21 Aligned_cols=32 Identities=16% Similarity=0.128 Sum_probs=28.4
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCcee
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSIS 117 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~ 117 (241)
...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 57899999999999998888899999987753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0034 Score=50.40 Aligned_cols=34 Identities=26% Similarity=0.226 Sum_probs=28.5
Q ss_pred CCCceeccCCCCCeeecCC----CCeEEeeccCceecC
Q 044022 86 PRPIVLRNFKTQNILFNEE----NVAKWFDFLLSISIP 119 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~----~~~~l~df~~~~~~~ 119 (241)
...++|+|+.+.||+++.+ +.+.|+||+.+....
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 5579999999999999874 678999999886543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0049 Score=50.77 Aligned_cols=31 Identities=16% Similarity=0.219 Sum_probs=26.0
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCcee
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSIS 117 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~ 117 (241)
...++|+|+.+.||+++.+ .+.++||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 4578999999999999865 488999987754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0034 Score=51.52 Aligned_cols=31 Identities=26% Similarity=0.310 Sum_probs=26.5
Q ss_pred CCCceeccCCCCCeeecCC----CCeEEeeccCce
Q 044022 86 PRPIVLRNFKTQNILFNEE----NVAKWFDFLLSI 116 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~----~~~~l~df~~~~ 116 (241)
...++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 219 ~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 219 PVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp CEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred CcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3468999999999999876 688999998774
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0082 Score=47.90 Aligned_cols=44 Identities=7% Similarity=-0.022 Sum_probs=35.3
Q ss_pred HHHHHHHHHHHHhcC---CCcccceeeeeeeCCcceEEEEecCCCCH
Q 044022 13 YGSCINNITYAAQMS---HNHILKRIGCCLQTPIPILVFQSVEYGTL 56 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 56 (241)
...+..|+..|+.|. ...+++++.+....+..++|||++++.++
T Consensus 72 ~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 72 RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 566889999999983 25677888888777889999999987654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.21 E-value=0.0031 Score=49.94 Aligned_cols=32 Identities=16% Similarity=0.007 Sum_probs=26.0
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceec
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISI 118 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~ 118 (241)
...++|+|+.+.||+ ..++.+.++||..+...
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 345899999999999 56677899999887643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.89 E-value=0.011 Score=49.30 Aligned_cols=39 Identities=13% Similarity=0.049 Sum_probs=26.8
Q ss_pred HHHHHHHHHHHhcCCCcc-cceeeeeeeCCcceEEEEecCCCCH
Q 044022 14 GSCINNITYAAQMSHNHI-LKRIGCCLQTPIPILVFQSVEYGTL 56 (241)
Q Consensus 14 ~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~sL 56 (241)
..+.+|..+++.|...++ .++++.+.+ .+|+||++|.+|
T Consensus 120 ~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 120 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 159 (429)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred HHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence 567789999998843334 567766532 389999986444
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=93.67 E-value=0.053 Score=44.95 Aligned_cols=32 Identities=9% Similarity=0.226 Sum_probs=28.2
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceec
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISI 118 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~ 118 (241)
...++|+|+.+.|||++.++ +.++||+.+...
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 67899999999999998776 999999888654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.79 E-value=0.052 Score=43.05 Aligned_cols=32 Identities=16% Similarity=0.452 Sum_probs=26.8
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCcee
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSIS 117 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~ 117 (241)
..+++|+|+.+.||+++.+..+.++||+.+..
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 45689999999999998876668999987753
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.54 E-value=0.34 Score=36.18 Aligned_cols=122 Identities=7% Similarity=-0.018 Sum_probs=77.5
Q ss_pred HHHHHHhcCCCcccceeeeeeeCCcceEEEEecC-CCCHHHhhcCCCchHHHHHHHHHHHhchhhcCCCCCceeccCCCC
Q 044022 19 NITYAAQMSHNHILKRIGCCLQTPIPILVFQSVE-YGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQ 97 (241)
Q Consensus 19 e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~ 97 (241)
|+.+|.. .||++++. .+-...+.+.+.++.-+ +-++...-+.....+++++.+|+....+++ .-+|--+.|+
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~ 108 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPD 108 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGG
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecc
Confidence 3333333 67888877 45555665555555433 234444333333468888989888776665 3478899999
Q ss_pred CeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhH-HHHHHHHHHHhcCccccc
Q 044022 98 NILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVF-SFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 98 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~-s~G~~~~~~~~g~~p~~~ 172 (241)
|++++.++.+++.--|+...+ +|. .+ ...|.| ..=+++..+++++..|.+
T Consensus 109 NL~f~~~~~p~i~~RGik~~l-------------------~P~-----~~-~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVV-------------------DPL-----PV-SEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp GEEECTTSCEEESCCEETTTB-------------------SCC-----CC-CHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred eEEEcCCCCEEEEEccCccCC-------------------CCC-----CC-CHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 999999999999887654221 221 11 222333 567778888889888854
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.67 E-value=1 Score=33.71 Aligned_cols=114 Identities=13% Similarity=0.113 Sum_probs=73.1
Q ss_pred CCCcccceeeeeeeCCcceEEEEecC-CCCHHHhhcCCCchHHHHHHHHHHHhc-hhhcCCCCCceeccCCCCCeeecCC
Q 044022 27 SHNHILKRIGCCLQTPIPILVFQSVE-YGTLRDCIFGAPLPRLKIASDIVNSLA-YLHFGFPRPIVLRNFKTQNILFNEE 104 (241)
Q Consensus 27 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~~sL~~~l~~~~~~~~~~~~~i~~~l~-~lh~~~~~~ivh~dl~~~nil~~~~ 104 (241)
.||++ -..+-..++.+.+.++.-+ +-++...-......+++++.+++.... +++ .-+|--+.|+|++++.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEEEeCC
Confidence 67777 3333345666666666543 234444433333468888888887776 555 45788899999999999
Q ss_pred CCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhH-HHHHHHHHHHhcCccccc
Q 044022 105 NVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVF-SFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 105 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~-s~G~~~~~~~~g~~p~~~ 172 (241)
+.+++...|+-.. ++|.. ....|.| ..=+++..++.++..|.+
T Consensus 121 ~~p~i~hRGi~~~-------------------lpP~e------~~ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 121 LEPFFLHVGVKES-------------------LPPDE------WDDERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp CCEEESCCEETTT-------------------BSSCS------CCHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred CcEEEEEcCCccc-------------------CCCCC------CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999998775422 22211 1223443 566777888888877754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=89.25 E-value=0.14 Score=40.55 Aligned_cols=30 Identities=13% Similarity=0.112 Sum_probs=25.6
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCcee
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSIS 117 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~ 117 (241)
...++|+|+++.||+++ + .+.++||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 45689999999999998 4 889999987754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=89.09 E-value=0.26 Score=39.53 Aligned_cols=33 Identities=12% Similarity=0.138 Sum_probs=28.3
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceec
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISI 118 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~ 118 (241)
...++|+|+.+.|++++.++.+.++||+.+...
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 456899999999999998888999999877543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=87.92 E-value=0.24 Score=40.08 Aligned_cols=31 Identities=16% Similarity=0.169 Sum_probs=24.8
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCcee
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSIS 117 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~ 117 (241)
...++|+|+.+.||+++.+. +.++||+.+..
T Consensus 211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp CEEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred CeEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 34689999999999997654 89999987753
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=87.74 E-value=0.043 Score=46.48 Aligned_cols=32 Identities=6% Similarity=-0.220 Sum_probs=25.8
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTP 42 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 42 (241)
.+.++|..|++.+.+++|+|+|++.|||....
T Consensus 321 ~g~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~ 352 (487)
T 3oja_A 321 QGSETERLECERENQARQREIDALKEQYRTVI 352 (487)
T ss_dssp ----CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred ccHHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence 45778999999999999999999999997643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=86.80 E-value=1.7 Score=32.53 Aligned_cols=98 Identities=12% Similarity=-0.004 Sum_probs=57.3
Q ss_pred CCHHHhhcCCC--c---hHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeec
Q 044022 54 GTLRDCIFGAP--L---PRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128 (241)
Q Consensus 54 ~sL~~~l~~~~--~---~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 128 (241)
.||.+.|+... . +.+.++.|.+.+|.-+-. ...-..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc------------
Confidence 47888876542 2 678888888888776521 11111233456888899998887653 1110
Q ss_pred ccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhcCcc
Q 044022 129 RVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIH 169 (241)
Q Consensus 129 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~~p 169 (241)
.....+.|||... ...+.+.-|||+|+++|.-+--..|
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122356777764 3445777899999999998875544
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=86.62 E-value=0.35 Score=40.66 Aligned_cols=36 Identities=8% Similarity=-0.119 Sum_probs=25.5
Q ss_pred HHHHHHHHhcCCCcc-cceeeeeeeCCcceEEEEecCCCCH
Q 044022 17 INNITYAAQMSHNHI-LKRIGCCLQTPIPILVFQSVEYGTL 56 (241)
Q Consensus 17 ~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~sL 56 (241)
.+|..+++.|...++ .++++.+. + .+|+||++|.+|
T Consensus 152 ~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 152 EREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp HHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred HHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 589999999965455 46777762 2 359999987544
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=82.60 E-value=0.67 Score=38.07 Aligned_cols=29 Identities=24% Similarity=0.287 Sum_probs=24.3
Q ss_pred ceeccCCCCCeee------cCCCCeEEeeccCcee
Q 044022 89 IVLRNFKTQNILF------NEENVAKWFDFLLSIS 117 (241)
Q Consensus 89 ivh~dl~~~nil~------~~~~~~~l~df~~~~~ 117 (241)
++|+|+.+.||++ +....+.++||..+..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4467799999988753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 241 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-30 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-27 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-26 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-26 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-25 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-25 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-25 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-24 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-24 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-23 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-23 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-23 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-23 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-23 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-23 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-23 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-22 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-21 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-21 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-21 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-21 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-21 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-21 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-21 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-20 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-20 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-20 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-20 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-19 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-19 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-19 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-19 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-18 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-17 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-17 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-17 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-16 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-16 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-16 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-16 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-16 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-16 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-16 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-15 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-14 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-14 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-14 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-14 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-14 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-13 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-13 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-13 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-12 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-12 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-11 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-10 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-09 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-09 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-08 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-08 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 5e-30
Identities = 47/233 (20%), Positives = 88/233 (37%), Gaps = 30/233 (12%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-----RLKIA 71
N + + H +IL +G P +V Q E +L + + IA
Sbjct: 52 KNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 110
Query: 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVI 131
+ YLH + I+ R+ K+ NI +E+ K DF L+ +++
Sbjct: 111 RQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 167
Query: 132 GTRGYSAPEYI---SICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYL 188
G+ + APE I + +S+V++FG L+EL+ G++ + N
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-------------YSNINN 214
Query: 189 KNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
++ + G +P + + K +L EC+ ++RP
Sbjct: 215 RDQIIFMVGRGYLSPDLSKVRSNCPKA-----MKRLMAECLKKKRDERPLFPQ 262
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 3e-27
Identities = 42/245 (17%), Positives = 88/245 (35%), Gaps = 24/245 (9%)
Query: 18 NNITYAAQMSHNHILKRIGCCLQTPIPI----LVFQSVEYGTLRDCIFGAPLP---RLKI 70
I + H +IL I + LV E+G+L D + + +K+
Sbjct: 46 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL 105
Query: 71 ASDIVNSLAYLH-----FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE--T 123
A + LA+LH I R+ K++NIL + D L++
Sbjct: 106 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 165
Query: 124 HITTDRVIGTRGYSAPEYISICV------LNEKSNVFSFGAFLFELLAGRIHIWDLLKDT 177
I + +GT+ Y APE + + +++++++ G +E+
Sbjct: 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI---HE 222
Query: 178 HDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIP-CIEKEQQLHASAQLTLECVNNSPEDR 236
+++ + ++ + + +IP + + L A++ EC + R
Sbjct: 223 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 282
Query: 237 PTMVD 241
T +
Sbjct: 283 LTALR 287
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 4e-26
Identities = 52/231 (22%), Positives = 88/231 (38%), Gaps = 33/231 (14%)
Query: 15 SCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF---GAPLP---RL 68
+ + Q+ H +++ Q PI ++ + +E G+L D + G L L
Sbjct: 54 AFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLL 112
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128
+A+ I +A++ R + R+ + NIL ++ K DF L+ I + E
Sbjct: 113 DMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE- 168
Query: 129 RVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYL 188
++APE I+ KS+V+SFG L E++ + G E +
Sbjct: 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP--------GMTNPEVI 220
Query: 189 KNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
+N R + + P QL C PEDRPT
Sbjct: 221 QNLERGYR------MVRPDNCP--------EELYQLMRLCWKERPEDRPTF 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 6e-26
Identities = 42/247 (17%), Positives = 85/247 (34%), Gaps = 30/247 (12%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA-PLP---RLKIAS 72
I + + + +I+ G + + ++ G+L + A +P K++
Sbjct: 52 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 111
Query: 73 DIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIG 132
++ L YL I+ R+ K NIL N K DF +S + + + +G
Sbjct: 112 AVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVG 165
Query: 133 TRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRI--------------------HIWD 172
TR Y +PE + + +S+++S G L E+ GR +
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225
Query: 173 LLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNS 232
G + Y + + I+ + P + +C+ +
Sbjct: 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285
Query: 233 PEDRPTM 239
P +R +
Sbjct: 286 PAERADL 292
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 4e-25
Identities = 43/228 (18%), Positives = 81/228 (35%), Gaps = 31/228 (13%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-----RLKIA 71
++ A + + H+ + +G C T L+ Q + +G L D + L
Sbjct: 59 LDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 117
Query: 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVI 131
I + YL R +V R+ +N+L K DF L+ + E +
Sbjct: 118 VQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 132 GTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNY 191
+ A E I + +S+V+S+G ++EL+ +D + +E
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISSIL 226
Query: 192 LEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
+ +R P PI D+ + ++C + RP
Sbjct: 227 EKGERLP-QP-PICTIDV------------YMIMVKCWMIDADSRPKF 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.0 bits (241), Expect = 7e-25
Identities = 43/232 (18%), Positives = 90/232 (38%), Gaps = 37/232 (15%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPI-LVFQSVEYGTLRDCIF---GAPLP---RLK 69
+ + Q+ H+++++ +G ++ + +V + + G+L D + + L LK
Sbjct: 48 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 107
Query: 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
+ D+ ++ YL V R+ +N+L +E+NVAK DF L+ T D
Sbjct: 108 FSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDT 159
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLK 189
++APE + + KS+V+SFG L+E+ + + + +
Sbjct: 160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP--------RIPLKDVVP 211
Query: 190 NYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
+ + P A ++ C + RP+ +
Sbjct: 212 RVEKGYK------MDAPDGCP--------PAVYEVMKNCWHLDAAMRPSFLQ 249
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.4 bits (242), Expect = 8e-25
Identities = 41/226 (18%), Positives = 83/226 (36%), Gaps = 29/226 (12%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP---RLKIASD 73
IN I + + +I+ + L +V + + G+L D + + + +
Sbjct: 65 INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE 124
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGT 133
+ +L +LH ++ R+ K+ NIL + K DF I ++ +T ++GT
Sbjct: 125 CLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179
Query: 134 RGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLE 193
+ APE ++ K +++S G E++ G + NE L
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP-------------YLNENPLRALY 226
Query: 194 DKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
G P + + I ++ C++ E R +
Sbjct: 227 LIATNGTPELQNPEKLSAIFRD--------FLNRCLDMDVEKRGSA 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.4 bits (234), Expect = 6e-24
Identities = 37/228 (16%), Positives = 84/228 (36%), Gaps = 31/228 (13%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-----RLKIA 71
I +SH +++ G C + ++ + + G L + + L++
Sbjct: 47 IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 106
Query: 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVI 131
D+ ++ YL + + R+ +N L N++ V K DF LS + + E +
Sbjct: 107 KDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSK 162
Query: 132 GTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNY 191
+S PE + + KS++++FG ++E+ + ++ ++ E++
Sbjct: 163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-----EHIAQG 217
Query: 192 LEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
L R + + C + ++RPT
Sbjct: 218 LRLYRPHLASEKVY-----------------TIMYSCWHEKADERPTF 248
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.8 bits (235), Expect = 7e-24
Identities = 43/228 (18%), Positives = 80/228 (35%), Gaps = 31/228 (13%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA-PLP---RLKIAS 72
+ Q+ + +I++ IG C + +LV + E G L + + +++
Sbjct: 56 LAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH 114
Query: 73 DIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITT-DRVI 131
+ + YL V R+ +N+L ++ AK DF LS ++ E +
Sbjct: 115 QVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171
Query: 132 GTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNY 191
+ APE I+ + KS+V+SFG ++E + + G +E
Sbjct: 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR--------GMKGSEVTAML 223
Query: 192 LEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
+ +R P L C E+RP
Sbjct: 224 EKGER------MGCPAGCP--------REMYDLMNLCWTYDVENRPGF 257
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.9 bits (233), Expect = 1e-23
Identities = 33/155 (21%), Positives = 62/155 (40%), Gaps = 11/155 (7%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA-PLP---RLKIAS 72
+ + + H +IL+ G L+ + GT+ + +
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 113
Query: 73 DIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIG 132
++ N+L+Y H + ++ R+ K +N+L K DF S+ P + G
Sbjct: 114 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCG 166
Query: 133 TRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
T Y PE I + +EK +++S G +E L G+
Sbjct: 167 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 201
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 94.5 bits (234), Expect = 1e-23
Identities = 49/253 (19%), Positives = 85/253 (33%), Gaps = 53/253 (20%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFG-------------- 62
A+ + +I+K +G C L+F+ + YG L + +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 63 -----------APLP---RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAK 108
PL +L IA + +AYL R V R+ T+N L E V K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVK 180
Query: 109 WFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRI 168
DF LS +I + + + PE I +S+V+++G L+E+ + +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 169 HIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLEC 228
+ +G E + + ++ P L C
Sbjct: 241 QPY--------YGMAHEEVIYYVRDGNI------LACPENCP--------LELYNLMRLC 278
Query: 229 VNNSPEDRPTMVD 241
+ P DRP+
Sbjct: 279 WSKLPADRPSFCS 291
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.0 bits (233), Expect = 1e-23
Identities = 50/229 (21%), Positives = 80/229 (34%), Gaps = 33/229 (14%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP------RLKI 70
+ ++ H +++ + PI I V + + G+L D + G + +
Sbjct: 60 LQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDM 118
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRV 130
A+ I + +AY+ V R+ + NIL E V K DF L+ I + E
Sbjct: 119 AAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GA 174
Query: 131 IGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKN 190
++APE KS+V+SFG L EL + G E L
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP--------GMVNREVLDQ 226
Query: 191 YLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
R + P + L +C PE+RPT
Sbjct: 227 VERGYR------MPCPPECP--------ESLHDLMCQCWRKEPEERPTF 261
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.6 bits (232), Expect = 2e-23
Identities = 45/231 (19%), Positives = 85/231 (36%), Gaps = 32/231 (13%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--PLP---RLKIA 71
+ Q+ + +I++ IG C Q +LV + G L + G +P ++
Sbjct: 57 MREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 115
Query: 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT-TDRV 130
+ + YL + V R+ +N+L + AK DF LS ++ +++ T
Sbjct: 116 HQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172
Query: 131 IGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKN 190
+ APE I+ + +S+V+S+G ++E L+ + E +
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK--------KMKGPEVMAF 224
Query: 191 YLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
+ KR + P L +C EDRP +
Sbjct: 225 IEQGKR------MECPPECP--------PELYALMSDCWIYKWEDRPDFLT 261
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.8 bits (230), Expect = 2e-23
Identities = 46/228 (20%), Positives = 87/228 (38%), Gaps = 31/228 (13%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-----RLKIA 71
I ++SH +++ G CL+ LVF+ +E+G L D + L +
Sbjct: 48 IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 107
Query: 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVI 131
D+ +AYL ++ R+ +N L E V K DF ++ + + + +
Sbjct: 108 LDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS-TGTK 163
Query: 132 GTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNY 191
+++PE S + KS+V+SFG ++E+ + + +E +++
Sbjct: 164 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY--------ENRSNSEVVEDI 215
Query: 192 LEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
R + P + Q+ C PEDRP
Sbjct: 216 STGFR---LYKPRLAST-----------HVYQIMNHCWKERPEDRPAF 249
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.8 bits (230), Expect = 3e-23
Identities = 46/230 (20%), Positives = 81/230 (35%), Gaps = 29/230 (12%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFG----APLPRLKIAS 72
I ++H +++K G + I L + G L D I +
Sbjct: 51 KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH 110
Query: 73 DIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIG 132
++ + YLH I R+ K +N+L +E + K DF L+ +++ G
Sbjct: 111 QLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 167
Query: 133 TRGYSAPEYISICVLN-EKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNY 191
T Y APE + + E +V+S G L +LAG + D + ++
Sbjct: 168 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP--------WDQPSDSCQEYSDW 219
Query: 192 LEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
E K + I + + K + +P R T+ D
Sbjct: 220 KEKKTYLNPWKKIDSAPLALLHK-------------ILVENPSARITIPD 256
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 93.1 bits (231), Expect = 4e-23
Identities = 43/230 (18%), Positives = 80/230 (34%), Gaps = 38/230 (16%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF-GAPLP---RLKIAS 72
I + + ++ H + ++ GC L+ LV + PL +
Sbjct: 63 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH 122
Query: 73 DIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIG 132
+ LAYLH ++ R+ K NIL +E + K DF + + + +G
Sbjct: 123 GALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVG 173
Query: 133 TRGYSAPEYISIC---VLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLK 189
T + APE I + K +V+S G EL + ++++ + ++
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMSALYH---- 225
Query: 190 NYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
I + P ++ C+ P+DRPT
Sbjct: 226 --------------IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTS 261
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.1 bits (228), Expect = 1e-22
Identities = 40/243 (16%), Positives = 80/243 (32%), Gaps = 51/243 (20%)
Query: 26 MSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP------------------- 66
SH +I+ +G C + L+F+ YG L + +
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 67 --------RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISI 118
L A + + +L F + V R+ +N+L V K DF L+ I
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 119 PEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTH 178
++ + APE + + KS+V+S+G L+E+ + ++ + +
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 179 DHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238
+ F + ++N + + I + C RP+
Sbjct: 275 N----FYKLIQNGFKMDQPFYATEEIY-----------------IIMQSCWAFDSRKRPS 313
Query: 239 MVD 241
+
Sbjct: 314 FPN 316
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.5 bits (219), Expect = 1e-21
Identities = 40/236 (16%), Positives = 78/236 (33%), Gaps = 38/236 (16%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF--GAPLP---RLKIA 71
+ I A H +I+K + ++ + G + + PL +
Sbjct: 57 MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 116
Query: 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVI 131
+++L YLH I+ R+ K NILF + K DF +S + I
Sbjct: 117 KQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FI 171
Query: 132 GTRGYSAPEYISICVL-----NEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNE 186
GT + APE + + K++V+S G L E+ + +
Sbjct: 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP----PHHELNPMRVLLK- 226
Query: 187 YLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQ-LTLECVNNSPEDRPTMVD 241
I + P + + + ++ + +C+ + + R T
Sbjct: 227 -----------------IAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQ 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.7 bits (219), Expect = 2e-21
Identities = 40/230 (17%), Positives = 84/230 (36%), Gaps = 27/230 (11%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTP-IPILVFQSVEYGTLRD--CIFGAPLPRLKIASD 73
+ SH ++L +G CL++ P++V +++G LR+ +
Sbjct: 76 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 135
Query: 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR--VI 131
+ + F + V R+ +N + +E+ K DF L+ + + E ++
Sbjct: 136 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195
Query: 132 GTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNY 191
+ A E + KS+V+SFG L+EL+ + +
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY--------PDVNTFDITVYL 247
Query: 192 LEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
L+ +R + + P ++ L+C + E RP+ +
Sbjct: 248 LQGRR------LLQPEYCP--------DPLYEVMLKCWHPKAEMRPSFSE 283
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.5 bits (219), Expect = 2e-21
Identities = 26/145 (17%), Positives = 56/145 (38%), Gaps = 1/145 (0%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA-PLPRLKIASDIVNSLAYLH 82
+++ H +K + G L I ++ L
Sbjct: 63 SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122
Query: 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYI 142
+ + I+ R+ K +NIL NE+ + DF + + + +GT Y +PE +
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 143 SICVLNEKSNVFSFGAFLFELLAGR 167
+ + S++++ G +++L+AG
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 88.3 bits (218), Expect = 2e-21
Identities = 45/233 (19%), Positives = 86/233 (36%), Gaps = 33/233 (14%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-----RLKIA 71
++ + Q H +++ G ++ +++ + +E G+L + + +
Sbjct: 75 LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML 134
Query: 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVI 131
I + YL V R+ +NIL N V K DF LS + + + T +
Sbjct: 135 RGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSAL 191
Query: 132 G---TRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYL 188
G ++APE I S+V+S+G ++E+++ + + + + +
Sbjct: 192 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--------QDVI 243
Query: 189 KNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
+D R P P D P A QL L+C RP
Sbjct: 244 NAIEQDYRL---PPP---MDCP--------SALHQLMLDCWQKDRNHRPKFGQ 282
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.7 bits (217), Expect = 2e-21
Identities = 40/237 (16%), Positives = 79/237 (33%), Gaps = 37/237 (15%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTP--IPILVFQSVEYGTLRDCIFGAPLPR------- 67
++ + ++ H +I++ + +V + E G L I R
Sbjct: 51 VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 110
Query: 68 -LKIASDIVNSLAYLH--FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH 124
L++ + + +L H ++ R+ K N+ + + K DF L+ + +
Sbjct: 111 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF 170
Query: 125 ITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFF 184
+GT Y +PE ++ NEKS+++S G L+EL A
Sbjct: 171 AKA--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF---------TAFSQ 219
Query: 185 NEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
E E K I ++ +N RP++ +
Sbjct: 220 KELAGKIREGKF------RRIPYRYS--------DELNEIITRMLNLKDYHRPSVEE 262
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.3 bits (218), Expect = 2e-21
Identities = 42/235 (17%), Positives = 78/235 (33%), Gaps = 46/235 (19%)
Query: 27 SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFG-------------------APLP- 66
+H +I+ +G C +++ + YG L + + L
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 67 --RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH 124
L + + +A+L + + R+ +NIL + K DF L+ I +
Sbjct: 145 EDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 125 ITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFF 184
+ + APE I CV +S+V+S+G FL+EL + + G
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG--------SSPYPGMPV 253
Query: 185 NEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
+ +I + + E + C + P RPT
Sbjct: 254 DSKFYK-------------MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF 295
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 86.7 bits (214), Expect = 8e-21
Identities = 43/231 (18%), Positives = 91/231 (39%), Gaps = 32/231 (13%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP------RLKI 70
+ ++ H ++++ +G C + P ++ + + YG L D + L +
Sbjct: 61 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 120
Query: 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRV 130
A+ I +++ YL + + R+ +N L E ++ K DF LS +
Sbjct: 121 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GA 176
Query: 131 IGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKN 190
++APE ++ + KS+V++FG L+E+ + + + + + E L+
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-----ELLEK 231
Query: 191 YLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
+R G P + +L C +P DRP+ +
Sbjct: 232 DYRMERPEGCPEKVY-----------------ELMRACWQWNPSDRPSFAE 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.5 bits (213), Expect = 1e-20
Identities = 43/240 (17%), Positives = 85/240 (35%), Gaps = 45/240 (18%)
Query: 23 AAQMSHNHILKRIGCCLQTPIPI-LVFQSVEYGTLRDCIFGAPLP--------------- 66
H +++ +G C + P+ ++ + ++G L +
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 67 -----RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEG 121
+ + + + +L R + R+ +NIL +E+NV K DF L+ I +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187
Query: 122 ETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHG 181
++ + APE I V +S+V+SFG L+E+ + + G
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--------PG 239
Query: 182 CFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
+E L++ P ++ Q L+C + P RPT +
Sbjct: 240 VKIDEEFCRRLKEGTRMRAP-DYTTPEM------------YQTMLDCWHGEPSQRPTFSE 286
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.0 bits (212), Expect = 1e-20
Identities = 42/229 (18%), Positives = 81/229 (35%), Gaps = 31/229 (13%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-----RLKIA 71
I + + H ++++ G TP +V + G+L D + + A
Sbjct: 59 IREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 117
Query: 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT-TDRV 130
+ + YL + + R+ +N+L ++ K DF L ++P+ + H +
Sbjct: 118 VQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 131 IGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKN 190
+ APE + + S+ + FG L+E+ W L + ++ K
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILHKIDKE 230
Query: 191 YLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
R P I + ++C + PEDRPT
Sbjct: 231 GERLPRPEDCPQDIY-----------------NVMVQCWAHKPEDRPTF 262
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.7 bits (211), Expect = 2e-20
Identities = 41/239 (17%), Positives = 93/239 (38%), Gaps = 39/239 (16%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF-----------GAPL 65
+N + + + +H+++ +G Q +++ + + G L+ + AP
Sbjct: 71 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 130
Query: 66 P---RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE 122
+++A +I + +AYL+ V R+ +N + E+ K DF ++ I E +
Sbjct: 131 SLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 187
Query: 123 THITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGC 182
+ + + + +PE + V S+V+SFG L+E+ + L +
Sbjct: 188 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------ 241
Query: 183 FFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
+ L+ +E + P +L C +P+ RP+ ++
Sbjct: 242 --EQVLRFVMEGGL------LDKPDNCP--------DMLFELMRMCWQYNPKMRPSFLE 284
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (207), Expect = 6e-20
Identities = 48/228 (21%), Positives = 84/228 (36%), Gaps = 25/228 (10%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFG--APLPRLKIASDI 74
+ Q SH++I++ G + +++ + +E G L + L++ +
Sbjct: 57 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 116
Query: 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI-TTDRVIGT 133
A + + V R+ +NIL N V K DF LS + + TT
Sbjct: 117 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 134 RGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLE 193
++APE IS S+V+SFG ++E++ + L + +E +K +
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVMKAIND 228
Query: 194 DKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
R D P A QL ++C RP D
Sbjct: 229 GFR------LPTPMDCP--------SAIYQLMMQCWQQERARRPKFAD 262
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.3 bits (205), Expect = 1e-19
Identities = 45/230 (19%), Positives = 82/230 (35%), Gaps = 32/230 (13%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-----RLKIA 71
+ Q H HI+K IG + P+ I + + G LR + + A
Sbjct: 56 LQEALTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVRKYSLDLASLILYA 114
Query: 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVI 131
+ +LAYL + V R+ +N+L + + K DF LS + + + + +
Sbjct: 115 YQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGK 170
Query: 132 GTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNY 191
+ APE I+ S+V+ FG ++E+L + + G N+ +
Sbjct: 171 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF--------QGVKNNDVIGRI 222
Query: 192 LEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
+R + + P L +C P RP +
Sbjct: 223 ENGER------LPMPPNCP--------PTLYSLMTKCWAYDPSRRPRFTE 258
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.1 bits (205), Expect = 1e-19
Identities = 38/231 (16%), Positives = 74/231 (32%), Gaps = 36/231 (15%)
Query: 20 ITYAAQMSHNHILKRIGCCLQT----PIPILVFQSVEYGTLRDCIF-GAPLP---RLKIA 71
+ H +I++ T +LV + + GTL+ + +
Sbjct: 59 AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWC 118
Query: 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEEN-VAKWFDFLLSISIPEGETHITTDRV 130
I+ L +LH P PI+ R+ K NI K D L+ V
Sbjct: 119 RQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AV 173
Query: 131 IGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKN 190
IGT + APE +E +V++FG + E+ +
Sbjct: 174 IGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYP-------------YSECQNAA 219
Query: 191 YLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
+ + +G+ + ++ C+ + ++R ++ D
Sbjct: 220 QIYRRVTSGVKPASFDKVAI--------PEVKEIIEGCIRQNKDERYSIKD 262
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.4 bits (205), Expect = 1e-19
Identities = 46/233 (19%), Positives = 79/233 (33%), Gaps = 45/233 (19%)
Query: 27 SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-------------------- 66
H +I+ +G C Q ++ + G LR+ + P
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 67 RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT 126
+ A + + YL + + R+ +N+L E+NV K DF L+ I + +
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 127 TDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNE 186
T + APE + + +S+V+SFG L+E+ + G E
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP--------GVPVEE 245
Query: 187 YLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
K E R D P + + +C + P RPT
Sbjct: 246 LFKLLKEGHRM----------DKP----SNCTNELYMMMRDCWHAVPSQRPTF 284
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.8 bits (201), Expect = 6e-19
Identities = 44/232 (18%), Positives = 79/232 (34%), Gaps = 48/232 (20%)
Query: 28 HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP--------------------R 67
H +I+ +G C L + +G L D + + +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 68 LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITT 127
L A+D+ + YL + + R+ +NIL E VAK DF LS E ++
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 128 DRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEY 187
+ A E ++ V S+V+S+G L+E+++ + + E
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AEL 235
Query: 188 LKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
+ + R P+ D L +C P +RP+
Sbjct: 236 YEKLPQGYRL---EKPLNCDD-----------EVYDLMRQCWREKPYERPSF 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 80.9 bits (199), Expect = 2e-18
Identities = 36/230 (15%), Positives = 78/230 (33%), Gaps = 35/230 (15%)
Query: 20 ITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-----RLKIASDI 74
I + + H ++ +++++ + G L + + ++ +
Sbjct: 74 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV 133
Query: 75 VNSLAYLHFGFPRPIVLRNFKTQNILFN--EENVAKWFDFLLSISIPEGETHITTDRVIG 132
L ++H V + K +NI+F N K DF L+ + ++ T G
Sbjct: 134 CKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TG 187
Query: 133 TRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNY- 191
T ++APE + ++++S G + LL+G +D N ++
Sbjct: 188 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS----PFGGENDDETLRNVKSCDWN 243
Query: 192 LEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
++D F+GI + + P R T+
Sbjct: 244 MDDSAFSGISEDGK-----------------DFIRKLLLADPNTRMTIHQ 276
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 77.4 bits (190), Expect = 3e-17
Identities = 30/158 (18%), Positives = 60/158 (37%), Gaps = 13/158 (8%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF--GAPLP---RLKIA 71
N I+ Q+ H ++ +L+ + + G L D I + +
Sbjct: 74 KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM 133
Query: 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILF--NEENVAKWFDFLLSISIPEGETHITTDR 129
L ++H IV + K +NI+ + + K DF L+ + E T
Sbjct: 134 RQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-- 188
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
T ++APE + + +++++ G + LL+G
Sbjct: 189 -TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 225
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 76.3 bits (187), Expect = 4e-17
Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 6/157 (3%)
Query: 17 INNITYAAQMSHNHILKRIGCCL----QTPIPILVFQSVEYGTLRDCIFGA-PLPRLKIA 71
AA ++H I+ P+P +V + V+ TLRD + P+ +
Sbjct: 55 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 114
Query: 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT-TDRV 130
I ++ L+F I+ R+ K NI+ + N K DF ++ +I + +T T V
Sbjct: 115 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 174
Query: 131 IGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
IGT Y +PE ++ +S+V+S G L+E+L G
Sbjct: 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 76.0 bits (186), Expect = 6e-17
Identities = 33/229 (14%), Positives = 67/229 (29%), Gaps = 32/229 (13%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF--GAPLP---RLKIASDIVNSL 78
M + I C ++ + +L D L +A +++ +
Sbjct: 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116
Query: 79 AYLHFGFPRPIVLRNFKTQNILFNEE---NVAKWFDFLLSISIPEGETH-----ITTDRV 130
Y+H + + R+ K N L N+ DF L+ + TH +
Sbjct: 117 EYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173
Query: 131 IGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKN 190
GT Y++ + + ++ S G L G + + K
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP--------WQGLKAATKRQKY 225
Query: 191 YLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
++ P ++ + P A C + +D+P
Sbjct: 226 ERISEKKMSTPIEVLCKGYP--------SEFATYLNFCRSLRFDDKPDY 266
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.9 bits (183), Expect = 2e-16
Identities = 39/238 (16%), Positives = 74/238 (31%), Gaps = 19/238 (7%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIP-----ILVFQSVEYGTLR--DCIFGAPLP--- 66
+ + + H ++++ C + LVF+ V+ D + +P
Sbjct: 58 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 117
Query: 67 RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHIT 126
+ ++ L +LH +V R+ K QNIL K DF L+ +
Sbjct: 118 IKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 174
Query: 127 TDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNE 186
V+ T Y APE + +++S G E+ +
Sbjct: 175 ---VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231
Query: 187 YLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQ---LTLECVNNSPEDRPTMVD 241
L + R +P ++ L L+C+ +P R +
Sbjct: 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 289
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (182), Expect = 2e-16
Identities = 45/237 (18%), Positives = 76/237 (32%), Gaps = 24/237 (10%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVN 76
+ I ++SH +I+ + LVF +E + + +
Sbjct: 48 LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYML 107
Query: 77 SLA-YLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRG 135
L + I+ R+ K N+L +E V K DF ++ G + + TR
Sbjct: 108 MTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADF--GLAKSFGSPNRAYTHQVVTRW 165
Query: 136 YSAPEYISIC-VLNEKSNVFSFGAFLFELLAGR------------IHIWDLLKDTHDHGC 182
Y APE + + ++++ G L ELL I++ L +
Sbjct: 166 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 225
Query: 183 FFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
L +Y+ K F GIP I L +P R T
Sbjct: 226 PDMCSLPDYVTFKSFPGIPLHHIFSAAG--------DDLLDLIQGLFLFNPCARITA 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.8 bits (183), Expect = 2e-16
Identities = 35/146 (23%), Positives = 54/146 (36%), Gaps = 3/146 (2%)
Query: 23 AAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLA-YL 81
+ H + V + + G L I L A+ + L
Sbjct: 57 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 116
Query: 82 HFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEY 141
F + IV R+ K NIL +++ K DF + G+ T GT Y APE
Sbjct: 117 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEI 174
Query: 142 ISICVLNEKSNVFSFGAFLFELLAGR 167
+ N + +SFG L+E+L G+
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.4 bits (182), Expect = 2e-16
Identities = 42/227 (18%), Positives = 79/227 (34%), Gaps = 28/227 (12%)
Query: 20 ITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF-GAPLPRLKIASDIVNSL 78
++ ++ H +++ IL+ + V G L D + L + + L
Sbjct: 64 VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 123
Query: 79 AYLHFGFPRPIVLRNFKTQNILFNEENVA----KWFDFLLSISIPEGETHITTDRVIGTR 134
+++ I + K +NI+ + NV K DF L+ I G + GT
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180
Query: 135 GYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLED 194
+ APE ++ L +++++S G + LL+G DT + ED
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG---DTKQETLANVSAVNYEFED 237
Query: 195 KRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
+ F+ A + P+ R T+ D
Sbjct: 238 EYFSNTSALAK-----------------DFIRRLLVKDPKKRMTIQD 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 73.5 bits (180), Expect = 4e-16
Identities = 37/171 (21%), Positives = 62/171 (36%), Gaps = 7/171 (4%)
Query: 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI 60
+K + GS N I ++ H +I+ L+ Q V G L D I
Sbjct: 39 IKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI 98
Query: 61 F-GAPLP---RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSI 116
++ +++++ YLH L+ +E++ DF LS
Sbjct: 99 VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158
Query: 117 SIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
G T GT GY APE ++ ++ + +S G + LL G
Sbjct: 159 MEDPGSVLST---ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.2 bits (179), Expect = 8e-16
Identities = 25/155 (16%), Positives = 58/155 (37%), Gaps = 13/155 (8%)
Query: 20 ITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-----RLKIASDI 74
I+ H +IL +++F+ + + + I + + +
Sbjct: 52 ISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQV 111
Query: 75 VNSLAYLHFGFPRPIVLRNFKTQNILF--NEENVAKWFDFLLSISIPEGETHITTDRVIG 132
+L +LH I + + +NI++ + K +F + + G+
Sbjct: 112 CEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---T 165
Query: 133 TRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
Y APE V++ ++++S G ++ LL+G
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 73.2 bits (179), Expect = 9e-16
Identities = 42/228 (18%), Positives = 72/228 (31%), Gaps = 33/228 (14%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF----GAPLPRLKIAS 72
++ + I+ + + G L + + A+
Sbjct: 55 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA 114
Query: 73 DIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIG 132
+I+ L ++H R +V R+ K NIL +E + D L+ + + H + +G
Sbjct: 115 EIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VG 167
Query: 133 TRGYSAPEYISICV-LNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNY 191
T GY APE + V + ++ FS G LF+LL G F K+
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS-------------PFRQHKTKDK 214
Query: 192 LEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
E R T A + L + R
Sbjct: 215 HEIDRMTLTMAVELPDSFS--------PELRSLLEGLLQRDVNRRLGC 254
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 70.5 bits (172), Expect = 5e-15
Identities = 40/151 (26%), Positives = 63/151 (41%), Gaps = 16/151 (10%)
Query: 27 SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF-GAPLP---RLKIASDIVNSLAYLH 82
H +I++ LVF ++ G L D + L KI ++ + LH
Sbjct: 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 127
Query: 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYI 142
IV R+ K +NIL +++ K DF S + GE V GT Y APE I
Sbjct: 128 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEII 181
Query: 143 SICVL------NEKSNVFSFGAFLFELLAGR 167
+ ++ +++S G ++ LLAG
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.5 bits (169), Expect = 2e-14
Identities = 40/238 (16%), Positives = 80/238 (33%), Gaps = 13/238 (5%)
Query: 17 INNITYAAQMSHNHILKRIGCC----LQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIAS 72
+ I + H +I+ ++ + + + L + L I
Sbjct: 54 LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICY 113
Query: 73 DIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLS-ISIPEGETHITTDRVI 131
+ L L + ++ R+ K N+L N K DF L+ ++ P+ + +
Sbjct: 114 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 173
Query: 132 GTRGYSAPEYISI-CVLNEKSNVFSFGAFLFELLAGRI------HIWDLLKDTHDHGCFF 184
TR Y APE + + +++S G L E+L+ R ++ L G
Sbjct: 174 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233
Query: 185 NEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQ-LTLECVNNSPEDRPTMVD 241
E L + K + + +P + A L + + +P R +
Sbjct: 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 291
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.4 bits (169), Expect = 2e-14
Identities = 39/229 (17%), Positives = 78/229 (34%), Gaps = 35/229 (15%)
Query: 26 MSHNHILKRIGCC----LQTPIPILVFQSVEYGTLRDCIFGAPLPRL------KIASDIV 75
HI++ + ++V + ++ G L I +I I
Sbjct: 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 121
Query: 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEEN---VAKWFDFLLSISIPEGETHITTDRVIG 132
++ YLH I R+ K +N+L+ + + K DF + + T
Sbjct: 122 EAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--- 175
Query: 133 TRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYL 192
T Y APE + ++ +++S G ++ LL G + +HG + +K +
Sbjct: 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS------NHGLAISPGMKTRI 229
Query: 193 EDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
++ + P E + L + P R T+ +
Sbjct: 230 RMGQY----------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 68.6 bits (167), Expect = 3e-14
Identities = 34/150 (22%), Positives = 65/150 (43%), Gaps = 6/150 (4%)
Query: 24 AQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLA-YLH 82
+ ++H I++ G ++ +E G L + + +A + L
Sbjct: 59 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 118
Query: 83 FGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYI 142
+ + I+ R+ K +NIL ++ K DF + +P+ + GT Y APE +
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEVV 173
Query: 143 SICVLNEKSNVFSFGAFLFELLAGRIHIWD 172
S N+ + +SFG ++E+LAG +D
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYD 203
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.4 bits (166), Expect = 3e-14
Identities = 35/234 (14%), Positives = 76/234 (32%), Gaps = 12/234 (5%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVN 76
+ I ++ H +I++ LVF+ + + +I +
Sbjct: 49 LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLF 108
Query: 77 SLA-YLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRG 135
L L F R ++ R+ K QN+L N K +F L+ + + V+
Sbjct: 109 QLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTLWY 167
Query: 136 YSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWD-------LLKDTHDHGCFFNEYL 188
+ + +++S G EL ++ L + G E
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227
Query: 189 KNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQ-LTLECVNNSPEDRPTMVD 241
+ + + P P+ + +L+A+ + L + +P R + +
Sbjct: 228 PSMTKLPDY--KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 67.5 bits (164), Expect = 6e-14
Identities = 29/227 (12%), Positives = 58/227 (25%), Gaps = 33/227 (14%)
Query: 27 SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP----RLKIASDIVNSLAYLH 82
I + +LV + A ++ + +H
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 83 FGFPRPIVLRNFKTQNILFNE-----ENVAKWFDFLLSISIPEGETHITTDR-----VIG 132
+ +V R+ K N L N+ DF + + T + G
Sbjct: 119 E---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 133 TRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYL 192
T Y + + + ++ + G L G + L T+ + +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK------QKYERIG 229
Query: 193 EDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239
E K+ T P + P + N + + P
Sbjct: 230 EKKQST--PLRELCAGFP--------EEFYKYMHYARNLAFDATPDY 266
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 66.4 bits (161), Expect = 1e-13
Identities = 40/233 (17%), Positives = 84/233 (36%), Gaps = 11/233 (4%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF-GAPLPRLKIASDIV 75
I I+ ++ H++I+K +LVF+ ++ + L + S ++
Sbjct: 48 IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL 107
Query: 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRG 135
L + + R ++ R+ K QN+L N E K DF L+ + T ++
Sbjct: 108 QLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWY 166
Query: 136 YSAPEYISICVLNEKSNVFSFGAFLFELLAGRI------HIWDLLKDTHDHGCFFNEYLK 189
+ + + +++S G E++ G L++ G ++
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226
Query: 190 NYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQ-LTLECVNNSPEDRPTMVD 241
N E ++ P + + +P + L S L + + P R T
Sbjct: 227 NVTELPKY--DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ 277
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (160), Expect = 2e-13
Identities = 25/157 (15%), Positives = 51/157 (32%), Gaps = 3/157 (1%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF-GAPLPRLKIASDIV 75
+ H + V + G L + +
Sbjct: 53 VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA 112
Query: 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRG 135
++ L + R +V R+ K +N++ +++ K DF L T GT
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPE 170
Query: 136 YSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWD 172
Y APE + + + G ++E++ GR+ ++
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.5 bits (156), Expect = 8e-13
Identities = 39/245 (15%), Positives = 71/245 (28%), Gaps = 20/245 (8%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPI--------LVFQSVEYGTLRDCIF-GAPLPR 67
+ I + H +++ I C P LVF E+
Sbjct: 57 LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL 116
Query: 68 LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLS--ISIPEGETHI 125
+I + L L++ I+ R+ K N+L + V K DF L+ S+ +
Sbjct: 117 SEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 176
Query: 126 TTDRVIGTRGYSAPEYI-SICVLNEKSNVFSFGAFLFELLAGRI------HIWDLLKDTH 178
+ T Y PE + +++ G + E+ L +
Sbjct: 177 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236
Query: 179 DHGCFFNEYLKNYLEDKRFTGIPAPIIV-QDIPCIEKEQQLHASAQ-LTLECVNNSPEDR 236
G E N + + + + + K A L + + P R
Sbjct: 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 296
Query: 237 PTMVD 241
D
Sbjct: 297 IDSDD 301
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.3 bits (153), Expect = 2e-12
Identities = 40/233 (17%), Positives = 74/233 (31%), Gaps = 10/233 (4%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLR--DCIFGAPLPRLKIASDI 74
I I+ +++H +I+K + LVF+ + + D +P I S +
Sbjct: 49 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTR 134
L L F ++ R+ K QN+L N E K DF L+ + T V+
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-EVVTLW 167
Query: 135 GYSAPEYISICVLNEKSNVFSFGAFLFELLAGRI------HIWDLLKDTHDHGCFFNEYL 188
+ + + +++S G E++ R I L + G
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227
Query: 189 KNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241
+ QD + L + ++ P R +
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG-RSLLSQMLHYDPNKRISAKA 279
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.7 bits (149), Expect = 8e-12
Identities = 47/243 (19%), Positives = 83/243 (34%), Gaps = 28/243 (11%)
Query: 20 ITYAAQMSHNHILKRIGCCLQT------PIPILVFQSVEYGTLRDCIF----GAPLP--- 66
+ ++ H +I++ + LV V R LP
Sbjct: 64 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 123
Query: 67 RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEEN-VAKWFDFLLSISIPEGETHI 125
+ SLAY+H I R+ K QN+L + + V K DF + + GE ++
Sbjct: 124 VKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 126 TTDRVIGTRGYSAP-EYISICVLNEKSNVFSFGAFLFELLAGRI------HIWDLLKDTH 178
+ I +R Y AP +V+S G L ELL G+ + L++
Sbjct: 181 SY---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237
Query: 179 DHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238
G E ++ + P I + + + + L + +P R T
Sbjct: 238 VLGTPTREQIREMNPNYTEFKFP-QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296
Query: 239 MVD 241
++
Sbjct: 297 PLE 299
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.9 bits (142), Expect = 5e-11
Identities = 24/147 (16%), Positives = 52/147 (35%), Gaps = 14/147 (9%)
Query: 28 HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLP-----RLKIASDIVNSLAYLH 82
+ +++ + + +L+ + E ++ ++ + H
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 83 FGFPRPIVLRNFKTQNILFNEEN-VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEY 141
++ R+ K +NIL + K DF + + GTR YS PE+
Sbjct: 128 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT----DFDGTRVYSPPEW 180
Query: 142 ISIC-VLNEKSNVFSFGAFLFELLAGR 167
I + V+S G L++++ G
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.6 bits (138), Expect = 2e-10
Identities = 39/248 (15%), Positives = 84/248 (33%), Gaps = 31/248 (12%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPI------PILVFQSVEYGTLRDCIFGAPLPRLK- 69
+ ++H +I+ + LV + ++ + R+
Sbjct: 64 YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 123
Query: 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDR 129
+ ++ + +LH I+ R+ K NI+ + K DF L+ +
Sbjct: 124 LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTP 177
Query: 130 VIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRI-------------HIWDLLKD 176
+ TR Y APE I E +++S G + E++ +I I L
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 177 THDHGCFFNEYLKNYLEDK-RFTGIPAPIIVQDIPCIEKEQQLHASAQLTLE----CVNN 231
+ ++NY+E++ ++ G+ P + D + A + +
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 232 SPEDRPTM 239
P R ++
Sbjct: 298 DPAKRISV 305
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.4 bits (130), Expect = 2e-09
Identities = 32/240 (13%), Positives = 69/240 (28%), Gaps = 22/240 (9%)
Query: 17 INNITYAAQMSHNHILKRIGCC-----LQTPIPILVFQSVEYGTLRDCIFGAPLP---RL 68
+ M H +++ + L + L + L
Sbjct: 65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQ 124
Query: 69 KIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTD 128
+ ++ L Y+H I+ R+ K N+ NE+ K DF L+ T
Sbjct: 125 FLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTG 177
Query: 129 RVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYL 188
V+ + ++ + +++S G + E++ G+
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 189 KNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLE-------CVNNSPEDRPTMVD 241
+R A ++ +P +EK+ + + E R T +
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 54.0 bits (129), Expect = 3e-09
Identities = 28/155 (18%), Positives = 58/155 (37%), Gaps = 12/155 (7%)
Query: 17 INNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF-GAPLP---RLKIAS 72
+N ++ ++K +V + V G + + A+
Sbjct: 89 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 73 DIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIG 132
IV + YLH ++ R+ K +N+L +++ + DF + + + G
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCG 200
Query: 133 TRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
T APE I N+ + ++ G ++E+ AG
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.2 bits (124), Expect = 1e-08
Identities = 28/143 (19%), Positives = 49/143 (34%), Gaps = 4/143 (2%)
Query: 28 HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF-GAPLPRLKIASDIVNSLAYLHFGFP 86
++ L+ + G L + ++ + + L
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK 147
Query: 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV 146
I+ R+ K +NIL + DF LS ET D GT Y AP+ +
Sbjct: 148 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF-CGTIEYMAPDIVRGGD 206
Query: 147 --LNEKSNVFSFGAFLFELLAGR 167
++ + +S G ++ELL G
Sbjct: 207 SGHDKAVDWWSLGVLMYELLTGA 229
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 50.0 bits (118), Expect = 6e-08
Identities = 31/159 (19%), Positives = 56/159 (35%), Gaps = 12/159 (7%)
Query: 19 NITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIF--------GAPLPRLK- 69
+ T M NHILK + + V + + G PL +K
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 70 IASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEEN-VAKWFDFLLSISIPEGETHITTD 128
I+ ++ L Y+H I+ + K +N+L + ++
Sbjct: 130 ISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 129 RVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR 167
I TR Y +PE + ++++S +FEL+ G
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 241 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.98 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.68 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.07 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.66 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.28 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.62 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.08 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 85.5 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-51 Score=321.43 Aligned_cols=217 Identities=22% Similarity=0.251 Sum_probs=166.5
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVN 76 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~ 76 (241)
||++..+...+..+++.+|++++++++|||||++++++..++..++|||||++|+|.+++..... ....++.|++.
T Consensus 35 iK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~ 114 (271)
T d1nvra_ 35 VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 114 (271)
T ss_dssp EEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHH
T ss_pred EEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 46665544445567799999999999999999999999999999999999999999999976532 46789999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCC-CcchhhHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVL-NEKSNVFS 155 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~s 155 (241)
||.||| +++|+||||||+|||++.++.+||+|||++...............+||+.|+|||++.+..+ +.++||||
T Consensus 115 al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwS 191 (271)
T d1nvra_ 115 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 191 (271)
T ss_dssp HHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHH
T ss_pred HHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeH
Confidence 999999 89999999999999999999999999999987654433333345689999999999988776 57899999
Q ss_pred HHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 156 FGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 156 ~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
+||++|+|++|+.||....... .. ........... +. .. ..++.+.+|+.+||+.||++
T Consensus 192 lGvilyeml~G~~pf~~~~~~~-------~~-~~~~~~~~~~~----~~-~~--------~~s~~~~~li~~~L~~dP~~ 250 (271)
T d1nvra_ 192 CGIVLTAMLAGELPWDQPSDSC-------QE-YSDWKEKKTYL----NP-WK--------KIDSAPLALLHKILVENPSA 250 (271)
T ss_dssp HHHHHHHHHHSSCSCSSSSTTS-------HH-HHHHHTTCTTS----TT-GG--------GSCHHHHHHHHHHSCSSTTT
T ss_pred hHHHHHHHHhCCCCCCCCChHH-------HH-HHHHhcCCCCC----Cc-cc--------cCCHHHHHHHHHHcCCChhH
Confidence 9999999999999996522111 11 11111111100 00 01 12356789999999999999
Q ss_pred CCCCCC
Q 044022 236 RPTMVD 241 (241)
Q Consensus 236 Rpt~~e 241 (241)
|||++|
T Consensus 251 R~t~~e 256 (271)
T d1nvra_ 251 RITIPD 256 (271)
T ss_dssp SCCHHH
T ss_pred CcCHHH
Confidence 999854
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-50 Score=316.47 Aligned_cols=219 Identities=21% Similarity=0.301 Sum_probs=162.2
Q ss_pred Cccccccc-ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHH
Q 044022 1 MKFYGHEY-HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDI 74 (241)
Q Consensus 1 iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i 74 (241)
||++.... .....+.|.+|++++++++|||||++++++.. +..++|||||++|+|.+++.... . .++.++.||
T Consensus 35 vK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi 113 (276)
T d1uwha_ 35 VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 113 (276)
T ss_dssp EEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHH
T ss_pred EEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHH
Confidence 46654332 34567889999999999999999999998754 56899999999999999986432 1 468899999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc---cCCCcch
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI---CVLNEKS 151 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~ 151 (241)
+.||+||| +++|+||||||+|||++.++.+||+|||++................||+.|+|||++.+ ..++.++
T Consensus 114 ~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~s 190 (276)
T d1uwha_ 114 AQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190 (276)
T ss_dssp HHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHH
T ss_pred HHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchh
Confidence 99999999 89999999999999999999999999999976654433333345679999999999864 3578999
Q ss_pred hhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccC
Q 044022 152 NVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNN 231 (241)
Q Consensus 152 Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~ 231 (241)
||||||+++|||++|+.||..... ..........+..... ...... ..++.+.+|+.+||+.
T Consensus 191 DiwS~Gv~l~el~tg~~Pf~~~~~---------~~~~~~~~~~~~~~p~-~~~~~~--------~~~~~l~~li~~cl~~ 252 (276)
T d1uwha_ 191 DVYAFGIVLYELMTGQLPYSNINN---------RDQIIFMVGRGYLSPD-LSKVRS--------NCPKAMKRLMAECLKK 252 (276)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCC---------HHHHHHHHHHTSCCCC-GGGSCT--------TCCHHHHHHHHHHTCS
T ss_pred hhhhhHHHHHHHHHCCCCCCCCCh---------HHHHHHHHhcCCCCCc-chhccc--------cchHHHHHHHHHHcCC
Confidence 999999999999999999965211 1112222222211110 011112 2236789999999999
Q ss_pred CCCCCCCCCC
Q 044022 232 SPEDRPTMVD 241 (241)
Q Consensus 232 ~p~~Rpt~~e 241 (241)
||++|||++|
T Consensus 253 dp~~RPt~~~ 262 (276)
T d1uwha_ 253 KRDERPLFPQ 262 (276)
T ss_dssp SGGGSCCHHH
T ss_pred CHhHCcCHHH
Confidence 9999999853
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=313.62 Aligned_cols=214 Identities=16% Similarity=0.236 Sum_probs=170.7
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNS 77 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~ 77 (241)
||++.... ....+.+.+|++++++++|||||++++++..++..|+|||||++|+|.+++..... ....++.||+.|
T Consensus 50 vK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~a 128 (293)
T d1yhwa1 50 IRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA 128 (293)
T ss_dssp EEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHH
T ss_pred EEEEeccc-ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHH
Confidence 45554332 23567899999999999999999999999999999999999999999998876543 467899999999
Q ss_pred hchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHH
Q 044022 78 LAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFG 157 (241)
Q Consensus 78 l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G 157 (241)
|.||| +++|+||||||+|||++.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||
T Consensus 129 L~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 203 (293)
T d1yhwa1 129 LEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203 (293)
T ss_dssp HHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHH
T ss_pred HHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccccc--ccccccCCCccChhhhcCCCCCchhceehHh
Confidence 99999 899999999999999999999999999999876543322 2345799999999999999999999999999
Q ss_pred HHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 158 AFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 158 ~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
|++|+|++|+.||... ...+........... ... ... ..++.+.+|+.+||+.||++||
T Consensus 204 vilyemltG~~Pf~~~---------~~~~~~~~~~~~~~~-~~~---~~~--------~~s~~~~~li~~~L~~dP~~R~ 262 (293)
T d1yhwa1 204 IMAIEMIEGEPPYLNE---------NPLRALYLIATNGTP-ELQ---NPE--------KLSAIFRDFLNRCLDMDVEKRG 262 (293)
T ss_dssp HHHHHHHHSSCTTTTS---------CHHHHHHHHHHHCSC-CCS---SGG--------GSCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHhhCCCCCCCC---------CHHHHHHHHHhCCCC-CCC---Ccc--------cCCHHHHHHHHHHccCChhHCc
Confidence 9999999999999541 112222222222211 111 111 2236789999999999999999
Q ss_pred CCCC
Q 044022 238 TMVD 241 (241)
Q Consensus 238 t~~e 241 (241)
|++|
T Consensus 263 s~~e 266 (293)
T d1yhwa1 263 SAKE 266 (293)
T ss_dssp CHHH
T ss_pred CHHH
Confidence 9854
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-49 Score=317.61 Aligned_cols=214 Identities=20% Similarity=0.277 Sum_probs=159.4
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~ 76 (241)
|...........++|.+|+++|++++|||||+++|+|..++..++|||||++|+|.+++..... .++.++.||+.
T Consensus 60 K~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~ 139 (299)
T d1jpaa_ 60 KTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139 (299)
T ss_dssp EECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHH
T ss_pred EEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHH
Confidence 4444444445667899999999999999999999999999999999999999999998876421 46789999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcce---eecccccCCCccCcccccccCCCcchhh
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI---TTDRVIGTRGYSAPEYISICVLNEKSNV 153 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di 153 (241)
||.||| +++++||||||+|||++.++.+||+|||+++......... ......+|+.|+|||.+.+..++.++||
T Consensus 140 gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv 216 (299)
T d1jpaa_ 140 GMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDV 216 (299)
T ss_dssp HHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHH
T ss_pred HHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCccccc
Confidence 999999 8999999999999999999999999999998665432211 1122357889999999999999999999
Q ss_pred HHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCC
Q 044022 154 FSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNS 232 (241)
Q Consensus 154 ~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~ 232 (241)
|||||++|||+| |+.||.... ..+...... .+..... .. ..+..+.+|+.+||+.|
T Consensus 217 wS~Gvvl~el~t~g~~Pf~~~~---------~~~~~~~i~-~~~~~~~-----~~--------~~~~~l~~li~~cl~~~ 273 (299)
T d1jpaa_ 217 WSYGIVMWEVMSYGERPYWDMT---------NQDVINAIE-QDYRLPP-----PM--------DCPSALHQLMLDCWQKD 273 (299)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCC---------HHHHHHHHH-TTCCCCC-----CT--------TCCHHHHHHHHHHTCSS
T ss_pred ccchHHHHHHHhCCCCCCCCCC---------HHHHHHHHH-cCCCCCC-----Cc--------cchHHHHHHHHHHcCCC
Confidence 999999999998 899996521 122222222 1211111 11 22367889999999999
Q ss_pred CCCCCCCCC
Q 044022 233 PEDRPTMVD 241 (241)
Q Consensus 233 p~~Rpt~~e 241 (241)
|++|||++|
T Consensus 274 P~~RPs~~e 282 (299)
T d1jpaa_ 274 RNHRPKFGQ 282 (299)
T ss_dssp TTTSCCHHH
T ss_pred HhHCcCHHH
Confidence 999999853
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=311.53 Aligned_cols=200 Identities=20% Similarity=0.327 Sum_probs=164.6
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+++.+|++++++++|||||++++++.+++..++|||||++|+|.+++..... ....++.||+.||.||| +
T Consensus 48 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH---~ 124 (263)
T d2j4za1 48 GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---S 124 (263)
T ss_dssp TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 4567899999999999999999999999999999999999999999999865322 46789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
++|+||||||+|||++.++.+||+|||++........ ....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 125 ~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G 200 (263)
T d2j4za1 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 200 (263)
T ss_dssp TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred CCeeeeeeccccceecCCCCEeecccceeeecCCCcc----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcC
Confidence 9999999999999999999999999999976654332 335799999999999999999999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+.||... ...+....... ... .+... .++.+.+|+.+||+.||++|||++|
T Consensus 201 ~~Pf~~~---------~~~~~~~~i~~-~~~------~~p~~--------~s~~~~~li~~~L~~dp~~R~t~~e 251 (263)
T d2j4za1 201 KPPFEAN---------TYQETYKRISR-VEF------TFPDF--------VTEGARDLISRLLKHNPSQRPMLRE 251 (263)
T ss_dssp SCTTCCS---------SHHHHHHHHHT-TCC------CCCTT--------SCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCC---------CHHHHHHHHHc-CCC------CCCcc--------CCHHHHHHHHHHccCCHhHCcCHHH
Confidence 9999541 12222222211 111 11111 2257889999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-50 Score=317.53 Aligned_cols=213 Identities=20% Similarity=0.288 Sum_probs=169.4
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~ 75 (241)
||++.........++|.+|+++|++++|||||+++|++.. +..++||||+++|+|.+++.... . .++.++.|++
T Consensus 41 vK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~ 119 (285)
T d1u59a_ 41 IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119 (285)
T ss_dssp EEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHH
T ss_pred EEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHH
Confidence 4666655555667889999999999999999999999864 46899999999999999875432 2 5788999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-eeecccccCCCccCcccccccCCCcchhhH
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-ITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
.||.||| +++++||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||
T Consensus 120 ~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVw 196 (285)
T d1u59a_ 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 196 (285)
T ss_dssp HHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHH
T ss_pred HHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhh
Confidence 9999999 899999999999999999999999999999877654322 223345688999999999989999999999
Q ss_pred HHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 155 SFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 155 s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
|||+++|||+| |+.||.... ..+.... ...+..... +.. .++.+.+|+.+||+.||
T Consensus 197 S~Gv~l~E~lt~G~~Pf~~~~---------~~~~~~~-i~~~~~~~~-----p~~--------~~~~l~~li~~cl~~~p 253 (285)
T d1u59a_ 197 SYGVTMWEALSYGQKPYKKMK---------GPEVMAF-IEQGKRMEC-----PPE--------CPPELYALMSDCWIYKW 253 (285)
T ss_dssp HHHHHHHHHHTTSCCTTTTCC---------THHHHHH-HHTTCCCCC-----CTT--------CCHHHHHHHHHTTCSSG
T ss_pred cchHHHHHHHhCCCCCCCCCC---------HHHHHHH-HHcCCCCCC-----CCc--------CCHHHHHHHHHHcCCCH
Confidence 99999999998 899996521 1222222 222222111 122 22578899999999999
Q ss_pred CCCCCCC
Q 044022 234 EDRPTMV 240 (241)
Q Consensus 234 ~~Rpt~~ 240 (241)
++|||+.
T Consensus 254 ~~RPs~~ 260 (285)
T d1u59a_ 254 EDRPDFL 260 (285)
T ss_dssp GGSCCHH
T ss_pred hHCcCHH
Confidence 9999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-50 Score=323.30 Aligned_cols=215 Identities=18% Similarity=0.270 Sum_probs=169.0
Q ss_pred cccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----------------
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---------------- 64 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------- 64 (241)
|.............+.+|+.++.++ +|||||+++++|...+..++|||||++|+|.++++...
T Consensus 73 K~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~ 152 (325)
T d1rjba_ 73 KMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152 (325)
T ss_dssp EEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC-------------
T ss_pred EEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhcccccc
Confidence 4444444555677899999999998 89999999999999999999999999999999986531
Q ss_pred -----------chHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccC
Q 044022 65 -----------LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGT 133 (241)
Q Consensus 65 -----------~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 133 (241)
..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++...............||
T Consensus 153 ~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 229 (325)
T d1rjba_ 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 229 (325)
T ss_dssp --------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEEC
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCC
Confidence 135679999999999999 899999999999999999999999999999876655544444566789
Q ss_pred CCccCcccccccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCch
Q 044022 134 RGYSAPEYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCI 212 (241)
Q Consensus 134 ~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (241)
+.|+|||++.+..++.++|||||||++|||++ |..||..... .+.+......+...+. ..
T Consensus 230 ~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~---------~~~~~~~~~~~~~~~~-----p~----- 290 (325)
T d1rjba_ 230 VKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV---------DANFYKLIQNGFKMDQ-----PF----- 290 (325)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC---------SHHHHHHHHTTCCCCC-----CT-----
T ss_pred CccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH---------HHHHHHHHhcCCCCCC-----CC-----
Confidence 99999999999999999999999999999998 8999964211 1112222222211111 11
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 213 EKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 213 ~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
..++.+.+|+.+||+.||++|||++|
T Consensus 291 ---~~~~~l~~li~~cl~~dP~~RPt~~e 316 (325)
T d1rjba_ 291 ---YATEEIYIIMQSCWAFDSRKRPSFPN 316 (325)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---cCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 12367899999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-49 Score=312.55 Aligned_cols=205 Identities=16% Similarity=0.210 Sum_probs=163.0
Q ss_pred cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCC
Q 044022 10 RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 10 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
....+.+.+|++++++++|||||++++++..++..|+||||+++|+|.+++.... .....++.|++.||.|||
T Consensus 49 ~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH--- 125 (288)
T d1uu3a_ 49 ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--- 125 (288)
T ss_dssp TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---
T ss_pred HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhc---
Confidence 3456789999999999999999999999999999999999999999999876532 246788999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHh
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~ 165 (241)
+++|+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 126 ~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~ 205 (288)
T d1uu3a_ 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 205 (288)
T ss_dssp HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhh
Confidence 99999999999999999999999999999987765443333345679999999999999999999999999999999999
Q ss_pred cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
|+.||... ...+....... ... . +... .++.+.+|+.+||+.||++|||++|
T Consensus 206 g~~Pf~~~---------~~~~~~~~i~~-~~~-~-----~p~~--------~s~~~~~li~~~L~~dP~~R~t~~e 257 (288)
T d1uu3a_ 206 GLPPFRAG---------NEYLIFQKIIK-LEY-D-----FPEK--------FFPKARDLVEKLLVLDATKRLGCEE 257 (288)
T ss_dssp SSCSSCCS---------SHHHHHHHHHT-TCC-C-----CCTT--------CCHHHHHHHHTTSCSSGGGSTTSGG
T ss_pred CCCCCCCc---------CHHHHHHHHHc-CCC-C-----CCcc--------CCHHHHHHHHHHccCCHhHCcCHHH
Confidence 99999641 11122222211 111 1 1111 2256889999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-49 Score=313.10 Aligned_cols=214 Identities=21% Similarity=0.290 Sum_probs=164.8
Q ss_pred Cccccccc-ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHH
Q 044022 1 MKFYGHEY-HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~ 75 (241)
||++..+. +....++|.+|+++|++++|||||+++++|.. +..++||||+++|+|.+++..... .++.++.||+
T Consensus 39 vK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~ 117 (277)
T d1xbba_ 39 VKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 117 (277)
T ss_dssp EEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHH
T ss_pred EEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHH
Confidence 45554433 22345789999999999999999999999854 457899999999999999876532 5788999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-eeecccccCCCccCcccccccCCCcchhhH
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-ITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
.||.||| +++++||||||+|||++.++.+||+|||+++........ .......||+.|+|||.+.+..++.++|||
T Consensus 118 ~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiw 194 (277)
T d1xbba_ 118 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 194 (277)
T ss_dssp HHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHH
T ss_pred HHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhc
Confidence 9999999 899999999999999999999999999999876554322 223345688999999999999999999999
Q ss_pred HHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 155 SFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 155 s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
|||+++|||++ |+.||.... ..+..... ..+.....+ .. .+..+.+|+.+||+.||
T Consensus 195 S~Gv~l~ellt~g~~Pf~~~~---------~~~~~~~i-~~~~~~~~p-----~~--------~~~~~~~li~~cl~~dp 251 (277)
T d1xbba_ 195 SFGVLMWEAFSYGQKPYRGMK---------GSEVTAML-EKGERMGCP-----AG--------CPREMYDLMNLCWTYDV 251 (277)
T ss_dssp HHHHHHHHHHTTTCCSSTTCC---------HHHHHHHH-HTTCCCCCC-----TT--------CCHHHHHHHHHHTCSST
T ss_pred cchhhhhHHhhCCCCCCCCCC---------HHHHHHHH-HcCCCCCCC-----cc--------cCHHHHHHHHHHcCCCH
Confidence 99999999998 899996521 12222222 222211111 11 23578899999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|||++|
T Consensus 252 ~~RPs~~~ 259 (277)
T d1xbba_ 252 ENRPGFAA 259 (277)
T ss_dssp TTSCCHHH
T ss_pred hHCcCHHH
Confidence 99999753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-50 Score=322.73 Aligned_cols=165 Identities=22% Similarity=0.289 Sum_probs=143.0
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVN 76 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~ 76 (241)
||++..+.......++.+|+++|++++|||||+++++|...++.|+||||+++|+|.+++.+... ....++.|++.
T Consensus 36 iK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~ 115 (322)
T d1s9ja_ 36 RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 115 (322)
T ss_dssp EEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred EEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHH
Confidence 46666555555677899999999999999999999999999999999999999999999865322 46789999999
Q ss_pred HhchhhcCCC-CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHH
Q 044022 77 SLAYLHFGFP-RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFS 155 (241)
Q Consensus 77 ~l~~lh~~~~-~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 155 (241)
||.||| + ++|+||||||+|||++.++.+||+|||+|....... ....+||+.|+|||++.+..++.++||||
T Consensus 116 aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWS 188 (322)
T d1s9ja_ 116 GLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWS 188 (322)
T ss_dssp HHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHH
T ss_pred HHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc----cccccCCccccCchHHcCCCCCcHHHHHH
Confidence 999999 6 489999999999999999999999999997653321 13457999999999999999999999999
Q ss_pred HHHHHHHHHhcCccccc
Q 044022 156 FGAFLFELLAGRIHIWD 172 (241)
Q Consensus 156 ~G~~~~~~~~g~~p~~~ 172 (241)
+||++|||++|+.||..
T Consensus 189 lGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 189 MGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp HHHHHHHHHHSSCCSSC
T ss_pred HHHHHHHHHHCCCCCCC
Confidence 99999999999999965
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=307.23 Aligned_cols=204 Identities=17% Similarity=0.256 Sum_probs=158.4
Q ss_pred ccccHHHHHHHHHHHHhcCCCcccceeeeeee----CCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhch
Q 044022 9 HRHTYGSCINNITYAAQMSHNHILKRIGCCLQ----TPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAY 80 (241)
Q Consensus 9 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~ 80 (241)
.....+.|.+|+++|++++|||||++++++.. ...+++||||+++|+|.+++..... ....++.||+.||.|
T Consensus 48 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~y 127 (270)
T d1t4ha_ 48 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 127 (270)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHH
Confidence 33456779999999999999999999999875 3467999999999999999865422 457899999999999
Q ss_pred hhcCCCCC--ceeccCCCCCeeec-CCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHH
Q 044022 81 LHFGFPRP--IVLRNFKTQNILFN-EENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFG 157 (241)
Q Consensus 81 lh~~~~~~--ivh~dl~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G 157 (241)
|| +++ |+||||||+|||++ .++.+||+|||++........ ....||+.|+|||++.+ .++.++||||||
T Consensus 128 LH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~----~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlG 199 (270)
T d1t4ha_ 128 LH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFG 199 (270)
T ss_dssp HH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHH
T ss_pred HH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCcc----CCcccCccccCHHHhCC-CCCCcCchhhHH
Confidence 99 777 99999999999996 578999999999975443322 34579999999999875 689999999999
Q ss_pred HHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 158 AFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 158 ~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
|++|+|++|+.||..... ..+....... + ......... .++++.+|+.+||+.||++||
T Consensus 200 vilyel~~g~~Pf~~~~~--------~~~~~~~i~~-~----~~~~~~~~~--------~~~~~~~li~~~l~~dp~~R~ 258 (270)
T d1t4ha_ 200 MCMLEMATSEYPYSECQN--------AAQIYRRVTS-G----VKPASFDKV--------AIPEVKEIIEGCIRQNKDERY 258 (270)
T ss_dssp HHHHHHHHSSCTTTTCSS--------HHHHHHHHTT-T----CCCGGGGGC--------CCHHHHHHHHHHSCSSGGGSC
T ss_pred HHHHHHHHCCCCCCCccc--------HHHHHHHHHc-C----CCCcccCcc--------CCHHHHHHHHHHccCCHhHCc
Confidence 999999999999954211 1111122111 1 111111111 225688999999999999999
Q ss_pred CCCC
Q 044022 238 TMVD 241 (241)
Q Consensus 238 t~~e 241 (241)
|++|
T Consensus 259 s~~e 262 (270)
T d1t4ha_ 259 SIKD 262 (270)
T ss_dssp CHHH
T ss_pred CHHH
Confidence 9864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=307.73 Aligned_cols=212 Identities=22% Similarity=0.318 Sum_probs=156.5
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~ 75 (241)
||.+.. +....++|.+|++++++++|||||+++|+|..++..++||||+++|+|.+++..... .++.++.|++
T Consensus 34 vK~i~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia 111 (263)
T d1sm2a_ 34 IKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 111 (263)
T ss_dssp EEECCS--SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHH
T ss_pred EEEECC--CcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHH
Confidence 455543 233567899999999999999999999999999999999999999999999865421 4678999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHH
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFS 155 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 155 (241)
.||.||| +++|+||||||+|||++.++.+||+|||+++......... .....||+.|+|||++.+..++.++||||
T Consensus 112 ~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS 187 (263)
T d1sm2a_ 112 EGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWS 187 (263)
T ss_dssp HHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHH
T ss_pred HHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCcee-ecceecCcccCChHHhcCCCCCchhhhcc
Confidence 9999999 8999999999999999999999999999997665433222 23346889999999999999999999999
Q ss_pred HHHHHHHHHhc-CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 156 FGAFLFELLAG-RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 156 ~G~~~~~~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
||+++|||+++ .+||.. ....+...... .+.... .+ . .+++.+.+++.+||+.||+
T Consensus 188 ~Gvil~el~t~~~~~~~~---------~~~~~~~~~i~-~~~~~~--~p---~--------~~~~~l~~li~~cl~~~p~ 244 (263)
T d1sm2a_ 188 FGVLMWEVFSEGKIPYEN---------RSNSEVVEDIS-TGFRLY--KP---R--------LASTHVYQIMNHCWKERPE 244 (263)
T ss_dssp HHHHHHHHHTTSCCTTCS---------CCHHHHHHHHH-HTCCCC--CC---T--------TSCHHHHHHHHHHTCSSGG
T ss_pred hHHHHHHHHHCCCCCCCC---------CCHHHHHHHHH-hcCCCC--Cc---c--------ccCHHHHHHHHHHccCCHh
Confidence 99999999995 554432 11122222222 221111 11 1 1235788999999999999
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
+|||++|
T Consensus 245 ~Rps~~~ 251 (263)
T d1sm2a_ 245 DRPAFSR 251 (263)
T ss_dssp GSCCHHH
T ss_pred HCcCHHH
Confidence 9999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.7e-49 Score=314.49 Aligned_cols=215 Identities=22% Similarity=0.258 Sum_probs=152.8
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVN 76 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~ 76 (241)
||++...........+.+|++++++++|||||++++++..++..++|||||+||+|.+++..... ....++.||+.
T Consensus 39 vK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~ 118 (307)
T d1a06a_ 39 IKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 118 (307)
T ss_dssp EEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHH
T ss_pred EEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHH
Confidence 46665555444566788999999999999999999999999999999999999999999876532 46789999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeec---CCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhh
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFN---EENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNV 153 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 153 (241)
||.||| +++++||||||+|||+. .++.+||+|||++........ .....||+.|+|||++.+..++.++||
T Consensus 119 al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~Di 192 (307)
T d1a06a_ 119 AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDC 192 (307)
T ss_dssp HHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHHHTTCCCCTHHHH
T ss_pred HHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHh
Confidence 999999 89999999999999995 578999999999976544322 234579999999999999999999999
Q ss_pred HHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 154 FSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
|||||++|+|++|+.||... ...+........... ....... ..++.+.+|+.+||+.||
T Consensus 193 wSlGvilyell~g~~Pf~~~---------~~~~~~~~i~~~~~~---~~~~~~~--------~~s~~~~~li~~~L~~dP 252 (307)
T d1a06a_ 193 WSIGVIAYILLCGYPPFYDE---------NDAKLFEQILKAEYE---FDSPYWD--------DISDSAKDFIRHLMEKDP 252 (307)
T ss_dssp HHHHHHHHHHHHSSCSCCCS---------SHHHHHHHHHTTCCC---CCTTTTT--------TSCHHHHHHHHHHSCSSG
T ss_pred hhhhHHHHHHHhCCCCCCCC---------CHHHHHHHHhccCCC---CCCcccc--------CCCHHHHHHHHHHccCCH
Confidence 99999999999999999641 112222222211110 1111111 223578999999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|||++|
T Consensus 253 ~~R~s~~e 260 (307)
T d1a06a_ 253 EKRFTCEQ 260 (307)
T ss_dssp GGSCCHHH
T ss_pred hHCcCHHH
Confidence 99999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=313.06 Aligned_cols=214 Identities=20% Similarity=0.236 Sum_probs=165.7
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC--Cc---hHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA--PL---PRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~---~~~~~~~~i~ 75 (241)
||++... .....++|.+|++++++++|||||++++++..++..++|||||++|+|.+++... .. .+..++.||+
T Consensus 42 vK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~ 120 (288)
T d2jfla1 42 AKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120 (288)
T ss_dssp EEEEECS-SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHH
T ss_pred EEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence 4555433 3345678999999999999999999999999999999999999999999986432 22 4678999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccc-----ccCCCcc
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYIS-----ICVLNEK 150 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~ 150 (241)
.||.||| +++|+||||||+|||++.++.+||+|||++....... .......||+.|+|||++. ...++.+
T Consensus 121 ~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k 195 (288)
T d2jfla1 121 DALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYK 195 (288)
T ss_dssp HHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTH
T ss_pred HHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--ccccccccccccCCHHHHhhcccCCCCCChh
Confidence 9999999 8999999999999999999999999999987543221 1123457999999999984 3467899
Q ss_pred hhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhcc
Q 044022 151 SNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVN 230 (241)
Q Consensus 151 ~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 230 (241)
+|||||||++|+|++|+.||..... .+......... ...... .. ..++.+.+|+.+||+
T Consensus 196 ~DiwSlGvilyemltg~~Pf~~~~~---------~~~~~~i~~~~-~~~~~~---~~--------~~s~~~~~li~~~L~ 254 (288)
T d2jfla1 196 ADVWSLGITLIEMAEIEPPHHELNP---------MRVLLKIAKSE-PPTLAQ---PS--------RWSSNFKDFLKKCLE 254 (288)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTSCG---------GGHHHHHHHSC-CCCCSS---GG--------GSCHHHHHHHHHHSC
T ss_pred hhHHHHHHHHHHHhhCCCCCCCCCH---------HHHHHHHHcCC-CCCCCc---cc--------cCCHHHHHHHHHHcc
Confidence 9999999999999999999965221 11122221111 111111 11 223678999999999
Q ss_pred CCCCCCCCCCC
Q 044022 231 NSPEDRPTMVD 241 (241)
Q Consensus 231 ~~p~~Rpt~~e 241 (241)
.||++|||++|
T Consensus 255 ~dp~~R~t~~e 265 (288)
T d2jfla1 255 KNVDARWTTSQ 265 (288)
T ss_dssp SSTTTSCCHHH
T ss_pred CChhHCcCHHH
Confidence 99999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-48 Score=311.41 Aligned_cols=213 Identities=19% Similarity=0.316 Sum_probs=166.8
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDI 74 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i 74 (241)
||.+..+ ....++|.+|+++|++++|||||+++++|.+++..++|||||++|+|.+++.... ..++.++.|+
T Consensus 47 vK~i~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi 124 (287)
T d1opja_ 47 VKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124 (287)
T ss_dssp EEECCTT--CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHH
T ss_pred EEEECCc--cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHH
Confidence 4555433 2356789999999999999999999999999999999999999999999985431 1467899999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhH
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
+.||.||| +++|+||||||+|||++.++.+||+|||+++........ ......|++.|+|||++.+..++.++|||
T Consensus 125 ~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~Diw 200 (287)
T d1opja_ 125 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVW 200 (287)
T ss_dssp HHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHH
T ss_pred HHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCCce-eeccccccccccChHHHcCCCCCchhhhh
Confidence 99999999 899999999999999999999999999999866544332 22334578899999999999999999999
Q ss_pred HHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 155 SFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 155 s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
|||+++|||++|..|+.... ..... ......+.... ... ..++.+.+|+.+||+.||+
T Consensus 201 S~Gv~l~ell~~~~p~~~~~--------~~~~~-~~~i~~~~~~~-----~~~--------~~~~~l~~li~~cl~~dP~ 258 (287)
T d1opja_ 201 AFGVLLWEIATYGMSPYPGI--------DLSQV-YELLEKDYRME-----RPE--------GCPEKVYELMRACWQWNPS 258 (287)
T ss_dssp HHHHHHHHHHTTSCCSSTTC--------CHHHH-HHHHHTTCCCC-----CCT--------TCCHHHHHHHHHHTCSSGG
T ss_pred hHHHHHHHHHhCCCCCCCcc--------hHHHH-HHHHhcCCCCC-----CCc--------cchHHHHHHHHHHcCCCHh
Confidence 99999999999777764311 11121 12222221111 111 1235789999999999999
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
+|||++|
T Consensus 259 ~Rps~~e 265 (287)
T d1opja_ 259 DRPSFAE 265 (287)
T ss_dssp GSCCHHH
T ss_pred HCcCHHH
Confidence 9999853
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-49 Score=309.94 Aligned_cols=216 Identities=18% Similarity=0.228 Sum_probs=154.4
Q ss_pred Cccccccc-ccccHHHHHHHHHHHHhcCCCcccceeeeeee--CCcceEEEEecCCCCHHHhhcCC-----C---chHHH
Q 044022 1 MKFYGHEY-HRHTYGSCINNITYAAQMSHNHILKRIGCCLQ--TPIPILVFQSVEYGTLRDCIFGA-----P---LPRLK 69 (241)
Q Consensus 1 iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~-----~---~~~~~ 69 (241)
||.+.... .+...+.+.+|++++++++|||||++++++.+ .+.+++|||||++|+|.+++... . ..+..
T Consensus 34 vK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~ 113 (269)
T d2java1 34 WKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 113 (269)
T ss_dssp EEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHH
T ss_pred EEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHH
Confidence 35554332 33446678999999999999999999999864 45689999999999999988532 1 24778
Q ss_pred HHHHHHHHhchhhcCC--CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCC
Q 044022 70 IASDIVNSLAYLHFGF--PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVL 147 (241)
Q Consensus 70 ~~~~i~~~l~~lh~~~--~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 147 (241)
++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++........ .....||+.|+|||++.+..+
T Consensus 114 i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~ 191 (269)
T d2java1 114 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMSPEQMNRMSY 191 (269)
T ss_dssp HHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCC
T ss_pred HHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCc--cccCCCCcccCCHHHHcCCCC
Confidence 9999999999999311 134999999999999999999999999999876543221 234578999999999998999
Q ss_pred CcchhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHH
Q 044022 148 NEKSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLE 227 (241)
Q Consensus 148 ~~~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 227 (241)
+.++|||||||++|+|++|+.||... ...+..... ..+..... ... .++.+.+|+.+
T Consensus 192 ~~~~DIwSlGvilyel~tg~~Pf~~~---------~~~~~~~~i-~~~~~~~~-----~~~--------~s~~l~~li~~ 248 (269)
T d2java1 192 NEKSDIWSLGCLLYELCALMPPFTAF---------SQKELAGKI-REGKFRRI-----PYR--------YSDELNEIITR 248 (269)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCSCCCS---------SHHHHHHHH-HHTCCCCC-----CTT--------SCHHHHHHHHH
T ss_pred ChHHHHHhhCHHHHHHhhCCCCCCCC---------CHHHHHHHH-HcCCCCCC-----Ccc--------cCHHHHHHHHH
Confidence 99999999999999999999999542 112222222 22222211 111 22578999999
Q ss_pred hccCCCCCCCCCCC
Q 044022 228 CVNNSPEDRPTMVD 241 (241)
Q Consensus 228 cl~~~p~~Rpt~~e 241 (241)
||+.||++|||++|
T Consensus 249 ~L~~dp~~Rps~~e 262 (269)
T d2java1 249 MLNLKDYHRPSVEE 262 (269)
T ss_dssp HTCSSGGGSCCHHH
T ss_pred HcCCChhHCcCHHH
Confidence 99999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=307.41 Aligned_cols=216 Identities=23% Similarity=0.266 Sum_probs=161.2
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~ 75 (241)
||.+..........+|.+|++++++++|||||+++|++...+..++|+||+.++++.+.+.... . .++.++.|++
T Consensus 41 vK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~ 120 (283)
T d1mqba_ 41 IKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120 (283)
T ss_dssp EEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHH
T ss_pred EEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHH
Confidence 4555554555556789999999999999999999999999999999999999999998875442 1 4678999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-eeecccccCCCccCcccccccCCCcchhhH
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-ITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
.|+.||| +++|+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||
T Consensus 121 ~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~ 197 (283)
T d1mqba_ 121 AGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVW 197 (283)
T ss_dssp HHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHH
T ss_pred Hhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCccccc
Confidence 9999999 899999999999999999999999999999865443221 122334578999999999999999999999
Q ss_pred HHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 155 SFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 155 s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
|||+++|||++|..|+.... ...+..... ..+..... ... .+..+.+|+.+||+.||+
T Consensus 198 S~Gvil~el~t~~~~~~~~~--------~~~~~~~~i-~~~~~~~~-----~~~--------~~~~l~~li~~cl~~~p~ 255 (283)
T d1mqba_ 198 SFGIVMWEVMTYGERPYWEL--------SNHEVMKAI-NDGFRLPT-----PMD--------CPSAIYQLMMQCWQQERA 255 (283)
T ss_dssp HHHHHHHHHHTTSCCTTTTC--------CHHHHHHHH-HTTCCCCC-----CTT--------CBHHHHHHHHHHTCSSTT
T ss_pred ccHHHHHHHHhCCCCccccC--------CHHHHHHHH-hccCCCCC-----chh--------hHHHHHHHHHHHCcCCHh
Confidence 99999999999766653311 112222222 22211111 111 225789999999999999
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
+|||+.|
T Consensus 256 ~RPt~~e 262 (283)
T d1mqba_ 256 RRPKFAD 262 (283)
T ss_dssp TSCCHHH
T ss_pred HCcCHHH
Confidence 9999853
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-48 Score=310.23 Aligned_cols=200 Identities=21% Similarity=0.318 Sum_probs=159.7
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC-Cc---hHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA-PL---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|++++++++|||||++++++..++..++|||||.+|+|..++... .. .+..++.||+.||.||| +
T Consensus 57 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH---~ 133 (309)
T d1u5ra_ 57 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---S 133 (309)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 34567999999999999999999999999999999999999999998765433 22 46789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc---cCCCcchhhHHHHHHHHHH
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI---CVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~s~G~~~~~~ 163 (241)
++|+||||||+|||++.++.+||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 134 ~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel 207 (309)
T d1u5ra_ 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207 (309)
T ss_dssp TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHH
T ss_pred CCEeccCCCcceEEECCCCCEEEeecccccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHH
Confidence 99999999999999999999999999999765432 34579999999999864 3588999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|+.||... ...+......... ...... . ..++.+.+|+.+||+.||++|||++|
T Consensus 208 ~~g~~Pf~~~---------~~~~~~~~i~~~~-~~~~~~----~--------~~s~~~~~li~~~L~~dP~~Rpt~~e 263 (309)
T d1u5ra_ 208 AERKPPLFNM---------NAMSALYHIAQNE-SPALQS----G--------HWSEYFRNFVDSCLQKIPQDRPTSEV 263 (309)
T ss_dssp HHSSCTTTTS---------CHHHHHHHHHHSC-CCCCSC----T--------TSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHCCCCCCCC---------CHHHHHHHHHhCC-CCCCCC----C--------CCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 9999999542 1112222221111 111111 1 12357899999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-48 Score=303.98 Aligned_cols=212 Identities=22% Similarity=0.256 Sum_probs=163.9
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC------chHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASDI 74 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i 74 (241)
||.+... ....++|.+|++++++++|||||++++++.+ +..++||||+++|+|.+++.... ..++.++.||
T Consensus 42 vK~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi 118 (272)
T d1qpca_ 42 VKSLKQG--SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118 (272)
T ss_dssp EEEECTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHH
T ss_pred EEEEccC--cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHH
Confidence 4555432 2356789999999999999999999998854 56799999999999999876532 2467899999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhH
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
+.||.||| +++|+||||||+|||++.++.+||+|||+++....... .......|++.|+|||++.+..++.++|||
T Consensus 119 ~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvw 194 (272)
T d1qpca_ 119 AEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVW 194 (272)
T ss_dssp HHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHH
T ss_pred HHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhh
Confidence 99999999 89999999999999999999999999999987654332 222345688999999999988999999999
Q ss_pred HHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 155 SFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 155 s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
|||+++|||+||..|+... ....+...... .+..... ... .++.+.+|+.+||+.||+
T Consensus 195 S~Gvvl~ellt~~~~~~~~--------~~~~~~~~~i~-~~~~~~~-----p~~--------~~~~l~~li~~cl~~~P~ 252 (272)
T d1qpca_ 195 SFGILLTEIVTHGRIPYPG--------MTNPEVIQNLE-RGYRMVR-----PDN--------CPEELYQLMRLCWKERPE 252 (272)
T ss_dssp HHHHHHHHHHTTTCCSSTT--------CCHHHHHHHHH-TTCCCCC-----CTT--------CCHHHHHHHHHHTCSSGG
T ss_pred hhHHHHHHHHhCCCCCCCC--------CCHHHHHHHHH-hcCCCCC-----ccc--------ChHHHHHHHHHHcCCCHh
Confidence 9999999999966555331 11222222222 2211111 111 225789999999999999
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
+|||++|
T Consensus 253 ~Rpt~~e 259 (272)
T d1qpca_ 253 DRPTFDY 259 (272)
T ss_dssp GSCCHHH
T ss_pred HCcCHHH
Confidence 9999853
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=299.41 Aligned_cols=212 Identities=18% Similarity=0.305 Sum_probs=168.3
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~ 75 (241)
||.+..+ ....++|++|++++++++|||||+++|+|.+++..++||||+++|+|.+++..... .+.+++.|++
T Consensus 33 vK~l~~~--~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~ 110 (258)
T d1k2pa_ 33 IKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 110 (258)
T ss_dssp EEEEESS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHH
T ss_pred EEEECcC--cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHH
Confidence 3555433 23567899999999999999999999999999999999999999999998655422 4778999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHH
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFS 155 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 155 (241)
.||.||| +.+|+||||||+||+++.++.+||+|||++......... ......+|..|+|||.+....++.++||||
T Consensus 111 ~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS 186 (258)
T d1k2pa_ 111 EAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 186 (258)
T ss_dssp HHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecc
Confidence 9999999 899999999999999999999999999999765543222 223356889999999999999999999999
Q ss_pred HHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 156 FGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 156 ~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
||+++|||+| |+.||.... ..+...... .+.... .+ .. .++.+.+|+.+||+.||+
T Consensus 187 ~G~~l~el~t~g~~Pf~~~~---------~~~~~~~i~-~~~~~~--~p---~~--------~~~~l~~li~~cl~~dP~ 243 (258)
T d1k2pa_ 187 FGVLMWEIYSLGKMPYERFT---------NSETAEHIA-QGLRLY--RP---HL--------ASEKVYTIMYSCWHEKAD 243 (258)
T ss_dssp HHHHHHHHHTTSCCTTTTSC---------HHHHHHHHH-TTCCCC--CC---TT--------CCHHHHHHHHHTTCSSGG
T ss_pred cchhhHhHHhcCCCCCCCCC---------HHHHHHHHH-hCCCCC--Cc---cc--------ccHHHHHHHHHHccCCHh
Confidence 9999999998 899996522 222222222 221111 11 11 225789999999999999
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
+|||++|
T Consensus 244 ~RPt~~e 250 (258)
T d1k2pa_ 244 ERPTFKI 250 (258)
T ss_dssp GSCCHHH
T ss_pred HCcCHHH
Confidence 9999853
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.7e-47 Score=308.39 Aligned_cols=214 Identities=16% Similarity=0.193 Sum_probs=167.9
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~ 75 (241)
||++.... ....+.+.+|+++|++++|||||++++++..++..++|||||++|+|.+++.... . ....++.||+
T Consensus 56 vK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~ 134 (350)
T d1koaa2 56 AKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134 (350)
T ss_dssp EEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHH
T ss_pred EEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHH
Confidence 45554332 2345678999999999999999999999999999999999999999999985432 2 4678999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecC--CCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhh
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNE--ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNV 153 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 153 (241)
.||.||| +++++||||||+|||++. ++.+||+|||++......... ....||+.|+|||++.+..++.++||
T Consensus 135 ~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~---~~~~gT~~Y~aPEv~~~~~~~~~~Di 208 (350)
T d1koaa2 135 KGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDM 208 (350)
T ss_dssp HHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE---EEECSCTTTCCHHHHHTCCBCHHHHH
T ss_pred HHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccc---ceecCcccccCHHHHcCCCCChhHhh
Confidence 9999999 999999999999999964 578999999999877654332 33578999999999999999999999
Q ss_pred HHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 154 FSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
|||||++|+|++|+.||... ...+......... . ........ ..++.+.+|+.+||+.||
T Consensus 209 wSlGvilyell~G~~Pf~~~---------~~~~~~~~i~~~~-~--~~~~~~~~--------~~s~~~~~li~~~L~~dP 268 (350)
T d1koaa2 209 WSVGVLSYILLSGLSPFGGE---------NDDETLRNVKSCD-W--NMDDSAFS--------GISEDGKDFIRKLLLADP 268 (350)
T ss_dssp HHHHHHHHHHHHSSCSSCCS---------SHHHHHHHHHHTC-C--CSCCGGGG--------GCCHHHHHHHHHHCCSSG
T ss_pred hhhhHHHHHHHhCCCCCCCC---------CHHHHHHHHHhCC-C--CCCccccc--------CCCHHHHHHHHHHccCCh
Confidence 99999999999999999541 1222222222111 1 11111111 123578999999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|||++|
T Consensus 269 ~~R~t~~e 276 (350)
T d1koaa2 269 NTRMTIHQ 276 (350)
T ss_dssp GGSCCHHH
T ss_pred hHCcCHHH
Confidence 99999854
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-47 Score=306.40 Aligned_cols=215 Identities=23% Similarity=0.332 Sum_probs=170.1
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----------------
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---------------- 64 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------- 64 (241)
||.+.........++|.+|++++++++||||++++++|...+..++++||+++|+|.+++....
T Consensus 48 vK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~ 127 (301)
T d1lufa_ 48 VKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127 (301)
T ss_dssp EEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC---------------
T ss_pred EEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhh
Confidence 4666555555567889999999999999999999999999999999999999999999985321
Q ss_pred ------------chHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeeccccc
Q 044022 65 ------------LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIG 132 (241)
Q Consensus 65 ------------~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 132 (241)
..++.++.|++.||+||| +++++||||||+|||++.++.+||+|||+++...............+
T Consensus 128 ~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~ 204 (301)
T d1lufa_ 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAI 204 (301)
T ss_dssp -------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCB
T ss_pred hccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCc
Confidence 136789999999999999 89999999999999999999999999999986655444444445678
Q ss_pred CCCccCcccccccCCCcchhhHHHHHHHHHHHhcC-cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCc
Q 044022 133 TRGYSAPEYISICVLNEKSNVFSFGAFLFELLAGR-IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPC 211 (241)
Q Consensus 133 ~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (241)
++.|+|||.+.+..++.++||||||+++|||++|. +||... ...+.... ...+.....+ ..
T Consensus 205 ~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~---------~~~e~~~~-v~~~~~~~~p-----~~--- 266 (301)
T d1lufa_ 205 PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM---------AHEEVIYY-VRDGNILACP-----EN--- 266 (301)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS---------CHHHHHHH-HHTTCCCCCC-----TT---
T ss_pred CcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC---------CHHHHHHH-HHcCCCCCCC-----cc---
Confidence 89999999999999999999999999999999986 566442 12222222 2222222221 12
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 212 IEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 212 ~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.++++.+|+.+||+.||++||||.|
T Consensus 267 -----~~~~~~~li~~cl~~~P~~RPt~~e 291 (301)
T d1lufa_ 267 -----CPLELYNLMRLCWSKLPADRPSFCS 291 (301)
T ss_dssp -----CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -----chHHHHHHHHHHcCCChhHCcCHHH
Confidence 2257889999999999999999854
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=301.89 Aligned_cols=212 Identities=20% Similarity=0.278 Sum_probs=154.8
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~~ 76 (241)
|...........+.|.+|++++++++|||||++++++. .+..++||||+++|+|.+++.... . .++.++.||+.
T Consensus 41 k~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~ 119 (273)
T d1mp8a_ 41 KTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119 (273)
T ss_dssp EECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHH
T ss_pred EEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHH
Confidence 34433344455678999999999999999999999995 567899999999999999865432 1 47789999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSF 156 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~ 156 (241)
||.||| +++++||||||+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||
T Consensus 120 gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSl 195 (273)
T d1mp8a_ 120 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMF 195 (273)
T ss_dssp HHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred Hhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCCcce-eccceecCcccchhhHhccCCCCCccccccc
Confidence 999999 999999999999999999999999999999865543222 2234568899999999999999999999999
Q ss_pred HHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 157 GAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 157 G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
|+++|||++ |.+||...... +..... ..+.... +... .++.+.+|+.+||+.||++
T Consensus 196 Gvil~e~lt~g~~P~~~~~~~---------~~~~~i-~~~~~~~-----~~~~--------~~~~~~~li~~cl~~dp~~ 252 (273)
T d1mp8a_ 196 GVCMWEILMHGVKPFQGVKNN---------DVIGRI-ENGERLP-----MPPN--------CPPTLYSLMTKCWAYDPSR 252 (273)
T ss_dssp HHHHHHHHTTSCCTTTTCCGG---------GHHHHH-HTTCCCC-----CCTT--------CCHHHHHHHHHHTCSSGGG
T ss_pred hHHHHHHHhcCCCCCCCCCHH---------HHHHHH-HcCCCCC-----CCCC--------CCHHHHHHHHHHcCCCHhH
Confidence 999999998 89998652211 112221 1221111 1122 2257899999999999999
Q ss_pred CCCCCC
Q 044022 236 RPTMVD 241 (241)
Q Consensus 236 Rpt~~e 241 (241)
|||++|
T Consensus 253 Rps~~e 258 (273)
T d1mp8a_ 253 RPRFTE 258 (273)
T ss_dssp SCCHHH
T ss_pred CcCHHH
Confidence 999854
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-46 Score=307.03 Aligned_cols=214 Identities=18% Similarity=0.207 Sum_probs=167.7
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~ 75 (241)
||++..... .....+.+|+++|++|+|||||+++++|..++.+++|||||++|+|.+++.... . ....++.||+
T Consensus 59 iK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~ 137 (352)
T d1koba_ 59 AKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 137 (352)
T ss_dssp EEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHH
T ss_pred EEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence 455543322 345678899999999999999999999999999999999999999998876542 2 4678999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeec--CCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhh
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFN--EENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNV 153 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 153 (241)
.||.||| +++|+||||||+|||++ .++.+||+|||++......... ....||+.|+|||++.+..++.++||
T Consensus 138 ~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di 211 (352)
T d1koba_ 138 EGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDM 211 (352)
T ss_dssp HHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHH
T ss_pred HHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCCce---eeccCcccccCHHHHcCCCCCCccch
Confidence 9999999 99999999999999998 5789999999999887654332 33478999999999999999999999
Q ss_pred HHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 154 FSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
|||||++|+|++|+.||... ...+....... ... . ....... ..++.+.+|+.+||+.||
T Consensus 212 wSlGvilyelltG~~Pf~~~---------~~~~~~~~i~~-~~~-~-~~~~~~~--------~~s~~~~~li~~~L~~dp 271 (352)
T d1koba_ 212 WAIGVLGYVLLSGLSPFAGE---------DDLETLQNVKR-CDW-E-FDEDAFS--------SVSPEAKDFIKNLLQKEP 271 (352)
T ss_dssp HHHHHHHHHHHHSCCSSCCS---------SHHHHHHHHHH-CCC-C-CCSSTTT--------TSCHHHHHHHHTTSCSSG
T ss_pred HHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHh-CCC-C-CCccccc--------CCCHHHHHHHHHHccCCh
Confidence 99999999999999999542 11222222211 111 0 1111111 122578899999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|||++|
T Consensus 272 ~~R~s~~e 279 (352)
T d1koba_ 272 RKRLTVHD 279 (352)
T ss_dssp GGSCCHHH
T ss_pred hHCcCHHH
Confidence 99999753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-47 Score=301.80 Aligned_cols=204 Identities=20% Similarity=0.264 Sum_probs=163.4
Q ss_pred cHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+.+.+|+++|++++|||||+++++|.+.+..++|||||++|+|.+++..... ....++.|++.||.||| ++
T Consensus 56 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH---~~ 132 (293)
T d1jksa_ 56 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SL 132 (293)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhh---hc
Confidence 467899999999999999999999999999999999999999999999865422 46789999999999999 99
Q ss_pred CceeccCCCCCeeecCCC----CeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHH
Q 044022 88 PIVLRNFKTQNILFNEEN----VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~ 163 (241)
+++||||||+|||++.++ .+|++|||++......... ....+|+.|+|||++.+..++.++|||||||++|+|
T Consensus 133 ~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyel 209 (293)
T d1jksa_ 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 209 (293)
T ss_dssp TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred ceeecccccceEEEecCCCcccceEecchhhhhhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHH
Confidence 999999999999998776 5999999999876544322 335689999999999988999999999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|+.||.... ..+......... . ........ ..+..+.+|+.+||+.||++|||++|
T Consensus 210 l~g~~Pf~~~~---------~~~~~~~i~~~~-~--~~~~~~~~--------~~s~~~~~li~~~L~~dP~~R~s~~e 267 (293)
T d1jksa_ 210 LSGASPFLGDT---------KQETLANVSAVN-Y--EFEDEYFS--------NTSALAKDFIRRLLVKDPKKRMTIQD 267 (293)
T ss_dssp HHSSCSSCCSS---------HHHHHHHHHTTC-C--CCCHHHHT--------TSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred HcCCCCCCCCC---------HHHHHHHHHhcC-C--CCCchhcC--------CCCHHHHHHHHHHccCChhHCcCHHH
Confidence 99999996421 122222221111 0 00111111 22367889999999999999999854
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=306.48 Aligned_cols=213 Identities=20% Similarity=0.259 Sum_probs=161.2
Q ss_pred cccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHHHH
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDIVN 76 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i~~ 76 (241)
|.+.........++|.+|++++++++|||||+++|+|.++ ..+++++++.+|+|.+++..... .++.++.||+.
T Consensus 44 K~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~ 122 (317)
T d1xkka_ 44 KELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122 (317)
T ss_dssp EEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHH
T ss_pred EEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHH
Confidence 4444444445678899999999999999999999999765 46788899999999988764421 46789999999
Q ss_pred HhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHH
Q 044022 77 SLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSF 156 (241)
Q Consensus 77 ~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~ 156 (241)
||.||| +++|+||||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||
T Consensus 123 gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~ 199 (317)
T d1xkka_ 123 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 199 (317)
T ss_dssp HHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhH
Confidence 999999 89999999999999999999999999999987655444333344568999999999999999999999999
Q ss_pred HHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCC
Q 044022 157 GAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPED 235 (241)
Q Consensus 157 G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 235 (241)
|+++|||+| |.+||...... +. ......+.....+ . ..++.+.+|+.+||+.||++
T Consensus 200 Gvil~el~t~g~~p~~~~~~~---------~~-~~~i~~~~~~~~p-----~--------~~~~~~~~li~~cl~~dP~~ 256 (317)
T d1xkka_ 200 GVTVWELMTFGSKPYDGIPAS---------EI-SSILEKGERLPQP-----P--------ICTIDVYMIMVKCWMIDADS 256 (317)
T ss_dssp HHHHHHHHTTSCCTTTTSCGG---------GH-HHHHHHTCCCCCC-----T--------TBCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHHCCCCCCCCCCHH---------HH-HHHHHcCCCCCCC-----c--------ccCHHHHHHHHHhCCCChhh
Confidence 999999998 78888542111 11 1112222111111 1 22357899999999999999
Q ss_pred CCCCCC
Q 044022 236 RPTMVD 241 (241)
Q Consensus 236 Rpt~~e 241 (241)
|||+.|
T Consensus 257 RPs~~e 262 (317)
T d1xkka_ 257 RPKFRE 262 (317)
T ss_dssp SCCHHH
T ss_pred CcCHHH
Confidence 999853
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=298.93 Aligned_cols=210 Identities=18% Similarity=0.237 Sum_probs=167.7
Q ss_pred Cccccccc--ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHH
Q 044022 1 MKFYGHEY--HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDI 74 (241)
Q Consensus 1 iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i 74 (241)
||++.+.. .....+++.+|+.+|++++||||+++++++.+.+.+|+|||||++|+|.+++..... ....++.|+
T Consensus 35 iK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qi 114 (337)
T d1o6la_ 35 MKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 114 (337)
T ss_dssp EEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHH
T ss_pred EEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHH
Confidence 35554332 234577899999999999999999999999999999999999999999999875422 467789999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhH
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
+.||.||| +++|+||||||+|||++.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||
T Consensus 115 l~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~Diw 189 (337)
T d1o6la_ 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWW 189 (337)
T ss_dssp HHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHH
T ss_pred hhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhccc
Confidence 99999999 99999999999999999999999999999986544322 22346799999999999999999999999
Q ss_pred HHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 155 SFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 155 s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
|+||++|+|++|++||... ...+...... .... .. ... .++.+.+|+.+||+.||+
T Consensus 190 SlGvilyeml~G~~pf~~~---------~~~~~~~~i~-~~~~-~~-----p~~--------~s~~~~dli~~~L~~dP~ 245 (337)
T d1o6la_ 190 GLGVVMYEMMCGRLPFYNQ---------DHERLFELIL-MEEI-RF-----PRT--------LSPEAKSLLAGLLKKDPK 245 (337)
T ss_dssp HHHHHHHHHHHSSCSSCCS---------SHHHHHHHHH-HCCC-CC-----CTT--------SCHHHHHHHHHHTCSSTT
T ss_pred chhhHHHHHHHCCCCCCCc---------CHHHHHHHHh-cCCC-CC-----Ccc--------CCHHHHHHHHhhccCCch
Confidence 9999999999999999652 1122222221 1111 11 111 225688999999999999
Q ss_pred CCCCC
Q 044022 235 DRPTM 239 (241)
Q Consensus 235 ~Rpt~ 239 (241)
+||+.
T Consensus 246 ~R~~~ 250 (337)
T d1o6la_ 246 QRLGG 250 (337)
T ss_dssp TSTTC
T ss_pred hhccc
Confidence 99963
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-45 Score=297.09 Aligned_cols=205 Identities=21% Similarity=0.287 Sum_probs=165.2
Q ss_pred Cccccccc--ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHH
Q 044022 1 MKFYGHEY--HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDI 74 (241)
Q Consensus 1 iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i 74 (241)
||++..+. .....+.+.+|+.++++++|||||++++++...+..++||||++||+|..++..... ....++.||
T Consensus 34 vK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi 113 (316)
T d1fota_ 34 MKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 113 (316)
T ss_dssp EEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHH
T ss_pred EEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHH
Confidence 45554332 234567899999999999999999999999999999999999999999998865532 356788999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhH
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
+.||.||| +++|+||||||+|||++.++.+||+|||++....... ....||+.|+|||++.+..++.++|||
T Consensus 114 ~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~Diw 185 (316)
T d1fota_ 114 CLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWW 185 (316)
T ss_dssp HHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHH
T ss_pred HHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecccc-----ccccCcccccCHHHHcCCCCCchhhcc
Confidence 99999999 9999999999999999999999999999998765432 345799999999999998999999999
Q ss_pred HHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 155 SFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 155 s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
|+||++|+|++|+.||... ...+....... +.. ...+. .++.+.+++.+||..||.
T Consensus 186 SlGvilyemltG~~Pf~~~---------~~~~~~~~i~~-~~~------~~p~~--------~s~~~~~li~~~L~~dp~ 241 (316)
T d1fota_ 186 SFGILIYEMLAGYTPFYDS---------NTMKTYEKILN-AEL------RFPPF--------FNEDVKDLLSRLITRDLS 241 (316)
T ss_dssp HHHHHHHHHHHSSCTTCCS---------SHHHHHHHHHH-CCC------CCCTT--------SCHHHHHHHHHHTCSCTT
T ss_pred ccchhHHHHHhCCCCCCCc---------CHHHHHHHHHc-CCC------CCCCC--------CCHHHHHHHHHHhhhCHH
Confidence 9999999999999999652 11222222211 111 11111 125688999999999999
Q ss_pred CCC
Q 044022 235 DRP 237 (241)
Q Consensus 235 ~Rp 237 (241)
+|+
T Consensus 242 ~R~ 244 (316)
T d1fota_ 242 QRL 244 (316)
T ss_dssp TCT
T ss_pred hcc
Confidence 997
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=297.82 Aligned_cols=215 Identities=20% Similarity=0.329 Sum_probs=162.6
Q ss_pred Cccccccc--ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHH
Q 044022 1 MKFYGHEY--HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASD 73 (241)
Q Consensus 1 iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~ 73 (241)
||++..+. .....++|.+|++++++++|||||+++|+|.+ +..++||||+++|++.+++.... ..++.++.|
T Consensus 41 iK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~q 119 (273)
T d1u46a_ 41 VKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119 (273)
T ss_dssp EEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHH
T ss_pred EEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHH
Confidence 35554332 23446789999999999999999999999965 46789999999999998875432 246789999
Q ss_pred HHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcce-eecccccCCCccCcccccccCCCcchh
Q 044022 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHI-TTDRVIGTRGYSAPEYISICVLNEKSN 152 (241)
Q Consensus 74 i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~D 152 (241)
|+.||.||| +++|+||||||+||+++.++.+||+|||++.......... ......++..|+|||.+.+..++.++|
T Consensus 120 i~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 196 (273)
T d1u46a_ 120 VAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASD 196 (273)
T ss_dssp HHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHH
T ss_pred HHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchh
Confidence 999999999 8999999999999999999999999999998775543322 223445778899999999999999999
Q ss_pred hHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccC
Q 044022 153 VFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNN 231 (241)
Q Consensus 153 i~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~ 231 (241)
|||||+++|||++ |..||... ...+........+...+. .... +..+.+|+.+||+.
T Consensus 197 i~S~Gvil~emlt~G~~Pf~~~---------~~~~~~~~i~~~~~~~~~-----~~~~--------~~~l~~li~~cl~~ 254 (273)
T d1u46a_ 197 TWMFGVTLWEMFTYGQEPWIGL---------NGSQILHKIDKEGERLPR-----PEDC--------PQDIYNVMVQCWAH 254 (273)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTC---------CHHHHHHHHHTSCCCCCC-----CTTC--------CHHHHHHHHHHTCS
T ss_pred hhhhHHHHHHHHhCCCCCCCCc---------CHHHHHHHHHhCCCCCCC-----cccc--------cHHHHHHHHHHcCC
Confidence 9999999999998 89999542 223333333333221111 1122 25788999999999
Q ss_pred CCCCCCCCCC
Q 044022 232 SPEDRPTMVD 241 (241)
Q Consensus 232 ~p~~Rpt~~e 241 (241)
||++|||+.|
T Consensus 255 dp~~RPt~~e 264 (273)
T d1u46a_ 255 KPEDRPTFVA 264 (273)
T ss_dssp SGGGSCCHHH
T ss_pred ChhHCcCHHH
Confidence 9999999753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=299.36 Aligned_cols=215 Identities=21% Similarity=0.331 Sum_probs=173.2
Q ss_pred CcccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC---------------
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--------------- 64 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------- 64 (241)
||.+..+.......++.+|+..+.++ +|||||+++++|.+++..++||||+++|+|.+++....
T Consensus 50 vK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~ 129 (299)
T d1fgka_ 50 VKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129 (299)
T ss_dssp EECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------C
T ss_pred EEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCcc
Confidence 46666666656678899999999998 89999999999999999999999999999999986431
Q ss_pred -----chHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCc
Q 044022 65 -----LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAP 139 (241)
Q Consensus 65 -----~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aP 139 (241)
..++.++.||+.||.||| +.+++||||||+|||++.++.+||+|||.+................+++.|+||
T Consensus 130 ~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 206 (299)
T d1fgka_ 130 EQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 206 (299)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCH
T ss_pred ccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhh
Confidence 146789999999999999 999999999999999999999999999999877655444444556788999999
Q ss_pred ccccccCCCcchhhHHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHH
Q 044022 140 EYISICVLNEKSNVFSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQL 218 (241)
Q Consensus 140 E~~~~~~~~~~~Di~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (241)
|.+.+..++.++||||||+++|||++ |.+||.... ..+ +......+.....+ .. .+
T Consensus 207 E~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~---------~~~-~~~~i~~~~~~~~p-----~~--------~~ 263 (299)
T d1fgka_ 207 EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---------VEE-LFKLLKEGHRMDKP-----SN--------CT 263 (299)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---------HHH-HHHHHHTTCCCCCC-----SS--------CC
T ss_pred hHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC---------HHH-HHHHHHcCCCCCCC-----cc--------ch
Confidence 99999999999999999999999998 688885411 112 22222223222211 12 22
Q ss_pred HHHHHHHHHhccCCCCCCCCCCC
Q 044022 219 HASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 219 ~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+.+.+|+.+||+.||++||||+|
T Consensus 264 ~~l~~li~~cl~~dP~~Rps~~e 286 (299)
T d1fgka_ 264 NELYMMMRDCWHAVPSQRPTFKQ 286 (299)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHH
Confidence 57899999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=297.08 Aligned_cols=212 Identities=21% Similarity=0.233 Sum_probs=158.3
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCC---C---chHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGA---P---LPRLKIASDI 74 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~---~~~~~~~~~i 74 (241)
||++.... ...+.|.+|+.++++++|||||+++++|. .+..++||||+++|+|..++... . ..++.++.+|
T Consensus 46 iK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i 122 (285)
T d1fmka3 46 IKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 122 (285)
T ss_dssp EEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHH
T ss_pred EEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHH
Confidence 46654332 34678999999999999999999999985 45679999999999999887542 1 2578999999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhH
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVF 154 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 154 (241)
+.||+||| +.+++||||||+|||++.++.+||+|||+++........ ......+|+.|+|||++....++.++|||
T Consensus 123 ~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~ 198 (285)
T d1fmka3 123 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVW 198 (285)
T ss_dssp HHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCce-eeccccccccccChHHHhCCCCCcHHhhh
Confidence 99999999 899999999999999999999999999999765433222 22345689999999999999999999999
Q ss_pred HHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCC
Q 044022 155 SFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 155 s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 234 (241)
|||+++|||++|..|+.... ...+...... .+...+. .. ..++.+.+++.+||+.||+
T Consensus 199 S~Giil~el~t~~~p~~~~~--------~~~~~~~~i~-~~~~~~~-----~~--------~~~~~l~~li~~cl~~dP~ 256 (285)
T d1fmka3 199 SFGILLTELTTKGRVPYPGM--------VNREVLDQVE-RGYRMPC-----PP--------ECPESLHDLMCQCWRKEPE 256 (285)
T ss_dssp HHHHHHHHHHTTTCCSSTTC--------CHHHHHHHHH-TTCCCCC-----CT--------TSCHHHHHHHHHHTCSSGG
T ss_pred cchHHHHHHHhCCCCCCCCC--------CHHHHHHHHH-hcCCCCC-----Cc--------ccCHHHHHHHHHHcccCHh
Confidence 99999999999766654311 1222222221 1211111 11 2235789999999999999
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
+|||++|
T Consensus 257 ~Rps~~~ 263 (285)
T d1fmka3 257 ERPTFEY 263 (285)
T ss_dssp GSCCHHH
T ss_pred HCcCHHH
Confidence 9999853
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=299.29 Aligned_cols=216 Identities=19% Similarity=0.306 Sum_probs=159.4
Q ss_pred CcccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeC-CcceEEEEecCCCCHHHhhcCCC--------------
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQT-PIPILVFQSVEYGTLRDCIFGAP-------------- 64 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~-------------- 64 (241)
||.+.........+.+.+|+.++.++ +|+|||.+++++... +..++|||||++|+|.+++....
T Consensus 48 vK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 127 (299)
T d1ywna1 48 VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 127 (299)
T ss_dssp EEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC---------
T ss_pred EEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhh
Confidence 35555444555677888999998888 688999999988764 46899999999999999985421
Q ss_pred ------chHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccC
Q 044022 65 ------LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSA 138 (241)
Q Consensus 65 ------~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~a 138 (241)
..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++...............||+.|+|
T Consensus 128 ~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~A 204 (299)
T d1ywna1 128 KDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 204 (299)
T ss_dssp --CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCC
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccc
Confidence 136789999999999999 89999999999999999999999999999987655544444455679999999
Q ss_pred cccccccCCCcchhhHHHHHHHHHHHhcC-cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHH
Q 044022 139 PEYISICVLNEKSNVFSFGAFLFELLAGR-IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQ 217 (241)
Q Consensus 139 PE~~~~~~~~~~~Di~s~G~~~~~~~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (241)
||++.+..++.++|||||||++|||++|. +||.... ..+........+.....++ ..
T Consensus 205 PE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~---------~~~~~~~~~~~~~~~~~~~-------------~~ 262 (299)
T d1ywna1 205 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK---------IDEEFCRRLKEGTRMRAPD-------------YT 262 (299)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---------CSHHHHHHHHHTCCCCCCT-------------TC
T ss_pred hhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC---------HHHHHHHHHhcCCCCCCCc-------------cC
Confidence 99999999999999999999999999875 5664311 1111222222222222111 12
Q ss_pred HHHHHHHHHHhccCCCCCCCCCCC
Q 044022 218 LHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 218 ~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++.+.+++.+||+.||++|||++|
T Consensus 263 ~~~l~~li~~cl~~dP~~Rpt~~e 286 (299)
T d1ywna1 263 TPEMYQTMLDCWHGEPSQRPTFSE 286 (299)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHH
Confidence 257899999999999999999864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-46 Score=298.21 Aligned_cols=216 Identities=19% Similarity=0.264 Sum_probs=167.1
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeee-CCcceEEEEecCCCCHHHhhcCCCc-----hHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQ-TPIPILVFQSVEYGTLRDCIFGAPL-----PRLKIASDI 74 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~i 74 (241)
||.+.........++|.+|++++++++||||++++|++.. ++..++|||||++|+|.+++..... .++.++.|+
T Consensus 60 vK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qi 139 (311)
T d1r0pa_ 60 VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 139 (311)
T ss_dssp EEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHH
T ss_pred EEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHH
Confidence 4555544555567889999999999999999999999876 4578999999999999998875532 467899999
Q ss_pred HHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc--eeecccccCCCccCcccccccCCCcchh
Q 044022 75 VNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH--ITTDRVIGTRGYSAPEYISICVLNEKSN 152 (241)
Q Consensus 75 ~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~D 152 (241)
+.||.||| +.+|+||||||+|||++.++.+||+|||+++........ .......||..|+|||.+....++.++|
T Consensus 140 a~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksD 216 (311)
T d1r0pa_ 140 AKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSD 216 (311)
T ss_dssp HHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHH
T ss_pred HHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhH
Confidence 99999999 899999999999999999999999999999876543221 1222346889999999999999999999
Q ss_pred hHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCC
Q 044022 153 VFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNS 232 (241)
Q Consensus 153 i~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~ 232 (241)
|||||+++|||++|..||...... .+...... .+..... +.. .++.+.+|+.+||+.|
T Consensus 217 I~SfGivl~El~t~~~p~~~~~~~--------~~~~~~i~-~g~~~~~-----p~~--------~~~~l~~li~~cl~~d 274 (311)
T d1r0pa_ 217 VWSFGVLLWELMTRGAPPYPDVNT--------FDITVYLL-QGRRLLQ-----PEY--------CPDPLYEVMLKCWHPK 274 (311)
T ss_dssp HHHHHHHHHHHHTTSCCSCC--------------CHHHHH-TTCCCCC-----CTT--------CCHHHHHHHHHHTCSS
T ss_pred hhhhHHHHHHHHHCCCCCCCCCCH--------HHHHHHHH-cCCCCCC-----ccc--------CcHHHHHHHHHHcCCC
Confidence 999999999999988887542111 11111111 1211111 111 2257889999999999
Q ss_pred CCCCCCCCC
Q 044022 233 PEDRPTMVD 241 (241)
Q Consensus 233 p~~Rpt~~e 241 (241)
|++|||+.|
T Consensus 275 P~~RPs~~e 283 (311)
T d1r0pa_ 275 AEMRPSFSE 283 (311)
T ss_dssp GGGSCCHHH
T ss_pred HhHCcCHHH
Confidence 999999854
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=293.75 Aligned_cols=207 Identities=22% Similarity=0.303 Sum_probs=154.7
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeee-CCcceEEEEecCCCCHHHhhcCCC------chHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQ-TPIPILVFQSVEYGTLRDCIFGAP------LPRLKIASD 73 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~ 73 (241)
||.+..+ ...++|.+|++++++++|||||+++|+|.+ .+.+++||||+++|+|.+++.... ..++.++.|
T Consensus 35 vK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ 111 (262)
T d1byga_ 35 VKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 111 (262)
T ss_dssp EEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred EEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHH
Confidence 4555332 345789999999999999999999999865 456899999999999999986431 247889999
Q ss_pred HHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhh
Q 044022 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNV 153 (241)
Q Consensus 74 i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 153 (241)
|+.||.||| +.+++||||||+|||++.++.+|++|||.++...... ....++..|+|||++.+..+++++||
T Consensus 112 i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDI 183 (262)
T d1byga_ 112 VCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDV 183 (262)
T ss_dssp HHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHH
T ss_pred HHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCCC-----ccccccccCCChHHHhCCCCChHHHH
Confidence 999999999 8999999999999999999999999999997654332 23457889999999998999999999
Q ss_pred HHHHHHHHHHHh-cCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCC
Q 044022 154 FSFGAFLFELLA-GRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNS 232 (241)
Q Consensus 154 ~s~G~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~ 232 (241)
||||+++|||++ |++||..... .+..... ..+... .+.... ++.+.+|+.+||+.|
T Consensus 184 wSfG~il~el~t~~~~p~~~~~~---------~~~~~~i-~~~~~~-----~~~~~~--------~~~~~~li~~cl~~d 240 (262)
T d1byga_ 184 WSFGILLWEIYSFGRVPYPRIPL---------KDVVPRV-EKGYKM-----DAPDGC--------PPAVYEVMKNCWHLD 240 (262)
T ss_dssp HHHHHHHHHHHTTSCCSCTTSCG---------GGHHHHH-TTTCCC-----CCCTTC--------CHHHHHHHHHHTCSS
T ss_pred HhHHHHHHHHHHCCCCCCCCCCH---------HHHHHHH-HcCCCC-----CCCccC--------CHHHHHHHHHHcccC
Confidence 999999999998 6877754211 1122222 112111 112222 257889999999999
Q ss_pred CCCCCCCCC
Q 044022 233 PEDRPTMVD 241 (241)
Q Consensus 233 p~~Rpt~~e 241 (241)
|++|||+.|
T Consensus 241 P~~Rps~~~ 249 (262)
T d1byga_ 241 AAMRPSFLQ 249 (262)
T ss_dssp GGGSCCHHH
T ss_pred HhHCcCHHH
Confidence 999999853
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-46 Score=298.27 Aligned_cols=216 Identities=19% Similarity=0.311 Sum_probs=171.9
Q ss_pred CcccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC---------------
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--------------- 64 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------- 64 (241)
||.+..+........|.+|+.+++++ +|||||+++++|...+..++|||||++|+|.+++....
T Consensus 58 vK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~ 137 (311)
T d1t46a_ 58 VKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137 (311)
T ss_dssp EEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC------------
T ss_pred EEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccc
Confidence 46665555555677899999999999 69999999999999999999999999999999986431
Q ss_pred -------chHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCcc
Q 044022 65 -------LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYS 137 (241)
Q Consensus 65 -------~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (241)
..+..++.||+.|+.||| +++++||||||+||+++.++.++++|||.++...............||+.|+
T Consensus 138 ~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~ 214 (311)
T d1t46a_ 138 DELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWM 214 (311)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGC
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHc
Confidence 146789999999999999 8999999999999999999999999999998776655555556678899999
Q ss_pred CcccccccCCCcchhhHHHHHHHHHHHhc-CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHH
Q 044022 138 APEYISICVLNEKSNVFSFGAFLFELLAG-RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQ 216 (241)
Q Consensus 138 aPE~~~~~~~~~~~Di~s~G~~~~~~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (241)
|||++.+..++.++||||||+++|||+++ .+||... . ..+........+.....+ . .
T Consensus 215 aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~-~--------~~~~~~~~i~~~~~~~~~-----~--------~ 272 (311)
T d1t46a_ 215 APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-P--------VDSKFYKMIKEGFRMLSP-----E--------H 272 (311)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-C--------SSHHHHHHHHHTCCCCCC-----T--------T
T ss_pred CHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC-C--------HHHHHHHHHhcCCCCCCc-----c--------c
Confidence 99999999999999999999999999995 4444331 1 112222222222211111 1 1
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 217 QLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 217 ~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.+..+.+|+..||+.||++|||++|
T Consensus 273 ~~~~l~~Li~~cl~~dP~~RPs~~~ 297 (311)
T d1t46a_ 273 APAEMYDIMKTCWDADPLKRPTFKQ 297 (311)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHH
Confidence 2257899999999999999999863
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.3e-45 Score=289.56 Aligned_cols=203 Identities=23% Similarity=0.330 Sum_probs=161.9
Q ss_pred HHHHHHHHHHHHhcC-CCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCCCC
Q 044022 13 YGSCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
.+++.+|+.++++++ ||||+++++++.+++..|+||||+++|+|.++++.... ....++.||+.||.||| ++
T Consensus 53 ~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH---~~ 129 (277)
T d1phka_ 53 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---KL 129 (277)
T ss_dssp HHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred HHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---Hc
Confidence 456889999999996 99999999999999999999999999999999965422 57889999999999999 89
Q ss_pred CceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc------cCCCcchhhHHHHHHHH
Q 044022 88 PIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI------CVLNEKSNVFSFGAFLF 161 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Di~s~G~~~~ 161 (241)
+|+||||||+|||++.++.+||+|||++......... ....||+.|+|||.+.+ ..++.++||||+|+++|
T Consensus 130 ~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvily 206 (277)
T d1phka_ 130 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY 206 (277)
T ss_dssp TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHH
T ss_pred CCcccccccceEEEcCCCCeEEccchheeEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhh
Confidence 9999999999999999999999999999876554322 33578999999999864 34678999999999999
Q ss_pred HHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 162 ELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 162 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+|++|+.||.... ..+....... +... .+.+ ... ..++.+.+|+.+||+.||++|||++|
T Consensus 207 eml~g~~Pf~~~~---------~~~~~~~i~~-~~~~-~~~~-~~~--------~~s~~~~~li~~~L~~~p~~R~s~~e 266 (277)
T d1phka_ 207 TLLAGSPPFWHRK---------QMLMLRMIMS-GNYQ-FGSP-EWD--------DYSDTVKDLVSRFLVVQPQKRYTAEE 266 (277)
T ss_dssp HHHHSSCSSCCSS---------HHHHHHHHHH-TCCC-CCTT-TGG--------GSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hhccCCCCCCCCC---------HHHHHHHHHh-CCCC-CCCc-ccc--------cCCHHHHHHHHHHccCChhHCcCHHH
Confidence 9999999996521 1222222222 1111 1111 111 23367899999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=296.53 Aligned_cols=215 Identities=18% Similarity=0.269 Sum_probs=171.9
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--------------ch
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--------------LP 66 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~ 66 (241)
||.+...........|.+|++++++++|||||+++++|...+..++||||+++|+|.+++.... ..
T Consensus 55 vK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~ 134 (308)
T d1p4oa_ 55 IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134 (308)
T ss_dssp EEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHH
T ss_pred EEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHH
Confidence 4666655555666789999999999999999999999999999999999999999999875421 14
Q ss_pred HHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccC
Q 044022 67 RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV 146 (241)
Q Consensus 67 ~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 146 (241)
+..++.+++.||.||| +++|+||||||+|||++.++++||+|||+++...............+++.|+|||.+.+..
T Consensus 135 ~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~ 211 (308)
T d1p4oa_ 135 MIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV 211 (308)
T ss_dssp HHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCC
Confidence 6789999999999999 8999999999999999999999999999998765554444445557899999999999999
Q ss_pred CCcchhhHHHHHHHHHHHhcC-cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHH
Q 044022 147 LNEKSNVFSFGAFLFELLAGR-IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLT 225 (241)
Q Consensus 147 ~~~~~Di~s~G~~~~~~~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 225 (241)
++.++||||||+++|||++|. +||... ...+..... ..+.....+ . ..++.+.+++
T Consensus 212 ~~~~~Dv~S~G~il~El~t~~~~p~~~~---------~~~~~~~~i-~~~~~~~~p-----~--------~~~~~l~~li 268 (308)
T d1p4oa_ 212 FTTYSDVWSFGVVLWEIATLAEQPYQGL---------SNEQVLRFV-MEGGLLDKP-----D--------NCPDMLFELM 268 (308)
T ss_dssp CCHHHHHHHHHHHHHHHHHTSCCTTTTS---------CHHHHHHHH-HTTCCCCCC-----T--------TCCHHHHHHH
T ss_pred CCcccccccHHHHHHHHHhCCCCCCCCC---------CHHHHHHHH-HhCCCCCCc-----c--------cchHHHHHHH
Confidence 999999999999999999985 666431 222222222 222222211 1 1225799999
Q ss_pred HHhccCCCCCCCCCCC
Q 044022 226 LECVNNSPEDRPTMVD 241 (241)
Q Consensus 226 ~~cl~~~p~~Rpt~~e 241 (241)
.+||+.||++|||++|
T Consensus 269 ~~cl~~~P~~RPs~~~ 284 (308)
T d1p4oa_ 269 RMCWQYNPKMRPSFLE 284 (308)
T ss_dssp HHHTCSSGGGSCCHHH
T ss_pred HHHcCCChhHCcCHHH
Confidence 9999999999999753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=292.18 Aligned_cols=211 Identities=20% Similarity=0.229 Sum_probs=166.2
Q ss_pred Cccccccc--ccccHHHHHHHHHHHH-hcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHH
Q 044022 1 MKFYGHEY--HRHTYGSCINNITYAA-QMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASD 73 (241)
Q Consensus 1 iK~~~~~~--~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~ 73 (241)
||++.+.. .....+.+.+|+.++. .++|||||++++++..++..|+||||+++|+|.+++..... ....++.|
T Consensus 32 vK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~q 111 (320)
T d1xjda_ 32 IKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE 111 (320)
T ss_dssp EEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHH
T ss_pred EEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHH
Confidence 35554332 2345567778887765 68999999999999999999999999999999999865432 46789999
Q ss_pred HHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhh
Q 044022 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNV 153 (241)
Q Consensus 74 i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 153 (241)
|+.||.||| +++++||||||+|||++.++.+||+|||.+........ ......||+.|+|||++.+..++.++||
T Consensus 112 i~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di 186 (320)
T d1xjda_ 112 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDW 186 (320)
T ss_dssp HHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHH
T ss_pred HHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhh
Confidence 999999999 89999999999999999999999999999986544322 2234579999999999999999999999
Q ss_pred HHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 154 FSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
|||||++|+|++|+.||... ...+....... ... ..... .++.+.+|+.+||+.||
T Consensus 187 wSlGvilyemltG~~PF~~~---------~~~~~~~~i~~-~~~------~~p~~--------~s~~~~dli~~~L~~dP 242 (320)
T d1xjda_ 187 WSFGVLLYEMLIGQSPFHGQ---------DEEELFHSIRM-DNP------FYPRW--------LEKEAKDLLVKLFVREP 242 (320)
T ss_dssp HHHHHHHHHHHHSSCSSCCS---------SHHHHHHHHHH-CCC------CCCTT--------SCHHHHHHHHHHSCSSG
T ss_pred hhhhHHHHHHHhCCCCCCCC---------CHHHHHHHHHc-CCC------CCCcc--------CCHHHHHHHHHhcccCC
Confidence 99999999999999999641 12222222211 111 11111 12568899999999999
Q ss_pred CCCCCCC
Q 044022 234 EDRPTMV 240 (241)
Q Consensus 234 ~~Rpt~~ 240 (241)
++|||+.
T Consensus 243 ~~R~s~~ 249 (320)
T d1xjda_ 243 EKRLGVR 249 (320)
T ss_dssp GGSBTTB
T ss_pred CCCcCHH
Confidence 9999984
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=296.78 Aligned_cols=211 Identities=19% Similarity=0.250 Sum_probs=161.2
Q ss_pred cccccccccccHHHHHHHHHHHHhc-CCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----------------
Q 044022 2 KFYGHEYHRHTYGSCINNITYAAQM-SHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP---------------- 64 (241)
Q Consensus 2 K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------- 64 (241)
|.+.........++|.+|+++|.++ +|||||+++++|..++..++||||+++|+|.++++...
T Consensus 43 K~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~ 122 (309)
T d1fvra_ 43 KRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122 (309)
T ss_dssp EEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSC
T ss_pred EEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccC
Confidence 4444444445677899999999999 79999999999999999999999999999999986541
Q ss_pred ----chHHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcc
Q 044022 65 ----LPRLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPE 140 (241)
Q Consensus 65 ----~~~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE 140 (241)
..++.++.||+.|+.||| +.+++||||||+|||++.++.+||+|||+++....... .....||..|+|||
T Consensus 123 ~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE 196 (309)
T d1fvra_ 123 TLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIE 196 (309)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCceEEcccccccccccccc---ccceecCCcccchH
Confidence 146789999999999999 89999999999999999999999999999875443222 12345889999999
Q ss_pred cccccCCCcchhhHHHHHHHHHHHhcC-cccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHH
Q 044022 141 YISICVLNEKSNVFSFGAFLFELLAGR-IHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLH 219 (241)
Q Consensus 141 ~~~~~~~~~~~Di~s~G~~~~~~~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (241)
.+....++.++||||||+++|||++|. +||... ...+...... .+.... .... .++
T Consensus 197 ~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~---------~~~~~~~~i~-~~~~~~-----~~~~--------~~~ 253 (309)
T d1fvra_ 197 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---------TCAELYEKLP-QGYRLE-----KPLN--------CDD 253 (309)
T ss_dssp HHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC---------CHHHHHHHGG-GTCCCC-----CCTT--------BCH
T ss_pred HhccCCCCccceeehhHHHHHHHHhcCCCCCCCC---------CHHHHHHHHH-hcCCCC-----CCcc--------CCH
Confidence 999999999999999999999999976 456431 2222222222 221111 1111 225
Q ss_pred HHHHHHHHhccCCCCCCCCCCC
Q 044022 220 ASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 220 ~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
.+.+|+.+||+.||++|||++|
T Consensus 254 ~~~~li~~cl~~dP~~RPs~~e 275 (309)
T d1fvra_ 254 EVYDLMRQCWREKPYERPSFAQ 275 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHH
Confidence 7899999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.1e-45 Score=295.86 Aligned_cols=195 Identities=15% Similarity=0.155 Sum_probs=160.8
Q ss_pred ccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCC
Q 044022 11 HTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
...+.+.+|+++|++++|||||++++++......++|+||+.+|+|.+++.... .....++.||+.||.||| +
T Consensus 83 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH---~ 159 (350)
T d1rdqe_ 83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---S 159 (350)
T ss_dssp TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 456789999999999999999999999999999999999999999999886532 256789999999999999 8
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHHHHHHHHhc
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGAFLFELLAG 166 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~~~~~~~g 166 (241)
++|+||||||+|||++.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 160 ~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG 234 (350)
T d1rdqe_ 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234 (350)
T ss_dssp TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhC
Confidence 999999999999999999999999999998765432 345789999999999999999999999999999999999
Q ss_pred CcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCC
Q 044022 167 RIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRP 237 (241)
Q Consensus 167 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 237 (241)
+.||... ........... +.. . .... .++.+.+++.+||..||++|+
T Consensus 235 ~~Pf~~~---------~~~~~~~~i~~-~~~-~-----~p~~--------~s~~~~~li~~~L~~dP~kR~ 281 (350)
T d1rdqe_ 235 YPPFFAD---------QPIQIYEKIVS-GKV-R-----FPSH--------FSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp SCSSCCS---------SHHHHHHHHHH-CCC-C-----CCTT--------CCHHHHHHHHHHSCSCTTTCT
T ss_pred CCCCCCc---------CHHHHHHHHhc-CCC-C-----CCcc--------CCHHHHHHHHHHhhhCHHhcc
Confidence 9999541 11222222211 111 0 1111 225788999999999999995
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.7e-45 Score=291.83 Aligned_cols=217 Identities=22% Similarity=0.312 Sum_probs=159.4
Q ss_pred Ccccccccc--cccHHHHHHHHHHHHhcCCCcccceeeeeeeCC----cceEEEEecCCCCHHHhhcCCCc----hHHHH
Q 044022 1 MKFYGHEYH--RHTYGSCINNITYAAQMSHNHILKRIGCCLQTP----IPILVFQSVEYGTLRDCIFGAPL----PRLKI 70 (241)
Q Consensus 1 iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~----~~~~~ 70 (241)
||++..+.. .....+|.+|++++++++|||||++++++...+ .+|+||||++|++|.+++..... ....+
T Consensus 37 iK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i 116 (277)
T d1o6ya_ 37 VKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 116 (277)
T ss_dssp EEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHH
T ss_pred EEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHH
Confidence 466654332 234667999999999999999999999998654 37899999999999988765422 46789
Q ss_pred HHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCC-cceeecccccCCCccCcccccccCCCc
Q 044022 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGE-THITTDRVIGTRGYSAPEYISICVLNE 149 (241)
Q Consensus 71 ~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~ 149 (241)
+.||+.||.||| +++++||||||+|||++.++..+++|||.+....... .........||+.|+|||++.+..+++
T Consensus 117 ~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~ 193 (277)
T d1o6ya_ 117 IADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDA 193 (277)
T ss_dssp HHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCH
T ss_pred HHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCc
Confidence 999999999999 8999999999999999999999999999987654332 222334567999999999999889999
Q ss_pred chhhHHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhc
Q 044022 150 KSNVFSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECV 229 (241)
Q Consensus 150 ~~Di~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 229 (241)
++||||||+++|+|++|+.||... ...+........... ......... ++.+.+++.+||
T Consensus 194 ~~DiwSlGvilyelltG~~Pf~~~---------~~~~~~~~~~~~~~~---~~~~~~~~~--------s~~l~~li~~~L 253 (277)
T d1o6ya_ 194 RSDVYSLGCVLYEVLTGEPPFTGD---------SPVSVAYQHVREDPI---PPSARHEGL--------SADLDAVVLKAL 253 (277)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCS---------SHHHHHHHHHHCCCC---CGGGTSSSC--------CHHHHHHHHHHT
T ss_pred ceecccchHHHHHHHhCCCCCCCc---------CHHHHHHHHHhcCCC---CCchhccCC--------CHHHHHHHHHHc
Confidence 999999999999999999999541 112222222222111 111111222 267889999999
Q ss_pred cCCCCCCC-CCC
Q 044022 230 NNSPEDRP-TMV 240 (241)
Q Consensus 230 ~~~p~~Rp-t~~ 240 (241)
+.||++|| |++
T Consensus 254 ~~dp~~R~~sa~ 265 (277)
T d1o6ya_ 254 AKNPENRYQTAA 265 (277)
T ss_dssp CSSGGGSCSSHH
T ss_pred cCCHhHCHhHHH
Confidence 99999999 543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-45 Score=290.65 Aligned_cols=215 Identities=20% Similarity=0.168 Sum_probs=159.9
Q ss_pred HHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC----chHHHHHHHHHHHhchhhcCCCCC
Q 044022 13 YGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGFPRP 88 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~~~~ 88 (241)
.+.+.+|++++++++|||||++++++..++..++||||+.++++........ ..+..++.||+.||.||| +++
T Consensus 44 ~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH---~~~ 120 (299)
T d1ua2a_ 44 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHW 120 (299)
T ss_dssp CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTT
T ss_pred HHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---ccc
Confidence 4578999999999999999999999999999999999999887777665432 257789999999999999 999
Q ss_pred ceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHHHhcC
Q 044022 89 IVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELLAGR 167 (241)
Q Consensus 89 ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~~g~ 167 (241)
++||||||+|||++.++.+||+|||.+........ ......||+.|+|||++... .++.++|||||||++|+|++|.
T Consensus 121 iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~ 198 (299)
T d1ua2a_ 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 198 (299)
T ss_dssp CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSS
T ss_pred eecccCCcceEEecCCCccccccCccccccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCc
Confidence 99999999999999999999999999976544322 12345789999999998755 5789999999999999999999
Q ss_pred cccccccccCCCcccchHHHHHHHhh---hcccCCCCC------CccccCCCch--h--HHHHHHHHHHHHHHhccCCCC
Q 044022 168 IHIWDLLKDTHDHGCFFNEYLKNYLE---DKRFTGIPA------PIIVQDIPCI--E--KEQQLHASAQLTLECVNNSPE 234 (241)
Q Consensus 168 ~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~------~~~~~~~~~~--~--~~~~~~~~~~l~~~cl~~~p~ 234 (241)
+||.... ..+.+..... ........+ .......+.. . ....++.+.+|+.+||+.||+
T Consensus 199 ~pf~~~~---------~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~ 269 (299)
T d1ua2a_ 199 PFLPGDS---------DLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPC 269 (299)
T ss_dssp CSSCCSS---------HHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTT
T ss_pred CCCCCCC---------HHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChh
Confidence 9995421 1111111111 000000000 0000000000 0 012236789999999999999
Q ss_pred CCCCCCC
Q 044022 235 DRPTMVD 241 (241)
Q Consensus 235 ~Rpt~~e 241 (241)
+||||+|
T Consensus 270 ~R~sa~e 276 (299)
T d1ua2a_ 270 ARITATQ 276 (299)
T ss_dssp TSCCHHH
T ss_pred hCcCHHH
Confidence 9999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=291.43 Aligned_cols=213 Identities=15% Similarity=0.202 Sum_probs=165.8
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~ 75 (241)
||++..+. .....+.+|+++|++++|||||++++++..++.+|+|||||+||+|.+++.... . ....++.||+
T Consensus 35 iK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~ 112 (321)
T d1tkia_ 35 AKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112 (321)
T ss_dssp EEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHH
T ss_pred EEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence 35554332 234568899999999999999999999999999999999999999999997643 2 4678999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCC--CCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhh
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEE--NVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNV 153 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 153 (241)
.||.||| +++|+||||||+|||++.+ ..++|+|||.+......... ....+++.|+|||...+..++.++||
T Consensus 113 ~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~---~~~~~t~~y~ape~~~~~~~~~~~Di 186 (321)
T d1tkia_ 113 EALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDM 186 (321)
T ss_dssp HHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE---EEEESCGGGSCHHHHTTCEECHHHHH
T ss_pred HHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCCcc---cccccccccccchhccCCCCCchhhc
Confidence 9999999 8999999999999999854 58999999999876544322 33468999999999999999999999
Q ss_pred HHHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCC
Q 044022 154 FSFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSP 233 (241)
Q Consensus 154 ~s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 233 (241)
||+||++|+|++|..||.... ..+......... . ..+..... ..++.+.+|+.+||..||
T Consensus 187 WSlGvily~ll~G~~Pf~~~~---------~~~~~~~i~~~~-~--~~~~~~~~--------~~s~~~~~li~~~L~~dp 246 (321)
T d1tkia_ 187 WSLGTLVYVLLSGINPFLAET---------NQQIIENIMNAE-Y--TFDEEAFK--------EISIEAMDFVDRLLVKER 246 (321)
T ss_dssp HHHHHHHHHHHHSSCTTCCSS---------HHHHHHHHHHTC-C--CCCHHHHT--------TSCHHHHHHHHTTSCSSG
T ss_pred ccHHHHHHHHHhCCCCCCCCC---------HHHHHHHHHhCC-C--CCChhhcc--------CCCHHHHHHHHHHccCCh
Confidence 999999999999999996521 122222222111 0 01111111 123578899999999999
Q ss_pred CCCCCCCC
Q 044022 234 EDRPTMVD 241 (241)
Q Consensus 234 ~~Rpt~~e 241 (241)
++|||++|
T Consensus 247 ~~R~s~~e 254 (321)
T d1tkia_ 247 KSRMTASE 254 (321)
T ss_dssp GGSCCHHH
T ss_pred hHCcCHHH
Confidence 99999853
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=293.17 Aligned_cols=207 Identities=17% Similarity=0.225 Sum_probs=159.2
Q ss_pred HHHHHHHHHHHHhc-CCCcccceeeeeee----CCcceEEEEecCCCCHHHhhcCCC---c---hHHHHHHHHHHHhchh
Q 044022 13 YGSCINNITYAAQM-SHNHILKRIGCCLQ----TPIPILVFQSVEYGTLRDCIFGAP---L---PRLKIASDIVNSLAYL 81 (241)
Q Consensus 13 ~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~---~---~~~~~~~~i~~~l~~l 81 (241)
...+.+|+.++.++ +|||||+++++|.. ...+|+|||||+||+|.+++.... . ....++.||+.||.||
T Consensus 48 ~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~yl 127 (335)
T d2ozaa1 48 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127 (335)
T ss_dssp SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHH
Confidence 45678999987655 89999999999875 457899999999999999997642 2 4678999999999999
Q ss_pred hcCCCCCceeccCCCCCeeecC---CCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchhhHHHHH
Q 044022 82 HFGFPRPIVLRNFKTQNILFNE---ENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGA 158 (241)
Q Consensus 82 h~~~~~~ivh~dl~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~ 158 (241)
| +++|+||||||+|||++. .+.+||+|||++........ .....||+.|+|||++.+..++.++|||||||
T Consensus 128 H---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGv 201 (335)
T d2ozaa1 128 H---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 201 (335)
T ss_dssp H---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHH
T ss_pred H---HcCCccccccccccccccccccccccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhch
Confidence 9 999999999999999985 46799999999987655432 23457999999999999999999999999999
Q ss_pred HHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 159 FLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 159 ~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
++|+|++|+.||........ ...... .+.. .....+.......++.+.+|+.+||+.||++|||
T Consensus 202 ily~lltg~~Pf~~~~~~~~---------~~~~~~-----~i~~--~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s 265 (335)
T d2ozaa1 202 IMYILLCGYPPFYSNHGLAI---------SPGMKT-----RIRM--GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT 265 (335)
T ss_dssp HHHHHTTSSCSCEETTCC----------------------CCCS--CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCC
T ss_pred hHHHHhhCCCCCCCCCHHHH---------HHHHHH-----HHhc--CCCCCCCcccccCCHHHHHHHHHHccCChhHCcC
Confidence 99999999999965211110 000000 0000 0011222223345578999999999999999999
Q ss_pred CCC
Q 044022 239 MVD 241 (241)
Q Consensus 239 ~~e 241 (241)
++|
T Consensus 266 ~~e 268 (335)
T d2ozaa1 266 ITE 268 (335)
T ss_dssp HHH
T ss_pred HHH
Confidence 853
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.6e-44 Score=294.64 Aligned_cols=199 Identities=19% Similarity=0.205 Sum_probs=155.8
Q ss_pred HHHHHHH---HHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCC
Q 044022 13 YGSCINN---ITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 13 ~~~~~~e---~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.+| +++++.++|||||++++++...+..|+||||+++|+|.+++..... ....++.||+.||.|||
T Consensus 48 ~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH--- 124 (364)
T d1omwa3 48 ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH--- 124 (364)
T ss_dssp HHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---
T ss_pred HHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHH---
Confidence 3444444 6677777899999999999999999999999999999999865422 56789999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFLFELL 164 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~~~~~ 164 (241)
+++++||||||+|||++.++.+||+|||++........ ....||+.|+|||++.. ..++.++|||||||++|+|+
T Consensus 125 ~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyeml 200 (364)
T d1omwa3 125 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 200 (364)
T ss_dssp HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHH
T ss_pred HCCccceeeccceeEEcCCCcEEEeeeceeeecCCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHH
Confidence 99999999999999999999999999999987654432 34579999999999874 56899999999999999999
Q ss_pred hcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 165 AGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 165 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
+|+.||....... ........ ... ....... .++.+.+|+.+||+.||++|||.
T Consensus 201 tG~~Pf~~~~~~~------~~~~~~~~-~~~------~~~~~~~--------~s~~~~~li~~~L~~dP~~R~t~ 254 (364)
T d1omwa3 201 RGHSPFRQHKTKD------KHEIDRMT-LTM------AVELPDS--------FSPELRSLLEGLLQRDVNRRLGC 254 (364)
T ss_dssp HSSCSSCSSCSSC------HHHHHHHS-SSC------CCCCCSS--------SCHHHHHHHHHHTCSSTTTSTTT
T ss_pred hCCCCCCCCCHHH------HHHHHHhc-ccC------CCCCCCC--------CCHHHHHHHHHHcccCHHHhCCC
Confidence 9999996522111 11111110 000 1111111 22578999999999999999994
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=287.69 Aligned_cols=217 Identities=20% Similarity=0.212 Sum_probs=154.9
Q ss_pred HHHHHHHhcCCCcccceeeeeeeCC----cceEEEEecCCCCHHHhhcCCCc---hHHHHHHHHHHHhchhhcC-----C
Q 044022 18 NNITYAAQMSHNHILKRIGCCLQTP----IPILVFQSVEYGTLRDCIFGAPL---PRLKIASDIVNSLAYLHFG-----F 85 (241)
Q Consensus 18 ~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~lh~~-----~ 85 (241)
.|+..+.+++|||||++++++...+ .+|+||||+++|+|.+++++... .++.++.+++.|+.|||.. .
T Consensus 46 ~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~ 125 (303)
T d1vjya_ 46 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125 (303)
T ss_dssp HHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTC
T ss_pred HHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhcc
Confidence 4555556789999999999998654 57999999999999999987654 4678999999999999942 1
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc--eeecccccCCCccCccccccc------CCCcchhhHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH--ITTDRVIGTRGYSAPEYISIC------VLNEKSNVFSFG 157 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~------~~~~~~Di~s~G 157 (241)
+++|+||||||+|||++.++.+||+|||++......... .......||+.|+|||++... .++.++||||||
T Consensus 126 ~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~G 205 (303)
T d1vjya_ 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205 (303)
T ss_dssp BCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH
T ss_pred CCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhH
Confidence 369999999999999999999999999999876543222 223456799999999998754 256789999999
Q ss_pred HHHHHHHhcCcccccccccCCC-----cccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCC
Q 044022 158 AFLFELLAGRIHIWDLLKDTHD-----HGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNS 232 (241)
Q Consensus 158 ~~~~~~~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~ 232 (241)
+++|||+||..||......... ......+........... .+.+... .........+.+++.+||+.|
T Consensus 206 vvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~p~~~~~---~~~~~~~~~l~~li~~cl~~d 278 (303)
T d1vjya_ 206 LVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL----RPNIPNR---WQSCEALRVMAKIMRECWYAN 278 (303)
T ss_dssp HHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC----CCCCCGG---GGGCHHHHHHHHHHHTTCCSS
T ss_pred HHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhcccc----CCCCCcc---cCChHHHHHHHHHHHHHcccC
Confidence 9999999999887542221110 111111222222211111 1111111 111245567899999999999
Q ss_pred CCCCCCCCC
Q 044022 233 PEDRPTMVD 241 (241)
Q Consensus 233 p~~Rpt~~e 241 (241)
|++|||+.|
T Consensus 279 p~~Rps~~e 287 (303)
T d1vjya_ 279 GAARLTALR 287 (303)
T ss_dssp GGGSCCHHH
T ss_pred HhHCcCHHH
Confidence 999999753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=283.90 Aligned_cols=166 Identities=22% Similarity=0.293 Sum_probs=134.7
Q ss_pred Ccccccccc-cccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhh-cCC--Cc---hHHHHHHH
Q 044022 1 MKFYGHEYH-RHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCI-FGA--PL---PRLKIASD 73 (241)
Q Consensus 1 iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l-~~~--~~---~~~~~~~~ 73 (241)
||++..+.. +...+++.+|++++++++|||||++++++..++..|+||||+.+ ++.+++ ... .. .+..++.|
T Consensus 32 vK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~q 110 (298)
T d1gz8a_ 32 LKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQ 110 (298)
T ss_dssp EEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHH
T ss_pred EEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHH
Confidence 466654332 24577899999999999999999999999999999999999975 444443 322 11 46789999
Q ss_pred HHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccC-CCcchh
Q 044022 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV-LNEKSN 152 (241)
Q Consensus 74 i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~D 152 (241)
++.||.||| +++|+||||||+|||++.++.+||+|||.+........ ......||+.|+|||.+.... ++.++|
T Consensus 111 il~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~D 185 (298)
T d1gz8a_ 111 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVD 185 (298)
T ss_dssp HHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHH
T ss_pred HHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCcc--cceeecccceeeehhhhccccCCCcccc
Confidence 999999999 89999999999999999999999999999976654322 123347899999999887665 578999
Q ss_pred hHHHHHHHHHHHhcCccccc
Q 044022 153 VFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 153 i~s~G~~~~~~~~g~~p~~~ 172 (241)
|||+|+++|+|++|+.||..
T Consensus 186 iwSlGvily~m~~G~~Pf~~ 205 (298)
T d1gz8a_ 186 IWSLGCIFAEMVTRRALFPG 205 (298)
T ss_dssp HHHHHHHHHHHHHSSCSCCC
T ss_pred ccccchhhhHHhhCCCCCCC
Confidence 99999999999999999954
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=277.86 Aligned_cols=166 Identities=19% Similarity=0.222 Sum_probs=134.0
Q ss_pred Ccccccccc-cccHHHHHHHHHHHHhc---CCCcccceeeeeee-----CCcceEEEEecCCCCHHHhhcCCC--c---h
Q 044022 1 MKFYGHEYH-RHTYGSCINNITYAAQM---SHNHILKRIGCCLQ-----TPIPILVFQSVEYGTLRDCIFGAP--L---P 66 (241)
Q Consensus 1 iK~~~~~~~-~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~--~---~ 66 (241)
||++..... .....++.+|+.+++.| +||||++++++|.. ....++++|++.++++........ . .
T Consensus 38 iK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~ 117 (305)
T d1blxa_ 38 LKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 117 (305)
T ss_dssp EEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHH
T ss_pred EEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHH
Confidence 455543332 23455677888888776 79999999999863 246899999998877655443321 1 3
Q ss_pred HHHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccC
Q 044022 67 RLKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV 146 (241)
Q Consensus 67 ~~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 146 (241)
...++.|++.||+||| +++|+||||||+|||++.++.+||+|||.+....... ......||+.|+|||++.+..
T Consensus 118 ~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~ 191 (305)
T d1blxa_ 118 IKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSS 191 (305)
T ss_dssp HHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCC
Confidence 5679999999999999 8999999999999999999999999999987544332 224467999999999999999
Q ss_pred CCcchhhHHHHHHHHHHHhcCccccc
Q 044022 147 LNEKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 147 ~~~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
++.++||||+||++|+|++|+.||..
T Consensus 192 y~~~~DiwSlG~il~ell~g~~pf~~ 217 (305)
T d1blxa_ 192 YATPVDLWSVGCIFAEMFRRKPLFRG 217 (305)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CChhehhhchHHHHHHHHHCCCCCCC
Confidence 99999999999999999999999964
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.7e-42 Score=274.56 Aligned_cols=167 Identities=21% Similarity=0.235 Sum_probs=137.6
Q ss_pred Cccccccc-ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHH
Q 044022 1 MKFYGHEY-HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~ 75 (241)
||++..+. ......++.+|+.+|++++|||||++++++...+..++++|++.++.+..+...... ....++.||+
T Consensus 31 vK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 110 (286)
T d1ob3a_ 31 LKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLL 110 (286)
T ss_dssp EEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHH
T ss_pred EEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHH
Confidence 46665443 334578899999999999999999999999999999999999987777766654422 5678999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhH
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVF 154 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~ 154 (241)
.||.||| +.+|+||||||+|||++.++.+|++|||.+......... .....+++.|+|||.+.+. .++.++|||
T Consensus 111 ~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~~Diw 185 (286)
T d1ob3a_ 111 NGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIW 185 (286)
T ss_dssp HHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHH
T ss_pred HHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCccc--cceecccchhhhHHHHhCCCCCCcceeeh
Confidence 9999999 899999999999999999999999999999776543221 2334688999999998754 568999999
Q ss_pred HHHHHHHHHHhcCccccc
Q 044022 155 SFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 155 s~G~~~~~~~~g~~p~~~ 172 (241)
|+|+++|+|++|+.||..
T Consensus 186 slGv~l~el~~G~~pf~~ 203 (286)
T d1ob3a_ 186 SVGCIFAEMVNGTPLFPG 203 (286)
T ss_dssp HHHHHHHHHHHSSCSCCC
T ss_pred hcCcHHHHHHHCCCCCCC
Confidence 999999999999999965
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=277.62 Aligned_cols=192 Identities=19% Similarity=0.266 Sum_probs=153.2
Q ss_pred HHHHHHHHHHHHhcC--CCcccceeeeeeeCCcceEEEEecCC-CCHHHhhcCCC----chHHHHHHHHHHHhchhhcCC
Q 044022 13 YGSCINNITYAAQMS--HNHILKRIGCCLQTPIPILVFQSVEY-GTLRDCIFGAP----LPRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~----~~~~~~~~~i~~~l~~lh~~~ 85 (241)
..++.+|+.++++++ |||||++++++...+..++||||+.+ +++.+++.... .....++.|++.||.|||
T Consensus 51 ~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH--- 127 (273)
T d1xwsa_ 51 GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 127 (273)
T ss_dssp CCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---
T ss_pred HHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 345779999999996 89999999999999999999999975 57777765432 246789999999999999
Q ss_pred CCCceeccCCCCCeeecCC-CCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCC-CcchhhHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEE-NVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVL-NEKSNVFSFGAFLFEL 163 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~s~G~~~~~~ 163 (241)
+++|+||||||+|||++.+ +.+||+|||++....... .+...||+.|+|||++.+..+ +.++||||+||++|+|
T Consensus 128 ~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyel 203 (273)
T d1xwsa_ 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 203 (273)
T ss_dssp HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHH
T ss_pred HCCCccccCcccceEEecCCCeEEECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhH
Confidence 9999999999999999854 799999999998654432 234579999999999987665 5678999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
++|+.||.... .... ... .+.... ++++.+|+.+||+.||++|||++|
T Consensus 204 l~g~~Pf~~~~---------------~i~~-~~~------~~~~~~--------s~~~~~li~~~L~~dp~~R~s~~e 251 (273)
T d1xwsa_ 204 VCGDIPFEHDE---------------EIIR-GQV------FFRQRV--------SSECQHLIRWCLALRPSDRPTFEE 251 (273)
T ss_dssp HHSSCSCCSHH---------------HHHH-CCC------CCSSCC--------CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hhCCCCCCCch---------------HHhh-ccc------CCCCCC--------CHHHHHHHHHHccCCHhHCcCHHH
Confidence 99999995411 0111 100 111122 257889999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=277.86 Aligned_cols=169 Identities=20% Similarity=0.212 Sum_probs=137.6
Q ss_pred CcccccccccccHHHHHHHHHHHHhcCCCcccceeeeeeeCC----cceEEEEecCCCCHHHhhcCCCc---hHHHHHHH
Q 044022 1 MKFYGHEYHRHTYGSCINNITYAAQMSHNHILKRIGCCLQTP----IPILVFQSVEYGTLRDCIFGAPL---PRLKIASD 73 (241)
Q Consensus 1 iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~ 73 (241)
||++.........+++++|+++|++++||||+++++++.... ..+++++++.+|+|.+++..... ....++.|
T Consensus 38 vK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~q 117 (345)
T d1pmea_ 38 IKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQ 117 (345)
T ss_dssp EEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHH
T ss_pred EEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHH
Confidence 466655444455678999999999999999999999997643 23445566668999999876544 46789999
Q ss_pred HHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcc-eeecccccCCCccCcccccc-cCCCcch
Q 044022 74 IVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETH-ITTDRVIGTRGYSAPEYISI-CVLNEKS 151 (241)
Q Consensus 74 i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~ 151 (241)
++.||.||| +++|+||||||+|||++.++.+||+|||++......... .......||+.|+|||++.. ..++.++
T Consensus 118 il~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~ 194 (345)
T d1pmea_ 118 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 194 (345)
T ss_dssp HHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHH
T ss_pred HHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchh
Confidence 999999999 899999999999999999999999999999765443221 12234578999999999854 4678899
Q ss_pred hhHHHHHHHHHHHhcCccccc
Q 044022 152 NVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 152 Di~s~G~~~~~~~~g~~p~~~ 172 (241)
||||+|+++|+|++|+.||..
T Consensus 195 DiwSlG~il~eml~g~~pf~~ 215 (345)
T d1pmea_ 195 DIWSVGCILAEMLSNRPIFPG 215 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSCCC
T ss_pred hhhccCceehHHhhCCCCCCC
Confidence 999999999999999999954
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-41 Score=274.38 Aligned_cols=163 Identities=19% Similarity=0.243 Sum_probs=138.1
Q ss_pred Cccccccc-ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCC------cceEEEEecCCCCHHHhhcCCCc---hHHHH
Q 044022 1 MKFYGHEY-HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTP------IPILVFQSVEYGTLRDCIFGAPL---PRLKI 70 (241)
Q Consensus 1 iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~---~~~~~ 70 (241)
||++.... .....+++.+|+++|++++|||||+++++|...+ .+|+||||+ +.+|....+.... ....+
T Consensus 48 iK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~ 126 (346)
T d1cm8a_ 48 IKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFL 126 (346)
T ss_dssp EEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHH
T ss_pred EEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHhccccHHHHHHH
Confidence 46665433 3345678999999999999999999999998654 569999999 5788887765543 46789
Q ss_pred HHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCc
Q 044022 71 ASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNE 149 (241)
Q Consensus 71 ~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~ 149 (241)
+.||+.||.||| +++|+||||||+|||++.++.+|++|||.+....... ....+|+.|+|||++.+. .++.
T Consensus 127 ~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~ 198 (346)
T d1cm8a_ 127 VYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQ 198 (346)
T ss_dssp HHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCT
T ss_pred HHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceeccCCcc-----ccccccccccCHHHHcCCCCCCc
Confidence 999999999999 9999999999999999999999999999998765433 345789999999998764 5689
Q ss_pred chhhHHHHHHHHHHHhcCccccc
Q 044022 150 KSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 150 ~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
++||||+||++|+|++|+.||..
T Consensus 199 ~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 199 TVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp THHHHHHHHHHHHHHHSSCSSCC
T ss_pred cchhhcchHHHHHHHHCcCCCCC
Confidence 99999999999999999999955
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=269.21 Aligned_cols=169 Identities=18% Similarity=0.169 Sum_probs=133.7
Q ss_pred Cccccccc-ccccHHHHHHHHHHHHhcCCCcccceeeeeee--------CCcceEEEEecCCCCHHHhhcCCCc----hH
Q 044022 1 MKFYGHEY-HRHTYGSCINNITYAAQMSHNHILKRIGCCLQ--------TPIPILVFQSVEYGTLRDCIFGAPL----PR 67 (241)
Q Consensus 1 iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~~----~~ 67 (241)
||++..+. ......++.+|+++|++++||||+++++++.. .+..|+||||+.++.+......... ..
T Consensus 40 vK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~ 119 (318)
T d3blha1 40 LKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 119 (318)
T ss_dssp EEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHH
T ss_pred EEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHH
Confidence 46554332 33566789999999999999999999999865 3468999999987766655443321 45
Q ss_pred HHHHHHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCc--ceeecccccCCCccCccccccc
Q 044022 68 LKIASDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGET--HITTDRVIGTRGYSAPEYISIC 145 (241)
Q Consensus 68 ~~~~~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~ 145 (241)
..++.|++.||.||| +++|+||||||+|||++.++.+|++|||++........ ........||+.|+|||++.+.
T Consensus 120 ~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 196 (318)
T d3blha1 120 KRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE 196 (318)
T ss_dssp HHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCC
Confidence 678999999999999 99999999999999999999999999999976553221 1222345689999999998765
Q ss_pred -CCCcchhhHHHHHHHHHHHhcCccccc
Q 044022 146 -VLNEKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 146 -~~~~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
.+++++||||+||++|+|++|+.||..
T Consensus 197 ~~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 197 RDYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp SSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 688999999999999999999999954
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-41 Score=269.65 Aligned_cols=205 Identities=19% Similarity=0.158 Sum_probs=159.9
Q ss_pred ccHHHHHHHHHHHHhcCC-CcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHHHHhchhhcCC
Q 044022 11 HTYGSCINNITYAAQMSH-NHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIVNSLAYLHFGF 85 (241)
Q Consensus 11 ~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~~~l~~lh~~~ 85 (241)
...+.+.+|++++++++| |||+++++++......++++||+.+|+|.+++..... ....++.|++.||.|||
T Consensus 70 ~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH--- 146 (322)
T d1vzoa_ 70 KTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH--- 146 (322)
T ss_dssp SSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred HHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhh---
Confidence 456778899999999977 8999999999999999999999999999999865432 46678999999999999
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc--CCCcchhhHHHHHHHHHH
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC--VLNEKSNVFSFGAFLFEL 163 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~s~G~~~~~~ 163 (241)
+++++||||||+|||++.++.++|+|||.+.......... .....|++.|+|||.+.+. .++.++|||||||++|+|
T Consensus 147 ~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyel 225 (322)
T d1vzoa_ 147 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 225 (322)
T ss_dssp HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHH
T ss_pred cCCEEeccCCccceeecCCCCEEEeeccchhhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHH
Confidence 8999999999999999999999999999998765433222 2345789999999999754 467899999999999999
Q ss_pred HhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCCC
Q 044022 164 LAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPTM 239 (241)
Q Consensus 164 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt~ 239 (241)
++|+.||...... .............. . .... ..++.+.+|+.+||+.||++|||+
T Consensus 226 ltG~~PF~~~~~~-----~~~~~i~~~~~~~~-~------~~~~--------~~s~~~~~li~~~l~~dP~~R~s~ 281 (322)
T d1vzoa_ 226 LTGASPFTVDGEK-----NSQAEISRRILKSE-P------PYPQ--------EMSALAKDLIQRLLMKDPKKRLGC 281 (322)
T ss_dssp HHSSCTTSCTTSC-----CCHHHHHHHHHHCC-C------CCCT--------TSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred HhCCCCCCCCCHH-----HHHHHHHHhcccCC-C------CCcc--------cCCHHHHHHHHHHcccCHHHcCCC
Confidence 9999999653211 11112222111111 0 1111 123678999999999999999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-40 Score=267.95 Aligned_cols=220 Identities=13% Similarity=0.163 Sum_probs=159.4
Q ss_pred cHHHHHHHHHHHHhcC-CCcccceeeeeee--CCcceEEEEecCCCCHHHhhcCCCc-hHHHHHHHHHHHhchhhcCCCC
Q 044022 12 TYGSCINNITYAAQMS-HNHILKRIGCCLQ--TPIPILVFQSVEYGTLRDCIFGAPL-PRLKIASDIVNSLAYLHFGFPR 87 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~~l~~lh~~~~~ 87 (241)
..+++.+|+++|++++ ||||++++++|.. ....++||||+.+++|....+.... ....++.||+.||.||| ++
T Consensus 72 ~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH---~~ 148 (328)
T d3bqca1 72 KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SM 148 (328)
T ss_dssp CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHh---hc
Confidence 4678899999999995 9999999999974 3568999999999999887765443 56789999999999999 99
Q ss_pred CceeccCCCCCeeecCCC-CeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcchhhHHHHHHHHHHHh
Q 044022 88 PIVLRNFKTQNILFNEEN-VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEKSNVFSFGAFLFELLA 165 (241)
Q Consensus 88 ~ivh~dl~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~~~~~~~ 165 (241)
+|+||||||+|||++.++ .++|+|||.+........ .....+|+.|+|||.+.+. .++.++||||+|+++|++++
T Consensus 149 gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~ 225 (328)
T d3bqca1 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 225 (328)
T ss_dssp TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccccccccceEEcCCCCeeeecccccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhcc
Confidence 999999999999998765 589999999987654432 2345689999999998765 47899999999999999999
Q ss_pred cCcccccccccCCCcccchHHHH--------HHHhhhccc------C----CCCCCccccCCCchhHHHHHHHHHHHHHH
Q 044022 166 GRIHIWDLLKDTHDHGCFFNEYL--------KNYLEDKRF------T----GIPAPIIVQDIPCIEKEQQLHASAQLTLE 227 (241)
Q Consensus 166 g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~------~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 227 (241)
|+.||....... ....... ......... . ...........+.......++++.+|+.+
T Consensus 226 g~~pf~~~~~~~----~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~ 301 (328)
T d3bqca1 226 RKEPFFHGHDNY----DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301 (328)
T ss_dssp TCSSSSCCSSHH----HHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHH
T ss_pred CCCCCCCCchhH----HHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHH
Confidence 999996522110 0000000 000000000 0 00001111111111112334678999999
Q ss_pred hccCCCCCCCCCCC
Q 044022 228 CVNNSPEDRPTMVD 241 (241)
Q Consensus 228 cl~~~p~~Rpt~~e 241 (241)
||..||++|||++|
T Consensus 302 mL~~dP~~R~ta~e 315 (328)
T d3bqca1 302 LLRYDHQSRLTARE 315 (328)
T ss_dssp HSCSSGGGSCCHHH
T ss_pred HccCChhHCcCHHH
Confidence 99999999999864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-40 Score=262.61 Aligned_cols=228 Identities=14% Similarity=0.135 Sum_probs=166.3
Q ss_pred Cccccccc-ccccHHHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCc----hHHHHHHHHH
Q 044022 1 MKFYGHEY-HRHTYGSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPL----PRLKIASDIV 75 (241)
Q Consensus 1 iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~i~ 75 (241)
||++..+. ......++.+|+.++++++||||+++++++......+++++++.+++|..++..... .+..++.|++
T Consensus 32 vK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~ 111 (292)
T d1unla_ 32 LKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLL 111 (292)
T ss_dssp EEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHH
T ss_pred EEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHH
Confidence 46664333 334578899999999999999999999999999999999999999998888765532 4678999999
Q ss_pred HHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccC-CCcchhhH
Q 044022 76 NSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV-LNEKSNVF 154 (241)
Q Consensus 76 ~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~ 154 (241)
.||+||| +++|+||||||+|||++.++.+||+|||.+.......... ....++..|+|||.+.... ++.++|||
T Consensus 112 ~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~~Diw 186 (292)
T d1unla_ 112 KGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMW 186 (292)
T ss_dssp HHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHH
T ss_pred HHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCccc--eeeccccchhhhhHhccCCCCCchhhcc
Confidence 9999999 8999999999999999999999999999998765443222 2345678899999887664 68999999
Q ss_pred HHHHHHHHHHhcCcccccccccCCCcccchHHHHHHHh---hhcc---------cCCCC-CCccc-cCCCchhHHHHHHH
Q 044022 155 SFGAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYL---EDKR---------FTGIP-APIIV-QDIPCIEKEQQLHA 220 (241)
Q Consensus 155 s~G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~---------~~~~~-~~~~~-~~~~~~~~~~~~~~ 220 (241)
|+||++|+|++|+.||..... ..+...... .... ..... .+... ...........++.
T Consensus 187 SlG~il~ell~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 258 (292)
T d1unla_ 187 SAGCIFAELANAGRPLFPGND--------VDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNAT 258 (292)
T ss_dssp HHHHHHHHHTTTSCCSCCCSS--------HHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHH
T ss_pred ccchHHHHHhhCCCCCCCCCC--------HHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHH
Confidence 999999999999999854211 111111111 0000 00000 00000 00000001123357
Q ss_pred HHHHHHHhccCCCCCCCCCCC
Q 044022 221 SAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 221 ~~~l~~~cl~~~p~~Rpt~~e 241 (241)
+.+|+.+||+.||++||||+|
T Consensus 259 ~~dll~~mL~~dP~~R~sa~e 279 (292)
T d1unla_ 259 GRDLLQNLLKCNPVQRISAEE 279 (292)
T ss_dssp HHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHccCChhHCcCHHH
Confidence 889999999999999999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-40 Score=270.24 Aligned_cols=235 Identities=16% Similarity=0.200 Sum_probs=158.1
Q ss_pred Ccccccccc-cccHHHHHHHHHHHHhcCCCcccceeeeeeeC------CcceEEEEecCCCCHHHhhcCCCc-hHHHHHH
Q 044022 1 MKFYGHEYH-RHTYGSCINNITYAAQMSHNHILKRIGCCLQT------PIPILVFQSVEYGTLRDCIFGAPL-PRLKIAS 72 (241)
Q Consensus 1 iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~ 72 (241)
||++..+.. .....++.+|+.++++++|||||+++++|... ++.|+||||+.++.+.......+. ....++.
T Consensus 47 vK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~ 126 (355)
T d2b1pa1 47 IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 126 (355)
T ss_dssp EEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHH
T ss_pred EEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhhcCCCHHHHHHHHH
Confidence 466654443 34456789999999999999999999999643 578999999976555544433332 5678999
Q ss_pred HHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCcccccccCCCcchh
Q 044022 73 DIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICVLNEKSN 152 (241)
Q Consensus 73 ~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 152 (241)
|++.||.||| +++|+||||||+|||++.++.++++|||.+........ .....+|+.|+|||++.+..+++++|
T Consensus 127 qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~D 200 (355)
T d2b1pa1 127 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVD 200 (355)
T ss_dssp HHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHH
T ss_pred HHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhccccccc---cccccccccccChhhhcCCCCCCCcc
Confidence 9999999999 89999999999999999999999999998876544322 23457899999999999999999999
Q ss_pred hHHHHHHHHHHHhcCcccccccccCC-------------CcccchHHHHHHHhhh-cccCCCCCCcc----ccCCCchhH
Q 044022 153 VFSFGAFLFELLAGRIHIWDLLKDTH-------------DHGCFFNEYLKNYLED-KRFTGIPAPII----VQDIPCIEK 214 (241)
Q Consensus 153 i~s~G~~~~~~~~g~~p~~~~~~~~~-------------~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~ 214 (241)
|||+||++|+|++|+.||........ ................ ........+.. .........
T Consensus 201 iwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (355)
T d2b1pa1 201 IWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 280 (355)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHH
T ss_pred cccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccccccccccccccccccccc
Confidence 99999999999999999954210000 0000000000111111 11111110000 011112233
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 044022 215 EQQLHASAQLTLECVNNSPEDRPTMVD 241 (241)
Q Consensus 215 ~~~~~~~~~l~~~cl~~~p~~Rpt~~e 241 (241)
...+..+.+|+++||..||++||||+|
T Consensus 281 ~~~s~~~~dll~~mL~~dP~~R~ta~e 307 (355)
T d2b1pa1 281 KLKASQARDLLSKMLVIDPAKRISVDD 307 (355)
T ss_dssp HHHHHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred ccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 456778999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-40 Score=269.17 Aligned_cols=210 Identities=22% Similarity=0.213 Sum_probs=148.4
Q ss_pred HHHHHHHHhcCCCcccceeeeeeeC------CcceEEEEecCCCCHHHhh---cCC-Cc---hHHHHHHHHHHHhchhhc
Q 044022 17 INNITYAAQMSHNHILKRIGCCLQT------PIPILVFQSVEYGTLRDCI---FGA-PL---PRLKIASDIVNSLAYLHF 83 (241)
Q Consensus 17 ~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l---~~~-~~---~~~~~~~~i~~~l~~lh~ 83 (241)
.+|+++|++++||||++++++|... .+.++|||||+++.+.... ... .. .+..++.||+.||.|||
T Consensus 61 ~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH- 139 (350)
T d1q5ka_ 61 NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 139 (350)
T ss_dssp CHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred HHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 4799999999999999999998643 2478999999865433332 222 12 46789999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCC-CeEEeeccCceecCCCCcceeecccccCCCccCcccccc-cCCCcchhhHHHHHHHH
Q 044022 84 GFPRPIVLRNFKTQNILFNEEN-VAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISI-CVLNEKSNVFSFGAFLF 161 (241)
Q Consensus 84 ~~~~~ivh~dl~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~~~ 161 (241)
+++|+||||||+|||++.++ .+||+|||++......... ....|++.|+|||.+.+ ..++.++||||+||++|
T Consensus 140 --~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~ 214 (350)
T d1q5ka_ 140 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214 (350)
T ss_dssp --TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred --hcCCcccCCCcceEEEecCCCceeEecccchhhccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEE
Confidence 99999999999999999875 8999999999876544322 33578999999998865 46899999999999999
Q ss_pred HHHhcCcccccccccCCCcccchHHHH-----------HHHhhh---cccCCCCCCccccCCCchhHHHHHHHHHHHHHH
Q 044022 162 ELLAGRIHIWDLLKDTHDHGCFFNEYL-----------KNYLED---KRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLE 227 (241)
Q Consensus 162 ~~~~g~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 227 (241)
||++|+.||...... ....... ...... ..+.......+.... ....++++.+|+.+
T Consensus 215 el~~g~~pf~~~~~~-----~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~s~~~~dLl~~ 285 (350)
T d1q5ka_ 215 ELLLGQPIFPGDSGV-----DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVF----RPRTPPEAIALCSR 285 (350)
T ss_dssp HHHHTSCSSCCSSHH-----HHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTS----CTTSCHHHHHHHHH
T ss_pred ehhhCCCCCCCCCHH-----HHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhc----ccCCCHHHHHHHHH
Confidence 999999999542111 0111110 110000 000111100000000 01223578899999
Q ss_pred hccCCCCCCCCCCC
Q 044022 228 CVNNSPEDRPTMVD 241 (241)
Q Consensus 228 cl~~~p~~Rpt~~e 241 (241)
||..||++||||+|
T Consensus 286 mL~~dP~~R~ta~e 299 (350)
T d1q5ka_ 286 LLEYTPTARLTPLE 299 (350)
T ss_dssp HSCSSGGGSCCHHH
T ss_pred HccCChhHCcCHHH
Confidence 99999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-39 Score=257.44 Aligned_cols=208 Identities=16% Similarity=0.189 Sum_probs=150.3
Q ss_pred HHHHHHHHHHHHhcCCCcccc-eeeeeeeCCcceEEEEecCCCCHHHhhcCCC-----chHHHHHHHHHHHhchhhcCCC
Q 044022 13 YGSCINNITYAAQMSHNHILK-RIGCCLQTPIPILVFQSVEYGTLRDCIFGAP-----LPRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~lh~~~~ 86 (241)
.+++.+|++++++++|+|++. +.+++...+..++||||+. ++|.+.+.... .....++.|++.||.||| +
T Consensus 46 ~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~ 121 (299)
T d1ckia_ 46 HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---S 121 (299)
T ss_dssp SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---H
Confidence 346889999999998776555 4556667788899999995 67766654321 157789999999999999 8
Q ss_pred CCceeccCCCCCeeecC---CCCeEEeeccCceecCCCCcc-----eeecccccCCCccCcccccccCCCcchhhHHHHH
Q 044022 87 RPIVLRNFKTQNILFNE---ENVAKWFDFLLSISIPEGETH-----ITTDRVIGTRGYSAPEYISICVLNEKSNVFSFGA 158 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~---~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~ 158 (241)
++|+||||||+|||++. +..++++|||+++........ .......||+.|+|||.+.+..++.++||||||+
T Consensus 122 ~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 201 (299)
T d1ckia_ 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGY 201 (299)
T ss_dssp TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHH
T ss_pred CCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCH
Confidence 99999999999999753 557999999999876543221 1234557999999999999999999999999999
Q ss_pred HHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCCCC
Q 044022 159 FLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDRPT 238 (241)
Q Consensus 159 ~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rpt 238 (241)
++|||++|+.||.......... ........... .+.+.... ..++.+.+++..||+.||++||+
T Consensus 202 ~l~el~tg~~P~~~~~~~~~~~--~~~~~~~~~~~------~~~~~~~~--------~~p~~~~~li~~cl~~~p~~RP~ 265 (299)
T d1ckia_ 202 VLMYFNLGSLPWQGLKAATKRQ--KYERISEKKMS------TPIEVLCK--------GYPSEFATYLNFCRSLRFDDKPD 265 (299)
T ss_dssp HHHHHHHSSCTTCCCC---------HHHHHHHHHH------SCHHHHTT--------TSCHHHHHHHHHHHHSCTTCCCC
T ss_pred HHHHHHhCCCcccccchHHHHH--HHHHhhcccCC------CChhHhcc--------CCCHHHHHHHHHHccCChhHCcC
Confidence 9999999999996532221100 00000000000 00111111 12257899999999999999998
Q ss_pred CC
Q 044022 239 MV 240 (241)
Q Consensus 239 ~~ 240 (241)
++
T Consensus 266 ~~ 267 (299)
T d1ckia_ 266 YS 267 (299)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=264.38 Aligned_cols=164 Identities=20% Similarity=0.291 Sum_probs=131.7
Q ss_pred Cccccccccc-ccHHHHHHHHHHHHhcCCCcccceeeeeeeC-----CcceEEEEecCCCCHHHhhcCCCc---hHHHHH
Q 044022 1 MKFYGHEYHR-HTYGSCINNITYAAQMSHNHILKRIGCCLQT-----PIPILVFQSVEYGTLRDCIFGAPL---PRLKIA 71 (241)
Q Consensus 1 iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~ 71 (241)
||++...... ...+++.+|+++|++++|||+|++++++... ...+++++++.+|+|.+++..... ....++
T Consensus 48 iK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~ 127 (348)
T d2gfsa1 48 VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 127 (348)
T ss_dssp EEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHH
T ss_pred EEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccccccHHHHHHHH
Confidence 4666544322 3456789999999999999999999998643 234666777889999999976544 467889
Q ss_pred HHHHHHhchhhcCCCCCceeccCCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccCccccccc-CCCcc
Q 044022 72 SDIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISIC-VLNEK 150 (241)
Q Consensus 72 ~~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~ 150 (241)
.||+.||.||| +++|+||||||+|||++.++.++++|||.+...... .....|++.|+|||...+. .++.+
T Consensus 128 ~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~ 199 (348)
T d2gfsa1 128 YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQT 199 (348)
T ss_dssp HHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTT
T ss_pred HHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcccCcc-----cccccccccccCchhhcCCccCCcc
Confidence 99999999999 899999999999999999999999999998654332 1335688899999987765 46889
Q ss_pred hhhHHHHHHHHHHHhcCccccc
Q 044022 151 SNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 151 ~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
+||||+||++|+|++|+.||..
T Consensus 200 ~DiwSlGv~l~~ll~g~~pF~~ 221 (348)
T d2gfsa1 200 VDIWSVGCIMAELLTGRTLFPG 221 (348)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCC
T ss_pred cchhhhhHHHHHHHhCCCCCCC
Confidence 9999999999999999999954
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.9e-38 Score=252.87 Aligned_cols=207 Identities=14% Similarity=0.095 Sum_probs=156.4
Q ss_pred HHHHHHHHHHHHhcCC-CcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCC--c---hHHHHHHHHHHHhchhhcCCC
Q 044022 13 YGSCINNITYAAQMSH-NHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAP--L---PRLKIASDIVNSLAYLHFGFP 86 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~---~~~~~~~~i~~~l~~lh~~~~ 86 (241)
.+++.+|+++++.|+| +|++.+++++......++||||+ +++|.+++.... . ....++.|++.||.||| +
T Consensus 44 ~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~ 119 (293)
T d1csna_ 44 APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---E 119 (293)
T ss_dssp SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---T
T ss_pred cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---H
Confidence 4567889999999966 89999999999999999999999 689999875432 1 46789999999999999 9
Q ss_pred CCceeccCCCCCeeecC-----CCCeEEeeccCceecCCCCcc-----eeecccccCCCccCcccccccCCCcchhhHHH
Q 044022 87 RPIVLRNFKTQNILFNE-----ENVAKWFDFLLSISIPEGETH-----ITTDRVIGTRGYSAPEYISICVLNEKSNVFSF 156 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~-----~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~ 156 (241)
++|+||||||+|||++. .+.++|+|||+++........ .......||+.|+|||.+.+..++.++|||||
T Consensus 120 ~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSl 199 (293)
T d1csna_ 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEAL 199 (293)
T ss_dssp TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred CCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHh
Confidence 99999999999999974 578999999999875432211 12234579999999999999999999999999
Q ss_pred HHHHHHHHhcCcccccccccCCCcccchHHHHHHHhhhcccCCCCCCccccCCCchhHHHHHHHHHHHHHHhccCCCCCC
Q 044022 157 GAFLFELLAGRIHIWDLLKDTHDHGCFFNEYLKNYLEDKRFTGIPAPIIVQDIPCIEKEQQLHASAQLTLECVNNSPEDR 236 (241)
Q Consensus 157 G~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 236 (241)
|+++|+|++|+.||....... .............. .+.+.+.... ++++.+++..||..+|++|
T Consensus 200 G~~l~elltg~~Pf~~~~~~~------~~~~~~~i~~~~~~--~~~~~l~~~~--------p~~l~~ii~~~~~~~~~~r 263 (293)
T d1csna_ 200 GHVFMYFLRGSLPWQGLKAAT------NKQKYERIGEKKQS--TPLRELCAGF--------PEEFYKYMHYARNLAFDAT 263 (293)
T ss_dssp HHHHHHHHHSSCTTSSCCSCC------HHHHHHHHHHHHHH--SCHHHHTTTS--------CHHHHHHHHHHHHCCTTCC
T ss_pred hHHHHHHHhCCCcCCCccchh------HHHHHHHHHhccCC--CChHHhcCCC--------CHHHHHHHHHHhcCCcccC
Confidence 999999999999996421111 11111111100000 0011111222 2578899999999999999
Q ss_pred CCC
Q 044022 237 PTM 239 (241)
Q Consensus 237 pt~ 239 (241)
|+.
T Consensus 264 P~y 266 (293)
T d1csna_ 264 PDY 266 (293)
T ss_dssp CCH
T ss_pred cCH
Confidence 974
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.98 E-value=3.2e-33 Score=228.81 Aligned_cols=153 Identities=21% Similarity=0.223 Sum_probs=118.2
Q ss_pred HHHHHHHHHHHHhcC-----------CCcccceeeeeeeC--CcceEEEEecCCC-CHHHhhcCC---C---chHHHHHH
Q 044022 13 YGSCINNITYAAQMS-----------HNHILKRIGCCLQT--PIPILVFQSVEYG-TLRDCIFGA---P---LPRLKIAS 72 (241)
Q Consensus 13 ~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~~--~~~~lv~e~~~~~-sL~~~l~~~---~---~~~~~~~~ 72 (241)
.+.+.+|+++++.++ |+||+++++++... ...+++++++..+ ......... . .....++.
T Consensus 53 ~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~ 132 (362)
T d1q8ya_ 53 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132 (362)
T ss_dssp HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHH
Confidence 467788999998885 47899999988653 3455666665433 332222211 1 13567899
Q ss_pred HHHHHhchhhcCCCCCceeccCCCCCeeecCCCC------eEEeeccCceecCCCCcceeecccccCCCccCcccccccC
Q 044022 73 DIVNSLAYLHFGFPRPIVLRNFKTQNILFNEENV------AKWFDFLLSISIPEGETHITTDRVIGTRGYSAPEYISICV 146 (241)
Q Consensus 73 ~i~~~l~~lh~~~~~~ivh~dl~~~nil~~~~~~------~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 146 (241)
|++.|+.|||+ ..+|+||||||+|||++.++. ++++|||.+....... ....||+.|+|||++....
T Consensus 133 qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~ 205 (362)
T d1q8ya_ 133 QLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAP 205 (362)
T ss_dssp HHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCC
T ss_pred HHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccceeeEeeccccccccccc-----ccccccccccChhhccccC
Confidence 99999999993 389999999999999987653 8999999987654332 3457899999999999999
Q ss_pred CCcchhhHHHHHHHHHHHhcCccccc
Q 044022 147 LNEKSNVFSFGAFLFELLAGRIHIWD 172 (241)
Q Consensus 147 ~~~~~Di~s~G~~~~~~~~g~~p~~~ 172 (241)
++.++||||+|+++++|++|+.||..
T Consensus 206 ~~~~~DiwSlG~il~el~~g~~pF~~ 231 (362)
T d1q8ya_ 206 WGCGADIWSTACLIFELITGDFLFEP 231 (362)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CCccccccchHHHHHHHHHCCCCCCC
Confidence 99999999999999999999999964
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.68 E-value=2.6e-17 Score=121.87 Aligned_cols=123 Identities=15% Similarity=0.070 Sum_probs=90.1
Q ss_pred HHHHHHHHHHHhcCCCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhhcCCCCCceecc
Q 044022 14 GSCINNITYAAQMSHNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHFGFPRPIVLRN 93 (241)
Q Consensus 14 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~~~~~~ivh~d 93 (241)
..+.+|...+.++.|.+++..+++. ..+++|||++++.+.++. ......++.+++.++.||| +++++|||
T Consensus 59 ~~~~~e~~~l~~l~~~~v~~~~~~~----~~~lvme~~~~~~~~~l~---~~~~~~i~~ql~~~l~~lH---~~giiHrD 128 (191)
T d1zara2 59 RSARNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELYRVR---VENPDEVLDMILEEVAKFY---HRGIVHGD 128 (191)
T ss_dssp HHHHHHHHHHHHTTTSSSCCEEEEE----TTEEEEECCCCEEGGGCC---CSCHHHHHHHHHHHHHHHH---HTTEECSC
T ss_pred HHHHHHHHHHHHccCCCcceEEEec----CCEEEEEeeccccccchh---hHHHHHHHHHHHHHHHHHh---hCCEEEcc
Confidence 3456789999999999998887653 248999999876654421 2345678999999999999 89999999
Q ss_pred CCCCCeeecCCCCeEEeeccCceecCCCCcceeecccccCCCccC------cccccccCCCcchhhHHHHH
Q 044022 94 FKTQNILFNEENVAKWFDFLLSISIPEGETHITTDRVIGTRGYSA------PEYISICVLNEKSNVFSFGA 158 (241)
Q Consensus 94 l~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~a------PE~~~~~~~~~~~Di~s~G~ 158 (241)
|||+|||++.+ .++++|||.++........ .|+. .+. ....++.++|+||..-
T Consensus 129 iKP~NILv~~~-~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 129 LSQYNVLVSEE-GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAID 187 (191)
T ss_dssp CSTTSEEEETT-EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHH
T ss_pred CChhheeeeCC-CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHH
Confidence 99999999965 4889999999765433210 0111 011 1246788899999753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.07 E-value=8.7e-06 Score=61.41 Aligned_cols=104 Identities=11% Similarity=-0.017 Sum_probs=68.3
Q ss_pred cHHHHHHHHHHHHhcC-CCcccceeeeeeeCCcceEEEEecCCCCHHHhhcCCCchHHHHHHHHHHHhchhhc-------
Q 044022 12 TYGSCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTLRDCIFGAPLPRLKIASDIVNSLAYLHF------- 83 (241)
Q Consensus 12 ~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~lh~------- 83 (241)
....+.+|...+..+. +--+.+++.+...++..++||++++|.++........ ....++.++...++.||.
T Consensus 52 ~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~~-~~~~~~~~l~~~l~~lH~~~~~~~~ 130 (263)
T d1j7la_ 52 TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQ-SPEKIIELYAECIRLFHSIDISDCP 130 (263)
T ss_dssp STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTCS-CHHHHHHHHHHHHHHHHTSCCTTCS
T ss_pred chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccccc-cHHHHHHHHHHHHHHHhccCccccc
Confidence 3445778999988884 3335677888888888999999999888765443221 111222222222333321
Q ss_pred -------------------------------------------------CCCCCceeccCCCCCeeecCCCCeEEeeccC
Q 044022 84 -------------------------------------------------GFPRPIVLRNFKTQNILFNEENVAKWFDFLL 114 (241)
Q Consensus 84 -------------------------------------------------~~~~~ivh~dl~~~nil~~~~~~~~l~df~~ 114 (241)
.....++|+|+.+.||+++.++.+.|+||+.
T Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~ 210 (263)
T d1j7la_ 131 YTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGR 210 (263)
T ss_dssp CBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTT
T ss_pred cCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechh
Confidence 0012378999999999999877777999987
Q ss_pred ce
Q 044022 115 SI 116 (241)
Q Consensus 115 ~~ 116 (241)
+.
T Consensus 211 a~ 212 (263)
T d1j7la_ 211 SG 212 (263)
T ss_dssp CE
T ss_pred cc
Confidence 74
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.66 E-value=5e-05 Score=56.75 Aligned_cols=44 Identities=7% Similarity=-0.013 Sum_probs=32.7
Q ss_pred HHHHHHHHHHHhcCCC--cccceeeeeeeCCcceEEEEecCCCCHH
Q 044022 14 GSCINNITYAAQMSHN--HILKRIGCCLQTPIPILVFQSVEYGTLR 57 (241)
Q Consensus 14 ~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~~sL~ 57 (241)
..+..|+..++.|... .+.+++.+....+..++||++++|.++.
T Consensus 49 ~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 49 NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 3567888888888432 3456788877778889999999876653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.28 E-value=0.0023 Score=50.80 Aligned_cols=30 Identities=17% Similarity=0.254 Sum_probs=25.6
Q ss_pred CCceeccCCCCCeeecCCCCeEEeeccCcee
Q 044022 87 RPIVLRNFKTQNILFNEENVAKWFDFLLSIS 117 (241)
Q Consensus 87 ~~ivh~dl~~~nil~~~~~~~~l~df~~~~~ 117 (241)
..++|+|+.+.|||++.+. ++|+||..+..
T Consensus 223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp CEEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred cceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 4589999999999998764 89999988754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.62 E-value=0.011 Score=46.61 Aligned_cols=39 Identities=10% Similarity=-0.076 Sum_probs=27.0
Q ss_pred HHHHHHHHHHHhcC-CCcccceeeeeeeCCcceEEEEecCCCCH
Q 044022 14 GSCINNITYAAQMS-HNHILKRIGCCLQTPIPILVFQSVEYGTL 56 (241)
Q Consensus 14 ~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 56 (241)
-...+|..+++.+. +.-..++++++. -.+|+||++|.+|
T Consensus 89 idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~efi~g~~l 128 (395)
T d1nw1a_ 89 SHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEEYIPSRPL 128 (395)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEECCCCEEEC
T ss_pred hHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEEEeccccC
Confidence 34568999999884 433447777763 2689999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.08 E-value=0.0068 Score=46.26 Aligned_cols=33 Identities=15% Similarity=0.458 Sum_probs=28.7
Q ss_pred CCCCceeccCCCCCeeecCCCCeEEeeccCcee
Q 044022 85 FPRPIVLRNFKTQNILFNEENVAKWFDFLLSIS 117 (241)
Q Consensus 85 ~~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~ 117 (241)
...+++|+|+.+.|++++.+...-|.||+.+..
T Consensus 181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccccCCcchhhhhcccccceeEeccccccc
Confidence 367899999999999999888788999998753
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=85.50 E-value=0.14 Score=38.84 Aligned_cols=30 Identities=13% Similarity=0.140 Sum_probs=24.3
Q ss_pred CCCceeccCCCCCeeecCCCCeEEeeccCcee
Q 044022 86 PRPIVLRNFKTQNILFNEENVAKWFDFLLSIS 117 (241)
Q Consensus 86 ~~~ivh~dl~~~nil~~~~~~~~l~df~~~~~ 117 (241)
..+++|+|+.+.|||++.+ ..++||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 5678999999999999743 46899988754
|